<SEC-DOCUMENT>0001628280-22-012290.txt : 20220504
<SEC-HEADER>0001628280-22-012290.hdr.sgml : 20220504
<ACCEPTANCE-DATETIME>20220504161820
ACCESSION NUMBER:		0001628280-22-012290
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		99
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220504
DATE AS OF CHANGE:		20220504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHPEAK PROPERTIES, INC.
		CENTRAL INDEX KEY:			0000765880
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		IRS NUMBER:				330091377
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08895
		FILM NUMBER:		22891747

	BUSINESS ADDRESS:	
		STREET 1:		5050 SOUTH SYRACUSE STREET
		STREET 2:		SUITE 800
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237
		BUSINESS PHONE:		949-407-0700

	MAIL ADDRESS:	
		STREET 1:		5050 SOUTH SYRACUSE STREET
		STREET 2:		SUITE 800
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCP, INC.
		DATE OF NAME CHANGE:	20070911

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTH CARE PROPERTY INVESTORS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>peak-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:18e02b9c-9339-4812-a396-3a502b171f3f,g:40f6f78a-d855-4bed-acda-5b3ebe369ddb,d:fa3dff468a15495db7b57c65ada0de74--><html xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:peak="http://www.healthpeak.com/20220331" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>peak-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N180LTEtMS0xLTEwNzg0Mg_09e0069c-c406-4d5a-b8b1-df681b1490aa">0000765880</ix:nonNumeric><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N181LTEtMS0xLTEwNzg0Mg_e986d5eb-139d-4a61-847d-11e10aa89d4a">false</ix:nonNumeric><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N182LTEtMS0xLTEwNzg0Mg_bf90db84-e66c-43de-83bf-89a07ca99ebb">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N183LTEtMS0xLTEwNzg0Mg_76c962ea-c30f-4168-9a4f-85fd79dd9da1">2022</ix:nonNumeric><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N184LTEtMS0xLTEwNzg0Mg_6c8e0925-ddcb-45de-afe3-2879f20e6411">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i8b45554983da4b40ab820d2cfc003ede_D20210101-20210331" name="peak:LoansReceivableInterestIncomeAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjYyOQ_aeb0d2ee-ccfb-4404-9b1a-c227b91e018e">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ibbcca059325e491ba0a93b64940f5ac3_D20220101-20220331" name="peak:OptionIndexedToIssuersEquityTerm" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTUzNQ_ad0445ae-2c5c-4d27-bf22-90d9ea20d009">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="peak-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82972ffaa0e486c8bf672e801389907_I20220502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i409ce78c858444d7a5dc1f973872f5b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i046e7a1a5f114e488bef10441f3f6b44_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i586d3ac1554b476b944978cf331446d1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27033f4128f14d61b570ee8fcfab4e19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcae3dea640a4b138a3f5795930bae95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf9ac731c8274ea6971c722ec208c696_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadd3477c47624974b897f92075a001c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i490f82b12d324a9c8138193ebcd5d1eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0bd8d0bfcbb44ad83c3862162bfa1c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67bf69a97b654c869301d6f090e62d57_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7404d45d41b64f609165eec044f08108_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb077a5f2244709819741b6cb0a3fa1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a7abe9391e6448ab7157b0bae0f272a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31c94325aaf34e408bb6acbdc569a1d7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367dd265e817411fae092d30372080c9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25b091a3184e4f5abf94f94d420796af_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24059380f4a4805a400b695962dbef6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98fdb8b9ba7546b3863ac5453d1d4595_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a20cc136a864b339ac00237669b9e4d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40a69eb101874a248f36e295dd95e2e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3663f069068045e992c69e3d404cae29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i872f9cc9bb7a47469e26e6f7e4849029_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19827d84f1614a0f8ad378b5470e253a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i797de15cd85c409c81c2fbde05db3a05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45b145e89da940f2b434e5038adee396_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ec0bcc69b44db7857a079e35c591cb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ce63109a747419ba702c25c06711c30_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15fe27c8a01a4beba1b7b922c1d0d182_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id42af16b8b5e46a3a93869820b193ece_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i947f359177e141dea98189810a16d2ce_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cc4bf949eda46e39539b8c05d956da6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41427d8508e34a328dd1abb7637f8a9c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64cd9f22bc634046912f6b976230977c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dcdd74b90db4a33a4202492ae24fe31_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9033e3f616764988932a09935d4445c5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5e2b4520099480cbcf7ae7a10b2633a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i366e3a8a7bb7447e9f752c396f34ef65_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3460b3e5b484c59b4ecbe639bdd4209_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedb4d8499ffb4004a3ee3195b72c71f9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:EquityIncomeLossFromUnconsolidatedJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i511cc9d57cc6454fbd2d5002ffde7b46_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:EquityIncomeLossFromUnconsolidatedJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5729311f850434baae5aecac89476bc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:IncomeLossFromDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6df88f30ff64438db2f6496ddd4694e7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:IncomeLossFromDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65f4e28b0f2b4c9ca073348ac7c5830f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib71827eba90f4c7dbd49266ebef243d8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68709d337a004bc49691880a5dff69f4_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd171034fe8747f7ab9643d2e6c8c934_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icabe4000b649414fba14f6ec77194207_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="property"><xbrli:measure>peak:property</xbrli:measure></xbrli:unit><xbrli:context id="id9cece3770b941ee9ae47c83081b1562_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id834faa0894c48b5b6ca7b84f1e97b10_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i157e2f27fbc8439583042a14aba3a3dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="acre"><xbrli:measure>utr:acre</xbrli:measure></xbrli:unit><xbrli:context id="id35ffdd058d5452aadfbd3058f25fe8d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0be770442a38456fa45fe909e5cf2209_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e70b2253cef459da26681df951e5714_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CO</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ae39df20f8a4003aa9f5bfc1350f2aa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a7d366dcb654ae3b1142ce1b04f07d8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3b94e67a8b43879bb61dbed6563aad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee85843b4241478fb2cc9b09850dd27d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0280b9f0a7bb49eb921ea3165bf8ee37_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e7dd1a3a6c46e1a92bd28eaa72af76_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18626c3b380148e1b0b293d23816dd72_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i946443381ff64eda82972caa7e61e937_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i498d7f8735954a6a9c9a9011ebbd9301_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6ddf70e2d074a11bf07c122fa0aa5eb_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib528caa7e34e44bd8bac451c88b62afb_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc2008e7de824d76a511c1ea5919c432_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdbfd36f6f614b35837a5d8868840c17_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9fdf60d4d6e4a599a3fe3f066788531_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaf70b6c82e34b11838baffaa23b60f8_D20210101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a3a9720e7e46b9b6608a5904b366ed_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7009785976254cb889191c52cf0d0cc9_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:BrookdaleTripleNetPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67a66f0a44e14e8e838fb65d4719fd54_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:BrookdaleTripleNetPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb30aa09ba6c452ba2bd4375f636fc3e_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief256427dde0496199ca30fcac9d8101_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:HRATripleNetPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6f2032fd45a433f82115899c3e766a1_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:HRATripleNetPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50d682bf346742efab2a94c7b022bd65_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OakmontSHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8726d2fcca104d9daaa243b22c892577_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OakmontSHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264d0be7c9de45749d3923b0d2446af1_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec4ce4170ce44a9b249e996d2135bcd_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a5d586f9aa34c6682d5b91cef0c31bf_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OakmontSHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia02702389d0b4036880c2a075882418f_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OakmontSHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e3fe506d4b44da2867a8fa3226473f2_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6a24264ae7f46a8a0b0ce1820a0cdf5_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib18e864b0cc2475eaf0549bdbf87abc9_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43ed19b259424a54a9fd61eca57de24e_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84af0aa9f7c94d4f9151e3e70da8c7e8_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SonataSHOPPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf84ca8adc6410fb6b01b46e57f6e91_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SonataSHOPPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i768fb35ae40b42f3b26d76cbebeb41db_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SLCSHOPPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2086cf237ad7470ba8bb6e299b0cd6eb_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SLCSHOPPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="peak:DefinitiveAgreementsAxisAxis">peak:DefinitiveAgreementFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d32d33aa964419bdb8080458aa58da_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9125ba7c2f5d440aac5f4ef2ac64e4f2_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeHospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3210bc367c264249ac6e064f04637f2a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee73f2738d114cb592962cd2a4fa756e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OtherDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b287810f73a4306ad1cedb5a7ee7ac9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2cc7e487b09456dbf42b7ac9a403d3b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84e02dec09e34ee98740b651f1f10e6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f3f388a745246ca875dc4aaac6cfe06_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1d24420f1c64c1f9b059b4ead94f57e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a55cc9f4374e7b973af8776b4c27d8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OtherDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c32446c755a4541aa55ba32256a090f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OtherDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19869f9aece14496a725bc23236ab8e6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bcca4d42b524e539e9a37568b990d49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1569210fb45b498ca4ddd9523c7ddcb6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56ab9d8a9a964a9c9b0142d3248692e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a389db75eb34b51821f969f46a2eb96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdbce058783d4ada87cc4191afef5777_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">peak:PlannedMOBDemolitionTenantRelocationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4353c6ea944e2cb45a86e8adbf210f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icadee8ad9d5d4a2ca975702b7fe2f6ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5761108dca5e417ab51b1f7ea8aa2e7f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ae13c73e634e68b31c4c1cdc3d0d7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23d980d9806942e0886bf4d30eb148c5_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i11671c496b994973af5e617cd736d08c_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1830004bc9a241ae9fa37e55c2d28202_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb0da742c3d4dc2878b9efd7818fd4a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia143e4423ee545cb944c9846d1bf5a01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7fff5de172f473c9b163cd5408ad706_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i861ec35878514b2cb35e6fe1f899825f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id286ba246e874843bc8dd2638e1faa98_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia298127fc81840afbfc9f29801f74a20_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b45554983da4b40ab820d2cfc003ede_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e457939b7f044ffbc4f9cf2945b94a2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie000ff8c480e49299647b1b49c710ab5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621bef727d6848c28d61e1f5dc2a0688_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="loan"><xbrli:measure>peak:loan</xbrli:measure></xbrli:unit><xbrli:context id="i8c295f7730a9480c8ecfc74218b82db1_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e06e81b0ec74155af21cdd896273b28_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i166380b792354cd99bcdce4b5c2a3d09_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280e47a3f1d647aeab62193c0845ca90_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c7caa3dd3149cd8911377afa83f122_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">peak:LessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6feec1d68f9349e7b96730a474b98cb8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">peak:LessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf2f708bf5a04fec813c493611999629_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:PerformingFinancingReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcbf460e68524351a14b60f7eacaa6f5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WatchListFinancingReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i073b62edbe4947b19f177c3595862f7b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WorkoutFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic484d7102e0c4eef9210903e4b7f1b12_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id73b3e04664a4d5497e0071f0132de90_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:MezzanineAndOtherLoansReceivableSecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:PerformingFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5edfb64270943259dee0a2cf06286d7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:MezzanineAndOtherLoansReceivableSecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WatchListFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i942914a4982a4fdc89cfe3c58112514c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:MezzanineAndOtherLoansReceivableSecuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WorkoutFinancingReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i476aa803f3b64a469836296cb0eb44e5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:MezzanineAndOtherLoansReceivableSecuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if88696dec76a41df8c3d36e71898301f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2caaa14451f4014ab34991c3b703764_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib39f0035285a4bfdadaf994fa845b4ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab0213b6338d474f9ab83b686f5a8aa0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01aa0bf4bb3d4669ab75f73ab638333e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4031be1cfa14447aa6b18dfbcfa6bd9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1af0c53b18b84f96a9445d33fed35d6c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice9d09a0cad14197a0d42beb434939dc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i858204adffd348408864f031fa32c574_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1ff4f2b11c94a78a5487085851cb371_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5746a20e0c541cb933dd8d9e8a18868_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SHOPJVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb1c53a80cf48d598dd59b38828089e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SHOPJVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6dac57d2d904eef8d5d5c6d6d560074_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af131706f2b4efd81b014492e74780e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie86b016e31384892bfe412d346cd92f5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib12448d242784ab084c7178415e35eef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd1af5b0be84236928af4f3b5238de4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib71d278abee9484ea60f89ad5ed8f50f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0fbe38d9b8f4c8096a62a13c0be0319_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i294e35e4fa6e4b7792baf4fb2a50d9e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib42e8c61652142339c59c133c0ca0201_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab41d51161f44fa3b2a7d722d1819d54_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="joint_venture"><xbrli:measure>peak:joint_venture</xbrli:measure></xbrli:unit><xbrli:context id="ib7d01dc5f33147a4821ce0ce3545c5f8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIVLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52b2c707e2b1428383dc2029f13bab25_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SuburbanPropertiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2847866fa494fa48669203a8b822e0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68d2f2250a954a959c1ab9c1001f3093_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:DiscoveryNaplesJVAndDiscoverySarasotaJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfa7cca0e764481b533b63888796ec6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">peak:DiscoveryNaplesJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id980870ccca047b5ae04fde6a8171675_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">peak:DiscoverySarasotaJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i322ecd64c5b44877a6a721cafa77d63f_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i642916b599bc4bf2b4a0e961d45d5a42_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i924e6cd0c4bb4c52bd6d1353893473da_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbdf5f35645b45b3984b9e5e46fceaf8_I20190523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="renewal_option"><xbrli:measure>peak:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="iaf4af4c66c4c4e4ea53929a8d99bf97f_D20190523-20190523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-23</xbrli:startDate><xbrli:endDate>2019-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7a0463d43594517865ced9f143c46a6_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:A2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82327d2d8e1b4698b0346d5bd3a79cbb_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:A2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae4f18c121f648d5826bfbc035300a67_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9065798c00ee41ef899c69a43f5251b6_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86a95c3d76e44658a7495876f84394fb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0667f584e1224d759496144ff96ccd4c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3aa132c8f884c44b097e6de1abfbc0d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc24c31340e402fa87c53d87f379dee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:LineOfCreditAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02de64e4627846b2bd3f09d7101c72f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06c55fa5097f4b26aaa7bc551ed8d8ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3f5c6f033e845d3853ee8dcbfd15aec_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f327e88a9264251811af5db4463a246_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017fec98dd774d41900ae8973e5e99b1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25a6dbcdd6414960b06cbb782d9985c4_I20210519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote3400PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic508faac831b42f2b021bb57d04db552_I20210519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i129edcf0ec22460cbebd897c6f2231cd_I20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4.250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cd5e36259d94f569780a9bbfeeb56e6_I20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4200PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b767842f4c4d8cae721f9d090787f9_I20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote3880PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia10cfac217664164a5ce11935398e38c_I20210128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4.250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15a32184ddc4244aafcaee4d492a613_I20210128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4200PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6442aff2a64388a38b157c25a0b7c8_I20210128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote3880PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i474fd2e8b00742c492b5f0a58c583148_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:SeniorNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e3cb94a01d48daa97d3bd61e3eb616_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:SeniorNotesDue2023And2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="bond"><xbrli:measure>peak:bond</xbrli:measure></xbrli:unit><xbrli:context id="ie4b8cef65132475f95dc36c24f9a9820_I20211124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote213PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic42f1d80f9104fb9a68ce6b17b49241f_I20210712"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote1350PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea6c0660aff54ba4b24294d1a82e7306_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabee9c868d9c47cba2cc55a571bc034f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="facility"><xbrli:measure>peak:facility</xbrli:measure></xbrli:unit><xbrli:context id="i4d184f2e01164a51b230c30bd85a30d0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i030603e4f5a54153b34a35b3214082f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfc6fff323874884beaa90a4c80a3577_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a84667f31d1411fa0eb153b19912c8e_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivativeheld"><xbrli:measure>peak:derivativeHeld</xbrli:measure></xbrli:unit><xbrli:context id="ice54f9998d0c43e8b7423fa1683f6226_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e027636867a4aa5b3815ba06a2d6117_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionRemainderOfFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i501441e9c9d04464a5eb510bce4935e3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionRemainderOfFiscalYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51db4181e1b54a7b863ce08ec4787ea6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a046d474cb44979dcf512ddc3fabb3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5faeb218c7d04966869e0fe60f447e98_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic626427f6d62400986df856754ecbb17_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fab30ca14f54624bfd030cd08d1042b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5fb318dd82744438c5d3c43a0a334fa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ee0feb90e464607b8cd21230c30e359_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b0beada91ec4b9783bd3b82faeb791f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia75891e9a77c482caedf11f0b1cc4f02_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionPeriodThereafterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic80ffcee88b3410c985f4e65c0eee19c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionPeriodThereafterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id155f3c6d1834c9fa8fe36e4b805553a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36d2ca6669b54c32aa2aad64db99b30d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie30fa114a84041be913e6a006cbdb670_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5441692de9104c1f8876f6126bb3cd18_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9703e7c732740bb93115889bd6185b4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic49d297efbc04b4899a13cad1f112a0b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bda4a0f83814d708728819ca12b1868_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c682ca877614372ac5d6a9eb54b1447_D20210430-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-30</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6bdb41bc18341e4874c99a5317a7474_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbcca059325e491ba0a93b64940f5ac3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i133dad541e4940469495f91e54645b82_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c9910ca8e3c43b58498430b0d7f692c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50abcbcb64fb40e899abb71cbd6e3653_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72cbe3fbdd9d4520b3ee1c9882ee17d6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramSettledMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbbd3434631b45fa866d0cbaac25a52f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:ATMDirectIssuancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7bb6050b89c41c0a9f564585e588a65_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:ATMDirectIssuancesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="interest"><xbrli:measure>peak:interest</xbrli:measure></xbrli:unit><xbrli:context id="id2262290d71c48d7997b11506be11d2e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ab0862bf034c7d9e3c84e8a429fc20_D20230101-20241231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib562c08096d84fc6a41f5ebd01b696fb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:DownREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7b05b8400df430195d0de28217faac1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:DownREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2522c73e41654167962362468542cfa4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide8b297bfe9444c5bf4d4192b08aecda_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd28c0a01e0b4e1687c11f71b4e146b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e285ee41e894f3fb7a5abcc3f145a7e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6194055e785642eebfc80c30a45c054f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f56e92e9a1411d871334a90b76fa9f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VenturesVLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec88d274781648d1946da5119782e172_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fefcab6d3cb41888c82058807af19ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:MorganStanleyRealEstateInvestmentJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fb4bb6009344e2d86a46be91dd2df36_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:DownreitPartnershipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i722f52bee0ee49709ef5ab8ea0678ab4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ba23ecabb554063a415b6201e35ad07_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1923a4d184d947fa8f63901661871fa1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbf991550f2b47db91f24f0f6930a30f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4433a7a0b6e549278122839d2dd4ef69_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i647df0ef5da942b7835d88ac03d98c68_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6748a224b94042acb5282ef7d9b2a15d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaec053ad2c7e489a8ceb2307e73640f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24c76c887bc045ea98faf15f07cdc7b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i688cf62ae17b4e4382d4717dfb3d857d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d6fb07e784b4ca69895402225c3412e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc10c45d3da4625bee7679905bbb7c3_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d2252cd7eba4d3b851fa2e3e157f14c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cee1167ebab48b7b2f82422612e3991_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d64ef81915d4315bc7730741c5095a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb5de1f1f0a24475b0f7d492a74824d6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33e11899bd7a43448fda5d94b27afd54_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b09eddbc9044df3944a2a85e555a381_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16a351f1ed484654b7fe74cc73addf0a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2e2a387bee947aea9537b5bd2acde51_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ifa3dff468a15495db7b57c65ada0de74_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDgw_7c02d062-8b07-42c9-9736-7377640b717a">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6YTlmNzVlNWU3OWQyNDRjOTkwNjg4MTQzMWQ1ZmRhYmIvdGFibGVyYW5nZTphOWY3NWU1ZTc5ZDI0NGM5OTA2ODgxNDMxZDVmZGFiYl8wLTAtMS0xLTEwNzg0Mg_2060aaed-c3e0-40de-8388-30f8aaffa2ae">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the quarterly period ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8xMzg_620dbad9-48f0-4c80-bfd6-f0aec4130f85">March 31, 2022</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NWY5YmQ3ZjczNjA5NDE2NWFlMTRjMjlhYTJmZTVjZjcvdGFibGVyYW5nZTo1ZjliZDdmNzM2MDk0MTY1YWUxNGMyOWFhMmZlNWNmN18wLTAtMS0xLTEwNzg0Mg_cc549630-f5ce-4ab5-8223-2b6ce4678d98">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDgx_3155f85f-0233-40f4-a011-2d789b1e56eb">001-08895</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDcz_bda9c275-171f-402f-953d-d0276692136e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">.</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NDE5ZjkwYjBkMTU1NDk1YWIzMmE3ODM1NmNhMDA4MmMvdGFibGVyYW5nZTo0MTlmOTBiMGQxNTU0OTVhYjMyYTc4MzU2Y2EwMDgyY18xLTAtMS0xLTEwNzg0Mg_adb3a532-a13f-4e87-96eb-8ef09750bf85">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NDE5ZjkwYjBkMTU1NDk1YWIzMmE3ODM1NmNhMDA4MmMvdGFibGVyYW5nZTo0MTlmOTBiMGQxNTU0OTVhYjMyYTc4MzU2Y2EwMDgyY18xLTItMS0xLTEwNzg0Mg_fd0ba06b-ed00-4d32-8e4b-4184d44adad2">33-0091377</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDgy_e26f894c-b828-4114-b4bd-65b268338b04">5050 South Syracuse Street</ix:nonNumeric>, <ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc0_a3924757-54e1-4961-8e80-58198c3d65d1">Suite 800</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDgz_5c4fcf23-b631-4298-ba89-8accf69b3f47">Denver</ix:nonNumeric>, <ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc1_a4f14c9a-c4a4-41b8-9e7e-328a7cd32c41">CO</ix:nonNumeric> <ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc2_65dd7ab3-408d-47ca-a506-e207a9c60626">80237</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc3_ed1e5ef3-72be-410b-b193-9cf4fc23fc71">720</ix:nonNumeric>) <ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDg0_1b142d07-48e9-46e4-8b78-b483f57b86e5">428-5050</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NGYwNDE3NTY5YTc1NGViMjhhNmQyNWRmMTQ5MzdjZGQvdGFibGVyYW5nZTo0ZjA0MTc1NjlhNzU0ZWIyOGE2ZDI1ZGYxNDkzN2NkZF8xLTAtMS0xLTEwNzg0Mg_987bcf83-1d37-4842-975c-bdf4d13bd560">Common Stock, $1.00 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NGYwNDE3NTY5YTc1NGViMjhhNmQyNWRmMTQ5MzdjZGQvdGFibGVyYW5nZTo0ZjA0MTc1NjlhNzU0ZWIyOGE2ZDI1ZGYxNDkzN2NkZF8xLTEtMS0xLTEwNzg0Mg_ab983c2a-b5a2-4755-8f11-db36bf0b2a40">PEAK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NGYwNDE3NTY5YTc1NGViMjhhNmQyNWRmMTQ5MzdjZGQvdGFibGVyYW5nZTo0ZjA0MTc1NjlhNzU0ZWIyOGE2ZDI1ZGYxNDkzN2NkZF8xLTItMS0xLTEwNzg0Mg_d77b5a67-7c87-4e61-8423-fd23aafea06e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc4_cbcac82f-52f8-41b0-a9d9-48fde5ed7497">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;No&#160;&#9744;</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc5_0158e569-5a50-447e-b095-0efe2c065468">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;No&#160;&#9744;</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NjE4MjQ3ODA4MGE2NGQ3YmE5MWM5MzhmNzZiNzg1YzEvdGFibGVyYW5nZTo2MTgyNDc4MDgwYTY0ZDdiYTkxYzkzOGY3NmI3ODVjMV8wLTAtMS0xLTEwNzg0Mg_7584dfae-b4fd-4636-97e3-2e463d61f336">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NjE4MjQ3ODA4MGE2NGQ3YmE5MWM5MzhmNzZiNzg1YzEvdGFibGVyYW5nZTo2MTgyNDc4MDgwYTY0ZDdiYTkxYzkzOGY3NmI3ODVjMV8xLTMtMS0xLTEwNzg0Mg_1647c83c-7657-4429-aedf-f8272ae17211">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NjE4MjQ3ODA4MGE2NGQ3YmE5MWM5MzhmNzZiNzg1YzEvdGFibGVyYW5nZTo2MTgyNDc4MDgwYTY0ZDdiYTkxYzkzOGY3NmI3ODVjMV8yLTMtMS0xLTEwNzg0Mg_46bc3eb3-c453-4ba5-93c1-36b6bab1aa3d">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDcy_6829c356-8b41-426b-8f2f-5dcf2a0a96b2">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of May&#160;2, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ie82972ffaa0e486c8bf672e801389907_I20220502" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDAw_0b65d2b9-aef6-4029-a428-9cc62b097c34">539,557,153</ix:nonFraction> shares of the registrant&#8217;s $1.00 par value common stock outstanding.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HEALTHPEAK PROPERTIES, INC.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_10">PART&#160;I. FINANCIAL INFORMATION</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_13">Financial Statements (Unaudited):</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_13">3</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_16">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_16">3</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_19">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_19">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_22">Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_22">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_25">Consolidated Statements of Equity and Redeemable Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_25">6</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_28">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_28">7</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_31">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_31">8</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_91">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_91">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_91">32</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_151">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_151">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_151">52</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_154">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_154">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_154">52</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_157">PART&#160;II. OTHER INFORMATION&#160;</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_160">Item 1A.&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_160">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_160">53</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_163">Item 2.&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_163">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_163">53</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_166">Item 6.&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_166">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_166">54</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_169">Signatures&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifa3dff468a15495db7b57c65ada0de74_169">55</a></span></div></td></tr></table></div><div style="margin-bottom:30pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I. FINANCIAL INFORMATION</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_13"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;Financial Statements (Unaudited)</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_16"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share and per share data)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Real estate:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMy0xLTEtMS0xMDc4NDI_acf70574-0e40-4f0c-9233-e2598806ead8">12,368,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMy0zLTEtMS0xMDc4NDI_2c1737f0-5336-46b7-b315-6b57beccf3a2">12,025,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Development costs and construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNC0xLTEtMS0xMDc4NDI_b23346c9-67eb-41a4-9551-765b8107a89d">739,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNC0zLTEtMS0xMDc4NDI_001acfd1-c2b7-4283-8ae5-fdb823f44bb8">877,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNS0xLTEtMS0xMDc4NDI_f694c58f-3b4e-4853-b5fc-f67fea9a00fc">2,706,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNS0zLTEtMS0xMDc4NDI_31dcf446-60b9-439e-8365-d966ac4cd457">2,603,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNi0xLTEtMS0xMDc4NDI_6553cd50-c4b5-448f-b67e-23da4118798f">2,975,337</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNi0zLTEtMS0xMDc4NDI_87041974-6444-47c0-9370-6645783ec66f">2,839,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNy0xLTEtMS0xMDc4NDI_2045521b-7593-4dff-8272-31173b552889">12,839,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNy0zLTEtMS0xMDc4NDI_4d4f9fb6-4445-4cc5-8d0d-39a7803aea6b">12,667,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net investment in direct financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOC0xLTEtMS0xMDc4NDI_a1339382-0d4f-4636-aae6-2cbe46761f09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOC0zLTEtMS0xMDc4NDI_761bf370-2700-40d3-a91f-9a6ccf37e68a">44,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loans receivable, net of reserves of $<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOS0wLTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjplMmMzYWZmYzUwOTU0MmMzOGI1M2U3NDY3MGVkNzcwZV80MQ_3024e3ba-d6fc-4d37-a9f0-9fcf71b8f09d">1,944</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOS0wLTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjplMmMzYWZmYzUwOTU0MmMzOGI1M2U3NDY3MGVkNzcwZV80OA_16d3ef77-4941-4751-b56f-65edc6c6e0ce">1,813</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOS0xLTEtMS0xMDc4NDI_f1e5f4ed-12ac-4dd4-ad8f-40e7b23433f7">409,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOS0zLTEtMS0xMDc4NDI_58a12428-0f37-4aa8-b2ac-5db984c88623">415,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in and advances to unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTAtMS0xLTEtMTA3ODQy_8510526b-1924-438d-9e02-99562d60078c">403,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTAtMy0xLTEtMTA3ODQy_6d7971ea-d45a-44d7-bfc7-ebd7a3714468">403,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTEtMC0xLTEtMTA3ODQyL3RleHRyZWdpb246ZmJhM2NmZDUyNzdhNDYxNWEyNTNhODlhMGEzZjI5MmZfNDU_d3dce2cb-18cf-4fd8-9d05-f6908e897732">2,068</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTEtMC0xLTEtMTA3ODQyL3RleHRyZWdpb246ZmJhM2NmZDUyNzdhNDYxNWEyNTNhODlhMGEzZjI5MmZfNTI_ab9f28f6-1bab-4ade-87ca-b23c843306b7">1,870</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTEtMS0xLTEtMTA3ODQy_ba5b80c1-5949-45ce-b36d-89066543b00a">54,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTEtMy0xLTEtMTA3ODQy_2a89f011-36b1-4283-988e-1c839a76965f">48,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTItMS0xLTEtMTA3ODQy_6313a142-7d12-4fa5-aec0-77f3d2550047">89,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTItMy0xLTEtMTA3ODQy_45a480c6-cf4b-4016-aea0-e17804bca9a8">158,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTMtMS0xLTEtMTA3ODQy_15925c6e-6ee5-4450-8572-3ece0b7272be">52,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTMtMy0xLTEtMTA3ODQy_243076dc-10a7-454f-85b3-bb644837865b">53,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTQtMS0xLTEtMTA3ODQy_8b8de7e9-53f5-4dcf-b897-ec3d16d7c28d">497,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTQtMy0xLTEtMTA3ODQy_d7200d09-d10a-40b4-9fd6-169f826b1f96">519,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets held for sale and discontinued operations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTUtMS0xLTEtMTA3ODQy_89ad9247-17f0-4f7e-8dfc-32c2b1fead17">33,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTUtMy0xLTEtMTA3ODQy_6dd304d8-34a1-44af-8a45-761b6a9fada4">37,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTYtMS0xLTEtMTA3ODQy_68f5fed7-a8a5-4f96-9a06-92a40a223a72">232,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTYtMy0xLTEtMTA3ODQy_88321dc9-5224-4f2e-ad2c-36b04d80a25c">233,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTctMS0xLTEtMTA3ODQy_38afe7cf-2d2f-4bb9-a88b-2fd4a6b2fae0">676,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTctMy0xLTEtMTA3ODQy_cc9e4895-6fe5-450e-a25b-58811acd3c59">674,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTgtMS0xLTEtMTA3ODQy_2160083a-9c4d-4f3a-a46f-6ed867a83498">15,287,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTgtMy0xLTEtMTA3ODQy_9728f086-93bf-469c-a845-da898fb13807">15,257,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bank line of credit and commercial paper</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjEtMS0xLTEtMTA3ODQy_81a766ab-b7df-4cdf-a5b7-07f250147dd6">1,330,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjEtMy0xLTEtMTA3ODQy_eac68cad-eb89-4e31-b473-c28d64f5f45f">1,165,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Senior unsecured notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjMtMS0xLTEtMTA3ODQy_f3c4d349-ee39-400f-af3f-48725f3d1c8a">4,654,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjMtMy0xLTEtMTA3ODQy_d4d26afd-f805-437c-9675-e7a3a571cfc1">4,651,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mortgage debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjQtMS0xLTEtMTA3ODQy_e83f68a7-cfca-4667-b796-55be185de6ba">350,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjQtMy0xLTEtMTA3ODQy_15baedf6-a1af-4b9c-bde6-df65f98ae64d">352,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:OffMarketLeaseUnfavorable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjUtMS0xLTEtMTA3ODQy_748ebcab-6603-48d4-a93f-f288aeb75a0f">175,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:OffMarketLeaseUnfavorable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjUtMy0xLTEtMTA3ODQy_1d65c913-558c-4b77-b3d7-7b6d205037c1">177,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale and discontinued operations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjYtMS0xLTEtMTA3ODQy_9408d5e4-ce55-418c-ab46-01c0067585c7">14,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjYtMy0xLTEtMTA3ODQy_29349b56-7d7d-42d1-abd6-4b1b52b997a4">15,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjctMS0xLTEtMTA3ODQy_78848bf1-aa19-4329-b091-5f884337c086">203,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjctMy0xLTEtMTA3ODQy_d4f7698d-a4d9-4de5-bed5-df0c7a5b6573">204,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjgtMS0xLTEtMTA3ODQy_1e0bae2c-1aef-4b78-aa66-e74382468909">695,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjgtMy0xLTEtMTA3ODQy_354626a0-8e0f-4741-a3f8-8f1d292a77c8">755,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjktMS0xLTEtMTA3ODQy_36acbb88-18f6-4090-8803-3a06ae833305">817,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjktMy0xLTEtMTA3ODQy_76059b01-bb7f-4256-8be9-f00f66df34f2">789,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzAtMS0xLTEtMTA3ODQy_9c5a41ae-70f6-42dc-ae62-b22879a04b40">8,241,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzAtMy0xLTEtMTA3ODQy_1c1db97f-a478-4007-bbaa-295584baa561">8,111,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzItMS0xLTEtMTA3ODQy_5ded9525-b602-4d67-b594-e5b669d56abb"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzItMy0xLTEtMTA3ODQy_8bed9591-7df1-4c33-b941-a41defd6623c"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzQtMS0xLTEtMTA3ODQy_54d382e8-c5aa-4346-98ed-e2ebf3777671">97,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzQtMy0xLTEtMTA3ODQy_add4b58f-7e3e-42e9-9c05-c3e2b54ad8b2">87,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfMTg_ab2a38ac-112b-4317-9bed-56ac50bf0b2a"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfMTg_c1222ba0-1d78-4894-8d5a-4e81dae4495a">1.00</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfMzI_7071d497-22b2-4e1a-975b-ba79a4ef00a2"><ix:nonFraction unitRef="shares" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfMzI_ba883f78-3767-4b23-b648-75cab7a40bf9">750,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfNTQ_cf596df3-21a2-46c4-9671-270d894c268b"><ix:nonFraction unitRef="shares" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfNTQ_f4d371af-119d-428a-9819-baa504ebfad5">539,523,537</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfNjE_0cea9c0f-ed38-452a-9003-9ee6b84530de"><ix:nonFraction unitRef="shares" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfNjE_28e3c8b9-afeb-411a-846e-55862796681e">539,096,879</ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMS0xLTEtMTA3ODQy_943a6ba9-fb24-457f-b043-c112e2adcde3">539,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMy0xLTEtMTA3ODQy_47e4fa8e-1bff-4f54-96c7-2602ed53861b">539,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzgtMS0xLTEtMTA3ODQy_b4b01017-43ef-4d7c-94a5-5df93671aac8">10,084,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzgtMy0xLTEtMTA3ODQy_919fe119-cf7a-4446-9446-dac274f568b7">10,100,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative dividends in excess of earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:AccumulatedDistributionsInExcessOfNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzktMS0xLTEtMTA3ODQy_ffeca10f-73e2-4f87-9af5-2c3e949d5311">4,212,941</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:AccumulatedDistributionsInExcessOfNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzktMy0xLTEtMTA3ODQy_162b79be-f828-40ea-adfc-d9dca99ab530">4,120,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDAtMS0xLTEtMTA3ODQy_c9ea420b-6419-4965-864f-e05a1f74d570">3,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDAtMy0xLTEtMTA3ODQy_fff31d24-22be-4d9f-84df-16b9ddac9571">3,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDEtMS0xLTEtMTA3ODQy_5f147df1-d25c-41a6-8d32-123f5fd77a3a">6,408,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDEtMy0xLTEtMTA3ODQy_f528d147-4a30-4280-be8a-cd3ecf70606e">6,515,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Joint venture partners</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:MinorityInterestInJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDItMS0xLTEtMTA3ODQy_e4b0a45b-782e-4bee-9a9e-f05b4a30508c">338,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:MinorityInterestInJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDItMy0xLTEtMTA3ODQy_d11a510f-a6a9-4acf-8d1d-6d6fefacfa82">342,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-managing member unitholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:MinorityInterestInPreferredUnitHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDMtMS0xLTEtMTA3ODQy_4e6c6810-fec7-4b50-a239-ce5eba207a16">201,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:MinorityInterestInPreferredUnitHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDMtMy0xLTEtMTA3ODQy_fe920664-a610-4463-86b6-2d73056659b8">201,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDQtMS0xLTEtMTA3ODQy_c0a170c0-7ee8-45d4-ae17-8a4151410d2c">539,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDQtMy0xLTEtMTA3ODQy_7d1431f6-ec75-40b1-a6bd-7db20671cb7f">543,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDUtMS0xLTEtMTA3ODQy_bcb5c88f-05ba-4afb-93bc-d08aa0d978fe">6,947,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDUtMy0xLTEtMTA3ODQy_78c4b278-c237-4610-a07b-c5535fe980dd">7,058,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDYtMS0xLTEtMTA3ODQy_509a01e7-a2f9-40b0-a91f-7e14bb361d1d">15,287,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDYtMy0xLTEtMTA3ODQy_f0cc888a-fac6-4a94-9c3a-3adb47a9035b">15,257,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="margin-bottom:30pt;margin-top:6pt;text-align:justify;text-indent:63pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rental and related revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMy0xLTEtMS0xMDc4NDI_2aeb2c32-bd71-4d12-bdf1-8392dfad5744">370,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMy0zLTEtMS0xMDc4NDI_72ace142-c031-40c6-8b19-dc50ca84f105">327,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Resident fees and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNC0xLTEtMS0xMDc4NDI_ea332410-ef63-4ab6-ac25-fd4cfa9341e1">121,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNC0zLTEtMS0xMDc4NDI_37173fba-f6f9-4be4-bf09-8b51a6858f11">116,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from direct financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:DirectFinancingLeaseRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNS0xLTEtMS0xMDc4NDI_b1be8c44-23a9-4f8d-9044-f5e78de74bfa">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:DirectFinancingLeaseRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNS0zLTEtMS0xMDc4NDI_72793d8b-ce1c-4710-8950-350715120fc0">2,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNi0xLTEtMS0xMDc4NDI_05ed4811-acf0-4a26-a368-0f14257fb451">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNi0zLTEtMS0xMDc4NDI_4de8fe70-c0a7-4de8-995c-788375505393">9,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNy0xLTEtMS0xMDc4NDI_ff43e578-01f5-41ac-9061-d03dc5653572">498,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNy0zLTEtMS0xMDc4NDI_cf52d9d0-441f-4dfc-85b0-d2dcc315e175">455,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfOS0xLTEtMS0xMDc4NDI_d92bf727-e57f-45cf-bf66-ad90c298bd80">37,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfOS0zLTEtMS0xMDc4NDI_dc8cef86-d8dd-410c-91ef-450a946be51e">46,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTAtMS0xLTEtMTA3ODQy_4a2f6375-5592-4eee-9e94-26ba5e2911be">177,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTAtMy0xLTEtMTA3ODQy_0741c264-1775-4f37-828b-7e01880f12cd">157,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTEtMS0xLTEtMTA3ODQy_7396f4cb-a46d-4948-a109-76f3cff2e2f1">207,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTEtMy0xLTEtMTA3ODQy_1ba893a7-3179-4103-9281-7ea5a64f7115">181,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTItMS0xLTEtMTA3ODQy_49a1f3ed-914d-4436-a67a-1ad60b6851d3">23,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTItMy0xLTEtMTA3ODQy_ac2967f5-4947-49b9-8004-6cd78e19418f">24,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTMtMS0xLTEtMTA3ODQy_4ed69e0e-b009-4783-97d9-9727e0688312">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTMtMy0xLTEtMTA3ODQy_fc726ccd-5baa-4a79-8ec8-ab55d69aec27">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and loan loss reserves (recoveries), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTUtMS0xLTEtMTA3ODQy_d8cf8ef5-7a93-4b01-9af4-13f4453474ba">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTUtMy0xLTEtMTA3ODQy_f0f7f7f2-80b4-4e2a-b3f5-d8b62dd2bb87">3,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTYtMS0xLTEtMTA3ODQy_9b691bee-80f0-4416-af70-71f177eaea8e">446,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTYtMy0xLTEtMTA3ODQy_d0ecad7b-22c4-4b57-8e7c-dd70da2455f4">415,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTgtMS0xLTEtMTA3ODQy_44dc576f-3806-49e9-9ced-87e8d20b22ca">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTgtMy0xLTEtMTA3ODQy_a151ca6f-0d27-42f9-8dc8-63b92497a241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) on debt extinguishments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTktMS0xLTEtMTA3ODQy_9a244f38-53d0-4371-a50d-5799b0a19b1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTktMy0xLTEtMTA3ODQy_e6ebe7dd-fe20-4bf8-94e0-90dee44541fd">164,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjAtMS0xLTEtMTA3ODQy_d09749f3-2a17-48a7-8ad0-f798b22b694e">18,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjAtMy0xLTEtMTA3ODQy_2bbac6f1-ebd8-4056-8ab0-f6c377167e10">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjEtMS0xLTEtMTA3ODQy_3e521808-7d68-4563-bac3-08465c76a54f">22,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjEtMy0xLTEtMTA3ODQy_cdb94c77-b7f8-418f-8b6a-332cbdbb4346">162,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjItMS0xLTEtMTA3ODQy_d5b73c92-e207-45ed-98d3-e03676f605ce">73,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjItMy0xLTEtMTA3ODQy_57ea312b-5707-45f1-965e-091aec1a0edd">121,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjMtMS0xLTEtMTA3ODQy_7ab41093-8e61-4734-ad35-805af4799e30">777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjMtMy0xLTEtMTA3ODQy_91acd8bf-5a9e-4c50-bda3-8ce1c5c299d9">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjQtMS0xLTEtMTA3ODQy_82be0aa6-27ec-47ec-9e6b-c7c692ae77f6">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjQtMy0xLTEtMTA3ODQy_eca2534f-d242-4670-8bfa-d064c16e6cdd">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjUtMS0xLTEtMTA3ODQy_555154b6-e257-4726-9358-0dc817ec4e07">75,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjUtMy0xLTEtMTA3ODQy_71f0fe07-a442-474c-bdc2-2509e13592d8">120,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjYtMS0xLTEtMTA3ODQy_b99b3900-02aa-4eb2-8a0c-4cc483af3d77">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjYtMy0xLTEtMTA3ODQy_3fe8abf9-8748-45ee-afff-8023cf87baac">270,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjctMS0xLTEtMTA3ODQy_d64ab5ca-9a46-45dc-b6d9-f35d8f2e211f">75,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjctMy0xLTEtMTA3ODQy_a19d5775-c8cd-46a8-b883-edb7cca291b1">149,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share in continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjgtMS0xLTEtMTA3ODQy_e0a8eb18-adee-45f1-8477-90326296d58f">3,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjgtMy0xLTEtMTA3ODQy_18a4a7d6-4d1e-4274-8254-e7ced9a52b77">3,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share in discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjktMS0xLTEtMTA3ODQy_b8270735-d80c-4523-8ca1-529d1cb6dca0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjktMy0xLTEtMTA3ODQy_f21e2fbc-0981-4c18-a9cb-e93ba96ec8bf">329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss) attributable to Healthpeak Properties, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzAtMS0xLTEtMTA3ODQy_9d0a77a3-ba41-4ca4-b670-0d7150f89e79">71,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzAtMy0xLTEtMTA3ODQy_bc287a37-8c1d-46c1-9c2f-263f1bef33fd">145,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating securities&#8217; share in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzItMS0xLTEtMTA3ODQy_a6f92290-0df3-4ce6-8613-18d10f98f55b">1,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzItMy0xLTEtMTA3ODQy_ab8b63ad-dcc6-48fe-ac27-e296264b6bdc">2,451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzMtMS0xLTEtMTA3ODQy_60706bae-3a94-4da8-a979-c72c5a31e76e">69,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzMtMy0xLTEtMTA3ODQy_518c3785-ffcc-4570-895c-d10d2b38633a">143,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic earnings (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzYtMS0xLTEtMTA3ODQy_ab3702ce-5878-44a3-b06f-1e1d7f93257f">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzYtMy0xLTEtMTA3ODQy_43e0a48a-a7bf-4df7-ac6d-54df6bc58f47">0.23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzctMS0xLTEtMTA3ODQy_ff8301c1-9e55-47f0-bc0e-2a6445108eb1">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzctMy0xLTEtMTA3ODQy_cd29157b-1b7e-46d5-932b-02f3b8ad8668">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzgtMS0xLTEtMTA3ODQy_fb7d5fef-ba0c-4256-a1ee-81493098177d">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzgtMy0xLTEtMTA3ODQy_aae6af37-2d97-40a6-9b67-39f61cd26cc0">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted earnings (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDAtMS0xLTEtMTA3ODQy_13a7858e-8155-4e93-b049-a9a0352c8297">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDAtMy0xLTEtMTA3ODQy_54000c52-e75d-46a4-b5dd-4f8810c0f533">0.23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDEtMS0xLTEtMTA3ODQy_63fd93e8-a99f-4fca-aac9-6f3c1ce197f3">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDEtMy0xLTEtMTA3ODQy_3b28d58b-b191-485f-8e45-2056c8464349">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDItMS0xLTEtMTA3ODQy_2e2c8dc9-9747-4f6c-85fd-0c6edbca193b">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDItMy0xLTEtMTA3ODQy_68827048-5989-4c39-b3c3-e84811e801d9">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDctMS0xLTEtMTA3ODQy_9daf2db0-b3d4-4150-8c7b-1404ea175a21">539,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDctMy0xLTEtMTA3ODQy_8b2ec2c7-8dfa-46ac-8f29-8e1de68beee9">538,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDgtMS0xLTEtMTA3ODQy_40c105d7-0fca-42b0-9df6-65e562acc6e5">539,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDgtMy0xLTEtMTA3ODQy_5553fe03-54f4-4297-bdb9-2c6bc9f52e0c">538,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="margin-bottom:30pt;margin-top:6pt;text-align:justify;text-indent:63pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMi0xLTEtMS0xMDc4NDI_b4f4e46d-2070-475c-b864-4852a1756072">75,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMi0zLTEtMS0xMDc4NDI_9666a7da-6d4e-4088-a8c4-bbb66f94227b">149,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized gains (losses) on derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfNi0xLTEtMS0xMDc4NDI_33e10578-7b56-4f08-948b-caef88c02850">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfNi0zLTEtMS0xMDc4NDI_8d6d1ecf-aabd-4a88-924d-905fadd4f64e">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in Supplemental Executive Retirement Plan obligation and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfNy0xLTEtMS0xMDc4NDI_78f2f5f7-15fa-4cb0-9a6e-4d574e0bdfea">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfNy0zLTEtMS0xMDc4NDI_064c6b04-ca16-4508-9153-77d9ef827644">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment realized in net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfOS0xLTEtMS0xMDc4NDI_f88a3d10-4e55-434a-ade4-feaccc6ae47b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfOS0zLTEtMS0xMDc4NDI_07dec02d-01c6-4170-8d09-881f3c48720d">251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTAtMS0xLTEtMTA3ODQy_6f066ede-908a-4810-90cd-eedb4fa2d96a">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTAtMy0xLTEtMTA3ODQy_5d62b301-11fc-4fc6-95e9-2159392ebd62">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTEtMS0xLTEtMTA3ODQy_44a03aa6-95d4-4486-81a9-b2ac4d3ac18e">75,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTEtMy0xLTEtMTA3ODQy_5f3325b4-4021-435d-957d-585338e15488">149,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive (income) loss attributable to noncontrolling interests&#8217; share in continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i409ce78c858444d7a5dc1f973872f5b5_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTItMS0xLTEtMTA3ODQy_549684c8-d258-4e37-8ddb-a9fefa9815cb">3,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i046e7a1a5f114e488bef10441f3f6b44_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTItMy0xLTEtMTA3ODQy_e2aeebb5-db5c-40da-ba66-6b28cdbc0733">3,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive (income) loss attributable to noncontrolling interests&#8217; share in discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTMtMS0xLTEtMTA3ODQy_0f1b8d5c-2170-4e2d-aeef-cdc7c06be087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i586d3ac1554b476b944978cf331446d1_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTMtMy0xLTEtMTA3ODQy_8275c53d-b952-4169-81b6-8cf5a256c261">329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Healthpeak Properties, Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTQtMS0xLTEtMTA3ODQy_8d4c1760-ff4f-4b9c-9dfe-415866e73404">71,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTQtMy0xLTEtMTA3ODQy_5a49c875-4711-40bc-9143-3cd7dabc2c7c">145,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.483%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative Dividends In&#160;Excess Of&#160;Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27033f4128f14d61b570ee8fcfab4e19_I20211231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xLTEtMS0xMDc4NDI_7f58aef6-88d8-4db7-ab46-f28f8e908857">539,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27033f4128f14d61b570ee8fcfab4e19_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0zLTEtMS0xMDc4NDI_df8d7663-a0b3-4922-9d76-b539c1b2233c">539,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcae3dea640a4b138a3f5795930bae95_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC01LTEtMS0xMDc4NDI_df417d95-c701-492e-8fb1-28f25d68cedd">10,100,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf9ac731c8274ea6971c722ec208c696_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC03LTEtMS0xMDc4NDI_ee0400b6-944d-4f82-9c11-f3296a261866">4,120,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadd3477c47624974b897f92075a001c6_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC05LTEtMS0xMDc4NDI_bd2c4712-2bff-4f93-9e86-a48bc56762cb">3,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i490f82b12d324a9c8138193ebcd5d1eb_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xMS0xLTEtMTA3ODQy_387540ce-516e-40fc-b1a9-d20de6442df2">6,515,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0bd8d0bfcbb44ad83c3862162bfa1c1_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xMy0xLTEtMTA3ODQy_521cb167-9852-41ea-9bcb-3fb269e36f9f">543,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xNS0xLTEtMTA3ODQy_18342a0a-ef46-4422-ab01-4ec19d4dd989">7,058,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xNy0xLTEtMTA3ODQy_ddbb0acd-87af-4758-a022-5ab0e94a0b65">87,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67bf69a97b654c869301d6f090e62d57_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS03LTEtMS0xMDc4NDI_6c0b86c9-f672-47dc-95be-6e971382f256">71,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS0xMS0xLTEtMTA3ODQy_274dd62a-b4e7-4399-bbce-70c2fa918ef9">71,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb077a5f2244709819741b6cb0a3fa1_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS0xMy0xLTEtMTA3ODQy_12ce18f2-2f3d-4b81-8cab-742c39acafda">3,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS0xNS0xLTEtMTA3ODQy_30b741ff-b556-468e-b1d3-f23dde186008">75,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS0xNy0xLTEtMTA3ODQy_9f2f5e04-efa3-42f3-a5ee-624681ee48f3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7abe9391e6448ab7157b0bae0f272a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNi05LTEtMS0xMDc4NDI_ceb8cae4-ae11-4786-844f-7420f38bacb1">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNi0xMS0xLTEtMTA3ODQy_705c992d-ce62-456b-a7c8-02ea1d2d16e1">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNi0xNS0xLTEtMTA3ODQy_a72e9990-8741-4bf3-b4e5-19322a5f9495">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy0xLTEtMS0xMDc4NDI_982822b7-34bf-4d7a-9251-ac8f2a0f40ac">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy0zLTEtMS0xMDc4NDI_b8ba73f3-d33d-4556-9ffa-bbb6f698eaa0">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy01LTEtMS0xMDc4NDI_815b4dd1-7e64-4576-adc8-3885efc2e49e">437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy0xMS0xLTEtMTA3ODQy_79a6cfd9-94bf-44e1-9532-937d6b13a063">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy0xNS0xLTEtMTA3ODQy_dd586c1f-af04-4181-b91c-1b18ee41196c">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS0xLTEtMS0xMDc4NDI_bb0608ed-c297-4a72-8158-d5a4af964ff1">339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS0zLTEtMS0xMDc4NDI_20f4cc38-f563-49fe-9ba4-0ef6fdac1c2a">339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS01LTEtMS0xMDc4NDI_d8665f47-6836-410a-93fa-96ceca7b5bcd">11,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS0xMS0xLTEtMTA3ODQy_40281d69-539b-468a-aea9-64635ba6532a">11,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS0xNS0xLTEtMTA3ODQy_f0a4e8f3-4c32-46fc-b1ad-8dd3c89c7d86">11,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of stock-based compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTEtNS0xLTEtMTA3ODQy_b5d15e84-d654-4187-96cd-0c4013fbc55f">6,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTEtMTEtMS0xLTEwNzg0Mg_b7aa5212-5ed4-4771-910d-84afe3af36aa">6,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTEtMTUtMS0xLTEwNzg0Mg_73b8580a-6ecf-4684-95dc-b7c94c503b4a">6,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTItMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MDIwMTJiNGUzNGNjNDUwZGJkODI4Yjg0Y2ZhNjJlNjFfMjI_e50cd9e1-8c1e-425a-b74c-be12063db602">0.30</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67bf69a97b654c869301d6f090e62d57_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTItNy0xLTEtMTA3ODQy_265dd851-133d-4330-bf7a-d48e551c9b78">163,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTItMTEtMS0xLTEwNzg0Mg_6bd2cdd3-6e13-4513-b4c0-f8c5b1ee6289">163,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTItMTUtMS0xLTEwNzg0Mg_a3b2d033-1f82-49e8-9657-91bfbfb20a6c">163,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcb077a5f2244709819741b6cb0a3fa1_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTMtMTMtMS0xLTEwNzg0Mg_15c8d87c-b30e-4b90-8f41-1dea489151c3">7,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTMtMTUtMS0xLTEwNzg0Mg_23a65f68-6574-4646-a400-11589c43a701">7,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTMtMTctMS0xLTEwNzg0Mg_34513c8b-634b-44a4-855b-217eaf16ffa3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTQtMTctMS0xLTEwNzg0Mg_bbe604b7-cca0-4758-a632-b953668bc6db">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to redemption value of redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTUtNS0xLTEtMTA3ODQy_2dca7395-58ae-4229-a721-2beafee3d8a5">10,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTUtMTEtMS0xLTEwNzg0Mg_ce330415-8db1-48f2-b3ab-79e387b09767">10,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTUtMTUtMS0xLTEwNzg0Mg_70b6998f-25d0-42e3-a142-a3e352952111">10,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTUtMTctMS0xLTEwNzg0Mg_c80d7ebe-e761-484f-9927-71a297c91173">10,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31c94325aaf34e408bb6acbdc569a1d7_I20220331" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMS0xLTEtMTA3ODQy_034b6534-39d8-4038-965b-174d757e4543">539,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31c94325aaf34e408bb6acbdc569a1d7_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMy0xLTEtMTA3ODQy_0f9ce3d2-583c-4ac0-95a8-ccd2108a150f">539,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367dd265e817411fae092d30372080c9_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktNS0xLTEtMTA3ODQy_dff85b0a-8eb0-4ea3-9ebe-17d6d7764b89">10,084,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25b091a3184e4f5abf94f94d420796af_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktNy0xLTEtMTA3ODQy_8e1113f4-513d-431e-9790-18b392227d14">4,212,941</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic24059380f4a4805a400b695962dbef6_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktOS0xLTEtMTA3ODQy_b7f70d95-cbba-4626-a0c8-3c9c9e009e9d">3,047</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98fdb8b9ba7546b3863ac5453d1d4595_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMTEtMS0xLTEwNzg0Mg_e6e09541-77cc-4ffc-8560-80c7cf67dcd3">6,408,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a20cc136a864b339ac00237669b9e4d_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMTMtMS0xLTEwNzg0Mg_a76267d2-8894-48da-8dec-2bc8bf734967">539,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMTUtMS0xLTEwNzg0Mg_b6c37e6d-b0be-4880-afc9-7f1ab651657d">6,947,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMTctMS0xLTEwNzg0Mg_155b9579-9764-43ba-a790-3c885de32fda">97,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.483%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative Dividends In&#160;Excess Of&#160;Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40a69eb101874a248f36e295dd95e2e3_I20201231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xLTEtMS0xMDc4NDI_ed340ad1-015d-49d0-ae7c-ae0c29d8fcb9">538,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40a69eb101874a248f36e295dd95e2e3_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0zLTEtMS0xMDc4NDI_b374d118-475e-40f3-a804-cc93ee152246">538,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3663f069068045e992c69e3d404cae29_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC01LTEtMS0xMDc4NDI_0fa8cdba-7713-4574-9caa-0f2e41a1cf89">10,175,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i872f9cc9bb7a47469e26e6f7e4849029_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC03LTEtMS0xMDc4NDI_05a53baf-b38a-4ec3-a080-157369da1119">3,976,232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19827d84f1614a0f8ad378b5470e253a_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC05LTEtMS0xMDc4NDI_c6e6ee33-e7fd-473e-a506-95bc91ec6a13">3,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i797de15cd85c409c81c2fbde05db3a05_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xMS0xLTEtMTA3ODQy_559d8b9c-3ad3-486b-88de-69ff8a3e2ba4">6,733,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b145e89da940f2b434e5038adee396_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xMy0xLTEtMTA3ODQy_2c919734-42c3-4a8e-9e94-851e29cb5729">556,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xNS0xLTEtMTA3ODQy_11f33d7c-6df5-476a-a229-58a14b210c6b">7,289,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xNy0xLTEtMTA3ODQy_9a6d3c1c-c4fc-4cf7-aea2-9f4a15d84450">57,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ec0bcc69b44db7857a079e35c591cb_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNS03LTEtMS0xMDc4NDI_e24718a1-0c76-4fc6-ac36-3d317315db83">145,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNS0xMS0xLTEtMTA3ODQy_cedd2503-82ef-4b6e-a0d4-a9fff2c79925">145,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ce63109a747419ba702c25c06711c30_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNS0xMy0xLTEtMTA3ODQy_f4fc0ae5-4bb6-4b18-b69f-ec0d1ee2502b">3,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNS0xNS0xLTEtMTA3ODQy_04181667-1f61-4e6d-a406-b6d0414c17e2">149,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fe27c8a01a4beba1b7b922c1d0d182_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNi05LTEtMS0xMDc4NDI_11f6487d-cea5-473e-9993-67975be4edda">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNi0xMS0xLTEtMTA3ODQy_583236f9-347a-4ef9-822e-13d69bb62c52">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNi0xNS0xLTEtMTA3ODQy_c472f46b-3ef6-4193-909c-58130c7d45f0">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy0xLTEtMS0xMDc4NDI_77ec7ca2-e171-4369-a6ec-1ac16be0dd31">879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy0zLTEtMS0xMDc4NDI_b8f25424-12d4-4c39-8ec2-be9a692ef4cd">879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy01LTEtMS0xMDc4NDI_f7fd1ddb-e3db-4357-87d9-c763241d120d">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy0xMS0xLTEtMTA3ODQy_281f58b6-6f09-4c7e-b8e1-5ab40078e15c">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy0xNS0xLTEtMTA3ODQy_56b70d86-4345-4010-8cfb-54a539b7a18a">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS0xLTEtMS0xMDc4NDI_0e84af96-fc03-40b7-9763-117a22077496">398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS0zLTEtMS0xMDc4NDI_3feca8f1-1047-4327-89b8-bb0afc2a79d5">398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS01LTEtMS0xMDc4NDI_82824c2c-bb20-4bd0-b32c-fe2bade3fce7">11,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS0xMS0xLTEtMTA3ODQy_d259a852-53a0-4c73-8d9f-e684ead7e498">12,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS0xNS0xLTEtMTA3ODQy_ab5cb8dc-0597-4dd0-81fc-ae713e500ab0">12,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTEtNS0xLTEtMTA3ODQy_5a901fde-4fb8-416a-84f1-2dbfb7212d68">5,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTEtMTEtMS0xLTEwNzg0Mg_ca970caa-413e-4af9-aa41-9113f8da6940">5,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTEtMTUtMS0xLTEwNzg0Mg_d572d753-57f5-49d2-b0c5-6bb42a40511b">5,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTItMC0xLTEtMTA3ODQyL3RleHRyZWdpb246NDZlYjExODE1MmUwNDBlMWEyN2E3NTNhOWQ2YTIwNDZfMjI_faced4b7-59a8-4230-92eb-00c6492815ab">0.30</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5ec0bcc69b44db7857a079e35c591cb_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTItNy0xLTEtMTA3ODQy_5c7a532b-726c-4c93-a24a-9e898a34afeb">164,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTItMTEtMS0xLTEwNzg0Mg_69ce9147-fee3-4aa7-821f-a11a898767a8">164,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTItMTUtMS0xLTEwNzg0Mg_b28115fd-ed83-429a-bf17-7b0dbb7d7e85">164,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ce63109a747419ba702c25c06711c30_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTMtMTMtMS0xLTEwNzg0Mg_9c617d4e-b1c2-4b99-965a-47564b03de51">7,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTMtMTUtMS0xLTEwNzg0Mg_8cff677c-fac3-4cc8-80b1-464002394517">7,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTMtMTctMS0xLTEwNzg0Mg_9ecda957-10a0-483c-b7d5-3b61f0e02b11">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTYtMTctMS0xLTEwNzg0Mg_298cd754-120b-47ee-8f68-f24ee46eaecc">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to redemption value of redeemable noncontrolling interests </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTctNS0xLTEtMTA3ODQy_4dde1343-c45a-48d3-8f7d-0a080a80b26a">20,921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTctMTEtMS0xLTEwNzg0Mg_9842d03e-6cc0-4de1-ba36-18cb1d8720b2">20,921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:AdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTctMTUtMS0xLTEwNzg0Mg_c8c60ec4-4e1f-48a9-bfca-e790975ac0d9">20,921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTctMTctMS0xLTEwNzg0Mg_5767f36c-a163-49ce-9ccd-af02d9ce2b16">20,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id42af16b8b5e46a3a93869820b193ece_I20210331" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMS0xLTEtMTA3ODQy_a79112ec-71ee-4b2c-ad79-5c39d9fb4033">538,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id42af16b8b5e46a3a93869820b193ece_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMy0xLTEtMTA3ODQy_eb511060-f603-4782-b966-0d8878da340f">538,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i947f359177e141dea98189810a16d2ce_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtNS0xLTEtMTA3ODQy_66c71549-8775-469e-9d81-b05c724b1254">10,148,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cc4bf949eda46e39539b8c05d956da6_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtNy0xLTEtMTA3ODQy_431bf685-0a9e-49be-a572-cb0fbd3a2202">3,994,562</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41427d8508e34a328dd1abb7637f8a9c_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtOS0xLTEtMTA3ODQy_7a1809eb-6c3d-4e9e-b03c-2eecb8ca37eb">3,497</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64cd9f22bc634046912f6b976230977c_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMTEtMS0xLTEwNzg0Mg_f96b3a22-9427-45ad-9a5a-36cf9768a3da">6,688,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dcdd74b90db4a33a4202492ae24fe31_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMTMtMS0xLTEwNzg0Mg_d4d48bb9-066f-4b61-8b7c-6f86e98cd614">552,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMTUtMS0xLTEwNzg0Mg_4e3d3563-1621-4f6f-bfa4-6f22dd90df7c">7,241,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMTctMS0xLTEwNzg0Mg_5843e7c2-f343-463c-ba6b-1155028cdfba">78,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMy0xLTEtMS0xMDc4NDI_2dd33f12-427d-4f0e-91c6-f5774beddb28">75,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMy0zLTEtMS0xMDc4NDI_15c6a7bc-cce2-4253-84c7-a8590a895579">149,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization of real estate, in-place lease, and other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNS0xLTEtMS0xMDc4NDI_69311ca4-ca07-4fe7-81f4-7c2662109b90">177,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNS0zLTEtMS0xMDc4NDI_b63e0a9d-f605-4e24-bb0f-1ba45b14f2ad">157,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfOC0xLTEtMS0xMDc4NDI_fbe69de2-3065-4dc4-97d2-b9eaf4b6c2cd">4,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfOC0zLTEtMS0xMDc4NDI_aaa4e7ff-9698-40b4-a2de-b9ad3a7ce39f">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfOS0xLTEtMS0xMDc4NDI_754c13ef-45be-4da7-91c1-9804120d9359">2,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfOS0zLTEtMS0xMDc4NDI_5eb8fab9-273b-4900-894e-5029dd95346f">2,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Straight-line rents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:StraightLineRent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTAtMS0xLTEtMTA3ODQy_54d79121-1996-4c92-a1ab-bfbb044ae950">11,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:StraightLineRent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTAtMy0xLTEtMTA3ODQy_b4cc5627-1225-4feb-a81f-42b1d87a619e">9,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of nonrefundable entrance fees and above/below market lease intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTQtMS0xLTEtMTA3ODQy_ef895106-682f-4a71-b193-9c060a12b088">24,725</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTQtMy0xLTEtMTA3ODQy_7370dc7d-5bdd-46ca-87e7-c3aada06d8e0">23,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity loss (income) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTUtMS0xLTEtMTA3ODQy_04a8c8b6-678a-4273-954b-f1208a6c8967">2,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTUtMy0xLTEtMTA3ODQy_4ea47e03-01ed-4f0e-976e-3b5b65024adc">1,008</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions of earnings from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTYtMS0xLTEtMTA3ODQy_f5f428b8-94a9-45fe-b3d1-06f1348bdaac">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTYtMy0xLTEtMTA3ODQy_d71b42c7-e3b1-4e0c-bbed-e52c3033d688">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on sale of real estate under direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTktMS0xLTEtMTA3ODQy_bce2fa43-a8fe-431e-b9ee-50bb14d49d1b">22,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTktMy0xLTEtMTA3ODQy_0fd6504f-58ba-4bc2-92a9-517e9a5f52a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjAtMS0xLTEtMTA3ODQy_fbd2bfd5-e15a-4f53-a545-de43195ace32">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjAtMy0xLTEtMTA3ODQy_26e9fc26-28c5-4017-8f96-ffea196ccf67">1,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairments and loan loss reserves (recoveries), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjEtMS0xLTEtMTA3ODQy_348cbc16-5c51-4d47-af0f-23b23bde8315">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjEtMy0xLTEtMTA3ODQy_16db0035-2e05-484a-948e-ad72ea0f4968">3,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjItMS0xLTEtMTA3ODQy_2c8fd331-289b-43b4-827f-b71aed19e34e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjItMy0xLTEtMTA3ODQy_143afda5-8264-432c-bb0a-4af8e58e8ed8">164,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on sales of real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjMtMS0xLTEtMTA3ODQy_1ba3cdf0-9567-4685-ac2d-0c9f0828989a">3,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjMtMy0xLTEtMTA3ODQy_a73a88d5-1178-4d5f-bcb5-ef26d197e6d9">259,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) upon change of control, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:GainLossFromChangeOfControl" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjQtMS0xLTEtMTA3ODQy_a3d2480a-7ec0-484f-a90e-b203d458d3ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:GainLossFromChangeOfControl" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjQtMy0xLTEtMTA3ODQy_c65e914c-ecd8-4501-9d44-9f9105b5668d">1,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Casualty-related loss (recoveries), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:InsuredEventGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjUtMS0xLTEtMTA3ODQy_22e03dc8-7e01-414f-87f2-b875f5486654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:InsuredEventGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjUtMy0xLTEtMTA3ODQy_9abfbddb-9593-46c9-9c37-23f7ccb18765">859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjktMS0xLTEtMTA3ODQy_01a94607-8391-4318-8ac3-ad36b882ae24">1,593</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjktMy0xLTEtMTA3ODQy_d915424e-d86c-4ba5-bf74-068ae89f4ec3">726</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decrease (increase) in accounts receivable and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzItMS0xLTEtMTA3ODQy_62d7a716-17ad-4486-a5a1-b0bc3e91271e">4,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzItMy0xLTEtMTA3ODQy_931865c0-6f7d-4031-a7ab-edd1b70bd79e">11,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzMtMS0xLTEtMTA3ODQy_29f8b8be-d291-455a-88dc-b14d82f103d1">3,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzMtMy0xLTEtMTA3ODQy_fadbeffe-8081-4b5e-a963-cb1255cd9e33">74,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzQtMS0xLTEtMTA3ODQy_a4818f6c-ec52-4b22-9aac-f6b9b05af512">194,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzQtMy0xLTEtMTA3ODQy_b22b9817-0dba-4658-b4f4-1461a4d327e5">122,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions of real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzgtMS0xLTEtMTA3ODQy_6433bff1-b97e-4882-a88a-7b946c267a90">134,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzgtMy0xLTEtMTA3ODQy_d0fa9c83-47c7-4a14-943f-d183f7dac36f">14,914</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Development, redevelopment, and other major improvements of real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzktMS0xLTEtMTA3ODQy_0dca0b5e-7c2c-46d1-a4f1-7d6ab60411c0">178,285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzktMy0xLTEtMTA3ODQy_231344f9-bdc2-4d32-a246-00ec944246d0">135,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leasing costs, tenant improvements, and recurring capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDAtMS0xLTEtMTA3ODQy_99aec1ec-5abc-4736-9f3d-9f4433c33916">22,839</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDAtMy0xLTEtMTA3ODQy_3d73c8a9-422a-4016-84d5-3397ec25ccf3">20,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDEtMS0xLTEtMTA3ODQy_5ab648f8-1f0a-4fc6-a185-80d984640832">13,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDEtMy0xLTEtMTA3ODQy_532701ee-7608-48f2-9a2d-f63df66e8e61">937,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions to unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDMtMS0xLTEtMTA3ODQy_3b16b8f7-ee93-46d9-a8f9-33c908bfe233">1,486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDMtMy0xLTEtMTA3ODQy_c5f8b89e-df09-405d-8d8b-ad6ea039288e">5,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions in excess of earnings from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDQtMS0xLTEtMTA3ODQy_77150885-1cf5-4a8a-8c18-49668a0a1f2e">3,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDQtMy0xLTEtMTA3ODQy_0ea57c5e-ae69-4952-851a-390a699ba8f3">10,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales/principal repayments on loans receivable and direct financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfFinanceReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTEtMS0xLTEtMTA3ODQy_10c992ef-db2b-40b4-9e9e-349364f94887">75,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfFinanceReceivables" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTEtMy0xLTEtMTA3ODQy_51289fd0-1eee-4d3b-80f0-228669d51618">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in loans receivable and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:PaymentsToAcquireLoansReceivableAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTItMS0xLTEtMTA3ODQy_08e1d00b-e763-4954-9513-0ab93445a0e9">1,860</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:PaymentsToAcquireLoansReceivableAndOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTItMy0xLTEtMTA3ODQy_7c1d7f3e-3957-45ac-b4ce-4cf39253d9c0">3,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTUtMS0xLTEtMTA3ODQy_ce86fce0-9288-494b-99ce-279b2a6e730a">245,962</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTUtMy0xLTEtMTA3ODQy_43b1fd78-55ea-40eb-838c-3395b89c7eec">767,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Borrowings under bank line of credit and commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTctMS0xLTEtMTA3ODQy_f97dd620-2eda-48ac-aff0-d0b3327d135d">3,732,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTctMy0xLTEtMTA3ODQy_319385cd-17a2-43b1-9b55-7876a568df1b">3,437,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments under bank line of credit and commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTgtMS0xLTEtMTA3ODQy_acd02861-795e-4b4b-ba03-b551da20f09e">3,567,830</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTgtMy0xLTEtMTA3ODQy_42a3f39e-3b4d-4acc-86f4-ffbedac4dfa8">2,528,640</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments and repurchase of debt, excluding bank line of credit and commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfBankDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjAtMS0xLTEtMTA3ODQy_70d92e05-8f59-46ae-b508-e234b217d1f8">1,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfBankDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjAtMy0xLTEtMTA3ODQy_3ba3cafb-1a3b-4781-88da-77afdd261554">1,491,754</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for debt extinguishment and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjYtMS0xLTEtMTA3ODQy_d684729e-1f2b-4cf3-90a5-ee8080f686e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjYtMy0xLTEtMTA3ODQy_83226713-2b1a-48b2-9e21-b14b7c91b56e">158,011</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock and exercise of options, net of offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjgtMS0xLTEtMTA3ODQy_2f2a6aaf-abde-4e06-ac02-2fc25c78c359">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjgtMy0xLTEtMTA3ODQy_d822869d-c30a-40ad-bdf6-03e1097a042a">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjktMS0xLTEtMTA3ODQy_6dd37f47-ae73-4ea7-860f-5feb4bfff6b5">11,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjktMy0xLTEtMTA3ODQy_5738afe3-c99d-4903-8b63-ca01a04bae90">12,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends paid on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzAtMS0xLTEtMTA3ODQy_8a8aaa2e-fc3b-4c70-aba8-9008509907c9">163,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzAtMy0xLTEtMTA3ODQy_a5ff4543-a0d1-49ff-b16b-56fcf05ecdb8">164,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchase of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzItMS0xLTEtMTA3ODQy_7e7b527a-2448-4ab6-be70-4f3d61e09963">7,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzItMy0xLTEtMTA3ODQy_6dc2a2e3-7c61-4cd6-a793-66d86697e6aa">7,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contributions from and issuance of noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzMtMS0xLTEtMTA3ODQy_89702e55-c10d-4c8e-9c91-05f5cefdbf2e">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzMtMy0xLTEtMTA3ODQy_893b3cdb-f582-446e-9f7e-c33b67d1b9cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzQtMS0xLTEtMTA3ODQy_0f11c09b-38f2-407c-adcd-b3456ee93c37">18,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzQtMy0xLTEtMTA3ODQy_74a31575-9769-40d2-a72a-5889912193c2">924,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzYtMS0xLTEtMTA3ODQy_71d26921-3ae7-4633-9aa1-bc176bd995f2">70,290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzYtMy0xLTEtMTA3ODQy_d34e3dc9-6812-493b-8a4e-4c4fb6040e94">33,667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzctMS0xLTEtMTA3ODQy_22c43217-e6d2-43c3-89b3-f812cc6c1cd7">219,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzctMy0xLTEtMTA3ODQy_e8fe33a9-b0f6-472b-aee2-7d91e32084c2">181,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzgtMS0xLTEtMTA3ODQy_37f77356-199d-45aa-8e55-cd20880a21cb">149,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzgtMy0xLTEtMTA3ODQy_64e83a59-d67a-4290-a8c5-aeaff8c8ff62">148,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to the Unaudited Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthpeak Properties, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_34"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNC9mcmFnOmM4NzVkNzM2NjFlOTQ2ZGI4OWZmMDljNTI4MzQxNWYzL3RleHRyZWdpb246Yzg3NWQ3MzY2MWU5NDZkYjg5ZmYwOWM1MjgzNDE1ZjNfMjQ4OQ_b0f1ceb9-3e88-48b8-b118-e8b8ec8fd553" continuedAt="i416886035bb54e1882ec987003227ae8" escape="true">Business</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i416886035bb54e1882ec987003227ae8"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc., a Standard&#160;&amp; Poor&#8217;s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (&#8220;REIT&#8221;) that, together with its consolidated entities (collectively, &#8220;Healthpeak&#8221; or the &#8220;Company&#8221;), invests primarily in real estate serving the healthcare industry in the United States (&#8220;U.S.&#8221;). Healthpeak&#174; acquires, develops, leases, owns, and manages healthcare real estate. The Company&#8217;s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i)&#160;life science; (ii) medical office;&#160;and (iii) continuing care retirement community (&#8220;CCRC&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters are in Denver, Colorado and it has additional offices in California, Tennessee, and Massachusetts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Covid Update</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus (&#8220;Covid&#8221;) pandemic has caused significant disruption to individuals, governments, financial markets, and businesses, including the Company.&#160;The Company&#8217;s tenants, operators, and borrowers have experienced significant cost increases as a result of increased health and safety measures, staffing shortages, increased governmental regulation and compliance, vaccine mandates, and other operational changes necessitated either directly or indirectly by the Covid pandemic. The Company evaluated the impacts of Covid on its business thus far and incorporated information concerning the impact of Covid into its assessments of liquidity, impairments, and collectibility from tenants, residents, and borrowers as of March&#160;31, 2022. The Company will continue to monitor such impacts and will adjust its estimates and assumptions based on the best available information.</span></div></ix:continuation><div id="ifa3dff468a15495db7b57c65ada0de74_37"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NDU_7ca0f6e0-e144-4b7e-93f6-dddc67e0c287" continuedAt="if2bafe5cebc54ff1b10862d6e1e4237a" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="if2bafe5cebc54ff1b10862d6e1e4237a" continuedAt="i432a66418e4a44f5bac25645ab267a12"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NTQ_fd0ca1ed-2404-451e-b239-cacdd86b6de4" escape="true"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#8217;s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#8220;JVs&#8221;), and variable interest entities (&#8220;VIEs&#8221;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021 filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revision to Additional Paid-In Capital and Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company identified and corrected immaterial errors in the classification and redemption value of redeemable noncontrolling interests of consolidated joint ventures in its life science segment. The Company corrected the classification of its redeemable noncontrolling interests and increased the balance to its estimated redemption value, with a corresponding decrease to additional paid-in capital (&#8220;APIC&#8221;) in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the unrealized value of the redeemable noncontrolling interests was largely attributable to rapidly rising rents and compressing capitalization rates in the market in which the entities operate, and was identified and corrected by management. The Company determined the impact of the adjustments to be immaterial, individually and in the aggregate, based on consideration of quantitative and qualitative factors. As such, these adjustments are reflected in this Quarterly Report on Form 10-Q for the three months ended March 31, 2021. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i432a66418e4a44f5bac25645ab267a12"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These adjustments had no impact on the Consolidated Statements of Cash Flows, Consolidated Statements of Operations, or any per share amounts. The Company made changes (all amounts in thousands) to the Consolidated Statements of Equity and Redeemable Noncontrolling Interests to decrease APIC, total stockholders&#8217; equity, and total equity as of March 31, 2021 by $<ix:nonFraction unitRef="usd" contextRef="ib5e2b4520099480cbcf7ae7a10b2633a_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMzQ0NQ_378673bc-b70c-43d9-8e79-f09ec2160d07">75,543</ix:nonFraction> with a corresponding increase to redeemable noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="ib5e2b4520099480cbcf7ae7a10b2633a_I20210331" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMzYwNQ_b04858f1-d2cd-49d6-8c7c-ff4580c3ac87">78,413</ix:nonFraction> and a decrease to accounts payable, accrued liabilities, and other liabilities as of March 31, 2021 of $<ix:nonFraction unitRef="usd" contextRef="ib5e2b4520099480cbcf7ae7a10b2633a_I20210331" decimals="-3" sign="-" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMzcxNw_fe15f296-57b9-4c67-a7ba-f99f0dd6fe93">2,870</ix:nonFraction> on the Consolidated Balance Sheet. </span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="peak:GovernmentGrantIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NDM_724193bf-c377-47b7-bff1-e2a892a39d56" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Government Grant Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) to provide financial aid to individuals, businesses, and state and local governments. During the three months ended March&#160;31, 2022 and 2021, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the Covid pandemic. Grant income is recognized when there is reasonable assurance that the grant will be received and the Company will comply with all conditions attached to the grant. Additionally, grants are recognized over the periods in which the Company recognizes the increased expenses and lost revenue the grants are intended to defray. As of March&#160;31, 2022, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.</span></div></ix:nonNumeric><div style="margin-top:6pt"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NjQ_3f222e29-f06d-48f4-b230-a325836a0d0d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information related to government grant income received and recognized by the Company (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in other income (expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366e3a8a7bb7447e9f752c396f34ef65_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfMi0xLTEtMS0xMDc4NDI_498db55a-17b6-4316-afdf-78f1d39e0918">6,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3460b3e5b484c59b4ecbe639bdd4209_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfMi0zLTEtMS0xMDc4NDI_0c7f717c-1446-4409-bde7-3dda81333f7a">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb4d8499ffb4004a3ee3195b72c71f9_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfMy0xLTEtMS0xMDc4NDI_52e47bdb-814b-45af-826f-7ef182cffa7b">648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511cc9d57cc6454fbd2d5002ffde7b46_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfMy0zLTEtMS0xMDc4NDI_c302b1b9-bab5-4b7a-b217-6d8af243a6c6">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5729311f850434baae5aecac89476bc_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfNC0xLTEtMS0xMDc4NDI_a36d48ae-858c-4140-914a-d4db23765e7f">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df88f30ff64438db2f6496ddd4694e7_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfNC0zLTEtMS0xMDc4NDI_702d4dc9-240b-49ac-a745-3ad9364db5a1">3,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total government grants received</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65f4e28b0f2b4c9ca073348ac7c5830f_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfNS0xLTEtMS0xMDc4NDI_ff1f98bd-bbfa-46d1-a880-41e0d2bef40a">7,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71827eba90f4c7dbd49266ebef243d8_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfNS0zLTEtMS0xMDc4NDI_b3df4a4c-98ca-4e08-a753-c3c922630267">4,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMzQwODQ4NjA0OTAxNTg_e47ddeaf-d7ff-49ad-bbf2-af82375653ef" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Discontinued Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company established and began executing a plan to dispose of its senior housing triple-net and Senior Housing Operating Property (&#8220;SHOP&#8221;) properties and concluded that the planned dispositions represented a strategic shift that had and will have a major effect on the Company&#8217;s operations and financial results. Therefore, senior housing triple-net and SHOP assets meeting the held for sale criteria are classified as discontinued operations in all periods presented herein. In September 2021, the Company successfully completed the disposition of the remaining senior housing triple-net and SHOP properties. See Note 4 for further information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NDA_52ad07f0-362e-4d48-8433-3819ba152141" escape="true"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-10&#8221;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#8217;s accounting for assistance, and the effect of the assistance on an entity&#8217;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Adopted</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Scope </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-01&#8221;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The amendments in ASU 2020-04 and ASU 2021-01 were effective immediately and may be applied through December 31, 2022. The Company is evaluating whether the optional relief provided by ASU 2020-04 or ASU 2021-01 will be adopted but does not expect the adoption of these standards to have a material impact on its consolidated financial position, results of operations, cash flows, or disclosures.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:RealEstateDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfNjM1MQ_b40cfef5-6c8e-42bc-b284-bb7a9fa49997" continuedAt="i990b0d1294b2475e96c702d09c13c52e" escape="true">Real Estate Transactions</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i990b0d1294b2475e96c702d09c13c52e"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Real Estate Investment Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">67 Smith Place</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="i68709d337a004bc49691880a5dff69f4_D20220101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTA5OTUxMTY0NTg4Mw_b4d2b933-e86f-483c-8229-fb5aa74994b8">72</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vista Sorrento Phase II</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company closed a life science acquisition in San Diego, California for $<ix:nonFraction unitRef="usd" contextRef="ibd171034fe8747f7ab9643d2e6c8c934_D20220101-20220131" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTA5OTUxMTY0NTkxMA_5521f745-f545-4acf-9dbf-56542456a2bd">24</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Webster MOB Portfolio</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company acquired a portfolio of <ix:nonFraction unitRef="property" contextRef="icabe4000b649414fba14f6ec77194207_D20220301-20220331" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTA5OTUxMTY0NDY5Nw_9f9d09ab-5501-4a75-80f4-6d4e64f827a2">two</ix:nonFraction> medical office buildings (&#8220;MOBs&#8221;) in Houston, Texas for $<ix:nonFraction unitRef="usd" contextRef="icabe4000b649414fba14f6ec77194207_D20220301-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTA5OTUxMTY0NDcwMQ_dcc1fb15-8a04-4860-87d5-d23d75618eb8">43</ix:nonFraction>&#160;million. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Real Estate Investment Acquisitions </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company closed the following life science acquisitions: (i) <ix:nonFraction unitRef="property" contextRef="id9cece3770b941ee9ae47c83081b1562_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTY0OTI2NzQ4MDcxOA_5f7e218e-608e-48a8-a02a-95400ba8b8ee">eight</ix:nonFraction> acquisitions in Cambridge, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="id9cece3770b941ee9ae47c83081b1562_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUwNg_076b08bb-3ea9-46d8-9ee9-d902941cf707">498</ix:nonFraction>&#160;million, (ii) <ix:nonFraction unitRef="property" contextRef="id834faa0894c48b5b6ca7b84f1e97b10_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUxMA_277d96ef-3892-44e4-a12c-8f3b774b4d9b">one</ix:nonFraction> life science acquisition in San Diego, California for $<ix:nonFraction unitRef="usd" contextRef="id834faa0894c48b5b6ca7b84f1e97b10_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTY0OTI2NzQ4MDcyMg_b477b012-e78f-4f4b-a734-9eb872feaa3a">20</ix:nonFraction>&#160;million, and (iii) <ix:nonFraction unitRef="acre" contextRef="i157e2f27fbc8439583042a14aba3a3dd_I20211231" decimals="0" name="us-gaap:AreaOfLand" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUxNA_bdff527f-cadc-4d03-a043-db9a8e404dcf">12</ix:nonFraction> acres of land for $<ix:nonFraction unitRef="usd" contextRef="id35ffdd058d5452aadfbd3058f25fe8d_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireLand" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUxOA_e4c54cb1-acb6-4ecd-8d5e-682fad32039d">128</ix:nonFraction>&#160;million in South San Francisco, California.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also during 2021, the Company closed the following MOB acquisitions: (i) <ix:nonFraction unitRef="property" contextRef="i0be770442a38456fa45fe909e5cf2209_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYwMw_1e420a32-1572-4efd-9768-0bc254bee44a">one</ix:nonFraction> MOB in Nashville, Tennessee for $<ix:nonFraction unitRef="usd" contextRef="i0be770442a38456fa45fe909e5cf2209_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUyMg_fff8666b-12b5-494f-81ac-88659fd1e435">13</ix:nonFraction>&#160;million, (ii) <ix:nonFraction unitRef="property" contextRef="i1e70b2253cef459da26681df951e5714_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDU4Nw_c190a197-1722-4302-8456-9daf3bc7e6bf">one</ix:nonFraction> MOB in Denver, Colorado for $<ix:nonFraction unitRef="usd" contextRef="i1e70b2253cef459da26681df951e5714_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDU5NQ_54962141-9f49-4f6a-9a76-f41d9164990d">38</ix:nonFraction>&#160;million, (iii) a portfolio of <ix:nonFraction unitRef="property" contextRef="i6ae39df20f8a4003aa9f5bfc1350f2aa_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYxMQ_28dfcfb1-5f65-460e-908a-3cdde836e01b">14</ix:nonFraction> MOBs for $<ix:nonFraction unitRef="usd" contextRef="i6ae39df20f8a4003aa9f5bfc1350f2aa_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYxOQ_1e8464f6-5996-42ee-aa98-3d07784a659d">371</ix:nonFraction>&#160;million (the &#8220;MOB Portfolio&#8221;), (iv) <ix:nonFraction unitRef="property" contextRef="i6a7d366dcb654ae3b1142ce1b04f07d8_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYyNw_8ce1b9ce-4fac-453f-8876-afecfa74b0b1">one</ix:nonFraction> MOB in Fort Lauderdale, Florida for $<ix:nonFraction unitRef="usd" contextRef="i6a7d366dcb654ae3b1142ce1b04f07d8_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYzNQ_1dccd65e-186b-4108-aa80-52c02dee3483">16</ix:nonFraction>&#160;million; (v) <ix:nonFraction unitRef="property" contextRef="ibb3b94e67a8b43879bb61dbed6563aad_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY0Mw_ca5cc5af-00ec-4c09-b8f2-825ec4428a22">one</ix:nonFraction> MOB in Wichita, Kansas for $<ix:nonFraction unitRef="usd" contextRef="ibb3b94e67a8b43879bb61dbed6563aad_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY1MQ_59d98ece-5acc-4b48-bbf9-11f5cb74e76b">50</ix:nonFraction>&#160;million, (vi) <ix:nonFraction unitRef="property" contextRef="iee85843b4241478fb2cc9b09850dd27d_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY1OQ_eae339dc-6daf-42ef-a904-5a287ec9deee">three</ix:nonFraction> MOBs in Morristown, New Jersey for $<ix:nonFraction unitRef="usd" contextRef="iee85843b4241478fb2cc9b09850dd27d_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY2Nw_2e583968-7f01-48e1-845c-aa656e6dfc22">155</ix:nonFraction>&#160;million, (vii) <ix:nonFraction unitRef="property" contextRef="i0280b9f0a7bb49eb921ea3165bf8ee37_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY3NQ_262a1c29-984e-4b42-ad83-625ff619619b">two</ix:nonFraction> MOBs in Dallas, Texas for $<ix:nonFraction unitRef="usd" contextRef="i0280b9f0a7bb49eb921ea3165bf8ee37_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY4Mw_d9f32df7-0207-4fca-9601-53c35a79c113">60</ix:nonFraction>&#160;million, (viii) <ix:nonFraction unitRef="property" contextRef="i37e7dd1a3a6c46e1a92bd28eaa72af76_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY5MQ_3cc2cf95-250b-47b3-9dcb-0f3dc80c34cb">one</ix:nonFraction> MOB in Seattle, Washington for $<ix:nonFraction unitRef="usd" contextRef="i37e7dd1a3a6c46e1a92bd28eaa72af76_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY5OQ_041bb50b-57f6-47ac-bc7e-89f915cef434">43</ix:nonFraction>&#160;million, (ix) <ix:nonFraction unitRef="property" contextRef="i18626c3b380148e1b0b293d23816dd72_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDcwNw_d7b5ec72-55e6-4e64-9468-7fe0443e0d72">one</ix:nonFraction> MOB in New Orleans, Louisiana for $<ix:nonFraction unitRef="usd" contextRef="i18626c3b380148e1b0b293d23816dd72_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDcxNQ_7d489442-eb0d-4e82-ab7f-dc3c2ebf430e">34</ix:nonFraction>&#160;million, and (x) <ix:nonFraction unitRef="property" contextRef="i946443381ff64eda82972caa7e61e937_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDcyMw_84c11058-ad44-4189-87fc-692cbc27d2d0">one</ix:nonFraction> MOB in Cambridge, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="i946443381ff64eda82972caa7e61e937_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUwMg_d357de56-46c7-4445-999e-6329965d01fb">55</ix:nonFraction>&#160;million. In conjunction with the acquisition of the MOB Portfolio, the Company originated $<ix:nonFraction unitRef="usd" contextRef="i498d7f8735954a6a9c9a9011ebbd9301_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDczMQ_596c312c-6cf0-40c5-b4b1-d4c5aeb4bc09">142</ix:nonFraction>&#160;million of secured mortgage debt.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Development Activities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commitments, which are primarily related to development and redevelopment projects and tenant improvements, decreased by $<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-6" sign="-" name="peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfNTI5Ng_70433812-805f-422b-9f5b-b8218547e44a">52</ix:nonFraction> million, to $<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-6" name="peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfNTMwMw_ab650d62-e01e-44f8-9d5f-f59417285d48">418</ix:nonFraction> million</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at March&#160;31, 2022, when compared to December&#160;31, 2021, primarily as a result of actual spend on existing projects in the first quarter of 2022.</span></div></ix:continuation><div id="ifa3dff468a15495db7b57c65ada0de74_46"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTM5NTY_95a405ee-dcfd-456b-b383-a88d5d84a712" continuedAt="i8652f7c7e6104ea9a599e084db51006c" escape="true">Dispositions of Real Estate and Discontinued Operations</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i8652f7c7e6104ea9a599e084db51006c" continuedAt="i2f78e9918b5f4b5d8ee312bcb3da4ee0"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Dispositions of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company sold <ix:nonFraction unitRef="property" contextRef="ic6ddf70e2d074a11bf07c122fa0aa5eb_D20220101-20220131" decimals="INF" name="peak:NumberOfPropertiesSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODM4MA_8692d8a7-e836-42fa-a430-3d734c9b8318">one</ix:nonFraction> life science facility in Salt Lake City, Utah for $<ix:nonFraction unitRef="usd" contextRef="ic6ddf70e2d074a11bf07c122fa0aa5eb_D20220101-20220131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODM4NA_50a9d2b9-e9fb-4fc1-9986-426b4f182acc">14</ix:nonFraction>&#160;million, resulting in a gain on sale of $<ix:nonFraction unitRef="usd" contextRef="ic6ddf70e2d074a11bf07c122fa0aa5eb_D20220101-20220131" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY2Njc1NA_87fa6d3f-a660-46c8-82f8-0a51b0faf9d6">4</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company sold <ix:nonFraction unitRef="property" contextRef="ib528caa7e34e44bd8bac451c88b62afb_D20220401-20220430" decimals="INF" name="peak:NumberOfPropertiesSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODM5Nw_9f53d12b-af49-43dc-ba1a-d9d8f270ad4c">one</ix:nonFraction> MOB in San Antonio, Texas for $<ix:nonFraction unitRef="usd" contextRef="ib528caa7e34e44bd8bac451c88b62afb_D20220401-20220430" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODQwMQ_67ffafa5-d7c9-4df9-947e-9d9ca58c9686">13</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Dispositions of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sunrise Senior Housing Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company sold a portfolio of <ix:nonFraction unitRef="property" contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTg2_96db2da1-15f8-4c57-8bb2-d90b2786b911">32</ix:nonFraction> SHOP assets (the &#8220;Sunrise Senior Housing Portfolio&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjQ2_efce19ae-8de4-4b32-b282-befeb8b75b99">664</ix:nonFraction>&#160;million, resulting in an immaterial loss on sale, which is recognized in income (loss) from discontinued operations, and provided the buyer with: (i) financing of $<ix:nonFraction unitRef="usd" contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131" decimals="-6" name="us-gaap:PaymentsToAcquireFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNDA0_3d8c263f-7a08-4dae-9e5a-970bc646cba3">410</ix:nonFraction>&#160;million (see Note 6) and (ii) a commitment to finance up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ifc2008e7de824d76a511c1ea5919c432_D20210101-20210131" decimals="-6" name="peak:CapitalExpenditureFundingAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNDYw_e493b825-c2cf-4a13-b0c6-781265bad8f8">92</ix:nonFraction>&#160;million of additional debt for capital expenditures. The commitment to finance additional debt for capital expenditures was subsequently reduced to $<ix:nonFraction unitRef="usd" contextRef="ifdbfd36f6f614b35837a5d8868840c17_D20210601-20210630" decimals="-6" name="peak:CapitalExpenditureFundingAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTY0OTI2NzQ4MjAxOA_a42b2a67-9e8c-49d3-b012-99b68bb7d6d4">56</ix:nonFraction>&#160;million in June 2021 and $<ix:nonFraction unitRef="usd" contextRef="ie9fdf60d4d6e4a599a3fe3f066788531_D20220201-20220228" decimals="-6" name="peak:CapitalExpenditureFundingAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY1NDc2MQ_7a04a7ab-6399-4c7a-9a39-5d19f4b86311">47</ix:nonFraction>&#160;million in February 2022,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ieaf70b6c82e34b11838baffaa23b60f8_D20210101-20220331" decimals="-5" name="peak:CapitalExpenditureFundingAmountFunded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNjI0_aaff3e59-05f6-40b6-b7d0-ce902f4ffc59">0.4</ix:nonFraction> million of which had been funded as of March&#160;31, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(see Note 6). Upon completion of the license transfer process in June 2021, the Company sold the <ix:nonFraction unitRef="property" contextRef="i03a3a9720e7e46b9b6608a5904b366ed_D20210601-20210630" decimals="INF" name="peak:NumberOfPropertiesToBeSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzU5_498107bf-b319-446d-bcd8-edf9cc449d1d">two</ix:nonFraction> remaining Sunrise senior housing triple-net assets for $<ix:nonFraction unitRef="usd" contextRef="i03a3a9720e7e46b9b6608a5904b366ed_D20210601-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfODE3_9ff53813-03ea-4510-a38d-9958b8eb93dc">80</ix:nonFraction>&#160;million, resulting in a gain on sale of $<ix:nonFraction unitRef="usd" contextRef="i03a3a9720e7e46b9b6608a5904b366ed_D20210601-20210630" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfODUy_c981566b-c713-4514-b312-2f3229cfedde">22</ix:nonFraction>&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brookdale Triple-Net Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company sold <ix:nonFraction unitRef="property" contextRef="i7009785976254cb889191c52cf0d0cc9_D20210101-20210131" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfOTg4_7b01d338-41bd-43b1-bb8d-0a8c8b8a92a3">24</ix:nonFraction> senior housing assets in a triple-net lease with Brookdale Senior Living Inc. for $<ix:nonFraction unitRef="usd" contextRef="i67a66f0a44e14e8e838fb65d4719fd54_D20210101-20210131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA1NA_492888e9-a866-49f1-870f-92ae5887657d">510</ix:nonFraction>&#160;million, resulting in total gain on sale of $<ix:nonFraction unitRef="usd" contextRef="i67a66f0a44e14e8e838fb65d4719fd54_D20210101-20210131" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5Mw_3c9c5a06-80f0-43ce-8ae9-edda8e20a401">169</ix:nonFraction>&#160;million, which is recognized in income (loss) from discontinued operations. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i2f78e9918b5f4b5d8ee312bcb3da4ee0" continuedAt="i768b9d7b626c4fbba6cdc60d7e98a343"><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional SHOP Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company sold a portfolio of <ix:nonFraction unitRef="property" contextRef="icb30aa09ba6c452ba2bd4375f636fc3e_D20210101-20210131" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTIzOQ_e07087c8-9757-4a0c-a2e3-d787c9137f08">16</ix:nonFraction> SHOP assets for $<ix:nonFraction unitRef="usd" contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTI1OA_bb1760c4-cc8b-4327-b649-9ebd781d3460">230</ix:nonFraction>&#160;million, resulting in total gain on sale of $<ix:nonFraction unitRef="usd" contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTI5Nw_8e6c1ab4-0788-4dbe-91f9-d314b847ff4b">59</ix:nonFraction>&#160;million, which is recognized in income (loss) from discontinued operations. The Company provided the buyer with financing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131" decimals="-6" name="us-gaap:PaymentsToAcquireFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTQxNw_5546f3fc-64e2-47c7-9d6b-8c57d4ce0c9b">150</ix:nonFraction>&#160;million (see Note </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HRA Triple-Net Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company sold <ix:nonFraction unitRef="property" contextRef="ief256427dde0496199ca30fcac9d8101_D20210201-20210228" decimals="INF" name="peak:NumberOfPropertiesToBeSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTQ5NQ_c04daa54-5634-4b01-bd39-2b5c05de5b87">eight</ix:nonFraction> senior housing assets in a triple-net lease with Harbor Retirement Associates for $<ix:nonFraction unitRef="usd" contextRef="ic6f2032fd45a433f82115899c3e766a1_D20210201-20210228" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTU4MA_81163cd0-8aa7-49b1-8ed6-59c8a5f7d04d">132</ix:nonFraction>&#160;million, resulting in total gain on sale of $<ix:nonFraction unitRef="usd" contextRef="ic6f2032fd45a433f82115899c3e766a1_D20210201-20210228" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTYxOQ_a00ea614-df26-4277-b9c2-79bc453d9515">33</ix:nonFraction>&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oakmont SHOP Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company sold a portfolio of <ix:nonFraction unitRef="property" contextRef="i50d682bf346742efab2a94c7b022bd65_D20210401-20210430" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTc2MA_57dae295-1c75-41ee-9d1a-249101a4b2c2">12</ix:nonFraction> SHOP assets for $<ix:nonFraction unitRef="usd" contextRef="i8726d2fcca104d9daaa243b22c892577_D20210401-20210430" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTc3OQ_018d427b-24e2-42a4-9e19-f147affd6cb8">564</ix:nonFraction>&#160;million. In conjunction with the sale, mortgage debt held on <ix:nonFraction unitRef="property" contextRef="i264d0be7c9de45749d3923b0d2446af1_I20210430" decimals="INF" name="peak:NumberOfAssetsClassifiedAsDiscontinuedOperations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTgzNQ_76fb1ab0-fde3-481b-a2e2-81d45d672699">two</ix:nonFraction> properties with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i0ec4ce4170ce44a9b249e996d2135bcd_D20210401-20210430" decimals="-6" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTg3NA_cdd10966-58d2-47fd-883b-0370ce9e781e">64</ix:nonFraction>&#160;million was repaid and the remaining mortgage debt held on <ix:nonFraction unitRef="property" contextRef="i8a5d586f9aa34c6682d5b91cef0c31bf_D20210401-20210430" decimals="INF" name="peak:DispositionOfPropertiesSoldNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTkyOA_6682bc78-4500-44f5-810a-bd6c7ca4b497">four</ix:nonFraction> properties with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="ia02702389d0b4036880c2a075882418f_D20210401-20210430" decimals="-6" name="peak:NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTk2Nw_d616c754-a887-479d-9ed2-9cf7044d2a38">107</ix:nonFraction>&#160;million was assumed by the buyer. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in total gain on sale of $<ix:nonFraction unitRef="usd" contextRef="i8726d2fcca104d9daaa243b22c892577_D20210401-20210430" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjA0Ng_27a8882e-5e03-4880-a968-de0aa4f7acb8">80</ix:nonFraction>&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discovery SHOP Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company sold a portfolio of <ix:nonFraction unitRef="property" contextRef="i7e3fe506d4b44da2867a8fa3226473f2_D20210401-20210430" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjE4OQ_b54d32fc-09fb-4e75-a98b-1778e74b9730">10</ix:nonFraction> SHOP assets for $<ix:nonFraction unitRef="usd" contextRef="ic6a24264ae7f46a8a0b0ce1820a0cdf5_D20210401-20210430" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjIwOA_76caf769-8ba5-4440-b67c-6802e62ca6d3">334</ix:nonFraction>&#160;million, resulting in total gain on sale of $<ix:nonFraction unitRef="usd" contextRef="ic6a24264ae7f46a8a0b0ce1820a0cdf5_D20210401-20210430" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjI0Nw_ad4dcfab-2b63-47f5-8e5a-d5b16418e0e3">9</ix:nonFraction>&#160;million, which is recognized in income (loss) from discontinued operations. Also included in this transaction was the sale of <ix:nonFraction unitRef="property" contextRef="ib18e864b0cc2475eaf0549bdbf87abc9_D20210401-20210430" decimals="INF" name="peak:FinancingReceivableNumberOfContractsSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjM2OA_e9f75ca5-bbb8-49b5-8f8e-7551beb7e258">two</ix:nonFraction> mezzanine loans and <ix:nonFraction unitRef="property" contextRef="i43ed19b259424a54a9fd61eca57de24e_I20210430" decimals="INF" name="peak:NumberOfPreferredEquityMethodInvestmentsSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjM5MQ_c8df3939-c388-42fb-855c-57a77c812776">two</ix:nonFraction> preferred equity investments for $<ix:nonFraction unitRef="usd" contextRef="ic6a24264ae7f46a8a0b0ce1820a0cdf5_D20210401-20210430" decimals="-6" name="peak:ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjQyNw_121ed1fb-72e4-4793-8a09-d7f240b49b50">21</ix:nonFraction>&#160;million, resulting in <ix:nonFraction unitRef="usd" contextRef="i7e3fe506d4b44da2867a8fa3226473f2_D20210401-20210430" decimals="INF" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjQ0NA_ec1162ba-4980-4a02-9d1d-a94eb00e6e01">no</ix:nonFraction> gain or loss on sale of the investments (collectively, the &#8220;Discovery SHOP Portfolio&#8221;).</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sonata SHOP Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Compa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny sold a portfolio of <ix:nonFraction unitRef="property" contextRef="i84af0aa9f7c94d4f9151e3e70da8c7e8_D20210401-20210430" decimals="INF" name="peak:NumberOfPropertiesToBeSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjYwNA_0a3f4858-5afc-442e-bff7-e4f6696fad56">five</ix:nonFraction> SHOP assets for $<ix:nonFraction unitRef="usd" contextRef="iaaf84ca8adc6410fb6b01b46e57f6e91_D20210401-20210430" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjYyMw_92bda1c0-b9db-4e4e-a90d-38beea43b327">64</ix:nonFraction>&#160;million, resulting in total gain on sale of $<ix:nonFraction unitRef="usd" contextRef="iaaf84ca8adc6410fb6b01b46e57f6e91_D20210401-20210430" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjY2Mg_e7b93947-eaf2-400e-8a2b-1c80c7a1a86c">3</ix:nonFraction>&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SLC SHOP Portfolio</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company sold <ix:nonFraction unitRef="property" contextRef="i768fb35ae40b42f3b26d76cbebeb41db_D20210501-20210531" decimals="INF" name="peak:NumberOfPropertiesToBeSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjc4Mg_7771a3ab-89bf-4520-b4b6-422c298f5f51">seven</ix:nonFraction> SHOP assets for $<ix:nonFraction unitRef="usd" contextRef="i2086cf237ad7470ba8bb6e299b0cd6eb_D20210501-20210531" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjgwMQ_24ee6437-23a8-4db6-ac95-2779261eed3c">113</ix:nonFraction>&#160;million and repaid $<ix:nonFraction unitRef="usd" contextRef="i768fb35ae40b42f3b26d76cbebeb41db_D20210501-20210531" decimals="-6" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjgxNQ_fe5572a2-3919-4385-afa6-b780a915d77e">70</ix:nonFraction>&#160;million of mortgage debt that was held on <ix:nonFraction unitRef="property" contextRef="i84d32d33aa964419bdb8080458aa58da_I20210531" decimals="INF" name="peak:NumberOfAssetsClassifiedAsDiscontinuedOperations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjg1Mg_bb7dcda7-c3e8-47bf-8237-86f197fc662f">six</ix:nonFraction> of the assets, resulting in total gain on sale of $<ix:nonFraction unitRef="usd" contextRef="i2086cf237ad7470ba8bb6e299b0cd6eb_D20210501-20210531" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjkwNQ_0ded2e39-fb43-4993-adfe-aa01c91d55e9">1</ix:nonFraction>&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hoag Hospital</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company sold </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="property" contextRef="i9125ba7c2f5d440aac5f4ef2ac64e4f2_D20210501-20210531" decimals="INF" name="peak:NumberOfPropertiesToBeSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzAyMA_9c694c3d-af20-4178-be47-b5eb84b296e0">one</ix:nonFraction> hospital for $<ix:nonFraction unitRef="usd" contextRef="i9125ba7c2f5d440aac5f4ef2ac64e4f2_D20210501-20210531" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzAzNg_89c1780e-f616-45b1-ad40-fcb4b27604ce">226</ix:nonFraction>&#160;million through the exercise of a purchase option by a tenant, resulting in gain on sale of $<ix:nonFraction unitRef="usd" contextRef="i9125ba7c2f5d440aac5f4ef2ac64e4f2_D20210501-20210531" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzEyMw_25112bb0-98a2-438d-9f5e-c8f29d36ce74">172</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Other Dispositions</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the portfolio and individual sales discussed above, during the year ended December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company sold the following: (i) <ix:nonFraction unitRef="property" contextRef="i3210bc367c264249ac6e064f04637f2a_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzcwNA_304395b3-4e96-4490-b16b-67a5caf27ca5">15</ix:nonFraction> SHOP assets for $<ix:nonFraction unitRef="usd" contextRef="iee73f2738d114cb592962cd2a4fa756e_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzcyMw_583ffc06-f1be-4652-b2fa-7dfe589a54a5">169</ix:nonFraction>&#160;million, (ii) <ix:nonFraction unitRef="property" contextRef="i6b287810f73a4306ad1cedb5a7ee7ac9_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzczMg_0eb6c1ed-5e7a-4488-9b15-a0dd53dc11c3">7</ix:nonFraction> senior housing triple-net assets for $<ix:nonFraction unitRef="usd" contextRef="id2cc7e487b09456dbf42b7ac9a403d3b_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzc3Mg_c6fe4ed1-174c-475f-89ea-8e26f5222df5">24</ix:nonFraction>&#160;million, and (iii) <ix:nonFraction unitRef="property" contextRef="i84e02dec09e34ee98740b651f1f10e6b_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzc4Ng_026f7b95-4ba6-4e8e-a41e-c9c58976ada3">10</ix:nonFraction> MOBs and a portion of 1 MOB land parcel for $<ix:nonFraction unitRef="usd" contextRef="i84e02dec09e34ee98740b651f1f10e6b_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzc5OA_d81eb716-bc15-4c8b-bc73-1058264c4d58">68</ix:nonFraction>&#160;million, resulting in total gain on sales of</span><span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i0f3f388a745246ca875dc4aaac6cfe06_D20210101-20211231" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzgzOA_da88f7fa-8d13-48c1-92db-b272625dbdea">58</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ia1d24420f1c64c1f9b059b4ead94f57e_D20210101-20211231" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzg0Mg_5efb32a3-24af-4766-bb8f-585695852918">39</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of which is recognized in income (loss) from discontinued operations). In conjunction with <ix:nonFraction unitRef="property" contextRef="i45a55cc9f4374e7b973af8776b4c27d8_D20210101-20211231" decimals="INF" name="peak:DispositionOfPropertiesSoldNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODgwNQ_5364748f-13aa-4015-91cb-d9db6170b940">one</ix:nonFraction> of the SHOP asset sales, mortgage debt held on the property with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i0c32446c755a4541aa55ba32256a090f_D20210101-20211231" decimals="-6" name="peak:NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODg5NA_47956e71-c972-4eb8-aee3-4738fdd40bf9">36</ix:nonFraction>&#160;million was assumed by the buyer. Of these sales, <ix:nonFraction unitRef="property" contextRef="i19869f9aece14496a725bc23236ab8e6_D20210101-20210331" decimals="INF" name="peak:NumberOfPropertiesToBeSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY3Mzc2OA_e64c358c-bb91-4fad-8e0a-95c22e2585b3">one</ix:nonFraction> SHOP asset was sold during the three months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for $<ix:nonFraction unitRef="usd" contextRef="i19869f9aece14496a725bc23236ab8e6_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY3Mzc4Nw_1ea26b5c-e35a-4c45-bd42-c8dd488692fd">5</ix:nonFraction>&#160;million resulting in an immaterial gain on sale, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale and Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company established and began executing a plan to dispose of its senior housing triple-net and SHOP properties. As of December 31, 2020, the Company concluded that the planned dispositions represented a strategic shift that had and will have a major effect on the Company&#8217;s operations and financial results. Therefore, senior housing triple-net and SHOP assets meeting the held for sale criteria are classified as discontinued operations in all periods presented herein. In September 2021, the Company successfully completed the disposition of the remaining senior housing triple-net and SHOP properties. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i768b9d7b626c4fbba6cdc60d7e98a343" continuedAt="ic0e2989af4514d2186711fe11ae0ae24"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTM5NTc_8741e2ee-d830-4347-988e-be6c9828c267" continuedAt="i703001d92f0941e6851749e312bf95c6" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the assets and liabilities classified as held for sale or as discontinued operations at March&#160;31, 2022 and December&#160;31, 2021, which are included in assets held for sale and discontinued operations, net and liabilities related to assets held for sale and discontinued operations, net, respectively, on the Consolidated Balance Sheets (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:73.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">ASSETS</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfOS0wLTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjowNzE2ZDRhNDY2YTE0MDgzYmRlM2Y1YWQzMmI5MzA3MF80NQ_a966e744-4f25-4357-824d-a415191eca73">4,146</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfOS0wLTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjowNzE2ZDRhNDY2YTE0MDgzYmRlM2Y1YWQzMmI5MzA3MF81Mg_64a0006a-c648-475a-8b0b-1aa6492d1954">4,138</ix:nonFraction></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfOS0xLTEtMS0xMDc4NDI_047b96a9-24a7-4035-ab6c-1b9e9d4fae39">2,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfOS0zLTEtMS0xMDc4NDI_7ef3148c-248a-49bd-a11b-84449d8953e3">2,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTAtMS0xLTEtMTA3ODQy_0ea00685-2b2b-40da-810c-7a8e5e1b2448">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTAtMy0xLTEtMTA3ODQy_4eb8d2a1-2ae2-426e-be99-1c0c521c035a">7,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTMtMS0xLTEtMTA3ODQy_7d5c748b-b29f-4166-800c-61cef7728f6f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTMtMy0xLTEtMTA3ODQy_274e8ccb-083d-4d18-a912-63eaebb26423">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTQtMS0xLTEtMTA3ODQy_e321b05b-ddb2-45c6-9ee3-e6f487e31d75">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTQtMy0xLTEtMTA3ODQy_c158f1ce-3295-4158-bc7f-33800084dda1">3,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets of discontinued operations, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTUtMS0xLTEtMTA3ODQy_2366b4b3-ae23-4c22-82ad-376855e0e5fc">12,752</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTUtMy0xLTEtMTA3ODQy_e2912c90-7f01-484e-8dc2-f8ddaba65d63">13,416</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets held for sale, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTYtMS0xLTEtMTA3ODQy_40ee9c5c-5c66-48b3-b25a-87657457d604">21,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTYtMy0xLTEtMTA3ODQy_5a470353-20fa-4266-a243-bb9ddbb6d7b3">23,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Assets held for sale and discontinued operations, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="peak:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTctMS0xLTEtMTA3ODQy_96eafec2-9ffe-45be-adcd-ede80a87b928">33,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="peak:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTctMy0xLTEtMTA3ODQy_655529d8-9dfd-42f1-855e-8f6fc067d3b7">37,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">LIABILITIES</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjAtMS0xLTEtMTA3ODQy_4ddc8515-38c6-4e94-b72b-9964f58048ed">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjAtMy0xLTEtMTA3ODQy_ff8cfb93-9067-4cfc-ae90-3a956d57ac26">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjEtMS0xLTEtMTA3ODQy_7118a09e-d209-4793-9b64-9e8395d06926">14,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjEtMy0xLTEtMTA3ODQy_d6ed2d88-88bb-4707-8574-0a5c196b67f3">14,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjItMS0xLTEtMTA3ODQy_f570e9da-43f1-4a26-a675-a40883f57d94">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjItMy0xLTEtMTA3ODQy_bafae696-09cf-429b-b5fe-b89acf7b66c2">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities of discontinued operations, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjMtMS0xLTEtMTA3ODQy_327d2f73-d0e4-43c5-ba31-5afefa61575b">14,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjMtMy0xLTEtMTA3ODQy_99e7461f-e990-478f-9071-9b8b1623f32a">14,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjQtMS0xLTEtMTA3ODQy_6367970d-da11-47ef-bc84-040c64569914">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjQtMy0xLTEtMTA3ODQy_babc681d-d2f3-4ecc-88d0-34c398612a3f">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Liabilities related to assets held for sale and discontinued operations, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-3" name="peak:LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjUtMS0xLTEtMTA3ODQy_9f8d6388-500b-4e6e-8131-4e11a073ad55">14,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-3" name="peak:LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjUtMy0xLTEtMTA3ODQy_af959f02-ef41-4c5a-80b2-f69fcc227b93">15,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of March&#160;31, 2022, primarily comprised of <ix:nonFraction unitRef="property" contextRef="i1569210fb45b498ca4ddd9523c7ddcb6_I20220331" decimals="INF" name="peak:PropertiesHeldForSaleNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzY2NQ_9e9424d3-5c4b-4735-8bd7-68ff95ff6d04">five</ix:nonFraction> MOBs with net real estate assets of $<ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-6" name="peak:NetRealEstateAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzczMw_b4ddf634-fbdd-4d04-9661-95fac2e7e179">20</ix:nonFraction>&#160;million and right-of-use asset, net of $<ix:nonFraction unitRef="usd" contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzc2Nw_340a449c-a257-4065-8c4e-484271aa539d">1</ix:nonFraction>&#160;million. As of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December&#160;31, 2021, primarily comprised of <ix:nonFraction unitRef="property" contextRef="i56ab9d8a9a964a9c9b0142d3248692e9_I20211231" decimals="INF" name="peak:PropertiesHeldForSaleNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzg2Ng_f6e1133d-eba1-4c8a-982b-d9e219f2e4c7">four</ix:nonFraction> MOBs and <ix:nonFraction unitRef="property" contextRef="i8a389db75eb34b51821f969f46a2eb96_I20211231" decimals="INF" name="peak:PropertiesHeldForSaleNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0OTE4NA_ee38f51f-07aa-4dca-a61d-f65cc2b357cb">one</ix:nonFraction> life science facility with net real estate assets of $<ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-6" name="peak:NetRealEstateAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzkwNQ_6f900058-957d-46b8-850b-cb0a104bc672">23</ix:nonFraction>&#160;million and right-of-use asset, net of $<ix:nonFraction unitRef="usd" contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzkzMg_303b377c-3077-4b67-ac7f-313401a01e25">1</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="ic0e2989af4514d2186711fe11ae0ae24" continuedAt="i255d785d2c6242a6b4363a2773241f7e"><ix:continuation id="i703001d92f0941e6851749e312bf95c6"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of discontinued operations during the three months ended March&#160;31, 2022 and 2021, or through the disposal date of each asset or portfolio of assets if they have been sold during such periods, as applicable, are included in the consolidated results of operations for the three months ended March&#160;31, 2022 and 2021. Summarized financial information for discontinued operations for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:73.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.289%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Rental and related revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRentalIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMy0xLTEtMS0xMDc4NDI_5f3eab05-fa62-4c87-a28d-eccaeb3dce40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRentalIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMy0zLTEtMS0xMDc4NDI_6a38d35f-0d7c-4e9d-87bb-5ca2471ac7bc">5,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Resident fees and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfNC0xLTEtMS0xMDc4NDI_6488cc78-28f8-4c50-9c36-d6cfc09eb2ee">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfNC0zLTEtMS0xMDc4NDI_e4750831-25f7-40ac-88ff-b3d5f0c518d7">72,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfNi0xLTEtMS0xMDc4NDI_1ff9cb1f-acf4-4be6-8965-03d9e23589e3">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfNi0zLTEtMS0xMDc4NDI_2bdf9112-c998-43c4-9d0d-8e2094bb54b1">78,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfOC0xLTEtMS0xMDc4NDI_ced2c001-0982-4578-8aad-1151170921cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfOC0zLTEtMS0xMDc4NDI_bba85852-8be5-434b-8816-cfc3417f7610">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTAtMS0xLTEtMTA3ODQy_b63ab16a-efc1-41b1-8d68-19082d666d77">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTAtMy0xLTEtMTA3ODQy_c3d87498-ac4d-40e9-a916-d787b2584978">71,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationTransactionCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTEtMS0xLTEtMTA3ODQy_8acb986b-375f-4b0e-a704-81f72dc0cc42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTEtMy0xLTEtMTA3ODQy_c3de9b1c-7960-40ae-9d6e-941c3d30427f">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTMtMS0xLTEtMTA3ODQy_da699e5f-b2ef-4afa-b617-c1a6e7385918">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTMtMy0xLTEtMTA3ODQy_46634df9-ffb1-4cc6-9d20-a4d5a010092e">74,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTUtMS0xLTEtMTA3ODQy_79fe3d93-38f3-4796-94dc-fd1bc4f68bb7">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTUtMy0xLTEtMTA3ODQy_9d72b265-842f-4019-9bde-924de224a929">259,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTYtMS0xLTEtMTA3ODQy_a1cecfc3-a121-450f-b299-c0b0701903fc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTYtMy0xLTEtMTA3ODQy_132077fb-c0ca-4f36-a5d9-1b4e49dcae78">5,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" sign="-" name="peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTctMS0xLTEtMTA3ODQy_4aecf6ab-aeac-45d7-8372-9704cba3e450">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTctMy0xLTEtMTA3ODQy_06c48986-3d31-4d95-bcf9-5f961ec95204">265,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTgtMS0xLTEtMTA3ODQy_e8cc4b3c-3605-4020-bb6a-cc8d66ee46e1">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTgtMy0xLTEtMTA3ODQy_f907a0de-1f85-4705-beb9-dfff8a34b69d">269,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTktMS0xLTEtMTA3ODQy_4058a5c1-f4fd-4f9e-ae2b-398711f446ee">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTktMy0xLTEtMTA3ODQy_03dc0d9a-18a7-4888-9895-51ef6da3d7bd">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMjAtMS0xLTEtMTA3ODQy_c2a49c78-b52b-4681-a3ae-71b1a355c599">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" sign="-" name="peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMjAtMy0xLTEtMTA3ODQy_9074b16a-8f18-4cc1-ad37-860979c719e9">315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMjItMS0xLTEtMTA3ODQy_685e0cc8-683e-4fc0-984f-50d0cb06d823">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMjItMy0xLTEtMTA3ODQy_130b9f21-9158-4d61-a146-f851fb7caf0e">270,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairments of Real Estate</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, the Company did <ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="INF" name="us-gaap:ImpairmentOfRealEstate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0OTkwNw_094278f1-4318-4493-80a8-bdf3e1e2f7f4"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="INF" name="us-gaap:ImpairmentOfRealEstate" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0OTkwNw_ec057448-e578-4fad-a17d-7e8534effe21">no</ix:nonFraction></ix:nonFraction>t recognize any impairment charges.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Losses</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i255d785d2c6242a6b4363a2773241f7e">During the three months ended March&#160;31, 2022, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="icdbce058783d4ada87cc4191afef5777_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonrecurringExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY2OTczNA_dfedf7a0-1595-4474-bc1b-9dd3d0fba889">14</ix:nonFraction>&#160;million of expenses within other income (expense), net on the Consolidated Statements of Operations for tenant relocation and other costs associated with a planned MOB demolition.</ix:continuation></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="ifa3dff468a15495db7b57c65ada0de74_49"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:OperatingLeasesOfLessorDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTQzOA_c4509fc7-875d-456c-9e8d-c0cd8721371d" continuedAt="ic288ca53229a494bac86d434b1e604a7" escape="true"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:LessorDirectFinancingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTQ1Mg_d323f71d-f0d5-4537-b895-bc436c05a228" continuedAt="ia1d0ec9e10354fa58fc50bfc44db8c2f" escape="true">Leases </ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="ic288ca53229a494bac86d434b1e604a7" continuedAt="i896be1ed10cb4b998cd6ee4b39e45943"><ix:continuation id="ia1d0ec9e10354fa58fc50bfc44db8c2f" continuedAt="i2b79374b18a24bce8ea00cf2cece07fb"><div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Income</span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTQzNw_f8149768-7741-429d-a421-1325e8574a31" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNS0xLTEtMS0xMDc4NDI_86dd7e22-f327-4d8d-bb13-21257994efe1">287,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNS0zLTEtMS0xMDc4NDI_ea492410-7ca0-40a2-931a-2802979a37b7">262,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseVariableLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNi0xLTEtMS0xMDc4NDI_a9ec9d6a-f732-48a6-9337-f7f947fb7ac4">82,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseVariableLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNi0zLTEtMS0xMDc4NDI_7fa425da-a0f2-45dc-8e4c-42070882e94f">65,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:DirectFinancingLeaseInterestIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNy0xLTEtMS0xMDc4NDI_a964849e-c3d7-417f-ba2f-b91875cd759f">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:DirectFinancingLeaseInterestIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNy0zLTEtMS0xMDc4NDI_e2b9bf51-e672-4aef-9129-717a6e87d1cc">2,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Direct Financing Leases</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Direct Financing Lease Sale</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company sold its remaining hospital classified as a direct financing lease (&#8220;DFL&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfLeaseReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTA5OTUxMTYzMDI1MQ_233cc321-688c-4259-a649-51dd5196fbe3">68</ix:nonFraction> million and recognized a gain on sale of $<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-6" name="us-gaap:GainLossOnSaleOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTA5OTUxMTYzMDI4OQ_5f20dddb-7b81-4315-8641-ed62e75ac5aa">23</ix:nonFraction> million, which is included in other income (expense), net. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i896be1ed10cb4b998cd6ee4b39e45943" continuedAt="ie018ad360f854175956031fdddb260cd"><ix:continuation id="i2b79374b18a24bce8ea00cf2cece07fb" continuedAt="i72924fc61f784feebdd00114b89f71f6"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="peak:ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTQ0OQ_38f82d48-d378-46c1-a094-5084a00ca84a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment in DFLs consists of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:DirectFinancingLeaseLeaseReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMS0xLTEtMS0xMDc4NDI_0e4c30a8-2f4b-4aad-a333-bf679862e55b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:DirectFinancingLeaseLeaseReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMS0zLTEtMS0xMDc4NDI_68474422-922e-430e-8a2c-8237157a0d35">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of estimated residual value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:DirectFinancingLeaseUnguaranteedResidualAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMi0xLTEtMS0xMDc4NDI_57e2a71f-e732-43b3-a99c-805a257ba1a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:DirectFinancingLeaseUnguaranteedResidualAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMi0zLTEtMS0xMDc4NDI_965c266c-57b4-4e70-888d-44f1b930492a">44,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less deferred selling profits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:DirectFinancingLeaseDeferredSellingProfit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMy0xLTEtMS0xMDc4NDI_2e37efad-7c77-4dae-8afe-8240cafe22e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:DirectFinancingLeaseDeferredSellingProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMy0zLTEtMS0xMDc4NDI_de2af938-8bf7-4b4b-8668-7cdd29f50db5">1,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in direct financing leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:DirectFinancingLeaseNetInvestmentInLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfNi0xLTEtMS0xMDc4NDI_1c927c71-3ff4-42db-86fa-44040998009a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:DirectFinancingLeaseNetInvestmentInLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfNi0zLTEtMS0xMDc4NDI_1a43a010-0acf-4ccb-ac15-5ec75c367581">44,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Direct Financing Lease Internal Ratings</span></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie018ad360f854175956031fdddb260cd"><ix:continuation id="i72924fc61f784feebdd00114b89f71f6">At March&#160;31, 2022, the Company had <ix:nonFraction unitRef="property" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="INF" name="peak:PropertiesWithDirectFinancingLeasesNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTA5OTUxMTYzMjE2MA_3640bc59-85ff-45a0-873d-d126e316b608">no</ix:nonFraction> properties classified as a DFL. At December&#160;31, 2021, the Company had <ix:nonFraction unitRef="property" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="INF" name="peak:PropertiesWithDirectFinancingLeasesNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMzEw_76e79dcc-0ca2-4bd8-be86-f7c57a92b262">one</ix:nonFraction> hospital classified as a DFL with a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-6" name="us-gaap:DirectFinancingLeaseNetInvestmentInLease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMzQwODQ4NjA0NjU2MjA_21a7ea50-ded2-4361-a4f2-03358ca6d73c">45</ix:nonFraction>&#160;million and an internal rating of &#8220;performing&#8221;.</ix:continuation></ix:continuation> </span></div><div id="ifa3dff468a15495db7b57c65ada0de74_52"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTAwNjk_fd8a7515-61e7-46af-ab42-52ebc00bc95d" continuedAt="i22f5a1f6eca64756a4757942ea7ec311" escape="true">Loans Receivable</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i22f5a1f6eca64756a4757942ea7ec311" continuedAt="i1f3431a5a06a4f3db12c322500cab70a"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTAwNTg_29287b30-dfc8-4651-8315-1e5db037bdc7" continuedAt="i9715a729fb444a5890ee8ac5b9a5b740" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s loans receivable (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4353c6ea944e2cb45a86e8adbf210f_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMS0xLTEtMS0xMDc4NDI_a9cc7b72-cbea-4686-bdae-93198abb2fcf">388,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icadee8ad9d5d4a2ca975702b7fe2f6ed_I20211231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMS0zLTEtMS0xMDc4NDI_643545d1-d403-4a24-8b05-b0241933e2e1">396,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5761108dca5e417ab51b1f7ea8aa2e7f_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMi0xLTEtMS0xMDc4NDI_9e30f96b-6c9f-4261-bb8e-adb7ebd34ef1">26,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37ae13c73e634e68b31c4c1cdc3d0d7b_I20211231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMi0zLTEtMS0xMDc4NDI_c23a32ec-707d-441c-a058-23a3eb910c16">25,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts, fees, and costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" sign="-" name="us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMy0xLTEtMS0xMDc4NDI_c38f65b1-0e53-4036-8592-adeb78c110d5">3,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" sign="-" name="us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMy0zLTEtMS0xMDc4NDI_ea10ae80-988b-4131-beac-65d594696c25">4,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfNC0xLTEtMS0xMDc4NDI_0c62874f-e7f4-4bc1-8512-17463740bd58">1,944</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfNC0zLTEtMS0xMDc4NDI_748ad4f3-a958-4767-9490-f90288e7ba7b">1,813</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfNS0xLTEtMS0xMDc4NDI_e69b1454-e404-4055-a2ac-d986ad82c9e1">409,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfNS0zLTEtMS0xMDc4NDI_411b0934-62c1-45c3-ae0a-f28a970f6d93">415,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div></ix:nonNumeric><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="i9715a729fb444a5890ee8ac5b9a5b740"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At March&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-6" name="peak:FinancingReceivableRemainingCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTc4_7a987b5d-643f-4922-b932-4759726c2dba">49</ix:nonFraction> million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects. At December&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-6" name="peak:FinancingReceivableRemainingCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzAw_f76e5412-993a-4d95-902e-9f25c95afd87">58</ix:nonFraction> million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.</span></ix:continuation><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SHOP Seller Financing</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the sale of <ix:nonFraction unitRef="property" contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDU0_0cbc9101-da1f-4e13-97f6-5a0f5db4b539">32</ix:nonFraction> SHOP facilities in the Sunrise Senior Housing Portfolio for $<ix:nonFraction unitRef="usd" contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNTE3_7c01807f-6431-4fd0-93ea-1266db7cded2">664</ix:nonFraction>&#160;million in January 2021 (see Note 4), the Company provided the buyer with initial financing of $<ix:nonFraction unitRef="usd" contextRef="ifc2008e7de824d76a511c1ea5919c432_D20210101-20210131" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNjA4_eeb05023-eb21-4abe-94cd-10ee87c155f4">410</ix:nonFraction>&#160;million. The remainder of the sales price was received in cash at the time of sale. Additionally, the Company agreed to provide up to $<ix:nonFraction unitRef="usd" contextRef="ifc2008e7de824d76a511c1ea5919c432_D20210101-20210131" decimals="-6" name="peak:CapitalExpenditureFundingAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNzM3_e493b825-c2cf-4a13-b0c6-781265bad8f8">92</ix:nonFraction>&#160;million of additional financing for capital expenditures (up to <ix:nonFraction unitRef="number" contextRef="i23d980d9806942e0886bf4d30eb148c5_I20210131" decimals="INF" name="peak:CapitalExpenditureFundingCostOfCapitalPercentCommitted" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNzk2_6bd7dd1d-26a0-459e-8c4e-5a5291f854ab">65</ix:nonFraction>% of the estimated cost of capital expenditures). The additional financing was subsequently reduced to $<ix:nonFraction unitRef="usd" contextRef="ifdbfd36f6f614b35837a5d8868840c17_D20210601-20210630" decimals="-6" name="peak:CapitalExpenditureFundingAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfOTAw_21e1c17c-c170-43b4-bb55-8c8de0a7d02f">56</ix:nonFraction>&#160;million in June 2021 and $<ix:nonFraction unitRef="usd" contextRef="ie9fdf60d4d6e4a599a3fe3f066788531_D20220201-20220228" decimals="-6" name="peak:CapitalExpenditureFundingAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTY0MTU2OQ_7a04a7ab-6399-4c7a-9a39-5d19f4b86311">47</ix:nonFraction>&#160;million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in February 2022 in conjunction with the principal repayments discussed below.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="ieaf70b6c82e34b11838baffaa23b60f8_D20210101-20220331" decimals="-5" name="peak:CapitalExpenditureFundingAmountFunded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfOTY1_aaff3e59-05f6-40b6-b7d0-ce902f4ffc59">0.4</ix:nonFraction> million of the additional financing had been funded. The initial and additional financing is secured by the buyer's equity ownership in each property.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company received principal repayments of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i11671c496b994973af5e617cd736d08c_D20210601-20210630" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTE2MA_be926c54-96dd-4c19-96ff-e3ba496329c5">246</ix:nonFraction>&#160;million on the initial financing provided in conjunction with the sale of the Sunrise Senior Housing Portfolio. Additionally, in February 2022, the Company received principal repayments of $<ix:nonFraction unitRef="usd" contextRef="i1830004bc9a241ae9fa37e55c2d28202_D20220201-20220228" decimals="-6" name="us-gaap:ProceedsFromCollectionOfLoansReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTY0MTQ4Mw_5fe1674b-3529-4784-86dd-7d8a627db868">8</ix:nonFraction>&#160;million in conjunction with the disposition of the underlying collateral. As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022 and December&#160;31, 2021, this secured loan had an outstanding balance of $<ix:nonFraction unitRef="usd" contextRef="ifdb0da742c3d4dc2878b9efd7818fd4a_I20220331" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTYzODU1MA_2014957f-5770-4c68-8d86-fac9b8dcd8fd">157</ix:nonFraction>&#160;million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ia143e4423ee545cb944c9846d1bf5a01_I20211231" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTY0MTQ5NQ_8c283202-f234-4bc2-866b-1b2b1e3061f7">165</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the sale of <ix:nonFraction unitRef="property" contextRef="icb30aa09ba6c452ba2bd4375f636fc3e_D20210101-20210131" decimals="INF" name="peak:NumberOfPropertiesToBeSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTUwNw_c9530107-273a-411d-8705-26a267de53b2">16</ix:nonFraction> additional SHOP facilities for $<ix:nonFraction unitRef="usd" contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTU0MQ_e1686ff4-ce8e-4970-a41a-75dbfc729fb8">230</ix:nonFraction>&#160;million in January 2021 (see Note 4), the Company provided the buyer with financing of $<ix:nonFraction unitRef="usd" contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTYyNA_b135fb62-b715-43fb-98ed-6bfca3e3c8f3">150</ix:nonFraction>&#160;million. The remainder of the sales price was received in cash at the time of sale. The financing is secured by the buyer's equity ownership in each property.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the Company reduced the consideration and reported gain on sales of real estate and recognized a mark-to-market discount of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ib7fff5de172f473c9b163cd5408ad706_D20210101-20210331" decimals="-6" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjI4MQ_f5fecd23-8031-4f2e-8e79-8619a9e3d17d">16</ix:nonFraction>&#160;million for certain transactions with seller financing. The Company&#8217;s discount is based on the difference between the stated interest rates (ranging from <ix:nonFraction unitRef="number" contextRef="i861ec35878514b2cb35e6fe1f899825f_I20210331" decimals="4" name="peak:LoansReceivableStatedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjQzMA_6c0abff9-ddb2-48c7-85ad-d519564e3474">3.50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id286ba246e874843bc8dd2638e1faa98_I20210331" decimals="4" name="peak:LoansReceivableStatedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjQzNg_2752c265-af25-4995-ac0b-6e15b7ae4407">4.50</ix:nonFraction>%) and corresponding prevailing market rates of approximately <ix:nonFraction unitRef="number" contextRef="ia298127fc81840afbfc9f29801f74a20_I20210331" decimals="4" name="peak:LoansReceivableMarketRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjQ5OQ_e8d8010d-5599-4a87-baf8-98d960cb2f31">5.25</ix:nonFraction>% as of the transaction dates.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount is recognized as interest income over the term of the discounted loans (ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjYyOQ_aeb0d2ee-ccfb-4404-9b1a-c227b91e018e">one</span> to <ix:nonNumeric contextRef="i8e457939b7f044ffbc4f9cf2945b94a2_D20210101-20210331" name="peak:LoansReceivableInterestIncomeAmortizationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjYzNQ_9ef7e5da-c8c9-4a34-94eb-e07436ca21bb">three years</ix:nonNumeric>) using the effective interest rate method. During the three months ended March&#160;31, 2022 and 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="ie000ff8c480e49299647b1b49c710ab5_D20220101-20220331" decimals="-6" name="peak:NoncashOrPartNoncashInterestIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjczNQ_98d31054-e90e-4a22-b09d-42ddb4562594">1</ix:nonFraction>&#160;million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ib7fff5de172f473c9b163cd5408ad706_D20210101-20210331" decimals="-6" name="peak:NoncashOrPartNoncashInterestIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjc0Mg_5bdb5b49-5f88-4be4-905b-a920cdb07645">2</ix:nonFraction>&#160;million, respectively, of non-cash interest income related to the amortization of its mark-to-market discounts.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i1f3431a5a06a4f3db12c322500cab70a" continuedAt="i79ae25326ef040fd926c1066a0ba6f76"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Other Loans Receivable Transactions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies a loan receivable as held for sale when management no longer has the intent or ability to hold the loan receivable for the foreseeable future or until maturity. If a loan receivable is classified as held for sale, previously recorded reserves for loan losses are reversed and the loan is reported at the lower of amortized cost or fair value. During the second quarter of 2021, <ix:nonFraction unitRef="property" contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630" decimals="INF" name="peak:FinancingReceivableHeldForSaleNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzU5OA_0fa7ea2d-5384-4d54-b36b-18f00db1f88a">two</ix:nonFraction> loans receivable with a total amortized cost of $<ix:nonFraction unitRef="usd" contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzY0OQ_b97f6f35-9e22-4587-bb09-877bf1aa5bc3">64</ix:nonFraction>&#160;million were classified as held for sale. Upon the transfer of these <ix:nonFraction unitRef="property" contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630" decimals="INF" name="peak:FinancingReceivableHeldForSaleNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzcxMw_0fa7ea2d-5384-4d54-b36b-18f00db1f88a">two</ix:nonFraction> loans to held for sale, the carrying value was decreased by $<ix:nonFraction unitRef="usd" contextRef="i621bef727d6848c28d61e1f5dc2a0688_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzc3Ng_028b8cd4-0e14-4f35-920d-b6db5cf474f6">11</ix:nonFraction>&#160;million to an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzgwOQ_2d512b84-5df5-4fe4-837e-8b3a7bb865a6">53</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630" decimals="-6" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzgxMw_eb346d7b-b58c-4103-ae9d-812cc9b18875">8</ix:nonFraction>&#160;million of which was previously recognized as a reserve for loan losses. In 2021, the Company sold these <ix:nonFraction unitRef="loan" contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" decimals="INF" name="peak:FinancingReceivableNumberOfContractsSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTYzOTQ4MA_6f5a46d4-f287-4555-aa5a-8f319e942ba5">two</ix:nonFraction> loans receivable previously classified as held for sale for their aggregate carrying value of $<ix:nonFraction unitRef="usd" contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTYzOTU2Mg_49cd1b87-7e94-4b75-a73a-a63f0c185ab8">53</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These fair value estimates were made for each individual loan classified as held for sale and primarily relied on a market approach, utilizing comparable market transactions, forecasted sales prices, and negotiations with prospective buyers. These estimates are considered to be a Level 3 measurement within the fair value hierarchy, and are subject to inherent uncertainties.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in April 2021, the Company sold <ix:nonFraction unitRef="property" contextRef="i8c295f7730a9480c8ecfc74218b82db1_I20210430" decimals="INF" name="peak:FinancingReceivableHeldForSaleNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDQyMA_9acf37cc-6101-44c5-a08f-0e48f88d3324">two</ix:nonFraction> mezzanine loans as part of the Discovery SHOP Portfolio disposition (see Note 4), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulting in <ix:nonFraction unitRef="usd" contextRef="ib18e864b0cc2475eaf0549bdbf87abc9_D20210401-20210430" decimals="INF" name="us-gaap:GainLossOnSaleOfNotesReceivable" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDUxOQ_1303eb8d-6664-4bfb-b26b-b201e5e33739">no</ix:nonFraction> gain or loss on sale of the mezzanine loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company received a $<ix:nonFraction unitRef="usd" contextRef="i3e06e81b0ec74155af21cdd896273b28_D20210501-20210531" decimals="-6" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDYwMw_52c5e2fe-2f8d-4b79-9b9c-d40fdaf52ae2">10</ix:nonFraction>&#160;million principal repayment related to <ix:nonFraction unitRef="property" contextRef="i3e06e81b0ec74155af21cdd896273b28_D20210501-20210531" decimals="INF" name="peak:FinancingReceivableNumberOfContracts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDYzNw_27c2a1a0-6cf2-4d40-a1f7-33ee989c33a0">one</ix:nonFraction> of its secured loans. In September 2021, the Company received repayment of the remaining $<ix:nonFraction unitRef="usd" contextRef="i166380b792354cd99bcdce4b5c2a3d09_D20210901-20210930" decimals="-6" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDcyOQ_b9e55ec5-d37a-4779-a5f1-81bb1eab651f">15</ix:nonFraction>&#160;million balance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company received full repayment of the outstanding balance of an $<ix:nonFraction unitRef="usd" contextRef="i280e47a3f1d647aeab62193c0845ca90_D20210701-20210731" decimals="-6" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDgyNA_86a5d393-ece6-432e-97a5-54e3575326e1">8</ix:nonFraction>&#160;million secured loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CCRC Resident Loans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain residents that qualify, CCRCs may offer to lend residents the necessary funds to satisfy the entrance fee requirements so that they are able to move into a community while still continuing the process of selling their previous home. The loans are due upon sale of the previous residence. At March&#160;31, 2022 and December&#160;31, 2021, the Company held</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ic4c7caa3dd3149cd8911377afa83f122_I20220331" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNTY2MQ_442b6747-bfed-4fca-9bf4-825a48ba800c">25</ix:nonFraction> million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i6feec1d68f9349e7b96730a474b98cb8_I20211231" decimals="-6" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTY0MDA2Mg_945125eb-150e-424f-970b-ad765206a4b3">24</ix:nonFraction>&#160;million, respectively, of such notes receivable, which are included in mezzanine and other in the table above.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loans Receivable Internal Ratings </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s quarterly review process or upon the occurrence of a significant event, loans receivable are reviewed and assigned an internal rating of Performing, Watch List, or Workout. Loans that are deemed Performing meet all present contractual obligations, and collection and timing of all amounts owed is reasonably assured. Watch List Loans are defined as loans that do not meet the definition of Performing or Workout. Workout Loans are defined as loans in which the Company has determined, based on current information and events, that: (i) it is probable it will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the borrower is delinquent on making payments under the contractual terms of the agreement, and (iii) the Company has commenced action or anticipates pursuing action in the near term to seek recovery of its investment.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i79ae25326ef040fd926c1066a0ba6f76"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTAwNzc_6c05beb4-ddb2-4315-9f82-cd8a4bf7220d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, by year of origination, the Company&#8217;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.164%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Origination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f708bf5a04fec813c493611999629_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC0yLTEtMS0xMDc4NDI_26aa6565-7845-4078-b689-b95a1796b901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f708bf5a04fec813c493611999629_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC00LTEtMS0xMDc4NDI_a29016aa-72fc-4d37-ae4e-b0a3154e861f">301,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f708bf5a04fec813c493611999629_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC02LTEtMS0xMDc4NDI_645d8e7f-c977-46ff-acdd-fdd4921f1b80">79,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f708bf5a04fec813c493611999629_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC04LTEtMS0xMDc4NDI_2e1ec6d1-cf37-49ea-be90-536268b81338">2,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f708bf5a04fec813c493611999629_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC0xMC0xLTEtMTA3ODQy_d026d958-6e46-4799-8f57-24c9d01c3388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f708bf5a04fec813c493611999629_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC0xMS0xLTEtMTA3ODQy_c7fce25c-17ea-4371-82e6-86f0358720a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf2f708bf5a04fec813c493611999629_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC0xMy0xLTEtMTA3ODQy_550668d0-92d5-41a1-ac6f-535d4fda6bce">383,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS0yLTEtMS0xMDc4NDI_1e7c8fdc-4ad0-4a70-a818-7684cd7efdb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS00LTEtMS0xMDc4NDI_68a8e354-0776-479a-b1ae-89b0238fe8ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS02LTEtMS0xMDc4NDI_d4f40e20-a383-4a77-820b-7b7e7645ea6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS04LTEtMS0xMDc4NDI_f11bc323-8a03-4387-8305-802bf3f91de7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS0xMC0xLTEtMTA3ODQy_517b039d-ff78-4d57-8cfa-6a3ff21d664c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS0xMS0xLTEtMTA3ODQy_20c402fb-842b-452e-877c-88c595cb890b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS0xMy0xLTEtMTA3ODQy_126f37d7-8879-4a02-8af3-584d3478e1c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi0yLTEtMS0xMDc4NDI_3c291e06-f9e9-4568-bcc9-fd69aa678d90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi00LTEtMS0xMDc4NDI_d49018e8-c533-4b4a-a4aa-30d9f33b43b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi02LTEtMS0xMDc4NDI_ad8f0dfa-f959-46e8-ab4e-6161b0d959d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi04LTEtMS0xMDc4NDI_7a3fb180-6310-420c-bef7-a7cd85565e42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi0xMC0xLTEtMTA3ODQy_d4c4b2c0-57af-4a70-b048-5a77fe880095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi0xMS0xLTEtMTA3ODQy_299b1555-2711-4367-baab-9e891451ff5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi0xMy0xLTEtMTA3ODQy_6410d281-d8f4-47cb-82ce-1213d9a5928b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy0yLTEtMS0xMDc4NDI_e0e4dde6-aaa8-40b7-9db9-e9e5690da92b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy00LTEtMS0xMDc4NDI_79b88183-595c-4c73-a5f0-db7ae847c6a3">301,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy02LTEtMS0xMDc4NDI_15a742a4-9c2a-414c-8830-750cb688ddcc">79,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy04LTEtMS0xMDc4NDI_7a556f2d-f4fe-4dca-86c2-e720c2d6dc95">2,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy0xMC0xLTEtMTA3ODQy_3800b819-99ed-4ee5-90f7-f45d4f3fa26f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy0xMS0xLTEtMTA3ODQy_3bb38422-73af-408a-9a22-79c57bc2b76d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy0xMy0xLTEtMTA3ODQy_60aa2f15-1017-413b-a4c4-875e5cfa4357">383,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtMi0xLTEtMTA3ODQy_98050eb0-9770-4d89-8b08-5a459858fbc5">12,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtNC0xLTEtMTA3ODQy_f4fa52da-b9da-4b1c-abd3-fd1cd53ab65a">12,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtNi0xLTEtMTA3ODQy_662a364e-958d-46a4-b902-c406a04e60c9">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtOC0xLTEtMTA3ODQy_c02ffaf5-4b87-4dc0-a42d-f67348f0fc14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtMTAtMS0xLTEwNzg0Mg_516a7155-8e00-46e9-b219-c3d5b2855f5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtMTEtMS0xLTEwNzg0Mg_73959924-9119-466b-b9c8-ab0f9235ab5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtMTMtMS0xLTEwNzg0Mg_31461522-7ad1-4111-83d9-bba2c95d8765">26,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtMi0xLTEtMTA3ODQy_0a4750e6-7a66-4ebd-bde0-6fbb8b6aa820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtNC0xLTEtMTA3ODQy_47b42e28-f23b-4149-8474-278931454630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtNi0xLTEtMTA3ODQy_6f645fb2-df33-4e4c-b72b-56e0b3f51c85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtOC0xLTEtMTA3ODQy_436f9b83-ba8b-4e29-92a3-7e07b21d9465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtMTAtMS0xLTEwNzg0Mg_62d2a050-1c06-46e5-9249-e25b8c4cf4aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtMTEtMS0xLTEwNzg0Mg_2dda99db-2bd3-4b3f-906a-9c9544f32ada">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtMTMtMS0xLTEwNzg0Mg_9b46acc9-c197-4077-ab87-fbbeb3a164ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtMi0xLTEtMTA3ODQy_3e7d6abf-1126-4250-b42a-9160b3c5b185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtNC0xLTEtMTA3ODQy_99d8d6b2-7f0d-41c9-9389-1b0b912f3570">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtNi0xLTEtMTA3ODQy_85b102b1-359f-488f-9580-2ebd87d26772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtOC0xLTEtMTA3ODQy_920bed4c-baba-41b0-831a-03b46c7e6514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtMTAtMS0xLTEwNzg0Mg_3e402992-6a86-474b-805f-9fb367c1dcf1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtMTEtMS0xLTEwNzg0Mg_7fe8204c-8805-4f3d-8cfa-d49006bcd1e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtMTMtMS0xLTEwNzg0Mg_3916826f-10e9-4323-adb4-e22ed22d4727">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total mezzanine and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtMi0xLTEtMTA3ODQy_6aa0fd6e-33da-4e93-aa51-3321b64fe5a7">12,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtNC0xLTEtMTA3ODQy_57e28b4f-8021-41f8-9de8-8d3a55a1860d">12,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtNi0xLTEtMTA3ODQy_f40bac68-0254-4650-9448-dc9059d53a08">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtOC0xLTEtMTA3ODQy_1b0b09b9-fdfb-48d7-b966-27428c74cc45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtMTAtMS0xLTEwNzg0Mg_b297ea79-b969-4e8e-b187-0980bc232abc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtMTEtMS0xLTEwNzg0Mg_6b9d7dd2-ea8e-4739-832f-441a2926b8f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtMTMtMS0xLTEwNzg0Mg_dab0f78e-d5d2-429d-84e3-d33957e9fc96">26,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserve for Loan Losses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, individual and portfolio property performance, credit enhancements, liquidity, and other factors. The determination of loan losses also considers concentration of credit risk associated with the senior housing industry to which its loans receivable relate. The Company&#8217;s borrowers furnish property, portfolio, and guarantor/operator-level financial statements, among other information, on a monthly or quarterly basis, which the Company utilizes to calculate the debt service coverages used in its assessment of internal ratings, which is a primary credit quality indicator. Debt service coverage information is evaluated together with other property, portfolio, and operator performance information, including revenue, expense, NOI, occupancy, rental rates, capital expenditures, and EBITDA (defined as earnings before interest, tax, and depreciation and amortization), along with other liquidity measures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its assessment of current expected credit losses for loans receivable and unfunded loan commitments, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each loan to estimate a probability of default and a resulting loss for each loan receivable. Future economic conditions are based primarily on near-term economic forecasts from the Federal Reserve and reasonable assumptions for long-term economic trends. </span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTAwNjg_b328c900-4863-4efe-8d72-fb00a41e157e" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s reserve for loan losses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mezzanine and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mezzanine and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88696dec76a41df8c3d36e71898301f_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi0xLTEtMS0xMDc4NDI_65e674ec-02c7-4446-808a-040e58f0b694">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2caaa14451f4014ab34991c3b703764_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi0zLTEtMS0xMDc4NDI_089c939a-214f-4fde-820c-cdec09b7f536">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi01LTEtMS0xMDc4NDI_d6fa56b9-fda9-431b-8323-b788be282c96">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib39f0035285a4bfdadaf994fa845b4ca_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi03LTEtMS0xMDc4NDI_5f502cb1-e8b7-4ee2-b178-87b32b4971a4">3,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0213b6338d474f9ab83b686f5a8aa0_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi05LTEtMS0xMDc4NDI_d1c59631-f2a2-4632-ab4f-06267cf66c44">7,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi0xMS0xLTEtMTA3ODQy_2341bdfb-388a-44a6-ae26-72215cf4bb33">10,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01aa0bf4bb3d4669ab75f73ab638333e_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0xLTEtMS0xMTE0MzE_517ef8cb-1865-414b-ad3c-9acd5987cca6">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4031be1cfa14447aa6b18dfbcfa6bd9_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0zLTEtMS0xMTE0MzE_c339387c-23e4-4da6-938c-d9410f8f5f89">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC01LTEtMS0xMTE0MzE_b031a4d5-b83d-4c29-8fa0-a31961ed9776">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af0c53b18b84f96a9445d33fed35d6c_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC03LTEtMS0xMTE0MzE_f8b382cf-ada3-49e8-9555-f1ce86a9a59b">793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice9d09a0cad14197a0d42beb434939dc_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC05LTEtMS0xMTE0MzE_f3371ee8-7064-465f-b303-fbb34b9d4925">896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0xMS0xLTEtMTExNDMx_01dd5efe-9c4d-43ae-919d-f631d9a8c0a1">1,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected loan losses related to loans sold or repaid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01aa0bf4bb3d4669ab75f73ab638333e_D20220101-20220331" decimals="-3" name="us-gaap:FinancingReceivableSignificantSales" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0xLTEtMS0xMDc4NDI_de4fdc69-4fa8-4d3d-bd09-27ac2a3f1569">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4031be1cfa14447aa6b18dfbcfa6bd9_D20220101-20220331" decimals="-3" name="us-gaap:FinancingReceivableSignificantSales" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0zLTEtMS0xMDc4NDI_eaa76e04-4689-4cb7-9221-c48f220516d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:FinancingReceivableSignificantSales" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC01LTEtMS0xMDc4NDI_832769c7-b08d-41e7-aade-a8d0d7425702">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1af0c53b18b84f96a9445d33fed35d6c_D20210101-20211231" decimals="-3" name="us-gaap:FinancingReceivableSignificantSales" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC03LTEtMS0xMDc4NDI_a89f7094-a3d8-4b27-8eb4-2057b88df91e">2,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice9d09a0cad14197a0d42beb434939dc_D20210101-20211231" decimals="-3" name="us-gaap:FinancingReceivableSignificantSales" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC05LTEtMS0xMDc4NDI_882457d2-e18a-4d75-b3ba-4035299a8427">8,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" decimals="-3" name="us-gaap:FinancingReceivableSignificantSales" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0xMS0xLTEtMTA3ODQy_9f867ab0-b130-44f7-9cfc-76a42f3075f6">10,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858204adffd348408864f031fa32c574_I20220331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS0xLTEtMS0xMDc4NDI_7fa3f3fc-884f-421a-ba4d-627e166d10bd">1,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ff4f2b11c94a78a5487085851cb371_I20220331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS0zLTEtMS0xMDc4NDI_8a42dcc7-ecb2-4dd6-a41f-07017875eac4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS01LTEtMS0xMDc4NDI_dc12dcd9-a098-4b84-858f-c3d31392aba9">1,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88696dec76a41df8c3d36e71898301f_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS03LTEtMS0xMDc4NDI_7ba8ee4f-49ec-4187-9a1f-b6e803099d7e">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2caaa14451f4014ab34991c3b703764_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS05LTEtMS0xMDc4NDI_7d1de084-80ba-42d6-b7e4-291110dae7d9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS0xMS0xLTEtMTA3ODQy_f382b533-45bf-4423-a224-733f570a729b">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes <ix:nonFraction unitRef="property" contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" decimals="INF" name="peak:FinancingReceivableNumberOfContractsSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfODkxMA_451b5c11-df63-489b-a713-b59c8f91d4a2">six</ix:nonFraction> loans sold or repaid during the year ended December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, at each of March&#160;31, 2022 and December&#160;31, 2021, a liability of $<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-5" name="peak:FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfOTA0MQ_5d5a7d7e-c02c-4607-979e-f3dd8bfcd8b4"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-5" name="peak:FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfOTA0MQ_ce856800-55d9-4548-aaf8-c87eecfa53b0">0.3</ix:nonFraction></ix:nonFraction> million related to expected credit losses for unfunded loan commitments was included in accounts payable, accrued liabilities, and other liabilities.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTkxOA_b41dd75a-a9b5-48c2-aae7-8c261e6233b6" continuedAt="i85da3053504b45b98aea25bd1c6e95d4" escape="true">Investments in and Advances to Unconsolidated Joint Ventures</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i85da3053504b45b98aea25bd1c6e95d4"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTkyMA_904d23fd-4446-416e-b465-96760d2e7785" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owns interests in the following entities that are accounted for under the equity method, excluding investments classified as discontinued operations (dollars in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:30.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership %</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SWF SH JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="id5746a20e0c541cb933dd8d9e8a18868_I20220331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMy01LTEtMS0xMDc4NDI_8a0e9f2b-cc7a-45d2-bfa9-522819f7dcdc">19</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5746a20e0c541cb933dd8d9e8a18868_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMy04LTEtMS0xMDc4NDI_11a34879-906e-4dc1-a9ba-dc81157d7f7c">54</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5746a20e0c541cb933dd8d9e8a18868_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMy0xMS0xLTEtMTA3ODQy_af2612ef-1d1e-43de-9992-90cd0e6c5dd1">353,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb1c53a80cf48d598dd59b38828089e_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMy0xMy0xLTEtMTA3ODQy_ce69af64-d086-44d2-8b7f-2b4e73da9345">355,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Science JV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="if6dac57d2d904eef8d5d5c6d6d560074_I20220331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNC01LTEtMS0xMDc4NDI_bd9793a6-0214-46cf-9453-a0475119715b">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if6dac57d2d904eef8d5d5c6d6d560074_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNC04LTEtMS0xMDc4NDI_ea5410d1-b8dc-4493-b819-42da8befc11e">49</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dac57d2d904eef8d5d5c6d6d560074_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNC0xMS0xLTEtMTA3ODQy_87ee0203-6524-4c81-91e2-038861668d70">26,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af131706f2b4efd81b014492e74780e_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNC0xMy0xLTEtMTA3ODQy_90359f54-89b5-4d18-bae7-711ee48c9a20">25,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="ie86b016e31384892bfe412d346cd92f5_I20220331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS01LTEtMS0xMTE1MDU_da90daed-910b-4f80-bb4a-3131b72346a1">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie86b016e31384892bfe412d346cd92f5_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS04LTEtMS0xMTE1MTI_2fb8e90c-a2a2-467a-9e64-907845686dd1">38</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie86b016e31384892bfe412d346cd92f5_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS0xMS0xLTEtMTExNTE4_fb53c59d-038f-456e-9465-df2f3e9969f2">14,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib12448d242784ab084c7178415e35eef_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS0xMy0xLTEtMTExNTI0_54620ebf-9a04-466a-9f5c-7caae8e82f0a">13,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Office JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical office</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="property" contextRef="i6cd1af5b0be84236928af4f3b5238de4_I20220331" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS01LTEtMS0xMDc4NDI_d6b82d6e-d7a4-49c0-9544-b42dd55fc1bf">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib71d278abee9484ea60f89ad5ed8f50f_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS04LTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjoxYWY2NDRkNWEzNzE0OTg1OTQ5ZDQ3YWRkMGQ1ZTZlM180_a6c96ed6-12f7-4148-adf0-3a35b6de2388">20</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="ie0fbe38d9b8f4c8096a62a13c0be0319_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS04LTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjoxYWY2NDRkNWEzNzE0OTg1OTQ5ZDQ3YWRkMGQ1ZTZlM185_15859811-cc44-4f82-93d1-db06cdd8fb15">67</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd1af5b0be84236928af4f3b5238de4_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS0xMS0xLTEtMTA3ODQy_5e07e463-4326-44c0-a2ab-233b26397e74">8,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i294e35e4fa6e4b7792baf4fb2a50d9e7_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS0xMy0xLTEtMTA3ODQy_110905b0-4364-4002-bda2-5c4b61fc00d2">9,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMTAtMTEtMS0xLTEwNzg0Mg_d452e790-2c7a-4a31-870c-6c6e85162542">403,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMTAtMTMtMS0xLTEwNzg0Mg_78607ac4-350a-452e-907c-2bcea2abe621">403,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Property counts and ownership percentages are as of March&#160;31, 2022. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In December 2021, the Company acquired a <ix:nonFraction unitRef="number" contextRef="ib12448d242784ab084c7178415e35eef_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTY0OTI2NzQ0OTE1OA_71c1da89-cfa9-4b54-a9b1-deeeecf9f591">38</ix:nonFraction>% interest in a life science development joint venture in Needham, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="ib42e8c61652142339c59c133c0ca0201_D20211201-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYzMjM2NA_419913cb-c8ca-4c0a-8220-4876f277abc8">13</ix:nonFraction>&#160;million. Land held for development is excluded from the property count as of March&#160;31, 2022.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes <ix:nonFraction unitRef="joint_venture" contextRef="iab41d51161f44fa3b2a7d722d1819d54_I20220331" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfOTU3_aa25f6c8-38bb-494b-9c8c-52375f815dcf">two</ix:nonFraction> unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (<ix:nonFraction unitRef="number" contextRef="ib7d01dc5f33147a4821ce0ce3545c5f8_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA4NQ_a1c8884a-9db4-4c99-a07d-16bb51c9d68b">20</ix:nonFraction>%) and (ii) Suburban Properties, LLC (<ix:nonFraction unitRef="number" contextRef="i52b2c707e2b1428383dc2029f13bab25_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTE1MA_a3c09400-4007-4a0c-b0d8-e2b01744a6a6">67</ix:nonFraction>%). During 2021, the Company also held a <ix:nonFraction unitRef="number" contextRef="ib2847866fa494fa48669203a8b822e0d_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYzMjQ2OA_47a154cb-9d19-4688-916b-085581496729">30</ix:nonFraction>% interest in Ventures III, which issued its final distribution and was dissolved.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company sold its <ix:nonFraction unitRef="property" contextRef="i43ed19b259424a54a9fd61eca57de24e_I20210430" decimals="INF" name="peak:NumberOfPreferredEquityMethodInvestmentsSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTE5MQ_c8df3939-c388-42fb-855c-57a77c812776">two</ix:nonFraction> preferred equity investments for their carrying value as part of the Discovery SHOP Portfolio disposition (see Note 4). Prior to the sale, the Company&#8217;s ownership percentage in these <ix:nonFraction unitRef="joint_venture" contextRef="i68d2f2250a954a959c1ab9c1001f3093_I20210331" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTMzMQ_0731a858-d9e3-423e-b548-b09cdd3c7084">two</ix:nonFraction> unconsolidated joint ventures was as follows: (i) Discovery Naples JV (<ix:nonFraction unitRef="number" contextRef="i2cfa7cca0e764481b533b63888796ec6_I20210331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTQ1NA_ed48da7f-5399-40f5-a14f-16038fe9dc00">41</ix:nonFraction>%) and (ii) Discovery Sarasota JV (<ix:nonFraction unitRef="number" contextRef="id980870ccca047b5ae04fde6a8171675_I20210331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTQ5MA_9afb14f1-9f64-48c5-91d7-ebda100f59fa">47</ix:nonFraction>%). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the <ix:nonFraction unitRef="property" contextRef="i322ecd64c5b44877a6a721cafa77d63f_D20210501-20210531" decimals="INF" name="peak:NumberOfPropertiesToBeSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYyOTcxMg_d84de37b-7d93-41dd-8db4-92c1985ca4f0">two</ix:nonFraction> remaining CCRCs in the CCRC JV were sold for $<ix:nonFraction unitRef="usd" contextRef="i322ecd64c5b44877a6a721cafa77d63f_D20210501-20210531" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYyOTcwMA_729fe5cd-6e41-4920-a59c-19b7cc574553">38</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i642916b599bc4bf2b4a0e961d45d5a42_D20210501-20210531" decimals="-6" name="us-gaap:ProceedsFromSaleOfBuildings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYyOTcwNA_a17fea09-31a0-4b3c-9038-7c4b373886d5">19</ix:nonFraction>&#160;million of which represents the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i924e6cd0c4bb4c52bd6d1353893473da_I20210531" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYyOTcwOA_2b6cd9a8-5c25-4c48-8ed3-c217c5fdde7c">49</ix:nonFraction>% interest, resulting in an immaterial gain on sale recorded within equity income (loss) from unconsolidated joint ventures during the year ended December 31, 2021.</span></div></ix:continuation><div id="ifa3dff468a15495db7b57c65ada0de74_58"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE1OQ_37385c78-7afa-4ba4-a51e-2173ec876cee" continuedAt="id7d94f6a82b548e284b4803652eb0332" escape="true">Intangibles</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="id7d94f6a82b548e284b4803652eb0332" continuedAt="idee4ad05590c437eb2c6990b8c188651"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE2MA_d024ec30-4fdf-4a35-ad12-103ea3d63ef9" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#8217;s intangible lease assets (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:72.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMS0yLTEtMS0xMDc4NDI_c2ea25d8-5397-44b1-86cf-2d237bcfe5d0">802,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMS00LTEtMS0xMDc4NDI_e804bda2-3047-47c5-9928-2a8409bf20f0">797,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMi0yLTEtMS0xMDc4NDI_a7675b2e-be0b-44ad-8163-a87c4a4ce83d">304,974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMi00LTEtMS0xMDc4NDI_51eb98f1-0126-438d-a079-df4756106de8">277,915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMy0yLTEtMS0xMDc4NDI_c9b25e1e-9718-4bbb-87a2-b6f345d3c066">497,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMy00LTEtMS0xMDc4NDI_1e7762af-ea3d-4b71-a1aa-c1c239de062b">519,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfNS0yLTEtMS0xMDc4NDI_ce37dcae-dcc2-4807-ae0c-9034dc882f50">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfNS00LTEtMS0xMDc4NDI_e4b92119-7c90-4155-8d4d-f43964db520a">6</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE2Mg_5a8d0935-a3ef-4130-8fdd-9b1f3fb6be25" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#8217;s intangible lease liabilities (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:72.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMS0yLTEtMS0xMDc4NDI_efc4c345-2d91-4c46-a557-183bb1a6c246">239,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMS00LTEtMS0xMDc4NDI_df2848dc-3b55-4d5c-bf51-2c30cf22cc59">234,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMi0yLTEtMS0xMDc4NDI_dfc0a92d-c0fc-463c-95d8-2b2f836810a0">64,322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMi00LTEtMS0xMDc4NDI_8d9bcb5f-3e97-4424-82f4-dea135bea662">57,685</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMy0yLTEtMS0xMDc4NDI_7cd11de7-3697-40b7-a2cc-0f5a9dae0c61">175,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:FiniteLivedIntangibleLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMy00LTEtMS0xMDc4NDI_5f5a9883-67ce-4bad-a95b-064a933d35a4">177,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfNS0yLTEtMS0xMDc4NDI_887d72d2-1926-44e3-ba59-913b971d67d3">8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" name="peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfNS00LTEtMS0xMDc4NDI_67444eaf-c5de-4ecc-9e7a-90318913e9c6">8</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="idee4ad05590c437eb2c6990b8c188651"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, in conjunction with the Company&#8217;s acquisitions of real estate, the Company acquired intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfNjc5_0ea9672c-8233-4f52-b5aa-48018e0bc351">4</ix:nonFraction> million and intangible liabilities of $<ix:nonFraction unitRef="usd" contextRef="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331" decimals="-6" name="peak:IntangibleLiabilitiesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfNzEy_c344b67b-a6f9-4854-a217-44f74c3e439d">5</ix:nonFraction> million. The intangible assets and liabilities acquired had a weighted average amortization period at acquisition of <ix:nonNumeric contextRef="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfODI0_800908a9-0638-4d4d-8143-ccbaecaf5ac1">9</ix:nonNumeric> years and <ix:nonNumeric contextRef="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331" name="peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfODMx_cfbd9c70-3a5c-446f-bf53-054ecbc0193f">12</ix:nonNumeric> years, respectively.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, in conjunction with the Company&#8217;s acquisitions of real estate, the Company acquired intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfOTgw_215eefbe-9826-423a-8bec-8ce9b8f7cee4">109</ix:nonFraction>&#160;million and intangible liabilities of $<ix:nonFraction unitRef="usd" contextRef="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231" decimals="-6" name="peak:IntangibleLiabilitiesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTAxMw_b25cad5a-6653-4d6d-abd6-fb53bd230a38">57</ix:nonFraction>&#160;million. The intangible assets and intangible liabilities acquired had a weighted average amortization period at acquisition of <ix:nonNumeric contextRef="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE0Mw_dd6542ad-3c2a-4db6-aff1-930b7e1bd77a"><ix:nonNumeric contextRef="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231" name="peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE0Mw_dee538ba-b032-4224-9589-73f7003b1409">9</ix:nonNumeric></ix:nonNumeric> years.</span></div></ix:continuation><div id="ifa3dff468a15495db7b57c65ada0de74_61"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODcwNA_830e37f5-760b-4a69-88fb-50aed5b32a1d" continuedAt="i73b8c61e86564c03877d1e93e328651b" escape="true">Debt</ix:nonNumeric></span></div><div style="margin-bottom:1pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i73b8c61e86564c03877d1e93e328651b" continuedAt="i270351f82afd4608830a6179c8dbe0a3"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bank Line of Credit and Term Loan </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2019, the Company executed a $<ix:nonFraction unitRef="usd" contextRef="ifbdf5f35645b45b3984b9e5e46fceaf8_I20190523" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfOTc_83941d9f-113e-4961-963a-c6d246878673">2.5</ix:nonFraction> billion unsecured revolving line of credit facility, with a maturity date of May&#160;23, 2023 and <ix:nonFraction unitRef="renewal_option" contextRef="ifbdf5f35645b45b3984b9e5e46fceaf8_I20190523" decimals="INF" name="peak:DebtInstrumentNumberofExtensions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTg2_01786ecf-40cd-436f-b2e9-50cbead2739e">two</ix:nonFraction>&#160;<ix:nonNumeric contextRef="iaf4af4c66c4c4e4ea53929a8d99bf97f_D20190523-20190523" name="peak:DebtInstrumentPeriodOfExtension" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTg5_436c37b9-78c7-4fac-acaa-29d8fc42632b">six-month</ix:nonNumeric> extension options, subject to certain customary conditions. Also in May 2019, the Company entered into a&#160;$<ix:nonFraction unitRef="usd" contextRef="ib7a0463d43594517865ced9f143c46a6_I20190531" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjk3_1b5124ba-a610-41c5-848e-fdf60ea2732b">250</ix:nonFraction> million&#160;unsecured term loan facility, with a maturity date of May 23, 2024 (the &#8220;2019 Term Loan&#8221;). In July 2021, the Company repaid the $<ix:nonFraction unitRef="usd" contextRef="i82327d2d8e1b4698b0346d5bd3a79cbb_D20210701-20210731" decimals="-6" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDI4_c9ce9ae3-c878-4243-b850-64016c88e63e">250</ix:nonFraction>&#160;million 2019 Term Loan. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company executed an amended and restated unsecured revolving line of credit (the &#8220;Revolving Facility&#8221;) to increase total revolving commitments from $<ix:nonFraction unitRef="usd" contextRef="ifbdf5f35645b45b3984b9e5e46fceaf8_I20190523" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNzMx_7e46ef0d-ace2-4c11-9897-12b579d7b695">2.5</ix:nonFraction>&#160;billion to $<ix:nonFraction unitRef="usd" contextRef="iae4f18c121f648d5826bfbc035300a67_I20210930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNzM3_e6915d59-9d7f-4663-831e-9ad38b0676ab">3.0</ix:nonFraction>&#160;billion and extend the maturity date to January 20, 2026. This maturity date may be further extended pursuant to <ix:nonFraction unitRef="renewal_option" contextRef="iae4f18c121f648d5826bfbc035300a67_I20210930" decimals="INF" name="peak:DebtInstrumentNumberofExtensions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQ1_56ca2bc4-5ad7-4fe9-9970-0a401e2bc096">two</ix:nonFraction> <ix:nonNumeric contextRef="i9065798c00ee41ef899c69a43f5251b6_D20210901-20210930" name="peak:DebtInstrumentPeriodOfExtension" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQ4_f808a00f-f54c-4c57-b08f-00759d078459">six-month</ix:nonNumeric> extension options, subject to certain customary conditions. Borrowings under the Revolving Facility accrue interest at LIBOR plus a margin that depends on the credit ratings of the Company&#8217;s senior unsecured long-term debt. The Company also pays a facility fee on the entire revolving commitment that depends on its credit ratings. Based on the Company&#8217;s credit ratings at March&#160;31, 2022, the margin on the Revolving Facility was <ix:nonFraction unitRef="number" contextRef="i86a95c3d76e44658a7495876f84394fb_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTM0OQ_d761e8ec-3085-41a2-b888-47f4c405a7b0">0.78</ix:nonFraction>%</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the facility fee was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i0667f584e1224d759496144ff96ccd4c_D20220101-20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTM3Nw_54dfee84-62ff-4b3f-be1f-d85b63179f24">0.15</ix:nonFraction>%</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At March&#160;31, 2022 and December&#160;31, 2021, the Company had <ix:nonFraction unitRef="usd" contextRef="ib3aa132c8f884c44b097e6de1abfbc0d_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTQxMQ_6619ad1a-47f5-4d79-86a2-8a848e0193dd"><ix:nonFraction unitRef="usd" contextRef="ibcc24c31340e402fa87c53d87f379dee_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTQxMQ_b797b898-055a-462b-8039-1d5e81833c27">no</ix:nonFraction></ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balance outstanding under the Revolving Facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="i9065798c00ee41ef899c69a43f5251b6_D20210901-20210930" decimals="INF" name="peak:LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTU5Nw_5b680366-96b1-44a0-a6bb-5ca50517327c">750</ix:nonFraction> million, subject to securing additional commitments. Further, the Revolving Facility includes customary LIBOR replacement language, including, but not limited to, the use of rates based on the secured overnight financing rate administered by the Federal Reserve Bank of New York. The Revolving Facility also includes a sustainability-linked pricing component whereby the applicable margin may be reduced by up to <ix:nonFraction unitRef="number" contextRef="i9065798c00ee41ef899c69a43f5251b6_D20210901-20210930" decimals="5" name="peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjAwNQ_75be5121-dc18-46e9-9b5a-6b4a3c2a02d1">0.025</ix:nonFraction>% based on the Company&#8217;s achievement of specified sustainability-linked metrics, subject to certain conditions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility also contains certain financial restrictions and other customary requirements, including financial covenants and cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreement: (i)&#160;limit the ratio of Enterprise Total Indebtedness to Enterprise Gross Asset Value to <ix:nonFraction unitRef="number" contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930" decimals="INF" name="peak:DebtInstrumentCovenantDebtToAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjQ2Ng_1f6846e3-ff3c-434e-84d4-4c546899fc4e">60</ix:nonFraction>%; (ii)&#160;limit the ratio of Enterprise Secured Debt to Enterprise Gross Asset Value to <ix:nonFraction unitRef="number" contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930" decimals="INF" name="peak:DebtInstrumentCovenantSecuredDebtToAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjU1Mw_72a67f59-f3cb-4e2b-b7cb-0a9c367b6825">40</ix:nonFraction>%; (iii)&#160;limit the ratio of Enterprise Unsecured Debt to Enterprise Unencumbered Asset Value to <ix:nonFraction unitRef="number" contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930" decimals="INF" name="peak:DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjY1MA_d3a040cf-d0bb-4d16-a1b8-931016842911">60</ix:nonFraction>%; (iv)&#160;require a minimum Fixed Charge Coverage ratio of <ix:nonFraction unitRef="number" contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930" decimals="INF" name="peak:DebtInstrumentCovenantFixedChargeRatioMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjcwOA_da71354c-7a6b-4e8e-92bc-8b5fec4cf07f">1.5</ix:nonFraction> times; and (v) require a minimum Consolidated Tangible Net Worth of $<ix:nonFraction unitRef="usd" contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930" decimals="INF" name="peak:DebtInstrumentCovenantNetWorth" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjc3OQ_b57769a3-6168-49b8-a528-45dad0207180">7.7</ix:nonFraction> billion.&#160;The Company believes it was in compliance with each of these covenants at March&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper Program</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company established an unsecured commercial paper program (the &#8220;Commercial Paper Program&#8221;). Under the terms of the Commercial Paper Program, the Company may issue, from time to time, unsecured short-term debt securities with varying maturities. Amounts available under the Commercial Paper Program may be borrowed, repaid, and re-borrowed from time to time. During 2021, the Company increased the maximum aggregate face or principal amount that can be outstanding at any one time from $<ix:nonFraction unitRef="usd" contextRef="i02de64e4627846b2bd3f09d7101c72f9_I20201231" decimals="INF" name="peak:DebtInstrumentMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzM5NA_da527efb-59b7-460f-b4b9-d04c1e11cdd9">1.0</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="i06c55fa5097f4b26aaa7bc551ed8d8ef_I20211231" decimals="INF" name="peak:DebtInstrumentMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzQwMA_6438cfa9-600c-4ca6-947a-2c25fa5d9562">1.5</ix:nonFraction>&#160;billion. Amounts borrowed under the Commercial Paper Program will be sold on terms that are customary for the U.S. commercial paper market and will be at least equal in right of payment with all of the Company&#8217;s other unsecured and unsubordinated indebtedness. The Company uses its Revolving Facility as a liquidity backstop for the repayment of unsecured short-term debt securities issued under the Commercial Paper Program. At March&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="if3f5c6f033e845d3853ee8dcbfd15aec_I20220331" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzg0NA_1363d775-e76f-4e2b-8f32-b0256d5e2a37">1.33</ix:nonFraction>&#160;billion</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of securities outstanding under the Commercial Paper Program, with original maturities of approximately</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzk1MQ_e3e8166b-7959-4f0a-8883-a98ea0e3e757">45</ix:nonNumeric> days and a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzk5NA_12812599-71bd-48c7-824e-26cc6feafcb3">0.93</ix:nonFraction>%. At December&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i06c55fa5097f4b26aaa7bc551ed8d8ef_I20211231" decimals="-7" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDAyMQ_73539cff-9fae-4df4-a124-ec2dc5d5b9ec">1.17</ix:nonFraction>&#160;billion of securities outstanding under the Commercial Paper Program, with original maturities of approximately <ix:nonNumeric contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODcwNw_1e273e61-a3ae-4e3b-87f4-1d2ff5019069">two months</ix:nonNumeric> and a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDE3Nw_8a22e23d-32af-4faf-a40d-7b19cf664b87">0.32</ix:nonFraction>%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each of March&#160;31, 2022 and December&#160;31, 2021, the Company had senior unsecured notes outstanding with an aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i3f327e88a9264251811af5db4463a246_I20211231" decimals="-8" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDMwMQ_8c1586d6-d3cd-422d-8f14-02120427beff"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-8" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDMwMQ_f89ff695-267f-4d79-85ca-239df452d2f5">4.7</ix:nonFraction></ix:nonFraction>&#160;billion. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes it was in compliance with these covenants at March&#160;31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i270351f82afd4608830a6179c8dbe0a3" continuedAt="iff2b5c8424a84b10959c9937637dc5dd"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, the Company did not repurchase or redeem any senior unsecured notes. </span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODY5NA_37b3f6d7-ebc0-4f91-951e-7588e338aca3" continuedAt="if78d9afce8094726953fd0a018b044b4" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company&#8217;s senior unsecured notes repurchases and redemptions during the year ended December&#160;31, 2021 (dollars in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:55.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payoff Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 19, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a6dbcdd6414960b06cbb782d9985c4_I20210519" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMS0yLTEtMS0xMDc4NDI_e5f7770c-d2e7-4896-a6e7-7b6f2ca4d06e">251,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25a6dbcdd6414960b06cbb782d9985c4_I20210519" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMS00LTEtMS0xMDc4NDI_d5725651-62f8-4bf3-b890-850dd7bb078a">3.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 19, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic508faac831b42f2b021bb57d04db552_I20210519" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMi0yLTEtMS0xMDc4NDI_54bd1d24-7289-4591-802c-f780192dd898">298,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic508faac831b42f2b021bb57d04db552_I20210519" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMi00LTEtMS0xMDc4NDI_bc6fd1bc-13cb-4bdb-ae05-dda6f26e9ad6">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i129edcf0ec22460cbebd897c6f2231cd_I20210226" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMy0yLTEtMS0xMDc4NDI_3ac42a47-7783-4572-bb1e-7af567e3507d">188,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i129edcf0ec22460cbebd897c6f2231cd_I20210226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMy00LTEtMS0xMDc4NDI_9ff375d0-1d8a-4b02-b7f2-54aec9ce15e0">4.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cd5e36259d94f569780a9bbfeeb56e6_I20210226" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNC0yLTEtMS0xMDc4NDI_0bab9f9d-81d3-4941-95fe-4038c416d988">149,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9cd5e36259d94f569780a9bbfeeb56e6_I20210226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNC00LTEtMS0xMDc4NDI_ccc0e523-a3bf-495a-aa0c-69b2c881eaf4">4.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b767842f4c4d8cae721f9d090787f9_I20210226" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNS0yLTEtMS0xMDc4NDI_7d45a94c-08a5-472e-bc7b-94fc81bc48f4">331,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58b767842f4c4d8cae721f9d090787f9_I20210226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNS00LTEtMS0xMDc4NDI_c71fa35b-e982-4a6f-b287-dca501cc7714">3.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia10cfac217664164a5ce11935398e38c_I20210128" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNi0yLTEtMS0xMDc4NDI_e24df5f5-ef13-4a88-8105-c77afcba476f">112,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia10cfac217664164a5ce11935398e38c_I20210128" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNi00LTEtMS0xMDc4NDI_c59f3967-2097-4935-806e-dc0b583053a2">4.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15a32184ddc4244aafcaee4d492a613_I20210128" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNy0yLTEtMS0xMDc4NDI_41c65e20-fb43-48b2-95f7-cc648f3442bd">201,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie15a32184ddc4244aafcaee4d492a613_I20210128" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNy00LTEtMS0xMDc4NDI_068a1305-ae92-4b8e-992a-c123d5024c9d">4.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6442aff2a64388a38b157c25a0b7c8_I20210128" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfOC0yLTEtMS0xMDc4NDI_e1d8304b-698c-475b-8603-94812ebff41a">469,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife6442aff2a64388a38b157c25a0b7c8_I20210128" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfOC00LTEtMS0xMDc4NDI_8a646810-6d8c-4415-9cfd-6897423e5d5b">3.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Upon repurchasing a portion of the <ix:nonFraction unitRef="number" contextRef="i25a6dbcdd6414960b06cbb782d9985c4_I20210519" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDc4MA_0867b6da-21ff-4569-b2ca-15ab7b7566b1">3.40</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic508faac831b42f2b021bb57d04db552_I20210519" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDc4Nw_f2f46636-76d1-4d09-acf0-e4b305e4dccb">4.00</ix:nonFraction>% senior unsecured notes due 2025, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i474fd2e8b00742c492b5f0a58c583148_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDg0OA_e2e3832c-8a39-44e2-a185-6f03b95ccf6f">61</ix:nonFraction>&#160;million loss on debt extinguishment during the year ended December&#160;31, 2021.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Upon completing the repurchases and redemptions of all outstanding <ix:nonFraction unitRef="number" contextRef="i129edcf0ec22460cbebd897c6f2231cd_I20210226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDk3Nw_90238dd8-d44b-4094-b630-57bbea99d8fc">4.25</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i9cd5e36259d94f569780a9bbfeeb56e6_I20210226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDk4MQ_7ebaad90-1525-4858-9ac1-780cdb3c63d0">4.20</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i58b767842f4c4d8cae721f9d090787f9_I20210226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDk4OQ_c7b7a647-e7d7-4fa2-b276-729ceb38df25">3.88</ix:nonFraction>% senior unsecured notes due 2023 and 2024, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i50e3cb94a01d48daa97d3bd61e3eb616_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNTA1OQ_be7bf32a-8bd5-4bf0-b14c-fa8187f26234">164</ix:nonFraction>&#160;million loss on debt extinguishment during the three months ended March&#160;31, 2021.</span></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, the Company did not issue any senior unsecured notes.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company completed <ix:nonFraction unitRef="bond" contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" decimals="INF" name="peak:NumberOfBondOfferings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTA5OTUxMTY0MTczMg_144fa062-5b00-4758-b3d8-31f2322a2631">two</ix:nonFraction> green bond offerings. The net proceeds from both green bonds are or will be allocated to eligible green projects, and the Company may choose to allocate or re-allocate net proceeds from such offerings to one more other eligible green projects. The following table summarizes these senior unsecured note issuances for the year ended December&#160;31, 2021<ix:continuation id="if78d9afce8094726953fd0a018b044b4" continuedAt="i4cc1dab219b643de8d3b47f868dbabe2"> (dollars in thousands):</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><ix:continuation id="i4cc1dab219b643de8d3b47f868dbabe2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:55.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 24, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b8cef65132475f95dc36c24f9a9820_I20211124" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOjgzZDA4MTI2ZjNiMTRkNmE5MGQxZDk5M2JlOTllZjU3L3RhYmxlcmFuZ2U6ODNkMDgxMjZmM2IxNGQ2YTkwZDFkOTkzYmU5OWVmNTdfMS0yLTEtMS0xMjg5OTc_bd187875-3400-47fa-b0f2-5f9d44b2bdc0">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4b8cef65132475f95dc36c24f9a9820_I20211124" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOjgzZDA4MTI2ZjNiMTRkNmE5MGQxZDk5M2JlOTllZjU3L3RhYmxlcmFuZ2U6ODNkMDgxMjZmM2IxNGQ2YTkwZDFkOTkzYmU5OWVmNTdfMS00LTEtMS0xMjg5OTc_02b38528-6733-4012-9474-26c63b211928">2.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 12, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic42f1d80f9104fb9a68ce6b17b49241f_I20210712" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOjgzZDA4MTI2ZjNiMTRkNmE5MGQxZDk5M2JlOTllZjU3L3RhYmxlcmFuZ2U6ODNkMDgxMjZmM2IxNGQ2YTkwZDFkOTkzYmU5OWVmNTdfMS0yLTEtMS0xMDc4NDI_145a0748-c821-4858-91ab-28008cb4b812">450,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic42f1d80f9104fb9a68ce6b17b49241f_I20210712" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOjgzZDA4MTI2ZjNiMTRkNmE5MGQxZDk5M2JlOTllZjU3L3RhYmxlcmFuZ2U6ODNkMDgxMjZmM2IxNGQ2YTkwZDFkOTkzYmU5OWVmNTdfMS00LTEtMS0xMDc4NDI_e39063e6-0a22-4870-bb0b-2b5f5c1dcfe5">1.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Mortgage Debt</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and December&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjM3MA_1bfd0c33-d1b4-414f-a056-38c88daff16d">349</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iabee9c868d9c47cba2cc55a571bc034f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjM3Nw_6f1bb4ab-d9b9-4bab-b33f-52d8ab74a28f">350</ix:nonFraction>&#160;million, respectively, in aggregate principal of mortgage debt outstanding, which was secured by <ix:nonFraction unitRef="facility" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="INF" name="peak:DebtInstrumentCollateralHealthcareFacilitiesNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjU0Nw_7ab632fa-1216-4036-8c99-df2733e14e9a"><ix:nonFraction unitRef="facility" contextRef="iabee9c868d9c47cba2cc55a571bc034f_I20211231" decimals="INF" name="peak:DebtInstrumentCollateralHealthcareFacilitiesNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjU0Nw_9aa177a6-7cce-4973-9e82-0b5b7e1d1bb9">18</ix:nonFraction></ix:nonFraction> healthcare facilities, with an aggregate carrying value of $<ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-6" name="peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjYzMA_68c2677b-619d-40ad-a525-27b68006deca">803</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iabee9c868d9c47cba2cc55a571bc034f_I20211231" decimals="-6" name="peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjYzNw_c2f687a0-84c6-4ca9-b0c3-b2d581e02947">811</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets, and is non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires insurance on the assets, and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2022 and March&#160;31, 2021, the Company made aggregate principal repayments of mortgage debt of $<ix:nonFraction unitRef="usd" contextRef="i4d184f2e01164a51b230c30bd85a30d0_D20210101-20210331" decimals="-6" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNzM5MQ_1c3096e6-a58c-4dae-91da-d4351bda4ba1"><ix:nonFraction unitRef="usd" contextRef="i030603e4f5a54153b34a35b3214082f5_D20220101-20220331" decimals="-6" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNzM5MQ_4863ca1a-51a2-4be2-9446-7e56be8f1aed">1</ix:nonFraction></ix:nonFraction>&#160;million (excluding mortgage debt on assets held for sale and discontinued operations). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, in conjunction with the acquisition of the MOB Portfolio, the Company originated $<ix:nonFraction unitRef="usd" contextRef="icfc6fff323874884beaa90a4c80a3577_I20210430" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzQwODQ4NjA0NzkyNzg_b76a183e-c3ac-410a-babe-ae646e079908">142</ix:nonFraction>&#160;million of secured mortgage debt (see Note 3) that matures in May 2026. In April 2022, the Company terminated its existing interest rate cap agreements associated with this variable rate mortgage debt and entered into <ix:nonFraction unitRef="derivativeheld" contextRef="i3a84667f31d1411fa0eb153b19912c8e_I20220430" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTY0OTI2NzQ1ODk0NQ_1fa3d627-a937-40af-aae7-7c20adc0a340">two</ix:nonFraction> interest rate swap contracts that are designated as cash flow hedges</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and mature in May 2026 (see Note 17). </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="iff2b5c8424a84b10959c9937637dc5dd"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Maturities</span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODY5MQ_ba10b7b7-6db8-4f01-9d0a-57f34ce4c551" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stated debt maturities and scheduled principal repayments at March&#160;31, 2022 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Senior Unsecured</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mortgage</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bank Line&#160;of<br/>Credit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0yLTEtMS0xMDc4NDI_d20a6bbd-218e-4ffb-b531-79a17c4753cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi00LTEtMS0xMDc4NDI_6eacb2be-80e3-444e-80fe-ac0cdb687d03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi04LTEtMS0xMDc4NDI_12f20136-e786-46ae-b167-2874cf2e69c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e027636867a4aa5b3815ba06a2d6117_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0xMC0xLTEtMTA3ODQy_d95e366a-309a-4a53-9718-dc8868f4631e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0xMi0xLTEtMTA3ODQy_b0616127-73f7-44f1-8341-a835d0902aea">3,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i501441e9c9d04464a5eb510bce4935e3_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0xNC0xLTEtMTA3ODQy_330b2096-773f-457b-b5c2-7f6e5c984311">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0xNi0xLTEtMTA3ODQy_a185654b-534f-4dc6-9692-eede74f2cff6">3,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0yLTEtMS0xMDc4NDI_3297bb90-461f-4e81-b368-173ce8916930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy00LTEtMS0xMDc4NDI_7c56fbaf-fc7f-4f0a-9a14-d33ee4cef66d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy04LTEtMS0xMDc4NDI_651aa128-b78d-428c-af1c-80ccf4251120">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51db4181e1b54a7b863ce08ec4787ea6_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0xMC0xLTEtMTA3ODQy_24f4b4e6-28ee-42a6-bf71-19877bff10b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0xMi0xLTEtMTA3ODQy_167d8af5-fbfc-49ac-9e19-4915df596eb5">90,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9a046d474cb44979dcf512ddc3fabb3_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0xNC0xLTEtMTA3ODQy_252f7746-d2ba-4ffb-8a10-60a600165006">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0xNi0xLTEtMTA3ODQy_fa016e97-446d-4fea-ae2f-ece633b4ab8a">90,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0yLTEtMS0xMDc4NDI_1abeea4b-39ca-4292-9b3e-bf15d52d0337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC00LTEtMS0xMDc4NDI_269f8f58-433f-493a-98df-775a9eb69157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC04LTEtMS0xMDc4NDI_91609d16-6957-42ac-80f3-e0e8730edd39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5faeb218c7d04966869e0fe60f447e98_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0xMC0xLTEtMTA3ODQy_cb208a89-ee12-464b-8ff3-af5a95bb08f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0xMi0xLTEtMTA3ODQy_f43d69f6-b53a-4de9-8de4-10d30aa1f3d8">7,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic626427f6d62400986df856754ecbb17_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0xNC0xLTEtMTA3ODQy_0da456be-cfb3-4e5e-b626-08c7224b9269">3.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0xNi0xLTEtMTA3ODQy_bfd2a6b5-9a92-4b08-be46-3509723ceb60">7,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0yLTEtMS0xMDc4NDI_005f7109-abcb-467b-aba6-1592c5b79647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS00LTEtMS0xMDc4NDI_9743c539-371c-4785-a20b-a2ca8529bb0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS04LTEtMS0xMDc4NDI_76606d76-32eb-46c8-8d16-3c99c8047f8a">800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9fab30ca14f54624bfd030cd08d1042b_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0xMC0xLTEtMTA3ODQy_d970ce25-c86c-4288-8593-3b2d6e565593">3.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0xMi0xLTEtMTA3ODQy_9ecd4672-b46b-43a4-a19b-32d0368e9d08">3,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5fb318dd82744438c5d3c43a0a334fa_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0xNC0xLTEtMTA3ODQy_37f9c9d4-9b4f-4e33-9704-b22c3b47af28">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0xNi0xLTEtMTA3ODQy_4a7ca519-c1b1-4309-ad7c-3b34c616cbe7">803,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0yLTEtMS0xMDc4NDI_db2b6c66-b3dd-4200-bd01-3c6c0c666f2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi00LTEtMS0xMDc4NDI_29581913-05c0-487f-9d20-d14b18f20366">1,330,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi04LTEtMS0xMDc4NDI_597462c7-1f4d-45b6-8acf-8e87706de036">650,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ee0feb90e464607b8cd21230c30e359_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0xMC0xLTEtMTA3ODQy_59154e91-5a92-4496-add8-e54768813e97">3.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0xMi0xLTEtMTA3ODQy_6c3f7edf-8029-4f7b-8877-d8b47d1d9f15">244,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b0beada91ec4b9783bd3b82faeb791f_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0xNC0xLTEtMTA3ODQy_5e175e99-ff1a-4f2e-a339-4db327c5ae14">3.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0xNi0xLTEtMTA3ODQy_58908f80-925d-4236-bf60-d68dab90b603">2,225,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0yLTEtMS0xMDc4NDI_e163136d-9a9f-46b3-943f-c374f880778b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy00LTEtMS0xMDc4NDI_e29679d5-9d7d-4a05-b2c5-133d827896e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy04LTEtMS0xMDc4NDI_a776e4a7-7055-4d43-8765-b1f72d0b5d14">3,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia75891e9a77c482caedf11f0b1cc4f02_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0xMC0xLTEtMTA3ODQy_19d58531-d15d-4318-8913-fd0b754560ce">3.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0xMi0xLTEtMTA3ODQy_de5f7db1-1564-4ebb-943f-a183db6ec8a7">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic80ffcee88b3410c985f4e65c0eee19c_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0xNC0xLTEtMTA3ODQy_63ae36c3-7ec3-4cc4-81fe-98c4d02c42e9">5.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0xNi0xLTEtMTA3ODQy_144332ec-c04e-4b74-a790-c6906cc071d3">3,250,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC0yLTEtMS0xMDc4NDI_052e4819-71a7-4c1b-811f-d0e74ea74a60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC00LTEtMS0xMDc4NDI_28cc6160-07ff-445c-bbdb-be7efb3a5b12">1,330,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC04LTEtMS0xMDc4NDI_fb679b0e-b088-4c62-919e-f68ae63f35bc">4,700,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC0xMi0xLTEtMTA3ODQy_6c223641-3f4a-4fb3-910c-e6bba5d2ce91">348,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC0xNi0xLTEtMTA3ODQy_10150e7a-a562-4379-ac04-168c38438df0">6,379,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Discounts), premium and debt costs, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS0yLTEtMS0xMDc4NDI_14b55847-ae5f-43db-97c4-848d726703e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS00LTEtMS0xMDc4NDI_bea617b6-6e80-457b-8db2-bd3af312c915">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS04LTEtMS0xMDc4NDI_4163d1fe-03b7-4895-8ea4-57a8ce943476">45,944</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS0xMi0xLTEtMTA3ODQy_c65f36c0-b8f1-439c-ac22-bcf6b941b669">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS0xNi0xLTEtMTA3ODQy_d7a6610a-a036-49e9-ae1f-b8eb9f806dc9">44,220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItMi0xLTEtMTA3ODQy_b0fd06b3-73fc-45e5-b4f4-d7a424efd8ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItNC0xLTEtMTA3ODQy_1727fc8a-77fa-4af8-aac8-a94c0f49d467">1,330,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItOC0xLTEtMTA3ODQy_0b3ca1c8-3251-49b1-8bdc-0809a7aa8d93">4,654,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItMTItMS0xLTEwNzg0Mg_be39c791-26dc-4fa0-b44f-b7a26993fdc2">350,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItMTYtMS0xLTEwNzg0Mg_383b9588-80b0-4255-8a21-4605d7a3dbaa">6,335,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the senior unsecured notes range from <ix:nonFraction unitRef="number" contextRef="id155f3c6d1834c9fa8fe36e4b805553a_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQyNg_e8cdc6d3-5582-46f1-9391-278b65aae0df">1.54</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i36d2ca6669b54c32aa2aad64db99b30d_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQzMg_9fad855d-ea56-4fe4-9285-43ae8ba54835">6.91</ix:nonFraction>% with a weighted average effective interest rate of <ix:nonFraction unitRef="number" contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQ4Ng_718e772a-c6af-40e9-ac52-7bbce0230f94">3.39</ix:nonFraction>% and a weighted average maturity of <ix:nonNumeric contextRef="ie30fa114a84041be913e6a006cbdb670_D20220101-20220331" name="peak:DebtInstrumentWeightedAverageMaturity" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODUyNA_f0ff9f96-4d80-4c35-832b-1491a5aa766f">7</ix:nonNumeric> years. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the mortgage debt range from <ix:nonFraction unitRef="number" contextRef="i5441692de9104c1f8876f6126bb3cd18_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODU4Ng_2ced4df7-a890-475e-aba7-5e4e00a76bf1">2.72</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id9703e7c732740bb93115889bd6185b4_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODU5Mg_85a526e1-f839-40d5-bc56-bfed88f43844">5.91</ix:nonFraction>% with a weighted average effective interest rate of <ix:nonFraction unitRef="number" contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODY0Ng_e87bb3d1-4055-42f1-a4d6-46ddc67b1d2b">3.36</ix:nonFraction>% and a weighted average maturity of <ix:nonNumeric contextRef="i030603e4f5a54153b34a35b3214082f5_D20220101-20220331" name="peak:DebtInstrumentWeightedAverageMaturity" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODY4NA_7ee40f97-d0cf-4f8f-80dd-013e4c2a9e08">4</ix:nonNumeric> years.</span></div></ix:nonNumeric></ix:continuation><div id="ifa3dff468a15495db7b57c65ada0de74_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82NC9mcmFnOmE4YjZmMTg4MDk2ZjQzYzg5MmVlODY1OWIxOWY2YWNhL3RleHRyZWdpb246YThiNmYxODgwOTZmNDNjODkyZWU4NjU5YjE5ZjZhY2FfMTc3MQ_41d88b02-cbb4-4270-be7f-c1c29272ea3a" continuedAt="iae8fe0786de84209be62932de14c400d" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="iae8fe0786de84209be62932de14c400d"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is a party to legal proceedings, lawsuits and other claims that arise in the ordinary course of the Company&#8217;s business. The Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company&#8217;s financial condition, results of operations, or cash flows. The Company&#8217;s policy is to expense legal costs as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%">DownREITs and Other Partnerships</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of certain limited liability companies (&#8220;DownREITs&#8221;), members may contribute appreciated real estate to a DownREIT in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the member. However, if a contributed property is later sold by the DownREIT, the unamortized pre-contribution gain that exists at the date of sale is specifically allocated and taxed to the contributing members. In many of the DownREITs, the Company has entered into indemnification agreements with those members who contributed appreciated property into the DownREIT. Under these indemnification agreements, if any of the appreciated real estate contributed by the members is sold by the DownREIT in a taxable transaction within a specified number of years, the Company will reimburse the affected members for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected member under the Internal Revenue Code (&#8220;make-whole payments&#8221;). These make-whole payments include a tax gross-up provision. These indemnification agreements have expirations terms that range through 2039 on a total of <ix:nonFraction unitRef="property" contextRef="ic49d297efbc04b4899a13cad1f112a0b_I20220331" decimals="INF" name="peak:ContributionOfPropertyNumberOfProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82NC9mcmFnOmE4YjZmMTg4MDk2ZjQzYzg5MmVlODY1OWIxOWY2YWNhL3RleHRyZWdpb246YThiNmYxODgwOTZmNDNjODkyZWU4NjU5YjE5ZjZhY2FfMTc1Mg_f6033248-5192-4780-b226-358215f21fe8">29</ix:nonFraction> properties. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company owns a <ix:nonFraction unitRef="number" contextRef="if6dac57d2d904eef8d5d5c6d6d560074_I20220331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82NC9mcmFnOmE4YjZmMTg4MDk2ZjQzYzg5MmVlODY1OWIxOWY2YWNhL3RleHRyZWdpb246YThiNmYxODgwOTZmNDNjODkyZWU4NjU5YjE5ZjZhY2FfMTA5OTUxMTYzMDA3Nw_ea5410d1-b8dc-4493-b819-42da8befc11e">49</ix:nonFraction>% interest in the Life Science JV (see Note 7). If the property in the joint venture is sold in a taxable transaction, the Company is generally obligated to indemnify its joint venture partner for its federal and state income taxes associated with the gain that existed at the time of the contribution to the joint venture.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNjI1MQ_c1ae0527-a1f0-40d8-b797-5ee4606c5040" continuedAt="i4bef368288c64c3389b13bef545ac87f" escape="true">Equity and Redeemable Noncontrolling Interests</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i4bef368288c64c3389b13bef545ac87f" continuedAt="i2daef2e5aaf74fe48a7bcfe5585fa7e1"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 28, 2022, the Company announced that its Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5bda4a0f83814d708728819ca12b1868_D20220428-20220428" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTgz_3f495259-b232-487b-b9d6-26c8770c8378">0.30</ix:nonFraction> per share. The common stock cash dividend will be paid on May 20, 2022 to stockholders of record as of the close of business on May 9, 2022.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, the Company declared and paid common stock cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNDM5_07938cf7-fa88-4af8-a9c4-e2bce68c0f11"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNDM5_a8eafdda-6760-44c4-b4e1-dd13ae273f9d"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNDM5_be47f767-6323-4fb1-84bb-37b8cf1b368d"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNDM5_c3f859e8-312a-4023-8b90-39c5d6879667">0.30</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At-The-Market Equity Offering Program</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company established an at-the-market equity offering program (as amended from time to time, the &#8220;ATM Program&#8221;), which was most recently amended in May 2021 to increase the size of the program from $<ix:nonFraction unitRef="usd" contextRef="i9c682ca877614372ac5d6a9eb54b1447_D20210430-20210430" decimals="-7" name="peak:AtmEquityOfferingProgramAggregateAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfODcx_d2c0a55f-2efa-4517-90e3-8fde7790fb0f">1.25</ix:nonFraction>&#160;billion to $<ix:nonFraction unitRef="usd" contextRef="ib6bdb41bc18341e4874c99a5317a7474_D20210501-20210531" decimals="-8" name="peak:AtmEquityOfferingProgramAggregateAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfODc3_1d96418f-6464-49f2-89c0-8f811ae51d81">1.5</ix:nonFraction> billion, pursuant to which shares of common stock having an aggregate gross sales price of up to $<ix:nonFraction unitRef="usd" contextRef="ib6bdb41bc18341e4874c99a5317a7474_D20210501-20210531" decimals="-8" name="peak:AtmEquityOfferingProgramAggregateAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfOTY5_1d96418f-6464-49f2-89c0-8f811ae51d81">1.5</ix:nonFraction> billion may be sold (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement (each, an &#8220;ATM forward contract&#8221;). The use of ATM forward contracts allows the Company to lock in a share price on the sale of shares at the time the ATM forward contract is effective, but defer receiving the proceeds from the sale of shares until a later date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ATM forward contracts generally have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTUzNQ_ad0445ae-2c5c-4d27-bf22-90d9ea20d009">one</span> to <ix:nonNumeric contextRef="i133dad541e4940469495f91e54645b82_D20220101-20220331" name="peak:OptionIndexedToIssuersEquityTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNjI2MQ_1ff18c0c-3a7d-4eb0-aca3-965a6ca7f5ff">two year</ix:nonNumeric> term. At any time during the term, the Company may settle a forward sale by delivery of physical shares of common stock to the forward seller or, at the Company&#8217;s election, in cash or net shares. The forward sale price the Company expects to receive upon settlement of outstanding ATM forward contracts will be the initial forward price established upon the effective date, subject to adjustments for: (i) accrued interest, (ii) the forward purchasers&#8217; stock borrowing costs, and (iii) certain fixed price reductions during the term of the ATM forward contract.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i8c9910ca8e3c43b58498430b0d7f692c_D20220101-20220331" decimals="-7" name="peak:ATMEquityOfferingProgramAggregateAmountRemaining" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjExOA_a45a8be0-8cc4-47b5-a406-2b722d74133b">1.18</ix:nonFraction> billion</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Company&#8217;s common stock remained available for sale under the ATM Program. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Forward Contracts</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company utilized the forward provisions under the ATM Program to allow for the sale of an aggregate of <ix:nonFraction unitRef="shares" contextRef="i50abcbcb64fb40e899abb71cbd6e3653_D20210101-20211231" decimals="-5" name="us-gaap:ForwardContractIndexedToIssuersEquityShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjM3Mw_c6f252f8-1d25-4026-a780-0190c9c3ce3a">9.1</ix:nonFraction>&#160;million shares of its common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at an initial weighted average net price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i50abcbcb64fb40e899abb71cbd6e3653_D20210101-20211231" decimals="2" name="us-gaap:ForwardContractIndexedToIssuersEquityForwardRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjQ0Nw_8b056961-3519-4586-9e0b-da65e5724143">35.25</ix:nonFraction> per share, after commissions. During the three months ended March&#160;31, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i72cbe3fbdd9d4520b3ee1c9882ee17d6_I20220331" decimals="INF" name="us-gaap:ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjUxMQ_927ab3c4-f2e6-4570-a29d-18eea8399a6c">no</ix:nonFraction> shares were settled under ATM forward contracts. Therefore, at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i72cbe3fbdd9d4520b3ee1c9882ee17d6_I20220331" decimals="-5" name="peak:ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjU4MQ_5deea4cd-acc3-49be-a86a-c68c889f03a7">9.1</ix:nonFraction>&#160;million shares remained outstanding under ATM forward contracts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company did not utilize the forward provisions under the ATM Program. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Direct Issuances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and March&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="idbbd3434631b45fa866d0cbaac25a52f_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMzQ1NA_0e334e15-e797-4790-b5d2-5852c86d506c"><ix:nonFraction unitRef="shares" contextRef="ic7bb6050b89c41c0a9f564585e588a65_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMzQ1NA_bd25c4ce-f677-4d27-afb5-34fefaff700b">no</ix:nonFraction></ix:nonFraction> shares of common stock were issued under the ATM Program.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNjI1MA_3485bdf9-e0e1-4345-b7b0-44d0d4751705" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accumulated other comprehensive income (loss) (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Plan minimum liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RhYmxlOjEzMjkzODIwNmU2YTRlZmFiYTEwNzJjODlmNGJiYWI0L3RhYmxlcmFuZ2U6MTMyOTM4MjA2ZTZhNGVmYWJhMTA3MmM4OWY0YmJhYjRfMy0xLTEtMS0xMDc4NDI_d054c701-d4c9-4a0a-a853-2fb259bc5fda">3,047</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RhYmxlOjEzMjkzODIwNmU2YTRlZmFiYTEwNzJjODlmNGJiYWI0L3RhYmxlcmFuZ2U6MTMyOTM4MjA2ZTZhNGVmYWJhMTA3MmM4OWY0YmJhYjRfMy0zLTEtMS0xMDc4NDI_03c6a026-cad7-48a4-8a63-03f680c53ab3">3,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RhYmxlOjEzMjkzODIwNmU2YTRlZmFiYTEwNzJjODlmNGJiYWI0L3RhYmxlcmFuZ2U6MTMyOTM4MjA2ZTZhNGVmYWJhMTA3MmM4OWY0YmJhYjRfNS0xLTEtMS0xMDc4NDI_075c7620-0bab-42be-8a50-0565ec429a58">3,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RhYmxlOjEzMjkzODIwNmU2YTRlZmFiYTEwNzJjODlmNGJiYWI0L3RhYmxlcmFuZ2U6MTMyOTM4MjA2ZTZhNGVmYWJhMTA3MmM4OWY0YmJhYjRfNS0zLTEtMS0xMDc4NDI_02d03f1c-17ef-403c-8d8f-b4d29a71b16e">3,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arrangements with noncontrolling interest holders are assessed for appropriate balance sheet classification based on the redemption and other rights held by the noncontrolling interest holder. Certain of the Company&#8217;s noncontrolling interest holders have the ability to put their equity interests to the Company upon specified events or after the passage of a predetermined period of time. Each put option is payable in cash and subject to increases in redemption value in the event that the underlying property generates specified returns for the Company and meets certain promote thresholds pursuant to the respective agreements. Accordingly, the Company records redeemable noncontrolling interests outside of permanent equity and presents the redeemable noncontrolling interests at the greater of their carrying amount or redemption value at the end of each reporting period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2daef2e5aaf74fe48a7bcfe5585fa7e1">During the year ended December&#160;31, 2021, <ix:nonFraction unitRef="interest" contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" decimals="INF" name="peak:NumberOfRedeemableNoncontrollingInterestRedemptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTY0OTI2NzQ1MDAwNA_bb9867f8-d488-4b12-8a6d-875aaa72a912">one</ix:nonFraction> of the redeemable noncontrolling interests met the conditions for redemption and the related put option was exercised during the year then ended. Accordingly, the Company made a cash payment for the redemption value of $<ix:nonFraction unitRef="usd" contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTY0OTI2NzQ1MDAyMA_274ae29e-77ff-4b92-a8de-3df8301f2187">60</ix:nonFraction>&#160;million to the related noncontrolling interest holder during the year ended December&#160;31, 2021 and acquired the redeemable noncontrolling interest associated with this entity. The remaining redeemable noncontrolling interests had not yet met the conditions for redemption as of March&#160;31, 2022 or December&#160;31, 2021. <ix:nonFraction unitRef="interest" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="INF" name="peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNTc4Nw_263aca11-124a-4c75-99e5-8efcb54f2fb1">Three</ix:nonFraction> of the interests will become redeemable following the passage of a predetermined amount of time, <ix:nonFraction unitRef="interest" contextRef="id2262290d71c48d7997b11506be11d2e_D20220101-20221231" decimals="INF" name="peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTA5OTUxMTY0MDA1Mw_b4878523-78a5-45b3-bc6c-78c6c055bc83">one</ix:nonFraction> of which will occur in late 2022, and the remaining <ix:nonFraction unitRef="interest" contextRef="i32ab0862bf034c7d9e3c84e8a429fc20_D20230101-20241231" decimals="INF" name="peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTA5OTUxMTY0MDA2MQ_81139581-bf15-4df9-a900-94c9f4ab852a">two</ix:nonFraction> in 2023 and 2024. The fourth interest will become redeemable at the earlier of a predetermined passage of time or stabilization of the underlying development property, which is expected to occur in 2023. The redemption values are subject to change based on the assessment of value at each redemption date.</ix:continuation></span></div><div id="ifa3dff468a15495db7b57c65ada0de74_70"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjgxOQ_20749622-8bec-4c4b-965f-407390539e2f" continuedAt="i960912e3de4b483bb0d3209a9ec52439" escape="true">Earnings Per Common Share</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i960912e3de4b483bb0d3209a9ec52439" continuedAt="iad54ceff4adf411b91d8e08b604b89ee"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income (loss) per common share (&#8220;EPS&#8221;) is computed based on the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed based on the weighted average number of common shares outstanding plus the impact of forward equity sales agreements using the treasury stock method and common shares issuable from the assumed conversion of DownREIT units, stock options, certain performance restricted stock units, and unvested restricted stock units. Only those instruments having a dilutive impact on the Company&#8217;s basic income (loss) per share are included in diluted income (loss) per share during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock and certain performance restricted stock units are considered participating securities, because dividend payments are not forfeited even if the underlying award does not vest, and require use of the two-class method when computing basic and diluted earnings per share.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for a discussion of the sale of shares under and settlement of forward sales agreements during the periods presented. The Company considered the potential dilution resulting from the forward agreements to the calculation of earnings per share. At inception, the agreements do not have an effect on the computation of basic EPS as no shares are delivered until settlement. However, the Company uses the treasury stock method to calculate the dilution, if any, resulting from the forward sales agreements during the period of time prior to settlement. The aggregate effect on the Company&#8217;s diluted weighted-average common shares for the&#160;three months ended March&#160;31, 2022 and 2021 was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="INF" name="us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMTY4MQ_6b1f0f42-c47e-44ea-8f5d-9db70fff7bc5"><ix:nonFraction unitRef="shares" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="INF" name="us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMTY4MQ_94e22af3-c5cd-4ff4-9357-a31a7d3c5d0b">zero</ix:nonFraction></ix:nonFraction> weighted-average incremental shares from the forward equity sales agreements.&#160;</span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjgxNw_4636bda8-d58d-49ff-b698-50d463e5ba73" continuedAt="ibdcad2a001bd4cb6a21d7b39e71aac32" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.282%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMy0xLTEtMS0xMDc4NDI_e1304f25-64a1-474e-ab3d-02fc894e739e">75,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMy0zLTEtMS0xMDc4NDI_bb508e5d-fe93-4b79-9637-fc4929f89834">120,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNC0xLTEtMS0xMDc4NDI_34f6b568-ed19-45dc-9850-10fed2cf2a63">3,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNC0zLTEtMS0xMDc4NDI_abe889d2-6b0b-4d39-bd11-bda1725e3305">3,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNS0xLTEtMS0xMDc4NDI_d79e00fb-58df-43b4-ada8-4f6184ad834a">71,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNS0zLTEtMS0xMDc4NDI_39616906-e680-4d1f-bc0d-a59941412ef0">123,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Participating securities' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNi0xLTEtMS0xMDc4NDI_d3f2a085-ff6e-412e-8dc1-b583efd5753b">1,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNi0zLTEtMS0xMDc4NDI_6c0fb101-dd26-457d-84f1-1578e01a359e">2,451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations applicable to common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNy0xLTEtMS0xMDc4NDI_650d5b4f-44a5-45b6-b4a9-892f5f7c61a6">69,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNy0zLTEtMS0xMDc4NDI_122438b7-8045-4e68-a42f-7b920911d3a4">126,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfOC0xLTEtMS0xMDc4NDI_bd53c987-90ae-45c3-8863-3c5c4c5f161c">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfOC0zLTEtMS0xMDc4NDI_3da6bd6a-835e-49a2-8931-3932a80f1a68">270,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:NoncontrollingInterestsShareInDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfOS0xLTEtMS0xMDc4NDI_21e10520-d014-43b0-ad91-793e702ce429">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="peak:NoncontrollingInterestsShareInDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfOS0zLTEtMS0xMDc4NDI_24eaa7bf-06ac-4386-9de4-ed7a5261679b">329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTAtMS0xLTEtMTA3ODQy_483a348c-40cc-4c6b-bc96-d7c1e45a1cd2">69,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTAtMy0xLTEtMTA3ODQy_16f540ed-3fb6-4a6b-a0f2-f53190bd799e">143,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTYtMS0xLTEtMTA3ODQy_e78a78a0-66a3-4c50-b839-5242213085c2">539,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTYtMy0xLTEtMTA3ODQy_fbe4c80a-390b-4011-8cd0-0792d9d7bf2a">538,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares - equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTctMS0xLTEtMTA3ODQy_2415c811-c1af-4bb3-af8c-49647b77d3b0">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTctMy0xLTEtMTA3ODQy_d175157e-e168-42a6-a057-5805fc3a8291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjAtMS0xLTEtMTA3ODQy_5df1576a-99fe-4239-be00-0a6b4dc791ab">539,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjAtMy0xLTEtMTA3ODQy_0a4a2d50-ba7a-466c-b0d7-1a2234151e21">538,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic earnings (loss) per common share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjItMS0xLTEtMTA3ODQy_fa633528-303b-47a7-948e-385eb8cceb73">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjItMy0xLTEtMTA3ODQy_a65064ec-d654-420f-a8c2-3a91a2d8b6ef">0.23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjMtMS0xLTEtMTA3ODQy_5553d415-4aba-4818-b86f-5d8e47e50552">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjMtMy0xLTEtMTA3ODQy_d89eaecd-b553-4c2f-ac1d-f16f3006570b">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjQtMS0xLTEtMTA3ODQy_cfe24b30-6832-4e15-a35e-2ca07e49ca8e">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjQtMy0xLTEtMTA3ODQy_02fd86ab-3d20-4c36-8f2a-2393067c6925">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings (loss) per common share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjYtMS0xLTEtMTA3ODQy_4823911c-7686-4941-90df-b68ee09d4b90">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjYtMy0xLTEtMTA3ODQy_bb44bcfd-acfe-4323-8dd1-4f5e2a15b29e">0.23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjctMS0xLTEtMTA3ODQy_c49dea64-e3af-4fd5-b12a-6fa1f2151c3b">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjctMy0xLTEtMTA3ODQy_9aaeac19-dbc0-46e4-b126-41445b136166">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjgtMS0xLTEtMTA3ODQy_156ea970-1c17-4a52-9f95-0f22e6c1fd8c">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjgtMy0xLTEtMTA3ODQy_db84ef60-d53f-4587-8184-acf52175714b">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For all periods presented, represents the dilutive impact of <ix:nonFraction unitRef="shares" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-6" name="peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjIxNQ_86a15d73-06f8-4e79-adb5-d5e4e36a6b09"><ix:nonFraction unitRef="shares" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-6" name="peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjIxNQ_df9a7035-c111-44b1-966d-07a3c975ed12">1</ix:nonFraction></ix:nonFraction> million outstanding equity awards (restricted stock units and stock options). </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iad54ceff4adf411b91d8e08b604b89ee" continuedAt="ib915312f51fb481ca923a9719ee235f0"><ix:continuation id="ibdcad2a001bd4cb6a21d7b39e71aac32">For the three months ended March&#160;31, 2022, the <ix:nonFraction unitRef="shares" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjMyMQ_598d480b-3c2a-4df3-82e5-63da46660ccd">9.1</ix:nonFraction> million shares under forward sales agreements that have not been settled as of March&#160;31, 2022 were anti-dilutive. For the three months ended March&#160;31, 2021, forward sales agreements had <ix:nonFraction unitRef="shares" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="INF" name="peak:IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjU3MA_92c1e049-1f3b-4a30-af00-f23c41b58b42">no</ix:nonFraction> dilutive impact as no shares remained outstanding under ATM forward contracts during the period.</ix:continuation></ix:continuation></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib915312f51fb481ca923a9719ee235f0">For the&#160;three months ended March&#160;31, 2022 and 2021, all <ix:nonFraction unitRef="shares" contextRef="ib562c08096d84fc6a41f5ebd01b696fb_D20210101-20210331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjcwNA_9d277a55-9be2-4062-a87f-719e2f579319"><ix:nonFraction unitRef="shares" contextRef="id7b05b8400df430195d0de28217faac1_D20220101-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjcwNA_ad834fe0-85ca-43c3-a7a9-597d7036d0e2">7</ix:nonFraction></ix:nonFraction> million shares issuable upon conversion of DownREIT units were not included because they were anti-dilutive.</ix:continuation> </span></div><div id="ifa3dff468a15495db7b57c65ada0de74_73"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RleHRyZWdpb246YmM2MmNkYmYyMDhiNDUzOGEyNjJhZjBiMTA0MGNhYmFfNDgzNA_ce8189df-7013-42f3-80fe-3ebe27fb24a3" continuedAt="ifdb8eef58ba74fa3869675985e5169a1" escape="true">Segment Disclosures</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="ifdb8eef58ba74fa3869675985e5169a1" continuedAt="i594497516132470881ecdfec3b3cbd49"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments, based on how its chief operating decision makers (&#8220;CODMs&#8221;) evaluate the business and allocate resources, are as follows: (i) life science, (ii) medical office, and (iii) CCRC. The Company has non-reportable segments that are comprised primarily of the Company&#8217;s interests in an unconsolidated JV that owns <ix:nonFraction unitRef="property" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="INF" name="peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RleHRyZWdpb246YmM2MmNkYmYyMDhiNDUzOGEyNjJhZjBiMTA0MGNhYmFfMTA5OTUxMTYzNzE5MQ_3bfc2483-0ef4-4fd1-a710-1da31a24a613">19</ix:nonFraction> senior housing assets (the &#8220;SWF SH JV&#8221;) and debt investments. The accounting policies of the segments are the same as those described in Note 2 to the Consolidated Financial Statements in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 filed with the SEC, as updated by Note 2 herein. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates performance based on property Adjusted NOI. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, income from direct financing leases, and government grant income and exclusive of interest income), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss). Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims&#160;that have been incurred but not reported, and the impact of deferred community fee income and expense. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOI and Adjusted NOI include the Company&#8217;s share of income (loss) from unconsolidated joint ventures and exclude noncontrolling interests&#8217; share of income (loss) from consolidated joint ventures. Management believes that Adjusted NOI is an important supplemental measure because it provides relevant and useful information by reflecting only income and operating expense items that are incurred at the property level and presenting it on an unlevered basis. Additionally, management believes that net income (loss) is the most directly comparable GAAP measure to NOI and Adjusted NOI. NOI and Adjusted NOI should not be viewed as alternative measures of operating performance to net income (loss) as defined by GAAP since they do not reflect various excluded items. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-segment assets consist of assets in the Company&#8217;s other non-reportable segments and corporate non-segment assets. Corporate non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, loans receivable, marketable equity securities, other assets, real estate assets held for sale and discontinued operations, and liabilities related to assets held for sale.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i594497516132470881ecdfec3b3cbd49" continuedAt="i7d5a7721e61749b4aab6255ce1f78cc1"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RleHRyZWdpb246YmM2MmNkYmYyMDhiNDUzOGEyNjJhZjBiMTA0MGNhYmFfNDg0NQ_10796e20-f806-4b29-a692-c1bf1cce1d21" continuedAt="i90cff9759e064a148a0cb8bf5edece0c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information for the reportable segments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS02LTEtMS0xMDc4NDI_340701f7-dea4-40aa-a9c7-a0acb0f50e31">194,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS04LTEtMS0xMDc4NDI_6f4188db-897e-4a67-9b0f-45445e158840">177,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS0xMC0xLTEtMTA3ODQy_06ba8907-b340-4ada-9918-d1dcc4575a4c">121,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS0xMi0xLTEtMTA3ODQy_41c65f23-f56b-47bc-ad87-6871079d3278">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS0xNC0xLTEtMTA3ODQy_644741aa-9132-4f02-8030-fe6d739820f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS0xNi0xLTEtMTA3ODQy_117d80e5-4115-418d-8c5a-f54cf8a9e9a8">498,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi02LTEtMS0xMDc4NDI_e279473b-62a7-4738-b920-0ef6e791a72c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi04LTEtMS0xMDc4NDI_96eb7d8e-ef4c-468a-b859-c97fbca44483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi0xMC0xLTEtMTA3ODQy_e3eca1c8-ab16-428d-a10c-be35d0ece496">6,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi0xMi0xLTEtMTA3ODQy_13de1c1d-6af5-4b9a-b3fb-b92704bfc674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi0xNC0xLTEtMTA3ODQy_4b6d2c20-0e32-43f4-9825-198470959f3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi0xNi0xLTEtMTA3ODQy_229523fc-c4cb-4687-b5c7-5de01cf58ef3">6,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy02LTEtMS0xMDc4NDI_13cfa413-4c89-4685-8701-660433d1203d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy04LTEtMS0xMDc4NDI_fb067264-4f68-4ba0-b421-f82a632310fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy0xMC0xLTEtMTA3ODQy_d9af3c21-e396-4696-96af-22d3505f23d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy0xMi0xLTEtMTA3ODQy_2cdccbe6-cc1d-4e17-b8bd-325ed480c3f0">5,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy0xNC0xLTEtMTA3ODQy_fde6fa80-0126-42dc-b4ae-f9bbec471633">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy0xNi0xLTEtMTA3ODQy_952774e3-7b06-46c8-b438-59cbb8c00c24">5,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC02LTEtMS0xMDc4NDI_044b39c7-ad65-4d9f-bfb2-fd305a058ac1">1,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC04LTEtMS0xMDc4NDI_895dce07-e321-4854-b6e1-e21344cdcdf7">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC0xMC0xLTEtMTA3ODQy_ca6b3055-2759-4af8-84ca-2ea110d190f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC0xMi0xLTEtMTA3ODQy_fe76db82-5daa-4e0a-8d4b-850a72496f91">18,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC0xNC0xLTEtMTA3ODQy_b18bf3cf-00fb-429f-9203-de6dbdd87fcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC0xNi0xLTEtMTA3ODQy_d2a1f132-7734-4bcf-95bd-97712440d143">20,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS02LTEtMS0xMDc4NDI_372a99e8-6b76-40eb-a0df-e9fe2f0f6e28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS04LTEtMS0xMDc4NDI_0f3699f6-80e6-4a02-be97-03d0541e3fe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS0xMC0xLTEtMTA3ODQy_9a6eae55-5eb8-4453-8ef7-f7aad3922957">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS0xMi0xLTEtMTA3ODQy_02572e3d-fab2-4e77-818a-e03811dee1b7">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS0xNC0xLTEtMTA3ODQy_dada40d4-9068-4e5e-8100-f9c52a41a4a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS0xNi0xLTEtMTA3ODQy_1a9a90ad-6b86-4ca7-8d6d-56762dc43cf3">648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi02LTEtMS0xMDc4NDI_aac9b4a6-2003-4233-bbb1-033e0775e73a">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi04LTEtMS0xMDc4NDI_56adc384-1b7b-461e-81c6-961b536e9a03">8,820</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi0xMC0xLTEtMTA3ODQy_c981f87c-e807-4c07-bad0-54a83771187e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi0xMi0xLTEtMTA3ODQy_a93ebb33-5650-4789-8601-8115eade25c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi0xNC0xLTEtMTA3ODQy_1f6d5936-8927-4c7d-bb7b-67ff6bc6334a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi0xNi0xLTEtMTA3ODQy_27f216df-6ccb-4c39-9dcd-89388531a286">8,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy02LTEtMS0xMDc4NDI_54dcadd6-e8b4-4858-a946-de209a30f9a0">48,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy04LTEtMS0xMDc4NDI_ad6a1a15-1ff1-4fb7-aaf8-a54bb789ce3b">61,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy0xMC0xLTEtMTA3ODQy_b1c32ff3-9035-4293-88c2-9cf82255d2e8">97,888</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy0xMi0xLTEtMTA3ODQy_7087ddb2-91e7-4ffd-ba67-f3635b078423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy0xNC0xLTEtMTA3ODQy_b4e8cae8-8e7c-46de-bafb-dd192f8f2dbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy0xNi0xLTEtMTA3ODQy_58c99138-a6ae-4574-a311-246e9ac6274d">207,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC02LTEtMS0xMDc4NDI_75905c39-eb56-4716-bc4a-c31d5f4a4341">483</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC04LTEtMS0xMDc4NDI_e9f1c839-e8fa-4b45-bbd6-addaa28c3351">299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC0xMC0xLTEtMTA3ODQy_8e6a9515-6669-425e-9806-1f784a5a8979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC0xMi0xLTEtMTA3ODQy_432cbb7a-9b73-4dfd-a5e4-c049308bbbe0">14,055</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC0xNC0xLTEtMTA3ODQy_741d1703-959e-40a2-9f17-d217cee0401b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC0xNi0xLTEtMTA3ODQy_5e1b07c7-5f05-4273-85d9-cbf32bda29eb">14,837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS02LTEtMS0xMDc4NDI_d8163f19-dd53-4717-b25f-0701576da809">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS04LTEtMS0xMDc4NDI_59885c04-93c3-4278-a41b-d08e03b4372f">2,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS0xMC0xLTEtMTA3ODQy_f28e7321-7e16-4a20-abcd-bbb913cce263">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS0xMi0xLTEtMTA3ODQy_5cf81f5b-94f5-4e8f-bd49-4746993b4db2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS0xNC0xLTEtMTA3ODQy_acc5bb6f-ec3f-4bb9-8952-fb94993ea8c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS0xNi0xLTEtMTA3ODQy_a256b32e-d80b-4e21-93f2-ca55e88a2dd0">2,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtNi0xLTEtMTA3ODQy_c22600de-2181-47e9-a398-2ec9164034aa">14,112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtOC0xLTEtMTA3ODQy_d96e25d8-fc08-4e55-baee-8dba418162c8">3,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtMTAtMS0xLTEwNzg0Mg_e454a7b6-1fb0-409b-8a56-b93d0ecabdd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtMTItMS0xLTEwNzg0Mg_61fd0d5b-aadc-40df-8f92-7dfb141af8ae">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtMTQtMS0xLTEwNzg0Mg_c7b734b7-0d4b-4df9-9b97-d1ec0a19316f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtMTYtMS0xLTEwNzg0Mg_ae32f8e1-5cc1-4415-a82e-7470b2e4188b">17,666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItNi0xLTEtMTA3ODQy_a233bb05-b7b0-429a-b551-e2500e57170a">132,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItOC0xLTEtMTA3ODQy_5477d976-6f63-44e2-9af1-3f6e88eaf4d3">106,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItMTAtMS0xLTEwNzg0Mg_76114c3c-d706-488d-a3b4-739824e0bf3b">30,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItMTItMS0xLTEwNzg0Mg_45cd4bd8-e252-45b1-b626-c642d59d8846">4,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItMTQtMS0xLTEwNzg0Mg_7830e28d-4ad7-4163-b94d-ec45f7b416f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItMTYtMS0xLTEwNzg0Mg_c690a5be-6ed9-48b3-8c08-8eb7977e051a">274,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtNi0xLTEtMTA3ODQy_4b7a6344-4dad-4fa1-86d0-d4bf3762169c">14,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtOC0xLTEtMTA3ODQy_176c436e-b85f-4649-9d8c-87eb7f9b1886">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtMTAtMS0xLTEwNzg0Mg_d1ef4b95-f31e-4921-a86e-2caf6afad4a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtMTItMS0xLTEwNzg0Mg_11c5bcd1-9ef9-492c-bffc-faa0a39e602f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtMTQtMS0xLTEwNzg0Mg_9594656f-d45c-47e6-8c94-628def9434fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtMTYtMS0xLTEwNzg0Mg_472da9a0-c799-4a95-9921-70bdadaac605">17,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtNi0xLTEtMTA3ODQy_9800b1ed-2b94-4fde-9f4a-81c03ba4b172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtOC0xLTEtMTA3ODQy_c0f5ec7b-f451-4097-b898-ea8bd884c763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtMTAtMS0xLTEwNzg0Mg_ef12447d-e5ca-469a-b2be-20bcbd03d275">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtMTItMS0xLTEwNzg0Mg_dfdd9e2b-c159-4e78-825c-35573c5c7101">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtMTQtMS0xLTEwNzg0Mg_f7969714-e0f5-4baa-9b62-c3788d7027d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtMTYtMS0xLTEwNzg0Mg_ecb0ec0c-11ab-4eae-9979-ad16ca239a50">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtNi0xLTEtMTA3ODQy_027e8c21-7fa7-4904-ba6f-889670524061">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtOC0xLTEtMTA3ODQy_0dd4519e-0b76-48f6-abcd-44cff2b17525">1,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtMTAtMS0xLTEwNzg0Mg_eae8d761-1d28-4594-ad6f-819dfca8133e">1,865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtMTItMS0xLTEwNzg0Mg_9cf92913-3962-43c4-9c03-938967ead8a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtMTQtMS0xLTEwNzg0Mg_65943a58-574d-4d16-b739-e5d08182aeb7">34,685</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtMTYtMS0xLTEwNzg0Mg_8ea18a2d-5f86-4178-888d-6dfd580e7370">37,586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtNi0xLTEtMTA3ODQy_67ecddc6-9879-4f25-b031-a734e48e5cd7">78,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtOC0xLTEtMTA3ODQy_28eb40da-25ac-4197-a574-330d6c6b6377">67,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtMTAtMS0xLTEwNzg0Mg_f929921c-c165-4335-9839-d0069a81f776">31,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtMTItMS0xLTEwNzg0Mg_53b348d8-78e7-4a64-b006-567c48b1607b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtMTQtMS0xLTEwNzg0Mg_0b4e7431-e308-424a-b20b-38c8b433cd33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtMTYtMS0xLTEwNzg0Mg_faa7909f-544c-4621-8955-84a49c9ddb63">177,733</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctNi0xLTEtMTA3ODQy_02b8eae6-7e6b-4e81-adc4-9af85c919fe6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctOC0xLTEtMTA3ODQy_fed5e131-b7f2-46d1-b38f-26af65f6a072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctMTAtMS0xLTEwNzg0Mg_cc69a10a-4b1e-4a82-8c6a-a30700b8ba6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctMTItMS0xLTEwNzg0Mg_08090a07-4ff9-43f5-bec4-2ba2fcceab4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctMTQtMS0xLTEwNzg0Mg_ce96dade-f29a-4777-8ea4-3bb3bcbe005c">23,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctMTYtMS0xLTEwNzg0Mg_4ded7bd3-f3c5-4cbb-ab5e-e686b112dc40">23,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtNi0xLTEtMTA3ODQy_82b92006-226d-4f18-8d33-8d0bef1fb0bf">292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtOC0xLTEtMTA3ODQy_ad56bda6-ad41-4b81-8b72-c8a355ccc048">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtMTAtMS0xLTEwNzg0Mg_631e8268-e521-49e8-90c4-7a1a3012dfd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtMTItMS0xLTEwNzg0Mg_00328171-a80d-46dd-91ac-4cf1ab16242a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtMTQtMS0xLTEwNzg0Mg_e5607059-dfa2-47bd-b649-8cbb5e6b5033">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtMTYtMS0xLTEwNzg0Mg_df043c42-3330-4629-be9c-1597aa3fd5ab">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktNi0xLTEtMTA3ODQy_def51425-9378-4d60-a717-97c0ec1c2013">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktOC0xLTEtMTA3ODQy_0dad9443-a732-41dc-a162-3a3e453c4c6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktMTAtMS0xLTEwNzg0Mg_c62bf653-b644-4f51-ac00-b1e2886ce567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktMTItMS0xLTEwNzg0Mg_005b30a7-a3e6-443c-8794-07ad4f4d4b87">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktMTQtMS0xLTEwNzg0Mg_756c5b76-edfd-465f-8a28-764f1b0988f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktMTYtMS0xLTEwNzg0Mg_9f2d595a-48ff-4ab0-bbe6-2dfe20b341ca">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtNi0xLTEtMTA3ODQy_35ac5cee-d3d4-4d54-8ab4-145ea6c574a2">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtOC0xLTEtMTA3ODQy_8d564165-8965-40c7-866a-8d5122e81047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtMTAtMS0xLTEwNzg0Mg_4e043e77-4c6c-4722-9ad4-93143aa9c46e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtMTItMS0xLTEwNzg0Mg_85815979-545e-431e-829f-9dc0fef730b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtMTQtMS0xLTEwNzg0Mg_debbaf83-c568-4da8-a59c-b6dae5641bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtMTYtMS0xLTEwNzg0Mg_08b3b37b-3f8f-41a8-bcb4-376fd9eae340">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItNi0xLTEtMTA3ODQy_816e1757-863b-41f7-b8bd-24912201fecc">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItOC0xLTEtMTA3ODQy_338c11b4-ae05-40a9-aa45-deb4bc88f6dd">10,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItMTAtMS0xLTEwNzg0Mg_8e3eb0ed-f92b-4db3-a87f-816ed8dc0742">6,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItMTItMS0xLTEwNzg0Mg_e9f2e3f5-0524-415b-afae-ba998717b062">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItMTQtMS0xLTEwNzg0Mg_0b228f82-6645-4b7e-b57e-35d389591166">909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItMTYtMS0xLTEwNzg0Mg_397b59b3-0a00-4300-afa5-1e40fb4c19a5">18,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtNi0xLTEtMTA3ODQy_998d6344-f89c-485b-bea5-9573daab03ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtOC0xLTEtMTA3ODQy_66db4830-0d43-4e84-8ffa-cd400d429e5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" sign="-" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtMTAtMS0xLTEwNzg0Mg_33533e04-4ced-4587-b6b4-7cb9934675d2">6,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtMTItMS0xLTEwNzg0Mg_dcf2918b-00c9-4aa7-8db5-331277f54a6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtMTQtMS0xLTEwNzg0Mg_ea16ca16-dbef-42eb-8eac-096e67ac2548">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtMTYtMS0xLTEwNzg0Mg_81e3301b-05ef-409a-9cb9-ccf5e8916769">6,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtNi0xLTEtMTA3ODQy_91cdf2d4-b33e-4136-a06c-191e8899aea9">948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtOC0xLTEtMTA3ODQy_da5bdb84-5471-4431-8fa4-9cacbd76fa45">433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtMTAtMS0xLTEwNzg0Mg_714b0ee2-bc06-48ce-8cca-56ca9f190b8b">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtMTItMS0xLTEwNzg0Mg_b8d4e0ff-cde3-4ebc-b462-bedc3b28c6ad">4,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtMTQtMS0xLTEwNzg0Mg_98ad4091-6340-45ed-9e94-96c01c3d0f5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtMTYtMS0xLTEwNzg0Mg_cbb70469-1b17-4e37-a43d-53f5284b6097">6,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtNi0xLTEtMTA3ODQy_f28c8d30-5ff8-4bee-b251-517c46a2e708">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtOC0xLTEtMTA3ODQy_eea956db-8a20-4cf9-acb1-a269d5505a4f">6,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtMTAtMS0xLTEwNzg0Mg_a668d83c-dc16-4599-9b0c-4fe3394e8fd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtMTItMS0xLTEwNzg0Mg_405c053a-bcca-429c-9e5d-f6e87af1225c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtMTQtMS0xLTEwNzg0Mg_d7478a74-0811-4122-914a-00c3f9fecd88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtMTYtMS0xLTEwNzg0Mg_199cde1d-f8b6-4c39-b9e7-99d2bea95edc">6,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtNi0xLTEtMTA3ODQy_b90125a8-c664-41dc-b9eb-d56573f77b5f">71,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtOC0xLTEtMTA3ODQy_f3ecbe8f-6611-4f8e-983a-9ba1e10ec462">58,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtMTAtMS0xLTEwNzg0Mg_d879c3a9-8488-4605-b708-c21de11d851f">3,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtMTItMS0xLTEwNzg0Mg_f68257be-68af-4878-95b3-41ddf12a2d7e">5,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtMTQtMS0xLTEwNzg0Mg_b05258f4-dcca-44d6-a9e1-a60a2f149c13">57,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtMTYtMS0xLTEwNzg0Mg_9074a2e4-a8e4-4048-b871-694ab16dd194">73,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctNi0xLTEtMTA3ODQy_a868642c-d22f-4b30-9e0d-be8207e2ce37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctOC0xLTEtMTA3ODQy_5c8ff29f-a34c-4fea-966c-466a84a97e22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctMTAtMS0xLTEwNzg0Mg_97ac498a-1346-489a-8123-17ffe7742a97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctMTItMS0xLTEwNzg0Mg_02e0f3bb-4d1e-4299-9070-b582246fa45f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctMTQtMS0xLTEwNzg0Mg_dc83ffb7-1a2d-421b-be14-27271dfffee1">777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctMTYtMS0xLTEwNzg0Mg_511f83cd-b8f0-42fc-b6b0-8f45afe4fe6b">777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtNi0xLTEtMTA3ODQy_1fccc0f1-1c35-43b0-bdd7-219177cd8275">966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtOC0xLTEtMTA3ODQy_2c8dcaf8-48c4-48b8-940f-f385f4b51b44">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtMTAtMS0xLTEwNzg0Mg_43f427fd-c1a0-470d-8a83-ec039bc71844">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtMTItMS0xLTEwNzg0Mg_5fec80a1-cf4f-46fd-b6b0-9839fc4e8689">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtMTQtMS0xLTEwNzg0Mg_036e5d1b-c323-4400-9127-fe212a10a245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtMTYtMS0xLTEwNzg0Mg_e474eecd-e9c7-4bf6-99b3-3c5d77ca3048">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtNi0xLTEtMTA3ODQy_f86bcd34-f989-4526-ae1b-92d1eef52eb7">72,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtOC0xLTEtMTA3ODQy_665a2da9-a115-47e9-9441-4bc460b6e808">58,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtMTAtMS0xLTEwNzg0Mg_d0a8c2e2-a2bf-4054-a883-0678e2290c4d">2,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtMTItMS0xLTEwNzg0Mg_f9710488-f0f7-423a-82d8-f533366d9acd">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtMTQtMS0xLTEwNzg0Mg_97dd7e38-e804-4721-b859-12e944bc75c0">58,384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtMTYtMS0xLTEwNzg0Mg_2b5bfc20-8768-4886-b66a-a409d581dd00">75,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtNi0xLTEtMTA3ODQy_45da4a2f-56ff-4637-9c61-b9a2f57de064">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtOC0xLTEtMTA3ODQy_96e05ba2-2a2a-46f9-91e3-b4ea60292307">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtMTAtMS0xLTEwNzg0Mg_068ebff1-2dba-450c-8b95-92b09fc5e163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtMTItMS0xLTEwNzg0Mg_ee78218c-8278-4e02-97b5-adb17e343d01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtMTQtMS0xLTEwNzg0Mg_baf722a0-a978-47b7-83db-5f034de71fa4">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtMTYtMS0xLTEwNzg0Mg_397f7cc5-0f24-4a68-838c-cb6fc975d0a7">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItNi0xLTEtMTA3ODQy_0da8d819-91d6-449f-854f-60f8dce961b2">72,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItOC0xLTEtMTA3ODQy_b750d6b0-ae80-4775-bcd5-ff4ee8293568">58,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItMTAtMS0xLTEwNzg0Mg_55f917bf-56be-4043-a671-8b028e92feec">2,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItMTItMS0xLTEwNzg0Mg_e55ef290-648f-44e5-89ab-b50ac1ad1df0">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItMTQtMS0xLTEwNzg0Mg_a6bd234a-c7bb-47b4-8043-4ce5a2414213">58,067</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItMTYtMS0xLTEwNzg0Mg_9724f3e3-874e-4374-a111-6779947fae96">75,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. </span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i7d5a7721e61749b4aab6255ce1f78cc1"><ix:continuation id="i90cff9759e064a148a0cb8bf5edece0c" continuedAt="i4fbce518137d4e909392f53aeec14270"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS02LTEtMS0xMDc4NDI_980ff7be-d7e1-4ee2-adb1-6ed04a6e4668">169,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS04LTEtMS0xMDc4NDI_d66db77f-2240-40d9-804f-cddc67f1c47e">160,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS0xMC0xLTEtMTA3ODQy_8e9053b7-a3b1-4c1e-874b-4f62e779ca52">116,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS0xMi0xLTEtMTA3ODQy_38711d0a-9b0a-41ba-86cd-fb35e456881e">9,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS0xNC0xLTEtMTA3ODQy_55abdfd5-9447-4d40-b1fa-337996bb62ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS0xNi0xLTEtMTA3ODQy_89ba9487-56d7-4553-8692-61cd5ee59c18">455,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi02LTEtMS0xMDc4NDI_2033412d-98fd-4497-92e3-cbc71107897a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi04LTEtMS0xMDc4NDI_077b8676-73e3-460f-ada9-a624a957af0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi0xMC0xLTEtMTA3ODQy_e64d2b77-924d-482d-b04b-dfef56c7c400">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi0xMi0xLTEtMTA3ODQy_dcdf8aff-df4f-4db2-ba14-7fb5aae51143">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi0xNC0xLTEtMTA3ODQy_09cfff2b-d14a-477e-bc9b-8ce1ed159187">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:GovernmentGrantIncomeFromCARESAct" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi0xNi0xLTEtMTA3ODQy_1542ec10-79e6-436f-bbc9-56ce939edb4b">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy02LTEtMS0xMDc4NDI_9f69847f-802f-4553-a798-a133bc2ade6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy04LTEtMS0xMDc4NDI_a8fd7ac7-2ffa-4353-8366-68bf5f7bc256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy0xMC0xLTEtMTA3ODQy_65f3f552-04ee-43ce-a0f7-2956c6afdeed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy0xMi0xLTEtMTA3ODQy_7813189c-fbe6-4c9f-ae9b-27275d046908">9,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy0xNC0xLTEtMTA3ODQy_6d2d0b9d-7364-4196-af06-4a540acccdfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy0xNi0xLTEtMTA3ODQy_4b9f4ed8-224f-4bb1-abb6-fbe491609293">9,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC02LTEtMS0xMDc4NDI_4ed6ec3a-de73-4666-b766-93f1875c0428">1,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC04LTEtMS0xMDc4NDI_93765e73-9183-497b-8fe6-3d1bb30646d6">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC0xMC0xLTEtMTA3ODQy_74092a8f-2879-4af1-bad7-bdecfffe0988">4,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC0xMi0xLTEtMTA3ODQy_1c807341-8969-48c6-8d86-c57b62cb25d7">16,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC0xNC0xLTEtMTA3ODQy_fedfea3b-d2d1-4a43-923f-33b921755139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC0xNi0xLTEtMTA3ODQy_e570c778-ef67-4d50-876a-978b84bdfd4a">23,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS02LTEtMS0xMDc4NDI_82b7df02-320a-44aa-b02d-4b9eb12274a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS04LTEtMS0xMDc4NDI_670a11f1-d399-4a61-953f-2c30d11e3c1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS0xMC0xLTEtMTA3ODQy_254dcea7-b0b0-44b6-9203-3a2d63e9b9bc">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS0xMi0xLTEtMTA3ODQy_8ca56174-cb53-43fd-a38f-db0d6973102b">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS0xNC0xLTEtMTA3ODQy_238b0c07-2fc6-4002-8ac4-8c98b65621d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS0xNi0xLTEtMTA3ODQy_d9b8ddcf-6b11-4d75-a349-ccd71be27824">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi02LTEtMS0xMDc4NDI_51161a26-e007-4cd7-af48-b00417011cf2">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi04LTEtMS0xMDc4NDI_02202927-ee49-4732-bd0c-6bb7a2b0e244">8,926</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi0xMC0xLTEtMTA3ODQy_b1f7a5c6-59ec-422b-b70c-d9ec91b67ded">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi0xMi0xLTEtMTA3ODQy_2efbea32-c244-4368-a17f-76d3cb516293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi0xNC0xLTEtMTA3ODQy_049d1535-c14b-45b6-85aa-44d75df316b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi0xNi0xLTEtMTA3ODQy_40b7c8df-8b47-429b-a833-975cfc74c558">8,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy02LTEtMS0xMDc4NDI_88f6f61a-5ca3-42b9-a55e-1c64bad342cf">39,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy04LTEtMS0xMDc4NDI_d3800326-db28-4e57-b627-549592510b53">51,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy0xMC0xLTEtMTA3ODQy_8d5d0f73-35ef-4da9-8926-8f1c91f989c9">91,179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy0xMi0xLTEtMTA3ODQy_8f93e7b3-e2c5-4bfb-8fb1-4f1933b91e27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy0xNC0xLTEtMTA3ODQy_64b94673-90f1-49df-b94e-3f63527714cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy0xNi0xLTEtMTA3ODQy_6fd58d5d-a787-4199-90d5-ba2616c09a80">181,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC02LTEtMS0xMDc4NDI_f0c8a2ab-0ec3-425f-b3f8-d38fc2240761">425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC04LTEtMS0xMDc4NDI_ee74695b-2411-4bf2-a6bf-35a28fac3988">294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC0xMC0xLTEtMTA3ODQy_56fc16fa-0d1a-4a10-9d6f-6d5c967838e2">4,745</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC0xMi0xLTEtMTA3ODQy_7fec4e04-fe51-4895-8ebe-a68c0bf4757e">12,595</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC0xNC0xLTEtMTA3ODQy_fe213f2d-6df3-4c78-901f-46acbcaf002a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToParentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC0xNi0xLTEtMTA3ODQy_7585b6a9-9c5b-44a3-adaf-a5282a38a5e4">18,059</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS02LTEtMS0xMDc4NDI_9776b23b-2bf8-4202-8a6c-ae35e93a8681">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS04LTEtMS0xMDc4NDI_56c53409-dff9-4a46-b210-bea1be8a0168">2,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS0xMC0xLTEtMTA3ODQy_6b73ed7b-e19b-48dc-8976-5a0e383eadb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS0xMi0xLTEtMTA3ODQy_99a09303-7627-4d69-b127-6d8e170d1202">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS0xNC0xLTEtMTA3ODQy_757184fc-4ec0-4e16-ba04-ee7b116fef3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS0xNi0xLTEtMTA3ODQy_fcf0574b-0471-47fd-bf01-533c4a05b777">2,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtNi0xLTEtMTA3ODQy_833449e8-43d5-40b7-8100-b642ed509883">11,810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtOC0xLTEtMTA3ODQy_5ae2dcdc-366a-4fb2-9df1-4c3c3b5c6d2c">1,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtMTAtMS0xLTEwNzg0Mg_9ad14614-b3b1-4cee-868a-b1a352624746">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtMTItMS0xLTEwNzg0Mg_be6666a0-19b9-45cc-8344-3358df0c45d1">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtMTQtMS0xLTEwNzg0Mg_a967313f-4690-42e2-8918-9f944c8bdbcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtMTYtMS0xLTEwNzg0Mg_54be40ef-0dee-461e-8683-15a9b00be1ec">13,601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItNi0xLTEtMTA3ODQy_c83f6d66-cef9-4437-b2b6-e245683c7571">119,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItOC0xLTEtMTA3ODQy_0fe65260-0db5-4ecf-a4ff-e60c67647159">101,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItMTAtMS0xLTEwNzg0Mg_df1647bb-4177-4b13-9908-ce9952964c97">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItMTItMS0xLTEwNzg0Mg_4820eeb4-d6ba-4aba-b842-920748377db0">4,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItMTQtMS0xLTEwNzg0Mg_a5e6200d-0e37-4b03-9e3b-dff0fcac133c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:AdjustedNetOperatingIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItMTYtMS0xLTEwNzg0Mg_479067f0-2b54-41e8-bcb5-06f107cc0ad1">251,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtNi0xLTEtMTA3ODQy_a86191a7-2173-4747-a8dd-9071782eedc9">11,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtOC0xLTEtMTA3ODQy_5c389a7f-28b8-4d91-a9e7-7e6b05e4417d">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" sign="-" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtMTAtMS0xLTEwNzg0Mg_8bc61b4b-adaa-42ae-b415-fe29fd1635a9">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" sign="-" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtMTItMS0xLTEwNzg0Mg_c5bba927-f7af-4ffa-9667-cd4344730c80">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtMTQtMS0xLTEwNzg0Mg_be38561f-7e10-413b-835e-8ccb0d494f87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtMTYtMS0xLTEwNzg0Mg_cd3a63ac-05d1-4384-9b44-7a52db8ac55b">13,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtNi0xLTEtMTA3ODQy_40eddf34-4496-4df6-8581-27c8f68f9a2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtOC0xLTEtMTA3ODQy_3f76d57d-0066-4fdc-a112-ede313470e68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtMTAtMS0xLTEwNzg0Mg_05cf3aee-e072-49ec-8873-e04f0aaa94cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtMTItMS0xLTEwNzg0Mg_9c6ebaf5-1131-4540-9e48-fa72cffdbd3e">9,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtMTQtMS0xLTEwNzg0Mg_c7569dde-5864-4265-b26d-cbc2fa945181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtMTYtMS0xLTEwNzg0Mg_d098cd16-e26d-4e8e-91d4-431dd48fd26c">9,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtNi0xLTEtMTA3ODQy_47163050-e4a3-4c21-8b7d-20fec8186e1a">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtOC0xLTEtMTA3ODQy_7335be00-6879-42f7-be38-92650f66c32f">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtMTAtMS0xLTEwNzg0Mg_9f368810-37e8-47db-b641-063f0cc72c1e">1,918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtMTItMS0xLTEwNzg0Mg_1d3c5277-06f6-4694-840d-59e136303b08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtMTQtMS0xLTEwNzg0Mg_93e7b065-5437-4a19-8f9a-fc6d2078cbe4">44,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtMTYtMS0xLTEwNzg0Mg_0e5049c9-0093-4b16-99b8-5147326bdbda">46,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtNi0xLTEtMTA3ODQy_af1aadfc-a71f-4857-b46f-253c27b9fa95">68,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtOC0xLTEtMTA3ODQy_dec94182-9f6f-4b9e-8b1c-7787379da459">57,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtMTAtMS0xLTEwNzg0Mg_df4ea755-41ea-400b-b630-35bf080135da">31,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtMTItMS0xLTEwNzg0Mg_d2acb204-176b-4d06-8a99-38c84ea7b6e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtMTQtMS0xLTEwNzg0Mg_1c4984a0-7133-4e48-a09b-1a5c99364f4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtMTYtMS0xLTEwNzg0Mg_3485a993-d526-4fa7-a192-30d9b56f48ed">157,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctNi0xLTEtMTA3ODQy_cfab3baa-3a18-40b6-9b46-49efeca12e44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctOC0xLTEtMTA3ODQy_c53ea167-bcad-4425-8ba0-32f473e5d6d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctMTAtMS0xLTEwNzg0Mg_d25ccaa1-1528-4054-9165-d4374466a2ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctMTItMS0xLTEwNzg0Mg_656e2cbb-0e86-4781-acd6-5db8834f08bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctMTQtMS0xLTEwNzg0Mg_858163aa-c09f-438b-8663-9c1c3a938917">24,902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctMTYtMS0xLTEwNzg0Mg_0deda661-2b2a-4977-830f-831c5d44c98e">24,902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtNi0xLTEtMTA3ODQy_713b4cbf-da72-495d-8dd0-382847c3eb2b">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtOC0xLTEtMTA3ODQy_6f9c42da-b019-4643-8f08-5310ac28329b">330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtMTAtMS0xLTEwNzg0Mg_18fd3b28-727e-40ab-bdc9-2b02d4d40a93">432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtMTItMS0xLTEwNzg0Mg_0128df64-8002-442b-959d-5345af822d74">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtMTQtMS0xLTEwNzg0Mg_401e41ac-7926-4bf1-b82c-2fca9ae7636d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtMTYtMS0xLTEwNzg0Mg_4cb815d1-ea13-4ed6-bdf7-b058358df4b3">798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktNi0xLTEtMTA3ODQy_31e0ea94-4a06-4478-8cb8-c498a83efb0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktOC0xLTEtMTA3ODQy_e8d70322-f1cb-4bd0-b2a7-cf987f705bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktMTAtMS0xLTEwNzg0Mg_e5216ebd-7f4a-4f19-b0a5-e3f139b902cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktMTItMS0xLTEwNzg0Mg_d4a53ced-ef41-4c7a-9ed3-aec71b8980e0">3,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktMTQtMS0xLTEwNzg0Mg_f1cbadd8-cf31-48fc-bcd3-a4e998e8c235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:ImpairmentsAndAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktMTYtMS0xLTEwNzg0Mg_5ba26caa-2831-482f-9f7a-f0e942464fef">3,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on debt extinguishments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtNi0xLTEtMTA3ODQy_d260da4c-d384-4d25-8480-8229d026a7f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtOC0xLTEtMTA3ODQy_edf60b99-da2a-4812-b15e-5a9632136e0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtMTAtMS0xLTEwNzg0Mg_69e14dd9-d2d7-40a3-a755-4bfe6507bceb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtMTItMS0xLTEwNzg0Mg_18af1f62-5243-41bc-bb02-ed450f938f1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtMTQtMS0xLTEwNzg0Mg_70820147-7c19-44e4-9672-0085a4bba119">164,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtMTYtMS0xLTEwNzg0Mg_4a456fb9-9689-42a1-a789-af952ac91497">164,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItNi0xLTEtMTA3ODQy_21258591-b204-4074-9068-fee0ef54fca3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItOC0xLTEtMTA3ODQy_439d25fc-9bfc-4d7e-b5ca-d752b039a518">2,279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItMTAtMS0xLTEwNzg0Mg_4e8a8ad4-6ca5-4c56-bb8c-053185e18536">2,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItMTItMS0xLTEwNzg0Mg_979dcf49-88b7-46c8-9f6e-42f00fec8678">482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItMTQtMS0xLTEwNzg0Mg_7fd95a0e-67aa-4895-acfd-75e63e33f299">1,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItMTYtMS0xLTEwNzg0Mg_de02b878-9570-456e-ae64-86eeea808e84">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtNi0xLTEtMTA3ODQy_4c0493c5-6451-4c3e-93f2-a1eda71c827d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtOC0xLTEtMTA3ODQy_f146b5b4-ede7-48cd-91ce-8f6b8d223bfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" sign="-" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtMTAtMS0xLTEwNzg0Mg_10670859-3f58-4144-ad62-2356e4d8828e">1,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtMTItMS0xLTEwNzg0Mg_6cc42af3-90d6-41b8-9796-2bb8875763c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtMTQtMS0xLTEwNzg0Mg_9be37e9e-7216-4dec-b08d-7e9e7083c7ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtMTYtMS0xLTEwNzg0Mg_4459561e-d2ed-46ad-9303-5ebf9fdc1e5a">1,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtNi0xLTEtMTA3ODQy_1a637bdf-2f10-4177-a5b4-107a1ab4751e">912</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtOC0xLTEtMTA3ODQy_9c7e072a-a75c-4522-b0af-e8c1948070dc">421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtMTAtMS0xLTEwNzg0Mg_68645c3c-ef6f-40b8-8469-3018cc018908">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtMTItMS0xLTEwNzg0Mg_2cbe215e-4d09-4653-b432-98a036bb4d2d">4,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtMTQtMS0xLTEwNzg0Mg_dab158f7-3985-4bb6-8a35-9892672c7c1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="peak:NetIncomeLossJointVenturePartnersAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtMTYtMS0xLTEwNzg0Mg_c8c417d1-2a1a-49e6-ac62-ed3c6f7f8d09">5,660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtNi0xLTEtMTA3ODQy_ac606e1b-969d-4793-b4c6-8b64e6457143">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtOC0xLTEtMTA3ODQy_9a019986-25bc-47e8-ae59-1e4f1cf6fe56">6,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtMTAtMS0xLTEwNzg0Mg_ee8de105-7fb0-4839-bbdd-a60175f76c81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtMTItMS0xLTEwNzg0Mg_4e42a9f3-67a6-453a-ad79-cef137482571">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtMTQtMS0xLTEwNzg0Mg_2e5bcb8e-8849-4bd9-9114-70321a5a622d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtMTYtMS0xLTEwNzg0Mg_2a52fe89-b398-419c-9f32-fa7555446552">6,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtNi0xLTEtMTA3ODQy_99b8f5e2-6ad8-4e6f-bf9a-d76a6ce75889">61,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtOC0xLTEtMTA3ODQy_f4da6998-ab0c-4a6b-a03d-7d41411cd9b5">48,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtMTAtMS0xLTEwNzg0Mg_f04100d8-7931-4108-9210-0f06ffa9d024">6,375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtMTItMS0xLTEwNzg0Mg_679daa3e-4843-4c95-a9ee-9d28285b060b">6,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtMTQtMS0xLTEwNzg0Mg_010415fd-de55-4dd0-9490-47c4cf22a972">232,105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtMTYtMS0xLTEwNzg0Mg_df86eae0-1503-422b-9c7b-1464e0b5ef12">121,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctNi0xLTEtMTA3ODQy_99c8cf1d-4b21-4d68-9e27-be4fb8e8aed4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctOC0xLTEtMTA3ODQy_a6cb2082-e14b-4209-af14-e423c0bb5a7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctMTAtMS0xLTEwNzg0Mg_7ac93b1b-b629-48a4-813d-3f5b098a2b62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctMTItMS0xLTEwNzg0Mg_dad5d9cf-18cb-44c9-bc09-dd20a96bd0bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctMTQtMS0xLTEwNzg0Mg_d6701524-a580-423e-a620-505d3f5278cb">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctMTYtMS0xLTEwNzg0Mg_7232edcd-d48b-4180-a424-8bdcfd505035">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtNi0xLTEtMTA3ODQy_4a0d7c29-c874-44af-aa99-3e2f86b9451f">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtOC0xLTEtMTA3ODQy_4caf1f50-c4bd-4fe2-af8d-fd1ca87df96b">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtMTAtMS0xLTEwNzg0Mg_93edf644-8c66-4a8e-8c09-8802ec18cd50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtMTItMS0xLTEwNzg0Mg_ab266260-bae3-4e36-b5cd-dc56b4c30a7a">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtMTQtMS0xLTEwNzg0Mg_560e0ed2-df7d-4226-b5a4-a1f8ddf6a652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtMTYtMS0xLTEwNzg0Mg_efc1ab6e-a5c1-4dab-ad4f-a61dd76d720b">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtNi0xLTEtMTA3ODQy_2c9f429a-0309-4afd-8d2c-cbaf58b93401">61,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtOC0xLTEtMTA3ODQy_1ab13272-b30b-4dbd-b90c-302de3b0e291">48,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtMTAtMS0xLTEwNzg0Mg_6a9b6790-4921-4ed2-97ee-41eeb798f507">6,375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtMTItMS0xLTEwNzg0Mg_f8eb6f2b-dd06-4eb5-9c5b-51ad6fc33674">7,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtMTQtMS0xLTEwNzg0Mg_a962c41d-1536-42e8-97a4-f8df4ec888dc">232,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtMTYtMS0xLTEwNzg0Mg_783c6e21-17fc-47af-84b0-b16dc0ecf831">120,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtNi0xLTEtMTA3ODQy_8c15cb35-7735-433d-9e61-d3fa2dcc7c97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtOC0xLTEtMTA3ODQy_6cc74991-ce54-41e1-a094-61f5c4e5ba46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtMTAtMS0xLTEwNzg0Mg_cce3861c-7eb0-4b5a-bdb4-ddb47a184806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtMTItMS0xLTEwNzg0Mg_36937fc5-b969-425d-a67c-3caa0917f8b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtMTQtMS0xLTEwNzg0Mg_062cf8cb-50b5-40ad-80a7-6696f462b3c7">270,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtMTYtMS0xLTEwNzg0Mg_abc05cb7-ea5d-484b-95ad-a8cf66cd70d9">270,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItNi0xLTEtMTA3ODQy_90cd8f3b-e47b-4aef-8e32-7bcda691abaa">61,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItOC0xLTEtMTA3ODQy_31c06040-2f5d-4cd3-9e04-d28fe267b694">48,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItMTAtMS0xLTEwNzg0Mg_d19f9943-064f-4871-b65a-77562d0a1a03">6,375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItMTItMS0xLTEwNzg0Mg_bc1d3d8c-841e-494c-93fa-9a15053467ec">7,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItMTQtMS0xLTEwNzg0Mg_397224f2-4a0c-475a-912e-2f509707045e">37,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItMTYtMS0xLTEwNzg0Mg_d3820c1b-3d95-4fd6-b5e9-f50bb60663b6">149,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i4fbce518137d4e909392f53aeec14270" continuedAt="ie7c99e657e5d4905a9565c49757c155f">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="ie7c99e657e5d4905a9565c49757c155f">Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures.</ix:continuation> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 3, 4, and 5 for significant transactions impacting the Company&#8217;s segment assets during the periods presented.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RleHRyZWdpb246ZGZjYTkzMzBlODkyNDk0ZGE1ZWEzZGY3ZDIyODI1MjJfNTEy_6efe1fb7-1c90-4969-8997-4de718ce4cf5" continuedAt="i35db758cc8ec45179d1d1a2a5c821bfa" escape="true">Supplemental Cash Flow Information</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i35db758cc8ec45179d1d1a2a5c821bfa"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RleHRyZWdpb246ZGZjYTkzMzBlODkyNDk0ZGE1ZWEzZGY3ZDIyODI1MjJfNTE1_1dd3066e-f947-4e6d-842e-defd25af2453" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental cash flow information (in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of capitalized interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfMy0xLTEtMS0xMDc4NDI_8c9c2552-c7a1-4cd7-bfb4-3b5716de6f09">58,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfMy0zLTEtMS0xMDc4NDI_c78d042a-d414-40ba-88e3-a0a740819358">90,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (refunded)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNC0xLTEtMS0xMDc4NDI_1657960a-6919-40f4-b416-d956bcc90cbe">1,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNC0zLTEtMS0xMDc4NDI_8eecbd07-adda-4ea6-852f-0ab5020ac689">2,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNS0xLTEtMS0xMDc4NDI_60a455fb-2771-4318-bcdf-a6f492fb497f">8,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:InterestCostsCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNS0zLTEtMS0xMDc4NDI_ac609f4b-b62a-4bd5-8f70-a687b99a14f9">5,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental schedule of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in ROU asset in exchange for new lease liability related to operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNy0xLTEtMS0xMTIwNzI_b9e08434-7afd-40cc-8e63-7b9f205efda2">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNy0zLTEtMS0xMTIwNzI_682d252d-e6e2-4d49-8e74-5fb683565ca4">5,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seller financing provided on disposition of real estate asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:SellerFinancingProvidedOnDispositionofRealEstateAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfOS0xLTEtMS0xMTIwODA_23a31b39-1a39-4743-b22f-a35864047d34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:SellerFinancingProvidedOnDispositionofRealEstateAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfOS0zLTEtMS0xMTIwODA_bc73512c-434c-469f-ab2a-6db5b60a4a82">559,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNy0xLTEtMS0xMDc4NDI_f9236f1d-1a2f-490a-93d4-b5a8f9de93df">163,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNy0zLTEtMS0xMDc4NDI_ae8e2900-b99d-4e6e-be5b-4220b600967c">107,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of restricted stock units and conversion of non-managing member units into common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-3" name="peak:RestrictedStockVested" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfOC0xLTEtMS0xMDc4NDI_406cf317-d662-44a6-9d1a-40028e248123">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-3" name="peak:RestrictedStockVested" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfOC0zLTEtMS0xMDc4NDI_e7df66a1-6908-4ba3-87d0-2c0d54ee5323">838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes certain cash flow information related to assets classified as discontinued operations (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing costs, tenant improvements, and recurring capital expenditures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfMy0xLTEtMS0xMjcxOTM_08085a31-08c0-41f8-becd-1c14f33c1c06">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586d3ac1554b476b944978cf331446d1_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfMy0zLTEtMS0xMjcxOTM_6b7ca1d2-9a29-43c6-a964-a444949588d2">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development, redevelopment, and other major improvements of real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfMy0xLTEtMS0xMDc4NDI_5f7b8b6e-85ed-476d-b91d-37c0be8ba493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586d3ac1554b476b944978cf331446d1_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfMy0zLTEtMS0xMDc4NDI_5e051991-9a52-4b09-baa2-c1b5dbb41e5a">3,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of real estate, in-place lease, and other intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfNS0xLTEtMS0xMjYxNDk_9b61cdbf-8134-4e83-b68f-9cf8486ccebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i586d3ac1554b476b944978cf331446d1_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfNS0zLTEtMS0xMjYxNTM_d8d9efc7-9014-4288-8880-6db1f60c3246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RleHRyZWdpb246ZGZjYTkzMzBlODkyNDk0ZGE1ZWEzZGY3ZDIyODI1MjJfNTI4_735547f6-bd04-4995-a8e8-559834f0f55c" escape="true"><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cash, cash equivalents and restricted cash (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC0yLTEtMS0xMDc4NDI_fe3514de-c0d5-49ca-a81b-498e584ed627">158,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC00LTEtMS0xMDc4NDI_f8956fbc-e7e9-4934-8b15-d61bbb04699e">44,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC02LTEtMS0xMDc4NDI_ea0d73e0-3515-4f08-901a-2fa1a55f1f14">7,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC04LTEtMS0xMDc4NDI_0bee3d29-4178-4c49-b2e6-34ef09feffd4">53,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC0xMC0xLTEtMTA3ODQy_0c0e2ce1-1730-4306-9ae4-2014a48b69ac">165,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC0xMi0xLTEtMTA3ODQy_d7a4d695-855a-4255-b8c2-2b382285636f">97,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS0yLTEtMS0xMDc4NDI_07f74df6-fc38-457d-b5f5-d6402309fbd4">53,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS00LTEtMS0xMDc4NDI_7de73747-0c49-4a27-b348-82035851f898">67,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS02LTEtMS0xMDc4NDI_cec439c9-00a7-4d0f-a97e-3bf20f82934e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS04LTEtMS0xMDc4NDI_050b8dfa-d129-4511-b57a-eeb849f9e11f">17,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS0xMC0xLTEtMTA3ODQy_80e966fa-550c-45f0-aad7-5425a6519a5d">53,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS0xMi0xLTEtMTA3ODQy_284a57e8-c615-4a6d-9a43-cdef60958163">84,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi0yLTEtMS0xMDc4NDI_6373841d-e6e4-4f8d-a572-73fdb167c599">211,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi00LTEtMS0xMDc4NDI_f55122c2-cee7-4b7b-9735-88fc9b280d55">111,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi02LTEtMS0xMDc4NDI_b286da0c-d99b-4898-a705-21b1c83638a2">7,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi04LTEtMS0xMDc4NDI_0f7483d6-5d15-4cee-a017-6ef18cbed961">70,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi0xMC0xLTEtMTA3ODQy_b823b553-14b0-4a0b-ac61-10f4c5dcf1eb">219,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi0xMi0xLTEtMTA3ODQy_33f04052-6250-435f-a89e-6bcb7589906e">181,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC0yLTEtMS0xMDc4NDI_473f08de-6373-4971-beb8-52b8d7399b0f">89,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC00LTEtMS0xMDc4NDI_996171c1-c61d-4f89-a97b-890220f0e0ca">34,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC02LTEtMS0xMDc4NDI_2e1641ae-9642-4a4a-b27e-8ae675165c39">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC04LTEtMS0xMDc4NDI_c01032e2-0a62-4f74-8783-8212a4ef21f7">40,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC0xMC0xLTEtMTA3ODQy_81921d6a-147f-4eeb-878c-c00795b83e70">97,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC0xMi0xLTEtMTA3ODQy_ec9140af-7249-4ea3-8e17-1500b0806a4b">74,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS0yLTEtMS0xMDc4NDI_2ddd7f3e-bb33-47d5-906a-1f1c78f1bb6f">52,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS00LTEtMS0xMDc4NDI_024cd23f-bfc7-4b37-9c8d-8958b2234a9e">68,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS02LTEtMS0xMDc4NDI_0ec57c89-5d49-4c88-b1a9-b061968f8ed1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS04LTEtMS0xMDc4NDI_e6f54896-083c-452b-8d81-53b41607aa78">5,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS0xMC0xLTEtMTA3ODQy_e2b5b5c5-c161-4fde-9939-daabdd98774c">52,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS0xMi0xLTEtMTA3ODQy_56d4261f-965d-46b9-a552-627c1fc6debb">73,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtMi0xLTEtMTA3ODQy_078372f7-d090-4b79-a78c-a7185ee3f5cc">141,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtNC0xLTEtMTA3ODQy_73a788a6-2b98-433a-b3f3-cc214091fd94">102,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtNi0xLTEtMTA3ODQy_c18b3767-0703-4e31-9e91-9a5e27a04ffa">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtOC0xLTEtMTA3ODQy_fc5c52d7-7b7f-4dc8-a73d-d8d644a3b2cd">45,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtMTAtMS0xLTEwNzg0Mg_65fe5c46-b5a5-4e79-93db-0c3668f47d3d">149,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9033e3f616764988932a09935d4445c5_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtMTItMS0xLTEwNzg0Mg_30b59b83-dae9-449b-ac00-dca668c5b2af">148,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ifa3dff468a15495db7b57c65ada0de74_79"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="peak:VariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTMyMTY_e07fbb36-984a-41b5-94c9-6d3fb05e12b1" continuedAt="i651a3ae02dc24f1abbfb74f0540339b6" escape="true">Variable Interest Entities</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i651a3ae02dc24f1abbfb74f0540339b6" continuedAt="ifb4a67e7b2bb4bdd8e461ef08ed6f029"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unconsolidated Variable Interest Entities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and December&#160;31, 2021, the Company had investments in: (i) <ix:nonFraction unitRef="joint_venture" contextRef="ide8b297bfe9444c5bf4d4192b08aecda_I20220331" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTI5_a4d9670f-b952-44b6-a330-48cf5cf32a87"><ix:nonFraction unitRef="joint_venture" contextRef="idd28c0a01e0b4e1687c11f71b4e146b7_I20211231" decimals="INF" name="peak:NumberOfUnconsolidatedJointVenture" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTI5_d1455a99-30dc-491b-97a5-5faac75e9cf7">two</ix:nonFraction></ix:nonFraction> unconsolidated VIE joint ventures and (ii) marketable debt securities of <ix:nonFraction unitRef="joint_venture" contextRef="ide8b297bfe9444c5bf4d4192b08aecda_I20220331" decimals="INF" name="peak:NumberOfVieBorrowersWithMarketableDebtSecurities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMjA0_caad9bf6-b437-488f-943a-d0231466eb0e"><ix:nonFraction unitRef="joint_venture" contextRef="idd28c0a01e0b4e1687c11f71b4e146b7_I20211231" decimals="INF" name="peak:NumberOfVieBorrowersWithMarketableDebtSecurities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMjA0_d2b4749d-8dec-4a71-8a81-579894982915">one</ix:nonFraction></ix:nonFraction> VIE. The Company determined it is not the primary beneficiary of and therefore does not consolidate these VIEs because it does not have the ability to control the activities that most significantly impact their economic performance. Except for the Company&#8217;s equity interest in the unconsolidated joint ventures (the LLC investment and Needham Land Parcel JV discussed below), it has no formal involvement in these VIEs beyond its investments.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="ifb4a67e7b2bb4bdd8e461ef08ed6f029" continuedAt="ibdf334107ae54dc8a8cf87f27635b6d6"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company holds commercial mortgage-backed securities (&#8220;CMBS&#8221;) issued by Federal Home Loan Mortgage Corporation (commonly referred to as Freddie MAC) through a special purpose entity that has been identified as a VIE because it is &#8220;thinly capitalized.&#8221; The CMBS issued by the VIE are backed by mortgage debt obligations on real estate assets. These securities are classified as held-to-maturity because the Company has the intent and ability to hold the securities until maturity. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LLC Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company holds a limited partner ownership interest in an unconsolidated LLC that has been identified as a VIE. The Company&#8217;s involvement in the entity is limited to its equity investment as a limited partner and it does not have any substantive participating rights or kick-out rights over the general partner. The assets and liabilities of the entity primarily consist of those associated with its senior housing real estate and development activities. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development expenses and debt service payments).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Needham Land Parcel JV.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2021, the Company acquired a <ix:nonFraction unitRef="number" contextRef="ib12448d242784ab084c7178415e35eef_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTA5OTUxMTY0MzkzOQ_fa65496f-5482-47e8-b2e5-faeedb5487c2">38</ix:nonFraction>% interest in a life science development joint venture in Needham, Massachusetts for $<ix:nonFraction unitRef="usd" contextRef="ib42e8c61652142339c59c133c0ca0201_D20211201-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTA5OTUxMTY0MzkyMg_9657da04-c88f-492d-99e7-e76c3ea14883">13</ix:nonFraction>&#160;million. Current equity at risk is not sufficient to finance the joint venture&#8217;s activities. The assets and liabilities of the entity primarily consist of real estate and debt service obligations. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development expenses and debt service payments).</span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTMyMDY_d7d5fa49-6a87-408a-ba4e-22d892db032c" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#8217;s involvement with these VIEs at March&#160;31, 2022 was as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">VIE Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exposure</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">and Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Continuing operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMBS and LLC investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e285ee41e894f3fb7a5abcc3f145a7e_I20220331" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjIxMmYxZDZhZWRiMjRmNmJhMTM3MzU2ZWFkYjkzOWQ4L3RhYmxlcmFuZ2U6MjEyZjFkNmFlZGIyNGY2YmExMzczNTZlYWRiOTM5ZDhfNC00LTEtMS0xMDc4NDI_6b77d68b-7573-4bb7-bd9d-88fb39053a7f">36,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in and advances to unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6194055e785642eebfc80c30a45c054f_I20220331" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjIxMmYxZDZhZWRiMjRmNmJhMTM3MzU2ZWFkYjkzOWQ4L3RhYmxlcmFuZ2U6MjEyZjFkNmFlZGIyNGY2YmExMzczNTZlYWRiOTM5ZDhfNS00LTEtMS0xMTE5Mjk_5ecb6065-aa5c-4a69-96df-c3ccaab7f5c7">14,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s maximum loss exposure represents the aggregate carrying amount of such investments (including accrued interest).</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including under circumstances in which it could be exposed to further losses (e.g., cash shortfalls).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 3, 4, and 7 for additional descriptions of the nature, purpose, and operating activities of the Company&#8217;s unconsolidated VIEs and interests therein.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated total assets and total liabilities at March&#160;31, 2022 and December&#160;31, 2021 include certain assets of VIEs that can only be used to settle the liabilities of the related VIE. The VIE creditors do not have recourse to the Company. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ventures V, LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; The Company holds a <ix:nonFraction unitRef="number" contextRef="i31f56e92e9a1411d871334a90b76fa9f_D20220101-20220331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfNTQ2Ng_335ebd65-4618-49eb-a70c-df53b92d578a">51</ix:nonFraction>% ownership interest in and is the managing member of a joint venture entity formed in October 2015 that owns and leases MOBs (&#8220;Ventures V&#8221;). The Company classifies Ventures V as a VIE due to the non-managing member lacking substantive participation rights in the management of Ventures V or kick-out rights over the managing member. The Company consolidates Ventures V as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#8217;s economic performance. The assets of Ventures V primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by Ventures V may only be used to settle its contractual obligations (primarily from capital expenditures).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Life Science JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;The Company holds a <ix:nonFraction unitRef="number" contextRef="iec88d274781648d1946da5119782e172_D20220101-20220331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfNjM1NA_8adfaf87-74cb-4275-a912-70639aa78955">99</ix:nonFraction>% ownership interest in multiple joint venture entities that own and lease life science assets (the &#8220;Life Science JVs&#8221;). The Life Science JVs are VIEs as the members share in control of the entities, but substantially all of the activities are performed on behalf of the Company. The Company consolidates the Life Science JVs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the Life Science JVs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Life Science JVs may only be used to settle their contractual obligations (primarily from capital expenditures). Refer to Note 11 for a discussion of certain put options associated with the Life Science JVs.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="ibdf334107ae54dc8a8cf87f27635b6d6" continuedAt="i4c230b879bb54d2b9e34ed07ea55c36e"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MSREI MOB JV.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a <ix:nonFraction unitRef="number" contextRef="i7fefcab6d3cb41888c82058807af19ee_D20220101-20220331" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfNzM0MQ_17614d0f-a31a-45e0-8699-4da20e57be6f">51</ix:nonFraction>% ownership interest in, and is the managing member of, a joint venture entity formed in August 2018 that owns and leases MOBs (the &#8220;MSREI JV&#8221;). The MSREI JV is a VIE due to the non-managing member lacking substantive participation rights in the management of the joint venture or kick-out rights over the managing member. The Company consolidates the MSREI JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#8217;s economic performance. The assets of the MSREI JV primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by the MSREI JV may only be used to settle its contractual obligations (primarily from capital expenditures).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; The Company holds a controlling ownership interest in and is the managing member of <ix:nonFraction unitRef="joint_venture" contextRef="i6fb4bb6009344e2d86a46be91dd2df36_D20220101-20220331" decimals="INF" name="peak:VariableInterestEntityControllingOwnershipInterestThroughPartnership" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfOTQ0OA_a0cfa3aa-cb2b-4c81-8307-a2eccae9760b">seven</ix:nonFraction> DownREITs. The Company classifies the DownREITs as VIEs due to the non-managing members lacking substantive participation rights in the management of the DownREITs or kick-out rights over the managing member. The Company consolidates the DownREITs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the DownREITs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the DownREITs (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Consolidated Real Estate Partnerships.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a controlling ownership interest in and is the general partner (or managing member) of multiple partnerships that own and lease real estate assets (the &#8220;Partnerships&#8221;). The Company classifies the Partnerships as VIEs due to the limited partners (non-managing members) lacking substantive participation rights in the management of the Partnerships or kick-out rights over the general partner (managing member). The Company consolidates the Partnerships as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the Partnerships primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Partnerships (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exchange Accommodation Titleholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  During the three months ended March&#160;31, 2022, the Company acquired <ix:nonFraction unitRef="property" contextRef="i722f52bee0ee49709ef5ab8ea0678ab4_D20210101-20210331" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTE0MzQ_c4d3d47c-5273-4789-a2e5-2e3dd53c9dad">two</ix:nonFraction> MOBs (the &#8220;acquired properties&#8221;) using a reverse like-kind exchange structure pursuant to Section 1031 of the Internal Revenue Code (a &#8220;reverse 1031 exchange&#8221;). As of March&#160;31, 2022, the Company had not completed the reverse 1031 exchange and as such, the acquired properties remained in the possession of the Exchange Accommodation Titleholder (&#8220;EAT&#8221;). The EAT was classified as a VIE as it was a &#8220;thinly capitalized&#8221; entity. The Company consolidated the EAT because it had the ability to control the activities that most significantly impacted the economic performance of the EAT and was, therefore, the primary beneficiary of the EAT. The properties held by the EAT had a carrying value of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-6" name="peak:ExchangeAccommodationTitleholderRealEstateCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTIxODM_7da7d42b-3a60-4627-a06a-57637c4b99a5">43</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of March&#160;31, 2022. The assets of the EAT primarily consisted of leased properties (net real estate, including intangibles), rents receivable, and cash and cash equivalents; their obligations primarily consisted of capital expenditures for the properties. Assets generated by the EAT may only be used to settle its contractual obligations (primarily from capital expenditures). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the year ended December&#160;31, 2021, the Company acquired <ix:nonFraction unitRef="property" contextRef="i84e02dec09e34ee98740b651f1f10e6b_D20210101-20211231" decimals="INF" name="peak:NumberOfPropertiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTY0OTI2NzQ2NTk0MQ_371accf2-a5e0-4624-b207-4c1bddf9cfe9">two</ix:nonFraction> MOBs using reverse 1031 exchanges. As of December&#160;31, 2021, the Company had not completed the reverse 1031 exchanges and as such, the acquired properties remained in the possession of the EAT. These properties held by the EAT had a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-6" name="peak:ExchangeAccommodationTitleholderRealEstateCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTY0OTI2NzQ2NTk4Mw_8ee3934a-6a72-4eee-9b4e-a9562b750b3e">77</ix:nonFraction>&#160;million as of December&#160;31, 2021. These reverse 1031 exchanges were completed in February 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><ix:continuation id="i4c230b879bb54d2b9e34ed07ea55c36e"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="peak:ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTMyMDg_30003891-ef71-4ad7-9e7e-f903c1e3dfe1" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities include VIE assets and liabilities as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMi0xLTEtMS0xMDc4NDI_0433c8c3-e3e4-4dff-8aba-8091a8e1b4b7">2,303,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMi0zLTEtMS0xMDc4NDI_1e1bf196-b35a-41bd-b35d-a8ebfb340d89">2,303,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development costs and construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMy0xLTEtMS0xMDc4NDI_01054468-8e14-4b9a-8b40-5a952ec7f4b7">107,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMy0zLTEtMS0xMDc4NDI_3d063beb-17e6-4960-b8df-60ea9030286e">82,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNC0xLTEtMS0xMDc4NDI_6d40549c-2953-46fb-b938-2a3f6a41076d">509,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNC0zLTEtMS0xMDc4NDI_62eb5b82-c94c-4b5f-b070-a91d61bfd912">548,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNS0xLTEtMS0xMDc4NDI_31e5f166-26c3-4b0a-8b86-b486897d21f8">569,437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNS0zLTEtMS0xMDc4NDI_e8712b06-cacb-49b6-9973-db910a236962">551,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNi0xLTEtMS0xMDc4NDI_e45822cb-131d-44f5-a0f9-f4aaaa773991">2,350,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNi0zLTEtMS0xMDc4NDI_568489b6-ca7e-48f8-b7e7-95ea8511733a">2,383,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfOC0xLTEtMS0xMDc4NDI_ebf81e6e-2325-47d6-a767-c11c7dd97dcf">4,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfOC0zLTEtMS0xMDc4NDI_babc2ca0-0c68-445d-bb14-b73aa3be2985">5,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfOS0xLTEtMS0xMDc4NDI_eb703143-0b75-4629-9ee8-9279fc0c4452">37,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfOS0zLTEtMS0xMDc4NDI_119ee668-38c8-4698-88de-7147d5013f4e">22,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTAtMS0xLTEtMTA3ODQy_29ce5daa-ece6-447b-b36d-467e5468fe39">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTAtMy0xLTEtMTA3ODQy_a4ec5ba8-b683-4bb0-88b2-9698ed66e290">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTEtMS0xLTEtMTA3ODQy_18e9f8d4-d0e7-4c5a-a41e-9b43bafbfdcc">109,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTEtMy0xLTEtMTA3ODQy_57483581-f411-4a73-9d3c-2ac0a90f0ee2">117,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale and discontinued operations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTItMS0xLTEtMTA3ODQy_a472bce2-7ca5-49b4-8660-a973cfd52385">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTItMy0xLTEtMTA3ODQy_53eaec34-cb7c-40cc-ae17-7f154e92d37f">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTMtMS0xLTEtMTA3ODQy_0359ff4f-2d14-498b-9e64-6a4094b74fc8">106,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTMtMy0xLTEtMTA3ODQy_7f55607d-b544-4c49-8318-2d522db36abf">107,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTQtMS0xLTEtMTA3ODQy_9355551f-b1b5-4da3-b1b3-0e1cfc39cf64">65,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTQtMy0xLTEtMTA3ODQy_d234c610-1c01-4d67-96da-712cbb645667">62,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTUtMS0xLTEtMTA3ODQy_75e8ae2a-2d27-43db-a9ea-2a7acdcdf0a4">2,674,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTUtMy0xLTEtMTA3ODQy_414e4520-be66-451d-92cb-147d230ca0f4">2,699,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTctMS0xLTEtMTA3ODQy_9c791d4f-b928-4c51-9bd7-4d0693a84e80">144,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTctMy0xLTEtMTA3ODQy_77efa664-c75e-4ef5-b489-e217bdafcc4e">144,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:OffMarketLeaseUnfavorable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTktMS0xLTEtMTA3ODQy_521ac5e7-b531-4917-b33f-3dbfaa4aa560">27,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:OffMarketLeaseUnfavorable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTktMy0xLTEtMTA3ODQy_3cf61d1c-5af4-40a9-bf89-3b5a22591d31">23,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale and discontinued operations, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjAtMS0xLTEtMTA3ODQy_82e78f25-0452-4df8-89f1-699b441e0ad8">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjAtMy0xLTEtMTA3ODQy_636d4a02-4649-4e84-8b90-92b45f9e9f42">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjEtMS0xLTEtMTA3ODQy_6679b829-6d5b-4bb3-b471-b9708ac4dad6">98,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjEtMy0xLTEtMTA3ODQy_f05bf10b-fbe2-452c-b162-d42be8d6c1a8">99,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjItMS0xLTEtMTA3ODQy_1a3ff5fe-4d3a-4ac9-8935-1590a9b0706b">56,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjItMy0xLTEtMTA3ODQy_a447cce1-1ff8-4a55-b462-2a1e89c6b53c">58,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjMtMS0xLTEtMTA3ODQy_4b2acb5d-0767-4d75-9d8b-76a2319b5166">24,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjMtMy0xLTEtMTA3ODQy_eb88c1e6-1011-421a-89b0-ddf12342f934">21,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjQtMS0xLTEtMTA3ODQy_32b3550b-2509-4f21-a8fc-092c25b9bc3c">353,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjQtMy0xLTEtMTA3ODQy_369fc426-49d2-480d-9e13-bd26cb0808cb">349,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and liabilities related to assets held for sale and discontinued operations include VIE assets and liabilities as follows (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfNy0yLTEtMS0xMDc4NDI_f7f5d70e-258e-4b5a-ab3b-2e145fa7f8fc">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfNy00LTEtMS0xMDc4NDI_f355cb87-ae85-4223-b523-cfbe1b5db27b">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfOC0yLTEtMS0xMDc4NDI_17334bac-5c81-49e7-a62f-ec1f7735730f">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfOC00LTEtMS0xMDc4NDI_95092f92-9e7c-46c0-bba1-9baf571b9546">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331" decimals="-3" name="us-gaap:OtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTItMi0xLTEtMTA3ODQy_9e501741-7744-4d3e-a220-2514532486d9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231" decimals="-3" name="us-gaap:OtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTItNC0xLTEtMTA3ODQy_18612373-acdb-4c56-9040-0c0d334659d4">633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331" decimals="-3" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTMtMi0xLTEtMTA3ODQy_836afb9a-fc07-473e-8452-2faeec1a7064">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231" decimals="-3" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTMtNC0xLTEtMTA3ODQy_2fabc02f-4d7a-4d12-886f-f5afe6e5fc7c">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTgtMi0xLTEtMTA3ODQy_5a516268-825a-4cde-b668-6a59fa8d1acd">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTgtNC0xLTEtMTA3ODQy_669f919c-3dd7-40a8-8ced-bc221e8526d6">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMjAtMi0xLTEtMTA3ODQy_9becbb71-2a8e-4ad5-ab11-a873e6be8771">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMjAtNC0xLTEtMTA3ODQy_d8bec21b-76a8-430c-85f1-ac825f23c2cd">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RleHRyZWdpb246YmI2NGVmMTc1M2NlNDM3OGFjZmQ0ODJkODg3YzdmYmNfMTIzNg_de007b29-78f8-4d86-93ab-64b993e9d796" continuedAt="i3f2c8c3c330844159075f5a20f1a272a" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i3f2c8c3c330844159075f5a20f1a272a"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the Consolidated Balance Sheets were immaterial at March&#160;31, 2022 and December&#160;31, 2021.</span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RleHRyZWdpb246YmI2NGVmMTc1M2NlNDM3OGFjZmQ0ODJkODg3YzdmYmNfMTIyOA_09ce3f56-e406-4824-9e9e-c603c37dd4da" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the carrying amounts and fair values of the Company&#8217;s financial instruments (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331" decimals="-3" name="us-gaap:LoansReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMi0xLTEtMS0xMDc4NDI_76d72fbd-3740-4c3d-98f3-f2d1413907a4">409,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331" decimals="-3" name="us-gaap:LoansReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMi0zLTEtMS0xMDc4NDI_a7dbeda4-ff8e-435c-9088-2537baa413bb">424,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231" decimals="-3" name="us-gaap:LoansReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMi01LTEtMS0xMDc4NDI_aaedf47f-b1f3-4970-903d-f6c4695261a0">415,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231" decimals="-3" name="us-gaap:LoansReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMi03LTEtMS0xMDc4NDI_f5c16be5-0434-4602-bc2d-eb42e7e417a6">437,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMy0xLTEtMS0xMDc4NDI_35106531-6953-49ef-b367-92b1c951497e">21,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMy0zLTEtMS0xMDc4NDI_87210470-0b52-48c4-a8ab-340c6607a5db">21,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMy01LTEtMS0xMDc4NDI_2a43ebe7-36b4-4a1a-918f-735dfadeab3c">21,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMy03LTEtMS0xMDc4NDI_89b7e03e-8d4d-4c54-bd9f-05d62a6e0203">21,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNC0xLTEtMS0xMDc4NDI_e5580de8-4383-442e-97c3-2ed7b5d818e6">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNC0zLTEtMS0xMDc4NDI_572cee03-1cfd-4372-bffd-4f824d3e9ea3">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNC01LTEtMS0xMDc4NDI_2ea5517b-b3b3-40bd-aec7-1dd8e0200f88">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNC03LTEtMS0xMDc4NDI_8d6ff4d2-6b6e-4847-a8ad-956a5a3c6197">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank line of credit and commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNy0xLTEtMS0xMDc4NDI_d7de49ba-4a1e-43c1-906b-fa9833b89d0e">1,330,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNy0zLTEtMS0xMDc4NDI_d5e0399e-2c36-4d0a-9d5f-e83841fc67ff">1,330,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNy01LTEtMS0xMDc4NDI_b085b448-30fc-4c35-94b6-fcfdf9522d1f">1,165,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNy03LTEtMS0xMDc4NDI_71c6c2fe-a902-4d3c-92f2-e24ca3eb99d1">1,165,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfOS0xLTEtMS0xMDc4NDI_7c73499b-6dc5-4a82-b29f-fc188093ab48">4,654,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688cf62ae17b4e4382d4717dfb3d857d_I20220331" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfOS0zLTEtMS0xMDc4NDI_bf5e76ba-875a-4256-80c8-98505ba4e09f">4,669,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfOS01LTEtMS0xMDc4NDI_ccca7978-f9cf-429b-867b-51f70d8e33c8">4,651,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6fb07e784b4ca69895402225c3412e_I20211231" decimals="-3" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfOS03LTEtMS0xMDc4NDI_edf74bb1-7c8c-4c47-a9d4-4a92ad845e86">5,054,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMTAtMS0xLTEtMTA3ODQy_c96677ae-c784-4297-adab-c03181aec688">350,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMTAtMy0xLTEtMTA3ODQy_0c73e704-ea1e-4f74-9338-f581e06c9197">344,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMTAtNS0xLTEtMTA3ODQy_e7cde444-1823-4f20-958a-20b3efce7aa5">352,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMTAtNy0xLTEtMTA3ODQy_19221ae9-dd62-40f8-9228-ad9d6d3f0d5d">352,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;1: Fair value calculated based on quoted prices in active markets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;2: Fair value based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and caps, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit and commercial paper, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#8217;s credit rating.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2022 and year ended December&#160;31, 2021, there were no material transfers of financial assets or liabilities within the fair value hierarchy.</span></div></ix:nonNumeric></ix:continuation><div id="ifa3dff468a15495db7b57c65ada0de74_85"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17.&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTMzNg_e34725ef-1352-4a18-bf4e-0212cf3355ea" continuedAt="ic35f3c423c764170954e023962d8b9c1" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="ic35f3c423c764170954e023962d8b9c1" continuedAt="i6dc5da22880f42a59649e34b86258ffd"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to mitigate the effects of interest rate fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest rates related to the potential impact these changes could have on future earnings and forecasted cash flows. The Company does not use derivative instruments for speculative or trading purposes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="idcc10c45d3da4625bee7679905bbb7c3_D20210301-20210331" decimals="-6" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTQxNQ_45bf287f-b9ef-4dab-9924-4d0167c4d44e">39</ix:nonFraction>&#160;million of variable rate secured debt on <ix:nonFraction unitRef="property" contextRef="i4d2252cd7eba4d3b851fa2e3e157f14c_I20210331" decimals="INF" name="peak:NumberOfAssetsClassifiedAsDiscontinuedOperations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTQ1Mg_b1a0ddde-389e-4cdb-a212-ed37eb90e7d7">two</ix:nonFraction> SHOP assets and terminated the <ix:nonFraction unitRef="derivativeheld" contextRef="i8cee1167ebab48b7b2f82422612e3991_I20210331" decimals="INF" name="peak:NumberOfInterestRateDerivativesTerminated" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTQ4Nw_12671d9b-8b24-42b5-8972-42692c935279">two</ix:nonFraction> remaining related interest rate swap contracts. Therefore, at March&#160;31, 2022 and December&#160;31, 2021, the Company had <ix:nonFraction unitRef="derivativeheld" contextRef="i1d64ef81915d4315bc7730741c5095a7_I20211231" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTU4Mg_0564426a-e636-474d-860c-d83e9d81791b"><ix:nonFraction unitRef="derivativeheld" contextRef="ifb5de1f1f0a24475b0f7d492a74824d6_I20220331" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTU4Mg_6d3b5776-1ab9-48d9-a6d2-03910cc83fa8">no</ix:nonFraction></ix:nonFraction> remaining interest rate swap contracts. </span></div><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTMzNA_0840bfdc-38a2-4b02-acf8-335184342e84" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company executed <ix:nonFraction unitRef="derivativeheld" contextRef="i33e11899bd7a43448fda5d94b27afd54_I20210430" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfNzk3_1c70214b-f3f7-446d-9b45-0110b10cb1a2">two</ix:nonFraction> interest rate cap agreements on its mortgage debt issued in conjunction with the acquisition of the MOB Portfolio (see Note 3). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s outstanding interest rate cap agreements as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Entered</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Strike Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April&#160;2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b09eddbc9044df3944a2a85e555a381_I20220331" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RhYmxlOjIzODc0NmRiMzVlMTQ5OThiZDRlY2EwZWExMWNiY2U5L3RhYmxlcmFuZ2U6MjM4NzQ2ZGIzNWUxNDk5OGJkNGVjYTBlYTExY2JjZTlfMi02LTEtMS0xMDc4NDI_652417e9-c2d3-4e59-8a4b-33118c5427aa">142,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b09eddbc9044df3944a2a85e555a381_I20220331" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RhYmxlOjIzODc0NmRiMzVlMTQ5OThiZDRlY2EwZWExMWNiY2U5L3RhYmxlcmFuZ2U6MjM4NzQ2ZGIzNWUxNDk5OGJkNGVjYTBlYTExY2JjZTlfMi04LTEtMS0xMDc4NDI_9093cf6d-5028-4d7d-8f37-304d3cacf912">2.00</ix:nonFraction> %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 mo. USD-LIBOR-BBA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b09eddbc9044df3944a2a85e555a381_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RhYmxlOjIzODc0NmRiMzVlMTQ5OThiZDRlY2EwZWExMWNiY2U5L3RhYmxlcmFuZ2U6MjM4NzQ2ZGIzNWUxNDk5OGJkNGVjYTBlYTExY2JjZTlfMi0xMi0xLTEtMTA3ODQy_a0aef6bf-93f1-4705-8f31-8e9bb491e481">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Derivative assets are recorded in other assets, net in the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents <ix:nonFraction unitRef="derivativeheld" contextRef="i33e11899bd7a43448fda5d94b27afd54_I20210430" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTE4MA_7edc66f0-4113-41f3-9623-051f9955f774">two</ix:nonFraction> interest rate cap agreements that manage the Company&#8217;s exposure to variable cash flows on certain mortgage debt borrowings by limiting interest rates.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i16a351f1ed484654b7fe74cc73addf0a_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMjUyOA_7f616734-1a6a-4202-8c7e-60fceda54dc7">2</ix:nonFraction>&#160;million increase in the fair value of the interest rate cap agreements within other income (expense), net.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6dc5da22880f42a59649e34b86258ffd">In April 2022, the Company terminated its existing interest rate cap agreements associated with $<ix:nonFraction unitRef="usd" contextRef="ia2e2a387bee947aea9537b5bd2acde51_I20220430" decimals="-6" name="peak:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMDk4Mw_602f2f0a-2632-4872-94d1-e2b6c953f243">142</ix:nonFraction>&#160;million of variable rate mortgage debt and entered into <ix:nonFraction unitRef="derivativeheld" contextRef="i3a84667f31d1411fa0eb153b19912c8e_I20220430" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTAzNQ_1fa3d627-a937-40af-aae7-7c20adc0a340">two</ix:nonFraction> interest rate swap contracts that are designated as cash flow hedges and mature in May 2026.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfNTQy_af65d9c3-5820-4da8-ac7c-4ff695f01215" continuedAt="i4ca6c3221e8d47bcb3531a15ee1d8d2b" escape="true">Accounts Payable, Accrued Liabilities, and Other Liabilities</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i4ca6c3221e8d47bcb3531a15ee1d8d2b"><ix:nonNumeric contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfNTQz_479bddd4-3d4a-4b1a-aa43-d76df53197af" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accounts payable, accrued liabilities, and other liabilities, excluding accounts payable, accrued liabilities, and other liabilities related to assets classified as discontinued operations (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refundable entrance fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="peak:RefundableEntranceFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMS0xLTEtMS0xMDc4NDI_339a75f9-9454-4682-897a-865c446a15c2">281,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="peak:RefundableEntranceFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMS0zLTEtMS0xMDc4NDI_df701e0e-9cfa-424f-93f3-74dea3e1423d">288,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:ConstructionPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMi0xLTEtMS0xMDc4NDI_cd68751f-b037-4633-acc2-99fee98748ca">163,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:ConstructionPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMi0zLTEtMS0xMDc4NDI_56fe8852-210f-4022-ad36-5679faddf098">179,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMy0xLTEtMS0xMDc4NDI_603e61ec-a1b0-4621-919f-a1b97a800da1">35,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMy0zLTEtMS0xMDc4NDI_40c8129d-bb28-440e-8045-b850379050e3">59,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfNC0xLTEtMS0xMDc4NDI_9ef85084-64be-418b-9762-ce956149bb64">215,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfNC0zLTEtMS0xMDc4NDI_ef3b1841-156c-4b0f-8f30-49a896fa4fad">227,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfNS0xLTEtMS0xMDc4NDI_c1ae3216-ed77-48fa-81cf-9b2b2581467e">695,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfNS0zLTEtMS0xMDc4NDI_0fa09430-44c1-4aad-a788-ef54dac4b435">755,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At March&#160;31, 2022 and December&#160;31, 2021, unamortized nonrefundable entrance fee liabilities were $<ix:nonFraction unitRef="usd" contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331" decimals="-6" name="peak:UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfNDQw_d7718895-1023-4e29-91f8-baee04597566">498</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231" decimals="-6" name="peak:UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfNDQ3_41e82ccc-5a77-4586-b982-17e7c38e2684">496</ix:nonFraction>&#160;million, respectively, which are recorded within deferred revenue on the Consolidated Balance Sheets. During the three months ended March&#160;31, 2022, the Company collected nonrefundable entrance fees of $<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-6" name="peak:ProceedsFromCollectionOfNonrefundableEntranceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfMTA5OTUxMTYyOTU4NA_7a98b28a-30ba-44f0-a370-fb79c54eb6b1">21</ix:nonFraction>&#160;million and recognized amortization of $<ix:nonFraction unitRef="usd" contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331" decimals="-6" name="peak:AmortizationOfNonrefundableEntranceFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfMTA5OTUxMTYyOTYyNA_74e9bc94-3004-4f59-8fdd-2663046e9b8f">19</ix:nonFraction>&#160;million. During the three months ended March&#160;31, 2021, the Company collected nonrefundable entrance fees of $<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-6" name="peak:ProceedsFromCollectionOfNonrefundableEntranceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfMTA5OTUxMTYyODU4Mg_a1a388e1-49c6-4fc0-8c18-515e9f9f19c8">15</ix:nonFraction>&#160;million and recognized amortization of $<ix:nonFraction unitRef="usd" contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331" decimals="-6" name="peak:AmortizationOfNonrefundableEntranceFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfMTA5OTUxMTYyODU5NQ_bc57c40b-23d6-42b0-8e0e-6b4008485075">20</ix:nonFraction>&#160;million. The amortization of nonrefundable entrance fees is included within resident fees and services on the Consolidated Statements of Operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All references in this report to &#8220;Healthpeak,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Healthpeak Properties, Inc., together with its consolidated subsidiaries. Unless the context suggests otherwise, references to &#8220;Healthpeak Properties, Inc.&#8221; mean the parent company without its subsidiaries.</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_94"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Language Regarding Forward-Looking Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).&#160;Forward-looking statements include, among other things, statements regarding our and our officers&#8217; intent, belief or expectation as identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;project,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;seek,&#8221; &#8220;target,&#8221; &#8220;forecast,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;estimate,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should&#8221; and other comparable and derivative terms or the negatives thereof. Forward-looking statements reflect our current expectations and views about future events and are subject to risks and uncertainties that could cause actual results, including our future financial condition and results of operations, to differ materially from those expressed or implied by any forward-looking statements. You are urged to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are based on certain assumptions and analysis made in light of our experience and perception of historical trends, current conditions and expected future developments as well as other factors that we believe are appropriate under the circumstances. While forward-looking statements reflect our good faith belief and assumptions we believe to be reasonable based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this Quarterly Report. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully set forth under Part I, Item 1A. &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, risks and uncertainties that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include, among other things:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the coronavirus (&#8220;Covid&#8221;) pandemic and health and safety measures intended to reduce its spread, the availability, effectiveness and public usage and acceptance of vaccines, and how quickly and to what extent normal economic and operating conditions can resume within the markets in which we operate;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our existing and future tenants, operators, and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and manage their expenses in order to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased competition, operating costs, and market changes affecting our tenants, operators, and borrowers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the financial condition of our tenants, operators, and borrowers, including potential bankruptcies and downturns in their businesses, and their legal and regulatory proceedings;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our concentration of real estate investments in the healthcare property sector, which makes us more vulnerable to a downturn in a specific sector than if we invested in multiple industries and exposes us to the risks inherent in illiquid investments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify and secure replacement tenants and operators and the potential renovation costs and regulatory approvals associated therewith;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our property development, redevelopment, and tenant improvement activity risks, including project abandonments, project delays, and lower profits than expected;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes within the life science industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">high levels of regulation, funding requirements, expense and uncertainty faced by our life science tenants;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the hospitals on whose campuses our medical office buildings (&#8220;MOBs&#8221;) are located and their affiliated healthcare systems to remain competitive or financially viable;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain or expand our hospital and health system client relationships;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operational risks associated with third party management contracts, including the additional regulation and liabilities of our properties operated through structures permitted by the Housing and Economic Recovery Act of 2008, which includes most of the provisions previously proposed in the REIT Investment Diversification and Empowerment Act of 2007 (commonly referred to as &#8220;RIDEA&#8221;);</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic and other conditions that negatively affect geographic areas from which we recognize a greater percentage of our revenue;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uninsured or underinsured losses, which could result in significant losses and/or performance declines by us or our tenants and operators;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our partners&#8217; financial condition and continued cooperation; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our use of fixed rent escalators, contingent rent provisions and/or rent escalators based on the Consumer Price Index;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition for suitable healthcare properties to grow our investment portfolio;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to foreclose on collateral securing our real estate-related loans;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to make material acquisitions and successfully integrate them;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential impact on us and our tenants, operators, and borrowers from litigation matters, including rising liability and insurance costs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in our borrowing costs, including due to higher interest rates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of external capital on acceptable terms or at all, including due to rising interest rates, changes in our credit ratings and the value of our common stock, volatility or uncertainty in the capital markets, and other factors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash available for distribution to stockholders and our ability to make dividend distributions at expected levels;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage our indebtedness level and covenants in and changes to the terms of such indebtedness;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in global, national and local economic and other conditions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws or regulations prohibiting eviction of our tenants;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of our tenants, operators, and borrowers to comply with federal, state and local laws and regulations, including resident health and safety requirements, as well as licensure, certification, and inspection requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required regulatory approvals to transfer our senior housing properties;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with the Americans with Disabilities Act and fire, safety and other regulations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">legislation to address federal government operations and administration decisions affecting the Centers for Medicare and Medicaid Services;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our participation in the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) Provider Relief Fund and other Covid-related stimulus and relief programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provisions of Maryland law and our charter that could prevent a transaction that may otherwise be in the interest of our stockholders;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">environmental compliance costs and liabilities associated with our real estate investments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain our qualification as a real estate investment trust (&#8220;REIT&#8221;);</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes to U.S. federal income tax laws, and potential deferred and contingent tax liabilities from corporate acquisitions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">calculating non-REIT tax earnings and profits distributions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ownership limits in our charter that restrict ownership in our stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss or limited availability of our key personnel; and </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on information technology systems and the potential impact of system failures, disruptions or breaches.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Executive Summary</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Covid Update</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Overview of Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-GAAP Financial Measures Reconciliations</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Critical Accounting Estimates and Recent Accounting Pronouncements</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_97"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) 500 company that acquires, develops, owns, leases and manages healthcare real estate across the United States (&#8220;U.S.&#8221;). Our company was originally founded in 1985. We are a Maryland corporation and qualify as a self-administered REIT. Our corporate headquarters are located in Denver, Colorado and we have additional offices in California, Tennessee, and Massachusetts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we began the process of disposing of our senior housing triple-net and senior housing operating property (&#8220;SHOP&#8221;) portfolios. As of December 31, 2020, we concluded that the planned dispositions represented a strategic shift that had and will have a major effect on our operations and financial results and, therefore, the assets are classified as discontinued operations in all periods presented herein. In September 2021, we successfully completed the disposition of both portfolios. See Note 4 to the Consolidated Financial Statements for further information regarding discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the disposal of our senior housing triple-net and SHOP portfolios, we focused our strategy on investing in a diversified portfolio of high-quality healthcare properties across our three core asset classes of life science, medical office, and continuing care retirement community (&#8220;CCRC&#8221;) real estate. Under the life science and medical office segments, we invest through the acquisition, development and management of life science facilities, MOBs, and hospitals. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of debt investments and an interest in an unconsolidated joint venture that owns 19 senior housing assets (our &#8220;SWF SH JV&#8221;).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, our portfolio of investments, including properties in our unconsolidated joint ventures, consisted of interests in 483 properties. The following table summarizes information for our reportable and other non-reportable segments, excluding discontinued operations, for the three months ended March&#160;31, 2022 (dollars in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:36.510%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Portfolio Adjusted NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Total Portfolio Adjusted NOI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Properties</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical office</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-reportable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total Portfolio metrics include results of operations from disposed properties through the disposition date. See &#8220;Item 2, Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Financial Measures&#8221; for additional information regarding Adjusted NOI and see Note 13 to the Consolidated Financial Statements for a reconciliation of Adjusted NOI by segment to net income (loss).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of our significant activities during 2022, see &#8220;Item 2, Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Overview of Transactions&#8221; in this report. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in and manage our real estate portfolio for the long-term to maximize benefit to our stockholders and support the growth of our dividends. Our strategy consists of four core elements:</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">real estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our portfolio is grounded in high-quality properties in desirable locations. We focus on three purposely selected private pay asset classes&#8212;life science, medical office, and continuing care retirement community&#8212;to provide stability through inevitable market cycles.</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">financials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We maintain a strong investment-grade balance sheet with ample liquidity as well as long-term fixed-rate debt financing with staggered maturities to reduce our exposure to interest rate volatility and refinancing risk.</span></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We work with leading healthcare companies, operators, and service providers and are responsive to their space and capital needs. We provide high-quality property management services to encourage tenants to renew, expand, and relocate into our properties, which drives increased occupancy, rental rates, and property values.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">Our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We have a people-first culture that we believe attracts, develops and retains top talent. We continually strive to create and maintain an industry-leading platform, with systems and tools that allow us to effectively and efficiently manage our assets and investment activity.</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_100"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Covid Update</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tenants, operators, and borrowers have experienced significant cost increases as a result of increased health and safety measures, staffing shortages, increased governmental regulation and compliance, vaccine mandates, and other operational changes necessitated either directly or indirectly by the Covid pandemic. We anticipate that many of these expenses will remain at these higher levels even after the pandemic passes, and may reduce margins in the business. In addition, the pandemic, including labor and supply chain disruptions and/or other economic conditions caused by the pandemic, could adversely impact the scheduled completion and/or cost of our development, redevelopment and tenant improvement projects.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior housing facilities have been disproportionately impacted by Covid and Covid-related fatalities compared to our life science and medical office segments. Although the wide availability of the vaccine has reduced the negative impacts of the pandemic in our CCRC communities and the senior housing facilities owned by our SWF SH JV, we do not yet know the full, long-term economic impact of the Covid pandemic and whether or when occupancy and revenue will return to pre-pandemic levels. Labor costs in particular have increased as a result of higher staffing hours, increased hourly wages and bonuses, greater overtime, and increased usage of contract labor. In addition, the pandemic has resulted in some potentially long-term changes in traditional economic patterns and arrangements, including that (i) seniors may not seek out senior housing at the same level that they did pre-pandemic; (ii) recent legislation that favors delivery of services at home rather than in an institutional setting could negatively impact the segment; (iii) qualified employees may view employment at senior housing facilities less attractively than they did pre-pandemic; (iv) the number of people who have not returned to the workforce could create long-term staffing shortages; (v) changing expectations around the protection required for residents in senior housing facilities may increase costs; (vi) senior housing operators are undertaking numerous adaptations in response to these changes, the success of which adaptations is uncertain; and (vii) the inflationary environment could permanently alter behavior in unpredictable ways.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we remain well-positioned to navigate economic changes resulting from the pandemic, with approximately $2.12 billion of liquidity available, including $1.69 billion of borrowing capacity under our Revolving Facility (as defined below), $313 million of net proceeds expected from the future settlement of shares issued through our ATM forward contracts (as defined below), and approximately $124 million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of cash and cash equivalents as of May&#160;2, 2022. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Part I, Item 1A. &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 for additional discussion of the risks posed by the Covid pandemic and uncertainties we and our tenants, operators, and borrowers may face as a result.</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">67 Smith Place</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we closed a life science acquisition in Cambridge, Massachusetts for $72&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vista Sorrento Phase II</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we closed a life science acquisition in San Diego, California for $24&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Webster MOB Portfolio </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we acquired a portfolio of two MOBs in Houston, Texas for $43&#160;million. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Real Estate Transactions</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended March&#160;31, 2022, we sold one life science facility in Utah for $14&#160;million.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Also during the three months ended March&#160;31, 2022, we sold our remaining hospital classified as a direct financing lease (&#8220;DFL&#8221;) for $68 million.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In April 2022, we sold one MOB in San Antonio, Texas for $13&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In April 2022, we terminated our existing interest rate cap agreements associated with $142&#160;million of variable rate mortgage debt and entered into two interest rate swap contracts that are designated as cash flow hedges and mature in May 2026. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Activities </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">At March&#160;31, 2022, we had seven life science development projects in process with an aggregate total estimated cost of approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.3 billion.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended March&#160;31, 2022, the following projects were placed in service: (i) three MOB development projects with total costs incurred of $58 million, (ii) one life science development project with total costs incurred of $36 million, (iii) one life science redevelopment project with total costs incurred of $60 million, and (iv) a portion of one life science development project with total costs incurred of $40 million.</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_106"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our common stock cash dividends declared in 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:53.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Declaration&#160;Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record&#160;Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dividend<br/>Payment&#160;Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 20</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="ifa3dff468a15495db7b57c65ada0de74_109"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our business and allocate resources among our reportable business segments: (i) life science, (ii) medical office, and (iii) CCRC.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the life science and medical office segments, we invest through the acquisition, development, and management of life science facilities, MOBs, and hospitals, which generally requires a greater level of property management. Our CCRCs are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in our unconsolidated SWF SH JV and (ii) debt investments. We evaluate performance based upon property adjusted net operating income (&#8220;Adjusted NOI&#8221; or &#8220;Cash NOI&#8221;) in each segment. The accounting policies of the segments are the same as those described in the summary of significant accounting policies in Note 2 to the Consolidated Financial Statements in our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021 filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;), as updated by Note 2 to the Consolidated Financial Statements herein.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Operating Income </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOI and Adjusted NOI are non-U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) supplemental financial measures used to evaluate the operating performance of real estate. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, income from direct financing leases, and government grant income and exclusive of interest income), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss) as presented in Note 13 to the Consolidated Financial Statements. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims&#160;that have been incurred but not reported, and the impact of deferred community fee income and expense. NOI and Adjusted NOI include our share of income (loss) generated by unconsolidated joint ventures and exclude noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. Adjusted NOI is oftentimes referred to as &#8220;Cash NOI.&#8221; Management believes NOI and Adjusted NOI are important supplemental measures because they provide relevant and useful information by reflecting only income and operating expense items that are incurred at the property level and present them on an unlevered basis. We use NOI and Adjusted NOI to make decisions about resource allocations, to assess and compare property level performance, and to evaluate our Same-Store (&#8220;SS&#8221;) performance, as described below. We believe that net income (loss) is the most directly comparable GAAP measure to NOI and Adjusted NOI. NOI and Adjusted NOI should not be viewed as alternative measures of operating performance to net income (loss) as defined by GAAP since they do not reflect various excluded items. Further, our definitions of NOI and Adjusted NOI may not be comparable to the definitions used by other REITs or real estate companies, as they may use different methodologies for calculating NOI and Adjusted NOI. For a reconciliation of NOI and Adjusted NOI to net income (loss) by segment, refer to Note&#160;13 to the Consolidated Financial Statements. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses generally relate to leased medical office and life science properties, as well as CCRC facilities. We generally recover all or a portion of our leased medical office and life science property expenses through tenant recoveries. We present expenses as operating or general and administrative based on the underlying nature of the expense. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Same-Store</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Same-Store NOI and Adjusted (Cash) NOI information allows us to evaluate the performance of our property portfolio under a consistent population by eliminating changes in the composition of our consolidated portfolio of properties. Same-Store Adjusted NOI excludes amortization of deferred revenue from tenant-funded improvements and certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Properties are included in Same-Store once they are stabilized for the full period in both comparison periods. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) control(s) the physical use of at least 80% of the space and rental payments have commenced) or 12 months from the acquisition date. Newly completed developments and redevelopments are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. Properties that experience a change in reporting structure are considered stabilized after 12 months in operations under a consistent reporting structure. A property is removed from Same-Store when it is classified as held for sale, sold, placed into redevelopment, experiences a casualty event that significantly impacts operations, a change in reporting structure or operator transition has been agreed to, or a significant tenant relocates from a Same-Store property to a non Same-Store property and that change results in a corresponding increase in revenue. We do not report Same-Store metrics for our other non-reportable segments. For a reconciliation of Same-Store to total portfolio Adjusted NOI and other relevant disclosures by segment, refer to our Segment Analysis below.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Funds From Operations (&#8220;FFO&#8221;)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FFO encompasses Nareit FFO and FFO as Adjusted, each of which is described in detail below. We believe FFO applicable to common shares, diluted FFO applicable to common shares, and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nareit FFO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  FFO, as defined by the National Association of Real Estate Investment Trusts (&#8220;Nareit&#8221;), is net income (loss) applicable to common shares (computed in accordance with GAAP), excluding gains or losses from sales of depreciable property, including any current and deferred taxes directly associated with sales of depreciable property, impairments of, or related to, depreciable real estate, plus real estate and other real estate-related depreciation and amortization, and adjustments to compute our share of Nareit FFO and FFO as Adjusted (see below) from joint ventures. Adjustments for joint ventures are calculated to reflect our pro-rata share of both our consolidated and unconsolidated joint ventures. We reflect our share of Nareit FFO for unconsolidated joint ventures by applying our actual ownership percentage for the period to the applicable reconciling items on an entity by entity basis. For consolidated joint ventures in which we do not own 100%, we reflect our share of the equity by adjusting our Nareit FFO to remove the third party ownership share of the applicable reconciling items based on actual ownership percentage for the applicable periods. Our pro-rata share information is prepared on a basis consistent with the comparable consolidated amounts, is intended to reflect our proportionate economic interest in the operating results of properties in our portfolio and is calculated by applying our actual ownership percentage for the period. We do not control the unconsolidated joint ventures, and the pro-rata presentations of reconciling items included in Nareit FFO do not represent our legal claim to such items. The joint venture members or partners are entitled to profit or loss allocations and distributions of cash flows according to the joint venture agreements, which provide for such allocations generally according to their invested capital. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presentation of pro-rata information has limitations, which include, but are not limited to, the following: (i) the amounts shown on the individual line items were derived by applying our overall economic ownership interest percentage determined when applying the equity method of accounting and do not necessarily represent our legal claim to the assets and liabilities, or the revenues and expenses and (ii) other companies in our industry may calculate their pro-rata interest differently, limiting the usefulness as a comparative measure. Because of these limitations, the pro-rata financial information should not be considered independently or as a substitute for our financial statements as reported under GAAP. We compensate for these limitations by relying primarily on our GAAP financial statements, using the pro-rata financial information as a supplement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nareit FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income (loss). We compute Nareit FFO in accordance with the current Nareit definition; however, other REITs may report Nareit FFO differently or have a different interpretation of the current Nareit definition from ours. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">FFO as Adjusted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In addition, we present Nareit FFO on an adjusted basis before the impact of non-comparable items including, but not limited to, transaction-related items, other impairments (recoveries) and other losses (gains), restructuring and severance related charges, prepayment costs (benefits) associated with early retirement or payment of debt, litigation costs (recoveries), casualty-related charges (recoveries), foreign currency remeasurement losses (gains), deferred tax asset valuation allowances, and changes in tax legislation (&#8220;FFO as Adjusted&#8221;). Transaction-related items include transaction expenses and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities. Prepayment costs (benefits) associated with early retirement of debt include the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of debt. Other impairments (recoveries) and other losses (gains) include interest income associated with early and partial repayments of loans receivable and other losses or gains associated with non-depreciable assets including goodwill, DFLs, undeveloped land parcels, and loans receivable. Management believes that FFO as Adjusted provides a meaningful supplemental measurement of our FFO run-rate and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. At the same time that Nareit created and defined its FFO measure for the REIT industry, it also recognized that &#8220;management of each of its member companies has the responsibility and authority to publish financial information that it regards as useful to the financial community.&#8221; We believe stockholders, potential investors, and financial analysts who review our operating performance are best served by an FFO run-rate earnings measure that includes certain other adjustments to net income (loss), in addition to adjustments made to arrive at the Nareit defined measure of FFO. FFO as Adjusted is used by management in analyzing our business and the performance of our properties and we believe it is important that stockholders, potential investors, and financial analysts understand this measure used by management. We use FFO as Adjusted to: (i) evaluate our performance in comparison with expected results and results of previous periods, relative to resource allocation decisions, (ii) evaluate the performance of our management, (iii) budget and forecast future results to assist in the allocation of resources, (iv) assess our performance as compared with similar real estate companies and the industry in general, and (v) evaluate how a specific potential investment will impact our future results. Other REITs or real estate companies may use different methodologies for calculating an adjusted FFO measure, and accordingly, our FFO as Adjusted may not be comparable to those reported by other REITs. For a reconciliation of net income (loss) to Nareit FFO and FFO as Adjusted and other relevant disclosure, refer to &#8220;Non-GAAP Financial Measures Reconciliations&#8221; below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted FFO (&#8220;AFFO&#8221;).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AFFO is defined as FFO as Adjusted after excluding the impact of the following: (i) amortization of stock-based compensation, (ii) amortization of deferred financing costs, net, (iii) straight-line rents, (iv) deferred income taxes, and (v) other AFFO adjustments, which include: (a) amortization of acquired market lease intangibles, net, (b) non-cash interest related to DFLs and lease incentive amortization (reduction of straight-line rents), (c) actuarial reserves for insurance claims&#160;that have been incurred but not reported, and (d) amortization of deferred revenues, excluding amounts amortized into rental income that are associated with tenant funded improvements owned/recognized by us and up-front cash payments made by tenants to reduce their contractual rents. Also, AFFO is computed after deducting recurring capital expenditures, including second generation leasing costs and second generation tenant and capital improvements, and includes adjustments to compute our share of AFFO from our unconsolidated joint ventures.</span><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More specifically, recurring capital expenditures, including second generation leasing costs and second generation tenant and capital improvements ("AFFO capital expenditures") excludes our share from unconsolidated joint ventures (reported in &#8220;other AFFO adjustments&#8221;). Adjustments for joint ventures are calculated to reflect our pro-rata share of both our consolidated and unconsolidated joint ventures. We reflect our share of AFFO for unconsolidated joint ventures by applying our actual ownership percentage for the period to the applicable reconciling items on an entity by entity basis. We reflect our share for consolidated joint ventures in which we do not own 100% of the equity by adjusting our AFFO to remove the third party ownership share of the applicable reconciling items based on actual ownership percentage for the applicable periods (reported in &#8220;other AFFO adjustments&#8221;). See FFO for further disclosure regarding our use of pro-rata share information and its limitations. Other REITs or real estate companies may use different methodologies for calculating AFFO, and accordingly, our AFFO may not be comparable to those reported by other REITs. Although our AFFO computation may not be comparable to that of other REITs, management believes AFFO provides a meaningful supplemental measure of our performance and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. We believe AFFO is an alternative run-rate earnings measure that improves the understanding of our operating results among investors and makes comparisons with: (i) expected results, (ii) results of previous periods, and (iii) results among REITs more meaningful. AFFO does not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs as it excludes the following items which generally flow through our cash flows from operating activities: (i) adjustments for changes in working capital or the actual timing of the payment of income or expense items that are accrued in the period, (ii) transaction-related costs, (iii) litigation settlement expenses, and (iv) restructuring and severance-related charges. Furthermore, AFFO is adjusted for recurring capital expenditures, which are generally not considered when determining cash flows from operations or liquidity. AFFO is a non-GAAP supplemental financial measure and should not be considered as an alternative to net income (loss) determined in accordance with GAAP. For a reconciliation of net income (loss) to AFFO and other relevant disclosure, refer to &#8220;Non-GAAP Financial Measures Reconciliations&#8221; below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2022 to the Three Months Ended March&#160;31, 2021 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended March&#160;31, 2022 and 2021 </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes results for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73,700)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nareit FFO</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,198&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FFO as Adjusted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFFO</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,033&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) applicable to common shares decreased primarily as a result of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in income from discontinued operations, primarily as a result of: (i) a decrease in gain on sales of real estate from the completion of dispositions of our senior housing portfolios and (ii) decreased NOI from dispositions of our senior housing portfolios;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in depreciation, primarily as a result of: (i) 2021 and 2022 acquisitions of real estate and (ii) development and redevelopment projects placed in service during 2021 and 2022; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses incurred for tenant relocation and other costs associated with a planned MOB demolition; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in interest income primarily as a result of principal repayments on and sales of loans receivable in 2021 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in net income (loss) applicable to common shares was partially offset by:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in loss on debt extinguishments related to our repurchase and redemption of certain outstanding senior notes in the first quarter of 2021;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in NOI generated from our life science and medical office segments related to: (i) 2021 and 2022 acquisitions of real estate, (ii) development and redevelopment projects placed in service during 2021 and 2022, and (iii) new leasing activity during 2021 and 2022 (including the impact to straight-line rents);</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a gain on sale of a hospital that was classified as a DFL; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a reduction in interest expense, primarily as a result of senior unsecured notes repurchases and redemptions in the first and second quarters of 2021;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in government grant income received under the CARES Act in 2022; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in gains on sale of depreciable real estate related to a life science facility sale in 2022; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a reduction in loan loss reserves in 2022 primarily due to a lower loans receivable balance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nareit FFO increased primarily as a result of the aforementioned events impacting net income (loss) applicable to common shares, except for the following, which are excluded from Nareit FFO:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net gain on sales of depreciable real estate; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">depreciation and amortization expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FFO as Adjusted increased primarily as a result of the aforementioned events impacting Nareit FFO, except for the following, which are excluded from FFO as Adjusted:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the gain on sale of a hospital that was classified as a DFL; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expenses for tenant relocation and other costs associated with an MOB that we intend to demolish; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loan loss reserves.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AFFO increased primarily as a result of the aforementioned events impacting FFO as Adjusted, except for the impact of straight-line rents, which is excluded from AFFO. The increase was partially offset by higher AFFO capital expenditures during the period.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Analysis&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide selected operating information for our Same-Store and total property portfolio for each of our reportable segments. For the three months ended March&#160;31, 2022, our Same-Store consists of 385</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2021 and that remained in operations under a consistent reporting structure through March&#160;31, 2022. Our total property portfolio consisted of 483 and 463 properties at March&#160;31, 2022 and 2021, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Life Science</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes results at and for the three months ended March&#160;31, 2022 and 2021 (dollars and square feet in thousands, except per square foot data):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Portfolio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental and related revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,664&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: non-SS Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SS Adjusted NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,220&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI % change</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">End of period occupancy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupancy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupied square feet</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual total revenues per occupied square foot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual base rent per occupied square foot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total Portfolio includes results of operations from disposed properties through the disposition date. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents adjustments to NOI in accordance with our definition of Adjusted NOI. Refer to &#8220;Non-GAAP Financial Measures&#8221; above for definitions of NOI and Adjusted NOI.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From our first quarter 2021 presentation of Same-Store, we added: (i) six stabilized developments placed in service, (ii) five stabilized acquisitions, (iii) four stabilized redevelopments placed in service, and (iv) one stabilized property that previously experienced a casualty event, and we removed: (i) three life science facilities that were placed into development and (ii) one life science facility that was sold. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Average annual total revenues does not include non-cash revenue adjustments (i.e.,&#160;straight-line rents, amortization of market lease intangibles, and deferred revenues).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Base rent does not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e.,&#160;straight-line rents, amortization of market lease intangibles, and deferred revenues).</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Same-Store Adjusted NOI increased primarily as a result of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">annual rent escalations;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new leasing activity; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mark-to-market lease renewals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Portfolio Adjusted NOI increased primarily as a result of the aforementioned impacts to Same-Store and the following Non-Same-Store impacts:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in NOI from (i) increased occupancy in developments and redevelopments placed in service in 2021 and 2022 and (ii) acquisitions in 2021 and 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Office</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes results at and for the three months ended March&#160;31, 2022 and 2021 (dollars and square feet in thousands, except per square foot data):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Portfolio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental and related revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from direct financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,820)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,926)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,049)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: non-SS Adjusted NOI</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SS Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI % change</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">End of period occupancy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupancy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupied square feet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual total revenues per occupied square foot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual base rent per occupied square foot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total Portfolio includes results of operations from disposed properties through the disposition date. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents adjustments to NOI in accordance with our definition of Adjusted NOI. Refer to &#8220;Non-GAAP Financial Measures&#8221; above for definitions of NOI and Adjusted NOI.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From our first quarter 2021 presentation of Same-Store, we added: (i) 10 stabilized acquisitions, (ii) 3 stabilized redevelopments placed in service, and (iii) 1 MOB that was removed from held for sale classification, and we removed: (i) 5 MOBs that were sold, (ii) 5 MOBs that were classified as held for sale, and (iii) 5 MOBs that were placed into redevelopment.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Average annual total revenues does not include non-cash revenue adjustments (i.e.,&#160;straight-line rents, amortization of market lease intangibles, DFL non-cash interest, and deferred revenues).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Base rent does not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e.,&#160;straight-line rents, amortization of market lease intangibles, DFL non-cash interest, and deferred revenues).</span></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Same-Store Adjusted NOI increased primarily as a result of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mark-to-market lease renewals;</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">annual rent escalations; and</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher parking income and percentage-based rents.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Portfolio Adjusted NOI increased primarily as a result of the aforementioned increases to Same-Store and the following Non-Same-Store impacts:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased NOI from our 2021 and 2022 acquisitions;</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased occupancy in former redevelopment and development properties that have been placed in service; partially offset by</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased NOI from our 2021 and 2022 dispositions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continuing Care Retirement Community</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes results at and for the three months ended March&#160;31, 2022 and 2021 (dollars in thousands, except per unit data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Portfolio</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Resident fees and services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,432&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,557&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,336&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: non-SS Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(630)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SS Adjusted NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI % change</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupancy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average occupied units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average annual rent per occupied unit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents adjustments to NOI in accordance with our definition of Adjusted NOI. Refer to &#8220;Non-GAAP Financial Measures&#8221; above for definitions of NOI and Adjusted NOI.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From our first quarter 2021 presentation of Same-Store, we added 13 properties that previously experienced an operator transition. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents average occupied units as reported by the operators for the three-month period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Same-Store Adjusted NOI and Total Portfolio Adjusted NOI increased primarily as a result of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased rates for resident fees;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased government grant income received under the CARES Act; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower Covid related expenses; partially offset by</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher labor costs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income and Expense Items</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the results of our other income and expense items for the three months ended March&#160;31, 2022 and 2021 (in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.201%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves (recoveries), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on debt extinguishments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(269,691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share in discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest income</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income decreased for the three months ended March&#160;31, 2022</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily as a result of principal repayments on and sales of loans receivable in 2021 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased for the three months ended March&#160;31, 2022 primarily as a result of senior unsecured notes repurchases and redemptions in the first and second quarters of 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization expense</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense increased for the three months ended March&#160;31, 2022&#160;primarily as a result of: (i) assets acquired during 2021 and 2022 and (ii) development and redevelopment projects placed in service during 2021 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expense</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses decreased for the three months ended March&#160;31, 2022 primarily as a result of lower restructuring and severance related charges.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairments and loan loss reserves (recoveries), net</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairments and loan loss reserves (recoveries), net decreased for the three months ended March&#160;31, 2022 as a result of a decrease in loan loss reserves under the current expected credit losses model. The reduction in loan loss reserves for the three months ended March&#160;31, 2022 is primarily due to a lower loans receivable balance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain (loss) on sales of real estate, net</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) on sales of real estate, net increased during the three months ended March&#160;31, 2022 primarily as a result of the sale of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">one life science facility for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$14&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the three months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> resulting in total gain on sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4&#160;million. Other than dispositions related to our senior housing portfolios included in income (loss) from discontinued operations as discussed below, there were no real estate sales </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uring the three months ended March&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain (loss) on debt extinguishments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on debt extinguishments decreased for the three months ended March&#160;31, 2022 as a result of no senior unsecured note repurchases or redemptions during the first quarter of 2022 as compared to the repurchase and redemption of certain outstanding senior notes in the first quarter of 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net increased for the three months ended March&#160;31, 2022 primarily as a result of: (i) a gain on sale of a hospital that was classified as a DFL and (ii) an increase in government grant income received under the CARES Act in 2022, partially offset by expenses incurred for tenant relocation and other costs associated with a planned MOB demolition. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax benefit (expense)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense increased for the three months ended March&#160;31, 2022 primarily as a result of the tax impact of an increase in government grant income received under the CARES Act. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity income (loss) from unconsolidated joint ventures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity income from unconsolidated joint ventures increased for the three months ended March&#160;31, 2022 as a result of our share of net income from the Life Science JV, partially offset by our share of decreased net income from the SWF SH JV.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) from discontinued operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from discontinued operations decreased for the three months ended March&#160;31, 2022 primarily as a result of: (i) decreased gain on sales of real estate from the completion of dispositions of our senior housing portfolios, (ii) decreased NOI following the dispositions of our senior housing portfolios, and (iii) a decline in government grant income received under the CARES Act for the senior housing portfolio. </span></div><div id="ifa3dff468a15495db7b57c65ada0de74_130"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our cash flow from operations, available cash balances, and cash from our various financing activities will be adequate for the next 12 months and for the foreseeable future for purposes of: (i) funding recurring operating expenses; (ii) meeting debt service requirements; and (iii) satisfying funding of distributions to our stockholders and non-controlling interest members. Distributions are made using a combination of cash flows from operations, funds available under our bank line of credit (the &#8220;Revolving Facility&#8221;) and commercial paper program, proceeds from the sale of properties, and other sources of cash available to us.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to funding the activities above, our principal liquidity needs for the next 12 months are to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fund capital expenditures, including tenant improvements and leasing costs; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fund future acquisition, transactional, and development and redevelopment activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our longer term liquidity needs include the items listed above as well as meeting debt service requirements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate satisfying these future needs using one or more of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash flow from operations;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sale of, or exchange of ownership interests in, properties or other investments;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">borrowings under our Revolving Facility and commercial paper program;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of additional debt, including unsecured notes, term loans, and mortgage debt; and/or</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of common or preferred stock or its equivalent, including the settlement of forward contracts or other sales of common stock under the ATM Program (as defined below).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to access the capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, our Revolving Facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our credit ratings for our senior unsecured long-term debt. Our Revolving Facility includes customary LIBOR replacement language, including, but not limited to, the use of rates based on the secured overnight financing rate administered by the Federal Reserve Bank of New York. We also pay a facility fee on the entire revolving commitment that depends upon our credit ratings. As of May&#160;2, 2022, we had long-term credit ratings of Baa1 from Moody&#8217;s and BBB+ from S&amp;P Global and Fitch, and short-term credit ratings of P-2, A-2, and F2 from Moody&#8217;s, S&amp;P Global, and Fitch, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A downgrade in credit ratings by Moody&#8217;s, S&amp;P Global, and Fitch may have a negative impact on the interest rates and facility fees for our Revolving Facility and may negatively impact the pricing of notes issued under our commercial paper program and senior unsecured notes. While a downgrade in our credit ratings would adversely impact our cost of borrowing, we believe we would continue to have access to the unsecured debt markets, and we could also seek to enter into one or more secured debt financings, issue additional securities, including under our ATM Program (as defined below), or dispose of certain assets to fund future operating costs, capital expenditures, or acquisitions, although no assurances can be made in this regard. Refer to &#8220;Covid Update&#8221; above for a more comprehensive discussion of the potential impact of Covid on our business.</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_142"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Material Cash Requirements and Off-Balance Sheet Arrangements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material cash requirements related to debt increased by $166 million to $6.3 billion at March&#160;31, 2022, when compared to December&#160;31, 2021, primarily as a result of issuances of securities under our commercial paper program. As of March&#160;31, 2022, we had $1.33 billion outstanding under our commercial paper program. See Note 9 to the Consolidated Financial Statements for additional information about our debt commitments.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material cash requirements related to development and redevelopment projects and tenant improvements decreased by $52 million, to $418 million at March&#160;31, 2022, when compared to December&#160;31, 2021, primarily as a result of actual spend on existing projects in the first quarter of 2022. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material cash requirements to provide additional funding for senior housing redevelopment and capital expenditure projects decreased by $9&#160;million, to $49 million at March&#160;31, 2022, when compared to December&#160;31, 2021, primarily as a result of reduced commitments from current quarter principal repayments on our seller financing. See Note 6 to the Consolidated Financial Statements for additional information. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our noncontrolling interest holders have the ability to put their equity interests to us upon specified events or after the passage of a predetermined period of time. Each put option is subject to changes in redemption value in the event that the underlying property generates specified returns for us and meets certain promote thresholds pursuant to the respective agreements. As of March&#160;31, 2022, we had $98 million of redeemable noncontrolling interests, none of which met the conditions for redemption as of the balance sheet date. See Note 11 to the Consolidated Financial Statements for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to our distribution and dividend requirements during the three months ended March&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own interests in certain unconsolidated joint ventures as described in Note 7 to the Consolidated Financial Statements. Two of these joint ventures have mortgage debt of $87 million, of which our share is $40 million. Except in limited circumstances, our risk of loss is limited to our investment in the joint ventures. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other material changes, outside of the ordinary course of business, during the three months ended March&#160;31, 2022 to the material cash requirements or material off-balance sheet arrangements disclosed in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 under &#8220;Material Cash Requirements&#8221; and &#8220;Off-Balance Sheet Arrangements&#8221; in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary discussion of our cash flows is based on the Consolidated Statements of Cash Flows and is not meant to be an all-inclusive discussion of the changes in our cash flows for the periods presented below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth changes in cash flows (in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,457&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245,962)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,013,688)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,511)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(924,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Cash Flows </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in operating cash flow is primarily the result of an increase in income related to: (i) 2021 and 2022 acquisitions, (ii) annual rent increases, (iii) new leasing and renewal activity, and (iv) developments and redevelopments placed in service during 2021 and 2022. The increase in operating cash flow is partially offset by a decrease in income related to assets sold during 2021 and 2022. Our cash flow from operations is dependent upon the occupancy levels of our buildings, rental rates on leases, our tenants&#8217; performance on their lease obligations, the level of operating expenses, and other factors.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are significant investing activities for the three months ended March&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">made investments of $339 million primarily related to the acquisition, development, and redevelopment of real estate; and </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">received net proceeds of $93 million primarily from sales of real estate assets and repayments on loans receivable and direct financing leases.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are significant investing activities for the three months ended March&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">received net proceeds of $948 million primarily from sales of real estate assets; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">made investments of $181 million primarily related to the acquisition, development, and redevelopment of real estate and funding of new and existing loans.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are significant financing activities for the three months ended March&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">made net borrowings of $165 million under our Revolving Facility and commercial paper program; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">paid cash dividends on common stock of $163 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are significant financing activities for the three months ended March&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">made repayments of $1.6 billion under our senior unsecured notes (including debt extinguishment costs) and mortgage debt;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">made net borrowings of $909 million under our Revolving Facility and commercial paper program; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">paid cash dividends on common stock of $164 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discontinued Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating, investing, and financing cash flows in our Consolidated Statements of Cash Flows are reported inclusive of both cash flows from continuing operations and cash flows from discontinued operations. Certain significant cash flows from discontinued operations are disclosed in Note 14 to the Consolidated Financial Statements. The absence of future cash flows from discontinued operations is not expected to significantly impact our liquidity, as the proceeds from senior housing triple-net and SHOP dispositions were used to pay down debt and invest in additional real estate in our other business lines. Additionally, we have multiple other sources of liquidity that can be utilized in the future, as needed. Refer to the beginning of the Liquidity and Capital Resources section above for additional information regarding our liquidity.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 to the Consolidated Financial Statements for additional information about our outstanding debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 77%</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 78% of our consolidated debt, excluding debt classified as liabilities related to assets held for sale and discontinued operations, net, was fixed rate debt as of March&#160;31, 2022 and 2021, respectively. At March&#160;31, 2022, our fixed rate debt and variable rate debt had weighted average interest rates of 3.40% and 1.13%, respectively. At March&#160;31, 2021, our fixed rate debt and variable rate debt had weighted average interest rates of 3.77% and 0.51%, respectively. As of March&#160;31, 2022 and 2021, we had $142&#160;million and zero, respectively, of variable rate debt subject to interest rate cap agreements. In April 2022, we terminated these interest rate cap agreements and entered into two interest rate swap contracts that are designated as cash flow hedges and mature in May 2026. For a more detailed discussion of our interest rate risk, see &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; in Item 3 below.</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_139"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had 540 million shares of common stock outstanding, equity totaled $6.9 billion, and our equity securities had a market value of $18.8 billion.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, non-managing members held an aggregate of five million units in seven limited liability companies (&#8220;DownREITs&#8221;) for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications). At March&#160;31, 2022, the outstanding DownREIT units were convertible into approximately</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">seven million shares of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-The-Market Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our at-the-market equity offering program (as amended from time to time, the &#8220;ATM Program&#8221;) has a capacity of $1.5 billion. In addition to the issuance and sale of shares of our common stock, we may also enter into one or more forward sales agreements (each, an &#8220;ATM forward contract&#8221;) with sales agents for the sale of our shares of common stock under our ATM Program. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended March&#160;31, 2022, no shares were settled under ATM forward contracts. Therefore, at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022, 9.1&#160;million shares remained outstanding under ATM forward contracts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we did </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issue any shares of our common stock under the ATM Program.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, $1.18 billion of our common stock remained available for sale under the ATM Program. Actual future sales of our common stock will depend upon a variety of factors, including but not limited to market conditions, the trading price of our common stock, and our capital needs. We have no obligation to sell any of the remaining shares under our ATM Program. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 to the Consolidated Financial Statements for additional information about our ATM Program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shelf Registration </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we filed a prospectus with the SEC as part of a registration statement on Form&#160;S-3, using an automatic shelf registration process. This shelf registration statement expires on May 13, 2024 and at or prior to such time, we expect to file a new shelf registration statement. Under the &#8220;shelf&#8221; process, we may sell any combination of the securities described in the prospectus through one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities, and warrants.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures Reconciliations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation from net income (loss) applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to Nareit FFO, FFO as Adjusted, and AFFO (in thousands, except per share data):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate related depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of real estate related depreciation and amortization from unconsolidated joint ventures </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of real estate related depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on sales of depreciable real estate, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of loss (gain) on sales of depreciable real estate, net, from unconsolidated joint ventures </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of gain (loss) on sales of depreciable real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) upon change of control, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,042)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes associated with real estate dispositions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nareit FFO applicable to common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,431&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions on dilutive convertible units and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Nareit FFO applicable to common shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,783&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted Nareit FFO</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adjustments to Nareit FFO:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction-related items</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other impairments (recoveries) and other losses (gains), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty-related charges (recoveries), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjustments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,613)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FFO as Adjusted applicable to common shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions on dilutive convertible units and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted FFO as Adjusted applicable to common shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,331&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted FFO as Adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FFO as Adjusted applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line rents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AFFO capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,710)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other AFFO adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,459)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,602)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AFFO applicable to common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,033&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,798&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions on dilutive convertible units and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted AFFO applicable to common shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,682&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted AFFO</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on sales of depreciable real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) upon change of control, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes associated with real estate dispositions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Nareit FFO per common share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction-related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other impairments (recoveries) and other losses (gains), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and severance related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Casualty-related charges (recoveries), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted FFO as Adjusted per common share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">This amount can be reconciled by combining the balances from the corresponding line of the Consolidated Statements of Operations and the detailed financial information for discontinued operations in Note 4 to the Consolidated Financial Statements.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The three months ended March 31, 2022 includes the following, which are included in other income (expense), net in the Consolidated Statements of Operations: (i) a $23 million gain on sale of a hospital that was in a direct financing lease and (ii) $14 million of expenses incurred for tenant relocation and other costs associated with a planned MOB demolition. The remaining activity for the three months ended March 31, 2022 and 2021 includes reserves for loan losses recognized in impairments and loan loss reserves (recoveries), net in the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ifa3dff468a15495db7b57c65ada0de74_148"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates and Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires our management to use judgment in the application of critical accounting estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A discussion of accounting estimates that we consider critical in that they may require complex judgment in their application or require estimates about matters that are inherently uncertain is included in our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021 in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and Note 2 to the Consolidated Financial Statements. There have been no significant changes to our critical accounting estimates during the three months ended March&#160;31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We use derivative and other financial instruments in the normal course of business to mitigate interest rate risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the Consolidated Balance Sheets at fair value (see Note 17 to the Consolidated Financial Statements).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At March&#160;31, 2022, our exposure to interest rate risk was primarily on our variable rate debt. At March&#160;31, 2022, $142&#160;million of our variable-rate debt was subject to interest rate cap agreements. The interest rate caps are non-designated hedges and manage our exposure to variable cash flows on certain mortgage debt borrowings by limiting interest rates. At March&#160;31, 2022, both the fair value and carrying value of the interest rate caps were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2 million. In April 2022, we terminated these interest rate cap agreements and entered into two interest rate swap contracts that mature in May 2026. The interest rate swaps are designated as cash flow hedges, with the objective of managing the exposure to interest rate risk by converting the interest rates on our variable-rate debt to fixed interest rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our remaining variable rate debt at March&#160;31, 2022 was comprised of our Revolving Facility, commercial paper program, and certain of our mortgage debt. Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets until their maturity or earlier prepayment and refinancing. If interest rates have risen at the time we seek to refinance our fixed rate debt, whether at maturity or otherwise, our future earnings and cash flows could be adversely affected by additional borrowing costs. Conversely, lower interest rates at the time of refinancing may reduce our overall borrowing costs. However, interest rate changes will affect the fair value of our fixed rate instruments. At March&#160;31, 2022, a one percentage point increase in interest rates would decrease the fair value of our fixed rate debt by approximately $270 million and a one percentage point decrease in interest rates would increase the fair value of our fixed rate debt by approximately $291 million. These changes would not materially impact earnings or cash flows. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not materially impact the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to our variable-rate debt and investments, and assuming no other changes in the outstanding balance at&#160;March&#160;31, 2022, our annual interest expense would increase by approximately</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$15 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;We have investments in marketable debt securities classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer&#8217;s financial condition, capital strength, and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At March&#160;31, 2022, both the fair value and carrying value of marketable debt securities was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$21 million. These marketable debt securities mature in December 2022.</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_154"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Controls and Procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules&#160;and forms and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Rules&#160;13a-15(b)&#160;and 15d-15(b)&#160;of the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of March&#160;31, 2022. Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control Over Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II. OTHER INFORMATION</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_160"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;Risk Factors</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.</span></div><div id="ifa3dff468a15495db7b57c65ada0de74_163"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information with respect to purchases of our common stock made by us or on our behalf during the three months ended March&#160;31, 2022.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period&#160;Covered</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Of&#160;Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Price<br/>Paid&#160;Per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;Of&#160;Shares<br/>(Or&#160;Units)&#160;Purchased&#160;As<br/>Part&#160;Of&#160;Publicly<br/>Announced&#160;Plans&#160;Or<br/>Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Number&#160;(Or<br/>Approximate&#160;Dollar&#160;Value)<br/>Of&#160;Shares&#160;(Or&#160;Units)&#160;That<br/>May&#160;Yet&#160;Be&#160;Purchased<br/>Under&#160;The&#160;Plans&#160;Or<br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1-31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1-28, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1-31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents shares of our common stock withheld under our equity incentive plans to offset tax withholding obligations that occur upon vesting of restricted shares. The value of the shares withheld is based on the closing price of our common stock on the last trading day prior to the date the relevant transaction occurred.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.783%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000076588017000007/ex31articlesofrestatement9.htm">Articles of Restatement of Healthpeak Properties, Inc. (formerly HCP, Inc.) dated June 1, 2012, as supplemented by the Articles Supplementary, dated July 31, 2017, and as amended by the Articles of Amendment, dated October 30, 2019 (incorporated herein by reference to Exhibit 3.1 to Healthpeak&#8217;s Annual Report on Form 10-K filed February 13, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000076588019000006/exh31articlesofamendme.htm">Articles of Amendment to Articles of Restatement of Healthpeak Properties, Inc. (formerly HCP, Inc.), dated October 30, 2019 (incorporated herein by reference to Exhibit 3.1 to Healthpeak&#8217;s Current Report on Form 8-K filed October 30, 2019). </a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/765880/000076588019000006/exh32sixtharbylaws.htm">Sixth Amended and Restated Bylaws of Healthpeak Properties, Inc., dated October 30, 2019 (incorporated herein by reference to Exhibit 3.2 to Healthpeak&#8217;s Current Report on Form 8-K filed October 30, 2019).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.1*</span><span style="color:#1f497d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8224;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex10103312022.htm">Form of 2014 Performance Incentive Plan NEO 3-Year Performance-Based Restricted Stock Unit Agreement (adopted 2022).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31103312022.htm">Certification by Thomas M. Herzog, Healthpeak&#8217;s Principal Executive Officer, pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31203312022.htm">Certification by Peter A. Scott, Healthpeak&#8217;s Principal Financial Officer, pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32103312022.htm">Certification by Thomas M. Herzog, Healthpeak&#8217;s Principal Executive Officer, pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32203312022.htm">Certification by Peter A. Scott, Healthpeak&#8217;s Principal Financial Officer, pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document&#160;- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Labels Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**&#160;&#160;&#160; &#160;Furnished herewith.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;  &#160; Management Contract or Compensatory Plan or Arrangement.</span></div><div style="text-align:justify"><span style="color:#1f497d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="ifa3dff468a15495db7b57c65ada0de74_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifa3dff468a15495db7b57c65ada0de74_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-align:center;text-indent:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 4, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthpeak Properties, Inc.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ THOMAS M. HERZOG</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas M. Herzog</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ PETER A. SCOTT</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter A. Scott</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SHAWN G. JOHNSTON</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawn G. Johnston</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10103312022.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i857ec8eb0205454db4e6b50e234e148f_77"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HEALTHPEAK PROPERTIES, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3-YEAR PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">THIS 3-YEAR PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) is effective as of &#91;_____&#93;, 20&#91;__&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Award Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) by and between Healthpeak Properties, Inc., a Maryland corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), and &#91;_____&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">W I T N E S S E T H</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, the Compensation and Human Capital Committee of the Board of Directors of the Corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) has determined that the Participant is eligible to receive an award of restricted stock units, as described below&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">WHEREAS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, pursuant to the Healthpeak Properties, Inc. 2014 Performance Incentive Plan, as amended and&#47;or restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), the Corporation hereby grants to the Participant, effective as of the date hereof, an award of restricted stock units under the Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), upon the terms and conditions set forth herein and in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">NOW THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, in consideration of services rendered and to be rendered by the Participant, and the mutual promises made herein and the mutual benefits to be derived therefrom, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  Subject to the terms of this Agreement, the Corporation hereby grants to the Participant a target award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) of &#91;_____&#93; stock units (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Performance Units</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) with respect to the performance period beginning on January 1, &#91;_____&#93; and ending on December 31, &#91;_____&#93; (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;).  As used herein, the term &#8220;stock unit&#8221; means a non-voting unit of measurement which is deemed for bookkeeping purposes to be equivalent to one outstanding share of the Corporation&#8217;s Common Stock solely for purposes of the Plan and this Agreement.  The Performance Units shall be used solely as a device for the determination of the payment to eventually be made to the Participant if such Performance Units vest pursuant to Section 3.  The Performance Units shall not be treated as property or as a trust fund of any kind.  The Committee is the Administrator of the Plan for purposes of the Performance Units.  The Award is subject to all of the terms and conditions set forth in this Agreement, and is further subject to all of the terms and conditions of the Plan, as it may be amended from time to time, and any rules adopted by the Committee, as such rules are in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Subject to this Section 3 and Section 8, the number of Performance Units ultimately earned and vested under the Award shall be determined in accordance with </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> attached hereto based on whether the Corporation has attained certain pre-established performance goals with respect to the Performance Period.  The determination as to whether the Corporation has attained the performance goals set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> with respect to the Performance Period shall be made by the Committee (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Committee Determination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;).  The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.474%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Committee Determination shall be made no later than March 15 following the end of the Performance Period (or such earlier time as provided in Section 9(b)).  The Performance Units shall not be deemed vested pursuant to any other provision of this Agreement earlier than the date that the Committee makes such determination.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Continuance of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  Except as otherwise expressly provided in Section 8, the vesting schedule requires continued employment through the date of the Committee Determination (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Vesting Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), as provided in Section 3, as a condition to the vesting of the Award and the rights and benefits under this Agreement.  Employment for only a portion of the Vesting Period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment as provided in Section 8 below or under the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation or any of its Subsidiaries, affects the Participant&#8217;s status as an employee at will who is subject to termination without Cause (as defined herein), confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Subsidiaries, interferes in any way with the right of the Corporation or any of its Subsidiaries at any time to terminate such employment or services, or affects the right of the Corporation or any of its Subsidiaries to increase or decrease the Participant&#8217;s other compensation or benefits. Nothing in this paragraph, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Dividend and Voting Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:22.57pt">Limitations on Rights Associated with Units.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  The Participant shall have no rights as a stockholder of the Corporation, no dividend rights (except as expressly provided in Section 5(b) with respect to Dividend Equivalent Rights) and no voting rights with respect to the Performance Units and any shares of Common Stock underlying or issuable in respect of such Performance Units until such shares of Common Stock are actually issued to and held of record by the Participant.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:21.97pt">Dividend Equivalent Rights.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Subject to vesting as provided below, the Participant will have the right to receive, with respect to each Performance Unit, an amount equal to the amount of any ordinary cash dividend paid by the Corporation on a share of Common Stock as to which the related dividend record date occurs on or after the first day of the Performance Period and before the date on which the Performance Unit is settled pursuant to Section 7 (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Dividend Equivalent Right</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;).  Any Dividend Equivalent Right credited with respect to an outstanding Performance Unit that does not vest pursuant to Section 3 shall immediately terminate upon the forfeiture of such Performance Unit, and the Participant shall not be entitled to any payment with respect thereto. In the case of Dividend Equivalent Rights credited with respect to an outstanding Performance Unit that vests pursuant to Section 3, the Dividend Equivalent Rights will be paid to the Participant in cash (without interest) as soon as practicable after the Committee Determination and in all events not later than March 15 of the year that follows the end of the Performance Period.  Dividend Equivalent Rights will not be paid </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">to the Participant with respect to any Performance Units that are forfeited or terminated pursuant to Section 3 or 8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Restrictions on Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  Neither the Award, nor any interest therein or amount or shares payable in respect thereof may be sold, assigned, transferred, pledged or otherwise disposed of, alienated or encumbered, either voluntarily or involuntarily.  The transfer restrictions in the preceding sentence shall not apply to (a) transfers to the Corporation, or (b) transfers by will or the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Time and Manner of Payment&#59; Minimum Holding Period Requirement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:22.57pt">Timing and Manner of Payment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  As soon as administratively practical following the Committee Determination (and in all events no later than March 15 of the year that follows the end of the Performance Period or such time as provided in Section 9(b)), the Corporation shall deliver to the Participant a number of shares of Common Stock (either by delivering one or more certificates for such shares or by entering such shares in book entry form, as determined by the Corporation in its discretion) equal to the number of Performance Units subject to the Award that vest in accordance with Section 3&#59; provided, however, that in the event that the vesting and payment of the Performance Units is triggered by the Participant&#8217;s &#8220;separation from service&#8221; (within the meaning of Treasury Regulation Section 1.409A-1(h)) and the Participant is a &#8220;specified employee&#8221; (within the meaning of Treasury Regulation Section 1.409A-1(i)) on the date of such separation from service, the Participant shall not be entitled to any payment of the Performance Units until the earlier of (a) the date which is six months after the Participant&#8217;s separation from service with the Corporation for any reason other than death, or (b) the date of the Participant&#8217;s death, if and to the extent such delay in payment is required to comply with Section 409A of the Code.  The Corporation&#8217;s obligation to deliver shares of Common Stock or otherwise make payment with respect to vested Performance Units is subject to the condition precedent that the Participant or other person entitled under the Plan to receive any shares with respect to the vested Performance Units deliver to the Corporation any representations or other documents or assurances that the Administrator may deem necessary or desirable to assure compliance with all applicable legal and accounting requirements.  The Participant shall have no further rights with respect to any Performance Units that are paid or that terminate pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:21.97pt">Minimum Holding Period Requirement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  As to any shares of Common Stock acquired by the Participant in payment of the Performance Units that vest pursuant to the Award, the Participant agrees that the Participant will not sell, pledge, assign, hypothecate, transfer or otherwise dispose of such shares prior to the date that is one (1) year after the last day of the Performance Period (as the Performance Period may be shortened pursuant to Section 9(b))&#59; provided, however, that the restrictions set forth in this Section 7(b) shall (i) not apply to any shares withheld or reacquired by the Corporation to satisfy tax withholding obligations as contemplated by Section 10, (ii) not apply to any shares sold by the Participant to satisfy any tax liability arising in connection with the payment of the Stock Units (to the extent such tax liability exceeds the tax withholding amounts applicable to such Stock Unit payment), (iii) not apply to any transfer of shares made without consideration (or for only nominal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">consideration) to a &#8220;family member&#8221; (as such term is defined in the SEC General Instructions to a Registration Statement on Form S-8) of the Participant solely for purposes of estate or tax planning, and provided the transfer restrictions on such shares continue in effect after any such transfer, and (iv) lapse upon the Participant&#8217;s death or Disability or as otherwise provided by the Corporation.  The Corporation may provide for any shares of Common Stock acquired under the Award and issued in book-entry form to include notations regarding the restrictions on transfer imposed under this Section 7(b) (or, as to any such shares issued in certificate form, provide for such certificates to bear appropriate legends regarding such transfer restrictions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Termination of Employment or Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Notwithstanding any provisions to the contrary in any employment agreement, the Healthpeak Properties, Inc. Executive Severance Plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), the Healthpeak Properties, Inc. Executive Change in Control Severance Plan or successor plan (as it may be amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">CIC Severance Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), or any other severance plan adopted by the Corporation, the provisions set forth in this Section 8 are applicable in the event of a termination of the Participant&#8217;s employment with the Corporation and its Subsidiaries.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:22.57pt">Qualifying Termination.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  If, at any time during the Vesting Period, the Participant ceases to be employed by the Corporation or one of its Subsidiaries  (the date of such termination of employment is referred to as the Participant&#8217;s &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Severance Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;) as a result of (i) the Participant&#8217;s death or Disability, or (ii) a termination of employment by the Corporation or one of its Subsidiaries without Cause (as defined herein), then, subject to the following paragraph and the release requirement set forth in the last paragraph of this Section 8(a), (x) the Performance Units will remain outstanding during the remainder of the Vesting Period and will remain subject to Section 3, and (y) the Participant will be entitled to the number of Performance Units the Participant would have received in accordance with Section 3, if any, had the Participant remained employed until the end of the Vesting Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">In the event that the Participant&#8217;s employment terminates in the circumstances described in the preceding paragraph and the Severance Date occurs on or before the last day of the second year of the Performance Period and on or before the Severance Date, or after the Severance Date and before the last day of the second year of the Performance Period, an Interim Date (as defined in Exhibit A) has been or is established with respect to Peer Group I, Peer Group II, or Peer Group III (as such terms are defined in Exhibit A), the Performance Period with respect to that Peer Group will end on such Interim Date (in the event there has been more than one Interim Date with respect to such Peer Group on or prior to the Severance Date, the most recent Interim Date as to that Peer Group on or prior to the Severance Date&#59; and in the event that there has been an Interim Date with respect to that Peer Group on or prior to the Severance Date, any new Interim Date after the Severance Date with respect to that Peer Group shall be disregarded) and there will be no new or additional measurement period with respect to such Peer Group after such Interim Date as otherwise provided for in Exhibit A.  In such circumstances, the determination as to whether the Corporation has attained the performance goals set forth in Exhibit A with respect to such Peer Group for the Performance Period shall be made by the Committee based solely on performance through such applicable Interim Date, such determination to be made no later than March 15 of the year that follows the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">later of the Severance Date or the applicable Interim Date as to that Peer Group (such determination to be the Committee Determination as to such Peer Group) and payment of any portion of the Award that vests as to such Peer Group will be made pursuant to Section 7(a) no later than such March 15 (subject to the Section 409A payment delay provisions as set forth in Section 7(a)).  In such circumstances, any Performance Units corresponding to that Peer Group that are not vested on the date of such Committee Determination (after giving effect to such Committee Determination) shall terminate.  No additional Performance Units will vest pursuant to Section 9(b) or Exhibit A with respect to performance after, or a Change in Control Event that occurs after, the applicable Interim Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Any benefit to the Participant pursuant to the preceding paragraphs of this Section 8 (other than in connection with the Participant&#8217;s death) is subject to the condition precedent that (i) the Participant has fully executed a valid and effective release (in the form attached to the Severance Plan or, if such release is executed on or after a Change in Control Event, in the form attached to the CIC Severance Plan, or in either case such other form as the Committee may reasonably require in the circumstances, which other form shall be substantially similar to the form attached to the Severance Plan or the CIC Severance Plan, as the case may be, that would otherwise apply in the circumstances but with such changes as the Committee may determine to be required or reasonably advisable in order to make the release enforceable and otherwise compliant with applicable laws), (ii) such executed release is delivered by the Participant to the Corporation so that it is received by the Corporation in the time period specified below, and (iii) such release is not revoked by the Participant (pursuant to any revocation rights afforded by applicable law).  In order to satisfy the requirements of this paragraph, the Participant&#8217;s release referred to in the preceding sentence must be delivered by the Participant to the Corporation so that it is received by the Corporation no later than twenty-five (25) calendar days after the Participant&#8217;s Severance Date (or such later date as may be required for an enforceable release of the Participant&#8217;s claims under the United States Age Discrimination in Employment Act of 1967, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), to the extent the ADEA is applicable in the circumstances, in which case the Participant will be provided with either twenty-one (21) or forty-five (45) days, depending on the circumstances of the termination, to consider the release).  In addition, the Corporation may require that the Participant&#8217;s release be executed no earlier than the Participant&#8217;s Severance Date.  If the period during which the Participant is permitted to consider the release in accordance with this paragraph begins in one calendar year and ends in a second calendar year, the payment of any Stock Units that remain eligible to vest or are payable pursuant to the preceding paragraphs of this Section 8 shall not be made earlier than the second calendar year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:21.97pt">Forfeiture of Performance Units upon Certain Terminations of Employment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  If, at any time during the Vesting Period, the Participant ceases to be employed by the Corporation or one of its Subsidiaries as a result of (i) a termination of employment by the Corporation or one of its Subsidiaries for Cause, or (ii) a termination of employment by the Participant, excluding any termination contemplated by Section 8(a) (other than a termination contemplated by Section 8(a) but as to which the Participant did not timely satisfy any applicable release requirement pursuant to Section 8(a)) and subject to the next paragraph, all of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Performance Units shall be automatically terminated and cancelled in full, effective as of the Severance Date, and this Agreement shall be null and void and of no further force and effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">If, however, the Participant ceases to be employed by the Corporation or one of its Subsidiaries and such termination of employment is a result of a retirement or resignation by the Participant (other than (x) any termination contemplated by Section 8(a) and (y) a termination of employment by the Corporation or one of its Subsidiaries for Cause) and, immediately after such termination of employment, the Participant is a member of the Board or provides consulting services to the Corporation or one of its Subsidiaries under a written consulting agreement entered into by and between the Participant and the Corporation or one of its Subsidiaries, then the termination of employment rules of the preceding paragraph shall not apply when the Participant ceases to be employed by the Corporation or one of its Subsidiaries but shall apply if and when, and effective as of the time that, the Participant ceases to be a member of the Board or ceases to provide consulting services to the Corporation or one of its Subsidiaries under such a written consulting agreement.  For clarity, the Participant&#8217;s obligations under a confidentiality, noncompetition, non-solicitation, cooperation or similar clause or agreement shall not constitute &#8220;consulting services&#8221; for purposes of the preceding sentence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:22.57pt">Termination of Performance Units.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Any Performance Units that are not vested on the date of the Committee Determination (after giving effect to such Committee Determination) shall terminate. If any unvested Performance Units are terminated pursuant to this Section 8, such Performance Units shall automatically terminate and be cancelled as of the Severance Date or as of the date of the Committee Determination, as the case may be, without payment of any consideration by the Corporation and without any other action by the Participant, or the Participant&#8217;s beneficiary or personal representative, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:21.97pt">Definitions.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> As used in this Agreement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:26.24pt">&#8220;Cause&#8221; shall have the meaning set forth in the Severance Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:23.8pt">&#8220;Disability&#8221; means a &#8220;permanent and total disability&#8221; (within the meaning of Section 22(e)(3) of the Code or as otherwise determined by the Administrator).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:26.84pt;text-decoration:underline">Adjustments upon Specified Events&#59; Change in Control Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:22.57pt">Adjustments.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  Upon the occurrence of certain events relating to the Corporation&#8217;s stock contemplated by Section 7.1 of the Plan (including, without limitation, an extraordinary cash dividend on such stock), the Administrator shall make adjustments in accordance with such section in the number of Performance Units then outstanding and the number and kind of securities that may be issued in respect of the Award.  No such adjustment shall be made with respect to any ordinary cash dividend for which dividend equivalents are paid pursuant to Section 5(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:21.97pt">Change in Control Event.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  Upon the occurrence, at any time during the Vesting Period, of a Change in Control Event with respect to the Corporation and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">notwithstanding any provision of Section 7.2 or 7.3 of the Plan, any employment agreement, the Severance Plan, the CIC Severance Plan (or successor plan) or any other severance plan adopted by the Corporation, the Performance Period for all Performance Units then outstanding will be shortened, if such Performance Period has not already ended, so that the Performance Period will be deemed to have ended on the day of the Change in Control Event and the Committee Determination pursuant to Section 3 shall be made not later than 20 days following the Change in Control Event.  The Vesting Period will be deemed to end on the date of the Change in Control Event even though the Committee Determination may not occur until after such date, such that a Participant employed by the Corporation or a Subsidiary on the date of the Change in Control Event shall be fully vested in any Performance Units that vest as a result of the Committee Determination even if the Participant does not remain employed by the Corporation or a Subsidiary through the date of the Committee Determination. A Participant shall become vested in a number of Performance Units, if any, determined in accordance with Section 3 based on such shortened Performance Period.  On or as soon as administratively practical following the Change in Control Event (and in all events no later than thirty (30) days following such Change in Control Event), the Corporation shall deliver to the Participant a number of shares of Common Stock (either by delivering one or more certificates for such shares or by entering such shares in book entry form, as determined by the Corporation in its discretion) equal to the number of Performance Units that vest in accordance with this Section 9(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  Upon vesting of any Performance Units or any distribution of shares of Common Stock in respect of the Performance Units, the Corporation shall reduce the number of shares to be delivered by (or otherwise reacquire) the appropriate number of whole shares, valued at their then fair market value, to satisfy any withholding obligations of the Corporation or its Subsidiaries with respect to such distribution of shares at the applicable withholding rates&#59; provided, however, that in the event that the Corporation cannot legally satisfy such withholding obligations by such reduction of shares, or in the event of a cash payment or any other withholding event in respect of the Performance Units, the Corporation (or a Subsidiary) shall be entitled to require a cash payment by or on behalf of the Participant and&#47;or to deduct from other compensation payable to the Participant any sums required by federal, state or local tax law to be withheld with respect to such distribution or payment.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant&#8217;s last address reflected on the Corporation&#8217;s payroll records.  Any notice shall be delivered in person or shall be enclosed in a properly sealed envelope, addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.  Any such notice shall be given only when received, but if the Participant is no longer an Eligible Person, shall be deemed to have been duly given five business days after the date mailed in accordance with the foregoing provisions of this Section 11.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan, incorporated herein by reference.  The Participant agrees to be bound by the terms of the Plan and this Agreement.  The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan and this Agreement.  Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under the Plan after the date hereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  This Agreement and the Plan together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof.  The Plan and this Agreement may be amended pursuant to Section&#160;8.6 of the Plan.  Any such amendment must be in writing and signed by the Corporation.  Any such amendment that materially and adversely affects the Participant&#8217;s rights under this Agreement requires the consent of the Participant in order to be effective with respect to the Award.  The Corporation may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.  The Participant acknowledges receipt of a copy of this Agreement, the Plan and the Prospectus for the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Limitation on Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Participation in the Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">confers no</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">rights or interests other than as herein provided.  This Agreement creates only a contractual obligation on the part of the Corporation as to amounts payable and shall not be construed as creating a trust.  Neither the Plan nor any underlying program, in and of itself, has any assets.  The Participant shall have only the rights of a general unsecured creditor of the Corporation with respect to amounts credited and benefits payable, if any, with respect to the Performance Units, and rights no greater than the right to receive the Common Stock as a general unsecured creditor with respect to the Performance Units, as and when payable hereunder.  The Award has been granted to the Participant in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Maryland without regard to conflict of law principles thereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code.  This Agreement shall be construed and interpreted consistent with that intent.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:20.73pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">  The Performance Units are subject to the terms of the Corporation&#8217;s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Performance Units or any shares of Common Stock or other cash or property received with respect to the Performance Units (including any value received from a disposition of the shares acquired upon payment of the Performance Units).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement, effective as of the date first written above. </font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Healthpeak Properties, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">By&#58;  _________________________________________</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name&#58;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Title&#58;</font></div><div style="padding-left:238.5pt;text-align:justify"><font><br></font></div><div style="padding-left:238.5pt;text-align:justify"><font><br></font></div><div style="padding-left:238.5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Participant</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">_________________________________________</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Name&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i857ec8eb0205454db4e6b50e234e148f_80"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Exhibit A</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">Award Subject to Relative TSR Performance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#91;_____&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex31103312022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i91d6cd79b7a444c784ee9d06745e1a61_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;31.1</font></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas M. Herzog, certify that&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form&#160;10-Q of Healthpeak Properties,&#160;Inc.&#160;for the period ended&#160;March&#160;31, 2022&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 4, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; THOMAS M. HERZOG</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas M. Herzog</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex31203312022.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1d662f49594d4b21b0d8ad2902c47748_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;31.2</font></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Peter A. Scott, certify that&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form&#160;10-Q of Healthpeak Properties,&#160;Inc.&#160;for the period ended March&#160;31, 2022&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 4, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PETER A. SCOTT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter A. Scott</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex32103312022.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i840f5c50af6a4502831349d940ef0315_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;32.1</font></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167;&#160;1350, as created by Section&#160;906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Healthpeak Properties,&#160;Inc., a Maryland corporation (the &#8220;Company&#8221;), hereby certifies, to his knowledge, that&#58;</font></div><div style="text-indent:96.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;the accompanying quarterly report on Form&#160;10-Q of the Company for the period ended March&#160;31, 2022 (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a)&#160;or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 4, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; THOMAS M. HERZOG</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas M. Herzog</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates it by reference.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>ex32203312022.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia0ac90fec2bc4b8f8bef93db0e2d2909_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;32.2</font></div><div style="text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167;&#160;1350, as created by Section&#160;906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Healthpeak Properties,&#160;Inc., a Maryland corporation (the &#8220;Company&#8221;), hereby certifies, to his knowledge, that&#58;</font></div><div style="text-indent:96.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;the accompanying quarterly report on Form&#160;10-Q of the Company for the period ended March&#160;31, 2022 (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a)&#160;or Section&#160;15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 4, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PETER A. SCOTT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter A. Scott</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates it by reference.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>peak-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18e02b9c-9339-4812-a396-3a502b171f3f,g:40f6f78a-d855-4bed-acda-5b3ebe369ddb-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:peak="http://www.healthpeak.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.healthpeak.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.healthpeak.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Business" roleURI="http://www.healthpeak.com/role/Business">
        <link:definition>2101101 - Disclosure - Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2102102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Government Grant Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateTransactions" roleURI="http://www.healthpeak.com/role/RealEstateTransactions">
        <link:definition>2107103 - Disclosure - Real Estate Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateTransactionsRealEstateInvestmentsDetails" roleURI="http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails">
        <link:definition>2408403 - Disclosure - Real Estate Transactions - Real Estate Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateTransactionsDevelopmentActivitiesDetails" roleURI="http://www.healthpeak.com/role/RealEstateTransactionsDevelopmentActivitiesDetails">
        <link:definition>2409404 - Disclosure - Real Estate Transactions - Development Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperations" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations">
        <link:definition>2110104 - Disclosure - Dispositions of Real Estate and Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperationsTables" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables">
        <link:definition>2311302 - Disclosure - Dispositions of Real Estate and Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails">
        <link:definition>2412405 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails">
        <link:definition>2413406 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Assets and Liabilities for Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails">
        <link:definition>2414407 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.healthpeak.com/role/Leases">
        <link:definition>2115105 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.healthpeak.com/role/LeasesTables">
        <link:definition>2316303 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseIncomeDetails" roleURI="http://www.healthpeak.com/role/LeasesLeaseIncomeDetails">
        <link:definition>2417408 - Disclosure - Leases - Lease Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.healthpeak.com/role/LeasesNarrativeDetails">
        <link:definition>2418409 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDirectFinancingLeasesDetails" roleURI="http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails">
        <link:definition>2419410 - Disclosure - Leases - Direct Financing Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivable" roleURI="http://www.healthpeak.com/role/LoansReceivable">
        <link:definition>2120106 - Disclosure - Loans Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableTables" roleURI="http://www.healthpeak.com/role/LoansReceivableTables">
        <link:definition>2321304 - Disclosure - Loans Receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableScheduleofLoansReceivableDetails" roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails">
        <link:definition>2422411 - Disclosure - Loans Receivable - Schedule of Loans Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableNarrativeDetails" roleURI="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails">
        <link:definition>2423412 - Disclosure - Loans Receivable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails">
        <link:definition>2424413 - Disclosure - Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivableScheduleofReserveforLoanLossesDetails" roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails">
        <link:definition>2425414 - Disclosure - Loans Receivable - Schedule of Reserve for Loan Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinandAdvancestoUnconsolidatedJointVentures" roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures">
        <link:definition>2126107 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables" roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables">
        <link:definition>2327305 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails">
        <link:definition>2428415 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Intangibles" roleURI="http://www.healthpeak.com/role/Intangibles">
        <link:definition>2129108 - Disclosure - Intangibles</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesTables" roleURI="http://www.healthpeak.com/role/IntangiblesTables">
        <link:definition>2330306 - Disclosure - Intangibles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesIntangiblesLeaseAssetsDetails" roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails">
        <link:definition>2431416 - Disclosure - Intangibles - Intangibles Lease Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesIntangiblesLeaseLiabilitiesDetails" roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails">
        <link:definition>2432417 - Disclosure - Intangibles - Intangibles Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesNarrativeDetails" roleURI="http://www.healthpeak.com/role/IntangiblesNarrativeDetails">
        <link:definition>2433418 - Disclosure - Intangibles - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.healthpeak.com/role/Debt">
        <link:definition>2134109 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.healthpeak.com/role/DebtTables">
        <link:definition>2335307 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtBankLineofCreditandTermLoansDetails" roleURI="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails">
        <link:definition>2436419 - Disclosure - Debt - Bank Line of Credit and Term Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtCommercialPaperProgramDetails" roleURI="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails">
        <link:definition>2437420 - Disclosure - Debt - Commercial Paper Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorUnsecuredNotesDetails" roleURI="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails">
        <link:definition>2438421 - Disclosure - Debt - Senior Unsecured Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtMortgageDebtDetails" roleURI="http://www.healthpeak.com/role/DebtMortgageDebtDetails">
        <link:definition>2439422 - Disclosure - Debt - Mortgage Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDebtMaturitiesDetails" roleURI="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails">
        <link:definition>2440423 - Disclosure - Debt - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.healthpeak.com/role/CommitmentsandContingencies">
        <link:definition>2141110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2442424 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterests" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests">
        <link:definition>2143111 - Disclosure - Equity and Redeemable Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsTables" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables">
        <link:definition>2344308 - Disclosure - Equity and Redeemable Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails">
        <link:definition>2445425 - Disclosure - Equity and Redeemable Noncontrolling Interests - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandRedeemableNoncontrollingInterestsAOCIDetails" roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails">
        <link:definition>2446426 - Disclosure - Equity and Redeemable Noncontrolling Interests - AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShare" roleURI="http://www.healthpeak.com/role/EarningsPerCommonShare">
        <link:definition>2147112 - Disclosure - Earnings Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShareTables" roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareTables">
        <link:definition>2348309 - Disclosure - Earnings Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShareNarrativeDetails" roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails">
        <link:definition>2449427 - Disclosure - Earnings Per Common Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerCommonShareComputationofEPSDetails" roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails">
        <link:definition>2450428 - Disclosure - Earnings Per Common Share - Computation of EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosures" roleURI="http://www.healthpeak.com/role/SegmentDisclosures">
        <link:definition>2151113 - Disclosure - Segment Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosuresTables" roleURI="http://www.healthpeak.com/role/SegmentDisclosuresTables">
        <link:definition>2352310 - Disclosure - Segment Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" roleURI="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails">
        <link:definition>2453429 - Disclosure - Segment Disclosures - Summary Information for the Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformation" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformation">
        <link:definition>2154114 - Disclosure - Supplemental Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationTables" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationTables">
        <link:definition>2355311 - Disclosure - Supplemental Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationSupplementalCashFlowInformationDetails" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails">
        <link:definition>2456430 - Disclosure - Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails">
        <link:definition>2457431 - Disclosure - Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2458432 - Disclosure - Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1">
        <link:definition>2458432 - Disclosure - Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://www.healthpeak.com/role/VariableInterestEntities">
        <link:definition>2159115 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesTables" roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesTables">
        <link:definition>2360312 - Disclosure - Variable Interest Entities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesNarrativeDetails" roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails">
        <link:definition>2461433 - Disclosure - Variable Interest Entities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails">
        <link:definition>2462434 - Disclosure - Variable Interest Entities - Schedule of Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails">
        <link:definition>2463435 - Disclosure - Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.healthpeak.com/role/FairValueMeasurements">
        <link:definition>2164116 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.healthpeak.com/role/FairValueMeasurementsTables">
        <link:definition>2365313 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.healthpeak.com/role/FairValueMeasurementsDetails">
        <link:definition>2466436 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstruments">
        <link:definition>2167117 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>2368314 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsNarrativeDetails" roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails">
        <link:definition>2469437 - Disclosure - Derivative Financial Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails">
        <link:definition>2470438 - Disclosure - Derivative Financial Instruments - Schedule of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableAccruedLiabilitiesandOtherLiabilities" roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities">
        <link:definition>2171118 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables" roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables">
        <link:definition>2372315 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails">
        <link:definition>2473439 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="peak_HCPVenturesIIILLCMember" abstract="true" name="HCPVenturesIIILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" abstract="false" name="ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="peak_NumberOfVieBorrowersWithMarketableDebtSecurities" abstract="false" name="NumberOfVieBorrowersWithMarketableDebtSecurities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" abstract="false" name="InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DefinitiveAgreementsAxisAxis" abstract="true" name="DefinitiveAgreementsAxisAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" abstract="false" name="RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfPropertiesSold" abstract="false" name="NumberOfPropertiesSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_FinancingReceivableHeldForSaleNumberOfContracts" abstract="false" name="FinancingReceivableHeldForSaleNumberOfContracts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_FiniteLivedIntangibleLiabilitiesGross" abstract="false" name="FiniteLivedIntangibleLiabilitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LessorAssetUnderOperatingLeaseMember" abstract="true" name="LessorAssetUnderOperatingLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" abstract="false" name="CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DiscoverySarasotaJVMember" abstract="true" name="DiscoverySarasotaJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" abstract="false" name="IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_FinancingReceivableNumberOfContracts" abstract="false" name="FinancingReceivableNumberOfContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" abstract="false" name="ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NetIncomeLossJointVenturePartnersAttributableToParent" abstract="false" name="NetIncomeLossJointVenturePartnersAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NoncashOrPartNoncashInterestIncome" abstract="false" name="NoncashOrPartNoncashInterestIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_AmortizationOfNonrefundableEntranceFee" abstract="false" name="AmortizationOfNonrefundableEntranceFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_RealEstateRevenuesFromJointVentureAttributableToParent" abstract="false" name="RealEstateRevenuesFromJointVentureAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DownREITMember" abstract="true" name="DownREITMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" abstract="false" name="ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" abstract="false" name="IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="peak_UnsecuredNote3880PercentMember" abstract="true" name="UnsecuredNote3880PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_AdjustedNetOperatingIncomeFromContinuingOperations" abstract="false" name="AdjustedNetOperatingIncomeFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_SeniorHousingOperatingPortfolioMember" abstract="true" name="SeniorHousingOperatingPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_UnsecuredNote4.250PercentMember" abstract="true" name="UnsecuredNote4.250PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_IncomeLossFromDiscontinuedOperationsMember" abstract="true" name="IncomeLossFromDiscontinuedOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_MedicalOfficeHospitalMember" abstract="true" name="MedicalOfficeHospitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_UnsecuredNote4200PercentMember" abstract="true" name="UnsecuredNote4200PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" abstract="false" name="ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantFixedChargeRatioMinimum" abstract="false" name="DebtInstrumentCovenantFixedChargeRatioMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="peak_HRATripleNetPortfolioMember" abstract="true" name="HRATripleNetPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" abstract="false" name="DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" abstract="false" name="DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" abstract="false" name="DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfAssetsClassifiedAsDiscontinuedOperations" abstract="false" name="NumberOfAssetsClassifiedAsDiscontinuedOperations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" abstract="false" name="IntangibleAssetsAndLiabilitiesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_MedicalOfficeMember" abstract="true" name="MedicalOfficeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DerivativeNotionalAmountTerminated" abstract="false" name="DerivativeNotionalAmountTerminated" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DebtInstrumentCollateralHealthcareFacilitiesNumber" abstract="false" name="DebtInstrumentCollateralHealthcareFacilitiesNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DebtInstrumentPeriodOfExtension" abstract="false" name="DebtInstrumentPeriodOfExtension" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" abstract="false" name="CapitalExpenditureFundingCostOfCapitalPercentCommitted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_DownreitPartnershipsMember" abstract="true" name="DownreitPartnershipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_ATMEquityOfferingProgramAggregateAmountRemaining" abstract="false" name="ATMEquityOfferingProgramAggregateAmountRemaining" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_OakmontSHOPPortfolioMember" abstract="true" name="OakmontSHOPPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_GainLossFromChangeOfControl" abstract="false" name="GainLossFromChangeOfControl" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LoansReceivableMarketRate" abstract="false" name="LoansReceivableMarketRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_FinancingReceivableRemainingCommitments" abstract="false" name="FinancingReceivableRemainingCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_FiniteLivedIntangibleLiabilitiesNet" abstract="false" name="FiniteLivedIntangibleLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" abstract="false" name="ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ImpairmentsAndAllowanceForCreditLossReserves" abstract="false" name="ImpairmentsAndAllowanceForCreditLossReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" abstract="false" name="ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_DefinitiveAgreementFourMember" abstract="true" name="DefinitiveAgreementFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantSecuredDebtToAssets" abstract="false" name="DebtInstrumentCovenantSecuredDebtToAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_NumberOfBondOfferings" abstract="false" name="NumberOfBondOfferings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_UnsecuredNote1350PercentMember" abstract="true" name="UnsecuredNote1350PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" abstract="false" name="RealEstateRevenuesFromJointVentureGovernmentGrantIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NetRealEstateAssets" abstract="false" name="NetRealEstateAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" abstract="false" name="OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" abstract="false" name="NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ATMDirectIssuancesMember" abstract="true" name="ATMDirectIssuancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" abstract="false" name="AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_CapitalExpenditureFundingAmountCommitted" abstract="false" name="CapitalExpenditureFundingAmountCommitted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" abstract="false" name="TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_VariableInterestEntitiesAbstract" abstract="true" name="VariableInterestEntitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="peak_DebtInstrumentRedemptionPeriodThereafterMember" abstract="true" name="DebtInstrumentRedemptionPeriodThereafterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" abstract="false" name="VariableInterestEntityControllingOwnershipInterestThroughPartnership" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantDebtToAssets" abstract="false" name="DebtInstrumentCovenantDebtToAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_A2020ATMProgramSettledMember" abstract="true" name="A2020ATMProgramSettledMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_LoansReceivableInterestIncomeAmortizationPeriod" abstract="false" name="LoansReceivableInterestIncomeAmortizationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_A2019TermLoanMember" abstract="true" name="A2019TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NeedhamLandParcelJVMember" abstract="true" name="NeedhamLandParcelJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CCRCSegmentMember" abstract="true" name="CCRCSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_OperatingExpensesFromJointVentureAttributableToParentNet" abstract="false" name="OperatingExpensesFromJointVentureAttributableToParentNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_VariableInterestEntitiesTextBlock" abstract="false" name="VariableInterestEntitiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_SeniorHousingTripleNetMember" abstract="true" name="SeniorHousingTripleNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_A2020ATMProgramMember" abstract="true" name="A2020ATMProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentCovenantNetWorth" abstract="false" name="DebtInstrumentCovenantNetWorth" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_AtmEquityOfferingProgramAggregateAmountAuthorized" abstract="false" name="AtmEquityOfferingProgramAggregateAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_UnsecuredNote4000PercentMember" abstract="true" name="UnsecuredNote4000PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SeniorNotesDue2023And2024Member" abstract="true" name="SeniorNotesDue2023And2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_VenturesVLLCMember" abstract="true" name="VenturesVLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SunriseSeniorHousingPortfolioMember" abstract="true" name="SunriseSeniorHousingPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentMaximumBorrowingCapacity" abstract="false" name="DebtInstrumentMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" abstract="false" name="UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" abstract="false" name="LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfPreferredEquityMethodInvestmentsSold" abstract="false" name="NumberOfPreferredEquityMethodInvestmentsSold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_HCPVenturesIVLLCMember" abstract="true" name="HCPVenturesIVLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfPropertiesToBeSold" abstract="false" name="NumberOfPropertiesToBeSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_ParticipatingDevelopmentLoansAndOtherMember" abstract="true" name="ParticipatingDevelopmentLoansAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" abstract="true" name="EquityIncomeLossFromUnconsolidatedJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NoncontrollingInterestsShareInDiscontinuedOperations" abstract="false" name="NoncontrollingInterestsShareInDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" abstract="false" name="InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ProceedsFromCollectionOfNonrefundableEntranceFees" abstract="false" name="ProceedsFromCollectionOfNonrefundableEntranceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_AtTheMarketProgramMember" abstract="true" name="AtTheMarketProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" abstract="true" name="VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SellerFinancingProvidedOnDispositionofRealEstateAsset" abstract="false" name="SellerFinancingProvidedOnDispositionofRealEstateAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" abstract="true" name="CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="peak_GovernmentGrantIncomePolicyPolicyTextBlock" abstract="false" name="GovernmentGrantIncomePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_LifeScienceJVsMember" abstract="true" name="LifeScienceJVsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_GovernmentAssistanceDomain" abstract="true" name="GovernmentAssistanceDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_UnsecuredNote3400PercentMember" abstract="true" name="UnsecuredNote3400PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CapitalExpenditureFundingAmountFunded" abstract="false" name="CapitalExpenditureFundingAmountFunded" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfRedeemableNoncontrollingInterestRedemptions" abstract="false" name="NumberOfRedeemableNoncontrollingInterestRedemptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DiscoveryNaplesJVMember" abstract="true" name="DiscoveryNaplesJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_WorkoutFinancingReceivableMember" abstract="true" name="WorkoutFinancingReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfPropertiesAcquired" abstract="false" name="NumberOfPropertiesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_PaymentsToAcquireLoansReceivableAndOther" abstract="false" name="PaymentsToAcquireLoansReceivableAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" abstract="false" name="ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_SLCSHOPPortfolioMember" abstract="true" name="SLCSHOPPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CCRVJVInvestmentMember" abstract="true" name="CCRVJVInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentWeightedAverageMaturity" abstract="false" name="DebtInstrumentWeightedAverageMaturity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_GovernmentAssistanceAxis" abstract="true" name="GovernmentAssistanceAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" abstract="false" name="ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="peak_ContributionOfPropertyNumberOfProperties" abstract="false" name="ContributionOfPropertyNumberOfProperties" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_OtherNonReportingSegmentMember" abstract="true" name="OtherNonReportingSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_IntangibleLiabilitiesAcquired" abstract="false" name="IntangibleLiabilitiesAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CommercialPaperProgramMember" abstract="true" name="CommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_LifeScienceMember" abstract="true" name="LifeScienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfUnconsolidatedJointVenture" abstract="false" name="NumberOfUnconsolidatedJointVenture" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_OtherDispositionsMember" abstract="true" name="OtherDispositionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" abstract="false" name="CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DispositionOfPropertiesSoldNumber" abstract="false" name="DispositionOfPropertiesSoldNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_BrookdaleTripleNetPortfolioMember" abstract="true" name="BrookdaleTripleNetPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" abstract="false" name="FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_UnsecuredNote213PercentMember" abstract="true" name="UnsecuredNote213PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_AssetsHeldForSaleAndDiscontinuedOperationsNet" abstract="false" name="AssetsHeldForSaleAndDiscontinuedOperationsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_GovernmentAssistanceCARESActMember" abstract="true" name="GovernmentAssistanceCARESActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_WatchListFinancingReceivableMember" abstract="true" name="WatchListFinancingReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" abstract="false" name="TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_ExchangeAccommodationTitleholderRealEstateCarryingValue" abstract="false" name="ExchangeAccommodationTitleholderRealEstateCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_SecuredMortgageLoansMember" abstract="true" name="SecuredMortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_IntangiblesAbstract" abstract="true" name="IntangiblesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" abstract="false" name="NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_MedicalOfficeJVsMember" abstract="true" name="MedicalOfficeJVsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_AdjustmentsOfPermanentEquityToTemporaryEquity" abstract="false" name="AdjustmentsOfPermanentEquityToTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_OptionIndexedToIssuersEquityTerm" abstract="false" name="OptionIndexedToIssuersEquityTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="peak_DiscoverySHOPPortfolioMember" abstract="true" name="DiscoverySHOPPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_PropertiesWithDirectFinancingLeasesNumber" abstract="false" name="PropertiesWithDirectFinancingLeasesNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_MezzanineMember" abstract="true" name="MezzanineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_MorganStanleyRealEstateInvestmentJVMember" abstract="true" name="MorganStanleyRealEstateInvestmentJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DefinitiveAgreementsDomain" abstract="true" name="DefinitiveAgreementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberOfInterestRateDerivativesTerminated" abstract="false" name="NumberOfInterestRateDerivativesTerminated" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_LoansReceivableStatedInterestRate" abstract="false" name="LoansReceivableStatedInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" abstract="false" name="GainLossOnSaleOfRealEstateUnderDirectFinancingLease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" abstract="false" name="CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" abstract="false" name="RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_RestrictedStockVested" abstract="false" name="RestrictedStockVested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_BrookdaleMTCAMember" abstract="true" name="BrookdaleMTCAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" abstract="false" name="FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_GovernmentGrantIncomeFromCARESAct" abstract="false" name="GovernmentGrantIncomeFromCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" abstract="false" name="NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" abstract="false" name="AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_LineOfCreditAndTermLoanMember" abstract="true" name="LineOfCreditAndTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SuburbanPropertiesLLCMember" abstract="true" name="SuburbanPropertiesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_RefundableEntranceFeesCurrentAndNoncurrent" abstract="false" name="RefundableEntranceFeesCurrentAndNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" abstract="false" name="NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_FinancingReceivableNumberOfContractsSold" abstract="false" name="FinancingReceivableNumberOfContractsSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_GovernmentGrantIncome" abstract="false" name="GovernmentGrantIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" abstract="false" name="DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" abstract="false" name="LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_MezzanineAndOtherMember" abstract="true" name="MezzanineAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" abstract="true" name="PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SHOPJVMember" abstract="true" name="SHOPJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_DebtInstrumentNumberofExtensions" abstract="false" name="DebtInstrumentNumberofExtensions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember" abstract="true" name="DiscoveryNaplesJVAndDiscoverySarasotaJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" abstract="true" name="DebtInstrumentRedemptionRemainderOfFiscalYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" abstract="true" name="VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" abstract="false" name="IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" abstract="false" name="ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="peak_PropertiesHeldForSaleNumber" abstract="false" name="PropertiesHeldForSaleNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="peak_MezzanineAndOtherLoansReceivableSecuredMember" abstract="true" name="MezzanineAndOtherLoansReceivableSecuredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SeniorNotesDue2025Member" abstract="true" name="SeniorNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_SonataSHOPPortfolioMember" abstract="true" name="SonataSHOPPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" abstract="false" name="NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>peak-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18e02b9c-9339-4812-a396-3a502b171f3f,g:40f6f78a-d855-4bed-acda-5b3ebe369ddb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f72fd845-9b72-4149-b615-dbc779453337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2ee0d5c0-184e-41b2-acc5-1e605932e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f72fd845-9b72-4149-b615-dbc779453337" xlink:to="loc_us-gaap_CommonStockValue_2ee0d5c0-184e-41b2-acc5-1e605932e82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_463b9392-2b70-4ecf-9223-cbb239cef62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f72fd845-9b72-4149-b615-dbc779453337" xlink:to="loc_us-gaap_AdditionalPaidInCapital_463b9392-2b70-4ecf-9223-cbb239cef62d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_8c7c61e4-94a8-4cfc-9ddd-e917c07f04dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncome"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f72fd845-9b72-4149-b615-dbc779453337" xlink:to="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_8c7c61e4-94a8-4cfc-9ddd-e917c07f04dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c93378b9-a24d-4b3a-95a0-e8188ca48a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f72fd845-9b72-4149-b615-dbc779453337" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c93378b9-a24d-4b3a-95a0-e8188ca48a45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_22924220-b579-4bc1-850c-bddd9cb37379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_fe03a250-8466-4fdb-8262-49ff5900b349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_22924220-b579-4bc1-850c-bddd9cb37379" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_fe03a250-8466-4fdb-8262-49ff5900b349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_98c13d9a-472a-430b-9d31-f33aeb8ec795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopmentInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_22924220-b579-4bc1-850c-bddd9cb37379" xlink:to="loc_us-gaap_DevelopmentInProcess_98c13d9a-472a-430b-9d31-f33aeb8ec795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_84fbf1e3-9fc3-4641-83b4-8ca893d854dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_22924220-b579-4bc1-850c-bddd9cb37379" xlink:to="loc_us-gaap_Land_84fbf1e3-9fc3-4641-83b4-8ca893d854dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_426d31b2-d41e-445f-9f2d-437225ab0661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_22924220-b579-4bc1-850c-bddd9cb37379" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_426d31b2-d41e-445f-9f2d-437225ab0661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f121da30-3834-4bd9-932d-3ad2797f49d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInJointVentures_72d86293-1742-49fc-b97b-a98f3380b154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInJointVentures"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MinorityInterest_f121da30-3834-4bd9-932d-3ad2797f49d9" xlink:to="loc_us-gaap_MinorityInterestInJointVentures_72d86293-1742-49fc-b97b-a98f3380b154" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInPreferredUnitHolders_f193d4c5-4187-4e8c-98b6-a4e93c38f9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInPreferredUnitHolders"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MinorityInterest_f121da30-3834-4bd9-932d-3ad2797f49d9" xlink:to="loc_us-gaap_MinorityInterestInPreferredUnitHolders_f193d4c5-4187-4e8c-98b6-a4e93c38f9f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3868428a-ddbf-46da-82af-3b4c1e2d363f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f68b1464-357d-490a-aecd-1c99b0c8e11b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3868428a-ddbf-46da-82af-3b4c1e2d363f" xlink:to="loc_us-gaap_StockholdersEquity_f68b1464-357d-490a-aecd-1c99b0c8e11b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_346713c3-7220-419d-9765-02eb8620fc10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3868428a-ddbf-46da-82af-3b4c1e2d363f" xlink:to="loc_us-gaap_MinorityInterest_346713c3-7220-419d-9765-02eb8620fc10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8af3ccfa-1afd-4c18-ad34-13271e7db6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1c625e88-41ff-49cc-96b1-5018e3ac6a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8af3ccfa-1afd-4c18-ad34-13271e7db6e5" xlink:to="loc_us-gaap_Liabilities_1c625e88-41ff-49cc-96b1-5018e3ac6a0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eabcbaea-12e1-4aa8-a107-4e7b3a5fa1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8af3ccfa-1afd-4c18-ad34-13271e7db6e5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eabcbaea-12e1-4aa8-a107-4e7b3a5fa1c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_65b77ba2-2014-47d2-864b-bed598dd8618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8af3ccfa-1afd-4c18-ad34-13271e7db6e5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_65b77ba2-2014-47d2-864b-bed598dd8618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_18cea1d8-70d4-48e7-a7bd-26b4e281317d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8af3ccfa-1afd-4c18-ad34-13271e7db6e5" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_18cea1d8-70d4-48e7-a7bd-26b4e281317d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_887c9d4a-0daa-422d-9ddf-37a76b643387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:to="loc_us-gaap_LineOfCredit_887c9d4a-0daa-422d-9ddf-37a76b643387" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_4ee4d7aa-94c1-4223-a122-060238dcfb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:to="loc_us-gaap_UnsecuredDebt_4ee4d7aa-94c1-4223-a122-060238dcfb6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_87d302d3-d193-4158-b1d8-9a5086d600bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:to="loc_us-gaap_SecuredDebt_87d302d3-d193-4158-b1d8-9a5086d600bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable_65d5f49b-630a-4be4-88e7-5478a4db30ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:to="loc_us-gaap_OffMarketLeaseUnfavorable_65d5f49b-630a-4be4-88e7-5478a4db30ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1ab365e4-6ead-4fcb-a3ac-2b3683f84e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_1ab365e4-6ead-4fcb-a3ac-2b3683f84e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b512da22-18f0-4e33-93f3-5319e3be6bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:to="loc_us-gaap_OperatingLeaseLiability_b512da22-18f0-4e33-93f3-5319e3be6bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6b6eedb3-e12a-4a24-95ea-1aba7e6f67f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6b6eedb3-e12a-4a24-95ea-1aba7e6f67f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_755490a3-063b-4dac-98de-0eb7e80894ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_56750ab1-d1b6-45e3-8e17-4691d3a283f0" xlink:to="loc_us-gaap_ContractWithCustomerLiability_755490a3-063b-4dac-98de-0eb7e80894ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_4238fe4d-6c70-4f7b-a392-b1e72bf04438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_4238fe4d-6c70-4f7b-a392-b1e72bf04438" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount_55db3798-ec13-41ff-88fc-50a6d5c7c2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount_55db3798-ec13-41ff-88fc-50a6d5c7c2d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_496fb22d-5f6c-4ce1-bc5c-c5d0bc32b09e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_496fb22d-5f6c-4ce1-bc5c-c5d0bc32b09e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e9b5ea26-c108-417d-aa42-2031e59273a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e9b5ea26-c108-417d-aa42-2031e59273a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_e3a2904e-1aab-441a-8adc-53a0c02868e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_AccountsReceivableNet_e3a2904e-1aab-441a-8adc-53a0c02868e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bee78fff-e24d-4340-a549-bb533c98fdba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bee78fff-e24d-4340-a549-bb533c98fdba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_cf2f5dd7-4e1d-4684-bc1a-315520b87e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_cf2f5dd7-4e1d-4684-bc1a-315520b87e20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bf863ad4-df0e-4751-ab43-7663acd5762c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bf863ad4-df0e-4751-ab43-7663acd5762c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_20f7e568-a31b-428e-b864-af71ff1b757a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_20f7e568-a31b-428e-b864-af71ff1b757a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0e28d6a2-81bc-43da-b443-7895e7447c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0e28d6a2-81bc-43da-b443-7895e7447c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_40d65c61-20ea-48d6-a898-c9f08bb56815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f5d2290-7ae4-4819-be7c-ec4649af0434" xlink:to="loc_us-gaap_OtherAssets_40d65c61-20ea-48d6-a898-c9f08bb56815" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f10a342c-26a3-4261-945d-9062a3e1f291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d1d9d88-73db-454d-9f62-c976921b3fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f10a342c-26a3-4261-945d-9062a3e1f291" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d1d9d88-73db-454d-9f62-c976921b3fae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e958a40a-1f62-4969-9433-fb914ee6a250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f10a342c-26a3-4261-945d-9062a3e1f291" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e958a40a-1f62-4969-9433-fb914ee6a250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9684dbcb-6e70-4a19-b548-b6cf481dcbad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f10a342c-26a3-4261-945d-9062a3e1f291" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9684dbcb-6e70-4a19-b548-b6cf481dcbad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_248f22cf-617b-4daf-88f3-9640a6a91bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_54757e9f-8b29-4f21-8439-2cf767ab97c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_248f22cf-617b-4daf-88f3-9640a6a91bdd" xlink:to="loc_us-gaap_Revenues_54757e9f-8b29-4f21-8439-2cf767ab97c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f2c346ab-d0d7-4b56-93d3-80e47c5f15a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_248f22cf-617b-4daf-88f3-9640a6a91bdd" xlink:to="loc_us-gaap_CostsAndExpenses_f2c346ab-d0d7-4b56-93d3-80e47c5f15a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_aaa15760-d0f3-4b29-8465-d59a2387bbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_248f22cf-617b-4daf-88f3-9640a6a91bdd" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_aaa15760-d0f3-4b29-8465-d59a2387bbf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7b34fece-8821-4891-aaf2-971e62e789de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d6b6c50c-3955-4461-acf6-b982f1008c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7b34fece-8821-4891-aaf2-971e62e789de" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d6b6c50c-3955-4461-acf6-b982f1008c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c6f79323-c7a1-40f3-8918-a40de08eaff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7b34fece-8821-4891-aaf2-971e62e789de" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c6f79323-c7a1-40f3-8918-a40de08eaff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e352cf9b-b18f-47ad-bd45-0aa047d30adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_29a0bdd4-d448-4103-a222-cef199189501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e352cf9b-b18f-47ad-bd45-0aa047d30adf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_29a0bdd4-d448-4103-a222-cef199189501" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest_b5a29c50-b34c-42f7-acde-90e7d6306668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e352cf9b-b18f-47ad-bd45-0aa047d30adf" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest_b5a29c50-b34c-42f7-acde-90e7d6306668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_58d59fb8-0352-4d37-b12c-79c839c6f8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e352cf9b-b18f-47ad-bd45-0aa047d30adf" xlink:to="loc_us-gaap_ProfitLoss_58d59fb8-0352-4d37-b12c-79c839c6f8e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_afd81c7c-16c0-497a-a881-829862881919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ed87a1d2-c60d-455e-bdd7-53aa4e3ade2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_afd81c7c-16c0-497a-a881-829862881919" xlink:to="loc_us-gaap_NetIncomeLoss_ed87a1d2-c60d-455e-bdd7-53aa4e3ade2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_c5780ad9-16d9-4df5-9c18-d655630c7243" xlink:href="peak-20220331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_afd81c7c-16c0-497a-a881-829862881919" xlink:to="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_c5780ad9-16d9-4df5-9c18-d655630c7243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_62fcc7db-c836-4135-8c8f-f661236f72f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e302ff90-a6f8-4285-9484-509795353ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_62fcc7db-c836-4135-8c8f-f661236f72f0" xlink:to="loc_us-gaap_InterestExpense_e302ff90-a6f8-4285-9484-509795353ae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_3d47dafb-d2ca-4d34-b9a8-a6d6095fd34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_62fcc7db-c836-4135-8c8f-f661236f72f0" xlink:to="loc_us-gaap_DepreciationAndAmortization_3d47dafb-d2ca-4d34-b9a8-a6d6095fd34e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_bb56a040-29fc-4605-bf13-57210c2e04ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_62fcc7db-c836-4135-8c8f-f661236f72f0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_bb56a040-29fc-4605-bf13-57210c2e04ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_38f57fb1-3e75-4c43-9f43-13a92424acb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_62fcc7db-c836-4135-8c8f-f661236f72f0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_38f57fb1-3e75-4c43-9f43-13a92424acb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_a9d14519-a041-466a-8e46-f0f595105a3a" xlink:href="peak-20220331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_62fcc7db-c836-4135-8c8f-f661236f72f0" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_a9d14519-a041-466a-8e46-f0f595105a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4d97f2e2-2585-42bc-b23e-9f43d56fa9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_62fcc7db-c836-4135-8c8f-f661236f72f0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4d97f2e2-2585-42bc-b23e-9f43d56fa9c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_17cb947d-bb9e-4da9-bf20-74b025eaf59b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_90754ff8-a067-4f3f-af5c-3832d57b94b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_17cb947d-bb9e-4da9-bf20-74b025eaf59b" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_90754ff8-a067-4f3f-af5c-3832d57b94b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_91d2b7e9-b254-4e8c-ba3c-538429a104d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_17cb947d-bb9e-4da9-bf20-74b025eaf59b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_91d2b7e9-b254-4e8c-ba3c-538429a104d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4f78d543-862b-493e-b2e9-5304f3aecf40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_17cb947d-bb9e-4da9-bf20-74b025eaf59b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4f78d543-862b-493e-b2e9-5304f3aecf40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fd07db56-fac3-4950-8f3b-a253ae61cdac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_427dee99-811a-44f1-be69-2e7ea81454ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_fd07db56-fac3-4950-8f3b-a253ae61cdac" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_427dee99-811a-44f1-be69-2e7ea81454ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aebf6249-859f-4b5d-828f-533816f8a94c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_fd07db56-fac3-4950-8f3b-a253ae61cdac" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aebf6249-859f-4b5d-828f-533816f8a94c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseRevenue_8890d327-41d1-4af8-a609-938201d78b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_fd07db56-fac3-4950-8f3b-a253ae61cdac" xlink:to="loc_us-gaap_DirectFinancingLeaseRevenue_8890d327-41d1-4af8-a609-938201d78b31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_25a05ff9-dffc-43e8-b540-c1ae4e1d7a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_fd07db56-fac3-4950-8f3b-a253ae61cdac" xlink:to="loc_us-gaap_InterestIncomeOperating_25a05ff9-dffc-43e8-b540-c1ae4e1d7a70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3657d88d-fb82-4a8a-b179-dc4d19b5efc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_c2a5d9a7-db66-4abd-adc5-7e590f03a7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_3657d88d-fb82-4a8a-b179-dc4d19b5efc0" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_c2a5d9a7-db66-4abd-adc5-7e590f03a7cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_8d8bcd4d-4bf6-4fcb-b1fb-f881b6f91f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_3657d88d-fb82-4a8a-b179-dc4d19b5efc0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_8d8bcd4d-4bf6-4fcb-b1fb-f881b6f91f9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4f0258c7-829f-4981-999a-d8a17b5908e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_63e48e1c-ddee-4aec-9a2d-e1c289525490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_4f0258c7-829f-4981-999a-d8a17b5908e8" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_63e48e1c-ddee-4aec-9a2d-e1c289525490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e1673c8d-8684-4edf-9980-4f5d06d5081f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_4f0258c7-829f-4981-999a-d8a17b5908e8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e1673c8d-8684-4edf-9980-4f5d06d5081f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_da39600b-1729-4c1c-9784-0733534d983b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8be4cb11-06fd-41d3-a943-4d03f2feb3da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_da39600b-1729-4c1c-9784-0733534d983b" xlink:to="loc_us-gaap_ProfitLoss_8be4cb11-06fd-41d3-a943-4d03f2feb3da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d1f1ed4-683b-4110-a9d7-8220714ddf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_da39600b-1729-4c1c-9784-0733534d983b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d1f1ed4-683b-4110-a9d7-8220714ddf71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_20887ebd-8d03-43cb-a869-ea08e96aecd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9d033229-65ae-4b13-8716-5e8b337b6e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_20887ebd-8d03-43cb-a869-ea08e96aecd0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9d033229-65ae-4b13-8716-5e8b337b6e7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2515c490-3a66-4e46-a38a-1b944c0ad3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_20887ebd-8d03-43cb-a869-ea08e96aecd0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2515c490-3a66-4e46-a38a-1b944c0ad3b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fa2d9888-c898-494f-ad9a-1416d3437200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_0d11a1cd-a9f1-44e1-ba4a-c599165d3b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fa2d9888-c898-494f-ad9a-1416d3437200" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_0d11a1cd-a9f1-44e1-ba4a-c599165d3b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b1267a34-71e9-472f-bebc-eeaea7a5ddad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fa2d9888-c898-494f-ad9a-1416d3437200" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b1267a34-71e9-472f-bebc-eeaea7a5ddad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_980983d4-576a-45ca-9518-b471a04e71a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fa2d9888-c898-494f-ad9a-1416d3437200" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_980983d4-576a-45ca-9518-b471a04e71a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_d4ae0b8d-7792-4347-8ee0-6b6a514413dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_d4ae0b8d-7792-4347-8ee0-6b6a514413dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_dd437cc5-2579-4957-a208-dc3701069e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_dd437cc5-2579-4957-a208-dc3701069e53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfBankDebt_58288011-b9d5-4984-8fe4-d48f43881732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_RepaymentsOfBankDebt_58288011-b9d5-4984-8fe4-d48f43881732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_104a00c6-6100-42e4-b78a-9ddb296c27cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_104a00c6-6100-42e4-b78a-9ddb296c27cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_38b091c9-03da-453e-b077-28e48feaa2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_38b091c9-03da-453e-b077-28e48feaa2b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ef301cc7-fe19-40f8-9c71-356e9575484e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ef301cc7-fe19-40f8-9c71-356e9575484e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_9e9b25fe-e27c-409e-9a8b-fe058a067150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_PaymentsOfDividends_9e9b25fe-e27c-409e-9a8b-fe058a067150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_8525e461-e197-4f1f-be0f-fcb0156d71af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_8525e461-e197-4f1f-be0f-fcb0156d71af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_1cdd7a07-335d-4e46-ac44-a504f4b9b210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8af6cb0-e42b-4aa7-ad83-49765e1785eb" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_1cdd7a07-335d-4e46-ac44-a504f4b9b210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_090ef48d-f1a8-4b25-aad6-2d38b97a22dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_090ef48d-f1a8-4b25-aad6-2d38b97a22dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherRealEstate_a6d8bf5b-9817-4216-8fab-f8f19b3bd53e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherRealEstate"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:to="loc_us-gaap_PaymentsToAcquireOtherRealEstate_a6d8bf5b-9817-4216-8fab-f8f19b3bd53e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables_36170fdf-56b4-48b0-9c95-836c775a984b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables_36170fdf-56b4-48b0-9c95-836c775a984b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_0b4e2b5b-3760-4ad7-8c99-e905ed73691b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_0b4e2b5b-3760-4ad7-8c99-e905ed73691b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_e0fc6565-3473-4d4c-9c9d-4a303a3f7e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_e0fc6565-3473-4d4c-9c9d-4a303a3f7e5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PaymentsToAcquireLoansReceivableAndOther_bf3c4b5e-0f4f-402b-aad3-e59b9292edff" xlink:href="peak-20220331.xsd#peak_PaymentsToAcquireLoansReceivableAndOther"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:to="loc_peak_PaymentsToAcquireLoansReceivableAndOther_bf3c4b5e-0f4f-402b-aad3-e59b9292edff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_1730ada8-8e6f-445d-9021-cc83d30766c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:to="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_1730ada8-8e6f-445d-9021-cc83d30766c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_a957e5da-9743-48f3-b2a8-7f2cdaaf4858" xlink:href="peak-20220331.xsd#peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a1b896c-1caf-4a6d-a6af-7f6ec1427573" xlink:to="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_a957e5da-9743-48f3-b2a8-7f2cdaaf4858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bcc3c847-880a-48dc-ae5d-df3f37dc1202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_ProfitLoss_bcc3c847-880a-48dc-ae5d-df3f37dc1202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_f692a6f9-ddd6-46b4-88ea-f82253463fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_f692a6f9-ddd6-46b4-88ea-f82253463fc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7690e6e4-5900-413f-b63c-4b20efe4a6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_ShareBasedCompensation_7690e6e4-5900-413f-b63c-4b20efe4a6d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_5d12a35b-134c-4e33-827b-5b19cbe041ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_5d12a35b-134c-4e33-827b-5b19cbe041ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StraightLineRent_c126fb08-e541-41b8-a978-96de8d701152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StraightLineRent"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_StraightLineRent_c126fb08-e541-41b8-a978-96de8d701152" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_c2c117a0-5605-4b60-baba-c655febb9d08" xlink:href="peak-20220331.xsd#peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_c2c117a0-5605-4b60-baba-c655febb9d08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_3c95a3f1-5634-49bb-9a33-605c0c655e49" xlink:href="peak-20220331.xsd#peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_3c95a3f1-5634-49bb-9a33-605c0c655e49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_39189825-8069-4881-9b7c-7432353875e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_39189825-8069-4881-9b7c-7432353875e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_d26db5d5-7d97-48b3-a688-7272c50b5fda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_d26db5d5-7d97-48b3-a688-7272c50b5fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_75d6a5f1-bd7f-4353-9aa6-502a91e04960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_AssetImpairmentCharges_75d6a5f1-bd7f-4353-9aa6-502a91e04960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_416f8e56-30cf-4e09-bc22-6549703697a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_416f8e56-30cf-4e09-bc22-6549703697a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_cb58446d-c2d6-4929-b2ed-db5d22b97119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_cb58446d-c2d6-4929-b2ed-db5d22b97119" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossFromChangeOfControl_b69b9023-02d1-465f-ab7c-ee593c6e7da3" xlink:href="peak-20220331.xsd#peak_GainLossFromChangeOfControl"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_peak_GainLossFromChangeOfControl_b69b9023-02d1-465f-ab7c-ee593c6e7da3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuredEventGainLoss_0e93355c-9d29-4415-9d6d-33fd0f7947a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuredEventGainLoss"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_InsuredEventGainLoss_0e93355c-9d29-4415-9d6d-33fd0f7947a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1182ffc5-2e33-4bce-961e-7ffdeb3e3a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1182ffc5-2e33-4bce-961e-7ffdeb3e3a41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_4a76d317-12b8-4426-969e-ac8af70c3c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_4a76d317-12b8-4426-969e-ac8af70c3c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0073200b-d4b3-4bd4-af5e-1e28226ff796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0073200b-d4b3-4bd4-af5e-1e28226ff796" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_3514b377-a132-4514-ae36-d80b37128792" xlink:href="peak-20220331.xsd#peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2275e3a-1d31-40ae-ac2a-475307ff9be7" xlink:to="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_3514b377-a132-4514-ae36-d80b37128792" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b2dbf7b-2052-484f-b039-bada1917ceaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_250af2e3-47bb-4176-849d-4f2ec2b993f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b2dbf7b-2052-484f-b039-bada1917ceaf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_250af2e3-47bb-4176-849d-4f2ec2b993f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11dd942a-5721-461a-8fd8-8de9f27a0bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b2dbf7b-2052-484f-b039-bada1917ceaf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11dd942a-5721-461a-8fd8-8de9f27a0bee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae33fbd-b4a6-4b87-b62a-e227bc05d111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b2dbf7b-2052-484f-b039-bada1917ceaf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae33fbd-b4a6-4b87-b62a-e227bc05d111" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_19fb4bd7-a8c0-411c-8522-f8e5c8d05989" xlink:href="peak-20220331.xsd#peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa633a13-744d-488e-b0cd-bf5c57f994ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_19fb4bd7-a8c0-411c-8522-f8e5c8d05989" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa633a13-744d-488e-b0cd-bf5c57f994ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_fc9057ce-fbde-4e14-8ee5-9dc67b67c185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_19fb4bd7-a8c0-411c-8522-f8e5c8d05989" xlink:to="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_fc9057ce-fbde-4e14-8ee5-9dc67b67c185" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_b04cb3c5-b4a2-45ad-ad3b-413dc2b487cb" xlink:href="peak-20220331.xsd#peak_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_2a1cfd56-3791-471c-b67b-97aab6feb10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_b04cb3c5-b4a2-45ad-ad3b-413dc2b487cb" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_2a1cfd56-3791-471c-b67b-97aab6feb10d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_705d92eb-b9d5-4afb-87f4-cf09e0c2ccd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_b04cb3c5-b4a2-45ad-ad3b-413dc2b487cb" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_705d92eb-b9d5-4afb-87f4-cf09e0c2ccd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_0493ca8d-4905-4f00-9a8b-3dd96bbc0a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_6134b1d4-b2e0-4d20-afed-8e804705a4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_0493ca8d-4905-4f00-9a8b-3dd96bbc0a00" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_6134b1d4-b2e0-4d20-afed-8e804705a4f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_6003b477-b253-4d1c-9113-0a90ec7b8fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_0493ca8d-4905-4f00-9a8b-3dd96bbc0a00" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_6003b477-b253-4d1c-9113-0a90ec7b8fea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_bf58a584-fda4-40b2-90d4-364dc07492cd" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_0493ca8d-4905-4f00-9a8b-3dd96bbc0a00" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_bf58a584-fda4-40b2-90d4-364dc07492cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_84062f9a-a69d-48e0-9eb6-d32b2cc02cd3" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_0493ca8d-4905-4f00-9a8b-3dd96bbc0a00" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_84062f9a-a69d-48e0-9eb6-d32b2cc02cd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a0ade539-de0f-4d25-a60c-84c592ecc118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_a6385825-3ef9-4df8-80c4-c135fe49eb22" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a0ade539-de0f-4d25-a60c-84c592ecc118" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_a6385825-3ef9-4df8-80c4-c135fe49eb22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_e7aa661c-16a9-40cf-8a2f-871ec2534f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a0ade539-de0f-4d25-a60c-84c592ecc118" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_e7aa661c-16a9-40cf-8a2f-871ec2534f12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_ed50bdd8-f2f5-4d1b-b711-56ab6a02a4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a0ade539-de0f-4d25-a60c-84c592ecc118" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_ed50bdd8-f2f5-4d1b-b711-56ab6a02a4e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_5ab99272-2690-4a3d-a4a9-0f264efb4359" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_69591773-9128-465a-a81a-0bd0301818c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_5ab99272-2690-4a3d-a4a9-0f264efb4359" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_69591773-9128-465a-a81a-0bd0301818c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_a937e9be-de14-49f8-8308-feb59a8035e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_5ab99272-2690-4a3d-a4a9-0f264efb4359" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_a937e9be-de14-49f8-8308-feb59a8035e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_c358f135-bccd-40ce-b1eb-3de1e5be3ab7" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_5ab99272-2690-4a3d-a4a9-0f264efb4359" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_c358f135-bccd-40ce-b1eb-3de1e5be3ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_de44dd09-20c6-446d-b9be-5390f0a61fe2" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_d8b6da61-bfc0-4b5e-b666-4ea456d62ea7" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_de44dd09-20c6-446d-b9be-5390f0a61fe2" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_d8b6da61-bfc0-4b5e-b666-4ea456d62ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_467c8de8-e7e2-493e-b94e-848f164e7adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_de44dd09-20c6-446d-b9be-5390f0a61fe2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_467c8de8-e7e2-493e-b94e-848f164e7adf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_307be3e7-48bf-45f2-a28c-93f2a943e894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome_ee1ef7b0-7b41-4266-901f-ae0f5ab9eec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_307be3e7-48bf-45f2-a28c-93f2a943e894" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome_ee1ef7b0-7b41-4266-901f-ae0f5ab9eec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_ff557510-01d5-4b6d-82d7-51da47d6cda8" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_307be3e7-48bf-45f2-a28c-93f2a943e894" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_ff557510-01d5-4b6d-82d7-51da47d6cda8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_5b25deb0-1ae7-4404-8a90-a6a06c43752e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_b2facb66-0ea4-48d1-b369-51e997b377f1" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_5b25deb0-1ae7-4404-8a90-a6a06c43752e" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_b2facb66-0ea4-48d1-b369-51e997b377f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_a5f3d725-d266-460f-bd17-c89a89c5be12" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_5b25deb0-1ae7-4404-8a90-a6a06c43752e" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_a5f3d725-d266-460f-bd17-c89a89c5be12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_88318d3d-0880-49a3-b3e5-98886c68c534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_5b25deb0-1ae7-4404-8a90-a6a06c43752e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_88318d3d-0880-49a3-b3e5-98886c68c534" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_e893d6f8-1c03-43f5-9e05-8a76135c11c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_995c2019-38ab-4678-8845-076528338ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_e893d6f8-1c03-43f5-9e05-8a76135c11c0" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_995c2019-38ab-4678-8845-076528338ebe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_1ad48a52-2bfa-47ea-8fb5-eae7330ce1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_e893d6f8-1c03-43f5-9e05-8a76135c11c0" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_1ad48a52-2bfa-47ea-8fb5-eae7330ce1ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c92a7ebb-d74b-4175-824e-51e57438e636" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_e893d6f8-1c03-43f5-9e05-8a76135c11c0" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c92a7ebb-d74b-4175-824e-51e57438e636" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LeasesDirectFinancingLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseNetInvestmentInLease_5a2a872b-fd30-4117-b0b9-bbb1459e39cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseNetInvestmentInLease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseDeferredSellingProfit_dc38fde3-e3e1-4de0-886d-7fc7c45e6f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseDeferredSellingProfit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DirectFinancingLeaseNetInvestmentInLease_5a2a872b-fd30-4117-b0b9-bbb1459e39cf" xlink:to="loc_us-gaap_DirectFinancingLeaseDeferredSellingProfit_dc38fde3-e3e1-4de0-886d-7fc7c45e6f25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseLeaseReceivable_57df0127-a9d9-4461-8d86-cc5f7c88dc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseLeaseReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DirectFinancingLeaseNetInvestmentInLease_5a2a872b-fd30-4117-b0b9-bbb1459e39cf" xlink:to="loc_us-gaap_DirectFinancingLeaseLeaseReceivable_57df0127-a9d9-4461-8d86-cc5f7c88dc7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset_a57a3521-94de-4564-86a0-b377b39538ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DirectFinancingLeaseNetInvestmentInLease_5a2a872b-fd30-4117-b0b9-bbb1459e39cf" xlink:to="loc_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset_a57a3521-94de-4564-86a0-b377b39538ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableScheduleofLoansReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_9f6e9993-eaa1-47c2-b483-4b9d0c52b0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_66fbe208-1129-4c2b-bc16-0b33b4816662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_9f6e9993-eaa1-47c2-b483-4b9d0c52b0cc" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_66fbe208-1129-4c2b-bc16-0b33b4816662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_dc91bd05-d13d-405f-a517-578c667f3a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_9f6e9993-eaa1-47c2-b483-4b9d0c52b0cc" xlink:to="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_dc91bd05-d13d-405f-a517-578c667f3a4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_227e1655-009c-4e86-a0f6-be10dbc0b6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_9f6e9993-eaa1-47c2-b483-4b9d0c52b0cc" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_227e1655-009c-4e86-a0f6-be10dbc0b6e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_21fb873f-e90a-40b0-8714-c43875430a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_cf201578-2014-44f8-9e9c-fbf80795fd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_21fb873f-e90a-40b0-8714-c43875430a15" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_cf201578-2014-44f8-9e9c-fbf80795fd7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_b57383e7-6d80-445e-b0f2-9eecf13610d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_21fb873f-e90a-40b0-8714-c43875430a15" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_b57383e7-6d80-445e-b0f2-9eecf13610d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_4cdde508-291b-416d-858c-0f1f43579534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_21fb873f-e90a-40b0-8714-c43875430a15" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_4cdde508-291b-416d-858c-0f1f43579534" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_1dc1ae31-9bb0-4f35-b470-2707a19c9e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_21fb873f-e90a-40b0-8714-c43875430a15" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_1dc1ae31-9bb0-4f35-b470-2707a19c9e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_da813e2e-be89-495c-a425-c6107e958d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_21fb873f-e90a-40b0-8714-c43875430a15" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_da813e2e-be89-495c-a425-c6107e958d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_d287336b-5175-480b-a9f4-1e0ff8e6b4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_21fb873f-e90a-40b0-8714-c43875430a15" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_d287336b-5175-480b-a9f4-1e0ff8e6b4c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_af393a04-3c33-4a50-9cc3-e0dbbae27393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ab47ea86-b612-4171-a60f-0891ae8a2693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_af393a04-3c33-4a50-9cc3-e0dbbae27393" xlink:to="loc_us-gaap_EquityMethodInvestments_ab47ea86-b612-4171-a60f-0891ae8a2693" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#IntangiblesIntangiblesLeaseAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_befbe9c6-977c-4d23-82bb-977d2d9b247b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b729f55f-9631-4365-b46e-8d65062dbc86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_befbe9c6-977c-4d23-82bb-977d2d9b247b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b729f55f-9631-4365-b46e-8d65062dbc86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d06aa12f-b547-4e76-80b1-600b5992ef3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_befbe9c6-977c-4d23-82bb-977d2d9b247b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d06aa12f-b547-4e76-80b1-600b5992ef3a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#IntangiblesIntangiblesLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesNet_0107a09e-d645-4c79-8e35-bdb5d6453b67" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_2015bd2d-26a3-4d06-9df0-94c77498f51e" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesNet_0107a09e-d645-4c79-8e35-bdb5d6453b67" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_2015bd2d-26a3-4d06-9df0-94c77498f51e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesGross_ae60b575-e2de-4690-ab90-973b18bba443" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesNet_0107a09e-d645-4c79-8e35-bdb5d6453b67" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesGross_ae60b575-e2de-4690-ab90-973b18bba443" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ab1ad5e4-1dd5-43a4-90ad-942431674e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b366af2f-b9b2-45aa-ab30-9311bdac7c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ab1ad5e4-1dd5-43a4-90ad-942431674e56" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b366af2f-b9b2-45aa-ab30-9311bdac7c80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7b7b77e4-3207-4ae1-b8ba-cd4f08dd0e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ab1ad5e4-1dd5-43a4-90ad-942431674e56" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7b7b77e4-3207-4ae1-b8ba-cd4f08dd0e1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f134a186-ec93-4962-8391-6df83b6ac954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_79a522e3-fa05-4aff-9ac9-cc0d07ad5d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f134a186-ec93-4962-8391-6df83b6ac954" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_79a522e3-fa05-4aff-9ac9-cc0d07ad5d9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_37372808-61f9-4923-af1e-94c03aa815ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f134a186-ec93-4962-8391-6df83b6ac954" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_37372808-61f9-4923-af1e-94c03aa815ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_896e858d-13f4-426b-b320-2ff97350316c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f134a186-ec93-4962-8391-6df83b6ac954" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_896e858d-13f4-426b-b320-2ff97350316c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_47146114-c4da-476d-8313-e7584c0b15d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f134a186-ec93-4962-8391-6df83b6ac954" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_47146114-c4da-476d-8313-e7584c0b15d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ac98f165-5ffa-4b91-b2bf-7369119ef300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f134a186-ec93-4962-8391-6df83b6ac954" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ac98f165-5ffa-4b91-b2bf-7369119ef300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LongTermDebtMaturityAfterYearFour_ec91d01d-10d2-4c47-a6be-ce56ccc28c30" xlink:href="peak-20220331.xsd#peak_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f134a186-ec93-4962-8391-6df83b6ac954" xlink:to="loc_peak_LongTermDebtMaturityAfterYearFour_ec91d01d-10d2-4c47-a6be-ce56ccc28c30" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#EquityandRedeemableNoncontrollingInterestsAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba81ec3a-b665-4838-8d55-1b5ce8fa2f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_00aed8de-80e5-453b-a4ae-7e14a448c893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba81ec3a-b665-4838-8d55-1b5ce8fa2f34" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_00aed8de-80e5-453b-a4ae-7e14a448c893" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#EarningsPerCommonShareComputationofEPSDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_456a534b-0325-4ddb-bad7-7129d37c7d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_776f7913-7734-40c8-94bd-63c77c1c3f8b" xlink:href="peak-20220331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_456a534b-0325-4ddb-bad7-7129d37c7d52" xlink:to="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_776f7913-7734-40c8-94bd-63c77c1c3f8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncontrollingInterestsShareInDiscontinuedOperations_79cdee17-33d4-49c6-85aa-009a6436aeed" xlink:href="peak-20220331.xsd#peak_NoncontrollingInterestsShareInDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_456a534b-0325-4ddb-bad7-7129d37c7d52" xlink:to="loc_peak_NoncontrollingInterestsShareInDiscontinuedOperations_79cdee17-33d4-49c6-85aa-009a6436aeed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_04aad046-6949-4fe3-9135-bd9875aa485c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_456a534b-0325-4ddb-bad7-7129d37c7d52" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_04aad046-6949-4fe3-9135-bd9875aa485c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_abcc8ec8-f481-4b17-9b07-6deee2f7d7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d1de8944-df4b-401b-8b28-bedec65c89a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_abcc8ec8-f481-4b17-9b07-6deee2f7d7e6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d1de8944-df4b-401b-8b28-bedec65c89a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_75d071a3-d478-44ec-86c2-5dd23069f6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_abcc8ec8-f481-4b17-9b07-6deee2f7d7e6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_75d071a3-d478-44ec-86c2-5dd23069f6b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_73aaa1a0-98cd-4cc4-bc77-f93c36c8567d" xlink:href="peak-20220331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_3a825b6c-5692-40a0-a7b5-de4308b07a39" xlink:href="peak-20220331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_73aaa1a0-98cd-4cc4-bc77-f93c36c8567d" xlink:to="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_3a825b6c-5692-40a0-a7b5-de4308b07a39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_4044f8e4-0013-4ea7-bad8-edef3a3b73ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_73aaa1a0-98cd-4cc4-bc77-f93c36c8567d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_4044f8e4-0013-4ea7-bad8-edef3a3b73ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_504e3ade-40ff-49f9-955a-583c44014167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_855f17e0-e13b-4e22-8477-b36ede0fb546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_504e3ade-40ff-49f9-955a-583c44014167" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_855f17e0-e13b-4e22-8477-b36ede0fb546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_ad4b4849-4f10-45bf-9454-9e8024f1e71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_504e3ade-40ff-49f9-955a-583c44014167" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_ad4b4849-4f10-45bf-9454-9e8024f1e71b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:href="peak-20220331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_eaa830c1-73e1-4a46-867f-45b9effd5f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_us-gaap_Revenues_eaa830c1-73e1-4a46-867f-45b9effd5f2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_1f258334-2ea2-4e78-9f40-2a088cf50221" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_1f258334-2ea2-4e78-9f40-2a088cf50221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_19788b97-0027-4e31-9e37-58cda8b4900f" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_19788b97-0027-4e31-9e37-58cda8b4900f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_406e678a-5d48-401e-9e15-5bbde39f0af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_us-gaap_OperatingExpenses_406e678a-5d48-401e-9e15-5bbde39f0af7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_19eb0f70-928d-439f-99b5-1b3568da65be" xlink:href="peak-20220331.xsd#peak_OperatingExpensesFromJointVentureAttributableToParentNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_19eb0f70-928d-439f-99b5-1b3568da65be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_94d0bd10-e179-47e9-9103-d3d7a5018a11" xlink:href="peak-20220331.xsd#peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_94d0bd10-e179-47e9-9103-d3d7a5018a11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_8087bd92-0792-471e-8389-d54ecbbe97e3" xlink:href="peak-20220331.xsd#peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_8087bd92-0792-471e-8389-d54ecbbe97e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_e06fbb53-b96b-43df-9035-ebcfb8573809" xlink:href="peak-20220331.xsd#peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_e06fbb53-b96b-43df-9035-ebcfb8573809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomeFromCARESAct_1ae4ca63-2576-41e2-ba72-3ea2dbed813e" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncomeFromCARESAct"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_peak_GovernmentGrantIncomeFromCARESAct_1ae4ca63-2576-41e2-ba72-3ea2dbed813e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_84cbc987-87a1-45ec-8712-034e7e7edc31" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_573c2075-aac6-4507-a9dd-90dd83a78263" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_84cbc987-87a1-45ec-8712-034e7e7edc31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_46f36c75-7bdf-4eba-b63e-abacc18d54e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_DepreciationAndAmortization_46f36c75-7bdf-4eba-b63e-abacc18d54e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_df995b9c-4aed-4e85-884c-8d5eace9c564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_df995b9c-4aed-4e85-884c-8d5eace9c564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_73afa937-3228-4541-9a31-aaedb16948cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_73afa937-3228-4541-9a31-aaedb16948cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_7b507573-d549-479b-9a39-5305e70f557c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_InterestIncomeOperating_7b507573-d549-479b-9a39-5305e70f557c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_f14fe20e-28db-4d64-bdeb-a13016e43e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_f14fe20e-28db-4d64-bdeb-a13016e43e88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6f64f540-76df-4cdd-82ba-cf822cc918c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_InterestExpense_6f64f540-76df-4cdd-82ba-cf822cc918c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_e9eadeeb-f21f-4f39-8e78-7f5c6d6f51aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_e9eadeeb-f21f-4f39-8e78-7f5c6d6f51aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_34946db4-570d-4697-9dc3-4b488dccd121" xlink:href="peak-20220331.xsd#peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_34946db4-570d-4697-9dc3-4b488dccd121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_446b3e08-c205-47c7-8741-0772b5043711" xlink:href="peak-20220331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_446b3e08-c205-47c7-8741-0772b5043711" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_745f5ae1-6eba-41ef-9b8a-5d4d22d57f1a" xlink:href="peak-20220331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReserves"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_745f5ae1-6eba-41ef-9b8a-5d4d22d57f1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b40e341c-ac48-48c1-b696-1c15304b5acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b40e341c-ac48-48c1-b696-1c15304b5acc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_4bd0db1b-2973-424d-ad2f-324ef4724229" xlink:href="peak-20220331.xsd#peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_4bd0db1b-2973-424d-ad2f-324ef4724229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_82defea3-fd93-4aa0-8e9f-6577ebca6081" xlink:href="peak-20220331.xsd#peak_NetIncomeLossJointVenturePartnersAttributableToParent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_82defea3-fd93-4aa0-8e9f-6577ebca6081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5484d8e1-0510-43cb-ae19-421ca2e77adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3857f7ae-bc22-481c-a3d8-fd2adca3ec7a" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5484d8e1-0510-43cb-ae19-421ca2e77adc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23dff519-4dcf-4d69-8024-8251d6ff2c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_222c112a-2745-4159-a751-c6022520c976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23dff519-4dcf-4d69-8024-8251d6ff2c98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_222c112a-2745-4159-a751-c6022520c976" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_922f678e-92ca-4a06-be81-994d14ac91da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23dff519-4dcf-4d69-8024-8251d6ff2c98" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_922f678e-92ca-4a06-be81-994d14ac91da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_5c70fd51-594a-42f0-94f1-bfe4777647f9" xlink:href="peak-20220331.xsd#peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_94f88246-c020-4295-8603-4dd1a86cdb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_5c70fd51-594a-42f0-94f1-bfe4777647f9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_94f88246-c020-4295-8603-4dd1a86cdb48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64d6c992-b748-49fc-8526-1d46659ca63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_5c70fd51-594a-42f0-94f1-bfe4777647f9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64d6c992-b748-49fc-8526-1d46659ca63b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_275446ab-c25a-44db-a5ba-6a5753710885" xlink:href="peak-20220331.xsd#peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_16aeaa06-efed-4706-acbe-a85c2ea1f92d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_275446ab-c25a-44db-a5ba-6a5753710885" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_16aeaa06-efed-4706-acbe-a85c2ea1f92d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_0f54b841-832d-4b77-81af-0df9fd6be89e" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_275446ab-c25a-44db-a5ba-6a5753710885" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_0f54b841-832d-4b77-81af-0df9fd6be89e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_47d5a172-d542-4b34-8613-0c5a248efb05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4877d117-f722-4a7e-9eb9-1933759addff" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_47d5a172-d542-4b34-8613-0c5a248efb05" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4877d117-f722-4a7e-9eb9-1933759addff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e23dd91c-9eca-4888-9ca4-9b8a79b95fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_47d5a172-d542-4b34-8613-0c5a248efb05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e23dd91c-9eca-4888-9ca4-9b8a79b95fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c93aef93-691e-4bec-9f86-c6740555d526" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_392f95e3-5521-452e-a102-91b79b690d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c93aef93-691e-4bec-9f86-c6740555d526" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_392f95e3-5521-452e-a102-91b79b690d44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_f64653b1-1d30-4f13-9c55-02515a34c643" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c93aef93-691e-4bec-9f86-c6740555d526" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_f64653b1-1d30-4f13-9c55-02515a34c643" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_c9f0d2b2-4898-4daa-9b25-14fc1d4a7f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_95a4e6a9-6a3d-4b99-8d92-709002d0d517" xlink:href="peak-20220331.xsd#peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_c9f0d2b2-4898-4daa-9b25-14fc1d4a7f94" xlink:to="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_95a4e6a9-6a3d-4b99-8d92-709002d0d517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_467e7295-0c4b-48de-a4f8-36ffd969c7e1" xlink:href="peak-20220331.xsd#peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_c9f0d2b2-4898-4daa-9b25-14fc1d4a7f94" xlink:to="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_467e7295-0c4b-48de-a4f8-36ffd969c7e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6225ff62-f7a6-4bd1-b71b-945bb0d26bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent_93f44b41-1368-4386-98b3-b8fa19d862a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6225ff62-f7a6-4bd1-b71b-945bb0d26bf9" xlink:to="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent_93f44b41-1368-4386-98b3-b8fa19d862a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent_d68e3277-92fd-4b3f-85ca-4775f60f031a" xlink:href="peak-20220331.xsd#peak_RefundableEntranceFeesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6225ff62-f7a6-4bd1-b71b-945bb0d26bf9" xlink:to="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent_d68e3277-92fd-4b3f-85ca-4775f60f031a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_bcf1427f-e37a-40bf-bff3-08979a3782cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6225ff62-f7a6-4bd1-b71b-945bb0d26bf9" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_bcf1427f-e37a-40bf-bff3-08979a3782cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_89a44473-0341-4ccc-bb82-2094976d968d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6225ff62-f7a6-4bd1-b71b-945bb0d26bf9" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_89a44473-0341-4ccc-bb82-2094976d968d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>peak-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18e02b9c-9339-4812-a396-3a502b171f3f,g:40f6f78a-d855-4bed-acda-5b3ebe369ddb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended" id="i4411ca60018b45e8986c3d7158234d45_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4261447b-65aa-419d-aff6-f3c22a6b8a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d0d0c4a2-e468-499c-9a4c-16100f2a1e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4261447b-65aa-419d-aff6-f3c22a6b8a33" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d0d0c4a2-e468-499c-9a4c-16100f2a1e19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_400bd991-5faa-4f27-8380-d6371908a693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4261447b-65aa-419d-aff6-f3c22a6b8a33" xlink:to="loc_us-gaap_StatementTable_400bd991-5faa-4f27-8380-d6371908a693" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_97e59578-9435-408d-8b89-948c93a7d08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_400bd991-5faa-4f27-8380-d6371908a693" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_97e59578-9435-408d-8b89-948c93a7d08e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_97e59578-9435-408d-8b89-948c93a7d08e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_97e59578-9435-408d-8b89-948c93a7d08e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_97e59578-9435-408d-8b89-948c93a7d08e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_4bf4dafb-b401-47ed-8063-9f88d623088c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_97e59578-9435-408d-8b89-948c93a7d08e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_4bf4dafb-b401-47ed-8063-9f88d623088c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_1304d057-a5a9-4db3-b63e-e438469211ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4bf4dafb-b401-47ed-8063-9f88d623088c" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_1304d057-a5a9-4db3-b63e-e438469211ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_01673e3a-4d71-47cb-a912-222e33b4baf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4bf4dafb-b401-47ed-8063-9f88d623088c" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_01673e3a-4d71-47cb-a912-222e33b4baf2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" xlink:type="extended" id="i39c07d6b0d394b099aa8a82d8702008f_CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ed7d9771-80d0-4a18-bf1e-3765417b2aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed7d9771-80d0-4a18-bf1e-3765417b2aed" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_985e6159-b0bf-4ec4-be18-55f8ff822e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_SharesIssued_985e6159-b0bf-4ec4-be18-55f8ff822e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f3f385d5-126a-475b-8dae-f32881154979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f3f385d5-126a-475b-8dae-f32881154979" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_f79fa908-9d80-4f9d-8300-454be84f2717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_f79fa908-9d80-4f9d-8300-454be84f2717" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_076dd364-7c98-4645-b03a-2861f47abe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_076dd364-7c98-4645-b03a-2861f47abe6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a3b7bbd0-1cb0-4373-bc9d-0d63e6fd9045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a3b7bbd0-1cb0-4373-bc9d-0d63e6fd9045" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6373988c-33ae-496c-b87a-effad9046342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6373988c-33ae-496c-b87a-effad9046342" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_b0f5b606-c1e8-4f35-90fb-5c8f38f3883b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_b0f5b606-c1e8-4f35-90fb-5c8f38f3883b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_3170801c-81cf-4649-8cee-5d873212b082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_3170801c-81cf-4649-8cee-5d873212b082" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1412925d-9594-437a-bd62-554d50f221cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1412925d-9594-437a-bd62-554d50f221cc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_bd5ff38b-3ec9-4762-b36b-0bc7e9b2acc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_DividendsCommonStock_bd5ff38b-3ec9-4762-b36b-0bc7e9b2acc6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4e7b41c1-0d0c-47a0-b8ec-5dc0f9064e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4e7b41c1-0d0c-47a0-b8ec-5dc0f9064e40" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_196a7433-14f4-4b71-99ed-6fba0716412d" xlink:href="peak-20220331.xsd#peak_AdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_196a7433-14f4-4b71-99ed-6fba0716412d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_fcaf5470-4959-453f-8a3f-cc1587ed64eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2b75be8a-10ca-4c53-9737-00e0e5d30188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed7d9771-80d0-4a18-bf1e-3765417b2aed" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3ead6758-d3b9-4141-8c48-a08b60fc2f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3ead6758-d3b9-4141-8c48-a08b60fc2f01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_5baf37c2-27df-4558-b349-0fc24d3eb578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_5baf37c2-27df-4558-b349-0fc24d3eb578" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_221ca3e0-9c16-48b0-a184-4e48221e60d4" xlink:href="peak-20220331.xsd#peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_221ca3e0-9c16-48b0-a184-4e48221e60d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_25f72620-3718-45ad-8650-26672888a2ca" xlink:href="peak-20220331.xsd#peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_25f72620-3718-45ad-8650-26672888a2ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_fc08fe57-919b-419e-8785-cbfc086fb4e8" xlink:href="peak-20220331.xsd#peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_fc08fe57-919b-419e-8785-cbfc086fb4e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_bea34efa-a06b-470c-96b8-e415caf47fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7db1e95b-91d2-4dbf-9d3e-c862353474c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ed7d9771-80d0-4a18-bf1e-3765417b2aed" xlink:to="loc_us-gaap_StatementTable_7db1e95b-91d2-4dbf-9d3e-c862353474c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bdf61e2b-f4d6-4de5-a1eb-feaae9559413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7db1e95b-91d2-4dbf-9d3e-c862353474c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bdf61e2b-f4d6-4de5-a1eb-feaae9559413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bdf61e2b-f4d6-4de5-a1eb-feaae9559413_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bdf61e2b-f4d6-4de5-a1eb-feaae9559413" xlink:to="loc_us-gaap_EquityComponentDomain_bdf61e2b-f4d6-4de5-a1eb-feaae9559413_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d747f3ce-c3d1-4525-93bc-12fea30f4cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bdf61e2b-f4d6-4de5-a1eb-feaae9559413" xlink:to="loc_us-gaap_EquityComponentDomain_d747f3ce-c3d1-4525-93bc-12fea30f4cf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d747f3ce-c3d1-4525-93bc-12fea30f4cf7" xlink:to="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4f47eb46-5d49-4ad5-9adc-bcb085cf766b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:to="loc_us-gaap_CommonStockMember_4f47eb46-5d49-4ad5-9adc-bcb085cf766b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5f54fdb3-f58d-4b9e-9622-c888684e243b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5f54fdb3-f58d-4b9e-9622-c888684e243b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_f97765b4-6777-4aca-822d-417aa3f528f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:to="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_f97765b4-6777-4aca-822d-417aa3f528f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1796360-af89-475a-baf2-bbe8c0023b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1796360-af89-475a-baf2-bbe8c0023b21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_1bec4c99-1f02-462c-bc7d-1fcfa14cedf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d747f3ce-c3d1-4525-93bc-12fea30f4cf7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_1bec4c99-1f02-462c-bc7d-1fcfa14cedf1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i85b73fb4ce9e42f5a86238735b6229e5_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5dc38eb2-e5e3-4fca-864e-01acf72db968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5dc38eb2-e5e3-4fca-864e-01acf72db968" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_308e2672-78c3-4e1c-b90b-266fe2644905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_308e2672-78c3-4e1c-b90b-266fe2644905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_1e5d1f22-7e3f-4095-8854-6506422dc13a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_1e5d1f22-7e3f-4095-8854-6506422dc13a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_93bd4863-4272-475f-8715-e3f1f8062626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_93bd4863-4272-475f-8715-e3f1f8062626" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_66fe4ada-b120-4ac0-8ada-6767902e60c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_93bd4863-4272-475f-8715-e3f1f8062626" xlink:to="loc_srt_RestatementAxis_66fe4ada-b120-4ac0-8ada-6767902e60c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_66fe4ada-b120-4ac0-8ada-6767902e60c3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_66fe4ada-b120-4ac0-8ada-6767902e60c3" xlink:to="loc_srt_RestatementDomain_66fe4ada-b120-4ac0-8ada-6767902e60c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7e4c2d5e-baf5-4936-88ee-2fef5529cc65" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_66fe4ada-b120-4ac0-8ada-6767902e60c3" xlink:to="loc_srt_RestatementDomain_7e4c2d5e-baf5-4936-88ee-2fef5529cc65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_cf1bf376-b5a9-4b1b-8d5c-9a83144e0243" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7e4c2d5e-baf5-4936-88ee-2fef5529cc65" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_cf1bf376-b5a9-4b1b-8d5c-9a83144e0243" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" xlink:type="extended" id="i202fceeaa1114821a44f8b4023abc8a0_SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_00c2a54f-cfa0-466f-aacc-df617c0aaf23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncome_38a4e000-2242-47ac-9aaf-29f3f10595dc" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_00c2a54f-cfa0-466f-aacc-df617c0aaf23" xlink:to="loc_peak_GovernmentGrantIncome_38a4e000-2242-47ac-9aaf-29f3f10595dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_00c2a54f-cfa0-466f-aacc-df617c0aaf23" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceAxis_314f2f3d-e62c-4bff-a730-4f820f62398e" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:to="loc_peak_GovernmentAssistanceAxis_314f2f3d-e62c-4bff-a730-4f820f62398e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceDomain_314f2f3d-e62c-4bff-a730-4f820f62398e_default" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_peak_GovernmentAssistanceAxis_314f2f3d-e62c-4bff-a730-4f820f62398e" xlink:to="loc_peak_GovernmentAssistanceDomain_314f2f3d-e62c-4bff-a730-4f820f62398e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceDomain_a27fe487-e158-4ca1-bb29-f812c7593e81" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_peak_GovernmentAssistanceAxis_314f2f3d-e62c-4bff-a730-4f820f62398e" xlink:to="loc_peak_GovernmentAssistanceDomain_a27fe487-e158-4ca1-bb29-f812c7593e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceCARESActMember_9ce19d98-f61d-47b9-bad5-23b90a43785d" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceCARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_peak_GovernmentAssistanceDomain_a27fe487-e158-4ca1-bb29-f812c7593e81" xlink:to="loc_peak_GovernmentAssistanceCARESActMember_9ce19d98-f61d-47b9-bad5-23b90a43785d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7dd480cd-1f98-429c-a396-e0ab0a984fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7dd480cd-1f98-429c-a396-e0ab0a984fac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7dd480cd-1f98-429c-a396-e0ab0a984fac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7dd480cd-1f98-429c-a396-e0ab0a984fac" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7dd480cd-1f98-429c-a396-e0ab0a984fac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7dd480cd-1f98-429c-a396-e0ab0a984fac" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b8989a39-ee97-4cad-96dc-b71fe40b683d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b8989a39-ee97-4cad-96dc-b71fe40b683d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_c3b0b21e-7847-4340-8ad3-3a83d8ffd12c" xlink:href="peak-20220331.xsd#peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:to="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_c3b0b21e-7847-4340-8ad3-3a83d8ffd12c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromDiscontinuedOperationsMember_dcfeb79d-97f9-4d16-b89a-08963bee257e" xlink:href="peak-20220331.xsd#peak_IncomeLossFromDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:to="loc_peak_IncomeLossFromDiscontinuedOperationsMember_dcfeb79d-97f9-4d16-b89a-08963bee257e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#RealEstateTransactionsRealEstateInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails" xlink:type="extended" id="i011e38b5f7394eb28cc7a31779dc4702_RealEstateTransactionsRealEstateInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_f37e65a6-984b-4269-80cf-1147377ed178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_f37e65a6-984b-4269-80cf-1147377ed178" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired_5c25fd0b-376e-482f-89bb-b8ebb0bbb3e5" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_peak_NumberOfPropertiesAcquired_5c25fd0b-376e-482f-89bb-b8ebb0bbb3e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand_1dab213d-864e-45e9-a9ff-56a6c40431d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_AreaOfLand_1dab213d-864e-45e9-a9ff-56a6c40431d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLand_bb932a36-af70-4495-8991-35ce6334c090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_PaymentsToAcquireLand_bb932a36-af70-4495-8991-35ce6334c090" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ad77081f-994a-4b95-a24a-4a498a074100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ad77081f-994a-4b95-a24a-4a498a074100" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_16025d19-5073-4994-abd0-e51c63c12872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_16025d19-5073-4994-abd0-e51c63c12872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_16025d19-5073-4994-abd0-e51c63c12872_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16025d19-5073-4994-abd0-e51c63c12872" xlink:to="loc_us-gaap_SegmentDomain_16025d19-5073-4994-abd0-e51c63c12872_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e060bb08-01ec-440d-8b43-697f2d9490f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16025d19-5073-4994-abd0-e51c63c12872" xlink:to="loc_us-gaap_SegmentDomain_e060bb08-01ec-440d-8b43-697f2d9490f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_26b0a2e5-f0df-4cbf-96cd-2e604e7155e9" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e060bb08-01ec-440d-8b43-697f2d9490f9" xlink:to="loc_peak_LifeScienceMember_26b0a2e5-f0df-4cbf-96cd-2e604e7155e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_b08cab6b-92ac-4270-bcb4-477f6efbff12" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e060bb08-01ec-440d-8b43-697f2d9490f9" xlink:to="loc_peak_MedicalOfficeMember_b08cab6b-92ac-4270-bcb4-477f6efbff12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_34303980-4cb6-4e5f-8008-87965c3fcbfe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:to="loc_srt_StatementGeographicalAxis_34303980-4cb6-4e5f-8008-87965c3fcbfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_34303980-4cb6-4e5f-8008-87965c3fcbfe_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_34303980-4cb6-4e5f-8008-87965c3fcbfe" xlink:to="loc_srt_SegmentGeographicalDomain_34303980-4cb6-4e5f-8008-87965c3fcbfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_34303980-4cb6-4e5f-8008-87965c3fcbfe" xlink:to="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_177633ba-6702-40d0-9687-293bf6f4e563" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_MA_177633ba-6702-40d0-9687-293bf6f4e563" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_3e754dda-db40-416b-be59-b51eee0b293b" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_CA_3e754dda-db40-416b-be59-b51eee0b293b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_449b6ae0-36e9-43d5-96ec-71a36f8bc3f4" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_TX_449b6ae0-36e9-43d5-96ec-71a36f8bc3f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_19c3ae05-5fc8-4af2-9e53-7006202c0e34" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_TN_19c3ae05-5fc8-4af2-9e53-7006202c0e34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO_5e454873-1a59-4a25-8887-36392c6a9ed6" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_CO_5e454873-1a59-4a25-8887-36392c6a9ed6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fbfec051-e788-4590-8f40-7a7f22237362" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_country_US_fbfec051-e788-4590-8f40-7a7f22237362" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_dae899a2-95bf-4c05-a993-3908145b91b9" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_FL_dae899a2-95bf-4c05-a993-3908145b91b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_25c8c3eb-d7c5-41e9-92b8-994940524053" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_KS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_KS_25c8c3eb-d7c5-41e9-92b8-994940524053" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_0311b087-00fd-4345-81d5-b4a0e1f57582" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_NJ_0311b087-00fd-4345-81d5-b4a0e1f57582" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA_060dd6bd-64ef-431d-b93c-93c180c5364d" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_WA_060dd6bd-64ef-431d-b93c-93c180c5364d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_73de33bb-da70-455b-a015-7219270cc04a" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_LA_73de33bb-da70-455b-a015-7219270cc04a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1204f1b2-54f0-4dc0-9522-366066f6ada3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:to="loc_us-gaap_DebtInstrumentAxis_1204f1b2-54f0-4dc0-9522-366066f6ada3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1204f1b2-54f0-4dc0-9522-366066f6ada3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1204f1b2-54f0-4dc0-9522-366066f6ada3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1204f1b2-54f0-4dc0-9522-366066f6ada3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_287fe698-a6fd-44f7-9641-a4131fb65dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1204f1b2-54f0-4dc0-9522-366066f6ada3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_287fe698-a6fd-44f7-9641-a4131fb65dd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_b85292ff-ada5-4b25-b104-fd6b21677396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_287fe698-a6fd-44f7-9641-a4131fb65dd2" xlink:to="loc_us-gaap_SecuredDebtMember_b85292ff-ada5-4b25-b104-fd6b21677396" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" xlink:type="extended" id="if334573fa47c4a46855f1160ff648e74_DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesSold_e8fb8eda-18a5-4e4c-aa43-7c7eca28d88a" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NumberOfPropertiesSold_e8fb8eda-18a5-4e4c-aa43-7c7eca28d88a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_1f52eeb9-f04f-4084-a16b-5805de7b8ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_1f52eeb9-f04f-4084-a16b-5805de7b8ca0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_f2a8a40e-c756-4dbd-b402-b54a68f5df58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_f2a8a40e-c756-4dbd-b402-b54a68f5df58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold_78e704ec-472f-49e4-a236-ff537442fa15" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NumberOfPropertiesToBeSold_78e704ec-472f-49e4-a236-ff537442fa15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables_f15bc1c9-9617-49a9-b9b6-c5f568a88c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_PaymentsToAcquireFinanceReceivables_f15bc1c9-9617-49a9-b9b6-c5f568a88c3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountCommitted_5bbc71cc-8407-4419-8e54-bc85cbcdb2c9" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_CapitalExpenditureFundingAmountCommitted_5bbc71cc-8407-4419-8e54-bc85cbcdb2c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountFunded_fd129c7b-2682-4922-a7c1-88bfa62af36b" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountFunded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_CapitalExpenditureFundingAmountFunded_fd129c7b-2682-4922-a7c1-88bfa62af36b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_50991ccd-1bd4-4698-ba8d-6996cd74266a" xlink:href="peak-20220331.xsd#peak_NumberOfAssetsClassifiedAsDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_50991ccd-1bd4-4698-ba8d-6996cd74266a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_df12825b-4e47-40dc-ae87-b35b8b53e704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_df12825b-4e47-40dc-ae87-b35b8b53e704" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DispositionOfPropertiesSoldNumber_9a0d7120-3798-4650-9d49-4513bbf1c0cf" xlink:href="peak-20220331.xsd#peak_DispositionOfPropertiesSoldNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_DispositionOfPropertiesSoldNumber_9a0d7120-3798-4650-9d49-4513bbf1c0cf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer_0de57620-7ff5-4a87-99bb-8cba130ed1b9" xlink:href="peak-20220331.xsd#peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer_0de57620-7ff5-4a87-99bb-8cba130ed1b9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold_5e9017d1-e25d-4c84-813a-ad1f7a83a021" xlink:href="peak-20220331.xsd#peak_NumberOfPreferredEquityMethodInvestmentsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold_5e9017d1-e25d-4c84-813a-ad1f7a83a021" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment_fd69dad3-bdfa-430c-a4f0-7532fab11d8a" xlink:href="peak-20220331.xsd#peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment_fd69dad3-bdfa-430c-a4f0-7532fab11d8a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_53d41baf-d41f-4c1a-a359-50f2f6f41655" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_53d41baf-d41f-4c1a-a359-50f2f6f41655" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense_57ae84f3-f243-44d6-9c35-c6f125b0e40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_OtherNonrecurringExpense_57ae84f3-f243-44d6-9c35-c6f125b0e40a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a1c65ee5-07c8-4b24-89c7-44436a875ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a1c65ee5-07c8-4b24-89c7-44436a875ce9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a1c65ee5-07c8-4b24-89c7-44436a875ce9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1c65ee5-07c8-4b24-89c7-44436a875ce9" xlink:to="loc_us-gaap_SegmentDomain_a1c65ee5-07c8-4b24-89c7-44436a875ce9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1c65ee5-07c8-4b24-89c7-44436a875ce9" xlink:to="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_8765221b-c2d2-4b52-83fc-940c13be3ba2" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_LifeScienceMember_8765221b-c2d2-4b52-83fc-940c13be3ba2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_78497bc0-c9fe-40e7-93cd-711bd5aa1eab" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_MedicalOfficeMember_78497bc0-c9fe-40e7-93cd-711bd5aa1eab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_5b0b281a-978a-431a-bf1e-c069551aa799" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_5b0b281a-978a-431a-bf1e-c069551aa799" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingTripleNetMember_2e05109e-32d9-453e-8079-460a8aa42702" xlink:href="peak-20220331.xsd#peak_SeniorHousingTripleNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_SeniorHousingTripleNetMember_2e05109e-32d9-453e-8079-460a8aa42702" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeHospitalMember_02c09148-5176-4360-89ee-bddf676a6c68" xlink:href="peak-20220331.xsd#peak_MedicalOfficeHospitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_MedicalOfficeHospitalMember_02c09148-5176-4360-89ee-bddf676a6c68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_33701906-c20b-4c61-9cb8-e8bf7bfb6595" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_33701906-c20b-4c61-9cb8-e8bf7bfb6595" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_33701906-c20b-4c61-9cb8-e8bf7bfb6595_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_33701906-c20b-4c61-9cb8-e8bf7bfb6595" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_33701906-c20b-4c61-9cb8-e8bf7bfb6595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8db25416-27b5-46eb-afc9-3815b82bc534" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_33701906-c20b-4c61-9cb8-e8bf7bfb6595" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8db25416-27b5-46eb-afc9-3815b82bc534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_41d110c4-c13e-4ba2-99d1-99a1848d115e" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8db25416-27b5-46eb-afc9-3815b82bc534" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_41d110c4-c13e-4ba2-99d1-99a1848d115e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingTripleNetMember_ec3ab710-4cb2-4350-b13f-bfb6aebe62f6" xlink:href="peak-20220331.xsd#peak_SeniorHousingTripleNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8db25416-27b5-46eb-afc9-3815b82bc534" xlink:to="loc_peak_SeniorHousingTripleNetMember_ec3ab710-4cb2-4350-b13f-bfb6aebe62f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_InvestmentTypeAxis_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SunriseSeniorHousingPortfolioMember_010d802a-b8ae-4f02-86b9-2cd77705a9b7" xlink:href="peak-20220331.xsd#peak_SunriseSeniorHousingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_SunriseSeniorHousingPortfolioMember_010d802a-b8ae-4f02-86b9-2cd77705a9b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleTripleNetPortfolioMember_afdff7d0-40d3-4115-ac2a-93bedb504d48" xlink:href="peak-20220331.xsd#peak_BrookdaleTripleNetPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_BrookdaleTripleNetPortfolioMember_afdff7d0-40d3-4115-ac2a-93bedb504d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HRATripleNetPortfolioMember_16cde378-4035-4458-9c5c-8416d86b265c" xlink:href="peak-20220331.xsd#peak_HRATripleNetPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_HRATripleNetPortfolioMember_16cde378-4035-4458-9c5c-8416d86b265c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OakmontSHOPPortfolioMember_7f9e80e1-2260-48b1-aa7d-a38390d5f2cd" xlink:href="peak-20220331.xsd#peak_OakmontSHOPPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_OakmontSHOPPortfolioMember_7f9e80e1-2260-48b1-aa7d-a38390d5f2cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySHOPPortfolioMember_21fe6034-1223-4245-a125-11719f7d2632" xlink:href="peak-20220331.xsd#peak_DiscoverySHOPPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_DiscoverySHOPPortfolioMember_21fe6034-1223-4245-a125-11719f7d2632" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SonataSHOPPortfolioMember_e9729b22-68cb-416b-b977-c80d37b70dc3" xlink:href="peak-20220331.xsd#peak_SonataSHOPPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_SonataSHOPPortfolioMember_e9729b22-68cb-416b-b977-c80d37b70dc3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SLCSHOPPortfolioMember_967036ff-2f1f-432c-b275-17e6dfc78851" xlink:href="peak-20220331.xsd#peak_SLCSHOPPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_SLCSHOPPortfolioMember_967036ff-2f1f-432c-b275-17e6dfc78851" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherDispositionsMember_adbba5f8-9674-4eab-8b69-cb309bb6f952" xlink:href="peak-20220331.xsd#peak_OtherDispositionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_OtherDispositionsMember_adbba5f8-9674-4eab-8b69-cb309bb6f952" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementsAxisAxis_a0c7725f-dc0e-460a-b491-e048b472369d" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementsAxisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_peak_DefinitiveAgreementsAxisAxis_a0c7725f-dc0e-460a-b491-e048b472369d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementsDomain_a0c7725f-dc0e-460a-b491-e048b472369d_default" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_peak_DefinitiveAgreementsAxisAxis_a0c7725f-dc0e-460a-b491-e048b472369d" xlink:to="loc_peak_DefinitiveAgreementsDomain_a0c7725f-dc0e-460a-b491-e048b472369d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementsDomain_cb1620be-5539-4bf7-8b92-415d684ae721" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_peak_DefinitiveAgreementsAxisAxis_a0c7725f-dc0e-460a-b491-e048b472369d" xlink:to="loc_peak_DefinitiveAgreementsDomain_cb1620be-5539-4bf7-8b92-415d684ae721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementFourMember_8d1933fe-7094-44d4-ac29-36394196f76b" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_peak_DefinitiveAgreementsDomain_cb1620be-5539-4bf7-8b92-415d684ae721" xlink:to="loc_peak_DefinitiveAgreementFourMember_8d1933fe-7094-44d4-ac29-36394196f76b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d3883972-5ad3-45f2-b275-0976a0cb91de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_srt_StatementGeographicalAxis_d3883972-5ad3-45f2-b275-0976a0cb91de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d3883972-5ad3-45f2-b275-0976a0cb91de_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d3883972-5ad3-45f2-b275-0976a0cb91de" xlink:to="loc_srt_SegmentGeographicalDomain_d3883972-5ad3-45f2-b275-0976a0cb91de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e343967a-5b11-437c-8d32-86df4e3142fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d3883972-5ad3-45f2-b275-0976a0cb91de" xlink:to="loc_srt_SegmentGeographicalDomain_e343967a-5b11-437c-8d32-86df4e3142fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_369a0586-c404-45be-8746-b46e50627714" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e343967a-5b11-437c-8d32-86df4e3142fd" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_369a0586-c404-45be-8746-b46e50627714" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a85a22c9-8375-4770-92f3-2c4181c030d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a85a22c9-8375-4770-92f3-2c4181c030d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a85a22c9-8375-4770-92f3-2c4181c030d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a85a22c9-8375-4770-92f3-2c4181c030d1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a85a22c9-8375-4770-92f3-2c4181c030d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bb829a0c-b43c-45f2-a0be-db8b6c4a77b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a85a22c9-8375-4770-92f3-2c4181c030d1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bb829a0c-b43c-45f2-a0be-db8b6c4a77b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_e5d6cd27-d458-42e9-989b-f55b5853019c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bb829a0c-b43c-45f2-a0be-db8b6c4a77b7" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_e5d6cd27-d458-42e9-989b-f55b5853019c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_0c5299b3-efd4-489c-a593-5033509fba13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bb829a0c-b43c-45f2-a0be-db8b6c4a77b7" xlink:to="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_0c5299b3-efd4-489c-a593-5033509fba13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_5fc0f7b1-ab09-4f08-8848-439600145fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_5fc0f7b1-ab09-4f08-8848-439600145fbd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_5fc0f7b1-ab09-4f08-8848-439600145fbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_5fc0f7b1-ab09-4f08-8848-439600145fbd" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_5fc0f7b1-ab09-4f08-8848-439600145fbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_7eccec78-b5e6-4e82-8d9a-23bbcacdb5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_5fc0f7b1-ab09-4f08-8848-439600145fbd" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_7eccec78-b5e6-4e82-8d9a-23bbcacdb5ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_40ccebc0-38b9-45c1-b82d-52ebbaf7e76b" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_7eccec78-b5e6-4e82-8d9a-23bbcacdb5ff" xlink:to="loc_peak_MezzanineMember_40ccebc0-38b9-45c1-b82d-52ebbaf7e76b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_489fe020-9597-4503-80ff-3372581276a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_489fe020-9597-4503-80ff-3372581276a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_489fe020-9597-4503-80ff-3372581276a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_489fe020-9597-4503-80ff-3372581276a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_489fe020-9597-4503-80ff-3372581276a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a640aacd-9a95-4311-b331-8d4014b948b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_489fe020-9597-4503-80ff-3372581276a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a640aacd-9a95-4311-b331-8d4014b948b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_a6236129-4624-4da2-a5ee-14a91735e564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a640aacd-9a95-4311-b331-8d4014b948b5" xlink:to="loc_us-gaap_SecuredDebtMember_a6236129-4624-4da2-a5ee-14a91735e564" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_eb48e55e-ab84-43c0-aa5d-5cb578a45b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_eb48e55e-ab84-43c0-aa5d-5cb578a45b28" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_eb48e55e-ab84-43c0-aa5d-5cb578a45b28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb48e55e-ab84-43c0-aa5d-5cb578a45b28" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_eb48e55e-ab84-43c0-aa5d-5cb578a45b28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_26ed6803-deea-45b1-91bb-3b5ee81d14af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb48e55e-ab84-43c0-aa5d-5cb578a45b28" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_26ed6803-deea-45b1-91bb-3b5ee81d14af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_31a08069-1981-4bd1-a25a-2277fea4a823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_26ed6803-deea-45b1-91bb-3b5ee81d14af" xlink:to="loc_us-gaap_SubsequentEventMember_31a08069-1981-4bd1-a25a-2277fea4a823" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_50762fed-120f-41ae-8153-b09492e6093f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_50762fed-120f-41ae-8153-b09492e6093f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_50762fed-120f-41ae-8153-b09492e6093f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_50762fed-120f-41ae-8153-b09492e6093f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_50762fed-120f-41ae-8153-b09492e6093f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_d462f7ab-7175-4d16-9e97-21ba780da6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_50762fed-120f-41ae-8153-b09492e6093f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_d462f7ab-7175-4d16-9e97-21ba780da6d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_c1eb08ee-0637-4ba7-86ae-ad4e5beeba75" xlink:href="peak-20220331.xsd#peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_d462f7ab-7175-4d16-9e97-21ba780da6d1" xlink:to="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_c1eb08ee-0637-4ba7-86ae-ad4e5beeba75" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails" xlink:type="extended" id="id4a1561e01274e4299143a1855c7ccca_DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_51b7cb14-d8e9-41aa-bfab-0ba50b82dbdc" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_51b7cb14-d8e9-41aa-bfab-0ba50b82dbdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_f7c06e4e-a8fb-4e5c-a446-4c12d6fd6e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_f7c06e4e-a8fb-4e5c-a446-4c12d6fd6e51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_9700fdf7-b9d5-4712-83bc-d9b551a3f5b8" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_9700fdf7-b9d5-4712-83bc-d9b551a3f5b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_eb728611-af39-4714-aca5-8ef276d6aafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_eb728611-af39-4714-aca5-8ef276d6aafc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fa8ffd68-79f7-4dd2-8f08-292ee365b2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fa8ffd68-79f7-4dd2-8f08-292ee365b2a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_80e19c64-825f-4cd2-9a83-ea5f16d536f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_80e19c64-825f-4cd2-9a83-ea5f16d536f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_be3343cb-f8dd-4ce5-84b2-d7325f465d6b" xlink:href="peak-20220331.xsd#peak_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_be3343cb-f8dd-4ce5-84b2-d7325f465d6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_0c5f7c2e-f5cf-4a9d-9fe5-c47f84741b02" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_0c5f7c2e-f5cf-4a9d-9fe5-c47f84741b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_4156b86d-2420-4fd4-a38b-cbeb338a8153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_4156b86d-2420-4fd4-a38b-cbeb338a8153" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_a03cdd0b-3c36-43ec-bb05-76cd754d4a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_a03cdd0b-3c36-43ec-bb05-76cd754d4a88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f769400f-e587-4486-bbc2-8dd3f9780cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f769400f-e587-4486-bbc2-8dd3f9780cec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_7fcb5bd6-0c0e-4e45-a23c-8ae862d3c35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_7fcb5bd6-0c0e-4e45-a23c-8ae862d3c35c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_3ab83c40-80cf-431f-a9db-4e05b08e5650" xlink:href="peak-20220331.xsd#peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_3ab83c40-80cf-431f-a9db-4e05b08e5650" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable_932cc8e5-a3a8-444a-81ef-e183a832e786" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable_932cc8e5-a3a8-444a-81ef-e183a832e786" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesHeldForSaleNumber_6391dd5e-aeb6-4daf-b09f-ea8bcbcc8aad" xlink:href="peak-20220331.xsd#peak_PropertiesHeldForSaleNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_peak_PropertiesHeldForSaleNumber_6391dd5e-aeb6-4daf-b09f-ea8bcbcc8aad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetRealEstateAssets_408e2060-8bbc-4453-825d-13e62bf08802" xlink:href="peak-20220331.xsd#peak_NetRealEstateAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_peak_NetRealEstateAssets_408e2060-8bbc-4453-825d-13e62bf08802" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_05e1a2e3-1ef8-462a-a657-c67967f350db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_05e1a2e3-1ef8-462a-a657-c67967f350db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_bc6a7c5d-8fba-4121-ab5e-129c93b3b93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_bc6a7c5d-8fba-4121-ab5e-129c93b3b93a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6f8d4dd6-aab8-42ae-8122-ba973e7242b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6f8d4dd6-aab8-42ae-8122-ba973e7242b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_479bae6c-5dd4-486d-8f25-21d5744ff66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6f8d4dd6-aab8-42ae-8122-ba973e7242b5" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_479bae6c-5dd4-486d-8f25-21d5744ff66e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3" xlink:to="loc_us-gaap_SegmentDomain_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_def6223d-8108-41eb-89f6-d22b6109afcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3" xlink:to="loc_us-gaap_SegmentDomain_def6223d-8108-41eb-89f6-d22b6109afcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_f6c9ce19-543c-4cae-aa3e-47b0b9d0221f" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_def6223d-8108-41eb-89f6-d22b6109afcc" xlink:to="loc_peak_MedicalOfficeMember_f6c9ce19-543c-4cae-aa3e-47b0b9d0221f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_89bc8bf7-c84b-419e-b0b0-817a70003775" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_def6223d-8108-41eb-89f6-d22b6109afcc" xlink:to="loc_peak_LifeScienceMember_89bc8bf7-c84b-419e-b0b0-817a70003775" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="extended" id="if0ebc158a6fd45939a6442b2dcf9315e_DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome_50a6c0c8-0468-432b-82eb-ebef94f59933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome_50a6c0c8-0468-432b-82eb-ebef94f59933" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_d2067d46-d857-4131-aa59-783efcfae40d" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_d2067d46-d857-4131-aa59-783efcfae40d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_05a1e5ac-7d04-4607-a389-79eecae930ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_05a1e5ac-7d04-4607-a389-79eecae930ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_8f3fa2d9-1825-4771-be3c-1103070a568f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_8f3fa2d9-1825-4771-be3c-1103070a568f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_dbbc6e91-b052-42cc-8a1f-4027ee6f44ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_dbbc6e91-b052-42cc-8a1f-4027ee6f44ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_2f7f3624-ac10-44dd-b14b-3ada8c681a9a" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_2f7f3624-ac10-44dd-b14b-3ada8c681a9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_3a3206a3-1044-496f-ac9b-1b92cce65224" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_3a3206a3-1044-496f-ac9b-1b92cce65224" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_04e40fc2-f031-4a93-a3ef-0f91a086ede2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_04e40fc2-f031-4a93-a3ef-0f91a086ede2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_ed8a7f17-f48f-486f-ad07-762aba4ed2a4" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_ed8a7f17-f48f-486f-ad07-762aba4ed2a4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_59909a38-5b7a-4055-ad07-3a2770ed4af1" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_59909a38-5b7a-4055-ad07-3a2770ed4af1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_86159515-81a3-452d-ac7e-2b9f6b437d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_86159515-81a3-452d-ac7e-2b9f6b437d4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_bb9e97f8-4453-4cc6-bc45-dc357fe50b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_bb9e97f8-4453-4cc6-bc45-dc357fe50b2e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5c2c6a6-4c28-4d47-9b14-1be78631cf2b" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5c2c6a6-4c28-4d47-9b14-1be78631cf2b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_7abb48e3-34f1-4855-912d-d98513adc67a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_7abb48e3-34f1-4855-912d-d98513adc67a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b3c19c59-01c3-4e69-8b60-21ed83ae1794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b3c19c59-01c3-4e69-8b60-21ed83ae1794" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5ba55929-bb0e-4139-8e54-aed22e9bfd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b3c19c59-01c3-4e69-8b60-21ed83ae1794" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5ba55929-bb0e-4139-8e54-aed22e9bfd2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5ba55929-bb0e-4139-8e54-aed22e9bfd2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ba55929-bb0e-4139-8e54-aed22e9bfd2b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5ba55929-bb0e-4139-8e54-aed22e9bfd2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_84be5c9c-470e-40bf-8160-d9017a3b4121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ba55929-bb0e-4139-8e54-aed22e9bfd2b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_84be5c9c-470e-40bf-8160-d9017a3b4121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_923a8396-4388-436e-9b95-53547c2ddc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_84be5c9c-470e-40bf-8160-d9017a3b4121" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_923a8396-4388-436e-9b95-53547c2ddc43" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableScheduleofLoansReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="extended" id="id3305380ed1f403caabb961af0e32a6c_LoansReceivableScheduleofLoansReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_7c53a806-3ec9-4285-b810-98409444e5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_7c53a806-3ec9-4285-b810-98409444e5ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_de869085-608d-4154-82e7-b5173fa35db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_de869085-608d-4154-82e7-b5173fa35db0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_a54496ec-e54e-4aae-ae3a-d8738378c73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_a54496ec-e54e-4aae-ae3a-d8738378c73a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_3a3900d7-b3a5-4039-a299-2d88764440f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_3a3900d7-b3a5-4039-a299-2d88764440f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableRemainingCommitments_152c06c4-e589-4900-b07f-b40476995d56" xlink:href="peak-20220331.xsd#peak_FinancingReceivableRemainingCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_peak_FinancingReceivableRemainingCommitments_152c06c4-e589-4900-b07f-b40476995d56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_937399ff-dcce-4986-9ecf-9fa2af035347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_937399ff-dcce-4986-9ecf-9fa2af035347" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_919df305-c643-460f-b2e7-9b55ee9db222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_937399ff-dcce-4986-9ecf-9fa2af035347" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_919df305-c643-460f-b2e7-9b55ee9db222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_919df305-c643-460f-b2e7-9b55ee9db222_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_919df305-c643-460f-b2e7-9b55ee9db222" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_919df305-c643-460f-b2e7-9b55ee9db222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_a0b3a842-3055-4251-b10e-2e3ad8feaaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_919df305-c643-460f-b2e7-9b55ee9db222" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_a0b3a842-3055-4251-b10e-2e3ad8feaaa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_779596f4-848c-46b0-8c38-f7b93b03efa0" xlink:href="peak-20220331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_a0b3a842-3055-4251-b10e-2e3ad8feaaa4" xlink:to="loc_peak_SecuredMortgageLoansMember_779596f4-848c-46b0-8c38-f7b93b03efa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineAndOtherMember_2b473ef5-bb87-408d-af4d-eb7bae0ef4c8" xlink:href="peak-20220331.xsd#peak_MezzanineAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_a0b3a842-3055-4251-b10e-2e3ad8feaaa4" xlink:to="loc_peak_MezzanineAndOtherMember_2b473ef5-bb87-408d-af4d-eb7bae0ef4c8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails" xlink:type="extended" id="icca7b8e90e08406293dd9f38509d7a11_LoansReceivableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold_a5612fd5-7201-425b-8b18-6de78c45ca12" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_NumberOfPropertiesToBeSold_a5612fd5-7201-425b-8b18-6de78c45ca12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_f3edd429-a8bb-4fe9-830c-9eccaddb4c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_f3edd429-a8bb-4fe9-830c-9eccaddb4c44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a2265967-451f-46e9-8674-182477d0bc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a2265967-451f-46e9-8674-182477d0bc5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountCommitted_e047712e-2253-4375-b499-4d45c1058aa6" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_CapitalExpenditureFundingAmountCommitted_e047712e-2253-4375-b499-4d45c1058aa6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_b341c581-60c4-4822-9cc2-a3d4ad282d39" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_b341c581-60c4-4822-9cc2-a3d4ad282d39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountFunded_9549b3df-dbd9-4b09-a01e-6b1214c011fb" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountFunded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_CapitalExpenditureFundingAmountFunded_9549b3df-dbd9-4b09-a01e-6b1214c011fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_8a7de6e6-fd60-471f-9f4d-ee81798bac98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_8a7de6e6-fd60-471f-9f4d-ee81798bac98" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_9d04cb76-f117-445d-9537-07a0187abb21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_9d04cb76-f117-445d-9537-07a0187abb21" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableStatedInterestRate_2f7a5fb9-bd5a-4c56-b1a8-645af76163ec" xlink:href="peak-20220331.xsd#peak_LoansReceivableStatedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_LoansReceivableStatedInterestRate_2f7a5fb9-bd5a-4c56-b1a8-645af76163ec" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableMarketRate_d1773120-2922-4b9d-9a69-79d5c15cb433" xlink:href="peak-20220331.xsd#peak_LoansReceivableMarketRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_LoansReceivableMarketRate_d1773120-2922-4b9d-9a69-79d5c15cb433" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableInterestIncomeAmortizationPeriod_eef8d351-20b1-45e0-b827-6514c615563a" xlink:href="peak-20220331.xsd#peak_LoansReceivableInterestIncomeAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_LoansReceivableInterestIncomeAmortizationPeriod_eef8d351-20b1-45e0-b827-6514c615563a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncashOrPartNoncashInterestIncome_cddf4eac-2850-497a-9188-0caa0a4caa92" xlink:href="peak-20220331.xsd#peak_NoncashOrPartNoncashInterestIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_NoncashOrPartNoncashInterestIncome_cddf4eac-2850-497a-9188-0caa0a4caa92" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableHeldForSaleNumberOfContracts_b84f175e-bec8-4d72-9fe4-82003ae13f3d" xlink:href="peak-20220331.xsd#peak_FinancingReceivableHeldForSaleNumberOfContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_FinancingReceivableHeldForSaleNumberOfContracts_b84f175e-bec8-4d72-9fe4-82003ae13f3d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbd7f79c-6a81-4ee0-ac7f-463d9c863785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbd7f79c-6a81-4ee0-ac7f-463d9c863785" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinanceReceivables_d123cba9-4610-4a55-89e9-67d86aca6c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFinanceReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_IncreaseDecreaseInFinanceReceivables_d123cba9-4610-4a55-89e9-67d86aca6c65" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_a2c64a5f-1076-4b3d-99e0-f049ae780499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_a2c64a5f-1076-4b3d-99e0-f049ae780499" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_20f617cf-74cb-4abd-8e6c-fdab735cb86a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_20f617cf-74cb-4abd-8e6c-fdab735cb86a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableNumberOfContractsSold_558781d7-155d-4885-bc27-ccbcf8a5428e" xlink:href="peak-20220331.xsd#peak_FinancingReceivableNumberOfContractsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_FinancingReceivableNumberOfContractsSold_558781d7-155d-4885-bc27-ccbcf8a5428e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfFinanceReceivables_0c2dab91-8fbc-46a2-af06-c574631b7248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfFinanceReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ProceedsFromSaleOfFinanceReceivables_0c2dab91-8fbc-46a2-af06-c574631b7248" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfNotesReceivable_96c42e06-66fc-4587-aaf6-d198e1d28611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_GainLossOnSaleOfNotesReceivable_96c42e06-66fc-4587-aaf6-d198e1d28611" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_592b366b-9844-451c-b2a3-e8df6cdd8ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_592b366b-9844-451c-b2a3-e8df6cdd8ac6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableNumberOfContracts_3b8cbf6f-999a-4142-a20f-8eb18bdf8257" xlink:href="peak-20220331.xsd#peak_FinancingReceivableNumberOfContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_FinancingReceivableNumberOfContracts_3b8cbf6f-999a-4142-a20f-8eb18bdf8257" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments_5ff5abf1-9d49-4fa7-a7a8-c3f68f8584ca" xlink:href="peak-20220331.xsd#peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments_5ff5abf1-9d49-4fa7-a7a8-c3f68f8584ca" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2d2cc760-5f8e-469f-826f-789a62cbaa2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2d2cc760-5f8e-469f-826f-789a62cbaa2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_2d2cc760-5f8e-469f-826f-789a62cbaa2b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2d2cc760-5f8e-469f-826f-789a62cbaa2b" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_2d2cc760-5f8e-469f-826f-789a62cbaa2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_baa49a75-d6fb-4052-8199-3eab0d68b33b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2d2cc760-5f8e-469f-826f-789a62cbaa2b" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_baa49a75-d6fb-4052-8199-3eab0d68b33b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_a662e1d8-d971-4fe6-a8b5-ee86345c6f66" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_baa49a75-d6fb-4052-8199-3eab0d68b33b" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_a662e1d8-d971-4fe6-a8b5-ee86345c6f66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRVJVInvestmentMember_82184aa5-7f56-4f59-b4e5-0242df2be083" xlink:href="peak-20220331.xsd#peak_CCRVJVInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_baa49a75-d6fb-4052-8199-3eab0d68b33b" xlink:to="loc_peak_CCRVJVInvestmentMember_82184aa5-7f56-4f59-b4e5-0242df2be083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorPropertyClassAxis_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorPropertyClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_MajorPropertyClassAxis_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorPropertyClassDomain_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorPropertyClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorPropertyClassAxis_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e" xlink:to="loc_us-gaap_MajorPropertyClassDomain_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorPropertyClassDomain_8bfe18ad-0c5e-4268-86d1-3e8ce69c66af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorPropertyClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorPropertyClassAxis_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e" xlink:to="loc_us-gaap_MajorPropertyClassDomain_8bfe18ad-0c5e-4268-86d1-3e8ce69c66af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LessorAssetUnderOperatingLeaseMember_92d93683-7621-4f55-ab3e-5d8c0f79dd9e" xlink:href="peak-20220331.xsd#peak_LessorAssetUnderOperatingLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorPropertyClassDomain_8bfe18ad-0c5e-4268-86d1-3e8ce69c66af" xlink:to="loc_peak_LessorAssetUnderOperatingLeaseMember_92d93683-7621-4f55-ab3e-5d8c0f79dd9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_031433a1-a662-402d-9455-dfae444d0bd8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_srt_CounterpartyNameAxis_031433a1-a662-402d-9455-dfae444d0bd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_031433a1-a662-402d-9455-dfae444d0bd8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_031433a1-a662-402d-9455-dfae444d0bd8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_031433a1-a662-402d-9455-dfae444d0bd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a35b7ad-30cb-46c7-9898-1753fd54cf8a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_031433a1-a662-402d-9455-dfae444d0bd8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a35b7ad-30cb-46c7-9898-1753fd54cf8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember_9792fe45-ba68-4fc3-9b1e-d769b99379c8" xlink:href="peak-20220331.xsd#peak_BrookdaleMTCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a35b7ad-30cb-46c7-9898-1753fd54cf8a" xlink:to="loc_peak_BrookdaleMTCAMember_9792fe45-ba68-4fc3-9b1e-d769b99379c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c7c4a221-cca7-43d4-a981-d8539d4c3f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c7c4a221-cca7-43d4-a981-d8539d4c3f34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c7c4a221-cca7-43d4-a981-d8539d4c3f34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c7c4a221-cca7-43d4-a981-d8539d4c3f34" xlink:to="loc_us-gaap_SegmentDomain_c7c4a221-cca7-43d4-a981-d8539d4c3f34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c7c4a221-cca7-43d4-a981-d8539d4c3f34" xlink:to="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_c878e224-9756-4e13-9e6b-82257ae6e4e9" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_c878e224-9756-4e13-9e6b-82257ae6e4e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_c254eda1-15fb-4688-aa2d-356afd746e62" xlink:href="peak-20220331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:to="loc_peak_SecuredMortgageLoansMember_c254eda1-15fb-4688-aa2d-356afd746e62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_96442c96-eee6-49fe-b766-b43cf7de9890" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:to="loc_peak_MezzanineMember_96442c96-eee6-49fe-b766-b43cf7de9890" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_c127e62c-5d13-4e78-805c-52664215546a" xlink:href="peak-20220331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:to="loc_peak_OtherNonReportingSegmentMember_c127e62c-5d13-4e78-805c-52664215546a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_611a40ad-a38a-4250-9df8-29ab32b2cbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_611a40ad-a38a-4250-9df8-29ab32b2cbe0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_611a40ad-a38a-4250-9df8-29ab32b2cbe0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_611a40ad-a38a-4250-9df8-29ab32b2cbe0" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_611a40ad-a38a-4250-9df8-29ab32b2cbe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_41491ad2-f610-4248-85ec-27085eb13dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_611a40ad-a38a-4250-9df8-29ab32b2cbe0" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_41491ad2-f610-4248-85ec-27085eb13dfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_6b2728c6-ea0d-498f-9054-353f0d49cf74" xlink:href="peak-20220331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_41491ad2-f610-4248-85ec-27085eb13dfd" xlink:to="loc_peak_SecuredMortgageLoansMember_6b2728c6-ea0d-498f-9054-353f0d49cf74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_3b5cfebe-95e7-4448-bf2f-0ab127696825" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_41491ad2-f610-4248-85ec-27085eb13dfd" xlink:to="loc_peak_MezzanineMember_3b5cfebe-95e7-4448-bf2f-0ab127696825" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c132f4e1-e667-4d52-8ccd-bf1ceeb10083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_InvestmentTypeAxis_c132f4e1-e667-4d52-8ccd-bf1ceeb10083" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c132f4e1-e667-4d52-8ccd-bf1ceeb10083_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_c132f4e1-e667-4d52-8ccd-bf1ceeb10083" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c132f4e1-e667-4d52-8ccd-bf1ceeb10083_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_73e9a7d4-f49f-4a28-a235-6cbd93d3d550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_c132f4e1-e667-4d52-8ccd-bf1ceeb10083" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_73e9a7d4-f49f-4a28-a235-6cbd93d3d550" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SunriseSeniorHousingPortfolioMember_4ce08d02-0641-415c-ab66-0f1e7d52e4ab" xlink:href="peak-20220331.xsd#peak_SunriseSeniorHousingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e9a7d4-f49f-4a28-a235-6cbd93d3d550" xlink:to="loc_peak_SunriseSeniorHousingPortfolioMember_4ce08d02-0641-415c-ab66-0f1e7d52e4ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySHOPPortfolioMember_cedd6522-0d73-410b-8794-07ab461c4c36" xlink:href="peak-20220331.xsd#peak_DiscoverySHOPPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e9a7d4-f49f-4a28-a235-6cbd93d3d550" xlink:to="loc_peak_DiscoverySHOPPortfolioMember_cedd6522-0d73-410b-8794-07ab461c4c36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_78484657-d28d-4fe0-aaa9-ac41b34eca6a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_srt_StatementGeographicalAxis_78484657-d28d-4fe0-aaa9-ac41b34eca6a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_78484657-d28d-4fe0-aaa9-ac41b34eca6a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_78484657-d28d-4fe0-aaa9-ac41b34eca6a" xlink:to="loc_srt_SegmentGeographicalDomain_78484657-d28d-4fe0-aaa9-ac41b34eca6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c2986343-e169-41de-b13f-66f56de446c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_78484657-d28d-4fe0-aaa9-ac41b34eca6a" xlink:to="loc_srt_SegmentGeographicalDomain_c2986343-e169-41de-b13f-66f56de446c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_c2353586-4bd2-479f-b2cc-42fae7c5d342" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c2986343-e169-41de-b13f-66f56de446c4" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_c2353586-4bd2-479f-b2cc-42fae7c5d342" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_srt_RangeAxis_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6" xlink:to="loc_srt_RangeMember_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2ec405c-e974-4a13-81c9-1fc02cb9b9c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6" xlink:to="loc_srt_RangeMember_d2ec405c-e974-4a13-81c9-1fc02cb9b9c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6954ec68-e866-4e8e-9132-532b093b40f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d2ec405c-e974-4a13-81c9-1fc02cb9b9c5" xlink:to="loc_srt_MinimumMember_6954ec68-e866-4e8e-9132-532b093b40f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d01a839-ba13-4e74-b81c-57bd40b5a31e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d2ec405c-e974-4a13-81c9-1fc02cb9b9c5" xlink:to="loc_srt_MaximumMember_5d01a839-ba13-4e74-b81c-57bd40b5a31e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="extended" id="i5978b282b69a4fb7ae2b6740fe8bd066_LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_438ea3ba-0d3a-4fcf-9ba8-85c9ff27973f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_438ea3ba-0d3a-4fcf-9ba8-85c9ff27973f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_4b54eb8e-6f4a-45c4-ac8d-fd34d4ccce32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_4b54eb8e-6f4a-45c4-ac8d-fd34d4ccce32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_20364beb-8a5a-46a6-8b49-2333e39b3cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_20364beb-8a5a-46a6-8b49-2333e39b3cbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_c92b23bd-4df8-47e1-a4fd-1dc55cc5f547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_c92b23bd-4df8-47e1-a4fd-1dc55cc5f547" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_e01ecc34-5e88-48ef-bf49-bc1fa84143f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_e01ecc34-5e88-48ef-bf49-bc1fa84143f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_377a9ace-3555-43cb-acb5-2124c1b6adfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_377a9ace-3555-43cb-acb5-2124c1b6adfc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_9702ff5c-506e-4134-b2da-e2275db1c9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_9702ff5c-506e-4134-b2da-e2275db1c9b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_3906f1eb-c8b9-4703-b399-dba95525364d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_3906f1eb-c8b9-4703-b399-dba95525364d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_3906f1eb-c8b9-4703-b399-dba95525364d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_3906f1eb-c8b9-4703-b399-dba95525364d" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_3906f1eb-c8b9-4703-b399-dba95525364d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_3906f1eb-c8b9-4703-b399-dba95525364d" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformingFinancingReceivableMember_8d4337af-dcc6-4697-b27d-aebf7b1c4f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformingFinancingReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:to="loc_us-gaap_PerformingFinancingReceivableMember_8d4337af-dcc6-4697-b27d-aebf7b1c4f9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WatchListFinancingReceivableMember_a099e483-576c-4f67-8171-81a8ef4985a1" xlink:href="peak-20220331.xsd#peak_WatchListFinancingReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:to="loc_peak_WatchListFinancingReceivableMember_a099e483-576c-4f67-8171-81a8ef4985a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WorkoutFinancingReceivableMember_7c5943a5-701d-42fc-9f10-7bad8c1a0cb0" xlink:href="peak-20220331.xsd#peak_WorkoutFinancingReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:to="loc_peak_WorkoutFinancingReceivableMember_7c5943a5-701d-42fc-9f10-7bad8c1a0cb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e89b3579-11f3-417e-a34a-3a1785c65ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e89b3579-11f3-417e-a34a-3a1785c65ad7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_e89b3579-11f3-417e-a34a-3a1785c65ad7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e89b3579-11f3-417e-a34a-3a1785c65ad7" xlink:to="loc_us-gaap_ReceivableTypeDomain_e89b3579-11f3-417e-a34a-3a1785c65ad7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_094fdd66-c9e5-4c50-8b14-c8bff67d8458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e89b3579-11f3-417e-a34a-3a1785c65ad7" xlink:to="loc_us-gaap_ReceivableTypeDomain_094fdd66-c9e5-4c50-8b14-c8bff67d8458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageReceivablesMember_63ad5038-c747-44b1-bb7a-501c5effc421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_094fdd66-c9e5-4c50-8b14-c8bff67d8458" xlink:to="loc_us-gaap_MortgageReceivablesMember_63ad5038-c747-44b1-bb7a-501c5effc421" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineAndOtherLoansReceivableSecuredMember_3123b449-b9c0-4c71-9bfc-f67e07b4f696" xlink:href="peak-20220331.xsd#peak_MezzanineAndOtherLoansReceivableSecuredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_094fdd66-c9e5-4c50-8b14-c8bff67d8458" xlink:to="loc_peak_MezzanineAndOtherLoansReceivableSecuredMember_3123b449-b9c0-4c71-9bfc-f67e07b4f696" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableScheduleofReserveforLoanLossesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails" xlink:type="extended" id="i3b113d4c58f5461fb9d32252ca0f0e05_LoansReceivableScheduleofReserveforLoanLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_4dc699f1-496b-4810-9435-8b3c5c1598c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_4dc699f1-496b-4810-9435-8b3c5c1598c1" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_717445c7-e453-4809-bc22-872ba6e782f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_717445c7-e453-4809-bc22-872ba6e782f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed_75778147-0c1d-405f-b841-75cddd7cf714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:to="loc_us-gaap_ProvisionForLoanLossesExpensed_75778147-0c1d-405f-b841-75cddd7cf714" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableSignificantSales_2eab2cc3-b9c4-46d2-a3ec-deacd5580702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableSignificantSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:to="loc_us-gaap_FinancingReceivableSignificantSales_2eab2cc3-b9c4-46d2-a3ec-deacd5580702" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_58dac112-4376-4c0b-8b01-ad21a5ca71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableNumberOfContractsSold_4cbc9d75-afb0-481e-ad17-de4369490c17" xlink:href="peak-20220331.xsd#peak_FinancingReceivableNumberOfContractsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_4dc699f1-496b-4810-9435-8b3c5c1598c1" xlink:to="loc_peak_FinancingReceivableNumberOfContractsSold_4cbc9d75-afb0-481e-ad17-de4369490c17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_64df9f9c-0e26-4536-8ef4-795a6189e174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_4dc699f1-496b-4810-9435-8b3c5c1598c1" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_64df9f9c-0e26-4536-8ef4-795a6189e174" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_fab83089-93af-4a2f-92a6-24c0d75327f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_64df9f9c-0e26-4536-8ef4-795a6189e174" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_fab83089-93af-4a2f-92a6-24c0d75327f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_fab83089-93af-4a2f-92a6-24c0d75327f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_fab83089-93af-4a2f-92a6-24c0d75327f5" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_fab83089-93af-4a2f-92a6-24c0d75327f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f34a76e6-b954-4327-bb8d-afb1930629e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_fab83089-93af-4a2f-92a6-24c0d75327f5" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f34a76e6-b954-4327-bb8d-afb1930629e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_1f50b27b-d6f8-4c19-bcd9-fb7dc6c3b060" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f34a76e6-b954-4327-bb8d-afb1930629e9" xlink:to="loc_peak_MezzanineMember_1f50b27b-d6f8-4c19-bcd9-fb7dc6c3b060" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingDevelopmentLoansAndOtherMember_0d0b93b9-4259-48ea-860f-6edf1eab3014" xlink:href="peak-20220331.xsd#peak_ParticipatingDevelopmentLoansAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f34a76e6-b954-4327-bb8d-afb1930629e9" xlink:to="loc_peak_ParticipatingDevelopmentLoansAndOtherMember_0d0b93b9-4259-48ea-860f-6edf1eab3014" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="extended" id="i9208aa2555f14f5daee8f2d0b1a617cc_InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_38ee20b7-8145-47c9-b4c0-ac742534b1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_38ee20b7-8145-47c9-b4c0-ac742534b1f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9345dba9-64a3-4a1f-b568-6aab0a34dae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9345dba9-64a3-4a1f-b568-6aab0a34dae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7400b7ef-2d1c-43f3-910d-66b4bbc26eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_EquityMethodInvestments_7400b7ef-2d1c-43f3-910d-66b4bbc26eee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_fb98e7f4-0e83-450e-9e4c-248cc89d2012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_fb98e7f4-0e83-450e-9e4c-248cc89d2012" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_e0d4b54f-2c8f-47bc-a174-21f37c0fe9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_e0d4b54f-2c8f-47bc-a174-21f37c0fe9b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture_6212174d-93f2-49c7-bc5f-26eb23a52eec" xlink:href="peak-20220331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_peak_NumberOfUnconsolidatedJointVenture_6212174d-93f2-49c7-bc5f-26eb23a52eec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold_a4393dc1-f4a5-42a1-9093-324d105ecdd4" xlink:href="peak-20220331.xsd#peak_NumberOfPreferredEquityMethodInvestmentsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold_a4393dc1-f4a5-42a1-9093-324d105ecdd4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold_157264e1-2b6a-423b-afbf-6a093b83b5fd" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_peak_NumberOfPropertiesToBeSold_157264e1-2b6a-423b-afbf-6a093b83b5fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_803dcd29-e7b5-49fd-a245-683ccbaf275c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_803dcd29-e7b5-49fd-a245-683ccbaf275c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fc541a85-279c-4982-b775-0f27fdc4b8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fc541a85-279c-4982-b775-0f27fdc4b8bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fc541a85-279c-4982-b775-0f27fdc4b8bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc541a85-279c-4982-b775-0f27fdc4b8bd" xlink:to="loc_us-gaap_SegmentDomain_fc541a85-279c-4982-b775-0f27fdc4b8bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc541a85-279c-4982-b775-0f27fdc4b8bd" xlink:to="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_61c03d62-88ba-4c44-8caf-f4f9ae97b112" xlink:href="peak-20220331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:to="loc_peak_OtherNonReportingSegmentMember_61c03d62-88ba-4c44-8caf-f4f9ae97b112" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_93691e89-0221-4c35-9b18-b2ce84899393" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:to="loc_peak_LifeScienceMember_93691e89-0221-4c35-9b18-b2ce84899393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_c1856f84-cd01-4df8-887c-62db2a79d3d7" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:to="loc_peak_MedicalOfficeMember_c1856f84-cd01-4df8-887c-62db2a79d3d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_3a766fa0-c130-4076-9217-78486de65230" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_3a766fa0-c130-4076-9217-78486de65230" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9c5e1a38-97b6-47b0-9140-d005d28bc61c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_srt_CounterpartyNameAxis_9c5e1a38-97b6-47b0-9140-d005d28bc61c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c5e1a38-97b6-47b0-9140-d005d28bc61c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_9c5e1a38-97b6-47b0-9140-d005d28bc61c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c5e1a38-97b6-47b0-9140-d005d28bc61c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5817f0a1-195e-48a7-9c0e-7dd4d9801009" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_9c5e1a38-97b6-47b0-9140-d005d28bc61c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5817f0a1-195e-48a7-9c0e-7dd4d9801009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember_531399b2-e399-414f-aae2-94644a2935c8" xlink:href="peak-20220331.xsd#peak_BrookdaleMTCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5817f0a1-195e-48a7-9c0e-7dd4d9801009" xlink:to="loc_peak_BrookdaleMTCAMember_531399b2-e399-414f-aae2-94644a2935c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SHOPJVMember_222686d1-6f13-4760-bd79-103f88376fef" xlink:href="peak-20220331.xsd#peak_SHOPJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_SHOPJVMember_222686d1-6f13-4760-bd79-103f88376fef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_8fb85794-1dcf-4bf9-8331-4c5227bb76a8" xlink:href="peak-20220331.xsd#peak_LifeScienceJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_LifeScienceJVsMember_8fb85794-1dcf-4bf9-8331-4c5227bb76a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember_0d890f67-0bf0-4f20-8b34-4299ac22b22d" xlink:href="peak-20220331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_NeedhamLandParcelJVMember_0d890f67-0bf0-4f20-8b34-4299ac22b22d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:href="peak-20220331.xsd#peak_MedicalOfficeJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIVLLCMember_d44a6da9-a38d-4393-aff7-66265f6e92cd" xlink:href="peak-20220331.xsd#peak_HCPVenturesIVLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:to="loc_peak_HCPVenturesIVLLCMember_d44a6da9-a38d-4393-aff7-66265f6e92cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SuburbanPropertiesLLCMember_4f78ce36-beb1-4e1e-b026-55c1dd0bfa3e" xlink:href="peak-20220331.xsd#peak_SuburbanPropertiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:to="loc_peak_SuburbanPropertiesLLCMember_4f78ce36-beb1-4e1e-b026-55c1dd0bfa3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIIILLCMember_50b52c88-0fb1-44b8-a7d5-0ca2d8e474d7" xlink:href="peak-20220331.xsd#peak_HCPVenturesIIILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:to="loc_peak_HCPVenturesIIILLCMember_50b52c88-0fb1-44b8-a7d5-0ca2d8e474d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember_9e9d1fbf-9dee-4818-b3dd-82e0137e1a99" xlink:href="peak-20220331.xsd#peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember_9e9d1fbf-9dee-4818-b3dd-82e0137e1a99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRVJVInvestmentMember_0c4470cc-a839-40c0-8ded-5fd52f7bf213" xlink:href="peak-20220331.xsd#peak_CCRVJVInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_CCRVJVInvestmentMember_0c4470cc-a839-40c0-8ded-5fd52f7bf213" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5de633a1-4006-4d7b-a7ca-4892d2dc4ced" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_srt_RangeAxis_5de633a1-4006-4d7b-a7ca-4892d2dc4ced" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5de633a1-4006-4d7b-a7ca-4892d2dc4ced_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5de633a1-4006-4d7b-a7ca-4892d2dc4ced" xlink:to="loc_srt_RangeMember_5de633a1-4006-4d7b-a7ca-4892d2dc4ced_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ef39e7b9-fdec-40ab-afa5-0808323267d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5de633a1-4006-4d7b-a7ca-4892d2dc4ced" xlink:to="loc_srt_RangeMember_ef39e7b9-fdec-40ab-afa5-0808323267d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aed5d8d5-ad4e-4a95-b54b-77134cd7cd15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ef39e7b9-fdec-40ab-afa5-0808323267d1" xlink:to="loc_srt_MinimumMember_aed5d8d5-ad4e-4a95-b54b-77134cd7cd15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d2a9eb30-0b9d-4ebc-8541-f3e942fb0745" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ef39e7b9-fdec-40ab-afa5-0808323267d1" xlink:to="loc_srt_MaximumMember_d2a9eb30-0b9d-4ebc-8541-f3e942fb0745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6365f6b5-57f6-4a68-81ba-af9cd86dd009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6365f6b5-57f6-4a68-81ba-af9cd86dd009" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6365f6b5-57f6-4a68-81ba-af9cd86dd009_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6365f6b5-57f6-4a68-81ba-af9cd86dd009" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_6365f6b5-57f6-4a68-81ba-af9cd86dd009_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0430f66d-8b52-43d6-8e44-6ef7dcdcb5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6365f6b5-57f6-4a68-81ba-af9cd86dd009" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0430f66d-8b52-43d6-8e44-6ef7dcdcb5a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoveryNaplesJVMember_7b88e8e3-06bb-4af0-87a2-dbc4d67f86e7" xlink:href="peak-20220331.xsd#peak_DiscoveryNaplesJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0430f66d-8b52-43d6-8e44-6ef7dcdcb5a3" xlink:to="loc_peak_DiscoveryNaplesJVMember_7b88e8e3-06bb-4af0-87a2-dbc4d67f86e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySarasotaJVMember_f39669f8-909b-42e4-ad79-9ab98e86d54c" xlink:href="peak-20220331.xsd#peak_DiscoverySarasotaJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0430f66d-8b52-43d6-8e44-6ef7dcdcb5a3" xlink:to="loc_peak_DiscoverySarasotaJVMember_f39669f8-909b-42e4-ad79-9ab98e86d54c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_bd821ecb-b196-43f8-84b2-21a5d03b609c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_us-gaap_InvestmentTypeAxis_bd821ecb-b196-43f8-84b2-21a5d03b609c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_bd821ecb-b196-43f8-84b2-21a5d03b609c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_bd821ecb-b196-43f8-84b2-21a5d03b609c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_bd821ecb-b196-43f8-84b2-21a5d03b609c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7e2d066a-a3f3-46b2-baa4-65f6b0b3c5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_bd821ecb-b196-43f8-84b2-21a5d03b609c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7e2d066a-a3f3-46b2-baa4-65f6b0b3c5e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySHOPPortfolioMember_6e85929f-8883-4d77-83b4-f914b8ab5ec4" xlink:href="peak-20220331.xsd#peak_DiscoverySHOPPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7e2d066a-a3f3-46b2-baa4-65f6b0b3c5e6" xlink:to="loc_peak_DiscoverySHOPPortfolioMember_6e85929f-8883-4d77-83b4-f914b8ab5ec4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#IntangiblesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/IntangiblesNarrativeDetails" xlink:type="extended" id="i1e6f3ca9b4da49958e25fe9a6aa33627_IntangiblesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6de2a488-4841-4866-8dcd-4c705317c970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6de2a488-4841-4866-8dcd-4c705317c970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangibleLiabilitiesAcquired_a7cfbf11-0d28-4ff2-9b70-1197aa791b4d" xlink:href="peak-20220331.xsd#peak_IntangibleLiabilitiesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_peak_IntangibleLiabilitiesAcquired_a7cfbf11-0d28-4ff2-9b70-1197aa791b4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fdb97ab6-de48-4f9e-993a-de7cf95d0a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fdb97ab6-de48-4f9e-993a-de7cf95d0a6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_2e8cbeac-228b-43cc-8dba-7e7f32fb0214" xlink:href="peak-20220331.xsd#peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_2e8cbeac-228b-43cc-8dba-7e7f32fb0214" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_9aba06f1-7e67-4c8c-b105-a4174d76c7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_758636a3-58a3-4c49-a7dd-ce3a15b8fb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_758636a3-58a3-4c49-a7dd-ce3a15b8fb2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b2b945e6-f21f-4c23-a469-b6744793db0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_758636a3-58a3-4c49-a7dd-ce3a15b8fb2b" xlink:to="loc_srt_CounterpartyNameAxis_b2b945e6-f21f-4c23-a469-b6744793db0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b2b945e6-f21f-4c23-a469-b6744793db0d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b2b945e6-f21f-4c23-a469-b6744793db0d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b2b945e6-f21f-4c23-a469-b6744793db0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29bae9-9ca3-4bcf-9ba6-e85ea07aae45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b2b945e6-f21f-4c23-a469-b6744793db0d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29bae9-9ca3-4bcf-9ba6-e85ea07aae45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember_70c5481c-678b-4f8a-8587-658646cfcf40" xlink:href="peak-20220331.xsd#peak_BrookdaleMTCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29bae9-9ca3-4bcf-9ba6-e85ea07aae45" xlink:to="loc_peak_BrookdaleMTCAMember_70c5481c-678b-4f8a-8587-658646cfcf40" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtBankLineofCreditandTermLoansDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails" xlink:type="extended" id="idaa9288fe130498c8c5ffc2ed2285087_DebtBankLineofCreditandTermLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_67229ed9-357f-4a82-a07f-244d9401d1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_67229ed9-357f-4a82-a07f-244d9401d1fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentNumberofExtensions_fdc5ea9c-9237-4a2d-89b0-334783df5d6f" xlink:href="peak-20220331.xsd#peak_DebtInstrumentNumberofExtensions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentNumberofExtensions_fdc5ea9c-9237-4a2d-89b0-334783df5d6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentPeriodOfExtension_43967780-cb13-409f-99c6-798a9372a636" xlink:href="peak-20220331.xsd#peak_DebtInstrumentPeriodOfExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentPeriodOfExtension_43967780-cb13-409f-99c6-798a9372a636" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_62b9e68c-5a26-45f4-b443-2c02c80d2ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_62b9e68c-5a26-45f4-b443-2c02c80d2ff1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_8dd65cb2-36c2-42ac-8807-0ad82571750f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_8dd65cb2-36c2-42ac-8807-0ad82571750f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2d50f814-44c5-42c0-a1e2-aba0b9df5419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2d50f814-44c5-42c0-a1e2-aba0b9df5419" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4b8f3844-579d-45c7-9028-552052440a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4b8f3844-579d-45c7-9028-552052440a47" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_0bae4538-72a5-4d63-a870-2034de3676f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_LineOfCredit_0bae4538-72a5-4d63-a870-2034de3676f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_a1cdd712-7949-410d-9847-440f523d1180" xlink:href="peak-20220331.xsd#peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_a1cdd712-7949-410d-9847-440f523d1180" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_c492a1da-ff6c-4281-8697-2eee50cd5919" xlink:href="peak-20220331.xsd#peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_c492a1da-ff6c-4281-8697-2eee50cd5919" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantDebtToAssets_a1c350ec-8f3c-4bce-ae64-0019da461721" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantDebtToAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantDebtToAssets_a1c350ec-8f3c-4bce-ae64-0019da461721" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets_03c8d8b7-6ecc-442f-902b-87171ed0796b" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantSecuredDebtToAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets_03c8d8b7-6ecc-442f-902b-87171ed0796b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_d4c35b19-fe1e-426b-95e5-08fe3a37f822" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_d4c35b19-fe1e-426b-95e5-08fe3a37f822" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_4697d84f-8684-48ea-a9ee-b82785cbb027" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantFixedChargeRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_4697d84f-8684-48ea-a9ee-b82785cbb027" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantNetWorth_d27b7a07-fc6d-445c-9c05-47c3a1d603fc" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantNetWorth"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantNetWorth_d27b7a07-fc6d-445c-9c05-47c3a1d603fc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_39a012df-aec1-4abd-b02f-107022801381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_39a012df-aec1-4abd-b02f-107022801381" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39a012df-aec1-4abd-b02f-107022801381_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_39a012df-aec1-4abd-b02f-107022801381" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39a012df-aec1-4abd-b02f-107022801381_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c5f9b424-cba0-4c92-8afe-dcf64a86ea09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_39a012df-aec1-4abd-b02f-107022801381" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c5f9b424-cba0-4c92-8afe-dcf64a86ea09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9ef97bae-454e-4db5-b776-e5090e12da83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c5f9b424-cba0-4c92-8afe-dcf64a86ea09" xlink:to="loc_us-gaap_LineOfCreditMember_9ef97bae-454e-4db5-b776-e5090e12da83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bfb15d42-1a13-490a-9c83-b4c186ab6435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_CreditFacilityAxis_bfb15d42-1a13-490a-9c83-b4c186ab6435" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bfb15d42-1a13-490a-9c83-b4c186ab6435_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_bfb15d42-1a13-490a-9c83-b4c186ab6435" xlink:to="loc_us-gaap_CreditFacilityDomain_bfb15d42-1a13-490a-9c83-b4c186ab6435_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_973b7c24-c6ac-420d-9049-5255f592fb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_bfb15d42-1a13-490a-9c83-b4c186ab6435" xlink:to="loc_us-gaap_CreditFacilityDomain_973b7c24-c6ac-420d-9049-5255f592fb0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c9f03081-1bbc-4814-8478-91d3213a45ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_973b7c24-c6ac-420d-9049-5255f592fb0e" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c9f03081-1bbc-4814-8478-91d3213a45ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2019TermLoanMember_3b44715c-8586-4484-a553-2d6cef82cb2d" xlink:href="peak-20220331.xsd#peak_A2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_973b7c24-c6ac-420d-9049-5255f592fb0e" xlink:to="loc_peak_A2019TermLoanMember_3b44715c-8586-4484-a553-2d6cef82cb2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5b5cd542-0299-47fd-9f91-443beaf5ee37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_VariableRateAxis_5b5cd542-0299-47fd-9f91-443beaf5ee37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5b5cd542-0299-47fd-9f91-443beaf5ee37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_5b5cd542-0299-47fd-9f91-443beaf5ee37" xlink:to="loc_us-gaap_VariableRateDomain_5b5cd542-0299-47fd-9f91-443beaf5ee37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1f39f4e9-e28a-4c94-8ad0-a0e9944d9579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_5b5cd542-0299-47fd-9f91-443beaf5ee37" xlink:to="loc_us-gaap_VariableRateDomain_1f39f4e9-e28a-4c94-8ad0-a0e9944d9579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d69d7531-ad10-4683-98e4-26e8498578e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1f39f4e9-e28a-4c94-8ad0-a0e9944d9579" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d69d7531-ad10-4683-98e4-26e8498578e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cdd47581-b1bc-4a8c-b263-d1e3ed434e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_DebtInstrumentAxis_cdd47581-b1bc-4a8c-b263-d1e3ed434e87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cdd47581-b1bc-4a8c-b263-d1e3ed434e87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cdd47581-b1bc-4a8c-b263-d1e3ed434e87" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cdd47581-b1bc-4a8c-b263-d1e3ed434e87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_752ebf5a-7373-4cd9-a34e-cbdaa2820eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cdd47581-b1bc-4a8c-b263-d1e3ed434e87" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_752ebf5a-7373-4cd9-a34e-cbdaa2820eee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditAndTermLoanMember_4eea5bfa-3e47-4693-bd7d-28e3cc21e9bd" xlink:href="peak-20220331.xsd#peak_LineOfCreditAndTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_752ebf5a-7373-4cd9-a34e-cbdaa2820eee" xlink:to="loc_peak_LineOfCreditAndTermLoanMember_4eea5bfa-3e47-4693-bd7d-28e3cc21e9bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtCommercialPaperProgramDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails" xlink:type="extended" id="i5aad5cdaaa494ef183096911414be531_DebtCommercialPaperProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMaximumBorrowingCapacity_7d1aa97e-30c5-4900-8e7e-ea66b9a4c976" xlink:href="peak-20220331.xsd#peak_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_peak_DebtInstrumentMaximumBorrowingCapacity_7d1aa97e-30c5-4900-8e7e-ea66b9a4c976" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3ad202ea-f1ac-4192-a45f-456773354429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_us-gaap_ShortTermBorrowings_3ad202ea-f1ac-4192-a45f-456773354429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_bd8cb816-08a9-496a-9538-b68c0382d2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_us-gaap_DebtInstrumentTerm_bd8cb816-08a9-496a-9538-b68c0382d2ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_a7acbae3-9a74-496e-9e69-4bd7dfceffd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_a7acbae3-9a74-496e-9e69-4bd7dfceffd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_38d3d4ac-919b-49e8-a6c0-e17243e2e29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_us-gaap_DebtInstrumentTable_38d3d4ac-919b-49e8-a6c0-e17243e2e29e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_15409931-8084-4f2b-862f-645e3f2a9998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_38d3d4ac-919b-49e8-a6c0-e17243e2e29e" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_15409931-8084-4f2b-862f-645e3f2a9998" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_15409931-8084-4f2b-862f-645e3f2a9998_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_15409931-8084-4f2b-862f-645e3f2a9998" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_15409931-8084-4f2b-862f-645e3f2a9998_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_fb137fb2-8973-4de8-9a3f-9935e85594e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_15409931-8084-4f2b-862f-645e3f2a9998" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_fb137fb2-8973-4de8-9a3f-9935e85594e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommercialPaperProgramMember_db2fcf3e-d54e-4d4c-8735-36910cdec77e" xlink:href="peak-20220331.xsd#peak_CommercialPaperProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_fb137fb2-8973-4de8-9a3f-9935e85594e0" xlink:to="loc_peak_CommercialPaperProgramMember_db2fcf3e-d54e-4d4c-8735-36910cdec77e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtSeniorUnsecuredNotesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails" xlink:type="extended" id="i42c4285d0c8d4c4ca2da1f765a55092b_DebtSeniorUnsecuredNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6123a3b6-7cf8-4d5a-ad05-1ba7de749bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6123a3b6-7cf8-4d5a-ad05-1ba7de749bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b868744e-e896-4de5-a8f2-39ec2ec5ee9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b868744e-e896-4de5-a8f2-39ec2ec5ee9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_315f377c-6151-4f3e-b87a-053ef5c4ac8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_315f377c-6151-4f3e-b87a-053ef5c4ac8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ce232abb-d123-408e-8b1c-fc829a4821aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ce232abb-d123-408e-8b1c-fc829a4821aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfBondOfferings_811ff7e2-1b7c-445f-8516-67c3339a4bf3" xlink:href="peak-20220331.xsd#peak_NumberOfBondOfferings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_peak_NumberOfBondOfferings_811ff7e2-1b7c-445f-8516-67c3339a4bf3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bc32e821-db7c-4a01-9225-e2b523263270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bc32e821-db7c-4a01-9225-e2b523263270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bc32e821-db7c-4a01-9225-e2b523263270_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bc32e821-db7c-4a01-9225-e2b523263270" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bc32e821-db7c-4a01-9225-e2b523263270_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_48c1d001-6edf-47b1-ac46-37bd905fda2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bc32e821-db7c-4a01-9225-e2b523263270" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_48c1d001-6edf-47b1-ac46-37bd905fda2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_51a2ebd5-06d1-4244-8eaa-02c4d5e616c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_48c1d001-6edf-47b1-ac46-37bd905fda2c" xlink:to="loc_us-gaap_UnsecuredDebtMember_51a2ebd5-06d1-4244-8eaa-02c4d5e616c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_79bb0b46-9a75-41a6-9661-000ec6d65578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:to="loc_us-gaap_DebtInstrumentAxis_79bb0b46-9a75-41a6-9661-000ec6d65578" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_79bb0b46-9a75-41a6-9661-000ec6d65578_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_79bb0b46-9a75-41a6-9661-000ec6d65578" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_79bb0b46-9a75-41a6-9661-000ec6d65578_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_79bb0b46-9a75-41a6-9661-000ec6d65578" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote3400PercentMember_73f4d228-b3a6-46c3-831c-1442de2faa6d" xlink:href="peak-20220331.xsd#peak_UnsecuredNote3400PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote3400PercentMember_73f4d228-b3a6-46c3-831c-1442de2faa6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4000PercentMember_fd522b0e-4cae-4077-9236-47a227016a94" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4000PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote4000PercentMember_fd522b0e-4cae-4077-9236-47a227016a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4.250PercentMember_93e516d0-a7ff-48fd-ab85-73975cad4a83" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4.250PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote4.250PercentMember_93e516d0-a7ff-48fd-ab85-73975cad4a83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4200PercentMember_dd90483e-2064-4d5e-beac-93cbe1a54982" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4200PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote4200PercentMember_dd90483e-2064-4d5e-beac-93cbe1a54982" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote3880PercentMember_bc000bf5-43e2-4f6b-af26-8e42b07f4e7c" xlink:href="peak-20220331.xsd#peak_UnsecuredNote3880PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote3880PercentMember_bc000bf5-43e2-4f6b-af26-8e42b07f4e7c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorNotesDue2025Member_abfe6f5f-6690-4826-bdc0-966ac969b852" xlink:href="peak-20220331.xsd#peak_SeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_SeniorNotesDue2025Member_abfe6f5f-6690-4826-bdc0-966ac969b852" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorNotesDue2023And2024Member_5b1cbb21-5a2e-4c59-9193-5faee9179982" xlink:href="peak-20220331.xsd#peak_SeniorNotesDue2023And2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_SeniorNotesDue2023And2024Member_5b1cbb21-5a2e-4c59-9193-5faee9179982" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote213PercentMember_f72e4ec6-15f9-470b-8679-74d1d93c9303" xlink:href="peak-20220331.xsd#peak_UnsecuredNote213PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote213PercentMember_f72e4ec6-15f9-470b-8679-74d1d93c9303" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote1350PercentMember_03f225ce-f979-4596-948a-3fa053f3e2b8" xlink:href="peak-20220331.xsd#peak_UnsecuredNote1350PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote1350PercentMember_03f225ce-f979-4596-948a-3fa053f3e2b8" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtMortgageDebtDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtMortgageDebtDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtMortgageDebtDetails" xlink:type="extended" id="i8ef61565ff134b409404c06af0811473_DebtMortgageDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2fac9ada-b22c-44a3-905f-b3169063f3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2fac9ada-b22c-44a3-905f-b3169063f3df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber_bd19c6c0-7a20-489c-bd50-30326c593aaf" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber_bd19c6c0-7a20-489c-bd50-30326c593aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_f4828ce9-cc8f-46cc-a343-b021ba8150ff" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_f4828ce9-cc8f-46cc-a343-b021ba8150ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_b546c984-3f62-4c38-8df6-45e6e71fd8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_b546c984-3f62-4c38-8df6-45e6e71fd8ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5baec944-3a08-4aba-9f38-c43b4f2e5521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5baec944-3a08-4aba-9f38-c43b4f2e5521" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_e6d2bc3d-672f-42ad-ae2b-da68fd552a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_e6d2bc3d-672f-42ad-ae2b-da68fd552a83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c7fbd08b-4775-4f65-992d-0900abcc544f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c7fbd08b-4775-4f65-992d-0900abcc544f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c7fbd08b-4775-4f65-992d-0900abcc544f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c7fbd08b-4775-4f65-992d-0900abcc544f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c7fbd08b-4775-4f65-992d-0900abcc544f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0c75a292-fc0c-4671-982f-3677618e0972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c7fbd08b-4775-4f65-992d-0900abcc544f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0c75a292-fc0c-4671-982f-3677618e0972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c4e11013-e6e9-4e13-8660-b91677dd6a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0c75a292-fc0c-4671-982f-3677618e0972" xlink:to="loc_us-gaap_SecuredDebtMember_c4e11013-e6e9-4e13-8660-b91677dd6a12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1186d3f5-8511-413d-99c1-6594d9c645e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1186d3f5-8511-413d-99c1-6594d9c645e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1186d3f5-8511-413d-99c1-6594d9c645e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1186d3f5-8511-413d-99c1-6594d9c645e8" xlink:to="loc_us-gaap_SegmentDomain_1186d3f5-8511-413d-99c1-6594d9c645e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5106d9f3-dce8-4687-a9fe-1fcc7cb28c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1186d3f5-8511-413d-99c1-6594d9c645e8" xlink:to="loc_us-gaap_SegmentDomain_5106d9f3-dce8-4687-a9fe-1fcc7cb28c38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_3113fa1e-5ccb-4e4d-b8f9-aa28e1e1cc7c" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5106d9f3-dce8-4687-a9fe-1fcc7cb28c38" xlink:to="loc_peak_MedicalOfficeMember_3113fa1e-5ccb-4e4d-b8f9-aa28e1e1cc7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_78072eee-18e9-4820-b070-07199d907f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_DebtInstrumentAxis_78072eee-18e9-4820-b070-07199d907f79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_78072eee-18e9-4820-b070-07199d907f79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_78072eee-18e9-4820-b070-07199d907f79" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_78072eee-18e9-4820-b070-07199d907f79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dd80d3ad-0c68-4cfa-83ae-83ed5bc96e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_78072eee-18e9-4820-b070-07199d907f79" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dd80d3ad-0c68-4cfa-83ae-83ed5bc96e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c436d28b-d59c-4086-99c3-6c445d26d9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dd80d3ad-0c68-4cfa-83ae-83ed5bc96e80" xlink:to="loc_us-gaap_SecuredDebtMember_c436d28b-d59c-4086-99c3-6c445d26d9e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_776434df-0c8f-4089-a90a-2f6257ea5485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_776434df-0c8f-4089-a90a-2f6257ea5485" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_776434df-0c8f-4089-a90a-2f6257ea5485_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_776434df-0c8f-4089-a90a-2f6257ea5485" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_776434df-0c8f-4089-a90a-2f6257ea5485_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d12ebd01-d02c-4272-9f29-c53fd47c6c27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_776434df-0c8f-4089-a90a-2f6257ea5485" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d12ebd01-d02c-4272-9f29-c53fd47c6c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1a33aa24-4e42-4daf-82e1-b067affacdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d12ebd01-d02c-4272-9f29-c53fd47c6c27" xlink:to="loc_us-gaap_SubsequentEventMember_1a33aa24-4e42-4daf-82e1-b067affacdaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_34cfd966-dbd4-407b-a1c2-085ef87e0172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_34cfd966-dbd4-407b-a1c2-085ef87e0172" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_34cfd966-dbd4-407b-a1c2-085ef87e0172_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_34cfd966-dbd4-407b-a1c2-085ef87e0172" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_34cfd966-dbd4-407b-a1c2-085ef87e0172_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_efae7997-1422-4f51-85a1-da108eb98029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_34cfd966-dbd4-407b-a1c2-085ef87e0172" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_efae7997-1422-4f51-85a1-da108eb98029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_055577f9-44dc-44b4-b275-f584d6261e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efae7997-1422-4f51-85a1-da108eb98029" xlink:to="loc_us-gaap_InterestRateSwapMember_055577f9-44dc-44b4-b275-f584d6261e2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_589acf3c-5913-4107-b248-c1834adea2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_589acf3c-5913-4107-b248-c1834adea2d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_589acf3c-5913-4107-b248-c1834adea2d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_589acf3c-5913-4107-b248-c1834adea2d7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_589acf3c-5913-4107-b248-c1834adea2d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_563d4a67-595c-4f9e-bd31-eba194d6d9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_589acf3c-5913-4107-b248-c1834adea2d7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_563d4a67-595c-4f9e-bd31-eba194d6d9ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_060a02de-1a0b-478f-b096-b19aa1611dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_563d4a67-595c-4f9e-bd31-eba194d6d9ab" xlink:to="loc_us-gaap_CashFlowHedgingMember_060a02de-1a0b-478f-b096-b19aa1611dca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b2d182ab-77a4-4f85-a3b8-236d635af4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_HedgingDesignationAxis_b2d182ab-77a4-4f85-a3b8-236d635af4f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b2d182ab-77a4-4f85-a3b8-236d635af4f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b2d182ab-77a4-4f85-a3b8-236d635af4f7" xlink:to="loc_us-gaap_HedgingDesignationDomain_b2d182ab-77a4-4f85-a3b8-236d635af4f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5450723d-bf80-4fce-b33d-e318530cac66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b2d182ab-77a4-4f85-a3b8-236d635af4f7" xlink:to="loc_us-gaap_HedgingDesignationDomain_5450723d-bf80-4fce-b33d-e318530cac66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5e81aaa5-a398-4dbb-a0af-eff7ecb7c56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5450723d-bf80-4fce-b33d-e318530cac66" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5e81aaa5-a398-4dbb-a0af-eff7ecb7c56c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtDebtMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="extended" id="iff8f3580018f400ea314ac012988175f_DebtDebtMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_012fe108-d699-4bcf-b24d-20a4f422b1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_012fe108-d699-4bcf-b24d-20a4f422b1e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_76ca2e57-f417-4938-8c5b-7d637c07134f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_76ca2e57-f417-4938-8c5b-7d637c07134f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3a27612c-6172-4957-9fc3-0e78ac9c9381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3a27612c-6172-4957-9fc3-0e78ac9c9381" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_862bc503-7355-4eec-841a-b6dedcc4c7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_862bc503-7355-4eec-841a-b6dedcc4c7ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_23d9636d-5ee5-4bd5-9e63-ea2281df99b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_23d9636d-5ee5-4bd5-9e63-ea2281df99b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LongTermDebtMaturityAfterYearFour_57533aeb-5f9a-4f72-88e2-8c67cd380fcc" xlink:href="peak-20220331.xsd#peak_LongTermDebtMaturityAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_peak_LongTermDebtMaturityAfterYearFour_57533aeb-5f9a-4f72-88e2-8c67cd380fcc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f9fecde7-dbbd-4787-b8d5-11c93dcc1063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f9fecde7-dbbd-4787-b8d5-11c93dcc1063" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_5083358d-49db-4f17-8dbf-15e9222d4cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_5083358d-49db-4f17-8dbf-15e9222d4cb0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a606d651-263e-4108-9092-d757dd666fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebt_a606d651-263e-4108-9092-d757dd666fbd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d75efd2e-0007-445b-8200-b086df7b6fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d75efd2e-0007-445b-8200-b086df7b6fa1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_a78b8545-bd8f-4e9d-91d3-4c440b3f41fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_a78b8545-bd8f-4e9d-91d3-4c440b3f41fd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentWeightedAverageMaturity_4346fe9b-5a1f-4ecc-b3ee-0dbb3dd2824e" xlink:href="peak-20220331.xsd#peak_DebtInstrumentWeightedAverageMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_peak_DebtInstrumentWeightedAverageMaturity_4346fe9b-5a1f-4ecc-b3ee-0dbb3dd2824e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a5a158a3-c73d-4e85-b293-da36a2408b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a5a158a3-c73d-4e85-b293-da36a2408b62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a5a158a3-c73d-4e85-b293-da36a2408b62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a5a158a3-c73d-4e85-b293-da36a2408b62" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a5a158a3-c73d-4e85-b293-da36a2408b62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a5a158a3-c73d-4e85-b293-da36a2408b62" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_dc4d14c5-a4cf-4b24-b0ac-53fd03513ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:to="loc_us-gaap_LineOfCreditMember_dc4d14c5-a4cf-4b24-b0ac-53fd03513ad6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8f7fae3d-3081-478e-9dce-bf1e03d74793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:to="loc_us-gaap_CommercialPaperMember_8f7fae3d-3081-478e-9dce-bf1e03d74793" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_ab2a4876-f9a7-4d5f-940a-81a950229518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:to="loc_us-gaap_UnsecuredDebtMember_ab2a4876-f9a7-4d5f-940a-81a950229518" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_860c4154-000f-4b10-b56f-6d70ee474662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:to="loc_us-gaap_SecuredDebtMember_860c4154-000f-4b10-b56f-6d70ee474662" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8eb58823-dbd0-446b-9650-09d2c12c94cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:to="loc_srt_RangeAxis_8eb58823-dbd0-446b-9650-09d2c12c94cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8eb58823-dbd0-446b-9650-09d2c12c94cf_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8eb58823-dbd0-446b-9650-09d2c12c94cf" xlink:to="loc_srt_RangeMember_8eb58823-dbd0-446b-9650-09d2c12c94cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9bc45a9-0688-4bd1-8ade-2e671129a168" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8eb58823-dbd0-446b-9650-09d2c12c94cf" xlink:to="loc_srt_RangeMember_d9bc45a9-0688-4bd1-8ade-2e671129a168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e9e80328-218f-4c37-8610-f1662edfc6f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d9bc45a9-0688-4bd1-8ade-2e671129a168" xlink:to="loc_srt_MinimumMember_e9e80328-218f-4c37-8610-f1662edfc6f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_565fb495-2cee-4493-909b-ac925ca8d206" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d9bc45a9-0688-4bd1-8ade-2e671129a168" xlink:to="loc_srt_MaximumMember_565fb495-2cee-4493-909b-ac925ca8d206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6cfb2882-f287-486e-ae61-03e40ef35a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6cfb2882-f287-486e-ae61-03e40ef35a5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6cfb2882-f287-486e-ae61-03e40ef35a5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6cfb2882-f287-486e-ae61-03e40ef35a5b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6cfb2882-f287-486e-ae61-03e40ef35a5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6cfb2882-f287-486e-ae61-03e40ef35a5b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_a4d1fc6b-b72e-4e94-8825-48e1a616a64f" xlink:href="peak-20220331.xsd#peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_a4d1fc6b-b72e-4e94-8825-48e1a616a64f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_46ada022-f6dd-4408-8958-fdccc443ee83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_46ada022-f6dd-4408-8958-fdccc443ee83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_13605ef3-bdb1-4cc6-8222-e821444c1fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_13605ef3-bdb1-4cc6-8222-e821444c1fff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_b7c2aca6-f3d5-49e0-b6a9-0815a03ca90f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_b7c2aca6-f3d5-49e0-b6a9-0815a03ca90f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3bbe6010-ec08-468f-b5ef-0ca8fb36705a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3bbe6010-ec08-468f-b5ef-0ca8fb36705a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember_899c473b-5e26-45b1-81c1-bd19dc0754c5" xlink:href="peak-20220331.xsd#peak_DebtInstrumentRedemptionPeriodThereafterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember_899c473b-5e26-45b1-81c1-bd19dc0754c5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i454aa4ca191340fdbc033381442d10c7_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c79712ed-edb8-48de-8446-73aac66b25a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ContributionOfPropertyNumberOfProperties_cb74336a-cd0e-4161-b9dd-4adc11bec4e6" xlink:href="peak-20220331.xsd#peak_ContributionOfPropertyNumberOfProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79712ed-edb8-48de-8446-73aac66b25a8" xlink:to="loc_peak_ContributionOfPropertyNumberOfProperties_cb74336a-cd0e-4161-b9dd-4adc11bec4e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3273ce80-d46f-4e0f-a090-2d885a9ae911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79712ed-edb8-48de-8446-73aac66b25a8" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3273ce80-d46f-4e0f-a090-2d885a9ae911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79712ed-edb8-48de-8446-73aac66b25a8" xlink:to="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_629b6bb4-ef43-4b80-9bb6-cb35138186f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_629b6bb4-ef43-4b80-9bb6-cb35138186f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_629b6bb4-ef43-4b80-9bb6-cb35138186f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_629b6bb4-ef43-4b80-9bb6-cb35138186f6" xlink:to="loc_us-gaap_LossContingencyNatureDomain_629b6bb4-ef43-4b80-9bb6-cb35138186f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_015ced67-eb0d-4cb8-b415-758ba66b5f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_629b6bb4-ef43-4b80-9bb6-cb35138186f6" xlink:to="loc_us-gaap_LossContingencyNatureDomain_015ced67-eb0d-4cb8-b415-758ba66b5f06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_fa75ae7c-74c7-41d9-bc5f-54cdee1ed069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_015ced67-eb0d-4cb8-b415-758ba66b5f06" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_fa75ae7c-74c7-41d9-bc5f-54cdee1ed069" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_77391b4a-edd2-4461-8702-5044fb1b0781" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_77391b4a-edd2-4461-8702-5044fb1b0781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_77391b4a-edd2-4461-8702-5044fb1b0781_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_77391b4a-edd2-4461-8702-5044fb1b0781" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_77391b4a-edd2-4461-8702-5044fb1b0781_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7827ccc9-327a-4494-b43e-5e56f47bb67d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_77391b4a-edd2-4461-8702-5044fb1b0781" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7827ccc9-327a-4494-b43e-5e56f47bb67d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_0be60f45-9c00-4414-9124-98f58aac0905" xlink:href="peak-20220331.xsd#peak_LifeScienceJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7827ccc9-327a-4494-b43e-5e56f47bb67d" xlink:to="loc_peak_LifeScienceJVsMember_0be60f45-9c00-4414-9124-98f58aac0905" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_25f2c348-dc4d-4bc9-8aee-de887ba6e34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_25f2c348-dc4d-4bc9-8aee-de887ba6e34c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_25f2c348-dc4d-4bc9-8aee-de887ba6e34c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25f2c348-dc4d-4bc9-8aee-de887ba6e34c" xlink:to="loc_us-gaap_SegmentDomain_25f2c348-dc4d-4bc9-8aee-de887ba6e34c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_744b28da-ba7b-4b2b-abff-936485c0a401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25f2c348-dc4d-4bc9-8aee-de887ba6e34c" xlink:to="loc_us-gaap_SegmentDomain_744b28da-ba7b-4b2b-abff-936485c0a401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_1eab17ff-537a-41b6-b840-b22dd44b38bd" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_744b28da-ba7b-4b2b-abff-936485c0a401" xlink:to="loc_peak_LifeScienceMember_1eab17ff-537a-41b6-b840-b22dd44b38bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails" xlink:type="extended" id="ic1e7d686e57147ee9e08506cd0cfa17b_EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_0af23500-a4d5-43e6-9e7d-221d9796647d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_0af23500-a4d5-43e6-9e7d-221d9796647d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d66fcb7b-dea6-4456-9348-41487d053718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d66fcb7b-dea6-4456-9348-41487d053718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_99875e68-d0b9-4392-adff-76437458d071" xlink:href="peak-20220331.xsd#peak_AtmEquityOfferingProgramAggregateAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_99875e68-d0b9-4392-adff-76437458d071" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OptionIndexedToIssuersEquityTerm_749ce2d3-7327-45bc-aa01-c54cebca70ba" xlink:href="peak-20220331.xsd#peak_OptionIndexedToIssuersEquityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_OptionIndexedToIssuersEquityTerm_749ce2d3-7327-45bc-aa01-c54cebca70ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining_caf5c28d-21f6-4065-a3ae-10287a487046" xlink:href="peak-20220331.xsd#peak_ATMEquityOfferingProgramAggregateAmountRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining_caf5c28d-21f6-4065-a3ae-10287a487046" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_c27fb79b-b183-4371-a397-52267040d792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_c27fb79b-b183-4371-a397-52267040d792" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_790c640e-7ccc-47cc-98bc-e1889b67ae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquityForwardRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_790c640e-7ccc-47cc-98bc-e1889b67ae9a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue_a1d7fc31-75ca-4e72-aec7-d55d49311818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue_a1d7fc31-75ca-4e72-aec7-d55d49311818" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares_89478e3f-3615-4b73-804f-aa07847f0cfe" xlink:href="peak-20220331.xsd#peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares_89478e3f-3615-4b73-804f-aa07847f0cfe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_12feb2f9-41f2-46b8-a727-a65924fb7bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_12feb2f9-41f2-46b8-a727-a65924fb7bde" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_a083d5ad-049e-468b-889e-4fdc3575ce5e" xlink:href="peak-20220331.xsd#peak_NumberOfRedeemableNoncontrollingInterestRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_a083d5ad-049e-468b-889e-4fdc3575ce5e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_0d76a4a4-68a5-4ce3-b85e-93fde58d6ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_0d76a4a4-68a5-4ce3-b85e-93fde58d6ef8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_7f0f221d-5bbb-45c6-99f1-fda0a268454b" xlink:href="peak-20220331.xsd#peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_7f0f221d-5bbb-45c6-99f1-fda0a268454b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_0258ed94-054c-48a6-ad79-56a449d64bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_0258ed94-054c-48a6-ad79-56a449d64bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0258ed94-054c-48a6-ad79-56a449d64bf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0258ed94-054c-48a6-ad79-56a449d64bf5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0258ed94-054c-48a6-ad79-56a449d64bf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0258ed94-054c-48a6-ad79-56a449d64bf5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramMember_856d7fdf-c74e-4b68-ac2e-b11ad338f00d" xlink:href="peak-20220331.xsd#peak_A2020ATMProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:to="loc_peak_A2020ATMProgramMember_856d7fdf-c74e-4b68-ac2e-b11ad338f00d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtTheMarketProgramMember_d7c592b4-dba4-4bd7-b800-724c7a4ed05e" xlink:href="peak-20220331.xsd#peak_AtTheMarketProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:to="loc_peak_AtTheMarketProgramMember_d7c592b4-dba4-4bd7-b800-724c7a4ed05e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramSettledMember_04bd34a1-366d-4557-8bbf-e33d88850473" xlink:href="peak-20220331.xsd#peak_A2020ATMProgramSettledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:to="loc_peak_A2020ATMProgramSettledMember_04bd34a1-366d-4557-8bbf-e33d88850473" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMDirectIssuancesMember_47bcc6e2-d038-4c3c-8fc8-2709cecf047f" xlink:href="peak-20220331.xsd#peak_ATMDirectIssuancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:to="loc_peak_ATMDirectIssuancesMember_47bcc6e2-d038-4c3c-8fc8-2709cecf047f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a868d7a4-95c8-470d-a166-93b756df9de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a868d7a4-95c8-470d-a166-93b756df9de3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a868d7a4-95c8-470d-a166-93b756df9de3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a868d7a4-95c8-470d-a166-93b756df9de3" xlink:to="loc_us-gaap_ClassOfStockDomain_a868d7a4-95c8-470d-a166-93b756df9de3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ca251fc0-91fe-4b8b-83c8-9c9c68ebbc53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a868d7a4-95c8-470d-a166-93b756df9de3" xlink:to="loc_us-gaap_ClassOfStockDomain_ca251fc0-91fe-4b8b-83c8-9c9c68ebbc53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4760fe51-05a3-452f-be3f-37301c13fe24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ca251fc0-91fe-4b8b-83c8-9c9c68ebbc53" xlink:to="loc_us-gaap_CommonStockMember_4760fe51-05a3-452f-be3f-37301c13fe24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_da49f414-6a31-4f27-9b1c-1681a7c5470b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_da49f414-6a31-4f27-9b1c-1681a7c5470b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1e973ec7-c064-43b9-99f2-09ad1ecd97ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_da49f414-6a31-4f27-9b1c-1681a7c5470b" xlink:to="loc_us-gaap_SubsequentEventMember_1e973ec7-c064-43b9-99f2-09ad1ecd97ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_595e5a3d-411b-4522-b2f2-c4f4c2653662" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_srt_RangeAxis_595e5a3d-411b-4522-b2f2-c4f4c2653662" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_595e5a3d-411b-4522-b2f2-c4f4c2653662_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_595e5a3d-411b-4522-b2f2-c4f4c2653662" xlink:to="loc_srt_RangeMember_595e5a3d-411b-4522-b2f2-c4f4c2653662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4d486bd0-95bb-45c5-b5db-047e1fa0758f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_595e5a3d-411b-4522-b2f2-c4f4c2653662" xlink:to="loc_srt_RangeMember_4d486bd0-95bb-45c5-b5db-047e1fa0758f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb2d2072-4d70-4287-a01a-5f55ca3467cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4d486bd0-95bb-45c5-b5db-047e1fa0758f" xlink:to="loc_srt_MinimumMember_cb2d2072-4d70-4287-a01a-5f55ca3467cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3a564747-c85d-4e51-bf77-f278e3df0872" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4d486bd0-95bb-45c5-b5db-047e1fa0758f" xlink:to="loc_srt_MaximumMember_3a564747-c85d-4e51-bf77-f278e3df0872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_52286700-84ca-4fe0-a4c7-1f0da643546f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_srt_StatementScenarioAxis_52286700-84ca-4fe0-a4c7-1f0da643546f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_52286700-84ca-4fe0-a4c7-1f0da643546f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_52286700-84ca-4fe0-a4c7-1f0da643546f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_52286700-84ca-4fe0-a4c7-1f0da643546f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a7d49aa6-30dc-4fe5-a046-983eb5c972c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_52286700-84ca-4fe0-a4c7-1f0da643546f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a7d49aa6-30dc-4fe5-a046-983eb5c972c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b67bffd4-530e-49bd-ba88-ec6ee590b0bc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a7d49aa6-30dc-4fe5-a046-983eb5c972c8" xlink:to="loc_srt_ScenarioForecastMember_b67bffd4-530e-49bd-ba88-ec6ee590b0bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#EarningsPerCommonShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails" xlink:type="extended" id="ifdb1834a3c49424e993f38fb29a353f6_EarningsPerCommonShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b514ecfa-4abb-4ac1-89a4-d6377d6d4057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_342eeb09-1b61-4c6c-9651-7d86da97b38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b514ecfa-4abb-4ac1-89a4-d6377d6d4057" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_342eeb09-1b61-4c6c-9651-7d86da97b38d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f038630d-0920-41f1-ab47-df7038aa6682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b514ecfa-4abb-4ac1-89a4-d6377d6d4057" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f038630d-0920-41f1-ab47-df7038aa6682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eef1b23f-dfbb-4dcc-b4aa-c2f9b4b5d949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b514ecfa-4abb-4ac1-89a4-d6377d6d4057" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eef1b23f-dfbb-4dcc-b4aa-c2f9b4b5d949" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5b0b262f-6d53-4e41-b474-9027c7e38dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eef1b23f-dfbb-4dcc-b4aa-c2f9b4b5d949" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5b0b262f-6d53-4e41-b474-9027c7e38dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5b0b262f-6d53-4e41-b474-9027c7e38dce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5b0b262f-6d53-4e41-b474-9027c7e38dce" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5b0b262f-6d53-4e41-b474-9027c7e38dce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_967e0c02-b3eb-4e91-9229-a042d51331d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5b0b262f-6d53-4e41-b474-9027c7e38dce" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_967e0c02-b3eb-4e91-9229-a042d51331d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITMember_45fdb6da-b2d0-40f5-86de-d6ca8366f915" xlink:href="peak-20220331.xsd#peak_DownREITMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_967e0c02-b3eb-4e91-9229-a042d51331d5" xlink:to="loc_peak_DownREITMember_45fdb6da-b2d0-40f5-86de-d6ca8366f915" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="extended" id="id7b7549823474026b5642245dd8788d2_SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bea8c690-f2a0-42e7-86ed-0190bdedd938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_24ecbd19-e0e8-4158-882a-2a80ca095022" xlink:href="peak-20220331.xsd#peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bea8c690-f2a0-42e7-86ed-0190bdedd938" xlink:to="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_24ecbd19-e0e8-4158-882a-2a80ca095022" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bea8c690-f2a0-42e7-86ed-0190bdedd938" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2a0d36e7-a912-40ee-990b-22f552157416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_Revenues_2a0d36e7-a912-40ee-990b-22f552157416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomeFromCARESAct_89402da7-7119-433f-820a-7927b3ce7493" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncomeFromCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_GovernmentGrantIncomeFromCARESAct_89402da7-7119-433f-820a-7927b3ce7493" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_f600b433-0157-4d65-a4b6-20b0a72778b4" xlink:href="peak-20220331.xsd#peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_f600b433-0157-4d65-a4b6-20b0a72778b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_ab2d8b63-6a8e-4913-b2da-89351558bc83" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_ab2d8b63-6a8e-4913-b2da-89351558bc83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_1276d7cf-2b92-451c-a85a-f27ba0b000b8" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_1276d7cf-2b92-451c-a85a-f27ba0b000b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_6a440266-6c9d-4d1c-837b-2dd0cf7b2caa" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_6a440266-6c9d-4d1c-837b-2dd0cf7b2caa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_947c726b-91d1-463f-b0a9-fd7c65f342b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_OperatingExpenses_947c726b-91d1-463f-b0a9-fd7c65f342b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_8e607400-083f-4304-b1ed-286772173380" xlink:href="peak-20220331.xsd#peak_OperatingExpensesFromJointVentureAttributableToParentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_8e607400-083f-4304-b1ed-286772173380" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_aef24ea7-5032-4fd0-bdc7-ba589f56ca90" xlink:href="peak-20220331.xsd#peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_aef24ea7-5032-4fd0-bdc7-ba589f56ca90" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_3f9dfc32-51fe-4a68-9a46-ff630f62bf73" xlink:href="peak-20220331.xsd#peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_3f9dfc32-51fe-4a68-9a46-ff630f62bf73" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_c3c53ee7-13fb-4e06-b23b-7c91838336e6" xlink:href="peak-20220331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_c3c53ee7-13fb-4e06-b23b-7c91838336e6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_7a02e5be-aa47-47bf-810a-6fa75ab025ae" xlink:href="peak-20220331.xsd#peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_7a02e5be-aa47-47bf-810a-6fa75ab025ae" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_560c83c6-16aa-4c0e-9113-a99b9daa4056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_InterestIncomeOperating_560c83c6-16aa-4c0e-9113-a99b9daa4056" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0e642f1b-d270-4afc-a358-402c290efe60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_InterestExpense_0e642f1b-d270-4afc-a358-402c290efe60" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d1031bc7-902c-487d-ae5c-6482b9a00037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_DepreciationAndAmortization_d1031bc7-902c-487d-ae5c-6482b9a00037" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ef0acbbf-cfc6-4725-b414-d116dbd0f889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ef0acbbf-cfc6-4725-b414-d116dbd0f889" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_db6844a4-3b91-4296-895c-5b83b73b80fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_db6844a4-3b91-4296-895c-5b83b73b80fa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_aba16f98-5cdd-40d3-97b0-329d358069d6" xlink:href="peak-20220331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_aba16f98-5cdd-40d3-97b0-329d358069d6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_b4576588-a758-4dee-a87f-51a4b2878760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_b4576588-a758-4dee-a87f-51a4b2878760" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd022511-448a-44b9-abff-3b3ce264f19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd022511-448a-44b9-abff-3b3ce264f19e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2131d55e-d5f9-4f9a-9623-1ceb3e7e4f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2131d55e-d5f9-4f9a-9623-1ceb3e7e4f49" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_2baebbcd-36c4-4ac2-a96d-78cbe2b188a7" xlink:href="peak-20220331.xsd#peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_2baebbcd-36c4-4ac2-a96d-78cbe2b188a7" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_3d0ac98f-fd15-4c63-9a7c-01e2df08eacb" xlink:href="peak-20220331.xsd#peak_NetIncomeLossJointVenturePartnersAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_3d0ac98f-fd15-4c63-9a7c-01e2df08eacb" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_5fc86600-6600-41b8-87fd-e3da826127d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_5fc86600-6600-41b8-87fd-e3da826127d4" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5945b900-bc35-401a-9e36-7ec75fc6af59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5945b900-bc35-401a-9e36-7ec75fc6af59" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_95e5088b-e6f2-4201-989b-e3bbdf8b3865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_95e5088b-e6f2-4201-989b-e3bbdf8b3865" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ee349a1-1f2f-4a0e-a0f8-e6d10f9b88fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ee349a1-1f2f-4a0e-a0f8-e6d10f9b88fa" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_31d8e21b-5d66-49ca-8149-2fe46adfc3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_31d8e21b-5d66-49ca-8149-2fe46adfc3f4" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e6bef460-9ede-4c5f-a503-a9560c8d4b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e6bef460-9ede-4c5f-a503-a9560c8d4b7b" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_70dee998-4c26-4ab0-a906-07556797bc09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_ProfitLoss_70dee998-4c26-4ab0-a906-07556797bc09" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bea8c690-f2a0-42e7-86ed-0190bdedd938" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_25b67446-3c9a-42db-a338-4f9b1be3f06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_25b67446-3c9a-42db-a338-4f9b1be3f06b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_25b67446-3c9a-42db-a338-4f9b1be3f06b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25b67446-3c9a-42db-a338-4f9b1be3f06b" xlink:to="loc_us-gaap_SegmentDomain_25b67446-3c9a-42db-a338-4f9b1be3f06b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25b67446-3c9a-42db-a338-4f9b1be3f06b" xlink:to="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_4e4d84c4-34a0-4444-ad2d-58c9b9463cbe" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:to="loc_peak_LifeScienceMember_4e4d84c4-34a0-4444-ad2d-58c9b9463cbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_763a09a5-e0a7-4e53-85c9-97c593a9bf47" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:to="loc_peak_MedicalOfficeMember_763a09a5-e0a7-4e53-85c9-97c593a9bf47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCSegmentMember_bcdc434c-5796-4708-a06b-c88c4d32858c" xlink:href="peak-20220331.xsd#peak_CCRCSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:to="loc_peak_CCRCSegmentMember_bcdc434c-5796-4708-a06b-c88c4d32858c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_3953b736-448b-4afc-baf1-41ecdcab1d34" xlink:href="peak-20220331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:to="loc_peak_OtherNonReportingSegmentMember_3953b736-448b-4afc-baf1-41ecdcab1d34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6d3a5c42-1cfa-4aed-a628-836ac91d86b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:to="loc_srt_ConsolidationItemsAxis_6d3a5c42-1cfa-4aed-a628-836ac91d86b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6d3a5c42-1cfa-4aed-a628-836ac91d86b4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6d3a5c42-1cfa-4aed-a628-836ac91d86b4" xlink:to="loc_srt_ConsolidationItemsDomain_6d3a5c42-1cfa-4aed-a628-836ac91d86b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d7037ac7-6942-496f-915e-a113e002fa38" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6d3a5c42-1cfa-4aed-a628-836ac91d86b4" xlink:to="loc_srt_ConsolidationItemsDomain_d7037ac7-6942-496f-915e-a113e002fa38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6459791f-e400-420a-90ff-03d6d58fe306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d7037ac7-6942-496f-915e-a113e002fa38" xlink:to="loc_us-gaap_OperatingSegmentsMember_6459791f-e400-420a-90ff-03d6d58fe306" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_332085f6-1577-425c-8c31-3038eabf6ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d7037ac7-6942-496f-915e-a113e002fa38" xlink:to="loc_us-gaap_CorporateNonSegmentMember_332085f6-1577-425c-8c31-3038eabf6ac7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" xlink:type="extended" id="id9bfe49d11af4db7959825de35971798_SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_f19c7535-206f-492d-8a37-d40e2ac3d81b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:to="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_f19c7535-206f-492d-8a37-d40e2ac3d81b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_e7226321-52c0-4456-9ec0-280cbd60e6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_e7226321-52c0-4456-9ec0-280cbd60e6e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_b145872a-48b6-4601-923c-f7c21fedbf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:to="loc_us-gaap_DepreciationAndAmortization_b145872a-48b6-4601-923c-f7c21fedbf6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_28359b50-8d2d-4d65-a475-015fb048fca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_28359b50-8d2d-4d65-a475-015fb048fca1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_1d5b686d-9bb3-4546-8030-0bbe186c3a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_28359b50-8d2d-4d65-a475-015fb048fca1" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_1d5b686d-9bb3-4546-8030-0bbe186c3a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_1d5b686d-9bb3-4546-8030-0bbe186c3a97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_1d5b686d-9bb3-4546-8030-0bbe186c3a97" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_1d5b686d-9bb3-4546-8030-0bbe186c3a97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_f7344b3c-12a6-4e15-bd4e-f089e05a0e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_1d5b686d-9bb3-4546-8030-0bbe186c3a97" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_f7344b3c-12a6-4e15-bd4e-f089e05a0e1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_23b41b11-2cf4-4cfc-9826-215299dff302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_f7344b3c-12a6-4e15-bd4e-f089e05a0e1c" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_23b41b11-2cf4-4cfc-9826-215299dff302" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#VariableInterestEntitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="extended" id="i2cb43a7b719d43cd924b59ff92eb3db3_VariableInterestEntitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture_56b125af-9497-46b2-a898-5e58a0397b8b" xlink:href="peak-20220331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_NumberOfUnconsolidatedJointVenture_56b125af-9497-46b2-a898-5e58a0397b8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_4300d3b9-e20b-492f-9dc5-fb841b88393c" xlink:href="peak-20220331.xsd#peak_NumberOfVieBorrowersWithMarketableDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_4300d3b9-e20b-492f-9dc5-fb841b88393c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6082abf8-3f40-4cba-b75c-91b368ce8f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6082abf8-3f40-4cba-b75c-91b368ce8f58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_148c9441-e1e4-4a6c-8614-13f382162f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_148c9441-e1e4-4a6c-8614-13f382162f3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_31860ebc-2f82-4fd2-b7bd-c1dee522e280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_31860ebc-2f82-4fd2-b7bd-c1dee522e280" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_c05744aa-83aa-466a-ba6c-d87b97af207e" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_c05744aa-83aa-466a-ba6c-d87b97af207e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired_7a87bb05-a68a-41b6-b3e5-3e1675a0a9e7" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_NumberOfPropertiesAcquired_7a87bb05-a68a-41b6-b3e5-3e1675a0a9e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue_715566e7-d94d-4e70-bd8b-dc456a4135fb" xlink:href="peak-20220331.xsd#peak_ExchangeAccommodationTitleholderRealEstateCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue_715566e7-d94d-4e70-bd8b-dc456a4135fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_960e3624-6767-48c2-aabc-ab2c620088fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_960e3624-6767-48c2-aabc-ab2c620088fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_960e3624-6767-48c2-aabc-ab2c620088fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_960e3624-6767-48c2-aabc-ab2c620088fe" xlink:to="loc_us-gaap_SegmentDomain_960e3624-6767-48c2-aabc-ab2c620088fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_47269690-370b-46db-9a53-20fbe72d7c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_960e3624-6767-48c2-aabc-ab2c620088fe" xlink:to="loc_us-gaap_SegmentDomain_47269690-370b-46db-9a53-20fbe72d7c42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_94dd655a-3ed3-456b-b22b-f4eb37964949" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_47269690-370b-46db-9a53-20fbe72d7c42" xlink:to="loc_peak_LifeScienceMember_94dd655a-3ed3-456b-b22b-f4eb37964949" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_bcb3bffe-5eff-4586-b01d-6eb0cf14b555" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_47269690-370b-46db-9a53-20fbe72d7c42" xlink:to="loc_peak_MedicalOfficeMember_bcb3bffe-5eff-4586-b01d-6eb0cf14b555" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_a7e517b4-7cbb-4177-9177-0873c599d3d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_a7e517b4-7cbb-4177-9177-0873c599d3d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a7e517b4-7cbb-4177-9177-0873c599d3d6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a7e517b4-7cbb-4177-9177-0873c599d3d6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a7e517b4-7cbb-4177-9177-0873c599d3d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a7e517b4-7cbb-4177-9177-0873c599d3d6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_df60d6ea-aa30-4b9d-b17d-b1adb653d647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_df60d6ea-aa30-4b9d-b17d-b1adb653d647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VenturesVLLCMember_fc8ef6f1-8bb9-48cb-b434-8b872ebb3933" xlink:href="peak-20220331.xsd#peak_VenturesVLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_peak_VenturesVLLCMember_fc8ef6f1-8bb9-48cb-b434-8b872ebb3933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_e72d25f3-9b6f-480f-8f5a-b23b2f3806c6" xlink:href="peak-20220331.xsd#peak_LifeScienceJVsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_peak_LifeScienceJVsMember_e72d25f3-9b6f-480f-8f5a-b23b2f3806c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MorganStanleyRealEstateInvestmentJVMember_abdd1c33-20f9-4680-9896-ae53155b9faa" xlink:href="peak-20220331.xsd#peak_MorganStanleyRealEstateInvestmentJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_peak_MorganStanleyRealEstateInvestmentJVMember_abdd1c33-20f9-4680-9896-ae53155b9faa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownreitPartnershipsMember_5fb6a348-6e0a-466c-bd6f-32f0b69e3b6b" xlink:href="peak-20220331.xsd#peak_DownreitPartnershipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_peak_DownreitPartnershipsMember_5fb6a348-6e0a-466c-bd6f-32f0b69e3b6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_33dffba9-c405-4e81-ac5a-d02033a70ac8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_33dffba9-c405-4e81-ac5a-d02033a70ac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember_f888aa23-6389-430b-9fb0-35a2ec7470a9" xlink:href="peak-20220331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_33dffba9-c405-4e81-ac5a-d02033a70ac8" xlink:to="loc_peak_NeedhamLandParcelJVMember_f888aa23-6389-430b-9fb0-35a2ec7470a9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="extended" id="i8881191c80b14c72a725cd2aa78557e0_VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_448a61de-b317-489c-b45e-e6256eb75d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_7ce89141-536e-4f1e-8d09-1760b82e7b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_448a61de-b317-489c-b45e-e6256eb75d96" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_7ce89141-536e-4f1e-8d09-1760b82e7b0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e04a24dc-e329-4ef0-a5cf-ccd55b281e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_448a61de-b317-489c-b45e-e6256eb75d96" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e04a24dc-e329-4ef0-a5cf-ccd55b281e38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_c00e3594-d8aa-420a-9da3-f16331577061" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e04a24dc-e329-4ef0-a5cf-ccd55b281e38" xlink:to="loc_srt_ConsolidatedEntitiesAxis_c00e3594-d8aa-420a-9da3-f16331577061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c00e3594-d8aa-420a-9da3-f16331577061_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c00e3594-d8aa-420a-9da3-f16331577061" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c00e3594-d8aa-420a-9da3-f16331577061_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e0636379-a306-48e6-a803-ef29b471db5d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c00e3594-d8aa-420a-9da3-f16331577061" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e0636379-a306-48e6-a803-ef29b471db5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_ba8634d9-b982-477d-a883-e32017e9174b" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e0636379-a306-48e6-a803-ef29b471db5d" xlink:to="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_ba8634d9-b982-477d-a883-e32017e9174b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_2cafe1dd-f77f-456e-a346-29a784c41d7c" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e0636379-a306-48e6-a803-ef29b471db5d" xlink:to="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_2cafe1dd-f77f-456e-a346-29a784c41d7c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" xlink:type="extended" id="i4ad679ec774a4e659f0a8cb0a05ffb64_VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_2093c6de-5092-4501-a647-192394616987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2093c6de-5092-4501-a647-192394616987" xlink:to="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_74f0151d-2f94-461c-83b3-3fa83e677c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_74f0151d-2f94-461c-83b3-3fa83e677c84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_4d1ac8ef-6898-468a-9839-4414a6c81487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_DevelopmentInProcess_4d1ac8ef-6898-468a-9839-4414a6c81487" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_c525ddfd-a7d6-4573-a0bf-346d87596e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_Land_c525ddfd-a7d6-4573-a0bf-346d87596e97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_72e158c3-e6b7-49dd-aab0-d017dc90f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_72e158c3-e6b7-49dd-aab0-d017dc90f0ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_d9378fb1-3b10-488f-926a-f98549f5e6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_d9378fb1-3b10-488f-926a-f98549f5e6a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_1b707470-25e6-4e59-ba55-6edc9c432de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_AccountsReceivableNet_1b707470-25e6-4e59-ba55-6edc9c432de0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6116cae5-1825-4c0e-813f-be10c575629a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6116cae5-1825-4c0e-813f-be10c575629a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f7b3b7bd-2f4b-43f6-90ad-050f2d2019e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f7b3b7bd-2f4b-43f6-90ad-050f2d2019e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5696cbfe-4792-4f68-912d-5bd46ce1fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5696cbfe-4792-4f68-912d-5bd46ce1fd14" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_cab75d0e-5e03-49f9-a4c5-d83cf30a6613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_cab75d0e-5e03-49f9-a4c5-d83cf30a6613" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8a762a5b-c1c4-4842-88ad-8a5228ef775b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8a762a5b-c1c4-4842-88ad-8a5228ef775b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_4f68e9e6-395c-4fd0-9375-748f8f8a05a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_OtherAssets_4f68e9e6-395c-4fd0-9375-748f8f8a05a0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e0ae7521-0571-4cbc-a5a3-8e5f44b09745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_Assets_e0ae7521-0571-4cbc-a5a3-8e5f44b09745" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2093c6de-5092-4501-a647-192394616987" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_b52c767d-d60f-4660-bcd5-bd6b95ab4dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_SecuredDebt_b52c767d-d60f-4660-bcd5-bd6b95ab4dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable_17695fe6-138a-4d68-bd02-d366502d6f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_OffMarketLeaseUnfavorable_17695fe6-138a-4d68-bd02-d366502d6f57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c59cc4a5-e712-4e92-bfad-975c0bd38a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c59cc4a5-e712-4e92-bfad-975c0bd38a12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_79402844-f15c-49a0-ab02-4131b4295300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_OperatingLeaseLiability_79402844-f15c-49a0-ab02-4131b4295300" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_45f89baa-183f-486f-9246-28ea1a391bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_45f89baa-183f-486f-9246-28ea1a391bad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_f13c2721-6f3f-425c-b928-135a9c0d192c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_f13c2721-6f3f-425c-b928-135a9c0d192c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1cef9808-4c45-4ab9-805f-dee2952206ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_Liabilities_1cef9808-4c45-4ab9-805f-dee2952206ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2093c6de-5092-4501-a647-192394616987" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_743d1ddd-3741-4bf4-a0ab-7e42f44f88a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_743d1ddd-3741-4bf4-a0ab-7e42f44f88a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_86d8b29a-d277-4779-8a2a-0720ae980f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_743d1ddd-3741-4bf4-a0ab-7e42f44f88a0" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_86d8b29a-d277-4779-8a2a-0720ae980f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_30b79d65-2d3d-4fd0-be63-377f43fa609d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_30b79d65-2d3d-4fd0-be63-377f43fa609d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_2697af9b-558b-49bd-8fb0-b9d9d22a8a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_30b79d65-2d3d-4fd0-be63-377f43fa609d" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_2697af9b-558b-49bd-8fb0-b9d9d22a8a1b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="ia1d2e3cd46424b09acbb5d9765ec41c0_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableFairValueDisclosure_c8f56422-01f6-4d4e-824f-975198a91313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_LoansReceivableFairValueDisclosure_c8f56422-01f6-4d4e-824f-975198a91313" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_19325866-8dbf-49d0-a8e4-d8c202506ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_19325866-8dbf-49d0-a8e4-d8c202506ab6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d1e27ae5-a2f4-4797-8767-8274aaba20c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_DerivativeAssets_d1e27ae5-a2f4-4797-8767-8274aaba20c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5a375eab-dbe4-45c8-9128-a7c124e3a016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_LineOfCredit_5a375eab-dbe4-45c8-9128-a7c124e3a016" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_f875cbb8-ec71-460c-93ce-f676ae9fced7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_UnsecuredDebt_f875cbb8-ec71-460c-93ce-f676ae9fced7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_7774bcce-263c-429d-abf3-7c3860d970a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_SecuredDebt_7774bcce-263c-429d-abf3-7c3860d970a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9a6508d-8224-4a5e-bc04-2fa2ce3ce02c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9a6508d-8224-4a5e-bc04-2fa2ce3ce02c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b0b53fa7-5020-41fd-96bd-d5fb195cccda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9a6508d-8224-4a5e-bc04-2fa2ce3ce02c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b0b53fa7-5020-41fd-96bd-d5fb195cccda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_8bfec39a-4882-4b01-9694-c58d4c440551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b0b53fa7-5020-41fd-96bd-d5fb195cccda" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_8bfec39a-4882-4b01-9694-c58d4c440551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3e82d27d-08f0-4da1-b16e-b43b5ee2e015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b0b53fa7-5020-41fd-96bd-d5fb195cccda" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3e82d27d-08f0-4da1-b16e-b43b5ee2e015" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_358b12d4-5bd2-4cb7-a973-843ca9a39ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_358b12d4-5bd2-4cb7-a973-843ca9a39ea2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_358b12d4-5bd2-4cb7-a973-843ca9a39ea2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_358b12d4-5bd2-4cb7-a973-843ca9a39ea2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_358b12d4-5bd2-4cb7-a973-843ca9a39ea2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9ffaceb-9fab-490a-a7c9-a8b0b959796f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_358b12d4-5bd2-4cb7-a973-843ca9a39ea2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9ffaceb-9fab-490a-a7c9-a8b0b959796f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8ce53384-ceec-4795-b3fa-f30410faa908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9ffaceb-9fab-490a-a7c9-a8b0b959796f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8ce53384-ceec-4795-b3fa-f30410faa908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_66d8faff-ddc7-4496-8da6-dad7b70ba290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9ffaceb-9fab-490a-a7c9-a8b0b959796f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_66d8faff-ddc7-4496-8da6-dad7b70ba290" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended" id="i383de62b095642c2aa592b409bd0eaf9_DerivativeFinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_bdae0888-7629-4d28-9131-150e3e1584cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_bdae0888-7629-4d28-9131-150e3e1584cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_fd27c109-2a5e-4d2f-ac62-90f84be66dd3" xlink:href="peak-20220331.xsd#peak_NumberOfAssetsClassifiedAsDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_fd27c109-2a5e-4d2f-ac62-90f84be66dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfInterestRateDerivativesTerminated_8bc0eda2-b992-464b-a737-df4cd1db5964" xlink:href="peak-20220331.xsd#peak_NumberOfInterestRateDerivativesTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_peak_NumberOfInterestRateDerivativesTerminated_8bc0eda2-b992-464b-a737-df4cd1db5964" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_1708bcdd-c7bb-47ef-bc34-3ba70233dcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_1708bcdd-c7bb-47ef-bc34-3ba70233dcc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_df75d9f9-c941-43d8-9154-33ffeb774278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_df75d9f9-c941-43d8-9154-33ffeb774278" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DerivativeNotionalAmountTerminated_3505d138-fa0e-488f-9d04-985b6ef2a873" xlink:href="peak-20220331.xsd#peak_DerivativeNotionalAmountTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_peak_DerivativeNotionalAmountTerminated_3505d138-fa0e-488f-9d04-985b6ef2a873" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_11e5b7bd-6f24-4dbd-9999-6732e27743f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_11e5b7bd-6f24-4dbd-9999-6732e27743f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_11e5b7bd-6f24-4dbd-9999-6732e27743f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_11e5b7bd-6f24-4dbd-9999-6732e27743f3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_11e5b7bd-6f24-4dbd-9999-6732e27743f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fa484d39-b3fa-4b9f-ac74-4e1b67561047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_11e5b7bd-6f24-4dbd-9999-6732e27743f3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fa484d39-b3fa-4b9f-ac74-4e1b67561047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_51a3bd2a-38a4-4971-8653-79a4429d36da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fa484d39-b3fa-4b9f-ac74-4e1b67561047" xlink:to="loc_us-gaap_SecuredDebtMember_51a3bd2a-38a4-4971-8653-79a4429d36da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_96510511-c046-40b6-ada7-98f77c60c3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_96510511-c046-40b6-ada7-98f77c60c3fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_96510511-c046-40b6-ada7-98f77c60c3fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96510511-c046-40b6-ada7-98f77c60c3fa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_96510511-c046-40b6-ada7-98f77c60c3fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_098462c9-01f3-418a-827e-1bffc5a07f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96510511-c046-40b6-ada7-98f77c60c3fa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_098462c9-01f3-418a-827e-1bffc5a07f66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_eb79eea4-61db-4976-b69f-d830400270e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_098462c9-01f3-418a-827e-1bffc5a07f66" xlink:to="loc_us-gaap_SubsequentEventMember_eb79eea4-61db-4976-b69f-d830400270e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e2923c94-b1f5-41a0-b81d-400c3e1dd417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e2923c94-b1f5-41a0-b81d-400c3e1dd417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cc2f8c22-d72b-4621-b64c-71fc47993636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e2923c94-b1f5-41a0-b81d-400c3e1dd417" xlink:to="loc_us-gaap_InterestRateSwapMember_cc2f8c22-d72b-4621-b64c-71fc47993636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_bb168f4d-53d2-4218-82a2-7f941a13f6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e2923c94-b1f5-41a0-b81d-400c3e1dd417" xlink:to="loc_us-gaap_InterestRateCapMember_bb168f4d-53d2-4218-82a2-7f941a13f6d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6ee376b3-cc0b-4022-8748-1896192f7cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_HedgingDesignationAxis_6ee376b3-cc0b-4022-8748-1896192f7cda" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6ee376b3-cc0b-4022-8748-1896192f7cda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_6ee376b3-cc0b-4022-8748-1896192f7cda" xlink:to="loc_us-gaap_HedgingDesignationDomain_6ee376b3-cc0b-4022-8748-1896192f7cda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e26b1f26-147b-42ed-a5c6-57a05fae816e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_6ee376b3-cc0b-4022-8748-1896192f7cda" xlink:to="loc_us-gaap_HedgingDesignationDomain_e26b1f26-147b-42ed-a5c6-57a05fae816e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_36bae637-dd90-4c28-a94a-09b3198a5b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_e26b1f26-147b-42ed-a5c6-57a05fae816e" xlink:to="loc_us-gaap_NondesignatedMember_36bae637-dd90-4c28-a94a-09b3198a5b2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fe0adeed-b177-4d0b-89e6-82de0f6a9a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_e26b1f26-147b-42ed-a5c6-57a05fae816e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fe0adeed-b177-4d0b-89e6-82de0f6a9a38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed24d1f-8ea9-4795-9a32-633abb1db381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed24d1f-8ea9-4795-9a32-633abb1db381" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7ed24d1f-8ea9-4795-9a32-633abb1db381_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed24d1f-8ea9-4795-9a32-633abb1db381" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7ed24d1f-8ea9-4795-9a32-633abb1db381_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_60699ebd-8db3-411c-872d-84e3668600f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed24d1f-8ea9-4795-9a32-633abb1db381" xlink:to="loc_us-gaap_HedgingRelationshipDomain_60699ebd-8db3-411c-872d-84e3668600f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0e27da98-746f-45b8-8da6-fbbc97ddbb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_60699ebd-8db3-411c-872d-84e3668600f6" xlink:to="loc_us-gaap_CashFlowHedgingMember_0e27da98-746f-45b8-8da6-fbbc97ddbb70" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" xlink:type="extended" id="i125bee49f3944d86b9c97b3f0a7bc335_DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_9f96e4de-5e87-4e08-8cb8-2e8f77599016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_9f96e4de-5e87-4e08-8cb8-2e8f77599016" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_4f24598d-061b-47cc-b106-6108dd322a75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_4f24598d-061b-47cc-b106-6108dd322a75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_a6412bfa-ccb1-4cb5-b489-5c6f87a6ea49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_a6412bfa-ccb1-4cb5-b489-5c6f87a6ea49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_8744195d-a4df-417e-a5e9-0189a8c5d2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_8744195d-a4df-417e-a5e9-0189a8c5d2f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7f760fa1-7036-4c0d-a641-37d048bc84af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7f760fa1-7036-4c0d-a641-37d048bc84af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7f760fa1-7036-4c0d-a641-37d048bc84af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f760fa1-7036-4c0d-a641-37d048bc84af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7f760fa1-7036-4c0d-a641-37d048bc84af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d8085069-c624-46b3-a0bc-36a5219b4342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f760fa1-7036-4c0d-a641-37d048bc84af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d8085069-c624-46b3-a0bc-36a5219b4342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_81ddc800-3434-4a7e-8e8e-e13dc35dfff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d8085069-c624-46b3-a0bc-36a5219b4342" xlink:to="loc_us-gaap_InterestRateCapMember_81ddc800-3434-4a7e-8e8e-e13dc35dfff8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_197fb595-831a-4b47-8ce0-3cac9e8336b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:to="loc_us-gaap_HedgingDesignationAxis_197fb595-831a-4b47-8ce0-3cac9e8336b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_197fb595-831a-4b47-8ce0-3cac9e8336b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_197fb595-831a-4b47-8ce0-3cac9e8336b0" xlink:to="loc_us-gaap_HedgingDesignationDomain_197fb595-831a-4b47-8ce0-3cac9e8336b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_61dfaa8f-f006-42de-b86b-1bd5d427f3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_197fb595-831a-4b47-8ce0-3cac9e8336b0" xlink:to="loc_us-gaap_HedgingDesignationDomain_61dfaa8f-f006-42de-b86b-1bd5d427f3d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_caa1d5e5-3a8e-45e2-8f3e-2a3992d4a095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_61dfaa8f-f006-42de-b86b-1bd5d427f3d0" xlink:to="loc_us-gaap_NondesignatedMember_caa1d5e5-3a8e-45e2-8f3e-2a3992d4a095" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>peak-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18e02b9c-9339-4812-a396-3a502b171f3f,g:40f6f78a-d855-4bed-acda-5b3ebe369ddb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_3644d254-03bf-4c68-a2ca-92746cfa7e7d_totalLabel_en-US" xlink:label="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale and discontinued operations, net</link:label>
    <link:label id="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_label_en-US" xlink:label="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Related to Assets Held For Sale And Discontinued Operations Net</link:label>
    <link:label id="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_documentation_en-US" xlink:label="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Related to Assets Held For Sale And Discontinued Operations Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:href="peak-20220331.xsd#peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:to="lab_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_e83dc692-33f3-48e6-bb82-06f948ca5fe2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_3cd2b930-8726-433a-9bf5-e25a93a70146_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseNetInvestmentInLease_11c4b5c8-8cd0-4f29-9e9e-45291e04c9e5_totalLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment in direct financing leases</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseNetInvestmentInLease_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseNetInvestmentInLease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseNetInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseNetInvestmentInLease" xlink:to="lab_us-gaap_DirectFinancingLeaseNetInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_193fc28d-cfd6-4b51-9d03-4233f78d0e19_terseLabel_en-US" xlink:label="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM aggregate amount authorized</link:label>
    <link:label id="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_label_en-US" xlink:label="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Equity Offering Program Aggregate Amount Authorized</link:label>
    <link:label id="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_documentation_en-US" xlink:label="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum aggregate gross sales price of stock authorized to be sold through an at-the-market continuous equity offering program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:href="peak-20220331.xsd#peak_AtmEquityOfferingProgramAggregateAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:to="lab_peak_AtmEquityOfferingProgramAggregateAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ed53c8da-ec83-4cfc-a8ba-9b3a948de44c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d4f4bc7d-c564-4189-94fa-9534e5012dd2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Healthpeak Properties, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_9d666e59-1378-4c86-b79b-d5bd7a1de8e0_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_766ef174-017f-40a4-9762-ccc8a8553798_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2b8354df-40c4-4857-8af0-5265b74f75e5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_bde4d6f7-cec2-42f8-96b2-0fdb87edc2e7_terseLabel_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_label_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture Government Grant Income</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_documentation_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture Government Grant Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:to="lab_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_e157b2bd-c902-4506-bc07-3c7468ad9177_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bb137248-8d6e-4831-aa21-35433865b60d_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_a15c34d4-e178-40a4-b804-fc8602de2572_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ebe3298c-6ed1-415a-8332-2a39f148ab51_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OakmontSHOPPortfolioMember_ec484eaf-086c-418f-b855-17e6e7cea335_terseLabel_en-US" xlink:label="lab_peak_OakmontSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oakmont SHOP Portfolio</link:label>
    <link:label id="lab_peak_OakmontSHOPPortfolioMember_label_en-US" xlink:label="lab_peak_OakmontSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oakmont SHOP Portfolio [Member]</link:label>
    <link:label id="lab_peak_OakmontSHOPPortfolioMember_documentation_en-US" xlink:label="lab_peak_OakmontSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oakmont SHOP Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OakmontSHOPPortfolioMember" xlink:href="peak-20220331.xsd#peak_OakmontSHOPPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OakmontSHOPPortfolioMember" xlink:to="lab_peak_OakmontSHOPPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_02a3f075-1848-4c0c-bd25-6ca4df581b5a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_5e5557e6-15ad-46d5-901d-0e1d3c6b6b3d_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfFinanceReceivables_4240dbf4-63c9-41f4-915c-dd81ee0e09e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of receivables</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfFinanceReceivables" xlink:to="lab_us-gaap_ProceedsFromSaleOfFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5711bb0c-8d0c-43f3-aebb-3d192ca97d34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Debt Maturities and Schedule Principal Repayments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a31a49fb-7c89-4f7d-8947-500a0d546e68_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_06d7a741-c5cd-4854-ab51-dcf0e82c1262_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_c253db98-2f04-4e54-b9bf-260ff05d64ab_terseLabel_en-US" xlink:label="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Assets and Liabilities of Variable Interest Entities</link:label>
    <link:label id="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Variable Interest Entities Included In The Balance Sheet [Table Text Block]</link:label>
    <link:label id="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_documentation_en-US" xlink:label="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the VIE's total assest and liabilities included in the consolidated balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:href="peak-20220331.xsd#peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:to="lab_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_9c8314b5-ba4a-4c7c-bbe4-1ebea88d1466_terseLabel_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Government grant income</link:label>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_label_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations</link:label>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_documentation_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:href="peak-20220331.xsd#peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:to="lab_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorPropertyClassDomain_ff4504d7-825d-437d-ad4f-723a9144303b_terseLabel_en-US" xlink:label="lab_us-gaap_MajorPropertyClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Property Class [Domain]</link:label>
    <link:label id="lab_us-gaap_MajorPropertyClassDomain_label_en-US" xlink:label="lab_us-gaap_MajorPropertyClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Property Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorPropertyClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorPropertyClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorPropertyClassDomain" xlink:to="lab_us-gaap_MajorPropertyClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnsecuredNote4000PercentMember_84cf1352-df65-4687-aadc-7d8e69b67e8b_terseLabel_en-US" xlink:label="lab_peak_UnsecuredNote4000PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.000 Percent</link:label>
    <link:label id="lab_peak_UnsecuredNote4000PercentMember_label_en-US" xlink:label="lab_peak_UnsecuredNote4000PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.000 Percent [Member]</link:label>
    <link:label id="lab_peak_UnsecuredNote4000PercentMember_documentation_en-US" xlink:label="lab_peak_UnsecuredNote4000PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.000 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4000PercentMember" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4000PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnsecuredNote4000PercentMember" xlink:to="lab_peak_UnsecuredNote4000PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffMarketLeaseUnfavorable_54fa148a-3425-4ce7-9943-f3c877d54573_terseLabel_en-US" xlink:label="lab_us-gaap_OffMarketLeaseUnfavorable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible liabilities, net</link:label>
    <link:label id="lab_us-gaap_OffMarketLeaseUnfavorable_label_en-US" xlink:label="lab_us-gaap_OffMarketLeaseUnfavorable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Off-market Lease, Unfavorable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffMarketLeaseUnfavorable" xlink:to="lab_us-gaap_OffMarketLeaseUnfavorable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_92ffcc57-d278-4cd1-b039-949ad5222650_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward equity sales agreement, initial net price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_label_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Forward Rate Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquityForwardRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:to="lab_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_48fd6eb4-a0f6-434a-bda3-98ce91d0a195_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_0b2ce0f4-ff12-4634-969e-72da33d87894_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_d69c819d-4105-4434-8eb5-7c1160c5761d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from and issuance of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d3f3f996-f4cb-473c-9f7c-86feff430208_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_d2f08ba1-6cea-44ed-84af-6ce5045704cc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_f4f26bb5-2012-4005-bc63-9cad0897dd20_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_025191b5-db73-490f-b94a-e8bf21c284b7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_32ebed7e-450a-47a4-8c5a-606eff7d265e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental and related revenues</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6cafa55f-80d9-4edd-9bdd-2a836a83a8a0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d24a3910-4172-437b-a0d2-aa0f3db6e3b9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_50eabd03-3fab-4925-9a8a-3179b0231532_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_88ae45ce-5479-4d1a-82d9-2cd5cb970e0f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_4b6889ee-7565-4f83-9ffa-cbf570ad198f_terseLabel_en-US" xlink:label="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collection of nonrefundable entrance fees</link:label>
    <link:label id="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_label_en-US" xlink:label="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Collection Of Nonrefundable Entrance Fees</link:label>
    <link:label id="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_documentation_en-US" xlink:label="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Collection Of Nonrefundable Entrance Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:href="peak-20220331.xsd#peak_ProceedsFromCollectionOfNonrefundableEntranceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:to="lab_peak_ProceedsFromCollectionOfNonrefundableEntranceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_A2020ATMProgramMember_629ea331-0ced-4042-bcf5-d0ccb732ef10_terseLabel_en-US" xlink:label="lab_peak_A2020ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program</link:label>
    <link:label id="lab_peak_A2020ATMProgramMember_label_en-US" xlink:label="lab_peak_A2020ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program [Member]</link:label>
    <link:label id="lab_peak_A2020ATMProgramMember_documentation_en-US" xlink:label="lab_peak_A2020ATMProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramMember" xlink:href="peak-20220331.xsd#peak_A2020ATMProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_A2020ATMProgramMember" xlink:to="lab_peak_A2020ATMProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LongTermDebtMaturityAfterYearFour_641c09af-7572-483e-af05-797808028de5_terseLabel_en-US" xlink:label="lab_peak_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_peak_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_peak_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:label id="lab_peak_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_peak_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LongTermDebtMaturityAfterYearFour" xlink:href="peak-20220331.xsd#peak_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LongTermDebtMaturityAfterYearFour" xlink:to="lab_peak_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnsecuredNote3400PercentMember_f6a6313e-ffc8-4e64-9c6e-a8793ed8198e_terseLabel_en-US" xlink:label="lab_peak_UnsecuredNote3400PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 3.400 Percent</link:label>
    <link:label id="lab_peak_UnsecuredNote3400PercentMember_label_en-US" xlink:label="lab_peak_UnsecuredNote3400PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 3.400 Percent [Member]</link:label>
    <link:label id="lab_peak_UnsecuredNote3400PercentMember_documentation_en-US" xlink:label="lab_peak_UnsecuredNote3400PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 3.400 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote3400PercentMember" xlink:href="peak-20220331.xsd#peak_UnsecuredNote3400PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnsecuredNote3400PercentMember" xlink:to="lab_peak_UnsecuredNote3400PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_86af5a53-319a-4972-9e19-53af487d75e0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions of Real Estate and Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_86d41450-600b-444e-9923-7511d735470d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d5fdbee1-ab75-4870-9490-e414a7814797_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfBankDebt_77bfcc4a-22a3-466b-b45a-ccbff350f46d_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfBankDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments and repurchase of debt, excluding bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfBankDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfBankDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Bank Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfBankDebt" xlink:to="lab_us-gaap_RepaymentsOfBankDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_31f32b22-f128-4e34-b3a9-c6b546794fec_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DownREITMember_d8237dc6-3d27-4949-b51a-7c67871ecccc_terseLabel_en-US" xlink:label="lab_peak_DownREITMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Down REIT</link:label>
    <link:label id="lab_peak_DownREITMember_label_en-US" xlink:label="lab_peak_DownREITMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Down R E I T [Member]</link:label>
    <link:label id="lab_peak_DownREITMember_documentation_en-US" xlink:label="lab_peak_DownREITMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental common shares attributable to the conversion of DownREIT units that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITMember" xlink:href="peak-20220331.xsd#peak_DownREITMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DownREITMember" xlink:to="lab_peak_DownREITMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d679fbe-e3d3-46e2-8c3a-b633d58c27a2_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d138aac3-86de-4913-a551-eee222bd136c_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining amortization period in years</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_4553be60-9408-468e-a72f-901c64e07116_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock and exercise of options, net of offering costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IntangiblesAbstract_167217f3-7c65-410b-a083-39d4644010a3_terseLabel_en-US" xlink:label="lab_peak_IntangiblesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles [Abstract]</link:label>
    <link:label id="lab_peak_IntangiblesAbstract_label_en-US" xlink:label="lab_peak_IntangiblesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles [Abstract]</link:label>
    <link:label id="lab_peak_IntangiblesAbstract_documentation_en-US" xlink:label="lab_peak_IntangiblesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract" xlink:href="peak-20220331.xsd#peak_IntangiblesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IntangiblesAbstract" xlink:to="lab_peak_IntangiblesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_baadb01c-326f-4447-88e1-4017bfb318ee_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_1690f986-f2e1-45f2-a3e2-5356542a9754_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OtherDispositionsMember_f7d718be-c1bc-4ebd-8298-3042de53e4e3_terseLabel_en-US" xlink:label="lab_peak_OtherDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Dispositions</link:label>
    <link:label id="lab_peak_OtherDispositionsMember_label_en-US" xlink:label="lab_peak_OtherDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Dispositions [Member]</link:label>
    <link:label id="lab_peak_OtherDispositionsMember_documentation_en-US" xlink:label="lab_peak_OtherDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Dispositions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherDispositionsMember" xlink:href="peak-20220331.xsd#peak_OtherDispositionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OtherDispositionsMember" xlink:to="lab_peak_OtherDispositionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ParticipatingDevelopmentLoansAndOtherMember_518131e2-a802-4338-9c12-b6d0382c1f20_terseLabel_en-US" xlink:label="lab_peak_ParticipatingDevelopmentLoansAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine and Other</link:label>
    <link:label id="lab_peak_ParticipatingDevelopmentLoansAndOtherMember_label_en-US" xlink:label="lab_peak_ParticipatingDevelopmentLoansAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Development Loans And Other [Member]</link:label>
    <link:label id="lab_peak_ParticipatingDevelopmentLoansAndOtherMember_documentation_en-US" xlink:label="lab_peak_ParticipatingDevelopmentLoansAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Development Loans And Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingDevelopmentLoansAndOtherMember" xlink:href="peak-20220331.xsd#peak_ParticipatingDevelopmentLoansAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ParticipatingDevelopmentLoansAndOtherMember" xlink:to="lab_peak_ParticipatingDevelopmentLoansAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanLossesExpensed_fbf3c7c3-b913-46cc-92ff-2cd9dce10f2d_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for expected loan losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLossesExpensed_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Loss, Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanLossesExpensed" xlink:to="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c0eab02a-c9e9-40aa-be63-b8865d7f685d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, facility fee (as a percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_3ff08a1e-1e5e-49f0-bfc3-21fde59f0f71_terseLabel_en-US" xlink:label="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: Adjustments to NOI</link:label>
    <link:label id="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_label_en-US" xlink:label="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments</link:label>
    <link:label id="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_documentation_en-US" xlink:label="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the addback of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees from segment portfolio income to consolidated net income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:href="peak-20220331.xsd#peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:to="lab_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_2df2a2c7-69c6-4954-8b76-e22c8ff4d3e2_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations_8ba591c7-c70c-457e-8501-4918e967a19e_totalLabel_en-US" xlink:label="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted NOI</link:label>
    <link:label id="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations_label_en-US" xlink:label="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Net Operating Income from Continuing Operations</link:label>
    <link:label id="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations_documentation_en-US" xlink:label="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:href="peak-20220331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:to="lab_peak_AdjustedNetOperatingIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber_46c9178b-ab26-4237-8ccc-19dcc84f9bf9_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of healthcare facilities used to secure debt (in facilities)</link:label>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber_label_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Collateral Healthcare Facilities, Number</link:label>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of healthcare facilities which are secured by mortgage debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber" xlink:to="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_39740309-8815-45da-aef5-b5b18ed1e31d_terseLabel_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of redeemable noncontrolling interest redemptions</link:label>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_label_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Redeemable Noncontrolling Interest Redemptions</link:label>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_documentation_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Redeemable Noncontrolling Interest Redemptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:href="peak-20220331.xsd#peak_NumberOfRedeemableNoncontrollingInterestRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:to="lab_peak_NumberOfRedeemableNoncontrollingInterestRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_32a690ec-a4fb-4873-892a-2e3caf7feaf1_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_7b2dd58e-e61e-4998-b5a9-b73b9f91962f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_ca51ebd9-bedd-476e-956b-d65184db78bf_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sales of real estate, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_9897845b-109d-4915-9baf-0e0358e50381_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AtTheMarketProgramMember_17ecbc0d-2ff1-4a0f-92cf-0eeb97d18244_terseLabel_en-US" xlink:label="lab_peak_AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Program</link:label>
    <link:label id="lab_peak_AtTheMarketProgramMember_label_en-US" xlink:label="lab_peak_AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Program [Member]</link:label>
    <link:label id="lab_peak_AtTheMarketProgramMember_documentation_en-US" xlink:label="lab_peak_AtTheMarketProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtTheMarketProgramMember" xlink:href="peak-20220331.xsd#peak_AtTheMarketProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AtTheMarketProgramMember" xlink:to="lab_peak_AtTheMarketProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_8a703e52-2a3d-4dd2-9f63-9cad3abe1c22_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset, net</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a7763c09-df2e-455d-9e09-ae85eada8c72_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SeniorNotesDue2025Member_77fa57d5-0db6-4413-b41b-31f5a5701a2c_terseLabel_en-US" xlink:label="lab_peak_SeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Due 2025</link:label>
    <link:label id="lab_peak_SeniorNotesDue2025Member_label_en-US" xlink:label="lab_peak_SeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Due 2025 [Member]</link:label>
    <link:label id="lab_peak_SeniorNotesDue2025Member_documentation_en-US" xlink:label="lab_peak_SeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorNotesDue2025Member" xlink:href="peak-20220331.xsd#peak_SeniorNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SeniorNotesDue2025Member" xlink:to="lab_peak_SeniorNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables_a75ea118-f857-4eac-8c44-56685e68f8b2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of lease receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Lease Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLeaseReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:to="lab_us-gaap_ProceedsFromSaleOfLeaseReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ea1b16c0-5298-4ac2-b9a8-9254863e424e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CommercialPaperProgramMember_a506c739-928c-4a46-8728-dc842c8b439c_terseLabel_en-US" xlink:label="lab_peak_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program</link:label>
    <link:label id="lab_peak_CommercialPaperProgramMember_label_en-US" xlink:label="lab_peak_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program [Member]</link:label>
    <link:label id="lab_peak_CommercialPaperProgramMember_documentation_en-US" xlink:label="lab_peak_CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommercialPaperProgramMember" xlink:href="peak-20220331.xsd#peak_CommercialPaperProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CommercialPaperProgramMember" xlink:to="lab_peak_CommercialPaperProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_2bb208e2-2ba5-4e4c-a5d7-9d437f73e215_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year Five, Originated, Four Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLand_e8577340-08f4-4c82-a84c-5bcbc11eed99_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire land</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLand_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLand" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLand" xlink:to="lab_us-gaap_PaymentsToAcquireLand" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ed8e3f32-7e1a-4b56-84fe-ee0773491cb2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_924a584e-8418-454c-b9c4-dd3d53391367_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Financing Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_b168b92c-4bb9-48a2-af90-cf20f60fd8ef_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a915901d-dc89-4772-8f83-8309ac3c919e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_27ecc4f3-afa6-4e02-b320-013d99bff2e1_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_ba339650-2a5f-4dce-a9f1-0629ed40cedc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconsolidated Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_61427256-5248-4187-928d-ac5880611bb2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7c21d857-047c-44a2-82c8-719ddfbf6c30_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_17400e12-1f40-41d9-9a94-c02e0d829063_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ac8ea54d-bbc8-4afd-aeea-517c69ae1a21_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_a019f410-a5bd-4a89-aa24-32c86f4bad89_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate 2026</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_8b96f6f8-515c-4f06-a34e-733c75c4e397_terseLabel_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_label_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest</link:label>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_documentation_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:href="peak-20220331.xsd#peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:to="lab_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FinancingReceivableNumberOfContracts_13d164d2-d13b-48bc-83fa-7fe3b3f64932_terseLabel_en-US" xlink:label="lab_peak_FinancingReceivableNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of loans receivable</link:label>
    <link:label id="lab_peak_FinancingReceivableNumberOfContracts_label_en-US" xlink:label="lab_peak_FinancingReceivableNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Number of Contracts</link:label>
    <link:label id="lab_peak_FinancingReceivableNumberOfContracts_documentation_en-US" xlink:label="lab_peak_FinancingReceivableNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Number of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableNumberOfContracts" xlink:href="peak-20220331.xsd#peak_FinancingReceivableNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FinancingReceivableNumberOfContracts" xlink:to="lab_peak_FinancingReceivableNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_b064d088-1139-4e50-b04c-a8dcc5daf04d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for loans receivable</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_af84792c-e9b6-4dbd-9dd5-41f8010e618b_negatedLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for loan losses</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_319397d4-3f4d-479d-8a9a-442a1546667c_periodStartLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for loan losses, beginning of period</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_ef81c9d4-fe77-4c02-96bf-e289a615535d_periodEndLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for loan losses, end of period</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_dcdbcf2d-c828-4f43-8f5d-ce45cfd2039f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions of earnings from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountFunded_8aa05cc2-d772-4aa2-ae00-eaba3fc8d02a_terseLabel_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountFunded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditure funding, amount funded</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountFunded_label_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountFunded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Amount Funded</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountFunded_documentation_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountFunded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Amount Funded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountFunded" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountFunded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CapitalExpenditureFundingAmountFunded" xlink:to="lab_peak_CapitalExpenditureFundingAmountFunded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_b2c8c3e8-fcab-46ea-ad3c-4eccee6faf2b_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_e27bd666-5eb1-48e9-bde9-54f24e4cf50f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_9db5baf5-52a4-4be7-995f-ed1f8d3c966a_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3494e253-eaf3-4300-9669-7ce13c4592ac_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in ROU asset in exchange for new lease liability related to operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_617cfb1a-1e11-4062-a64e-ed0a8e6b58ef_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_270550ff-4d4c-479c-b879-7ef7db26a566_terseLabel_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interests redeemable over time</link:label>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_label_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Redeemable Noncontrolling Interests, Redeemable Over Time</link:label>
    <link:label id="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_documentation_en-US" xlink:label="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Redeemable Noncontrolling Interests, Redeemable Over Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:href="peak-20220331.xsd#peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:to="lab_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7ade6c2d-e55a-488e-a48e-d339e938adc8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_85f1b800-6c5a-40a9-aa26-c9f065b5f4a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7c6446cd-22f3-49bd-8a4b-ccb42dd6d378_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract_3d035354-3034-43e6-a3f1-65c366e21649_terseLabel_en-US" xlink:label="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Including Discontinued Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashIncludingDiscontinuedOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:to="lab_us-gaap_CashIncludingDiscontinuedOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MedicalOfficeMember_1e16bdad-8b9c-4893-8436-1093feb49cd9_terseLabel_en-US" xlink:label="lab_peak_MedicalOfficeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office Buildings</link:label>
    <link:label id="lab_peak_MedicalOfficeMember_7e0ea166-f11e-4ccb-93a0-43157f2fdab1_verboseLabel_en-US" xlink:label="lab_peak_MedicalOfficeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office</link:label>
    <link:label id="lab_peak_MedicalOfficeMember_label_en-US" xlink:label="lab_peak_MedicalOfficeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office [Member]</link:label>
    <link:label id="lab_peak_MedicalOfficeMember_documentation_en-US" xlink:label="lab_peak_MedicalOfficeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties that are part of continuing operations, and which are classified as medical office.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MedicalOfficeMember" xlink:to="lab_peak_MedicalOfficeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f9d3c39d-bf72-4045-a7f6-3750c668637a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VenturesVLLCMember_cc06f29e-bbf7-444f-acfa-41799f6ad6cb_terseLabel_en-US" xlink:label="lab_peak_VenturesVLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventures V</link:label>
    <link:label id="lab_peak_VenturesVLLCMember_label_en-US" xlink:label="lab_peak_VenturesVLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventures V, LLC [Member]</link:label>
    <link:label id="lab_peak_VenturesVLLCMember_documentation_en-US" xlink:label="lab_peak_VenturesVLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to HCP Ventures V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VenturesVLLCMember" xlink:href="peak-20220331.xsd#peak_VenturesVLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VenturesVLLCMember" xlink:to="lab_peak_VenturesVLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_1d0f0cba-d8dc-42f1-8113-6c4c5e1a0135_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_c0a9161b-6dd1-46c0-974a-de323ca1eef0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest-rate contracts held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_4aceda19-0ebc-4b7f-add6-777da8364759_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strike Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_cc214ba9-7590-4cce-beb3-9053411b8c05_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income recorded in other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b117da6d-3ab7-4dd3-855a-51d22f910054_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) applicable to common shares (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_6bc341aa-11dc-4c11-bc28-82b787eca9cb_totalLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Nonoperating Income Expense</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Nonoperating Income Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_dbf214b8-d46d-479c-9c59-f00a011efdd3_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Supplemental Executive Retirement Plan obligation and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentNumberofExtensions_578a8d33-207a-469c-9098-bdfd2e0034eb_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of extensions</link:label>
    <link:label id="lab_peak_DebtInstrumentNumberofExtensions_label_en-US" xlink:label="lab_peak_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Extensions</link:label>
    <link:label id="lab_peak_DebtInstrumentNumberofExtensions_documentation_en-US" xlink:label="lab_peak_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Extensions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentNumberofExtensions" xlink:href="peak-20220331.xsd#peak_DebtInstrumentNumberofExtensions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentNumberofExtensions" xlink:to="lab_peak_DebtInstrumentNumberofExtensions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_d5f9b2f0-5a6e-41ee-bd78-9027fbb73984_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, net of reserves of $1,944 and $1,813</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_edbc5aa3-e3a1-4719-a6da-33ffb7f7db53_totalLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, net</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_773eb004-9b9c-48ea-a0ba-1b9335e7aa5c_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable, after allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_5ceb38ba-bf99-4e17-8599-c0ff225cee5c_negatedLabel_en-US" xlink:label="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity loss (income) from unconsolidated joint ventures</link:label>
    <link:label id="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Equity Method Investments, Including Discontinued Operations</link:label>
    <link:label id="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_documentation_en-US" xlink:label="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Equity Method Investments, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:href="peak-20220331.xsd#peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:to="lab_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LifeScienceMember_86031b2a-3eb9-4450-8bdd-a2c639330118_terseLabel_en-US" xlink:label="lab_peak_LifeScienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science</link:label>
    <link:label id="lab_peak_LifeScienceMember_cbba04fc-f70a-418c-9476-9014d9e7dd58_verboseLabel_en-US" xlink:label="lab_peak_LifeScienceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science</link:label>
    <link:label id="lab_peak_LifeScienceMember_label_en-US" xlink:label="lab_peak_LifeScienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science [Member]</link:label>
    <link:label id="lab_peak_LifeScienceMember_documentation_en-US" xlink:label="lab_peak_LifeScienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties that are part of continuing operations, and which are classified as life science.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LifeScienceMember" xlink:to="lab_peak_LifeScienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IntangibleLiabilitiesAcquired_8b204159-bba8-45e9-b27b-6293ed36f6a1_terseLabel_en-US" xlink:label="lab_peak_IntangibleLiabilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible liabilities acquired</link:label>
    <link:label id="lab_peak_IntangibleLiabilitiesAcquired_label_en-US" xlink:label="lab_peak_IntangibleLiabilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Liabilities Acquired</link:label>
    <link:label id="lab_peak_IntangibleLiabilitiesAcquired_documentation_en-US" xlink:label="lab_peak_IntangibleLiabilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Liabilities Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangibleLiabilitiesAcquired" xlink:href="peak-20220331.xsd#peak_IntangibleLiabilitiesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IntangibleLiabilitiesAcquired" xlink:to="lab_peak_IntangibleLiabilitiesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_HCPVenturesIVLLCMember_32c880e5-5931-4a70-95de-848e5ea9cfee_terseLabel_en-US" xlink:label="lab_peak_HCPVenturesIVLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCP Ventures IV, LLC</link:label>
    <link:label id="lab_peak_HCPVenturesIVLLCMember_label_en-US" xlink:label="lab_peak_HCPVenturesIVLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">H C P Ventures IV, LLC [Member]</link:label>
    <link:label id="lab_peak_HCPVenturesIVLLCMember_documentation_en-US" xlink:label="lab_peak_HCPVenturesIVLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to HCP Ventures IV, LLC, an unconsolidated joint venture of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIVLLCMember" xlink:href="peak-20220331.xsd#peak_HCPVenturesIVLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_HCPVenturesIVLLCMember" xlink:to="lab_peak_HCPVenturesIVLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a35bbea4-edc0-478d-b644-2dbb9159de26_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DerivativeNotionalAmountTerminated_0035cb78-bf02-4a70-8873-51b110a82a60_terseLabel_en-US" xlink:label="lab_peak_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative amount terminated</link:label>
    <link:label id="lab_peak_DerivativeNotionalAmountTerminated_label_en-US" xlink:label="lab_peak_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:label id="lab_peak_DerivativeNotionalAmountTerminated_documentation_en-US" xlink:label="lab_peak_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DerivativeNotionalAmountTerminated" xlink:href="peak-20220331.xsd#peak_DerivativeNotionalAmountTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DerivativeNotionalAmountTerminated" xlink:to="lab_peak_DerivativeNotionalAmountTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SeniorHousingOperatingPortfolioMember_664b9eab-6b3e-4bef-a8a5-1d11e523bfb9_terseLabel_en-US" xlink:label="lab_peak_SeniorHousingOperatingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHOP</link:label>
    <link:label id="lab_peak_SeniorHousingOperatingPortfolioMember_label_en-US" xlink:label="lab_peak_SeniorHousingOperatingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Housing Operating Portfolio [Member]</link:label>
    <link:label id="lab_peak_SeniorHousingOperatingPortfolioMember_documentation_en-US" xlink:label="lab_peak_SeniorHousingOperatingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represent senior housing operating portfolio.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SeniorHousingOperatingPortfolioMember" xlink:to="lab_peak_SeniorHousingOperatingPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset_92742f02-aa7e-4934-8337-49867cf61228_terseLabel_en-US" xlink:label="lab_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seller financing provided on disposition of real estate asset</link:label>
    <link:label id="lab_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset_label_en-US" xlink:label="lab_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seller Financing Provided On Disposition of Real Estate Asset</link:label>
    <link:label id="lab_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset_documentation_en-US" xlink:label="lab_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seller Financing Provided On Disposition of Real Estate Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset" xlink:href="peak-20220331.xsd#peak_SellerFinancingProvidedOnDispositionofRealEstateAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset" xlink:to="lab_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DownreitPartnershipsMember_809ee61f-8e8b-40a4-a3ea-a1dc49e0d352_terseLabel_en-US" xlink:label="lab_peak_DownreitPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DownREIT Partnerships</link:label>
    <link:label id="lab_peak_DownreitPartnershipsMember_label_en-US" xlink:label="lab_peak_DownreitPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Downreit Partnerships [Member]</link:label>
    <link:label id="lab_peak_DownreitPartnershipsMember_documentation_en-US" xlink:label="lab_peak_DownreitPartnershipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents a joint venture, DownREIT Partnerships.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownreitPartnershipsMember" xlink:href="peak-20220331.xsd#peak_DownreitPartnershipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DownreitPartnershipsMember" xlink:to="lab_peak_DownreitPartnershipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestInJointVentures_755a69fd-e7fa-4d7b-9d75-a673be997a67_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestInJointVentures_label_en-US" xlink:label="lab_us-gaap_MinorityInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestInJointVentures" xlink:to="lab_us-gaap_MinorityInterestInJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_d17a544d-b6b0-4a13-9e63-7d660bd213f8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_deb6319f-2b21-47be-9803-f3e84f356d16_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_473d2d56-3388-49b6-90bd-3d2990f6f9fc_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LifeScienceJVsMember_8fd784ea-3722-4b0f-95ec-c32b36747676_terseLabel_en-US" xlink:label="lab_peak_LifeScienceJVsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science JV</link:label>
    <link:label id="lab_peak_LifeScienceJVsMember_label_en-US" xlink:label="lab_peak_LifeScienceJVsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life Science JVs [Member]</link:label>
    <link:label id="lab_peak_LifeScienceJVsMember_documentation_en-US" xlink:label="lab_peak_LifeScienceJVsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to HCP Life Science, an unconsolidated joint venture of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember" xlink:href="peak-20220331.xsd#peak_LifeScienceJVsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LifeScienceJVsMember" xlink:to="lab_peak_LifeScienceJVsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract_57f46473-69c1-4154-bf26-a473d24a86b8_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Owned, at Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Owned, at Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireFinanceReceivables_5c026c98-897b-45de-88f6-b087d0797314_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire finance receivables</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:to="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_3ef34d6c-034c-4efd-8b41-31dad4f0995d_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SonataSHOPPortfolioMember_6d3ca598-bf2d-4e9d-a750-0f7cf075b772_terseLabel_en-US" xlink:label="lab_peak_SonataSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sonata SHOP Portfolio</link:label>
    <link:label id="lab_peak_SonataSHOPPortfolioMember_label_en-US" xlink:label="lab_peak_SonataSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sonata SHOP Portfolio [Member]</link:label>
    <link:label id="lab_peak_SonataSHOPPortfolioMember_documentation_en-US" xlink:label="lab_peak_SonataSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sonata SHOP Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SonataSHOPPortfolioMember" xlink:href="peak-20220331.xsd#peak_SonataSHOPPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SonataSHOPPortfolioMember" xlink:to="lab_peak_SonataSHOPPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_58856517-631b-423a-9a14-0a21100504ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MezzanineMember_86571182-f9ef-4d4a-91df-efd2811c2523_terseLabel_en-US" xlink:label="lab_peak_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Loans</link:label>
    <link:label id="lab_peak_MezzanineMember_label_en-US" xlink:label="lab_peak_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine [Member]</link:label>
    <link:label id="lab_peak_MezzanineMember_documentation_en-US" xlink:label="lab_peak_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MezzanineMember" xlink:to="lab_peak_MezzanineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain_bd75eb86-2fa7-4bac-b492-5f708d3a47a0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:to="lab_us-gaap_FinancialInstrumentPerformanceStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebt_482005fc-d0e9-4b7f-94f1-3776b5275839_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_99d2998b-6374-49b5-b322-9a20be6cca01_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_label_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebt" xlink:to="lab_us-gaap_SecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_73004821-04c0-4e70-bfc8-7335c3731cff_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_a0a0ac25-96cf-4fd8-8372-25cec7e674d3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of real estate, in-place lease, and other intangibles</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MezzanineAndOtherLoansReceivableSecuredMember_0ec70019-b3b9-4607-918c-88a4556636e3_terseLabel_en-US" xlink:label="lab_peak_MezzanineAndOtherLoansReceivableSecuredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine and other</link:label>
    <link:label id="lab_peak_MezzanineAndOtherLoansReceivableSecuredMember_label_en-US" xlink:label="lab_peak_MezzanineAndOtherLoansReceivableSecuredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine And Other Loans Receivable Secured [Member]</link:label>
    <link:label id="lab_peak_MezzanineAndOtherLoansReceivableSecuredMember_documentation_en-US" xlink:label="lab_peak_MezzanineAndOtherLoansReceivableSecuredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents other secured loans receivable not otherwise specified in the taxonomy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineAndOtherLoansReceivableSecuredMember" xlink:href="peak-20220331.xsd#peak_MezzanineAndOtherLoansReceivableSecuredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MezzanineAndOtherLoansReceivableSecuredMember" xlink:to="lab_peak_MezzanineAndOtherLoansReceivableSecuredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_a5718ac0-f2f5-4c6a-b7b5-25c9ac62f927_totalLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Total Costs And Expenses</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Total Costs And Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4e7163bf-8f45-4701-a47d-9eaf428fd6e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_4c3d9a6d-4022-4c6a-9bf1-fbc26741978e_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal balance on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_77153be2-4d16-4fd2-b971-99e709c532bd_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt before discount, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d21d5cbb-c151-4c74-83e4-19ca6fdd9140_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate 2024</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_08679afe-850d-4b1c-9cb8-d83894aa4a0b_terseLabel_en-US" xlink:label="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations [Roll Forward]</link:label>
    <link:label id="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_label_en-US" xlink:label="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations [Roll Forward]</link:label>
    <link:label id="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_documentation_en-US" xlink:label="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:href="peak-20220331.xsd#peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:to="lab_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentAssistanceAxis_e7df381d-bc39-4045-8d7b-3647c4adbd34_terseLabel_en-US" xlink:label="lab_peak_GovernmentAssistanceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Axis]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceAxis_label_en-US" xlink:label="lab_peak_GovernmentAssistanceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Axis]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceAxis_documentation_en-US" xlink:label="lab_peak_GovernmentAssistanceAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceAxis" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentAssistanceAxis" xlink:to="lab_peak_GovernmentAssistanceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e8d93aa1-ea26-4cc7-944c-5931ca7cf9de_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_dc0cb9d4-7f41-4cfa-9b8a-728576b672af_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_0e5b0d96-7b77-4685-8514-250b8e1fa39a_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9c54bdc5-1ef5-4d0e-8109-ac20041649e9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2c8e0392-c612-43e1-9cec-eb0c4c26353b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_7b78b978-ce83-4b98-9867-5c28f679538c_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares - forward equity agreements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c76abdae-99c7-40cb-b904-937b8967dcd4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment_b4a38411-84d6-48ea-9e35-b1aa9f23140e_terseLabel_en-US" xlink:label="lab_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of loans and preferred equity method investments</link:label>
    <link:label id="lab_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment_label_en-US" xlink:label="lab_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Financing Receivable, after Allowance for Credit Loss and Preferred Equity Method Investment</link:label>
    <link:label id="lab_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment_documentation_en-US" xlink:label="lab_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Financing Receivable, after Allowance for Credit Loss and Preferred Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" xlink:href="peak-20220331.xsd#peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" xlink:to="lab_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NeedhamLandParcelJVMember_4cc787f5-5566-4516-ae03-6f10fb7a6057_terseLabel_en-US" xlink:label="lab_peak_NeedhamLandParcelJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Needham Land Parcel JV</link:label>
    <link:label id="lab_peak_NeedhamLandParcelJVMember_label_en-US" xlink:label="lab_peak_NeedhamLandParcelJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Needham Land Parcel JV [Member]</link:label>
    <link:label id="lab_peak_NeedhamLandParcelJVMember_documentation_en-US" xlink:label="lab_peak_NeedhamLandParcelJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Needham Land Parcel JV</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember" xlink:href="peak-20220331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NeedhamLandParcelJVMember" xlink:to="lab_peak_NeedhamLandParcelJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_fcae9c53-ccfc-49b1-9cbe-3c28e64b2816_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_05c97965-6eae-4262-b4c4-b519b77d49be_terseLabel_en-US" xlink:label="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of facilities owned by unconsolidated joint venture</link:label>
    <link:label id="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_label_en-US" xlink:label="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Facilities Owned by Unconsolidated Joint Venture</link:label>
    <link:label id="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_documentation_en-US" xlink:label="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Facilities Owned by Unconsolidated Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:href="peak-20220331.xsd#peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:to="lab_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_127adef4-ce3e-4460-8d1d-19b6c3cf2437_negatedTerseLabel_en-US" xlink:label="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sale of real estate under direct financing leases</link:label>
    <link:label id="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_label_en-US" xlink:label="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease</link:label>
    <link:label id="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_documentation_en-US" xlink:label="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:href="peak-20220331.xsd#peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:to="lab_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_498d7dec-0f6f-4b29-8ceb-02631c0d3d4b_terseLabel_en-US" xlink:label="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of VIE borrowers with marketable debt securities (in joint ventures)</link:label>
    <link:label id="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_label_en-US" xlink:label="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of VIE Borrowers With Marketable Debt Securities</link:label>
    <link:label id="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_documentation_en-US" xlink:label="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of VIE borrowers in which the entity has invested in marketable debt securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:href="peak-20220331.xsd#peak_NumberOfVieBorrowersWithMarketableDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:to="lab_peak_NumberOfVieBorrowersWithMarketableDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentGrantIncomeFromCARESAct_bc7ccb42-5df9-48d9-991a-e317575fe3e0_terseLabel_en-US" xlink:label="lab_peak_GovernmentGrantIncomeFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income</link:label>
    <link:label id="lab_peak_GovernmentGrantIncomeFromCARESAct_label_en-US" xlink:label="lab_peak_GovernmentGrantIncomeFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income From CARES Act</link:label>
    <link:label id="lab_peak_GovernmentGrantIncomeFromCARESAct_documentation_en-US" xlink:label="lab_peak_GovernmentGrantIncomeFromCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income From CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomeFromCARESAct" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncomeFromCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentGrantIncomeFromCARESAct" xlink:to="lab_peak_GovernmentGrantIncomeFromCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnsecuredNote3880PercentMember_4655d7c2-ca46-4801-bc6b-04a32527cba9_terseLabel_en-US" xlink:label="lab_peak_UnsecuredNote3880PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 3.880 Percent</link:label>
    <link:label id="lab_peak_UnsecuredNote3880PercentMember_label_en-US" xlink:label="lab_peak_UnsecuredNote3880PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 3.880 Percent [Member]</link:label>
    <link:label id="lab_peak_UnsecuredNote3880PercentMember_documentation_en-US" xlink:label="lab_peak_UnsecuredNote3880PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 3.880 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote3880PercentMember" xlink:href="peak-20220331.xsd#peak_UnsecuredNote3880PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnsecuredNote3880PercentMember" xlink:to="lab_peak_UnsecuredNote3880PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NoncontrollingInterestsShareInDiscontinuedOperations_b3ec7cb4-8d82-4672-8bb4-cf4e56707854_terseLabel_en-US" xlink:label="lab_peak_NoncontrollingInterestsShareInDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests' share in discontinued operations</link:label>
    <link:label id="lab_peak_NoncontrollingInterestsShareInDiscontinuedOperations_label_en-US" xlink:label="lab_peak_NoncontrollingInterestsShareInDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests' Share In Discontinued Operations</link:label>
    <link:label id="lab_peak_NoncontrollingInterestsShareInDiscontinuedOperations_documentation_en-US" xlink:label="lab_peak_NoncontrollingInterestsShareInDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests' Share In Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncontrollingInterestsShareInDiscontinuedOperations" xlink:href="peak-20220331.xsd#peak_NoncontrollingInterestsShareInDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NoncontrollingInterestsShareInDiscontinuedOperations" xlink:to="lab_peak_NoncontrollingInterestsShareInDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_b232cf2a-1b04-4ad8-8757-a2600a056aab_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financing Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_94a9598b-f831-4a08-afa6-b8723e48e8cb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndOtherIncomeAbstract_7e6a0f27-0c35-4f19-877f-a6e6958e6a2b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Other Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_InterestAndOtherIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Other Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndOtherIncomeAbstract" xlink:to="lab_us-gaap_InterestAndOtherIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_31c0de87-e255-43a6-a889-0792fc2422a0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_36a1c09f-6578-4fb8-8711-e312f7dc42d3_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year Two, Originated, Fiscal Year before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_d3a5734e-57cf-48e7-bfdf-a9871e0b058a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $2,068 and $1,870</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_30d5256e-831d-46cc-b55d-973290935b00_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2187f7cf-d59c-4d5d-be8a-4fbcb05b8a87_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_a22d6b34-43d5-4dc2-b0e5-75b7e85367d4_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_PropertiesWithDirectFinancingLeasesNumber_3a6db091-379e-4ce3-9357-06b1fb034b2c_terseLabel_en-US" xlink:label="lab_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties subject to direct financing leases</link:label>
    <link:label id="lab_peak_PropertiesWithDirectFinancingLeasesNumber_label_en-US" xlink:label="lab_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties with Direct Financing Leases, Number</link:label>
    <link:label id="lab_peak_PropertiesWithDirectFinancingLeasesNumber_documentation_en-US" xlink:label="lab_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties with direct financing leases at the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:href="peak-20220331.xsd#peak_PropertiesWithDirectFinancingLeasesNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:to="lab_peak_PropertiesWithDirectFinancingLeasesNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CCRCSegmentMember_f26e218c-6cb9-4822-9493-34bfe7f8149f_terseLabel_en-US" xlink:label="lab_peak_CCRCSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC</link:label>
    <link:label id="lab_peak_CCRCSegmentMember_label_en-US" xlink:label="lab_peak_CCRCSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC Segment [Member]</link:label>
    <link:label id="lab_peak_CCRCSegmentMember_documentation_en-US" xlink:label="lab_peak_CCRCSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCSegmentMember" xlink:href="peak-20220331.xsd#peak_CCRCSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CCRCSegmentMember" xlink:to="lab_peak_CCRCSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfPropertiesSold_80283ab4-9482-49eb-9d5b-b5c63e6565cc_terseLabel_en-US" xlink:label="lab_peak_NumberOfPropertiesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties sold</link:label>
    <link:label id="lab_peak_NumberOfPropertiesSold_label_en-US" xlink:label="lab_peak_NumberOfPropertiesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties Sold</link:label>
    <link:label id="lab_peak_NumberOfPropertiesSold_documentation_en-US" xlink:label="lab_peak_NumberOfPropertiesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesSold" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfPropertiesSold" xlink:to="lab_peak_NumberOfPropertiesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_b7839efa-3f23-4b57-a92e-93b423ff7eee_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_6e744d01-1005-4726-8ac9-7d3f81ef4d59_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_f74d7a5a-9461-48cc-88ec-e63af36bb4c1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends In&#160;Excess Of&#160;Earnings</link:label>
    <link:label id="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Distributions in Excess of Net Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:to="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember_0f7baea7-1789-4b9c-bd47-4a921bd32a12_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Thereafter</link:label>
    <link:label id="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember_label_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Redemption Period Thereafter [Member]</link:label>
    <link:label id="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember_documentation_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the period after the last period separately disclosed of debt redemption features under terms of the debt agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:href="peak-20220331.xsd#peak_DebtInstrumentRedemptionPeriodThereafterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:to="lab_peak_DebtInstrumentRedemptionPeriodThereafterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent_75d3642f-c6b1-45d9-9556-c8750fe3be81_terseLabel_en-US" xlink:label="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable entrance fees</link:label>
    <link:label id="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent_label_en-US" xlink:label="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable Entrance Fees, Current and Noncurrent</link:label>
    <link:label id="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent_documentation_en-US" xlink:label="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable Entrance Fees, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:href="peak-20220331.xsd#peak_RefundableEntranceFeesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:to="lab_peak_RefundableEntranceFeesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d8cf66ae-66de-4651-9f0c-faf51a3a386f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_da83cb57-b319-422e-9f5d-2d7b5dd1ca72_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares_0d989540-4bb7-449e-bbd9-858a8408635c_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum shares issuable under forward equity sales agreement (in shares)</link:label>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares_label_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:to="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfBondOfferings_300618d7-59d6-41b6-abf6-ab682801fc0c_terseLabel_en-US" xlink:label="lab_peak_NumberOfBondOfferings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of bond offerings</link:label>
    <link:label id="lab_peak_NumberOfBondOfferings_label_en-US" xlink:label="lab_peak_NumberOfBondOfferings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Bond Offerings</link:label>
    <link:label id="lab_peak_NumberOfBondOfferings_documentation_en-US" xlink:label="lab_peak_NumberOfBondOfferings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Bond Offerings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfBondOfferings" xlink:href="peak-20220331.xsd#peak_NumberOfBondOfferings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfBondOfferings" xlink:to="lab_peak_NumberOfBondOfferings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_507ea4fd-9578-49a3-bac4-e1002bb93a30_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_51af67af-34b5-47d9-8f4a-81dbec4c19fe_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_4540f716-f42f-46a0-a01a-4d3a92c529e5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest-rate Swap Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_7d0d5d47-a3e1-4d63-a9a1-4ad34c5cfe85_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale, net</link:label>
    <link:label id="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_label_en-US" xlink:label="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Liabilities Associated with Assets Held for Development and Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:to="lab_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_6949a3ce-0095-442b-adfb-34bd3567ec37_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_7431b129-bb24-42d6-a76a-0007f25ff51b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_bfe83232-4186-42e6-8527-d9ec723388e4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale and discontinued operations, net</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c4e0cccd-36af-485c-8fdc-f2b17c333990_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets of discontinued operations, net</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_f0ccdad2-4fd2-4fea-a462-ee698eaca606_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_0052a2ad-fede-4085-8478-e038f9de58d4_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_64679e65-c3e6-4025-863d-a846ebc220db_terseLabel_en-US" xlink:label="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditure funding, cost of capital, percent committed</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_label_en-US" xlink:label="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Cost of Capital, Percent Committed</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_documentation_en-US" xlink:label="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Cost of Capital, Percent Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:to="lab_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfPreferredEquityMethodInvestmentsSold_622a9164-a3b3-4e00-aeff-b099ebbda873_terseLabel_en-US" xlink:label="lab_peak_NumberOfPreferredEquityMethodInvestmentsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of preferred equity method investments sold</link:label>
    <link:label id="lab_peak_NumberOfPreferredEquityMethodInvestmentsSold_label_en-US" xlink:label="lab_peak_NumberOfPreferredEquityMethodInvestmentsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Preferred Equity Method Investments Sold</link:label>
    <link:label id="lab_peak_NumberOfPreferredEquityMethodInvestmentsSold_documentation_en-US" xlink:label="lab_peak_NumberOfPreferredEquityMethodInvestmentsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Preferred Equity Method Investments Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold" xlink:href="peak-20220331.xsd#peak_NumberOfPreferredEquityMethodInvestmentsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold" xlink:to="lab_peak_NumberOfPreferredEquityMethodInvestmentsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_35fc862d-ab8b-47db-a798-3ccbb72f0d4a_terseLabel_en-US" xlink:label="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Liabilities Disclosure [Text Block]</link:label>
    <link:label id="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_documentation_en-US" xlink:label="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This block of text may be used to disclose all or part of the information related to intangible assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:href="peak-20220331.xsd#peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:to="lab_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d9118678-6be4-469c-b666-10ba2c7b8493_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OtherNonReportingSegmentMember_aaa3b214-c43d-4ee6-b409-8ae8d69b4fbe_terseLabel_en-US" xlink:label="lab_peak_OtherNonReportingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Reporting Segment</link:label>
    <link:label id="lab_peak_OtherNonReportingSegmentMember_93883273-49e0-422a-b64d-96018146f8dc_netLabel_en-US" xlink:label="lab_peak_OtherNonReportingSegmentMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-reportable</link:label>
    <link:label id="lab_peak_OtherNonReportingSegmentMember_label_en-US" xlink:label="lab_peak_OtherNonReportingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Reporting Segment [Member]</link:label>
    <link:label id="lab_peak_OtherNonReportingSegmentMember_documentation_en-US" xlink:label="lab_peak_OtherNonReportingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to other non-reporting segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember" xlink:href="peak-20220331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OtherNonReportingSegmentMember" xlink:to="lab_peak_OtherNonReportingSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_fbe47b8e-ff2f-4694-bcd1-d8d09df4b3e5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_b25d401a-0298-4f1c-bb44-8895dafa07ea_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_219d184a-59bd-4a27-9b20-8e5bd543893b_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a0266858-6620-4bb6-b181-8d6d006b9f4a_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive (income) loss attributable to noncontrolling interests'</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_88518195-58aa-419d-86d0-031169e6453a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentAssistanceCARESActMember_a113d521-b8dd-4b6e-a4db-9147eebfead3_terseLabel_en-US" xlink:label="lab_peak_GovernmentAssistanceCARESActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, CARES Act</link:label>
    <link:label id="lab_peak_GovernmentAssistanceCARESActMember_label_en-US" xlink:label="lab_peak_GovernmentAssistanceCARESActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, CARES Act [Member]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceCARESActMember_documentation_en-US" xlink:label="lab_peak_GovernmentAssistanceCARESActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceCARESActMember" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceCARESActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentAssistanceCARESActMember" xlink:to="lab_peak_GovernmentAssistanceCARESActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_321e486c-3af0-4202-976e-c43a17e1dd09_terseLabel_en-US" xlink:label="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Government Grant Receivables, CARES Act</link:label>
    <link:label id="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_label_en-US" xlink:label="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Government Grant Receivables, CARES Act [Table Text Block]</link:label>
    <link:label id="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_documentation_en-US" xlink:label="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Government Grant Receivables, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:href="peak-20220331.xsd#peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:to="lab_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_07f10b53-2652-4d57-882d-a35f58242223_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FinancingReceivableRemainingCommitments_d1c31870-470b-4b90-b830-7251df52c7f6_terseLabel_en-US" xlink:label="lab_peak_FinancingReceivableRemainingCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining loans receivable commitments</link:label>
    <link:label id="lab_peak_FinancingReceivableRemainingCommitments_label_en-US" xlink:label="lab_peak_FinancingReceivableRemainingCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Remaining Commitments</link:label>
    <link:label id="lab_peak_FinancingReceivableRemainingCommitments_documentation_en-US" xlink:label="lab_peak_FinancingReceivableRemainingCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Remaining Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableRemainingCommitments" xlink:href="peak-20220331.xsd#peak_FinancingReceivableRemainingCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FinancingReceivableRemainingCommitments" xlink:to="lab_peak_FinancingReceivableRemainingCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_877bd9b1-ed05-4dfd-a451-485a1dbb2706_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasing costs, tenant improvements, and recurring capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_3fc39294-de4b-409f-9396-3e7119d11832_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasing costs, tenant improvements, and recurring capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Leasing Costs, Commissions, and Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:to="lab_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4efbb207-627f-4b51-817e-83613550430a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b3cff443-78af-480e-ae90-e19a8b516aec_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_ce4f07bf-8385-46bc-b8e1-e78c20cae7de_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_027f3128-1aa4-4b00-86de-494433d49608_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_952502d8-d0db-45cf-b391-3df41eee68b3_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_ffe296dc-6130-42dd-b321-a8df30136736_negatedLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_e387a200-578b-4d93-b012-8875d0f4bc8f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DispositionOfPropertiesSoldNumber_81eb56c8-91e2-4ba8-ac44-a78d9d359e63_terseLabel_en-US" xlink:label="lab_peak_DispositionOfPropertiesSoldNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties disposed</link:label>
    <link:label id="lab_peak_DispositionOfPropertiesSoldNumber_label_en-US" xlink:label="lab_peak_DispositionOfPropertiesSoldNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of Properties Sold Number</link:label>
    <link:label id="lab_peak_DispositionOfPropertiesSoldNumber_documentation_en-US" xlink:label="lab_peak_DispositionOfPropertiesSoldNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of properties sold during the period, not categorized as discontinued operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DispositionOfPropertiesSoldNumber" xlink:href="peak-20220331.xsd#peak_DispositionOfPropertiesSoldNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DispositionOfPropertiesSoldNumber" xlink:to="lab_peak_DispositionOfPropertiesSoldNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_f7165e80-0b4f-49f3-88b7-7e998cb1f7dd_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_0963fd4d-2be6-42bb-80c7-f77913695843_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_35216801-279d-4049-a628-f348adb8b4d4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Line&#160;of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_353fc82d-4b0c-4fa1-a91d-1d06a9b9a2ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageReceivablesMember_b54aca3f-e773-4418-b150-c035f2a46871_verboseLabel_en-US" xlink:label="lab_us-gaap_MortgageReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Mortgage Loans</link:label>
    <link:label id="lab_us-gaap_MortgageReceivablesMember_label_en-US" xlink:label="lab_us-gaap_MortgageReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageReceivablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageReceivablesMember" xlink:to="lab_us-gaap_MortgageReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_f962cfb6-b889-4b69-9dc3-9e17eb6272c1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2eaf6b3a-86c7-418c-abe7-220eb91cd23d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_c89ee1a6-801e-4973-bff4-40795bf59004_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions to unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FinancingReceivableNumberOfContractsSold_2e10584f-ece8-4895-bca8-9de8c8128cc6_terseLabel_en-US" xlink:label="lab_peak_FinancingReceivableNumberOfContractsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of loans sold</link:label>
    <link:label id="lab_peak_FinancingReceivableNumberOfContractsSold_label_en-US" xlink:label="lab_peak_FinancingReceivableNumberOfContractsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Number of Contracts Sold</link:label>
    <link:label id="lab_peak_FinancingReceivableNumberOfContractsSold_documentation_en-US" xlink:label="lab_peak_FinancingReceivableNumberOfContractsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Number of Contracts Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableNumberOfContractsSold" xlink:href="peak-20220331.xsd#peak_FinancingReceivableNumberOfContractsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FinancingReceivableNumberOfContractsSold" xlink:to="lab_peak_FinancingReceivableNumberOfContractsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SeniorHousingTripleNetMember_8f1aef33-2a45-4838-a3aa-942681ce6688_terseLabel_en-US" xlink:label="lab_peak_SeniorHousingTripleNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Housing Triple Net</link:label>
    <link:label id="lab_peak_SeniorHousingTripleNetMember_label_en-US" xlink:label="lab_peak_SeniorHousingTripleNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Housing Triple Net [Member]</link:label>
    <link:label id="lab_peak_SeniorHousingTripleNetMember_documentation_en-US" xlink:label="lab_peak_SeniorHousingTripleNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to the Senior Housing Triple Net [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingTripleNetMember" xlink:href="peak-20220331.xsd#peak_SeniorHousingTripleNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SeniorHousingTripleNetMember" xlink:to="lab_peak_SeniorHousingTripleNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_217442b3-5ac4-4272-a071-ed42eb659ae8_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate:</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_0f6ff73f-80a5-495b-b0c4-2d3ce587d077_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities, and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_6b0b9743-0c0a-44b9-bff5-9778232d32db_negatedLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities, and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_8ce4cdb4-c179-4588-8047-f2b09f53c3a9_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities, and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_b04aeb11-6851-4792-944d-8cb4f2f4b656_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, collateral, healthcare facilities carrying value</link:label>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_label_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Collateral Healthcare Facilities, Carrying Value</link:label>
    <link:label id="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of healthcare facilities which are secured by mortgage debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:to="lab_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_6b5a7724-92d6-4fc4-826e-27331c7cf07b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_266b204d-d4aa-462e-8f5d-7693c0187f06_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5e844384-f4da-4ed4-95de-2cc1b0fdea68_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_4aca7625-630d-417a-86e2-4dacae83f6de_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e5b1e233-a48e-47e8-b6db-82ec7d3cabd3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $1.00 par value: 750,000,000 shares authorized; 539,523,537 and 539,096,879 shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_a566d9fe-3a45-4d2a-ba9d-aad314f09cf6_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantDebtToAssets_398b36cf-9dbc-4985-bafe-083dabe3f8e0_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant debt to assets (as a percent)</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantDebtToAssets_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Debt to Assets</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantDebtToAssets_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The limit of the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantDebtToAssets" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantDebtToAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantDebtToAssets" xlink:to="lab_peak_DebtInstrumentCovenantDebtToAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_13a366b4-9afe-4ba3-9d98-bd58d1db9f7d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale and discontinued operations, net</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c29032cd-2627-4c1b-bf7c-e98ee2826ee2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities of discontinued operations, net</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_63d8a655-e16c-49d5-9f42-a64fd7bb91ee_terseLabel_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding equity awards (in shares)</link:label>
    <link:label id="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_label_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards</link:label>
    <link:label id="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_documentation_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Equity Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:href="peak-20220331.xsd#peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:to="lab_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_BrookdaleTripleNetPortfolioMember_7f77e1de-7ea6-40ef-ad01-02bd8484ee92_terseLabel_en-US" xlink:label="lab_peak_BrookdaleTripleNetPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookdale Triple Net Portfolio</link:label>
    <link:label id="lab_peak_BrookdaleTripleNetPortfolioMember_label_en-US" xlink:label="lab_peak_BrookdaleTripleNetPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookdale Triple Net Portfolio [Member]</link:label>
    <link:label id="lab_peak_BrookdaleTripleNetPortfolioMember_documentation_en-US" xlink:label="lab_peak_BrookdaleTripleNetPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookdale Triple Net Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleTripleNetPortfolioMember" xlink:href="peak-20220331.xsd#peak_BrookdaleTripleNetPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_BrookdaleTripleNetPortfolioMember" xlink:to="lab_peak_BrookdaleTripleNetPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_96809f9f-9263-4773-9485-2227314e64cc_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_afd7c799-4802-4355-b4a1-36dfa1e833b8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_6988469c-80f8-4255-850c-139618157468_negatedTerseLabel_en-US" xlink:label="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to redemption value of redeemable noncontrolling interests</link:label>
    <link:label id="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_label_en-US" xlink:label="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments Of Permanent Equity To Temporary Equity</link:label>
    <link:label id="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_documentation_en-US" xlink:label="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments Of Permanent Equity To Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:href="peak-20220331.xsd#peak_AdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:to="lab_peak_AdjustmentsOfPermanentEquityToTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c72eb08d-e5f9-493f-8f39-807379bea1ff_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_06a1fef3-bc4e-444d-bb2b-8002f0741321_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_62ae49b1-b997-49d0-bde6-edfdf8ba9cd7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Carry Amounts and Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_64fc9430-b6d7-4881-814f-58900667d46b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_4b1f49f8-3e03-41b5-bec1-458a298e6eb8_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuredEventGainLoss_b535eacc-4d56-437b-8222-86f5db38efcf_negatedLabel_en-US" xlink:label="lab_us-gaap_InsuredEventGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casualty-related loss (recoveries), net</link:label>
    <link:label id="lab_us-gaap_InsuredEventGainLoss_label_en-US" xlink:label="lab_us-gaap_InsuredEventGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insured Event, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuredEventGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuredEventGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuredEventGainLoss" xlink:to="lab_us-gaap_InsuredEventGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_A2019TermLoanMember_da1a36b6-0b53-418d-a4cf-27e2f770610b_terseLabel_en-US" xlink:label="lab_peak_A2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan</link:label>
    <link:label id="lab_peak_A2019TermLoanMember_label_en-US" xlink:label="lab_peak_A2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan [Member]</link:label>
    <link:label id="lab_peak_A2019TermLoanMember_documentation_en-US" xlink:label="lab_peak_A2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2019TermLoanMember" xlink:href="peak-20220331.xsd#peak_A2019TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_A2019TermLoanMember" xlink:to="lab_peak_A2019TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableSignificantSales_6e10c752-c8f6-41de-b69d-323066c78617_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableSignificantSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected loan losses related to loans sold and repaid</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableSignificantSales_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableSignificantSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableSignificantSales" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableSignificantSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableSignificantSales" xlink:to="lab_us-gaap_FinancingReceivableSignificantSales" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock_1f4bd647-d623-43be-9363-cf517d814a70_terseLabel_en-US" xlink:label="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income</link:label>
    <link:label id="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income, Policy [Policy Text Block]</link:label>
    <link:label id="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:to="lab_peak_GovernmentGrantIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_14a2c590-d3c1-475e-aa7f-9d391efa74ff_terseLabel_en-US" xlink:label="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Lease Liabilities</link:label>
    <link:label id="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_label_en-US" xlink:label="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite Lived Intangible Liabilities by Major Class [Table Text Block]</link:label>
    <link:label id="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_documentation_en-US" xlink:label="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of liabilities, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:href="peak-20220331.xsd#peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:to="lab_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_65841565-ecf6-40eb-a804-7c29d784d879_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_b873aa01-8cf9-4989-a834-8924824b5bb3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SecuredMortgageLoansMember_3b048857-6287-4304-9f3a-dff193829386_terseLabel_en-US" xlink:label="lab_peak_SecuredMortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured mortgage loans</link:label>
    <link:label id="lab_peak_SecuredMortgageLoansMember_label_en-US" xlink:label="lab_peak_SecuredMortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Mortgage Loans [Member]</link:label>
    <link:label id="lab_peak_SecuredMortgageLoansMember_documentation_en-US" xlink:label="lab_peak_SecuredMortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Mortgage Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember" xlink:href="peak-20220331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SecuredMortgageLoansMember" xlink:to="lab_peak_SecuredMortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CO_42ff38a7-eccb-4800-82b0-ab925a22ad6b_terseLabel_en-US" xlink:label="lab_stpr_CO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COLORADO</link:label>
    <link:label id="lab_stpr_CO_label_en-US" xlink:label="lab_stpr_CO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COLORADO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CO" xlink:to="lab_stpr_CO" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_eaebe94c-3f4e-4422-b072-70c16d56cb28_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of real estate</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfRealEstate" xlink:to="lab_us-gaap_ImpairmentOfRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_4695dc59-bb96-4cd8-853c-976351fb131b_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6bfcd8d9-95d2-49d2-a063-a35b2517773a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares - equity awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_57008402-be85-4521-baed-bc54b1abb890_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_85c0ebec-7e93-4f35-adf1-f7ae812fd5c9_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_429a7b46-4f62-48fa-b0fd-89d8d1053f95_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_e50f1456-a5e6-4771-a362-f6c907ab0f3e_terseLabel_en-US" xlink:label="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to NOI</link:label>
    <link:label id="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_label_en-US" xlink:label="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Adjustments To Net Operating Income From Continuing Operations</link:label>
    <link:label id="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_documentation_en-US" xlink:label="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:href="peak-20220331.xsd#peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:to="lab_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_03cee159-2c0e-4b95-9fe4-57ac72b8c946_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_4c48b511-9103-48bc-86f1-d9afa42ab6b6_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StraightLineRent_75acaea4-6cbd-45a0-91d8-ca05f0eed2c5_negatedLabel_en-US" xlink:label="lab_us-gaap_StraightLineRent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line rents</link:label>
    <link:label id="lab_us-gaap_StraightLineRent_label_en-US" xlink:label="lab_us-gaap_StraightLineRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight Line Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StraightLineRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StraightLineRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StraightLineRent" xlink:to="lab_us-gaap_StraightLineRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_3c267234-8320-4085-9343-8cc9c7ea5050_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_7e6e4d39-d7d5-496a-898e-974388095ec9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnsecuredNote4200PercentMember_a9f3c557-54ce-4a04-a8bc-e0d91e948149_terseLabel_en-US" xlink:label="lab_peak_UnsecuredNote4200PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.200 Percent</link:label>
    <link:label id="lab_peak_UnsecuredNote4200PercentMember_label_en-US" xlink:label="lab_peak_UnsecuredNote4200PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.200 Percent [Member]</link:label>
    <link:label id="lab_peak_UnsecuredNote4200PercentMember_documentation_en-US" xlink:label="lab_peak_UnsecuredNote4200PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.200 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4200PercentMember" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4200PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnsecuredNote4200PercentMember" xlink:to="lab_peak_UnsecuredNote4200PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseLeaseReceivable_dc9f52cc-6c44-41cc-8baf-c3a23600be42_terseLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of minimum lease payments receivable</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseLeaseReceivable" xlink:to="lab_us-gaap_DirectFinancingLeaseLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfBuildings_1464247e-2f34-4199-b923-f495f8d030ff_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfBuildings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of buildings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfBuildings_dd949a00-e54d-4fd5-ac61-8775ce3d41ac_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfBuildings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfBuildings_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfBuildings" xlink:to="lab_us-gaap_ProceedsFromSaleOfBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IncomeLossFromDiscontinuedOperationsMember_10db4a7e-92eb-4c50-885f-92978b2f92c9_terseLabel_en-US" xlink:label="lab_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income recorded in income (loss) from discontinued operations</link:label>
    <link:label id="lab_peak_IncomeLossFromDiscontinuedOperationsMember_label_en-US" xlink:label="lab_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Discontinued Operations [Member]</link:label>
    <link:label id="lab_peak_IncomeLossFromDiscontinuedOperationsMember_documentation_en-US" xlink:label="lab_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:href="peak-20220331.xsd#peak_IncomeLossFromDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:to="lab_peak_IncomeLossFromDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_bdddc39a-04d8-435c-9d0c-0f792fbfbb59_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends, per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_10114591-e60c-4a05-b7ad-f5051b91b804_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e6adead5-4354-4d80-b714-3e6175a38366_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resident fees and services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_dde11588-7a54-4c89-9cbb-6c6a1dc14377_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:to="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_72bb2ebd-fce1-43f5-a2b4-67a8ada58b3e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_4b4d6155-6201-4513-85c7-45ebf34dcf19_terseLabel_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development commitments</link:label>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_label_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Development and Redevelopment Projects and Tenant Improvements</link:label>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_documentation_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Development and Redevelopment Projects and Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:href="peak-20220331.xsd#peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:to="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_8157d2c6-0bc3-46e3-8da4-81b208d126d7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_789fabec-0917-46d5-97ac-63a7b02b9575_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_d0c5e2f3-b2d9-4a9e-a850-6b80fc9fd19a_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LineOfCreditAndTermLoanMember_23aa9070-0f3f-4ff3-8f96-9f20695c8022_terseLabel_en-US" xlink:label="lab_peak_LineOfCreditAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit and Term Loan</link:label>
    <link:label id="lab_peak_LineOfCreditAndTermLoanMember_label_en-US" xlink:label="lab_peak_LineOfCreditAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit And Term Loan [Member]</link:label>
    <link:label id="lab_peak_LineOfCreditAndTermLoanMember_documentation_en-US" xlink:label="lab_peak_LineOfCreditAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The combination of the entity's revolving line of credit facility and term loan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditAndTermLoanMember" xlink:href="peak-20220331.xsd#peak_LineOfCreditAndTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LineOfCreditAndTermLoanMember" xlink:to="lab_peak_LineOfCreditAndTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_630b2f20-9293-44ca-9f5e-43a6014d635f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities, and other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d5acda8-7b53-4784-a2a8-d7163dfa9a99_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_de3c78c4-d0a5-4a35-84ad-81f8923f18e3_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_029c887a-5342-4019-8666-b5cfbf70654c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_52d05129-53cb-4ea9-9f7c-390637d8b3c0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_399d1505-73d9-4211-9b9c-ac8484367077_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Operating Lease Liability</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_4fe5ea73-f453-44de-a9e8-6f83fc9af9d8_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesGross_af225eb9-931d-43df-ae68-40d71b477106_terseLabel_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross intangible lease liabilities</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesGross_label_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Liabilities, Gross</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesGross_documentation_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:to="lab_peak_FiniteLivedIntangibleLiabilitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments_e601043c-72e1-4d6a-aff6-5d6cd1d93f55_terseLabel_en-US" xlink:label="lab_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss reserve on unfunded loan commitments</link:label>
    <link:label id="lab_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments_label_en-US" xlink:label="lab_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance For Credit Loss, Unfunded Loan Commitments</link:label>
    <link:label id="lab_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments_documentation_en-US" xlink:label="lab_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance For Credit Loss, Unfunded Loan Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" xlink:href="peak-20220331.xsd#peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" xlink:to="lab_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_726f4a17-cd01-4bab-bc5f-835fecc878d8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_be03c74d-4ff0-4d35-af3f-77d1f7892862_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_5b74d673-16e0-4e58-a255-c5b425c9f769_terseLabel_en-US" xlink:label="lab_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of assets classified as discontinued operations</link:label>
    <link:label id="lab_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_label_en-US" xlink:label="lab_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Assets Classified as Discontinued Operations</link:label>
    <link:label id="lab_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_documentation_en-US" xlink:label="lab_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Assets Classified as Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations" xlink:href="peak-20220331.xsd#peak_NumberOfAssetsClassifiedAsDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations" xlink:to="lab_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d033332e-732d-47d7-ac77-ab43ea62b95e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Disclosures</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MedicalOfficeHospitalMember_26369f6c-084c-4a6b-a601-c951c616ce29_terseLabel_en-US" xlink:label="lab_peak_MedicalOfficeHospitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office, Hospital</link:label>
    <link:label id="lab_peak_MedicalOfficeHospitalMember_label_en-US" xlink:label="lab_peak_MedicalOfficeHospitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office, Hospital [Member]</link:label>
    <link:label id="lab_peak_MedicalOfficeHospitalMember_documentation_en-US" xlink:label="lab_peak_MedicalOfficeHospitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office, Hospital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeHospitalMember" xlink:href="peak-20220331.xsd#peak_MedicalOfficeHospitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MedicalOfficeHospitalMember" xlink:to="lab_peak_MedicalOfficeHospitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_a7c34a94-18ca-48fb-aec8-cd2734e04cc8_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_880ba7d1-16fe-497c-a6e3-838945a11c61_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_542bdfe0-42b5-444d-99dc-ad146f1d4a2a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_12f2cf15-b7e1-43ce-8241-16bcf7d49621_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ae29defa-6f7d-4823-836d-ae319992915d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_549b4641-6ccf-4022-a213-7399d83d426c_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_0e8969e3-9e5a-4619-98fd-e075c866cfe7_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_654833de-c414-4c28-aad0-c64a85c642dd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f5bf79fc-7dc3-4b2f-86ba-78a6085b2d91_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentAssistanceDomain_91558881-3ffe-40ec-81bd-cbd07b05516f_terseLabel_en-US" xlink:label="lab_peak_GovernmentAssistanceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Domain]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceDomain_label_en-US" xlink:label="lab_peak_GovernmentAssistanceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance [Domain]</link:label>
    <link:label id="lab_peak_GovernmentAssistanceDomain_documentation_en-US" xlink:label="lab_peak_GovernmentAssistanceDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceDomain" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentAssistanceDomain" xlink:to="lab_peak_GovernmentAssistanceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest_1b2f4bda-e901-499c-9bdf-e73f4be613c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests&#8217; share in discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_fcd6235f-efe6-4cac-aef5-1b329269ca97_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock_41c27f50-7b5a-42a7-9c93-e9d33669d4d5_terseLabel_en-US" xlink:label="lab_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Investment in DFLs</link:label>
    <link:label id="lab_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock_label_en-US" xlink:label="lab_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment in Direct Financing and Sales Type Leases [Table Text Block]</link:label>
    <link:label id="lab_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock_documentation_en-US" xlink:label="lab_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the components of the net amount due as of the balance sheet date consisting of: (a) minimum lease payments due on direct financing and sales-type leases, (b) unguaranteed residual value, and (c) any unamortized initial direct costs on direct financing leases; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" xlink:href="peak-20220331.xsd#peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" xlink:to="lab_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c1007a96-93cb-4093-be83-6a3a8c652496_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_f0c6586a-0b99-4595-96cf-841506b6c491_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_db622cbf-c811-4446-9cd1-3d7157b1999d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_15067a87-8614-4974-a0b4-ad74a415a6d4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome_0c466db4-6d32-4217-ad27-7bf1ca502836_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental and related revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Rental Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_192856ae-87d2-4480-b133-d8598d2fe85f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_4ba997ae-be2d-4e92-b46c-64233156ae73_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and loan loss reserves (recoveries), net</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnsecuredNote1350PercentMember_124a5243-b49f-4c27-866e-b9cbb6b36804_terseLabel_en-US" xlink:label="lab_peak_UnsecuredNote1350PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 1.35 Percent</link:label>
    <link:label id="lab_peak_UnsecuredNote1350PercentMember_label_en-US" xlink:label="lab_peak_UnsecuredNote1350PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 1.350 Percent [Member]</link:label>
    <link:label id="lab_peak_UnsecuredNote1350PercentMember_documentation_en-US" xlink:label="lab_peak_UnsecuredNote1350PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 1.350 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote1350PercentMember" xlink:href="peak-20220331.xsd#peak_UnsecuredNote1350PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnsecuredNote1350PercentMember" xlink:to="lab_peak_UnsecuredNote1350PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_a790e143-80c1-4fe6-b6c3-3d2b919bbb6f_terseLabel_en-US" xlink:label="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining amortization period in years</link:label>
    <link:label id="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_b492f853-f7d5-48dc-a548-2c4a5f2b9b0c_verboseLabel_en-US" xlink:label="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining amortization period, liabilities</link:label>
    <link:label id="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_label_en-US" xlink:label="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life</link:label>
    <link:label id="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_documentation_en-US" xlink:label="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:href="peak-20220331.xsd#peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:to="lab_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock_0d26441a-aa11-4368-87aa-40574552075c_terseLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Company's Lease Income</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_4986fb60-fd9a-4f07-86c2-f7dbe3b46209_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5ef4b61a-b550-4d1e-954e-b9cb526c871f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFinanceReceivables_43b93a2f-7064-4da0-a0ff-cd618a7976dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in financing receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable_b993139c-3256-4219-b041-bf1d435524f2_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts receivable</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Allowance For Doubtful Accounts Receivable</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Allowance For Doubtful Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_ac591c2a-3825-453b-a70c-5318e1b258bc_terseLabel_en-US" xlink:label="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned MOB Demolition, Tenant Relocation and Other Costs</link:label>
    <link:label id="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_label_en-US" xlink:label="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned MOB Demolition, Tenant Relocation And Other Costs [Member]</link:label>
    <link:label id="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_documentation_en-US" xlink:label="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned MOB Demolition, Tenant Relocation And Other Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:href="peak-20220331.xsd#peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:to="lab_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LoansReceivableMarketRate_b3005801-d67d-4ef9-99e6-66710190310c_terseLabel_en-US" xlink:label="lab_peak_LoansReceivableMarketRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, market rate</link:label>
    <link:label id="lab_peak_LoansReceivableMarketRate_label_en-US" xlink:label="lab_peak_LoansReceivableMarketRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Market Rate</link:label>
    <link:label id="lab_peak_LoansReceivableMarketRate_documentation_en-US" xlink:label="lab_peak_LoansReceivableMarketRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Market Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableMarketRate" xlink:href="peak-20220331.xsd#peak_LoansReceivableMarketRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LoansReceivableMarketRate" xlink:to="lab_peak_LoansReceivableMarketRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d6e9bea7-cde9-4895-b5a7-72f84dd4d8cb_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_9c0abc96-b266-4b7d-9f05-f6983ae1da4c_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate 2022</link:label>
    <link:label id="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_label_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Remainder of Fiscal Year [Member]</link:label>
    <link:label id="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_documentation_en-US" xlink:label="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:href="peak-20220331.xsd#peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:to="lab_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DiscoverySHOPPortfolioMember_9842dc91-5c0f-4b8a-84fb-48fdc570542a_terseLabel_en-US" xlink:label="lab_peak_DiscoverySHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery SHOP Portfolio</link:label>
    <link:label id="lab_peak_DiscoverySHOPPortfolioMember_label_en-US" xlink:label="lab_peak_DiscoverySHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery SHOP Portfolio [Member]</link:label>
    <link:label id="lab_peak_DiscoverySHOPPortfolioMember_documentation_en-US" xlink:label="lab_peak_DiscoverySHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery SHOP Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySHOPPortfolioMember" xlink:href="peak-20220331.xsd#peak_DiscoverySHOPPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DiscoverySHOPPortfolioMember" xlink:to="lab_peak_DiscoverySHOPPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_502bd0f3-b95e-4924-b56f-76adf5e8bc82_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_e861ca2e-f797-495e-a33f-dbd9c0f20a72_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLORIDA</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NetRealEstateAssets_6e9bc92d-eb55-40ac-8119-c6d714c27cb5_terseLabel_en-US" xlink:label="lab_peak_NetRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net real estate assets</link:label>
    <link:label id="lab_peak_NetRealEstateAssets_label_en-US" xlink:label="lab_peak_NetRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Real Estate Assets</link:label>
    <link:label id="lab_peak_NetRealEstateAssets_documentation_en-US" xlink:label="lab_peak_NetRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Real Estate Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetRealEstateAssets" xlink:href="peak-20220331.xsd#peak_NetRealEstateAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NetRealEstateAssets" xlink:to="lab_peak_NetRealEstateAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_f54ecfd9-7c5a-4bb6-9327-e24db8952b53_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_02d1bc03-0bc8-41e6-b1fb-d4384d6c7b5e_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Needham Land Parcel JV</link:label>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_label_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Not Primary Beneficiary Investment In Joint Venture [Member]</link:label>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_documentation_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to investments in an unconsolidated joint venture, which is a Variable Interest Entity (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:to="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MezzanineAndOtherMember_58cd698d-99fa-45a1-ba16-833d8ac42690_terseLabel_en-US" xlink:label="lab_peak_MezzanineAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine and other</link:label>
    <link:label id="lab_peak_MezzanineAndOtherMember_label_en-US" xlink:label="lab_peak_MezzanineAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine And Other [Member]</link:label>
    <link:label id="lab_peak_MezzanineAndOtherMember_documentation_en-US" xlink:label="lab_peak_MezzanineAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine And Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineAndOtherMember" xlink:href="peak-20220331.xsd#peak_MezzanineAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MezzanineAndOtherMember" xlink:to="lab_peak_MezzanineAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_4a4a0247-c843-4f6b-8b9c-e85945ff33a4_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_f6ded8f7-6409-4ad6-820c-d722a23ccaee_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishment and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cb366a35-88e0-4013-af57-414142caed31_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_39702b5e-282a-43c7-8571-a65e6b9eba93_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_7243c801-36e0-4ef0-9fc6-c9d684955023_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_ad724b5c-0689-4721-8d3f-1f2acff19868_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_a7f70719-5221-479a-bed5-34abe0b8d27e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_d5ad6c14-8306-4a84-ab0c-0757e6b41260_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_WorkoutFinancingReceivableMember_427db3dd-7143-470f-b40b-efa5565c7a63_verboseLabel_en-US" xlink:label="lab_peak_WorkoutFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workout loans</link:label>
    <link:label id="lab_peak_WorkoutFinancingReceivableMember_label_en-US" xlink:label="lab_peak_WorkoutFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workout Financing Receivable [Member]</link:label>
    <link:label id="lab_peak_WorkoutFinancingReceivableMember_documentation_en-US" xlink:label="lab_peak_WorkoutFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workout Financing Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WorkoutFinancingReceivableMember" xlink:href="peak-20220331.xsd#peak_WorkoutFinancingReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_WorkoutFinancingReceivableMember" xlink:to="lab_peak_WorkoutFinancingReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_b8b19c11-a9a0-4b42-9f76-b14116d8ab03_terseLabel_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of nonrefundable entrance fees and above/below market lease intangibles</link:label>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_label_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net</link:label>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_documentation_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:href="peak-20220331.xsd#peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:to="lab_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_2878c5b7-6ae8-4bcf-a5f4-728c2f5bc313_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_96873753-c1d8-4901-b255-f225a934466f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_e84b0e13-0373-4c03-a35b-42ab41eda3f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6af477f7-106e-4b95-ac74-0a9f91d64f5f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RestrictedStockVested_35d44b89-7c29-403c-8f8b-3f95e53c75dc_terseLabel_en-US" xlink:label="lab_peak_RestrictedStockVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units and conversion of non-managing member units into common stock</link:label>
    <link:label id="lab_peak_RestrictedStockVested_label_en-US" xlink:label="lab_peak_RestrictedStockVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Vested</link:label>
    <link:label id="lab_peak_RestrictedStockVested_documentation_en-US" xlink:label="lab_peak_RestrictedStockVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The value of stock issued upon which restrictions have lapsed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedStockVested" xlink:href="peak-20220331.xsd#peak_RestrictedStockVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RestrictedStockVested" xlink:to="lab_peak_RestrictedStockVested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_61c6b69c-cc04-462e-a2a3-3868eac1b38a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_91d66a14-bb4b-485e-ac5d-496ea6b15a35_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_aa6138cb-1051-45b1-9f4f-a2947f47834e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_4ddcc8b2-5ae3-4a0a-93f5-adb159565ae3_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b8d83d77-111f-4e26-844d-2cd4602f0b4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b30cd4a7-a612-4f1f-b8f0-4735e6d61851_totalLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9dfce1fb-09e5-4525-98a5-d08433124296_verboseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on debt extinguishments</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2ceb4dbc-6023-4d88-9418-b8a837404567_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt extinguishments</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_4619ada5-8428-47ef-b44d-28e6ec5f1005_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_3725fc67-692c-44da-a5b2-adbb52147259_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on debt extinguishments</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_8bf96b54-7314-4159-a58c-dec4b8786438_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_ebfbe288-3930-45a2-bb3c-ce19a0dfdc87_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SuburbanPropertiesLLCMember_75a8da4c-5471-495b-85e1-20768d69ac6c_terseLabel_en-US" xlink:label="lab_peak_SuburbanPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suburban Properties, LLC</link:label>
    <link:label id="lab_peak_SuburbanPropertiesLLCMember_label_en-US" xlink:label="lab_peak_SuburbanPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suburban Properties L L C [Member]</link:label>
    <link:label id="lab_peak_SuburbanPropertiesLLCMember_documentation_en-US" xlink:label="lab_peak_SuburbanPropertiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to Suburban Properties, LLC, an unconsolidated joint venture of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SuburbanPropertiesLLCMember" xlink:href="peak-20220331.xsd#peak_SuburbanPropertiesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SuburbanPropertiesLLCMember" xlink:to="lab_peak_SuburbanPropertiesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c4d11a70-95b8-4cdf-ab5f-429b32efdd2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4ab8d0cf-0597-4e76-95b5-1e536df7363b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ContributionOfPropertyNumberOfProperties_ba720f49-d30d-45bd-9cb9-6e8afe2731d6_terseLabel_en-US" xlink:label="lab_peak_ContributionOfPropertyNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties may be contributed in the agreement</link:label>
    <link:label id="lab_peak_ContributionOfPropertyNumberOfProperties_label_en-US" xlink:label="lab_peak_ContributionOfPropertyNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Of Property, Number Of Properties</link:label>
    <link:label id="lab_peak_ContributionOfPropertyNumberOfProperties_documentation_en-US" xlink:label="lab_peak_ContributionOfPropertyNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Of Property, Number Of Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ContributionOfPropertyNumberOfProperties" xlink:href="peak-20220331.xsd#peak_ContributionOfPropertyNumberOfProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ContributionOfPropertyNumberOfProperties" xlink:to="lab_peak_ContributionOfPropertyNumberOfProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformingFinancingReceivableMember_a20f2f94-04a8-41c4-a204-699cbb25463c_terseLabel_en-US" xlink:label="lab_us-gaap_PerformingFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performing loans</link:label>
    <link:label id="lab_us-gaap_PerformingFinancingReceivableMember_label_en-US" xlink:label="lab_us-gaap_PerformingFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performing Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformingFinancingReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformingFinancingReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformingFinancingReceivableMember" xlink:to="lab_us-gaap_PerformingFinancingReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfPropertiesAcquired_f6ece62a-c619-4bab-86bd-64813bd4ce09_terseLabel_en-US" xlink:label="lab_peak_NumberOfPropertiesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties acquired</link:label>
    <link:label id="lab_peak_NumberOfPropertiesAcquired_label_en-US" xlink:label="lab_peak_NumberOfPropertiesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties Acquired</link:label>
    <link:label id="lab_peak_NumberOfPropertiesAcquired_documentation_en-US" xlink:label="lab_peak_NumberOfPropertiesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfPropertiesAcquired" xlink:to="lab_peak_NumberOfPropertiesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_9aff1dc0-bf2a-432a-b9f9-bba3849181f6_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MA_a8539a7a-54cf-4617-8643-123fbc28bfa4_terseLabel_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:label id="lab_stpr_MA_label_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MA" xlink:to="lab_stpr_MA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebt_08ff0329-e86d-4017-af93-616388a4621e_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured notes</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebt" xlink:to="lab_us-gaap_UnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_da07d0bc-2597-4628-b37c-39e1d4848fff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Nonredeemable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:to="lab_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DiscoveryNaplesJVMember_3fd45cf9-82af-457b-96f1-2bf857f9692e_terseLabel_en-US" xlink:label="lab_peak_DiscoveryNaplesJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Naples JV</link:label>
    <link:label id="lab_peak_DiscoveryNaplesJVMember_label_en-US" xlink:label="lab_peak_DiscoveryNaplesJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Naples JV [Member]</link:label>
    <link:label id="lab_peak_DiscoveryNaplesJVMember_documentation_en-US" xlink:label="lab_peak_DiscoveryNaplesJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Naples JV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoveryNaplesJVMember" xlink:href="peak-20220331.xsd#peak_DiscoveryNaplesJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DiscoveryNaplesJVMember" xlink:to="lab_peak_DiscoveryNaplesJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset_8dd826bb-d143-4b2b-82e3-12810cdec81d_terseLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of estimated residual value</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Unguaranteed Residual Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset" xlink:to="lab_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_a22502ef-193e-4300-a93c-2c3f56f46875_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_d6808730-0cd6-499a-ba8f-3097a816ea52_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_24d33236-8354-4b4c-b4e3-475d7c91fc0b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_0950e9f8-9101-4836-92f2-780af8c5f07e_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_94f992a0-c12f-462f-ae41-3ff56bbce10e_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Executive Retirement Plan minimum liability</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_1448302b-53df-4053-a86b-b82b9019e4e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NoncashOrPartNoncashInterestIncome_65aba077-e183-441f-9776-e03f616cd251_terseLabel_en-US" xlink:label="lab_peak_NoncashOrPartNoncashInterestIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest income</link:label>
    <link:label id="lab_peak_NoncashOrPartNoncashInterestIncome_label_en-US" xlink:label="lab_peak_NoncashOrPartNoncashInterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash, Interest Income</link:label>
    <link:label id="lab_peak_NoncashOrPartNoncashInterestIncome_documentation_en-US" xlink:label="lab_peak_NoncashOrPartNoncashInterestIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash, Interest Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncashOrPartNoncashInterestIncome" xlink:href="peak-20220331.xsd#peak_NoncashOrPartNoncashInterestIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NoncashOrPartNoncashInterestIncome" xlink:to="lab_peak_NoncashOrPartNoncashInterestIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_142811af-aa2e-411d-8e79-ff38a8dae96f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_a9e12d68-d12c-4644-bf46-4fb993ce24c6_terseLabel_en-US" xlink:label="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to redemption value of redeemable noncontrolling interests</link:label>
    <link:label id="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_label_en-US" xlink:label="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity</link:label>
    <link:label id="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_documentation_en-US" xlink:label="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:href="peak-20220331.xsd#peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:to="lab_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DefinitiveAgreementsAxisAxis_e0a6d676-5934-4ed8-bba9-79c384cff7e9_terseLabel_en-US" xlink:label="lab_peak_DefinitiveAgreementsAxisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreements Axis [Axis]</link:label>
    <link:label id="lab_peak_DefinitiveAgreementsAxisAxis_label_en-US" xlink:label="lab_peak_DefinitiveAgreementsAxisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreements Axis [Axis]</link:label>
    <link:label id="lab_peak_DefinitiveAgreementsAxisAxis_documentation_en-US" xlink:label="lab_peak_DefinitiveAgreementsAxisAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreements Axis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementsAxisAxis" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementsAxisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DefinitiveAgreementsAxisAxis" xlink:to="lab_peak_DefinitiveAgreementsAxisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_6d3670f9-50a9-44d1-98dc-0f2378eec508_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segment</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_cbaf8fb1-a0c4-4d5a-a5e4-510bb5f5c9c0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_357ef90f-0bfe-447c-8b62-8b3f880d1ebe_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_daaf1953-262f-4d2f-96f8-7256c183cf6e_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Transaction Costs</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_c83b18d5-7721-49f5-b757-a2bfeb745b29_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_9f320106-e50a-4814-8c04-0093684215c4_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseVariableLeaseIncome_b92086b6-313f-4a67-8519-f56e10a630b8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable income from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseVariableLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Variable Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseVariableLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentWeightedAverageMaturity_50f62d06-5f02-43e8-a42c-888fb5084acf_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentWeightedAverageMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average maturity (in years)</link:label>
    <link:label id="lab_peak_DebtInstrumentWeightedAverageMaturity_label_en-US" xlink:label="lab_peak_DebtInstrumentWeightedAverageMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Weighted Average Maturity</link:label>
    <link:label id="lab_peak_DebtInstrumentWeightedAverageMaturity_documentation_en-US" xlink:label="lab_peak_DebtInstrumentWeightedAverageMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents weighted average maturity of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentWeightedAverageMaturity" xlink:href="peak-20220331.xsd#peak_DebtInstrumentWeightedAverageMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentWeightedAverageMaturity" xlink:to="lab_peak_DebtInstrumentWeightedAverageMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable_a1408f94-80bc-41a8-b4a3-5fce97a9b93f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the collection of loans receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Loans Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfLoansReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_cb574fd6-9719-4085-a1f8-4d58c538f97b_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_cf31051a-d2be-440d-84c2-52bb65ffe5bb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1a8043a1-c26b-4aaa-96a6-f9528e5eb8f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_020fb061-1409-438d-bc95-931b29d1dc71_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopmentInProcess_318ff068-7296-4dc2-a0e1-964adbdbd138_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development costs and construction in progress</link:label>
    <link:label id="lab_us-gaap_DevelopmentInProcess_d2ed605c-1894-4dc6-acf5-94052b4194ad_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development costs and construction in progress</link:label>
    <link:label id="lab_us-gaap_DevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopmentInProcess" xlink:to="lab_us-gaap_DevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f6457314-ecb9-41f7-8705-7eafa0da215a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SLCSHOPPortfolioMember_74cfbb9a-4090-4fa3-af05-27534bbea5e7_terseLabel_en-US" xlink:label="lab_peak_SLCSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLC SHOP Portfolio</link:label>
    <link:label id="lab_peak_SLCSHOPPortfolioMember_label_en-US" xlink:label="lab_peak_SLCSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLC SHOP Portfolio [Member]</link:label>
    <link:label id="lab_peak_SLCSHOPPortfolioMember_documentation_en-US" xlink:label="lab_peak_SLCSHOPPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLC SHOP Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SLCSHOPPortfolioMember" xlink:href="peak-20220331.xsd#peak_SLCSHOPPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SLCSHOPPortfolioMember" xlink:to="lab_peak_SLCSHOPPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GovernmentGrantIncome_13429a55-7c84-4a77-b478-62defb8fca1d_terseLabel_en-US" xlink:label="lab_peak_GovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income received</link:label>
    <link:label id="lab_peak_GovernmentGrantIncome_label_en-US" xlink:label="lab_peak_GovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income</link:label>
    <link:label id="lab_peak_GovernmentGrantIncome_documentation_en-US" xlink:label="lab_peak_GovernmentGrantIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncome" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GovernmentGrantIncome" xlink:to="lab_peak_GovernmentGrantIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_807b6eed-3f01-4fbf-a506-9fa32ac6608f_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under bank line of credit and commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_dbe6c66b-8760-4cad-b93b-22eb9d0f6d3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests&#8217; share in continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_2051eeb8-b460-47a4-8623-4a650d35a5db_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests' share in continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_22dbd474-ecd1-4626-88dd-58feb53f709f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember_cdfa154a-0a43-46bb-bc3f-b1e01357e82b_terseLabel_en-US" xlink:label="lab_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Naples JV and Discovery Sarasota JV</link:label>
    <link:label id="lab_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember_label_en-US" xlink:label="lab_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Naples JV and Discovery Sarasota JV [Member]</link:label>
    <link:label id="lab_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember_documentation_en-US" xlink:label="lab_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Naples JV and Discovery Sarasota JV</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember" xlink:href="peak-20220331.xsd#peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember" xlink:to="lab_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_79e1567b-9e12-4ef4-851f-90cf9dba6da1_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2db8785d-5e74-4e04-9502-11d48b1dd808_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1bb325d6-aabf-421b-ac31-efd84d92b2bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6fa99d14-1b13-4166-af56-16d1acf027a1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f040889b-9378-4d87-8177-c65bf742d35f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fee5a9e6-92f2-4225-ab10-d5df5e2f2dac_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2921f969-5be8-4837-aa48-72d164287479_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eea7d9f8-a521-4671-89c2-f1392453357c_negatedLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect adjustment</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2b74f782-f50a-4882-a373-78e68f052e89_negatedTerseLabel_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="peak-20220331.xsd#peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_756c17e6-651f-400c-9082-4895377904a0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_63d0d09b-641b-4099-adee-5b48db1be86d_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Note</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherRealEstate_6b862044-bb35-4037-82d3-7c9dac72015a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherRealEstate_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:to="lab_us-gaap_PaymentsToAcquireOtherRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_3c1d6cd0-08e1-4603-b0e0-9600bc0cbb76_negatedLabel_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_label_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Liabilities Accumulated Amortization</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_documentation_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amount of amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:to="lab_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6e4dfefe-9d0e-420c-8900-4dde7738ce81_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_843d2b41-45b3-4f31-9e00-82e449bb3891_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2457fe34-a551-442b-a022-ffa2e1d4447a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_6f12c529-2077-4fa5-b7b4-52c464b49a94_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_11436080-4e37-4fbc-94eb-a4dfcb10fde2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_92edb416-5000-4ecc-b075-dd70901c56e7_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a5c3052b-af4c-42c2-955b-4e87267f44ea_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentPeriodOfExtension_58118f43-90d0-46d9-ba02-46ad80edaeec_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentPeriodOfExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Length of debt instrument extension period (in months)</link:label>
    <link:label id="lab_peak_DebtInstrumentPeriodOfExtension_label_en-US" xlink:label="lab_peak_DebtInstrumentPeriodOfExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Period of Extension</link:label>
    <link:label id="lab_peak_DebtInstrumentPeriodOfExtension_documentation_en-US" xlink:label="lab_peak_DebtInstrumentPeriodOfExtension" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the length of the debt instrument extension period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentPeriodOfExtension" xlink:href="peak-20220331.xsd#peak_DebtInstrumentPeriodOfExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentPeriodOfExtension" xlink:to="lab_peak_DebtInstrumentPeriodOfExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_846600e6-6f5e-460b-b55d-f73576e96b33_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income, Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7aabcd44-01a5-4cf7-beb4-13e0476d384e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment realized in net income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8274781a-1dee-49dd-aa3d-0ad161a3299c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Information of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_e7062396-67ac-47be-aa8a-f497116c2ff4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_b5093902-0584-42e6-a8fe-ef5879579239_terseLabel_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and loan loss reserves (recoveries), net</link:label>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_label_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments And Allowance For Credit Loss Reserves (Recoveries), Net</link:label>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_documentation_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments And Allowance For Credit Loss Reserves (Recoveries), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:href="peak-20220331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:to="lab_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_cfdcec17-7298-4833-9a4c-217d09768099_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_d0ab876e-2e5f-4771-aaf5-0c75341c0732_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_c7f3ee66-feed-41c9-932b-d3bc94ebe672_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_bcc16060-0972-49ac-bc03-4d4f5e6331a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_aec48a73-ea63-41d9-92f2-bfb63e6457fb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_427b56a8-b0f3-42bb-8b25-4f4273b89325_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SHOPJVMember_66808559-f55a-4108-9b8b-60e30d7cc94b_verboseLabel_en-US" xlink:label="lab_peak_SHOPJVMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWF SH JV</link:label>
    <link:label id="lab_peak_SHOPJVMember_label_en-US" xlink:label="lab_peak_SHOPJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHOP JV [Member]</link:label>
    <link:label id="lab_peak_SHOPJVMember_documentation_en-US" xlink:label="lab_peak_SHOPJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHOP JV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SHOPJVMember" xlink:href="peak-20220331.xsd#peak_SHOPJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SHOPJVMember" xlink:to="lab_peak_SHOPJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_db63b021-4411-4765-8fa3-e4f2ca9f2f7d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_5442eacf-76bf-4636-b8ad-39b090792875_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sales of real estate, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gross Profit (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_7969fe59-dd3e-47e7-8b8d-0b5ee73dd722_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_420a7e9e-3bf7-47d1-a023-edecd5b760a3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in accounts receivable and other assets, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable and Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_058f2ad6-ad67-4aad-ac2f-53f1285da5a7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of real estate, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Real Estate Held-for-investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:to="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining_d0fb8baa-1c3b-4ff8-9ade-84b700072032_terseLabel_en-US" xlink:label="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM aggregate amount remaining</link:label>
    <link:label id="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining_label_en-US" xlink:label="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Equity Offering Program Aggregate Amount Remaining</link:label>
    <link:label id="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining_documentation_en-US" xlink:label="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Equity Offering Program Aggregate Amount Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:href="peak-20220331.xsd#peak_ATMEquityOfferingProgramAggregateAmountRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:to="lab_peak_ATMEquityOfferingProgramAggregateAmountRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_14a330f8-61cf-4373-ba5b-02a07890acc3_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued construction costs</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_d89fcabf-f8df-4a92-b69d-e6cfa8731f8f_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMBS and LLC investment</link:label>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_label_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Not Primary Beneficiary Debt Investment [Member]</link:label>
    <link:label id="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_documentation_en-US" xlink:label="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents a debt investment with a party that has been identified as a Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:to="lab_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_524161c7-af11-4794-83c9-54a6dc0c21c8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_1e7193c4-7a93-4fc6-9f9d-d5a8ce628b5d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_733a16be-29de-41b8-95ea-965de53dc963_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate 2025</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_95812015-e9a8-4f1a-8492-6cb286ef1824_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_60760461-34b8-4089-8a53-4b00c9455a19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_0a923fba-a336-4d49-b70f-0772f1fe038b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0026e787-2b5a-46e3-b418-81965a77c379_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_LA_3e7eeaee-f1c7-48f7-92ea-67c44bddd315_terseLabel_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOUISIANA</link:label>
    <link:label id="lab_stpr_LA_label_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOUISIANA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_LA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_LA" xlink:to="lab_stpr_LA" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent_7c933540-a97f-421d-97cd-b0bb88309783_terseLabel_en-US" xlink:label="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</link:label>
    <link:label id="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent_label_en-US" xlink:label="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Joint Venture Partners, Attributable To Parent</link:label>
    <link:label id="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent_documentation_en-US" xlink:label="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Joint Venture Partners, Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:href="peak-20220331.xsd#peak_NetIncomeLossJointVenturePartnersAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:to="lab_peak_NetIncomeLossJointVenturePartnersAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ATMDirectIssuancesMember_e62c70f2-b766-4798-93b8-5b212ee01968_terseLabel_en-US" xlink:label="lab_peak_ATMDirectIssuancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Direct Issuances</link:label>
    <link:label id="lab_peak_ATMDirectIssuancesMember_label_en-US" xlink:label="lab_peak_ATMDirectIssuancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Direct Issuances [Member]</link:label>
    <link:label id="lab_peak_ATMDirectIssuancesMember_documentation_en-US" xlink:label="lab_peak_ATMDirectIssuancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Direct Issuances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMDirectIssuancesMember" xlink:href="peak-20220331.xsd#peak_ATMDirectIssuancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ATMDirectIssuancesMember" xlink:to="lab_peak_ATMDirectIssuancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_1fdaa165-5cb6-454b-9631-9208989a6057_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_6ac5589a-8b38-4de8-b6ca-82d8e45f302e_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e0a718fc-1854-4721-8907-0be23e74d32e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on derivatives</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b642ef58-9ba9-4df1-8104-88a38d0cd0a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_KS_009669b1-4666-4ef4-8a20-86d7dd98619d_terseLabel_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KANSAS</link:label>
    <link:label id="lab_stpr_KS_label_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_KS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_KS" xlink:to="lab_stpr_KS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_1acdd21d-d7e9-40c5-9378-14d6610f5978_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financing Receivable Credit Quality Indicators and by Year of Origination</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Credit Quality Indicators [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:to="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_A2020ATMProgramSettledMember_1f515f02-ec50-4a9d-9a01-1f1dc63ab379_terseLabel_en-US" xlink:label="lab_peak_A2020ATMProgramSettledMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program, Settled</link:label>
    <link:label id="lab_peak_A2020ATMProgramSettledMember_label_en-US" xlink:label="lab_peak_A2020ATMProgramSettledMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program, Settled [Member]</link:label>
    <link:label id="lab_peak_A2020ATMProgramSettledMember_documentation_en-US" xlink:label="lab_peak_A2020ATMProgramSettledMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 ATM Program, Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramSettledMember" xlink:href="peak-20220331.xsd#peak_A2020ATMProgramSettledMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_A2020ATMProgramSettledMember" xlink:to="lab_peak_A2020ATMProgramSettledMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_7c2c5a21-1ca6-4fe7-8b7d-e948ee33a23f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfNotesReceivable_d3a64018-4f30-436f-bda0-d559a1f6e016_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of direct financing lease</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfNotesReceivable_68697a4f-cf85-44ea-b325-36c982939d21_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of financing receivable</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Financing Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:to="lab_us-gaap_GainLossOnSaleOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_439b32b5-4f07-4942-8b44-ad9dee31f7ff_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_2aa48ec7-3c46-4399-bccf-12fd2a03a724_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_a7b98e77-414f-420a-99e7-07f1bcc429b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_adc2e2a9-9edf-4e8e-8df2-6fc032650f7d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in the fair value of the interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_06cd3912-809e-4c73-8516-5a7a09b72ed9_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Non-segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_725a91c0-8f44-4145-962c-e69f836252d0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DiscoverySarasotaJVMember_eaaea8b9-0468-4495-929d-0856f67dcfc8_terseLabel_en-US" xlink:label="lab_peak_DiscoverySarasotaJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Sarasota JV</link:label>
    <link:label id="lab_peak_DiscoverySarasotaJVMember_label_en-US" xlink:label="lab_peak_DiscoverySarasotaJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Sarasota JV [Member]</link:label>
    <link:label id="lab_peak_DiscoverySarasotaJVMember_documentation_en-US" xlink:label="lab_peak_DiscoverySarasotaJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discovery Sarasota JV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySarasotaJVMember" xlink:href="peak-20220331.xsd#peak_DiscoverySarasotaJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DiscoverySarasotaJVMember" xlink:to="lab_peak_DiscoverySarasotaJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_e569bebc-fa6f-4b1b-96a3-cba95e486e8e_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_e14ff682-e26c-47a0-8575-f3c801316dab_negatedLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_786e532e-16e2-46bb-bf20-ab96cb1009c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4b147867-6cd3-451f-b0f1-454436ec885e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_8dd44ca3-13a8-43de-9508-902a61a4865a_totalLabel_en-US" xlink:label="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, total</link:label>
    <link:label id="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_label_en-US" xlink:label="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Including Discontinued Operations, Total</link:label>
    <link:label id="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_documentation_en-US" xlink:label="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Including Discontinued Operations, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:href="peak-20220331.xsd#peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:to="lab_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfPropertiesToBeSold_8eb00644-126a-4db4-9a76-fb46ed418bec_terseLabel_en-US" xlink:label="lab_peak_NumberOfPropertiesToBeSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of assets to be sold</link:label>
    <link:label id="lab_peak_NumberOfPropertiesToBeSold_label_en-US" xlink:label="lab_peak_NumberOfPropertiesToBeSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties To Be Sold</link:label>
    <link:label id="lab_peak_NumberOfPropertiesToBeSold_documentation_en-US" xlink:label="lab_peak_NumberOfPropertiesToBeSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Properties To Be Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfPropertiesToBeSold" xlink:to="lab_peak_NumberOfPropertiesToBeSold" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_75f347c0-6a12-47b5-a1b0-cfced30506bf_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseInterestIncome_aee7d03b-6aa3-4d5f-a073-980e7541ce05_terseLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseInterestIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income from direct financing leases</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseInterestIncome_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseInterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Interest Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseInterestIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseInterestIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseInterestIncome" xlink:to="lab_us-gaap_DirectFinancingLeaseInterestIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d34779a8-2f95-49c8-ada2-65f152cc2b6f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e772c2f4-a2d5-4355-adf3-e725d097f560_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_ff5159b9-86dd-4a55-8731-406264458f53_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_0b01cce9-50e0-40d6-99c3-fbb3c401c92a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_6f9248b8-dc52-461f-a35a-9444ae1f9f3c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to and purchase of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_54097c8d-1c9c-4997-9909-12d5fd9dd5a7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_404bf9a6-9c06-4e58-9d21-cc6d787f75cf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, net of capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_97b08796-2fea-43f9-8a51-eb1b2730fc47_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_29ae9f72-7eec-47e7-a4a3-94477fdcba1a_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of secured debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_27293061-9373-4ead-a141-f9a384b44c8a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_label_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Building and Building Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:to="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_46498080-1e6e-4492-98a6-d4bacf91f449_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) applicable to common shares</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_16ea123e-f3d0-46b5-a740-af7bfd84b35c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_PropertiesHeldForSaleNumber_96f4c81d-38fd-47c6-af32-973daff80267_terseLabel_en-US" xlink:label="lab_peak_PropertiesHeldForSaleNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties classified as held for sale</link:label>
    <link:label id="lab_peak_PropertiesHeldForSaleNumber_label_en-US" xlink:label="lab_peak_PropertiesHeldForSaleNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Properties Held for Sale, Number</link:label>
    <link:label id="lab_peak_PropertiesHeldForSaleNumber_documentation_en-US" xlink:label="lab_peak_PropertiesHeldForSaleNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of properties held for sale at the reporting date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesHeldForSaleNumber" xlink:href="peak-20220331.xsd#peak_PropertiesHeldForSaleNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_PropertiesHeldForSaleNumber" xlink:to="lab_peak_PropertiesHeldForSaleNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_b13cedf0-f8fd-4862-a85c-d892987ecaca_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_f4825128-00e4-4ae5-924d-8f923efcd486_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_e78a4643-cd25-4812-82cb-506cbd32ff54_negatedLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_72323e62-8140-41ba-9a28-4ba81581209b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of real estate, in-place lease, and other intangibles</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_bcc52101-a598-49a9-a99f-4648b28fcc7a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_43206264-d28e-4ea3-80aa-257b2cf51a9a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_9ce316c4-46c0-44cc-91c3-d4d1388cce50_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discounts, fees, and costs</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Unamortized Loan Fee (Cost) and Purchase Premium (Discount)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:to="lab_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_ffd9e036-1a39-4118-bc1d-01e78a9adaa5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loans Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_f054d8ef-a34d-4e8c-9dc1-c4b73ee0f0b3_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c33b5bad-cb12-4bc1-b0cc-1cb6653c7d4d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntitiesAbstract_31dfc0c7-e186-4d9e-9949-947d443643be_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:label id="lab_peak_VariableInterestEntitiesAbstract_label_en-US" xlink:label="lab_peak_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:label id="lab_peak_VariableInterestEntitiesAbstract_documentation_en-US" xlink:label="lab_peak_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract" xlink:href="peak-20220331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntitiesAbstract" xlink:to="lab_peak_VariableInterestEntitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_683f149d-12ef-4216-9424-ab19cbb62642_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative dividends in excess of earnings</link:label>
    <link:label id="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_label_en-US" xlink:label="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Distributions in Excess of Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:to="lab_us-gaap_AccumulatedDistributionsInExcessOfNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_c925e577-7853-4837-8c66-cba6f03c6aae_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_3b0235fb-7894-4235-8f19-b3026dbc9b57_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets_58c8592a-dad0-455f-b8a9-213d4bbab109_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant secured debt to assets (as a percent)</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Secured Debt to Assets</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The limit of the ratio of Secured Debt to Consolidated Total Asset Value contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantSecuredDebtToAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:to="lab_peak_DebtInstrumentCovenantSecuredDebtToAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLineItems_8e2d8226-020d-4696-9ec9-3347a04cd133_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstateLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLineItems" xlink:to="lab_us-gaap_RealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_8dc121e5-d91a-492e-ae6b-3be2c0bce508_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_d2f321e4-abb1-4596-8228-1c0003ec6d89_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LoansReceivableInterestIncomeAmortizationPeriod_60ca8c55-cbd4-43b4-ad30-8332069fc65f_terseLabel_en-US" xlink:label="lab_peak_LoansReceivableInterestIncomeAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, amortization period (in years)</link:label>
    <link:label id="lab_peak_LoansReceivableInterestIncomeAmortizationPeriod_label_en-US" xlink:label="lab_peak_LoansReceivableInterestIncomeAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Interest Income, Amortization Period</link:label>
    <link:label id="lab_peak_LoansReceivableInterestIncomeAmortizationPeriod_documentation_en-US" xlink:label="lab_peak_LoansReceivableInterestIncomeAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Interest Income, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableInterestIncomeAmortizationPeriod" xlink:href="peak-20220331.xsd#peak_LoansReceivableInterestIncomeAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LoansReceivableInterestIncomeAmortizationPeriod" xlink:to="lab_peak_LoansReceivableInterestIncomeAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fd8b351-dbca-4c88-9e09-a322ec6401b0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_b476c12e-de11-4a81-b2ff-4aaa32900f43_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sales of real estate, net</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:to="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_c8a66b96-87fe-479f-a114-f305a247752f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable:</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_85d18bff-481c-4dd7-b065-ec43ae0b11c4_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_a2d72024-4e20-4e59-8010-eaf0ba2c3297_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant minimum fixed charge coverage ratio</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Fixed Charge Ratio, Minimum</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The required minimum Fixed Charge Coverage ratio contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantFixedChargeRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:to="lab_peak_DebtInstrumentCovenantFixedChargeRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f8e81065-3457-45f3-8da6-24e48fbcc4cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount_8362efc8-be8e-4a1b-bc19-8f3c7f8dcf53_terseLabel_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment in direct financing leases</link:label>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount_label_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Direct Financing Lease, Assumptions and Judgments, Value of Underlying Asset, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount" xlink:to="lab_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_5831bf54-74b4-43d6-a40c-9d39302b8ff2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per common share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_74bdbb84-b7f2-4ab4-8920-886b3bba8857_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_6f1dfb94-c13a-4d12-bc16-b4f6e57a67c7_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet_8a8d08b4-fe6c-4234-88a7-673b216453de_negatedTerseLabel_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</link:label>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet_label_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses From Joint Venture, Attributable To Parent Net</link:label>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet_documentation_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses From Joint Venture, Attributable To Parent Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:href="peak-20220331.xsd#peak_OperatingExpensesFromJointVentureAttributableToParentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:to="lab_peak_OperatingExpensesFromJointVentureAttributableToParentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4f9f2b63-d3f1-432e-aacb-3a3c4817492a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4a15818-c162-47da-b396-3c76a5e8166a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_9750bcef-6054-4d90-aea3-c906fcdefe03_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) applicable to common shares (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_d1f5a80f-1816-44d9-a2d9-a705fdcfd5d4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_b83f73d2-c58a-4618-b09a-ff1ed03f06c5_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of 2019 term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_21eafa92-064e-47c7-b29d-5b7b7451999c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_964af1e0-7e8e-4307-aead-35a89dd8474a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_b6f238b4-e3d1-486c-8484-3fbd7f69abef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid (refunded)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_a1c1b383-2489-4a24-b5e5-bb1b13937be1_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $4,146 and $4,138</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Accounts Receivable Net</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Accounts Receivable Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_061f2c5f-4628-4f13-a9c8-813d2242a413_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and advances to unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_aeaeef24-099f-42fa-9b4c-7598791da226_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and advances to unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NJ_e7f89006-244e-4ea5-ab3c-746e87d28f4f_terseLabel_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW JERSEY</link:label>
    <link:label id="lab_stpr_NJ_label_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW JERSEY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NJ"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NJ" xlink:to="lab_stpr_NJ" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_25177caa-8896-4866-aa93-f6921824d1f4_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss) attributable to Healthpeak Properties, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5ec8646b-8c1c-41ef-b011-015c1f2b43e5_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_222004fd-8281-475f-9a32-634fc4e997ca_negatedLabel_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and redevelopment projects, amount decrease</link:label>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_label_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Development and Redevelopment Projects and Tenant Improvements, Amount Increase (Decrease)</link:label>
    <link:label id="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_documentation_en-US" xlink:label="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Development and Redevelopment Projects, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:href="peak-20220331.xsd#peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:to="lab_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_acb26252-9e06-4d0d-90b2-39065c269b31_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ff9bc094-7e20-4c09-b80a-4e968e14db2f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e55dbbb-a597-48a0-971e-eb107f312e58_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_766db4ab-08d3-48a9-9c5c-97632837e5a7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_7e6e7ee9-b833-48f3-866b-5fdb70cc26e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseRevenue_28548f3d-7ba7-4e56-8c7a-8924960539e6_terseLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from direct financing leases</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseRevenue_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseRevenue" xlink:to="lab_us-gaap_DirectFinancingLeaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_a0b3e5bb-65b6-4b3e-90e5-965df4e87db0_negatedTerseLabel_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_documentation_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:to="lab_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectFinancingLeaseDeferredSellingProfit_4c38f41b-31c7-4390-a164-78c87febeccd_negatedLabel_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less deferred selling profits</link:label>
    <link:label id="lab_us-gaap_DirectFinancingLeaseDeferredSellingProfit_label_en-US" xlink:label="lab_us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Financing Lease, Deferred Selling Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseDeferredSellingProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:to="lab_us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_c3eee2a5-cb7b-408f-a9f9-641f01f9869e_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income (Expense), Net</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_02f56f59-e77f-49b7-a82c-c614b53b534f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_4f9de1f8-4f14-4d11-bc52-fc8136b1e329_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OptionIndexedToIssuersEquityTerm_80f5335b-ff08-46d4-938b-f37622289534_terseLabel_en-US" xlink:label="lab_peak_OptionIndexedToIssuersEquityTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option indexed to issuers equity, term (in years)</link:label>
    <link:label id="lab_peak_OptionIndexedToIssuersEquityTerm_label_en-US" xlink:label="lab_peak_OptionIndexedToIssuersEquityTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed To Issuers Equity, Term</link:label>
    <link:label id="lab_peak_OptionIndexedToIssuersEquityTerm_documentation_en-US" xlink:label="lab_peak_OptionIndexedToIssuersEquityTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed To Issuers Equity, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OptionIndexedToIssuersEquityTerm" xlink:href="peak-20220331.xsd#peak_OptionIndexedToIssuersEquityTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OptionIndexedToIssuersEquityTerm" xlink:to="lab_peak_OptionIndexedToIssuersEquityTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_e416e3fe-cad1-4816-bd66-0a9a0bb0b1bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MorganStanleyRealEstateInvestmentJVMember_1280823d-2a3c-4617-a8cd-2f2c562b9ae6_terseLabel_en-US" xlink:label="lab_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MSREI JV</link:label>
    <link:label id="lab_peak_MorganStanleyRealEstateInvestmentJVMember_label_en-US" xlink:label="lab_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Morgan Stanley Real Estate Investment JV [Member]</link:label>
    <link:label id="lab_peak_MorganStanleyRealEstateInvestmentJVMember_documentation_en-US" xlink:label="lab_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Morgan Stanley Real Estate Investment JV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:href="peak-20220331.xsd#peak_MorganStanleyRealEstateInvestmentJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:to="lab_peak_MorganStanleyRealEstateInvestmentJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_5a81ec3e-cc86-4a06-83c4-49846190b70d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Lessees VIE</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_09b64fa2-96fd-473a-96eb-f340fe84d41d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year One, Originated, Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_c5ae86ed-d421-4bfe-86ec-cd2ef6ea5684_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis_dc9e9190-c8a1-43f3-8ce0-2c4ee956eb62_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument Performance Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:to="lab_us-gaap_FinancialInstrumentPerformanceStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_f6a33eee-a88b-4c70-bfef-3ed7e05bace0_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_8ea94868-1cd0-412d-a9c3-2ce2c6697fc8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled_e8c51bd6-6bb8-410f-a722-fbc4dffc0981_terseLabel_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward sales agreements that have been settled (in shares)</link:label>
    <link:label id="lab_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled_label_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements, Settled</link:label>
    <link:label id="lab_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled_documentation_en-US" xlink:label="lab_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements, Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" xlink:href="peak-20220331.xsd#peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" xlink:to="lab_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4359d759-e5b9-4d07-9920-4658cb4d2945_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_HRATripleNetPortfolioMember_fe2a3b25-14ef-4ea0-aa4a-9cc78198f35e_terseLabel_en-US" xlink:label="lab_peak_HRATripleNetPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Triple Net Portfolio</link:label>
    <link:label id="lab_peak_HRATripleNetPortfolioMember_label_en-US" xlink:label="lab_peak_HRATripleNetPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Triple Net Portfolio [Member]</link:label>
    <link:label id="lab_peak_HRATripleNetPortfolioMember_documentation_en-US" xlink:label="lab_peak_HRATripleNetPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HRA Triple Net Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HRATripleNetPortfolioMember" xlink:href="peak-20220331.xsd#peak_HRATripleNetPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_HRATripleNetPortfolioMember" xlink:to="lab_peak_HRATripleNetPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_PaymentsToAcquireLoansReceivableAndOther_d744053c-cfe1-4a25-83d0-c92f4bbe16f6_negatedLabel_en-US" xlink:label="lab_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in loans receivable and other</link:label>
    <link:label id="lab_peak_PaymentsToAcquireLoansReceivableAndOther_label_en-US" xlink:label="lab_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Loans Receivable and Other</link:label>
    <link:label id="lab_peak_PaymentsToAcquireLoansReceivableAndOther_documentation_en-US" xlink:label="lab_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Loans Receivable and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:href="peak-20220331.xsd#peak_PaymentsToAcquireLoansReceivableAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:to="lab_peak_PaymentsToAcquireLoansReceivableAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_d559fd09-6602-4600-9415-127afcc5974b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_64703985-78c1-4d62-b7e9-3fbf2fee2b92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_e305f478-4f2e-4fed-aed6-5603ae362a4d_terseLabel_en-US" xlink:label="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility additional aggregate amount, maximum</link:label>
    <link:label id="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_label_en-US" xlink:label="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Facility Additional Available Borrowing Capacity Maximum</link:label>
    <link:label id="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_documentation_en-US" xlink:label="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the maximum additional borrowing capacity available under the credit facility, subject to customary conditions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:href="peak-20220331.xsd#peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:to="lab_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_c7454df8-a257-498c-9037-c095c261228b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1176b823-3e19-4291-8182-530d5ed48a7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFee_aa9cefcd-fa58-4102-b835-9ce1e7e02a69_terseLabel_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of nonrefundable entrance fee</link:label>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFee_label_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Nonrefundable Entrance Fee</link:label>
    <link:label id="lab_peak_AmortizationOfNonrefundableEntranceFee_documentation_en-US" xlink:label="lab_peak_AmortizationOfNonrefundableEntranceFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Nonrefundable Entrance Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFee" xlink:href="peak-20220331.xsd#peak_AmortizationOfNonrefundableEntranceFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AmortizationOfNonrefundableEntranceFee" xlink:to="lab_peak_AmortizationOfNonrefundableEntranceFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_37c32528-c525-48d0-a0a3-53bfc34c4bb8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations</link:label>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentContinuingOperationsMember" xlink:to="lab_us-gaap_SegmentContinuingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_3067541a-747d-4cfc-b6ac-9ef6b7a71a51_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_3b0e97e7-40ff-4271-9bf4-668f47f6abfd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_49dc2505-ced4-4503-9e3a-f0464b12f359_terseLabel_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resident fees and services</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_label_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Resident Fees And Services</link:label>
    <link:label id="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_documentation_en-US" xlink:label="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation Resident Fees And Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:to="lab_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnsecuredNote213PercentMember_806e7129-393c-4555-85ca-30274b7007a0_terseLabel_en-US" xlink:label="lab_peak_UnsecuredNote213PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 2.13 Percent</link:label>
    <link:label id="lab_peak_UnsecuredNote213PercentMember_label_en-US" xlink:label="lab_peak_UnsecuredNote213PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 2.13 Percent [Member]</link:label>
    <link:label id="lab_peak_UnsecuredNote213PercentMember_documentation_en-US" xlink:label="lab_peak_UnsecuredNote213PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 2.13 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote213PercentMember" xlink:href="peak-20220331.xsd#peak_UnsecuredNote213PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnsecuredNote213PercentMember" xlink:to="lab_peak_UnsecuredNote213PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_083dcdf7-7544-4f3e-9155-c934ec8a1bfd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_49c69dc9-ca01-41e0-93f6-dafebd2b93be_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f3f2335b-ba1d-45ef-8e54-676b018446ce_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_WatchListFinancingReceivableMember_72adc669-3467-42e0-a5a6-ba449dfbc789_verboseLabel_en-US" xlink:label="lab_peak_WatchListFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watch list loans</link:label>
    <link:label id="lab_peak_WatchListFinancingReceivableMember_label_en-US" xlink:label="lab_peak_WatchListFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Watch List Financing Receivable [Member]</link:label>
    <link:label id="lab_peak_WatchListFinancingReceivableMember_documentation_en-US" xlink:label="lab_peak_WatchListFinancingReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents a financing receivable that is being monitored closely in order to spot irregularities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WatchListFinancingReceivableMember" xlink:href="peak-20220331.xsd#peak_WatchListFinancingReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_WatchListFinancingReceivableMember" xlink:to="lab_peak_WatchListFinancingReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_1717cb41-fc80-4aa0-8113-af22187c6e0c_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables_085d5362-f597-4a1c-99b4-f77cc946a4df_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales/principal repayments on loans receivable and direct financing leases</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fc7106f2-d660-400d-9231-05b50ef28c73_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_7582181d-d646-4b14-bd79-473be0731672_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_d34b0116-de04-48e0-80ff-f628a48ba963_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_767624f2-1996-48d4-96e2-91ed4ef853e7_terseLabel_en-US" xlink:label="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_label_en-US" xlink:label="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Income (Loss) From Unconsolidated Joint Ventures [Member]</link:label>
    <link:label id="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_documentation_en-US" xlink:label="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Income (Loss) From Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:href="peak-20220331.xsd#peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:to="lab_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestInPreferredUnitHolders_e81d34e9-1ff8-4b4b-aab5-5279c63907ab_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-managing member unitholders</link:label>
    <link:label id="lab_us-gaap_MinorityInterestInPreferredUnitHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Preferred Unit Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInPreferredUnitHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:to="lab_us-gaap_MinorityInterestInPreferredUnitHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_acd51098-b5be-422c-b458-f1ae112a6a82_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_42115d9b-c1cb-43ec-a8f2-8d1becbabb14_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:to="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_b5dd529e-424d-4c0f-99eb-574b8391f7ac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term (in months)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_810b8d05-8e41-47d3-8c5e-f701856a6157_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_b15ecee6-cb98-464f-b712-89249d4abeb8_totalLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net real estate</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_1b4ccf16-09f0-4252-b8c4-cf06adbb976b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent_e0466f9c-4933-401b-9769-ff5a3cbf110e_terseLabel_en-US" xlink:label="lab_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized nonrefundable entrance fee</link:label>
    <link:label id="lab_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent_label_en-US" xlink:label="lab_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Nonrefundable Entrance Fee, Current and Noncurrent</link:label>
    <link:label id="lab_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent_documentation_en-US" xlink:label="lab_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Nonrefundable Entrance Fee, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" xlink:href="peak-20220331.xsd#peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" xlink:to="lab_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_ad4b7dc7-992e-4f67-93e5-73c700040b9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_HCPVenturesIIILLCMember_a031fb7a-9129-4ea8-8934-cec708adb4c0_terseLabel_en-US" xlink:label="lab_peak_HCPVenturesIIILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HCP Ventures III, LLC</link:label>
    <link:label id="lab_peak_HCPVenturesIIILLCMember_label_en-US" xlink:label="lab_peak_HCPVenturesIIILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">H C P Ventures III, LLC [Member]</link:label>
    <link:label id="lab_peak_HCPVenturesIIILLCMember_documentation_en-US" xlink:label="lab_peak_HCPVenturesIIILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to HCP Ventures III, LLC, an unconsolidated joint venture of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIIILLCMember" xlink:href="peak-20220331.xsd#peak_HCPVenturesIIILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_HCPVenturesIIILLCMember" xlink:to="lab_peak_HCPVenturesIIILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_a49e0434-e94c-4862-93ce-223179938084_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_382bdbee-9912-48e7-b7c2-620fdb0cf790_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Senior Notes Issuances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_caa8ae8f-3264-4132-b829-ee3ac531da65_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6ba433fd-b463-4535-97c8-2d397f98f8d9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_4cbc14ed-b68c-423a-ae88-bb23de70da67_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LoansReceivableStatedInterestRate_b94ce1ec-39f0-470f-84f2-58c226be0daa_terseLabel_en-US" xlink:label="lab_peak_LoansReceivableStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, stated interest rate</link:label>
    <link:label id="lab_peak_LoansReceivableStatedInterestRate_label_en-US" xlink:label="lab_peak_LoansReceivableStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Stated Interest Rate</link:label>
    <link:label id="lab_peak_LoansReceivableStatedInterestRate_documentation_en-US" xlink:label="lab_peak_LoansReceivableStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Stated Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableStatedInterestRate" xlink:href="peak-20220331.xsd#peak_LoansReceivableStatedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LoansReceivableStatedInterestRate" xlink:to="lab_peak_LoansReceivableStatedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b8b143ca-908e-4d2f-ab09-f58b832d459f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SeniorNotesDue2023And2024Member_d3b51370-fa50-4c76-82dd-fca2fe544f84_terseLabel_en-US" xlink:label="lab_peak_SeniorNotesDue2023And2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Due 2023 and 2024</link:label>
    <link:label id="lab_peak_SeniorNotesDue2023And2024Member_label_en-US" xlink:label="lab_peak_SeniorNotesDue2023And2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Due 2023 and 2024 [Member]</link:label>
    <link:label id="lab_peak_SeniorNotesDue2023And2024Member_documentation_en-US" xlink:label="lab_peak_SeniorNotesDue2023And2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Due 2023 and 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorNotesDue2023And2024Member" xlink:href="peak-20220331.xsd#peak_SeniorNotesDue2023And2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SeniorNotesDue2023And2024Member" xlink:to="lab_peak_SeniorNotesDue2023And2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_274a4c16-c906-4a3c-bfbe-5c1c54f2b301_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_bcccd2ed-8478-4085-a6a7-9f86bb84b341_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_cfa9f497-6fd9-41ae-a077-e85576246e93_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_88a0cf18-81c8-4d97-b27a-87d3ea667efa_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentMaximumBorrowingCapacity_82697bb1-4465-4fd6-b655-60ad14763fcb_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum outstanding amount capacity</link:label>
    <link:label id="lab_peak_DebtInstrumentMaximumBorrowingCapacity_label_en-US" xlink:label="lab_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_peak_DebtInstrumentMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:href="peak-20220331.xsd#peak_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:to="lab_peak_DebtInstrumentMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue_94e87e33-a77a-401f-a21b-a52df8e4cb70_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share settlement (in shares)</link:label>
    <link:label id="lab_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contract Indexed to Equity, Settlement, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue" xlink:to="lab_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_0717d219-0b14-4f70-93db-1415e7225c98_totalLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_009b25aa-043c-4759-963a-126bd9508dcc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_1742e84b-a2fc-4452-8d7d-8a4d9f0a9c73_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer_0b4b2a80-035a-4ec6-89de-7685a5da4121_terseLabel_en-US" xlink:label="lab_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of mortgages assumed by buyer in real estate dispositions</link:label>
    <link:label id="lab_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer_label_en-US" xlink:label="lab_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash, Discontinued Operations, Secured Debt Assumed by Buyer</link:label>
    <link:label id="lab_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer_documentation_en-US" xlink:label="lab_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash, Discontinued Operations, Secured Debt Assumed by Buyer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" xlink:href="peak-20220331.xsd#peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" xlink:to="lab_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_de7757ca-d823-4f37-9ca2-879114c7a732_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_9b9b1870-9fc4-4d83-9d02-1b0e188127ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_de476321-f1fb-4e39-b4d3-458fadf9b297_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:to="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_aad78d27-0430-4546-b78b-cf9889142c1e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantNetWorth_dcc817ee-a441-48a4-a5c4-f21c1286b690_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantNetWorth" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant net worth</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantNetWorth_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantNetWorth" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Net Worth</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantNetWorth_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantNetWorth" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The required Minimum Consolidated Tangible Net Worth contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantNetWorth" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantNetWorth"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantNetWorth" xlink:to="lab_peak_DebtInstrumentCovenantNetWorth" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfUnconsolidatedJointVenture_d71e7ec0-cc8e-4925-94a2-10c588219540_terseLabel_en-US" xlink:label="lab_peak_NumberOfUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures (in joint ventures)</link:label>
    <link:label id="lab_peak_NumberOfUnconsolidatedJointVenture_label_en-US" xlink:label="lab_peak_NumberOfUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Venture</link:label>
    <link:label id="lab_peak_NumberOfUnconsolidatedJointVenture_documentation_en-US" xlink:label="lab_peak_NumberOfUnconsolidatedJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents number of unconsolidated joint ventures between entity and an institutional capital partner.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture" xlink:href="peak-20220331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfUnconsolidatedJointVenture" xlink:to="lab_peak_NumberOfUnconsolidatedJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TN_b2affcfe-d1c1-4253-8f79-9dbf2204ae31_terseLabel_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TENNESSEE</link:label>
    <link:label id="lab_stpr_TN_label_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TENNESSEE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TN" xlink:to="lab_stpr_TN" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_861d0aee-b9f6-44c4-a286-6ac296005c57_totalLabel_en-US" xlink:label="lab_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale and discontinued operations, net</link:label>
    <link:label id="lab_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_label_en-US" xlink:label="lab_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held For Sale And Discontinued Operations Net</link:label>
    <link:label id="lab_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_documentation_en-US" xlink:label="lab_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held For Sale And Discontinued Operations Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:href="peak-20220331.xsd#peak_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:to="lab_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_caeb6f6e-d026-4c15-a959-638309b58726_terseLabel_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement</link:label>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_label_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndemnificationGuaranteeMember" xlink:to="lab_us-gaap_IndemnificationGuaranteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_58bfe0cd-a11e-4ad3-be34-756e4d4f2539_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_c4833e18-e6a4-4c05-8cad-efefdce4a3de_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_b74bdeee-1252-4621-a010-6530cf32fff6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_524d59b8-0526-4aae-ad70-523b401b9592_negatedLabel_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest income</link:label>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_label_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations</link:label>
    <link:label id="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_documentation_en-US" xlink:label="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:href="peak-20220331.xsd#peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:to="lab_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_88e54c68-6ef6-483d-9a44-9a66c6f4fd1e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, redevelopment, and other major improvements of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_2198b304-52d8-4bfb-93af-763cde18874b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, redevelopment, and other major improvements of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Real Estate Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:to="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_d89f2464-873d-413a-a56c-9a3e68439cfd_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_8227f6b3-faa2-4530-8072-f48403a3de5f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Originated, More than Five Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_be40b41c-86e6-4bca-939b-833641cfd002_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesNet_a4278a19-479d-4dff-8333-4223ff1470ee_totalLabel_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible liabilities, net</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesNet_label_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Liabilities, Net</link:label>
    <link:label id="lab_peak_FiniteLivedIntangibleLiabilitiesNet_documentation_en-US" xlink:label="lab_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate sum of the gross carrying value of major finite-lived intangible liabilities class, less accumulated accretion and any impairment charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:to="lab_peak_FiniteLivedIntangibleLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_cf9c730b-7be7-45c7-beb3-cd26bd2034a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_8624e3a5-9d8c-4aff-b313-fa6c31d65860_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_ef6e5934-f1d1-4d0f-a8e2-35ff9b7c1732_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_6c76db92-1bf7-47d2-877e-c6fde8677665_terseLabel_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Direct Financing Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:to="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_525433a9-4b8d-4601-b2a3-b919977b4828_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_f60831e1-d7ee-4645-8d3e-fc7903d99742_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_UnsecuredNote4.250PercentMember_38635585-b6e6-4c88-8e08-6057177c6a4e_terseLabel_en-US" xlink:label="lab_peak_UnsecuredNote4.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.250 Percent</link:label>
    <link:label id="lab_peak_UnsecuredNote4.250PercentMember_label_en-US" xlink:label="lab_peak_UnsecuredNote4.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.250 Percent [Member]</link:label>
    <link:label id="lab_peak_UnsecuredNote4.250PercentMember_documentation_en-US" xlink:label="lab_peak_UnsecuredNote4.250PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Note 4.250 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4.250PercentMember" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4.250PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_UnsecuredNote4.250PercentMember" xlink:to="lab_peak_UnsecuredNote4.250PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5928d991-4d9e-4a8f-9af1-e6c352c4008a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3a3144be-9fdf-4e31-bfa2-9eac32159fde_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate 2023</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4ca00dad-9b2e-4e6c-b94d-bd07044ef340_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross intangible lease assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateTable_37b25c62-6f2c-49eb-b93c-5a07173e6487_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:label id="lab_us-gaap_RealEstateTable_label_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateTable" xlink:to="lab_us-gaap_RealEstateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_GainLossFromChangeOfControl_4259d657-399b-45ef-a2a1-ead61e69e641_negatedTerseLabel_en-US" xlink:label="lab_peak_GainLossFromChangeOfControl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) upon change of control, net</link:label>
    <link:label id="lab_peak_GainLossFromChangeOfControl_label_en-US" xlink:label="lab_peak_GainLossFromChangeOfControl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) From Change Of Control</link:label>
    <link:label id="lab_peak_GainLossFromChangeOfControl_documentation_en-US" xlink:label="lab_peak_GainLossFromChangeOfControl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) From Change Of Control</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossFromChangeOfControl" xlink:href="peak-20220331.xsd#peak_GainLossFromChangeOfControl"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_GainLossFromChangeOfControl" xlink:to="lab_peak_GainLossFromChangeOfControl" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_0661040b-f28d-474c-b1e9-e4a223791550_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of controlling ownership interest entities as a managing member</link:label>
    <link:label id="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_label_en-US" xlink:label="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Controlling Ownership Interest Through Partnership</link:label>
    <link:label id="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_documentation_en-US" xlink:label="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of controlling ownership interest entities, in which the company holds the interest and is the managing member of the partnership.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:to="lab_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_821b2832-a0be-478b-a238-5e68de06e04a_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DefinitiveAgreementsDomain_1243b3c4-3c44-44bd-bd21-f241f30de67d_terseLabel_en-US" xlink:label="lab_peak_DefinitiveAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreements [Domain]</link:label>
    <link:label id="lab_peak_DefinitiveAgreementsDomain_label_en-US" xlink:label="lab_peak_DefinitiveAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreements [Domain]</link:label>
    <link:label id="lab_peak_DefinitiveAgreementsDomain_documentation_en-US" xlink:label="lab_peak_DefinitiveAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementsDomain" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DefinitiveAgreementsDomain" xlink:to="lab_peak_DefinitiveAgreementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_3e73e92d-762d-42f3-8694-d9b77531ed9f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_70777ee3-612c-4145-8b23-f1e399585036_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Lease Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_3fc42724-0d7a-4114-8b40-0525b153cc2b_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_c9cb4f86-999e-49f9-a694-fbb1cce94e3d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7115045c-2933-4460-9be9-1da044b0cc42_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_52c229ed-7c1d-4e46-be44-9ffd5145da6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80e7ea0c-3a71-458b-9546-bf319981732a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f30cbe92-c655-448c-9810-19427ef81a6b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f6f19061-c0a9-4d0d-a648-24c2c355f4b6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_534d985b-9c9b-4188-b869-c988eb7aabf8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_6ec518d6-fe7d-4271-b0d6-1662c939a8ef_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, interest rate, reduction available for sustainability metrics</link:label>
    <link:label id="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_label_en-US" xlink:label="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics</link:label>
    <link:label id="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_documentation_en-US" xlink:label="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:href="peak-20220331.xsd#peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:to="lab_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent_e1c6bb1b-bc1d-4cb7-a241-4dbf07ae5581_terseLabel_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent_label_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture, Attributable To Parent</link:label>
    <link:label id="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent_documentation_en-US" xlink:label="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Revenues From Joint Venture, Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:to="lab_peak_RealEstateRevenuesFromJointVentureAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_bf0d85b1-ab62-4159-949d-7a86fbb39015_terseLabel_en-US" xlink:label="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant unsecured debt to unencumbered assets (as a percent)</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_label_en-US" xlink:label="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Unsecured Debt to Unencumbered Assets</link:label>
    <link:label id="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_documentation_en-US" xlink:label="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The limit of the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value contained in the debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:to="lab_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_0cda6016-cbf2-44a5-aadd-2d480f31c9a4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_fffd994f-c835-4f2f-b5fc-21eafb74a029_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_6e4253ca-27c9-49fc-820e-91dadb652dd9_terseLabel_en-US" xlink:label="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Parenthetical Disclosures</link:label>
    <link:label id="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Transactions, Parenthetical Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:to="lab_us-gaap_StockTransactionsParentheticalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_c3346f16-d00a-43d6-9cdd-5f1e5fd1f576_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateAbstract_6ddaf0ac-e571-4b11-85f5-83db76178b5b_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Abstract]</link:label>
    <link:label id="lab_us-gaap_RealEstateAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateAbstract" xlink:to="lab_us-gaap_RealEstateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_3429bf0f-2967-4eed-b6f2-72a01d8a7e48_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:to="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_61865091-b701-43af-989c-5efbe450dff9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e62adaaf-9e39-4e26-8272-5ca522f20fc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CCRVJVInvestmentMember_d61a1d72-3b6c-4a70-8aca-bfc8a6685cf3_terseLabel_en-US" xlink:label="lab_peak_CCRVJVInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRC JV</link:label>
    <link:label id="lab_peak_CCRVJVInvestmentMember_label_en-US" xlink:label="lab_peak_CCRVJVInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CCRV JV Investment [Member]</link:label>
    <link:label id="lab_peak_CCRVJVInvestmentMember_documentation_en-US" xlink:label="lab_peak_CCRVJVInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the unconsolidated joint venture formed by the Company and Brookdale, under a RIDEA structure, to own and operate CCRC campuses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRVJVInvestmentMember" xlink:href="peak-20220331.xsd#peak_CCRVJVInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CCRVJVInvestmentMember" xlink:to="lab_peak_CCRVJVInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_17292559-cdda-4688-b3d0-83e3889ae23b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_VariableInterestEntitiesTextBlock_cbbd7550-d172-4b04-aafb-747b525ef097_terseLabel_en-US" xlink:label="lab_peak_VariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_peak_VariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_peak_VariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Text Block]</link:label>
    <link:label id="lab_peak_VariableInterestEntitiesTextBlock_documentation_en-US" xlink:label="lab_peak_VariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for variable interest entities, including description of the terms of arrangements and categorized by: (1) VIEs consolidated because the entity is the primary beneficiary, (2) VIEs not consolidated because the entity is not the primary beneficiary, and (3) VIEs or potential VIEs that are not consolidated because necessary information is not available.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesTextBlock" xlink:href="peak-20220331.xsd#peak_VariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_VariableInterestEntitiesTextBlock" xlink:to="lab_peak_VariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DefinitiveAgreementFourMember_15dfcb53-9995-49be-ad2b-8ef644063188_terseLabel_en-US" xlink:label="lab_peak_DefinitiveAgreementFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreement Four</link:label>
    <link:label id="lab_peak_DefinitiveAgreementFourMember_label_en-US" xlink:label="lab_peak_DefinitiveAgreementFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreement Four [Member]</link:label>
    <link:label id="lab_peak_DefinitiveAgreementFourMember_documentation_en-US" xlink:label="lab_peak_DefinitiveAgreementFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreement Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementFourMember" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DefinitiveAgreementFourMember" xlink:to="lab_peak_DefinitiveAgreementFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c5a7efc1-536e-4cbd-bcca-8303f6cf52fa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_e829a150-06ad-4517-9a76-3680a217b811_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_f09672a5-666d-427b-9f9c-7533f041ea40_terseLabel_en-US" xlink:label="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions in excess of earnings from unconsolidated joint ventures</link:label>
    <link:label id="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_label_en-US" xlink:label="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions in Excess of Earnings from Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow from unconsolidated joint ventures in which the entity does not have sufficient US GAAP earnings (accumulated or in the current period) to distribute funds to partners, thereby constituting a return of investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:href="peak-20220331.xsd#peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:to="lab_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_f55a7207-ce61-4919-8f49-c9d9be212921_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Loss Exposure and Carrying Amount</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_186a7c5d-d5a4-43d9-881c-f033ef02ec1a_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansReceivableFairValueDisclosure_3340b76c-4a00-4e23-9a19-17c07c1e5047_terseLabel_en-US" xlink:label="lab_us-gaap_LoansReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, net</link:label>
    <link:label id="lab_us-gaap_LoansReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LoansReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansReceivableFairValueDisclosure" xlink:to="lab_us-gaap_LoansReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves_a12cf919-8226-4b12-8d4d-80c672ecf3b8_negatedLabel_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments and loan loss reserves</link:label>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves_label_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments And Allowance For Credit Loss Reserves</link:label>
    <link:label id="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves_documentation_en-US" xlink:label="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments And Allowance For Credit Loss Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:href="peak-20220331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:to="lab_peak_ImpairmentsAndAllowanceForCreditLossReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_4fa5b850-a41d-4cd8-8c30-e1391a35c51c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_1c9d2497-a821-4f65-9ce0-214602a70fdd_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_c6272a0b-bc0e-439d-bc80-50fb8c8b4320_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares_e2fa3fc5-5bd6-4571-acb4-c7336fda28cf_terseLabel_en-US" xlink:label="lab_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder outstanding (in shares)</link:label>
    <link:label id="lab_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares_label_en-US" xlink:label="lab_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Remainder Outstanding, Shares</link:label>
    <link:label id="lab_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares_documentation_en-US" xlink:label="lab_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Remainder Outstanding, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" xlink:href="peak-20220331.xsd#peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" xlink:to="lab_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_59621b60-98cc-4c26-a54b-cbae5d04cd12_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d72df570-5258-4b25-aa5c-3c44a2397bc8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_e266ca63-9123-4872-95cf-f62c2ae7238e_totalLabel_en-US" xlink:label="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, total</link:label>
    <link:label id="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_label_en-US" xlink:label="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total</link:label>
    <link:label id="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_documentation_en-US" xlink:label="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:href="peak-20220331.xsd#peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:to="lab_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfLand_72e53aac-eab0-452d-bd9f-7751ab14b57b_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of land (in acres)</link:label>
    <link:label id="lab_us-gaap_AreaOfLand_label_en-US" xlink:label="lab_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfLand" xlink:to="lab_us-gaap_AreaOfLand" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_98560904-bf70-4461-9d6c-0edc429cab14_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_ebe8a892-8d3b-4122-ac05-3134839fbed5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_0b465e69-b8fb-48e2-b36f-dbb8650247cc_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b8c9dada-3fa1-41e6-96a3-582f30f4ab42_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_a29c639f-1b0f-49b7-ae4a-9b04cb6d6fc4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4076e4a4-d289-4ed1-a212-b7a9e283a33f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0edc8dbb-8a05-4c98-8730-7512c7f80def_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_e0a5d42c-666f-4234-8dfa-2120c38eba10_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_84a78dfb-0bb5-4898-a006-004d40ba7f8f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue_3b8a8c3e-6171-4c55-9521-3b0b374999e7_terseLabel_en-US" xlink:label="lab_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange accommodation titleholder, real estate, carrying value</link:label>
    <link:label id="lab_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue_label_en-US" xlink:label="lab_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Accommodation Titleholder, Real Estate, Carrying Value</link:label>
    <link:label id="lab_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue_documentation_en-US" xlink:label="lab_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Accommodation Titleholder, Real Estate, Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue" xlink:href="peak-20220331.xsd#peak_ExchangeAccommodationTitleholderRealEstateCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue" xlink:to="lab_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5a75cbe0-9c07-421e-89d9-f2a1ac2859e1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_d5ed3228-0618-45f3-93ad-9ac956f786eb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_70b54ac6-6fbd-4f60-816a-ec34d4b376f4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Disclosure</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d9f4303e-6b3d-41be-98a7-39d2d5cfda65_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_2e017672-ede1-40d3-8eab-537ebcd83442_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year Four, Originated, Three Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_cc01d058-6dfc-42c8-b77f-c03d4359b70e_terseLabel_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</link:label>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest</link:label>
    <link:label id="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_documentation_en-US" xlink:label="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:href="peak-20220331.xsd#peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:to="lab_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_5b74cf07-0bc2-4cdf-9000-9e4ab43e2acc_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2c7c945d-8350-476e-b972-9e7e89bd38bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_691b2d3b-d554-44dd-86a1-c3f32c6d2326_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Year Three, Originated, Two Years before Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_7ce4e2c2-c472-45f7-8556-ce88928d23ed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountCommitted_69c2350a-f87b-4b7b-acb2-04bb2ed4dc28_terseLabel_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditure funding, amount committed</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountCommitted_label_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Amount Committed</link:label>
    <link:label id="lab_peak_CapitalExpenditureFundingAmountCommitted_documentation_en-US" xlink:label="lab_peak_CapitalExpenditureFundingAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditure Funding, Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountCommitted" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_CapitalExpenditureFundingAmountCommitted" xlink:to="lab_peak_CapitalExpenditureFundingAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8be9cdc0-e4aa-4825-a803-e60ce1f03690_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_LessorAssetUnderOperatingLeaseMember_965fc5ae-4c5f-4fb3-b0e8-51f0f3e8efeb_terseLabel_en-US" xlink:label="lab_peak_LessorAssetUnderOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor Asset Under Operating Lease</link:label>
    <link:label id="lab_peak_LessorAssetUnderOperatingLeaseMember_label_en-US" xlink:label="lab_peak_LessorAssetUnderOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor Asset Under Operating Lease [Member]</link:label>
    <link:label id="lab_peak_LessorAssetUnderOperatingLeaseMember_documentation_en-US" xlink:label="lab_peak_LessorAssetUnderOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor Asset Under Operating Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LessorAssetUnderOperatingLeaseMember" xlink:href="peak-20220331.xsd#peak_LessorAssetUnderOperatingLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_LessorAssetUnderOperatingLeaseMember" xlink:to="lab_peak_LessorAssetUnderOperatingLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_FinancingReceivableHeldForSaleNumberOfContracts_74593edc-b17a-44e0-9f82-8c5777d48f15_terseLabel_en-US" xlink:label="lab_peak_FinancingReceivableHeldForSaleNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of loans held for sale</link:label>
    <link:label id="lab_peak_FinancingReceivableHeldForSaleNumberOfContracts_label_en-US" xlink:label="lab_peak_FinancingReceivableHeldForSaleNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Held For Sale, Number Of Contracts</link:label>
    <link:label id="lab_peak_FinancingReceivableHeldForSaleNumberOfContracts_documentation_en-US" xlink:label="lab_peak_FinancingReceivableHeldForSaleNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Held For Sale, Number Of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableHeldForSaleNumberOfContracts" xlink:href="peak-20220331.xsd#peak_FinancingReceivableHeldForSaleNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_FinancingReceivableHeldForSaleNumberOfContracts" xlink:to="lab_peak_FinancingReceivableHeldForSaleNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_a86ed97f-5681-4847-bc28-75dc3b37cfd3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WA_08101336-9137-4c8c-9642-66f942ec9258_terseLabel_en-US" xlink:label="lab_stpr_WA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WASHINGTON</link:label>
    <link:label id="lab_stpr_WA_label_en-US" xlink:label="lab_stpr_WA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WASHINGTON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WA" xlink:to="lab_stpr_WA" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_MedicalOfficeJVsMember_00402bb3-1b1e-479f-9700-1d8bf7d37427_terseLabel_en-US" xlink:label="lab_peak_MedicalOfficeJVsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office JVs</link:label>
    <link:label id="lab_peak_MedicalOfficeJVsMember_label_en-US" xlink:label="lab_peak_MedicalOfficeJVsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office JVs [Member]</link:label>
    <link:label id="lab_peak_MedicalOfficeJVsMember_documentation_en-US" xlink:label="lab_peak_MedicalOfficeJVsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office JVs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeJVsMember" xlink:href="peak-20220331.xsd#peak_MedicalOfficeJVsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_MedicalOfficeJVsMember" xlink:to="lab_peak_MedicalOfficeJVsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_SunriseSeniorHousingPortfolioMember_a68d7ed0-831e-4aa9-9a83-a1e57d53f27a_terseLabel_en-US" xlink:label="lab_peak_SunriseSeniorHousingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunrise Senior Housing Portfolio</link:label>
    <link:label id="lab_peak_SunriseSeniorHousingPortfolioMember_label_en-US" xlink:label="lab_peak_SunriseSeniorHousingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunrise Senior Housing Portfolio [Member]</link:label>
    <link:label id="lab_peak_SunriseSeniorHousingPortfolioMember_documentation_en-US" xlink:label="lab_peak_SunriseSeniorHousingPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunrise Senior Housing Portfolio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SunriseSeniorHousingPortfolioMember" xlink:href="peak-20220331.xsd#peak_SunriseSeniorHousingPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_SunriseSeniorHousingPortfolioMember" xlink:to="lab_peak_SunriseSeniorHousingPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6c5c0df4-d5c7-49c4-a191-3b676cdb82ee_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateDisclosureTextBlock_40c07764-8728-42a5-b0c0-cbbc0bf2e18f_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Transactions</link:label>
    <link:label id="lab_us-gaap_RealEstateDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RealEstateDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateDisclosureTextBlock" xlink:to="lab_us-gaap_RealEstateDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonrecurringExpense_39241223-7509-4421-80ed-ffbfd712f40d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense on other</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonrecurring Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringExpense" xlink:to="lab_us-gaap_OtherNonrecurringExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_0e1b1520-f799-4457-8928-8d71df41ae85_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Discounts), premium and debt costs, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_f541d379-5d7f-431f-9476-8fa9e8a65f4b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5dd43dd6-b544-44c6-b916-f81be8de31e8_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4734b2df-4004-484b-8d92-5bbb148f8b34_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_74c0a40e-05b5-40a8-a0b4-2b27a76dbc3e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, total</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_5b725836-6853-49ff-b107-1ed124f26047_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_ff886409-edc6-474e-9d0b-2528f379c08a_totalLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_9108e355-8682-48ec-861c-066b93632714_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property count</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_label_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfRealEstateProperties" xlink:to="lab_us-gaap_NumberOfRealEstateProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent_b417ef68-2732-4bd5-b982-f077f391caa8_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued construction costs</link:label>
    <link:label id="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_ConstructionPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_bd93e5f3-213e-41db-b704-a54f9f86e535_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_88557491-1e0e-4c01-ace1-39906fb771c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NumberOfInterestRateDerivativesTerminated_2bcb2697-b549-4c4f-bebc-47361531a11b_terseLabel_en-US" xlink:label="lab_peak_NumberOfInterestRateDerivativesTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate derivatives terminated</link:label>
    <link:label id="lab_peak_NumberOfInterestRateDerivativesTerminated_label_en-US" xlink:label="lab_peak_NumberOfInterestRateDerivativesTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Terminated</link:label>
    <link:label id="lab_peak_NumberOfInterestRateDerivativesTerminated_documentation_en-US" xlink:label="lab_peak_NumberOfInterestRateDerivativesTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfInterestRateDerivativesTerminated" xlink:href="peak-20220331.xsd#peak_NumberOfInterestRateDerivativesTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NumberOfInterestRateDerivativesTerminated" xlink:to="lab_peak_NumberOfInterestRateDerivativesTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_407f4d3e-b875-46ef-8e2d-249bb7b83c5f_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_63ec03c2-e2b3-4fd8-ba5c-efbd6bee995c_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_0bdcb002-03ba-4a77-9c05-02f0063af279_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable, gross</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_96af08f3-0015-4af6-a828-d1d95b49c2f9_totalLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_58536e35-bd27-417d-9e43-3d9a51a87f04_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_72aa9b74-d395-4943-bdd1-f2f3ccf92152_negatedLabel_en-US" xlink:label="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating securities&#8217; share in earnings</link:label>
    <link:label id="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_fad31f57-d138-41e4-923e-5e380f2869f7_negatedTerseLabel_en-US" xlink:label="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Participating securities' share in continuing operations</link:label>
    <link:label id="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_label_en-US" xlink:label="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities Distributed And Undistributed Earnings Loss Basic and Diluted</link:label>
    <link:label id="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_documentation_en-US" xlink:label="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the earnings (loss) per share or per unit calculation under the two-class method.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:href="peak-20220331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:to="lab_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_e33307cb-3a4b-4044-bc99-08d99171541a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorPropertyClassAxis_54a960cd-0431-486b-abe7-fc377b3daa36_terseLabel_en-US" xlink:label="lab_us-gaap_MajorPropertyClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Property Class [Axis]</link:label>
    <link:label id="lab_us-gaap_MajorPropertyClassAxis_label_en-US" xlink:label="lab_us-gaap_MajorPropertyClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Property Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorPropertyClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorPropertyClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorPropertyClassAxis" xlink:to="lab_us-gaap_MajorPropertyClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_ec2d2849-0923-49f8-b99c-fbd172b538b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_BrookdaleMTCAMember_aa24ab7d-8db6-44fd-aee8-318fa7507dec_terseLabel_en-US" xlink:label="lab_peak_BrookdaleMTCAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookedale MTCA</link:label>
    <link:label id="lab_peak_BrookdaleMTCAMember_label_en-US" xlink:label="lab_peak_BrookdaleMTCAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookdale MTCA [Member]</link:label>
    <link:label id="lab_peak_BrookdaleMTCAMember_documentation_en-US" xlink:label="lab_peak_BrookdaleMTCAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brookdale MTCA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember" xlink:href="peak-20220331.xsd#peak_BrookdaleMTCAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_BrookdaleMTCAMember" xlink:to="lab_peak_BrookdaleMTCAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_5b69b650-d5fb-49e7-8bc8-5c847ef55d62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3aa155bd-f487-4183-8199-974c16105d34_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_4bbd4dc6-6b91-4a9e-9eeb-57d85e1c7e4b_totalLabel_en-US" xlink:label="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations applicable to common shares</link:label>
    <link:label id="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Loss Continuing Operations Available To Common Stockholders Basic</link:label>
    <link:label id="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_documentation_en-US" xlink:label="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Loss Continuing Operations Available To Common Stockholders Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:href="peak-20220331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:to="lab_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>peak-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:18e02b9c-9339-4812-a396-3a502b171f3f,g:40f6f78a-d855-4bed-acda-5b3ebe369ddb-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.healthpeak.com/role/CoverPage" xlink:type="simple" xlink:href="peak-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8641adf4-e067-44f9-88c7-e7d2da345426" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_DocumentType_8641adf4-e067-44f9-88c7-e7d2da345426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3a88bf90-a17a-4655-92ae-48b9b0b6303b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_DocumentQuarterlyReport_3a88bf90-a17a-4655-92ae-48b9b0b6303b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c7113c6f-3a3a-4f6e-bf66-32a12e36da14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_DocumentPeriodEndDate_c7113c6f-3a3a-4f6e-bf66-32a12e36da14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9088f7db-892c-4029-95fb-98f89be8dd5d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_DocumentTransitionReport_9088f7db-892c-4029-95fb-98f89be8dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0f88e719-d2e9-4d23-b4d2-b50501324023" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityFileNumber_0f88e719-d2e9-4d23-b4d2-b50501324023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fa4378a9-00e8-4d46-b7b8-5b4dd8a454a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityRegistrantName_fa4378a9-00e8-4d46-b7b8-5b4dd8a454a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e59e53f9-4364-4f8e-be96-3f08890d1543" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e59e53f9-4364-4f8e-be96-3f08890d1543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9f2b075d-240b-43e9-87cb-93e5176b888a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityTaxIdentificationNumber_9f2b075d-240b-43e9-87cb-93e5176b888a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ddc7cb01-46ff-4317-8715-29a35da8a547" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityAddressAddressLine1_ddc7cb01-46ff-4317-8715-29a35da8a547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_0acd5f20-9772-48e4-991a-d659db01764c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityAddressAddressLine2_0acd5f20-9772-48e4-991a-d659db01764c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2b346e3e-6264-44ec-be3f-3dc954da6fcd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityAddressCityOrTown_2b346e3e-6264-44ec-be3f-3dc954da6fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8deffc8f-5237-4389-953e-adfc043af2b7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityAddressStateOrProvince_8deffc8f-5237-4389-953e-adfc043af2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3666a8e2-6383-4de1-9c78-0cda70be9620" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityAddressPostalZipCode_3666a8e2-6383-4de1-9c78-0cda70be9620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_787c7074-3288-40c9-bc19-7353a7155984" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_CityAreaCode_787c7074-3288-40c9-bc19-7353a7155984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8ff9d5b5-7785-4eaa-b517-d0a55759f6c6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_LocalPhoneNumber_8ff9d5b5-7785-4eaa-b517-d0a55759f6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ae6bc8b0-508c-403d-a899-eae3ecf4e622" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_Security12bTitle_ae6bc8b0-508c-403d-a899-eae3ecf4e622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_82d2743c-4c64-4161-9a45-15441e690cff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_TradingSymbol_82d2743c-4c64-4161-9a45-15441e690cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b52f4286-edf4-4f63-80bc-05e28e6a879f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_SecurityExchangeName_b52f4286-edf4-4f63-80bc-05e28e6a879f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6d047d7d-a3c3-4aca-82cf-faea41eafde8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityCurrentReportingStatus_6d047d7d-a3c3-4aca-82cf-faea41eafde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e078c890-8f31-4754-95ba-cbe5e777b268" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityInteractiveDataCurrent_e078c890-8f31-4754-95ba-cbe5e777b268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_bccec01c-9ab7-4172-b173-d90e40e56495" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityFilerCategory_bccec01c-9ab7-4172-b173-d90e40e56495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_12043c54-1202-4996-9b76-e4bd69cb4f2b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntitySmallBusiness_12043c54-1202-4996-9b76-e4bd69cb4f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_caca996e-ad18-44ef-9c55-f0f4df8a6fdd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityEmergingGrowthCompany_caca996e-ad18-44ef-9c55-f0f4df8a6fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e19e4d6e-6794-420a-bbb0-e2c1268f37de" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityShellCompany_e19e4d6e-6794-420a-bbb0-e2c1268f37de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f759de65-167b-46dd-a6ac-39e4f5e0b833" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f759de65-167b-46dd-a6ac-39e4f5e0b833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a55de1fd-8fa2-46b9-8e2a-d15da672941b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_EntityCentralIndexKey_a55de1fd-8fa2-46b9-8e2a-d15da672941b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2ce193d6-964a-44d0-9831-3471c04be923" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_AmendmentFlag_2ce193d6-964a-44d0-9831-3471c04be923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_774c41c9-c207-4183-8250-1372d0d7016a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_CurrentFiscalYearEndDate_774c41c9-c207-4183-8250-1372d0d7016a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b51a8a46-d802-457a-aacb-079527602603" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_DocumentFiscalYearFocus_b51a8a46-d802-457a-aacb-079527602603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_46c8d790-33b6-4fa4-b37a-4b7a00a1b457" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b32daf7b-f7e9-45d5-b57d-f1f5b23730a5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_46c8d790-33b6-4fa4-b37a-4b7a00a1b457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f0abc1a1-b69f-411f-a1f4-196b1f9d0848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f0abc1a1-b69f-411f-a1f4-196b1f9d0848" xlink:to="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_d5197003-ed38-4250-baa2-78a1f40714a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_d5197003-ed38-4250-baa2-78a1f40714a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_bef27cfe-fdd0-4d86-88a9-781997df3872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_d5197003-ed38-4250-baa2-78a1f40714a4" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_bef27cfe-fdd0-4d86-88a9-781997df3872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_69fc45c0-e63f-4382-91b4-fcb3a3f794b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopmentInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_d5197003-ed38-4250-baa2-78a1f40714a4" xlink:to="loc_us-gaap_DevelopmentInProcess_69fc45c0-e63f-4382-91b4-fcb3a3f794b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_fc039a26-3c7a-4174-9b93-1e3e007b7ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_d5197003-ed38-4250-baa2-78a1f40714a4" xlink:to="loc_us-gaap_Land_fc039a26-3c7a-4174-9b93-1e3e007b7ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_1ef1cf2c-5275-4873-bd54-d6efb63aa67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_d5197003-ed38-4250-baa2-78a1f40714a4" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_1ef1cf2c-5275-4873-bd54-d6efb63aa67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_55d6b20f-ae78-45f0-a067-9f2465689fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_d5197003-ed38-4250-baa2-78a1f40714a4" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_55d6b20f-ae78-45f0-a067-9f2465689fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount_d25503e7-3b4d-41a1-8934-6fa35eb1828e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount_d25503e7-3b4d-41a1-8934-6fa35eb1828e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_5ef6fe41-1021-42e0-8121-c21ffe4b64ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_5ef6fe41-1021-42e0-8121-c21ffe4b64ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_759654ac-7710-41ab-bd24-caf274fdd978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_759654ac-7710-41ab-bd24-caf274fdd978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_93e1b128-cc7f-49f8-a3ca-db6729a0de9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_AccountsReceivableNet_93e1b128-cc7f-49f8-a3ca-db6729a0de9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1b5ae36d-7835-4c36-bd72-ac9123ebcd54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1b5ae36d-7835-4c36-bd72-ac9123ebcd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_4638139f-04ed-4a32-b82c-c536b375edc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_4638139f-04ed-4a32-b82c-c536b375edc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f12fe08b-a1b2-49be-8758-999950d1a528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f12fe08b-a1b2-49be-8758-999950d1a528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8dc53ab8-a289-4255-99ba-2b19229178fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8dc53ab8-a289-4255-99ba-2b19229178fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_33d34c9f-da0b-49bb-978a-5429924c2dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_33d34c9f-da0b-49bb-978a-5429924c2dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_cf59a98c-973f-4418-9bc3-389d905bfe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_OtherAssets_cf59a98c-973f-4418-9bc3-389d905bfe7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6b14faaa-ee56-4c18-80b2-ed41b4a15b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d75d0cc1-715a-423f-8f65-2eb6e8ec52e6" xlink:to="loc_us-gaap_Assets_6b14faaa-ee56-4c18-80b2-ed41b4a15b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f0abc1a1-b69f-411f-a1f4-196b1f9d0848" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a99a4015-5d6f-447c-b501-1f67b63e18b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_LineOfCredit_a99a4015-5d6f-447c-b501-1f67b63e18b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_889d56e8-29d9-4785-bce4-c8619d095e13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_UnsecuredDebt_889d56e8-29d9-4785-bce4-c8619d095e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_f3ebd36b-7939-42f2-854a-f2973c3bf55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_SecuredDebt_f3ebd36b-7939-42f2-854a-f2973c3bf55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable_7c50bd3e-e5a3-4c31-925a-041fe84dff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_OffMarketLeaseUnfavorable_7c50bd3e-e5a3-4c31-925a-041fe84dff3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_705683cd-d4a8-41f6-b58d-b2a6e9a23d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_705683cd-d4a8-41f6-b58d-b2a6e9a23d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_63aa9b4c-7381-41c9-bb50-692af182efbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_OperatingLeaseLiability_63aa9b4c-7381-41c9-bb50-692af182efbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_3c35cb6c-0eb8-42d0-8b11-8e2d6e331ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_3c35cb6c-0eb8-42d0-8b11-8e2d6e331ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1009ad59-c08d-4d58-9f17-5eca60c21fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1009ad59-c08d-4d58-9f17-5eca60c21fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dc1d6b39-26e4-40c4-bbc2-e1a0367963d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_Liabilities_dc1d6b39-26e4-40c4-bbc2-e1a0367963d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_09fb715c-35b5-4df1-acff-e494a3f763b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_09fb715c-35b5-4df1-acff-e494a3f763b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_bbbb5157-a2e3-47d2-bedb-fe98921b092f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_bbbb5157-a2e3-47d2-bedb-fe98921b092f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e41e0594-f8e3-47a2-8d42-1cfa16ba8264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_CommonStockValue_e41e0594-f8e3-47a2-8d42-1cfa16ba8264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_883a2d75-248e-401e-afb7-b1198573beee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_883a2d75-248e-401e-afb7-b1198573beee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_69329d98-99dc-4411-8d27-c80a2cf84700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncome"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncome_69329d98-99dc-4411-8d27-c80a2cf84700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5953183b-5bf0-423d-a732-c305d34735fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5953183b-5bf0-423d-a732-c305d34735fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_15bdf168-2f2d-494f-b076-7369aba79669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_StockholdersEquity_15bdf168-2f2d-494f-b076-7369aba79669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInJointVentures_c2adae45-496c-4f1e-b2b7-e1f32fcaabb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInJointVentures"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_MinorityInterestInJointVentures_c2adae45-496c-4f1e-b2b7-e1f32fcaabb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInPreferredUnitHolders_b4b17916-4d60-4e1e-8678-517894a75694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestInPreferredUnitHolders"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_MinorityInterestInPreferredUnitHolders_b4b17916-4d60-4e1e-8678-517894a75694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f5d36119-f417-42d2-aa62-038b5f24039e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_MinorityInterest_f5d36119-f417-42d2-aa62-038b5f24039e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_979b03f4-60e1-4af7-9d28-23572f9b3b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_979b03f4-60e1-4af7-9d28-23572f9b3b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fbe4ade6-90b5-43fe-af2c-4348132c2fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_add408be-e66d-4508-b174-3366406e177f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fbe4ade6-90b5-43fe-af2c-4348132c2fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6189f43c-ddf0-4f8c-a154-fcb89b3ff4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_a276dc35-1384-4dd0-9bde-f5662bff07ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockTransactionsParentheticalDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6189f43c-ddf0-4f8c-a154-fcb89b3ff4b5" xlink:to="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_a276dc35-1384-4dd0-9bde-f5662bff07ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_764d229e-2508-45a8-be3f-21bde5d2bc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_a276dc35-1384-4dd0-9bde-f5662bff07ab" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_764d229e-2508-45a8-be3f-21bde5d2bc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_bdd20962-1346-4ed8-a98a-0c1390b5c2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_a276dc35-1384-4dd0-9bde-f5662bff07ab" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_bdd20962-1346-4ed8-a98a-0c1390b5c2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0995ac30-f31b-4606-b4f3-de1d683bace4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_a276dc35-1384-4dd0-9bde-f5662bff07ab" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0995ac30-f31b-4606-b4f3-de1d683bace4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_48a0ff2a-0570-4da6-8b28-1654cefec1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_a276dc35-1384-4dd0-9bde-f5662bff07ab" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_48a0ff2a-0570-4da6-8b28-1654cefec1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a4294e45-0892-48ae-8ad1-f3e9a1d37b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_a276dc35-1384-4dd0-9bde-f5662bff07ab" xlink:to="loc_us-gaap_CommonStockSharesIssued_a4294e45-0892-48ae-8ad1-f3e9a1d37b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_15efd36d-d962-475d-a253-9bcb585e5b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockTransactionsParentheticalDisclosuresAbstract_a276dc35-1384-4dd0-9bde-f5662bff07ab" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_15efd36d-d962-475d-a253-9bcb585e5b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_c9b4a04f-9239-44eb-bb77-ea965ed25d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_RevenuesAbstract_c9b4a04f-9239-44eb-bb77-ea965ed25d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_35c5723b-0da7-43c6-b381-7d2fff8d30a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c9b4a04f-9239-44eb-bb77-ea965ed25d9c" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_35c5723b-0da7-43c6-b381-7d2fff8d30a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d34864d-fa68-48c9-9be1-e09e8d4597b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c9b4a04f-9239-44eb-bb77-ea965ed25d9c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d34864d-fa68-48c9-9be1-e09e8d4597b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseRevenue_c849cfda-82ef-4474-8b95-247220bca1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c9b4a04f-9239-44eb-bb77-ea965ed25d9c" xlink:to="loc_us-gaap_DirectFinancingLeaseRevenue_c849cfda-82ef-4474-8b95-247220bca1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_c0f1e61e-b903-44c7-906e-4466799b6123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c9b4a04f-9239-44eb-bb77-ea965ed25d9c" xlink:to="loc_us-gaap_InterestIncomeOperating_c0f1e61e-b903-44c7-906e-4466799b6123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0b948951-df06-4d90-a3c7-ff8f91fac5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_c9b4a04f-9239-44eb-bb77-ea965ed25d9c" xlink:to="loc_us-gaap_Revenues_0b948951-df06-4d90-a3c7-ff8f91fac5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b89be3dc-80b7-4d51-826c-1f75ee7c028c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:to="loc_us-gaap_InterestExpense_b89be3dc-80b7-4d51-826c-1f75ee7c028c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_37301659-63d9-483c-a5ad-6cdec267a213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:to="loc_us-gaap_DepreciationAndAmortization_37301659-63d9-483c-a5ad-6cdec267a213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_42fc56b2-6982-4ceb-95b0-429f3131d685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_42fc56b2-6982-4ceb-95b0-429f3131d685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_692dcbb1-a333-4204-bdb8-8437271b7ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_692dcbb1-a333-4204-bdb8-8437271b7ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3ef31fe5-a983-45d0-b8bd-9226cfe6d261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_3ef31fe5-a983-45d0-b8bd-9226cfe6d261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_8fee6148-0e42-4ecb-9b2c-8ebddae039a7" xlink:href="peak-20220331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet_8fee6148-0e42-4ecb-9b2c-8ebddae039a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_c54529c3-0fa2-40a9-9398-6372ff0d99eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_447ecb32-55df-4684-b8cb-ac3ef4e49b74" xlink:to="loc_us-gaap_CostsAndExpenses_c54529c3-0fa2-40a9-9398-6372ff0d99eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ebf455f0-8254-4f3b-adc2-8304cfae13c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ebf455f0-8254-4f3b-adc2-8304cfae13c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_3f562a32-c7e7-4108-865a-a26bba07fc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ebf455f0-8254-4f3b-adc2-8304cfae13c6" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_3f562a32-c7e7-4108-865a-a26bba07fc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7eac254e-1b20-47ba-8494-6fbeda7d4650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ebf455f0-8254-4f3b-adc2-8304cfae13c6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7eac254e-1b20-47ba-8494-6fbeda7d4650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f4ad0aa2-9b54-45fa-b372-2fd35e6bd1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ebf455f0-8254-4f3b-adc2-8304cfae13c6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f4ad0aa2-9b54-45fa-b372-2fd35e6bd1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b3b8231e-f6ac-4516-9e41-113fa978d449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ebf455f0-8254-4f3b-adc2-8304cfae13c6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b3b8231e-f6ac-4516-9e41-113fa978d449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_17d5c77b-8a7e-480c-86ce-839aeb1cf564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_17d5c77b-8a7e-480c-86ce-839aeb1cf564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_05113995-cfe3-4680-b8ba-b73b6e612ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_05113995-cfe3-4680-b8ba-b73b6e612ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c1300e92-7c52-4844-ab55-77da6af70de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c1300e92-7c52-4844-ab55-77da6af70de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6f102766-0a01-4e14-8baa-0822fc3f8d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_6f102766-0a01-4e14-8baa-0822fc3f8d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ed511cd9-9bd5-470c-a08f-d2f086fed353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ed511cd9-9bd5-470c-a08f-d2f086fed353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_01537ae3-1a8f-4d3e-b097-2652361e7fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_ProfitLoss_01537ae3-1a8f-4d3e-b097-2652361e7fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_031b2606-a592-44e9-9308-de8b2c4d0d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_031b2606-a592-44e9-9308-de8b2c4d0d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest_de699a68-2585-4152-a1f9-5e3b37495a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest_de699a68-2585-4152-a1f9-5e3b37495a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ddae0090-b34b-4821-9c2f-1b068be012cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_NetIncomeLoss_ddae0090-b34b-4821-9c2f-1b068be012cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_341331ac-2cfe-4733-9309-533c43139169" xlink:href="peak-20220331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_341331ac-2cfe-4733-9309-533c43139169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_53274ac7-bc82-4060-8e96-8d8f744a0bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_53274ac7-bc82-4060-8e96-8d8f744a0bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_588e28da-2882-4bba-8fe6-743ce61a7662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_EarningsPerShareAbstract_588e28da-2882-4bba-8fe6-743ce61a7662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_10377963-c7f2-4196-9742-3706e402ca65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_588e28da-2882-4bba-8fe6-743ce61a7662" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_10377963-c7f2-4196-9742-3706e402ca65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_919bab6d-620d-41fc-9177-1302fedd2ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_588e28da-2882-4bba-8fe6-743ce61a7662" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_919bab6d-620d-41fc-9177-1302fedd2ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9b525a2f-e163-4eb3-9f9b-177cbd008665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_588e28da-2882-4bba-8fe6-743ce61a7662" xlink:to="loc_us-gaap_EarningsPerShareBasic_9b525a2f-e163-4eb3-9f9b-177cbd008665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_d1477e0f-025d-4003-a592-0cc4cf37c08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_d1477e0f-025d-4003-a592-0cc4cf37c08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c8c08da2-314a-4041-90c8-f26c1974a303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_d1477e0f-025d-4003-a592-0cc4cf37c08b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c8c08da2-314a-4041-90c8-f26c1974a303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_aa64506a-8676-42ab-acca-9734e21587d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_d1477e0f-025d-4003-a592-0cc4cf37c08b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_aa64506a-8676-42ab-acca-9734e21587d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9449f399-bd6b-4519-aa84-3f1695579a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_d1477e0f-025d-4003-a592-0cc4cf37c08b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9449f399-bd6b-4519-aa84-3f1695579a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_08042912-65e8-4e8f-b118-42a6edae4d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b1500661-9ee6-4836-9b4d-c7bfa7ba089f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_08042912-65e8-4e8f-b118-42a6edae4d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f468e9ad-ce8c-4257-98e0-c7901b9663ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_08042912-65e8-4e8f-b118-42a6edae4d9e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f468e9ad-ce8c-4257-98e0-c7901b9663ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a19fbbb-7057-492f-b1e0-64cb83300616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_08042912-65e8-4e8f-b118-42a6edae4d9e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a19fbbb-7057-492f-b1e0-64cb83300616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f86e85a9-d3ea-4997-ac9e-67d209d7524e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f116f774-59b5-43e9-8f73-98fa920ef80f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f86e85a9-d3ea-4997-ac9e-67d209d7524e" xlink:to="loc_us-gaap_ProfitLoss_f116f774-59b5-43e9-8f73-98fa920ef80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ed433aa-d32e-4c35-8b86-cac0267bc5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f86e85a9-d3ea-4997-ac9e-67d209d7524e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ed433aa-d32e-4c35-8b86-cac0267bc5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_2963e908-b754-4592-8d8a-05e8b7318910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ed433aa-d32e-4c35-8b86-cac0267bc5cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_2963e908-b754-4592-8d8a-05e8b7318910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9efb7a31-670d-4318-8fe2-368783ef9665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ed433aa-d32e-4c35-8b86-cac0267bc5cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9efb7a31-670d-4318-8fe2-368783ef9665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8fde2d69-40b8-4a79-8886-6854e13efa7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ed433aa-d32e-4c35-8b86-cac0267bc5cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8fde2d69-40b8-4a79-8886-6854e13efa7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3e54d02d-6b2e-48e1-a784-cd15b56c5030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8ed433aa-d32e-4c35-8b86-cac0267bc5cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3e54d02d-6b2e-48e1-a784-cd15b56c5030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_415fec03-1bca-4c64-934e-68a6d16b2c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f86e85a9-d3ea-4997-ac9e-67d209d7524e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_415fec03-1bca-4c64-934e-68a6d16b2c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_400bd991-5faa-4f27-8380-d6371908a693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f86e85a9-d3ea-4997-ac9e-67d209d7524e" xlink:to="loc_us-gaap_StatementTable_400bd991-5faa-4f27-8380-d6371908a693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_97e59578-9435-408d-8b89-948c93a7d08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_400bd991-5faa-4f27-8380-d6371908a693" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_97e59578-9435-408d-8b89-948c93a7d08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_4bf4dafb-b401-47ed-8063-9f88d623088c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_97e59578-9435-408d-8b89-948c93a7d08e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_4bf4dafb-b401-47ed-8063-9f88d623088c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_1304d057-a5a9-4db3-b63e-e438469211ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4bf4dafb-b401-47ed-8063-9f88d623088c" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_1304d057-a5a9-4db3-b63e-e438469211ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_01673e3a-4d71-47cb-a912-222e33b4baf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4bf4dafb-b401-47ed-8063-9f88d623088c" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_01673e3a-4d71-47cb-a912-222e33b4baf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4261447b-65aa-419d-aff6-f3c22a6b8a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_400bd991-5faa-4f27-8380-d6371908a693" xlink:to="loc_us-gaap_StatementLineItems_4261447b-65aa-419d-aff6-f3c22a6b8a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d0d0c4a2-e468-499c-9a4c-16100f2a1e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4261447b-65aa-419d-aff6-f3c22a6b8a33" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d0d0c4a2-e468-499c-9a4c-16100f2a1e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a6cfba97-bb17-41ca-9ee0-01bf39b8fdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f86e85a9-d3ea-4997-ac9e-67d209d7524e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a6cfba97-bb17-41ca-9ee0-01bf39b8fdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9faed6e5-f0ea-4cbc-a582-3e120f2e69c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7db1e95b-91d2-4dbf-9d3e-c862353474c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9faed6e5-f0ea-4cbc-a582-3e120f2e69c2" xlink:to="loc_us-gaap_StatementTable_7db1e95b-91d2-4dbf-9d3e-c862353474c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bdf61e2b-f4d6-4de5-a1eb-feaae9559413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7db1e95b-91d2-4dbf-9d3e-c862353474c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bdf61e2b-f4d6-4de5-a1eb-feaae9559413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d747f3ce-c3d1-4525-93bc-12fea30f4cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bdf61e2b-f4d6-4de5-a1eb-feaae9559413" xlink:to="loc_us-gaap_EquityComponentDomain_d747f3ce-c3d1-4525-93bc-12fea30f4cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d747f3ce-c3d1-4525-93bc-12fea30f4cf7" xlink:to="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4f47eb46-5d49-4ad5-9adc-bcb085cf766b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:to="loc_us-gaap_CommonStockMember_4f47eb46-5d49-4ad5-9adc-bcb085cf766b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5f54fdb3-f58d-4b9e-9622-c888684e243b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5f54fdb3-f58d-4b9e-9622-c888684e243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_f97765b4-6777-4aca-822d-417aa3f528f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:to="loc_us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember_f97765b4-6777-4aca-822d-417aa3f528f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1796360-af89-475a-baf2-bbe8c0023b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_97684aaa-79d6-467c-9b3f-a7d89da4abbb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1796360-af89-475a-baf2-bbe8c0023b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_1bec4c99-1f02-462c-bc7d-1fcfa14cedf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d747f3ce-c3d1-4525-93bc-12fea30f4cf7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_1bec4c99-1f02-462c-bc7d-1fcfa14cedf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ed7d9771-80d0-4a18-bf1e-3765417b2aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7db1e95b-91d2-4dbf-9d3e-c862353474c5" xlink:to="loc_us-gaap_StatementLineItems_ed7d9771-80d0-4a18-bf1e-3765417b2aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed7d9771-80d0-4a18-bf1e-3765417b2aed" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_985e6159-b0bf-4ec4-be18-55f8ff822e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_SharesIssued_985e6159-b0bf-4ec4-be18-55f8ff822e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f3f385d5-126a-475b-8dae-f32881154979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f3f385d5-126a-475b-8dae-f32881154979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_f79fa908-9d80-4f9d-8300-454be84f2717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_f79fa908-9d80-4f9d-8300-454be84f2717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_076dd364-7c98-4645-b03a-2861f47abe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_076dd364-7c98-4645-b03a-2861f47abe6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a3b7bbd0-1cb0-4373-bc9d-0d63e6fd9045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a3b7bbd0-1cb0-4373-bc9d-0d63e6fd9045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6373988c-33ae-496c-b87a-effad9046342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6373988c-33ae-496c-b87a-effad9046342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_b0f5b606-c1e8-4f35-90fb-5c8f38f3883b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_b0f5b606-c1e8-4f35-90fb-5c8f38f3883b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_3170801c-81cf-4649-8cee-5d873212b082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_3170801c-81cf-4649-8cee-5d873212b082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1412925d-9594-437a-bd62-554d50f221cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1412925d-9594-437a-bd62-554d50f221cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_bd5ff38b-3ec9-4762-b36b-0bc7e9b2acc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_DividendsCommonStock_bd5ff38b-3ec9-4762-b36b-0bc7e9b2acc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4e7b41c1-0d0c-47a0-b8ec-5dc0f9064e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4e7b41c1-0d0c-47a0-b8ec-5dc0f9064e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_196a7433-14f4-4b71-99ed-6fba0716412d" xlink:href="peak-20220331.xsd#peak_AdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_peak_AdjustmentsOfPermanentEquityToTemporaryEquity_196a7433-14f4-4b71-99ed-6fba0716412d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_fcaf5470-4959-453f-8a3f-cc1587ed64eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_SharesIssued_fcaf5470-4959-453f-8a3f-cc1587ed64eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2b75be8a-10ca-4c53-9737-00e0e5d30188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_34d23313-72bb-4fb7-9b39-10351a374c2d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2b75be8a-10ca-4c53-9737-00e0e5d30188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed7d9771-80d0-4a18-bf1e-3765417b2aed" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3ead6758-d3b9-4141-8c48-a08b60fc2f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3ead6758-d3b9-4141-8c48-a08b60fc2f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_5baf37c2-27df-4558-b349-0fc24d3eb578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_5baf37c2-27df-4558-b349-0fc24d3eb578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_221ca3e0-9c16-48b0-a184-4e48221e60d4" xlink:href="peak-20220331.xsd#peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_221ca3e0-9c16-48b0-a184-4e48221e60d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_25f72620-3718-45ad-8650-26672888a2ca" xlink:href="peak-20220331.xsd#peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest_25f72620-3718-45ad-8650-26672888a2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_fc08fe57-919b-419e-8785-cbfc086fb4e8" xlink:href="peak-20220331.xsd#peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity_fc08fe57-919b-419e-8785-cbfc086fb4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_bea34efa-a06b-470c-96b8-e415caf47fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_21cee5a3-ebb4-4b7c-a7a4-61ee193a7b39" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_bea34efa-a06b-470c-96b8-e415caf47fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c01bf4f3-6f9e-44c5-a2cc-aced24026b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1996d000-f986-49e4-bda6-527228b6d836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c01bf4f3-6f9e-44c5-a2cc-aced24026b98" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1996d000-f986-49e4-bda6-527228b6d836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="peak-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c86adc63-225c-41b5-96ab-262198b7d415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_58cdec9f-80aa-4ffd-ad11-f22a00d131de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c86adc63-225c-41b5-96ab-262198b7d415" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_58cdec9f-80aa-4ffd-ad11-f22a00d131de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c313e676-e82f-4315-8847-1ca7ec742d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_58cdec9f-80aa-4ffd-ad11-f22a00d131de" xlink:to="loc_us-gaap_ProfitLoss_c313e676-e82f-4315-8847-1ca7ec742d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_58cdec9f-80aa-4ffd-ad11-f22a00d131de" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_15fbc9bf-7b0d-4bd4-83be-42966f79ae96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_15fbc9bf-7b0d-4bd4-83be-42966f79ae96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6f5752e2-9016-4cf5-8ffa-3b9e474fad44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_ShareBasedCompensation_6f5752e2-9016-4cf5-8ffa-3b9e474fad44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1b6cf55f-e16e-4459-b62d-57d9f3f198ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1b6cf55f-e16e-4459-b62d-57d9f3f198ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StraightLineRent_b947d9e8-57cc-4664-9697-c5fae6bfa040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StraightLineRent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_StraightLineRent_b947d9e8-57cc-4664-9697-c5fae6bfa040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_7d5d46c4-e307-43c8-8db9-25d7d370913c" xlink:href="peak-20220331.xsd#peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet_7d5d46c4-e307-43c8-8db9-25d7d370913c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_b1e6d318-dd8e-4a67-8311-9fe918dcdef2" xlink:href="peak-20220331.xsd#peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations_b1e6d318-dd8e-4a67-8311-9fe918dcdef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_e45af850-fe3c-447a-96e5-2fc55e8a0d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_e45af850-fe3c-447a-96e5-2fc55e8a0d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_ad31a96c-f84f-4bf6-8bbb-c3cca674e5e8" xlink:href="peak-20220331.xsd#peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_ad31a96c-f84f-4bf6-8bbb-c3cca674e5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease_d464ff4f-0123-4715-85f8-20e16d07a4e1" xlink:href="peak-20220331.xsd#peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_bea55ff7-b1fa-462f-8811-ead13781f7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_bea55ff7-b1fa-462f-8811-ead13781f7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_eaf328db-df02-4f02-af73-92a2ecb2479a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_AssetImpairmentCharges_eaf328db-df02-4f02-af73-92a2ecb2479a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b32f5580-baba-464f-b524-b9151289747f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b32f5580-baba-464f-b524-b9151289747f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_a16e79a8-9b94-445a-8b36-45c15b89f97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_a16e79a8-9b94-445a-8b36-45c15b89f97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GainLossFromChangeOfControl_4b34114b-0900-4e40-8fdf-8a50d0150f58" xlink:href="peak-20220331.xsd#peak_GainLossFromChangeOfControl"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_peak_GainLossFromChangeOfControl_4b34114b-0900-4e40-8fdf-8a50d0150f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuredEventGainLoss_abb8b8df-3522-4a47-addb-b982360ec66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuredEventGainLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_InsuredEventGainLoss_abb8b8df-3522-4a47-addb-b982360ec66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_cf34b111-bada-47ef-8eaa-07d2caf5b09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_cf34b111-bada-47ef-8eaa-07d2caf5b09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a267bd4c-3f12-4427-a02a-a6173a3d6a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6efc4bbd-f6b5-4836-8eba-bc80b6f6d5e4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a267bd4c-3f12-4427-a02a-a6173a3d6a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_5419eb65-bff6-47b4-b97f-13f9975473ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a267bd4c-3f12-4427-a02a-a6173a3d6a57" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_5419eb65-bff6-47b4-b97f-13f9975473ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_15db5840-33b2-43d4-a353-fa51436a6513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a267bd4c-3f12-4427-a02a-a6173a3d6a57" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_15db5840-33b2-43d4-a353-fa51436a6513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_806d4996-e7c8-47c6-b406-72ee4e332938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_58cdec9f-80aa-4ffd-ad11-f22a00d131de" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_806d4996-e7c8-47c6-b406-72ee4e332938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c86adc63-225c-41b5-96ab-262198b7d415" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherRealEstate_3052adbc-b176-4a64-b3b5-a1ee828ad4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_us-gaap_PaymentsToAcquireOtherRealEstate_3052adbc-b176-4a64-b3b5-a1ee828ad4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_98ba1266-9007-4e8c-b044-294373af7ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_98ba1266-9007-4e8c-b044-294373af7ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_c1d70c67-409c-4430-9628-1d873f338ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_c1d70c67-409c-4430-9628-1d873f338ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_3e35c819-fb71-447c-b110-aea24aa523d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_3e35c819-fb71-447c-b110-aea24aa523d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_e87d8898-61d0-47a4-822f-97ee50ba9147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_e87d8898-61d0-47a4-822f-97ee50ba9147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_ba5da907-0fda-433f-8c7e-0746c4f20ad1" xlink:href="peak-20220331.xsd#peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures_ba5da907-0fda-433f-8c7e-0746c4f20ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables_3549117d-091c-4179-99b1-dc7a8bad9f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables_3549117d-091c-4179-99b1-dc7a8bad9f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PaymentsToAcquireLoansReceivableAndOther_819860e2-81cb-4e8a-a406-68c8c3d16048" xlink:href="peak-20220331.xsd#peak_PaymentsToAcquireLoansReceivableAndOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_peak_PaymentsToAcquireLoansReceivableAndOther_819860e2-81cb-4e8a-a406-68c8c3d16048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0edb83f-b71e-4947-b3fa-15ecc3aa5e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44cf0b88-9b8d-48fa-874d-33783cbe0364" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0edb83f-b71e-4947-b3fa-15ecc3aa5e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c86adc63-225c-41b5-96ab-262198b7d415" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_643e7d65-9602-4210-8013-30c3298ffd76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_643e7d65-9602-4210-8013-30c3298ffd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_21fe6576-cec4-47c6-956b-b0d8d8e1d687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_21fe6576-cec4-47c6-956b-b0d8d8e1d687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfBankDebt_89f6c6dd-a6e7-4cca-8a29-8a8df4ce3546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_RepaymentsOfBankDebt_89f6c6dd-a6e7-4cca-8a29-8a8df4ce3546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_5c5c43af-5457-485e-9b9b-7f7cb2556f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_5c5c43af-5457-485e-9b9b-7f7cb2556f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_0aee01eb-295a-4b1e-9e9a-d8d230f55527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_0aee01eb-295a-4b1e-9e9a-d8d230f55527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7be3e3ff-8577-4010-9225-3fa055ada79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7be3e3ff-8577-4010-9225-3fa055ada79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_e07056f6-acf0-4d7e-9fa3-be41f98798db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_PaymentsOfDividends_e07056f6-acf0-4d7e-9fa3-be41f98798db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_b9a6e71d-5b97-4efc-8e97-700f851217dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_b9a6e71d-5b97-4efc-8e97-700f851217dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_8c745a39-1ab0-4926-8445-4cc217cbab62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_8c745a39-1ab0-4926-8445-4cc217cbab62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0fe45ea-66ef-4306-9fbf-d4190dc83436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d777459-b157-416b-b1f5-f9d05693a4a2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0fe45ea-66ef-4306-9fbf-d4190dc83436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce297d6d-3069-4860-a2cd-78543ec9b33c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c86adc63-225c-41b5-96ab-262198b7d415" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce297d6d-3069-4860-a2cd-78543ec9b33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_eb8fc0c2-4544-47cd-997f-8b4c9ed94059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c86adc63-225c-41b5-96ab-262198b7d415" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_eb8fc0c2-4544-47cd-997f-8b4c9ed94059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9604fe02-8c56-4101-9f84-b76503165d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c86adc63-225c-41b5-96ab-262198b7d415" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9604fe02-8c56-4101-9f84-b76503165d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/Business" xlink:type="simple" xlink:href="peak-20220331.xsd#Business"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/Business" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_878fab21-cd27-4cf1-b8ff-bcd265b1235c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_55de6858-1cb0-4e08-9dbf-5378ec6392bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_878fab21-cd27-4cf1-b8ff-bcd265b1235c" xlink:to="loc_us-gaap_NatureOfOperations_55de6858-1cb0-4e08-9dbf-5378ec6392bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="peak-20220331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_92ab369f-615f-4ed0-a3cd-042b63782a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_0707bb48-db7b-4055-af80-7ccdb954f8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92ab369f-615f-4ed0-a3cd-042b63782a43" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_0707bb48-db7b-4055-af80-7ccdb954f8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="peak-20220331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4d6d90f9-a7d1-4015-b999-4dc424ba58b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ab0cf611-8d1d-4270-8115-ade0bcc3b012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d6d90f9-a7d1-4015-b999-4dc424ba58b3" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ab0cf611-8d1d-4270-8115-ade0bcc3b012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomePolicyPolicyTextBlock_4da979cc-d853-4763-9f50-b72ca254c8b4" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d6d90f9-a7d1-4015-b999-4dc424ba58b3" xlink:to="loc_peak_GovernmentGrantIncomePolicyPolicyTextBlock_4da979cc-d853-4763-9f50-b72ca254c8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_6cc81e28-bbc4-45aa-9466-237ebb685ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d6d90f9-a7d1-4015-b999-4dc424ba58b3" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_6cc81e28-bbc4-45aa-9466-237ebb685ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e5116b24-7b5b-442c-b8fb-e6ecf645a44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4d6d90f9-a7d1-4015-b999-4dc424ba58b3" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e5116b24-7b5b-442c-b8fb-e6ecf645a44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="peak-20220331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_69d2e8e9-adcd-4f98-ac2c-cf6f7d8df620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_765d824a-dfc3-4600-a769-75bf40606e4b" xlink:href="peak-20220331.xsd#peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_69d2e8e9-adcd-4f98-ac2c-cf6f7d8df620" xlink:to="loc_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock_765d824a-dfc3-4600-a769-75bf40606e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c5c3559d-1ed9-4540-b576-6d19a2daa987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_93bd4863-4272-475f-8715-e3f1f8062626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c5c3559d-1ed9-4540-b576-6d19a2daa987" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_93bd4863-4272-475f-8715-e3f1f8062626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_66fe4ada-b120-4ac0-8ada-6767902e60c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_93bd4863-4272-475f-8715-e3f1f8062626" xlink:to="loc_srt_RestatementAxis_66fe4ada-b120-4ac0-8ada-6767902e60c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7e4c2d5e-baf5-4936-88ee-2fef5529cc65" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_66fe4ada-b120-4ac0-8ada-6767902e60c3" xlink:to="loc_srt_RestatementDomain_7e4c2d5e-baf5-4936-88ee-2fef5529cc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_cf1bf376-b5a9-4b1b-8d5c-9a83144e0243" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7e4c2d5e-baf5-4936-88ee-2fef5529cc65" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_cf1bf376-b5a9-4b1b-8d5c-9a83144e0243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_93bd4863-4272-475f-8715-e3f1f8062626" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5dc38eb2-e5e3-4fca-864e-01acf72db968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5dc38eb2-e5e3-4fca-864e-01acf72db968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_308e2672-78c3-4e1c-b90b-266fe2644905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_308e2672-78c3-4e1c-b90b-266fe2644905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_1e5d1f22-7e3f-4095-8854-6506422dc13a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_86626c46-a0ab-44e4-bab3-3d0c886b3d03" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_1e5d1f22-7e3f-4095-8854-6506422dc13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fcfd04f3-7be7-438d-9515-a179fbe1e157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fcfd04f3-7be7-438d-9515-a179fbe1e157" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceAxis_314f2f3d-e62c-4bff-a730-4f820f62398e" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:to="loc_peak_GovernmentAssistanceAxis_314f2f3d-e62c-4bff-a730-4f820f62398e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceDomain_a27fe487-e158-4ca1-bb29-f812c7593e81" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_GovernmentAssistanceAxis_314f2f3d-e62c-4bff-a730-4f820f62398e" xlink:to="loc_peak_GovernmentAssistanceDomain_a27fe487-e158-4ca1-bb29-f812c7593e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentAssistanceCARESActMember_9ce19d98-f61d-47b9-bad5-23b90a43785d" xlink:href="peak-20220331.xsd#peak_GovernmentAssistanceCARESActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_GovernmentAssistanceDomain_a27fe487-e158-4ca1-bb29-f812c7593e81" xlink:to="loc_peak_GovernmentAssistanceCARESActMember_9ce19d98-f61d-47b9-bad5-23b90a43785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7dd480cd-1f98-429c-a396-e0ab0a984fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7dd480cd-1f98-429c-a396-e0ab0a984fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7dd480cd-1f98-429c-a396-e0ab0a984fac" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b8989a39-ee97-4cad-96dc-b71fe40b683d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b8989a39-ee97-4cad-96dc-b71fe40b683d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_c3b0b21e-7847-4340-8ad3-3a83d8ffd12c" xlink:href="peak-20220331.xsd#peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:to="loc_peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember_c3b0b21e-7847-4340-8ad3-3a83d8ffd12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncomeLossFromDiscontinuedOperationsMember_dcfeb79d-97f9-4d16-b89a-08963bee257e" xlink:href="peak-20220331.xsd#peak_IncomeLossFromDiscontinuedOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f81c8b88-a99b-40fb-b529-9f77dd31be65" xlink:to="loc_peak_IncomeLossFromDiscontinuedOperationsMember_dcfeb79d-97f9-4d16-b89a-08963bee257e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_00c2a54f-cfa0-466f-aacc-df617c0aaf23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_6e70e5ec-2d1d-48f7-aacc-f620fd9cd1a4" xlink:to="loc_us-gaap_UnusualOrInfrequentItemLineItems_00c2a54f-cfa0-466f-aacc-df617c0aaf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncome_38a4e000-2242-47ac-9aaf-29f3f10595dc" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_00c2a54f-cfa0-466f-aacc-df617c0aaf23" xlink:to="loc_peak_GovernmentGrantIncome_38a4e000-2242-47ac-9aaf-29f3f10595dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/RealEstateTransactions" xlink:type="simple" xlink:href="peak-20220331.xsd#RealEstateTransactions"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/RealEstateTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_3715e979-41df-4847-a2b7-a33d57ded519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateDisclosureTextBlock_080ae43d-33c9-4301-8475-2e73346766d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_3715e979-41df-4847-a2b7-a33d57ded519" xlink:to="loc_us-gaap_RealEstateDisclosureTextBlock_080ae43d-33c9-4301-8475-2e73346766d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#RealEstateTransactionsRealEstateInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_23a934af-734a-4183-85f4-f5dacc4b2121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_23a934af-734a-4183-85f4-f5dacc4b2121" xlink:to="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_16025d19-5073-4994-abd0-e51c63c12872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_16025d19-5073-4994-abd0-e51c63c12872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e060bb08-01ec-440d-8b43-697f2d9490f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16025d19-5073-4994-abd0-e51c63c12872" xlink:to="loc_us-gaap_SegmentDomain_e060bb08-01ec-440d-8b43-697f2d9490f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_26b0a2e5-f0df-4cbf-96cd-2e604e7155e9" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e060bb08-01ec-440d-8b43-697f2d9490f9" xlink:to="loc_peak_LifeScienceMember_26b0a2e5-f0df-4cbf-96cd-2e604e7155e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_b08cab6b-92ac-4270-bcb4-477f6efbff12" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e060bb08-01ec-440d-8b43-697f2d9490f9" xlink:to="loc_peak_MedicalOfficeMember_b08cab6b-92ac-4270-bcb4-477f6efbff12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_34303980-4cb6-4e5f-8008-87965c3fcbfe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:to="loc_srt_StatementGeographicalAxis_34303980-4cb6-4e5f-8008-87965c3fcbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_34303980-4cb6-4e5f-8008-87965c3fcbfe" xlink:to="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_177633ba-6702-40d0-9687-293bf6f4e563" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_MA_177633ba-6702-40d0-9687-293bf6f4e563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_3e754dda-db40-416b-be59-b51eee0b293b" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_CA_3e754dda-db40-416b-be59-b51eee0b293b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_449b6ae0-36e9-43d5-96ec-71a36f8bc3f4" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TX"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_TX_449b6ae0-36e9-43d5-96ec-71a36f8bc3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_19c3ae05-5fc8-4af2-9e53-7006202c0e34" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_TN"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_TN_19c3ae05-5fc8-4af2-9e53-7006202c0e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO_5e454873-1a59-4a25-8887-36392c6a9ed6" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_CO"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_CO_5e454873-1a59-4a25-8887-36392c6a9ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fbfec051-e788-4590-8f40-7a7f22237362" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_country_US_fbfec051-e788-4590-8f40-7a7f22237362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_dae899a2-95bf-4c05-a993-3908145b91b9" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_FL"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_FL_dae899a2-95bf-4c05-a993-3908145b91b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_25c8c3eb-d7c5-41e9-92b8-994940524053" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_KS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_KS_25c8c3eb-d7c5-41e9-92b8-994940524053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_0311b087-00fd-4345-81d5-b4a0e1f57582" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_NJ"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_NJ_0311b087-00fd-4345-81d5-b4a0e1f57582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA_060dd6bd-64ef-431d-b93c-93c180c5364d" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_WA"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_WA_060dd6bd-64ef-431d-b93c-93c180c5364d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_73de33bb-da70-455b-a015-7219270cc04a" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_LA"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_533c805b-71d0-4547-9815-0c2a91488830" xlink:to="loc_stpr_LA_73de33bb-da70-455b-a015-7219270cc04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1204f1b2-54f0-4dc0-9522-366066f6ada3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:to="loc_us-gaap_DebtInstrumentAxis_1204f1b2-54f0-4dc0-9522-366066f6ada3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_287fe698-a6fd-44f7-9641-a4131fb65dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1204f1b2-54f0-4dc0-9522-366066f6ada3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_287fe698-a6fd-44f7-9641-a4131fb65dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_b85292ff-ada5-4b25-b104-fd6b21677396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_287fe698-a6fd-44f7-9641-a4131fb65dd2" xlink:to="loc_us-gaap_SecuredDebtMember_b85292ff-ada5-4b25-b104-fd6b21677396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_e8a340c3-cdff-4c16-8fc1-73fc8bf096ca" xlink:to="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_f37e65a6-984b-4269-80cf-1147377ed178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_f37e65a6-984b-4269-80cf-1147377ed178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired_5c25fd0b-376e-482f-89bb-b8ebb0bbb3e5" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_peak_NumberOfPropertiesAcquired_5c25fd0b-376e-482f-89bb-b8ebb0bbb3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand_1dab213d-864e-45e9-a9ff-56a6c40431d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_AreaOfLand_1dab213d-864e-45e9-a9ff-56a6c40431d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLand_bb932a36-af70-4495-8991-35ce6334c090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLand"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_PaymentsToAcquireLand_bb932a36-af70-4495-8991-35ce6334c090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ad77081f-994a-4b95-a24a-4a498a074100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_eb83e900-7cd2-4de0-98a2-481ed29fe82b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ad77081f-994a-4b95-a24a-4a498a074100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/RealEstateTransactionsDevelopmentActivitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#RealEstateTransactionsDevelopmentActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/RealEstateTransactionsDevelopmentActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_52195c5d-988d-48de-b5f0-c07f517954fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_fbfac050-3d7a-4e70-9b12-ca54e00cfb49" xlink:href="peak-20220331.xsd#peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_52195c5d-988d-48de-b5f0-c07f517954fe" xlink:to="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease_fbfac050-3d7a-4e70-9b12-ca54e00cfb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_167a4392-9ed5-4175-bc7a-c25bdc9cff9e" xlink:href="peak-20220331.xsd#peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_52195c5d-988d-48de-b5f0-c07f517954fe" xlink:to="loc_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements_167a4392-9ed5-4175-bc7a-c25bdc9cff9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_69efb140-7f85-46dd-9fb0-af4711284835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b471a7f8-b951-4c5d-8e19-5614baf29519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_69efb140-7f85-46dd-9fb0-af4711284835" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b471a7f8-b951-4c5d-8e19-5614baf29519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_91bf9810-d06b-464e-86da-32782a1fa641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_ea791cc6-47f7-4506-96a4-86ccf3643b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_91bf9810-d06b-464e-86da-32782a1fa641" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_ea791cc6-47f7-4506-96a4-86ccf3643b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ba71a3d1-f5f7-4167-9c2c-a9c911fd9cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ba71a3d1-f5f7-4167-9c2c-a9c911fd9cbd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a1c65ee5-07c8-4b24-89c7-44436a875ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a1c65ee5-07c8-4b24-89c7-44436a875ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1c65ee5-07c8-4b24-89c7-44436a875ce9" xlink:to="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_8765221b-c2d2-4b52-83fc-940c13be3ba2" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_LifeScienceMember_8765221b-c2d2-4b52-83fc-940c13be3ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_78497bc0-c9fe-40e7-93cd-711bd5aa1eab" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_MedicalOfficeMember_78497bc0-c9fe-40e7-93cd-711bd5aa1eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_5b0b281a-978a-431a-bf1e-c069551aa799" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_5b0b281a-978a-431a-bf1e-c069551aa799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingTripleNetMember_2e05109e-32d9-453e-8079-460a8aa42702" xlink:href="peak-20220331.xsd#peak_SeniorHousingTripleNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_SeniorHousingTripleNetMember_2e05109e-32d9-453e-8079-460a8aa42702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeHospitalMember_02c09148-5176-4360-89ee-bddf676a6c68" xlink:href="peak-20220331.xsd#peak_MedicalOfficeHospitalMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6bc4df98-3de9-4284-af1f-ff3708a1f4e1" xlink:to="loc_peak_MedicalOfficeHospitalMember_02c09148-5176-4360-89ee-bddf676a6c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_33701906-c20b-4c61-9cb8-e8bf7bfb6595" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_33701906-c20b-4c61-9cb8-e8bf7bfb6595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8db25416-27b5-46eb-afc9-3815b82bc534" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_33701906-c20b-4c61-9cb8-e8bf7bfb6595" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8db25416-27b5-46eb-afc9-3815b82bc534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_41d110c4-c13e-4ba2-99d1-99a1848d115e" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8db25416-27b5-46eb-afc9-3815b82bc534" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_41d110c4-c13e-4ba2-99d1-99a1848d115e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingTripleNetMember_ec3ab710-4cb2-4350-b13f-bfb6aebe62f6" xlink:href="peak-20220331.xsd#peak_SeniorHousingTripleNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_8db25416-27b5-46eb-afc9-3815b82bc534" xlink:to="loc_peak_SeniorHousingTripleNetMember_ec3ab710-4cb2-4350-b13f-bfb6aebe62f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_InvestmentTypeAxis_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_89e3d43d-58d5-4d7d-b41d-5366ea54a4a3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SunriseSeniorHousingPortfolioMember_010d802a-b8ae-4f02-86b9-2cd77705a9b7" xlink:href="peak-20220331.xsd#peak_SunriseSeniorHousingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_SunriseSeniorHousingPortfolioMember_010d802a-b8ae-4f02-86b9-2cd77705a9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleTripleNetPortfolioMember_afdff7d0-40d3-4115-ac2a-93bedb504d48" xlink:href="peak-20220331.xsd#peak_BrookdaleTripleNetPortfolioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_BrookdaleTripleNetPortfolioMember_afdff7d0-40d3-4115-ac2a-93bedb504d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HRATripleNetPortfolioMember_16cde378-4035-4458-9c5c-8416d86b265c" xlink:href="peak-20220331.xsd#peak_HRATripleNetPortfolioMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_HRATripleNetPortfolioMember_16cde378-4035-4458-9c5c-8416d86b265c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OakmontSHOPPortfolioMember_7f9e80e1-2260-48b1-aa7d-a38390d5f2cd" xlink:href="peak-20220331.xsd#peak_OakmontSHOPPortfolioMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_OakmontSHOPPortfolioMember_7f9e80e1-2260-48b1-aa7d-a38390d5f2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySHOPPortfolioMember_21fe6034-1223-4245-a125-11719f7d2632" xlink:href="peak-20220331.xsd#peak_DiscoverySHOPPortfolioMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_DiscoverySHOPPortfolioMember_21fe6034-1223-4245-a125-11719f7d2632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SonataSHOPPortfolioMember_e9729b22-68cb-416b-b977-c80d37b70dc3" xlink:href="peak-20220331.xsd#peak_SonataSHOPPortfolioMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_SonataSHOPPortfolioMember_e9729b22-68cb-416b-b977-c80d37b70dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SLCSHOPPortfolioMember_967036ff-2f1f-432c-b275-17e6dfc78851" xlink:href="peak-20220331.xsd#peak_SLCSHOPPortfolioMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_SLCSHOPPortfolioMember_967036ff-2f1f-432c-b275-17e6dfc78851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherDispositionsMember_adbba5f8-9674-4eab-8b69-cb309bb6f952" xlink:href="peak-20220331.xsd#peak_OtherDispositionsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c5564a95-5e4d-4d62-8b80-75811c4e3507" xlink:to="loc_peak_OtherDispositionsMember_adbba5f8-9674-4eab-8b69-cb309bb6f952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementsAxisAxis_a0c7725f-dc0e-460a-b491-e048b472369d" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementsAxisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_peak_DefinitiveAgreementsAxisAxis_a0c7725f-dc0e-460a-b491-e048b472369d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementsDomain_cb1620be-5539-4bf7-8b92-415d684ae721" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_DefinitiveAgreementsAxisAxis_a0c7725f-dc0e-460a-b491-e048b472369d" xlink:to="loc_peak_DefinitiveAgreementsDomain_cb1620be-5539-4bf7-8b92-415d684ae721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DefinitiveAgreementFourMember_8d1933fe-7094-44d4-ac29-36394196f76b" xlink:href="peak-20220331.xsd#peak_DefinitiveAgreementFourMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_DefinitiveAgreementsDomain_cb1620be-5539-4bf7-8b92-415d684ae721" xlink:to="loc_peak_DefinitiveAgreementFourMember_8d1933fe-7094-44d4-ac29-36394196f76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d3883972-5ad3-45f2-b275-0976a0cb91de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_srt_StatementGeographicalAxis_d3883972-5ad3-45f2-b275-0976a0cb91de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e343967a-5b11-437c-8d32-86df4e3142fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d3883972-5ad3-45f2-b275-0976a0cb91de" xlink:to="loc_srt_SegmentGeographicalDomain_e343967a-5b11-437c-8d32-86df4e3142fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_369a0586-c404-45be-8746-b46e50627714" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e343967a-5b11-437c-8d32-86df4e3142fd" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_369a0586-c404-45be-8746-b46e50627714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a85a22c9-8375-4770-92f3-2c4181c030d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a85a22c9-8375-4770-92f3-2c4181c030d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bb829a0c-b43c-45f2-a0be-db8b6c4a77b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a85a22c9-8375-4770-92f3-2c4181c030d1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bb829a0c-b43c-45f2-a0be-db8b6c4a77b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_e5d6cd27-d458-42e9-989b-f55b5853019c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bb829a0c-b43c-45f2-a0be-db8b6c4a77b7" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_e5d6cd27-d458-42e9-989b-f55b5853019c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_0c5299b3-efd4-489c-a593-5033509fba13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bb829a0c-b43c-45f2-a0be-db8b6c4a77b7" xlink:to="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_0c5299b3-efd4-489c-a593-5033509fba13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_5fc0f7b1-ab09-4f08-8848-439600145fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_5fc0f7b1-ab09-4f08-8848-439600145fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_7eccec78-b5e6-4e82-8d9a-23bbcacdb5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_5fc0f7b1-ab09-4f08-8848-439600145fbd" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_7eccec78-b5e6-4e82-8d9a-23bbcacdb5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_40ccebc0-38b9-45c1-b82d-52ebbaf7e76b" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_7eccec78-b5e6-4e82-8d9a-23bbcacdb5ff" xlink:to="loc_peak_MezzanineMember_40ccebc0-38b9-45c1-b82d-52ebbaf7e76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_489fe020-9597-4503-80ff-3372581276a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_489fe020-9597-4503-80ff-3372581276a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a640aacd-9a95-4311-b331-8d4014b948b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_489fe020-9597-4503-80ff-3372581276a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a640aacd-9a95-4311-b331-8d4014b948b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_a6236129-4624-4da2-a5ee-14a91735e564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a640aacd-9a95-4311-b331-8d4014b948b5" xlink:to="loc_us-gaap_SecuredDebtMember_a6236129-4624-4da2-a5ee-14a91735e564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_eb48e55e-ab84-43c0-aa5d-5cb578a45b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_eb48e55e-ab84-43c0-aa5d-5cb578a45b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_26ed6803-deea-45b1-91bb-3b5ee81d14af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb48e55e-ab84-43c0-aa5d-5cb578a45b28" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_26ed6803-deea-45b1-91bb-3b5ee81d14af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_31a08069-1981-4bd1-a25a-2277fea4a823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_26ed6803-deea-45b1-91bb-3b5ee81d14af" xlink:to="loc_us-gaap_SubsequentEventMember_31a08069-1981-4bd1-a25a-2277fea4a823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_50762fed-120f-41ae-8153-b09492e6093f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_50762fed-120f-41ae-8153-b09492e6093f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_d462f7ab-7175-4d16-9e97-21ba780da6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_50762fed-120f-41ae-8153-b09492e6093f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_d462f7ab-7175-4d16-9e97-21ba780da6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_c1eb08ee-0637-4ba7-86ae-ad4e5beeba75" xlink:href="peak-20220331.xsd#peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_d462f7ab-7175-4d16-9e97-21ba780da6d1" xlink:to="loc_peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember_c1eb08ee-0637-4ba7-86ae-ad4e5beeba75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_365f1cf6-8fa0-414e-81de-9c617aa824b5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesSold_e8fb8eda-18a5-4e4c-aa43-7c7eca28d88a" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NumberOfPropertiesSold_e8fb8eda-18a5-4e4c-aa43-7c7eca28d88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_1f52eeb9-f04f-4084-a16b-5805de7b8ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_1f52eeb9-f04f-4084-a16b-5805de7b8ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_f2a8a40e-c756-4dbd-b402-b54a68f5df58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_f2a8a40e-c756-4dbd-b402-b54a68f5df58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold_78e704ec-472f-49e4-a236-ff537442fa15" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NumberOfPropertiesToBeSold_78e704ec-472f-49e4-a236-ff537442fa15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables_f15bc1c9-9617-49a9-b9b6-c5f568a88c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_PaymentsToAcquireFinanceReceivables_f15bc1c9-9617-49a9-b9b6-c5f568a88c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountCommitted_5bbc71cc-8407-4419-8e54-bc85cbcdb2c9" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountCommitted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_CapitalExpenditureFundingAmountCommitted_5bbc71cc-8407-4419-8e54-bc85cbcdb2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountFunded_fd129c7b-2682-4922-a7c1-88bfa62af36b" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountFunded"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_CapitalExpenditureFundingAmountFunded_fd129c7b-2682-4922-a7c1-88bfa62af36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_50991ccd-1bd4-4698-ba8d-6996cd74266a" xlink:href="peak-20220331.xsd#peak_NumberOfAssetsClassifiedAsDiscontinuedOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_50991ccd-1bd4-4698-ba8d-6996cd74266a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_df12825b-4e47-40dc-ae87-b35b8b53e704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_df12825b-4e47-40dc-ae87-b35b8b53e704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DispositionOfPropertiesSoldNumber_9a0d7120-3798-4650-9d49-4513bbf1c0cf" xlink:href="peak-20220331.xsd#peak_DispositionOfPropertiesSoldNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_DispositionOfPropertiesSoldNumber_9a0d7120-3798-4650-9d49-4513bbf1c0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer_0de57620-7ff5-4a87-99bb-8cba130ed1b9" xlink:href="peak-20220331.xsd#peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer_0de57620-7ff5-4a87-99bb-8cba130ed1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold_5e9017d1-e25d-4c84-813a-ad1f7a83a021" xlink:href="peak-20220331.xsd#peak_NumberOfPreferredEquityMethodInvestmentsSold"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold_5e9017d1-e25d-4c84-813a-ad1f7a83a021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment_fd69dad3-bdfa-430c-a4f0-7532fab11d8a" xlink:href="peak-20220331.xsd#peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment_fd69dad3-bdfa-430c-a4f0-7532fab11d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_53d41baf-d41f-4c1a-a359-50f2f6f41655" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_53d41baf-d41f-4c1a-a359-50f2f6f41655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringExpense_57ae84f3-f243-44d6-9c35-c6f125b0e40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonrecurringExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45bddc4e-19a1-4b97-8af6-006b3879e8f8" xlink:to="loc_us-gaap_OtherNonrecurringExpense_57ae84f3-f243-44d6-9c35-c6f125b0e40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ac19b3d9-64ab-4144-b941-d54edbd61f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ac19b3d9-64ab-4144-b941-d54edbd61f20" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6f8d4dd6-aab8-42ae-8122-ba973e7242b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_709608b0-15ff-48cb-88a5-7ad0f7b4d8b6" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6f8d4dd6-aab8-42ae-8122-ba973e7242b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_479bae6c-5dd4-486d-8f25-21d5744ff66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6f8d4dd6-aab8-42ae-8122-ba973e7242b5" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_479bae6c-5dd4-486d-8f25-21d5744ff66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_def6223d-8108-41eb-89f6-d22b6109afcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7f3b3712-5af5-4eb6-aa71-3d7c14f32fb3" xlink:to="loc_us-gaap_SegmentDomain_def6223d-8108-41eb-89f6-d22b6109afcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_f6c9ce19-543c-4cae-aa3e-47b0b9d0221f" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_def6223d-8108-41eb-89f6-d22b6109afcc" xlink:to="loc_peak_MedicalOfficeMember_f6c9ce19-543c-4cae-aa3e-47b0b9d0221f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_89bc8bf7-c84b-419e-b0b0-817a70003775" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_def6223d-8108-41eb-89f6-d22b6109afcc" xlink:to="loc_peak_LifeScienceMember_89bc8bf7-c84b-419e-b0b0-817a70003775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a907047b-8ebb-46d8-b2ab-159ed2a6530a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_51b7cb14-d8e9-41aa-bfab-0ba50b82dbdc" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet_51b7cb14-d8e9-41aa-bfab-0ba50b82dbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_f7c06e4e-a8fb-4e5c-a446-4c12d6fd6e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_f7c06e4e-a8fb-4e5c-a446-4c12d6fd6e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_9700fdf7-b9d5-4712-83bc-d9b551a3f5b8" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset_9700fdf7-b9d5-4712-83bc-d9b551a3f5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_eb728611-af39-4714-aca5-8ef276d6aafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_eb728611-af39-4714-aca5-8ef276d6aafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fa8ffd68-79f7-4dd2-8f08-292ee365b2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fa8ffd68-79f7-4dd2-8f08-292ee365b2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_80e19c64-825f-4cd2-9a83-ea5f16d536f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup_80e19c64-825f-4cd2-9a83-ea5f16d536f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_be3343cb-f8dd-4ce5-84b2-d7325f465d6b" xlink:href="peak-20220331.xsd#peak_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90689fcd-75e2-4e53-a348-b3600ba9bad4" xlink:to="loc_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet_be3343cb-f8dd-4ce5-84b2-d7325f465d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_0c5f7c2e-f5cf-4a9d-9fe5-c47f84741b02" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability_0c5f7c2e-f5cf-4a9d-9fe5-c47f84741b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_4156b86d-2420-4fd4-a38b-cbeb338a8153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_4156b86d-2420-4fd4-a38b-cbeb338a8153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_a03cdd0b-3c36-43ec-bb05-76cd754d4a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_a03cdd0b-3c36-43ec-bb05-76cd754d4a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f769400f-e587-4486-bbc2-8dd3f9780cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f769400f-e587-4486-bbc2-8dd3f9780cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_7fcb5bd6-0c0e-4e45-a23c-8ae862d3c35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale_7fcb5bd6-0c0e-4e45-a23c-8ae862d3c35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_3ab83c40-80cf-431f-a9db-4e05b08e5650" xlink:href="peak-20220331.xsd#peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_c8c41fab-2e6d-48b7-9efe-aaa07f698239" xlink:to="loc_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet_3ab83c40-80cf-431f-a9db-4e05b08e5650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable_932cc8e5-a3a8-444a-81ef-e183a832e786" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable_932cc8e5-a3a8-444a-81ef-e183a832e786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesHeldForSaleNumber_6391dd5e-aeb6-4daf-b09f-ea8bcbcc8aad" xlink:href="peak-20220331.xsd#peak_PropertiesHeldForSaleNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_peak_PropertiesHeldForSaleNumber_6391dd5e-aeb6-4daf-b09f-ea8bcbcc8aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetRealEstateAssets_408e2060-8bbc-4453-825d-13e62bf08802" xlink:href="peak-20220331.xsd#peak_NetRealEstateAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_peak_NetRealEstateAssets_408e2060-8bbc-4453-825d-13e62bf08802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_05e1a2e3-1ef8-462a-a657-c67967f350db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_05e1a2e3-1ef8-462a-a657-c67967f350db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_bc6a7c5d-8fba-4121-ab5e-129c93b3b93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f841f11e-d60c-4dc5-ba2d-2163244f23d1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_bc6a7c5d-8fba-4121-ab5e-129c93b3b93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_63e31821-6e9b-4ffd-9ba0-cf2123e9303b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b3c19c59-01c3-4e69-8b60-21ed83ae1794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_63e31821-6e9b-4ffd-9ba0-cf2123e9303b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b3c19c59-01c3-4e69-8b60-21ed83ae1794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5ba55929-bb0e-4139-8e54-aed22e9bfd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b3c19c59-01c3-4e69-8b60-21ed83ae1794" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5ba55929-bb0e-4139-8e54-aed22e9bfd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_84be5c9c-470e-40bf-8160-d9017a3b4121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5ba55929-bb0e-4139-8e54-aed22e9bfd2b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_84be5c9c-470e-40bf-8160-d9017a3b4121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_923a8396-4388-436e-9b95-53547c2ddc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_84be5c9c-470e-40bf-8160-d9017a3b4121" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_923a8396-4388-436e-9b95-53547c2ddc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b3c19c59-01c3-4e69-8b60-21ed83ae1794" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome_50a6c0c8-0468-432b-82eb-ebef94f59933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome_50a6c0c8-0468-432b-82eb-ebef94f59933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_d2067d46-d857-4131-aa59-783efcfae40d" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices_d2067d46-d857-4131-aa59-783efcfae40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_05a1e5ac-7d04-4607-a389-79eecae930ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_05a1e5ac-7d04-4607-a389-79eecae930ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_8f3fa2d9-1825-4771-be3c-1103070a568f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_8f3fa2d9-1825-4771-be3c-1103070a568f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_dbbc6e91-b052-42cc-8a1f-4027ee6f44ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_dbbc6e91-b052-42cc-8a1f-4027ee6f44ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_2f7f3624-ac10-44dd-b14b-3ada8c681a9a" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_2f7f3624-ac10-44dd-b14b-3ada8c681a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_3a3206a3-1044-496f-ac9b-1b92cce65224" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses_3a3206a3-1044-496f-ac9b-1b92cce65224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_04e40fc2-f031-4a93-a3ef-0f91a086ede2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_04e40fc2-f031-4a93-a3ef-0f91a086ede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_ed8a7f17-f48f-486f-ad07-762aba4ed2a4" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_ed8a7f17-f48f-486f-ad07-762aba4ed2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_59909a38-5b7a-4055-ad07-3a2770ed4af1" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense_59909a38-5b7a-4055-ad07-3a2770ed4af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_86159515-81a3-452d-ac7e-2b9f6b437d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_86159515-81a3-452d-ac7e-2b9f6b437d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_bb9e97f8-4453-4cc6-bc45-dc357fe50b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_bb9e97f8-4453-4cc6-bc45-dc357fe50b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5c2c6a6-4c28-4d47-9b14-1be78631cf2b" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5c2c6a6-4c28-4d47-9b14-1be78631cf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_7abb48e3-34f1-4855-912d-d98513adc67a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_9c9623d2-6ddd-4dda-b974-1e7e31efb93c" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_7abb48e3-34f1-4855-912d-d98513adc67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/Leases" xlink:type="simple" xlink:href="peak-20220331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1099ca52-d69e-4db6-b9f9-d2d8fd5f40cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_8c6cedd3-96fb-4e1a-84c4-2338323d899e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1099ca52-d69e-4db6-b9f9-d2d8fd5f40cb" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_8c6cedd3-96fb-4e1a-84c4-2338323d899e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_34cd6ab8-fcee-45f5-ba79-9dc6f5b9054e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1099ca52-d69e-4db6-b9f9-d2d8fd5f40cb" xlink:to="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_34cd6ab8-fcee-45f5-ba79-9dc6f5b9054e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesTables" xlink:type="simple" xlink:href="peak-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a07e0589-2f77-4b06-99d1-da30e6159eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock_e206b8ef-de5b-4648-bf82-ae48434e6cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a07e0589-2f77-4b06-99d1-da30e6159eff" xlink:to="loc_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock_e206b8ef-de5b-4648-bf82-ae48434e6cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock_81ed0ffa-ba1b-4498-8ed9-4baff98c0718" xlink:href="peak-20220331.xsd#peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a07e0589-2f77-4b06-99d1-da30e6159eff" xlink:to="loc_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock_81ed0ffa-ba1b-4498-8ed9-4baff98c0718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesLeaseIncomeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LeasesLeaseIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LeasesLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_16d3f7df-4578-448d-a488-0445cb974943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncomeAbstract_f0417828-31a6-4509-9c0f-1ca7337e29e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndOtherIncomeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_16d3f7df-4578-448d-a488-0445cb974943" xlink:to="loc_us-gaap_InterestAndOtherIncomeAbstract_f0417828-31a6-4509-9c0f-1ca7337e29e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_3a490951-a8d0-4b67-8571-a05a4083d79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestAndOtherIncomeAbstract_f0417828-31a6-4509-9c0f-1ca7337e29e9" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_3a490951-a8d0-4b67-8571-a05a4083d79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseVariableLeaseIncome_d1ebd711-020a-42b5-a636-e5b6a3f3d5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseVariableLeaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestAndOtherIncomeAbstract_f0417828-31a6-4509-9c0f-1ca7337e29e9" xlink:to="loc_us-gaap_OperatingLeaseVariableLeaseIncome_d1ebd711-020a-42b5-a636-e5b6a3f3d5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseInterestIncome_692fc3bb-f261-43cd-8cd2-11774cae162b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseInterestIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestAndOtherIncomeAbstract_f0417828-31a6-4509-9c0f-1ca7337e29e9" xlink:to="loc_us-gaap_DirectFinancingLeaseInterestIncome_692fc3bb-f261-43cd-8cd2-11774cae162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_616cdaa8-3b38-408f-9f2c-2d6760c9544b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables_59bbfdbb-8036-4cf6-baa3-f53f2bf0eaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLeaseReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_616cdaa8-3b38-408f-9f2c-2d6760c9544b" xlink:to="loc_us-gaap_ProceedsFromSaleOfLeaseReceivables_59bbfdbb-8036-4cf6-baa3-f53f2bf0eaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfNotesReceivable_6710065f-643a-49a4-bdbb-afb62951ab68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfNotesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_616cdaa8-3b38-408f-9f2c-2d6760c9544b" xlink:to="loc_us-gaap_GainLossOnSaleOfNotesReceivable_6710065f-643a-49a4-bdbb-afb62951ab68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LeasesDirectFinancingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_93ef8aae-f866-4b32-8795-05c3d89d00f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseLeaseReceivable_49b6c9c5-66d0-4e2e-8edf-ba28d5c45f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseLeaseReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93ef8aae-f866-4b32-8795-05c3d89d00f9" xlink:to="loc_us-gaap_DirectFinancingLeaseLeaseReceivable_49b6c9c5-66d0-4e2e-8edf-ba28d5c45f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset_534cb343-8d73-448c-8d3e-d71c0de1bf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93ef8aae-f866-4b32-8795-05c3d89d00f9" xlink:to="loc_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset_534cb343-8d73-448c-8d3e-d71c0de1bf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseDeferredSellingProfit_b583c19a-2804-40e8-ba7d-e7ae54022577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseDeferredSellingProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93ef8aae-f866-4b32-8795-05c3d89d00f9" xlink:to="loc_us-gaap_DirectFinancingLeaseDeferredSellingProfit_b583c19a-2804-40e8-ba7d-e7ae54022577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectFinancingLeaseNetInvestmentInLease_68f4626f-53d9-4f70-97d6-198f00e6504f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectFinancingLeaseNetInvestmentInLease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93ef8aae-f866-4b32-8795-05c3d89d00f9" xlink:to="loc_us-gaap_DirectFinancingLeaseNetInvestmentInLease_68f4626f-53d9-4f70-97d6-198f00e6504f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_PropertiesWithDirectFinancingLeasesNumber_c3b731bf-1046-4fd4-be59-6cf3d9d82bf9" xlink:href="peak-20220331.xsd#peak_PropertiesWithDirectFinancingLeasesNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93ef8aae-f866-4b32-8795-05c3d89d00f9" xlink:to="loc_peak_PropertiesWithDirectFinancingLeasesNumber_c3b731bf-1046-4fd4-be59-6cf3d9d82bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivable" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivable"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_c1970b2a-d422-4ed6-9c75-1cc4d059157c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_0fffcc0b-3903-4f0b-a109-d1d33782d695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_c1970b2a-d422-4ed6-9c75-1cc4d059157c" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_0fffcc0b-3903-4f0b-a109-d1d33782d695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableTables" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_19b47b79-ff50-4b6c-9886-a0c8a7a965fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4ce1f8c4-b448-46de-9aac-b2e0775bc775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_19b47b79-ff50-4b6c-9886-a0c8a7a965fb" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4ce1f8c4-b448-46de-9aac-b2e0775bc775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_39a650a9-56a6-4bc0-968f-2a44980bfd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_19b47b79-ff50-4b6c-9886-a0c8a7a965fb" xlink:to="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_39a650a9-56a6-4bc0-968f-2a44980bfd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_13b4351a-9e6c-405b-a6fd-c48a58fd6a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_19b47b79-ff50-4b6c-9886-a0c8a7a965fb" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_13b4351a-9e6c-405b-a6fd-c48a58fd6a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableScheduleofLoansReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_52883cda-13ed-487c-8102-fdb8d1d0bdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_937399ff-dcce-4986-9ecf-9fa2af035347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_52883cda-13ed-487c-8102-fdb8d1d0bdd4" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_937399ff-dcce-4986-9ecf-9fa2af035347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_919df305-c643-460f-b2e7-9b55ee9db222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_937399ff-dcce-4986-9ecf-9fa2af035347" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_919df305-c643-460f-b2e7-9b55ee9db222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_a0b3a842-3055-4251-b10e-2e3ad8feaaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_919df305-c643-460f-b2e7-9b55ee9db222" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_a0b3a842-3055-4251-b10e-2e3ad8feaaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_779596f4-848c-46b0-8c38-f7b93b03efa0" xlink:href="peak-20220331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_a0b3a842-3055-4251-b10e-2e3ad8feaaa4" xlink:to="loc_peak_SecuredMortgageLoansMember_779596f4-848c-46b0-8c38-f7b93b03efa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineAndOtherMember_2b473ef5-bb87-408d-af4d-eb7bae0ef4c8" xlink:href="peak-20220331.xsd#peak_MezzanineAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_a0b3a842-3055-4251-b10e-2e3ad8feaaa4" xlink:to="loc_peak_MezzanineAndOtherMember_2b473ef5-bb87-408d-af4d-eb7bae0ef4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_937399ff-dcce-4986-9ecf-9fa2af035347" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_7c53a806-3ec9-4285-b810-98409444e5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_7c53a806-3ec9-4285-b810-98409444e5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_de869085-608d-4154-82e7-b5173fa35db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount_de869085-608d-4154-82e7-b5173fa35db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_a54496ec-e54e-4aae-ae3a-d8738378c73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_a54496ec-e54e-4aae-ae3a-d8738378c73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_3a3900d7-b3a5-4039-a299-2d88764440f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_3a3900d7-b3a5-4039-a299-2d88764440f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableRemainingCommitments_152c06c4-e589-4900-b07f-b40476995d56" xlink:href="peak-20220331.xsd#peak_FinancingReceivableRemainingCommitments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_13365b81-e746-42db-8a90-fb6b6ba8ff07" xlink:to="loc_peak_FinancingReceivableRemainingCommitments_152c06c4-e589-4900-b07f-b40476995d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_a53cb323-e995-4687-84db-770c5d9a3c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_a53cb323-e995-4687-84db-770c5d9a3c3a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2d2cc760-5f8e-469f-826f-789a62cbaa2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2d2cc760-5f8e-469f-826f-789a62cbaa2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_baa49a75-d6fb-4052-8199-3eab0d68b33b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2d2cc760-5f8e-469f-826f-789a62cbaa2b" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_baa49a75-d6fb-4052-8199-3eab0d68b33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_a662e1d8-d971-4fe6-a8b5-ee86345c6f66" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_baa49a75-d6fb-4052-8199-3eab0d68b33b" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_a662e1d8-d971-4fe6-a8b5-ee86345c6f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRVJVInvestmentMember_82184aa5-7f56-4f59-b4e5-0242df2be083" xlink:href="peak-20220331.xsd#peak_CCRVJVInvestmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_baa49a75-d6fb-4052-8199-3eab0d68b33b" xlink:to="loc_peak_CCRVJVInvestmentMember_82184aa5-7f56-4f59-b4e5-0242df2be083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorPropertyClassAxis_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorPropertyClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_MajorPropertyClassAxis_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorPropertyClassDomain_8bfe18ad-0c5e-4268-86d1-3e8ce69c66af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MajorPropertyClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorPropertyClassAxis_ea47b3d3-2fe0-47c0-ae45-657a2dd7b71e" xlink:to="loc_us-gaap_MajorPropertyClassDomain_8bfe18ad-0c5e-4268-86d1-3e8ce69c66af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LessorAssetUnderOperatingLeaseMember_92d93683-7621-4f55-ab3e-5d8c0f79dd9e" xlink:href="peak-20220331.xsd#peak_LessorAssetUnderOperatingLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorPropertyClassDomain_8bfe18ad-0c5e-4268-86d1-3e8ce69c66af" xlink:to="loc_peak_LessorAssetUnderOperatingLeaseMember_92d93683-7621-4f55-ab3e-5d8c0f79dd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_031433a1-a662-402d-9455-dfae444d0bd8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_srt_CounterpartyNameAxis_031433a1-a662-402d-9455-dfae444d0bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a35b7ad-30cb-46c7-9898-1753fd54cf8a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_031433a1-a662-402d-9455-dfae444d0bd8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a35b7ad-30cb-46c7-9898-1753fd54cf8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember_9792fe45-ba68-4fc3-9b1e-d769b99379c8" xlink:href="peak-20220331.xsd#peak_BrookdaleMTCAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a35b7ad-30cb-46c7-9898-1753fd54cf8a" xlink:to="loc_peak_BrookdaleMTCAMember_9792fe45-ba68-4fc3-9b1e-d769b99379c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c7c4a221-cca7-43d4-a981-d8539d4c3f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c7c4a221-cca7-43d4-a981-d8539d4c3f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c7c4a221-cca7-43d4-a981-d8539d4c3f34" xlink:to="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_c878e224-9756-4e13-9e6b-82257ae6e4e9" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_c878e224-9756-4e13-9e6b-82257ae6e4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_c254eda1-15fb-4688-aa2d-356afd746e62" xlink:href="peak-20220331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:to="loc_peak_SecuredMortgageLoansMember_c254eda1-15fb-4688-aa2d-356afd746e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_96442c96-eee6-49fe-b766-b43cf7de9890" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:to="loc_peak_MezzanineMember_96442c96-eee6-49fe-b766-b43cf7de9890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_c127e62c-5d13-4e78-805c-52664215546a" xlink:href="peak-20220331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_85f88d81-d678-4cf3-bbb4-7000369ff9b6" xlink:to="loc_peak_OtherNonReportingSegmentMember_c127e62c-5d13-4e78-805c-52664215546a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_611a40ad-a38a-4250-9df8-29ab32b2cbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_611a40ad-a38a-4250-9df8-29ab32b2cbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_41491ad2-f610-4248-85ec-27085eb13dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_611a40ad-a38a-4250-9df8-29ab32b2cbe0" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_41491ad2-f610-4248-85ec-27085eb13dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SecuredMortgageLoansMember_6b2728c6-ea0d-498f-9054-353f0d49cf74" xlink:href="peak-20220331.xsd#peak_SecuredMortgageLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_41491ad2-f610-4248-85ec-27085eb13dfd" xlink:to="loc_peak_SecuredMortgageLoansMember_6b2728c6-ea0d-498f-9054-353f0d49cf74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_3b5cfebe-95e7-4448-bf2f-0ab127696825" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_41491ad2-f610-4248-85ec-27085eb13dfd" xlink:to="loc_peak_MezzanineMember_3b5cfebe-95e7-4448-bf2f-0ab127696825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c132f4e1-e667-4d52-8ccd-bf1ceeb10083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_InvestmentTypeAxis_c132f4e1-e667-4d52-8ccd-bf1ceeb10083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_73e9a7d4-f49f-4a28-a235-6cbd93d3d550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_c132f4e1-e667-4d52-8ccd-bf1ceeb10083" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_73e9a7d4-f49f-4a28-a235-6cbd93d3d550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SunriseSeniorHousingPortfolioMember_4ce08d02-0641-415c-ab66-0f1e7d52e4ab" xlink:href="peak-20220331.xsd#peak_SunriseSeniorHousingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e9a7d4-f49f-4a28-a235-6cbd93d3d550" xlink:to="loc_peak_SunriseSeniorHousingPortfolioMember_4ce08d02-0641-415c-ab66-0f1e7d52e4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySHOPPortfolioMember_cedd6522-0d73-410b-8794-07ab461c4c36" xlink:href="peak-20220331.xsd#peak_DiscoverySHOPPortfolioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_73e9a7d4-f49f-4a28-a235-6cbd93d3d550" xlink:to="loc_peak_DiscoverySHOPPortfolioMember_cedd6522-0d73-410b-8794-07ab461c4c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_78484657-d28d-4fe0-aaa9-ac41b34eca6a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_srt_StatementGeographicalAxis_78484657-d28d-4fe0-aaa9-ac41b34eca6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c2986343-e169-41de-b13f-66f56de446c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_78484657-d28d-4fe0-aaa9-ac41b34eca6a" xlink:to="loc_srt_SegmentGeographicalDomain_c2986343-e169-41de-b13f-66f56de446c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_c2353586-4bd2-479f-b2cc-42fae7c5d342" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c2986343-e169-41de-b13f-66f56de446c4" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_c2353586-4bd2-479f-b2cc-42fae7c5d342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_srt_RangeAxis_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2ec405c-e974-4a13-81c9-1fc02cb9b9c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dfdc972b-c3d6-4120-abff-dc35f3aaf4c6" xlink:to="loc_srt_RangeMember_d2ec405c-e974-4a13-81c9-1fc02cb9b9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6954ec68-e866-4e8e-9132-532b093b40f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d2ec405c-e974-4a13-81c9-1fc02cb9b9c5" xlink:to="loc_srt_MinimumMember_6954ec68-e866-4e8e-9132-532b093b40f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d01a839-ba13-4e74-b81c-57bd40b5a31e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d2ec405c-e974-4a13-81c9-1fc02cb9b9c5" xlink:to="loc_srt_MaximumMember_5d01a839-ba13-4e74-b81c-57bd40b5a31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_311fae82-d024-47d5-b328-9ce16c5a4ef7" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold_a5612fd5-7201-425b-8b18-6de78c45ca12" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_NumberOfPropertiesToBeSold_a5612fd5-7201-425b-8b18-6de78c45ca12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_f3edd429-a8bb-4fe9-830c-9eccaddb4c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_f3edd429-a8bb-4fe9-830c-9eccaddb4c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a2265967-451f-46e9-8674-182477d0bc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a2265967-451f-46e9-8674-182477d0bc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountCommitted_e047712e-2253-4375-b499-4d45c1058aa6" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountCommitted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_CapitalExpenditureFundingAmountCommitted_e047712e-2253-4375-b499-4d45c1058aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_b341c581-60c4-4822-9cc2-a3d4ad282d39" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted_b341c581-60c4-4822-9cc2-a3d4ad282d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CapitalExpenditureFundingAmountFunded_9549b3df-dbd9-4b09-a01e-6b1214c011fb" xlink:href="peak-20220331.xsd#peak_CapitalExpenditureFundingAmountFunded"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_CapitalExpenditureFundingAmountFunded_9549b3df-dbd9-4b09-a01e-6b1214c011fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_8a7de6e6-fd60-471f-9f4d-ee81798bac98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLoansReceivable_8a7de6e6-fd60-471f-9f4d-ee81798bac98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_9d04cb76-f117-445d-9537-07a0187abb21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_9d04cb76-f117-445d-9537-07a0187abb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableStatedInterestRate_2f7a5fb9-bd5a-4c56-b1a8-645af76163ec" xlink:href="peak-20220331.xsd#peak_LoansReceivableStatedInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_LoansReceivableStatedInterestRate_2f7a5fb9-bd5a-4c56-b1a8-645af76163ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableMarketRate_d1773120-2922-4b9d-9a69-79d5c15cb433" xlink:href="peak-20220331.xsd#peak_LoansReceivableMarketRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_LoansReceivableMarketRate_d1773120-2922-4b9d-9a69-79d5c15cb433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LoansReceivableInterestIncomeAmortizationPeriod_eef8d351-20b1-45e0-b827-6514c615563a" xlink:href="peak-20220331.xsd#peak_LoansReceivableInterestIncomeAmortizationPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_LoansReceivableInterestIncomeAmortizationPeriod_eef8d351-20b1-45e0-b827-6514c615563a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncashOrPartNoncashInterestIncome_cddf4eac-2850-497a-9188-0caa0a4caa92" xlink:href="peak-20220331.xsd#peak_NoncashOrPartNoncashInterestIncome"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_NoncashOrPartNoncashInterestIncome_cddf4eac-2850-497a-9188-0caa0a4caa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableHeldForSaleNumberOfContracts_b84f175e-bec8-4d72-9fe4-82003ae13f3d" xlink:href="peak-20220331.xsd#peak_FinancingReceivableHeldForSaleNumberOfContracts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_FinancingReceivableHeldForSaleNumberOfContracts_b84f175e-bec8-4d72-9fe4-82003ae13f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbd7f79c-6a81-4ee0-ac7f-463d9c863785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_dbd7f79c-6a81-4ee0-ac7f-463d9c863785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinanceReceivables_d123cba9-4610-4a55-89e9-67d86aca6c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFinanceReceivables"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_IncreaseDecreaseInFinanceReceivables_d123cba9-4610-4a55-89e9-67d86aca6c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_a2c64a5f-1076-4b3d-99e0-f049ae780499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_a2c64a5f-1076-4b3d-99e0-f049ae780499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_20f617cf-74cb-4abd-8e6c-fdab735cb86a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_20f617cf-74cb-4abd-8e6c-fdab735cb86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableNumberOfContractsSold_558781d7-155d-4885-bc27-ccbcf8a5428e" xlink:href="peak-20220331.xsd#peak_FinancingReceivableNumberOfContractsSold"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_FinancingReceivableNumberOfContractsSold_558781d7-155d-4885-bc27-ccbcf8a5428e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfFinanceReceivables_0c2dab91-8fbc-46a2-af06-c574631b7248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfFinanceReceivables"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ProceedsFromSaleOfFinanceReceivables_0c2dab91-8fbc-46a2-af06-c574631b7248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfNotesReceivable_96c42e06-66fc-4587-aaf6-d198e1d28611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfNotesReceivable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_GainLossOnSaleOfNotesReceivable_96c42e06-66fc-4587-aaf6-d198e1d28611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_592b366b-9844-451c-b2a3-e8df6cdd8ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_592b366b-9844-451c-b2a3-e8df6cdd8ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableNumberOfContracts_3b8cbf6f-999a-4142-a20f-8eb18bdf8257" xlink:href="peak-20220331.xsd#peak_FinancingReceivableNumberOfContracts"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_FinancingReceivableNumberOfContracts_3b8cbf6f-999a-4142-a20f-8eb18bdf8257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments_5ff5abf1-9d49-4fa7-a7a8-c3f68f8584ca" xlink:href="peak-20220331.xsd#peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_bfe49541-6d26-444b-bdaa-9ef0e5f9a9cc" xlink:to="loc_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments_5ff5abf1-9d49-4fa7-a7a8-c3f68f8584ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_7fd263af-0ea5-48a2-802e-4e1c3a36ccff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_7fd263af-0ea5-48a2-802e-4e1c3a36ccff" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_3906f1eb-c8b9-4703-b399-dba95525364d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentPerformanceStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_3906f1eb-c8b9-4703-b399-dba95525364d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentPerformanceStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusAxis_3906f1eb-c8b9-4703-b399-dba95525364d" xlink:to="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformingFinancingReceivableMember_8d4337af-dcc6-4697-b27d-aebf7b1c4f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformingFinancingReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:to="loc_us-gaap_PerformingFinancingReceivableMember_8d4337af-dcc6-4697-b27d-aebf7b1c4f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WatchListFinancingReceivableMember_a099e483-576c-4f67-8171-81a8ef4985a1" xlink:href="peak-20220331.xsd#peak_WatchListFinancingReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:to="loc_peak_WatchListFinancingReceivableMember_a099e483-576c-4f67-8171-81a8ef4985a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_WorkoutFinancingReceivableMember_7c5943a5-701d-42fc-9f10-7bad8c1a0cb0" xlink:href="peak-20220331.xsd#peak_WorkoutFinancingReceivableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentPerformanceStatusDomain_b056179f-7bb6-4672-bbb0-d59aff698561" xlink:to="loc_peak_WorkoutFinancingReceivableMember_7c5943a5-701d-42fc-9f10-7bad8c1a0cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e89b3579-11f3-417e-a34a-3a1785c65ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e89b3579-11f3-417e-a34a-3a1785c65ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_094fdd66-c9e5-4c50-8b14-c8bff67d8458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e89b3579-11f3-417e-a34a-3a1785c65ad7" xlink:to="loc_us-gaap_ReceivableTypeDomain_094fdd66-c9e5-4c50-8b14-c8bff67d8458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageReceivablesMember_63ad5038-c747-44b1-bb7a-501c5effc421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_094fdd66-c9e5-4c50-8b14-c8bff67d8458" xlink:to="loc_us-gaap_MortgageReceivablesMember_63ad5038-c747-44b1-bb7a-501c5effc421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineAndOtherLoansReceivableSecuredMember_3123b449-b9c0-4c71-9bfc-f67e07b4f696" xlink:href="peak-20220331.xsd#peak_MezzanineAndOtherLoansReceivableSecuredMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_094fdd66-c9e5-4c50-8b14-c8bff67d8458" xlink:to="loc_peak_MezzanineAndOtherLoansReceivableSecuredMember_3123b449-b9c0-4c71-9bfc-f67e07b4f696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b9d61433-cb54-4c27-a29c-b1a9ff00b441" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_438ea3ba-0d3a-4fcf-9ba8-85c9ff27973f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear_438ea3ba-0d3a-4fcf-9ba8-85c9ff27973f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_4b54eb8e-6f4a-45c4-ac8d-fd34d4ccce32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear_4b54eb8e-6f4a-45c4-ac8d-fd34d4ccce32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_20364beb-8a5a-46a6-8b49-2333e39b3cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear_20364beb-8a5a-46a6-8b49-2333e39b3cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_c92b23bd-4df8-47e1-a4fd-1dc55cc5f547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear_c92b23bd-4df8-47e1-a4fd-1dc55cc5f547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_e01ecc34-5e88-48ef-bf49-bc1fa84143f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear_e01ecc34-5e88-48ef-bf49-bc1fa84143f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_377a9ace-3555-43cb-acb5-2124c1b6adfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear_377a9ace-3555-43cb-acb5-2124c1b6adfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_9702ff5c-506e-4134-b2da-e2275db1c9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8510d968-f25c-4d60-a70c-40ab9fec98a2" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_9702ff5c-506e-4134-b2da-e2275db1c9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#LoansReceivableScheduleofReserveforLoanLossesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_6d9cab6d-faae-42e0-ad87-60a842f32eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_64df9f9c-0e26-4536-8ef4-795a6189e174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_6d9cab6d-faae-42e0-ad87-60a842f32eb6" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_64df9f9c-0e26-4536-8ef4-795a6189e174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_fab83089-93af-4a2f-92a6-24c0d75327f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_64df9f9c-0e26-4536-8ef4-795a6189e174" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_fab83089-93af-4a2f-92a6-24c0d75327f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f34a76e6-b954-4327-bb8d-afb1930629e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis_fab83089-93af-4a2f-92a6-24c0d75327f5" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f34a76e6-b954-4327-bb8d-afb1930629e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MezzanineMember_1f50b27b-d6f8-4c19-bcd9-fb7dc6c3b060" xlink:href="peak-20220331.xsd#peak_MezzanineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f34a76e6-b954-4327-bb8d-afb1930629e9" xlink:to="loc_peak_MezzanineMember_1f50b27b-d6f8-4c19-bcd9-fb7dc6c3b060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingDevelopmentLoansAndOtherMember_0d0b93b9-4259-48ea-860f-6edf1eab3014" xlink:href="peak-20220331.xsd#peak_ParticipatingDevelopmentLoansAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain_f34a76e6-b954-4327-bb8d-afb1930629e9" xlink:to="loc_peak_ParticipatingDevelopmentLoansAndOtherMember_0d0b93b9-4259-48ea-860f-6edf1eab3014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_4dc699f1-496b-4810-9435-8b3c5c1598c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable_64df9f9c-0e26-4536-8ef4-795a6189e174" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_4dc699f1-496b-4810-9435-8b3c5c1598c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_4dc699f1-496b-4810-9435-8b3c5c1598c1" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_717445c7-e453-4809-bc22-872ba6e782f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_717445c7-e453-4809-bc22-872ba6e782f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed_75778147-0c1d-405f-b841-75cddd7cf714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:to="loc_us-gaap_ProvisionForLoanLossesExpensed_75778147-0c1d-405f-b841-75cddd7cf714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableSignificantSales_2eab2cc3-b9c4-46d2-a3ec-deacd5580702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableSignificantSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:to="loc_us-gaap_FinancingReceivableSignificantSales_2eab2cc3-b9c4-46d2-a3ec-deacd5580702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_58dac112-4376-4c0b-8b01-ad21a5ca71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_433fa818-94f8-4cab-8281-67a909488d41" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_58dac112-4376-4c0b-8b01-ad21a5ca71e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FinancingReceivableNumberOfContractsSold_4cbc9d75-afb0-481e-ad17-de4369490c17" xlink:href="peak-20220331.xsd#peak_FinancingReceivableNumberOfContractsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems_4dc699f1-496b-4810-9435-8b3c5c1598c1" xlink:to="loc_peak_FinancingReceivableNumberOfContractsSold_4cbc9d75-afb0-481e-ad17-de4369490c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures" xlink:type="simple" xlink:href="peak-20220331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVentures"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_fb9aa74d-fb3e-4e72-9ec7-839a9033c03e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_56558743-3bfe-40ae-948a-8779bd027778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_fb9aa74d-fb3e-4e72-9ec7-839a9033c03e" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_56558743-3bfe-40ae-948a-8779bd027778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables" xlink:type="simple" xlink:href="peak-20220331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_dc4a2918-3c29-44f9-a46f-4fb588c65ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_6669e042-6ef5-4f6e-9b9b-fe4ac7ace747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_dc4a2918-3c29-44f9-a46f-4fb588c65ee9" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_6669e042-6ef5-4f6e-9b9b-fe4ac7ace747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6e344aac-9635-425a-b51b-f43bc7ca457c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_6e344aac-9635-425a-b51b-f43bc7ca457c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fc541a85-279c-4982-b775-0f27fdc4b8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fc541a85-279c-4982-b775-0f27fdc4b8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fc541a85-279c-4982-b775-0f27fdc4b8bd" xlink:to="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_61c03d62-88ba-4c44-8caf-f4f9ae97b112" xlink:href="peak-20220331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:to="loc_peak_OtherNonReportingSegmentMember_61c03d62-88ba-4c44-8caf-f4f9ae97b112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_93691e89-0221-4c35-9b18-b2ce84899393" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:to="loc_peak_LifeScienceMember_93691e89-0221-4c35-9b18-b2ce84899393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_c1856f84-cd01-4df8-887c-62db2a79d3d7" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:to="loc_peak_MedicalOfficeMember_c1856f84-cd01-4df8-887c-62db2a79d3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorHousingOperatingPortfolioMember_3a766fa0-c130-4076-9217-78486de65230" xlink:href="peak-20220331.xsd#peak_SeniorHousingOperatingPortfolioMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_402eebfb-b787-467c-8e45-d3c85aba91be" xlink:to="loc_peak_SeniorHousingOperatingPortfolioMember_3a766fa0-c130-4076-9217-78486de65230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9c5e1a38-97b6-47b0-9140-d005d28bc61c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_srt_CounterpartyNameAxis_9c5e1a38-97b6-47b0-9140-d005d28bc61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5817f0a1-195e-48a7-9c0e-7dd4d9801009" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9c5e1a38-97b6-47b0-9140-d005d28bc61c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5817f0a1-195e-48a7-9c0e-7dd4d9801009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember_531399b2-e399-414f-aae2-94644a2935c8" xlink:href="peak-20220331.xsd#peak_BrookdaleMTCAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5817f0a1-195e-48a7-9c0e-7dd4d9801009" xlink:to="loc_peak_BrookdaleMTCAMember_531399b2-e399-414f-aae2-94644a2935c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7733a69d-e2cb-4b1e-9ebd-134a2635fa3a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SHOPJVMember_222686d1-6f13-4760-bd79-103f88376fef" xlink:href="peak-20220331.xsd#peak_SHOPJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_SHOPJVMember_222686d1-6f13-4760-bd79-103f88376fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_8fb85794-1dcf-4bf9-8331-4c5227bb76a8" xlink:href="peak-20220331.xsd#peak_LifeScienceJVsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_LifeScienceJVsMember_8fb85794-1dcf-4bf9-8331-4c5227bb76a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember_0d890f67-0bf0-4f20-8b34-4299ac22b22d" xlink:href="peak-20220331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_NeedhamLandParcelJVMember_0d890f67-0bf0-4f20-8b34-4299ac22b22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:href="peak-20220331.xsd#peak_MedicalOfficeJVsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIVLLCMember_d44a6da9-a38d-4393-aff7-66265f6e92cd" xlink:href="peak-20220331.xsd#peak_HCPVenturesIVLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:to="loc_peak_HCPVenturesIVLLCMember_d44a6da9-a38d-4393-aff7-66265f6e92cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SuburbanPropertiesLLCMember_4f78ce36-beb1-4e1e-b026-55c1dd0bfa3e" xlink:href="peak-20220331.xsd#peak_SuburbanPropertiesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:to="loc_peak_SuburbanPropertiesLLCMember_4f78ce36-beb1-4e1e-b026-55c1dd0bfa3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_HCPVenturesIIILLCMember_50b52c88-0fb1-44b8-a7d5-0ca2d8e474d7" xlink:href="peak-20220331.xsd#peak_HCPVenturesIIILLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_MedicalOfficeJVsMember_a38fbdd4-b548-408e-94fd-bfbea58432c9" xlink:to="loc_peak_HCPVenturesIIILLCMember_50b52c88-0fb1-44b8-a7d5-0ca2d8e474d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember_9e9d1fbf-9dee-4818-b3dd-82e0137e1a99" xlink:href="peak-20220331.xsd#peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember_9e9d1fbf-9dee-4818-b3dd-82e0137e1a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRVJVInvestmentMember_0c4470cc-a839-40c0-8ded-5fd52f7bf213" xlink:href="peak-20220331.xsd#peak_CCRVJVInvestmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d6aeafee-45f1-433c-b8ce-c02f08bb15ef" xlink:to="loc_peak_CCRVJVInvestmentMember_0c4470cc-a839-40c0-8ded-5fd52f7bf213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5de633a1-4006-4d7b-a7ca-4892d2dc4ced" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_srt_RangeAxis_5de633a1-4006-4d7b-a7ca-4892d2dc4ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ef39e7b9-fdec-40ab-afa5-0808323267d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5de633a1-4006-4d7b-a7ca-4892d2dc4ced" xlink:to="loc_srt_RangeMember_ef39e7b9-fdec-40ab-afa5-0808323267d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_aed5d8d5-ad4e-4a95-b54b-77134cd7cd15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ef39e7b9-fdec-40ab-afa5-0808323267d1" xlink:to="loc_srt_MinimumMember_aed5d8d5-ad4e-4a95-b54b-77134cd7cd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d2a9eb30-0b9d-4ebc-8541-f3e942fb0745" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ef39e7b9-fdec-40ab-afa5-0808323267d1" xlink:to="loc_srt_MaximumMember_d2a9eb30-0b9d-4ebc-8541-f3e942fb0745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6365f6b5-57f6-4a68-81ba-af9cd86dd009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6365f6b5-57f6-4a68-81ba-af9cd86dd009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0430f66d-8b52-43d6-8e44-6ef7dcdcb5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_6365f6b5-57f6-4a68-81ba-af9cd86dd009" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0430f66d-8b52-43d6-8e44-6ef7dcdcb5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoveryNaplesJVMember_7b88e8e3-06bb-4af0-87a2-dbc4d67f86e7" xlink:href="peak-20220331.xsd#peak_DiscoveryNaplesJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0430f66d-8b52-43d6-8e44-6ef7dcdcb5a3" xlink:to="loc_peak_DiscoveryNaplesJVMember_7b88e8e3-06bb-4af0-87a2-dbc4d67f86e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySarasotaJVMember_f39669f8-909b-42e4-ad79-9ab98e86d54c" xlink:href="peak-20220331.xsd#peak_DiscoverySarasotaJVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0430f66d-8b52-43d6-8e44-6ef7dcdcb5a3" xlink:to="loc_peak_DiscoverySarasotaJVMember_f39669f8-909b-42e4-ad79-9ab98e86d54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_bd821ecb-b196-43f8-84b2-21a5d03b609c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_us-gaap_InvestmentTypeAxis_bd821ecb-b196-43f8-84b2-21a5d03b609c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7e2d066a-a3f3-46b2-baa4-65f6b0b3c5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_bd821ecb-b196-43f8-84b2-21a5d03b609c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7e2d066a-a3f3-46b2-baa4-65f6b0b3c5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DiscoverySHOPPortfolioMember_6e85929f-8883-4d77-83b4-f914b8ab5ec4" xlink:href="peak-20220331.xsd#peak_DiscoverySHOPPortfolioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7e2d066a-a3f3-46b2-baa4-65f6b0b3c5e6" xlink:to="loc_peak_DiscoverySHOPPortfolioMember_6e85929f-8883-4d77-83b4-f914b8ab5ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9e19565c-32fd-45bc-abff-3f4e0c105333" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_38ee20b7-8145-47c9-b4c0-ac742534b1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_38ee20b7-8145-47c9-b4c0-ac742534b1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9345dba9-64a3-4a1f-b568-6aab0a34dae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9345dba9-64a3-4a1f-b568-6aab0a34dae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7400b7ef-2d1c-43f3-910d-66b4bbc26eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_EquityMethodInvestments_7400b7ef-2d1c-43f3-910d-66b4bbc26eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_fb98e7f4-0e83-450e-9e4c-248cc89d2012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_fb98e7f4-0e83-450e-9e4c-248cc89d2012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_e0d4b54f-2c8f-47bc-a174-21f37c0fe9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_e0d4b54f-2c8f-47bc-a174-21f37c0fe9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture_6212174d-93f2-49c7-bc5f-26eb23a52eec" xlink:href="peak-20220331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_peak_NumberOfUnconsolidatedJointVenture_6212174d-93f2-49c7-bc5f-26eb23a52eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold_a4393dc1-f4a5-42a1-9093-324d105ecdd4" xlink:href="peak-20220331.xsd#peak_NumberOfPreferredEquityMethodInvestmentsSold"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_peak_NumberOfPreferredEquityMethodInvestmentsSold_a4393dc1-f4a5-42a1-9093-324d105ecdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesToBeSold_157264e1-2b6a-423b-afbf-6a093b83b5fd" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesToBeSold"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_peak_NumberOfPropertiesToBeSold_157264e1-2b6a-423b-afbf-6a093b83b5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfBuildings_803dcd29-e7b5-49fd-a245-683ccbaf275c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfBuildings"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_46bf89cc-2c3a-481b-958d-c7b9d3cdfe00" xlink:to="loc_us-gaap_ProceedsFromSaleOfBuildings_803dcd29-e7b5-49fd-a245-683ccbaf275c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/Intangibles" xlink:type="simple" xlink:href="peak-20220331.xsd#Intangibles"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/Intangibles" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_e8e9b0eb-ae47-45a0-ad34-eeae97a18f77" xlink:href="peak-20220331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_d36ecf65-c4dc-46af-a130-5b8c719bce26" xlink:href="peak-20220331.xsd#peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_e8e9b0eb-ae47-45a0-ad34-eeae97a18f77" xlink:to="loc_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock_d36ecf65-c4dc-46af-a130-5b8c719bce26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesTables" xlink:type="simple" xlink:href="peak-20220331.xsd#IntangiblesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/IntangiblesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_35c74efe-e64d-4f2a-83cf-91c4a087ae70" xlink:href="peak-20220331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_abf2368a-ba7b-4ecd-a78d-00366f2e602d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_35c74efe-e64d-4f2a-83cf-91c4a087ae70" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_abf2368a-ba7b-4ecd-a78d-00366f2e602d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_f9c25507-ec97-4737-90d9-4358aa26460f" xlink:href="peak-20220331.xsd#peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_35c74efe-e64d-4f2a-83cf-91c4a087ae70" xlink:to="loc_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock_f9c25507-ec97-4737-90d9-4358aa26460f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#IntangiblesIntangiblesLeaseAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_48aaf335-bcf5-4502-b37c-fa19579afaeb" xlink:href="peak-20220331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_859adb42-1177-4af2-bec3-9df98a1db6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_48aaf335-bcf5-4502-b37c-fa19579afaeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_859adb42-1177-4af2-bec3-9df98a1db6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e729cbdb-4f3d-4ce4-92a1-c1dd89ba3395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_48aaf335-bcf5-4502-b37c-fa19579afaeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e729cbdb-4f3d-4ce4-92a1-c1dd89ba3395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7422a58d-89de-47e6-80e8-be59630ca9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_48aaf335-bcf5-4502-b37c-fa19579afaeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7422a58d-89de-47e6-80e8-be59630ca9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_317e2575-c89d-4ee0-8746-870989791b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_48aaf335-bcf5-4502-b37c-fa19579afaeb" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_317e2575-c89d-4ee0-8746-870989791b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#IntangiblesIntangiblesLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_36a4a399-0a58-4279-9d65-2b7ba6f1f58a" xlink:href="peak-20220331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesGross_64d8b564-419b-41b8-9b32-3cd0811004ac" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_36a4a399-0a58-4279-9d65-2b7ba6f1f58a" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesGross_64d8b564-419b-41b8-9b32-3cd0811004ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_6a9d787f-de3a-4368-a325-0cd24cfbb573" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_36a4a399-0a58-4279-9d65-2b7ba6f1f58a" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization_6a9d787f-de3a-4368-a325-0cd24cfbb573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_FiniteLivedIntangibleLiabilitiesNet_919115ef-fade-418a-a75d-b2a3476e339b" xlink:href="peak-20220331.xsd#peak_FiniteLivedIntangibleLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_36a4a399-0a58-4279-9d65-2b7ba6f1f58a" xlink:to="loc_peak_FiniteLivedIntangibleLiabilitiesNet_919115ef-fade-418a-a75d-b2a3476e339b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_7dc57e42-98cc-440b-b300-8c77f2f3497c" xlink:href="peak-20220331.xsd#peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_36a4a399-0a58-4279-9d65-2b7ba6f1f58a" xlink:to="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_7dc57e42-98cc-440b-b300-8c77f2f3497c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/IntangiblesNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#IntangiblesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/IntangiblesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangiblesAbstract_5fb179e6-6c17-472a-82c0-3c7f82fd8669" xlink:href="peak-20220331.xsd#peak_IntangiblesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_758636a3-58a3-4c49-a7dd-ce3a15b8fb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_IntangiblesAbstract_5fb179e6-6c17-472a-82c0-3c7f82fd8669" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_758636a3-58a3-4c49-a7dd-ce3a15b8fb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b2b945e6-f21f-4c23-a469-b6744793db0d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_758636a3-58a3-4c49-a7dd-ce3a15b8fb2b" xlink:to="loc_srt_CounterpartyNameAxis_b2b945e6-f21f-4c23-a469-b6744793db0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29bae9-9ca3-4bcf-9ba6-e85ea07aae45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b2b945e6-f21f-4c23-a469-b6744793db0d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29bae9-9ca3-4bcf-9ba6-e85ea07aae45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_BrookdaleMTCAMember_70c5481c-678b-4f8a-8587-658646cfcf40" xlink:href="peak-20220331.xsd#peak_BrookdaleMTCAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29bae9-9ca3-4bcf-9ba6-e85ea07aae45" xlink:to="loc_peak_BrookdaleMTCAMember_70c5481c-678b-4f8a-8587-658646cfcf40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_758636a3-58a3-4c49-a7dd-ce3a15b8fb2b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6de2a488-4841-4866-8dcd-4c705317c970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6de2a488-4841-4866-8dcd-4c705317c970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IntangibleLiabilitiesAcquired_a7cfbf11-0d28-4ff2-9b70-1197aa791b4d" xlink:href="peak-20220331.xsd#peak_IntangibleLiabilitiesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_peak_IntangibleLiabilitiesAcquired_a7cfbf11-0d28-4ff2-9b70-1197aa791b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fdb97ab6-de48-4f9e-993a-de7cf95d0a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fdb97ab6-de48-4f9e-993a-de7cf95d0a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_2e8cbeac-228b-43cc-8dba-7e7f32fb0214" xlink:href="peak-20220331.xsd#peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28bea8d-a216-46a2-b130-8647ecdf1ac7" xlink:to="loc_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife_2e8cbeac-228b-43cc-8dba-7e7f32fb0214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_9aba06f1-7e67-4c8c-b105-a4174d76c7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/Debt" xlink:type="simple" xlink:href="peak-20220331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a9910462-2a34-4213-af86-07e81bdc0f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e3df0914-6ab1-4dc2-ae9e-eaf5fe6f8489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a9910462-2a34-4213-af86-07e81bdc0f32" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e3df0914-6ab1-4dc2-ae9e-eaf5fe6f8489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtTables" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_608c2d68-b389-4274-9c6f-32381bb4d1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_32898be9-e772-401a-92a4-e2cd8bab3e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_608c2d68-b389-4274-9c6f-32381bb4d1f6" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_32898be9-e772-401a-92a4-e2cd8bab3e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1280bdb9-d0bb-4f63-a040-b031dede2bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_608c2d68-b389-4274-9c6f-32381bb4d1f6" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1280bdb9-d0bb-4f63-a040-b031dede2bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtBankLineofCreditandTermLoansDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_40264a9a-2466-4fd8-ac15-046c02ceadf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40264a9a-2466-4fd8-ac15-046c02ceadf9" xlink:to="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_39a012df-aec1-4abd-b02f-107022801381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_39a012df-aec1-4abd-b02f-107022801381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c5f9b424-cba0-4c92-8afe-dcf64a86ea09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_39a012df-aec1-4abd-b02f-107022801381" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c5f9b424-cba0-4c92-8afe-dcf64a86ea09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9ef97bae-454e-4db5-b776-e5090e12da83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c5f9b424-cba0-4c92-8afe-dcf64a86ea09" xlink:to="loc_us-gaap_LineOfCreditMember_9ef97bae-454e-4db5-b776-e5090e12da83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bfb15d42-1a13-490a-9c83-b4c186ab6435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_CreditFacilityAxis_bfb15d42-1a13-490a-9c83-b4c186ab6435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_973b7c24-c6ac-420d-9049-5255f592fb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_bfb15d42-1a13-490a-9c83-b4c186ab6435" xlink:to="loc_us-gaap_CreditFacilityDomain_973b7c24-c6ac-420d-9049-5255f592fb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c9f03081-1bbc-4814-8478-91d3213a45ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_973b7c24-c6ac-420d-9049-5255f592fb0e" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c9f03081-1bbc-4814-8478-91d3213a45ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2019TermLoanMember_3b44715c-8586-4484-a553-2d6cef82cb2d" xlink:href="peak-20220331.xsd#peak_A2019TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_973b7c24-c6ac-420d-9049-5255f592fb0e" xlink:to="loc_peak_A2019TermLoanMember_3b44715c-8586-4484-a553-2d6cef82cb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5b5cd542-0299-47fd-9f91-443beaf5ee37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_VariableRateAxis_5b5cd542-0299-47fd-9f91-443beaf5ee37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1f39f4e9-e28a-4c94-8ad0-a0e9944d9579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_5b5cd542-0299-47fd-9f91-443beaf5ee37" xlink:to="loc_us-gaap_VariableRateDomain_1f39f4e9-e28a-4c94-8ad0-a0e9944d9579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d69d7531-ad10-4683-98e4-26e8498578e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1f39f4e9-e28a-4c94-8ad0-a0e9944d9579" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d69d7531-ad10-4683-98e4-26e8498578e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cdd47581-b1bc-4a8c-b263-d1e3ed434e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_DebtInstrumentAxis_cdd47581-b1bc-4a8c-b263-d1e3ed434e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_752ebf5a-7373-4cd9-a34e-cbdaa2820eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cdd47581-b1bc-4a8c-b263-d1e3ed434e87" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_752ebf5a-7373-4cd9-a34e-cbdaa2820eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditAndTermLoanMember_4eea5bfa-3e47-4693-bd7d-28e3cc21e9bd" xlink:href="peak-20220331.xsd#peak_LineOfCreditAndTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_752ebf5a-7373-4cd9-a34e-cbdaa2820eee" xlink:to="loc_peak_LineOfCreditAndTermLoanMember_4eea5bfa-3e47-4693-bd7d-28e3cc21e9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26151321-ec0a-4a2f-97d5-3d88bd4e8f94" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_67229ed9-357f-4a82-a07f-244d9401d1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_67229ed9-357f-4a82-a07f-244d9401d1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentNumberofExtensions_fdc5ea9c-9237-4a2d-89b0-334783df5d6f" xlink:href="peak-20220331.xsd#peak_DebtInstrumentNumberofExtensions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentNumberofExtensions_fdc5ea9c-9237-4a2d-89b0-334783df5d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentPeriodOfExtension_43967780-cb13-409f-99c6-798a9372a636" xlink:href="peak-20220331.xsd#peak_DebtInstrumentPeriodOfExtension"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentPeriodOfExtension_43967780-cb13-409f-99c6-798a9372a636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_62b9e68c-5a26-45f4-b443-2c02c80d2ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_62b9e68c-5a26-45f4-b443-2c02c80d2ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_8dd65cb2-36c2-42ac-8807-0ad82571750f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_8dd65cb2-36c2-42ac-8807-0ad82571750f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2d50f814-44c5-42c0-a1e2-aba0b9df5419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2d50f814-44c5-42c0-a1e2-aba0b9df5419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4b8f3844-579d-45c7-9028-552052440a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4b8f3844-579d-45c7-9028-552052440a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_0bae4538-72a5-4d63-a870-2034de3676f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_us-gaap_LineOfCredit_0bae4538-72a5-4d63-a870-2034de3676f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_a1cdd712-7949-410d-9847-440f523d1180" xlink:href="peak-20220331.xsd#peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum_a1cdd712-7949-410d-9847-440f523d1180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_c492a1da-ff6c-4281-8697-2eee50cd5919" xlink:href="peak-20220331.xsd#peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics_c492a1da-ff6c-4281-8697-2eee50cd5919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantDebtToAssets_a1c350ec-8f3c-4bce-ae64-0019da461721" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantDebtToAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantDebtToAssets_a1c350ec-8f3c-4bce-ae64-0019da461721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets_03c8d8b7-6ecc-442f-902b-87171ed0796b" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantSecuredDebtToAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantSecuredDebtToAssets_03c8d8b7-6ecc-442f-902b-87171ed0796b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_d4c35b19-fe1e-426b-95e5-08fe3a37f822" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets_d4c35b19-fe1e-426b-95e5-08fe3a37f822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_4697d84f-8684-48ea-a9ee-b82785cbb027" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantFixedChargeRatioMinimum"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantFixedChargeRatioMinimum_4697d84f-8684-48ea-a9ee-b82785cbb027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCovenantNetWorth_d27b7a07-fc6d-445c-9c05-47c3a1d603fc" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCovenantNetWorth"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fabd397f-c1d4-433e-9cdb-94dd23f7abdd" xlink:to="loc_peak_DebtInstrumentCovenantNetWorth_d27b7a07-fc6d-445c-9c05-47c3a1d603fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtCommercialPaperProgramDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_851420dc-aeff-42cc-9f59-4d66c3ee220a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_38d3d4ac-919b-49e8-a6c0-e17243e2e29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_851420dc-aeff-42cc-9f59-4d66c3ee220a" xlink:to="loc_us-gaap_DebtInstrumentTable_38d3d4ac-919b-49e8-a6c0-e17243e2e29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_15409931-8084-4f2b-862f-645e3f2a9998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_38d3d4ac-919b-49e8-a6c0-e17243e2e29e" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_15409931-8084-4f2b-862f-645e3f2a9998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_fb137fb2-8973-4de8-9a3f-9935e85594e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_15409931-8084-4f2b-862f-645e3f2a9998" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_fb137fb2-8973-4de8-9a3f-9935e85594e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CommercialPaperProgramMember_db2fcf3e-d54e-4d4c-8735-36910cdec77e" xlink:href="peak-20220331.xsd#peak_CommercialPaperProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_fb137fb2-8973-4de8-9a3f-9935e85594e0" xlink:to="loc_peak_CommercialPaperProgramMember_db2fcf3e-d54e-4d4c-8735-36910cdec77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_38d3d4ac-919b-49e8-a6c0-e17243e2e29e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentMaximumBorrowingCapacity_7d1aa97e-30c5-4900-8e7e-ea66b9a4c976" xlink:href="peak-20220331.xsd#peak_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_peak_DebtInstrumentMaximumBorrowingCapacity_7d1aa97e-30c5-4900-8e7e-ea66b9a4c976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3ad202ea-f1ac-4192-a45f-456773354429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_us-gaap_ShortTermBorrowings_3ad202ea-f1ac-4192-a45f-456773354429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_bd8cb816-08a9-496a-9538-b68c0382d2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_us-gaap_DebtInstrumentTerm_bd8cb816-08a9-496a-9538-b68c0382d2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_a7acbae3-9a74-496e-9e69-4bd7dfceffd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0ca9a0b3-a5cb-4d0a-89f3-d7fd9818df7e" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_a7acbae3-9a74-496e-9e69-4bd7dfceffd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtSeniorUnsecuredNotesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f02aa68d-5a41-4b22-9783-633db787ee18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f02aa68d-5a41-4b22-9783-633db787ee18" xlink:to="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bc32e821-db7c-4a01-9225-e2b523263270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bc32e821-db7c-4a01-9225-e2b523263270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_48c1d001-6edf-47b1-ac46-37bd905fda2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bc32e821-db7c-4a01-9225-e2b523263270" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_48c1d001-6edf-47b1-ac46-37bd905fda2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_51a2ebd5-06d1-4244-8eaa-02c4d5e616c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_48c1d001-6edf-47b1-ac46-37bd905fda2c" xlink:to="loc_us-gaap_UnsecuredDebtMember_51a2ebd5-06d1-4244-8eaa-02c4d5e616c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_79bb0b46-9a75-41a6-9661-000ec6d65578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:to="loc_us-gaap_DebtInstrumentAxis_79bb0b46-9a75-41a6-9661-000ec6d65578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_79bb0b46-9a75-41a6-9661-000ec6d65578" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote3400PercentMember_73f4d228-b3a6-46c3-831c-1442de2faa6d" xlink:href="peak-20220331.xsd#peak_UnsecuredNote3400PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote3400PercentMember_73f4d228-b3a6-46c3-831c-1442de2faa6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4000PercentMember_fd522b0e-4cae-4077-9236-47a227016a94" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4000PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote4000PercentMember_fd522b0e-4cae-4077-9236-47a227016a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4.250PercentMember_93e516d0-a7ff-48fd-ab85-73975cad4a83" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4.250PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote4.250PercentMember_93e516d0-a7ff-48fd-ab85-73975cad4a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote4200PercentMember_dd90483e-2064-4d5e-beac-93cbe1a54982" xlink:href="peak-20220331.xsd#peak_UnsecuredNote4200PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote4200PercentMember_dd90483e-2064-4d5e-beac-93cbe1a54982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote3880PercentMember_bc000bf5-43e2-4f6b-af26-8e42b07f4e7c" xlink:href="peak-20220331.xsd#peak_UnsecuredNote3880PercentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote3880PercentMember_bc000bf5-43e2-4f6b-af26-8e42b07f4e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorNotesDue2025Member_abfe6f5f-6690-4826-bdc0-966ac969b852" xlink:href="peak-20220331.xsd#peak_SeniorNotesDue2025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_SeniorNotesDue2025Member_abfe6f5f-6690-4826-bdc0-966ac969b852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SeniorNotesDue2023And2024Member_5b1cbb21-5a2e-4c59-9193-5faee9179982" xlink:href="peak-20220331.xsd#peak_SeniorNotesDue2023And2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_SeniorNotesDue2023And2024Member_5b1cbb21-5a2e-4c59-9193-5faee9179982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote213PercentMember_f72e4ec6-15f9-470b-8679-74d1d93c9303" xlink:href="peak-20220331.xsd#peak_UnsecuredNote213PercentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote213PercentMember_f72e4ec6-15f9-470b-8679-74d1d93c9303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnsecuredNote1350PercentMember_03f225ce-f979-4596-948a-3fa053f3e2b8" xlink:href="peak-20220331.xsd#peak_UnsecuredNote1350PercentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f29899f7-ca1e-4361-bb19-e508b8e2590f" xlink:to="loc_peak_UnsecuredNote1350PercentMember_03f225ce-f979-4596-948a-3fa053f3e2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_09db9317-8ce5-4a6f-adb1-6241a70a2a47" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6123a3b6-7cf8-4d5a-ad05-1ba7de749bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6123a3b6-7cf8-4d5a-ad05-1ba7de749bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b868744e-e896-4de5-a8f2-39ec2ec5ee9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b868744e-e896-4de5-a8f2-39ec2ec5ee9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_315f377c-6151-4f3e-b87a-053ef5c4ac8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_315f377c-6151-4f3e-b87a-053ef5c4ac8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ce232abb-d123-408e-8b1c-fc829a4821aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ce232abb-d123-408e-8b1c-fc829a4821aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfBondOfferings_811ff7e2-1b7c-445f-8516-67c3339a4bf3" xlink:href="peak-20220331.xsd#peak_NumberOfBondOfferings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b889e3ec-a779-4b0e-ae1c-200119d0656d" xlink:to="loc_peak_NumberOfBondOfferings_811ff7e2-1b7c-445f-8516-67c3339a4bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtMortgageDebtDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtMortgageDebtDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtMortgageDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f34509cb-584c-4cef-9e27-45febb8c8a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f34509cb-584c-4cef-9e27-45febb8c8a57" xlink:to="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c7fbd08b-4775-4f65-992d-0900abcc544f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c7fbd08b-4775-4f65-992d-0900abcc544f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0c75a292-fc0c-4671-982f-3677618e0972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c7fbd08b-4775-4f65-992d-0900abcc544f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0c75a292-fc0c-4671-982f-3677618e0972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c4e11013-e6e9-4e13-8660-b91677dd6a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0c75a292-fc0c-4671-982f-3677618e0972" xlink:to="loc_us-gaap_SecuredDebtMember_c4e11013-e6e9-4e13-8660-b91677dd6a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1186d3f5-8511-413d-99c1-6594d9c645e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1186d3f5-8511-413d-99c1-6594d9c645e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5106d9f3-dce8-4687-a9fe-1fcc7cb28c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1186d3f5-8511-413d-99c1-6594d9c645e8" xlink:to="loc_us-gaap_SegmentDomain_5106d9f3-dce8-4687-a9fe-1fcc7cb28c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_3113fa1e-5ccb-4e4d-b8f9-aa28e1e1cc7c" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5106d9f3-dce8-4687-a9fe-1fcc7cb28c38" xlink:to="loc_peak_MedicalOfficeMember_3113fa1e-5ccb-4e4d-b8f9-aa28e1e1cc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_78072eee-18e9-4820-b070-07199d907f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_DebtInstrumentAxis_78072eee-18e9-4820-b070-07199d907f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dd80d3ad-0c68-4cfa-83ae-83ed5bc96e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_78072eee-18e9-4820-b070-07199d907f79" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dd80d3ad-0c68-4cfa-83ae-83ed5bc96e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c436d28b-d59c-4086-99c3-6c445d26d9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dd80d3ad-0c68-4cfa-83ae-83ed5bc96e80" xlink:to="loc_us-gaap_SecuredDebtMember_c436d28b-d59c-4086-99c3-6c445d26d9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_776434df-0c8f-4089-a90a-2f6257ea5485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_776434df-0c8f-4089-a90a-2f6257ea5485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d12ebd01-d02c-4272-9f29-c53fd47c6c27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_776434df-0c8f-4089-a90a-2f6257ea5485" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d12ebd01-d02c-4272-9f29-c53fd47c6c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1a33aa24-4e42-4daf-82e1-b067affacdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d12ebd01-d02c-4272-9f29-c53fd47c6c27" xlink:to="loc_us-gaap_SubsequentEventMember_1a33aa24-4e42-4daf-82e1-b067affacdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_34cfd966-dbd4-407b-a1c2-085ef87e0172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_34cfd966-dbd4-407b-a1c2-085ef87e0172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_efae7997-1422-4f51-85a1-da108eb98029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_34cfd966-dbd4-407b-a1c2-085ef87e0172" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_efae7997-1422-4f51-85a1-da108eb98029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_055577f9-44dc-44b4-b275-f584d6261e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efae7997-1422-4f51-85a1-da108eb98029" xlink:to="loc_us-gaap_InterestRateSwapMember_055577f9-44dc-44b4-b275-f584d6261e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_589acf3c-5913-4107-b248-c1834adea2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_589acf3c-5913-4107-b248-c1834adea2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_563d4a67-595c-4f9e-bd31-eba194d6d9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_589acf3c-5913-4107-b248-c1834adea2d7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_563d4a67-595c-4f9e-bd31-eba194d6d9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_060a02de-1a0b-478f-b096-b19aa1611dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_563d4a67-595c-4f9e-bd31-eba194d6d9ab" xlink:to="loc_us-gaap_CashFlowHedgingMember_060a02de-1a0b-478f-b096-b19aa1611dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b2d182ab-77a4-4f85-a3b8-236d635af4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_HedgingDesignationAxis_b2d182ab-77a4-4f85-a3b8-236d635af4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5450723d-bf80-4fce-b33d-e318530cac66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b2d182ab-77a4-4f85-a3b8-236d635af4f7" xlink:to="loc_us-gaap_HedgingDesignationDomain_5450723d-bf80-4fce-b33d-e318530cac66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5e81aaa5-a398-4dbb-a0af-eff7ecb7c56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5450723d-bf80-4fce-b33d-e318530cac66" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5e81aaa5-a398-4dbb-a0af-eff7ecb7c56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c3d2c7d6-4bd7-4f74-989a-4915dc91f31e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2fac9ada-b22c-44a3-905f-b3169063f3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2fac9ada-b22c-44a3-905f-b3169063f3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber_bd19c6c0-7a20-489c-bd50-30326c593aaf" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber_bd19c6c0-7a20-489c-bd50-30326c593aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_f4828ce9-cc8f-46cc-a343-b021ba8150ff" xlink:href="peak-20220331.xsd#peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue_f4828ce9-cc8f-46cc-a343-b021ba8150ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_b546c984-3f62-4c38-8df6-45e6e71fd8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_b546c984-3f62-4c38-8df6-45e6e71fd8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5baec944-3a08-4aba-9f38-c43b4f2e5521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5baec944-3a08-4aba-9f38-c43b4f2e5521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_e6d2bc3d-672f-42ad-ae2b-da68fd552a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_58b001d3-a062-411e-96b1-04b4d4f69af7" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_e6d2bc3d-672f-42ad-ae2b-da68fd552a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DebtDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3d8d7f8b-963c-4f9c-aab0-0d26122e58a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3d8d7f8b-963c-4f9c-aab0-0d26122e58a9" xlink:to="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a5a158a3-c73d-4e85-b293-da36a2408b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a5a158a3-c73d-4e85-b293-da36a2408b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a5a158a3-c73d-4e85-b293-da36a2408b62" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_dc4d14c5-a4cf-4b24-b0ac-53fd03513ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:to="loc_us-gaap_LineOfCreditMember_dc4d14c5-a4cf-4b24-b0ac-53fd03513ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8f7fae3d-3081-478e-9dce-bf1e03d74793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:to="loc_us-gaap_CommercialPaperMember_8f7fae3d-3081-478e-9dce-bf1e03d74793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_ab2a4876-f9a7-4d5f-940a-81a950229518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:to="loc_us-gaap_UnsecuredDebtMember_ab2a4876-f9a7-4d5f-940a-81a950229518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_860c4154-000f-4b10-b56f-6d70ee474662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f1581f3-2c6f-484e-a4c3-3b90ceefa835" xlink:to="loc_us-gaap_SecuredDebtMember_860c4154-000f-4b10-b56f-6d70ee474662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8eb58823-dbd0-446b-9650-09d2c12c94cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:to="loc_srt_RangeAxis_8eb58823-dbd0-446b-9650-09d2c12c94cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9bc45a9-0688-4bd1-8ade-2e671129a168" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8eb58823-dbd0-446b-9650-09d2c12c94cf" xlink:to="loc_srt_RangeMember_d9bc45a9-0688-4bd1-8ade-2e671129a168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e9e80328-218f-4c37-8610-f1662edfc6f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d9bc45a9-0688-4bd1-8ade-2e671129a168" xlink:to="loc_srt_MinimumMember_e9e80328-218f-4c37-8610-f1662edfc6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_565fb495-2cee-4493-909b-ac925ca8d206" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d9bc45a9-0688-4bd1-8ade-2e671129a168" xlink:to="loc_srt_MaximumMember_565fb495-2cee-4493-909b-ac925ca8d206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6cfb2882-f287-486e-ae61-03e40ef35a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6cfb2882-f287-486e-ae61-03e40ef35a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6cfb2882-f287-486e-ae61-03e40ef35a5b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_a4d1fc6b-b72e-4e94-8825-48e1a616a64f" xlink:href="peak-20220331.xsd#peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember_a4d1fc6b-b72e-4e94-8825-48e1a616a64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_46ada022-f6dd-4408-8958-fdccc443ee83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_46ada022-f6dd-4408-8958-fdccc443ee83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_13605ef3-bdb1-4cc6-8222-e821444c1fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_13605ef3-bdb1-4cc6-8222-e821444c1fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_b7c2aca6-f3d5-49e0-b6a9-0815a03ca90f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_b7c2aca6-f3d5-49e0-b6a9-0815a03ca90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3bbe6010-ec08-468f-b5ef-0ca8fb36705a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3bbe6010-ec08-468f-b5ef-0ca8fb36705a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember_899c473b-5e26-45b1-81c1-bd19dc0754c5" xlink:href="peak-20220331.xsd#peak_DebtInstrumentRedemptionPeriodThereafterMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5408c0f9-7bc3-4369-af7f-f78a33e998d0" xlink:to="loc_peak_DebtInstrumentRedemptionPeriodThereafterMember_899c473b-5e26-45b1-81c1-bd19dc0754c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d1c2d290-4baa-48d8-aabe-e431863fba41" xlink:to="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_012fe108-d699-4bcf-b24d-20a4f422b1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_012fe108-d699-4bcf-b24d-20a4f422b1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_76ca2e57-f417-4938-8c5b-7d637c07134f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_76ca2e57-f417-4938-8c5b-7d637c07134f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3a27612c-6172-4957-9fc3-0e78ac9c9381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3a27612c-6172-4957-9fc3-0e78ac9c9381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_862bc503-7355-4eec-841a-b6dedcc4c7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_862bc503-7355-4eec-841a-b6dedcc4c7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_23d9636d-5ee5-4bd5-9e63-ea2281df99b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_23d9636d-5ee5-4bd5-9e63-ea2281df99b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LongTermDebtMaturityAfterYearFour_57533aeb-5f9a-4f72-88e2-8c67cd380fcc" xlink:href="peak-20220331.xsd#peak_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_peak_LongTermDebtMaturityAfterYearFour_57533aeb-5f9a-4f72-88e2-8c67cd380fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f9fecde7-dbbd-4787-b8d5-11c93dcc1063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f9fecde7-dbbd-4787-b8d5-11c93dcc1063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_5083358d-49db-4f17-8dbf-15e9222d4cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_5083358d-49db-4f17-8dbf-15e9222d4cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a606d651-263e-4108-9092-d757dd666fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_LongTermDebt_a606d651-263e-4108-9092-d757dd666fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d75efd2e-0007-445b-8200-b086df7b6fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d75efd2e-0007-445b-8200-b086df7b6fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_a78b8545-bd8f-4e9d-91d3-4c440b3f41fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_a78b8545-bd8f-4e9d-91d3-4c440b3f41fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DebtInstrumentWeightedAverageMaturity_4346fe9b-5a1f-4ecc-b3ee-0dbb3dd2824e" xlink:href="peak-20220331.xsd#peak_DebtInstrumentWeightedAverageMaturity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_49868c31-30b7-4d65-8487-1645a8d83775" xlink:to="loc_peak_DebtInstrumentWeightedAverageMaturity_4346fe9b-5a1f-4ecc-b3ee-0dbb3dd2824e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="peak-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_00d314e2-ef7a-46df-a27f-09175e33ac9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6a706732-2d5f-492e-9f57-33ac27aacdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_00d314e2-ef7a-46df-a27f-09175e33ac9a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6a706732-2d5f-492e-9f57-33ac27aacdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a05198e7-8673-4f90-8d6d-131fc2760724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a05198e7-8673-4f90-8d6d-131fc2760724" xlink:to="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_629b6bb4-ef43-4b80-9bb6-cb35138186f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_629b6bb4-ef43-4b80-9bb6-cb35138186f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_015ced67-eb0d-4cb8-b415-758ba66b5f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_629b6bb4-ef43-4b80-9bb6-cb35138186f6" xlink:to="loc_us-gaap_LossContingencyNatureDomain_015ced67-eb0d-4cb8-b415-758ba66b5f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_fa75ae7c-74c7-41d9-bc5f-54cdee1ed069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_015ced67-eb0d-4cb8-b415-758ba66b5f06" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_fa75ae7c-74c7-41d9-bc5f-54cdee1ed069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_77391b4a-edd2-4461-8702-5044fb1b0781" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_77391b4a-edd2-4461-8702-5044fb1b0781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7827ccc9-327a-4494-b43e-5e56f47bb67d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_77391b4a-edd2-4461-8702-5044fb1b0781" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7827ccc9-327a-4494-b43e-5e56f47bb67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_0be60f45-9c00-4414-9124-98f58aac0905" xlink:href="peak-20220331.xsd#peak_LifeScienceJVsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7827ccc9-327a-4494-b43e-5e56f47bb67d" xlink:to="loc_peak_LifeScienceJVsMember_0be60f45-9c00-4414-9124-98f58aac0905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_25f2c348-dc4d-4bc9-8aee-de887ba6e34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_25f2c348-dc4d-4bc9-8aee-de887ba6e34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_744b28da-ba7b-4b2b-abff-936485c0a401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25f2c348-dc4d-4bc9-8aee-de887ba6e34c" xlink:to="loc_us-gaap_SegmentDomain_744b28da-ba7b-4b2b-abff-936485c0a401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_1eab17ff-537a-41b6-b840-b22dd44b38bd" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_744b28da-ba7b-4b2b-abff-936485c0a401" xlink:to="loc_peak_LifeScienceMember_1eab17ff-537a-41b6-b840-b22dd44b38bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c79712ed-edb8-48de-8446-73aac66b25a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d62a5eb8-9d64-400b-a744-ca5953b81de1" xlink:to="loc_us-gaap_LossContingenciesLineItems_c79712ed-edb8-48de-8446-73aac66b25a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ContributionOfPropertyNumberOfProperties_cb74336a-cd0e-4161-b9dd-4adc11bec4e6" xlink:href="peak-20220331.xsd#peak_ContributionOfPropertyNumberOfProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79712ed-edb8-48de-8446-73aac66b25a8" xlink:to="loc_peak_ContributionOfPropertyNumberOfProperties_cb74336a-cd0e-4161-b9dd-4adc11bec4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3273ce80-d46f-4e0f-a090-2d885a9ae911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c79712ed-edb8-48de-8446-73aac66b25a8" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3273ce80-d46f-4e0f-a090-2d885a9ae911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests" xlink:type="simple" xlink:href="peak-20220331.xsd#EquityandRedeemableNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6ea38cf2-f7cb-477d-8d5d-b649c56f495c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7e2a414a-81c6-4f44-b401-4c620f5bda32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ea38cf2-f7cb-477d-8d5d-b649c56f495c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7e2a414a-81c6-4f44-b401-4c620f5bda32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables" xlink:type="simple" xlink:href="peak-20220331.xsd#EquityandRedeemableNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_aefe0096-220c-4b30-94ff-fe3a59305bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dd55ff0c-c714-4a55-992c-de0ac351edb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_aefe0096-220c-4b30-94ff-fe3a59305bf6" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dd55ff0c-c714-4a55-992c-de0ac351edb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7650c452-ee4a-406c-929d-a107edca13a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7650c452-ee4a-406c-929d-a107edca13a6" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_0258ed94-054c-48a6-ad79-56a449d64bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_0258ed94-054c-48a6-ad79-56a449d64bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0258ed94-054c-48a6-ad79-56a449d64bf5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramMember_856d7fdf-c74e-4b68-ac2e-b11ad338f00d" xlink:href="peak-20220331.xsd#peak_A2020ATMProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:to="loc_peak_A2020ATMProgramMember_856d7fdf-c74e-4b68-ac2e-b11ad338f00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtTheMarketProgramMember_d7c592b4-dba4-4bd7-b800-724c7a4ed05e" xlink:href="peak-20220331.xsd#peak_AtTheMarketProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:to="loc_peak_AtTheMarketProgramMember_d7c592b4-dba4-4bd7-b800-724c7a4ed05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_A2020ATMProgramSettledMember_04bd34a1-366d-4557-8bbf-e33d88850473" xlink:href="peak-20220331.xsd#peak_A2020ATMProgramSettledMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:to="loc_peak_A2020ATMProgramSettledMember_04bd34a1-366d-4557-8bbf-e33d88850473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMDirectIssuancesMember_47bcc6e2-d038-4c3c-8fc8-2709cecf047f" xlink:href="peak-20220331.xsd#peak_ATMDirectIssuancesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_869c64bd-a321-4427-8ff0-3c5b99af745f" xlink:to="loc_peak_ATMDirectIssuancesMember_47bcc6e2-d038-4c3c-8fc8-2709cecf047f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a868d7a4-95c8-470d-a166-93b756df9de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a868d7a4-95c8-470d-a166-93b756df9de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ca251fc0-91fe-4b8b-83c8-9c9c68ebbc53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a868d7a4-95c8-470d-a166-93b756df9de3" xlink:to="loc_us-gaap_ClassOfStockDomain_ca251fc0-91fe-4b8b-83c8-9c9c68ebbc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4760fe51-05a3-452f-be3f-37301c13fe24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ca251fc0-91fe-4b8b-83c8-9c9c68ebbc53" xlink:to="loc_us-gaap_CommonStockMember_4760fe51-05a3-452f-be3f-37301c13fe24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_da49f414-6a31-4f27-9b1c-1681a7c5470b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_107ca0a9-97a0-4ca1-af4c-dce10cd8edfc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_da49f414-6a31-4f27-9b1c-1681a7c5470b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1e973ec7-c064-43b9-99f2-09ad1ecd97ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_da49f414-6a31-4f27-9b1c-1681a7c5470b" xlink:to="loc_us-gaap_SubsequentEventMember_1e973ec7-c064-43b9-99f2-09ad1ecd97ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_595e5a3d-411b-4522-b2f2-c4f4c2653662" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_srt_RangeAxis_595e5a3d-411b-4522-b2f2-c4f4c2653662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4d486bd0-95bb-45c5-b5db-047e1fa0758f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_595e5a3d-411b-4522-b2f2-c4f4c2653662" xlink:to="loc_srt_RangeMember_4d486bd0-95bb-45c5-b5db-047e1fa0758f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb2d2072-4d70-4287-a01a-5f55ca3467cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4d486bd0-95bb-45c5-b5db-047e1fa0758f" xlink:to="loc_srt_MinimumMember_cb2d2072-4d70-4287-a01a-5f55ca3467cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3a564747-c85d-4e51-bf77-f278e3df0872" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4d486bd0-95bb-45c5-b5db-047e1fa0758f" xlink:to="loc_srt_MaximumMember_3a564747-c85d-4e51-bf77-f278e3df0872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_52286700-84ca-4fe0-a4c7-1f0da643546f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_srt_StatementScenarioAxis_52286700-84ca-4fe0-a4c7-1f0da643546f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a7d49aa6-30dc-4fe5-a046-983eb5c972c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_52286700-84ca-4fe0-a4c7-1f0da643546f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a7d49aa6-30dc-4fe5-a046-983eb5c972c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b67bffd4-530e-49bd-ba88-ec6ee590b0bc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a7d49aa6-30dc-4fe5-a046-983eb5c972c8" xlink:to="loc_srt_ScenarioForecastMember_b67bffd4-530e-49bd-ba88-ec6ee590b0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13975f36-b60b-44c9-af19-1a5a704e90d2" xlink:to="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_0af23500-a4d5-43e6-9e7d-221d9796647d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_0af23500-a4d5-43e6-9e7d-221d9796647d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d66fcb7b-dea6-4456-9348-41487d053718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d66fcb7b-dea6-4456-9348-41487d053718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_99875e68-d0b9-4392-adff-76437458d071" xlink:href="peak-20220331.xsd#peak_AtmEquityOfferingProgramAggregateAmountAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_AtmEquityOfferingProgramAggregateAmountAuthorized_99875e68-d0b9-4392-adff-76437458d071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OptionIndexedToIssuersEquityTerm_749ce2d3-7327-45bc-aa01-c54cebca70ba" xlink:href="peak-20220331.xsd#peak_OptionIndexedToIssuersEquityTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_OptionIndexedToIssuersEquityTerm_749ce2d3-7327-45bc-aa01-c54cebca70ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining_caf5c28d-21f6-4065-a3ae-10287a487046" xlink:href="peak-20220331.xsd#peak_ATMEquityOfferingProgramAggregateAmountRemaining"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_ATMEquityOfferingProgramAggregateAmountRemaining_caf5c28d-21f6-4065-a3ae-10287a487046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_c27fb79b-b183-4371-a397-52267040d792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_c27fb79b-b183-4371-a397-52267040d792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_790c640e-7ccc-47cc-98bc-e1889b67ae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquityForwardRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate_790c640e-7ccc-47cc-98bc-e1889b67ae9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue_a1d7fc31-75ca-4e72-aec7-d55d49311818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue_a1d7fc31-75ca-4e72-aec7-d55d49311818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares_89478e3f-3615-4b73-804f-aa07847f0cfe" xlink:href="peak-20220331.xsd#peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares_89478e3f-3615-4b73-804f-aa07847f0cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_12feb2f9-41f2-46b8-a727-a65924fb7bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_12feb2f9-41f2-46b8-a727-a65924fb7bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_a083d5ad-049e-468b-889e-4fdc3575ce5e" xlink:href="peak-20220331.xsd#peak_NumberOfRedeemableNoncontrollingInterestRedemptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_NumberOfRedeemableNoncontrollingInterestRedemptions_a083d5ad-049e-468b-889e-4fdc3575ce5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_0d76a4a4-68a5-4ce3-b85e-93fde58d6ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_0d76a4a4-68a5-4ce3-b85e-93fde58d6ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_7f0f221d-5bbb-45c6-99f1-fda0a268454b" xlink:href="peak-20220331.xsd#peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0120f490-26d2-42d9-b8ac-cbf6aeb5ca7d" xlink:to="loc_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime_7f0f221d-5bbb-45c6-99f1-fda0a268454b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#EquityandRedeemableNoncontrollingInterestsAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_bc6df4b1-fbb9-44c9-9104-46c9f76b504d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7f4d0f5b-54fa-44c4-a0b2-18cb06fe816b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bc6df4b1-fbb9-44c9-9104-46c9f76b504d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7f4d0f5b-54fa-44c4-a0b2-18cb06fe816b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_345ccb3a-f71c-487d-bb0f-06de6d234bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7f4d0f5b-54fa-44c4-a0b2-18cb06fe816b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_345ccb3a-f71c-487d-bb0f-06de6d234bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b0f1008a-a1bf-45c6-a7e1-f115e3c73274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7f4d0f5b-54fa-44c4-a0b2-18cb06fe816b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b0f1008a-a1bf-45c6-a7e1-f115e3c73274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShare" xlink:type="simple" xlink:href="peak-20220331.xsd#EarningsPerCommonShare"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_92567eef-2c38-4a56-b992-5920a3feb5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a067aef3-3169-4b17-9353-a27f8bfcf798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_92567eef-2c38-4a56-b992-5920a3feb5a2" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a067aef3-3169-4b17-9353-a27f8bfcf798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareTables" xlink:type="simple" xlink:href="peak-20220331.xsd#EarningsPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7c7e6c91-4b3b-42f0-85bf-9ea0a5361cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_681b091c-5949-41bc-93ce-40135d8b8b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c7e6c91-4b3b-42f0-85bf-9ea0a5361cf7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_681b091c-5949-41bc-93ce-40135d8b8b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#EarningsPerCommonShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f528f3bf-058d-4b59-8bb5-b19ec2a34f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eef1b23f-dfbb-4dcc-b4aa-c2f9b4b5d949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f528f3bf-058d-4b59-8bb5-b19ec2a34f0e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eef1b23f-dfbb-4dcc-b4aa-c2f9b4b5d949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5b0b262f-6d53-4e41-b474-9027c7e38dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eef1b23f-dfbb-4dcc-b4aa-c2f9b4b5d949" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5b0b262f-6d53-4e41-b474-9027c7e38dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_967e0c02-b3eb-4e91-9229-a042d51331d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5b0b262f-6d53-4e41-b474-9027c7e38dce" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_967e0c02-b3eb-4e91-9229-a042d51331d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownREITMember_45fdb6da-b2d0-40f5-86de-d6ca8366f915" xlink:href="peak-20220331.xsd#peak_DownREITMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_967e0c02-b3eb-4e91-9229-a042d51331d5" xlink:to="loc_peak_DownREITMember_45fdb6da-b2d0-40f5-86de-d6ca8366f915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b514ecfa-4abb-4ac1-89a4-d6377d6d4057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eef1b23f-dfbb-4dcc-b4aa-c2f9b4b5d949" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b514ecfa-4abb-4ac1-89a4-d6377d6d4057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_342eeb09-1b61-4c6c-9651-7d86da97b38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b514ecfa-4abb-4ac1-89a4-d6377d6d4057" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_342eeb09-1b61-4c6c-9651-7d86da97b38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f038630d-0920-41f1-ab47-df7038aa6682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b514ecfa-4abb-4ac1-89a4-d6377d6d4057" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f038630d-0920-41f1-ab47-df7038aa6682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#EarningsPerCommonShareComputationofEPSDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6d3548c5-ebe5-431c-8d98-daa9d057ee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3548c5-ebe5-431c-8d98-daa9d057ee3d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e50802c3-4b3e-4ca8-b9e2-c3397a45ccfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e50802c3-4b3e-4ca8-b9e2-c3397a45ccfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_52ed9a06-38d4-4f58-94c5-41c4eb6bb6db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_52ed9a06-38d4-4f58-94c5-41c4eb6bb6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_43f5970e-c37f-406c-ba62-e7a98857873b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_43f5970e-c37f-406c-ba62-e7a98857873b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_1631d52e-f7b6-474d-b93e-167124c356ab" xlink:href="peak-20220331.xsd#peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:to="loc_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted_1631d52e-f7b6-474d-b93e-167124c356ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_b81434f2-c7a9-4819-962d-8c642d871999" xlink:href="peak-20220331.xsd#peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:to="loc_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic_b81434f2-c7a9-4819-962d-8c642d871999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_209a2910-b52c-4529-83fa-027debc44f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_209a2910-b52c-4529-83fa-027debc44f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NoncontrollingInterestsShareInDiscontinuedOperations_b6fafb16-d96a-43f9-9171-6f698ed90e33" xlink:href="peak-20220331.xsd#peak_NoncontrollingInterestsShareInDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:to="loc_peak_NoncontrollingInterestsShareInDiscontinuedOperations_b6fafb16-d96a-43f9-9171-6f698ed90e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1dd0cffd-c0d4-43d9-bb53-32f1370058a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_135ec2f7-a853-44e4-9445-5ba0332f430a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1dd0cffd-c0d4-43d9-bb53-32f1370058a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a73f758e-1393-47d6-9dae-05449c180322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3548c5-ebe5-431c-8d98-daa9d057ee3d" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a73f758e-1393-47d6-9dae-05449c180322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ad629567-b67b-49b5-a863-7b50defc1e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a73f758e-1393-47d6-9dae-05449c180322" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ad629567-b67b-49b5-a863-7b50defc1e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b561c7c1-b28b-4f0a-8628-dc219f187716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a73f758e-1393-47d6-9dae-05449c180322" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b561c7c1-b28b-4f0a-8628-dc219f187716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f496ae8-0384-4b4c-ab93-d63846089ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a73f758e-1393-47d6-9dae-05449c180322" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f496ae8-0384-4b4c-ab93-d63846089ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_4a9e092c-e96d-4a20-ad00-9056f49c0846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3548c5-ebe5-431c-8d98-daa9d057ee3d" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_4a9e092c-e96d-4a20-ad00-9056f49c0846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c4aefef3-23e6-4480-9524-17f600e2a04a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_4a9e092c-e96d-4a20-ad00-9056f49c0846" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c4aefef3-23e6-4480-9524-17f600e2a04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d9fa7102-369a-4ca1-836d-d2484100a5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_4a9e092c-e96d-4a20-ad00-9056f49c0846" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d9fa7102-369a-4ca1-836d-d2484100a5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_951c7795-decb-4430-9d1c-770c0b49ef07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_4a9e092c-e96d-4a20-ad00-9056f49c0846" xlink:to="loc_us-gaap_EarningsPerShareBasic_951c7795-decb-4430-9d1c-770c0b49ef07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_bfb0398d-f0e1-4290-a569-586e68c869a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3548c5-ebe5-431c-8d98-daa9d057ee3d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_bfb0398d-f0e1-4290-a569-586e68c869a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_28a87c0b-8788-4596-9786-113219aa27db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_bfb0398d-f0e1-4290-a569-586e68c869a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_28a87c0b-8788-4596-9786-113219aa27db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_bb6b0659-6ef3-45fb-a96d-0b81eb6d1d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_bfb0398d-f0e1-4290-a569-586e68c869a4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_bb6b0659-6ef3-45fb-a96d-0b81eb6d1d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4165017d-a464-4276-918e-26f91f14fd47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_bfb0398d-f0e1-4290-a569-586e68c869a4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4165017d-a464-4276-918e-26f91f14fd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_43d9cc43-4176-479f-9c48-daaaf9f2bc9c" xlink:href="peak-20220331.xsd#peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3548c5-ebe5-431c-8d98-daa9d057ee3d" xlink:to="loc_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards_43d9cc43-4176-479f-9c48-daaaf9f2bc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_95aee96e-6d22-4fd1-9df2-fa3cbee532b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3548c5-ebe5-431c-8d98-daa9d057ee3d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_95aee96e-6d22-4fd1-9df2-fa3cbee532b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled_13e51342-5ad4-4812-b352-756630ab5d34" xlink:href="peak-20220331.xsd#peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3548c5-ebe5-431c-8d98-daa9d057ee3d" xlink:to="loc_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled_13e51342-5ad4-4812-b352-756630ab5d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosures" xlink:type="simple" xlink:href="peak-20220331.xsd#SegmentDisclosures"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bd069e9b-950e-4983-bb8c-4adb0adbd6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9ca9542c-c8dc-4830-8103-e45872509d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bd069e9b-950e-4983-bb8c-4adb0adbd6a2" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_9ca9542c-c8dc-4830-8103-e45872509d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresTables" xlink:type="simple" xlink:href="peak-20220331.xsd#SegmentDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_54ad6fd8-43cb-4e46-905d-c4743401d5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_af6ea5d0-ecb9-4cf1-813e-50fa95915c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_54ad6fd8-43cb-4e46-905d-c4743401d5ae" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_af6ea5d0-ecb9-4cf1-813e-50fa95915c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_19c13a6e-3955-497a-8f8d-53b441e53110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_19c13a6e-3955-497a-8f8d-53b441e53110" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_25b67446-3c9a-42db-a338-4f9b1be3f06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_25b67446-3c9a-42db-a338-4f9b1be3f06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25b67446-3c9a-42db-a338-4f9b1be3f06b" xlink:to="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_4e4d84c4-34a0-4444-ad2d-58c9b9463cbe" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:to="loc_peak_LifeScienceMember_4e4d84c4-34a0-4444-ad2d-58c9b9463cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_763a09a5-e0a7-4e53-85c9-97c593a9bf47" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:to="loc_peak_MedicalOfficeMember_763a09a5-e0a7-4e53-85c9-97c593a9bf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CCRCSegmentMember_bcdc434c-5796-4708-a06b-c88c4d32858c" xlink:href="peak-20220331.xsd#peak_CCRCSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:to="loc_peak_CCRCSegmentMember_bcdc434c-5796-4708-a06b-c88c4d32858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OtherNonReportingSegmentMember_3953b736-448b-4afc-baf1-41ecdcab1d34" xlink:href="peak-20220331.xsd#peak_OtherNonReportingSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ed42c4a1-1822-41b4-8b3e-5ad462465d1f" xlink:to="loc_peak_OtherNonReportingSegmentMember_3953b736-448b-4afc-baf1-41ecdcab1d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6d3a5c42-1cfa-4aed-a628-836ac91d86b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:to="loc_srt_ConsolidationItemsAxis_6d3a5c42-1cfa-4aed-a628-836ac91d86b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d7037ac7-6942-496f-915e-a113e002fa38" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6d3a5c42-1cfa-4aed-a628-836ac91d86b4" xlink:to="loc_srt_ConsolidationItemsDomain_d7037ac7-6942-496f-915e-a113e002fa38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6459791f-e400-420a-90ff-03d6d58fe306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d7037ac7-6942-496f-915e-a113e002fa38" xlink:to="loc_us-gaap_OperatingSegmentsMember_6459791f-e400-420a-90ff-03d6d58fe306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_332085f6-1577-425c-8c31-3038eabf6ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d7037ac7-6942-496f-915e-a113e002fa38" xlink:to="loc_us-gaap_CorporateNonSegmentMember_332085f6-1577-425c-8c31-3038eabf6ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bea8c690-f2a0-42e7-86ed-0190bdedd938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e838a02f-f78c-4121-963b-92c01f4b54d2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_bea8c690-f2a0-42e7-86ed-0190bdedd938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_24ecbd19-e0e8-4158-882a-2a80ca095022" xlink:href="peak-20220331.xsd#peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bea8c690-f2a0-42e7-86ed-0190bdedd938" xlink:to="loc_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture_24ecbd19-e0e8-4158-882a-2a80ca095022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bea8c690-f2a0-42e7-86ed-0190bdedd938" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2a0d36e7-a912-40ee-990b-22f552157416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_Revenues_2a0d36e7-a912-40ee-990b-22f552157416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_GovernmentGrantIncomeFromCARESAct_89402da7-7119-433f-820a-7927b3ce7493" xlink:href="peak-20220331.xsd#peak_GovernmentGrantIncomeFromCARESAct"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_GovernmentGrantIncomeFromCARESAct_89402da7-7119-433f-820a-7927b3ce7493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_f600b433-0157-4d65-a4b6-20b0a72778b4" xlink:href="peak-20220331.xsd#peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations_f600b433-0157-4d65-a4b6-20b0a72778b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_ab2d8b63-6a8e-4913-b2da-89351558bc83" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToParent_ab2d8b63-6a8e-4913-b2da-89351558bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_1276d7cf-2b92-451c-a85a-f27ba0b000b8" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome_1276d7cf-2b92-451c-a85a-f27ba0b000b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_6a440266-6c9d-4d1c-837b-2dd0cf7b2caa" xlink:href="peak-20220331.xsd#peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest_6a440266-6c9d-4d1c-837b-2dd0cf7b2caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_947c726b-91d1-463f-b0a9-fd7c65f342b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_OperatingExpenses_947c726b-91d1-463f-b0a9-fd7c65f342b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_8e607400-083f-4304-b1ed-286772173380" xlink:href="peak-20220331.xsd#peak_OperatingExpensesFromJointVentureAttributableToParentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToParentNet_8e607400-083f-4304-b1ed-286772173380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_aef24ea7-5032-4fd0-bdc7-ba589f56ca90" xlink:href="peak-20220331.xsd#peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest_aef24ea7-5032-4fd0-bdc7-ba589f56ca90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_3f9dfc32-51fe-4a68-9a46-ff630f62bf73" xlink:href="peak-20220331.xsd#peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations_3f9dfc32-51fe-4a68-9a46-ff630f62bf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_c3c53ee7-13fb-4e06-b23b-7c91838336e6" xlink:href="peak-20220331.xsd#peak_AdjustedNetOperatingIncomeFromContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_AdjustedNetOperatingIncomeFromContinuingOperations_c3c53ee7-13fb-4e06-b23b-7c91838336e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_7a02e5be-aa47-47bf-810a-6fa75ab025ae" xlink:href="peak-20220331.xsd#peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments_7a02e5be-aa47-47bf-810a-6fa75ab025ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_560c83c6-16aa-4c0e-9113-a99b9daa4056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_InterestIncomeOperating_560c83c6-16aa-4c0e-9113-a99b9daa4056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0e642f1b-d270-4afc-a358-402c290efe60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_InterestExpense_0e642f1b-d270-4afc-a358-402c290efe60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d1031bc7-902c-487d-ae5c-6482b9a00037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_DepreciationAndAmortization_d1031bc7-902c-487d-ae5c-6482b9a00037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ef0acbbf-cfc6-4725-b414-d116dbd0f889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ef0acbbf-cfc6-4725-b414-d116dbd0f889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_db6844a4-3b91-4296-895c-5b83b73b80fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_db6844a4-3b91-4296-895c-5b83b73b80fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_aba16f98-5cdd-40d3-97b0-329d358069d6" xlink:href="peak-20220331.xsd#peak_ImpairmentsAndAllowanceForCreditLossReserves"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_ImpairmentsAndAllowanceForCreditLossReserves_aba16f98-5cdd-40d3-97b0-329d358069d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_b4576588-a758-4dee-a87f-51a4b2878760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_b4576588-a758-4dee-a87f-51a4b2878760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd022511-448a-44b9-abff-3b3ce264f19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fd022511-448a-44b9-abff-3b3ce264f19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2131d55e-d5f9-4f9a-9623-1ceb3e7e4f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2131d55e-d5f9-4f9a-9623-1ceb3e7e4f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_2baebbcd-36c4-4ac2-a96d-78cbe2b188a7" xlink:href="peak-20220331.xsd#peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations_2baebbcd-36c4-4ac2-a96d-78cbe2b188a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_3d0ac98f-fd15-4c63-9a7c-01e2df08eacb" xlink:href="peak-20220331.xsd#peak_NetIncomeLossJointVenturePartnersAttributableToParent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_peak_NetIncomeLossJointVenturePartnersAttributableToParent_3d0ac98f-fd15-4c63-9a7c-01e2df08eacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_5fc86600-6600-41b8-87fd-e3da826127d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable_5fc86600-6600-41b8-87fd-e3da826127d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5945b900-bc35-401a-9e36-7ec75fc6af59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5945b900-bc35-401a-9e36-7ec75fc6af59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_95e5088b-e6f2-4201-989b-e3bbdf8b3865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_95e5088b-e6f2-4201-989b-e3bbdf8b3865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ee349a1-1f2f-4a0e-a0f8-e6d10f9b88fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ee349a1-1f2f-4a0e-a0f8-e6d10f9b88fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_31d8e21b-5d66-49ca-8149-2fe46adfc3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_31d8e21b-5d66-49ca-8149-2fe46adfc3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e6bef460-9ede-4c5f-a503-a9560c8d4b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e6bef460-9ede-4c5f-a503-a9560c8d4b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_70dee998-4c26-4ab0-a906-07556797bc09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_7cd791c5-afb0-4c20-ad3d-d4734df44cbc" xlink:to="loc_us-gaap_ProfitLoss_70dee998-4c26-4ab0-a906-07556797bc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformation" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_d720f1b8-41b3-427b-9e7d-5c3eb9e51d13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_b11e38f2-b7c9-4be1-8f1a-504763f619c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_d720f1b8-41b3-427b-9e7d-5c3eb9e51d13" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_b11e38f2-b7c9-4be1-8f1a-504763f619c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationTables" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_7832d9ff-312d-405b-a703-bc48d13c670c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_e70a5683-4721-4dc1-bafc-7b34d2084fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_7832d9ff-312d-405b-a703-bc48d13c670c" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_e70a5683-4721-4dc1-bafc-7b34d2084fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_0875a540-71a6-46a8-89b2-d8ce836b0212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_7832d9ff-312d-405b-a703-bc48d13c670c" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_0875a540-71a6-46a8-89b2-d8ce836b0212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_2b73d956-d860-4c5a-811c-d6fd073170bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_ccc1306b-52dc-4bf0-89ec-913a3e53e498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2b73d956-d860-4c5a-811c-d6fd073170bf" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_ccc1306b-52dc-4bf0-89ec-913a3e53e498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_68d05196-b4ac-4fe2-b6c8-5f93f7225e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ccc1306b-52dc-4bf0-89ec-913a3e53e498" xlink:to="loc_us-gaap_InterestPaidNet_68d05196-b4ac-4fe2-b6c8-5f93f7225e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_20723c8a-e6c5-4106-a3e9-2a1501539172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ccc1306b-52dc-4bf0-89ec-913a3e53e498" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_20723c8a-e6c5-4106-a3e9-2a1501539172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_f1e43a8d-70b7-4c1e-a289-18c1e06fe23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ccc1306b-52dc-4bf0-89ec-913a3e53e498" xlink:to="loc_us-gaap_InterestCostsCapitalized_f1e43a8d-70b7-4c1e-a289-18c1e06fe23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c6fa8431-a220-4028-80ab-6fa42d17d90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2b73d956-d860-4c5a-811c-d6fd073170bf" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c6fa8431-a220-4028-80ab-6fa42d17d90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1c9bf33a-f31a-4404-96fb-f22b9ca4ac4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c6fa8431-a220-4028-80ab-6fa42d17d90d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1c9bf33a-f31a-4404-96fb-f22b9ca4ac4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset_a1436e22-dc13-4ebb-b183-7ed5f57f0b7f" xlink:href="peak-20220331.xsd#peak_SellerFinancingProvidedOnDispositionofRealEstateAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c6fa8431-a220-4028-80ab-6fa42d17d90d" xlink:to="loc_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset_a1436e22-dc13-4ebb-b183-7ed5f57f0b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_bcf5ed41-17f4-47fe-952d-13df037aa7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c6fa8431-a220-4028-80ab-6fa42d17d90d" xlink:to="loc_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_bcf5ed41-17f4-47fe-952d-13df037aa7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedStockVested_5483f681-721d-4737-b571-90a331fd0889" xlink:href="peak-20220331.xsd#peak_RestrictedStockVested"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c6fa8431-a220-4028-80ab-6fa42d17d90d" xlink:to="loc_peak_RestrictedStockVested_5483f681-721d-4737-b571-90a331fd0889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_547167c6-371c-481e-b949-99b65fcf540f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_28359b50-8d2d-4d65-a475-015fb048fca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_547167c6-371c-481e-b949-99b65fcf540f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_28359b50-8d2d-4d65-a475-015fb048fca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_1d5b686d-9bb3-4546-8030-0bbe186c3a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_28359b50-8d2d-4d65-a475-015fb048fca1" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_1d5b686d-9bb3-4546-8030-0bbe186c3a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_f7344b3c-12a6-4e15-bd4e-f089e05a0e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_1d5b686d-9bb3-4546-8030-0bbe186c3a97" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_f7344b3c-12a6-4e15-bd4e-f089e05a0e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_23b41b11-2cf4-4cfc-9826-215299dff302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_f7344b3c-12a6-4e15-bd4e-f089e05a0e1c" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_23b41b11-2cf4-4cfc-9826-215299dff302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_28359b50-8d2d-4d65-a475-015fb048fca1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_f19c7535-206f-492d-8a37-d40e2ac3d81b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:to="loc_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements_f19c7535-206f-492d-8a37-d40e2ac3d81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_e7226321-52c0-4456-9ec0-280cbd60e6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_e7226321-52c0-4456-9ec0-280cbd60e6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_b145872a-48b6-4601-923c-f7c21fedbf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_682ac1c6-a507-49ef-a23b-63de81baeec8" xlink:to="loc_us-gaap_DepreciationAndAmortization_b145872a-48b6-4601-923c-f7c21fedbf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_76563c3e-bb39-416a-88c5-f1857db165d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_8f5acd02-2f62-4dcf-b688-22bc3caeed11" xlink:href="peak-20220331.xsd#peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_76563c3e-bb39-416a-88c5-f1857db165d7" xlink:to="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_8f5acd02-2f62-4dcf-b688-22bc3caeed11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_bd43a5c6-5c17-4308-a550-ab4a91a427d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_8f5acd02-2f62-4dcf-b688-22bc3caeed11" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_bd43a5c6-5c17-4308-a550-ab4a91a427d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4062e81a-2608-4568-add8-20909f82eb61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_bd43a5c6-5c17-4308-a550-ab4a91a427d1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4062e81a-2608-4568-add8-20909f82eb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_322ae5e1-4897-460c-ac9e-0547a0b1c51b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_bd43a5c6-5c17-4308-a550-ab4a91a427d1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_322ae5e1-4897-460c-ac9e-0547a0b1c51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7318f586-0a1a-4c9a-b15a-60c11c886d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_bd43a5c6-5c17-4308-a550-ab4a91a427d1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7318f586-0a1a-4c9a-b15a-60c11c886d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_ae1556d8-6579-400f-a22c-bc16b9cb3384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashIncludingDiscontinuedOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward_8f5acd02-2f62-4dcf-b688-22bc3caeed11" xlink:to="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_ae1556d8-6579-400f-a22c-bc16b9cb3384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_18bca4fd-dbe9-40df-af60-721e62f75bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_ae1556d8-6579-400f-a22c-bc16b9cb3384" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_18bca4fd-dbe9-40df-af60-721e62f75bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_c34d8d93-13e8-4220-bbf3-034e21521187" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_ae1556d8-6579-400f-a22c-bc16b9cb3384" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents_c34d8d93-13e8-4220-bbf3-034e21521187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_64d9157e-8447-4ddc-9efe-ba3881dbb594" xlink:href="peak-20220331.xsd#peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashIncludingDiscontinuedOperationsAbstract_ae1556d8-6579-400f-a22c-bc16b9cb3384" xlink:to="loc_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_64d9157e-8447-4ddc-9efe-ba3881dbb594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_cc83b9ad-d4a7-418b-98fc-9b83522a83b7" xlink:href="peak-20220331.xsd#peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_76563c3e-bb39-416a-88c5-f1857db165d7" xlink:to="loc_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_cc83b9ad-d4a7-418b-98fc-9b83522a83b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_13ff42fd-32d8-41a0-aee5-02bc02590435" xlink:href="peak-20220331.xsd#peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_76563c3e-bb39-416a-88c5-f1857db165d7" xlink:to="loc_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal_13ff42fd-32d8-41a0-aee5-02bc02590435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3eeaf0fc-bfb5-4fb6-8671-c84df11861d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_76563c3e-bb39-416a-88c5-f1857db165d7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3eeaf0fc-bfb5-4fb6-8671-c84df11861d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="simple" xlink:href="peak-20220331.xsd#SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="peak-20220331.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_c5427db2-b711-4384-b13a-36c2e223152c" xlink:href="peak-20220331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesTextBlock_9eed96c4-4fdd-4f84-865e-40fd73e2e8eb" xlink:href="peak-20220331.xsd#peak_VariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_c5427db2-b711-4384-b13a-36c2e223152c" xlink:to="loc_peak_VariableInterestEntitiesTextBlock_9eed96c4-4fdd-4f84-865e-40fd73e2e8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesTables" xlink:type="simple" xlink:href="peak-20220331.xsd#VariableInterestEntitiesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_c63f707b-643a-4a78-9c1b-0d9d00c88806" xlink:href="peak-20220331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_183bceb5-decf-4b18-9b96-2658bef1cbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_c63f707b-643a-4a78-9c1b-0d9d00c88806" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_183bceb5-decf-4b18-9b96-2658bef1cbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_442a6144-4229-464b-b305-f86f7a8995c7" xlink:href="peak-20220331.xsd#peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_c63f707b-643a-4a78-9c1b-0d9d00c88806" xlink:to="loc_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock_442a6144-4229-464b-b305-f86f7a8995c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#VariableInterestEntitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_3371787c-9457-4753-9cf1-435b1259f32a" xlink:href="peak-20220331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_3371787c-9457-4753-9cf1-435b1259f32a" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_960e3624-6767-48c2-aabc-ab2c620088fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_960e3624-6767-48c2-aabc-ab2c620088fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_47269690-370b-46db-9a53-20fbe72d7c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_960e3624-6767-48c2-aabc-ab2c620088fe" xlink:to="loc_us-gaap_SegmentDomain_47269690-370b-46db-9a53-20fbe72d7c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceMember_94dd655a-3ed3-456b-b22b-f4eb37964949" xlink:href="peak-20220331.xsd#peak_LifeScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_47269690-370b-46db-9a53-20fbe72d7c42" xlink:to="loc_peak_LifeScienceMember_94dd655a-3ed3-456b-b22b-f4eb37964949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MedicalOfficeMember_bcb3bffe-5eff-4586-b01d-6eb0cf14b555" xlink:href="peak-20220331.xsd#peak_MedicalOfficeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_47269690-370b-46db-9a53-20fbe72d7c42" xlink:to="loc_peak_MedicalOfficeMember_bcb3bffe-5eff-4586-b01d-6eb0cf14b555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_a7e517b4-7cbb-4177-9177-0873c599d3d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_a7e517b4-7cbb-4177-9177-0873c599d3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a7e517b4-7cbb-4177-9177-0873c599d3d6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_df60d6ea-aa30-4b9d-b17d-b1adb653d647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_df60d6ea-aa30-4b9d-b17d-b1adb653d647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VenturesVLLCMember_fc8ef6f1-8bb9-48cb-b434-8b872ebb3933" xlink:href="peak-20220331.xsd#peak_VenturesVLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_peak_VenturesVLLCMember_fc8ef6f1-8bb9-48cb-b434-8b872ebb3933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_LifeScienceJVsMember_e72d25f3-9b6f-480f-8f5a-b23b2f3806c6" xlink:href="peak-20220331.xsd#peak_LifeScienceJVsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_peak_LifeScienceJVsMember_e72d25f3-9b6f-480f-8f5a-b23b2f3806c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_MorganStanleyRealEstateInvestmentJVMember_abdd1c33-20f9-4680-9896-ae53155b9faa" xlink:href="peak-20220331.xsd#peak_MorganStanleyRealEstateInvestmentJVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_peak_MorganStanleyRealEstateInvestmentJVMember_abdd1c33-20f9-4680-9896-ae53155b9faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DownreitPartnershipsMember_5fb6a348-6e0a-466c-bd6f-32f0b69e3b6b" xlink:href="peak-20220331.xsd#peak_DownreitPartnershipsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_55de2c35-ec37-4b2e-8aa2-263a3640e061" xlink:to="loc_peak_DownreitPartnershipsMember_5fb6a348-6e0a-466c-bd6f-32f0b69e3b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_33dffba9-c405-4e81-ac5a-d02033a70ac8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b810dbc1-ee50-4fe8-af5b-c1282ef0ad4a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_33dffba9-c405-4e81-ac5a-d02033a70ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NeedhamLandParcelJVMember_f888aa23-6389-430b-9fb0-35a2ec7470a9" xlink:href="peak-20220331.xsd#peak_NeedhamLandParcelJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_33dffba9-c405-4e81-ac5a-d02033a70ac8" xlink:to="loc_peak_NeedhamLandParcelJVMember_f888aa23-6389-430b-9fb0-35a2ec7470a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_a5b3b7cc-a0d9-4850-9139-bd6c1d2487dc" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfUnconsolidatedJointVenture_56b125af-9497-46b2-a898-5e58a0397b8b" xlink:href="peak-20220331.xsd#peak_NumberOfUnconsolidatedJointVenture"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_NumberOfUnconsolidatedJointVenture_56b125af-9497-46b2-a898-5e58a0397b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_4300d3b9-e20b-492f-9dc5-fb841b88393c" xlink:href="peak-20220331.xsd#peak_NumberOfVieBorrowersWithMarketableDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_NumberOfVieBorrowersWithMarketableDebtSecurities_4300d3b9-e20b-492f-9dc5-fb841b88393c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6082abf8-3f40-4cba-b75c-91b368ce8f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_6082abf8-3f40-4cba-b75c-91b368ce8f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_148c9441-e1e4-4a6c-8614-13f382162f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_148c9441-e1e4-4a6c-8614-13f382162f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_31860ebc-2f82-4fd2-b7bd-c1dee522e280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_31860ebc-2f82-4fd2-b7bd-c1dee522e280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_c05744aa-83aa-466a-ba6c-d87b97af207e" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership_c05744aa-83aa-466a-ba6c-d87b97af207e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfPropertiesAcquired_7a87bb05-a68a-41b6-b3e5-3e1675a0a9e7" xlink:href="peak-20220331.xsd#peak_NumberOfPropertiesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_NumberOfPropertiesAcquired_7a87bb05-a68a-41b6-b3e5-3e1675a0a9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue_715566e7-d94d-4e70-bd8b-dc456a4135fb" xlink:href="peak-20220331.xsd#peak_ExchangeAccommodationTitleholderRealEstateCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_34cc78fa-eccb-4350-a44f-a8ce8eaff2cd" xlink:to="loc_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue_715566e7-d94d-4e70-bd8b-dc456a4135fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_b9ce2505-d51d-4be9-a40c-937d9f374a87" xlink:href="peak-20220331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e04a24dc-e329-4ef0-a5cf-ccd55b281e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_b9ce2505-d51d-4be9-a40c-937d9f374a87" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e04a24dc-e329-4ef0-a5cf-ccd55b281e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_c00e3594-d8aa-420a-9da3-f16331577061" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e04a24dc-e329-4ef0-a5cf-ccd55b281e38" xlink:to="loc_srt_ConsolidatedEntitiesAxis_c00e3594-d8aa-420a-9da3-f16331577061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e0636379-a306-48e6-a803-ef29b471db5d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c00e3594-d8aa-420a-9da3-f16331577061" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e0636379-a306-48e6-a803-ef29b471db5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_ba8634d9-b982-477d-a883-e32017e9174b" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e0636379-a306-48e6-a803-ef29b471db5d" xlink:to="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember_ba8634d9-b982-477d-a883-e32017e9174b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_2cafe1dd-f77f-456e-a346-29a784c41d7c" xlink:href="peak-20220331.xsd#peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e0636379-a306-48e6-a803-ef29b471db5d" xlink:to="loc_peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember_2cafe1dd-f77f-456e-a346-29a784c41d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_448a61de-b317-489c-b45e-e6256eb75d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_e04a24dc-e329-4ef0-a5cf-ccd55b281e38" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_448a61de-b317-489c-b45e-e6256eb75d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_7ce89141-536e-4f1e-8d09-1760b82e7b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_448a61de-b317-489c-b45e-e6256eb75d96" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_7ce89141-536e-4f1e-8d09-1760b82e7b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_peak_VariableInterestEntitiesAbstract_9d90b016-5992-4dfb-ac28-ead7b7317473" xlink:href="peak-20220331.xsd#peak_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_peak_VariableInterestEntitiesAbstract_9d90b016-5992-4dfb-ac28-ead7b7317473" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_743d1ddd-3741-4bf4-a0ab-7e42f44f88a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6f5678a6-b4d6-450f-9e0b-e8b8236b41ee" xlink:to="loc_srt_ConsolidatedEntitiesDomain_743d1ddd-3741-4bf4-a0ab-7e42f44f88a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_86d8b29a-d277-4779-8a2a-0720ae980f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_743d1ddd-3741-4bf4-a0ab-7e42f44f88a0" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_86d8b29a-d277-4779-8a2a-0720ae980f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_30b79d65-2d3d-4fd0-be63-377f43fa609d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_8b5a0bf6-5faf-4b01-8f0e-2f9f79037294" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_30b79d65-2d3d-4fd0-be63-377f43fa609d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_2697af9b-558b-49bd-8fb0-b9d9d22a8a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_30b79d65-2d3d-4fd0-be63-377f43fa609d" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_2697af9b-558b-49bd-8fb0-b9d9d22a8a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_2093c6de-5092-4501-a647-192394616987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_0cd50f63-c519-4628-8961-c020838e1f77" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_2093c6de-5092-4501-a647-192394616987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2093c6de-5092-4501-a647-192394616987" xlink:to="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_74f0151d-2f94-461c-83b3-3fa83e677c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_74f0151d-2f94-461c-83b3-3fa83e677c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_4d1ac8ef-6898-468a-9839-4414a6c81487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopmentInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_DevelopmentInProcess_4d1ac8ef-6898-468a-9839-4414a6c81487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_c525ddfd-a7d6-4573-a0bf-346d87596e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_Land_c525ddfd-a7d6-4573-a0bf-346d87596e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_72e158c3-e6b7-49dd-aab0-d017dc90f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_72e158c3-e6b7-49dd-aab0-d017dc90f0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_d9378fb1-3b10-488f-926a-f98549f5e6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_d9378fb1-3b10-488f-926a-f98549f5e6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_1b707470-25e6-4e59-ba55-6edc9c432de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_AccountsReceivableNet_1b707470-25e6-4e59-ba55-6edc9c432de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6116cae5-1825-4c0e-813f-be10c575629a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6116cae5-1825-4c0e-813f-be10c575629a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f7b3b7bd-2f4b-43f6-90ad-050f2d2019e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f7b3b7bd-2f4b-43f6-90ad-050f2d2019e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5696cbfe-4792-4f68-912d-5bd46ce1fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5696cbfe-4792-4f68-912d-5bd46ce1fd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_cab75d0e-5e03-49f9-a4c5-d83cf30a6613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_cab75d0e-5e03-49f9-a4c5-d83cf30a6613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8a762a5b-c1c4-4842-88ad-8a5228ef775b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8a762a5b-c1c4-4842-88ad-8a5228ef775b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_4f68e9e6-395c-4fd0-9375-748f8f8a05a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_OtherAssets_4f68e9e6-395c-4fd0-9375-748f8f8a05a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e0ae7521-0571-4cbc-a5a3-8e5f44b09745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9c10c1c2-b233-4c00-a8e5-71243c73a5b5" xlink:to="loc_us-gaap_Assets_e0ae7521-0571-4cbc-a5a3-8e5f44b09745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2093c6de-5092-4501-a647-192394616987" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_b52c767d-d60f-4660-bcd5-bd6b95ab4dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_SecuredDebt_b52c767d-d60f-4660-bcd5-bd6b95ab4dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffMarketLeaseUnfavorable_17695fe6-138a-4d68-bd02-d366502d6f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffMarketLeaseUnfavorable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_OffMarketLeaseUnfavorable_17695fe6-138a-4d68-bd02-d366502d6f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c59cc4a5-e712-4e92-bfad-975c0bd38a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c59cc4a5-e712-4e92-bfad-975c0bd38a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_79402844-f15c-49a0-ab02-4131b4295300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_OperatingLeaseLiability_79402844-f15c-49a0-ab02-4131b4295300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_45f89baa-183f-486f-9246-28ea1a391bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_45f89baa-183f-486f-9246-28ea1a391bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_f13c2721-6f3f-425c-b928-135a9c0d192c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_f13c2721-6f3f-425c-b928-135a9c0d192c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1cef9808-4c45-4ab9-805f-dee2952206ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6ef7f584-a716-4efe-8a0e-0ec092d6faf1" xlink:to="loc_us-gaap_Liabilities_1cef9808-4c45-4ab9-805f-dee2952206ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="peak-20220331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract_00e67f87-78f1-4d6e-ae91-a68632a2b7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8796a46a-0bd6-415a-be41-7372df2aa8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract_00e67f87-78f1-4d6e-ae91-a68632a2b7b0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8796a46a-0bd6-415a-be41-7372df2aa8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="peak-20220331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract_1f95abaa-dd7f-46aa-87a9-1a1068093f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a3e68e39-5dfd-44a6-a2f8-a01d1effb43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract_1f95abaa-dd7f-46aa-87a9-1a1068093f89" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a3e68e39-5dfd-44a6-a2f8-a01d1effb43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract_2238375f-c2fa-4c73-acba-6b4616dc50bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract_2238375f-c2fa-4c73-acba-6b4616dc50bd" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9a6508d-8224-4a5e-bc04-2fa2ce3ce02c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e16ad3a6-f71d-44b5-ba3a-cfe7c75169ce" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9a6508d-8224-4a5e-bc04-2fa2ce3ce02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b0b53fa7-5020-41fd-96bd-d5fb195cccda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b9a6508d-8224-4a5e-bc04-2fa2ce3ce02c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b0b53fa7-5020-41fd-96bd-d5fb195cccda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_8bfec39a-4882-4b01-9694-c58d4c440551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b0b53fa7-5020-41fd-96bd-d5fb195cccda" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_8bfec39a-4882-4b01-9694-c58d4c440551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3e82d27d-08f0-4da1-b16e-b43b5ee2e015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b0b53fa7-5020-41fd-96bd-d5fb195cccda" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3e82d27d-08f0-4da1-b16e-b43b5ee2e015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_358b12d4-5bd2-4cb7-a973-843ca9a39ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_358b12d4-5bd2-4cb7-a973-843ca9a39ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9ffaceb-9fab-490a-a7c9-a8b0b959796f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_358b12d4-5bd2-4cb7-a973-843ca9a39ea2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9ffaceb-9fab-490a-a7c9-a8b0b959796f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8ce53384-ceec-4795-b3fa-f30410faa908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9ffaceb-9fab-490a-a7c9-a8b0b959796f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8ce53384-ceec-4795-b3fa-f30410faa908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_66d8faff-ddc7-4496-8da6-dad7b70ba290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9ffaceb-9fab-490a-a7c9-a8b0b959796f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_66d8faff-ddc7-4496-8da6-dad7b70ba290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_2e45ae38-e3fd-4989-91e4-988cb335f70f" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableFairValueDisclosure_c8f56422-01f6-4d4e-824f-975198a91313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_LoansReceivableFairValueDisclosure_c8f56422-01f6-4d4e-824f-975198a91313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_19325866-8dbf-49d0-a8e4-d8c202506ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_19325866-8dbf-49d0-a8e4-d8c202506ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d1e27ae5-a2f4-4797-8767-8274aaba20c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_DerivativeAssets_d1e27ae5-a2f4-4797-8767-8274aaba20c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_5a375eab-dbe4-45c8-9128-a7c124e3a016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_LineOfCredit_5a375eab-dbe4-45c8-9128-a7c124e3a016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_f875cbb8-ec71-460c-93ce-f676ae9fced7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_UnsecuredDebt_f875cbb8-ec71-460c-93ce-f676ae9fced7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_7774bcce-263c-429d-abf3-7c3860d970a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f9d23ce5-7462-439f-b13d-2e8f7e2164ac" xlink:to="loc_us-gaap_SecuredDebt_7774bcce-263c-429d-abf3-7c3860d970a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="peak-20220331.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_12872fdc-b7af-44f2-94cb-59fe2840ee8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b831375a-a956-4ec3-a4a2-20e0f0373a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_12872fdc-b7af-44f2-94cb-59fe2840ee8e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_b831375a-a956-4ec3-a4a2-20e0f0373a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="peak-20220331.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_11fef3e6-4a2a-45cb-bb70-8dd18f1e88a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_60c1f807-6a0b-45e4-8f5d-3965fb64545a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_11fef3e6-4a2a-45cb-bb70-8dd18f1e88a6" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_60c1f807-6a0b-45e4-8f5d-3965fb64545a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DerivativeFinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_846bdb80-0df0-47f4-b469-d98a441e8ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_846bdb80-0df0-47f4-b469-d98a441e8ab6" xlink:to="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_11e5b7bd-6f24-4dbd-9999-6732e27743f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_11e5b7bd-6f24-4dbd-9999-6732e27743f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fa484d39-b3fa-4b9f-ac74-4e1b67561047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_11e5b7bd-6f24-4dbd-9999-6732e27743f3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fa484d39-b3fa-4b9f-ac74-4e1b67561047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_51a3bd2a-38a4-4971-8653-79a4429d36da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fa484d39-b3fa-4b9f-ac74-4e1b67561047" xlink:to="loc_us-gaap_SecuredDebtMember_51a3bd2a-38a4-4971-8653-79a4429d36da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_96510511-c046-40b6-ada7-98f77c60c3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_96510511-c046-40b6-ada7-98f77c60c3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_098462c9-01f3-418a-827e-1bffc5a07f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96510511-c046-40b6-ada7-98f77c60c3fa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_098462c9-01f3-418a-827e-1bffc5a07f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_eb79eea4-61db-4976-b69f-d830400270e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_098462c9-01f3-418a-827e-1bffc5a07f66" xlink:to="loc_us-gaap_SubsequentEventMember_eb79eea4-61db-4976-b69f-d830400270e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e2923c94-b1f5-41a0-b81d-400c3e1dd417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0c1fbcf8-440c-4dad-a8ab-74e2f3ec6d48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e2923c94-b1f5-41a0-b81d-400c3e1dd417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cc2f8c22-d72b-4621-b64c-71fc47993636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e2923c94-b1f5-41a0-b81d-400c3e1dd417" xlink:to="loc_us-gaap_InterestRateSwapMember_cc2f8c22-d72b-4621-b64c-71fc47993636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_bb168f4d-53d2-4218-82a2-7f941a13f6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e2923c94-b1f5-41a0-b81d-400c3e1dd417" xlink:to="loc_us-gaap_InterestRateCapMember_bb168f4d-53d2-4218-82a2-7f941a13f6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6ee376b3-cc0b-4022-8748-1896192f7cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_HedgingDesignationAxis_6ee376b3-cc0b-4022-8748-1896192f7cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e26b1f26-147b-42ed-a5c6-57a05fae816e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_6ee376b3-cc0b-4022-8748-1896192f7cda" xlink:to="loc_us-gaap_HedgingDesignationDomain_e26b1f26-147b-42ed-a5c6-57a05fae816e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_36bae637-dd90-4c28-a94a-09b3198a5b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_e26b1f26-147b-42ed-a5c6-57a05fae816e" xlink:to="loc_us-gaap_NondesignatedMember_36bae637-dd90-4c28-a94a-09b3198a5b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fe0adeed-b177-4d0b-89e6-82de0f6a9a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_e26b1f26-147b-42ed-a5c6-57a05fae816e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fe0adeed-b177-4d0b-89e6-82de0f6a9a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed24d1f-8ea9-4795-9a32-633abb1db381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed24d1f-8ea9-4795-9a32-633abb1db381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_60699ebd-8db3-411c-872d-84e3668600f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7ed24d1f-8ea9-4795-9a32-633abb1db381" xlink:to="loc_us-gaap_HedgingRelationshipDomain_60699ebd-8db3-411c-872d-84e3668600f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_0e27da98-746f-45b8-8da6-fbbc97ddbb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_60699ebd-8db3-411c-872d-84e3668600f6" xlink:to="loc_us-gaap_CashFlowHedgingMember_0e27da98-746f-45b8-8da6-fbbc97ddbb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_041da5e1-f32b-4157-820d-53e3629d0a6f" xlink:to="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_bdae0888-7629-4d28-9131-150e3e1584cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_bdae0888-7629-4d28-9131-150e3e1584cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_fd27c109-2a5e-4d2f-ac62-90f84be66dd3" xlink:href="peak-20220331.xsd#peak_NumberOfAssetsClassifiedAsDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations_fd27c109-2a5e-4d2f-ac62-90f84be66dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_NumberOfInterestRateDerivativesTerminated_8bc0eda2-b992-464b-a737-df4cd1db5964" xlink:href="peak-20220331.xsd#peak_NumberOfInterestRateDerivativesTerminated"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_peak_NumberOfInterestRateDerivativesTerminated_8bc0eda2-b992-464b-a737-df4cd1db5964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_1708bcdd-c7bb-47ef-bc34-3ba70233dcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_1708bcdd-c7bb-47ef-bc34-3ba70233dcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_df75d9f9-c941-43d8-9154-33ffeb774278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_df75d9f9-c941-43d8-9154-33ffeb774278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_DerivativeNotionalAmountTerminated_3505d138-fa0e-488f-9d04-985b6ef2a873" xlink:href="peak-20220331.xsd#peak_DerivativeNotionalAmountTerminated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3d75e424-5dc0-464f-b17c-d5c843035de3" xlink:to="loc_peak_DerivativeNotionalAmountTerminated_3505d138-fa0e-488f-9d04-985b6ef2a873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6e9ea095-1f07-4bba-9be7-600a0a65f5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6e9ea095-1f07-4bba-9be7-600a0a65f5a6" xlink:to="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7f760fa1-7036-4c0d-a641-37d048bc84af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7f760fa1-7036-4c0d-a641-37d048bc84af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d8085069-c624-46b3-a0bc-36a5219b4342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f760fa1-7036-4c0d-a641-37d048bc84af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d8085069-c624-46b3-a0bc-36a5219b4342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_81ddc800-3434-4a7e-8e8e-e13dc35dfff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d8085069-c624-46b3-a0bc-36a5219b4342" xlink:to="loc_us-gaap_InterestRateCapMember_81ddc800-3434-4a7e-8e8e-e13dc35dfff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_197fb595-831a-4b47-8ce0-3cac9e8336b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:to="loc_us-gaap_HedgingDesignationAxis_197fb595-831a-4b47-8ce0-3cac9e8336b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_61dfaa8f-f006-42de-b86b-1bd5d427f3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_197fb595-831a-4b47-8ce0-3cac9e8336b0" xlink:to="loc_us-gaap_HedgingDesignationDomain_61dfaa8f-f006-42de-b86b-1bd5d427f3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_caa1d5e5-3a8e-45e2-8f3e-2a3992d4a095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_61dfaa8f-f006-42de-b86b-1bd5d427f3d0" xlink:to="loc_us-gaap_NondesignatedMember_caa1d5e5-3a8e-45e2-8f3e-2a3992d4a095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83585d03-e3d8-4dfe-9ca5-c67a76cb5742" xlink:to="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_9f96e4de-5e87-4e08-8cb8-2e8f77599016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_9f96e4de-5e87-4e08-8cb8-2e8f77599016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_4f24598d-061b-47cc-b106-6108dd322a75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_4f24598d-061b-47cc-b106-6108dd322a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_a6412bfa-ccb1-4cb5-b489-5c6f87a6ea49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_a6412bfa-ccb1-4cb5-b489-5c6f87a6ea49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_8744195d-a4df-417e-a5e9-0189a8c5d2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ffad7296-717e-42c2-801b-d0c673d0fc27" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_8744195d-a4df-417e-a5e9-0189a8c5d2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities" xlink:type="simple" xlink:href="peak-20220331.xsd#AccountsPayableAccruedLiabilitiesandOtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_7728166d-371c-42ec-937d-f89546dbf152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_4d48d724-97f3-44b2-944d-bd67df778000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7728166d-371c-42ec-937d-f89546dbf152" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_4d48d724-97f3-44b2-944d-bd67df778000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables" xlink:type="simple" xlink:href="peak-20220331.xsd#AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_bdb819bc-9714-48f4-ad27-dbd33db959f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_8f2f19e7-8f4e-4e7b-814a-8b3852f2ee19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_bdb819bc-9714-48f4-ad27-dbd33db959f2" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_8f2f19e7-8f4e-4e7b-814a-8b3852f2ee19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="peak-20220331.xsd#AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent_fddfecff-b975-46e3-aa38-0a3b473951d5" xlink:href="peak-20220331.xsd#peak_RefundableEntranceFeesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:to="loc_peak_RefundableEntranceFeesCurrentAndNoncurrent_fddfecff-b975-46e3-aa38-0a3b473951d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent_3fb94063-06fb-4e13-9a14-0104032c2c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:to="loc_us-gaap_ConstructionPayableCurrentAndNoncurrent_3fb94063-06fb-4e13-9a14-0104032c2c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_d1990661-7a39-491d-8340-2867e68ad5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_d1990661-7a39-491d-8340-2867e68ad5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_e9478885-b58e-4acc-8f63-6552109043e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_e9478885-b58e-4acc-8f63-6552109043e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_352342b7-a3cb-4464-9b5f-fc5815f96513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_352342b7-a3cb-4464-9b5f-fc5815f96513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent_ea434e47-b79f-4562-a52a-63354af2b836" xlink:href="peak-20220331.xsd#peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:to="loc_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent_ea434e47-b79f-4562-a52a-63354af2b836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_2c360156-2b0c-4c2b-aadb-cd9b1439c54d" xlink:href="peak-20220331.xsd#peak_ProceedsFromCollectionOfNonrefundableEntranceFees"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:to="loc_peak_ProceedsFromCollectionOfNonrefundableEntranceFees_2c360156-2b0c-4c2b-aadb-cd9b1439c54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_peak_AmortizationOfNonrefundableEntranceFee_e5d2ebe4-0efa-4da3-be55-a22a02936d57" xlink:href="peak-20220331.xsd#peak_AmortizationOfNonrefundableEntranceFee"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_405c958b-e51d-48e6-86bd-0eabbef55f9d" xlink:to="loc_peak_AmortizationOfNonrefundableEntranceFee_e5d2ebe4-0efa-4da3-be55-a22a02936d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481321302456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 02, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-08895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Healthpeak Properties, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0091377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5050 South Syracuse Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">428-5050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PEAK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539,557,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000765880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481324959128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNetAbstract', window );"><strong>Real estate:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">$ 12,368,124<span></span>
</td>
<td class="nump">$ 12,025,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Development costs and construction in progress</a></td>
<td class="nump">739,451<span></span>
</td>
<td class="nump">877,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">2,706,909<span></span>
</td>
<td class="nump">2,603,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(2,975,337)<span></span>
</td>
<td class="num">(2,839,229)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate</a></td>
<td class="nump">12,839,147<span></span>
</td>
<td class="nump">12,667,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount', window );">Net investment in direct financing leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">44,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Loans receivable, net of reserves of $1,944 and $1,813</a></td>
<td class="nump">409,753<span></span>
</td>
<td class="nump">415,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in and advances to unconsolidated joint ventures</a></td>
<td class="nump">403,159<span></span>
</td>
<td class="nump">403,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net of allowance of $2,068 and $1,870</a></td>
<td class="nump">54,106<span></span>
</td>
<td class="nump">48,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">89,066<span></span>
</td>
<td class="nump">158,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">52,103<span></span>
</td>
<td class="nump">53,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">497,104<span></span>
</td>
<td class="nump">519,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale and discontinued operations, net</a></td>
<td class="nump">33,812<span></span>
</td>
<td class="nump">37,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset, net</a></td>
<td class="nump">232,457<span></span>
</td>
<td class="nump">233,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">676,543<span></span>
</td>
<td class="nump">674,615<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,287,250<span></span>
</td>
<td class="nump">15,257,519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES AND EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="nump">1,330,813<span></span>
</td>
<td class="nump">1,165,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Senior unsecured notes</a></td>
<td class="nump">4,654,056<span></span>
</td>
<td class="nump">4,651,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">350,713<span></span>
</td>
<td class="nump">352,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffMarketLeaseUnfavorable', window );">Intangible liabilities, net</a></td>
<td class="nump">175,355<span></span>
</td>
<td class="nump">177,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale and discontinued operations, net</a></td>
<td class="nump">14,318<span></span>
</td>
<td class="nump">15,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">203,988<span></span>
</td>
<td class="nump">204,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">695,373<span></span>
</td>
<td class="nump">755,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">817,022<span></span>
</td>
<td class="nump">789,207<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">8,241,638<span></span>
</td>
<td class="nump">8,111,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">97,890<span></span>
</td>
<td class="nump">87,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $1.00 par value: 750,000,000 shares authorized; 539,523,537 and 539,096,879 shares issued and outstanding</a></td>
<td class="nump">539,524<span></span>
</td>
<td class="nump">539,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">10,084,687<span></span>
</td>
<td class="nump">10,100,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDistributionsInExcessOfNetIncome', window );">Cumulative dividends in excess of earnings</a></td>
<td class="num">(4,212,941)<span></span>
</td>
<td class="num">(4,120,774)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(3,047)<span></span>
</td>
<td class="num">(3,147)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">6,408,223<span></span>
</td>
<td class="nump">6,515,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestInJointVentures', window );">Joint venture partners</a></td>
<td class="nump">338,443<span></span>
</td>
<td class="nump">342,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestInPreferredUnitHolders', window );">Non-managing member unitholders</a></td>
<td class="nump">201,056<span></span>
</td>
<td class="nump">201,056<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Total noncontrolling interests</a></td>
<td class="nump">539,499<span></span>
</td>
<td class="nump">543,290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">6,947,722<span></span>
</td>
<td class="nump">7,058,760<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 15,287,250<span></span>
</td>
<td class="nump">$ 15,257,519<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123366838&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDistributionsInExcessOfNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount as of the balance sheet date by which cumulative distributions to shareholders (or partners) exceed retained earnings (or accumulated earnings).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66023616&amp;loc=d3e9120-115832<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDistributionsInExcessOfNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of expenditures for a real estate project that has not yet been completed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, after allowance for credit loss, of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount lessor expects from underlying asset following end of direct financing lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the equity interests owned by noncontrolling shareholders, partners, or other equity holders in joint ventures included in the entity's consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInPreferredUnitHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the equity interests owned by noncontrolling preferred unit holders in an entity included in the reporting entity's consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInPreferredUnitHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffMarketLeaseUnfavorable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents a liability associated with the acquisition of an off-market lease when the terms of the lease are unfavorable to the market terms for the lease at the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffMarketLeaseUnfavorable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481321150056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract', window );"><strong>Balance Sheet Parenthetical Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserves for loans receivable</a></td>
<td class="nump">$ 1,944<span></span>
</td>
<td class="nump">$ 1,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for accounts receivable</a></td>
<td class="nump">$ 2,068<span></span>
</td>
<td class="nump">$ 1,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">539,523,537<span></span>
</td>
<td class="nump">539,096,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">539,523,537<span></span>
</td>
<td class="nump">539,096,879<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockTransactionsParentheticalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockTransactionsParentheticalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322526856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental and related revenues</a></td>
<td class="nump">$ 370,150<span></span>
</td>
<td class="nump">$ 327,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Resident fees and services</a></td>
<td class="nump">121,560<span></span>
</td>
<td class="nump">116,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseRevenue', window );">Income from direct financing leases</a></td>
<td class="nump">1,168<span></span>
</td>
<td class="nump">2,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">5,494<span></span>
</td>
<td class="nump">9,013<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">498,372<span></span>
</td>
<td class="nump">455,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">37,586<span></span>
</td>
<td class="nump">46,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">177,733<span></span>
</td>
<td class="nump">157,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Operating</a></td>
<td class="nump">207,247<span></span>
</td>
<td class="nump">181,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">23,831<span></span>
</td>
<td class="nump">24,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet', window );">Impairments and loan loss reserves (recoveries), net</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">3,242<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">446,825<span></span>
</td>
<td class="nump">415,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="nump">3,856<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on debt extinguishments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(164,292)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">18,316<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">22,172<span></span>
</td>
<td class="num">(162,092)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="nump">73,719<span></span>
</td>
<td class="num">(121,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(777)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">1,323<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">75,026<span></span>
</td>
<td class="num">(120,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">270,008<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">75,343<span></span>
</td>
<td class="nump">149,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Noncontrolling interests&#8217; share in continuing operations</a></td>
<td class="num">(3,730)<span></span>
</td>
<td class="num">(3,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(329)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Healthpeak Properties, Inc.</a></td>
<td class="nump">71,613<span></span>
</td>
<td class="nump">145,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted', window );">Participating securities&#8217; share in earnings</a></td>
<td class="num">(1,976)<span></span>
</td>
<td class="num">(2,451)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) applicable to common shares</a></td>
<td class="nump">$ 69,637<span></span>
</td>
<td class="nump">$ 143,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic earnings (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) applicable to common shares (in dollars per share)</a></td>
<td class="nump">0.13<span></span>
</td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">0.13<span></span>
</td>
<td class="num">(0.23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) applicable to common shares (in dollars per share)</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">539,352<span></span>
</td>
<td class="nump">538,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">539,586<span></span>
</td>
<td class="nump">538,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairments And Allowance For Credit Loss Reserves (Recoveries), Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct financing lease revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123605587&amp;loc=d3e23528-158515<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23439-158514<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23415-158514<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481320549208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 75,343<span></span>
</td>
<td class="nump">$ 149,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Net unrealized gains (losses) on derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Change in Supplemental Executive Retirement Plan obligation and other</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustment realized in net income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="nump">75,443<span></span>
</td>
<td class="nump">149,611<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss) attributable to Healthpeak Properties, Inc.</a></td>
<td class="nump">71,713<span></span>
</td>
<td class="nump">145,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Total comprehensive (income) loss attributable to noncontrolling interests'</a></td>
<td class="num">(3,730)<span></span>
</td>
<td class="num">(3,306)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Total comprehensive (income) loss attributable to noncontrolling interests'</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (329)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481323629240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Stockholders&#8217; Equity</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Cumulative Dividends In&#160;Excess Of&#160;Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Total Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 7,289,950<span></span>
</td>
<td class="nump">$ 6,733,723<span></span>
</td>
<td class="nump">$ 538,405<span></span>
</td>
<td class="nump">$ 10,175,235<span></span>
</td>
<td class="num">$ (3,976,232)<span></span>
</td>
<td class="num">$ (3,685)<span></span>
</td>
<td class="nump">$ 556,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">149,423<span></span>
</td>
<td class="nump">145,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(398)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(12,165)<span></span>
</td>
<td class="num">(12,165)<span></span>
</td>
<td class="num">$ (398)<span></span>
</td>
<td class="num">(11,767)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Amortization of stock-based compensation</a></td>
<td class="nump">5,413<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common dividends</a></td>
<td class="num">(164,118)<span></span>
</td>
<td class="num">(164,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(164,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(7,718)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,718)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AdjustmentsOfPermanentEquityToTemporaryEquity', window );">Adjustments to redemption value of redeemable noncontrolling interests</a></td>
<td class="num">(20,921)<span></span>
</td>
<td class="num">(20,921)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,921)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">7,241,139<span></span>
</td>
<td class="nump">6,688,995<span></span>
</td>
<td class="nump">$ 538,886<span></span>
</td>
<td class="nump">10,148,168<span></span>
</td>
<td class="num">(3,994,562)<span></span>
</td>
<td class="num">(3,497)<span></span>
</td>
<td class="nump">552,144<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">57,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity', window );">Adjustments to redemption value of redeemable noncontrolling interests</a></td>
<td class="nump">20,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">78,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">7,058,760<span></span>
</td>
<td class="nump">6,515,470<span></span>
</td>
<td class="nump">$ 539,097<span></span>
</td>
<td class="nump">10,100,294<span></span>
</td>
<td class="num">(4,120,774)<span></span>
</td>
<td class="num">(3,147)<span></span>
</td>
<td class="nump">543,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">75,331<span></span>
</td>
<td class="nump">71,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">$ 766<span></span>
</td>
<td class="num">(437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(11,352)<span></span>
</td>
<td class="num">(11,352)<span></span>
</td>
<td class="num">$ (339)<span></span>
</td>
<td class="num">(11,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Amortization of stock-based compensation</a></td>
<td class="nump">6,144<span></span>
</td>
<td class="nump">6,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common dividends</a></td>
<td class="num">(163,780)<span></span>
</td>
<td class="num">(163,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(7,509)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,509)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AdjustmentsOfPermanentEquityToTemporaryEquity', window );">Adjustments to redemption value of redeemable noncontrolling interests</a></td>
<td class="num">(10,301)<span></span>
</td>
<td class="num">(10,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">6,947,722<span></span>
</td>
<td class="nump">$ 6,408,223<span></span>
</td>
<td class="nump">$ 539,524<span></span>
</td>
<td class="nump">$ 10,084,687<span></span>
</td>
<td class="num">$ (4,212,941)<span></span>
</td>
<td class="num">$ (3,047)<span></span>
</td>
<td class="nump">$ 539,499<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">87,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income (loss)</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity', window );">Adjustments to redemption value of redeemable noncontrolling interests</a></td>
<td class="nump">10,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 97,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AdjustmentsOfPermanentEquityToTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments Of Permanent Equity To Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AdjustmentsOfPermanentEquityToTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481327503048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common dividends, per share (in dollars per share)</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322590440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 75,343<span></span>
</td>
<td class="nump">$ 149,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization of real estate, in-place lease, and other intangibles</a></td>
<td class="nump">177,733<span></span>
</td>
<td class="nump">157,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Amortization of stock-based compensation</a></td>
<td class="nump">4,721<span></span>
</td>
<td class="nump">4,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">2,689<span></span>
</td>
<td class="nump">2,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StraightLineRent', window );">Straight-line rents</a></td>
<td class="num">(11,158)<span></span>
</td>
<td class="num">(9,135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet', window );">Amortization of nonrefundable entrance fees and above/below market lease intangibles</a></td>
<td class="num">(24,725)<span></span>
</td>
<td class="num">(23,764)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations', window );">Equity loss (income) from unconsolidated joint ventures</a></td>
<td class="num">(2,148)<span></span>
</td>
<td class="num">(1,008)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distributions of earnings from unconsolidated joint ventures</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease', window );">Loss (gain) on sale of real estate under direct financing leases</a></td>
<td class="num">(22,693)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(1,148)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairments and loan loss reserves (recoveries), net</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">3,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">164,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Loss (gain) on sales of real estate, net</a></td>
<td class="num">(3,785)<span></span>
</td>
<td class="num">(259,662)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GainLossFromChangeOfControl', window );">Loss (gain) upon change of control, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,042)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuredEventGainLoss', window );">Casualty-related loss (recoveries), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="num">(1,593)<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets', window );">Decrease (increase) in accounts receivable and other assets, net</a></td>
<td class="num">(4,144)<span></span>
</td>
<td class="nump">11,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue</a></td>
<td class="nump">3,653<span></span>
</td>
<td class="num">(74,524)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">194,183<span></span>
</td>
<td class="nump">122,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherRealEstate', window );">Acquisitions of real estate</a></td>
<td class="num">(134,067)<span></span>
</td>
<td class="num">(14,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development, redevelopment, and other major improvements of real estate</a></td>
<td class="num">(178,285)<span></span>
</td>
<td class="num">(135,339)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements', window );">Leasing costs, tenant improvements, and recurring capital expenditures</a></td>
<td class="num">(22,839)<span></span>
</td>
<td class="num">(20,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">Proceeds from sales of real estate, net</a></td>
<td class="nump">13,265<span></span>
</td>
<td class="nump">937,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Contributions to unconsolidated joint ventures</a></td>
<td class="num">(1,486)<span></span>
</td>
<td class="num">(5,924)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures', window );">Distributions in excess of earnings from unconsolidated joint ventures</a></td>
<td class="nump">3,875<span></span>
</td>
<td class="nump">10,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables', window );">Proceeds from sales/principal repayments on loans receivable and direct financing leases</a></td>
<td class="nump">75,435<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_PaymentsToAcquireLoansReceivableAndOther', window );">Investments in loans receivable and other</a></td>
<td class="num">(1,860)<span></span>
</td>
<td class="num">(3,704)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(245,962)<span></span>
</td>
<td class="nump">767,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under bank line of credit and commercial paper</a></td>
<td class="nump">3,732,668<span></span>
</td>
<td class="nump">3,437,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under bank line of credit and commercial paper</a></td>
<td class="num">(3,567,830)<span></span>
</td>
<td class="num">(2,528,640)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfBankDebt', window );">Repayments and repurchase of debt, excluding bank line of credit and commercial paper</a></td>
<td class="num">(1,270)<span></span>
</td>
<td class="num">(1,491,754)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishment and deferred financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(158,011)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Issuance of common stock and exercise of options, net of offering costs</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(11,352)<span></span>
</td>
<td class="num">(12,165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid on common stock</a></td>
<td class="num">(163,447)<span></span>
</td>
<td class="num">(164,118)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to and purchase of noncontrolling interests</a></td>
<td class="num">(7,509)<span></span>
</td>
<td class="num">(7,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Contributions from and issuance of noncontrolling interests</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(18,511)<span></span>
</td>
<td class="num">(924,119)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(70,290)<span></span>
</td>
<td class="num">(33,667)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">219,448<span></span>
</td>
<td class="nump">181,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">$ 149,158<span></span>
</td>
<td class="nump">$ 148,018<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from unconsolidated joint ventures in which the entity does not have sufficient US GAAP earnings (accumulated or in the current period) to distribute funds to partners, thereby constituting a return of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GainLossFromChangeOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) From Change Of Control</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GainLossFromChangeOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Loss From Equity Method Investments, Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_PaymentsToAcquireLoansReceivableAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Loans Receivable and Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_PaymentsToAcquireLoansReceivableAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables, and operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuredEventGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess (deficiency) of insurance recovery over the loss incurred from an insured event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuredEventGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy; for costs that are essential to originating the lease and would not otherwise have been incurred without the lease agreement, including but not limited to, evaluating the lessee's credit condition, guarantees, and collateral and costs incurred in negotiating, processing, and executing the lease agreement; and for any commission(s) incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of other real estate investments held by the entity for investment purposes not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale or collection of receivables arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfBankDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle a bank borrowing during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfBankDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StraightLineRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between actual rental income due and rental income recognized on a straight-line basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StraightLineRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322175928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Business</a></td>
<td class="text">Business<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc., a Standard&#160;&amp; Poor&#8217;s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (&#8220;REIT&#8221;) that, together with its consolidated entities (collectively, &#8220;Healthpeak&#8221; or the &#8220;Company&#8221;), invests primarily in real estate serving the healthcare industry in the United States (&#8220;U.S.&#8221;). Healthpeak&#174; acquires, develops, leases, owns, and manages healthcare real estate. The Company&#8217;s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i)&#160;life science; (ii) medical office;&#160;and (iii) continuing care retirement community (&#8220;CCRC&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters are in Denver, Colorado and it has additional offices in California, Tennessee, and Massachusetts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Covid Update</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus (&#8220;Covid&#8221;) pandemic has caused significant disruption to individuals, governments, financial markets, and businesses, including the Company.&#160;The Company&#8217;s tenants, operators, and borrowers have experienced significant cost increases as a result of increased health and safety measures, staffing shortages, increased governmental regulation and compliance, vaccine mandates, and other operational changes necessitated either directly or indirectly by the Covid pandemic. The Company evaluated the impacts of Covid on its business thus far and incorporated information concerning the impact of Covid into its assessments of liquidity, impairments, and collectibility from tenants, residents, and borrowers as of March&#160;31, 2022. The Company will continue to monitor such impacts and will adjust its estimates and assumptions based on the best available information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322134664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#8217;s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#8220;JVs&#8221;), and variable interest entities (&#8220;VIEs&#8221;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021 filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revision to Additional Paid-In Capital and Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company identified and corrected immaterial errors in the classification and redemption value of redeemable noncontrolling interests of consolidated joint ventures in its life science segment. The Company corrected the classification of its redeemable noncontrolling interests and increased the balance to its estimated redemption value, with a corresponding decrease to additional paid-in capital (&#8220;APIC&#8221;) in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the unrealized value of the redeemable noncontrolling interests was largely attributable to rapidly rising rents and compressing capitalization rates in the market in which the entities operate, and was identified and corrected by management. The Company determined the impact of the adjustments to be immaterial, individually and in the aggregate, based on consideration of quantitative and qualitative factors. As such, these adjustments are reflected in this Quarterly Report on Form 10-Q for the three months ended March 31, 2021. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These adjustments had no impact on the Consolidated Statements of Cash Flows, Consolidated Statements of Operations, or any per share amounts. The Company made changes (all amounts in thousands) to the Consolidated Statements of Equity and Redeemable Noncontrolling Interests to decrease APIC, total stockholders&#8217; equity, and total equity as of March 31, 2021 by $75,543 with a corresponding increase to redeemable noncontrolling interests of $78,413 and a decrease to accounts payable, accrued liabilities, and other liabilities as of March 31, 2021 of $2,870 on the Consolidated Balance Sheet. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Government Grant Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) to provide financial aid to individuals, businesses, and state and local governments. During the three months ended March&#160;31, 2022 and 2021, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the Covid pandemic. Grant income is recognized when there is reasonable assurance that the grant will be received and the Company will comply with all conditions attached to the grant. Additionally, grants are recognized over the periods in which the Company recognizes the increased expenses and lost revenue the grants are intended to defray. As of March&#160;31, 2022, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information related to government grant income received and recognized by the Company (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in other income (expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total government grants received</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Discontinued Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company established and began executing a plan to dispose of its senior housing triple-net and Senior Housing Operating Property (&#8220;SHOP&#8221;) properties and concluded that the planned dispositions represented a strategic shift that had and will have a major effect on the Company&#8217;s operations and financial results. Therefore, senior housing triple-net and SHOP assets meeting the held for sale criteria are classified as discontinued operations in all periods presented herein. In September 2021, the Company successfully completed the disposition of the remaining senior housing triple-net and SHOP properties. See Note 4 for further information.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-10&#8221;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#8217;s accounting for assistance, and the effect of the assistance on an entity&#8217;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Adopted</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Scope </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-01&#8221;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The amendments in ASU 2020-04 and ASU 2021-01 were effective immediately and may be applied through December 31, 2022. The Company is evaluating whether the optional relief provided by ASU 2020-04 or ASU 2021-01 will be adopted but does not expect the adoption of these standards to have a material impact on its consolidated financial position, results of operations, cash flows, or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322320488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateAbstract', window );"><strong>Real Estate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateDisclosureTextBlock', window );">Real Estate Transactions</a></td>
<td class="text">Real Estate Transactions<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Real Estate Investment Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">67 Smith Place</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $72&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vista Sorrento Phase II</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company closed a life science acquisition in San Diego, California for $24&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Webster MOB Portfolio</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company acquired a portfolio of two medical office buildings (&#8220;MOBs&#8221;) in Houston, Texas for $43&#160;million. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Real Estate Investment Acquisitions </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company closed the following life science acquisitions: (i) eight acquisitions in Cambridge, Massachusetts for $498&#160;million, (ii) one life science acquisition in San Diego, California for $20&#160;million, and (iii) 12 acres of land for $128&#160;million in South San Francisco, California.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also during 2021, the Company closed the following MOB acquisitions: (i) one MOB in Nashville, Tennessee for $13&#160;million, (ii) one MOB in Denver, Colorado for $38&#160;million, (iii) a portfolio of 14 MOBs for $371&#160;million (the &#8220;MOB Portfolio&#8221;), (iv) one MOB in Fort Lauderdale, Florida for $16&#160;million; (v) one MOB in Wichita, Kansas for $50&#160;million, (vi) three MOBs in Morristown, New Jersey for $155&#160;million, (vii) two MOBs in Dallas, Texas for $60&#160;million, (viii) one MOB in Seattle, Washington for $43&#160;million, (ix) one MOB in New Orleans, Louisiana for $34&#160;million, and (x) one MOB in Cambridge, Massachusetts for $55&#160;million. In conjunction with the acquisition of the MOB Portfolio, the Company originated $142&#160;million of secured mortgage debt.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Development Activities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commitments, which are primarily related to development and redevelopment projects and tenant improvements, decreased by $52 million, to $418 million</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at March&#160;31, 2022, when compared to December&#160;31, 2021, primarily as a result of actual spend on existing projects in the first quarter of 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 970<br> -URI http://asc.fasb.org/topic&amp;trid=2156125<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 978<br> -URI http://asc.fasb.org/topic&amp;trid=2134977<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 976<br> -URI http://asc.fasb.org/topic&amp;trid=2134846<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 974<br> -URI http://asc.fasb.org/topic&amp;trid=2156429<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 972<br> -URI http://asc.fasb.org/topic&amp;trid=2134617<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322328712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Dispositions of Real Estate and Discontinued Operations</a></td>
<td class="text">Dispositions of Real Estate and Discontinued Operations<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Dispositions of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company sold one life science facility in Salt Lake City, Utah for $14&#160;million, resulting in a gain on sale of $4&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company sold one MOB in San Antonio, Texas for $13&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Dispositions of Real Estate</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sunrise Senior Housing Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company sold a portfolio of 32 SHOP assets (the &#8220;Sunrise Senior Housing Portfolio&#8221;) for $664&#160;million, resulting in an immaterial loss on sale, which is recognized in income (loss) from discontinued operations, and provided the buyer with: (i) financing of $410&#160;million (see Note 6) and (ii) a commitment to finance up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$92&#160;million of additional debt for capital expenditures. The commitment to finance additional debt for capital expenditures was subsequently reduced to $56&#160;million in June 2021 and $47&#160;million in February 2022,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.4 million of which had been funded as of March&#160;31, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(see Note 6). Upon completion of the license transfer process in June 2021, the Company sold the two remaining Sunrise senior housing triple-net assets for $80&#160;million, resulting in a gain on sale of $22&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brookdale Triple-Net Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company sold 24 senior housing assets in a triple-net lease with Brookdale Senior Living Inc. for $510&#160;million, resulting in total gain on sale of $169&#160;million, which is recognized in income (loss) from discontinued operations. </span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional SHOP Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company sold a portfolio of 16 SHOP assets for $230&#160;million, resulting in total gain on sale of $59&#160;million, which is recognized in income (loss) from discontinued operations. The Company provided the buyer with financing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$150&#160;million (see Note </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HRA Triple-Net Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company sold eight senior housing assets in a triple-net lease with Harbor Retirement Associates for $132&#160;million, resulting in total gain on sale of $33&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oakmont SHOP Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company sold a portfolio of 12 SHOP assets for $564&#160;million. In conjunction with the sale, mortgage debt held on two properties with a carrying value of $64&#160;million was repaid and the remaining mortgage debt held on four properties with a carrying value of $107&#160;million was assumed by the buyer. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in total gain on sale of $80&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discovery SHOP Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company sold a portfolio of 10 SHOP assets for $334&#160;million, resulting in total gain on sale of $9&#160;million, which is recognized in income (loss) from discontinued operations. Also included in this transaction was the sale of two mezzanine loans and two preferred equity investments for $21&#160;million, resulting in no gain or loss on sale of the investments (collectively, the &#8220;Discovery SHOP Portfolio&#8221;).</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sonata SHOP Portfolio</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Compa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny sold a portfolio of five SHOP assets for $64&#160;million, resulting in total gain on sale of $3&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SLC SHOP Portfolio</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company sold seven SHOP assets for $113&#160;million and repaid $70&#160;million of mortgage debt that was held on six of the assets, resulting in total gain on sale of $1&#160;million, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hoag Hospital</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company sold </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">one hospital for $226&#160;million through the exercise of a purchase option by a tenant, resulting in gain on sale of $172&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Other Dispositions</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the portfolio and individual sales discussed above, during the year ended December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company sold the following: (i) 15 SHOP assets for $169&#160;million, (ii) 7 senior housing triple-net assets for $24&#160;million, and (iii) 10 MOBs and a portion of 1 MOB land parcel for $68&#160;million, resulting in total gain on sales of</span><span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$58&#160;million ($39&#160;million</span><span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of which is recognized in income (loss) from discontinued operations). In conjunction with one of the SHOP asset sales, mortgage debt held on the property with a carrying value of $36&#160;million was assumed by the buyer. Of these sales, one SHOP asset was sold during the three months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for $5&#160;million resulting in an immaterial gain on sale, which is recognized in income (loss) from discontinued operations.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale and Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company established and began executing a plan to dispose of its senior housing triple-net and SHOP properties. As of December 31, 2020, the Company concluded that the planned dispositions represented a strategic shift that had and will have a major effect on the Company&#8217;s operations and financial results. Therefore, senior housing triple-net and SHOP assets meeting the held for sale criteria are classified as discontinued operations in all periods presented herein. In September 2021, the Company successfully completed the disposition of the remaining senior housing triple-net and SHOP properties. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the assets and liabilities classified as held for sale or as discontinued operations at March&#160;31, 2022 and December&#160;31, 2021, which are included in assets held for sale and discontinued operations, net and liabilities related to assets held for sale and discontinued operations, net, respectively, on the Consolidated Balance Sheets (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:73.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">ASSETS</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accounts receivable, net of allowance of $4,146 and $4,138</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets of discontinued operations, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">12,752</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">13,416</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets held for sale, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">21,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Assets held for sale and discontinued operations, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">33,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">37,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">LIABILITIES</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities of discontinued operations, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Liabilities related to assets held for sale and discontinued operations, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">15,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of March&#160;31, 2022, primarily comprised of five MOBs with net real estate assets of $20&#160;million and right-of-use asset, net of $1&#160;million. As of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December&#160;31, 2021, primarily comprised of four MOBs and one life science facility with net real estate assets of $23&#160;million and right-of-use asset, net of $1&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of discontinued operations during the three months ended March&#160;31, 2022 and 2021, or through the disposal date of each asset or portfolio of assets if they have been sold during such periods, as applicable, are included in the consolidated results of operations for the three months ended March&#160;31, 2022 and 2021. Summarized financial information for discontinued operations for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:73.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Rental and related revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Resident fees and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">72,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">78,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">71,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">74,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">259,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(68)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">265,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(87)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">269,502&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(315)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">270,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairments of Real Estate</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, the Company did not recognize any impairment charges.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Losses</span></div>During the three months ended March&#160;31, 2022, the Company recognized $14&#160;million of expenses within other income (expense), net on the Consolidated Statements of Operations for tenant relocation and other costs associated with a planned MOB demolition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481407533864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Direct Financing Leases</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Direct Financing Lease Sale</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company sold its remaining hospital classified as a direct financing lease (&#8220;DFL&#8221;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment in DFLs consists of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of estimated residual value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less deferred selling profits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in direct financing leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Direct Financing Lease Internal Ratings</span></div>At March&#160;31, 2022, the Company had no properties classified as a DFL. At December&#160;31, 2021, the Company had one hospital classified as a DFL with a carrying amount of $45&#160;million and an internal rating of &#8220;performing&#8221;.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorDirectFinancingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Direct Financing Leases</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Direct Financing Lease Sale</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company sold its remaining hospital classified as a direct financing lease (&#8220;DFL&#8221;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment in DFLs consists of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of estimated residual value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less deferred selling profits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in direct financing leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Direct Financing Lease Internal Ratings</span></div>At March&#160;31, 2022, the Company had no properties classified as a DFL. At December&#160;31, 2021, the Company had one hospital classified as a DFL with a carrying amount of $45&#160;million and an internal rating of &#8220;performing&#8221;.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorDirectFinancingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorDirectFinancingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322119448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Loans Receivable</a></td>
<td class="text">Loans Receivable<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s loans receivable (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts, fees, and costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,944)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,813)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,811&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At March&#160;31, 2022, the Company had $49 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects. At December&#160;31, 2021, the Company had $58 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SHOP Seller Financing</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the sale of 32 SHOP facilities in the Sunrise Senior Housing Portfolio for $664&#160;million in January 2021 (see Note 4), the Company provided the buyer with initial financing of $410&#160;million. The remainder of the sales price was received in cash at the time of sale. Additionally, the Company agreed to provide up to $92&#160;million of additional financing for capital expenditures (up to 65% of the estimated cost of capital expenditures). The additional financing was subsequently reduced to $56&#160;million in June 2021 and $47&#160;million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in February 2022 in conjunction with the principal repayments discussed below.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through March&#160;31, 2022, $0.4 million of the additional financing had been funded. The initial and additional financing is secured by the buyer's equity ownership in each property.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company received principal repayments of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$246&#160;million on the initial financing provided in conjunction with the sale of the Sunrise Senior Housing Portfolio. Additionally, in February 2022, the Company received principal repayments of $8&#160;million in conjunction with the disposition of the underlying collateral. As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022 and December&#160;31, 2021, this secured loan had an outstanding balance of $157&#160;million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $165&#160;million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the sale of 16 additional SHOP facilities for $230&#160;million in January 2021 (see Note 4), the Company provided the buyer with financing of $150&#160;million. The remainder of the sales price was received in cash at the time of sale. The financing is secured by the buyer's equity ownership in each property.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the Company reduced the consideration and reported gain on sales of real estate and recognized a mark-to-market discount of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$16&#160;million for certain transactions with seller financing. The Company&#8217;s discount is based on the difference between the stated interest rates (ranging from 3.50% to 4.50%) and corresponding prevailing market rates of approximately 5.25% as of the transaction dates.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount is recognized as interest income over the term of the discounted loans (ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjYyOQ_aeb0d2ee-ccfb-4404-9b1a-c227b91e018e">one</span> to three years) using the effective interest rate method. During the three months ended March&#160;31, 2022 and 2021, the Company recognized $1&#160;million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $2&#160;million, respectively, of non-cash interest income related to the amortization of its mark-to-market discounts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Other Loans Receivable Transactions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies a loan receivable as held for sale when management no longer has the intent or ability to hold the loan receivable for the foreseeable future or until maturity. If a loan receivable is classified as held for sale, previously recorded reserves for loan losses are reversed and the loan is reported at the lower of amortized cost or fair value. During the second quarter of 2021, two loans receivable with a total amortized cost of $64&#160;million were classified as held for sale. Upon the transfer of these two loans to held for sale, the carrying value was decreased by $11&#160;million to an estimated fair value of $53&#160;million, $8&#160;million of which was previously recognized as a reserve for loan losses. In 2021, the Company sold these two loans receivable previously classified as held for sale for their aggregate carrying value of $53&#160;million. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These fair value estimates were made for each individual loan classified as held for sale and primarily relied on a market approach, utilizing comparable market transactions, forecasted sales prices, and negotiations with prospective buyers. These estimates are considered to be a Level 3 measurement within the fair value hierarchy, and are subject to inherent uncertainties.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in April 2021, the Company sold two mezzanine loans as part of the Discovery SHOP Portfolio disposition (see Note 4), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulting in no gain or loss on sale of the mezzanine loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company received a $10&#160;million principal repayment related to one of its secured loans. In September 2021, the Company received repayment of the remaining $15&#160;million balance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company received full repayment of the outstanding balance of an $8&#160;million secured loan.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CCRC Resident Loans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain residents that qualify, CCRCs may offer to lend residents the necessary funds to satisfy the entrance fee requirements so that they are able to move into a community while still continuing the process of selling their previous home. The loans are due upon sale of the previous residence. At March&#160;31, 2022 and December&#160;31, 2021, the Company held</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$25 million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $24&#160;million, respectively, of such notes receivable, which are included in mezzanine and other in the table above.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loans Receivable Internal Ratings </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s quarterly review process or upon the occurrence of a significant event, loans receivable are reviewed and assigned an internal rating of Performing, Watch List, or Workout. Loans that are deemed Performing meet all present contractual obligations, and collection and timing of all amounts owed is reasonably assured. Watch List Loans are defined as loans that do not meet the definition of Performing or Workout. Workout Loans are defined as loans in which the Company has determined, based on current information and events, that: (i) it is probable it will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the borrower is delinquent on making payments under the contractual terms of the agreement, and (iii) the Company has commenced action or anticipates pursuing action in the near term to seek recovery of its investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, by year of origination, the Company&#8217;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.164%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Origination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total mezzanine and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,284&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserve for Loan Losses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, individual and portfolio property performance, credit enhancements, liquidity, and other factors. The determination of loan losses also considers concentration of credit risk associated with the senior housing industry to which its loans receivable relate. The Company&#8217;s borrowers furnish property, portfolio, and guarantor/operator-level financial statements, among other information, on a monthly or quarterly basis, which the Company utilizes to calculate the debt service coverages used in its assessment of internal ratings, which is a primary credit quality indicator. Debt service coverage information is evaluated together with other property, portfolio, and operator performance information, including revenue, expense, NOI, occupancy, rental rates, capital expenditures, and EBITDA (defined as earnings before interest, tax, and depreciation and amortization), along with other liquidity measures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its assessment of current expected credit losses for loans receivable and unfunded loan commitments, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each loan to estimate a probability of default and a resulting loss for each loan receivable. Future economic conditions are based primarily on near-term economic forecasts from the Federal Reserve and reasonable assumptions for long-term economic trends. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s reserve for loan losses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mezzanine and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mezzanine and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected loan losses related to loans sold or repaid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes six loans sold or repaid during the year ended December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, at each of March&#160;31, 2022 and December&#160;31, 2021, a liability of $0.3 million related to expected credit losses for unfunded loan commitments was included in accounts payable, accrued liabilities, and other liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322121848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in and Advances to Unconsolidated Joint Ventures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments in and Advances to Unconsolidated Joint Ventures</a></td>
<td class="text">Investments in and Advances to Unconsolidated Joint Ventures<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owns interests in the following entities that are accounted for under the equity method, excluding investments classified as discontinued operations (dollars in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:30.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership %</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SWF SH JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Science JV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Office JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical office</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 - 67</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Property counts and ownership percentages are as of March&#160;31, 2022. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In December 2021, the Company acquired a 38% interest in a life science development joint venture in Needham, Massachusetts for $13&#160;million. Land held for development is excluded from the property count as of March&#160;31, 2022.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes two unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (20%) and (ii) Suburban Properties, LLC (67%). During 2021, the Company also held a 30% interest in Ventures III, which issued its final distribution and was dissolved.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company sold its two preferred equity investments for their carrying value as part of the Discovery SHOP Portfolio disposition (see Note 4). Prior to the sale, the Company&#8217;s ownership percentage in these two unconsolidated joint ventures was as follows: (i) Discovery Naples JV (41%) and (ii) Discovery Sarasota JV (47%). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the two remaining CCRCs in the CCRC JV were sold for $38&#160;million, $19&#160;million of which represents the Company&#8217;s 49% interest, resulting in an immaterial gain on sale recorded within equity income (loss) from unconsolidated joint ventures during the year ended December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322255816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock', window );">Intangibles</a></td>
<td class="text">Intangibles<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#8217;s intangible lease assets (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:72.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277,915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#8217;s intangible lease liabilities (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:72.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,355&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, in conjunction with the Company&#8217;s acquisitions of real estate, the Company acquired intangible assets of $4 million and intangible liabilities of $5 million. The intangible assets and liabilities acquired had a weighted average amortization period at acquisition of 9 years and 12 years, respectively.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, in conjunction with the Company&#8217;s acquisitions of real estate, the Company acquired intangible assets of $109&#160;million and intangible liabilities of $57&#160;million. The intangible assets and intangible liabilities acquired had a weighted average amortization period at acquisition of 9 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This block of text may be used to disclose all or part of the information related to intangible assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangiblesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangibles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangiblesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322345288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bank Line of Credit and Term Loan </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2019, the Company executed a $2.5 billion unsecured revolving line of credit facility, with a maturity date of May&#160;23, 2023 and two&#160;six-month extension options, subject to certain customary conditions. Also in May 2019, the Company entered into a&#160;$250 million&#160;unsecured term loan facility, with a maturity date of May 23, 2024 (the &#8220;2019 Term Loan&#8221;). In July 2021, the Company repaid the $250&#160;million 2019 Term Loan. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company executed an amended and restated unsecured revolving line of credit (the &#8220;Revolving Facility&#8221;) to increase total revolving commitments from $2.5&#160;billion to $3.0&#160;billion and extend the maturity date to January 20, 2026. This maturity date may be further extended pursuant to two six-month extension options, subject to certain customary conditions. Borrowings under the Revolving Facility accrue interest at LIBOR plus a margin that depends on the credit ratings of the Company&#8217;s senior unsecured long-term debt. The Company also pays a facility fee on the entire revolving commitment that depends on its credit ratings. Based on the Company&#8217;s credit ratings at March&#160;31, 2022, the margin on the Revolving Facility was 0.78%</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the facility fee was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.15%</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At March&#160;31, 2022 and December&#160;31, 2021, the Company had no</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balance outstanding under the Revolving Facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $750 million, subject to securing additional commitments. Further, the Revolving Facility includes customary LIBOR replacement language, including, but not limited to, the use of rates based on the secured overnight financing rate administered by the Federal Reserve Bank of New York. The Revolving Facility also includes a sustainability-linked pricing component whereby the applicable margin may be reduced by up to 0.025% based on the Company&#8217;s achievement of specified sustainability-linked metrics, subject to certain conditions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Facility also contains certain financial restrictions and other customary requirements, including financial covenants and cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreement: (i)&#160;limit the ratio of Enterprise Total Indebtedness to Enterprise Gross Asset Value to 60%; (ii)&#160;limit the ratio of Enterprise Secured Debt to Enterprise Gross Asset Value to 40%; (iii)&#160;limit the ratio of Enterprise Unsecured Debt to Enterprise Unencumbered Asset Value to 60%; (iv)&#160;require a minimum Fixed Charge Coverage ratio of 1.5 times; and (v) require a minimum Consolidated Tangible Net Worth of $7.7 billion.&#160;The Company believes it was in compliance with each of these covenants at March&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper Program</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company established an unsecured commercial paper program (the &#8220;Commercial Paper Program&#8221;). Under the terms of the Commercial Paper Program, the Company may issue, from time to time, unsecured short-term debt securities with varying maturities. Amounts available under the Commercial Paper Program may be borrowed, repaid, and re-borrowed from time to time. During 2021, the Company increased the maximum aggregate face or principal amount that can be outstanding at any one time from $1.0 billion to $1.5&#160;billion. Amounts borrowed under the Commercial Paper Program will be sold on terms that are customary for the U.S. commercial paper market and will be at least equal in right of payment with all of the Company&#8217;s other unsecured and unsubordinated indebtedness. The Company uses its Revolving Facility as a liquidity backstop for the repayment of unsecured short-term debt securities issued under the Commercial Paper Program. At March&#160;31, 2022, the Company had $1.33&#160;billion</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of securities outstanding under the Commercial Paper Program, with original maturities of approximately</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45 days and a weighted average interest rate of 0.93%. At December&#160;31, 2021, the Company had $1.17&#160;billion of securities outstanding under the Commercial Paper Program, with original maturities of approximately two months and a weighted average interest rate of 0.32%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each of March&#160;31, 2022 and December&#160;31, 2021, the Company had senior unsecured notes outstanding with an aggregate principal balance of $4.7&#160;billion. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes it was in compliance with these covenants at March&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, the Company did not repurchase or redeem any senior unsecured notes. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company&#8217;s senior unsecured notes repurchases and redemptions during the year ended December&#160;31, 2021 (dollars in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:55.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payoff Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 19, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 19, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Upon repurchasing a portion of the 3.40% and 4.00% senior unsecured notes due 2025, the Company recognized a $61&#160;million loss on debt extinguishment during the year ended December&#160;31, 2021.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Upon completing the repurchases and redemptions of all outstanding 4.25%, 4.20%, and 3.88% senior unsecured notes due 2023 and 2024, the Company recognized a $164&#160;million loss on debt extinguishment during the three months ended March&#160;31, 2021.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, the Company did not issue any senior unsecured notes.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company completed two green bond offerings. The net proceeds from both green bonds are or will be allocated to eligible green projects, and the Company may choose to allocate or re-allocate net proceeds from such offerings to one more other eligible green projects. The following table summarizes these senior unsecured note issuances for the year ended December&#160;31, 2021 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:55.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 24, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 12, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Mortgage Debt</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and December&#160;31, 2021, the Company had $349 million and $350&#160;million, respectively, in aggregate principal of mortgage debt outstanding, which was secured by 18 healthcare facilities, with an aggregate carrying value of $803 million and $811&#160;million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets, and is non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires insurance on the assets, and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2022 and March&#160;31, 2021, the Company made aggregate principal repayments of mortgage debt of $1&#160;million (excluding mortgage debt on assets held for sale and discontinued operations). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, in conjunction with the acquisition of the MOB Portfolio, the Company originated $142&#160;million of secured mortgage debt (see Note 3) that matures in May 2026. In April 2022, the Company terminated its existing interest rate cap agreements associated with this variable rate mortgage debt and entered into two interest rate swap contracts that are designated as cash flow hedges</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and mature in May 2026 (see Note 17). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Maturities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stated debt maturities and scheduled principal repayments at March&#160;31, 2022 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.584%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Senior Unsecured</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mortgage</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bank Line&#160;of<br/>Credit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">803,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,225,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,250,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,700,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,379,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Discounts), premium and debt costs, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,944)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,654,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,335,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the senior unsecured notes range from 1.54% to 6.91% with a weighted average effective interest rate of 3.39% and a weighted average maturity of 7 years. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the mortgage debt range from 2.72% to 5.91% with a weighted average effective interest rate of 3.36% and a weighted average maturity of 4 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322189736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is a party to legal proceedings, lawsuits and other claims that arise in the ordinary course of the Company&#8217;s business. The Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company&#8217;s financial condition, results of operations, or cash flows. The Company&#8217;s policy is to expense legal costs as they are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%">DownREITs and Other Partnerships</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of certain limited liability companies (&#8220;DownREITs&#8221;), members may contribute appreciated real estate to a DownREIT in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the member. However, if a contributed property is later sold by the DownREIT, the unamortized pre-contribution gain that exists at the date of sale is specifically allocated and taxed to the contributing members. In many of the DownREITs, the Company has entered into indemnification agreements with those members who contributed appreciated property into the DownREIT. Under these indemnification agreements, if any of the appreciated real estate contributed by the members is sold by the DownREIT in a taxable transaction within a specified number of years, the Company will reimburse the affected members for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected member under the Internal Revenue Code (&#8220;make-whole payments&#8221;). These make-whole payments include a tax gross-up provision. These indemnification agreements have expirations terms that range through 2039 on a total of 29 properties. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company owns a 49% interest in the Life Science JV (see Note 7). If the property in the joint venture is sold in a taxable transaction, the Company is generally obligated to indemnify its joint venture partner for its federal and state income taxes associated with the gain that existed at the time of the contribution to the joint venture.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322193784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity and Redeemable Noncontrolling Interests</a></td>
<td class="text">Equity and Redeemable Noncontrolling Interests<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 28, 2022, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.30 per share. The common stock cash dividend will be paid on May 20, 2022 to stockholders of record as of the close of business on May 9, 2022.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, the Company declared and paid common stock cash dividends of $0.30</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At-The-Market Equity Offering Program</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company established an at-the-market equity offering program (as amended from time to time, the &#8220;ATM Program&#8221;), which was most recently amended in May 2021 to increase the size of the program from $1.25&#160;billion to $1.5 billion, pursuant to which shares of common stock having an aggregate gross sales price of up to $1.5 billion may be sold (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement (each, an &#8220;ATM forward contract&#8221;). The use of ATM forward contracts allows the Company to lock in a share price on the sale of shares at the time the ATM forward contract is effective, but defer receiving the proceeds from the sale of shares until a later date.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ATM forward contracts generally have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTUzNQ_ad0445ae-2c5c-4d27-bf22-90d9ea20d009">one</span> to two year term. At any time during the term, the Company may settle a forward sale by delivery of physical shares of common stock to the forward seller or, at the Company&#8217;s election, in cash or net shares. The forward sale price the Company expects to receive upon settlement of outstanding ATM forward contracts will be the initial forward price established upon the effective date, subject to adjustments for: (i) accrued interest, (ii) the forward purchasers&#8217; stock borrowing costs, and (iii) certain fixed price reductions during the term of the ATM forward contract.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, $1.18 billion</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Company&#8217;s common stock remained available for sale under the ATM Program. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Forward Contracts</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company utilized the forward provisions under the ATM Program to allow for the sale of an aggregate of 9.1&#160;million shares of its common stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at an initial weighted average net price of $35.25 per share, after commissions. During the three months ended March&#160;31, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no shares were settled under ATM forward contracts. Therefore, at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022, 9.1&#160;million shares remained outstanding under ATM forward contracts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company did not utilize the forward provisions under the ATM Program. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Direct Issuances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and March&#160;31, 2021, no shares of common stock were issued under the ATM Program.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accumulated other comprehensive income (loss) (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Plan minimum liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,047)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,147)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,047)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,147)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arrangements with noncontrolling interest holders are assessed for appropriate balance sheet classification based on the redemption and other rights held by the noncontrolling interest holder. Certain of the Company&#8217;s noncontrolling interest holders have the ability to put their equity interests to the Company upon specified events or after the passage of a predetermined period of time. Each put option is payable in cash and subject to increases in redemption value in the event that the underlying property generates specified returns for the Company and meets certain promote thresholds pursuant to the respective agreements. Accordingly, the Company records redeemable noncontrolling interests outside of permanent equity and presents the redeemable noncontrolling interests at the greater of their carrying amount or redemption value at the end of each reporting period.</span></div>During the year ended December&#160;31, 2021, one of the redeemable noncontrolling interests met the conditions for redemption and the related put option was exercised during the year then ended. Accordingly, the Company made a cash payment for the redemption value of $60&#160;million to the related noncontrolling interest holder during the year ended December&#160;31, 2021 and acquired the redeemable noncontrolling interest associated with this entity. The remaining redeemable noncontrolling interests had not yet met the conditions for redemption as of March&#160;31, 2022 or December&#160;31, 2021. Three of the interests will become redeemable following the passage of a predetermined amount of time, one of which will occur in late 2022, and the remaining two in 2023 and 2024. The fourth interest will become redeemable at the earlier of a predetermined passage of time or stabilization of the underlying development property, which is expected to occur in 2023. The redemption values are subject to change based on the assessment of value at each redemption date.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322230776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Common Share</a></td>
<td class="text">Earnings Per Common Share<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income (loss) per common share (&#8220;EPS&#8221;) is computed based on the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed based on the weighted average number of common shares outstanding plus the impact of forward equity sales agreements using the treasury stock method and common shares issuable from the assumed conversion of DownREIT units, stock options, certain performance restricted stock units, and unvested restricted stock units. Only those instruments having a dilutive impact on the Company&#8217;s basic income (loss) per share are included in diluted income (loss) per share during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock and certain performance restricted stock units are considered participating securities, because dividend payments are not forfeited even if the underlying award does not vest, and require use of the two-class method when computing basic and diluted earnings per share.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for a discussion of the sale of shares under and settlement of forward sales agreements during the periods presented. The Company considered the potential dilution resulting from the forward agreements to the calculation of earnings per share. At inception, the agreements do not have an effect on the computation of basic EPS as no shares are delivered until settlement. However, the Company uses the treasury stock method to calculate the dilution, if any, resulting from the forward sales agreements during the period of time prior to settlement. The aggregate effect on the Company&#8217;s diluted weighted-average common shares for the&#160;three months ended March&#160;31, 2022 and 2021 was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">zero weighted-average incremental shares from the forward equity sales agreements.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.282%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(120,585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123,891)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Participating securities' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,451)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations applicable to common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares - equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic earnings (loss) per common share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings (loss) per common share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). </span></div>For the three months ended March&#160;31, 2022, the 9.1 million shares under forward sales agreements that have not been settled as of March&#160;31, 2022 were anti-dilutive. For the three months ended March&#160;31, 2021, forward sales agreements had no dilutive impact as no shares remained outstanding under ATM forward contracts during the period.For the&#160;three months ended March&#160;31, 2022 and 2021, all 7 million shares issuable upon conversion of DownREIT units were not included because they were anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322137864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Disclosures</a></td>
<td class="text">Segment Disclosures<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments, based on how its chief operating decision makers (&#8220;CODMs&#8221;) evaluate the business and allocate resources, are as follows: (i) life science, (ii) medical office, and (iii) CCRC. The Company has non-reportable segments that are comprised primarily of the Company&#8217;s interests in an unconsolidated JV that owns 19 senior housing assets (the &#8220;SWF SH JV&#8221;) and debt investments. The accounting policies of the segments are the same as those described in Note 2 to the Consolidated Financial Statements in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 filed with the SEC, as updated by Note 2 herein. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates performance based on property Adjusted NOI. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, income from direct financing leases, and government grant income and exclusive of interest income), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss). Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims&#160;that have been incurred but not reported, and the impact of deferred community fee income and expense. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOI and Adjusted NOI include the Company&#8217;s share of income (loss) from unconsolidated joint ventures and exclude noncontrolling interests&#8217; share of income (loss) from consolidated joint ventures. Management believes that Adjusted NOI is an important supplemental measure because it provides relevant and useful information by reflecting only income and operating expense items that are incurred at the property level and presenting it on an unlevered basis. Additionally, management believes that net income (loss) is the most directly comparable GAAP measure to NOI and Adjusted NOI. NOI and Adjusted NOI should not be viewed as alternative measures of operating performance to net income (loss) as defined by GAAP since they do not reflect various excluded items. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-segment assets consist of assets in the Company&#8217;s other non-reportable segments and corporate non-segment assets. Corporate non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, loans receivable, marketable equity securities, other assets, real estate assets held for sale and discontinued operations, and liabilities related to assets held for sale.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information for the reportable segments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">498,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,820)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(207,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,055)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,837)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,773)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(177,733)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,504)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,607)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,384)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,926)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(181,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,810)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,918)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(157,538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on debt extinguishments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(912)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,422&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,375)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,249&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232,105)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,375)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232,113)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(120,585)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,375)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,895&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 3, 4, and 5 for significant transactions impacting the Company&#8217;s segment assets during the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322314264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text">Supplemental Cash Flow Information<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental cash flow information (in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of capitalized interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (refunded)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental schedule of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in ROU asset in exchange for new lease liability related to operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seller financing provided on disposition of real estate asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of restricted stock units and conversion of non-managing member units into common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes certain cash flow information related to assets classified as discontinued operations (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing costs, tenant improvements, and recurring capital expenditures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development, redevelopment, and other major improvements of real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of real estate, in-place lease, and other intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cash, cash equivalents and restricted cash (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,040&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,158&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322244344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_VariableInterestEntitiesAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_VariableInterestEntitiesTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unconsolidated Variable Interest Entities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and December&#160;31, 2021, the Company had investments in: (i) two unconsolidated VIE joint ventures and (ii) marketable debt securities of one VIE. The Company determined it is not the primary beneficiary of and therefore does not consolidate these VIEs because it does not have the ability to control the activities that most significantly impact their economic performance. Except for the Company&#8217;s equity interest in the unconsolidated joint ventures (the LLC investment and Needham Land Parcel JV discussed below), it has no formal involvement in these VIEs beyond its investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company holds commercial mortgage-backed securities (&#8220;CMBS&#8221;) issued by Federal Home Loan Mortgage Corporation (commonly referred to as Freddie MAC) through a special purpose entity that has been identified as a VIE because it is &#8220;thinly capitalized.&#8221; The CMBS issued by the VIE are backed by mortgage debt obligations on real estate assets. These securities are classified as held-to-maturity because the Company has the intent and ability to hold the securities until maturity. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LLC Investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company holds a limited partner ownership interest in an unconsolidated LLC that has been identified as a VIE. The Company&#8217;s involvement in the entity is limited to its equity investment as a limited partner and it does not have any substantive participating rights or kick-out rights over the general partner. The assets and liabilities of the entity primarily consist of those associated with its senior housing real estate and development activities. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development expenses and debt service payments).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Needham Land Parcel JV.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2021, the Company acquired a 38% interest in a life science development joint venture in Needham, Massachusetts for $13&#160;million. Current equity at risk is not sufficient to finance the joint venture&#8217;s activities. The assets and liabilities of the entity primarily consist of real estate and debt service obligations. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development expenses and debt service payments).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#8217;s involvement with these VIEs at March&#160;31, 2022 was as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">VIE Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exposure</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">and Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Continuing operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMBS and LLC investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in and advances to unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s maximum loss exposure represents the aggregate carrying amount of such investments (including accrued interest).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including under circumstances in which it could be exposed to further losses (e.g., cash shortfalls).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 3, 4, and 7 for additional descriptions of the nature, purpose, and operating activities of the Company&#8217;s unconsolidated VIEs and interests therein.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated total assets and total liabilities at March&#160;31, 2022 and December&#160;31, 2021 include certain assets of VIEs that can only be used to settle the liabilities of the related VIE. The VIE creditors do not have recourse to the Company. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ventures V, LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; The Company holds a 51% ownership interest in and is the managing member of a joint venture entity formed in October 2015 that owns and leases MOBs (&#8220;Ventures V&#8221;). The Company classifies Ventures V as a VIE due to the non-managing member lacking substantive participation rights in the management of Ventures V or kick-out rights over the managing member. The Company consolidates Ventures V as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#8217;s economic performance. The assets of Ventures V primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by Ventures V may only be used to settle its contractual obligations (primarily from capital expenditures).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Life Science JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;The Company holds a 99% ownership interest in multiple joint venture entities that own and lease life science assets (the &#8220;Life Science JVs&#8221;). The Life Science JVs are VIEs as the members share in control of the entities, but substantially all of the activities are performed on behalf of the Company. The Company consolidates the Life Science JVs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the Life Science JVs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Life Science JVs may only be used to settle their contractual obligations (primarily from capital expenditures). Refer to Note 11 for a discussion of certain put options associated with the Life Science JVs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MSREI MOB JV.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a 51% ownership interest in, and is the managing member of, a joint venture entity formed in August 2018 that owns and leases MOBs (the &#8220;MSREI JV&#8221;). The MSREI JV is a VIE due to the non-managing member lacking substantive participation rights in the management of the joint venture or kick-out rights over the managing member. The Company consolidates the MSREI JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#8217;s economic performance. The assets of the MSREI JV primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by the MSREI JV may only be used to settle its contractual obligations (primarily from capital expenditures).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DownREITs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; The Company holds a controlling ownership interest in and is the managing member of seven DownREITs. The Company classifies the DownREITs as VIEs due to the non-managing members lacking substantive participation rights in the management of the DownREITs or kick-out rights over the managing member. The Company consolidates the DownREITs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the DownREITs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the DownREITs (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Consolidated Real Estate Partnerships.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds a controlling ownership interest in and is the general partner (or managing member) of multiple partnerships that own and lease real estate assets (the &#8220;Partnerships&#8221;). The Company classifies the Partnerships as VIEs due to the limited partners (non-managing members) lacking substantive participation rights in the management of the Partnerships or kick-out rights over the general partner (managing member). The Company consolidates the Partnerships as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#8217; economic performance. The assets of the Partnerships primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Partnerships (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exchange Accommodation Titleholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  During the three months ended March&#160;31, 2022, the Company acquired two MOBs (the &#8220;acquired properties&#8221;) using a reverse like-kind exchange structure pursuant to Section 1031 of the Internal Revenue Code (a &#8220;reverse 1031 exchange&#8221;). As of March&#160;31, 2022, the Company had not completed the reverse 1031 exchange and as such, the acquired properties remained in the possession of the Exchange Accommodation Titleholder (&#8220;EAT&#8221;). The EAT was classified as a VIE as it was a &#8220;thinly capitalized&#8221; entity. The Company consolidated the EAT because it had the ability to control the activities that most significantly impacted the economic performance of the EAT and was, therefore, the primary beneficiary of the EAT. The properties held by the EAT had a carrying value of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$43&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of March&#160;31, 2022. The assets of the EAT primarily consisted of leased properties (net real estate, including intangibles), rents receivable, and cash and cash equivalents; their obligations primarily consisted of capital expenditures for the properties. Assets generated by the EAT may only be used to settle its contractual obligations (primarily from capital expenditures). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the year ended December&#160;31, 2021, the Company acquired two MOBs using reverse 1031 exchanges. As of December&#160;31, 2021, the Company had not completed the reverse 1031 exchanges and as such, the acquired properties remained in the possession of the EAT. These properties held by the EAT had a carrying value of $77&#160;million as of December&#160;31, 2021. These reverse 1031 exchanges were completed in February 2022.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities include VIE assets and liabilities as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development costs and construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(569,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(551,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale and discontinued operations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,699,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale and discontinued operations, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,135&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and liabilities related to assets held for sale and discontinued operations include VIE assets and liabilities as follows (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_VariableInterestEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_VariableInterestEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_VariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for variable interest entities, including description of the terms of arrangements and categorized by: (1) VIEs consolidated because the entity is the primary beneficiary, (2) VIEs not consolidated because the entity is not the primary beneficiary, and (3) VIEs or potential VIEs that are not consolidated because necessary information is not available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_VariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481326331256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract', window );"><strong>Financial Instruments, Owned, at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis in the Consolidated Balance Sheets were immaterial at March&#160;31, 2022 and December&#160;31, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the carrying amounts and fair values of the Company&#8217;s financial instruments (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,811&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank line of credit and commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,654,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,669,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,651,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,054,747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;1: Fair value calculated based on quoted prices in active markets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;2: Fair value based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and caps, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit and commercial paper, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#8217;s credit rating.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2022 and year ended December&#160;31, 2021, there were no material transfers of financial assets or liabilities within the fair value hierarchy.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322127800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative instruments to mitigate the effects of interest rate fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest rates related to the potential impact these changes could have on future earnings and forecasted cash flows. The Company does not use derivative instruments for speculative or trading purposes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company repaid $39&#160;million of variable rate secured debt on two SHOP assets and terminated the two remaining related interest rate swap contracts. Therefore, at March&#160;31, 2022 and December&#160;31, 2021, the Company had no remaining interest rate swap contracts. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company executed two interest rate cap agreements on its mortgage debt issued in conjunction with the acquisition of the MOB Portfolio (see Note 3). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s outstanding interest rate cap agreements as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.436%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Entered</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Strike Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April&#160;2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00 %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 mo. USD-LIBOR-BBA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Derivative assets are recorded in other assets, net in the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents two interest rate cap agreements that manage the Company&#8217;s exposure to variable cash flows on certain mortgage debt borrowings by limiting interest rates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, the Company recognized a $2&#160;million increase in the fair value of the interest rate cap agreements within other income (expense), net.</span></div>In April 2022, the Company terminated its existing interest rate cap agreements associated with $142&#160;million of variable rate mortgage debt and entered into two interest rate swap contracts that are designated as cash flow hedges and mature in May 2026.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481326332952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable, Accrued Liabilities, and Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable, Accrued Liabilities, and Other Liabilities</a></td>
<td class="text">Accounts Payable, Accrued Liabilities, and Other Liabilities<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accounts payable, accrued liabilities, and other liabilities, excluding accounts payable, accrued liabilities, and other liabilities related to assets classified as discontinued operations (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refundable entrance fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At March&#160;31, 2022 and December&#160;31, 2021, unamortized nonrefundable entrance fee liabilities were $498&#160;million and $496&#160;million, respectively, which are recorded within deferred revenue on the Consolidated Balance Sheets. During the three months ended March&#160;31, 2022, the Company collected nonrefundable entrance fees of $21&#160;million and recognized amortization of $19&#160;million. During the three months ended March&#160;31, 2021, the Company collected nonrefundable entrance fees of $15&#160;million and recognized amortization of $20&#160;million. The amortization of nonrefundable entrance fees is included within resident fees and services on the Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481327271640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#8217;s estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#8220;JVs&#8221;), and variable interest entities (&#8220;VIEs&#8221;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021 filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncomePolicyPolicyTextBlock', window );">Government Grant Income</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Government Grant Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) to provide financial aid to individuals, businesses, and state and local governments. During the three months ended March&#160;31, 2022 and 2021, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the Covid pandemic. Grant income is recognized when there is reasonable assurance that the grant will be received and the Company will comply with all conditions attached to the grant. Additionally, grants are recognized over the periods in which the Company recognizes the increased expenses and lost revenue the grants are intended to defray. As of March&#160;31, 2022, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued Operations</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Discontinued Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company established and began executing a plan to dispose of its senior housing triple-net and Senior Housing Operating Property (&#8220;SHOP&#8221;) properties and concluded that the planned dispositions represented a strategic shift that had and will have a major effect on the Company&#8217;s operations and financial results. Therefore, senior housing triple-net and SHOP assets meeting the held for sale criteria are classified as discontinued operations in all periods presented herein. In September 2021, the Company successfully completed the disposition of the remaining senior housing triple-net and SHOP properties. See Note 4 for further information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2021-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2021-10&#8221;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#8217;s accounting for assistance, and the effect of the assistance on an entity&#8217;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#8217;s consolidated financial position, results of operations, cash flows, or disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Adopted</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2020-04&#8221;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Scope </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2021-01&#8221;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The amendments in ASU 2020-04 and ASU 2021-01 were effective immediately and may be applied through December 31, 2022. The Company is evaluating whether the optional relief provided by ASU 2020-04 or ASU 2021-01 will be adopted but does not expect the adoption of these standards to have a material impact on its consolidated financial position, results of operations, cash flows, or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GovernmentGrantIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government Grant Income, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GovernmentGrantIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322229944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock', window );">Schedule of Government Grant Receivables, CARES Act</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information related to government grant income received and recognized by the Company (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in other income (expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant income recorded in income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total government grants received</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Government Grant Receivables, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322240328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Summary of Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the assets and liabilities classified as held for sale or as discontinued operations at March&#160;31, 2022 and December&#160;31, 2021, which are included in assets held for sale and discontinued operations, net and liabilities related to assets held for sale and discontinued operations, net, respectively, on the Consolidated Balance Sheets (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:73.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">ASSETS</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accounts receivable, net of allowance of $4,146 and $4,138</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets of discontinued operations, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">12,752</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">13,416</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets held for sale, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">21,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Assets held for sale and discontinued operations, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">33,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">37,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">LIABILITIES</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities of discontinued operations, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Liabilities related to assets held for sale and discontinued operations, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">15,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of March&#160;31, 2022, primarily comprised of five MOBs with net real estate assets of $20&#160;million and right-of-use asset, net of $1&#160;million. As of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December&#160;31, 2021, primarily comprised of four MOBs and one life science facility with net real estate assets of $23&#160;million and right-of-use asset, net of $1&#160;million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of discontinued operations during the three months ended March&#160;31, 2022 and 2021, or through the disposal date of each asset or portfolio of assets if they have been sold during such periods, as applicable, are included in the consolidated results of operations for the three months ended March&#160;31, 2022 and 2021. Summarized financial information for discontinued operations for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:73.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Rental and related revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Resident fees and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">72,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">78,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">71,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">74,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gain (loss) on sales of real estate, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">259,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(68)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">265,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(87)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">269,502&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(315)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Income (loss) from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">270,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481321440328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock', window );">Schedule of Company's Lease Income</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s lease income, excluding discontinued operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable income from operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income from direct financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock', window );">Schedule of Components of Net Investment in DFLs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment in DFLs consists of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of estimated residual value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less deferred selling profits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in direct financing leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of the net amount due as of the balance sheet date consisting of: (a) minimum lease payments due on direct financing and sales-type leases, (b) unguaranteed residual value, and (c) any unamortized initial direct costs on direct financing leases; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of lease income from direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481321279464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Loans Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s loans receivable (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discounts, fees, and costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,944)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,813)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,811&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At March&#160;31, 2022, the Company had $49 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects. At December&#160;31, 2021, the Company had $58 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock', window );">Schedule of Financing Receivable Credit Quality Indicators and by Year of Origination</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, by year of origination, the Company&#8217;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.164%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year of Origination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,796&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk rating:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performing loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Watch list loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workout loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total mezzanine and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,284&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Schedule of Financing Receivable, Allowance for Credit Loss</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s reserve for loan losses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mezzanine and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Secured Loans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mezzanine and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected loan losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected loan losses related to loans sold or repaid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loan losses, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes six loans sold or repaid during the year ended December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953659-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322143304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in and Advances to Unconsolidated Joint Ventures (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company owns interests in the following entities that are accounted for under the equity method, excluding investments classified as discontinued operations (dollars in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:30.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property Count</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership %</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SWF SH JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Science JV</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Office JVs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical office</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 - 67</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Property counts and ownership percentages are as of March&#160;31, 2022. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In December 2021, the Company acquired a 38% interest in a life science development joint venture in Needham, Massachusetts for $13&#160;million. Land held for development is excluded from the property count as of March&#160;31, 2022.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes two unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (20%) and (ii) Suburban Properties, LLC (67%). During 2021, the Company also held a 30% interest in Ventures III, which issued its final distribution and was dissolved.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481320907480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Lease Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#8217;s intangible lease assets (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:72.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277,915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock', window );">Schedule of Intangible Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#8217;s intangible lease liabilities (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:72.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible&#160;lease&#160;liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross intangible lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,355&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining amortization period in years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangiblesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangibles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangiblesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481320475928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Senior Notes Issuances</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company&#8217;s senior unsecured notes repurchases and redemptions during the year ended December&#160;31, 2021 (dollars in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:55.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payoff Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 19, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 19, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 28, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Upon repurchasing a portion of the 3.40% and 4.00% senior unsecured notes due 2025, the Company recognized a $61&#160;million loss on debt extinguishment during the year ended December&#160;31, 2021.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Upon completing the repurchases and redemptions of all outstanding 4.25%, 4.20%, and 3.88% senior unsecured notes due 2023 and 2024, the Company recognized a $164&#160;million loss on debt extinguishment during the three months ended March&#160;31, 2021.</span></div> (dollars in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:55.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 24, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 12, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Summary of Debt Maturities and Schedule Principal Repayments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s stated debt maturities and scheduled principal repayments at March&#160;31, 2022 (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.584%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Senior Unsecured</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mortgage</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bank Line&#160;of<br/>Credit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commercial Paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">803,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,225,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,250,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,700,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,379,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Discounts), premium and debt costs, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,944)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,654,056&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,335,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the senior unsecured notes range from 1.54% to 6.91% with a weighted average effective interest rate of 3.39% and a weighted average maturity of 7 years. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective interest rates on the mortgage debt range from 2.72% to 5.91% with a weighted average effective interest rate of 3.36% and a weighted average maturity of 4 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322132136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other comprehensive Loss</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accumulated other comprehensive income (loss) (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.218%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Executive Retirement Plan minimum liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,047)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,147)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,047)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,147)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322143304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.282%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(120,585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123,891)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Participating securities' share in continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,451)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations applicable to common shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests' share in discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares - equity awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average common shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic earnings (loss) per common share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted earnings (loss) per common share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) applicable to common shares</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). </span></div>For the three months ended March&#160;31, 2022, the 9.1 million shares under forward sales agreements that have not been settled as of March&#160;31, 2022 were anti-dilutive. For the three months ended March&#160;31, 2021, forward sales agreements had no dilutive impact as no shares remained outstanding under ATM forward contracts during the period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322311144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Financial Information of Reportable Segments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize information for the reportable segments (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">498,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,820)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(207,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,055)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,837)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,773)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(177,733)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,831)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on sales of real estate, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,504)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,607)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,384)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,417&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,067)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life Science</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Office</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CCRC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Non-reportable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Non-segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government grant income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,926)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(181,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,810)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted NOI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Adjustments to NOI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,918)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(157,538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairments and loan loss reserves</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on debt extinguishments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Government grant income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(912)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,660)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,422&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,375)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,249&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232,105)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity income (loss) from unconsolidated joint ventures</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,375)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232,113)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(120,585)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,375)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,473&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,895&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">______________________________________________________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).</span></div>(2)Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#8217;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#8217; share of income (loss) generated by consolidated joint ventures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481317510824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental cash flow information (in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid, net of capitalized interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid (refunded)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Supplemental schedule of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in ROU asset in exchange for new lease liability related to operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seller financing provided on disposition of real estate asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of restricted stock units and conversion of non-managing member units into common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes certain cash flow information related to assets classified as discontinued operations (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasing costs, tenant improvements, and recurring capital expenditures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development, redevelopment, and other major improvements of real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of real estate, in-place lease, and other intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cash, cash equivalents and restricted cash (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Continuing operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Discontinued operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,448&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,040&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,158&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481327290488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_VariableInterestEntitiesAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#8217;s involvement with these VIEs at March&#160;31, 2022 was as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">VIE Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset&#160;Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum&#160;Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exposure</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">and Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Continuing operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMBS and LLC investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Needham Land Parcel JV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in and advances to unconsolidated joint ventures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s maximum loss exposure represents the aggregate carrying amount of such investments (including accrued interest).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock', window );">Consolidated Assets and Liabilities of Variable Interest Entities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and total liabilities include VIE assets and liabilities as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development costs and construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(569,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(551,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net real estate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale and discontinued operations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,699,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities related to assets held for sale and discontinued operations, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,135&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and liabilities related to assets held for sale and discontinued operations include VIE assets and liabilities as follows (in thousands):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the VIE's total assest and liabilities included in the consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_VariableInterestEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_VariableInterestEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322181400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract', window );"><strong>Financial Instruments, Owned, at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Summary of Carry Amounts and Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the carrying amounts and fair values of the Company&#8217;s financial instruments (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,811&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank line of credit and commercial paper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior unsecured notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,654,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,669,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,651,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,054,747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;1: Fair value calculated based on quoted prices in active markets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Level&#160;2: Fair value based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and caps, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit and commercial paper, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#8217;s credit rating.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2022 and year ended December&#160;31, 2021, there were no material transfers of financial assets or liabilities within the fair value hierarchy.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322178376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company executed two interest rate cap agreements on its mortgage debt issued in conjunction with the acquisition of the MOB Portfolio (see Note 3). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s outstanding interest rate cap agreements as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.436%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Entered</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity&#160;Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Strike Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April&#160;2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00 %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 mo. USD-LIBOR-BBA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Derivative assets are recorded in other assets, net in the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents two interest rate cap agreements that manage the Company&#8217;s exposure to variable cash flows on certain mortgage debt borrowings by limiting interest rates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481322111864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s accounts payable, accrued liabilities, and other liabilities, excluding accounts payable, accrued liabilities, and other liabilities related to assets classified as discontinued operations (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refundable entrance fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued construction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At March&#160;31, 2022 and December&#160;31, 2021, unamortized nonrefundable entrance fee liabilities were $498&#160;million and $496&#160;million, respectively, which are recorded within deferred revenue on the Consolidated Balance Sheets. During the three months ended March&#160;31, 2022, the Company collected nonrefundable entrance fees of $21&#160;million and recognized amortization of $19&#160;million. During the three months ended March&#160;31, 2021, the Company collected nonrefundable entrance fees of $15&#160;million and recognized amortization of $20&#160;million. The amortization of nonrefundable entrance fees is included within resident fees and services on the Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481324073560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="num">$ (6,947,722)<span></span>
</td>
<td class="num">$ (7,058,760)<span></span>
</td>
<td class="num">$ (7,241,139)<span></span>
</td>
<td class="num">$ (7,289,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">97,890<span></span>
</td>
<td class="nump">87,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="num">$ (695,373)<span></span>
</td>
<td class="num">$ (755,384)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Revision of Prior Period, Error Correction, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481324819576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Government Grant Income (Details) - Government Assistance, CARES Act - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncome', window );">Government grant income received</a></td>
<td class="nump">$ 7,406<span></span>
</td>
<td class="nump">$ 4,968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember', window );">Government grant income recorded in other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncome', window );">Government grant income received</a></td>
<td class="nump">6,552<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember', window );">Government grant income recorded in equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncome', window );">Government grant income received</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember', window );">Government grant income recorded in income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncome', window );">Government grant income received</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 3,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GovernmentGrantIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government Grant Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GovernmentGrantIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GovernmentAssistanceAxis=peak_GovernmentAssistanceCARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=peak_IncomeLossFromDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=peak_IncomeLossFromDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481317322136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Transactions - Real Estate Investments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>a </div>
<div>property</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MA', window );">MASSACHUSETTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land (in acres) | a</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLand', window );">Payments to acquire land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | MASSACHUSETTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | MASSACHUSETTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | TEXAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | TENNESSEE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | COLORADO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | FLORIDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | KANSAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | NEW JERSEY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | WASHINGTON</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | LOUISIANA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLineItems', window );"><strong>Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Payments to acquire real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_KS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_KS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481324885896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Transactions - Development Activities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateAbstract', window );"><strong>Real Estate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease', window );">Development and redevelopment projects, amount decrease</a></td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements', window );">Development commitments</a></td>
<td class="nump">$ 418<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments, Development and Redevelopment Projects and Tenant Improvements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments, Development and Redevelopment Projects, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481310028728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="9">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,856,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfRealEstate', window );">Impairment of real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember', window );">Planned MOB Demolition, Tenant Relocation and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonrecurringExpense', window );">Expense on other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations', window );">Number of assets classified as discontinued operations | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayments of secured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,000,000<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember', window );">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember', window );">Sunrise Senior Housing Portfolio | SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_CapitalExpenditureFundingAmountCommitted', window );">Capital expenditure funding, amount committed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_CapitalExpenditureFundingAmountFunded', window );">Capital expenditure funding, amount funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=peak_OakmontSHOPPortfolioMember', window );">Oakmont SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer', window );">Carrying value of mortgages assumed by buyer in real estate dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=peak_OakmontSHOPPortfolioMember', window );">Oakmont SHOP Portfolio | Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DispositionOfPropertiesSoldNumber', window );">Number of properties disposed | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=peak_OtherDispositionsMember', window );">Other Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer', window );">Carrying value of mortgages assumed by buyer in real estate dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=peak_OtherDispositionsMember', window );">Other Dispositions | Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DispositionOfPropertiesSoldNumber', window );">Number of properties disposed | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireFinanceReceivables', window );">Payments to acquire finance receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Oakmont SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 564,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Discovery SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment', window );">Proceeds from sale of loans and preferred equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Sonata SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Other Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingTripleNetMember', window );">Senior Housing Triple Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingTripleNetMember', window );">Senior Housing Triple Net | Brookdale Triple Net Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingTripleNetMember', window );">Senior Housing Triple Net | HRA Triple Net Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesSold', window );">Number of properties sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesSold', window );">Number of properties sold | property</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Sunrise Senior Housing Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 664,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireFinanceReceivables', window );">Payments to acquire finance receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Oakmont SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Discovery SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPreferredEquityMethodInvestmentsSold', window );">Number of preferred equity method investments sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Sonata SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | SLC SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayments of secured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | SLC SHOP Portfolio | Definitive Agreement Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingTripleNetMember', window );">Senior Housing Triple Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingTripleNetMember', window );">Senior Housing Triple Net | Sunrise Senior Housing Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingTripleNetMember', window );">Senior Housing Triple Net | Brookdale Triple Net Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingTripleNetMember', window );">Senior Housing Triple Net | HRA Triple Net Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeHospitalMember', window );">Medical Office, Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CapitalExpenditureFundingAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditure Funding, Amount Committed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CapitalExpenditureFundingAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CapitalExpenditureFundingAmountFunded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditure Funding, Amount Funded</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CapitalExpenditureFundingAmountFunded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DispositionOfPropertiesSoldNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of properties sold during the period, not categorized as discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DispositionOfPropertiesSoldNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash or Part Noncash, Discontinued Operations, Secured Debt Assumed by Buyer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Assets Classified as Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfAssetsClassifiedAsDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPreferredEquityMethodInvestmentsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Preferred Equity Method Investments Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPreferredEquityMethodInvestmentsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesToBeSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties To Be Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesToBeSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Sale of Financing Receivable, after Allowance for Credit Loss and Preferred Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123605587&amp;loc=d3e23528-158515<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23439-158514<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23415-158514<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings in the period to reduce the carrying amount of real property to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=114868883&amp;loc=SL114871943-224233<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of amounts due from customers, clients, lessees, borrowers, or others under the terms of its agreements therewith.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of buildings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_OakmontSHOPPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_OakmontSHOPPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_OtherDispositionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_OtherDispositionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_DiscoverySHOPPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_DiscoverySHOPPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_SonataSHOPPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_SonataSHOPPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingTripleNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingTripleNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_BrookdaleTripleNetPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_BrookdaleTripleNetPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_HRATripleNetPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_HRATripleNetPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_SLCSHOPPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_SLCSHOPPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DefinitiveAgreementsAxisAxis=peak_DefinitiveAgreementFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DefinitiveAgreementsAxisAxis=peak_DefinitiveAgreementFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingTripleNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingTripleNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeHospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeHospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481309877640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations - Assets and Liabilities for Discontinued Operations (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,989<span></span>
</td>
<td class="nump">$ 7,707<span></span>
</td>
<td class="nump">$ 40,161<span></span>
</td>
<td class="nump">$ 53,085<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets of discontinued operations, net</a></td>
<td class="nump">33,812<span></span>
</td>
<td class="nump">37,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities of discontinued operations, net</a></td>
<td class="nump">14,318<span></span>
</td>
<td class="nump">15,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts receivable</a></td>
<td class="nump">4,146<span></span>
</td>
<td class="nump">4,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="nump">232,457<span></span>
</td>
<td class="nump">233,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">817,022<span></span>
</td>
<td class="nump">789,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet', window );">Accounts receivable, net of allowance of $4,146 and $4,138</a></td>
<td class="nump">2,764<span></span>
</td>
<td class="nump">2,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset', window );">Right-of-use asset, net</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets, net</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">3,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets of discontinued operations, net</a></td>
<td class="nump">12,752<span></span>
</td>
<td class="nump">13,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup', window );">Assets held for sale, net</a></td>
<td class="nump">21,060<span></span>
</td>
<td class="nump">23,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale and discontinued operations, net</a></td>
<td class="nump">33,812<span></span>
</td>
<td class="nump">37,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">14,072<span></span>
</td>
<td class="nump">14,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities of discontinued operations, net</a></td>
<td class="nump">14,234<span></span>
</td>
<td class="nump">14,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale', window );">Liabilities related to assets held for sale, net</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Liabilities related to assets held for sale and discontinued operations, net</a></td>
<td class="nump">14,318<span></span>
</td>
<td class="nump">15,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NetRealEstateAssets', window );">Net real estate assets</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Held-for-sale | Medical Office Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_PropertiesHeldForSaleNumber', window );">Number of properties classified as held for sale | property</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Held-for-sale | Life Science</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_PropertiesHeldForSaleNumber', window );">Number of properties classified as held for sale | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AssetsHeldForSaleAndDiscontinuedOperationsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets Held For Sale And Discontinued Operations Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AssetsHeldForSaleAndDiscontinuedOperationsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Accounts Receivable Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Allowance For Doubtful Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liabilities Related to Assets Held For Sale And Discontinued Operations Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NetRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Real Estate Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NetRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_PropertiesHeldForSaleNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of properties held for sale at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_PropertiesHeldForSaleNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123398962&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For banks, amount of all liabilities for which a financial institution is required to include in its calculation of net investment in real estate assets held for development or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481317484328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details) - Held-for-sale - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome', window );">Rental and related revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices', window );">Resident fees and services</a></td>
<td class="nump">2,655<span></span>
</td>
<td class="nump">72,998<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">2,655<span></span>
</td>
<td class="nump">78,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Operating</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">71,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">74,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="num">(71)<span></span>
</td>
<td class="nump">259,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet', window );">Other income (expense), net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5,885<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="num">(68)<span></span>
</td>
<td class="nump">265,547<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">269,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit (expense)</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="nump">64<span></span>
</td>
<td class="num">(315)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">$ 270,008<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Nonoperating Income Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Income (Expense), Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Resident Fees And Services</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Total Costs And Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1063-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1060-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rental income attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481327131032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncomeAbstract', window );"><strong>Interest and Other Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments', window );">Fixed income from operating leases</a></td>
<td class="nump">$ 287,292<span></span>
</td>
<td class="nump">$ 262,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseVariableLeaseIncome', window );">Variable income from operating leases</a></td>
<td class="nump">82,858<span></span>
</td>
<td class="nump">65,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseInterestIncome', window );">Interest income from direct financing leases</a></td>
<td class="nump">$ 1,168<span></span>
</td>
<td class="nump">$ 2,163<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from net investment in direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseVariableLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from variable lease payments paid and payable to lessor, excluding amount included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseVariableLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481320564712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLeaseReceivables', window );">Proceeds from sale of lease receivable</a></td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfNotesReceivable', window );">Gain on sale of direct financing lease</a></td>
<td class="nump">$ 23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107425-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of receivables arising from the lease of real estate, equipment or other fixed assets for a specified time in exchange for payment, usually in the form of rent; excludes proceeds from sales-type lease transactions, which are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481324080456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Direct Financing Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseLeaseReceivable', window );">Present value of minimum lease payments receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset', window );">Present value of estimated residual value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">44,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseDeferredSellingProfit', window );">Less deferred selling profits</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,220)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseNetInvestmentInLease', window );">Net investment in direct financing leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 44,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_PropertiesWithDirectFinancingLeasesNumber', window );">Properties subject to direct financing leases | property</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_PropertiesWithDirectFinancingLeasesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of properties with direct financing leases at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_PropertiesWithDirectFinancingLeasesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseDeferredSellingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred selling profit from direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseDeferredSellingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term, guaranteed by lessee or other third party unrelated to lessor, from direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of net investment in direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value expected to be derived from underlying asset, following end of lease term, not guaranteed by lessee or other third party unrelated to lessor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481321168184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loans Receivable - Schedule of Loans Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems', window );"><strong>Financing Receivable, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount', window );">Unamortized discounts, fees, and costs</a></td>
<td class="num">$ (3,301)<span></span>
</td>
<td class="num">$ (4,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses</a></td>
<td class="num">(1,944)<span></span>
</td>
<td class="num">(1,813)<span></span>
</td>
<td class="num">$ (10,280)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Loans receivable, net</a></td>
<td class="nump">409,753<span></span>
</td>
<td class="nump">415,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FinancingReceivableRemainingCommitments', window );">Remaining loans receivable commitments</a></td>
<td class="nump">49,000<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems', window );"><strong>Financing Receivable, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Financing receivable, gross</a></td>
<td class="nump">388,746<span></span>
</td>
<td class="nump">396,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineAndOtherMember', window );">Mezzanine and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems', window );"><strong>Financing Receivable, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Financing receivable, gross</a></td>
<td class="nump">$ 26,252<span></span>
</td>
<td class="nump">$ 25,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FinancingReceivableRemainingCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Remaining Commitments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FinancingReceivableRemainingCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, after allowance for credit loss, of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, before allowance for credit loss, of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized loan commitment, origination, and other fees (costs) and purchase premium (discount) on financing receivable. Excludes financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10152-111534<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6378536&amp;loc=d3e10092-111533<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481315041640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="7">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18,511,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (924,119,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Financing receivable, after allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 415,811,000<span></span>
</td>
<td class="nump">$ 415,811,000<span></span>
</td>
<td class="nump">$ 415,811,000<span></span>
</td>
<td class="nump">$ 409,753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserves for loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,944,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,813,000<span></span>
</td>
<td class="nump">$ 1,813,000<span></span>
</td>
<td class="nump">$ 1,813,000<span></span>
</td>
<td class="nump">1,944,000<span></span>
</td>
<td class="nump">$ 10,280,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FinancingReceivableNumberOfContractsSold', window );">Number of loans sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfFinanceReceivables', window );">Proceeds from sale of receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfNotesReceivable', window );">Gain (loss) on sale of financing receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments', window );">Credit loss reserve on unfunded loan commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember', window );">Sunrise Senior Housing Portfolio | SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_CapitalExpenditureFundingAmountCommitted', window );">Capital expenditure funding, amount committed</a></td>
<td class="nump">$ 47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted', window );">Capital expenditure funding, cost of capital, percent committed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_CapitalExpenditureFundingAmountFunded', window );">Capital expenditure funding, amount funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Financing receivable, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396,281,000<span></span>
</td>
<td class="nump">396,281,000<span></span>
</td>
<td class="nump">396,281,000<span></span>
</td>
<td class="nump">388,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineMember', window );">Secured Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserves for loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,938,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,804,000<span></span>
</td>
<td class="nump">$ 1,804,000<span></span>
</td>
<td class="nump">1,804,000<span></span>
</td>
<td class="nump">1,938,000<span></span>
</td>
<td class="nump">$ 3,152,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Sunrise Senior Housing Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 664,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLoansReceivable', window );">Proceeds from the collection of loans receivable</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Financing receivable, after allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,000,000<span></span>
</td>
<td class="nump">$ 165,000,000<span></span>
</td>
<td class="nump">165,000,000<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Discovery SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Secured Loans | Discovery SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FinancingReceivableHeldForSaleNumberOfContracts', window );">Number of loans held for sale | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FinancingReceivableNumberOfContractsSold', window );">Number of loans sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfNotesReceivable', window );">Gain (loss) on sale of financing receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember', window );">Secured mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FinancingReceivableHeldForSaleNumberOfContracts', window );">Number of loans held for sale | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Financing receivable, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFinanceReceivables', window );">Decrease in financing receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Financing receivable, after allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserves for loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables', window );">Principal repayments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FinancingReceivableNumberOfContracts', window );">Number of loans receivable | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LoansReceivableMarketRate', window );">Loans receivable, market rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NoncashOrPartNoncashInterestIncome', window );">Non-cash interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LoansReceivableStatedInterestRate', window );">Loans receivable, stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LoansReceivableInterestIncomeAmortizationPeriod', window );">Interest income, amortization period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LoansReceivableStatedInterestRate', window );">Loans receivable, stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LoansReceivableInterestIncomeAmortizationPeriod', window );">Interest income, amortization period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Discovery SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_CCRVJVInvestmentMember', window );">CCRC JV | Lessor Asset Under Operating Lease | Brookedale MTCA | Other Non-Reporting Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Financing receivable, after allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CapitalExpenditureFundingAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditure Funding, Amount Committed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CapitalExpenditureFundingAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CapitalExpenditureFundingAmountFunded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditure Funding, Amount Funded</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CapitalExpenditureFundingAmountFunded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditure Funding, Cost of Capital, Percent Committed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance For Credit Loss, Unfunded Loan Commitments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FinancingReceivableHeldForSaleNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Held For Sale, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FinancingReceivableHeldForSaleNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FinancingReceivableNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Number of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FinancingReceivableNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FinancingReceivableNumberOfContractsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Number of Contracts Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FinancingReceivableNumberOfContractsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LoansReceivableInterestIncomeAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loans Receivable, Interest Income, Amortization Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LoansReceivableInterestIncomeAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LoansReceivableMarketRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loans Receivable, Market Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LoansReceivableMarketRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LoansReceivableStatedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loans Receivable, Stated Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LoansReceivableStatedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NoncashOrPartNoncashInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash or Part Noncash, Interest Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NoncashOrPartNoncashInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesToBeSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties To Be Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesToBeSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, after allowance for credit loss, of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, before allowance for credit loss, of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107425-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123605587&amp;loc=d3e23528-158515<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23439-158514<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23415-158514<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in outstanding loans including accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection of receivables arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of buildings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of receivables arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_SunriseSeniorHousingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_SecuredMortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_DiscoverySHOPPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_DiscoverySHOPPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_SecuredMortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_CCRVJVInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=peak_CCRVJVInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorPropertyClassAxis=peak_LessorAssetUnderOperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorPropertyClassAxis=peak_LessorAssetUnderOperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481323317544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_MortgageReceivablesMember', window );">Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2022</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">301,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">79,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">2,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">383,507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=peak_MezzanineAndOtherLoansReceivableSecuredMember', window );">Mezzanine and other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2022</a></td>
<td class="nump">12,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">12,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">1,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">26,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=us-gaap_PerformingFinancingReceivableMember', window );">Performing loans | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">301,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">79,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">2,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">383,507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=us-gaap_PerformingFinancingReceivableMember', window );">Performing loans | Mezzanine and other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2022</a></td>
<td class="nump">12,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">12,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">1,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">26,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WatchListFinancingReceivableMember', window );">Watch list loans | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WatchListFinancingReceivableMember', window );">Watch list loans | Mezzanine and other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WorkoutFinancingReceivableMember', window );">Workout loans | Secured Mortgage Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WorkoutFinancingReceivableMember', window );">Workout loans | Mezzanine and other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Loans receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear', window );">2019</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear', window );">2018</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear', window );">Prior</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, before allowance for credit loss, of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest of financing receivable originated more than five years prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI http://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest of financing receivable originated four years prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI http://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest of financing receivable originated three years prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI http://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest of financing receivable originated in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI http://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest of financing receivable originated two years prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI http://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest of financing receivable originated in fiscal year prior to current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919232-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 55<br> -Paragraph 79<br> -URI http://asc.fasb.org/extlink&amp;oid=124267575&amp;loc=SL82922352-210448<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_MortgageReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_MortgageReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=peak_MezzanineAndOtherLoansReceivableSecuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=peak_MezzanineAndOtherLoansReceivableSecuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=us-gaap_PerformingFinancingReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=us-gaap_PerformingFinancingReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WatchListFinancingReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WatchListFinancingReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WorkoutFinancingReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentPerformanceStatusAxis=peak_WorkoutFinancingReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481309819320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable - Schedule of Reserve for Loan Losses (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>loan</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, beginning of period</a></td>
<td class="nump">$ 1,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Provision for expected loan losses</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableSignificantSales', window );">Expected loan losses related to loans sold and repaid</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, end of period</a></td>
<td class="nump">1,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FinancingReceivableNumberOfContractsSold', window );">Number of loans sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineMember', window );">Secured Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, beginning of period</a></td>
<td class="nump">1,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Provision for expected loan losses</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableSignificantSales', window );">Expected loan losses related to loans sold and repaid</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, end of period</a></td>
<td class="nump">1,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_ParticipatingDevelopmentLoansAndOtherMember', window );">Mezzanine and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, beginning of period</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Provision for expected loan losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableSignificantSales', window );">Expected loan losses related to loans sold and repaid</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Reserve for loan losses, end of period</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FinancingReceivableNumberOfContractsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Number of Contracts Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FinancingReceivableNumberOfContractsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableSignificantSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease from sale and reclassification to held-for-sale of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919244-210447<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableSignificantSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLossesExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of credit loss expense (reversal of expense) for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLossesExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_MezzanineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_ParticipatingDevelopmentLoansAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis=peak_ParticipatingDevelopmentLoansAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481315804584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in and Advances to Unconsolidated Joint Ventures (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>property</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>joint_venture </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>joint_venture</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in and advances to unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 403,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 403,634<span></span>
</td>
<td class="nump">$ 403,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=peak_DiscoveryNaplesJVMember', window );">Discovery Naples JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=peak_DiscoverySarasotaJVMember', window );">Discovery Sarasota JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_MedicalOfficeJVsMember', window );">Medical Office JVs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfUnconsolidatedJointVenture', window );">Number of unconsolidated joint ventures (in joint ventures) | joint_venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIVLLCMember', window );">HCP Ventures IV, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SuburbanPropertiesLLCMember', window );">Suburban Properties, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIIILLCMember', window );">HCP Ventures III, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember', window );">Discovery Naples JV and Discovery Sarasota JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfUnconsolidatedJointVenture', window );">Number of unconsolidated joint ventures (in joint ventures) | joint_venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_CCRVJVInvestmentMember', window );">CCRC JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember', window );">Brookedale MTCA | CCRC JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember', window );">Other Non-Reporting Segment | SWF SH JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355,394<span></span>
</td>
<td class="nump">$ 353,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Life Science JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,605<span></span>
</td>
<td class="nump">$ 26,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Needham Land Parcel JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,566<span></span>
</td>
<td class="nump">$ 14,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfBuildings', window );">Proceeds from sale of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office | Medical Office JVs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Property count | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,069<span></span>
</td>
<td class="nump">$ 8,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office | Medical Office JVs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office | Medical Office JVs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember', window );">SHOP | Discovery SHOP Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPreferredEquityMethodInvestmentsSold', window );">Number of preferred equity method investments sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesToBeSold', window );">Number of assets to be sold | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPreferredEquityMethodInvestmentsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Preferred Equity Method Investments Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPreferredEquityMethodInvestmentsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesToBeSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties To Be Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesToBeSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfUnconsolidatedJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of unconsolidated joint ventures between entity and an institutional capital partner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfUnconsolidatedJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of buildings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=peak_DiscoveryNaplesJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=peak_DiscoveryNaplesJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=peak_DiscoverySarasotaJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=peak_DiscoverySarasotaJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_MedicalOfficeJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_MedicalOfficeJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SuburbanPropertiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SuburbanPropertiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIIILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIIILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_CCRVJVInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_CCRVJVInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SHOPJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SHOPJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_SeniorHousingOperatingPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=peak_DiscoverySHOPPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=peak_DiscoverySHOPPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481323592088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles - Intangibles Lease Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross intangible lease assets</a></td>
<td class="nump">$ 802,078<span></span>
</td>
<td class="nump">$ 797,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(304,974)<span></span>
</td>
<td class="num">(277,915)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 497,104<span></span>
</td>
<td class="nump">$ 519,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average remaining amortization period in years</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangiblesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangibles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangiblesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481320476968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles - Intangibles Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IntangiblesAbstract', window );"><strong>Intangibles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FiniteLivedIntangibleLiabilitiesGross', window );">Gross intangible lease liabilities</a></td>
<td class="nump">$ 239,677<span></span>
</td>
<td class="nump">$ 234,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(64,322)<span></span>
</td>
<td class="num">(57,685)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_FiniteLivedIntangibleLiabilitiesNet', window );">Intangible liabilities, net</a></td>
<td class="nump">$ 175,355<span></span>
</td>
<td class="nump">$ 177,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife', window );">Weighted average remaining amortization period in years</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FiniteLivedIntangibleLiabilitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FiniteLivedIntangibleLiabilitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_FiniteLivedIntangibleLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate sum of the gross carrying value of major finite-lived intangible liabilities class, less accumulated accretion and any impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_FiniteLivedIntangibleLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangiblesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangibles [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangiblesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481324103384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average remaining amortization period in years</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife', window );">Weighted average remaining amortization period, liabilities</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember', window );">Brookedale MTCA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Intangible assets acquired</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IntangibleLiabilitiesAcquired', window );">Intangible liabilities acquired</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average remaining amortization period in years</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife', window );">Weighted average remaining amortization period, liabilities</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IntangibleLiabilitiesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Liabilities Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IntangibleLiabilitiesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=peak_BrookdaleMTCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481323198200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Bank Line of Credit and Term Loans (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 23, 2019 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>renewal_option</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Balance outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,330,813,000<span></span>
</td>
<td class="nump">$ 1,165,975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=peak_LineOfCreditAndTermLoanMember', window );">Line of Credit and Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentCovenantDebtToAssets', window );">Debt instrument, covenant debt to assets (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentCovenantSecuredDebtToAssets', window );">Debt instrument, covenant secured debt to assets (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets', window );">Debt instrument, covenant unsecured debt to unencumbered assets (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentCovenantFixedChargeRatioMinimum', window );">Debt instrument, covenant minimum fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentCovenantNetWorth', window );">Debt instrument, covenant net worth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Bank Line&#160;of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentNumberofExtensions', window );">Number of extensions | renewal_option</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentPeriodOfExtension', window );">Length of debt instrument extension period (in months)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Debt instrument, facility fee (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Balance outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum', window );">Line of credit facility additional aggregate amount, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics', window );">Debt Instrument, interest rate, reduction available for sustainability metrics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Bank Line&#160;of Credit | Revolving Credit Facility | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Bank Line&#160;of Credit | 2019 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayment of 2019 term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantDebtToAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The limit of the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantDebtToAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantFixedChargeRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The required minimum Fixed Charge Coverage ratio contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantFixedChargeRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantNetWorth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The required Minimum Consolidated Tangible Net Worth contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantNetWorth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantSecuredDebtToAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The limit of the ratio of Secured Debt to Consolidated Total Asset Value contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantSecuredDebtToAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The limit of the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value contained in the debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentNumberofExtensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Extensions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentNumberofExtensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentPeriodOfExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the length of the debt instrument extension period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentPeriodOfExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the maximum additional borrowing capacity available under the credit facility, subject to customary conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_LineOfCreditAndTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_LineOfCreditAndTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=peak_A2019TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=peak_A2019TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481323187544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Commercial Paper Program (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term (in months)</a></td>
<td class="text">45 days<span></span>
</td>
<td class="text">2 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted-average interest rate (as a percent)</a></td>
<td class="nump">0.93%<span></span>
</td>
<td class="nump">0.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=peak_CommercialPaperProgramMember', window );">Commercial Paper Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentMaximumBorrowingCapacity', window );">Maximum outstanding amount capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Borrowings</a></td>
<td class="nump">$ 1,330,000,000<span></span>
</td>
<td class="nump">$ 1,170,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=peak_CommercialPaperProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=peak_CommercialPaperProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481317755192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Senior Unsecured Notes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>bond</div>
</th>
<th class="th">
<div>Nov. 24, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 12, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 19, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 26, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 28, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance on debt</a></td>
<td class="nump">$ 6,379,802,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 164,292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfBondOfferings', window );">Number of bond offerings | bond</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance on debt</a></td>
<td class="nump">$ 4,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Unsecured Note 3.400 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251,806,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Unsecured Note 4.000 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298,194,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Unsecured Note 4.250 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,000,000<span></span>
</td>
<td class="nump">$ 112,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Unsecured Note 4.200 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,000,000<span></span>
</td>
<td class="nump">$ 201,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Unsecured Note 3.880 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 331,000,000<span></span>
</td>
<td class="nump">$ 469,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.88%<span></span>
</td>
<td class="nump">3.88%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Senior Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Senior Notes Due 2023 and 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Unsecured Note 2.13 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Unsecured Note 1.35 Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfBondOfferings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Bond Offerings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfBondOfferings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_UnsecuredNote3400PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_UnsecuredNote3400PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_UnsecuredNote4000PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_UnsecuredNote4000PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_UnsecuredNote4.250PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_UnsecuredNote4.250PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_UnsecuredNote4200PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_UnsecuredNote4200PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_UnsecuredNote3880PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_UnsecuredNote3880PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_SeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_SeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_SeniorNotesDue2023And2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_SeniorNotesDue2023And2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_UnsecuredNote213PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_UnsecuredNote213PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=peak_UnsecuredNote1350PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=peak_UnsecuredNote1350PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481317712936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Mortgage Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>derivativeHeld </div>
<div>facility</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>derivativeHeld</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>facility </div>
<div>derivativeHeld</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance on debt</a></td>
<td class="nump">$ 6,379,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest-rate Swap Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivativeHeld</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Interest-rate Swap Contracts | Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivativeHeld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings | Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142,000<span></span>
</td>
<td class="nump">$ 142,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance on debt</a></td>
<td class="nump">$ 348,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber', window );">Number of healthcare facilities used to secure debt (in facilities) | facility</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue', window );">Debt instrument, collateral, healthcare facilities carrying value</a></td>
<td class="nump">$ 803,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 811,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt instrument, periodic payment</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of healthcare facilities which are secured by mortgage debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentCollateralHealthcareFacilitiesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of healthcare facilities which are secured by mortgage debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentCollateralHealthcareFacilitiesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481323893480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Debt Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 3,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">90,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">7,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">803,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">2,225,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">3,250,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">6,379,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">(Discounts), premium and debt costs, net</a></td>
<td class="num">(44,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 6,335,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted-average interest rate (as a percent)</a></td>
<td class="nump">0.93%<span></span>
</td>
<td class="nump">0.32%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Bank Line&#160;of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">(Discounts), premium and debt costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">1,330,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">1,330,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">(Discounts), premium and debt costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">1,330,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">3,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">4,700,000<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">(Discounts), premium and debt costs, net</a></td>
<td class="num">(45,944)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 4,654,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted-average interest rate (as a percent)</a></td>
<td class="nump">3.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentWeightedAverageMaturity', window );">Weighted-average maturity (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Interest Rate 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Interest Rate 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Interest Rate 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Interest Rate 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Interest Rate 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Interest Rate Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">1.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Senior Unsecured Note | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">6.91%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 3,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">90,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">7,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">3,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">244,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt before discount, net</a></td>
<td class="nump">348,989<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">(Discounts), premium and debt costs, net</a></td>
<td class="nump">1,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 350,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted-average interest rate (as a percent)</a></td>
<td class="nump">3.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DebtInstrumentWeightedAverageMaturity', window );">Weighted-average maturity (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Interest Rate 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Interest Rate 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Interest Rate 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Interest Rate 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Interest Rate 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Interest Rate Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.91%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.91%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DebtInstrumentWeightedAverageMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents weighted average maturity of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DebtInstrumentWeightedAverageMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=peak_DebtInstrumentRedemptionPeriodThereafterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=peak_DebtInstrumentRedemptionPeriodThereafterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481316766984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>property</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember', window );">Life Science JV | Life Science</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember', window );">Indemnification Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ContributionOfPropertyNumberOfProperties', window );">Number of properties may be contributed in the agreement</a></td>
<td class="nump">29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ContributionOfPropertyNumberOfProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contribution Of Property, Number Of Properties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ContributionOfPropertyNumberOfProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481315853432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 28, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>interest </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>interest</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>interest </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>interest</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfRedeemableNoncontrollingInterestRedemptions', window );">Number of redeemable noncontrolling interest redemptions | interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for repurchase of redeemable noncontrolling interest | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime', window );">Number of interests redeemable over time | interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime', window );">Number of interests redeemable over time | interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramMember', window );">2020 ATM Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AtmEquityOfferingProgramAggregateAmountAuthorized', window );">ATM aggregate amount authorized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ATMEquityOfferingProgramAggregateAmountRemaining', window );">ATM aggregate amount remaining | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquityShares', window );">Maximum shares issuable under forward equity sales agreement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate', window );">Forward equity sales agreement, initial net price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember', window );">At-The-Market Program | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OptionIndexedToIssuersEquityTerm', window );">Option indexed to issuers equity, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember', window );">At-The-Market Program | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OptionIndexedToIssuersEquityTerm', window );">Option indexed to issuers equity, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramSettledMember', window );">2020 ATM Program, Settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue', window );">Share settlement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares', window );">Remainder outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=peak_ATMDirectIssuancesMember', window );">ATM Direct Issuances | Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ATMEquityOfferingProgramAggregateAmountRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ATM Equity Offering Program Aggregate Amount Remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ATMEquityOfferingProgramAggregateAmountRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AtmEquityOfferingProgramAggregateAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate gross sales price of stock authorized to be sold through an at-the-market continuous equity offering program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AtmEquityOfferingProgramAggregateAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forward Contract Indexed to Issuer's Equity, Remainder Outstanding, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfRedeemableNoncontrollingInterestRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Redeemable Noncontrolling Interest Redemptions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfRedeemableNoncontrollingInterestRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Redeemable Noncontrolling Interests, Redeemable Over Time</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_OptionIndexedToIssuersEquityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Option Indexed To Issuers Equity, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_OptionIndexedToIssuersEquityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForwardContractIndexedToIssuersEquityForwardRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share price of the Company's stock at which the contract holder of the freestanding contract has the right to purchase or sell the Company's stock at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForwardContractIndexedToIssuersEquityForwardRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares as a settlement alternative for each freestanding forward contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForwardContractIndexedToIssuersEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForwardContractIndexedToIssuersEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=peak_AtTheMarketProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramSettledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=peak_A2020ATMProgramSettledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=peak_ATMDirectIssuancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=peak_ATMDirectIssuancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481407464424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity and Redeemable Noncontrolling Interests - AOCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Supplemental Executive Retirement Plan minimum liability</a></td>
<td class="num">$ (3,047)<span></span>
</td>
<td class="num">$ (3,147)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive income (loss)</a></td>
<td class="num">$ (3,047)<span></span>
</td>
<td class="num">$ (3,147)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481327315480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements', window );">Dilutive potential common shares - forward equity agreements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)</a></td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_DownREITMember', window );">Down REIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shared included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity forward arrangements using the reverse treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2366-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_DownREITMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=peak_DownREITMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481315815176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share - Computation of EPS (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 75,026<span></span>
</td>
<td class="num">$ (120,585)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Noncontrolling interests' share in continuing operations</a></td>
<td class="num">(3,730)<span></span>
</td>
<td class="num">(3,306)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.</a></td>
<td class="nump">71,296<span></span>
</td>
<td class="num">(123,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted', window );">Less: Participating securities' share in continuing operations</a></td>
<td class="num">(1,976)<span></span>
</td>
<td class="num">(2,451)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic', window );">Income (loss) from continuing operations applicable to common shares</a></td>
<td class="nump">69,320<span></span>
</td>
<td class="num">(126,342)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">270,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NoncontrollingInterestsShareInDiscontinuedOperations', window );">Noncontrolling interests' share in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(329)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) applicable to common shares</a></td>
<td class="nump">$ 69,637<span></span>
</td>
<td class="nump">$ 143,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">539,352,000<span></span>
</td>
<td class="nump">538,679,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares - equity awards (in shares)</a></td>
<td class="nump">234,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares (in shares)</a></td>
<td class="nump">539,586,000<span></span>
</td>
<td class="nump">538,679,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings (loss) per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) applicable to common shares (in dollars per share)</a></td>
<td class="nump">0.13<span></span>
</td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings (loss) per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">0.13<span></span>
</td>
<td class="num">(0.23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) applicable to common shares (in dollars per share)</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards', window );">Outstanding equity awards (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)</a></td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled', window );">Forward sales agreements that have been settled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable to Dilutive Effect of Equity Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements, Settled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income Loss Continuing Operations Available To Common Stockholders Basic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NoncontrollingInterestsShareInDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests' Share In Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NoncontrollingInterestsShareInDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481309544840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Disclosures - Summary Information for the Reportable Segments (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture', window );">Number of facilities owned by unconsolidated joint venture | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498,372<span></span>
</td>
<td class="nump">$ 455,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,552<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,494)<span></span>
</td>
<td class="num">(9,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,208<span></span>
</td>
<td class="nump">23,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">648<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,877)<span></span>
</td>
<td class="num">(8,991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(207,247)<span></span>
</td>
<td class="num">(181,761)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,837)<span></span>
</td>
<td class="num">(18,059)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,621<span></span>
</td>
<td class="nump">2,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,666)<span></span>
</td>
<td class="num">(13,601)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,280<span></span>
</td>
<td class="nump">251,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,666<span></span>
</td>
<td class="nump">13,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,494<span></span>
</td>
<td class="nump">9,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,586)<span></span>
</td>
<td class="num">(46,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177,733)<span></span>
</td>
<td class="num">(157,538)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,831)<span></span>
</td>
<td class="num">(24,902)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(296)<span></span>
</td>
<td class="num">(798)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="num">(3,242)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,856<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(164,292)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,316<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,552)<span></span>
</td>
<td class="num">(1,310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,019)<span></span>
</td>
<td class="num">(5,660)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,256<span></span>
</td>
<td class="nump">6,467<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,719<span></span>
</td>
<td class="num">(121,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(777)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">1,323<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,026<span></span>
</td>
<td class="num">(120,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">270,008<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,343<span></span>
</td>
<td class="nump">149,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Non-segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,685)<span></span>
</td>
<td class="num">(44,728)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,831)<span></span>
</td>
<td class="num">(24,902)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(164,292)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909<span></span>
</td>
<td class="nump">1,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,607)<span></span>
</td>
<td class="num">(232,105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(777)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,384)<span></span>
</td>
<td class="num">(232,113)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">270,008<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,067)<span></span>
</td>
<td class="nump">37,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,055<span></span>
</td>
<td class="nump">169,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">1,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,189)<span></span>
</td>
<td class="num">(39,461)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(483)<span></span>
</td>
<td class="num">(425)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,112)<span></span>
</td>
<td class="num">(11,810)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,664<span></span>
</td>
<td class="nump">119,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,112<span></span>
</td>
<td class="nump">11,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,138)<span></span>
</td>
<td class="num">(68,434)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(292)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(948)<span></span>
</td>
<td class="num">(912)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,283<span></span>
</td>
<td class="nump">61,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,249<span></span>
</td>
<td class="nump">61,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,249<span></span>
</td>
<td class="nump">61,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,263<span></span>
</td>
<td class="nump">160,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">732<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,820)<span></span>
</td>
<td class="num">(8,926)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,170)<span></span>
</td>
<td class="num">(51,121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(299)<span></span>
</td>
<td class="num">(294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
<td class="nump">2,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,546)<span></span>
</td>
<td class="num">(1,923)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,762<span></span>
</td>
<td class="nump">101,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,546<span></span>
</td>
<td class="nump">1,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,036)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67,773)<span></span>
</td>
<td class="num">(57,954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(330)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,937<span></span>
</td>
<td class="num">(2,279)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(433)<span></span>
</td>
<td class="num">(421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,218<span></span>
</td>
<td class="nump">6,422<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,217<span></span>
</td>
<td class="nump">48,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,417<span></span>
</td>
<td class="nump">48,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,417<span></span>
</td>
<td class="nump">48,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember', window );">CCRC | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,560<span></span>
</td>
<td class="nump">116,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,552<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,888)<span></span>
</td>
<td class="num">(91,179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,745)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,557<span></span>
</td>
<td class="nump">26,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,865)<span></span>
</td>
<td class="num">(1,918)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,822)<span></span>
</td>
<td class="num">(31,150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(432)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,511<span></span>
</td>
<td class="nump">2,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,552)<span></span>
</td>
<td class="num">(1,310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,504)<span></span>
</td>
<td class="num">(6,375)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
<td class="num">(6,375)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
<td class="num">(6,375)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember', window );">Other Non-reportable | Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Reporting Information, Revenue for Reportable Segment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,494<span></span>
</td>
<td class="nump">9,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_GovernmentGrantIncomeFromCARESAct', window );">Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations', window );">Less: Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,494)<span></span>
</td>
<td class="num">(9,013)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent', window );">Healthpeak&#8217;s share of unconsolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,045<span></span>
</td>
<td class="nump">16,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome', window );">Healthpeak&#8217;s share of unconsolidated joint venture government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet', window );">Healthpeak&#8217;s share of unconsolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,055)<span></span>
</td>
<td class="num">(12,595)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest', window );">Noncontrolling interests&#8217; share of consolidated joint venture operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations', window );">Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations', window );">Adjusted NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,297<span></span>
</td>
<td class="nump">4,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments', window );">Plus: Adjustments to NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,494<span></span>
</td>
<td class="nump">9,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ImpairmentsAndAllowanceForCreditLossReserves', window );">Impairments and loan loss reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="num">(3,242)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain (loss) on sales of real estate, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="nump">482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations', window );">Less: Government grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent', window );">Less: Healthpeak&#8217;s share of unconsolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,305)<span></span>
</td>
<td class="num">(4,385)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable', window );">Plus: Noncontrolling interests&#8217; share of consolidated joint venture NOI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">6,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity income (loss) from unconsolidated joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,709<span></span>
</td>
<td class="nump">7,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,709<span></span>
</td>
<td class="nump">$ 7,473<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AdjustedNetOperatingIncomeFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AdjustedNetOperatingIncomeFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_GovernmentGrantIncomeFromCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government Grant Income From CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_GovernmentGrantIncomeFromCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ImpairmentsAndAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairments And Allowance For Credit Loss Reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ImpairmentsAndAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NetIncomeLossJointVenturePartnersAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) Joint Venture Partners, Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NetIncomeLossJointVenturePartnersAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Facilities Owned by Unconsolidated Joint Venture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_OperatingExpensesFromJointVentureAttributableToParentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses From Joint Venture, Attributable To Parent Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_OperatingExpensesFromJointVentureAttributableToParentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RealEstateRevenuesFromJointVentureAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Real Estate Revenues From Joint Venture, Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RealEstateRevenuesFromJointVentureAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Real Estate Revenues From Joint Venture Government Grant Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the addback of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees from segment portfolio income to consolidated net income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123605587&amp;loc=d3e23528-158515<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23439-158514<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 360<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123605564&amp;loc=d3e23415-158514<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to nonredeemable noncontrolling shareholder, unit holder, partner, or other equity holder of a joint venture.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_CCRCSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481324042392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid, net of capitalized interest</a></td>
<td class="nump">$ 58,487<span></span>
</td>
<td class="nump">$ 90,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid (refunded)</a></td>
<td class="num">(1,947)<span></span>
</td>
<td class="nump">2,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">8,305<span></span>
</td>
<td class="nump">5,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Increase in ROU asset in exchange for new lease liability related to operating leases</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">5,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset', window );">Seller financing provided on disposition of real estate asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">559,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid', window );">Accrued construction costs</a></td>
<td class="nump">163,277<span></span>
</td>
<td class="nump">107,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RestrictedStockVested', window );">Vesting of restricted stock units and conversion of non-managing member units into common stock</a></td>
<td class="nump">$ 752<span></span>
</td>
<td class="nump">$ 838<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RestrictedStockVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of stock issued upon which restrictions have lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RestrictedStockVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_SellerFinancingProvidedOnDispositionofRealEstateAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Seller Financing Provided On Disposition of Real Estate Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_SellerFinancingProvidedOnDispositionofRealEstateAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for construction in progress expenditures that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481321254216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements', window );">Leasing costs, tenant improvements, and recurring capital expenditures</a></td>
<td class="nump">$ 22,839<span></span>
</td>
<td class="nump">$ 20,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development, redevelopment, and other major improvements of real estate</a></td>
<td class="nump">178,285<span></span>
</td>
<td class="nump">135,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of real estate, in-place lease, and other intangibles</a></td>
<td class="nump">177,733<span></span>
</td>
<td class="nump">157,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements', window );">Leasing costs, tenant improvements, and recurring capital expenditures</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">1,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development, redevelopment, and other major improvements of real estate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of real estate, in-place lease, and other intangibles</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy; for costs that are essential to originating the lease and would not otherwise have been incurred without the lease agreement, including but not limited to, evaluating the lessee's credit condition, guarantees, and collateral and costs incurred in negotiating, processing, and executing the lease agreement; and for any commission(s) incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481317490312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Continuing operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 89,066<span></span>
</td>
<td class="nump">$ 158,287<span></span>
</td>
<td class="nump">$ 34,007<span></span>
</td>
<td class="nump">$ 44,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">52,103<span></span>
</td>
<td class="nump">53,454<span></span>
</td>
<td class="nump">68,033<span></span>
</td>
<td class="nump">67,206<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">141,169<span></span>
</td>
<td class="nump">211,741<span></span>
</td>
<td class="nump">102,040<span></span>
</td>
<td class="nump">111,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashIncludingDiscontinuedOperationsAbstract', window );"><strong>Discontinued operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,707<span></span>
</td>
<td class="nump">40,161<span></span>
</td>
<td class="nump">53,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,817<span></span>
</td>
<td class="nump">17,168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,707<span></span>
</td>
<td class="nump">45,978<span></span>
</td>
<td class="nump">70,253<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal', window );">Cash and cash equivalents, total</a></td>
<td class="nump">97,055<span></span>
</td>
<td class="nump">165,994<span></span>
</td>
<td class="nump">74,168<span></span>
</td>
<td class="nump">97,311<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal', window );">Restricted cash, total</a></td>
<td class="nump">52,103<span></span>
</td>
<td class="nump">53,454<span></span>
</td>
<td class="nump">73,850<span></span>
</td>
<td class="nump">84,374<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, total</a></td>
<td class="nump">$ 149,158<span></span>
</td>
<td class="nump">$ 219,448<span></span>
</td>
<td class="nump">$ 148,018<span></span>
</td>
<td class="nump">$ 181,685<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents, Including Discontinued Operations, Total</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashIncludingDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashIncludingDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481317777016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>joint_venture</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>joint_venture</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>joint_venture </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue', window );">Exchange accommodation titleholder, real estate, carrying value | $</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Unconsolidated Variable Interest Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfUnconsolidatedJointVenture', window );">Number of unconsolidated joint ventures (in joint ventures)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfVieBorrowersWithMarketableDebtSecurities', window );">Number of VIE borrowers with marketable debt securities (in joint ventures)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_VenturesVLLCMember', window );">Ventures V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_LifeScienceJVsMember', window );">Life Science JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_MorganStanleyRealEstateInvestmentJVMember', window );">MSREI JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_DownreitPartnershipsMember', window );">DownREIT Partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership', window );">Number of controlling ownership interest entities as a managing member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember', window );">Life Science | Needham Land Parcel JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment ownership percentage</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investment | $</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember', window );">Medical Office Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfPropertiesAcquired', window );">Number of properties acquired | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ExchangeAccommodationTitleholderRealEstateCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Accommodation Titleholder, Real Estate, Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ExchangeAccommodationTitleholderRealEstateCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfPropertiesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Properties Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfPropertiesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfUnconsolidatedJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of unconsolidated joint ventures between entity and an institutional capital partner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfUnconsolidatedJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfVieBorrowersWithMarketableDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of VIE borrowers in which the entity has invested in marketable debt securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfVieBorrowersWithMarketableDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of controlling ownership interest entities, in which the company holds the interest and is the managing member of the partnership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_VenturesVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_VenturesVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_LifeScienceJVsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_LifeScienceJVsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_MorganStanleyRealEstateInvestmentJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_MorganStanleyRealEstateInvestmentJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_DownreitPartnershipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_DownreitPartnershipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_LifeScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=peak_MedicalOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481326962584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities - Schedule of Variable Interest Entities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember', window );">CMBS and LLC investment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Loss Exposure and Carrying Amount</a></td>
<td class="nump">$ 36,492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember', window );">Needham Land Parcel JV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Loss Exposure and Carrying Amount</a></td>
<td class="nump">$ 14,346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481317233752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">$ 12,368,124<span></span>
</td>
<td class="nump">$ 12,025,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Development costs and construction in progress</a></td>
<td class="nump">739,451<span></span>
</td>
<td class="nump">877,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">2,706,909<span></span>
</td>
<td class="nump">2,603,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(2,975,337)<span></span>
</td>
<td class="num">(2,839,229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate</a></td>
<td class="nump">12,839,147<span></span>
</td>
<td class="nump">12,667,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">54,106<span></span>
</td>
<td class="nump">48,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">89,066<span></span>
</td>
<td class="nump">158,287<span></span>
</td>
<td class="nump">$ 34,007<span></span>
</td>
<td class="nump">$ 44,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">497,104<span></span>
</td>
<td class="nump">519,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale and discontinued operations, net</a></td>
<td class="nump">33,812<span></span>
</td>
<td class="nump">37,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset, net</a></td>
<td class="nump">232,457<span></span>
</td>
<td class="nump">233,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">676,543<span></span>
</td>
<td class="nump">674,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,287,250<span></span>
</td>
<td class="nump">15,257,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">350,713<span></span>
</td>
<td class="nump">352,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffMarketLeaseUnfavorable', window );">Intangible liabilities, net</a></td>
<td class="nump">175,355<span></span>
</td>
<td class="nump">177,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale and discontinued operations, net</a></td>
<td class="nump">14,318<span></span>
</td>
<td class="nump">15,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">203,988<span></span>
</td>
<td class="nump">204,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">695,373<span></span>
</td>
<td class="nump">755,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">817,022<span></span>
</td>
<td class="nump">789,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">8,241,638<span></span>
</td>
<td class="nump">8,111,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Consolidated Lessees VIE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">2,303,407<span></span>
</td>
<td class="nump">2,303,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Development costs and construction in progress</a></td>
<td class="nump">107,066<span></span>
</td>
<td class="nump">82,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">509,678<span></span>
</td>
<td class="nump">548,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(569,437)<span></span>
</td>
<td class="num">(551,097)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate</a></td>
<td class="nump">2,350,714<span></span>
</td>
<td class="nump">2,383,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">4,854<span></span>
</td>
<td class="nump">5,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">37,080<span></span>
</td>
<td class="nump">22,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">109,993<span></span>
</td>
<td class="nump">117,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Assets held for sale and discontinued operations, net</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset, net</a></td>
<td class="nump">106,600<span></span>
</td>
<td class="nump">107,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">65,201<span></span>
</td>
<td class="nump">62,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,674,892<span></span>
</td>
<td class="nump">2,699,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">144,425<span></span>
</td>
<td class="nump">144,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffMarketLeaseUnfavorable', window );">Intangible liabilities, net</a></td>
<td class="nump">27,549<span></span>
</td>
<td class="nump">23,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale and discontinued operations, net</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">1,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">98,474<span></span>
</td>
<td class="nump">99,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">56,712<span></span>
</td>
<td class="nump">58,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">24,405<span></span>
</td>
<td class="nump">21,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">353,242<span></span>
</td>
<td class="nump">349,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Consolidated Lessees VIE | Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities related to assets held for sale and discontinued operations, net</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">1,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 1,677<span></span>
</td>
<td class="nump">$ 1,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123366838&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of expenditures for a real estate project that has not yet been completed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffMarketLeaseUnfavorable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents a liability associated with the acquisition of an off-market lease when the terms of the lease are unfavorable to the market terms for the lease at the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffMarketLeaseUnfavorable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481326521224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="nump">$ 1,330,813<span></span>
</td>
<td class="nump">$ 1,165,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Senior unsecured notes</a></td>
<td class="nump">4,654,056<span></span>
</td>
<td class="nump">4,651,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">350,713<span></span>
</td>
<td class="nump">352,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansReceivableFairValueDisclosure', window );">Loans receivable, net</a></td>
<td class="nump">409,753<span></span>
</td>
<td class="nump">415,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Marketable debt securities</a></td>
<td class="nump">21,172<span></span>
</td>
<td class="nump">21,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap assets</a></td>
<td class="nump">2,391<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="nump">1,330,813<span></span>
</td>
<td class="nump">1,165,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Senior unsecured notes</a></td>
<td class="nump">4,654,056<span></span>
</td>
<td class="nump">4,651,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">350,713<span></span>
</td>
<td class="nump">352,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair&#160;Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Senior unsecured notes</a></td>
<td class="nump">4,669,414<span></span>
</td>
<td class="nump">5,054,747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair&#160;Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Summary of financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansReceivableFairValueDisclosure', window );">Loans receivable, net</a></td>
<td class="nump">424,346<span></span>
</td>
<td class="nump">437,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Marketable debt securities</a></td>
<td class="nump">21,172<span></span>
</td>
<td class="nump">21,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap assets</a></td>
<td class="nump">2,391<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Bank line of credit and commercial paper</a></td>
<td class="nump">1,330,813<span></span>
</td>
<td class="nump">1,165,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Mortgage debt</a></td>
<td class="nump">$ 344,995<span></span>
</td>
<td class="nump">$ 352,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL120269820-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of loan receivable, including, but not limited to, mortgage loans held for investment, finance receivables held for investment, policy loans on insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481309445640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>property </div>
<div>derivativeHeld</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>property </div>
<div>derivativeHeld</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>derivativeHeld</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($) </div>
<div>derivativeHeld</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>derivativeHeld</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>property</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest-rate Swap Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Increase in the fair value of the interest rate cap agreements | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Interest-rate Swap Contracts | Designated as Hedging Instrument | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Interest Rate Cap | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_DerivativeNotionalAmountTerminated', window );">Derivative amount terminated | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayments of secured debt | $</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations', window );">Number of assets classified as discontinued operations | property</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Mortgage Debt | Interest-rate Swap Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_NumberOfInterestRateDerivativesTerminated', window );">Number of interest rate derivatives terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_DerivativeNotionalAmountTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Terminated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_DerivativeNotionalAmountTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfAssetsClassifiedAsDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Assets Classified as Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfAssetsClassifiedAsDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_NumberOfInterestRateDerivativesTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Interest Rate Derivatives Terminated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_NumberOfInterestRateDerivativesTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481327426136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Schedule of Derivative Instruments (Details) - Not Designated as Hedging Instrument<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>derivativeHeld</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest-rate contracts held | derivativeHeld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">$ 142,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Strike Rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Fair Value</a></td>
<td class="nump">$ 2,391,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all derivative assets not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140481321253224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable, Accrued Liabilities, and Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_RefundableEntranceFeesCurrentAndNoncurrent', window );">Refundable entrance fees</a></td>
<td class="nump">$ 281,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionPayableCurrentAndNoncurrent', window );">Accrued construction costs</a></td>
<td class="nump">163,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="nump">35,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other accounts payable and accrued liabilities</a></td>
<td class="nump">215,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,638<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable, accrued liabilities, and other liabilities</a></td>
<td class="nump">695,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent', window );">Unamortized nonrefundable entrance fee</a></td>
<td class="nump">498,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_ProceedsFromCollectionOfNonrefundableEntranceFees', window );">Proceeds from collection of nonrefundable entrance fees</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_peak_AmortizationOfNonrefundableEntranceFee', window );">Amortization of nonrefundable entrance fee</a></td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_AmortizationOfNonrefundableEntranceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Nonrefundable Entrance Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_AmortizationOfNonrefundableEntranceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_ProceedsFromCollectionOfNonrefundableEntranceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Collection Of Nonrefundable Entrance Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_ProceedsFromCollectionOfNonrefundableEntranceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_RefundableEntranceFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refundable Entrance Fees, Current and Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_RefundableEntranceFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized Nonrefundable Entrance Fee, Current and Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>peak_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>peak-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:peak="http://www.healthpeak.com/20220331"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2021"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="peak-20220331.xsd" xlink:type="simple"/>
    <context id="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie82972ffaa0e486c8bf672e801389907_I20220502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2022-05-02</instant>
        </period>
    </context>
    <context id="i8b4c4223887d4f649dd6bf793e09faaf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i52f832c5fe6045a8ad198b8d80128bd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i409ce78c858444d7a5dc1f973872f5b5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i046e7a1a5f114e488bef10441f3f6b44_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i586d3ac1554b476b944978cf331446d1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i27033f4128f14d61b570ee8fcfab4e19_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibcae3dea640a4b138a3f5795930bae95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf9ac731c8274ea6971c722ec208c696_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iadd3477c47624974b897f92075a001c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i490f82b12d324a9c8138193ebcd5d1eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0bd8d0bfcbb44ad83c3862162bfa1c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67bf69a97b654c869301d6f090e62d57_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7404d45d41b64f609165eec044f08108_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifcb077a5f2244709819741b6cb0a3fa1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3a7abe9391e6448ab7157b0bae0f272a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i31c94325aaf34e408bb6acbdc569a1d7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i367dd265e817411fae092d30372080c9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i25b091a3184e4f5abf94f94d420796af_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic24059380f4a4805a400b695962dbef6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i98fdb8b9ba7546b3863ac5453d1d4595_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7a20cc136a864b339ac00237669b9e4d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i40a69eb101874a248f36e295dd95e2e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3663f069068045e992c69e3d404cae29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i872f9cc9bb7a47469e26e6f7e4849029_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19827d84f1614a0f8ad378b5470e253a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i797de15cd85c409c81c2fbde05db3a05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45b145e89da940f2b434e5038adee396_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i173d3dfdd8d6443cb9dd85428368d67a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5ec0bcc69b44db7857a079e35c591cb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5ce63109a747419ba702c25c06711c30_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i15fe27c8a01a4beba1b7b922c1d0d182_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id42af16b8b5e46a3a93869820b193ece_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i947f359177e141dea98189810a16d2ce_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3cc4bf949eda46e39539b8c05d956da6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i41427d8508e34a328dd1abb7637f8a9c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i64cd9f22bc634046912f6b976230977c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0dcdd74b90db4a33a4202492ae24fe31_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9033e3f616764988932a09935d4445c5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib5e2b4520099480cbcf7ae7a10b2633a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i366e3a8a7bb7447e9f752c396f34ef65_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib3460b3e5b484c59b4ecbe639bdd4209_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iedb4d8499ffb4004a3ee3195b72c71f9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:EquityIncomeLossFromUnconsolidatedJointVenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i511cc9d57cc6454fbd2d5002ffde7b46_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:EquityIncomeLossFromUnconsolidatedJointVenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie5729311f850434baae5aecac89476bc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:IncomeLossFromDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6df88f30ff64438db2f6496ddd4694e7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">peak:IncomeLossFromDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i65f4e28b0f2b4c9ca073348ac7c5830f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib71827eba90f4c7dbd49266ebef243d8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="peak:GovernmentAssistanceAxis">peak:GovernmentAssistanceCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i68709d337a004bc49691880a5dff69f4_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ibd171034fe8747f7ab9643d2e6c8c934_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="icabe4000b649414fba14f6ec77194207_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id9cece3770b941ee9ae47c83081b1562_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id834faa0894c48b5b6ca7b84f1e97b10_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i157e2f27fbc8439583042a14aba3a3dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id35ffdd058d5452aadfbd3058f25fe8d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0be770442a38456fa45fe909e5cf2209_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e70b2253cef459da26681df951e5714_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CO</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6ae39df20f8a4003aa9f5bfc1350f2aa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6a7d366dcb654ae3b1142ce1b04f07d8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibb3b94e67a8b43879bb61dbed6563aad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iee85843b4241478fb2cc9b09850dd27d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0280b9f0a7bb49eb921ea3165bf8ee37_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i37e7dd1a3a6c46e1a92bd28eaa72af76_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i18626c3b380148e1b0b293d23816dd72_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i946443381ff64eda82972caa7e61e937_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i498d7f8735954a6a9c9a9011ebbd9301_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6ddf70e2d074a11bf07c122fa0aa5eb_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="ib528caa7e34e44bd8bac451c88b62afb_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ifc2008e7de824d76a511c1ea5919c432_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ifdbfd36f6f614b35837a5d8868840c17_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9fdf60d4d6e4a599a3fe3f066788531_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="ieaf70b6c82e34b11838baffaa23b60f8_D20210101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i03a3a9720e7e46b9b6608a5904b366ed_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7009785976254cb889191c52cf0d0cc9_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:BrookdaleTripleNetPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i67a66f0a44e14e8e838fb65d4719fd54_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:BrookdaleTripleNetPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="icb30aa09ba6c452ba2bd4375f636fc3e_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ief256427dde0496199ca30fcac9d8101_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:HRATripleNetPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ic6f2032fd45a433f82115899c3e766a1_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:HRATripleNetPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i50d682bf346742efab2a94c7b022bd65_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OakmontSHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i8726d2fcca104d9daaa243b22c892577_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OakmontSHOPPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i264d0be7c9de45749d3923b0d2446af1_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i0ec4ce4170ce44a9b249e996d2135bcd_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i8a5d586f9aa34c6682d5b91cef0c31bf_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OakmontSHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="ia02702389d0b4036880c2a075882418f_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OakmontSHOPPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i7e3fe506d4b44da2867a8fa3226473f2_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="ic6a24264ae7f46a8a0b0ce1820a0cdf5_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="ib18e864b0cc2475eaf0549bdbf87abc9_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i43ed19b259424a54a9fd61eca57de24e_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i84af0aa9f7c94d4f9151e3e70da8c7e8_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SonataSHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="iaaf84ca8adc6410fb6b01b46e57f6e91_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SonataSHOPPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i768fb35ae40b42f3b26d76cbebeb41db_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SLCSHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i2086cf237ad7470ba8bb6e299b0cd6eb_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SLCSHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="peak:DefinitiveAgreementsAxisAxis">peak:DefinitiveAgreementFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i84d32d33aa964419bdb8080458aa58da_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i9125ba7c2f5d440aac5f4ef2ac64e4f2_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeHospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i3210bc367c264249ac6e064f04637f2a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iee73f2738d114cb592962cd2a4fa756e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OtherDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6b287810f73a4306ad1cedb5a7ee7ac9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id2cc7e487b09456dbf42b7ac9a403d3b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingTripleNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84e02dec09e34ee98740b651f1f10e6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0f3f388a745246ca875dc4aaac6cfe06_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia1d24420f1c64c1f9b059b4ead94f57e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45a55cc9f4374e7b973af8776b4c27d8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OtherDispositionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0c32446c755a4541aa55ba32256a090f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:OtherDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i19869f9aece14496a725bc23236ab8e6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i902208c44cb84f8abe9e3fa90efb8d36_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9bcca4d42b524e539e9a37568b990d49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1569210fb45b498ca4ddd9523c7ddcb6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56ab9d8a9a964a9c9b0142d3248692e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a389db75eb34b51821f969f46a2eb96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icdbce058783d4ada87cc4191afef5777_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">peak:PlannedMOBDemolitionTenantRelocationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife4353c6ea944e2cb45a86e8adbf210f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icadee8ad9d5d4a2ca975702b7fe2f6ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5761108dca5e417ab51b1f7ea8aa2e7f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i37ae13c73e634e68b31c4c1cdc3d0d7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23d980d9806942e0886bf4d30eb148c5_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i11671c496b994973af5e617cd736d08c_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1830004bc9a241ae9fa37e55c2d28202_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="ifdb0da742c3d4dc2878b9efd7818fd4a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia143e4423ee545cb944c9846d1bf5a01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:SunriseSeniorHousingPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7fff5de172f473c9b163cd5408ad706_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i861ec35878514b2cb35e6fe1f899825f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id286ba246e874843bc8dd2638e1faa98_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia298127fc81840afbfc9f29801f74a20_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8b45554983da4b40ab820d2cfc003ede_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8e457939b7f044ffbc4f9cf2945b94a2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie000ff8c480e49299647b1b49c710ab5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i621bef727d6848c28d61e1f5dc2a0688_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8c295f7730a9480c8ecfc74218b82db1_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">peak:DiscoverySHOPPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SeniorHousingOperatingPortfolioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i3e06e81b0ec74155af21cdd896273b28_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i166380b792354cd99bcdce4b5c2a3d09_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i280e47a3f1d647aeab62193c0845ca90_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:SecuredMortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="ic4c7caa3dd3149cd8911377afa83f122_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">peak:LessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6feec1d68f9349e7b96730a474b98cb8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">peak:LessorAssetUnderOperatingLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf2f708bf5a04fec813c493611999629_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:PerformingFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idcbf460e68524351a14b60f7eacaa6f5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WatchListFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i073b62edbe4947b19f177c3595862f7b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WorkoutFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic484d7102e0c4eef9210903e4b7f1b12_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:MortgageReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id73b3e04664a4d5497e0071f0132de90_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:MezzanineAndOtherLoansReceivableSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">us-gaap:PerformingFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib5edfb64270943259dee0a2cf06286d7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:MezzanineAndOtherLoansReceivableSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WatchListFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i942914a4982a4fdc89cfe3c58112514c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:MezzanineAndOtherLoansReceivableSecuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentPerformanceStatusAxis">peak:WorkoutFinancingReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i476aa803f3b64a469836296cb0eb44e5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">peak:MezzanineAndOtherLoansReceivableSecuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if88696dec76a41df8c3d36e71898301f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id2caaa14451f4014ab34991c3b703764_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib39f0035285a4bfdadaf994fa845b4ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab0213b6338d474f9ab83b686f5a8aa0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01aa0bf4bb3d4669ab75f73ab638333e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if4031be1cfa14447aa6b18dfbcfa6bd9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1af0c53b18b84f96a9445d33fed35d6c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice9d09a0cad14197a0d42beb434939dc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i858204adffd348408864f031fa32c574_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id1ff4f2b11c94a78a5487085851cb371_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis">peak:ParticipatingDevelopmentLoansAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id5746a20e0c541cb933dd8d9e8a18868_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SHOPJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifeb1c53a80cf48d598dd59b38828089e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SHOPJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6dac57d2d904eef8d5d5c6d6d560074_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7af131706f2b4efd81b014492e74780e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie86b016e31384892bfe412d346cd92f5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib12448d242784ab084c7178415e35eef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cd1af5b0be84236928af4f3b5238de4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib71d278abee9484ea60f89ad5ed8f50f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie0fbe38d9b8f4c8096a62a13c0be0319_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i294e35e4fa6e4b7792baf4fb2a50d9e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib42e8c61652142339c59c133c0ca0201_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:NeedhamLandParcelJVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iab41d51161f44fa3b2a7d722d1819d54_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:MedicalOfficeJVsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib7d01dc5f33147a4821ce0ce3545c5f8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIVLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i52b2c707e2b1428383dc2029f13bab25_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:SuburbanPropertiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib2847866fa494fa48669203a8b822e0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:HCPVenturesIIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i68d2f2250a954a959c1ab9c1001f3093_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:DiscoveryNaplesJVAndDiscoverySarasotaJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2cfa7cca0e764481b533b63888796ec6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">peak:DiscoveryNaplesJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id980870ccca047b5ae04fde6a8171675_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">peak:DiscoverySarasotaJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i322ecd64c5b44877a6a721cafa77d63f_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i642916b599bc4bf2b4a0e961d45d5a42_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i924e6cd0c4bb4c52bd6d1353893473da_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">peak:CCRVJVInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">peak:BrookdaleMTCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifbdf5f35645b45b3984b9e5e46fceaf8_I20190523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-23</instant>
        </period>
    </context>
    <context id="iaf4af4c66c4c4e4ea53929a8d99bf97f_D20190523-20190523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-23</startDate>
            <endDate>2019-05-23</endDate>
        </period>
    </context>
    <context id="ib7a0463d43594517865ced9f143c46a6_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:A2019TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="i82327d2d8e1b4698b0346d5bd3a79cbb_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">peak:A2019TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="iae4f18c121f648d5826bfbc035300a67_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9065798c00ee41ef899c69a43f5251b6_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i86a95c3d76e44658a7495876f84394fb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0667f584e1224d759496144ff96ccd4c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib3aa132c8f884c44b097e6de1abfbc0d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibcc24c31340e402fa87c53d87f379dee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:LineOfCreditAndTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i02de64e4627846b2bd3f09d7101c72f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06c55fa5097f4b26aaa7bc551ed8d8ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if3f5c6f033e845d3853ee8dcbfd15aec_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">peak:CommercialPaperProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f327e88a9264251811af5db4463a246_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i017fec98dd774d41900ae8973e5e99b1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i25a6dbcdd6414960b06cbb782d9985c4_I20210519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote3400PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-19</instant>
        </period>
    </context>
    <context id="ic508faac831b42f2b021bb57d04db552_I20210519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-19</instant>
        </period>
    </context>
    <context id="i129edcf0ec22460cbebd897c6f2231cd_I20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4.250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-26</instant>
        </period>
    </context>
    <context id="i9cd5e36259d94f569780a9bbfeeb56e6_I20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4200PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-26</instant>
        </period>
    </context>
    <context id="i58b767842f4c4d8cae721f9d090787f9_I20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote3880PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-26</instant>
        </period>
    </context>
    <context id="ia10cfac217664164a5ce11935398e38c_I20210128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4.250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-28</instant>
        </period>
    </context>
    <context id="ie15a32184ddc4244aafcaee4d492a613_I20210128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote4200PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-28</instant>
        </period>
    </context>
    <context id="ife6442aff2a64388a38b157c25a0b7c8_I20210128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote3880PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-28</instant>
        </period>
    </context>
    <context id="i474fd2e8b00742c492b5f0a58c583148_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:SeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i50e3cb94a01d48daa97d3bd61e3eb616_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:SeniorNotesDue2023And2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie4b8cef65132475f95dc36c24f9a9820_I20211124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote213PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-24</instant>
        </period>
    </context>
    <context id="ic42f1d80f9104fb9a68ce6b17b49241f_I20210712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">peak:UnsecuredNote1350PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-12</instant>
        </period>
    </context>
    <context id="iea6c0660aff54ba4b24294d1a82e7306_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iabee9c868d9c47cba2cc55a571bc034f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d184f2e01164a51b230c30bd85a30d0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i030603e4f5a54153b34a35b3214082f5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icfc6fff323874884beaa90a4c80a3577_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i3a84667f31d1411fa0eb153b19912c8e_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ice54f9998d0c43e8b7423fa1683f6226_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2e027636867a4aa5b3815ba06a2d6117_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionRemainderOfFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i501441e9c9d04464a5eb510bce4935e3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionRemainderOfFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i51db4181e1b54a7b863ce08ec4787ea6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id9a046d474cb44979dcf512ddc3fabb3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5faeb218c7d04966869e0fe60f447e98_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic626427f6d62400986df856754ecbb17_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9fab30ca14f54624bfd030cd08d1042b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id5fb318dd82744438c5d3c43a0a334fa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6ee0feb90e464607b8cd21230c30e359_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6b0beada91ec4b9783bd3b82faeb791f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia75891e9a77c482caedf11f0b1cc4f02_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionPeriodThereafterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic80ffcee88b3410c985f4e65c0eee19c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">peak:DebtInstrumentRedemptionPeriodThereafterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id155f3c6d1834c9fa8fe36e4b805553a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i36d2ca6669b54c32aa2aad64db99b30d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie30fa114a84041be913e6a006cbdb670_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5441692de9104c1f8876f6126bb3cd18_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id9703e7c732740bb93115889bd6185b4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic49d297efbc04b4899a13cad1f112a0b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5bda4a0f83814d708728819ca12b1868_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <context id="i9c682ca877614372ac5d6a9eb54b1447_D20210430-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="ib6bdb41bc18341e4874c99a5317a7474_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="ibbcca059325e491ba0a93b64940f5ac3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i133dad541e4940469495f91e54645b82_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:AtTheMarketProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8c9910ca8e3c43b58498430b0d7f692c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i50abcbcb64fb40e899abb71cbd6e3653_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72cbe3fbdd9d4520b3ee1c9882ee17d6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:A2020ATMProgramSettledMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idbbd3434631b45fa866d0cbaac25a52f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:ATMDirectIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic7bb6050b89c41c0a9f564585e588a65_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">peak:ATMDirectIssuancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id2262290d71c48d7997b11506be11d2e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i32ab0862bf034c7d9e3c84e8a429fc20_D20230101-20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="ib562c08096d84fc6a41f5ebd01b696fb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:DownREITMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id7b05b8400df430195d0de28217faac1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">peak:DownREITMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2522c73e41654167962362468542cfa4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:LifeScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:CCRCSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if92d81e5ad874807b203a630764ea27a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:OtherNonReportingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ide8b297bfe9444c5bf4d4192b08aecda_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idd28c0a01e0b4e1687c11f71b4e146b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e285ee41e894f3fb7a5abcc3f145a7e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6194055e785642eebfc80c30a45c054f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i31f56e92e9a1411d871334a90b76fa9f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:VenturesVLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iec88d274781648d1946da5119782e172_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:LifeScienceJVsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7fefcab6d3cb41888c82058807af19ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:MorganStanleyRealEstateInvestmentJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6fb4bb6009344e2d86a46be91dd2df36_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">peak:DownreitPartnershipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i722f52bee0ee49709ef5ab8ea0678ab4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">peak:MedicalOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6ba23ecabb554063a415b6201e35ad07_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1923a4d184d947fa8f63901661871fa1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idbf991550f2b47db91f24f0f6930a30f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4433a7a0b6e549278122839d2dd4ef69_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i647df0ef5da942b7835d88ac03d98c68_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6748a224b94042acb5282ef7d9b2a15d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaec053ad2c7e489a8ceb2307e73640f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24c76c887bc045ea98faf15f07cdc7b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i688cf62ae17b4e4382d4717dfb3d857d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9d6fb07e784b4ca69895402225c3412e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idcc10c45d3da4625bee7679905bbb7c3_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4d2252cd7eba4d3b851fa2e3e157f14c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8cee1167ebab48b7b2f82422612e3991_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1d64ef81915d4315bc7730741c5095a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb5de1f1f0a24475b0f7d492a74824d6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i33e11899bd7a43448fda5d94b27afd54_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i8b09eddbc9044df3944a2a85e555a381_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i16a351f1ed484654b7fe74cc73addf0a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia2e2a387bee947aea9537b5bd2acde51_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="property">
        <measure>peak:property</measure>
    </unit>
    <unit id="acre">
        <measure>utr:acre</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="loan">
        <measure>peak:loan</measure>
    </unit>
    <unit id="joint_venture">
        <measure>peak:joint_venture</measure>
    </unit>
    <unit id="renewal_option">
        <measure>peak:renewal_option</measure>
    </unit>
    <unit id="bond">
        <measure>peak:bond</measure>
    </unit>
    <unit id="facility">
        <measure>peak:facility</measure>
    </unit>
    <unit id="derivativeheld">
        <measure>peak:derivativeHeld</measure>
    </unit>
    <unit id="interest">
        <measure>peak:interest</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N180LTEtMS0xLTEwNzg0Mg_09e0069c-c406-4d5a-b8b1-df681b1490aa">0000765880</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N181LTEtMS0xLTEwNzg0Mg_e986d5eb-139d-4a61-847d-11e10aa89d4a">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N182LTEtMS0xLTEwNzg0Mg_bf90db84-e66c-43de-83bf-89a07ca99ebb">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N183LTEtMS0xLTEwNzg0Mg_76c962ea-c30f-4168-9a4f-85fd79dd9da1">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80L2ZyYWc6OWVjYmY3YjljOTU1NGNkODk5MjIzNWVhNWMwYzdjZDQvdGFibGU6N2FlMjk0YjJlY2I3NDU4OGJhYzc5MjljMGM4NjI2ODcvdGFibGVyYW5nZTo3YWUyOTRiMmVjYjc0NTg4YmFjNzkyOWMwYzg2MjY4N184LTEtMS0xLTEwNzg0Mg_6c8e0925-ddcb-45de-afe3-2879f20e6411">Q1</dei:DocumentFiscalPeriodFocus>
    <peak:LoansReceivableInterestIncomeAmortizationPeriod
      contextRef="i8b45554983da4b40ab820d2cfc003ede_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjYyOQ_aeb0d2ee-ccfb-4404-9b1a-c227b91e018e">P1Y</peak:LoansReceivableInterestIncomeAmortizationPeriod>
    <peak:OptionIndexedToIssuersEquityTerm
      contextRef="ibbcca059325e491ba0a93b64940f5ac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTUzNQ_ad0445ae-2c5c-4d27-bf22-90d9ea20d009">P1Y</peak:OptionIndexedToIssuersEquityTerm>
    <dei:DocumentType
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDgw_7c02d062-8b07-42c9-9736-7377640b717a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6YTlmNzVlNWU3OWQyNDRjOTkwNjg4MTQzMWQ1ZmRhYmIvdGFibGVyYW5nZTphOWY3NWU1ZTc5ZDI0NGM5OTA2ODgxNDMxZDVmZGFiYl8wLTAtMS0xLTEwNzg0Mg_2060aaed-c3e0-40de-8388-30f8aaffa2ae">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8xMzg_620dbad9-48f0-4c80-bfd6-f0aec4130f85">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NWY5YmQ3ZjczNjA5NDE2NWFlMTRjMjlhYTJmZTVjZjcvdGFibGVyYW5nZTo1ZjliZDdmNzM2MDk0MTY1YWUxNGMyOWFhMmZlNWNmN18wLTAtMS0xLTEwNzg0Mg_cc549630-f5ce-4ab5-8223-2b6ce4678d98">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDgx_3155f85f-0233-40f4-a011-2d789b1e56eb">001-08895</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDcz_bda9c275-171f-402f-953d-d0276692136e">Healthpeak Properties, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NDE5ZjkwYjBkMTU1NDk1YWIzMmE3ODM1NmNhMDA4MmMvdGFibGVyYW5nZTo0MTlmOTBiMGQxNTU0OTVhYjMyYTc4MzU2Y2EwMDgyY18xLTAtMS0xLTEwNzg0Mg_adb3a532-a13f-4e87-96eb-8ef09750bf85">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NDE5ZjkwYjBkMTU1NDk1YWIzMmE3ODM1NmNhMDA4MmMvdGFibGVyYW5nZTo0MTlmOTBiMGQxNTU0OTVhYjMyYTc4MzU2Y2EwMDgyY18xLTItMS0xLTEwNzg0Mg_fd0ba06b-ed00-4d32-8e4b-4184d44adad2">33-0091377</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDgy_e26f894c-b828-4114-b4bd-65b268338b04">5050 South Syracuse Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc0_a3924757-54e1-4961-8e80-58198c3d65d1">Suite 800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDgz_5c4fcf23-b631-4298-ba89-8accf69b3f47">Denver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc1_a4f14c9a-c4a4-41b8-9e7e-328a7cd32c41">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc2_65dd7ab3-408d-47ca-a506-e207a9c60626">80237</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc3_ed1e5ef3-72be-410b-b193-9cf4fc23fc71">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDg0_1b142d07-48e9-46e4-8b78-b483f57b86e5">428-5050</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NGYwNDE3NTY5YTc1NGViMjhhNmQyNWRmMTQ5MzdjZGQvdGFibGVyYW5nZTo0ZjA0MTc1NjlhNzU0ZWIyOGE2ZDI1ZGYxNDkzN2NkZF8xLTAtMS0xLTEwNzg0Mg_987bcf83-1d37-4842-975c-bdf4d13bd560">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NGYwNDE3NTY5YTc1NGViMjhhNmQyNWRmMTQ5MzdjZGQvdGFibGVyYW5nZTo0ZjA0MTc1NjlhNzU0ZWIyOGE2ZDI1ZGYxNDkzN2NkZF8xLTEtMS0xLTEwNzg0Mg_ab983c2a-b5a2-4755-8f11-db36bf0b2a40">PEAK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NGYwNDE3NTY5YTc1NGViMjhhNmQyNWRmMTQ5MzdjZGQvdGFibGVyYW5nZTo0ZjA0MTc1NjlhNzU0ZWIyOGE2ZDI1ZGYxNDkzN2NkZF8xLTItMS0xLTEwNzg0Mg_d77b5a67-7c87-4e61-8423-fd23aafea06e">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc4_cbcac82f-52f8-41b0-a9d9-48fde5ed7497">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDc5_0158e569-5a50-447e-b095-0efe2c065468">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NjE4MjQ3ODA4MGE2NGQ3YmE5MWM5MzhmNzZiNzg1YzEvdGFibGVyYW5nZTo2MTgyNDc4MDgwYTY0ZDdiYTkxYzkzOGY3NmI3ODVjMV8wLTAtMS0xLTEwNzg0Mg_7584dfae-b4fd-4636-97e3-2e463d61f336">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NjE4MjQ3ODA4MGE2NGQ3YmE5MWM5MzhmNzZiNzg1YzEvdGFibGVyYW5nZTo2MTgyNDc4MDgwYTY0ZDdiYTkxYzkzOGY3NmI3ODVjMV8xLTMtMS0xLTEwNzg0Mg_1647c83c-7657-4429-aedf-f8272ae17211">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGFibGU6NjE4MjQ3ODA4MGE2NGQ3YmE5MWM5MzhmNzZiNzg1YzEvdGFibGVyYW5nZTo2MTgyNDc4MDgwYTY0ZDdiYTkxYzkzOGY3NmI3ODVjMV8yLTMtMS0xLTEwNzg0Mg_46bc3eb3-c453-4ba5-93c1-36b6bab1aa3d">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDcy_6829c356-8b41-426b-8f2f-5dcf2a0a96b2">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie82972ffaa0e486c8bf672e801389907_I20220502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xL2ZyYWc6M2ZiZDYyNzdjMzdlNDUwM2JiMmNkZGQ3MTc4YTI3YzYvdGV4dHJlZ2lvbjozZmJkNjI3N2MzN2U0NTAzYmIyY2RkZDcxNzhhMjdjNl8yMDAw_0b65d2b9-aef6-4029-a428-9cc62b097c34"
      unitRef="shares">539557153</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMy0xLTEtMS0xMDc4NDI_acf70574-0e40-4f0c-9233-e2598806ead8"
      unitRef="usd">12368124000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMy0zLTEtMS0xMDc4NDI_2c1737f0-5336-46b7-b315-6b57beccf3a2"
      unitRef="usd">12025271000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:DevelopmentInProcess
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNC0xLTEtMS0xMDc4NDI_b23346c9-67eb-41a4-9551-765b8107a89d"
      unitRef="usd">739451000</us-gaap:DevelopmentInProcess>
    <us-gaap:DevelopmentInProcess
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNC0zLTEtMS0xMDc4NDI_001acfd1-c2b7-4283-8ae5-fdb823f44bb8"
      unitRef="usd">877423000</us-gaap:DevelopmentInProcess>
    <us-gaap:Land
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNS0xLTEtMS0xMDc4NDI_f694c58f-3b4e-4853-b5fc-f67fea9a00fc"
      unitRef="usd">2706909000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNS0zLTEtMS0xMDc4NDI_31dcf446-60b9-439e-8365-d966ac4cd457"
      unitRef="usd">2603964000</us-gaap:Land>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNi0xLTEtMS0xMDc4NDI_6553cd50-c4b5-448f-b67e-23da4118798f"
      unitRef="usd">2975337000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNi0zLTEtMS0xMDc4NDI_87041974-6444-47c0-9370-6645783ec66f"
      unitRef="usd">2839229000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNy0xLTEtMS0xMDc4NDI_2045521b-7593-4dff-8272-31173b552889"
      unitRef="usd">12839147000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNy0zLTEtMS0xMDc4NDI_4d4f9fb6-4445-4cc5-8d0d-39a7803aea6b"
      unitRef="usd">12667429000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOC0xLTEtMS0xMDc4NDI_a1339382-0d4f-4636-aae6-2cbe46761f09"
      unitRef="usd">0</us-gaap:LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount>
    <us-gaap:LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOC0zLTEtMS0xMDc4NDI_761bf370-2700-40d3-a91f-9a6ccf37e68a"
      unitRef="usd">44706000</us-gaap:LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOS0wLTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjplMmMzYWZmYzUwOTU0MmMzOGI1M2U3NDY3MGVkNzcwZV80MQ_3024e3ba-d6fc-4d37-a9f0-9fcf71b8f09d"
      unitRef="usd">1944000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOS0wLTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjplMmMzYWZmYzUwOTU0MmMzOGI1M2U3NDY3MGVkNzcwZV80OA_16d3ef77-4941-4751-b56f-65edc6c6e0ce"
      unitRef="usd">1813000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOS0xLTEtMS0xMDc4NDI_f1e5f4ed-12ac-4dd4-ad8f-40e7b23433f7"
      unitRef="usd">409753000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfOS0zLTEtMS0xMDc4NDI_58a12428-0f37-4aa8-b2ac-5db984c88623"
      unitRef="usd">415811000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTAtMS0xLTEtMTA3ODQy_8510526b-1924-438d-9e02-99562d60078c"
      unitRef="usd">403159000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTAtMy0xLTEtMTA3ODQy_6d7971ea-d45a-44d7-bfc7-ebd7a3714468"
      unitRef="usd">403634000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTEtMC0xLTEtMTA3ODQyL3RleHRyZWdpb246ZmJhM2NmZDUyNzdhNDYxNWEyNTNhODlhMGEzZjI5MmZfNDU_d3dce2cb-18cf-4fd8-9d05-f6908e897732"
      unitRef="usd">2068000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTEtMC0xLTEtMTA3ODQyL3RleHRyZWdpb246ZmJhM2NmZDUyNzdhNDYxNWEyNTNhODlhMGEzZjI5MmZfNTI_ab9f28f6-1bab-4ade-87ca-b23c843306b7"
      unitRef="usd">1870000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTEtMS0xLTEtMTA3ODQy_ba5b80c1-5949-45ce-b36d-89066543b00a"
      unitRef="usd">54106000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTEtMy0xLTEtMTA3ODQy_2a89f011-36b1-4283-988e-1c839a76965f"
      unitRef="usd">48691000</us-gaap:AccountsReceivableNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTItMS0xLTEtMTA3ODQy_6313a142-7d12-4fa5-aec0-77f3d2550047"
      unitRef="usd">89066000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTItMy0xLTEtMTA3ODQy_45a480c6-cf4b-4016-aea0-e17804bca9a8"
      unitRef="usd">158287000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTMtMS0xLTEtMTA3ODQy_15925c6e-6ee5-4450-8572-3ece0b7272be"
      unitRef="usd">52103000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTMtMy0xLTEtMTA3ODQy_243076dc-10a7-454f-85b3-bb644837865b"
      unitRef="usd">53454000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTQtMS0xLTEtMTA3ODQy_8b8de7e9-53f5-4dcf-b897-ec3d16d7c28d"
      unitRef="usd">497104000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTQtMy0xLTEtMTA3ODQy_d7200d09-d10a-40b4-9fd6-169f826b1f96"
      unitRef="usd">519760000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTUtMS0xLTEtMTA3ODQy_89ad9247-17f0-4f7e-8dfc-32c2b1fead17"
      unitRef="usd">33812000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTUtMy0xLTEtMTA3ODQy_6dd304d8-34a1-44af-8a45-761b6a9fada4"
      unitRef="usd">37190000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTYtMS0xLTEtMTA3ODQy_68f5fed7-a8a5-4f96-9a06-92a40a223a72"
      unitRef="usd">232457000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTYtMy0xLTEtMTA3ODQy_88321dc9-5224-4f2e-ad2c-36b04d80a25c"
      unitRef="usd">233942000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssets
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTctMS0xLTEtMTA3ODQy_38afe7cf-2d2f-4bb9-a88b-2fd4a6b2fae0"
      unitRef="usd">676543000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTctMy0xLTEtMTA3ODQy_cc9e4895-6fe5-450e-a25b-58811acd3c59"
      unitRef="usd">674615000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTgtMS0xLTEtMTA3ODQy_2160083a-9c4d-4f3a-a46f-6ed867a83498"
      unitRef="usd">15287250000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMTgtMy0xLTEtMTA3ODQy_9728f086-93bf-469c-a845-da898fb13807"
      unitRef="usd">15257519000</us-gaap:Assets>
    <us-gaap:LineOfCredit
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjEtMS0xLTEtMTA3ODQy_81a766ab-b7df-4cdf-a5b7-07f250147dd6"
      unitRef="usd">1330813000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjEtMy0xLTEtMTA3ODQy_eac68cad-eb89-4e31-b473-c28d64f5f45f"
      unitRef="usd">1165975000</us-gaap:LineOfCredit>
    <us-gaap:UnsecuredDebt
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjMtMS0xLTEtMTA3ODQy_f3c4d349-ee39-400f-af3f-48725f3d1c8a"
      unitRef="usd">4654056000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjMtMy0xLTEtMTA3ODQy_d4d26afd-f805-437c-9675-e7a3a571cfc1"
      unitRef="usd">4651933000</us-gaap:UnsecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjQtMS0xLTEtMTA3ODQy_e83f68a7-cfca-4667-b796-55be185de6ba"
      unitRef="usd">350713000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjQtMy0xLTEtMTA3ODQy_15baedf6-a1af-4b9c-bde6-df65f98ae64d"
      unitRef="usd">352081000</us-gaap:SecuredDebt>
    <us-gaap:OffMarketLeaseUnfavorable
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjUtMS0xLTEtMTA3ODQy_748ebcab-6603-48d4-a93f-f288aeb75a0f"
      unitRef="usd">175355000</us-gaap:OffMarketLeaseUnfavorable>
    <us-gaap:OffMarketLeaseUnfavorable
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjUtMy0xLTEtMTA3ODQy_1d65c913-558c-4b77-b3d7-7b6d205037c1"
      unitRef="usd">177232000</us-gaap:OffMarketLeaseUnfavorable>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjYtMS0xLTEtMTA3ODQy_9408d5e4-ce55-418c-ab46-01c0067585c7"
      unitRef="usd">14318000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjYtMy0xLTEtMTA3ODQy_29349b56-7d7d-42d1-abd6-4b1b52b997a4"
      unitRef="usd">15056000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseLiability
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjctMS0xLTEtMTA3ODQy_78848bf1-aa19-4329-b091-5f884337c086"
      unitRef="usd">203988000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjctMy0xLTEtMTA3ODQy_d4f7698d-a4d9-4de5-bed5-df0c7a5b6573"
      unitRef="usd">204547000</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjgtMS0xLTEtMTA3ODQy_1e0bae2c-1aef-4b78-aa66-e74382468909"
      unitRef="usd">695373000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjgtMy0xLTEtMTA3ODQy_354626a0-8e0f-4741-a3f8-8f1d292a77c8"
      unitRef="usd">755384000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjktMS0xLTEtMTA3ODQy_36acbb88-18f6-4090-8803-3a06ae833305"
      unitRef="usd">817022000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMjktMy0xLTEtMTA3ODQy_76059b01-bb7f-4256-8be9-f00f66df34f2"
      unitRef="usd">789207000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:Liabilities
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzAtMS0xLTEtMTA3ODQy_9c5a41ae-70f6-42dc-ae62-b22879a04b40"
      unitRef="usd">8241638000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzAtMy0xLTEtMTA3ODQy_1c1db97f-a478-4007-bbaa-295584baa561"
      unitRef="usd">8111415000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzItMS0xLTEtMTA3ODQy_5ded9525-b602-4d67-b594-e5b669d56abb"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzItMy0xLTEtMTA3ODQy_8bed9591-7df1-4c33-b941-a41defd6623c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzQtMS0xLTEtMTA3ODQy_54d382e8-c5aa-4346-98ed-e2ebf3777671"
      unitRef="usd">97890000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzQtMy0xLTEtMTA3ODQy_add4b58f-7e3e-42e9-9c05-c3e2b54ad8b2"
      unitRef="usd">87344000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfMTg_ab2a38ac-112b-4317-9bed-56ac50bf0b2a"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfMTg_c1222ba0-1d78-4894-8d5a-4e81dae4495a"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfMzI_7071d497-22b2-4e1a-975b-ba79a4ef00a2"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfMzI_ba883f78-3767-4b23-b648-75cab7a40bf9"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfNTQ_cf596df3-21a2-46c4-9671-270d894c268b"
      unitRef="shares">539523537</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfNTQ_f4d371af-119d-428a-9819-baa504ebfad5"
      unitRef="shares">539523537</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfNjE_0cea9c0f-ed38-452a-9003-9ee6b84530de"
      unitRef="shares">539096879</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MzQzN2NmOTIyNGU1NGZlZGFhMGJjM2M0ZjA3YmZjN2JfNjE_28e3c8b9-afeb-411a-846e-55862796681e"
      unitRef="shares">539096879</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMS0xLTEtMTA3ODQy_943a6ba9-fb24-457f-b043-c112e2adcde3"
      unitRef="usd">539524000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzctMy0xLTEtMTA3ODQy_47e4fa8e-1bff-4f54-96c7-2602ed53861b"
      unitRef="usd">539097000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzgtMS0xLTEtMTA3ODQy_b4b01017-43ef-4d7c-94a5-5df93671aac8"
      unitRef="usd">10084687000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzgtMy0xLTEtMTA3ODQy_919fe119-cf7a-4446-9446-dac274f568b7"
      unitRef="usd">10100294000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedDistributionsInExcessOfNetIncome
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzktMS0xLTEtMTA3ODQy_ffeca10f-73e2-4f87-9af5-2c3e949d5311"
      unitRef="usd">4212941000</us-gaap:AccumulatedDistributionsInExcessOfNetIncome>
    <us-gaap:AccumulatedDistributionsInExcessOfNetIncome
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfMzktMy0xLTEtMTA3ODQy_162b79be-f828-40ea-adfc-d9dca99ab530"
      unitRef="usd">4120774000</us-gaap:AccumulatedDistributionsInExcessOfNetIncome>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDAtMS0xLTEtMTA3ODQy_c9ea420b-6419-4965-864f-e05a1f74d570"
      unitRef="usd">-3047000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDAtMy0xLTEtMTA3ODQy_fff31d24-22be-4d9f-84df-16b9ddac9571"
      unitRef="usd">-3147000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDEtMS0xLTEtMTA3ODQy_5f147df1-d25c-41a6-8d32-123f5fd77a3a"
      unitRef="usd">6408223000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDEtMy0xLTEtMTA3ODQy_f528d147-4a30-4280-be8a-cd3ecf70606e"
      unitRef="usd">6515470000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterestInJointVentures
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDItMS0xLTEtMTA3ODQy_e4b0a45b-782e-4bee-9a9e-f05b4a30508c"
      unitRef="usd">338443000</us-gaap:MinorityInterestInJointVentures>
    <us-gaap:MinorityInterestInJointVentures
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDItMy0xLTEtMTA3ODQy_d11a510f-a6a9-4acf-8d1d-6d6fefacfa82"
      unitRef="usd">342234000</us-gaap:MinorityInterestInJointVentures>
    <us-gaap:MinorityInterestInPreferredUnitHolders
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDMtMS0xLTEtMTA3ODQy_4e6c6810-fec7-4b50-a239-ce5eba207a16"
      unitRef="usd">201056000</us-gaap:MinorityInterestInPreferredUnitHolders>
    <us-gaap:MinorityInterestInPreferredUnitHolders
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDMtMy0xLTEtMTA3ODQy_fe920664-a610-4463-86b6-2d73056659b8"
      unitRef="usd">201056000</us-gaap:MinorityInterestInPreferredUnitHolders>
    <us-gaap:MinorityInterest
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDQtMS0xLTEtMTA3ODQy_c0a170c0-7ee8-45d4-ae17-8a4151410d2c"
      unitRef="usd">539499000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDQtMy0xLTEtMTA3ODQy_7d1431f6-ec75-40b1-a6bd-7db20671cb7f"
      unitRef="usd">543290000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDUtMS0xLTEtMTA3ODQy_bcb5c88f-05ba-4afb-93bc-d08aa0d978fe"
      unitRef="usd">6947722000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDUtMy0xLTEtMTA3ODQy_78c4b278-c237-4610-a07b-c5535fe980dd"
      unitRef="usd">7058760000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDYtMS0xLTEtMTA3ODQy_509a01e7-a2f9-40b0-a91f-7e14bb361d1d"
      unitRef="usd">15287250000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xNi9mcmFnOmQ1NTA2ZTQ1OGU1ZjQ0Mjg5NjAxZmM5OGIwYzI3YWNhL3RhYmxlOjQ4NTUyNzJmZTI4OTQ0NWM4MjA5OTY5ODhlMmZjNzEwL3RhYmxlcmFuZ2U6NDg1NTI3MmZlMjg5NDQ1YzgyMDk5Njk4OGUyZmM3MTBfNDYtMy0xLTEtMTA3ODQy_f0cc888a-fac6-4a94-9c3a-3adb47a9035b"
      unitRef="usd">15257519000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMy0xLTEtMS0xMDc4NDI_2aeb2c32-bd71-4d12-bdf1-8392dfad5744"
      unitRef="usd">370150000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMy0zLTEtMS0xMDc4NDI_72ace142-c031-40c6-8b19-dc50ca84f105"
      unitRef="usd">327972000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNC0xLTEtMS0xMDc4NDI_ea332410-ef63-4ab6-ac25-fd4cfa9341e1"
      unitRef="usd">121560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNC0zLTEtMS0xMDc4NDI_37173fba-f6f9-4be4-bf09-8b51a6858f11"
      unitRef="usd">116128000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DirectFinancingLeaseRevenue
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNS0xLTEtMS0xMDc4NDI_b1be8c44-23a9-4f8d-9044-f5e78de74bfa"
      unitRef="usd">1168000</us-gaap:DirectFinancingLeaseRevenue>
    <us-gaap:DirectFinancingLeaseRevenue
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNS0zLTEtMS0xMDc4NDI_72793d8b-ce1c-4710-8950-350715120fc0"
      unitRef="usd">2163000</us-gaap:DirectFinancingLeaseRevenue>
    <us-gaap:InterestIncomeOperating
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNi0xLTEtMS0xMDc4NDI_05ed4811-acf0-4a26-a368-0f14257fb451"
      unitRef="usd">5494000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNi0zLTEtMS0xMDc4NDI_4de8fe70-c0a7-4de8-995c-788375505393"
      unitRef="usd">9013000</us-gaap:InterestIncomeOperating>
    <us-gaap:Revenues
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNy0xLTEtMS0xMDc4NDI_ff43e578-01f5-41ac-9061-d03dc5653572"
      unitRef="usd">498372000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNy0zLTEtMS0xMDc4NDI_cf52d9d0-441f-4dfc-85b0-d2dcc315e175"
      unitRef="usd">455276000</us-gaap:Revenues>
    <us-gaap:InterestExpense
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfOS0xLTEtMS0xMDc4NDI_d92bf727-e57f-45cf-bf66-ad90c298bd80"
      unitRef="usd">37586000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfOS0zLTEtMS0xMDc4NDI_dc8cef86-d8dd-410c-91ef-450a946be51e"
      unitRef="usd">46843000</us-gaap:InterestExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTAtMS0xLTEtMTA3ODQy_4a2f6375-5592-4eee-9e94-26ba5e2911be"
      unitRef="usd">177733000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTAtMy0xLTEtMTA3ODQy_0741c264-1775-4f37-828b-7e01880f12cd"
      unitRef="usd">157538000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTEtMS0xLTEtMTA3ODQy_7396f4cb-a46d-4948-a109-76f3cff2e2f1"
      unitRef="usd">207247000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTEtMy0xLTEtMTA3ODQy_1ba893a7-3179-4103-9281-7ea5a64f7115"
      unitRef="usd">181761000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTItMS0xLTEtMTA3ODQy_49a1f3ed-914d-4436-a67a-1ad60b6851d3"
      unitRef="usd">23831000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTItMy0xLTEtMTA3ODQy_ac2967f5-4947-49b9-8004-6cd78e19418f"
      unitRef="usd">24902000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTMtMS0xLTEtMTA3ODQy_4ed69e0e-b009-4783-97d9-9727e0688312"
      unitRef="usd">296000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTMtMy0xLTEtMTA3ODQy_fc726ccd-5baa-4a79-8ec8-ab55d69aec27"
      unitRef="usd">798000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTUtMS0xLTEtMTA3ODQy_d8cf8ef5-7a93-4b01-9af4-13f4453474ba"
      unitRef="usd">132000</peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet>
    <peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTUtMy0xLTEtMTA3ODQy_f0f7f7f2-80b4-4e2a-b3f5-d8b62dd2bb87"
      unitRef="usd">3242000</peak:ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet>
    <us-gaap:CostsAndExpenses
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTYtMS0xLTEtMTA3ODQy_9b691bee-80f0-4416-af70-71f177eaea8e"
      unitRef="usd">446825000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTYtMy0xLTEtMTA3ODQy_d0ecad7b-22c4-4b57-8e7c-dd70da2455f4"
      unitRef="usd">415084000</us-gaap:CostsAndExpenses>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTgtMS0xLTEtMTA3ODQy_44dc576f-3806-49e9-9ced-87e8d20b22ca"
      unitRef="usd">3856000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTgtMy0xLTEtMTA3ODQy_a151ca6f-0d27-42f9-8dc8-63b92497a241"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTktMS0xLTEtMTA3ODQy_9a244f38-53d0-4371-a50d-5799b0a19b1c"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMTktMy0xLTEtMTA3ODQy_e6ebe7dd-fe20-4bf8-94e0-90dee44541fd"
      unitRef="usd">-164292000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjAtMS0xLTEtMTA3ODQy_d09749f3-2a17-48a7-8ad0-f798b22b694e"
      unitRef="usd">18316000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjAtMy0xLTEtMTA3ODQy_2bbac6f1-ebd8-4056-8ab0-f6c377167e10"
      unitRef="usd">2200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjEtMS0xLTEtMTA3ODQy_3e521808-7d68-4563-bac3-08465c76a54f"
      unitRef="usd">22172000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjEtMy0xLTEtMTA3ODQy_cdb94c77-b7f8-418f-8b6a-332cbdbb4346"
      unitRef="usd">-162092000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjItMS0xLTEtMTA3ODQy_d5b73c92-e207-45ed-98d3-e03676f605ce"
      unitRef="usd">73719000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjItMy0xLTEtMTA3ODQy_57ea312b-5707-45f1-965e-091aec1a0edd"
      unitRef="usd">-121900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjMtMS0xLTEtMTA3ODQy_7ab41093-8e61-4734-ad35-805af4799e30"
      unitRef="usd">777000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjMtMy0xLTEtMTA3ODQy_91acd8bf-5a9e-4c50-bda3-8ce1c5c299d9"
      unitRef="usd">8000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjQtMS0xLTEtMTA3ODQy_82be0aa6-27ec-47ec-9e6b-c7c692ae77f6"
      unitRef="usd">2084000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjQtMy0xLTEtMTA3ODQy_eca2534f-d242-4670-8bfa-d064c16e6cdd"
      unitRef="usd">1323000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjUtMS0xLTEtMTA3ODQy_555154b6-e257-4726-9358-0dc817ec4e07"
      unitRef="usd">75026000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjUtMy0xLTEtMTA3ODQy_71f0fe07-a442-474c-bdc2-2509e13592d8"
      unitRef="usd">-120585000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjYtMS0xLTEtMTA3ODQy_b99b3900-02aa-4eb2-8a0c-4cc483af3d77"
      unitRef="usd">317000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjYtMy0xLTEtMTA3ODQy_3fe8abf9-8748-45ee-afff-8023cf87baac"
      unitRef="usd">270008000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjctMS0xLTEtMTA3ODQy_d64ab5ca-9a46-45dc-b6d9-f35d8f2e211f"
      unitRef="usd">75343000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjctMy0xLTEtMTA3ODQy_a19d5775-c8cd-46a8-b883-edb7cca291b1"
      unitRef="usd">149423000</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjgtMS0xLTEtMTA3ODQy_e0a8eb18-adee-45f1-8477-90326296d58f"
      unitRef="usd">3730000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjgtMy0xLTEtMTA3ODQy_18a4a7d6-4d1e-4274-8254-e7ced9a52b77"
      unitRef="usd">3306000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjktMS0xLTEtMTA3ODQy_b8270735-d80c-4523-8ca1-529d1cb6dca0"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMjktMy0xLTEtMTA3ODQy_f21e2fbc-0981-4c18-a9cb-e93ba96ec8bf"
      unitRef="usd">329000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzAtMS0xLTEtMTA3ODQy_9d0a77a3-ba41-4ca4-b670-0d7150f89e79"
      unitRef="usd">71613000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzAtMy0xLTEtMTA3ODQy_bc287a37-8c1d-46c1-9c2f-263f1bef33fd"
      unitRef="usd">145788000</us-gaap:NetIncomeLoss>
    <peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzItMS0xLTEtMTA3ODQy_a6f92290-0df3-4ce6-8613-18d10f98f55b"
      unitRef="usd">1976000</peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted>
    <peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzItMy0xLTEtMTA3ODQy_ab8b63ad-dcc6-48fe-ac27-e296264b6bdc"
      unitRef="usd">2451000</peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzMtMS0xLTEtMTA3ODQy_60706bae-3a94-4da8-a979-c72c5a31e76e"
      unitRef="usd">69637000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzMtMy0xLTEtMTA3ODQy_518c3785-ffcc-4570-895c-d10d2b38633a"
      unitRef="usd">143337000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzYtMS0xLTEtMTA3ODQy_ab3702ce-5878-44a3-b06f-1e1d7f93257f"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzYtMy0xLTEtMTA3ODQy_43e0a48a-a7bf-4df7-ac6d-54df6bc58f47"
      unitRef="usdPerShare">-0.23</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzctMS0xLTEtMTA3ODQy_ff8301c1-9e55-47f0-bc0e-2a6445108eb1"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzctMy0xLTEtMTA3ODQy_cd29157b-1b7e-46d5-932b-02f3b8ad8668"
      unitRef="usdPerShare">0.50</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzgtMS0xLTEtMTA3ODQy_fb7d5fef-ba0c-4256-a1ee-81493098177d"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfMzgtMy0xLTEtMTA3ODQy_aae6af37-2d97-40a6-9b67-39f61cd26cc0"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDAtMS0xLTEtMTA3ODQy_13a7858e-8155-4e93-b049-a9a0352c8297"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDAtMy0xLTEtMTA3ODQy_54000c52-e75d-46a4-b5dd-4f8810c0f533"
      unitRef="usdPerShare">-0.23</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDEtMS0xLTEtMTA3ODQy_63fd93e8-a99f-4fca-aac9-6f3c1ce197f3"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDEtMy0xLTEtMTA3ODQy_3b28d58b-b191-485f-8e45-2056c8464349"
      unitRef="usdPerShare">0.50</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDItMS0xLTEtMTA3ODQy_2e2c8dc9-9747-4f6c-85fd-0c6edbca193b"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDItMy0xLTEtMTA3ODQy_68827048-5989-4c39-b3c3-e84811e801d9"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDctMS0xLTEtMTA3ODQy_9daf2db0-b3d4-4150-8c7b-1404ea175a21"
      unitRef="shares">539352000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDctMy0xLTEtMTA3ODQy_8b2ec2c7-8dfa-46ac-8f29-8e1de68beee9"
      unitRef="shares">538679000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDgtMS0xLTEtMTA3ODQy_40c105d7-0fca-42b0-9df6-65e562acc6e5"
      unitRef="shares">539586000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8xOS9mcmFnOjY5MWI2ZGU2N2UwNjQ5MmJiMGQ1M2UyZjk2ZWUyMWI5L3RhYmxlOmQxYWZkNzM2NDZlMDQ1ZTQ5OWQ4ZWU2NjY2MzYyMWQzL3RhYmxlcmFuZ2U6ZDFhZmQ3MzY0NmUwNDVlNDk5ZDhlZTY2NjYzNjIxZDNfNDgtMy0xLTEtMTA3ODQy_5553fe03-54f4-4297-bdb9-2c6bc9f52e0c"
      unitRef="shares">538679000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMi0xLTEtMS0xMDc4NDI_b4f4e46d-2070-475c-b864-4852a1756072"
      unitRef="usd">75343000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMi0zLTEtMS0xMDc4NDI_9666a7da-6d4e-4088-a8c4-bbb66f94227b"
      unitRef="usd">149423000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfNi0xLTEtMS0xMDc4NDI_33e10578-7b56-4f08-948b-caef88c02850"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfNi0zLTEtMS0xMDc4NDI_8d6d1ecf-aabd-4a88-924d-905fadd4f64e"
      unitRef="usd">332000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfNy0xLTEtMS0xMDc4NDI_78f2f5f7-15fa-4cb0-9a6e-4d574e0bdfea"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfNy0zLTEtMS0xMDc4NDI_064c6b04-ca16-4508-9153-77d9ef827644"
      unitRef="usd">-107000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfOS0xLTEtMS0xMDc4NDI_f88a3d10-4e55-434a-ade4-feaccc6ae47b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfOS0zLTEtMS0xMDc4NDI_07dec02d-01c6-4170-8d09-881f3c48720d"
      unitRef="usd">251000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTAtMS0xLTEtMTA3ODQy_6f066ede-908a-4810-90cd-eedb4fa2d96a"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTAtMy0xLTEtMTA3ODQy_5d62b301-11fc-4fc6-95e9-2159392ebd62"
      unitRef="usd">188000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTEtMS0xLTEtMTA3ODQy_44a03aa6-95d4-4486-81a9-b2ac4d3ac18e"
      unitRef="usd">75443000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTEtMy0xLTEtMTA3ODQy_5f3325b4-4021-435d-957d-585338e15488"
      unitRef="usd">149611000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i409ce78c858444d7a5dc1f973872f5b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTItMS0xLTEtMTA3ODQy_549684c8-d258-4e37-8ddb-a9fefa9815cb"
      unitRef="usd">3730000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i046e7a1a5f114e488bef10441f3f6b44_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTItMy0xLTEtMTA3ODQy_e2aeebb5-db5c-40da-ba66-6b28cdbc0733"
      unitRef="usd">3306000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTMtMS0xLTEtMTA3ODQy_0f1b8d5c-2170-4e2d-aeef-cdc7c06be087"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i586d3ac1554b476b944978cf331446d1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTMtMy0xLTEtMTA3ODQy_8275c53d-b952-4169-81b6-8cf5a256c261"
      unitRef="usd">329000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTQtMS0xLTEtMTA3ODQy_8d4c1760-ff4f-4b9c-9dfe-415866e73404"
      unitRef="usd">71713000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yMi9mcmFnOjY4M2U2Y2MwZjkyODRlMjk4ZjY4YTRmNTEyZDM4ZGNiL3RhYmxlOjI5Yjc1YTE4NmMzMjRkYmVhMjhkOGY2MzlkOWY1NDVmL3RhYmxlcmFuZ2U6MjliNzVhMTg2YzMyNGRiZWEyOGQ4ZjYzOWQ5ZjU0NWZfMTQtMy0xLTEtMTA3ODQy_5a49c875-4711-40bc-9143-3cd7dabc2c7c"
      unitRef="usd">145976000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i27033f4128f14d61b570ee8fcfab4e19_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xLTEtMS0xMDc4NDI_7f58aef6-88d8-4db7-ab46-f28f8e908857"
      unitRef="shares">539097000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27033f4128f14d61b570ee8fcfab4e19_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0zLTEtMS0xMDc4NDI_df8d7663-a0b3-4922-9d76-b539c1b2233c"
      unitRef="usd">539097000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibcae3dea640a4b138a3f5795930bae95_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC01LTEtMS0xMDc4NDI_df417d95-c701-492e-8fb1-28f25d68cedd"
      unitRef="usd">10100294000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf9ac731c8274ea6971c722ec208c696_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC03LTEtMS0xMDc4NDI_ee0400b6-944d-4f82-9c11-f3296a261866"
      unitRef="usd">-4120774000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iadd3477c47624974b897f92075a001c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC05LTEtMS0xMDc4NDI_bd2c4712-2bff-4f93-9e86-a48bc56762cb"
      unitRef="usd">-3147000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i490f82b12d324a9c8138193ebcd5d1eb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xMS0xLTEtMTA3ODQy_387540ce-516e-40fc-b1a9-d20de6442df2"
      unitRef="usd">6515470000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0bd8d0bfcbb44ad83c3862162bfa1c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xMy0xLTEtMTA3ODQy_521cb167-9852-41ea-9bcb-3fb269e36f9f"
      unitRef="usd">543290000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xNS0xLTEtMTA3ODQy_18342a0a-ef46-4422-ab01-4ec19d4dd989"
      unitRef="usd">7058760000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNC0xNy0xLTEtMTA3ODQy_ddbb0acd-87af-4758-a022-5ab0e94a0b65"
      unitRef="usd">87344000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i67bf69a97b654c869301d6f090e62d57_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS03LTEtMS0xMDc4NDI_6c0b86c9-f672-47dc-95be-6e971382f256"
      unitRef="usd">71613000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS0xMS0xLTEtMTA3ODQy_274dd62a-b4e7-4399-bbce-70c2fa918ef9"
      unitRef="usd">71613000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ifcb077a5f2244709819741b6cb0a3fa1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS0xMy0xLTEtMTA3ODQy_12ce18f2-2f3d-4b81-8cab-742c39acafda"
      unitRef="usd">3718000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS0xNS0xLTEtMTA3ODQy_30b741ff-b556-468e-b1d3-f23dde186008"
      unitRef="usd">75331000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNS0xNy0xLTEtMTA3ODQy_9f2f5e04-efa3-42f3-a5ee-624681ee48f3"
      unitRef="usd">12000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3a7abe9391e6448ab7157b0bae0f272a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNi05LTEtMS0xMDc4NDI_ceb8cae4-ae11-4786-844f-7420f38bacb1"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNi0xMS0xLTEtMTA3ODQy_705c992d-ce62-456b-a7c8-02ea1d2d16e1"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNi0xNS0xLTEtMTA3ODQy_a72e9990-8741-4bf3-b4e5-19322a5f9495"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy0xLTEtMS0xMDc4NDI_982822b7-34bf-4d7a-9251-ac8f2a0f40ac"
      unitRef="shares">766000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy0zLTEtMS0xMDc4NDI_b8ba73f3-d33d-4556-9ffa-bbb6f698eaa0"
      unitRef="usd">766000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy01LTEtMS0xMDc4NDI_815b4dd1-7e64-4576-adc8-3885efc2e49e"
      unitRef="usd">-437000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy0xMS0xLTEtMTA3ODQy_79a6cfd9-94bf-44e1-9532-937d6b13a063"
      unitRef="usd">329000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfNy0xNS0xLTEtMTA3ODQy_dd586c1f-af04-4181-b91c-1b18ee41196c"
      unitRef="usd">329000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS0xLTEtMS0xMDc4NDI_bb0608ed-c297-4a72-8158-d5a4af964ff1"
      unitRef="shares">339000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9f07b36276214de996cffb4da5bc5fd3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS0zLTEtMS0xMDc4NDI_20f4cc38-f563-49fe-9ba4-0ef6fdac1c2a"
      unitRef="usd">339000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS01LTEtMS0xMDc4NDI_d8665f47-6836-410a-93fa-96ceca7b5bcd"
      unitRef="usd">11013000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS0xMS0xLTEtMTA3ODQy_40281d69-539b-468a-aea9-64635ba6532a"
      unitRef="usd">11352000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfOS0xNS0xLTEtMTA3ODQy_f0a4e8f3-4c32-46fc-b1ad-8dd3c89c7d86"
      unitRef="usd">11352000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTEtNS0xLTEtMTA3ODQy_b5d15e84-d654-4187-96cd-0c4013fbc55f"
      unitRef="usd">6144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTEtMTEtMS0xLTEwNzg0Mg_b7aa5212-5ed4-4771-910d-84afe3af36aa"
      unitRef="usd">6144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTEtMTUtMS0xLTEwNzg0Mg_73b8580a-6ecf-4684-95dc-b7c94c503b4a"
      unitRef="usd">6144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTItMC0xLTEtMTA3ODQyL3RleHRyZWdpb246MDIwMTJiNGUzNGNjNDUwZGJkODI4Yjg0Y2ZhNjJlNjFfMjI_e50cd9e1-8c1e-425a-b74c-be12063db602"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock
      contextRef="i67bf69a97b654c869301d6f090e62d57_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTItNy0xLTEtMTA3ODQy_265dd851-133d-4330-bf7a-d48e551c9b78"
      unitRef="usd">163780000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTItMTEtMS0xLTEwNzg0Mg_6bd2cdd3-6e13-4513-b4c0-f8c5b1ee6289"
      unitRef="usd">163780000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTItMTUtMS0xLTEwNzg0Mg_a3b2d033-1f82-49e8-9657-91bfbfb20a6c"
      unitRef="usd">163780000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ifcb077a5f2244709819741b6cb0a3fa1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTMtMTMtMS0xLTEwNzg0Mg_15c8d87c-b30e-4b90-8f41-1dea489151c3"
      unitRef="usd">7509000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTMtMTUtMS0xLTEwNzg0Mg_23a65f68-6574-4646-a400-11589c43a701"
      unitRef="usd">7509000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTMtMTctMS0xLTEwNzg0Mg_34513c8b-634b-44a4-855b-217eaf16ffa3"
      unitRef="usd">0</peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTQtMTctMS0xLTEwNzg0Mg_bbe604b7-cca0-4758-a632-b953668bc6db"
      unitRef="usd">233000</peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="ifd4d855e9acd4022968a45d3bd69dfa8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTUtNS0xLTEtMTA3ODQy_2dca7395-58ae-4229-a721-2beafee3d8a5"
      unitRef="usd">10301000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="i7404d45d41b64f609165eec044f08108_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTUtMTEtMS0xLTEwNzg0Mg_ce330415-8db1-48f2-b3ab-79e387b09767"
      unitRef="usd">10301000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTUtMTUtMS0xLTEwNzg0Mg_70b6998f-25d0-42e3-a142-a3e352952111"
      unitRef="usd">10301000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTUtMTctMS0xLTEwNzg0Mg_c80d7ebe-e761-484f-9927-71a297c91173"
      unitRef="usd">10301000</peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity>
    <us-gaap:SharesIssued
      contextRef="i31c94325aaf34e408bb6acbdc569a1d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMS0xLTEtMTA3ODQy_034b6534-39d8-4038-965b-174d757e4543"
      unitRef="shares">539524000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31c94325aaf34e408bb6acbdc569a1d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMy0xLTEtMTA3ODQy_0f9ce3d2-583c-4ac0-95a8-ccd2108a150f"
      unitRef="usd">539524000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i367dd265e817411fae092d30372080c9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktNS0xLTEtMTA3ODQy_dff85b0a-8eb0-4ea3-9ebe-17d6d7764b89"
      unitRef="usd">10084687000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25b091a3184e4f5abf94f94d420796af_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktNy0xLTEtMTA3ODQy_8e1113f4-513d-431e-9790-18b392227d14"
      unitRef="usd">-4212941000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic24059380f4a4805a400b695962dbef6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktOS0xLTEtMTA3ODQy_b7f70d95-cbba-4626-a0c8-3c9c9e009e9d"
      unitRef="usd">-3047000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i98fdb8b9ba7546b3863ac5453d1d4595_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMTEtMS0xLTEwNzg0Mg_e6e09541-77cc-4ffc-8560-80c7cf67dcd3"
      unitRef="usd">6408223000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a20cc136a864b339ac00237669b9e4d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMTMtMS0xLTEwNzg0Mg_a76267d2-8894-48da-8dec-2bc8bf734967"
      unitRef="usd">539499000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMTUtMS0xLTEwNzg0Mg_b6c37e6d-b0be-4880-afc9-7f1ab651657d"
      unitRef="usd">6947722000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOjYzZWFmN2U2NTRiZDQ0YWQ5NDI3ZjMzYjBiMzViMTI2L3RhYmxlcmFuZ2U6NjNlYWY3ZTY1NGJkNDRhZDk0MjdmMzNiMGIzNWIxMjZfMTktMTctMS0xLTEwNzg0Mg_155b9579-9764-43ba-a790-3c885de32fda"
      unitRef="usd">97890000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesIssued
      contextRef="i40a69eb101874a248f36e295dd95e2e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xLTEtMS0xMDc4NDI_ed340ad1-015d-49d0-ae7c-ae0c29d8fcb9"
      unitRef="shares">538405000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40a69eb101874a248f36e295dd95e2e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0zLTEtMS0xMDc4NDI_b374d118-475e-40f3-a804-cc93ee152246"
      unitRef="usd">538405000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3663f069068045e992c69e3d404cae29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC01LTEtMS0xMDc4NDI_0fa8cdba-7713-4574-9caa-0f2e41a1cf89"
      unitRef="usd">10175235000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i872f9cc9bb7a47469e26e6f7e4849029_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC03LTEtMS0xMDc4NDI_05a53baf-b38a-4ec3-a080-157369da1119"
      unitRef="usd">-3976232000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19827d84f1614a0f8ad378b5470e253a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC05LTEtMS0xMDc4NDI_c6e6ee33-e7fd-473e-a506-95bc91ec6a13"
      unitRef="usd">-3685000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i797de15cd85c409c81c2fbde05db3a05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xMS0xLTEtMTA3ODQy_559d8b9c-3ad3-486b-88de-69ff8a3e2ba4"
      unitRef="usd">6733723000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45b145e89da940f2b434e5038adee396_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xMy0xLTEtMTA3ODQy_2c919734-42c3-4a8e-9e94-851e29cb5729"
      unitRef="usd">556227000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xNS0xLTEtMTA3ODQy_11f33d7c-6df5-476a-a229-58a14b210c6b"
      unitRef="usd">7289950000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNC0xNy0xLTEtMTA3ODQy_9a6d3c1c-c4fc-4cf7-aea2-9f4a15d84450"
      unitRef="usd">57396000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ia5ec0bcc69b44db7857a079e35c591cb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNS03LTEtMS0xMDc4NDI_e24718a1-0c76-4fc6-ac36-3d317315db83"
      unitRef="usd">145788000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNS0xMS0xLTEtMTA3ODQy_cedd2503-82ef-4b6e-a0d4-a9fff2c79925"
      unitRef="usd">145788000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5ce63109a747419ba702c25c06711c30_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNS0xMy0xLTEtMTA3ODQy_f4fc0ae5-4bb6-4b18-b69f-ec0d1ee2502b"
      unitRef="usd">3635000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNS0xNS0xLTEtMTA3ODQy_04181667-1f61-4e6d-a406-b6d0414c17e2"
      unitRef="usd">149423000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i15fe27c8a01a4beba1b7b922c1d0d182_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNi05LTEtMS0xMDc4NDI_11f6487d-cea5-473e-9993-67975be4edda"
      unitRef="usd">188000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNi0xMS0xLTEtMTA3ODQy_583236f9-347a-4ef9-822e-13d69bb62c52"
      unitRef="usd">188000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNi0xNS0xLTEtMTA3ODQy_c472f46b-3ef6-4193-909c-58130c7d45f0"
      unitRef="usd">188000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy0xLTEtMS0xMDc4NDI_77ec7ca2-e171-4369-a6ec-1ac16be0dd31"
      unitRef="shares">879000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy0zLTEtMS0xMDc4NDI_b8f25424-12d4-4c39-8ec2-be9a692ef4cd"
      unitRef="usd">879000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy01LTEtMS0xMDc4NDI_f7fd1ddb-e3db-4357-87d9-c763241d120d"
      unitRef="usd">208000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy0xMS0xLTEtMTA3ODQy_281f58b6-6f09-4c7e-b8e1-5ab40078e15c"
      unitRef="usd">1087000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfNy0xNS0xLTEtMTA3ODQy_56b70d86-4345-4010-8cfb-54a539b7a18a"
      unitRef="usd">1087000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS0xLTEtMS0xMDc4NDI_0e84af96-fc03-40b7-9763-117a22077496"
      unitRef="shares">398000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0b3f21e1fa79449085bc043477d76dd5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS0zLTEtMS0xMDc4NDI_3feca8f1-1047-4327-89b8-bb0afc2a79d5"
      unitRef="usd">398000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS01LTEtMS0xMDc4NDI_82824c2c-bb20-4bd0-b32c-fe2bade3fce7"
      unitRef="usd">11767000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS0xMS0xLTEtMTA3ODQy_d259a852-53a0-4c73-8d9f-e684ead7e498"
      unitRef="usd">12165000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfOS0xNS0xLTEtMTA3ODQy_ab5cb8dc-0597-4dd0-81fc-ae713e500ab0"
      unitRef="usd">12165000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTEtNS0xLTEtMTA3ODQy_5a901fde-4fb8-416a-84f1-2dbfb7212d68"
      unitRef="usd">5413000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTEtMTEtMS0xLTEwNzg0Mg_ca970caa-413e-4af9-aa41-9113f8da6940"
      unitRef="usd">5413000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTEtMTUtMS0xLTEwNzg0Mg_d572d753-57f5-49d2-b0c5-6bb42a40511b"
      unitRef="usd">5413000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTItMC0xLTEtMTA3ODQyL3RleHRyZWdpb246NDZlYjExODE1MmUwNDBlMWEyN2E3NTNhOWQ2YTIwNDZfMjI_faced4b7-59a8-4230-92eb-00c6492815ab"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock
      contextRef="ia5ec0bcc69b44db7857a079e35c591cb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTItNy0xLTEtMTA3ODQy_5c7a532b-726c-4c93-a24a-9e898a34afeb"
      unitRef="usd">164118000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTItMTEtMS0xLTEwNzg0Mg_69ce9147-fee3-4aa7-821f-a11a898767a8"
      unitRef="usd">164118000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTItMTUtMS0xLTEwNzg0Mg_b28115fd-ed83-429a-bf17-7b0dbb7d7e85"
      unitRef="usd">164118000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5ce63109a747419ba702c25c06711c30_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTMtMTMtMS0xLTEwNzg0Mg_9c617d4e-b1c2-4b99-965a-47564b03de51"
      unitRef="usd">7718000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTMtMTUtMS0xLTEwNzg0Mg_8cff677c-fac3-4cc8-80b1-464002394517"
      unitRef="usd">7718000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTMtMTctMS0xLTEwNzg0Mg_9ecda957-10a0-483c-b7d5-3b61f0e02b11"
      unitRef="usd">52000</peak:TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTYtMTctMS0xLTEwNzg0Mg_298cd754-120b-47ee-8f68-f24ee46eaecc"
      unitRef="usd">148000</peak:TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="iafb29bc0ad59424ba8da9a77a8ab6e9d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTctNS0xLTEtMTA3ODQy_4dde1343-c45a-48d3-8f7d-0a080a80b26a"
      unitRef="usd">20921000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="ifbe8319010ed4f97b4582e9dc05dbbe8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTctMTEtMS0xLTEwNzg0Mg_9842d03e-6cc0-4de1-ba36-18cb1d8720b2"
      unitRef="usd">20921000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:AdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTctMTUtMS0xLTEwNzg0Mg_c8c60ec4-4e1f-48a9-bfca-e790975ac0d9"
      unitRef="usd">20921000</peak:AdjustmentsOfPermanentEquityToTemporaryEquity>
    <peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTctMTctMS0xLTEwNzg0Mg_5767f36c-a163-49ce-9ccd-af02d9ce2b16"
      unitRef="usd">20921000</peak:TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity>
    <us-gaap:SharesIssued
      contextRef="id42af16b8b5e46a3a93869820b193ece_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMS0xLTEtMTA3ODQy_a79112ec-71ee-4b2c-ad79-5c39d9fb4033"
      unitRef="shares">538886000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id42af16b8b5e46a3a93869820b193ece_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMy0xLTEtMTA3ODQy_eb511060-f603-4782-b966-0d8878da340f"
      unitRef="usd">538886000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i947f359177e141dea98189810a16d2ce_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtNS0xLTEtMTA3ODQy_66c71549-8775-469e-9d81-b05c724b1254"
      unitRef="usd">10148168000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3cc4bf949eda46e39539b8c05d956da6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtNy0xLTEtMTA3ODQy_431bf685-0a9e-49be-a572-cb0fbd3a2202"
      unitRef="usd">-3994562000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i41427d8508e34a328dd1abb7637f8a9c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtOS0xLTEtMTA3ODQy_7a1809eb-6c3d-4e9e-b03c-2eecb8ca37eb"
      unitRef="usd">-3497000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64cd9f22bc634046912f6b976230977c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMTEtMS0xLTEwNzg0Mg_f96b3a22-9427-45ad-9a5a-36cf9768a3da"
      unitRef="usd">6688995000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0dcdd74b90db4a33a4202492ae24fe31_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMTMtMS0xLTEwNzg0Mg_d4d48bb9-066f-4b61-8b7c-6f86e98cd614"
      unitRef="usd">552144000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMTUtMS0xLTEwNzg0Mg_4e3d3563-1621-4f6f-bfa4-6f22dd90df7c"
      unitRef="usd">7241139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yNS9mcmFnOjJkOGNlNTA4YTQwNjQ3OTliZWFjMGZlNTFhN2ZmYjg2L3RhYmxlOmI0ZGE4YTM3YTdkMjQ4NjY4N2M3ZDIxNjQxMzEyOWI2L3RhYmxlcmFuZ2U6YjRkYThhMzdhN2QyNDg2Njg3YzdkMjE2NDEzMTI5YjZfMTgtMTctMS0xLTEwNzg0Mg_5843e7c2-f343-463c-ba6b-1155028cdfba"
      unitRef="usd">78413000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:ProfitLoss
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMy0xLTEtMS0xMDc4NDI_2dd33f12-427d-4f0e-91c6-f5774beddb28"
      unitRef="usd">75343000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMy0zLTEtMS0xMDc4NDI_15c6a7bc-cce2-4253-84c7-a8590a895579"
      unitRef="usd">149423000</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNS0xLTEtMS0xMDc4NDI_69311ca4-ca07-4fe7-81f4-7c2662109b90"
      unitRef="usd">177733000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNS0zLTEtMS0xMDc4NDI_b63e0a9d-f605-4e24-bb0f-1ba45b14f2ad"
      unitRef="usd">157538000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfOC0xLTEtMS0xMDc4NDI_fbe69de2-3065-4dc4-97d2-b9eaf4b6c2cd"
      unitRef="usd">4721000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfOC0zLTEtMS0xMDc4NDI_aaa4e7ff-9698-40b4-a2de-b9ad3a7ce39f"
      unitRef="usd">4364000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfOS0xLTEtMS0xMDc4NDI_754c13ef-45be-4da7-91c1-9804120d9359"
      unitRef="usd">2689000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfOS0zLTEtMS0xMDc4NDI_5eb8fab9-273b-4900-894e-5029dd95346f"
      unitRef="usd">2213000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:StraightLineRent
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTAtMS0xLTEtMTA3ODQy_54d79121-1996-4c92-a1ab-bfbb044ae950"
      unitRef="usd">11158000</us-gaap:StraightLineRent>
    <us-gaap:StraightLineRent
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTAtMy0xLTEtMTA3ODQy_b4cc5627-1225-4feb-a81f-42b1d87a619e"
      unitRef="usd">9135000</us-gaap:StraightLineRent>
    <peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTQtMS0xLTEtMTA3ODQy_ef895106-682f-4a71-b193-9c060a12b088"
      unitRef="usd">-24725000</peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet>
    <peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTQtMy0xLTEtMTA3ODQy_7370dc7d-5bdd-46ca-87e7-c3aada06d8e0"
      unitRef="usd">-23764000</peak:AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet>
    <peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTUtMS0xLTEtMTA3ODQy_04a8c8b6-678a-4273-954b-f1208a6c8967"
      unitRef="usd">2148000</peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations>
    <peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTUtMy0xLTEtMTA3ODQy_4ea47e03-01ed-4f0e-976e-3b5b65024adc"
      unitRef="usd">1008000</peak:IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTYtMS0xLTEtMTA3ODQy_f5f428b8-94a9-45fe-b3d1-06f1348bdaac"
      unitRef="usd">237000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTYtMy0xLTEtMTA3ODQy_d71b42c7-e3b1-4e0c-bbed-e52c3033d688"
      unitRef="usd">237000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTktMS0xLTEtMTA3ODQy_bce2fa43-a8fe-431e-b9ee-50bb14d49d1b"
      unitRef="usd">22693000</peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease>
    <peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMTktMy0xLTEtMTA3ODQy_0fd6504f-58ba-4bc2-92a9-517e9a5f52a6"
      unitRef="usd">0</peak:GainLossOnSaleOfRealEstateUnderDirectFinancingLease>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjAtMS0xLTEtMTA3ODQy_fbd2bfd5-e15a-4f53-a545-de43195ace32"
      unitRef="usd">-79000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjAtMy0xLTEtMTA3ODQy_26e9fc26-28c5-4017-8f96-ffea196ccf67"
      unitRef="usd">-1148000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:AssetImpairmentCharges
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjEtMS0xLTEtMTA3ODQy_348cbc16-5c51-4d47-af0f-23b23bde8315"
      unitRef="usd">132000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjEtMy0xLTEtMTA3ODQy_16db0035-2e05-484a-948e-ad72ea0f4968"
      unitRef="usd">3242000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjItMS0xLTEtMTA3ODQy_2c8fd331-289b-43b4-827f-b71aed19e34e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjItMy0xLTEtMTA3ODQy_143afda5-8264-432c-bb0a-4af8e58e8ed8"
      unitRef="usd">-164292000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjMtMS0xLTEtMTA3ODQy_1ba3cdf0-9567-4685-ac2d-0c9f0828989a"
      unitRef="usd">3785000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjMtMy0xLTEtMTA3ODQy_a73a88d5-1178-4d5f-bcb5-ef26d197e6d9"
      unitRef="usd">259662000</us-gaap:GainLossOnSaleOfInvestments>
    <peak:GainLossFromChangeOfControl
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjQtMS0xLTEtMTA3ODQy_a3d2480a-7ec0-484f-a90e-b203d458d3ec"
      unitRef="usd">0</peak:GainLossFromChangeOfControl>
    <peak:GainLossFromChangeOfControl
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjQtMy0xLTEtMTA3ODQy_c65e914c-ecd8-4501-9d44-9f9105b5668d"
      unitRef="usd">1042000</peak:GainLossFromChangeOfControl>
    <us-gaap:InsuredEventGainLoss
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjUtMS0xLTEtMTA3ODQy_22e03dc8-7e01-414f-87f2-b875f5486654"
      unitRef="usd">0</us-gaap:InsuredEventGainLoss>
    <us-gaap:InsuredEventGainLoss
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjUtMy0xLTEtMTA3ODQy_9abfbddb-9593-46c9-9c37-23f7ccb18765"
      unitRef="usd">-859000</us-gaap:InsuredEventGainLoss>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjktMS0xLTEtMTA3ODQy_01a94607-8391-4318-8ac3-ad36b882ae24"
      unitRef="usd">1593000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMjktMy0xLTEtMTA3ODQy_d915424e-d86c-4ba5-bf74-068ae89f4ec3"
      unitRef="usd">726000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzItMS0xLTEtMTA3ODQy_62d7a716-17ad-4486-a5a1-b0bc3e91271e"
      unitRef="usd">4144000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzItMy0xLTEtMTA3ODQy_931865c0-6f7d-4031-a7ab-edd1b70bd79e"
      unitRef="usd">-11567000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzMtMS0xLTEtMTA3ODQy_29f8b8be-d291-455a-88dc-b14d82f103d1"
      unitRef="usd">3653000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzMtMy0xLTEtMTA3ODQy_fadbeffe-8081-4b5e-a963-cb1255cd9e33"
      unitRef="usd">-74524000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzQtMS0xLTEtMTA3ODQy_a4818f6c-ec52-4b22-9aac-f6b9b05af512"
      unitRef="usd">194183000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzQtMy0xLTEtMTA3ODQy_b22b9817-0dba-4658-b4f4-1461a4d327e5"
      unitRef="usd">122726000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireOtherRealEstate
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzgtMS0xLTEtMTA3ODQy_6433bff1-b97e-4882-a88a-7b946c267a90"
      unitRef="usd">134067000</us-gaap:PaymentsToAcquireOtherRealEstate>
    <us-gaap:PaymentsToAcquireOtherRealEstate
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzgtMy0xLTEtMTA3ODQy_d0fa9c83-47c7-4a14-943f-d183f7dac36f"
      unitRef="usd">14914000</us-gaap:PaymentsToAcquireOtherRealEstate>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzktMS0xLTEtMTA3ODQy_0dca0b5e-7c2c-46d1-a4f1-7d6ab60411c0"
      unitRef="usd">178285000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfMzktMy0xLTEtMTA3ODQy_231344f9-bdc2-4d32-a246-00ec944246d0"
      unitRef="usd">135339000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDAtMS0xLTEtMTA3ODQy_99aec1ec-5abc-4736-9f3d-9f4433c33916"
      unitRef="usd">22839000</us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements>
    <us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDAtMy0xLTEtMTA3ODQy_3d73c8a9-422a-4016-84d5-3397ec25ccf3"
      unitRef="usd">20710000</us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDEtMS0xLTEtMTA3ODQy_5ab648f8-1f0a-4fc6-a185-80d984640832"
      unitRef="usd">13265000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDEtMy0xLTEtMTA3ODQy_532701ee-7608-48f2-9a2d-f63df66e8e61"
      unitRef="usd">937492000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDMtMS0xLTEtMTA3ODQy_3b16b8f7-ee93-46d9-a8f9-33c908bfe233"
      unitRef="usd">1486000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDMtMy0xLTEtMTA3ODQy_c5f8b89e-df09-405d-8d8b-ad6ea039288e"
      unitRef="usd">5924000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDQtMS0xLTEtMTA3ODQy_77150885-1cf5-4a8a-8c18-49668a0a1f2e"
      unitRef="usd">3875000</peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures>
    <peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNDQtMy0xLTEtMTA3ODQy_0ea57c5e-ae69-4952-851a-390a699ba8f3"
      unitRef="usd">10825000</peak:DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures>
    <us-gaap:ProceedsFromSaleAndCollectionOfFinanceReceivables
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTEtMS0xLTEtMTA3ODQy_10c992ef-db2b-40b4-9e9e-349364f94887"
      unitRef="usd">75435000</us-gaap:ProceedsFromSaleAndCollectionOfFinanceReceivables>
    <us-gaap:ProceedsFromSaleAndCollectionOfFinanceReceivables
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTEtMy0xLTEtMTA3ODQy_51289fd0-1eee-4d3b-80f0-228669d51618"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndCollectionOfFinanceReceivables>
    <peak:PaymentsToAcquireLoansReceivableAndOther
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTItMS0xLTEtMTA3ODQy_08e1d00b-e763-4954-9513-0ab93445a0e9"
      unitRef="usd">1860000</peak:PaymentsToAcquireLoansReceivableAndOther>
    <peak:PaymentsToAcquireLoansReceivableAndOther
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTItMy0xLTEtMTA3ODQy_7c1d7f3e-3957-45ac-b4ce-4cf39253d9c0"
      unitRef="usd">3704000</peak:PaymentsToAcquireLoansReceivableAndOther>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTUtMS0xLTEtMTA3ODQy_ce86fce0-9288-494b-99ce-279b2a6e730a"
      unitRef="usd">-245962000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTUtMy0xLTEtMTA3ODQy_43b1fd78-55ea-40eb-838c-3395b89c7eec"
      unitRef="usd">767726000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTctMS0xLTEtMTA3ODQy_f97dd620-2eda-48ac-aff0-d0b3327d135d"
      unitRef="usd">3732668000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTctMy0xLTEtMTA3ODQy_319385cd-17a2-43b1-9b55-7876a568df1b"
      unitRef="usd">3437200000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTgtMS0xLTEtMTA3ODQy_acd02861-795e-4b4b-ba03-b551da20f09e"
      unitRef="usd">3567830000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNTgtMy0xLTEtMTA3ODQy_42a3f39e-3b4d-4acc-86f4-ffbedac4dfa8"
      unitRef="usd">2528640000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjAtMS0xLTEtMTA3ODQy_70d92e05-8f59-46ae-b508-e234b217d1f8"
      unitRef="usd">1270000</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjAtMy0xLTEtMTA3ODQy_3ba3cafb-1a3b-4781-88da-77afdd261554"
      unitRef="usd">1491754000</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjYtMS0xLTEtMTA3ODQy_d684729e-1f2b-4cf3-90a5-ee8080f686e2"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjYtMy0xLTEtMTA3ODQy_83226713-2b1a-48b2-9e21-b14b7c91b56e"
      unitRef="usd">158011000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjgtMS0xLTEtMTA3ODQy_2f2a6aaf-abde-4e06-ac02-2fc25c78c359"
      unitRef="usd">-4000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjgtMy0xLTEtMTA3ODQy_d822869d-c30a-40ad-bdf6-03e1097a042a"
      unitRef="usd">1087000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjktMS0xLTEtMTA3ODQy_6dd37f47-ae73-4ea7-860f-5feb4bfff6b5"
      unitRef="usd">11352000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNjktMy0xLTEtMTA3ODQy_5738afe3-c99d-4903-8b63-ca01a04bae90"
      unitRef="usd">12165000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzAtMS0xLTEtMTA3ODQy_8a8aaa2e-fc3b-4c70-aba8-9008509907c9"
      unitRef="usd">163447000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzAtMy0xLTEtMTA3ODQy_a5ff4543-a0d1-49ff-b16b-56fcf05ecdb8"
      unitRef="usd">164118000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzItMS0xLTEtMTA3ODQy_7e7b527a-2448-4ab6-be70-4f3d61e09963"
      unitRef="usd">7509000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzItMy0xLTEtMTA3ODQy_6dc2a2e3-7c61-4cd6-a793-66d86697e6aa"
      unitRef="usd">7718000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzMtMS0xLTEtMTA3ODQy_89702e55-c10d-4c8e-9c91-05f5cefdbf2e"
      unitRef="usd">233000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzMtMy0xLTEtMTA3ODQy_893b3cdb-f582-446e-9f7e-c33b67d1b9cd"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzQtMS0xLTEtMTA3ODQy_0f11c09b-38f2-407c-adcd-b3456ee93c37"
      unitRef="usd">-18511000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzQtMy0xLTEtMTA3ODQy_74a31575-9769-40d2-a72a-5889912193c2"
      unitRef="usd">-924119000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzYtMS0xLTEtMTA3ODQy_71d26921-3ae7-4633-9aa1-bc176bd995f2"
      unitRef="usd">-70290000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzYtMy0xLTEtMTA3ODQy_d34e3dc9-6812-493b-8a4e-4c4fb6040e94"
      unitRef="usd">-33667000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzctMS0xLTEtMTA3ODQy_22c43217-e6d2-43c3-89b3-f812cc6c1cd7"
      unitRef="usd">219448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzctMy0xLTEtMTA3ODQy_e8fe33a9-b0f6-472b-aee2-7d91e32084c2"
      unitRef="usd">181685000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzgtMS0xLTEtMTA3ODQy_37f77356-199d-45aa-8e55-cd20880a21cb"
      unitRef="usd">149158000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8yOC9mcmFnOjkwNDI2ZmM3ZjkwOTQ1OTM4OGZiZGMxNTkyNmY5YjdjL3RhYmxlOmU1MWQxYjYzNWEzMDRhODZhY2M2NmYwN2Q4ZmEyNWMzL3RhYmxlcmFuZ2U6ZTUxZDFiNjM1YTMwNGE4NmFjYzY2ZjA3ZDhmYTI1YzNfNzgtMy0xLTEtMTA3ODQy_64e83a59-d67a-4290-a8c5-aeaff8c8ff62"
      unitRef="usd">148018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:NatureOfOperations
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNC9mcmFnOmM4NzVkNzM2NjFlOTQ2ZGI4OWZmMDljNTI4MzQxNWYzL3RleHRyZWdpb246Yzg3NWQ3MzY2MWU5NDZkYjg5ZmYwOWM1MjgzNDE1ZjNfMjQ4OQ_b0f1ceb9-3e88-48b8-b118-e8b8ec8fd553">Business&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Healthpeak Properties, Inc., a Standard&#160;&amp;amp; Poor&#x2019;s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (&#x201c;REIT&#x201d;) that, together with its consolidated entities (collectively, &#x201c;Healthpeak&#x201d; or the &#x201c;Company&#x201d;), invests primarily in real estate serving the healthcare industry in the United States (&#x201c;U.S.&#x201d;). Healthpeak&#xae; acquires, develops, leases, owns, and manages healthcare real estate. The Company&#x2019;s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i)&#160;life science; (ii) medical office;&#160;and (iii) continuing care retirement community (&#x201c;CCRC&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s corporate headquarters are in Denver, Colorado and it has additional offices in California, Tennessee, and Massachusetts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Covid Update&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The coronavirus (&#x201c;Covid&#x201d;) pandemic has caused significant disruption to individuals, governments, financial markets, and businesses, including the Company.&#160;The Company&#x2019;s tenants, operators, and borrowers have experienced significant cost increases as a result of increased health and safety measures, staffing shortages, increased governmental regulation and compliance, vaccine mandates, and other operational changes necessitated either directly or indirectly by the Covid pandemic. The Company evaluated the impacts of Covid on its business thus far and incorporated information concerning the impact of Covid into its assessments of liquidity, impairments, and collectibility from tenants, residents, and borrowers as of March&#160;31, 2022. The Company will continue to monitor such impacts and will adjust its estimates and assumptions based on the best available information.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NDU_7ca0f6e0-e144-4b7e-93f6-dddc67e0c287">Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#x201c;JVs&#x201d;), and variable interest entities (&#x201c;VIEs&#x201d;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#x2019;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021 filed with the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revision to Additional Paid-In Capital and Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company identified and corrected immaterial errors in the classification and redemption value of redeemable noncontrolling interests of consolidated joint ventures in its life science segment. The Company corrected the classification of its redeemable noncontrolling interests and increased the balance to its estimated redemption value, with a corresponding decrease to additional paid-in capital (&#x201c;APIC&#x201d;) in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in the unrealized value of the redeemable noncontrolling interests was largely attributable to rapidly rising rents and compressing capitalization rates in the market in which the entities operate, and was identified and corrected by management. The Company determined the impact of the adjustments to be immaterial, individually and in the aggregate, based on consideration of quantitative and qualitative factors. As such, these adjustments are reflected in this Quarterly Report on Form 10-Q for the three months ended March 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These adjustments had no impact on the Consolidated Statements of Cash Flows, Consolidated Statements of Operations, or any per share amounts. The Company made changes (all amounts in thousands) to the Consolidated Statements of Equity and Redeemable Noncontrolling Interests to decrease APIC, total stockholders&#x2019; equity, and total equity as of March 31, 2021 by $75,543 with a corresponding increase to redeemable noncontrolling interests of $78,413 and a decrease to accounts payable, accrued liabilities, and other liabilities as of March 31, 2021 of $2,870 on the Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%"&gt;Government Grant Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) to provide financial aid to individuals, businesses, and state and local governments. During the three months ended March&#160;31, 2022 and 2021, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the Covid pandemic. Grant income is recognized when there is reasonable assurance that the grant will be received and the Company will comply with all conditions attached to the grant. Additionally, grants are recognized over the periods in which the Company recognizes the increased expenses and lost revenue the grants are intended to defray. As of March&#160;31, 2022, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information related to government grant income received and recognized by the Company (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total government grants received&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company established and began executing a plan to dispose of its senior housing triple-net and Senior Housing Operating Property (&#x201c;SHOP&#x201d;) properties and concluded that the planned dispositions represented a strategic shift that had and will have a major effect on the Company&#x2019;s operations and financial results. Therefore, senior housing triple-net and SHOP assets meeting the held for sale criteria are classified as discontinued operations in all periods presented herein. In September 2021, the Company successfully completed the disposition of the remaining senior housing triple-net and SHOP properties. See Note 4 for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2021-10&#x201d;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#x2019;s accounting for assistance, and the effect of the assistance on an entity&#x2019;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#x2019;s consolidated financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-04&#x201d;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Scope &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2021-01&#x201d;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The amendments in ASU 2020-04 and ASU 2021-01 were effective immediately and may be applied through December 31, 2022. The Company is evaluating whether the optional relief provided by ASU 2020-04 or ASU 2021-01 will be adopted but does not expect the adoption of these standards to have a material impact on its consolidated financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NTQ_fd0ca1ed-2404-451e-b239-cacdd86b6de4">&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of Healthpeak Properties, Inc., its wholly-owned subsidiaries, joint ventures (&#x201c;JVs&#x201d;), and variable interest entities (&#x201c;VIEs&#x201d;) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. All adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company&#x2019;s financial position, results of operations, and cash flows have been included. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021 filed with the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib5e2b4520099480cbcf7ae7a10b2633a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMzQ0NQ_378673bc-b70c-43d9-8e79-f09ec2160d07"
      unitRef="usd">-75543000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib5e2b4520099480cbcf7ae7a10b2633a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMzYwNQ_b04858f1-d2cd-49d6-8c7c-ff4580c3ac87"
      unitRef="usd">78413000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="ib5e2b4520099480cbcf7ae7a10b2633a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMzcxNw_fe15f296-57b9-4c67-a7ba-f99f0dd6fe93"
      unitRef="usd">-2870000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <peak:GovernmentGrantIncomePolicyPolicyTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NDM_724193bf-c377-47b7-bff1-e2a892a39d56">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%"&gt;Government Grant Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) to provide financial aid to individuals, businesses, and state and local governments. During the three months ended March&#160;31, 2022 and 2021, the Company received government grants under the CARES Act primarily to cover increased expenses and lost revenue during the Covid pandemic. Grant income is recognized when there is reasonable assurance that the grant will be received and the Company will comply with all conditions attached to the grant. Additionally, grants are recognized over the periods in which the Company recognizes the increased expenses and lost revenue the grants are intended to defray. As of March&#160;31, 2022, the amount of qualifying expenditures and lost revenue exceeded grant income recognized and the Company believes it has complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts received are subject to recapture.&lt;/span&gt;&lt;/div&gt;</peak:GovernmentGrantIncomePolicyPolicyTextBlock>
    <peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NjQ_3f222e29-f06d-48f4-b230-a325836a0d0d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information related to government grant income received and recognized by the Company (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant income recorded in income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total government grants received&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock>
    <peak:GovernmentGrantIncome
      contextRef="i366e3a8a7bb7447e9f752c396f34ef65_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfMi0xLTEtMS0xMDc4NDI_498db55a-17b6-4316-afdf-78f1d39e0918"
      unitRef="usd">6552000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="ib3460b3e5b484c59b4ecbe639bdd4209_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfMi0zLTEtMS0xMDc4NDI_0c7f717c-1446-4409-bde7-3dda81333f7a"
      unitRef="usd">1310000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="iedb4d8499ffb4004a3ee3195b72c71f9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfMy0xLTEtMS0xMDc4NDI_52e47bdb-814b-45af-826f-7ef182cffa7b"
      unitRef="usd">648000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="i511cc9d57cc6454fbd2d5002ffde7b46_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfMy0zLTEtMS0xMDc4NDI_c302b1b9-bab5-4b7a-b217-6d8af243a6c6"
      unitRef="usd">426000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="ie5729311f850434baae5aecac89476bc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfNC0xLTEtMS0xMDc4NDI_a36d48ae-858c-4140-914a-d4db23765e7f"
      unitRef="usd">206000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="i6df88f30ff64438db2f6496ddd4694e7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfNC0zLTEtMS0xMDc4NDI_702d4dc9-240b-49ac-a745-3ad9364db5a1"
      unitRef="usd">3232000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="i65f4e28b0f2b4c9ca073348ac7c5830f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfNS0xLTEtMS0xMDc4NDI_ff1f98bd-bbfa-46d1-a880-41e0d2bef40a"
      unitRef="usd">7406000</peak:GovernmentGrantIncome>
    <peak:GovernmentGrantIncome
      contextRef="ib71827eba90f4c7dbd49266ebef243d8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RhYmxlOjFhZDhiNmEzZDQwMTQyNDZiNjlhYjIxMmI5ZTUyYmJmL3RhYmxlcmFuZ2U6MWFkOGI2YTNkNDAxNDI0NmI2OWFiMjEyYjllNTJiYmZfNS0zLTEtMS0xMDc4NDI_b3df4a4c-98ca-4e08-a753-c3c922630267"
      unitRef="usd">4968000</peak:GovernmentGrantIncome>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMzQwODQ4NjA0OTAxNTg_e47ddeaf-d7ff-49ad-bbf2-af82375653ef">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Housing Triple-Net and Senior Housing Operating Portfolio Dispositions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company established and began executing a plan to dispose of its senior housing triple-net and Senior Housing Operating Property (&#x201c;SHOP&#x201d;) properties and concluded that the planned dispositions represented a strategic shift that had and will have a major effect on the Company&#x2019;s operations and financial results. Therefore, senior housing triple-net and SHOP assets meeting the held for sale criteria are classified as discontinued operations in all periods presented herein. In September 2021, the Company successfully completed the disposition of the remaining senior housing triple-net and SHOP properties. See Note 4 for further information.&lt;/span&gt;&lt;/div&gt;</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF8zNy9mcmFnOmY0MWMzMzExMWIxNjRlZDU4OWQ1OWU2MGIyNzUyMDhmL3RleHRyZWdpb246ZjQxYzMzMTExYjE2NGVkNTg5ZDU5ZTYwYjI3NTIwOGZfMTA1NDA_52ad07f0-362e-4d48-8433-3819ba152141">&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2021-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2021-10&#x201d;), which increases the transparency of government assistance including the disclosure of the types of assistance, an entity&#x2019;s accounting for assistance, and the effect of the assistance on an entity&#x2019;s financial statements. The adoption of ASU 2021-10 on January 1, 2022 did not have a material impact on the Company&#x2019;s consolidated financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2020-04&#x201d;), which provides optional guidance for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. In January 2021, the FASB issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Scope &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2021-01&#x201d;), which amends the scope of ASU 2020-04 to include derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The amendments in ASU 2020-04 and ASU 2021-01 were effective immediately and may be applied through December 31, 2022. The Company is evaluating whether the optional relief provided by ASU 2020-04 or ASU 2021-01 will be adopted but does not expect the adoption of these standards to have a material impact on its consolidated financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RealEstateDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfNjM1MQ_b40cfef5-6c8e-42bc-b284-bb7a9fa49997">Real Estate Transactions&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022 Real Estate Investment Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;67 Smith Place&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, the Company closed a life science acquisition in Cambridge, Massachusetts for $72&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Vista Sorrento Phase II&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, the Company closed a life science acquisition in San Diego, California for $24&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Webster MOB Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the Company acquired a portfolio of two medical office buildings (&#x201c;MOBs&#x201d;) in Houston, Texas for $43&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021 Real Estate Investment Acquisitions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, the Company closed the following life science acquisitions: (i) eight acquisitions in Cambridge, Massachusetts for $498&#160;million, (ii) one life science acquisition in San Diego, California for $20&#160;million, and (iii) 12 acres of land for $128&#160;million in South San Francisco, California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also during 2021, the Company closed the following MOB acquisitions: (i) one MOB in Nashville, Tennessee for $13&#160;million, (ii) one MOB in Denver, Colorado for $38&#160;million, (iii) a portfolio of 14 MOBs for $371&#160;million (the &#x201c;MOB Portfolio&#x201d;), (iv) one MOB in Fort Lauderdale, Florida for $16&#160;million; (v) one MOB in Wichita, Kansas for $50&#160;million, (vi) three MOBs in Morristown, New Jersey for $155&#160;million, (vii) two MOBs in Dallas, Texas for $60&#160;million, (viii) one MOB in Seattle, Washington for $43&#160;million, (ix) one MOB in New Orleans, Louisiana for $34&#160;million, and (x) one MOB in Cambridge, Massachusetts for $55&#160;million. In conjunction with the acquisition of the MOB Portfolio, the Company originated $142&#160;million of secured mortgage debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Development Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s commitments, which are primarily related to development and redevelopment projects and tenant improvements, decreased by $52 million, to $418 million&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;at March&#160;31, 2022, when compared to December&#160;31, 2021, primarily as a result of actual spend on existing projects in the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RealEstateDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i68709d337a004bc49691880a5dff69f4_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTA5OTUxMTY0NTg4Mw_b4d2b933-e86f-483c-8229-fb5aa74994b8"
      unitRef="usd">72000000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="ibd171034fe8747f7ab9643d2e6c8c934_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTA5OTUxMTY0NTkxMA_5521f745-f545-4acf-9dbf-56542456a2bd"
      unitRef="usd">24000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="icabe4000b649414fba14f6ec77194207_D20220301-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTA5OTUxMTY0NDY5Nw_9f9d09ab-5501-4a75-80f4-6d4e64f827a2"
      unitRef="property">2</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="icabe4000b649414fba14f6ec77194207_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTA5OTUxMTY0NDcwMQ_dcc1fb15-8a04-4860-87d5-d23d75618eb8"
      unitRef="usd">43000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="id9cece3770b941ee9ae47c83081b1562_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTY0OTI2NzQ4MDcxOA_5f7e218e-608e-48a8-a02a-95400ba8b8ee"
      unitRef="property">8</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="id9cece3770b941ee9ae47c83081b1562_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUwNg_076b08bb-3ea9-46d8-9ee9-d902941cf707"
      unitRef="usd">498000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="id834faa0894c48b5b6ca7b84f1e97b10_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUxMA_277d96ef-3892-44e4-a12c-8f3b774b4d9b"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="id834faa0894c48b5b6ca7b84f1e97b10_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMTY0OTI2NzQ4MDcyMg_b477b012-e78f-4f4b-a734-9eb872feaa3a"
      unitRef="usd">20000000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:AreaOfLand
      contextRef="i157e2f27fbc8439583042a14aba3a3dd_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUxNA_bdff527f-cadc-4d03-a043-db9a8e404dcf"
      unitRef="acre">12</us-gaap:AreaOfLand>
    <us-gaap:PaymentsToAcquireLand
      contextRef="id35ffdd058d5452aadfbd3058f25fe8d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUxOA_e4c54cb1-acb6-4ecd-8d5e-682fad32039d"
      unitRef="usd">128000000</us-gaap:PaymentsToAcquireLand>
    <peak:NumberOfPropertiesAcquired
      contextRef="i0be770442a38456fa45fe909e5cf2209_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYwMw_1e420a32-1572-4efd-9768-0bc254bee44a"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i0be770442a38456fa45fe909e5cf2209_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUyMg_fff8666b-12b5-494f-81ac-88659fd1e435"
      unitRef="usd">13000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="i1e70b2253cef459da26681df951e5714_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDU4Nw_c190a197-1722-4302-8456-9daf3bc7e6bf"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i1e70b2253cef459da26681df951e5714_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDU5NQ_54962141-9f49-4f6a-9a76-f41d9164990d"
      unitRef="usd">38000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="i6ae39df20f8a4003aa9f5bfc1350f2aa_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYxMQ_28dfcfb1-5f65-460e-908a-3cdde836e01b"
      unitRef="property">14</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i6ae39df20f8a4003aa9f5bfc1350f2aa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYxOQ_1e8464f6-5996-42ee-aa98-3d07784a659d"
      unitRef="usd">371000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="i6a7d366dcb654ae3b1142ce1b04f07d8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYyNw_8ce1b9ce-4fac-453f-8876-afecfa74b0b1"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i6a7d366dcb654ae3b1142ce1b04f07d8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDYzNQ_1dccd65e-186b-4108-aa80-52c02dee3483"
      unitRef="usd">16000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="ibb3b94e67a8b43879bb61dbed6563aad_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY0Mw_ca5cc5af-00ec-4c09-b8f2-825ec4428a22"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="ibb3b94e67a8b43879bb61dbed6563aad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY1MQ_59d98ece-5acc-4b48-bbf9-11f5cb74e76b"
      unitRef="usd">50000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="iee85843b4241478fb2cc9b09850dd27d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY1OQ_eae339dc-6daf-42ef-a904-5a287ec9deee"
      unitRef="property">3</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="iee85843b4241478fb2cc9b09850dd27d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY2Nw_2e583968-7f01-48e1-845c-aa656e6dfc22"
      unitRef="usd">155000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="i0280b9f0a7bb49eb921ea3165bf8ee37_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY3NQ_262a1c29-984e-4b42-ad83-625ff619619b"
      unitRef="property">2</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i0280b9f0a7bb49eb921ea3165bf8ee37_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY4Mw_d9f32df7-0207-4fca-9601-53c35a79c113"
      unitRef="usd">60000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="i37e7dd1a3a6c46e1a92bd28eaa72af76_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY5MQ_3cc2cf95-250b-47b3-9dcb-0f3dc80c34cb"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i37e7dd1a3a6c46e1a92bd28eaa72af76_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDY5OQ_041bb50b-57f6-47ac-bc7e-89f915cef434"
      unitRef="usd">43000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="i18626c3b380148e1b0b293d23816dd72_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDcwNw_d7b5ec72-55e6-4e64-9468-7fe0443e0d72"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i18626c3b380148e1b0b293d23816dd72_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDcxNQ_7d489442-eb0d-4e82-ab7f-dc3c2ebf430e"
      unitRef="usd">34000000</us-gaap:PaymentsToAcquireRealEstate>
    <peak:NumberOfPropertiesAcquired
      contextRef="i946443381ff64eda82972caa7e61e937_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDcyMw_84c11058-ad44-4189-87fc-692cbc27d2d0"
      unitRef="property">1</peak:NumberOfPropertiesAcquired>
    <us-gaap:PaymentsToAcquireRealEstate
      contextRef="i946443381ff64eda82972caa7e61e937_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTEwODUwMg_d357de56-46c7-4445-999e-6329965d01fb"
      unitRef="usd">55000000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i498d7f8735954a6a9c9a9011ebbd9301_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfMjc0ODc3OTExMDczMQ_596c312c-6cf0-40c5-b4b1-d4c5aeb4bc09"
      unitRef="usd">142000000</us-gaap:DebtInstrumentFaceAmount>
    <peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfNTI5Ng_70433812-805f-422b-9f5b-b8218547e44a"
      unitRef="usd">-52000000</peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease>
    <peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80My9mcmFnOmE1Y2MxMDA1YmVhODQ3Y2VhMjE3YTAwMjRhYjc0MmJjL3RleHRyZWdpb246YTVjYzEwMDViZWE4NDdjZWEyMTdhMDAyNGFiNzQyYmNfNTMwMw_ab650d62-e01e-44f8-9d5f-f59417285d48"
      unitRef="usd">418000000</peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTM5NTY_95a405ee-dcfd-456b-b383-a88d5d84a712">Dispositions of Real Estate and Discontinued Operations&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022 Dispositions of Real Estate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, the Company sold one life science facility in Salt Lake City, Utah for $14&#160;million, resulting in a gain on sale of $4&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, the Company sold one MOB in San Antonio, Texas for $13&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021 Dispositions of Real Estate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sunrise Senior Housing Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company sold a portfolio of 32 SHOP assets (the &#x201c;Sunrise Senior Housing Portfolio&#x201d;) for $664&#160;million, resulting in an immaterial loss on sale, which is recognized in income (loss) from discontinued operations, and provided the buyer with: (i) financing of $410&#160;million (see Note 6) and (ii) a commitment to finance up to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$92&#160;million of additional debt for capital expenditures. The commitment to finance additional debt for capital expenditures was subsequently reduced to $56&#160;million in June 2021 and $47&#160;million in February 2022,&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.4 million of which had been funded as of March&#160;31, 2022 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(see Note 6). Upon completion of the license transfer process in June 2021, the Company sold the two remaining Sunrise senior housing triple-net assets for $80&#160;million, resulting in a gain on sale of $22&#160;million, which is recognized in income (loss) from discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Brookdale Triple-Net Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company sold 24 senior housing assets in a triple-net lease with Brookdale Senior Living Inc. for $510&#160;million, resulting in total gain on sale of $169&#160;million, which is recognized in income (loss) from discontinued operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Additional SHOP Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company sold a portfolio of 16 SHOP assets for $230&#160;million, resulting in total gain on sale of $59&#160;million, which is recognized in income (loss) from discontinued operations. The Company provided the buyer with financing of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$150&#160;million (see Note &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HRA Triple-Net Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company sold eight senior housing assets in a triple-net lease with Harbor Retirement Associates for $132&#160;million, resulting in total gain on sale of $33&#160;million, which is recognized in income (loss) from discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oakmont SHOP Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company sold a portfolio of 12 SHOP assets for $564&#160;million. In conjunction with the sale, mortgage debt held on two properties with a carrying value of $64&#160;million was repaid and the remaining mortgage debt held on four properties with a carrying value of $107&#160;million was assumed by the buyer. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resulted in total gain on sale of $80&#160;million, which is recognized in income (loss) from discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discovery SHOP Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company sold a portfolio of 10 SHOP assets for $334&#160;million, resulting in total gain on sale of $9&#160;million, which is recognized in income (loss) from discontinued operations. Also included in this transaction was the sale of two mezzanine loans and two preferred equity investments for $21&#160;million, resulting in no gain or loss on sale of the investments (collectively, the &#x201c;Discovery SHOP Portfolio&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sonata SHOP Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Compa&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ny sold a portfolio of five SHOP assets for $64&#160;million, resulting in total gain on sale of $3&#160;million, which is recognized in income (loss) from discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;SLC SHOP Portfolio&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company sold seven SHOP assets for $113&#160;million and repaid $70&#160;million of mortgage debt that was held on six of the assets, resulting in total gain on sale of $1&#160;million, which is recognized in income (loss) from discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hoag Hospital&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company sold &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;one hospital for $226&#160;million through the exercise of a purchase option by a tenant, resulting in gain on sale of $172&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Other Dispositions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the portfolio and individual sales discussed above, during the year ended December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company sold the following: (i) 15 SHOP assets for $169&#160;million, (ii) 7 senior housing triple-net assets for $24&#160;million, and (iii) 10 MOBs and a portion of 1 MOB land parcel for $68&#160;million, resulting in total gain on sales of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$58&#160;million ($39&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of which is recognized in income (loss) from discontinued operations). In conjunction with one of the SHOP asset sales, mortgage debt held on the property with a carrying value of $36&#160;million was assumed by the buyer. Of these sales, one SHOP asset was sold during the three months ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for $5&#160;million resulting in an immaterial gain on sale, which is recognized in income (loss) from discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Held for Sale and Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company established and began executing a plan to dispose of its senior housing triple-net and SHOP properties. As of December 31, 2020, the Company concluded that the planned dispositions represented a strategic shift that had and will have a major effect on the Company&#x2019;s operations and financial results. Therefore, senior housing triple-net and SHOP assets meeting the held for sale criteria are classified as discontinued operations in all periods presented herein. In September 2021, the Company successfully completed the disposition of the remaining senior housing triple-net and SHOP properties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the assets and liabilities classified as held for sale or as discontinued operations at March&#160;31, 2022 and December&#160;31, 2021, which are included in assets held for sale and discontinued operations, net and liabilities related to assets held for sale and discontinued operations, net, respectively, on the Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;ASSETS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accounts receivable, net of allowance of $4,146 and $4,138&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Right-of-use asset, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets of discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,752&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;13,416&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;21,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;23,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Assets held for sale and discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;33,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;37,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;LIABILITIES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities of discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities related to assets held for sale, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Liabilities related to assets held for sale and discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;15,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;As of March&#160;31, 2022, primarily comprised of five MOBs with net real estate assets of $20&#160;million and right-of-use asset, net of $1&#160;million. As of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021, primarily comprised of four MOBs and one life science facility with net real estate assets of $23&#160;million and right-of-use asset, net of $1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of discontinued operations during the three months ended March&#160;31, 2022 and 2021, or through the disposal date of each asset or portfolio of assets if they have been sold during such periods, as applicable, are included in the consolidated results of operations for the three months ended March&#160;31, 2022 and 2021. Summarized financial information for discontinued operations for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Rental and related revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Resident fees and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;72,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;78,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;71,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;74,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;259,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;265,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;269,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;270,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairments of Real Estate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022 and&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021, the Company did not recognize any impairment charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Losses&lt;/span&gt;&lt;/div&gt;During the three months ended March&#160;31, 2022, the Company recognized $14&#160;million of expenses within other income (expense), net on the Consolidated Statements of Operations for tenant relocation and other costs associated with a planned MOB demolition.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <peak:NumberOfPropertiesSold
      contextRef="ic6ddf70e2d074a11bf07c122fa0aa5eb_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODM4MA_8692d8a7-e836-42fa-a430-3d734c9b8318"
      unitRef="property">1</peak:NumberOfPropertiesSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="ic6ddf70e2d074a11bf07c122fa0aa5eb_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODM4NA_50a9d2b9-e9fb-4fc1-9986-426b4f182acc"
      unitRef="usd">14000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ic6ddf70e2d074a11bf07c122fa0aa5eb_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY2Njc1NA_87fa6d3f-a660-46c8-82f8-0a51b0faf9d6"
      unitRef="usd">4000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesSold
      contextRef="ib528caa7e34e44bd8bac451c88b62afb_D20220401-20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODM5Nw_9f53d12b-af49-43dc-ba1a-d9d8f270ad4c"
      unitRef="property">1</peak:NumberOfPropertiesSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="ib528caa7e34e44bd8bac451c88b62afb_D20220401-20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODQwMQ_67ffafa5-d7c9-4df9-947e-9d9ca58c9686"
      unitRef="usd">13000000</us-gaap:ProceedsFromSaleOfBuildings>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTg2_96db2da1-15f8-4c57-8bb2-d90b2786b911"
      unitRef="property">32</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjQ2_efce19ae-8de4-4b32-b282-befeb8b75b99"
      unitRef="usd">664000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:PaymentsToAcquireFinanceReceivables
      contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNDA0_3d8c263f-7a08-4dae-9e5a-970bc646cba3"
      unitRef="usd">410000000</us-gaap:PaymentsToAcquireFinanceReceivables>
    <peak:CapitalExpenditureFundingAmountCommitted
      contextRef="ifc2008e7de824d76a511c1ea5919c432_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNDYw_e493b825-c2cf-4a13-b0c6-781265bad8f8"
      unitRef="usd">92000000</peak:CapitalExpenditureFundingAmountCommitted>
    <peak:CapitalExpenditureFundingAmountCommitted
      contextRef="ifdbfd36f6f614b35837a5d8868840c17_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTY0OTI2NzQ4MjAxOA_a42b2a67-9e8c-49d3-b012-99b68bb7d6d4"
      unitRef="usd">56000000</peak:CapitalExpenditureFundingAmountCommitted>
    <peak:CapitalExpenditureFundingAmountCommitted
      contextRef="ie9fdf60d4d6e4a599a3fe3f066788531_D20220201-20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY1NDc2MQ_7a04a7ab-6399-4c7a-9a39-5d19f4b86311"
      unitRef="usd">47000000</peak:CapitalExpenditureFundingAmountCommitted>
    <peak:CapitalExpenditureFundingAmountFunded
      contextRef="ieaf70b6c82e34b11838baffaa23b60f8_D20210101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNjI0_aaff3e59-05f6-40b6-b7d0-ce902f4ffc59"
      unitRef="usd">400000</peak:CapitalExpenditureFundingAmountFunded>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i03a3a9720e7e46b9b6608a5904b366ed_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzU5_498107bf-b319-446d-bcd8-edf9cc449d1d"
      unitRef="property">2</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i03a3a9720e7e46b9b6608a5904b366ed_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfODE3_9ff53813-03ea-4510-a38d-9958b8eb93dc"
      unitRef="usd">80000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i03a3a9720e7e46b9b6608a5904b366ed_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfODUy_c981566b-c713-4514-b312-2f3229cfedde"
      unitRef="usd">22000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i7009785976254cb889191c52cf0d0cc9_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfOTg4_7b01d338-41bd-43b1-bb8d-0a8c8b8a92a3"
      unitRef="property">24</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i67a66f0a44e14e8e838fb65d4719fd54_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA1NA_492888e9-a866-49f1-870f-92ae5887657d"
      unitRef="usd">510000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i67a66f0a44e14e8e838fb65d4719fd54_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5Mw_3c9c5a06-80f0-43ce-8ae9-edda8e20a401"
      unitRef="usd">169000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesToBeSold
      contextRef="icb30aa09ba6c452ba2bd4375f636fc3e_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTIzOQ_e07087c8-9757-4a0c-a2e3-d787c9137f08"
      unitRef="property">16</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTI1OA_bb1760c4-cc8b-4327-b649-9ebd781d3460"
      unitRef="usd">230000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTI5Nw_8e6c1ab4-0788-4dbe-91f9-d314b847ff4b"
      unitRef="usd">59000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:PaymentsToAcquireFinanceReceivables
      contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTQxNw_5546f3fc-64e2-47c7-9d6b-8c57d4ce0c9b"
      unitRef="usd">150000000</us-gaap:PaymentsToAcquireFinanceReceivables>
    <peak:NumberOfPropertiesToBeSold
      contextRef="ief256427dde0496199ca30fcac9d8101_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTQ5NQ_c04daa54-5634-4b01-bd39-2b5c05de5b87"
      unitRef="property">8</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="ic6f2032fd45a433f82115899c3e766a1_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTU4MA_81163cd0-8aa7-49b1-8ed6-59c8a5f7d04d"
      unitRef="usd">132000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ic6f2032fd45a433f82115899c3e766a1_D20210201-20210228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTYxOQ_a00ea614-df26-4277-b9c2-79bc453d9515"
      unitRef="usd">33000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i50d682bf346742efab2a94c7b022bd65_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTc2MA_57dae295-1c75-41ee-9d1a-249101a4b2c2"
      unitRef="property">12</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i8726d2fcca104d9daaa243b22c892577_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTc3OQ_018d427b-24e2-42a4-9e19-f147affd6cb8"
      unitRef="usd">564000000</us-gaap:ProceedsFromSaleOfBuildings>
    <peak:NumberOfAssetsClassifiedAsDiscontinuedOperations
      contextRef="i264d0be7c9de45749d3923b0d2446af1_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTgzNQ_76fb1ab0-fde3-481b-a2e2-81d45d672699"
      unitRef="property">2</peak:NumberOfAssetsClassifiedAsDiscontinuedOperations>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i0ec4ce4170ce44a9b249e996d2135bcd_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTg3NA_cdd10966-58d2-47fd-883b-0370ce9e781e"
      unitRef="usd">64000000</us-gaap:RepaymentsOfSecuredDebt>
    <peak:DispositionOfPropertiesSoldNumber
      contextRef="i8a5d586f9aa34c6682d5b91cef0c31bf_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTkyOA_6682bc78-4500-44f5-810a-bd6c7ca4b497"
      unitRef="property">4</peak:DispositionOfPropertiesSoldNumber>
    <peak:NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer
      contextRef="ia02702389d0b4036880c2a075882418f_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTk2Nw_d616c754-a887-479d-9ed2-9cf7044d2a38"
      unitRef="usd">107000000</peak:NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i8726d2fcca104d9daaa243b22c892577_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjA0Ng_27a8882e-5e03-4880-a968-de0aa4f7acb8"
      unitRef="usd">80000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i7e3fe506d4b44da2867a8fa3226473f2_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjE4OQ_b54d32fc-09fb-4e75-a98b-1778e74b9730"
      unitRef="property">10</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="ic6a24264ae7f46a8a0b0ce1820a0cdf5_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjIwOA_76caf769-8ba5-4440-b67c-6802e62ca6d3"
      unitRef="usd">334000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ic6a24264ae7f46a8a0b0ce1820a0cdf5_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjI0Nw_ad4dcfab-2b63-47f5-8e5a-d5b16418e0e3"
      unitRef="usd">9000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:FinancingReceivableNumberOfContractsSold
      contextRef="ib18e864b0cc2475eaf0549bdbf87abc9_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjM2OA_e9f75ca5-bbb8-49b5-8f8e-7551beb7e258"
      unitRef="property">2</peak:FinancingReceivableNumberOfContractsSold>
    <peak:NumberOfPreferredEquityMethodInvestmentsSold
      contextRef="i43ed19b259424a54a9fd61eca57de24e_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjM5MQ_c8df3939-c388-42fb-855c-57a77c812776"
      unitRef="property">2</peak:NumberOfPreferredEquityMethodInvestmentsSold>
    <peak:ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment
      contextRef="ic6a24264ae7f46a8a0b0ce1820a0cdf5_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjQyNw_121ed1fb-72e4-4793-8a09-d7f240b49b50"
      unitRef="usd">21000000</peak:ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i7e3fe506d4b44da2867a8fa3226473f2_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjQ0NA_ec1162ba-4980-4a02-9d1d-a94eb00e6e01"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i84af0aa9f7c94d4f9151e3e70da8c7e8_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjYwNA_0a3f4858-5afc-442e-bff7-e4f6696fad56"
      unitRef="property">5</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="iaaf84ca8adc6410fb6b01b46e57f6e91_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjYyMw_92bda1c0-b9db-4e4e-a90d-38beea43b327"
      unitRef="usd">64000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="iaaf84ca8adc6410fb6b01b46e57f6e91_D20210401-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjY2Mg_e7b93947-eaf2-400e-8a2b-1c80c7a1a86c"
      unitRef="usd">3000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i768fb35ae40b42f3b26d76cbebeb41db_D20210501-20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjc4Mg_7771a3ab-89bf-4520-b4b6-422c298f5f51"
      unitRef="property">7</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i2086cf237ad7470ba8bb6e299b0cd6eb_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjgwMQ_24ee6437-23a8-4db6-ac95-2779261eed3c"
      unitRef="usd">113000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i768fb35ae40b42f3b26d76cbebeb41db_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjgxNQ_fe5572a2-3919-4385-afa6-b780a915d77e"
      unitRef="usd">70000000</us-gaap:RepaymentsOfSecuredDebt>
    <peak:NumberOfAssetsClassifiedAsDiscontinuedOperations
      contextRef="i84d32d33aa964419bdb8080458aa58da_I20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjg1Mg_bb7dcda7-c3e8-47bf-8237-86f197fc662f"
      unitRef="property">6</peak:NumberOfAssetsClassifiedAsDiscontinuedOperations>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i2086cf237ad7470ba8bb6e299b0cd6eb_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMjkwNQ_0ded2e39-fb43-4993-adfe-aa01c91d55e9"
      unitRef="usd">1000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i9125ba7c2f5d440aac5f4ef2ac64e4f2_D20210501-20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzAyMA_9c694c3d-af20-4178-be47-b5eb84b296e0"
      unitRef="property">1</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i9125ba7c2f5d440aac5f4ef2ac64e4f2_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzAzNg_89c1780e-f616-45b1-ad40-fcb4b27604ce"
      unitRef="usd">226000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i9125ba7c2f5d440aac5f4ef2ac64e4f2_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzEyMw_25112bb0-98a2-438d-9f5e-c8f29d36ce74"
      unitRef="usd">172000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i3210bc367c264249ac6e064f04637f2a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzcwNA_304395b3-4e96-4490-b16b-67a5caf27ca5"
      unitRef="property">15</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="iee73f2738d114cb592962cd2a4fa756e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzcyMw_583ffc06-f1be-4652-b2fa-7dfe589a54a5"
      unitRef="usd">169000000</us-gaap:ProceedsFromSaleOfBuildings>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i6b287810f73a4306ad1cedb5a7ee7ac9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzczMg_0eb6c1ed-5e7a-4488-9b15-a0dd53dc11c3"
      unitRef="property">7</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="id2cc7e487b09456dbf42b7ac9a403d3b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzc3Mg_c6fe4ed1-174c-475f-89ea-8e26f5222df5"
      unitRef="usd">24000000</us-gaap:ProceedsFromSaleOfBuildings>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i84e02dec09e34ee98740b651f1f10e6b_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzc4Ng_026f7b95-4ba6-4e8e-a41e-c9c58976ada3"
      unitRef="property">10</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i84e02dec09e34ee98740b651f1f10e6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzc5OA_d81eb716-bc15-4c8b-bc73-1058264c4d58"
      unitRef="usd">68000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i0f3f388a745246ca875dc4aaac6cfe06_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzgzOA_da88f7fa-8d13-48c1-92db-b272625dbdea"
      unitRef="usd">58000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ia1d24420f1c64c1f9b059b4ead94f57e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMzg0Mg_5efb32a3-24af-4766-bb8f-585695852918"
      unitRef="usd">39000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:DispositionOfPropertiesSoldNumber
      contextRef="i45a55cc9f4374e7b973af8776b4c27d8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODgwNQ_5364748f-13aa-4015-91cb-d9db6170b940"
      unitRef="property">1</peak:DispositionOfPropertiesSoldNumber>
    <peak:NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer
      contextRef="i0c32446c755a4541aa55ba32256a090f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0ODg5NA_47956e71-c972-4eb8-aee3-4738fdd40bf9"
      unitRef="usd">36000000</peak:NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i19869f9aece14496a725bc23236ab8e6_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY3Mzc2OA_e64c358c-bb91-4fad-8e0a-95c22e2585b3"
      unitRef="property">1</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i19869f9aece14496a725bc23236ab8e6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY3Mzc4Nw_1ea26b5c-e35a-4c45-bd42-c8dd488692fd"
      unitRef="usd">5000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTM5NTc_8741e2ee-d830-4347-988e-be6c9828c267">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the assets and liabilities classified as held for sale or as discontinued operations at March&#160;31, 2022 and December&#160;31, 2021, which are included in assets held for sale and discontinued operations, net and liabilities related to assets held for sale and discontinued operations, net, respectively, on the Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;ASSETS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accounts receivable, net of allowance of $4,146 and $4,138&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Right-of-use asset, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets of discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;12,752&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;13,416&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;21,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;23,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Assets held for sale and discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;33,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;37,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;LIABILITIES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities of discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities related to assets held for sale, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Liabilities related to assets held for sale and discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;14,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;15,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;As of March&#160;31, 2022, primarily comprised of five MOBs with net real estate assets of $20&#160;million and right-of-use asset, net of $1&#160;million. As of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021, primarily comprised of four MOBs and one life science facility with net real estate assets of $23&#160;million and right-of-use asset, net of $1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of discontinued operations during the three months ended March&#160;31, 2022 and 2021, or through the disposal date of each asset or portfolio of assets if they have been sold during such periods, as applicable, are included in the consolidated results of operations for the three months ended March&#160;31, 2022 and 2021. Summarized financial information for discontinued operations for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Rental and related revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Resident fees and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;72,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;78,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;71,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;74,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Other income (expense):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;259,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Total other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;265,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;269,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:11.25pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;270,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <peak:DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfOS0wLTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjowNzE2ZDRhNDY2YTE0MDgzYmRlM2Y1YWQzMmI5MzA3MF80NQ_a966e744-4f25-4357-824d-a415191eca73"
      unitRef="usd">4146000</peak:DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable>
    <peak:DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfOS0wLTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjowNzE2ZDRhNDY2YTE0MDgzYmRlM2Y1YWQzMmI5MzA3MF81Mg_64a0006a-c648-475a-8b0b-1aa6492d1954"
      unitRef="usd">4138000</peak:DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable>
    <peak:DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfOS0xLTEtMS0xMDc4NDI_047b96a9-24a7-4035-ab6c-1b9e9d4fae39"
      unitRef="usd">2764000</peak:DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet>
    <peak:DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfOS0zLTEtMS0xMDc4NDI_7ef3148c-248a-49bd-a11b-84449d8953e3"
      unitRef="usd">2446000</peak:DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTAtMS0xLTEtMTA3ODQy_0ea00685-2b2b-40da-810c-7a8e5e1b2448"
      unitRef="usd">7989000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTAtMy0xLTEtMTA3ODQy_4eb8d2a1-2ae2-426e-be99-1c0c521c035a"
      unitRef="usd">7707000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTMtMS0xLTEtMTA3ODQy_7d5c748b-b29f-4166-800c-61cef7728f6f"
      unitRef="usd">23000</peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset>
    <peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTMtMy0xLTEtMTA3ODQy_274e8ccb-083d-4d18-a912-63eaebb26423"
      unitRef="usd">26000</peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTQtMS0xLTEtMTA3ODQy_e321b05b-ddb2-45c6-9ee3-e6f487e31d75"
      unitRef="usd">1976000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTQtMy0xLTEtMTA3ODQy_c158f1ce-3295-4158-bc7f-33800084dda1"
      unitRef="usd">3237000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTUtMS0xLTEtMTA3ODQy_2366b4b3-ae23-4c22-82ad-376855e0e5fc"
      unitRef="usd">12752000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTUtMy0xLTEtMTA3ODQy_e2912c90-7f01-484e-8dc2-f8ddaba65d63"
      unitRef="usd">13416000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTYtMS0xLTEtMTA3ODQy_40ee9c5c-5c66-48b3-b25a-87657457d604"
      unitRef="usd">21060000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTYtMy0xLTEtMTA3ODQy_5a470353-20fa-4266-a243-bb9ddbb6d7b3"
      unitRef="usd">23774000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroup>
    <peak:AssetsHeldForSaleAndDiscontinuedOperationsNet
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTctMS0xLTEtMTA3ODQy_96eafec2-9ffe-45be-adcd-ede80a87b928"
      unitRef="usd">33812000</peak:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <peak:AssetsHeldForSaleAndDiscontinuedOperationsNet
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMTctMy0xLTEtMTA3ODQy_655529d8-9dfd-42f1-855e-8f6fc067d3b7"
      unitRef="usd">37190000</peak:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjAtMS0xLTEtMTA3ODQy_4ddc8515-38c6-4e94-b72b-9964f58048ed"
      unitRef="usd">23000</peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability>
    <peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjAtMy0xLTEtMTA3ODQy_ff8cfb93-9067-4cfc-ae90-3a956d57ac26"
      unitRef="usd">26000</peak:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjEtMS0xLTEtMTA3ODQy_7118a09e-d209-4793-9b64-9e8395d06926"
      unitRef="usd">14072000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjEtMy0xLTEtMTA3ODQy_d6ed2d88-88bb-4707-8574-0a5c196b67f3"
      unitRef="usd">14843000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjItMS0xLTEtMTA3ODQy_f570e9da-43f1-4a26-a675-a40883f57d94"
      unitRef="usd">139000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjItMy0xLTEtMTA3ODQy_bafae696-09cf-429b-b5fe-b89acf7b66c2"
      unitRef="usd">92000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjMtMS0xLTEtMTA3ODQy_327d2f73-d0e4-43c5-ba31-5afefa61575b"
      unitRef="usd">14234000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjMtMy0xLTEtMTA3ODQy_99e7461f-e990-478f-9071-9b8b1623f32a"
      unitRef="usd">14961000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjQtMS0xLTEtMTA3ODQy_6367970d-da11-47ef-bc84-040c64569914"
      unitRef="usd">84000</us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale>
    <us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjQtMy0xLTEtMTA3ODQy_babc681d-d2f3-4ecc-88d0-34c398612a3f"
      unitRef="usd">95000</us-gaap:RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale>
    <peak:LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjUtMS0xLTEtMTA3ODQy_9f8d6388-500b-4e6e-8131-4e11a073ad55"
      unitRef="usd">14318000</peak:LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet>
    <peak:LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjllOTIwNzk5OTMxYzQ2OTFhYzY3OTg5NzFmMThlNmY0L3RhYmxlcmFuZ2U6OWU5MjA3OTk5MzFjNDY5MWFjNjc5ODk3MWYxOGU2ZjRfMjUtMy0xLTEtMTA3ODQy_af959f02-ef41-4c5a-80b2-f69fcc227b93"
      unitRef="usd">15056000</peak:LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet>
    <peak:PropertiesHeldForSaleNumber
      contextRef="i1569210fb45b498ca4ddd9523c7ddcb6_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzY2NQ_9e9424d3-5c4b-4735-8bd7-68ff95ff6d04"
      unitRef="property">5</peak:PropertiesHeldForSaleNumber>
    <peak:NetRealEstateAssets
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzczMw_b4ddf634-fbdd-4d04-9661-95fac2e7e179"
      unitRef="usd">20000000</peak:NetRealEstateAssets>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i902208c44cb84f8abe9e3fa90efb8d36_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzc2Nw_340a449c-a257-4065-8c4e-484271aa539d"
      unitRef="usd">1000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <peak:PropertiesHeldForSaleNumber
      contextRef="i56ab9d8a9a964a9c9b0142d3248692e9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzg2Ng_f6e1133d-eba1-4c8a-982b-d9e219f2e4c7"
      unitRef="property">4</peak:PropertiesHeldForSaleNumber>
    <peak:PropertiesHeldForSaleNumber
      contextRef="i8a389db75eb34b51821f969f46a2eb96_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0OTE4NA_ee38f51f-07aa-4dca-a61d-f65cc2b357cb"
      unitRef="property">1</peak:PropertiesHeldForSaleNumber>
    <peak:NetRealEstateAssets
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzkwNQ_6f900058-957d-46b8-850b-cb0a104bc672"
      unitRef="usd">23000000</peak:NetRealEstateAssets>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9bcca4d42b524e539e9a37568b990d49_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfNzkzMg_303b377c-3077-4b67-ac7f-313401a01e25"
      unitRef="usd">1000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRentalIncome
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMy0xLTEtMS0xMDc4NDI_5f3eab05-fa62-4c87-a28d-eccaeb3dce40"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRentalIncome>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRentalIncome
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMy0zLTEtMS0xMDc4NDI_6a38d35f-0d7c-4e9d-87bb-5ca2471ac7bc"
      unitRef="usd">5228000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRentalIncome>
    <peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfNC0xLTEtMS0xMDc4NDI_6488cc78-28f8-4c50-9c36-d6cfc09eb2ee"
      unitRef="usd">2655000</peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices>
    <peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfNC0zLTEtMS0xMDc4NDI_e4750831-25f7-40ac-88ff-b3d5f0c518d7"
      unitRef="usd">72998000</peak:DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfNi0xLTEtMS0xMDc4NDI_1ff9cb1f-acf4-4be6-8965-03d9e23589e3"
      unitRef="usd">2655000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfNi0zLTEtMS0xMDc4NDI_2bdf9112-c998-43c4-9d0d-8e2094bb54b1"
      unitRef="usd">78226000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfOC0xLTEtMS0xMDc4NDI_ced2c001-0982-4578-8aad-1151170921cd"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfOC0zLTEtMS0xMDc4NDI_bba85852-8be5-434b-8816-cfc3417f7610"
      unitRef="usd">2676000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTAtMS0xLTEtMTA3ODQy_b63ab16a-efc1-41b1-8d68-19082d666d77"
      unitRef="usd">2674000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTAtMy0xLTEtMTA3ODQy_c3d87498-ac4d-40e9-a916-d787b2584978"
      unitRef="usd">71519000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <peak:DisposalGroupIncludingDiscontinuedOperationTransactionCosts
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTEtMS0xLTEtMTA3ODQy_8acb986b-375f-4b0e-a704-81f72dc0cc42"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationTransactionCosts>
    <peak:DisposalGroupIncludingDiscontinuedOperationTransactionCosts
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTEtMy0xLTEtMTA3ODQy_c3de9b1c-7960-40ae-9d6e-941c3d30427f"
      unitRef="usd">76000</peak:DisposalGroupIncludingDiscontinuedOperationTransactionCosts>
    <peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTMtMS0xLTEtMTA3ODQy_da699e5f-b2ef-4afa-b617-c1a6e7385918"
      unitRef="usd">2674000</peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses>
    <peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTMtMy0xLTEtMTA3ODQy_46634df9-ffb1-4cc6-9d20-a4d5a010092e"
      unitRef="usd">74271000</peak:DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTUtMS0xLTEtMTA3ODQy_79fe3d93-38f3-4796-94dc-fd1bc4f68bb7"
      unitRef="usd">-71000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTUtMy0xLTEtMTA3ODQy_9d72b265-842f-4019-9bde-924de224a929"
      unitRef="usd">259662000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <peak:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTYtMS0xLTEtMTA3ODQy_a1cecfc3-a121-450f-b299-c0b0701903fc"
      unitRef="usd">3000</peak:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet>
    <peak:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTYtMy0xLTEtMTA3ODQy_132077fb-c0ca-4f36-a5d9-1b4e49dcae78"
      unitRef="usd">5885000</peak:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet>
    <peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTctMS0xLTEtMTA3ODQy_4aecf6ab-aeac-45d7-8372-9704cba3e450"
      unitRef="usd">-68000</peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense>
    <peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTctMy0xLTEtMTA3ODQy_06c48986-3d31-4d95-bcf9-5f961ec95204"
      unitRef="usd">265547000</peak:DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTgtMS0xLTEtMTA3ODQy_e8cc4b3c-3605-4020-bb6a-cc8d66ee46e1"
      unitRef="usd">-87000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTgtMy0xLTEtMTA3ODQy_f907a0de-1f85-4705-beb9-dfff8a34b69d"
      unitRef="usd">269502000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTktMS0xLTEtMTA3ODQy_4058a5c1-f4fd-4f9e-ae2b-398711f446ee"
      unitRef="usd">-340000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMTktMy0xLTEtMTA3ODQy_03dc0d9a-18a7-4888-9895-51ef6da3d7bd"
      unitRef="usd">-821000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMjAtMS0xLTEtMTA3ODQy_c2a49c78-b52b-4681-a3ae-71b1a355c599"
      unitRef="usd">64000</peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMjAtMy0xLTEtMTA3ODQy_9074b16a-8f18-4cc1-ad37-860979c719e9"
      unitRef="usd">-315000</peak:DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="id50f8338c88249ecb8e1064283870f4f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMjItMS0xLTEtMTA3ODQy_685e0cc8-683e-4fc0-984f-50d0cb06d823"
      unitRef="usd">317000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="i83a139f93f554829a81fdb0d2878d522_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RhYmxlOjE4NTI4YTFiOTg5MjQ0NDg5ZDc4OGMxMjc0NjcyYmIyL3RhYmxlcmFuZ2U6MTg1MjhhMWI5ODkyNDQ0ODlkNzg4YzEyNzQ2NzJiYjJfMjItMy0xLTEtMTA3ODQy_130b9f21-9158-4d61-a146-f851fb7caf0e"
      unitRef="usd">270008000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:ImpairmentOfRealEstate
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0OTkwNw_094278f1-4318-4493-80a8-bdf3e1e2f7f4"
      unitRef="usd">0</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:ImpairmentOfRealEstate
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY0OTkwNw_ec057448-e578-4fad-a17d-7e8534effe21"
      unitRef="usd">0</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:OtherNonrecurringExpense
      contextRef="icdbce058783d4ada87cc4191afef5777_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80Ni9mcmFnOjdiMmRhM2ViNzM2YTRmOWY4MjNjZWY5ZjAzYThkYmJiL3RleHRyZWdpb246N2IyZGEzZWI3MzZhNGY5ZjgyM2NlZjlmMDNhOGRiYmJfMTA5OTUxMTY2OTczNA_dfedf7a0-1595-4474-bc1b-9dd3d0fba889"
      unitRef="usd">14000000</us-gaap:OtherNonrecurringExpense>
    <us-gaap:OperatingLeasesOfLessorDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTQzOA_c4509fc7-875d-456c-9e8d-c0cd8721371d">Leases &lt;div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s lease income, excluding discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income from direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Direct Financing Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Direct Financing Lease Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company sold its remaining hospital classified as a direct financing lease (&#x201c;DFL&#x201d;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment in DFLs consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of estimated residual value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less deferred selling profits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Direct Financing Lease Internal Ratings&lt;/span&gt;&lt;/div&gt;At March&#160;31, 2022, the Company had no properties classified as a DFL. At December&#160;31, 2021, the Company had one hospital classified as a DFL with a carrying amount of $45&#160;million and an internal rating of &#x201c;performing&#x201d;.</us-gaap:OperatingLeasesOfLessorDisclosureTextBlock>
    <us-gaap:LessorDirectFinancingLeasesTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTQ1Mg_d323f71d-f0d5-4537-b895-bc436c05a228">Leases &lt;div style="margin-bottom:6pt;margin-top:1pt;padding-left:54pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s lease income, excluding discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income from direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Direct Financing Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Direct Financing Lease Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company sold its remaining hospital classified as a direct financing lease (&#x201c;DFL&#x201d;) for $68 million and recognized a gain on sale of $23 million, which is included in other income (expense), net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment in DFLs consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of estimated residual value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less deferred selling profits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Direct Financing Lease Internal Ratings&lt;/span&gt;&lt;/div&gt;At March&#160;31, 2022, the Company had no properties classified as a DFL. At December&#160;31, 2021, the Company had one hospital classified as a DFL with a carrying amount of $45&#160;million and an internal rating of &#x201c;performing&#x201d;.</us-gaap:LessorDirectFinancingLeasesTextBlock>
    <us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTQzNw_f8149768-7741-429d-a421-1325e8574a31">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s lease income, excluding discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable income from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income from direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNS0xLTEtMS0xMDc4NDI_86dd7e22-f327-4d8d-bb13-21257994efe1"
      unitRef="usd">287292000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNS0zLTEtMS0xMDc4NDI_ea492410-7ca0-40a2-931a-2802979a37b7"
      unitRef="usd">262937000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseVariableLeaseIncome
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNi0xLTEtMS0xMDc4NDI_a9ec9d6a-f732-48a6-9337-f7f947fb7ac4"
      unitRef="usd">82858000</us-gaap:OperatingLeaseVariableLeaseIncome>
    <us-gaap:OperatingLeaseVariableLeaseIncome
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNi0zLTEtMS0xMDc4NDI_7fa425da-a0f2-45dc-8e4c-42070882e94f"
      unitRef="usd">65035000</us-gaap:OperatingLeaseVariableLeaseIncome>
    <us-gaap:DirectFinancingLeaseInterestIncome
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNy0xLTEtMS0xMDc4NDI_a964849e-c3d7-417f-ba2f-b91875cd759f"
      unitRef="usd">1168000</us-gaap:DirectFinancingLeaseInterestIncome>
    <us-gaap:DirectFinancingLeaseInterestIncome
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRjMGY4ZmI0YjA0NzRmZTdhMWNlYTZjMmFkOGNiMTU4L3RhYmxlcmFuZ2U6NGMwZjhmYjRiMDQ3NGZlN2ExY2VhNmMyYWQ4Y2IxNThfNy0zLTEtMS0xMDc4NDI_e2b9bf51-e672-4aef-9129-717a6e87d1cc"
      unitRef="usd">2163000</us-gaap:DirectFinancingLeaseInterestIncome>
    <us-gaap:ProceedsFromSaleOfLeaseReceivables
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTA5OTUxMTYzMDI1MQ_233cc321-688c-4259-a649-51dd5196fbe3"
      unitRef="usd">68000000</us-gaap:ProceedsFromSaleOfLeaseReceivables>
    <us-gaap:GainLossOnSaleOfNotesReceivable
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTA5OTUxMTYzMDI4OQ_5f20dddb-7b81-4315-8641-ed62e75ac5aa"
      unitRef="usd">23000000</us-gaap:GainLossOnSaleOfNotesReceivable>
    <peak:ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTQ0OQ_38f82d48-d378-46c1-a094-5084a00ca84a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment in DFLs consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of estimated residual value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less deferred selling profits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in direct financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</peak:ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock>
    <us-gaap:DirectFinancingLeaseLeaseReceivable
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMS0xLTEtMS0xMDc4NDI_0e4c30a8-2f4b-4aad-a333-bf679862e55b"
      unitRef="usd">0</us-gaap:DirectFinancingLeaseLeaseReceivable>
    <us-gaap:DirectFinancingLeaseLeaseReceivable
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMS0zLTEtMS0xMDc4NDI_68474422-922e-430e-8a2c-8237157a0d35"
      unitRef="usd">1220000</us-gaap:DirectFinancingLeaseLeaseReceivable>
    <us-gaap:DirectFinancingLeaseUnguaranteedResidualAsset
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMi0xLTEtMS0xMDc4NDI_57e2a71f-e732-43b3-a99c-805a257ba1a1"
      unitRef="usd">0</us-gaap:DirectFinancingLeaseUnguaranteedResidualAsset>
    <us-gaap:DirectFinancingLeaseUnguaranteedResidualAsset
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMi0zLTEtMS0xMDc4NDI_965c266c-57b4-4e70-888d-44f1b930492a"
      unitRef="usd">44706000</us-gaap:DirectFinancingLeaseUnguaranteedResidualAsset>
    <us-gaap:DirectFinancingLeaseDeferredSellingProfit
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMy0xLTEtMS0xMDc4NDI_2e37efad-7c77-4dae-8afe-8240cafe22e2"
      unitRef="usd">0</us-gaap:DirectFinancingLeaseDeferredSellingProfit>
    <us-gaap:DirectFinancingLeaseDeferredSellingProfit
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfMy0zLTEtMS0xMDc4NDI_de2af938-8bf7-4b4b-8668-7cdd29f50db5"
      unitRef="usd">1220000</us-gaap:DirectFinancingLeaseDeferredSellingProfit>
    <us-gaap:DirectFinancingLeaseNetInvestmentInLease
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfNi0xLTEtMS0xMDc4NDI_1c927c71-3ff4-42db-86fa-44040998009a"
      unitRef="usd">0</us-gaap:DirectFinancingLeaseNetInvestmentInLease>
    <us-gaap:DirectFinancingLeaseNetInvestmentInLease
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RhYmxlOjRlYTQzZDI5ODdlMDRiNWFiNWU5ZTA5YTcxODZkZDJiL3RhYmxlcmFuZ2U6NGVhNDNkMjk4N2UwNGI1YWI1ZTllMDlhNzE4NmRkMmJfNi0zLTEtMS0xMDc4NDI_1a43a010-0acf-4ccb-ac15-5ec75c367581"
      unitRef="usd">44706000</us-gaap:DirectFinancingLeaseNetInvestmentInLease>
    <peak:PropertiesWithDirectFinancingLeasesNumber
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMTA5OTUxMTYzMjE2MA_3640bc59-85ff-45a0-873d-d126e316b608"
      unitRef="property">0</peak:PropertiesWithDirectFinancingLeasesNumber>
    <peak:PropertiesWithDirectFinancingLeasesNumber
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMzEw_76e79dcc-0ca2-4bd8-be86-f7c57a92b262"
      unitRef="property">1</peak:PropertiesWithDirectFinancingLeasesNumber>
    <us-gaap:DirectFinancingLeaseNetInvestmentInLease
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF80OS9mcmFnOjY5ODczMThmNTUyZTQ4MGY5ZTRmMDE5MzI5OGU0N2Q4L3RleHRyZWdpb246Njk4NzMxOGY1NTJlNDgwZjllNGYwMTkzMjk4ZTQ3ZDhfMzQwODQ4NjA0NjU2MjA_21a7ea50-ded2-4361-a4f2-03358ca6d73c"
      unitRef="usd">45000000</us-gaap:DirectFinancingLeaseNetInvestmentInLease>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTAwNjk_fd8a7515-61e7-46af-ab42-52ebc00bc95d">Loans Receivable&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s loans receivable (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Secured loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mezzanine and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discounts, fees, and costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;At March&#160;31, 2022, the Company had $49 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects. At December&#160;31, 2021, the Company had $58 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;SHOP Seller Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the sale of 32 SHOP facilities in the Sunrise Senior Housing Portfolio for $664&#160;million in January 2021 (see Note 4), the Company provided the buyer with initial financing of $410&#160;million. The remainder of the sales price was received in cash at the time of sale. Additionally, the Company agreed to provide up to $92&#160;million of additional financing for capital expenditures (up to 65% of the estimated cost of capital expenditures). The additional financing was subsequently reduced to $56&#160;million in June 2021 and $47&#160;million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in February 2022 in conjunction with the principal repayments discussed below.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through March&#160;31, 2022, $0.4 million of the additional financing had been funded. The initial and additional financing is secured by the buyer's equity ownership in each property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company received principal repayments of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$246&#160;million on the initial financing provided in conjunction with the sale of the Sunrise Senior Housing Portfolio. Additionally, in February 2022, the Company received principal repayments of $8&#160;million in conjunction with the disposition of the underlying collateral. As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2022 and December&#160;31, 2021, this secured loan had an outstanding balance of $157&#160;million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $165&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the sale of 16 additional SHOP facilities for $230&#160;million in January 2021 (see Note 4), the Company provided the buyer with financing of $150&#160;million. The remainder of the sales price was received in cash at the time of sale. The financing is secured by the buyer's equity ownership in each property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, the Company reduced the consideration and reported gain on sales of real estate and recognized a mark-to-market discount of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$16&#160;million for certain transactions with seller financing. The Company&#x2019;s discount is based on the difference between the stated interest rates (ranging from 3.50% to 4.50%) and corresponding prevailing market rates of approximately 5.25% as of the transaction dates.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The discount is recognized as interest income over the term of the discounted loans (ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjYyOQ_aeb0d2ee-ccfb-4404-9b1a-c227b91e018e"&gt;one&lt;/span&gt; to three years) using the effective interest rate method. During the three months ended March&#160;31, 2022 and 2021, the Company recognized $1&#160;million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $2&#160;million, respectively, of non-cash interest income related to the amortization of its mark-to-market discounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Other Loans Receivable Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies a loan receivable as held for sale when management no longer has the intent or ability to hold the loan receivable for the foreseeable future or until maturity. If a loan receivable is classified as held for sale, previously recorded reserves for loan losses are reversed and the loan is reported at the lower of amortized cost or fair value. During the second quarter of 2021, two loans receivable with a total amortized cost of $64&#160;million were classified as held for sale. Upon the transfer of these two loans to held for sale, the carrying value was decreased by $11&#160;million to an estimated fair value of $53&#160;million, $8&#160;million of which was previously recognized as a reserve for loan losses. In 2021, the Company sold these two loans receivable previously classified as held for sale for their aggregate carrying value of $53&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These fair value estimates were made for each individual loan classified as held for sale and primarily relied on a market approach, utilizing comparable market transactions, forecasted sales prices, and negotiations with prospective buyers. These estimates are considered to be a Level 3 measurement within the fair value hierarchy, and are subject to inherent uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, in April 2021, the Company sold two mezzanine loans as part of the Discovery SHOP Portfolio disposition (see Note 4), &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resulting in no gain or loss on sale of the mezzanine loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company received a $10&#160;million principal repayment related to one of its secured loans. In September 2021, the Company received repayment of the remaining $15&#160;million balance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company received full repayment of the outstanding balance of an $8&#160;million secured loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CCRC Resident Loans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For certain residents that qualify, CCRCs may offer to lend residents the necessary funds to satisfy the entrance fee requirements so that they are able to move into a community while still continuing the process of selling their previous home. The loans are due upon sale of the previous residence. At March&#160;31, 2022 and December&#160;31, 2021, the Company held&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$25 million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $24&#160;million, respectively, of such notes receivable, which are included in mezzanine and other in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loans Receivable Internal Ratings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s quarterly review process or upon the occurrence of a significant event, loans receivable are reviewed and assigned an internal rating of Performing, Watch List, or Workout. Loans that are deemed Performing meet all present contractual obligations, and collection and timing of all amounts owed is reasonably assured. Watch List Loans are defined as loans that do not meet the definition of Performing or Workout. Workout Loans are defined as loans in which the Company has determined, based on current information and events, that: (i) it is probable it will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the borrower is delinquent on making payments under the contractual terms of the agreement, and (iii) the Company has commenced action or anticipates pursuing action in the near term to seek recovery of its investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes, by year of origination, the Company&#x2019;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investment Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performing loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Watch list loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workout loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mezzanine and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performing loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Watch list loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workout loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total mezzanine and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserve for Loan Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#x2019;s evaluation considers industry and economic conditions, individual and portfolio property performance, credit enhancements, liquidity, and other factors. The determination of loan losses also considers concentration of credit risk associated with the senior housing industry to which its loans receivable relate. The Company&#x2019;s borrowers furnish property, portfolio, and guarantor/operator-level financial statements, among other information, on a monthly or quarterly basis, which the Company utilizes to calculate the debt service coverages used in its assessment of internal ratings, which is a primary credit quality indicator. Debt service coverage information is evaluated together with other property, portfolio, and operator performance information, including revenue, expense, NOI, occupancy, rental rates, capital expenditures, and EBITDA (defined as earnings before interest, tax, and depreciation and amortization), along with other liquidity measures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In its assessment of current expected credit losses for loans receivable and unfunded loan commitments, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each loan to estimate a probability of default and a resulting loss for each loan receivable. Future economic conditions are based primarily on near-term economic forecasts from the Federal Reserve and reasonable assumptions for long-term economic trends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s reserve for loan losses (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Secured Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mezzanine and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Secured Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mezzanine and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for expected loan losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected loan losses related to loans sold or repaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes six loans sold or repaid during the year ended December&#160;31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, at each of March&#160;31, 2022 and December&#160;31, 2021, a liability of $0.3 million related to expected credit losses for unfunded loan commitments was included in accounts payable, accrued liabilities, and other liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTAwNTg_29287b30-dfc8-4651-8315-1e5db037bdc7">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s loans receivable (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Secured loans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mezzanine and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discounts, fees, and costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;At March&#160;31, 2022, the Company had $49 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects. At December&#160;31, 2021, the Company had $58 million remaining of commitments to fund additional loans for senior housing redevelopment and capital expenditure projects.&lt;/span&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ife4353c6ea944e2cb45a86e8adbf210f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMS0xLTEtMS0xMDc4NDI_a9cc7b72-cbea-4686-bdae-93198abb2fcf"
      unitRef="usd">388746000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="icadee8ad9d5d4a2ca975702b7fe2f6ed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMS0zLTEtMS0xMDc4NDI_643545d1-d403-4a24-8b05-b0241933e2e1"
      unitRef="usd">396281000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i5761108dca5e417ab51b1f7ea8aa2e7f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMi0xLTEtMS0xMDc4NDI_9e30f96b-6c9f-4261-bb8e-adb7ebd34ef1"
      unitRef="usd">26252000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i37ae13c73e634e68b31c4c1cdc3d0d7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMi0zLTEtMS0xMDc4NDI_c23a32ec-707d-441c-a058-23a3eb910c16"
      unitRef="usd">25529000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMy0xLTEtMS0xMDc4NDI_c38f65b1-0e53-4036-8592-adeb78c110d5"
      unitRef="usd">-3301000</us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount>
    <us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfMy0zLTEtMS0xMDc4NDI_ea10ae80-988b-4131-beac-65d594696c25"
      unitRef="usd">-4186000</us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfNC0xLTEtMS0xMDc4NDI_0c62874f-e7f4-4bc1-8512-17463740bd58"
      unitRef="usd">1944000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfNC0zLTEtMS0xMDc4NDI_748ad4f3-a958-4767-9490-f90288e7ba7b"
      unitRef="usd">1813000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfNS0xLTEtMS0xMDc4NDI_e69b1454-e404-4055-a2ac-d986ad82c9e1"
      unitRef="usd">409753000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOjgzZTA2YzI3NjVjZDQzNjA4NjcxZmVmMWFlOGY0MGJmL3RhYmxlcmFuZ2U6ODNlMDZjMjc2NWNkNDM2MDg2NzFmZWYxYWU4ZjQwYmZfNS0zLTEtMS0xMDc4NDI_411b0934-62c1-45c3-ae0a-f28a970f6d93"
      unitRef="usd">415811000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <peak:FinancingReceivableRemainingCommitments
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTc4_7a987b5d-643f-4922-b932-4759726c2dba"
      unitRef="usd">49000000</peak:FinancingReceivableRemainingCommitments>
    <peak:FinancingReceivableRemainingCommitments
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzAw_f76e5412-993a-4d95-902e-9f25c95afd87"
      unitRef="usd">58000000</peak:FinancingReceivableRemainingCommitments>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDU0_0cbc9101-da1f-4e13-97f6-5a0f5db4b539"
      unitRef="property">32</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i489bbf17569c4c14b003c877f71855ad_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNTE3_7c01807f-6431-4fd0-93ea-1266db7cded2"
      unitRef="usd">664000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifc2008e7de824d76a511c1ea5919c432_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNjA4_eeb05023-eb21-4abe-94cd-10ee87c155f4"
      unitRef="usd">410000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <peak:CapitalExpenditureFundingAmountCommitted
      contextRef="ifc2008e7de824d76a511c1ea5919c432_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNzM3_e493b825-c2cf-4a13-b0c6-781265bad8f8"
      unitRef="usd">92000000</peak:CapitalExpenditureFundingAmountCommitted>
    <peak:CapitalExpenditureFundingCostOfCapitalPercentCommitted
      contextRef="i23d980d9806942e0886bf4d30eb148c5_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNzk2_6bd7dd1d-26a0-459e-8c4e-5a5291f854ab"
      unitRef="number">0.65</peak:CapitalExpenditureFundingCostOfCapitalPercentCommitted>
    <peak:CapitalExpenditureFundingAmountCommitted
      contextRef="ifdbfd36f6f614b35837a5d8868840c17_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfOTAw_21e1c17c-c170-43b4-bb55-8c8de0a7d02f"
      unitRef="usd">56000000</peak:CapitalExpenditureFundingAmountCommitted>
    <peak:CapitalExpenditureFundingAmountCommitted
      contextRef="ie9fdf60d4d6e4a599a3fe3f066788531_D20220201-20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTY0MTU2OQ_7a04a7ab-6399-4c7a-9a39-5d19f4b86311"
      unitRef="usd">47000000</peak:CapitalExpenditureFundingAmountCommitted>
    <peak:CapitalExpenditureFundingAmountFunded
      contextRef="ieaf70b6c82e34b11838baffaa23b60f8_D20210101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfOTY1_aaff3e59-05f6-40b6-b7d0-ce902f4ffc59"
      unitRef="usd">400000</peak:CapitalExpenditureFundingAmountFunded>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="i11671c496b994973af5e617cd736d08c_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTE2MA_be926c54-96dd-4c19-96ff-e3ba496329c5"
      unitRef="usd">246000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:ProceedsFromCollectionOfLoansReceivable
      contextRef="i1830004bc9a241ae9fa37e55c2d28202_D20220201-20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTY0MTQ4Mw_5fe1674b-3529-4784-86dd-7d8a627db868"
      unitRef="usd">8000000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ifdb0da742c3d4dc2878b9efd7818fd4a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTYzODU1MA_2014957f-5770-4c68-8d86-fac9b8dcd8fd"
      unitRef="usd">157000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ia143e4423ee545cb944c9846d1bf5a01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTY0MTQ5NQ_8c283202-f234-4bc2-866b-1b2b1e3061f7"
      unitRef="usd">165000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <peak:NumberOfPropertiesToBeSold
      contextRef="icb30aa09ba6c452ba2bd4375f636fc3e_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTUwNw_c9530107-273a-411d-8705-26a267de53b2"
      unitRef="property">16</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTU0MQ_e1686ff4-ce8e-4970-a41a-75dbfc729fb8"
      unitRef="usd">230000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if7816ec707df46cea70367c7e82d41e9_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTYyNA_b135fb62-b715-43fb-98ed-6bfca3e3c8f3"
      unitRef="usd">150000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ib7fff5de172f473c9b163cd5408ad706_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjI4MQ_f5fecd23-8031-4f2e-8e79-8619a9e3d17d"
      unitRef="usd">16000000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <peak:LoansReceivableStatedInterestRate
      contextRef="i861ec35878514b2cb35e6fe1f899825f_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjQzMA_6c0abff9-ddb2-48c7-85ad-d519564e3474"
      unitRef="number">0.0350</peak:LoansReceivableStatedInterestRate>
    <peak:LoansReceivableStatedInterestRate
      contextRef="id286ba246e874843bc8dd2638e1faa98_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjQzNg_2752c265-af25-4995-ac0b-6e15b7ae4407"
      unitRef="number">0.0450</peak:LoansReceivableStatedInterestRate>
    <peak:LoansReceivableMarketRate
      contextRef="ia298127fc81840afbfc9f29801f74a20_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjQ5OQ_e8d8010d-5599-4a87-baf8-98d960cb2f31"
      unitRef="number">0.0525</peak:LoansReceivableMarketRate>
    <peak:LoansReceivableInterestIncomeAmortizationPeriod
      contextRef="i8e457939b7f044ffbc4f9cf2945b94a2_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjYzNQ_9ef7e5da-c8c9-4a34-94eb-e07436ca21bb">P3Y</peak:LoansReceivableInterestIncomeAmortizationPeriod>
    <peak:NoncashOrPartNoncashInterestIncome
      contextRef="ie000ff8c480e49299647b1b49c710ab5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjczNQ_98d31054-e90e-4a22-b09d-42ddb4562594"
      unitRef="usd">1000000</peak:NoncashOrPartNoncashInterestIncome>
    <peak:NoncashOrPartNoncashInterestIncome
      contextRef="ib7fff5de172f473c9b163cd5408ad706_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMjc0Mg_5bdb5b49-5f88-4be4-905b-a920cdb07645"
      unitRef="usd">2000000</peak:NoncashOrPartNoncashInterestIncome>
    <peak:FinancingReceivableHeldForSaleNumberOfContracts
      contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzU5OA_0fa7ea2d-5384-4d54-b36b-18f00db1f88a"
      unitRef="property">2</peak:FinancingReceivableHeldForSaleNumberOfContracts>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzY0OQ_b97f6f35-9e22-4587-bb09-877bf1aa5bc3"
      unitRef="usd">64000000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <peak:FinancingReceivableHeldForSaleNumberOfContracts
      contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzcxMw_0fa7ea2d-5384-4d54-b36b-18f00db1f88a"
      unitRef="property">2</peak:FinancingReceivableHeldForSaleNumberOfContracts>
    <us-gaap:IncreaseDecreaseInFinanceReceivables
      contextRef="i621bef727d6848c28d61e1f5dc2a0688_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzc3Ng_028b8cd4-0e14-4f35-920d-b6db5cf474f6"
      unitRef="usd">-11000000</us-gaap:IncreaseDecreaseInFinanceReceivables>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzgwOQ_2d512b84-5df5-4fe4-837e-8b3a7bb865a6"
      unitRef="usd">53000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i2f48f4c74adc4fa9a52f9d29da702af6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMzgxMw_eb346d7b-b58c-4103-ae9d-812cc9b18875"
      unitRef="usd">8000000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <peak:FinancingReceivableNumberOfContractsSold
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTYzOTQ4MA_6f5a46d4-f287-4555-aa5a-8f319e942ba5"
      unitRef="loan">2</peak:FinancingReceivableNumberOfContractsSold>
    <us-gaap:ProceedsFromSaleOfFinanceReceivables
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTYzOTU2Mg_49cd1b87-7e94-4b75-a73a-a63f0c185ab8"
      unitRef="usd">53000000</us-gaap:ProceedsFromSaleOfFinanceReceivables>
    <peak:FinancingReceivableHeldForSaleNumberOfContracts
      contextRef="i8c295f7730a9480c8ecfc74218b82db1_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDQyMA_9acf37cc-6101-44c5-a08f-0e48f88d3324"
      unitRef="property">2</peak:FinancingReceivableHeldForSaleNumberOfContracts>
    <us-gaap:GainLossOnSaleOfNotesReceivable
      contextRef="ib18e864b0cc2475eaf0549bdbf87abc9_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDUxOQ_1303eb8d-6664-4bfb-b26b-b201e5e33739"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables
      contextRef="i3e06e81b0ec74155af21cdd896273b28_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDYwMw_52c5e2fe-2f8d-4b79-9b9c-d40fdaf52ae2"
      unitRef="usd">10000000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <peak:FinancingReceivableNumberOfContracts
      contextRef="i3e06e81b0ec74155af21cdd896273b28_D20210501-20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDYzNw_27c2a1a0-6cf2-4d40-a1f7-33ee989c33a0"
      unitRef="property">1</peak:FinancingReceivableNumberOfContracts>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables
      contextRef="i166380b792354cd99bcdce4b5c2a3d09_D20210901-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDcyOQ_b9e55ec5-d37a-4779-a5f1-81bb1eab651f"
      unitRef="usd">15000000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables
      contextRef="i280e47a3f1d647aeab62193c0845ca90_D20210701-20210731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNDgyNA_86a5d393-ece6-432e-97a5-54e3575326e1"
      unitRef="usd">8000000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ic4c7caa3dd3149cd8911377afa83f122_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfNTY2MQ_442b6747-bfed-4fca-9bf4-825a48ba800c"
      unitRef="usd">25000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i6feec1d68f9349e7b96730a474b98cb8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTA5OTUxMTY0MDA2Mg_945125eb-150e-424f-970b-ad765206a4b3"
      unitRef="usd">24000000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTAwNzc_6c05beb4-ddb2-4315-9f82-cd8a4bf7220d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes, by year of origination, the Company&#x2019;s internal ratings for loans receivable, net of unamortized discounts, fees, and reserves for loan losses, as of March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investment Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performing loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Watch list loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workout loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mezzanine and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performing loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Watch list loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workout loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total mezzanine and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="icf2f708bf5a04fec813c493611999629_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC0yLTEtMS0xMDc4NDI_26aa6565-7845-4078-b689-b95a1796b901"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="icf2f708bf5a04fec813c493611999629_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC00LTEtMS0xMDc4NDI_a29016aa-72fc-4d37-ae4e-b0a3154e861f"
      unitRef="usd">301796000</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="icf2f708bf5a04fec813c493611999629_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC02LTEtMS0xMDc4NDI_645d8e7f-c977-46ff-acdd-fdd4921f1b80"
      unitRef="usd">79512000</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="icf2f708bf5a04fec813c493611999629_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC04LTEtMS0xMDc4NDI_2e1ec6d1-cf37-49ea-be90-536268b81338"
      unitRef="usd">2199000</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="icf2f708bf5a04fec813c493611999629_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC0xMC0xLTEtMTA3ODQy_d026d958-6e46-4799-8f57-24c9d01c3388"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="icf2f708bf5a04fec813c493611999629_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC0xMS0xLTEtMTA3ODQy_c7fce25c-17ea-4371-82e6-86f0358720a8"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="icf2f708bf5a04fec813c493611999629_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNC0xMy0xLTEtMTA3ODQy_550668d0-92d5-41a1-ac6f-535d4fda6bce"
      unitRef="usd">383507000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS0yLTEtMS0xMDc4NDI_1e7c8fdc-4ad0-4a70-a818-7684cd7efdb4"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS00LTEtMS0xMDc4NDI_68a8e354-0776-479a-b1ae-89b0238fe8ac"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS02LTEtMS0xMDc4NDI_d4f40e20-a383-4a77-820b-7b7e7645ea6b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS04LTEtMS0xMDc4NDI_f11bc323-8a03-4387-8305-802bf3f91de7"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS0xMC0xLTEtMTA3ODQy_517b039d-ff78-4d57-8cfa-6a3ff21d664c"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS0xMS0xLTEtMTA3ODQy_20c402fb-842b-452e-877c-88c595cb890b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="idcbf460e68524351a14b60f7eacaa6f5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNS0xMy0xLTEtMTA3ODQy_126f37d7-8879-4a02-8af3-584d3478e1c6"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi0yLTEtMS0xMDc4NDI_3c291e06-f9e9-4568-bcc9-fd69aa678d90"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi00LTEtMS0xMDc4NDI_d49018e8-c533-4b4a-a4aa-30d9f33b43b6"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi02LTEtMS0xMDc4NDI_ad8f0dfa-f959-46e8-ab4e-6161b0d959d7"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi04LTEtMS0xMDc4NDI_7a3fb180-6310-420c-bef7-a7cd85565e42"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi0xMC0xLTEtMTA3ODQy_d4c4b2c0-57af-4a70-b048-5a77fe880095"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi0xMS0xLTEtMTA3ODQy_299b1555-2711-4367-baab-9e891451ff5b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i073b62edbe4947b19f177c3595862f7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNi0xMy0xLTEtMTA3ODQy_6410d281-d8f4-47cb-82ce-1213d9a5928b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy0yLTEtMS0xMDc4NDI_e0e4dde6-aaa8-40b7-9db9-e9e5690da92b"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy00LTEtMS0xMDc4NDI_79b88183-595c-4c73-a5f0-db7ae847c6a3"
      unitRef="usd">301796000</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy02LTEtMS0xMDc4NDI_15a742a4-9c2a-414c-8830-750cb688ddcc"
      unitRef="usd">79512000</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy04LTEtMS0xMDc4NDI_7a556f2d-f4fe-4dca-86c2-e720c2d6dc95"
      unitRef="usd">2199000</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy0xMC0xLTEtMTA3ODQy_3800b819-99ed-4ee5-90f7-f45d4f3fa26f"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy0xMS0xLTEtMTA3ODQy_3bb38422-73af-408a-9a22-79c57bc2b76d"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ic484d7102e0c4eef9210903e4b7f1b12_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfNy0xMy0xLTEtMTA3ODQy_60aa2f15-1017-413b-a4c4-875e5cfa4357"
      unitRef="usd">383507000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtMi0xLTEtMTA3ODQy_98050eb0-9770-4d89-8b08-5a459858fbc5"
      unitRef="usd">12521000</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtNC0xLTEtMTA3ODQy_f4fa52da-b9da-4b1c-abd3-fd1cd53ab65a"
      unitRef="usd">12284000</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtNi0xLTEtMTA3ODQy_662a364e-958d-46a4-b902-c406a04e60c9"
      unitRef="usd">1441000</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtOC0xLTEtMTA3ODQy_c02ffaf5-4b87-4dc0-a42d-f67348f0fc14"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtMTAtMS0xLTEwNzg0Mg_516a7155-8e00-46e9-b219-c3d5b2855f5f"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtMTEtMS0xLTEwNzg0Mg_73959924-9119-466b-b9c8-ab0f9235ab5c"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="id73b3e04664a4d5497e0071f0132de90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTMtMTMtMS0xLTEwNzg0Mg_31461522-7ad1-4111-83d9-bba2c95d8765"
      unitRef="usd">26246000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtMi0xLTEtMTA3ODQy_0a4750e6-7a66-4ebd-bde0-6fbb8b6aa820"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtNC0xLTEtMTA3ODQy_47b42e28-f23b-4149-8474-278931454630"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtNi0xLTEtMTA3ODQy_6f645fb2-df33-4e4c-b72b-56e0b3f51c85"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtOC0xLTEtMTA3ODQy_436f9b83-ba8b-4e29-92a3-7e07b21d9465"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtMTAtMS0xLTEwNzg0Mg_62d2a050-1c06-46e5-9249-e25b8c4cf4aa"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtMTEtMS0xLTEwNzg0Mg_2dda99db-2bd3-4b3f-906a-9c9544f32ada"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="ib5edfb64270943259dee0a2cf06286d7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTQtMTMtMS0xLTEwNzg0Mg_9b46acc9-c197-4077-ab87-fbbeb3a164ad"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtMi0xLTEtMTA3ODQy_3e7d6abf-1126-4250-b42a-9160b3c5b185"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtNC0xLTEtMTA3ODQy_99d8d6b2-7f0d-41c9-9389-1b0b912f3570"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtNi0xLTEtMTA3ODQy_85b102b1-359f-488f-9580-2ebd87d26772"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtOC0xLTEtMTA3ODQy_920bed4c-baba-41b0-831a-03b46c7e6514"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtMTAtMS0xLTEwNzg0Mg_3e402992-6a86-474b-805f-9fb367c1dcf1"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtMTEtMS0xLTEwNzg0Mg_7fe8204c-8805-4f3d-8cfa-d49006bcd1e7"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i942914a4982a4fdc89cfe3c58112514c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTUtMTMtMS0xLTEwNzg0Mg_3916826f-10e9-4323-adb4-e22ed22d4727"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
      contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtMi0xLTEtMTA3ODQy_6aa0fd6e-33da-4e93-aa51-3321b64fe5a7"
      unitRef="usd">12521000</us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
      contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtNC0xLTEtMTA3ODQy_57e28b4f-8021-41f8-9de8-8d3a55a1860d"
      unitRef="usd">12284000</us-gaap:FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
      contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtNi0xLTEtMTA3ODQy_f40bac68-0254-4650-9448-dc9059d53a08"
      unitRef="usd">1441000</us-gaap:FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
      contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtOC0xLTEtMTA3ODQy_1b0b09b9-fdfb-48d7-b966-27428c74cc45"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
      contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtMTAtMS0xLTEwNzg0Mg_b297ea79-b969-4e8e-b187-0980bc232abc"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
      contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtMTEtMS0xLTEwNzg0Mg_6b9d7dd2-ea8e-4739-832f-441a2926b8f5"
      unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i476aa803f3b64a469836296cb0eb44e5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmYjBmZmQzNmE3OTRiN2NhOGNiNzBiNThkM2I5ZjhhL3RhYmxlcmFuZ2U6ZWZiMGZmZDM2YTc5NGI3Y2E4Y2I3MGI1OGQzYjlmOGFfMTYtMTMtMS0xLTEwNzg0Mg_dab0f78e-d5d2-429d-84e3-d33957e9fc96"
      unitRef="usd">26246000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfMTAwNjg_b328c900-4863-4efe-8d72-fb00a41e157e">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s reserve for loan losses (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Secured Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mezzanine and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Secured Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mezzanine and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for expected loan losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected loan losses related to loans sold or repaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for loan losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes six loans sold or repaid during the year ended December&#160;31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="if88696dec76a41df8c3d36e71898301f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi0xLTEtMS0xMDc4NDI_65e674ec-02c7-4446-808a-040e58f0b694"
      unitRef="usd">1804000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="id2caaa14451f4014ab34991c3b703764_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi0zLTEtMS0xMDc4NDI_089c939a-214f-4fde-820c-cdec09b7f536"
      unitRef="usd">9000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi01LTEtMS0xMDc4NDI_d6fa56b9-fda9-431b-8323-b788be282c96"
      unitRef="usd">1813000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="ib39f0035285a4bfdadaf994fa845b4ca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi03LTEtMS0xMDc4NDI_5f502cb1-e8b7-4ee2-b178-87b32b4971a4"
      unitRef="usd">3152000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="iab0213b6338d474f9ab83b686f5a8aa0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi05LTEtMS0xMDc4NDI_d1c59631-f2a2-4632-ab4f-06267cf66c44"
      unitRef="usd">7128000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfMi0xMS0xLTEtMTA3ODQy_2341bdfb-388a-44a6-ae26-72215cf4bb33"
      unitRef="usd">10280000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i01aa0bf4bb3d4669ab75f73ab638333e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0xLTEtMS0xMTE0MzE_517ef8cb-1865-414b-ad3c-9acd5987cca6"
      unitRef="usd">134000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="if4031be1cfa14447aa6b18dfbcfa6bd9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0zLTEtMS0xMTE0MzE_c339387c-23e4-4da6-938c-d9410f8f5f89"
      unitRef="usd">-3000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC01LTEtMS0xMTE0MzE_b031a4d5-b83d-4c29-8fa0-a31961ed9776"
      unitRef="usd">131000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i1af0c53b18b84f96a9445d33fed35d6c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC03LTEtMS0xMTE0MzE_f8b382cf-ada3-49e8-9555-f1ce86a9a59b"
      unitRef="usd">793000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="ice9d09a0cad14197a0d42beb434939dc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC05LTEtMS0xMTE0MzE_f3371ee8-7064-465f-b303-fbb34b9d4925"
      unitRef="usd">896000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0xMS0xLTEtMTExNDMx_01dd5efe-9c4d-43ae-919d-f631d9a8c0a1"
      unitRef="usd">1689000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:FinancingReceivableSignificantSales
      contextRef="i01aa0bf4bb3d4669ab75f73ab638333e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0xLTEtMS0xMDc4NDI_de4fdc69-4fa8-4d3d-bd09-27ac2a3f1569"
      unitRef="usd">0</us-gaap:FinancingReceivableSignificantSales>
    <us-gaap:FinancingReceivableSignificantSales
      contextRef="if4031be1cfa14447aa6b18dfbcfa6bd9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0zLTEtMS0xMDc4NDI_eaa76e04-4689-4cb7-9221-c48f220516d0"
      unitRef="usd">0</us-gaap:FinancingReceivableSignificantSales>
    <us-gaap:FinancingReceivableSignificantSales
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC01LTEtMS0xMDc4NDI_832769c7-b08d-41e7-aade-a8d0d7425702"
      unitRef="usd">0</us-gaap:FinancingReceivableSignificantSales>
    <us-gaap:FinancingReceivableSignificantSales
      contextRef="i1af0c53b18b84f96a9445d33fed35d6c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC03LTEtMS0xMDc4NDI_a89f7094-a3d8-4b27-8eb4-2057b88df91e"
      unitRef="usd">2141000</us-gaap:FinancingReceivableSignificantSales>
    <us-gaap:FinancingReceivableSignificantSales
      contextRef="ice9d09a0cad14197a0d42beb434939dc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC05LTEtMS0xMDc4NDI_882457d2-e18a-4d75-b3ba-4035299a8427"
      unitRef="usd">8015000</us-gaap:FinancingReceivableSignificantSales>
    <us-gaap:FinancingReceivableSignificantSales
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfNC0xMS0xLTEtMTA3ODQy_9f867ab0-b130-44f7-9cfc-76a42f3075f6"
      unitRef="usd">10156000</us-gaap:FinancingReceivableSignificantSales>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i858204adffd348408864f031fa32c574_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS0xLTEtMS0xMDc4NDI_7fa3f3fc-884f-421a-ba4d-627e166d10bd"
      unitRef="usd">1938000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="id1ff4f2b11c94a78a5487085851cb371_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS0zLTEtMS0xMDc4NDI_8a42dcc7-ecb2-4dd6-a41f-07017875eac4"
      unitRef="usd">6000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS01LTEtMS0xMDc4NDI_dc12dcd9-a098-4b84-858f-c3d31392aba9"
      unitRef="usd">1944000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="if88696dec76a41df8c3d36e71898301f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS03LTEtMS0xMDc4NDI_7ba8ee4f-49ec-4187-9a1f-b6e803099d7e"
      unitRef="usd">1804000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="id2caaa14451f4014ab34991c3b703764_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS05LTEtMS0xMDc4NDI_7d1de084-80ba-42d6-b7e4-291110dae7d9"
      unitRef="usd">9000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RhYmxlOmVmOTM1ZjhhMWY3YjQwYzA5ZTlhNzMyNjViY2NiYzQzL3RhYmxlcmFuZ2U6ZWY5MzVmOGExZjdiNDBjMDllOWE3MzI2NWJjY2JjNDNfOS0xMS0xLTEtMTA3ODQy_f382b533-45bf-4423-a224-733f570a729b"
      unitRef="usd">1813000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <peak:FinancingReceivableNumberOfContractsSold
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfODkxMA_451b5c11-df63-489b-a713-b59c8f91d4a2"
      unitRef="property">6</peak:FinancingReceivableNumberOfContractsSold>
    <peak:FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfOTA0MQ_5d5a7d7e-c02c-4607-979e-f3dd8bfcd8b4"
      unitRef="usd">300000</peak:FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments>
    <peak:FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81Mi9mcmFnOmRhZTA4Y2MzOTJmMDQxNWE4MzM2MmQxMmU1MDY0NmVkL3RleHRyZWdpb246ZGFlMDhjYzM5MmYwNDE1YTgzMzYyZDEyZTUwNjQ2ZWRfOTA0MQ_ce856800-55d9-4548-aaf8-c87eecfa53b0"
      unitRef="usd">300000</peak:FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTkxOA_b41dd75a-a9b5-48c2-aae7-8c261e6233b6">Investments in and Advances to Unconsolidated Joint Ventures&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company owns interests in the following entities that are accounted for under the equity method, excluding investments classified as discontinued operations (dollars in thousands):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property Count&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership %&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SWF SH JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Science JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Needham Land Parcel JV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Office JVs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 - 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Property counts and ownership percentages are as of March&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In December 2021, the Company acquired a 38% interest in a life science development joint venture in Needham, Massachusetts for $13&#160;million. Land held for development is excluded from the property count as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes two unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (20%) and (ii) Suburban Properties, LLC (67%). During 2021, the Company also held a 30% interest in Ventures III, which issued its final distribution and was dissolved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company sold its two preferred equity investments for their carrying value as part of the Discovery SHOP Portfolio disposition (see Note 4). Prior to the sale, the Company&#x2019;s ownership percentage in these two unconsolidated joint ventures was as follows: (i) Discovery Naples JV (41%) and (ii) Discovery Sarasota JV (47%). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the two remaining CCRCs in the CCRC JV were sold for $38&#160;million, $19&#160;million of which represents the Company&#x2019;s 49% interest, resulting in an immaterial gain on sale recorded within equity income (loss) from unconsolidated joint ventures during the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTkyMA_904d23fd-4446-416e-b465-96760d2e7785">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company owns interests in the following entities that are accounted for under the equity method, excluding investments classified as discontinued operations (dollars in thousands):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property Count&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership %&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SWF SH JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life Science JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Needham Land Parcel JV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Office JVs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20 - 67&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Property counts and ownership percentages are as of March&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In December 2021, the Company acquired a 38% interest in a life science development joint venture in Needham, Massachusetts for $13&#160;million. Land held for development is excluded from the property count as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes two unconsolidated medical office joint ventures in which the Company holds an ownership percentage as follows: (i) Ventures IV (20%) and (ii) Suburban Properties, LLC (67%). During 2021, the Company also held a 30% interest in Ventures III, which issued its final distribution and was dissolved.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="id5746a20e0c541cb933dd8d9e8a18868_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMy01LTEtMS0xMDc4NDI_8a0e9f2b-cc7a-45d2-bfa9-522819f7dcdc"
      unitRef="property">19</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id5746a20e0c541cb933dd8d9e8a18868_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMy04LTEtMS0xMDc4NDI_11a34879-906e-4dc1-a9ba-dc81157d7f7c"
      unitRef="number">0.54</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="id5746a20e0c541cb933dd8d9e8a18868_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMy0xMS0xLTEtMTA3ODQy_af2612ef-1d1e-43de-9992-90cd0e6c5dd1"
      unitRef="usd">353268000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ifeb1c53a80cf48d598dd59b38828089e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMy0xMy0xLTEtMTA3ODQy_ce69af64-d086-44d2-8b7f-2b4e73da9345"
      unitRef="usd">355394000</us-gaap:EquityMethodInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="if6dac57d2d904eef8d5d5c6d6d560074_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNC01LTEtMS0xMDc4NDI_bd9793a6-0214-46cf-9453-a0475119715b"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="if6dac57d2d904eef8d5d5c6d6d560074_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNC04LTEtMS0xMDc4NDI_ea5410d1-b8dc-4493-b819-42da8befc11e"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="if6dac57d2d904eef8d5d5c6d6d560074_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNC0xMS0xLTEtMTA3ODQy_87ee0203-6524-4c81-91e2-038861668d70"
      unitRef="usd">26572000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i7af131706f2b4efd81b014492e74780e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNC0xMy0xLTEtMTA3ODQy_90359f54-89b5-4d18-bae7-711ee48c9a20"
      unitRef="usd">25605000</us-gaap:EquityMethodInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="ie86b016e31384892bfe412d346cd92f5_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS01LTEtMS0xMTE1MDU_da90daed-910b-4f80-bb4a-3131b72346a1"
      unitRef="property">0</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie86b016e31384892bfe412d346cd92f5_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS04LTEtMS0xMTE1MTI_2fb8e90c-a2a2-467a-9e64-907845686dd1"
      unitRef="number">0.38</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="ie86b016e31384892bfe412d346cd92f5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS0xMS0xLTEtMTExNTE4_fb53c59d-038f-456e-9465-df2f3e9969f2"
      unitRef="usd">14346000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ib12448d242784ab084c7178415e35eef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS0xMy0xLTEtMTExNTI0_54620ebf-9a04-466a-9f5c-7caae8e82f0a"
      unitRef="usd">13566000</us-gaap:EquityMethodInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i6cd1af5b0be84236928af4f3b5238de4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS01LTEtMS0xMDc4NDI_d6b82d6e-d7a4-49c0-9544-b42dd55fc1bf"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib71d278abee9484ea60f89ad5ed8f50f_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS04LTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjoxYWY2NDRkNWEzNzE0OTg1OTQ5ZDQ3YWRkMGQ1ZTZlM180_a6c96ed6-12f7-4148-adf0-3a35b6de2388"
      unitRef="number">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie0fbe38d9b8f4c8096a62a13c0be0319_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS04LTEtMS0xMDc4NDIvdGV4dHJlZ2lvbjoxYWY2NDRkNWEzNzE0OTg1OTQ5ZDQ3YWRkMGQ1ZTZlM185_15859811-cc44-4f82-93d1-db06cdd8fb15"
      unitRef="number">0.67</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i6cd1af5b0be84236928af4f3b5238de4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS0xMS0xLTEtMTA3ODQy_5e07e463-4326-44c0-a2ab-233b26397e74"
      unitRef="usd">8973000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i294e35e4fa6e4b7792baf4fb2a50d9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfNS0xMy0xLTEtMTA3ODQy_110905b0-4364-4002-bda2-5c4b61fc00d2"
      unitRef="usd">9069000</us-gaap:EquityMethodInvestments>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMTAtMTEtMS0xLTEwNzg0Mg_d452e790-2c7a-4a31-870c-6c6e85162542"
      unitRef="usd">403159000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RhYmxlOjUzZjQ1ZWEyZDNhZDQ1ZTJiZWRlOGMyMTE2M2E0OGE3L3RhYmxlcmFuZ2U6NTNmNDVlYTJkM2FkNDVlMmJlZGU4YzIxMTYzYTQ4YTdfMTAtMTMtMS0xLTEwNzg0Mg_78607ac4-350a-452e-907c-2bcea2abe621"
      unitRef="usd">403634000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib12448d242784ab084c7178415e35eef_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTY0OTI2NzQ0OTE1OA_71c1da89-cfa9-4b54-a9b1-deeeecf9f591"
      unitRef="number">0.38</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ib42e8c61652142339c59c133c0ca0201_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYzMjM2NA_419913cb-c8ca-4c0a-8220-4876f277abc8"
      unitRef="usd">13000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="iab41d51161f44fa3b2a7d722d1819d54_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfOTU3_aa25f6c8-38bb-494b-9c8c-52375f815dcf"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib7d01dc5f33147a4821ce0ce3545c5f8_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA4NQ_a1c8884a-9db4-4c99-a07d-16bb51c9d68b"
      unitRef="number">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i52b2c707e2b1428383dc2029f13bab25_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTE1MA_a3c09400-4007-4a0c-b0d8-e2b01744a6a6"
      unitRef="number">0.67</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib2847866fa494fa48669203a8b822e0d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYzMjQ2OA_47a154cb-9d19-4688-916b-085581496729"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <peak:NumberOfPreferredEquityMethodInvestmentsSold
      contextRef="i43ed19b259424a54a9fd61eca57de24e_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTE5MQ_c8df3939-c388-42fb-855c-57a77c812776"
      unitRef="property">2</peak:NumberOfPreferredEquityMethodInvestmentsSold>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="i68d2f2250a954a959c1ab9c1001f3093_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTMzMQ_0731a858-d9e3-423e-b548-b09cdd3c7084"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i2cfa7cca0e764481b533b63888796ec6_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTQ1NA_ed48da7f-5399-40f5-a14f-16038fe9dc00"
      unitRef="number">0.41</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id980870ccca047b5ae04fde6a8171675_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTQ5MA_9afb14f1-9f64-48c5-91d7-ebda100f59fa"
      unitRef="number">0.47</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <peak:NumberOfPropertiesToBeSold
      contextRef="i322ecd64c5b44877a6a721cafa77d63f_D20210501-20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYyOTcxMg_d84de37b-7d93-41dd-8db4-92c1985ca4f0"
      unitRef="property">2</peak:NumberOfPropertiesToBeSold>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i322ecd64c5b44877a6a721cafa77d63f_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYyOTcwMA_729fe5cd-6e41-4920-a59c-19b7cc574553"
      unitRef="usd">38000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:ProceedsFromSaleOfBuildings
      contextRef="i642916b599bc4bf2b4a0e961d45d5a42_D20210501-20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYyOTcwNA_a17fea09-31a0-4b3c-9038-7c4b373886d5"
      unitRef="usd">19000000</us-gaap:ProceedsFromSaleOfBuildings>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i924e6cd0c4bb4c52bd6d1353893473da_I20210531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81NS9mcmFnOmIwZDE5NTMyYzc3YzQ0MTdhMTEyNjAyYWVhNGQzNmFkL3RleHRyZWdpb246YjBkMTk1MzJjNzdjNDQxN2ExMTI2MDJhZWE0ZDM2YWRfMTA5OTUxMTYyOTcwOA_2b6cd9a8-5c25-4c48-8ed3-c217c5fdde7c"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE1OQ_37385c78-7afa-4ba4-a51e-2173ec876cee">Intangibles&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#x2019;s intangible lease assets (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible&#160;lease&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross intangible lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(277,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining amortization period in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#x2019;s intangible lease liabilities (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible&#160;lease&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross intangible lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining amortization period in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022, in conjunction with the Company&#x2019;s acquisitions of real estate, the Company acquired intangible assets of $4 million and intangible liabilities of $5 million. The intangible assets and liabilities acquired had a weighted average amortization period at acquisition of 9 years and 12 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, in conjunction with the Company&#x2019;s acquisitions of real estate, the Company acquired intangible assets of $109&#160;million and intangible liabilities of $57&#160;million. The intangible assets and intangible liabilities acquired had a weighted average amortization period at acquisition of 9 years.&lt;/span&gt;&lt;/div&gt;</peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE2MA_d024ec30-4fdf-4a35-ad12-103ea3d63ef9">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets primarily consist of lease-up intangibles and above market tenant lease intangibles. The following table summarizes the Company&#x2019;s intangible lease assets (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible&#160;lease&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross intangible lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(277,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining amortization period in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMS0yLTEtMS0xMDc4NDI_c2ea25d8-5397-44b1-86cf-2d237bcfe5d0"
      unitRef="usd">802078000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMS00LTEtMS0xMDc4NDI_e804bda2-3047-47c5-9928-2a8409bf20f0"
      unitRef="usd">797675000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMi0yLTEtMS0xMDc4NDI_a7675b2e-be0b-44ad-8163-a87c4a4ce83d"
      unitRef="usd">304974000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMi00LTEtMS0xMDc4NDI_51eb98f1-0126-438d-a079-df4756106de8"
      unitRef="usd">277915000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMy0yLTEtMS0xMDc4NDI_c9b25e1e-9718-4bbb-87a2-b6f345d3c066"
      unitRef="usd">497104000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfMy00LTEtMS0xMDc4NDI_1e7762af-ea3d-4b71-a1aa-c1c239de062b"
      unitRef="usd">519760000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfNS0yLTEtMS0xMDc4NDI_ce37dcae-dcc2-4807-ae0c-9034dc882f50">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjkzNDg2MmUwYjg4YjRkNmQ4ZWZiMTk1MTBhN2NlYzJlL3RhYmxlcmFuZ2U6OTM0ODYyZTBiODhiNGQ2ZDhlZmIxOTUxMGE3Y2VjMmVfNS00LTEtMS0xMDc4NDI_e4b92119-7c90-4155-8d4d-f43964db520a">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE2Mg_5a8d0935-a3ef-4130-8fdd-9b1f3fb6be25">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company&#x2019;s intangible lease liabilities (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.307%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible&#160;lease&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross intangible lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining amortization period in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock>
    <peak:FiniteLivedIntangibleLiabilitiesGross
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMS0yLTEtMS0xMDc4NDI_efc4c345-2d91-4c46-a557-183bb1a6c246"
      unitRef="usd">239677000</peak:FiniteLivedIntangibleLiabilitiesGross>
    <peak:FiniteLivedIntangibleLiabilitiesGross
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMS00LTEtMS0xMDc4NDI_df2848dc-3b55-4d5c-bf51-2c30cf22cc59"
      unitRef="usd">234917000</peak:FiniteLivedIntangibleLiabilitiesGross>
    <peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMi0yLTEtMS0xMDc4NDI_dfc0a92d-c0fc-463c-95d8-2b2f836810a0"
      unitRef="usd">64322000</peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization>
    <peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMi00LTEtMS0xMDc4NDI_8d9bcb5f-3e97-4424-82f4-dea135bea662"
      unitRef="usd">57685000</peak:FiniteLivedIntangibleLiabilitiesAccumulatedAmortization>
    <peak:FiniteLivedIntangibleLiabilitiesNet
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMy0yLTEtMS0xMDc4NDI_7cd11de7-3697-40b7-a2cc-0f5a9dae0c61"
      unitRef="usd">175355000</peak:FiniteLivedIntangibleLiabilitiesNet>
    <peak:FiniteLivedIntangibleLiabilitiesNet
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfMy00LTEtMS0xMDc4NDI_5f5a9883-67ce-4bad-a95b-064a933d35a4"
      unitRef="usd">177232000</peak:FiniteLivedIntangibleLiabilitiesNet>
    <peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfNS0yLTEtMS0xMDc4NDI_887d72d2-1926-44e3-ba59-913b971d67d3">P8Y</peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife>
    <peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RhYmxlOjc3NjM3M2MyMjJjMTQxMWY5YWFmMWE1NmVjZGZmYzg4L3RhYmxlcmFuZ2U6Nzc2MzczYzIyMmMxNDExZjlhYWYxYTU2ZWNkZmZjODhfNS00LTEtMS0xMDc4NDI_67444eaf-c5de-4ecc-9e7a-90318913e9c6">P8Y</peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfNjc5_0ea9672c-8233-4f52-b5aa-48018e0bc351"
      unitRef="usd">4000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <peak:IntangibleLiabilitiesAcquired
      contextRef="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfNzEy_c344b67b-a6f9-4854-a217-44f74c3e439d"
      unitRef="usd">5000000</peak:IntangibleLiabilitiesAcquired>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfODI0_800908a9-0638-4d4d-8143-ccbaecaf5ac1">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
      contextRef="i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfODMx_cfbd9c70-3a5c-446f-bf53-054ecbc0193f">P12Y</peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfOTgw_215eefbe-9826-423a-8bec-8ce9b8f7cee4"
      unitRef="usd">109000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <peak:IntangibleLiabilitiesAcquired
      contextRef="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTAxMw_b25cad5a-6653-4d6d-abd6-fb53bd230a38"
      unitRef="usd">57000000</peak:IntangibleLiabilitiesAcquired>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE0Mw_dd6542ad-3c2a-4db6-aff1-930b7e1bd77a">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife
      contextRef="i6ed2844b815f4554b47973de9af646fd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF81OC9mcmFnOmQ1Y2Y0OTc1NTE2YjQ0M2ZiODUwODc1NzhjODI1ZmI2L3RleHRyZWdpb246ZDVjZjQ5NzU1MTZiNDQzZmI4NTA4NzU3OGM4MjVmYjZfMTE0Mw_dee538ba-b032-4224-9589-73f7003b1409">P9Y</peak:AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODcwNA_830e37f5-760b-4a69-88fb-50aed5b32a1d">Debt&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bank Line of Credit and Term Loan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 23, 2019, the Company executed a $2.5 billion unsecured revolving line of credit facility, with a maturity date of May&#160;23, 2023 and two&#160;six-month extension options, subject to certain customary conditions. Also in May 2019, the Company entered into a&#160;$250 million&#160;unsecured term loan facility, with a maturity date of May 23, 2024 (the &#x201c;2019 Term Loan&#x201d;). In July 2021, the Company repaid the $250&#160;million 2019 Term Loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company executed an amended and restated unsecured revolving line of credit (the &#x201c;Revolving Facility&#x201d;) to increase total revolving commitments from $2.5&#160;billion to $3.0&#160;billion and extend the maturity date to January 20, 2026. This maturity date may be further extended pursuant to two six-month extension options, subject to certain customary conditions. Borrowings under the Revolving Facility accrue interest at LIBOR plus a margin that depends on the credit ratings of the Company&#x2019;s senior unsecured long-term debt. The Company also pays a facility fee on the entire revolving commitment that depends on its credit ratings. Based on the Company&#x2019;s credit ratings at March&#160;31, 2022, the margin on the Revolving Facility was 0.78%&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and the facility fee was&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.15%&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; At March&#160;31, 2022 and December&#160;31, 2021, the Company had no&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;balance outstanding under the Revolving Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Facility includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $750 million, subject to securing additional commitments. Further, the Revolving Facility includes customary LIBOR replacement language, including, but not limited to, the use of rates based on the secured overnight financing rate administered by the Federal Reserve Bank of New York. The Revolving Facility also includes a sustainability-linked pricing component whereby the applicable margin may be reduced by up to 0.025% based on the Company&#x2019;s achievement of specified sustainability-linked metrics, subject to certain conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Facility also contains certain financial restrictions and other customary requirements, including financial covenants and cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreement: (i)&#160;limit the ratio of Enterprise Total Indebtedness to Enterprise Gross Asset Value to 60%; (ii)&#160;limit the ratio of Enterprise Secured Debt to Enterprise Gross Asset Value to 40%; (iii)&#160;limit the ratio of Enterprise Unsecured Debt to Enterprise Unencumbered Asset Value to 60%; (iv)&#160;require a minimum Fixed Charge Coverage ratio of 1.5 times; and (v) require a minimum Consolidated Tangible Net Worth of $7.7 billion.&#160;The Company believes it was in compliance with each of these covenants at March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, the Company established an unsecured commercial paper program (the &#x201c;Commercial Paper Program&#x201d;). Under the terms of the Commercial Paper Program, the Company may issue, from time to time, unsecured short-term debt securities with varying maturities. Amounts available under the Commercial Paper Program may be borrowed, repaid, and re-borrowed from time to time. During 2021, the Company increased the maximum aggregate face or principal amount that can be outstanding at any one time from $1.0 billion to $1.5&#160;billion. Amounts borrowed under the Commercial Paper Program will be sold on terms that are customary for the U.S. commercial paper market and will be at least equal in right of payment with all of the Company&#x2019;s other unsecured and unsubordinated indebtedness. The Company uses its Revolving Facility as a liquidity backstop for the repayment of unsecured short-term debt securities issued under the Commercial Paper Program. At March&#160;31, 2022, the Company had $1.33&#160;billion&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of securities outstanding under the Commercial Paper Program, with original maturities of approximately&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45 days and a weighted average interest rate of 0.93%. At December&#160;31, 2021, the Company had $1.17&#160;billion of securities outstanding under the Commercial Paper Program, with original maturities of approximately two months and a weighted average interest rate of 0.32%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Unsecured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each of March&#160;31, 2022 and December&#160;31, 2021, the Company had senior unsecured notes outstanding with an aggregate principal balance of $4.7&#160;billion. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes it was in compliance with these covenants at March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022, the Company did not repurchase or redeem any senior unsecured notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the Company&#x2019;s senior unsecured notes repurchases and redemptions during the year ended December&#160;31, 2021 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payoff Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 19, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 19, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 26, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 26, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 26, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 28, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 28, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 28, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Upon repurchasing a portion of the 3.40% and 4.00% senior unsecured notes due 2025, the Company recognized a $61&#160;million loss on debt extinguishment during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Upon completing the repurchases and redemptions of all outstanding 4.25%, 4.20%, and 3.88% senior unsecured notes due 2023 and 2024, the Company recognized a $164&#160;million loss on debt extinguishment during the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022, the Company did not issue any senior unsecured notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, the Company completed two green bond offerings. The net proceeds from both green bonds are or will be allocated to eligible green projects, and the Company may choose to allocate or re-allocate net proceeds from such offerings to one more other eligible green projects. The following table summarizes these senior unsecured note issuances for the year ended December&#160;31, 2021 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 24, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 12, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Mortgage Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022 and December&#160;31, 2021, the Company had $349 million and $350&#160;million, respectively, in aggregate principal of mortgage debt outstanding, which was secured by 18 healthcare facilities, with an aggregate carrying value of $803 million and $811&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets, and is non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires insurance on the assets, and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During each of the three months ended March&#160;31, 2022 and March&#160;31, 2021, the Company made aggregate principal repayments of mortgage debt of $1&#160;million (excluding mortgage debt on assets held for sale and discontinued operations). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, in conjunction with the acquisition of the MOB Portfolio, the Company originated $142&#160;million of secured mortgage debt (see Note 3) that matures in May 2026. In April 2022, the Company terminated its existing interest rate cap agreements associated with this variable rate mortgage debt and entered into two interest rate swap contracts that are designated as cash flow hedges&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and mature in May 2026 (see Note 17). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Maturities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stated debt maturities and scheduled principal repayments at March&#160;31, 2022 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Senior Unsecured&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mortgage&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Bank Line&#160;of&lt;br/&gt;Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial Paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;803,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,225,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,250,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,379,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Discounts), premium and debt costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,654,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,335,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective interest rates on the senior unsecured notes range from 1.54% to 6.91% with a weighted average effective interest rate of 3.39% and a weighted average maturity of 7 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective interest rates on the mortgage debt range from 2.72% to 5.91% with a weighted average effective interest rate of 3.36% and a weighted average maturity of 4 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifbdf5f35645b45b3984b9e5e46fceaf8_I20190523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfOTc_83941d9f-113e-4961-963a-c6d246878673"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <peak:DebtInstrumentNumberofExtensions
      contextRef="ifbdf5f35645b45b3984b9e5e46fceaf8_I20190523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTg2_01786ecf-40cd-436f-b2e9-50cbead2739e"
      unitRef="renewal_option">2</peak:DebtInstrumentNumberofExtensions>
    <peak:DebtInstrumentPeriodOfExtension
      contextRef="iaf4af4c66c4c4e4ea53929a8d99bf97f_D20190523-20190523"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTg5_436c37b9-78c7-4fac-acaa-29d8fc42632b">P6M</peak:DebtInstrumentPeriodOfExtension>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib7a0463d43594517865ced9f143c46a6_I20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjk3_1b5124ba-a610-41c5-848e-fdf60ea2732b"
      unitRef="usd">250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i82327d2d8e1b4698b0346d5bd3a79cbb_D20210701-20210731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDI4_c9ce9ae3-c878-4243-b850-64016c88e63e"
      unitRef="usd">250000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifbdf5f35645b45b3984b9e5e46fceaf8_I20190523"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNzMx_7e46ef0d-ace2-4c11-9897-12b579d7b695"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iae4f18c121f648d5826bfbc035300a67_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNzM3_e6915d59-9d7f-4663-831e-9ad38b0676ab"
      unitRef="usd">3000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <peak:DebtInstrumentNumberofExtensions
      contextRef="iae4f18c121f648d5826bfbc035300a67_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQ1_56ca2bc4-5ad7-4fe9-9970-0a401e2bc096"
      unitRef="renewal_option">2</peak:DebtInstrumentNumberofExtensions>
    <peak:DebtInstrumentPeriodOfExtension
      contextRef="i9065798c00ee41ef899c69a43f5251b6_D20210901-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQ4_f808a00f-f54c-4c57-b08f-00759d078459">P6M</peak:DebtInstrumentPeriodOfExtension>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i86a95c3d76e44658a7495876f84394fb_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTM0OQ_d761e8ec-3085-41a2-b888-47f4c405a7b0"
      unitRef="number">0.0078</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i0667f584e1224d759496144ff96ccd4c_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTM3Nw_54dfee84-62ff-4b3f-be1f-d85b63179f24"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCredit
      contextRef="ib3aa132c8f884c44b097e6de1abfbc0d_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTQxMQ_6619ad1a-47f5-4d79-86a2-8a848e0193dd"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ibcc24c31340e402fa87c53d87f379dee_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTQxMQ_b797b898-055a-462b-8039-1d5e81833c27"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <peak:LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum
      contextRef="i9065798c00ee41ef899c69a43f5251b6_D20210901-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTU5Nw_5b680366-96b1-44a0-a6bb-5ca50517327c"
      unitRef="usd">750000000</peak:LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum>
    <peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics
      contextRef="i9065798c00ee41ef899c69a43f5251b6_D20210901-20210930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjAwNQ_75be5121-dc18-46e9-9b5a-6b4a3c2a02d1"
      unitRef="number">0.00025</peak:DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics>
    <peak:DebtInstrumentCovenantDebtToAssets
      contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjQ2Ng_1f6846e3-ff3c-434e-84d4-4c546899fc4e"
      unitRef="number">0.60</peak:DebtInstrumentCovenantDebtToAssets>
    <peak:DebtInstrumentCovenantSecuredDebtToAssets
      contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjU1Mw_72a67f59-f3cb-4e2b-b7cb-0a9c367b6825"
      unitRef="number">0.40</peak:DebtInstrumentCovenantSecuredDebtToAssets>
    <peak:DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets
      contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjY1MA_d3a040cf-d0bb-4d16-a1b8-931016842911"
      unitRef="number">0.60</peak:DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets>
    <peak:DebtInstrumentCovenantFixedChargeRatioMinimum
      contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjcwOA_da71354c-7a6b-4e8e-92bc-8b5fec4cf07f"
      unitRef="number">1.5</peak:DebtInstrumentCovenantFixedChargeRatioMinimum>
    <peak:DebtInstrumentCovenantNetWorth
      contextRef="iaa4506fa371a4f6b80d98b0ab321c80e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMjc3OQ_b57769a3-6168-49b8-a528-45dad0207180"
      unitRef="usd">7700000000</peak:DebtInstrumentCovenantNetWorth>
    <peak:DebtInstrumentMaximumBorrowingCapacity
      contextRef="i02de64e4627846b2bd3f09d7101c72f9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzM5NA_da527efb-59b7-460f-b4b9-d04c1e11cdd9"
      unitRef="usd">1000000000</peak:DebtInstrumentMaximumBorrowingCapacity>
    <peak:DebtInstrumentMaximumBorrowingCapacity
      contextRef="i06c55fa5097f4b26aaa7bc551ed8d8ef_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzQwMA_6438cfa9-600c-4ca6-947a-2c25fa5d9562"
      unitRef="usd">1500000000</peak:DebtInstrumentMaximumBorrowingCapacity>
    <us-gaap:ShortTermBorrowings
      contextRef="if3f5c6f033e845d3853ee8dcbfd15aec_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzg0NA_1363d775-e76f-4e2b-8f32-b0256d5e2a37"
      unitRef="usd">1330000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzk1MQ_e3e8166b-7959-4f0a-8883-a98ea0e3e757">P45D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzk5NA_12812599-71bd-48c7-824e-26cc6feafcb3"
      unitRef="number">0.0093</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:ShortTermBorrowings
      contextRef="i06c55fa5097f4b26aaa7bc551ed8d8ef_I20211231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDAyMQ_73539cff-9fae-4df4-a124-ec2dc5d5b9ec"
      unitRef="usd">1170000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentTerm
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODcwNw_1e273e61-a3ae-4e3b-87f4-1d2ff5019069">P2M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDE3Nw_8a22e23d-32af-4faf-a40d-7b19cf664b87"
      unitRef="number">0.0032</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3f327e88a9264251811af5db4463a246_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDMwMQ_8c1586d6-d3cd-422d-8f14-02120427beff"
      unitRef="usd">4700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDMwMQ_f89ff695-267f-4d79-85ca-239df452d2f5"
      unitRef="usd">4700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODY5NA_37b3f6d7-ebc0-4f91-951e-7588e338aca3">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the Company&#x2019;s senior unsecured notes repurchases and redemptions during the year ended December&#160;31, 2021 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payoff Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 19, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 19, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 26, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 26, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 26, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 28, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 28, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 28, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Upon repurchasing a portion of the 3.40% and 4.00% senior unsecured notes due 2025, the Company recognized a $61&#160;million loss on debt extinguishment during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Upon completing the repurchases and redemptions of all outstanding 4.25%, 4.20%, and 3.88% senior unsecured notes due 2023 and 2024, the Company recognized a $164&#160;million loss on debt extinguishment during the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt; (dollars in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 24, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 12, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i25a6dbcdd6414960b06cbb782d9985c4_I20210519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMS0yLTEtMS0xMDc4NDI_e5f7770c-d2e7-4896-a6e7-7b6f2ca4d06e"
      unitRef="usd">251806000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i25a6dbcdd6414960b06cbb782d9985c4_I20210519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMS00LTEtMS0xMDc4NDI_d5725651-62f8-4bf3-b890-850dd7bb078a"
      unitRef="number">0.0340</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic508faac831b42f2b021bb57d04db552_I20210519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMi0yLTEtMS0xMDc4NDI_54bd1d24-7289-4591-802c-f780192dd898"
      unitRef="usd">298194000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic508faac831b42f2b021bb57d04db552_I20210519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMi00LTEtMS0xMDc4NDI_bc6fd1bc-13cb-4bdb-ae05-dda6f26e9ad6"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i129edcf0ec22460cbebd897c6f2231cd_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMy0yLTEtMS0xMDc4NDI_3ac42a47-7783-4572-bb1e-7af567e3507d"
      unitRef="usd">188000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i129edcf0ec22460cbebd897c6f2231cd_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfMy00LTEtMS0xMDc4NDI_9ff375d0-1d8a-4b02-b7f2-54aec9ce15e0"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9cd5e36259d94f569780a9bbfeeb56e6_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNC0yLTEtMS0xMDc4NDI_0bab9f9d-81d3-4941-95fe-4038c416d988"
      unitRef="usd">149000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9cd5e36259d94f569780a9bbfeeb56e6_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNC00LTEtMS0xMDc4NDI_ccc0e523-a3bf-495a-aa0c-69b2c881eaf4"
      unitRef="number">0.0420</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i58b767842f4c4d8cae721f9d090787f9_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNS0yLTEtMS0xMDc4NDI_7d45a94c-08a5-472e-bc7b-94fc81bc48f4"
      unitRef="usd">331000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i58b767842f4c4d8cae721f9d090787f9_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNS00LTEtMS0xMDc4NDI_c71fa35b-e982-4a6f-b287-dca501cc7714"
      unitRef="number">0.0388</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia10cfac217664164a5ce11935398e38c_I20210128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNi0yLTEtMS0xMDc4NDI_e24df5f5-ef13-4a88-8105-c77afcba476f"
      unitRef="usd">112000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia10cfac217664164a5ce11935398e38c_I20210128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNi00LTEtMS0xMDc4NDI_c59f3967-2097-4935-806e-dc0b583053a2"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie15a32184ddc4244aafcaee4d492a613_I20210128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNy0yLTEtMS0xMDc4NDI_41c65e20-fb43-48b2-95f7-cc648f3442bd"
      unitRef="usd">201000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie15a32184ddc4244aafcaee4d492a613_I20210128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfNy00LTEtMS0xMDc4NDI_068a1305-ae92-4b8e-992a-c123d5024c9d"
      unitRef="number">0.0420</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ife6442aff2a64388a38b157c25a0b7c8_I20210128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfOC0yLTEtMS0xMDc4NDI_e1d8304b-698c-475b-8603-94812ebff41a"
      unitRef="usd">469000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ife6442aff2a64388a38b157c25a0b7c8_I20210128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmJhZjRlZjk1MTE3MjQyMzdiYmM5ZGY5NjkzNDcwZGY3L3RhYmxlcmFuZ2U6YmFmNGVmOTUxMTcyNDIzN2JiYzlkZjk2OTM0NzBkZjdfOC00LTEtMS0xMDc4NDI_8a646810-6d8c-4415-9cfd-6897423e5d5b"
      unitRef="number">0.0388</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i25a6dbcdd6414960b06cbb782d9985c4_I20210519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDc4MA_0867b6da-21ff-4569-b2ca-15ab7b7566b1"
      unitRef="number">0.0340</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic508faac831b42f2b021bb57d04db552_I20210519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDc4Nw_f2f46636-76d1-4d09-acf0-e4b305e4dccb"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i474fd2e8b00742c492b5f0a58c583148_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDg0OA_e2e3832c-8a39-44e2-a185-6f03b95ccf6f"
      unitRef="usd">-61000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i129edcf0ec22460cbebd897c6f2231cd_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDk3Nw_90238dd8-d44b-4094-b630-57bbea99d8fc"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9cd5e36259d94f569780a9bbfeeb56e6_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDk4MQ_7ebaad90-1525-4858-9ac1-780cdb3c63d0"
      unitRef="number">0.0420</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i58b767842f4c4d8cae721f9d090787f9_I20210226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNDk4OQ_c7b7a647-e7d7-4fa2-b276-729ceb38df25"
      unitRef="number">0.0388</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i50e3cb94a01d48daa97d3bd61e3eb616_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNTA1OQ_be7bf32a-8bd5-4bf0-b14c-fa8187f26234"
      unitRef="usd">-164000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <peak:NumberOfBondOfferings
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTA5OTUxMTY0MTczMg_144fa062-5b00-4758-b3d8-31f2322a2631"
      unitRef="bond">2</peak:NumberOfBondOfferings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie4b8cef65132475f95dc36c24f9a9820_I20211124"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOjgzZDA4MTI2ZjNiMTRkNmE5MGQxZDk5M2JlOTllZjU3L3RhYmxlcmFuZ2U6ODNkMDgxMjZmM2IxNGQ2YTkwZDFkOTkzYmU5OWVmNTdfMS0yLTEtMS0xMjg5OTc_bd187875-3400-47fa-b0f2-5f9d44b2bdc0"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie4b8cef65132475f95dc36c24f9a9820_I20211124"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOjgzZDA4MTI2ZjNiMTRkNmE5MGQxZDk5M2JlOTllZjU3L3RhYmxlcmFuZ2U6ODNkMDgxMjZmM2IxNGQ2YTkwZDFkOTkzYmU5OWVmNTdfMS00LTEtMS0xMjg5OTc_02b38528-6733-4012-9474-26c63b211928"
      unitRef="number">0.0213</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic42f1d80f9104fb9a68ce6b17b49241f_I20210712"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOjgzZDA4MTI2ZjNiMTRkNmE5MGQxZDk5M2JlOTllZjU3L3RhYmxlcmFuZ2U6ODNkMDgxMjZmM2IxNGQ2YTkwZDFkOTkzYmU5OWVmNTdfMS0yLTEtMS0xMDc4NDI_145a0748-c821-4858-91ab-28008cb4b812"
      unitRef="usd">450000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic42f1d80f9104fb9a68ce6b17b49241f_I20210712"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOjgzZDA4MTI2ZjNiMTRkNmE5MGQxZDk5M2JlOTllZjU3L3RhYmxlcmFuZ2U6ODNkMDgxMjZmM2IxNGQ2YTkwZDFkOTkzYmU5OWVmNTdfMS00LTEtMS0xMDc4NDI_e39063e6-0a22-4870-bb0b-2b5f5c1dcfe5"
      unitRef="number">0.0135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjM3MA_1bfd0c33-d1b4-414f-a056-38c88daff16d"
      unitRef="usd">349000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iabee9c868d9c47cba2cc55a571bc034f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjM3Nw_6f1bb4ab-d9b9-4bab-b33f-52d8ab74a28f"
      unitRef="usd">350000000</us-gaap:DebtInstrumentCarryingAmount>
    <peak:DebtInstrumentCollateralHealthcareFacilitiesNumber
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjU0Nw_7ab632fa-1216-4036-8c99-df2733e14e9a"
      unitRef="facility">18</peak:DebtInstrumentCollateralHealthcareFacilitiesNumber>
    <peak:DebtInstrumentCollateralHealthcareFacilitiesNumber
      contextRef="iabee9c868d9c47cba2cc55a571bc034f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjU0Nw_9aa177a6-7cce-4973-9e82-0b5b7e1d1bb9"
      unitRef="facility">18</peak:DebtInstrumentCollateralHealthcareFacilitiesNumber>
    <peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjYzMA_68c2677b-619d-40ad-a525-27b68006deca"
      unitRef="usd">803000000</peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue>
    <peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue
      contextRef="iabee9c868d9c47cba2cc55a571bc034f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNjYzNw_c2f687a0-84c6-4ca9-b0c3-b2d581e02947"
      unitRef="usd">811000000</peak:DebtInstrumentCollateralHealthcareFacilitiesCarryingValue>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i4d184f2e01164a51b230c30bd85a30d0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNzM5MQ_1c3096e6-a58c-4dae-91da-d4351bda4ba1"
      unitRef="usd">1000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i030603e4f5a54153b34a35b3214082f5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfNzM5MQ_4863ca1a-51a2-4be2-9446-7e56be8f1aed"
      unitRef="usd">1000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icfc6fff323874884beaa90a4c80a3577_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMzQwODQ4NjA0NzkyNzg_b76a183e-c3ac-410a-babe-ae646e079908"
      unitRef="usd">142000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i3a84667f31d1411fa0eb153b19912c8e_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfMTY0OTI2NzQ1ODk0NQ_1fa3d627-a937-40af-aae7-7c20adc0a340"
      unitRef="derivativeheld">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODY5MQ_ba10b7b7-6db8-4f01-9d0a-57f34ce4c551">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s stated debt maturities and scheduled principal repayments at March&#160;31, 2022 (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Senior Unsecured&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Mortgage&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Bank Line&#160;of&lt;br/&gt;Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Commercial Paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;803,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;244,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,225,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,250,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,379,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Discounts), premium and debt costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,654,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,335,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Commercial Paper Program borrowings are backstopped by the Revolving Facility. As such, the Company calculates the weighted average remaining term of its Commercial Paper Program borrowings using the maturity date of the Revolving Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective interest rates on the senior unsecured notes range from 1.54% to 6.91% with a weighted average effective interest rate of 3.39% and a weighted average maturity of 7 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective interest rates on the mortgage debt range from 2.72% to 5.91% with a weighted average effective interest rate of 3.36% and a weighted average maturity of 4 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0yLTEtMS0xMDc4NDI_d20a6bbd-218e-4ffb-b531-79a17c4753cb"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi00LTEtMS0xMDc4NDI_6eacb2be-80e3-444e-80fe-ac0cdb687d03"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi04LTEtMS0xMDc4NDI_12f20136-e786-46ae-b167-2874cf2e69c5"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2e027636867a4aa5b3815ba06a2d6117_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0xMC0xLTEtMTA3ODQy_d95e366a-309a-4a53-9718-dc8868f4631e"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0xMi0xLTEtMTA3ODQy_b0616127-73f7-44f1-8341-a835d0902aea"
      unitRef="usd">3778000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i501441e9c9d04464a5eb510bce4935e3_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0xNC0xLTEtMTA3ODQy_330b2096-773f-457b-b5c2-7f6e5c984311"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMi0xNi0xLTEtMTA3ODQy_a185654b-534f-4dc6-9692-eede74f2cff6"
      unitRef="usd">3778000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0yLTEtMS0xMDc4NDI_3297bb90-461f-4e81-b368-173ce8916930"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy00LTEtMS0xMDc4NDI_7c56fbaf-fc7f-4f0a-9a14-d33ee4cef66d"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy04LTEtMS0xMDc4NDI_651aa128-b78d-428c-af1c-80ccf4251120"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i51db4181e1b54a7b863ce08ec4787ea6_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0xMC0xLTEtMTA3ODQy_24f4b4e6-28ee-42a6-bf71-19877bff10b8"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0xMi0xLTEtMTA3ODQy_167d8af5-fbfc-49ac-9e19-4915df596eb5"
      unitRef="usd">90089000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id9a046d474cb44979dcf512ddc3fabb3_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0xNC0xLTEtMTA3ODQy_252f7746-d2ba-4ffb-8a10-60a600165006"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMy0xNi0xLTEtMTA3ODQy_fa016e97-446d-4fea-ae2f-ece633b4ab8a"
      unitRef="usd">90089000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0yLTEtMS0xMDc4NDI_1abeea4b-39ca-4292-9b3e-bf15d52d0337"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC00LTEtMS0xMDc4NDI_269f8f58-433f-493a-98df-775a9eb69157"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC04LTEtMS0xMDc4NDI_91609d16-6957-42ac-80f3-e0e8730edd39"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5faeb218c7d04966869e0fe60f447e98_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0xMC0xLTEtMTA3ODQy_cb208a89-ee12-464b-8ff3-af5a95bb08f3"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0xMi0xLTEtMTA3ODQy_f43d69f6-b53a-4de9-8de4-10d30aa1f3d8"
      unitRef="usd">7024000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic626427f6d62400986df856754ecbb17_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0xNC0xLTEtMTA3ODQy_0da456be-cfb3-4e5e-b626-08c7224b9269"
      unitRef="number">0.0381</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNC0xNi0xLTEtMTA3ODQy_bfd2a6b5-9a92-4b08-be46-3509723ceb60"
      unitRef="usd">7024000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0yLTEtMS0xMDc4NDI_005f7109-abcb-467b-aba6-1592c5b79647"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS00LTEtMS0xMDc4NDI_9743c539-371c-4785-a20b-a2ca8529bb0f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS04LTEtMS0xMDc4NDI_76606d76-32eb-46c8-8d16-3c99c8047f8a"
      unitRef="usd">800000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9fab30ca14f54624bfd030cd08d1042b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0xMC0xLTEtMTA3ODQy_d970ce25-c86c-4288-8593-3b2d6e565593"
      unitRef="number">0.0393</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0xMi0xLTEtMTA3ODQy_9ecd4672-b46b-43a4-a19b-32d0368e9d08"
      unitRef="usd">3209000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id5fb318dd82744438c5d3c43a0a334fa_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0xNC0xLTEtMTA3ODQy_37f9c9d4-9b4f-4e33-9704-b22c3b47af28"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNS0xNi0xLTEtMTA3ODQy_4a7ca519-c1b1-4309-ad7c-3b34c616cbe7"
      unitRef="usd">803209000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0yLTEtMS0xMDc4NDI_db2b6c66-b3dd-4200-bd01-3c6c0c666f2c"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi00LTEtMS0xMDc4NDI_29581913-05c0-487f-9d20-d14b18f20366"
      unitRef="usd">1330813000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi04LTEtMS0xMDc4NDI_597462c7-1f4d-45b6-8acf-8e87706de036"
      unitRef="usd">650000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6ee0feb90e464607b8cd21230c30e359_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0xMC0xLTEtMTA3ODQy_59154e91-5a92-4496-add8-e54768813e97"
      unitRef="number">0.0339</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0xMi0xLTEtMTA3ODQy_6c3f7edf-8029-4f7b-8877-d8b47d1d9f15"
      unitRef="usd">244523000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6b0beada91ec4b9783bd3b82faeb791f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0xNC0xLTEtMTA3ODQy_5e175e99-ff1a-4f2e-a339-4db327c5ae14"
      unitRef="number">0.0311</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNi0xNi0xLTEtMTA3ODQy_58908f80-925d-4236-bf60-d68dab90b603"
      unitRef="usd">2225336000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0yLTEtMS0xMDc4NDI_e163136d-9a9f-46b3-943f-c374f880778b"
      unitRef="usd">0</peak:LongTermDebtMaturityAfterYearFour>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy00LTEtMS0xMDc4NDI_e29679d5-9d7d-4a05-b2c5-133d827896e7"
      unitRef="usd">0</peak:LongTermDebtMaturityAfterYearFour>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy04LTEtMS0xMDc4NDI_a776e4a7-7055-4d43-8765-b1f72d0b5d14"
      unitRef="usd">3250000000</peak:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia75891e9a77c482caedf11f0b1cc4f02_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0xMC0xLTEtMTA3ODQy_19d58531-d15d-4318-8913-fd0b754560ce"
      unitRef="number">0.0324</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0xMi0xLTEtMTA3ODQy_de5f7db1-1564-4ebb-943f-a183db6ec8a7"
      unitRef="usd">366000</peak:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic80ffcee88b3410c985f4e65c0eee19c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0xNC0xLTEtMTA3ODQy_63ae36c3-7ec3-4cc4-81fe-98c4d02c42e9"
      unitRef="number">0.0591</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <peak:LongTermDebtMaturityAfterYearFour
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfNy0xNi0xLTEtMTA3ODQy_144332ec-c04e-4b74-a790-c6906cc071d3"
      unitRef="usd">3250366000</peak:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC0yLTEtMS0xMDc4NDI_052e4819-71a7-4c1b-811f-d0e74ea74a60"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC00LTEtMS0xMDc4NDI_28cc6160-07ff-445c-bbdb-be7efb3a5b12"
      unitRef="usd">1330813000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC04LTEtMS0xMDc4NDI_fb679b0e-b088-4c62-919e-f68ae63f35bc"
      unitRef="usd">4700000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC0xMi0xLTEtMTA3ODQy_6c223641-3f4a-4fb3-910c-e6bba5d2ce91"
      unitRef="usd">348989000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOC0xNi0xLTEtMTA3ODQy_10150e7a-a562-4379-ac04-168c38438df0"
      unitRef="usd">6379802000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS0yLTEtMS0xMDc4NDI_14b55847-ae5f-43db-97c4-848d726703e1"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS00LTEtMS0xMDc4NDI_bea617b6-6e80-457b-8db2-bd3af312c915"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS04LTEtMS0xMDc4NDI_4163d1fe-03b7-4895-8ea4-57a8ce943476"
      unitRef="usd">45944000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS0xMi0xLTEtMTA3ODQy_c65f36c0-b8f1-439c-ac22-bcf6b941b669"
      unitRef="usd">-1724000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfOS0xNi0xLTEtMTA3ODQy_d7a6610a-a036-49e9-ae1f-b8eb9f806dc9"
      unitRef="usd">44220000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermDebt
      contextRef="ice54f9998d0c43e8b7423fa1683f6226_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItMi0xLTEtMTA3ODQy_b0fd06b3-73fc-45e5-b4f4-d7a424efd8ea"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic986df063c7f4cd9b87a2ea72a14eeed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItNC0xLTEtMTA3ODQy_1727fc8a-77fa-4af8-aac8-a94c0f49d467"
      unitRef="usd">1330813000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItOC0xLTEtMTA3ODQy_0b3ca1c8-3251-49b1-8bdc-0809a7aa8d93"
      unitRef="usd">4654056000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItMTItMS0xLTEwNzg0Mg_be39c791-26dc-4fa0-b44f-b7a26993fdc2"
      unitRef="usd">350713000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RhYmxlOmEyZTY1ZTE2MDU4NjRlMjE4NGQzNWM1NmM3MzVlMjE5L3RhYmxlcmFuZ2U6YTJlNjVlMTYwNTg2NGUyMTg0ZDM1YzU2YzczNWUyMTlfMTItMTYtMS0xLTEwNzg0Mg_383b9588-80b0-4255-8a21-4605d7a3dbaa"
      unitRef="usd">6335582000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id155f3c6d1834c9fa8fe36e4b805553a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQyNg_e8cdc6d3-5582-46f1-9391-278b65aae0df"
      unitRef="number">0.0154</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i36d2ca6669b54c32aa2aad64db99b30d_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQzMg_9fad855d-ea56-4fe4-9285-43ae8ba54835"
      unitRef="number">0.0691</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i017fec98dd774d41900ae8973e5e99b1_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODQ4Ng_718e772a-c6af-40e9-ac52-7bbce0230f94"
      unitRef="number">0.0339</us-gaap:DebtWeightedAverageInterestRate>
    <peak:DebtInstrumentWeightedAverageMaturity
      contextRef="ie30fa114a84041be913e6a006cbdb670_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODUyNA_f0ff9f96-4d80-4c35-832b-1491a5aa766f">P7Y</peak:DebtInstrumentWeightedAverageMaturity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5441692de9104c1f8876f6126bb3cd18_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODU4Ng_2ced4df7-a890-475e-aba7-5e4e00a76bf1"
      unitRef="number">0.0272</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id9703e7c732740bb93115889bd6185b4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODU5Mg_85a526e1-f839-40d5-bc56-bfed88f43844"
      unitRef="number">0.0591</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="iea6c0660aff54ba4b24294d1a82e7306_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODY0Ng_e87bb3d1-4055-42f1-a4d6-46ddc67b1d2b"
      unitRef="number">0.0336</us-gaap:DebtWeightedAverageInterestRate>
    <peak:DebtInstrumentWeightedAverageMaturity
      contextRef="i030603e4f5a54153b34a35b3214082f5_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82MS9mcmFnOjYzMWY3MmNkMmI1NzQ1MjRhMjljNzEzMDg0Mjk0YjE4L3RleHRyZWdpb246NjMxZjcyY2QyYjU3NDUyNGEyOWM3MTMwODQyOTRiMThfODY4NA_7ee40f97-d0cf-4f8f-80dd-013e4c2a9e08">P4Y</peak:DebtInstrumentWeightedAverageMaturity>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82NC9mcmFnOmE4YjZmMTg4MDk2ZjQzYzg5MmVlODY1OWIxOWY2YWNhL3RleHRyZWdpb246YThiNmYxODgwOTZmNDNjODkyZWU4NjU5YjE5ZjZhY2FfMTc3MQ_41d88b02-cbb4-4270-be7f-c1c29272ea3a">Commitments and Contingencies&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is a party to legal proceedings, lawsuits and other claims that arise in the ordinary course of the Company&#x2019;s business. The Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company&#x2019;s financial condition, results of operations, or cash flows. The Company&#x2019;s policy is to expense legal costs as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%"&gt;DownREITs and Other Partnerships&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the formation of certain limited liability companies (&#x201c;DownREITs&#x201d;), members may contribute appreciated real estate to a DownREIT in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the member. However, if a contributed property is later sold by the DownREIT, the unamortized pre-contribution gain that exists at the date of sale is specifically allocated and taxed to the contributing members. In many of the DownREITs, the Company has entered into indemnification agreements with those members who contributed appreciated property into the DownREIT. Under these indemnification agreements, if any of the appreciated real estate contributed by the members is sold by the DownREIT in a taxable transaction within a specified number of years, the Company will reimburse the affected members for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected member under the Internal Revenue Code (&#x201c;make-whole payments&#x201d;). These make-whole payments include a tax gross-up provision. These indemnification agreements have expirations terms that range through 2039 on a total of 29 properties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the Company owns a 49% interest in the Life Science JV (see Note 7). If the property in the joint venture is sold in a taxable transaction, the Company is generally obligated to indemnify its joint venture partner for its federal and state income taxes associated with the gain that existed at the time of the contribution to the joint venture.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <peak:ContributionOfPropertyNumberOfProperties
      contextRef="ic49d297efbc04b4899a13cad1f112a0b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82NC9mcmFnOmE4YjZmMTg4MDk2ZjQzYzg5MmVlODY1OWIxOWY2YWNhL3RleHRyZWdpb246YThiNmYxODgwOTZmNDNjODkyZWU4NjU5YjE5ZjZhY2FfMTc1Mg_f6033248-5192-4780-b226-358215f21fe8"
      unitRef="property">29</peak:ContributionOfPropertyNumberOfProperties>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="if6dac57d2d904eef8d5d5c6d6d560074_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82NC9mcmFnOmE4YjZmMTg4MDk2ZjQzYzg5MmVlODY1OWIxOWY2YWNhL3RleHRyZWdpb246YThiNmYxODgwOTZmNDNjODkyZWU4NjU5YjE5ZjZhY2FfMTA5OTUxMTYzMDA3Nw_ea5410d1-b8dc-4493-b819-42da8befc11e"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNjI1MQ_c1ae0527-a1f0-40d8-b797-5ee4606c5040">Equity and Redeemable Noncontrolling Interests&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 28, 2022, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.30 per share. The common stock cash dividend will be paid on May 20, 2022 to stockholders of record as of the close of business on May 9, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022 and 2021, the Company declared and paid common stock cash dividends of $0.30&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;At-The-Market Equity Offering Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company established an at-the-market equity offering program (as amended from time to time, the &#x201c;ATM Program&#x201d;), which was most recently amended in May 2021 to increase the size of the program from $1.25&#160;billion to $1.5 billion, pursuant to which shares of common stock having an aggregate gross sales price of up to $1.5 billion may be sold (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement (each, an &#x201c;ATM forward contract&#x201d;). The use of ATM forward contracts allows the Company to lock in a share price on the sale of shares at the time the ATM forward contract is effective, but defer receiving the proceeds from the sale of shares until a later date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ATM forward contracts generally have a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTUzNQ_ad0445ae-2c5c-4d27-bf22-90d9ea20d009"&gt;one&lt;/span&gt; to two year term. At any time during the term, the Company may settle a forward sale by delivery of physical shares of common stock to the forward seller or, at the Company&#x2019;s election, in cash or net shares. The forward sale price the Company expects to receive upon settlement of outstanding ATM forward contracts will be the initial forward price established upon the effective date, subject to adjustments for: (i) accrued interest, (ii) the forward purchasers&#x2019; stock borrowing costs, and (iii) certain fixed price reductions during the term of the ATM forward contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022, $1.18 billion&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the Company&#x2019;s common stock remained available for sale under the ATM Program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ATM Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company utilized the forward provisions under the ATM Program to allow for the sale of an aggregate of 9.1&#160;million shares of its common stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;at an initial weighted average net price of $35.25 per share, after commissions. During the three months ended March&#160;31, 2022, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;no shares were settled under ATM forward contracts. Therefore, at &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2022, 9.1&#160;million shares remained outstanding under ATM forward contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, the Company did not utilize the forward provisions under the ATM Program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ATM Direct Issuances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022 and March&#160;31, 2021, no shares of common stock were issued under the ATM Program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s accumulated other comprehensive income (loss) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplemental Executive Retirement Plan minimum liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Arrangements with noncontrolling interest holders are assessed for appropriate balance sheet classification based on the redemption and other rights held by the noncontrolling interest holder. Certain of the Company&#x2019;s noncontrolling interest holders have the ability to put their equity interests to the Company upon specified events or after the passage of a predetermined period of time. Each put option is payable in cash and subject to increases in redemption value in the event that the underlying property generates specified returns for the Company and meets certain promote thresholds pursuant to the respective agreements. Accordingly, the Company records redeemable noncontrolling interests outside of permanent equity and presents the redeemable noncontrolling interests at the greater of their carrying amount or redemption value at the end of each reporting period.&lt;/span&gt;&lt;/div&gt;During the year ended December&#160;31, 2021, one of the redeemable noncontrolling interests met the conditions for redemption and the related put option was exercised during the year then ended. Accordingly, the Company made a cash payment for the redemption value of $60&#160;million to the related noncontrolling interest holder during the year ended December&#160;31, 2021 and acquired the redeemable noncontrolling interest associated with this entity. The remaining redeemable noncontrolling interests had not yet met the conditions for redemption as of March&#160;31, 2022 or December&#160;31, 2021. Three of the interests will become redeemable following the passage of a predetermined amount of time, one of which will occur in late 2022, and the remaining two in 2023 and 2024. The fourth interest will become redeemable at the earlier of a predetermined passage of time or stabilization of the underlying development property, which is expected to occur in 2023. The redemption values are subject to change based on the assessment of value at each redemption date.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5bda4a0f83814d708728819ca12b1868_D20220428-20220428"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTgz_3f495259-b232-487b-b9d6-26c8770c8378"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNDM5_07938cf7-fa88-4af8-a9c4-e2bce68c0f11"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNDM5_a8eafdda-6760-44c4-b4e1-dd13ae273f9d"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNDM5_be47f767-6323-4fb1-84bb-37b8cf1b368d"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNDM5_c3f859e8-312a-4023-8b90-39c5d6879667"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareCashPaid>
    <peak:AtmEquityOfferingProgramAggregateAmountAuthorized
      contextRef="i9c682ca877614372ac5d6a9eb54b1447_D20210430-20210430"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfODcx_d2c0a55f-2efa-4517-90e3-8fde7790fb0f"
      unitRef="usd">1250000000</peak:AtmEquityOfferingProgramAggregateAmountAuthorized>
    <peak:AtmEquityOfferingProgramAggregateAmountAuthorized
      contextRef="ib6bdb41bc18341e4874c99a5317a7474_D20210501-20210531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfODc3_1d96418f-6464-49f2-89c0-8f811ae51d81"
      unitRef="usd">1500000000</peak:AtmEquityOfferingProgramAggregateAmountAuthorized>
    <peak:AtmEquityOfferingProgramAggregateAmountAuthorized
      contextRef="ib6bdb41bc18341e4874c99a5317a7474_D20210501-20210531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfOTY5_1d96418f-6464-49f2-89c0-8f811ae51d81"
      unitRef="usd">1500000000</peak:AtmEquityOfferingProgramAggregateAmountAuthorized>
    <peak:OptionIndexedToIssuersEquityTerm
      contextRef="i133dad541e4940469495f91e54645b82_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNjI2MQ_1ff18c0c-3a7d-4eb0-aca3-965a6ca7f5ff">P2Y</peak:OptionIndexedToIssuersEquityTerm>
    <peak:ATMEquityOfferingProgramAggregateAmountRemaining
      contextRef="i8c9910ca8e3c43b58498430b0d7f692c_D20220101-20220331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjExOA_a45a8be0-8cc4-47b5-a406-2b722d74133b"
      unitRef="usd">1180000000</peak:ATMEquityOfferingProgramAggregateAmountRemaining>
    <us-gaap:ForwardContractIndexedToIssuersEquityShares
      contextRef="i50abcbcb64fb40e899abb71cbd6e3653_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjM3Mw_c6f252f8-1d25-4026-a780-0190c9c3ce3a"
      unitRef="shares">9100000</us-gaap:ForwardContractIndexedToIssuersEquityShares>
    <us-gaap:ForwardContractIndexedToIssuersEquityForwardRate
      contextRef="i50abcbcb64fb40e899abb71cbd6e3653_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjQ0Nw_8b056961-3519-4586-9e0b-da65e5724143"
      unitRef="usdPerShare">35.25</us-gaap:ForwardContractIndexedToIssuersEquityForwardRate>
    <us-gaap:ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue
      contextRef="i72cbe3fbdd9d4520b3ee1c9882ee17d6_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjUxMQ_927ab3c4-f2e6-4570-a29d-18eea8399a6c"
      unitRef="shares">0</us-gaap:ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue>
    <peak:ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares
      contextRef="i72cbe3fbdd9d4520b3ee1c9882ee17d6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMjU4MQ_5deea4cd-acc3-49be-a86a-c68c889f03a7"
      unitRef="shares">9100000</peak:ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="idbbd3434631b45fa866d0cbaac25a52f_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMzQ1NA_0e334e15-e797-4790-b5d2-5852c86d506c"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic7bb6050b89c41c0a9f564585e588a65_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMzQ1NA_bd25c4ce-f677-4d27-afb5-34fefaff700b"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNjI1MA_3485bdf9-e0e1-4345-b7b0-44d0d4751705">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s accumulated other comprehensive income (loss) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplemental Executive Retirement Plan minimum liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RhYmxlOjEzMjkzODIwNmU2YTRlZmFiYTEwNzJjODlmNGJiYWI0L3RhYmxlcmFuZ2U6MTMyOTM4MjA2ZTZhNGVmYWJhMTA3MmM4OWY0YmJhYjRfMy0xLTEtMS0xMDc4NDI_d054c701-d4c9-4a0a-a853-2fb259bc5fda"
      unitRef="usd">3047000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RhYmxlOjEzMjkzODIwNmU2YTRlZmFiYTEwNzJjODlmNGJiYWI0L3RhYmxlcmFuZ2U6MTMyOTM4MjA2ZTZhNGVmYWJhMTA3MmM4OWY0YmJhYjRfMy0zLTEtMS0xMDc4NDI_03c6a026-cad7-48a4-8a63-03f680c53ab3"
      unitRef="usd">3147000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RhYmxlOjEzMjkzODIwNmU2YTRlZmFiYTEwNzJjODlmNGJiYWI0L3RhYmxlcmFuZ2U6MTMyOTM4MjA2ZTZhNGVmYWJhMTA3MmM4OWY0YmJhYjRfNS0xLTEtMS0xMDc4NDI_075c7620-0bab-42be-8a50-0565ec429a58"
      unitRef="usd">-3047000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RhYmxlOjEzMjkzODIwNmU2YTRlZmFiYTEwNzJjODlmNGJiYWI0L3RhYmxlcmFuZ2U6MTMyOTM4MjA2ZTZhNGVmYWJhMTA3MmM4OWY0YmJhYjRfNS0zLTEtMS0xMDc4NDI_02d03f1c-17ef-403c-8d8f-b4d29a71b16e"
      unitRef="usd">-3147000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <peak:NumberOfRedeemableNoncontrollingInterestRedemptions
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTY0OTI2NzQ1MDAwNA_bb9867f8-d488-4b12-8a6d-875aaa72a912"
      unitRef="interest">1</peak:NumberOfRedeemableNoncontrollingInterestRedemptions>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTY0OTI2NzQ1MDAyMA_274ae29e-77ff-4b92-a8de-3df8301f2187"
      unitRef="usd">60000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfNTc4Nw_263aca11-124a-4c75-99e5-8efcb54f2fb1"
      unitRef="interest">3</peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime>
    <peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime
      contextRef="id2262290d71c48d7997b11506be11d2e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTA5OTUxMTY0MDA1Mw_b4878523-78a5-45b3-bc6c-78c6c055bc83"
      unitRef="interest">1</peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime>
    <peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime
      contextRef="i32ab0862bf034c7d9e3c84e8a429fc20_D20230101-20241231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF82Ny9mcmFnOmY4NDU5YjBmYjBmMDQ3NmNiNTJhMGVjNzNkZDMwZjM2L3RleHRyZWdpb246Zjg0NTliMGZiMGYwNDc2Y2I1MmEwZWM3M2RkMzBmMzZfMTA5OTUxMTY0MDA2MQ_81139581-bf15-4df9-a900-94c9f4ab852a"
      unitRef="interest">2</peak:NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjgxOQ_20749622-8bec-4c4b-965f-407390539e2f">Earnings Per Common Share&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income (loss) per common share (&#x201c;EPS&#x201d;) is computed based on the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed based on the weighted average number of common shares outstanding plus the impact of forward equity sales agreements using the treasury stock method and common shares issuable from the assumed conversion of DownREIT units, stock options, certain performance restricted stock units, and unvested restricted stock units. Only those instruments having a dilutive impact on the Company&#x2019;s basic income (loss) per share are included in diluted income (loss) per share during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock and certain performance restricted stock units are considered participating securities, because dividend payments are not forfeited even if the underlying award does not vest, and require use of the two-class method when computing basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 11 for a discussion of the sale of shares under and settlement of forward sales agreements during the periods presented. The Company considered the potential dilution resulting from the forward agreements to the calculation of earnings per share. At inception, the agreements do not have an effect on the computation of basic EPS as no shares are delivered until settlement. However, the Company uses the treasury stock method to calculate the dilution, if any, resulting from the forward sales agreements during the period of time prior to settlement. The aggregate effect on the Company&#x2019;s diluted weighted-average common shares for the&#160;three months ended March&#160;31, 2022 and 2021 was&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;zero weighted-average incremental shares from the forward equity sales agreements.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(120,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests' share in continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(123,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Participating securities' share in continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests' share in discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;538,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares - equity awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;538,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). &lt;/span&gt;&lt;/div&gt;For the three months ended March&#160;31, 2022, the 9.1 million shares under forward sales agreements that have not been settled as of March&#160;31, 2022 were anti-dilutive. For the three months ended March&#160;31, 2021, forward sales agreements had no dilutive impact as no shares remained outstanding under ATM forward contracts during the period.For the&#160;three months ended March&#160;31, 2022 and 2021, all 7 million shares issuable upon conversion of DownREIT units were not included because they were anti-dilutive.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMTY4MQ_6b1f0f42-c47e-44ea-8f5d-9db70fff7bc5"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements>
    <us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMTY4MQ_94e22af3-c5cd-4ff4-9357-a31a7d3c5d0b"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjgxNw_4636bda8-d58d-49ff-b698-50d463e5ba73">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(120,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests' share in continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(123,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Participating securities' share in continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests' share in discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;538,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares - equity awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;538,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) applicable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). &lt;/span&gt;&lt;/div&gt;For the three months ended March&#160;31, 2022, the 9.1 million shares under forward sales agreements that have not been settled as of March&#160;31, 2022 were anti-dilutive. For the three months ended March&#160;31, 2021, forward sales agreements had no dilutive impact as no shares remained outstanding under ATM forward contracts during the period.</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMy0xLTEtMS0xMDc4NDI_e1304f25-64a1-474e-ab3d-02fc894e739e"
      unitRef="usd">75026000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMy0zLTEtMS0xMDc4NDI_bb508e5d-fe93-4b79-9637-fc4929f89834"
      unitRef="usd">-120585000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNC0xLTEtMS0xMDc4NDI_34f6b568-ed19-45dc-9850-10fed2cf2a63"
      unitRef="usd">3730000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNC0zLTEtMS0xMDc4NDI_abe889d2-6b0b-4d39-bd11-bda1725e3305"
      unitRef="usd">3306000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNS0xLTEtMS0xMDc4NDI_d79e00fb-58df-43b4-ada8-4f6184ad834a"
      unitRef="usd">71296000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNS0zLTEtMS0xMDc4NDI_39616906-e680-4d1f-bc0d-a59941412ef0"
      unitRef="usd">-123891000</us-gaap:IncomeLossFromContinuingOperations>
    <peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNi0xLTEtMS0xMDc4NDI_d3f2a085-ff6e-412e-8dc1-b583efd5753b"
      unitRef="usd">1976000</peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted>
    <peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNi0zLTEtMS0xMDc4NDI_6c0fb101-dd26-457d-84f1-1578e01a359e"
      unitRef="usd">2451000</peak:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted>
    <peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNy0xLTEtMS0xMDc4NDI_650d5b4f-44a5-45b6-b4a9-892f5f7c61a6"
      unitRef="usd">69320000</peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic>
    <peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfNy0zLTEtMS0xMDc4NDI_122438b7-8045-4e68-a42f-7b920911d3a4"
      unitRef="usd">-126342000</peak:NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfOC0xLTEtMS0xMDc4NDI_bd53c987-90ae-45c3-8863-3c5c4c5f161c"
      unitRef="usd">317000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfOC0zLTEtMS0xMDc4NDI_3da6bd6a-835e-49a2-8931-3932a80f1a68"
      unitRef="usd">270008000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <peak:NoncontrollingInterestsShareInDiscontinuedOperations
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfOS0xLTEtMS0xMDc4NDI_21e10520-d014-43b0-ad91-793e702ce429"
      unitRef="usd">0</peak:NoncontrollingInterestsShareInDiscontinuedOperations>
    <peak:NoncontrollingInterestsShareInDiscontinuedOperations
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfOS0zLTEtMS0xMDc4NDI_24eaa7bf-06ac-4386-9de4-ed7a5261679b"
      unitRef="usd">-329000</peak:NoncontrollingInterestsShareInDiscontinuedOperations>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTAtMS0xLTEtMTA3ODQy_483a348c-40cc-4c6b-bc96-d7c1e45a1cd2"
      unitRef="usd">69637000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTAtMy0xLTEtMTA3ODQy_16f540ed-3fb6-4a6b-a0f2-f53190bd799e"
      unitRef="usd">143337000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTYtMS0xLTEtMTA3ODQy_e78a78a0-66a3-4c50-b839-5242213085c2"
      unitRef="shares">539352000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTYtMy0xLTEtMTA3ODQy_fbe4c80a-390b-4011-8cd0-0792d9d7bf2a"
      unitRef="shares">538679000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTctMS0xLTEtMTA3ODQy_2415c811-c1af-4bb3-af8c-49647b77d3b0"
      unitRef="shares">234000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMTctMy0xLTEtMTA3ODQy_d175157e-e168-42a6-a057-5805fc3a8291"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjAtMS0xLTEtMTA3ODQy_5df1576a-99fe-4239-be00-0a6b4dc791ab"
      unitRef="shares">539586000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjAtMy0xLTEtMTA3ODQy_0a4a2d50-ba7a-466c-b0d7-1a2234151e21"
      unitRef="shares">538679000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjItMS0xLTEtMTA3ODQy_fa633528-303b-47a7-948e-385eb8cceb73"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjItMy0xLTEtMTA3ODQy_a65064ec-d654-420f-a8c2-3a91a2d8b6ef"
      unitRef="usdPerShare">-0.23</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjMtMS0xLTEtMTA3ODQy_5553d415-4aba-4818-b86f-5d8e47e50552"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjMtMy0xLTEtMTA3ODQy_d89eaecd-b553-4c2f-ac1d-f16f3006570b"
      unitRef="usdPerShare">0.50</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjQtMS0xLTEtMTA3ODQy_cfe24b30-6832-4e15-a35e-2ca07e49ca8e"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjQtMy0xLTEtMTA3ODQy_02fd86ab-3d20-4c36-8f2a-2393067c6925"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjYtMS0xLTEtMTA3ODQy_4823911c-7686-4941-90df-b68ee09d4b90"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjYtMy0xLTEtMTA3ODQy_bb44bcfd-acfe-4323-8dd1-4f5e2a15b29e"
      unitRef="usdPerShare">-0.23</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjctMS0xLTEtMTA3ODQy_c49dea64-e3af-4fd5-b12a-6fa1f2151c3b"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjctMy0xLTEtMTA3ODQy_9aaeac19-dbc0-46e4-b126-41445b136166"
      unitRef="usdPerShare">0.50</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjgtMS0xLTEtMTA3ODQy_156ea970-1c17-4a52-9f95-0f22e6c1fd8c"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RhYmxlOjVmOGQ1ZDcwYmFlNjQ3YTJiZDlmNzhjZWY0NGExYmI0L3RhYmxlcmFuZ2U6NWY4ZDVkNzBiYWU2NDdhMmJkOWY3OGNlZjQ0YTFiYjRfMjgtMy0xLTEtMTA3ODQy_db84ef60-d53f-4587-8184-acf52175714b"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareDiluted>
    <peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjIxNQ_86a15d73-06f8-4e79-adb5-d5e4e36a6b09"
      unitRef="shares">1000000</peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards>
    <peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjIxNQ_df9a7035-c111-44b1-966d-07a3c975ed12"
      unitRef="shares">1000000</peak:IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjMyMQ_598d480b-3c2a-4df3-82e5-63da46660ccd"
      unitRef="shares">9100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <peak:IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjU3MA_92c1e049-1f3b-4a30-af00-f23c41b58b42"
      unitRef="shares">0</peak:IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib562c08096d84fc6a41f5ebd01b696fb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjcwNA_9d277a55-9be2-4062-a87f-719e2f579319"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id7b05b8400df430195d0de28217faac1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83MC9mcmFnOjc4MDgyOWU5ZDhhZjQ5NzM4ZjQxNDcyYjY3MzRlYTEwL3RleHRyZWdpb246NzgwODI5ZTlkOGFmNDk3MzhmNDE0NzJiNjczNGVhMTBfMjcwNA_ad834fe0-85ca-43c3-a7a9-597d7036d0e2"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RleHRyZWdpb246YmM2MmNkYmYyMDhiNDUzOGEyNjJhZjBiMTA0MGNhYmFfNDgzNA_ce8189df-7013-42f3-80fe-3ebe27fb24a3">Segment Disclosures&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reportable segments, based on how its chief operating decision makers (&#x201c;CODMs&#x201d;) evaluate the business and allocate resources, are as follows: (i) life science, (ii) medical office, and (iii) CCRC. The Company has non-reportable segments that are comprised primarily of the Company&#x2019;s interests in an unconsolidated JV that owns 19 senior housing assets (the &#x201c;SWF SH JV&#x201d;) and debt investments. The accounting policies of the segments are the same as those described in Note 2 to the Consolidated Financial Statements in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 filed with the SEC, as updated by Note 2 herein. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates performance based on property Adjusted NOI. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, income from direct financing leases, and government grant income and exclusive of interest income), less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss). Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims&#160;that have been incurred but not reported, and the impact of deferred community fee income and expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NOI and Adjusted NOI include the Company&#x2019;s share of income (loss) from unconsolidated joint ventures and exclude noncontrolling interests&#x2019; share of income (loss) from consolidated joint ventures. Management believes that Adjusted NOI is an important supplemental measure because it provides relevant and useful information by reflecting only income and operating expense items that are incurred at the property level and presenting it on an unlevered basis. Additionally, management believes that net income (loss) is the most directly comparable GAAP measure to NOI and Adjusted NOI. NOI and Adjusted NOI should not be viewed as alternative measures of operating performance to net income (loss) as defined by GAAP since they do not reflect various excluded items. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-segment assets consist of assets in the Company&#x2019;s other non-reportable segments and corporate non-segment assets. Corporate non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, loans receivable, marketable equity securities, other assets, real estate assets held for sale and discontinued operations, and liabilities related to assets held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize information for the reportable segments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CCRC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Non-reportable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Non-segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;498,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government grant income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(207,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(177,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments and loan loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Healthpeak&#x2019;s share of unconsolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Noncontrolling interests&#x2019; share of consolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#x2019;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#x2019; share of income (loss) generated by consolidated joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CCRC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Non-reportable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Non-segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;455,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government grant income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(91,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(181,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(157,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments and loan loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on debt extinguishments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(164,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(164,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Healthpeak&#x2019;s share of unconsolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(912)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Noncontrolling interests&#x2019; share of consolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(120,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;______________________________________________________________________________&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#x2019;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#x2019; share of income (loss) generated by consolidated joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Notes 3, 4, and 5 for significant transactions impacting the Company&#x2019;s segment assets during the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RleHRyZWdpb246YmM2MmNkYmYyMDhiNDUzOGEyNjJhZjBiMTA0MGNhYmFfMTA5OTUxMTYzNzE5MQ_3bfc2483-0ef4-4fd1-a710-1da31a24a613"
      unitRef="property">19</peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RleHRyZWdpb246YmM2MmNkYmYyMDhiNDUzOGEyNjJhZjBiMTA0MGNhYmFfNDg0NQ_10796e20-f806-4b29-a692-c1bf1cce1d21">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize information for the reportable segments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CCRC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Non-reportable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Non-segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;498,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government grant income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(207,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(299)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,837)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;132,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(177,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments and loan loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on sales of real estate, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Healthpeak&#x2019;s share of unconsolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Noncontrolling interests&#x2019; share of consolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#x2019;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#x2019; share of income (loss) generated by consolidated joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Life Science&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Office&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CCRC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Non-reportable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Non-segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;455,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government grant income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(91,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(181,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Healthpeak&#x2019;s share of unconsolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&#x2019; share of consolidated joint venture operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Adjustments to NOI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(68,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(157,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairments and loan loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain (loss) on debt extinguishments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(164,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(164,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Government grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Healthpeak&#x2019;s share of unconsolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(912)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plus: Noncontrolling interests&#x2019; share of consolidated joint venture NOI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity income (loss) from unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(120,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;______________________________________________________________________________&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents government grant income received under the CARES Act, which is recorded in other income (expense), net in the Consolidated Statements of Operations (see Note 2).&lt;/span&gt;&lt;/div&gt;(2)Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims&#160;that have been incurred but not reported, deferral of community fees, and termination fees. Includes the Company&#x2019;s share of income (loss) generated by unconsolidated joint ventures and excludes noncontrolling interests&#x2019; share of income (loss) generated by consolidated joint ventures.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS02LTEtMS0xMDc4NDI_340701f7-dea4-40aa-a9c7-a0acb0f50e31"
      unitRef="usd">194055000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS04LTEtMS0xMDc4NDI_6f4188db-897e-4a67-9b0f-45445e158840"
      unitRef="usd">177263000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS0xMC0xLTEtMTA3ODQy_06ba8907-b340-4ada-9918-d1dcc4575a4c"
      unitRef="usd">121560000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS0xMi0xLTEtMTA3ODQy_41c65f23-f56b-47bc-ad87-6871079d3278"
      unitRef="usd">5494000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS0xNC0xLTEtMTA3ODQy_644741aa-9132-4f02-8030-fe6d739820f4"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMS0xNi0xLTEtMTA3ODQy_117d80e5-4115-418d-8c5a-f54cf8a9e9a8"
      unitRef="usd">498372000</us-gaap:Revenues>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi02LTEtMS0xMDc4NDI_e279473b-62a7-4738-b920-0ef6e791a72c"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi04LTEtMS0xMDc4NDI_96eb7d8e-ef4c-468a-b859-c97fbca44483"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi0xMC0xLTEtMTA3ODQy_e3eca1c8-ab16-428d-a10c-be35d0ece496"
      unitRef="usd">6552000</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi0xMi0xLTEtMTA3ODQy_13de1c1d-6af5-4b9a-b3fb-b92704bfc674"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi0xNC0xLTEtMTA3ODQy_4b6d2c20-0e32-43f4-9825-198470959f3f"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMi0xNi0xLTEtMTA3ODQy_229523fc-c4cb-4687-b5c7-5de01cf58ef3"
      unitRef="usd">6552000</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy02LTEtMS0xMDc4NDI_13cfa413-4c89-4685-8701-660433d1203d"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy04LTEtMS0xMDc4NDI_fb067264-4f68-4ba0-b421-f82a632310fa"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy0xMC0xLTEtMTA3ODQy_d9af3c21-e396-4696-96af-22d3505f23d6"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy0xMi0xLTEtMTA3ODQy_2cdccbe6-cc1d-4e17-b8bd-325ed480c3f0"
      unitRef="usd">5494000</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy0xNC0xLTEtMTA3ODQy_fde6fa80-0126-42dc-b4ae-f9bbec471633"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMy0xNi0xLTEtMTA3ODQy_952774e3-7b06-46c8-b438-59cbb8c00c24"
      unitRef="usd">5494000</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC02LTEtMS0xMDc4NDI_044b39c7-ad65-4d9f-bfb2-fd305a058ac1"
      unitRef="usd">1431000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC04LTEtMS0xMDc4NDI_895dce07-e321-4854-b6e1-e21344cdcdf7"
      unitRef="usd">732000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC0xMC0xLTEtMTA3ODQy_ca6b3055-2759-4af8-84ca-2ea110d190f8"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC0xMi0xLTEtMTA3ODQy_fe76db82-5daa-4e0a-8d4b-850a72496f91"
      unitRef="usd">18045000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC0xNC0xLTEtMTA3ODQy_b18bf3cf-00fb-429f-9203-de6dbdd87fcf"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNC0xNi0xLTEtMTA3ODQy_d2a1f132-7734-4bcf-95bd-97712440d143"
      unitRef="usd">20208000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS02LTEtMS0xMDc4NDI_372a99e8-6b76-40eb-a0df-e9fe2f0f6e28"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS04LTEtMS0xMDc4NDI_0f3699f6-80e6-4a02-be97-03d0541e3fe7"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS0xMC0xLTEtMTA3ODQy_9a6eae55-5eb8-4453-8ef7-f7aad3922957"
      unitRef="usd">333000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS0xMi0xLTEtMTA3ODQy_02572e3d-fab2-4e77-818a-e03811dee1b7"
      unitRef="usd">315000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS0xNC0xLTEtMTA3ODQy_dada40d4-9068-4e5e-8100-f9c52a41a4a9"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNS0xNi0xLTEtMTA3ODQy_1a9a90ad-6b86-4ca7-8d6d-56762dc43cf3"
      unitRef="usd">648000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi02LTEtMS0xMDc4NDI_aac9b4a6-2003-4233-bbb1-033e0775e73a"
      unitRef="usd">57000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi04LTEtMS0xMDc4NDI_56adc384-1b7b-461e-81c6-961b536e9a03"
      unitRef="usd">8820000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi0xMC0xLTEtMTA3ODQy_c981f87c-e807-4c07-bad0-54a83771187e"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi0xMi0xLTEtMTA3ODQy_a93ebb33-5650-4789-8601-8115eade25c8"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi0xNC0xLTEtMTA3ODQy_1f6d5936-8927-4c7d-bb7b-67ff6bc6334a"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNi0xNi0xLTEtMTA3ODQy_27f216df-6ccb-4c39-9dcd-89388531a286"
      unitRef="usd">8877000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <us-gaap:OperatingExpenses
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy02LTEtMS0xMDc4NDI_54dcadd6-e8b4-4858-a946-de209a30f9a0"
      unitRef="usd">48189000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy04LTEtMS0xMDc4NDI_ad6a1a15-1ff1-4fb7-aaf8-a54bb789ce3b"
      unitRef="usd">61170000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy0xMC0xLTEtMTA3ODQy_b1c32ff3-9035-4293-88c2-9cf82255d2e8"
      unitRef="usd">97888000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy0xMi0xLTEtMTA3ODQy_7087ddb2-91e7-4ffd-ba67-f3635b078423"
      unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy0xNC0xLTEtMTA3ODQy_b4e8cae8-8e7c-46de-bafb-dd192f8f2dbe"
      unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfNy0xNi0xLTEtMTA3ODQy_58c99138-a6ae-4574-a311-246e9ac6274d"
      unitRef="usd">207247000</us-gaap:OperatingExpenses>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC02LTEtMS0xMDc4NDI_75905c39-eb56-4716-bc4a-c31d5f4a4341"
      unitRef="usd">483000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC04LTEtMS0xMDc4NDI_e9f1c839-e8fa-4b45-bbd6-addaa28c3351"
      unitRef="usd">299000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC0xMC0xLTEtMTA3ODQy_8e6a9515-6669-425e-9806-1f784a5a8979"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC0xMi0xLTEtMTA3ODQy_432cbb7a-9b73-4dfd-a5e4-c049308bbbe0"
      unitRef="usd">14055000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC0xNC0xLTEtMTA3ODQy_741d1703-959e-40a2-9f17-d217cee0401b"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOC0xNi0xLTEtMTA3ODQy_5e1b07c7-5f05-4273-85d9-cbf32bda29eb"
      unitRef="usd">14837000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS02LTEtMS0xMDc4NDI_d8163f19-dd53-4717-b25f-0701576da809"
      unitRef="usd">19000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS04LTEtMS0xMDc4NDI_59885c04-93c3-4278-a41b-d08e03b4372f"
      unitRef="usd">2602000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS0xMC0xLTEtMTA3ODQy_f28e7321-7e16-4a20-abcd-bbb913cce263"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS0xMi0xLTEtMTA3ODQy_5cf81f5b-94f5-4e8f-bd49-4746993b4db2"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS0xNC0xLTEtMTA3ODQy_acc5bb6f-ec3f-4bb9-8952-fb94993ea8c8"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfOS0xNi0xLTEtMTA3ODQy_a256b32e-d80b-4e21-93f2-ca55e88a2dd0"
      unitRef="usd">2621000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtNi0xLTEtMTA3ODQy_c22600de-2181-47e9-a398-2ec9164034aa"
      unitRef="usd">-14112000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtOC0xLTEtMTA3ODQy_d96e25d8-fc08-4e55-baee-8dba418162c8"
      unitRef="usd">-3546000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtMTAtMS0xLTEwNzg0Mg_e454a7b6-1fb0-409b-8a56-b93d0ecabdd9"
      unitRef="usd">0</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtMTItMS0xLTEwNzg0Mg_61fd0d5b-aadc-40df-8f92-7dfb141af8ae"
      unitRef="usd">-8000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtMTQtMS0xLTEwNzg0Mg_c7b734b7-0d4b-4df9-9b97-d1ec0a19316f"
      unitRef="usd">0</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTEtMTYtMS0xLTEwNzg0Mg_ae32f8e1-5cc1-4415-a82e-7470b2e4188b"
      unitRef="usd">-17666000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItNi0xLTEtMTA3ODQy_a233bb05-b7b0-429a-b551-e2500e57170a"
      unitRef="usd">132664000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItOC0xLTEtMTA3ODQy_5477d976-6f63-44e2-9af1-3f6e88eaf4d3"
      unitRef="usd">106762000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItMTAtMS0xLTEwNzg0Mg_76114c3c-d706-488d-a3b4-739824e0bf3b"
      unitRef="usd">30557000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItMTItMS0xLTEwNzg0Mg_45cd4bd8-e252-45b1-b626-c642d59d8846"
      unitRef="usd">4297000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItMTQtMS0xLTEwNzg0Mg_7830e28d-4ad7-4163-b94d-ec45f7b416f4"
      unitRef="usd">0</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTItMTYtMS0xLTEwNzg0Mg_c690a5be-6ed9-48b3-8c08-8eb7977e051a"
      unitRef="usd">274280000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtNi0xLTEtMTA3ODQy_4b7a6344-4dad-4fa1-86d0-d4bf3762169c"
      unitRef="usd">14112000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtOC0xLTEtMTA3ODQy_176c436e-b85f-4649-9d8c-87eb7f9b1886"
      unitRef="usd">3546000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtMTAtMS0xLTEwNzg0Mg_d1ef4b95-f31e-4921-a86e-2caf6afad4a2"
      unitRef="usd">0</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtMTItMS0xLTEwNzg0Mg_11c5bcd1-9ef9-492c-bffc-faa0a39e602f"
      unitRef="usd">8000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtMTQtMS0xLTEwNzg0Mg_9594656f-d45c-47e6-8c94-628def9434fe"
      unitRef="usd">0</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTMtMTYtMS0xLTEwNzg0Mg_472da9a0-c799-4a95-9921-70bdadaac605"
      unitRef="usd">17666000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <us-gaap:InterestIncomeOperating
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtNi0xLTEtMTA3ODQy_9800b1ed-2b94-4fde-9f4a-81c03ba4b172"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtOC0xLTEtMTA3ODQy_c0f5ec7b-f451-4097-b898-ea8bd884c763"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtMTAtMS0xLTEwNzg0Mg_ef12447d-e5ca-469a-b2be-20bcbd03d275"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtMTItMS0xLTEwNzg0Mg_dfdd9e2b-c159-4e78-825c-35573c5c7101"
      unitRef="usd">5494000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtMTQtMS0xLTEwNzg0Mg_f7969714-e0f5-4baa-9b62-c3788d7027d6"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTQtMTYtMS0xLTEwNzg0Mg_ecb0ec0c-11ab-4eae-9979-ad16ca239a50"
      unitRef="usd">5494000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestExpense
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtNi0xLTEtMTA3ODQy_027e8c21-7fa7-4904-ba6f-889670524061"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtOC0xLTEtMTA3ODQy_0dd4519e-0b76-48f6-abcd-44cff2b17525"
      unitRef="usd">1036000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtMTAtMS0xLTEwNzg0Mg_eae8d761-1d28-4594-ad6f-819dfca8133e"
      unitRef="usd">1865000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtMTItMS0xLTEwNzg0Mg_9cf92913-3962-43c4-9c03-938967ead8a2"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtMTQtMS0xLTEwNzg0Mg_65943a58-574d-4d16-b739-e5d08182aeb7"
      unitRef="usd">34685000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTUtMTYtMS0xLTEwNzg0Mg_8ea18a2d-5f86-4178-888d-6dfd580e7370"
      unitRef="usd">37586000</us-gaap:InterestExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtNi0xLTEtMTA3ODQy_67ecddc6-9879-4f25-b031-a734e48e5cd7"
      unitRef="usd">78138000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtOC0xLTEtMTA3ODQy_28eb40da-25ac-4197-a574-330d6c6b6377"
      unitRef="usd">67773000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtMTAtMS0xLTEwNzg0Mg_f929921c-c165-4335-9839-d0069a81f776"
      unitRef="usd">31822000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtMTItMS0xLTEwNzg0Mg_53b348d8-78e7-4a64-b006-567c48b1607b"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtMTQtMS0xLTEwNzg0Mg_0b4e7431-e308-424a-b20b-38c8b433cd33"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTYtMTYtMS0xLTEwNzg0Mg_faa7909f-544c-4621-8955-84a49c9ddb63"
      unitRef="usd">177733000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctNi0xLTEtMTA3ODQy_02b8eae6-7e6b-4e81-adc4-9af85c919fe6"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctOC0xLTEtMTA3ODQy_fed5e131-b7f2-46d1-b38f-26af65f6a072"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctMTAtMS0xLTEwNzg0Mg_cc69a10a-4b1e-4a82-8c6a-a30700b8ba6d"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctMTItMS0xLTEwNzg0Mg_08090a07-4ff9-43f5-bec4-2ba2fcceab4f"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctMTQtMS0xLTEwNzg0Mg_ce96dade-f29a-4777-8ea4-3bb3bcbe005c"
      unitRef="usd">23831000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTctMTYtMS0xLTEwNzg0Mg_4ded7bd3-f3c5-4cbb-ab5e-e686b112dc40"
      unitRef="usd">23831000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtNi0xLTEtMTA3ODQy_82b92006-226d-4f18-8d33-8d0bef1fb0bf"
      unitRef="usd">292000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtOC0xLTEtMTA3ODQy_ad56bda6-ad41-4b81-8b72-c8a355ccc048"
      unitRef="usd">4000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtMTAtMS0xLTEwNzg0Mg_631e8268-e521-49e8-90c4-7a1a3012dfd1"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtMTItMS0xLTEwNzg0Mg_00328171-a80d-46dd-91ac-4cf1ab16242a"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtMTQtMS0xLTEwNzg0Mg_e5607059-dfa2-47bd-b649-8cbb5e6b5033"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTgtMTYtMS0xLTEwNzg0Mg_df043c42-3330-4629-be9c-1597aa3fd5ab"
      unitRef="usd">296000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktNi0xLTEtMTA3ODQy_def51425-9378-4d60-a717-97c0ec1c2013"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktOC0xLTEtMTA3ODQy_0dad9443-a732-41dc-a162-3a3e453c4c6a"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktMTAtMS0xLTEwNzg0Mg_c62bf653-b644-4f51-ac00-b1e2886ce567"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktMTItMS0xLTEwNzg0Mg_005b30a7-a3e6-443c-8794-07ad4f4d4b87"
      unitRef="usd">132000</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktMTQtMS0xLTEwNzg0Mg_756c5b76-edfd-465f-8a28-764f1b0988f8"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMTktMTYtMS0xLTEwNzg0Mg_9f2d595a-48ff-4ab0-bbe6-2dfe20b341ca"
      unitRef="usd">132000</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtNi0xLTEtMTA3ODQy_35ac5cee-d3d4-4d54-8ab4-145ea6c574a2"
      unitRef="usd">3856000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtOC0xLTEtMTA3ODQy_8d564165-8965-40c7-866a-8d5122e81047"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtMTAtMS0xLTEwNzg0Mg_4e043e77-4c6c-4722-9ad4-93143aa9c46e"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtMTItMS0xLTEwNzg0Mg_85815979-545e-431e-829f-9dc0fef730b5"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtMTQtMS0xLTEwNzg0Mg_debbaf83-c568-4da8-a59c-b6dae5641bca"
      unitRef="usd">0</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjAtMTYtMS0xLTEwNzg0Mg_08b3b37b-3f8f-41a8-bcb4-376fd9eae340"
      unitRef="usd">3856000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItNi0xLTEtMTA3ODQy_816e1757-863b-41f7-b8bd-24912201fecc"
      unitRef="usd">-9000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItOC0xLTEtMTA3ODQy_338c11b4-ae05-40a9-aa45-deb4bc88f6dd"
      unitRef="usd">10937000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItMTAtMS0xLTEwNzg0Mg_8e3eb0ed-f92b-4db3-a87f-816ed8dc0742"
      unitRef="usd">6511000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItMTItMS0xLTEwNzg0Mg_e9f2e3f5-0524-415b-afae-ba998717b062"
      unitRef="usd">-32000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItMTQtMS0xLTEwNzg0Mg_0b228f82-6645-4b7e-b57e-35d389591166"
      unitRef="usd">909000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjItMTYtMS0xLTEwNzg0Mg_397b59b3-0a00-4300-afa5-1e40fb4c19a5"
      unitRef="usd">18316000</us-gaap:OtherNonoperatingIncomeExpense>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtNi0xLTEtMTA3ODQy_998d6344-f89c-485b-bea5-9573daab03ef"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtOC0xLTEtMTA3ODQy_66db4830-0d43-4e84-8ffa-cd400d429e5f"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtMTAtMS0xLTEwNzg0Mg_33533e04-4ced-4587-b6b4-7cb9934675d2"
      unitRef="usd">-6552000</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtMTItMS0xLTEwNzg0Mg_dcf2918b-00c9-4aa7-8db5-331277f54a6c"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtMTQtMS0xLTEwNzg0Mg_ea16ca16-dbef-42eb-8eac-096e67ac2548"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjMtMTYtMS0xLTEwNzg0Mg_81e3301b-05ef-409a-9cb9-ccf5e8916769"
      unitRef="usd">-6552000</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtNi0xLTEtMTA3ODQy_91cdf2d4-b33e-4136-a06c-191e8899aea9"
      unitRef="usd">-948000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtOC0xLTEtMTA3ODQy_da5bdb84-5471-4431-8fa4-9cacbd76fa45"
      unitRef="usd">-433000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtMTAtMS0xLTEwNzg0Mg_714b0ee2-bc06-48ce-8cca-56ca9f190b8b"
      unitRef="usd">-333000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtMTItMS0xLTEwNzg0Mg_b8d4e0ff-cde3-4ebc-b462-bedc3b28c6ad"
      unitRef="usd">-4305000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtMTQtMS0xLTEwNzg0Mg_98ad4091-6340-45ed-9e94-96c01c3d0f5d"
      unitRef="usd">0</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjQtMTYtMS0xLTEwNzg0Mg_cbb70469-1b17-4e37-a43d-53f5284b6097"
      unitRef="usd">-6019000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtNi0xLTEtMTA3ODQy_f28c8d30-5ff8-4bee-b251-517c46a2e708"
      unitRef="usd">-38000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtOC0xLTEtMTA3ODQy_eea956db-8a20-4cf9-acb1-a269d5505a4f"
      unitRef="usd">-6218000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtMTAtMS0xLTEwNzg0Mg_a668d83c-dc16-4599-9b0c-4fe3394e8fd3"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtMTItMS0xLTEwNzg0Mg_405c053a-bcca-429c-9e5d-f6e87af1225c"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtMTQtMS0xLTEwNzg0Mg_d7478a74-0811-4122-914a-00c3f9fecd88"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjUtMTYtMS0xLTEwNzg0Mg_199cde1d-f8b6-4c39-b9e7-99d2bea95edc"
      unitRef="usd">-6256000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtNi0xLTEtMTA3ODQy_b90125a8-c664-41dc-b9eb-d56573f77b5f"
      unitRef="usd">71283000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtOC0xLTEtMTA3ODQy_f3ecbe8f-6611-4f8e-983a-9ba1e10ec462"
      unitRef="usd">58217000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtMTAtMS0xLTEwNzg0Mg_d879c3a9-8488-4605-b708-c21de11d851f"
      unitRef="usd">-3504000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtMTItMS0xLTEwNzg0Mg_f68257be-68af-4878-95b3-41ddf12a2d7e"
      unitRef="usd">5330000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtMTQtMS0xLTEwNzg0Mg_b05258f4-dcca-44d6-a9e1-a60a2f149c13"
      unitRef="usd">-57607000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjYtMTYtMS0xLTEwNzg0Mg_9074a2e4-a8e4-4048-b871-694ab16dd194"
      unitRef="usd">73719000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctNi0xLTEtMTA3ODQy_a868642c-d22f-4b30-9e0d-be8207e2ce37"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctOC0xLTEtMTA3ODQy_5c8ff29f-a34c-4fea-966c-466a84a97e22"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctMTAtMS0xLTEwNzg0Mg_97ac498a-1346-489a-8123-17ffe7742a97"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctMTItMS0xLTEwNzg0Mg_02e0f3bb-4d1e-4299-9070-b582246fa45f"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctMTQtMS0xLTEwNzg0Mg_dc83ffb7-1a2d-421b-be14-27271dfffee1"
      unitRef="usd">777000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjctMTYtMS0xLTEwNzg0Mg_511f83cd-b8f0-42fc-b6b0-8f45afe4fe6b"
      unitRef="usd">777000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtNi0xLTEtMTA3ODQy_1fccc0f1-1c35-43b0-bdd7-219177cd8275"
      unitRef="usd">966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtOC0xLTEtMTA3ODQy_2c8dcaf8-48c4-48b8-940f-f385f4b51b44"
      unitRef="usd">200000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtMTAtMS0xLTEwNzg0Mg_43f427fd-c1a0-470d-8a83-ec039bc71844"
      unitRef="usd">539000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtMTItMS0xLTEwNzg0Mg_5fec80a1-cf4f-46fd-b6b0-9839fc4e8689"
      unitRef="usd">379000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtMTQtMS0xLTEwNzg0Mg_036e5d1b-c323-4400-9127-fe212a10a245"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMjgtMTYtMS0xLTEwNzg0Mg_e474eecd-e9c7-4bf6-99b3-3c5d77ca3048"
      unitRef="usd">2084000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtNi0xLTEtMTA3ODQy_f86bcd34-f989-4526-ae1b-92d1eef52eb7"
      unitRef="usd">72249000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtOC0xLTEtMTA3ODQy_665a2da9-a115-47e9-9441-4bc460b6e808"
      unitRef="usd">58417000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtMTAtMS0xLTEwNzg0Mg_d0a8c2e2-a2bf-4054-a883-0678e2290c4d"
      unitRef="usd">-2965000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtMTItMS0xLTEwNzg0Mg_f9710488-f0f7-423a-82d8-f533366d9acd"
      unitRef="usd">5709000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtMTQtMS0xLTEwNzg0Mg_97dd7e38-e804-4721-b859-12e944bc75c0"
      unitRef="usd">-58384000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzAtMTYtMS0xLTEwNzg0Mg_2b5bfc20-8768-4886-b66a-a409d581dd00"
      unitRef="usd">75026000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtNi0xLTEtMTA3ODQy_45da4a2f-56ff-4637-9c61-b9a2f57de064"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtOC0xLTEtMTA3ODQy_96e05ba2-2a2a-46f9-91e3-b4ea60292307"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtMTAtMS0xLTEwNzg0Mg_068ebff1-2dba-450c-8b95-92b09fc5e163"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtMTItMS0xLTEwNzg0Mg_ee78218c-8278-4e02-97b5-adb17e343d01"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtMTQtMS0xLTEwNzg0Mg_baf722a0-a978-47b7-83db-5f034de71fa4"
      unitRef="usd">317000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzEtMTYtMS0xLTEwNzg0Mg_397f7cc5-0f24-4a68-838c-cb6fc975d0a7"
      unitRef="usd">317000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i3bd712913ccb4f70a096f599405eac00_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItNi0xLTEtMTA3ODQy_0da8d819-91d6-449f-854f-60f8dce961b2"
      unitRef="usd">72249000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4fcece6b643741d89a8151c791613d6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItOC0xLTEtMTA3ODQy_b750d6b0-ae80-4775-bcd5-ff4ee8293568"
      unitRef="usd">58417000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia0c627724aa54a40a209f2e2745fc1d0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItMTAtMS0xLTEwNzg0Mg_55f917bf-56be-4043-a671-8b028e92feec"
      unitRef="usd">-2965000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie835e53766534f2daeb357cb1d6a00b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItMTItMS0xLTEwNzg0Mg_e55ef290-648f-44e5-89ab-b50ac1ad1df0"
      unitRef="usd">5709000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2522c73e41654167962362468542cfa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItMTQtMS0xLTEwNzg0Mg_a6bd234a-c7bb-47b4-8043-4ce5a2414213"
      unitRef="usd">-58067000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmE4NzMwZjQ4ZjUwZDQxMGY5N2MzYmRlZjI4ZDAzZDRmL3RhYmxlcmFuZ2U6YTg3MzBmNDhmNTBkNDEwZjk3YzNiZGVmMjhkMDNkNGZfMzItMTYtMS0xLTEwNzg0Mg_9724f3e3-874e-4374-a111-6779947fae96"
      unitRef="usd">75343000</us-gaap:ProfitLoss>
    <us-gaap:Revenues
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS02LTEtMS0xMDc4NDI_980ff7be-d7e1-4ee2-adb1-6ed04a6e4668"
      unitRef="usd">169934000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS04LTEtMS0xMDc4NDI_d66db77f-2240-40d9-804f-cddc67f1c47e"
      unitRef="usd">160201000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS0xMC0xLTEtMTA3ODQy_8e9053b7-a3b1-4c1e-874b-4f62e779ca52"
      unitRef="usd">116128000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS0xMi0xLTEtMTA3ODQy_38711d0a-9b0a-41ba-86cd-fb35e456881e"
      unitRef="usd">9013000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS0xNC0xLTEtMTA3ODQy_55abdfd5-9447-4d40-b1fa-337996bb62ff"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMS0xNi0xLTEtMTA3ODQy_89ba9487-56d7-4553-8692-61cd5ee59c18"
      unitRef="usd">455276000</us-gaap:Revenues>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi02LTEtMS0xMDc4NDI_2033412d-98fd-4497-92e3-cbc71107897a"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi04LTEtMS0xMDc4NDI_077b8676-73e3-460f-ada9-a624a957af0d"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi0xMC0xLTEtMTA3ODQy_e64d2b77-924d-482d-b04b-dfef56c7c400"
      unitRef="usd">1310000</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi0xMi0xLTEtMTA3ODQy_dcdf8aff-df4f-4db2-ba14-7fb5aae51143"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi0xNC0xLTEtMTA3ODQy_09cfff2b-d14a-477e-bc9b-8ce1ed159187"
      unitRef="usd">0</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:GovernmentGrantIncomeFromCARESAct
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMi0xNi0xLTEtMTA3ODQy_1542ec10-79e6-436f-bbc9-56ce939edb4b"
      unitRef="usd">1310000</peak:GovernmentGrantIncomeFromCARESAct>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy02LTEtMS0xMDc4NDI_9f69847f-802f-4553-a798-a133bc2ade6c"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy04LTEtMS0xMDc4NDI_a8fd7ac7-2ffa-4353-8366-68bf5f7bc256"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy0xMC0xLTEtMTA3ODQy_65f3f552-04ee-43ce-a0f7-2956c6afdeed"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy0xMi0xLTEtMTA3ODQy_7813189c-fbe6-4c9f-ae9b-27275d046908"
      unitRef="usd">9013000</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy0xNC0xLTEtMTA3ODQy_6d2d0b9d-7364-4196-af06-4a540acccdfd"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMy0xNi0xLTEtMTA3ODQy_4b9f4ed8-224f-4bb1-abb6-fbe491609293"
      unitRef="usd">9013000</peak:InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC02LTEtMS0xMDc4NDI_4ed6ec3a-de73-4666-b766-93f1875c0428"
      unitRef="usd">1337000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC04LTEtMS0xMDc4NDI_93765e73-9183-497b-8fe6-3d1bb30646d6"
      unitRef="usd">715000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC0xMC0xLTEtMTA3ODQy_74092a8f-2879-4af1-bad7-bdecfffe0988"
      unitRef="usd">4488000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC0xMi0xLTEtMTA3ODQy_1c807341-8969-48c6-8d86-c57b62cb25d7"
      unitRef="usd">16753000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC0xNC0xLTEtMTA3ODQy_fedfea3b-d2d1-4a43-923f-33b921755139"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureAttributableToParent
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNC0xNi0xLTEtMTA3ODQy_e570c778-ef67-4d50-876a-978b84bdfd4a"
      unitRef="usd">23293000</peak:RealEstateRevenuesFromJointVentureAttributableToParent>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS02LTEtMS0xMDc4NDI_82b7df02-320a-44aa-b02d-4b9eb12274a1"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS04LTEtMS0xMDc4NDI_670a11f1-d399-4a61-953f-2c30d11e3c1b"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS0xMC0xLTEtMTA3ODQy_254dcea7-b0b0-44b6-9203-3a2d63e9b9bc"
      unitRef="usd">199000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS0xMi0xLTEtMTA3ODQy_8ca56174-cb53-43fd-a38f-db0d6973102b"
      unitRef="usd">227000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS0xNC0xLTEtMTA3ODQy_238b0c07-2fc6-4002-8ac4-8c98b65621d5"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNS0xNi0xLTEtMTA3ODQy_d9b8ddcf-6b11-4d75-a349-ccd71be27824"
      unitRef="usd">426000</peak:RealEstateRevenuesFromJointVentureGovernmentGrantIncome>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi02LTEtMS0xMDc4NDI_51161a26-e007-4cd7-af48-b00417011cf2"
      unitRef="usd">65000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi04LTEtMS0xMDc4NDI_02202927-ee49-4732-bd0c-6bb7a2b0e244"
      unitRef="usd">8926000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi0xMC0xLTEtMTA3ODQy_b1f7a5c6-59ec-422b-b70c-d9ec91b67ded"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi0xMi0xLTEtMTA3ODQy_2efbea32-c244-4368-a17f-76d3cb516293"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi0xNC0xLTEtMTA3ODQy_049d1535-c14b-45b6-85aa-44d75df316b9"
      unitRef="usd">0</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNi0xNi0xLTEtMTA3ODQy_40b7c8df-8b47-429b-a833-975cfc74c558"
      unitRef="usd">8991000</peak:RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest>
    <us-gaap:OperatingExpenses
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy02LTEtMS0xMDc4NDI_88f6f61a-5ca3-42b9-a55e-1c64bad342cf"
      unitRef="usd">39461000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy04LTEtMS0xMDc4NDI_d3800326-db28-4e57-b627-549592510b53"
      unitRef="usd">51121000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy0xMC0xLTEtMTA3ODQy_8d5d0f73-35ef-4da9-8926-8f1c91f989c9"
      unitRef="usd">91179000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy0xMi0xLTEtMTA3ODQy_8f93e7b3-e2c5-4bfb-8fb1-4f1933b91e27"
      unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy0xNC0xLTEtMTA3ODQy_64b94673-90f1-49df-b94e-3f63527714cf"
      unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfNy0xNi0xLTEtMTA3ODQy_6fd58d5d-a787-4199-90d5-ba2616c09a80"
      unitRef="usd">181761000</us-gaap:OperatingExpenses>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC02LTEtMS0xMDc4NDI_f0c8a2ab-0ec3-425f-b3f8-d38fc2240761"
      unitRef="usd">425000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC04LTEtMS0xMDc4NDI_ee74695b-2411-4bf2-a6bf-35a28fac3988"
      unitRef="usd">294000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC0xMC0xLTEtMTA3ODQy_56fc16fa-0d1a-4a10-9d6f-6d5c967838e2"
      unitRef="usd">4745000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC0xMi0xLTEtMTA3ODQy_7fec4e04-fe51-4895-8ebe-a68c0bf4757e"
      unitRef="usd">12595000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC0xNC0xLTEtMTA3ODQy_fe213f2d-6df3-4c78-901f-46acbcaf002a"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToParentNet
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOC0xNi0xLTEtMTA3ODQy_7585b6a9-9c5b-44a3-adaf-a5282a38a5e4"
      unitRef="usd">18059000</peak:OperatingExpensesFromJointVentureAttributableToParentNet>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS02LTEtMS0xMDc4NDI_9776b23b-2bf8-4202-8a6c-ae35e93a8681"
      unitRef="usd">20000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS04LTEtMS0xMDc4NDI_56c53409-dff9-4a46-b210-bea1be8a0168"
      unitRef="usd">2504000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS0xMC0xLTEtMTA3ODQy_6b73ed7b-e19b-48dc-8976-5a0e383eadb9"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS0xMi0xLTEtMTA3ODQy_99a09303-7627-4d69-b127-6d8e170d1202"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS0xNC0xLTEtMTA3ODQy_757184fc-4ec0-4e16-ba04-ee7b116fef3e"
      unitRef="usd">0</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfOS0xNi0xLTEtMTA3ODQy_fcf0574b-0471-47fd-bf01-533c4a05b777"
      unitRef="usd">2524000</peak:OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtNi0xLTEtMTA3ODQy_833449e8-43d5-40b7-8100-b642ed509883"
      unitRef="usd">-11810000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtOC0xLTEtMTA3ODQy_5ae2dcdc-366a-4fb2-9df1-4c3c3b5c6d2c"
      unitRef="usd">-1923000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtMTAtMS0xLTEwNzg0Mg_9ad14614-b3b1-4cee-868a-b1a352624746"
      unitRef="usd">20000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtMTItMS0xLTEwNzg0Mg_be6666a0-19b9-45cc-8344-3358df0c45d1"
      unitRef="usd">112000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtMTQtMS0xLTEwNzg0Mg_a967313f-4690-42e2-8918-9f944c8bdbcc"
      unitRef="usd">0</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTEtMTYtMS0xLTEwNzg0Mg_54be40ef-0dee-461e-8683-15a9b00be1ec"
      unitRef="usd">-13601000</peak:NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItNi0xLTEtMTA3ODQy_c83f6d66-cef9-4437-b2b6-e245683c7571"
      unitRef="usd">119530000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItOC0xLTEtMTA3ODQy_0fe65260-0db5-4ecf-a4ff-e60c67647159"
      unitRef="usd">101156000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItMTAtMS0xLTEwNzg0Mg_df1647bb-4177-4b13-9908-ce9952964c97"
      unitRef="usd">26221000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItMTItMS0xLTEwNzg0Mg_4820eeb4-d6ba-4aba-b842-920748377db0"
      unitRef="usd">4497000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItMTQtMS0xLTEwNzg0Mg_a5e6200d-0e37-4b03-9e3b-dff0fcac133c"
      unitRef="usd">0</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:AdjustedNetOperatingIncomeFromContinuingOperations
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTItMTYtMS0xLTEwNzg0Mg_479067f0-2b54-41e8-bcb5-06f107cc0ad1"
      unitRef="usd">251404000</peak:AdjustedNetOperatingIncomeFromContinuingOperations>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtNi0xLTEtMTA3ODQy_a86191a7-2173-4747-a8dd-9071782eedc9"
      unitRef="usd">11810000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtOC0xLTEtMTA3ODQy_5c389a7f-28b8-4d91-a9e7-7e6b05e4417d"
      unitRef="usd">1923000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtMTAtMS0xLTEwNzg0Mg_8bc61b4b-adaa-42ae-b415-fe29fd1635a9"
      unitRef="usd">-20000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtMTItMS0xLTEwNzg0Mg_c5bba927-f7af-4ffa-9667-cd4344730c80"
      unitRef="usd">-112000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtMTQtMS0xLTEwNzg0Mg_be38561f-7e10-413b-835e-8ccb0d494f87"
      unitRef="usd">0</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTMtMTYtMS0xLTEwNzg0Mg_cd3a63ac-05d1-4384-9b44-7a52db8ac55b"
      unitRef="usd">13601000</peak:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments>
    <us-gaap:InterestIncomeOperating
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtNi0xLTEtMTA3ODQy_40eddf34-4496-4df6-8581-27c8f68f9a2a"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtOC0xLTEtMTA3ODQy_3f76d57d-0066-4fdc-a112-ede313470e68"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtMTAtMS0xLTEwNzg0Mg_05cf3aee-e072-49ec-8873-e04f0aaa94cc"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtMTItMS0xLTEwNzg0Mg_9c6ebaf5-1131-4540-9e48-fa72cffdbd3e"
      unitRef="usd">9013000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtMTQtMS0xLTEwNzg0Mg_c7569dde-5864-4265-b26d-cbc2fa945181"
      unitRef="usd">0</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTQtMTYtMS0xLTEwNzg0Mg_d098cd16-e26d-4e8e-91d4-431dd48fd26c"
      unitRef="usd">9013000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestExpense
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtNi0xLTEtMTA3ODQy_47163050-e4a3-4c21-8b7d-20fec8186e1a"
      unitRef="usd">102000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtOC0xLTEtMTA3ODQy_7335be00-6879-42f7-be38-92650f66c32f"
      unitRef="usd">95000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtMTAtMS0xLTEwNzg0Mg_9f368810-37e8-47db-b641-063f0cc72c1e"
      unitRef="usd">1918000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtMTItMS0xLTEwNzg0Mg_1d3c5277-06f6-4694-840d-59e136303b08"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtMTQtMS0xLTEwNzg0Mg_93e7b065-5437-4a19-8f9a-fc6d2078cbe4"
      unitRef="usd">44728000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTUtMTYtMS0xLTEwNzg0Mg_0e5049c9-0093-4b16-99b8-5147326bdbda"
      unitRef="usd">46843000</us-gaap:InterestExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtNi0xLTEtMTA3ODQy_af1aadfc-a71f-4857-b46f-253c27b9fa95"
      unitRef="usd">68434000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtOC0xLTEtMTA3ODQy_dec94182-9f6f-4b9e-8b1c-7787379da459"
      unitRef="usd">57954000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtMTAtMS0xLTEwNzg0Mg_df4ea755-41ea-400b-b630-35bf080135da"
      unitRef="usd">31150000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtMTItMS0xLTEwNzg0Mg_d2acb204-176b-4d06-8a99-38c84ea7b6e9"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtMTQtMS0xLTEwNzg0Mg_1c4984a0-7133-4e48-a09b-1a5c99364f4b"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTYtMTYtMS0xLTEwNzg0Mg_3485a993-d526-4fa7-a192-30d9b56f48ed"
      unitRef="usd">157538000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctNi0xLTEtMTA3ODQy_cfab3baa-3a18-40b6-9b46-49efeca12e44"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctOC0xLTEtMTA3ODQy_c53ea167-bcad-4425-8ba0-32f473e5d6d8"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctMTAtMS0xLTEwNzg0Mg_d25ccaa1-1528-4054-9165-d4374466a2ef"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctMTItMS0xLTEwNzg0Mg_656e2cbb-0e86-4781-acd6-5db8834f08bc"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctMTQtMS0xLTEwNzg0Mg_858163aa-c09f-438b-8663-9c1c3a938917"
      unitRef="usd">24902000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTctMTYtMS0xLTEwNzg0Mg_0deda661-2b2a-4977-830f-831c5d44c98e"
      unitRef="usd">24902000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtNi0xLTEtMTA3ODQy_713b4cbf-da72-495d-8dd0-382847c3eb2b"
      unitRef="usd">32000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtOC0xLTEtMTA3ODQy_6f9c42da-b019-4643-8f08-5310ac28329b"
      unitRef="usd">330000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtMTAtMS0xLTEwNzg0Mg_18fd3b28-727e-40ab-bdc9-2b02d4d40a93"
      unitRef="usd">432000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtMTItMS0xLTEwNzg0Mg_0128df64-8002-442b-959d-5345af822d74"
      unitRef="usd">4000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtMTQtMS0xLTEwNzg0Mg_401e41ac-7926-4bf1-b82c-2fca9ae7636d"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTgtMTYtMS0xLTEwNzg0Mg_4cb815d1-ea13-4ed6-bdf7-b058358df4b3"
      unitRef="usd">798000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktNi0xLTEtMTA3ODQy_31e0ea94-4a06-4478-8cb8-c498a83efb0c"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktOC0xLTEtMTA3ODQy_e8d70322-f1cb-4bd0-b2a7-cf987f705bca"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktMTAtMS0xLTEwNzg0Mg_e5216ebd-7f4a-4f19-b0a5-e3f139b902cb"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktMTItMS0xLTEwNzg0Mg_d4a53ced-ef41-4c7a-9ed3-aec71b8980e0"
      unitRef="usd">3242000</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktMTQtMS0xLTEwNzg0Mg_f1cbadd8-cf31-48fc-bcd3-a4e998e8c235"
      unitRef="usd">0</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <peak:ImpairmentsAndAllowanceForCreditLossReserves
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMTktMTYtMS0xLTEwNzg0Mg_5ba26caa-2831-482f-9f7a-f0e942464fef"
      unitRef="usd">3242000</peak:ImpairmentsAndAllowanceForCreditLossReserves>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtNi0xLTEtMTA3ODQy_d260da4c-d384-4d25-8480-8229d026a7f8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtOC0xLTEtMTA3ODQy_edf60b99-da2a-4812-b15e-5a9632136e0b"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtMTAtMS0xLTEwNzg0Mg_69e14dd9-d2d7-40a3-a755-4bfe6507bceb"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtMTItMS0xLTEwNzg0Mg_18af1f62-5243-41bc-bb02-ed450f938f1f"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtMTQtMS0xLTEwNzg0Mg_70820147-7c19-44e4-9672-0085a4bba119"
      unitRef="usd">-164292000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjEtMTYtMS0xLTEwNzg0Mg_4a456fb9-9689-42a1-a789-af952ac91497"
      unitRef="usd">-164292000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItNi0xLTEtMTA3ODQy_21258591-b204-4074-9068-fee0ef54fca3"
      unitRef="usd">4000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItOC0xLTEtMTA3ODQy_439d25fc-9bfc-4d7e-b5ca-d752b039a518"
      unitRef="usd">-2279000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItMTAtMS0xLTEwNzg0Mg_4e8a8ad4-6ca5-4c56-bb8c-053185e18536"
      unitRef="usd">2176000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItMTItMS0xLTEwNzg0Mg_979dcf49-88b7-46c8-9f6e-42f00fec8678"
      unitRef="usd">482000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItMTQtMS0xLTEwNzg0Mg_7fd95a0e-67aa-4895-acfd-75e63e33f299"
      unitRef="usd">1817000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjItMTYtMS0xLTEwNzg0Mg_de02b878-9570-456e-ae64-86eeea808e84"
      unitRef="usd">2200000</us-gaap:OtherNonoperatingIncomeExpense>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtNi0xLTEtMTA3ODQy_4c0493c5-6451-4c3e-93f2-a1eda71c827d"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtOC0xLTEtMTA3ODQy_f146b5b4-ede7-48cd-91ce-8f6b8d223bfd"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtMTAtMS0xLTEwNzg0Mg_10670859-3f58-4144-ad62-2356e4d8828e"
      unitRef="usd">-1310000</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtMTItMS0xLTEwNzg0Mg_6cc42af3-90d6-41b8-9796-2bb8875763c1"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtMTQtMS0xLTEwNzg0Mg_9be37e9e-7216-4dec-b08d-7e9e7083c7ef"
      unitRef="usd">0</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjMtMTYtMS0xLTEwNzg0Mg_4459561e-d2ed-46ad-9303-5ebf9fdc1e5a"
      unitRef="usd">-1310000</peak:InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtNi0xLTEtMTA3ODQy_1a637bdf-2f10-4177-a5b4-107a1ab4751e"
      unitRef="usd">-912000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtOC0xLTEtMTA3ODQy_9c7e072a-a75c-4522-b0af-e8c1948070dc"
      unitRef="usd">-421000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtMTAtMS0xLTEwNzg0Mg_68645c3c-ef6f-40b8-8469-3018cc018908"
      unitRef="usd">58000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtMTItMS0xLTEwNzg0Mg_2cbe215e-4d09-4653-b432-98a036bb4d2d"
      unitRef="usd">-4385000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtMTQtMS0xLTEwNzg0Mg_dab158f7-3985-4bb6-8a35-9892672c7c1d"
      unitRef="usd">0</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <peak:NetIncomeLossJointVenturePartnersAttributableToParent
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjQtMTYtMS0xLTEwNzg0Mg_c8c417d1-2a1a-49e6-ac62-ed3c6f7f8d09"
      unitRef="usd">-5660000</peak:NetIncomeLossJointVenturePartnersAttributableToParent>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtNi0xLTEtMTA3ODQy_ac606e1b-969d-4793-b4c6-8b64e6457143"
      unitRef="usd">-45000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtOC0xLTEtMTA3ODQy_9a019986-25bc-47e8-ae59-1e4f1cf6fe56"
      unitRef="usd">-6422000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtMTAtMS0xLTEwNzg0Mg_ee8de105-7fb0-4839-bbdd-a60175f76c81"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtMTItMS0xLTEwNzg0Mg_4e42a9f3-67a6-453a-ad79-cef137482571"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtMTQtMS0xLTEwNzg0Mg_2e5bcb8e-8849-4bd9-9114-70321a5a622d"
      unitRef="usd">0</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjUtMTYtMS0xLTEwNzg0Mg_2a52fe89-b398-419c-9f32-fa7555446552"
      unitRef="usd">-6467000</us-gaap:NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtNi0xLTEtMTA3ODQy_99b8f5e2-6ad8-4e6f-bf9a-d76a6ce75889"
      unitRef="usd">61909000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtOC0xLTEtMTA3ODQy_f4da6998-ab0c-4a6b-a03d-7d41411cd9b5"
      unitRef="usd">48422000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtMTAtMS0xLTEwNzg0Mg_f04100d8-7931-4108-9210-0f06ffa9d024"
      unitRef="usd">-6375000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtMTItMS0xLTEwNzg0Mg_679daa3e-4843-4c95-a9ee-9d28285b060b"
      unitRef="usd">6249000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtMTQtMS0xLTEwNzg0Mg_010415fd-de55-4dd0-9490-47c4cf22a972"
      unitRef="usd">-232105000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjYtMTYtMS0xLTEwNzg0Mg_df86eae0-1503-422b-9c7b-1464e0b5ef12"
      unitRef="usd">-121900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctNi0xLTEtMTA3ODQy_99c8cf1d-4b21-4d68-9e27-be4fb8e8aed4"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctOC0xLTEtMTA3ODQy_a6cb2082-e14b-4209-af14-e423c0bb5a7e"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctMTAtMS0xLTEwNzg0Mg_7ac93b1b-b629-48a4-813d-3f5b098a2b62"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctMTItMS0xLTEwNzg0Mg_dad5d9cf-18cb-44c9-bc09-dd20a96bd0bf"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctMTQtMS0xLTEwNzg0Mg_d6701524-a580-423e-a620-505d3f5278cb"
      unitRef="usd">8000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjctMTYtMS0xLTEwNzg0Mg_7232edcd-d48b-4180-a424-8bdcfd505035"
      unitRef="usd">8000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtNi0xLTEtMTA3ODQy_4a0d7c29-c874-44af-aa99-3e2f86b9451f"
      unitRef="usd">-93000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtOC0xLTEtMTA3ODQy_4caf1f50-c4bd-4fe2-af8d-fd1ca87df96b"
      unitRef="usd">192000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtMTAtMS0xLTEwNzg0Mg_93edf644-8c66-4a8e-8c09-8802ec18cd50"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtMTItMS0xLTEwNzg0Mg_ab266260-bae3-4e36-b5cd-dc56b4c30a7a"
      unitRef="usd">1224000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtMTQtMS0xLTEwNzg0Mg_560e0ed2-df7d-4226-b5a4-a1f8ddf6a652"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMjgtMTYtMS0xLTEwNzg0Mg_efc1ab6e-a5c1-4dab-ad4f-a61dd76d720b"
      unitRef="usd">1323000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtNi0xLTEtMTA3ODQy_2c9f429a-0309-4afd-8d2c-cbaf58b93401"
      unitRef="usd">61816000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtOC0xLTEtMTA3ODQy_1ab13272-b30b-4dbd-b90c-302de3b0e291"
      unitRef="usd">48614000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtMTAtMS0xLTEwNzg0Mg_6a9b6790-4921-4ed2-97ee-41eeb798f507"
      unitRef="usd">-6375000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtMTItMS0xLTEwNzg0Mg_f8eb6f2b-dd06-4eb5-9c5b-51ad6fc33674"
      unitRef="usd">7473000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtMTQtMS0xLTEwNzg0Mg_a962c41d-1536-42e8-97a4-f8df4ec888dc"
      unitRef="usd">-232113000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzAtMTYtMS0xLTEwNzg0Mg_783c6e21-17fc-47af-84b0-b16dc0ecf831"
      unitRef="usd">-120585000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtNi0xLTEtMTA3ODQy_8c15cb35-7735-433d-9e61-d3fa2dcc7c97"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtOC0xLTEtMTA3ODQy_6cc74991-ce54-41e1-a094-61f5c4e5ba46"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtMTAtMS0xLTEwNzg0Mg_cce3861c-7eb0-4b5a-bdb4-ddb47a184806"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtMTItMS0xLTEwNzg0Mg_36937fc5-b969-425d-a67c-3caa0917f8b1"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtMTQtMS0xLTEwNzg0Mg_062cf8cb-50b5-40ad-80a7-6696f462b3c7"
      unitRef="usd">270008000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzEtMTYtMS0xLTEwNzg0Mg_abc05cb7-ea5d-484b-95ad-a8cf66cd70d9"
      unitRef="usd">270008000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i8af4d709ab414fe8aa0762c47f799255_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItNi0xLTEtMTA3ODQy_90cd8f3b-e47b-4aef-8e32-7bcda691abaa"
      unitRef="usd">61816000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie196f5ef8517477d8b214c95228a7dba_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItOC0xLTEtMTA3ODQy_31c06040-2f5d-4cd3-9e04-d28fe267b694"
      unitRef="usd">48614000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6f78eab96fc4463bacc6039e5dfe7926_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItMTAtMS0xLTEwNzg0Mg_d19f9943-064f-4871-b65a-77562d0a1a03"
      unitRef="usd">-6375000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if92d81e5ad874807b203a630764ea27a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItMTItMS0xLTEwNzg0Mg_bc1d3d8c-841e-494c-93fa-9a15053467ec"
      unitRef="usd">7473000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9b91f93d95644d8db89f2a3fb1360b88_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItMTQtMS0xLTEwNzg0Mg_397224f2-4a0c-475a-912e-2f509707045e"
      unitRef="usd">37895000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83My9mcmFnOmJjNjJjZGJmMjA4YjQ1MzhhMjYyYWYwYjEwNDBjYWJhL3RhYmxlOmZhMTZjZjcwNGQ2MDQyN2NhNjk5Y2E4NDI5YzcwN2I5L3RhYmxlcmFuZ2U6ZmExNmNmNzA0ZDYwNDI3Y2E2OTljYTg0MjljNzA3YjlfMzItMTYtMS0xLTEwNzg0Mg_d3820c1b-3d95-4fd6-b5e9-f50bb60663b6"
      unitRef="usd">149423000</us-gaap:ProfitLoss>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RleHRyZWdpb246ZGZjYTkzMzBlODkyNDk0ZGE1ZWEzZGY3ZDIyODI1MjJfNTEy_6efe1fb7-1c90-4969-8997-4de718ce4cf5">Supplemental Cash Flow Information&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides supplemental cash flow information (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Supplemental cash flow information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid (refunded)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Supplemental schedule of non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in ROU asset in exchange for new lease liability related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Seller financing provided on disposition of real estate asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued construction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vesting of restricted stock units and conversion of non-managing member units into common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes certain cash flow information related to assets classified as discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasing costs, tenant improvements, and recurring capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development, redevelopment, and other major improvements of real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of real estate, in-place lease, and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes cash, cash equivalents and restricted cash (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RleHRyZWdpb246ZGZjYTkzMzBlODkyNDk0ZGE1ZWEzZGY3ZDIyODI1MjJfNTE1_1dd3066e-f947-4e6d-842e-defd25af2453">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides supplemental cash flow information (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Supplemental cash flow information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid (refunded)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Supplemental schedule of non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in ROU asset in exchange for new lease liability related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Seller financing provided on disposition of real estate asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued construction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vesting of restricted stock units and conversion of non-managing member units into common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes certain cash flow information related to assets classified as discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasing costs, tenant improvements, and recurring capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development, redevelopment, and other major improvements of real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of real estate, in-place lease, and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfMy0xLTEtMS0xMDc4NDI_8c9c2552-c7a1-4cd7-bfb4-3b5716de6f09"
      unitRef="usd">58487000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfMy0zLTEtMS0xMDc4NDI_c78d042a-d414-40ba-88e3-a0a740819358"
      unitRef="usd">90032000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNC0xLTEtMS0xMDc4NDI_1657960a-6919-40f4-b416-d956bcc90cbe"
      unitRef="usd">-1947000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNC0zLTEtMS0xMDc4NDI_8eecbd07-adda-4ea6-852f-0ab5020ac689"
      unitRef="usd">2521000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestCostsCapitalized
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNS0xLTEtMS0xMDc4NDI_60a455fb-2771-4318-bcdf-a6f492fb497f"
      unitRef="usd">8305000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNS0zLTEtMS0xMDc4NDI_ac609f4b-b62a-4bd5-8f70-a687b99a14f9"
      unitRef="usd">5453000</us-gaap:InterestCostsCapitalized>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNy0xLTEtMS0xMTIwNzI_b9e08434-7afd-40cc-8e63-7b9f205efda2"
      unitRef="usd">179000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNy0zLTEtMS0xMTIwNzI_682d252d-e6e2-4d49-8e74-5fb683565ca4"
      unitRef="usd">5020000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <peak:SellerFinancingProvidedOnDispositionofRealEstateAsset
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfOS0xLTEtMS0xMTIwODA_23a31b39-1a39-4743-b22f-a35864047d34"
      unitRef="usd">0</peak:SellerFinancingProvidedOnDispositionofRealEstateAsset>
    <peak:SellerFinancingProvidedOnDispositionofRealEstateAsset
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfOS0zLTEtMS0xMTIwODA_bc73512c-434c-469f-ab2a-6db5b60a4a82"
      unitRef="usd">559745000</peak:SellerFinancingProvidedOnDispositionofRealEstateAsset>
    <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNy0xLTEtMS0xMDc4NDI_f9236f1d-1a2f-490a-93d4-b5a8f9de93df"
      unitRef="usd">163277000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
    <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfNy0zLTEtMS0xMDc4NDI_ae8e2900-b99d-4e6e-be5b-4220b600967c"
      unitRef="usd">107798000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
    <peak:RestrictedStockVested
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfOC0xLTEtMS0xMDc4NDI_406cf317-d662-44a6-9d1a-40028e248123"
      unitRef="usd">752000</peak:RestrictedStockVested>
    <peak:RestrictedStockVested
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjEwZGRiOTUxNzA1YzQ5OWI5NWE4MzBjNWJiMzQxZWFkL3RhYmxlcmFuZ2U6MTBkZGI5NTE3MDVjNDk5Yjk1YTgzMGM1YmIzNDFlYWRfOC0zLTEtMS0xMDc4NDI_e7df66a1-6908-4ba3-87d0-2c0d54ee5323"
      unitRef="usd">838000</peak:RestrictedStockVested>
    <us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements
      contextRef="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfMy0xLTEtMS0xMjcxOTM_08085a31-08c0-41f8-becd-1c14f33c1c06"
      unitRef="usd">18000</us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements>
    <us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements
      contextRef="i586d3ac1554b476b944978cf331446d1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfMy0zLTEtMS0xMjcxOTM_6b7ca1d2-9a29-43c6-a964-a444949588d2"
      unitRef="usd">1873000</us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfMy0xLTEtMS0xMDc4NDI_5f7b8b6e-85ed-476d-b91d-37c0be8ba493"
      unitRef="usd">0</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToDevelopRealEstateAssets
      contextRef="i586d3ac1554b476b944978cf331446d1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfMy0zLTEtMS0xMDc4NDI_5e051991-9a52-4b09-baa2-c1b5dbb41e5a"
      unitRef="usd">3861000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:DepreciationAndAmortization
      contextRef="id763cea71736445ca443b2ecd9a206b2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfNS0xLTEtMS0xMjYxNDk_9b61cdbf-8134-4e83-b68f-9cf8486ccebd"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i586d3ac1554b476b944978cf331446d1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOjUyNzg5YzFiOWE4ODQxNjA4ZTI2YjZiMGFjNzA1ODRiL3RhYmxlcmFuZ2U6NTI3ODljMWI5YTg4NDE2MDhlMjZiNmIwYWM3MDU4NGJfNS0zLTEtMS0xMjYxNTM_d8d9efc7-9014-4288-8880-6db1f60c3246"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RleHRyZWdpb246ZGZjYTkzMzBlODkyNDk0ZGE1ZWEzZGY3ZDIyODI1MjJfNTI4_735547f6-bd04-4995-a8e8-559834f0f55c">&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes cash, cash equivalents and restricted cash (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Beginning of period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;End of period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC0yLTEtMS0xMDc4NDI_fe3514de-c0d5-49ca-a81b-498e584ed627"
      unitRef="usd">158287000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC00LTEtMS0xMDc4NDI_f8956fbc-e7e9-4934-8b15-d61bbb04699e"
      unitRef="usd">44226000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC02LTEtMS0xMDc4NDI_ea0d73e0-3515-4f08-901a-2fa1a55f1f14"
      unitRef="usd">7707000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC04LTEtMS0xMDc4NDI_0bee3d29-4178-4c49-b2e6-34ef09feffd4"
      unitRef="usd">53085000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC0xMC0xLTEtMTA3ODQy_0c0e2ce1-1730-4306-9ae4-2014a48b69ac"
      unitRef="usd">165994000</peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNC0xMi0xLTEtMTA3ODQy_d7a4d695-855a-4255-b8c2-2b382285636f"
      unitRef="usd">97311000</peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS0yLTEtMS0xMDc4NDI_07f74df6-fc38-457d-b5f5-d6402309fbd4"
      unitRef="usd">53454000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS00LTEtMS0xMDc4NDI_7de73747-0c49-4a27-b348-82035851f898"
      unitRef="usd">67206000</us-gaap:RestrictedCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS02LTEtMS0xMDc4NDI_cec439c9-00a7-4d0f-a97e-3bf20f82934e"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS04LTEtMS0xMDc4NDI_050b8dfa-d129-4511-b57a-eeb849f9e11f"
      unitRef="usd">17168000</peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents>
    <peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS0xMC0xLTEtMTA3ODQy_80e966fa-550c-45f0-aad7-5425a6519a5d"
      unitRef="usd">53454000</peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNS0xMi0xLTEtMTA3ODQy_284a57e8-c615-4a6d-9a43-cdef60958163"
      unitRef="usd">84374000</peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi0yLTEtMS0xMDc4NDI_6373841d-e6e4-4f8d-a572-73fdb167c599"
      unitRef="usd">211741000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi00LTEtMS0xMDc4NDI_f55122c2-cee7-4b7b-9735-88fc9b280d55"
      unitRef="usd">111432000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi02LTEtMS0xMDc4NDI_b286da0c-d99b-4898-a705-21b1c83638a2"
      unitRef="usd">7707000</peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi04LTEtMS0xMDc4NDI_0f7483d6-5d15-4cee-a017-6ef18cbed961"
      unitRef="usd">70253000</peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi0xMC0xLTEtMTA3ODQy_b823b553-14b0-4a0b-ac61-10f4c5dcf1eb"
      unitRef="usd">219448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i173d3dfdd8d6443cb9dd85428368d67a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfNi0xMi0xLTEtMTA3ODQy_33f04052-6250-435f-a89e-6bcb7589906e"
      unitRef="usd">181685000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC0yLTEtMS0xMDc4NDI_473f08de-6373-4971-beb8-52b8d7399b0f"
      unitRef="usd">89066000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC00LTEtMS0xMDc4NDI_996171c1-c61d-4f89-a97b-890220f0e0ca"
      unitRef="usd">34007000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC02LTEtMS0xMDc4NDI_2e1641ae-9642-4a4a-b27e-8ae675165c39"
      unitRef="usd">7989000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC04LTEtMS0xMDc4NDI_c01032e2-0a62-4f74-8783-8212a4ef21f7"
      unitRef="usd">40161000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC0xMC0xLTEtMTA3ODQy_81921d6a-147f-4eeb-878c-c00795b83e70"
      unitRef="usd">97055000</peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOC0xMi0xLTEtMTA3ODQy_ec9140af-7249-4ea3-8e17-1500b0806a4b"
      unitRef="usd">74168000</peak:CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS0yLTEtMS0xMDc4NDI_2ddd7f3e-bb33-47d5-906a-1f1c78f1bb6f"
      unitRef="usd">52103000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS00LTEtMS0xMDc4NDI_024cd23f-bfc7-4b37-9c8d-8958b2234a9e"
      unitRef="usd">68033000</us-gaap:RestrictedCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS02LTEtMS0xMDc4NDI_0ec57c89-5d49-4c88-b1a9-b061968f8ed1"
      unitRef="usd">0</peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS04LTEtMS0xMDc4NDI_e6f54896-083c-452b-8d81-53b41607aa78"
      unitRef="usd">5817000</peak:DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents>
    <peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS0xMC0xLTEtMTA3ODQy_e2b5b5c5-c161-4fde-9939-daabdd98774c"
      unitRef="usd">52103000</peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfOS0xMi0xLTEtMTA3ODQy_56d4261f-965d-46b9-a552-627c1fc6debb"
      unitRef="usd">73850000</peak:RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtMi0xLTEtMTA3ODQy_078372f7-d090-4b79-a78c-a7185ee3f5cc"
      unitRef="usd">141169000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtNC0xLTEtMTA3ODQy_73a788a6-2b98-433a-b3f3-cc214091fd94"
      unitRef="usd">102040000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtNi0xLTEtMTA3ODQy_c18b3767-0703-4e31-9e91-9a5e27a04ffa"
      unitRef="usd">7989000</peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtOC0xLTEtMTA3ODQy_fc5c52d7-7b7f-4dc8-a73d-d8d644a3b2cd"
      unitRef="usd">45978000</peak:DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtMTAtMS0xLTEwNzg0Mg_65fe5c46-b5a5-4e79-93db-0c3668f47d3d"
      unitRef="usd">149158000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i9033e3f616764988932a09935d4445c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83Ni9mcmFnOmRmY2E5MzMwZTg5MjQ5NGRhNWVhM2RmN2QyMjgyNTIyL3RhYmxlOmNhMTdmMGU3YmUxZjQ0NzE4ZmE0ZTRkMTg2Y2NkNzRkL3RhYmxlcmFuZ2U6Y2ExN2YwZTdiZTFmNDQ3MThmYTRlNGQxODZjY2Q3NGRfMTAtMTItMS0xLTEwNzg0Mg_30b59b83-dae9-449b-ac00-dca668c5b2af"
      unitRef="usd">148018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <peak:VariableInterestEntitiesTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTMyMTY_e07fbb36-984a-41b5-94c9-6d3fb05e12b1">Variable Interest Entities&lt;div style="margin-bottom:6pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unconsolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022 and December&#160;31, 2021, the Company had investments in: (i) two unconsolidated VIE joint ventures and (ii) marketable debt securities of one VIE. The Company determined it is not the primary beneficiary of and therefore does not consolidate these VIEs because it does not have the ability to control the activities that most significantly impact their economic performance. Except for the Company&#x2019;s equity interest in the unconsolidated joint ventures (the LLC investment and Needham Land Parcel JV discussed below), it has no formal involvement in these VIEs beyond its investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities Investment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company holds commercial mortgage-backed securities (&#x201c;CMBS&#x201d;) issued by Federal Home Loan Mortgage Corporation (commonly referred to as Freddie MAC) through a special purpose entity that has been identified as a VIE because it is &#x201c;thinly capitalized.&#x201d; The CMBS issued by the VIE are backed by mortgage debt obligations on real estate assets. These securities are classified as held-to-maturity because the Company has the intent and ability to hold the securities until maturity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;LLC Investment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company holds a limited partner ownership interest in an unconsolidated LLC that has been identified as a VIE. The Company&#x2019;s involvement in the entity is limited to its equity investment as a limited partner and it does not have any substantive participating rights or kick-out rights over the general partner. The assets and liabilities of the entity primarily consist of those associated with its senior housing real estate and development activities. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development expenses and debt service payments).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Needham Land Parcel JV.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2021, the Company acquired a 38% interest in a life science development joint venture in Needham, Massachusetts for $13&#160;million. Current equity at risk is not sufficient to finance the joint venture&#x2019;s activities. The assets and liabilities of the entity primarily consist of real estate and debt service obligations. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development expenses and debt service payments).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#x2019;s involvement with these VIEs at March&#160;31, 2022 was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;VIE Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&#160;Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum&#160;Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exposure&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;and Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Continuing operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CMBS and LLC investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Needham Land Parcel JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in and advances to unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s maximum loss exposure represents the aggregate carrying amount of such investments (including accrued interest).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the Company had not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including under circumstances in which it could be exposed to further losses (e.g., cash shortfalls).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Notes 3, 4, and 7 for additional descriptions of the nature, purpose, and operating activities of the Company&#x2019;s unconsolidated VIEs and interests therein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s consolidated total assets and total liabilities at March&#160;31, 2022 and December&#160;31, 2021 include certain assets of VIEs that can only be used to settle the liabilities of the related VIE. The VIE creditors do not have recourse to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ventures V, LLC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160; The Company holds a 51% ownership interest in and is the managing member of a joint venture entity formed in October 2015 that owns and leases MOBs (&#x201c;Ventures V&#x201d;). The Company classifies Ventures V as a VIE due to the non-managing member lacking substantive participation rights in the management of Ventures V or kick-out rights over the managing member. The Company consolidates Ventures V as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#x2019;s economic performance. The assets of Ventures V primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by Ventures V may only be used to settle its contractual obligations (primarily from capital expenditures).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Life Science JVs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;&#160;The Company holds a 99% ownership interest in multiple joint venture entities that own and lease life science assets (the &#x201c;Life Science JVs&#x201d;). The Life Science JVs are VIEs as the members share in control of the entities, but substantially all of the activities are performed on behalf of the Company. The Company consolidates the Life Science JVs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#x2019; economic performance. The assets of the Life Science JVs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Life Science JVs may only be used to settle their contractual obligations (primarily from capital expenditures). Refer to Note 11 for a discussion of certain put options associated with the Life Science JVs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MSREI MOB JV.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds a 51% ownership interest in, and is the managing member of, a joint venture entity formed in August 2018 that owns and leases MOBs (the &#x201c;MSREI JV&#x201d;). The MSREI JV is a VIE due to the non-managing member lacking substantive participation rights in the management of the joint venture or kick-out rights over the managing member. The Company consolidates the MSREI JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE&#x2019;s economic performance. The assets of the MSREI JV primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by the MSREI JV may only be used to settle its contractual obligations (primarily from capital expenditures).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DownREITs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160; The Company holds a controlling ownership interest in and is the managing member of seven DownREITs. The Company classifies the DownREITs as VIEs due to the non-managing members lacking substantive participation rights in the management of the DownREITs or kick-out rights over the managing member. The Company consolidates the DownREITs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#x2019; economic performance. The assets of the DownREITs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the DownREITs (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Consolidated Real Estate Partnerships.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds a controlling ownership interest in and is the general partner (or managing member) of multiple partnerships that own and lease real estate assets (the &#x201c;Partnerships&#x201d;). The Company classifies the Partnerships as VIEs due to the limited partners (non-managing members) lacking substantive participation rights in the management of the Partnerships or kick-out rights over the general partner (managing member). The Company consolidates the Partnerships as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs&#x2019; economic performance. The assets of the Partnerships primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Partnerships (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exchange Accommodation Titleholder&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  During the three months ended March&#160;31, 2022, the Company acquired two MOBs (the &#x201c;acquired properties&#x201d;) using a reverse like-kind exchange structure pursuant to Section 1031 of the Internal Revenue Code (a &#x201c;reverse 1031 exchange&#x201d;). As of March&#160;31, 2022, the Company had not completed the reverse 1031 exchange and as such, the acquired properties remained in the possession of the Exchange Accommodation Titleholder (&#x201c;EAT&#x201d;). The EAT was classified as a VIE as it was a &#x201c;thinly capitalized&#x201d; entity. The Company consolidated the EAT because it had the ability to control the activities that most significantly impacted the economic performance of the EAT and was, therefore, the primary beneficiary of the EAT. The properties held by the EAT had a carrying value of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$43&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as of March&#160;31, 2022. The assets of the EAT primarily consisted of leased properties (net real estate, including intangibles), rents receivable, and cash and cash equivalents; their obligations primarily consisted of capital expenditures for the properties. Assets generated by the EAT may only be used to settle its contractual obligations (primarily from capital expenditures). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, during the year ended December&#160;31, 2021, the Company acquired two MOBs using reverse 1031 exchanges. As of December&#160;31, 2021, the Company had not completed the reverse 1031 exchanges and as such, the acquired properties remained in the possession of the EAT. These properties held by the EAT had a carrying value of $77&#160;million as of December&#160;31, 2021. These reverse 1031 exchanges were completed in February 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and total liabilities include VIE assets and liabilities as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development costs and construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(569,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(551,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,350,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,383,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale and discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,699,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities related to assets held for sale and discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and liabilities related to assets held for sale and discontinued operations include VIE assets and liabilities as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</peak:VariableInterestEntitiesTextBlock>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="ide8b297bfe9444c5bf4d4192b08aecda_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTI5_a4d9670f-b952-44b6-a330-48cf5cf32a87"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <peak:NumberOfUnconsolidatedJointVenture
      contextRef="idd28c0a01e0b4e1687c11f71b4e146b7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTI5_d1455a99-30dc-491b-97a5-5faac75e9cf7"
      unitRef="joint_venture">2</peak:NumberOfUnconsolidatedJointVenture>
    <peak:NumberOfVieBorrowersWithMarketableDebtSecurities
      contextRef="ide8b297bfe9444c5bf4d4192b08aecda_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMjA0_caad9bf6-b437-488f-943a-d0231466eb0e"
      unitRef="joint_venture">1</peak:NumberOfVieBorrowersWithMarketableDebtSecurities>
    <peak:NumberOfVieBorrowersWithMarketableDebtSecurities
      contextRef="idd28c0a01e0b4e1687c11f71b4e146b7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMjA0_d2b4749d-8dec-4a71-8a81-579894982915"
      unitRef="joint_venture">1</peak:NumberOfVieBorrowersWithMarketableDebtSecurities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib12448d242784ab084c7178415e35eef_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTA5OTUxMTY0MzkzOQ_fa65496f-5482-47e8-b2e5-faeedb5487c2"
      unitRef="number">0.38</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ib42e8c61652142339c59c133c0ca0201_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTA5OTUxMTY0MzkyMg_9657da04-c88f-492d-99e7-e76c3ea14883"
      unitRef="usd">13000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTMyMDY_d7d5fa49-6a87-408a-ba4e-22d892db032c">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification of the related assets and liabilities and the maximum loss exposure as a result of the Company&#x2019;s involvement with these VIEs at March&#160;31, 2022 was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;VIE Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&#160;Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum&#160;Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exposure&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;and Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Continuing operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CMBS and LLC investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Needham Land Parcel JV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in and advances to unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s maximum loss exposure represents the aggregate carrying amount of such investments (including accrued interest).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i6e285ee41e894f3fb7a5abcc3f145a7e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjIxMmYxZDZhZWRiMjRmNmJhMTM3MzU2ZWFkYjkzOWQ4L3RhYmxlcmFuZ2U6MjEyZjFkNmFlZGIyNGY2YmExMzczNTZlYWRiOTM5ZDhfNC00LTEtMS0xMDc4NDI_6b77d68b-7573-4bb7-bd9d-88fb39053a7f"
      unitRef="usd">36492000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i6194055e785642eebfc80c30a45c054f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjIxMmYxZDZhZWRiMjRmNmJhMTM3MzU2ZWFkYjkzOWQ4L3RhYmxlcmFuZ2U6MjEyZjFkNmFlZGIyNGY2YmExMzczNTZlYWRiOTM5ZDhfNS00LTEtMS0xMTE5Mjk_5ecb6065-aa5c-4a69-96df-c3ccaab7f5c7"
      unitRef="usd">14346000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i31f56e92e9a1411d871334a90b76fa9f_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfNTQ2Ng_335ebd65-4618-49eb-a70c-df53b92d578a"
      unitRef="number">0.51</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="iec88d274781648d1946da5119782e172_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfNjM1NA_8adfaf87-74cb-4275-a912-70639aa78955"
      unitRef="number">0.99</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i7fefcab6d3cb41888c82058807af19ee_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfNzM0MQ_17614d0f-a31a-45e0-8699-4da20e57be6f"
      unitRef="number">0.51</us-gaap:VariableInterestEntityOwnershipPercentage>
    <peak:VariableInterestEntityControllingOwnershipInterestThroughPartnership
      contextRef="i6fb4bb6009344e2d86a46be91dd2df36_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfOTQ0OA_a0cfa3aa-cb2b-4c81-8307-a2eccae9760b"
      unitRef="joint_venture">7</peak:VariableInterestEntityControllingOwnershipInterestThroughPartnership>
    <peak:NumberOfPropertiesAcquired
      contextRef="i722f52bee0ee49709ef5ab8ea0678ab4_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTE0MzQ_c4d3d47c-5273-4789-a2e5-2e3dd53c9dad"
      unitRef="property">2</peak:NumberOfPropertiesAcquired>
    <peak:ExchangeAccommodationTitleholderRealEstateCarryingValue
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTIxODM_7da7d42b-3a60-4627-a06a-57637c4b99a5"
      unitRef="usd">43000000</peak:ExchangeAccommodationTitleholderRealEstateCarryingValue>
    <peak:NumberOfPropertiesAcquired
      contextRef="i84e02dec09e34ee98740b651f1f10e6b_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTY0OTI2NzQ2NTk0MQ_371accf2-a5e0-4624-b207-4c1bddf9cfe9"
      unitRef="property">2</peak:NumberOfPropertiesAcquired>
    <peak:ExchangeAccommodationTitleholderRealEstateCarryingValue
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTY0OTI2NzQ2NTk4Mw_8ee3934a-6a72-4eee-9b4e-a9562b750b3e"
      unitRef="usd">77000000</peak:ExchangeAccommodationTitleholderRealEstateCarryingValue>
    <peak:ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RleHRyZWdpb246ZTk3MmJhNjFhNzA5NGVhNjk4NTk1YjVkMmNjYmUzMGFfMTMyMDg_30003891-ef71-4ad7-9e7e-f903c1e3dfe1">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and total liabilities include VIE assets and liabilities as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development costs and construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(569,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(551,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,350,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,383,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale and discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,699,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities related to assets held for sale and discontinued operations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and liabilities related to assets held for sale and discontinued operations include VIE assets and liabilities as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</peak:ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMi0xLTEtMS0xMDc4NDI_0433c8c3-e3e4-4dff-8aba-8091a8e1b4b7"
      unitRef="usd">2303407000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMi0zLTEtMS0xMDc4NDI_1e1bf196-b35a-41bd-b35d-a8ebfb340d89"
      unitRef="usd">2303920000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:DevelopmentInProcess
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMy0xLTEtMS0xMDc4NDI_01054468-8e14-4b9a-8b40-5a952ec7f4b7"
      unitRef="usd">107066000</us-gaap:DevelopmentInProcess>
    <us-gaap:DevelopmentInProcess
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMy0zLTEtMS0xMDc4NDI_3d063beb-17e6-4960-b8df-60ea9030286e"
      unitRef="usd">82303000</us-gaap:DevelopmentInProcess>
    <us-gaap:Land
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNC0xLTEtMS0xMDc4NDI_6d40549c-2953-46fb-b938-2a3f6a41076d"
      unitRef="usd">509678000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNC0zLTEtMS0xMDc4NDI_62eb5b82-c94c-4b5f-b070-a91d61bfd912"
      unitRef="usd">548168000</us-gaap:Land>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNS0xLTEtMS0xMDc4NDI_31e5f166-26c3-4b0a-8b86-b486897d21f8"
      unitRef="usd">569437000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNS0zLTEtMS0xMDc4NDI_e8712b06-cacb-49b6-9973-db910a236962"
      unitRef="usd">551097000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNi0xLTEtMS0xMDc4NDI_e45822cb-131d-44f5-a0f9-f4aaaa773991"
      unitRef="usd">2350714000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfNi0zLTEtMS0xMDc4NDI_568489b6-ca7e-48f8-b7e7-95ea8511733a"
      unitRef="usd">2383294000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfOC0xLTEtMS0xMDc4NDI_ebf81e6e-2325-47d6-a767-c11c7dd97dcf"
      unitRef="usd">4854000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfOC0zLTEtMS0xMDc4NDI_babc2ca0-0c68-445d-bb14-b73aa3be2985"
      unitRef="usd">5455000</us-gaap:AccountsReceivableNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfOS0xLTEtMS0xMDc4NDI_eb703143-0b75-4629-9ee8-9279fc0c4452"
      unitRef="usd">37080000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfOS0zLTEtMS0xMDc4NDI_119ee668-38c8-4698-88de-7147d5013f4e"
      unitRef="usd">22295000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTAtMS0xLTEtMTA3ODQy_29ce5daa-ece6-447b-b36d-467e5468fe39"
      unitRef="usd">162000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTAtMy0xLTEtMTA3ODQy_a4ec5ba8-b683-4bb0-88b2-9698ed66e290"
      unitRef="usd">114000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTEtMS0xLTEtMTA3ODQy_18e9f8d4-d0e7-4c5a-a41e-9b43bafbfdcc"
      unitRef="usd">109993000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTEtMy0xLTEtMTA3ODQy_57483581-f411-4a73-9d3c-2ac0a90f0ee2"
      unitRef="usd">117180000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTItMS0xLTEtMTA3ODQy_a472bce2-7ca5-49b4-8660-a973cfd52385"
      unitRef="usd">288000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTItMy0xLTEtMTA3ODQy_53eaec34-cb7c-40cc-ae17-7f154e92d37f"
      unitRef="usd">754000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTMtMS0xLTEtMTA3ODQy_0359ff4f-2d14-498b-9e64-6a4094b74fc8"
      unitRef="usd">106600000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTMtMy0xLTEtMTA3ODQy_7f55607d-b544-4c49-8318-2d522db36abf"
      unitRef="usd">107993000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssets
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTQtMS0xLTEtMTA3ODQy_9355551f-b1b5-4da3-b1b3-0e1cfc39cf64"
      unitRef="usd">65201000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTQtMy0xLTEtMTA3ODQy_d234c610-1c01-4d67-96da-712cbb645667"
      unitRef="usd">62886000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTUtMS0xLTEtMTA3ODQy_75e8ae2a-2d27-43db-a9ea-2a7acdcdf0a4"
      unitRef="usd">2674892000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTUtMy0xLTEtMTA3ODQy_414e4520-be66-451d-92cb-147d230ca0f4"
      unitRef="usd">2699971000</us-gaap:Assets>
    <us-gaap:SecuredDebt
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTctMS0xLTEtMTA3ODQy_9c791d4f-b928-4c51-9bd7-4d0693a84e80"
      unitRef="usd">144425000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTctMy0xLTEtMTA3ODQy_77efa664-c75e-4ef5-b489-e217bdafcc4e"
      unitRef="usd">144350000</us-gaap:SecuredDebt>
    <us-gaap:OffMarketLeaseUnfavorable
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTktMS0xLTEtMTA3ODQy_521ac5e7-b531-4917-b33f-3dbfaa4aa560"
      unitRef="usd">27549000</us-gaap:OffMarketLeaseUnfavorable>
    <us-gaap:OffMarketLeaseUnfavorable
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMTktMy0xLTEtMTA3ODQy_3cf61d1c-5af4-40a9-bf89-3b5a22591d31"
      unitRef="usd">23909000</us-gaap:OffMarketLeaseUnfavorable>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjAtMS0xLTEtMTA3ODQy_82e78f25-0452-4df8-89f1-699b441e0ad8"
      unitRef="usd">1677000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjAtMy0xLTEtMTA3ODQy_636d4a02-4649-4e84-8b90-92b45f9e9f42"
      unitRef="usd">1677000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjEtMS0xLTEtMTA3ODQy_6679b829-6d5b-4bb3-b471-b9708ac4dad6"
      unitRef="usd">98474000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjEtMy0xLTEtMTA3ODQy_f05bf10b-fbe2-452c-b162-d42be8d6c1a8"
      unitRef="usd">99213000</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjItMS0xLTEtMTA3ODQy_1a3ff5fe-4d3a-4ac9-8935-1590a9b0706b"
      unitRef="usd">56712000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjItMy0xLTEtMTA3ODQy_a447cce1-1ff8-4a55-b462-2a1e89c6b53c"
      unitRef="usd">58440000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjMtMS0xLTEtMTA3ODQy_4b2acb5d-0767-4d75-9d8b-76a2319b5166"
      unitRef="usd">24405000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjMtMy0xLTEtMTA3ODQy_eb88c1e6-1011-421a-89b0-ddf12342f934"
      unitRef="usd">21546000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:Liabilities
      contextRef="i6ba23ecabb554063a415b6201e35ad07_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjQtMS0xLTEtMTA3ODQy_32b3550b-2509-4f21-a8fc-092c25b9bc3c"
      unitRef="usd">353242000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i1923a4d184d947fa8f63901661871fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOmUwMmIyOThlOGFkZDQ4NzA4MWMxZjQ1ZGMwMWJlM2YzL3RhYmxlcmFuZ2U6ZTAyYjI5OGU4YWRkNDg3MDgxYzFmNDVkYzAxYmUzZjNfMjQtMy0xLTEtMTA3ODQy_369fc426-49d2-480d-9e13-bd26cb0808cb"
      unitRef="usd">349135000</us-gaap:Liabilities>
    <us-gaap:AccountsReceivableNet
      contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfNy0yLTEtMS0xMDc4NDI_f7f5d70e-258e-4b5a-ab3b-2e145fa7f8fc"
      unitRef="usd">62000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfNy00LTEtMS0xMDc4NDI_f355cb87-ae85-4223-b523-cfbe1b5db27b"
      unitRef="usd">62000</us-gaap:AccountsReceivableNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfOC0yLTEtMS0xMDc4NDI_17334bac-5c81-49e7-a62f-ec1f7735730f"
      unitRef="usd">225000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfOC00LTEtMS0xMDc4NDI_95092f92-9e7c-46c0-bba1-9baf571b9546"
      unitRef="usd">59000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherAssets
      contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTItMi0xLTEtMTA3ODQy_9e501741-7744-4d3e-a220-2514532486d9"
      unitRef="usd">1000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTItNC0xLTEtMTA3ODQy_18612373-acdb-4c56-9040-0c0d334659d4"
      unitRef="usd">633000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTMtMi0xLTEtMTA3ODQy_836afb9a-fc07-473e-8452-2faeec1a7064"
      unitRef="usd">288000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTMtNC0xLTEtMTA3ODQy_2fabc02f-4d7a-4d12-886f-f5afe6e5fc7c"
      unitRef="usd">754000</us-gaap:Assets>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTgtMi0xLTEtMTA3ODQy_5a516268-825a-4cde-b668-6a59fa8d1acd"
      unitRef="usd">1677000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMTgtNC0xLTEtMTA3ODQy_669f919c-3dd7-40a8-8ced-bc221e8526d6"
      unitRef="usd">1677000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:Liabilities
      contextRef="idbf991550f2b47db91f24f0f6930a30f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMjAtMi0xLTEtMTA3ODQy_9becbb71-2a8e-4ad5-ab11-a873e6be8771"
      unitRef="usd">1677000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4433a7a0b6e549278122839d2dd4ef69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF83OS9mcmFnOmU5NzJiYTYxYTcwOTRlYTY5ODU5NWI1ZDJjY2JlMzBhL3RhYmxlOjRhYThkNjkzMmZmNTRiMTJhMGYzYWUwMTYxYTM5YTM5L3RhYmxlcmFuZ2U6NGFhOGQ2OTMyZmY1NGIxMmEwZjNhZTAxNjFhMzlhMzlfMjAtNC0xLTEtMTA3ODQy_d8bec21b-76a8-430c-85f1-ac825f23c2cd"
      unitRef="usd">1677000</us-gaap:Liabilities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RleHRyZWdpb246YmI2NGVmMTc1M2NlNDM3OGFjZmQ0ODJkODg3YzdmYmNfMTIzNg_de007b29-78f8-4d86-93ab-64b993e9d796">Fair Value Measurements&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis in the Consolidated Balance Sheets were immaterial at March&#160;31, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the carrying amounts and fair values of the Company&#x2019;s financial instruments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank line of credit and commercial paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior unsecured notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,654,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,669,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,651,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,054,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Level&#160;1: Fair value calculated based on quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Level&#160;2: Fair value based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and caps, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit and commercial paper, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#x2019;s credit rating.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2022 and year ended December&#160;31, 2021, there were no material transfers of financial assets or liabilities within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RleHRyZWdpb246YmI2NGVmMTc1M2NlNDM3OGFjZmQ0ODJkODg3YzdmYmNfMTIyOA_09ce3f56-e406-4824-9e9e-c603c37dd4da">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the carrying amounts and fair values of the Company&#x2019;s financial instruments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank line of credit and commercial paper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,330,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior unsecured notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,654,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,669,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,651,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,054,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Level&#160;1: Fair value calculated based on quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Level&#160;2: Fair value based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and caps, standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit and commercial paper, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company&#x2019;s credit rating.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2022 and year ended December&#160;31, 2021, there were no material transfers of financial assets or liabilities within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:LoansReceivableFairValueDisclosure
      contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMi0xLTEtMS0xMDc4NDI_76d72fbd-3740-4c3d-98f3-f2d1413907a4"
      unitRef="usd">409753000</us-gaap:LoansReceivableFairValueDisclosure>
    <us-gaap:LoansReceivableFairValueDisclosure
      contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMi0zLTEtMS0xMDc4NDI_a7dbeda4-ff8e-435c-9088-2537baa413bb"
      unitRef="usd">424346000</us-gaap:LoansReceivableFairValueDisclosure>
    <us-gaap:LoansReceivableFairValueDisclosure
      contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMi01LTEtMS0xMDc4NDI_aaedf47f-b1f3-4970-903d-f6c4695261a0"
      unitRef="usd">415811000</us-gaap:LoansReceivableFairValueDisclosure>
    <us-gaap:LoansReceivableFairValueDisclosure
      contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMi03LTEtMS0xMDc4NDI_f5c16be5-0434-4602-bc2d-eb42e7e417a6"
      unitRef="usd">437607000</us-gaap:LoansReceivableFairValueDisclosure>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMy0xLTEtMS0xMDc4NDI_35106531-6953-49ef-b367-92b1c951497e"
      unitRef="usd">21172000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMy0zLTEtMS0xMDc4NDI_87210470-0b52-48c4-a8ab-340c6607a5db"
      unitRef="usd">21172000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMy01LTEtMS0xMDc4NDI_2a43ebe7-36b4-4a1a-918f-735dfadeab3c"
      unitRef="usd">21003000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMy03LTEtMS0xMDc4NDI_89b7e03e-8d4d-4c54-bd9f-05d62a6e0203"
      unitRef="usd">21003000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:DerivativeAssets
      contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNC0xLTEtMS0xMDc4NDI_e5580de8-4383-442e-97c3-2ed7b5d818e6"
      unitRef="usd">2391000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNC0zLTEtMS0xMDc4NDI_572cee03-1cfd-4372-bffd-4f824d3e9ea3"
      unitRef="usd">2391000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNC01LTEtMS0xMDc4NDI_2ea5517b-b3b3-40bd-aec7-1dd8e0200f88"
      unitRef="usd">397000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNC03LTEtMS0xMDc4NDI_8d6ff4d2-6b6e-4847-a8ad-956a5a3c6197"
      unitRef="usd">397000</us-gaap:DerivativeAssets>
    <us-gaap:LineOfCredit
      contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNy0xLTEtMS0xMDc4NDI_d7de49ba-4a1e-43c1-906b-fa9833b89d0e"
      unitRef="usd">1330813000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNy0zLTEtMS0xMDc4NDI_d5e0399e-2c36-4d0a-9d5f-e83841fc67ff"
      unitRef="usd">1330813000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNy01LTEtMS0xMDc4NDI_b085b448-30fc-4c35-94b6-fcfdf9522d1f"
      unitRef="usd">1165975000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfNy03LTEtMS0xMDc4NDI_71c6c2fe-a902-4d3c-92f2-e24ca3eb99d1"
      unitRef="usd">1165975000</us-gaap:LineOfCredit>
    <us-gaap:UnsecuredDebt
      contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfOS0xLTEtMS0xMDc4NDI_7c73499b-6dc5-4a82-b29f-fc188093ab48"
      unitRef="usd">4654056000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i688cf62ae17b4e4382d4717dfb3d857d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfOS0zLTEtMS0xMDc4NDI_bf5e76ba-875a-4256-80c8-98505ba4e09f"
      unitRef="usd">4669414000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfOS01LTEtMS0xMDc4NDI_ccca7978-f9cf-429b-867b-51f70d8e33c8"
      unitRef="usd">4651933000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i9d6fb07e784b4ca69895402225c3412e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfOS03LTEtMS0xMDc4NDI_edf74bb1-7c8c-4c47-a9d4-4a92ad845e86"
      unitRef="usd">5054747000</us-gaap:UnsecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i647df0ef5da942b7835d88ac03d98c68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMTAtMS0xLTEtMTA3ODQy_c96677ae-c784-4297-adab-c03181aec688"
      unitRef="usd">350713000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i6748a224b94042acb5282ef7d9b2a15d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMTAtMy0xLTEtMTA3ODQy_0c73e704-ea1e-4f74-9338-f581e06c9197"
      unitRef="usd">344995000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="iaec053ad2c7e489a8ceb2307e73640f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMTAtNS0xLTEtMTA3ODQy_e7cde444-1823-4f20-958a-20b3efce7aa5"
      unitRef="usd">352081000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i24c76c887bc045ea98faf15f07cdc7b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84Mi9mcmFnOmJiNjRlZjE3NTNjZTQzNzhhY2ZkNDgyZDg4N2M3ZmJjL3RhYmxlOmRlNWVlNGQ1Yjg3ZjQxMGFiZjYwZGYxOGE4ZDRjNWNjL3RhYmxlcmFuZ2U6ZGU1ZWU0ZDViODdmNDEwYWJmNjBkZjE4YThkNGM1Y2NfMTAtNy0xLTEtMTA3ODQy_19221ae9-dd62-40f8-9228-ad9d6d3f0d5d"
      unitRef="usd">352800000</us-gaap:SecuredDebt>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTMzNg_e34725ef-1352-4a18-bf4e-0212cf3355ea">Derivative Financial Instruments&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative instruments to mitigate the effects of interest rate fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest rates related to the potential impact these changes could have on future earnings and forecasted cash flows. The Company does not use derivative instruments for speculative or trading purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, the Company repaid $39&#160;million of variable rate secured debt on two SHOP assets and terminated the two remaining related interest rate swap contracts. Therefore, at March&#160;31, 2022 and December&#160;31, 2021, the Company had no remaining interest rate swap contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company executed two interest rate cap agreements on its mortgage debt issued in conjunction with the acquisition of the MOB Portfolio (see Note 3). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s outstanding interest rate cap agreements as of March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Date&#160;Entered&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Strike Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Index&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April&#160;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 mo. USD-LIBOR-BBA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Derivative assets are recorded in other assets, net in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents two interest rate cap agreements that manage the Company&#x2019;s exposure to variable cash flows on certain mortgage debt borrowings by limiting interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022, the Company recognized a $2&#160;million increase in the fair value of the interest rate cap agreements within other income (expense), net.&lt;/span&gt;&lt;/div&gt;In April 2022, the Company terminated its existing interest rate cap agreements associated with $142&#160;million of variable rate mortgage debt and entered into two interest rate swap contracts that are designated as cash flow hedges and mature in May 2026.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="idcc10c45d3da4625bee7679905bbb7c3_D20210301-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTQxNQ_45bf287f-b9ef-4dab-9924-4d0167c4d44e"
      unitRef="usd">39000000</us-gaap:RepaymentsOfSecuredDebt>
    <peak:NumberOfAssetsClassifiedAsDiscontinuedOperations
      contextRef="i4d2252cd7eba4d3b851fa2e3e157f14c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTQ1Mg_b1a0ddde-389e-4cdb-a212-ed37eb90e7d7"
      unitRef="property">2</peak:NumberOfAssetsClassifiedAsDiscontinuedOperations>
    <peak:NumberOfInterestRateDerivativesTerminated
      contextRef="i8cee1167ebab48b7b2f82422612e3991_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTQ4Nw_12671d9b-8b24-42b5-8972-42692c935279"
      unitRef="derivativeheld">2</peak:NumberOfInterestRateDerivativesTerminated>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i1d64ef81915d4315bc7730741c5095a7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTU4Mg_0564426a-e636-474d-860c-d83e9d81791b"
      unitRef="derivativeheld">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="ifb5de1f1f0a24475b0f7d492a74824d6_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTU4Mg_6d3b5776-1ab9-48d9-a6d2-03910cc83fa8"
      unitRef="derivativeheld">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTMzNA_0840bfdc-38a2-4b02-acf8-335184342e84">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company executed two interest rate cap agreements on its mortgage debt issued in conjunction with the acquisition of the MOB Portfolio (see Note 3). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s outstanding interest rate cap agreements as of March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Date&#160;Entered&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Strike Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Index&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April&#160;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00 %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 mo. USD-LIBOR-BBA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Derivative assets are recorded in other assets, net in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Represents two interest rate cap agreements that manage the Company&#x2019;s exposure to variable cash flows on certain mortgage debt borrowings by limiting interest rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i33e11899bd7a43448fda5d94b27afd54_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfNzk3_1c70214b-f3f7-446d-9b45-0110b10cb1a2"
      unitRef="derivativeheld">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8b09eddbc9044df3944a2a85e555a381_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RhYmxlOjIzODc0NmRiMzVlMTQ5OThiZDRlY2EwZWExMWNiY2U5L3RhYmxlcmFuZ2U6MjM4NzQ2ZGIzNWUxNDk5OGJkNGVjYTBlYTExY2JjZTlfMi02LTEtMS0xMDc4NDI_652417e9-c2d3-4e59-8a4b-33118c5427aa"
      unitRef="usd">142100000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i8b09eddbc9044df3944a2a85e555a381_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RhYmxlOjIzODc0NmRiMzVlMTQ5OThiZDRlY2EwZWExMWNiY2U5L3RhYmxlcmFuZ2U6MjM4NzQ2ZGIzNWUxNDk5OGJkNGVjYTBlYTExY2JjZTlfMi04LTEtMS0xMDc4NDI_9093cf6d-5028-4d7d-8f37-304d3cacf912"
      unitRef="number">0.0200</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i8b09eddbc9044df3944a2a85e555a381_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RhYmxlOjIzODc0NmRiMzVlMTQ5OThiZDRlY2EwZWExMWNiY2U5L3RhYmxlcmFuZ2U6MjM4NzQ2ZGIzNWUxNDk5OGJkNGVjYTBlYTExY2JjZTlfMi0xMi0xLTEtMTA3ODQy_a0aef6bf-93f1-4705-8f31-8e9bb491e481"
      unitRef="usd">2391000</us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i33e11899bd7a43448fda5d94b27afd54_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTE4MA_7edc66f0-4113-41f3-9623-051f9955f774"
      unitRef="derivativeheld">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i16a351f1ed484654b7fe74cc73addf0a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMjUyOA_7f616734-1a6a-4202-8c7e-60fceda54dc7"
      unitRef="usd">2000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <peak:DerivativeNotionalAmountTerminated
      contextRef="ia2e2a387bee947aea9537b5bd2acde51_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMDk4Mw_602f2f0a-2632-4872-94d1-e2b6c953f243"
      unitRef="usd">142000000</peak:DerivativeNotionalAmountTerminated>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i3a84667f31d1411fa0eb153b19912c8e_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84NS9mcmFnOmNlOTdkODhhMDk3MDQ3Njc4MDdiYWEyOWU1ZTFmMmE3L3RleHRyZWdpb246Y2U5N2Q4OGEwOTcwNDc2NzgwN2JhYTI5ZTVlMWYyYTdfMTA5OTUxMTYzMTAzNQ_1fa3d627-a937-40af-aae7-7c20adc0a340"
      unitRef="derivativeheld">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfNTQy_af65d9c3-5820-4da8-ac7c-4ff695f01215">Accounts Payable, Accrued Liabilities, and Other Liabilities&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s accounts payable, accrued liabilities, and other liabilities, excluding accounts payable, accrued liabilities, and other liabilities related to assets classified as discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Refundable entrance fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued construction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;At March&#160;31, 2022 and December&#160;31, 2021, unamortized nonrefundable entrance fee liabilities were $498&#160;million and $496&#160;million, respectively, which are recorded within deferred revenue on the Consolidated Balance Sheets. During the three months ended March&#160;31, 2022, the Company collected nonrefundable entrance fees of $21&#160;million and recognized amortization of $19&#160;million. During the three months ended March&#160;31, 2021, the Company collected nonrefundable entrance fees of $15&#160;million and recognized amortization of $20&#160;million. The amortization of nonrefundable entrance fees is included within resident fees and services on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfNTQz_479bddd4-3d4a-4b1a-aa43-d76df53197af">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s accounts payable, accrued liabilities, and other liabilities, excluding accounts payable, accrued liabilities, and other liabilities related to assets classified as discontinued operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Refundable entrance fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued construction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable, accrued liabilities, and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;At March&#160;31, 2022 and December&#160;31, 2021, unamortized nonrefundable entrance fee liabilities were $498&#160;million and $496&#160;million, respectively, which are recorded within deferred revenue on the Consolidated Balance Sheets. During the three months ended March&#160;31, 2022, the Company collected nonrefundable entrance fees of $21&#160;million and recognized amortization of $19&#160;million. During the three months ended March&#160;31, 2021, the Company collected nonrefundable entrance fees of $15&#160;million and recognized amortization of $20&#160;million. The amortization of nonrefundable entrance fees is included within resident fees and services on the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <peak:RefundableEntranceFeesCurrentAndNoncurrent
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMS0xLTEtMS0xMDc4NDI_339a75f9-9454-4682-897a-865c446a15c2"
      unitRef="usd">281242000</peak:RefundableEntranceFeesCurrentAndNoncurrent>
    <peak:RefundableEntranceFeesCurrentAndNoncurrent
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMS0zLTEtMS0xMDc4NDI_df701e0e-9cfa-424f-93f3-74dea3e1423d"
      unitRef="usd">288409000</peak:RefundableEntranceFeesCurrentAndNoncurrent>
    <us-gaap:ConstructionPayableCurrentAndNoncurrent
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMi0xLTEtMS0xMDc4NDI_cd68751f-b037-4633-acc2-99fee98748ca"
      unitRef="usd">163277000</us-gaap:ConstructionPayableCurrentAndNoncurrent>
    <us-gaap:ConstructionPayableCurrentAndNoncurrent
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMi0zLTEtMS0xMDc4NDI_56fe8852-210f-4022-ad36-5679faddf098"
      unitRef="usd">179995000</us-gaap:ConstructionPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMy0xLTEtMS0xMDc4NDI_603e61ec-a1b0-4621-919f-a1b97a800da1"
      unitRef="usd">35753000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfMy0zLTEtMS0xMDc4NDI_40c8129d-bb28-440e-8045-b850379050e3"
      unitRef="usd">59342000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfNC0xLTEtMS0xMDc4NDI_9ef85084-64be-418b-9762-ce956149bb64"
      unitRef="usd">215101000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfNC0zLTEtMS0xMDc4NDI_ef3b1841-156c-4b0f-8f30-49a896fa4fad"
      unitRef="usd">227638000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfNS0xLTEtMS0xMDc4NDI_c1ae3216-ed77-48fa-81cf-9b2b2581467e"
      unitRef="usd">695373000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RhYmxlOjE4OTdkZmY1M2NlZjQ2OTM4NTA4YTZkNTkxYTU2NTcxL3RhYmxlcmFuZ2U6MTg5N2RmZjUzY2VmNDY5Mzg1MDhhNmQ1OTFhNTY1NzFfNS0zLTEtMS0xMDc4NDI_0fa09430-44c1-4aad-a788-ef54dac4b435"
      unitRef="usd">755384000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <peak:UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent
      contextRef="i8b4c4223887d4f649dd6bf793e09faaf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfNDQw_d7718895-1023-4e29-91f8-baee04597566"
      unitRef="usd">498000000</peak:UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent>
    <peak:UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent
      contextRef="i52f832c5fe6045a8ad198b8d80128bd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfNDQ3_41e82ccc-5a77-4586-b982-17e7c38e2684"
      unitRef="usd">496000000</peak:UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent>
    <peak:ProceedsFromCollectionOfNonrefundableEntranceFees
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfMTA5OTUxMTYyOTU4NA_7a98b28a-30ba-44f0-a370-fb79c54eb6b1"
      unitRef="usd">21000000</peak:ProceedsFromCollectionOfNonrefundableEntranceFees>
    <peak:AmortizationOfNonrefundableEntranceFee
      contextRef="ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfMTA5OTUxMTYyOTYyNA_74e9bc94-3004-4f59-8fdd-2663046e9b8f"
      unitRef="usd">19000000</peak:AmortizationOfNonrefundableEntranceFee>
    <peak:ProceedsFromCollectionOfNonrefundableEntranceFees
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfMTA5OTUxMTYyODU4Mg_a1a388e1-49c6-4fc0-8c18-515e9f9f19c8"
      unitRef="usd">15000000</peak:ProceedsFromCollectionOfNonrefundableEntranceFees>
    <peak:AmortizationOfNonrefundableEntranceFee
      contextRef="i3e31056fa01744eda0ca090324f0952b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZhM2RmZjQ2OGExNTQ5NWRiN2I1N2M2NWFkYTBkZTc0L3NlYzpmYTNkZmY0NjhhMTU0OTVkYjdiNTdjNjVhZGEwZGU3NF84OC9mcmFnOmViZjhjZmEyMGMyNTQ5MGZhMDZkMTU5MmFjOTQ2ZGMyL3RleHRyZWdpb246ZWJmOGNmYTIwYzI1NDkwZmEwNmQxNTkyYWM5NDZkYzJfMTA5OTUxMTYyODU5NQ_bc57c40b-23d6-42b0-8e0e-6b4008485075"
      unitRef="usd">20000000</peak:AmortizationOfNonrefundableEntranceFee>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>94
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MG4(GL Y<2>;)\I-9B_I-SW!I,(JC,'!\V"<71"2<0#FP)9FGRT=E@,\[E%Z
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M:4 Y"L&YMA]&0"\)L50*]+Y06GMS!W,)^9AA9P;G%2-3G,@&WF;SO-UEYS:
MUJK(1:W__K>$DOC7=NC@)W+F$G04X(32,?'Y!$,"3#[17;*!RMD\E?]C?QYE
M0]Y4 -T+UB5?:(,#IVWSR06@TI2'#"3-WIC$JNJXY!5_L<FT%.63L$V -+VY
MO9A=+J80<D[]_[;<(>:!L]G/</;_100N+T-:"]+Q^,\G%S Z-6]@ WVS>?KN
M(,\XK3M(C=( 2OMQ(>01C'&83(YV@H%C@WF.=2JAEE>F(??;'7PP\C?T?DE?
M0[_<^[)H/^M^Y#4XID:%>(:E^$,,>M?=E]+NQJA-^['Q21FCRO9R+3AXKA6
MWY\5%$;]C?U^N?M>??X_4$L#!!0    ( $:"I%1PP%9'W (  "L(   8
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&ULE99K;]HP%(;_BA7U0RMUS8V04 $2
MMZF3NA8U[?;9) =BU8DSVX%NOWZV0R,N@;9\(+Z<]YSG=;!-?\/XJ\@ )'K+
M:2$&5B9E>6O;(LD@Q^*&E5"HF27C.9:JRU>V*#G@U(AR:GN.T[5S3 IKV#=C
M<S[LLTI24L"<(U'E.>9_QT#99F"YUOO $UEE4@_8PWZ)5Q"#?"GG7/7L)DM*
M<B@$807BL!Q8(_=V$NEX$_"+P$;LM)%VLF#L57=^I /+T4! (9$Z U:/-4R
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M,ON(/YS'U QH$?\3_$GM_4;&E7LIOYF+J^7)+#*,>,D7VIA@\/7(SWE9&DO
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M)6\, /Y?2:EW%^8!P^'[Z3]02P,$%     @ 1H*D5!!Q46GO P  DPP  !@
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M0,0?PDU2W>3/E[Q-R*W]+?.D;/Z"YQ;KC,!R4U9YVAJ+"-(XV_X/O[8#L6<
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MQW:.?\L9 E;)GNZKZW8@AJ""/M1A>GNG^7;=,.0, 6MZ9D@Q\Y1S_(' \P'
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MSGO.9P<RNB8[KA?B\)76^7PT?*G@RG[A4/MZ#J0[I451@U%!P<IJ)4_U.YP
MD.=M@%\#_-> SAE 4 ,"FVBES*8U(IJ$72D.((TWLIF-?1N+QFQ8::J8:(FW
M#'$Z',[B9#89C_K+: 3)$I=I%"\3F-U#].UAO/P)_7@$BV@41=/^8!)!/(L1
MLUS,)I-Q_ 7&\3):1 DBKN9$TE+G5+.4\&OX ._ !96C575=C5I-1#>M=0TJ
M7?X970%,!9(IB,J,9O_B7<RQ2=0_)CKP+Q).B6Q!T+X!W_/]-_0,_Q_>OB G
M:-X]L'S!&;Y$$TVQ&S2(-21:I(^YX!F5ZCU$?W9,/\.O_DIIB;_Y[POA.DVX
MC@W7.5=F4138-!G;LXR6F;J!+955<>"*X87@G$CU8KU^JV15C%L;PXR'?>BU
M@JZ[/WW&RSZ5>/?D?RVHW-@V5I"*7:FKBC;69E+T;8.\L@]P@E0-_T)3C1^L
MUX:5"CA=(Z77NL7^DU5+5P<MMK8K5D)CC]EMCE.02N. ]VLA]/%@ C1S-?P+
M4$L#!!0    ( $:"I%2#I7)N(PD  #,F   8    >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&ULK9I=;]NX$H;_"A'L10,DM?EA22[2 &G2Q1;H%YKNV6M:HF.V
MDNBEZ"0]O_X,*<>T15*)S^Y-8LDC:5YR.,\,K8L'I7]V*R$,>FSJMGM[LC)F
M_68RZ<J5:'CW6JU%"]\LE6ZX@4-]-^G66O#*7=34$S*=9I.&R_;D\L*=^ZHO
M+]3&U+(57S7J-DW#]:]WHE8/;T_PR=.);_)N9>R)R>7%FM^)6V'^7'_5<#39
MW:62C6@[J5JDQ?+MR15^<\T*>X&S^(\4#]W>9V2E+)3Z:0\^5&]/IM8C48O2
MV%MP^'<OKD5=VSN!'W]O;WJR>Z:]</_ST]U_=^)!S()WXEK5?\G*K-Z>%">H
M$DN^J<TW]?"'V J:V?N5JN[<7_2PM9V>H'+3&=5L+P8/&MGV__GC=B#V+H#[
MQ"\@VPO(\ *6N(!N+Z!.:.^9DW7##;^\T.H!:6L-=[,?W-BXJT&-;.TTWAH-
MWTJXSEQ>?_E\^^7CAYNK[^]OT.UW^/?I_>?OM^C+[^CZZO8/]/O'+W_=HG/T
MY^T->O7;*?H-R19]7ZE-Q]NJNY@8\,'>:5)NG_>N?QY)/(^B3ZHUJPZ];RM1
M'5X_ =]W LB3@'=D](:?N'Z-*#Y#9$I(Q)_KEU^.1]RAN_&D[GXT-9Z\6Z$E
M+(X.+;5J$*PWS8UL[_J E4:*[LW(<]CN.<P]AR6>\QE6N&Q+U0CTJE9==QJ;
MBOX6F;N%7<_WE_F,,GHQN=\?H- *LSDCWNS P=G.P=GH0%Q5/R!Z8<&;#AD%
M*[Y4;2EK@=JAY_9K>[*T0[?6ZEY"9*#%+_1JT\$'V9X>/8K9SLEL=!1O!.2^
M4O(^H[05XHW21OZW/Z&6X#:OD>@,-^(,/#E?U[P4J!:0.,[<!<JLA(9O#&_O
MY*(6T271.S';'^$\S^EP(B)F,YBP(CX1^4YC/JKQ:B )4DKY\]RFO@K!+  /
M.O==S/$\\(CE=ID<N!TQHAF+.UWLG"Z.<AH2L] :/%[*ED,<0224JC/1T2X"
M?TA6S =.1XP(3H3\?.?T?-1I^,PM-<[M%Q Z;=R_>?#H<XSQK!AX&#&;8SJ+
MNXBG/M]/CQK95K4 SDU;<8A>!#YK&%^!ED)T_8I8J'LQ65C> W?T3UBH+OR?
MB_FM&P?^$XB>V4!FU([FJ0#">V##HT+?_[V1YA>R*0:]ZA/.:9^3-W#0=JJ6
M%2SK"OU0( 7=@_2-3FC!$1\Q&\Y8S Q/IXGUBXE70L:SE.R,EHN-G;+.SIG@
MNH4ET/V_<D@8_#0?BADW.I3BZ8CIJ)2/;C;NN$OJ+>HXQ-QAF@4Y%6342D)B
M-GO+W05=7 Z-S [)YL/T&K&;)O1X"N-Q#-\\Y:4MT0Q_1.+1YE2@VT*T8BE-
M%,W;^QXXG0^35,P([\?=H=<>S7@VZO6'9LVE[MELUWBM>-LO%(@8H>]AZ;^R
MP+X7&D![>F;Q'!4Q"XE%R5!$:$0)(PD-GMQX'-V#2*K$PL#(VQIA([M5DTJ^
M.(3L=.APA,,9(_.4RQ[$>)S$D>#O@B(C-=0A9<]I7@39-&)&9O,L2SGO@8S'
MB;SO_&8-[I<K2/]N]4+Z,5K5:=]#V 9C'II ZDQ&B2<R'D<RE.,;7IM?YUK4
M+COV.'A1<(< #KP.38K9/.XS\80FXX3^XDI*X/*YJXBE$4TTE$F$G'@6I+V8
M64ZRA)<>KP2/-SIN^CM(?&.%./&0(\] 3I3:U166U>[3J6TU>5FJC<U3,&5"
MWKLBQ=?=O.N$Z9)32$*&G3/,V'"$0C.HQ[($[(B''1F'W8?V25(E8I+6_)?5
M<V;/Z(T-3LD7LG;=3=]=[,I>+0#H&Q$5&6*-9K,@"B*0S-F,),HLX@E(GF]$
MC^S<HBI"U.$YPT6@(V)'2#J>/1/)>+\Z;-QE"Q@\HN4DGEQDG%Q7)52FG=Q5
M<WOI/SHR(8[.,673;%BQ10W9'*>FV'.+C'/K!H*O5FO+U#/PMMH_]&NQX3\4
M=,*-C0/1UQ8O$!?A%<X+$H M:DAGE*;2K0<;>09LL#!W_>09,@(J3G.@HU<)
M"6BCM;/D:VFL+%OH53)99Y,(U @IZ+#,B]I-<YRH3HFG'QFGWU>M2B&J;40?
M56^0$&U0VF7!M(1F<YJS5*U$/03I. 2O;4VQZWF,.K[+H3$\LB(;*(B9S>:I
MO$@]'^EX^WG8M$':%X^EZ/Z-]HV&;28M\N',1*SPM"")_0/J.4W'.1V)J<D:
MED4IUQ!56@#4MHN_=7U%0.XC.CL:@CF?,1I(#<T22X?N;>,^QVZ;_GLE,J'$
MY;VHWQ'8XB(;EH\Q,YI/4Z'GD4S_$9)C9(NJB'2?A$$S,>SP(H9YEB>93#V3
MZ7%,]C'S,B93SV0ZSN1W2L,U;E'V^P\+WOY$;A_/-C@ /6G<G$.7WPA=2HCU
M-5\GIC\$,<TA>6;##:.8(:,YF:;"UR.;CB/[FU^'_X*>6.\)]7%!@XB.MI^D
MR%A*D<<T'<?TGJ*>QNN-AA:T$_WV\ )J$<BP]::RX?&/U,9:49('4F-F4&U!
M@DI(]=BFSV#[2>@2"JK(QL9A:_""'7'Z?"L;,8%FLIAB'%?#/,G9.,D_=-""
MVRUEMU/0-';GP_X$X52(1SL=_22JM6.E*TG<\1(4CNIB$78/F[N(#7 PT=LQ
MCW<VCO=O!_&WKROJ:&QG&,K782:-VA&<):C-/+79<UO(%@1M99M.65DV/^MR
MI'?&&65LV';$#1G&B6U*YAG,QAE\6$)!#6@C9G_86]5N]YYJ&R=0. FHF1*Q
M$FN 9]-A+1XURY-:]GZN'6?R83WK:&;5R+W%<92:$+DD^#TQ8I1(P\PCF8UO
M'3]36\0('?4_W!2&"FF&A[\MQNR@.,<XT?8Q3WPV3OSM#^BQ#1JK[ZQ7*:!5
MOX<:UV/'AF1I"W7[?51:I W/IV0^S+@Q.TJSU+83\^QGX^R_?K'[9V@A[F1K
MFQ$;@ !$J:JHII#K!,]9\ M8Q X7."M2^<O3GXW3_QA-PI;FHVJ*V!L/X2^P
M43M XC 93/9>OX'RXLZ]E=0AM\O7O\BR.[M[\^G*O>\S./\.O[GNWU_RM^E?
MI_K$-4Q4![W2$FXY?9W#$.O^#:7^P*BU>\EGH8Q1C?NX$APJ/VL WR^5,D\'
M]@&[]\0N_P=02P,$%     @ 1H*D5/Q3[ <N!0  60L  !@   !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6R=5DUOVS@0_2N$%RA:P+ =)]T6S0?0N"W:0] @
M:78/BSW0Y,CBAB)5DK+K_?7[AI1D!VB+8B^V1,X,WYMY,^+%SH?'6!,E\:VQ
M+EY.ZI3:-_-Y5#4U,LY\2PX[E0^-3'@-FWEL TF=G1H[7RX6O\\;:=SDZB*O
MW8:K"]\E:QS=!A&[II%A?TW6[RXG)Y-AX<YLZL0+\ZN+5F[HGM)#>QOP-A^C
M:-.0B\8[$:BZG+P]>7-]QO;9X ]#NWCT+)C)VOM'?OFD+R<+!D265.(($G];
M6I&U' @POO8Q)^.1['C\/$3_D+F#RUI&6GG[I]&IOIR\G@A-E>QLNO.[C]3S
M><GQE+<Q_XI=;[N8"-7%Y)O>&0@:X\J__-;GX5<<EKW#,N,N!V64[V225Q?!
M[T1@:T3CATPU>P.<<5R4^Q2P:^"7KJZ[B)48+^8)T7AMKGK/Z^*Y_('GJ;CQ
M+M51O'>:]%/_.5",4)8#E.OE3P/>R# 3IR=3L5PLES^)=SI2.\WQ3G\0[W/8
M2&?^E5S]J5AY%[TU6A8Q."UN T5RJ2SX2GPP3CIEI!7W6"0H+T7QU]MU3 ':
M^?LGB,Y&1&<9T=G_2/:O>8K/6PI;%OM'DC;5+<E'$$&/AF0H3L4GIV93(9F"
MTS)H\4PV[;FX]3X\^^WU\N35>10O%PNA?--*MY\*$V&-U.\MYT3YT/I04I)J
MF7C;ESR2%LF+KYVTIMH+R6Z8 E90Y&P)X[9XXJ2)%*!;\9S/6R[.[]Y_^I(?
M3\Y?Y)A3Q-E0JBE ZZD6!FE68W5P#&(89B.>0]VY?;=D ;4/>&#>AP5"!*9A
M?U6H#6=.>VA1M,%@\!B[Q\H3[)%SZC8Y2)VC*QF8D@:1D,UYZ\$9AI?5$4=^
M#[/[V7#63!R#.WEU=HZQ\[4S@4NC"31\BR=+F"/X]SN'7\Y[(QU&8#P^_0C@
M3'S!\4>\<ADUTA(B"10L54B>YV)Q78.)@ E%'VH2!PXPQ!QFLH'84:[M$\Z1
M-MG^C7AN7@B4&DO*D%-TCA4L-:2- C)?5887&3TVL(,:)N,ZCMT32"">%0%4
M38?L[<>LK59WJT/6OD=OD&*&IZ&[D$!7E,*(=P1N@=O:PDC[C,,D4;,PM3:L
MX!%E9K]BX?K@C)R*+^2XFXA*]F]DC%+57:2$+QQB;HT6#RVK,4,#%$3;&NCZ
M0("-1ET#N:;&J'R^DAT7()J-,SA>(@':Q-"UI:T\"\O &ZV$\F\\B+B<]*FH
MQAD$I3Y2ZN6Q[MN?16.<LIT>Y-IG[?LI3(1H'(/G@TP^#.%\P.3B;-9R2X*^
M83O7^"EHY='&."YDN0XM'_&]*^(J&[J73XX<946H<H.-+HL>^D4) #;6K+9-
MSZ#W/' 'XT";SA[&,RO9&F0#1=I*I9  ;A,N2D_#YQE2N)5RJUHZ;B-'*'HT
MJ8P3D^TTQ*@2FA_3@@O0OZWW?1ZYYD,9GZ13T%;:+H=B2X-%A89""HH3\/((
M&VH$(\BDDJ%(THTZYI=RBV**Z!8%[D,=2]1#4.-8)XFSCMS'TL/8M0;C!/+F
MR0T7$WKAE(R5:;DVEENM"KXY2 #5,/I@>Y" S''Q!5#U^/5]RG]GK!VZFUB_
MC4<O>[[:P6?(!T?-EE+_P_.?P6/Z8.3RM.1=4.F:W 0QWZ1RZIC\&G9";J6Q
M>1P=I6GVO:_N_.BZTU#8Y$L=#XS.I7+S&5?'>^/;<ETZF)=+)VAO#.!8JN"Z
MF+UZ.1&A7.3*2_)MOCRM?<)5+#_R.*+ !MBOO$_#"Q\PWJ:O_@-02P,$%
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M4P"2C)=9]"DPL9 EQ5D_$E6ID2%89\W:FIX6.4QF92ED_@TY):CP.3W7GEF
MY@P%%)DM:QQ;M[?V;\(HG.4);Q!6ZP C8BFU0UB3#<X#GZU!.Z.MK=?$P*#U
M"!Q&EF&V?%!I)GTAEJ@0^O)$&\.E/H?EI*M(@V"!SH4JE1)5R#.*\@S@P&5%
MFR8$L FRU:T$&AQKDP,MJ1Y(49+HLJTJ>0L.V-TS]L!XV*V2C@XA1MZ"7+6
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MD[/,.-6!_0,+26#<:BCA;R^^YQUR0\)SRH'O* <.'EKVN9<ZP1[9!'>00TC
M6+EMFZR2*)0"^"+K2RH#8H''6K"-ASZ1XV&Q1UB,0?%4Z 7!-N IE&$66W/&
MLMEWU&&PKX^92"@F'7PSK%+Q,#YY6]WDH,].7@Q>3(_WXTP;L!143T/>9R>G
M@^GX.!3PVT"5ZLNUO"4R [KC&K55>@?.0P&W59'O8Y^.FPQ.3T9[W>(L@NR<
MNOJA>&]OE#/<WKQWU.*AF+65$I]-)#LY8;*CD,F6BL*F%*MNFS*RS0;GU@%R
M;[1KD/QU/H A2ZV6@?T+:,=6.DNY^Y:*^19#SV?7%W.ZTU6V5 M:Q+3JU2/
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M]>#P'GV,!Q&[/CRC-SX=]=BX_Q320UP,A9*(4B_J!V%_P/YWV)]5Z&+'46B
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M$#P3%2W \YE2IKD@ >L?_+SY/U!+ P04    " !&@J14@_5<'+(#  !5#
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MHL1J, Y;JYN!D$34=-7^5-TV8']G6=Y8>Z/2F/.BD:EBGN+$4/>0Y-3<.E7
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MH22R@@3P?N80S>:&#'2_'YW_ U!+ P04    " !&@J14>OD]=C &   I$0
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MPPXSX6(>)DY7_C(\U0ZOUGZX (Z'&Q+ [S.-!;*:T +MKR-G_P%02P,$%
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M*]T81"9I+),DV:8V\1S@*XB_P5C;=1\QX.-0+TU'H' 9TIL3B8^3'T*#.YA
M.^3)R-F&^( :&:$?L)FKZ]!LFIMX1\R=Z]+ EV$0C=A.QB+$,HKP<B/]N3XH
M1P%:DTC&D2=\!SX5BT!Z:;P^/,9SXHCW*+-/]S%A>1#,P; S67L!GWYO-[5A
M8_-IV-N7*6O1I.-'I >91&.K^8&,DI#T$LLPP8KG"H4*BGE[246M]KAFGL3
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M@6CL+_CL0ULO^5=ST[IMZP4/YRJ#,]$"O)_5T$SW0 <,/Z-\^E]02P,$%
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MF8R._,*Y^F+5REWKGRMK5>X>4\'1Y-( _+Y0RE9?B$']=QXO_PM02P,$%
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M[$8[;[O@)V>_;C14G G/!J'X\W*)(E@Q?[UAN-@;+H+AXO^'^#\!L2?/A'.
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M6./;$BP)X/[*X)'I)V1@_UJ]^!=02P,$%     @ 1H*D5 V@9,/A!   2@L
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M5AAVV8L!OI<.-;M\D0/6X_/I/U!+ P04    " !&@J14<E1FXL4#  #""0
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M+5*60M) ; 09N852V(+J4"B?C_J;X;Y#6'@G%"U*-Y;2VO>70-555*&\;K#
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M LG/\$#+U2%(#$7LETXLR#B/"Z@O&B5\B*H&VC(8W*!P9>4FY*;06;&)=]S
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MX=@2"I8U+GJ-IUYCO$5C N])8&W@O"VQ?,H_)O0;$^*U":?QBP+?"[T/211
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M=(%RRYINK*B9@/8KI>SZA15L[L#'_P-02P,$%     @ 1H*D5$VIMSL^ P
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M0>VDJ[9% E_6W=+M2@EJ42[70!ZXY8X!&;/ -%+S)*J0C@(T!Z"@HFFO@R7
MW ,, %\24:3.!#_*6"*8,7S%29L92+DA3EDN"]K3<-',M2>1*27_3%=P5&$H
MT:9U"3.F]:LS>9T["$"53C)?ZEM,,%\2$K>Y<YA?H=EKP0+7SC$\:6>>#F=>
ML1FVX'$G49N,;^#"[QU;W$\/%M\_PN(3?'Z&1PI,0V\,_1@^0-2/@G P\JM^
M$(UCN.<KA$7"D9K$R?N]J?8]B,<0#H+^D.SV@T&W#W\@IAG+X=XQYXG0HW!J
MS:AUJOKK+Z.P%_X.T0AZ<1#% ^A%07\PH/*G/&$"'E<K[EU2LN)6?:S*XXCB
M@-]@,(11,!Y&, ZZ@S'!CKM1T.OO5X,HAK__WY_/)='&X($0C@M263B9"DM,
M6$%2]HABJ2+I2M)J)0*ZU:I89[!5UE53NW%I@-BD?+YS9-($WL8_OKNV57>U
M?:'J6GH>EEVHZF+254+B](J4$(EFU#T'IK@RMWW&Y_) &U?WX 0U2XC/VO&4
MJG!1MXB?C"".BY7BEAZTC>?9"5XG6U4\( 3&L"2CY%C"[%KG0R^B,2X$4;Y=
M,B)#47;5L4ENJEYR':=5[E%N3G)P+LC8!>E5J7]WBIKUI%CY*6M.<^W [S).
M!H^SDBF1NHR_F7 'HYP<YA*:O'68BG/B>-B]:/E:-3E=+8IEH9=DJ*HF,2J
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M2D3O(<*I]Q*A)XA0'WI<$8IN+#T1V[\ *GM>A;I?88XRHW"O+)NZ%DC3ZIB
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M,2?<Z23JM9.>_:,3U!>,V[-[:&8H M(\";W6HH_=--PH7;<9\5BK!X%,A'9
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M\T-#\DD_SQ^2X\KS>'S=B6_PC!K"G_]@.1U:70[EZCOOOE[?/%+'M\H5UX5
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MN&O[X1(?-UP[ ;R?*V6W$^=@][ET]A=02P,$%     @ 1H*D5/]K3@2#!
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MWKR*P#:]OYF0J4*_71OB[AV&!3^7:+T![V\,R[^=^ #'!WCZ/U!+ P04
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M1CZ+T17+$C$L#YR@%CR<8!Q?GZ[N'Z#EJN0H,DR.(I*C",Q19][23X6]1.S
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MD;LRQR583R SP4A;M?KF57"FBZ[NO^;2E)9%0M$XR=$\& 3:A@J"B2D&.WF
M+Z@/C:_0+1 V5#19$5U;A^Z^/IY7DTT+CKLSPD.6%LQ4-+O^#4,GQX]J2T6C
M/=/LPG&W3*)A:[*@,,)34>PT 9XB"G^NCM#2ZE$4#MN"#88#.!7@3A+@+S3A
M0'RKNT.M"J8[3',=MW<$_;D_Y&J!X2@*)KAV.@#=0F#C6D^UWX[Y6 5L2Q(;
M;'I- CNQ@,D+K$I0U]J1N[7?4;UC;-<EMI7[5>/!.8%MF(GZ0IU(('A:9]^3
M'X>VKI<;PN2IMXXZJ[/(Z[G>>VP="+2LG_QHF#HK+ [PQ'!ZNPBW4)TB]&@L
M+! />[H%E$PL0E"G/<BM/2^R0$5CM8$!PD/YM,*2WH[D> R=*B&W*O7WU((6
M>C^> <6?&^QI?0J-I2@>\1]CDHF-$NKD"KGEZC?(_U'C0A:EL^P>;+#I[0/J
MM ZYM>Z#7I$)<U!"FX.2>EQ6HF.Y0K[^&Q*UP' ?=DRT4S7D5K73M@R-D_YV
M&5HX_@)U3+$3,^06LZ/U./@)WM.,I3JT'_.<Z;7N5<6*C)4/TJ40G>*@EU <
MW"D.=BO.AVJWT;U:=Y?FN,@4?%KH2+.<Z5(FPV+_"1SG2E=XK#SA( L6R,1Z
M G?:A-W:-$S!'<LI6*>,ZLV&*TR=6F#WH=.)8>\=/;G[^\N&_1I;6O@@IE[O
MA-4<H+\GXH&5$A0TUS;^VT@;B\.9].%&\7U]Z+KA2O%=?;FE)*/" /3[G'/U
M?&/.<=M?!I;_ 5!+ P04    " !&@J14XZ,$7%D$  "\#@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970T.2YX;6RMEU]OVS80P+\*8?0A 9)(HBS)+AP#^;<V
M0(L%2;L]#'M@K+/-52)=DHJ3;[\CI<BN*2D9L!=;HNZ.O[LC>;S95JH?>@U@
MR'-9"'T^6ANS^1@$>K&&DNDSN0&!7Y92E<S@JUH%>J. Y4ZI+ (:AFE0,BY&
M\YD;NU/SF:Q,P07<*:*KLF3JY1(*N3T?1:/7@7N^6AL[$,QG&[:"!S#?-W<*
MWX+62LY+$)I+010LST<7T<>K*+,*3N(/#EN]]TRL*X]2_K OM_GY*+1$4,#"
M6!,,_Y[@"HK"6D*.GXW143NG5=Q_?K7^FW,>G7ED&JYD\2?/S?I\-!F1'):L
M*LR]W'Z&QJ'$VEO(0KM?LFUDPQ%95-K(LE%&@I*+^I\]-X'84T [W0JT4:"'
M"N,>A;A1B)VC-9ESZYH9-I\IN27*2J,U^^!BX[31&RYL&A^,PJ\<]<S\FNN-
MU-R&5!.Y)/? "G*C#3- F,@)?E](8;BH(">_;T"Q6O24/."*RJL":BV-87,&
M^A2.KL$P7NAC5/T,17Z*2_!4,]0_)=\?KLG1AV/R@7!!OJUEI7%J/0L,.F@Q
M@T7CS&7M#.UQ)B9?<>JU)C<BA_Q7_0 #TT:'OD;GD@X:_,K4&8FC$T)#2CMX
MKMZO'@W@Q&VR8F<O[K%W*Q:R!/)@LX-;R9R02U8PL< AM^5MPB[RW&43TVA3
M44A=*=#D\874J<;Q3TI6&WU"T%Q1Y5RL>I/VUQ<D(+<XF_Y[@'_<\H\=_[B'
M_QZ9<7Z+J:! )^S_$^"LG<FNC:7.F#V.GN;A+'C:#[\OD5 Z:85^@4Q:R.0-
M2,US!"5+P+A95@WJB2^Z&6M;R1X!39/D -,7RNATVL.9MISI(.<W:6,Y%+_T
M/6R^4#:A-.UFRUJV;)#M5AC 56<(/&.]T=!%EWD3'V;7EZ!IUD,V:<DF@V3-
MXA:K+J1)UX3C RI?*(N2:-J--6VQIL/)5$QH5E>VA=2F,Y_3-R/F2_3%*PIW
M!2)\QSIS4&XW-"GM/I[#]T2P0RH;TRSJ(=TK9=$@Z2>\M9 C//&PR& <;7%Q
M)4G9F@:NIIT0 ::3//*83O>(&G!?B";3-*4]Y'1'3H=7I5F#PN+GCO>C)L+'
M_;#4XX@/47V19#))>D!W!2B*W[$8Y'_$C?W8II-#8%_(GE;CK =Y5W.BX:+3
M%,UF73P"WCO@E=VPY^:,AY\5-R^M3[7P4LF25#@DM"QX[@K6/Y)C;<!#U]BZ
MVNGNV'=WDAVZZPO1=)J$?4MI5[VBX?)UVWJ&O@I8<K/+4">M7YSB\>&YTB$T
MH7W[=5? HN$*=O,_QMPO8ZEW[/@RIW'4MR5VI2YZJ]9Y^/G^=4JVUZE.\,R[
MPL21MUA\(9J%87AX@PCV^H 2U,JU1QK/[DJ8^M+;CK8MV(5K/ [&+VUKYOJ+
MG9FZK\,K[8KCS;" )9H,SS(,IZI;I?K%R(WK-AZEP=[%/:ZQO01E!?#[4DKS
M^F(G:!O6^;]02P,$%     @ 1H*D5,_T=H>1 @  D 8  !D   !X;"]W;W)K
M<VAE971S+W-H965T-3 N>&ULE551;YLP$/XK%NI#*VTEF$#2*D%*TE6KM&I5
MLW8/TQX<.()5L#/;2;I_O[,AC*9)M+V ?;[ON^_N\#':2O6B"P!#7JM2Z+%7
M&+.Z]GV=%E Q?2E7(/ DEZIB!K=JZ>N5 I8Y4%7ZM->+_8IQX24C9WM0R4BN
M3<D%/"BBUU7%U.\IE'([]@)O9WCDR\)8@Y^,5FP)<S!/JP>%.[]ER7@%0G,I
MB()\[$V"ZUEL_9W#,X>M[JR)S60AY8O=W&5CKV<%00FIL0P,7QN805E:(I3Q
MJ^'TVI 6V%WOV&]=[IC+@FF8R?([STPQ]H8>R2!GZ](\RNUG:/*)+%\J2^V>
M9%O[1@./I&MM9-6 44'%1?UFKTT=.@#D.0R@#8#N _I' &$#"%VBM3*7U@TS
M+!DIN27*>B.;7;C:.#1FPX7MXMPH/.6(,\D7P!IH\I&X!;D3J:R G-^ 8;S4
M%WCP-+\AYV<7Y(QP0;X5<JV9R/3(-QC=<OAI$VE:1Z)'(H7D7@I3:/))9)"]
MQ?NHNI5.=]*G]"3A/5.7) P^$-JC](">V;_#@Q-RPK:2H>,+C_#="0,*M"%8
M'O+5%*!VU?PQ66BC\(/]>2),OPW3=V'Z1\+<\E?(L!6..5>R(GBC%3-<+$GI
MFGFH-35G[#CMQ=XD=#B@5UBV3;=B!]QB>A4.6K<WDJ-6<G12\C-3G"U*^&_5
M-6W4D3.DPVBX)_J]5QSUPNBPYKC5')_4W':SJSGC"J</R;E@(CTM/7Y7R2"(
M]Y6_=Z)!'.X)]SN7NP*U=#-/DU2NA:DO2VMMQ^K$39,]^Q3';3T=_]+4LQJO
MPI(+C>GD2-F['& Q53W_ZHV1*S="%M+@0'++ G\9H*P#GN=2FMW&!FA_0LD?
M4$L#!!0    ( $:"I%3^]F?K-@(  .8$   9    >&PO=V]R:W-H965T<R]S
M:&5E=#4Q+GAM;'U4WV_:,!#^5TY1'UII(Y! 5U4A$I3]DLJ$BKH]3'LPR26Q
MZMC,-J3[[W=V0L8VX"7VV?=]]]WESDFC](NI$"V\UD*::5!9N[T/0Y-56#,S
M4%N4=%,H73-+IBY#L]7(<@^J11@-A[=AS;@,TL2?K72:J)T57.)*@]G5-=._
MYBA4,PU&P>'@B9>5=0=AFFQ9B6NTS]N5)BOL67)>HS1<2=!83(/9Z'X^<?[>
MX2O'QASMP66R4>K%&9_S:3!T@E!@9AT#HV6/#RB$(R(9/SO.H _I@,?[ _L'
MGSOELF$&'Y3XQG-;38.[ '(LV$[8)]5\PBX?+S!3PO@O-*WO. X@VQFKZ@Y,
M"FHNVY6]=G4X D2C,X"H T1>=QO(JUPPR])$JP:T\R8VM_&I>C2)X]+]E+75
M=,L)9]-'I)0,O(4O3&OF*@37"[2,"W,#5\ E++D05#^3A);B.528==SSECLZ
MPQW#4DE;&7@O<\S_QH>DLQ<;'<3.HXN$2Z8'$(_>0#2,HN?U JZO;B[0QGT-
M8D\;7Z[!]]G&6$UM\N,"Y[CG''O.\1G.E5898FZ@T*H&PP2"*D"X2-3+&?(]
MVP@\5=.6]];SNI':I[=W2;@_H672:YE<U/*19A-H @XJ<DX*+!1<,IEQ6;:R
M3FF9_*<EBO_1$A[U7HVZ]!-F(%,[:=LV[$_[(9ZUO?O'O7T!Z/>67!J24Q!T
M.'A'X74[5:UAU=9W\D99F@N_K>@A0NT<Z+Y0RAX,%Z!_VM+?4$L#!!0    (
M $:"I%1HK:I'K0(  &,'   9    >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM
M;)55WV^;,!#^5RS4AU9:"R&_MHH@M8FJ36JGJ%FWAVD/#AS!J[&9;9)6VA^_
MLR$L6Q*RO8"-[[[[[N/N'&VD>M8Y@"$O!1=ZXN7&E->^KY,<"JJO9 D"3S*I
M"FIPJU:^+A70U#D5W ^#8.07E DOCMRWN8HC61G.!,P5T5514/5Z"UQN)E[/
MVWYX9*O<V ]^')5T!0LP3^5<X<YO45)6@-!,"J(@FW@WO>OIV-H[@\\,-GIG
M36PF2RF?[>9#.O$"2P@X),8B4'RM80J<6R"D\:/!]-J0UG%WO46_<[EC+DNJ
M82KY%Y::?.*]]4@*&:VX>92;]]#D,[1XB>3:/<FFMAVB<5)I(XO&&1D43-1O
M^M+HL.,0OCOB$#8.X;\Z]!N'ODNT9N;2FE%#XTC)#5'6&M'LPFGCO#$;)NQ?
M7!B%IPS]3'P/J($FEV3&%"I+[IB@(F%B19J3\QD8RKB^(&>$"?(IEY6F(M61
M;S"\!?&3)M1M'2H\$NJ!JBO2[[TA81"&3XL9.3^[*!76HS*O!]"FW6@S2%JT
M7B>:CY*TNH2M+J&#[W?K\O5FJ8W"6OO6@=EO,?L.<W $<ZY @S!D37D%1&;V
M?[*B*@BWP4A)7[$]C,;F2("MZ9+#(9'K&",7P_;H.@XB?[TKW+Y%+PQ_&_W!
M?=!R'_P?=]"&81=!BG0U2RO*Z[-#E&OH80?E?8O!8!R,#G,>MIR'G9SO06O;
MTJ 4TL31P6U=8Y%DS!RLW^%)GOL6E\>U';4\1YT\/^*P9F*-BMK_;[LLK9LQ
M:YO15<A!SJ.3Y;!OT:'MN.4\/E$/KM48]HBNEM\M6R./\28_24>CWXY/RKYO
MT?N+OK\S NWU@\-FQ81& AGZ!%=C=%;U2*\W1I9N*BZEP1GKECG>@J"L 9YG
M4IKMQ@[:]EZ-?P%02P,$%     @ 1H*D5"Y&AU@W P  5PH  !D   !X;"]W
M;W)K<VAE971S+W-H965T-3,N>&ULQ5;;CM,P$/T5*^(!I&43.Y>FJ*T$K1!(
M(*VV+#P@'KS)M+5([&*[[;)?SSC)9K-M&O8!B9?$ESEGSLSX-CDH_=-L "RY
M*PMIIM[&VNT;WS?9!DIN+M46),ZLE"ZYQ:Y>^V:K@><5J"Q\%@2)7W(AO=FD
M&KO2LXG:V4)(N-+$[,J2Z]_OH%"'J4>]AX%KL=Y8-^#/)EN^AB78F^V5QI[?
MLN2B!&F$DD3#:NJ]I6\6E#E 9?%5P,%TVL2%<JO43]?YF$^]P"F" C+K*#C^
M]C"'HG!,J.-70^JU/AVPVWY@?U\%C\'<<@-S57P3N=U,O=0C.:SXKK#7ZO !
MFH!BQY>IPE1?<FAL X]D.V-5V8!102ED_>=W32(Z !J= ; &P)X+"!M ^%Q
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M_!CI1W'^"3*#!@9O(R)EK^2<R;H]LCDJ+>),&1G$89+^\J?,$24%1EL46*;
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M3>X^@JNKD<D7FE0V[G (-,IL\L;1/FY0A%93M&ODV69$S5;W*W%/8S#-U_&
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M$'9,F0DPOI!2[U[,#4AY:S?^'U!+ P04    " !&@J140F;?$,\"  "P"
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MX3LT>OJ6+Y>E=O_D4-OVTXCD.VTD;\ 8 6>B?M+7)@\G .1I!Z0-(/T;,/@
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M>/ <;+9</C!FTYVWH2^4O^Z>$G%G5"RK(*)Q&K 8)'1].;J"%_<$2T#>XN^
M[M.#:R!=63+V0][<KRY'IK2(AM3GDL(3/V]T3L-0,@D[_BU)1U6?$GAX_<%^
MFSLOG%EZ*9VS\)]@Q;>7(V<$5G3M92%_9OL[6CID23Z?A6G^'^R+MI8U GZ6
M<A:58&%!%,3%K_=>!N( @& + )4 U!> 2P ^!;291$H Z=N#50*LO@"[!-BG
M +,%,"D!D[X]."7 Z0MP2X";ET.1OSSY"X][LVG"]B"1K06;O,@K*$>+G >Q
M+/87GHBW@<#QV8(N.?@=O- X8 EXC5/J9PE=@4?&:0J^+RCW@C#]=6IPT9F$
M&'Y)?%T0HQ9B#!Y8S+<IN(E7=-6 7^CQ$&D(#.%EY2KZ</4::1D?O&0,,/P-
M(!.AUY<%^/Y+DU_S_BRPG66A9UE0O\:R9'%3G&[T3(_L;0P0Z;+G5L_R9Q:.
M 41=+']TQ>8G@&X7R9V>Y)8NA4-V%\M]AT->+%@<#<M1#>%JN."<%NN&RWV<
M\B03BL\UC*1B)#DC:6%\2H+8#W9>*#0[]&*? C$%K$0W34.NH+)S*CF-O<UL
M/'$=4TQMYM1X:S##JLRPM&;\Q=)4]DS?>1!OLB#=2O\ 6[?:4O!9![8H$XJ!
M9-6LA39!;KNQ=F6LK37V,8N6-)'&R3$C?M=41'&3@O] RR!:V#5K4;,-D\J&
MB=:&1L74U(-3\3H#59A;,;K#59A;RQF9F.7?<7H7O9H>60Q--2N9YT=7I/?D
M 1X3TP1/-/'UH8('TR$<*/P0*4ZD=>8J8MDI52&G)? PALB"CFFWAU I%<3:
M7N<LVXE$/WNG95EVK4?+R'[3>:_T#>H%KF<JR=CLETJE:- :*I5*>*!>>32I
MM.NI=!WHDO94*JF!>JWI2J4>+2.K3:62)N@,DTID]4JE4C#H#I1*I"0&Z26F
M-95W)?!HXG*<)@V\;VH*D4X#D9(B!+^0];L.M$S"M\9UT]FX8_N5["&][/6O
MEEX#'RGE0T,MTI!2,:17,4VUU!=ED+C-U5)OBDRHK1:E=DB_@.NJ%CU:)J&Y
M6L[&'=NOE!7IE;7WC"]&8I]J4>**)D-5BQ)*I!=*3;4XM1+ ^+0$RM#7FQ+[
MM+".#52"BO1KPJYJT:-E$IJKY6S<\2Y,B3?^W/JP?%Y\O5AD5&[_+%V/2HWQ
M4 M#K!02ZQ7R[$W7 M<7C+960/#!SE:_XCLGI!AX8M\E+H@N#DI<,1DJMDH/
M\< ;VCENW*]J@ZO4#0^B;F@,<0]QPTK<\%#BAI6XX4^*VPVN*Y:EWQ%BI5CX
M*XIUTX&6@=4I#U'*0P;9F<(QMGIDDBC](4/I#U'Z0SZY,;TE=9TAEC:31 D-
M^<K&]+8#+0/;F$GCX"-X1)--?H*2 E^Z6'PDKIY6IS17^=G$R?-K>#$OSEH4
M37'T\^ EFR!.04C7@M(<3X1B),5I2G'#V2[_U+YDG+,HO]Q2;T43V4"\7S-1
M&^6-[* ZTYK]#U!+ P04    " !&@J14@'OX60,$  "7#@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970V-"YX;6R]5UUOXC@4_2L6FH>IU&GB!"A4@%2@J'WH
M;C7LS#R;Y$*L<>*,[<!4FA^_UTE(^$Q9">T+Q,Z]Q^=^^,0>;*3ZJ2, 0W['
M(M'#5F1,^N X.H@@9OI.II#@FZ54,3,X5"M'IPI8F#O%PO%<M^O$C">MT2"?
M>U.C@<R,X F\*:*S.&;J?0Q";H8MVMI.?.6KR-@)9S1(V0KF8+ZE;PI'3H42
M\A@2S65"%"R'K4?Z,*-]ZY!;?.>PT3O/Q(:RD/*G';R$PY9K&8& P%@(AG]K
MF( 0%@EY_"I!6]6:UG'W>8L^RX/'8!9,PT2*'SPTT;#5:Y$0EBP3YJO</$,9
M4,?B!5+H_)=L2ENW18),&QF7SL@@YDGQSWZ7B=AQ:/MG'+S2P3MP\.@9![]T
M\ \=>F<<VJ5#^U)*G=*A<RFE;NG0S7-?)"O/])09-AHHN2'*6B.:?<C+E7MC
M@GEB.VMN%+[EZ&=&4U@8\H6\2F56V$DD'W^>@F%<Z!ORB?"$_!/)3+,DU /'
MX)+6T0E*^'$![YV!]Q$Y,9$F3TD(X;Z_@U0KOMZ6[]AK!'QEZH[X])9XKN=]
MFT_)YT\W(2B^9K9#GT&$2Q9PP<W[";*3R[%IB7T"9=J,\IA:%+=@N$_M!-A3
M,]@4@B-*VP _Q)Y=3O1TN'L5\JN.\G-8OZFC7A)M5(8*9!H0VQ5B.T=LGT%\
M4SP)>,H$:HA@20 $)2G$94[U8P'5S:&LK*Y'7?^^WW.]@;,^P:%3<>@T<GA)
M#"C0YHMB!LA\PU(RP<Y6J(RZ(<1N!=^]4M+N*\3[1L)_9?$"%)%+W,&[U(,M
M:Q)AUY _Y,,V&A<+=792ZE;)+)JXR6*/?:]BWVMD/\\6&GYEF KRM+:_?TA3
M!?#UA.F(S/!#29XA7/%DA7-3T'R5H'E(F*[F+TISOR+:OU+AJ%M+LOL_E6Y:
MKK1;F3,;@>Y\,6@CO5<(>8";\>_EDN->'&=<A)A76X2]STA3+KQZ,>]:^:T%
MBOJ- 3S&,CN$*OJX=-Q5#]K&0]I!O\\^MMNG5BL=;9:ZBQ-8ZQ;M7"N!M5C1
M[O4$N<3:S97?[O5[_0,-.677<<_GM!9">JD21L"$B0*F@)0?40Z:9!KUP4BB
M(<CP39B?@/#84YO<8&LW'"O&]%C_:.\PO$:;_=!JE:3-,ID7EU?%O46)$ *E
M0C%Q>R9:'*MW*X-K)C(X&4WOJ! ]US_:!$^G["@]7[!:4FG_OT65HLY)%!V2
MLO?C)BY9]X^WY!'GR4=6!6-GYSP=@UKE-Q],G96-XJA:S5:WJ\?\3G$P/Z8/
MD^*.5,,45S8\:^+'2!,!2X1T[^ZQ,51Q"RH&1J;YJ7TA#=X!\D<L*"J^-<#W
M2RG-=F 7J.ZBHW\!4$L#!!0    ( $:"I%1 FR,U_P<  #XT   9    >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;*V;;6_;-A#'OPKA/2 %&IM/DJ@M"; D
M&S9@&8IVW5XK-A,+M:1,HIL6V(<?);L^.2*/6JV^J"U;=__36?F)_(NZ>*[J
M#\U::T,^%9NRN9RMC7GZ8;%HEFM=9,V\>M*E_>:AJHO,V,WZ<=$\U3I;=4'%
M9L$IC1=%EI>SJXONLS?UU46U-9N\U&]JTFR+(JL_7^M-]7PY8[,O'[S-']>F
M_6!Q=?&4/>IWVKQ_>E/;K<4ARRHO=-GD54EJ_7 Y^XG]<,-HVD9TN_R5Z^>F
M]YZTQW)?51_:C=]6ES/:EJ0W>FG:')E]^:AO]&;3IK*%_+//.CN(MH']]U^R
M_](=O3V:^ZS1-]7F[WQEUI<S-2,K_9!M-^9M]?RKWA]1U.9;5INF^Y\\[_:-
M[,[+;6.J8A]L*RCR<O>:?=IWHA=@\[@#^#Z OPR0G@"Q#Q#=@>XJZP[K-C/9
MU45=/9.ZW=MF:]]TO>FB[='D9?L[OC.U_3:W<>;J5M\;<DZZE[O,;.O<Y+HA
M9[?:9/FF>66_>__NEIQ]^XI\2_*2_+FNMDU6KIJ+A;'R;9+%<B]UO9/B'BE!
M[JK2K!OR<[G2J^/XA2W[4#O_4OLU1Q/>9?6<"/::<,JYHYX;//Q6+P_A#"E'
M'%HINGP":^5O96/JK3W1#9)1'C+*+J/T9/0<U_4N*NZBVC_4CU<B2=3%XJ-#
M*SIH12$MX=+:144]K912E;K%XH-8'!*3+K%X()9T>[JTDH-6$M**7%K)0$M1
MP:GGR-1!38748I>:&JAQSB,A8K=<>I!+4;D_U]K2^\'HVB6:#D0%CZB(/:*,
M C0H+EN9;&-I:4_X>VTO)IJL\F99;4OSFI3:.-E !\7$(DD5Y9YB>@1C:#%G
MMWOMYM5K8B]F1;XMB$74KKYEU9C&7Q4;5'4N)>?44Q2'HCA:U.]5^7AN?Y:B
MJ\(IS0=_Q;$04:1\#0$.,8%J_]U=N_3J//NH:WLQMMRVE>C&D#HSFIQE#<G(
MDZZ7EE*OG*7A^>D\%=^Y>!N,$_P[!(L,N,AP,%YGY0?RN_WP^V]83'^L'LA-
MK5<YQEP&(&311!QGP#L6!)Z3Y/NP_DG@._6 =RP(/"?)V9!X/BV@'0OBS@ER
M-N2=3PM0QW#6^4#.AICS:'$ ',<!Y\,X'U+,IP7\XCB_<(;S(:%\B@ GCL/I
M*_"]SSBF#. 4QWEP"KCWJ<?4 U3A.%7"S-XG&*,*N.'XP.NF*@K+XMS^(F^R
MIY<GP7%2X V/)V(8!Z[P(%><#..CN<*!*SS(%2?#^&BN<. *#W+%R3 ^FBL"
MN"*"7'$R3(SFB@"N")PK/H:)(5&8$%0QX5$$KH@ 5U"2B=$($;TI%XZ0KR"9
M&)(#/WS@A\#Y<0K/Q&BR"""+P,D2YID8SN[P7@" !#[@>:?+O*K)^[+1RZT=
MFY$_*J.Q239@2"03H4T ;D00-TZTB=&X$8 ;$<2-$VUB-&XDX$8&<>-$FQR-
M&PFXD4'<.-$FA[A1M/WG$03:2)PV/K[)(6?B"!$$V,@ ;%"\R2%7VMFV7[?G
M N%<^0K(R2%.9'+<]=V430Z]I)<['E<-])$X?4ZAH1QRZ5Q&J?1801*P)'$L
MA9$HAS,R&4>21A[31 *X)#Y^.GE:'L@OYB+%IM<2<"AQ' XJ+7;.\&=REI?D
ML\[JQET@GC;9A6(E D4E3E'G]87\:R\,^YZ^;7LZY/JQ-PH@C>A$%YT(@!GA
MP#PJU6F]XO%T3BGV>T= T@@GZ>AF"DP..!I-991'P,@(9V2XF7A\L)D]'QWG
MWNAF2DP.B!9--=.+@%013I)P,_'X8#.!1!&.C-'-C# YH$J43M3,&- 1XV.P
M8#,#\6+HMAY7 L")<6",;F:,R0%58CY5,P$=,3X$"S<3CP]=(V, 3HP#8UPS
M?4/&8U%@2SR5-1WW;L7A0Z)P2_%X,><2;2E@)\:QX6OI75[FQ;; -  HL9JJ
M@T"-&!^+A#N(Q[-YA'8P =8D."N\'<P^!3J8 $42-E$'$T!%@@] @AT,Q,?S
ME*$=!, D."#NJMH\MD/>V\'\X#@C@"*14_4+.) $;]8[_8I]V+B5 0D@(@G>
MO7):%LGP?CVR."#IW;$/.LU.VR(9.LW(^@!@0A)T?]PK!(;NCW^!0 *X2((&
MD-.W2(8&$)<RXAXO3@$55.!N/>I;J*$7Y%TAH( 2*G!3Z_][%FIH% FITM[I
MM+,L]OL=G>2(SZ* 0@JGR"F.A1J:3BSQG9H*<*1P'(7]BGV"%]U(? ZN FXI
M?(!SLET1R&^'8C'&; 4T5#@-O]:N"*250;M" 4$53M"CR\K_M2D4@%--Y8VK
MWH(FG([!:W,@7LP5.AE4 $Z%@S/81,R>2 &7Z51>3PHX3$_T>@+QH2:F +D4
MAURPB9@MD0*XTJD\GA2(E)[H\03B;1/146(*Q$EQ- 2;B-D1*5 CG<K;20$1
MZ8G>3B ^>"8"6%(<#,$F8C9$VELA.96GPVA_ >2)KDXH@9@S]&1DM+< DN)T
MP#LYRH-@M+>TD4YE[##:6[1(3[1V0@FBP"20T=[Z0HJCXF5'PQ8$H[T%AG2R
M%8:TM\20GFCDA!+P>8*OSZ2]-8@4Q\2@@4$'@M'>JD,ZE8O3/F$"64_T<4()
MO&?@HO> 1J'KQ^ZYE89TDXW=LQJ'3P\/Q_S4/1&R@-UW3];<9?5C7C9DHQ]L
M*)VW4_YZ]ZS*;L-43]WC'O>5,571O5WK;*7K=@?[_4-5F2\;K<#AD:&K_P!0
M2P,$%     @ 1H*D5'>4U"U/ @  I04  !D   !X;"]W;W)K<VAE971S+W-H
M965T-C8N>&ULM53=:]LP$/]7#L-@@Q&[3M*L)3&T*6,=VR@MZQ[&'A3['(M:
MDB==XA;VQ^\DNR8;C?>TEU@?]_NXB^Z6K;$/KD(D>%2U=JNH(FK.X]CE%2KA
M)J9!S3>EL4H0;^TV=HU%4020JN,T24YC):2.LF4XN['9TNRHEAIO++B=4L(^
M76)MVE5T$CT?W,IM1?X@SI:-V.(=TM?FQO(N'E@*J5 [:318+%?1Q<GYY<+'
MAX![B:T[6(//9&/,@]]<%ZLH\8:PQIP\@^#/'M=8UYZ(;?SL.:-!T@,/U\_L
M[T/NG,M&.%R;^ILLJ%I%[R(HL!2[FFY-^P'[?.:>+S>U"[_0=K'S103YSI%1
M/9@=**F[KWCLZW  2-,C@+0'I,%W)Q1<7@D2V=*:%JR/9C:_"*D&-)N3VO\I
M=V3Y5C*.LK512A)7F1P(7<#::))ZBSJ7Z.#U%9*0M7NSC(G%/"3.>^++CC@]
M0OQ9V E,3]Y"FJ1I8_D567KZDR9FKX/A=#"<!M[9$=Y/LD2X8W<Z1_AX#[_@
M\&1$8#H(3(/ ])B <>ZO,GS_Q#%P3:C<CQ&%V: P&TWA6N_1A9J#:35:5\D&
MN#XYGW CO%3K<<+9V21)7HTXFP_.YO]P5J#2LI2Y"#USL;6(WN@(]^G ??J?
MZKH8%!:C[K_LU 8MF!+Z]^8UE'B"#4+.PE9N=H0%2 U4(8B7D^L*WBG-@Y(?
M;/LL/5O&^T-W\4'7^0'&+WXKM8,:2P8EDP6C;3<4N@V9)C3BQA"W=5A6/$?1
M^@"^+XVAYXWO[6$R9[\!4$L#!!0    ( $:"I%3I0GPD604  /P6   9
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MPCRL@,/DDN#Q$1X[6AKY><"VB^]5X<S^J>/'>PT4D\,Z.,RB/B$[=OL$<$L
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M++,4"+BE/$R'!L09Q2UJM-8*EG<*!,Q3'J-% ^*.X@W)(J%IWBBQ6C3$.YZ
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MH^MTD)PU7=<LUK]>5^5%M>H!^O\OFZ:[^Z/_@D_-ZL,Z[./_ U!+ P04
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M\6[\FE[TBRN:VDQQ8X3G1V0G0V(8H\GF20?CT<4E3/%BU32_91@I:U62/T;
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M.1]2BTW];-2!TV48U:5V-/AA6=!+B\8GT/E::_<<^.EOW^[L-U!+ P04
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MK](B]TJYOIB](B^O!:\;-(K/J7RH>J^]>BAW1?&E?O-F=3'S:T<RDTM5=Y'
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M0D$,;%VB!DVD$0$'D0I_:!%5BA!VL,6DYA\1SKREERPZDA>BP47<Y'H+;-I
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M!?#]NBC4CS?U#WJZGXA=_@=02P,$%     @ 1H*D5&M_<(SP P  &1   !D
M  !X;"]W;W)K<VAE971S+W-H965T-S@N>&ULM5AM;]LV$/XKA%<,+=!%(O5F
M=;:!Q4'1 @T0U&OWF9;/-A&)]$@Z;H']^)&2*KD6Q33K\B76RW-WSQV/SXF9
MG82\5WL C;Y4)5?SR5[KPYL@4,4>*JJNQ &X>;,5LJ+:W,I=H X2Z*8VJLJ
MA&$:5)3QR6)6/[N3BYDXZI)QN)-(':N*RJ_74(K3?((GWQY\9+N]M@^"Q>Q
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M?PK?.O=[5XV]YO%<XMG6A,,6D<'H C=6-5=GTS&R<K?/1AJ\RURSP*\-*%N
M\ULIS6O'7FC=]RO]#5!+ P04    " !&@J14*)9^\FL#  #!"@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970X,2YX;6R-EEUOVS84AO\*(?2B!;+H^RNP#23V
MA@UH42-IMHMA%[1T9!&52(^DXG:_?A0E*[)%*[FQ1>J\A\_+#_$LCHQ_%R6
M1#_JBHJE54IYN+-MD9508W'+#D#5FX+Q&DO5Y'M;'#C@7(OJRO8<)[)K3*BU
M6NB^+5\M6",K0F'+D6CJ&O.?#U"QX])RK5/'(]F7LNVP5XL#WL,3R.?#EJN6
M/63)20U4$$81AV)IW;MW&U<+=,2?!(YB](Q:*SO&OK>-/_*EY;1$4$$FVQ18
M_;W &JJJS:0X_NV36L.8K7#\?,K^FS:OS.RP@#6K_B*Y+)=68J$<"MQ4\I$=
M?X?>4-CFRU@E]"\Z]K&.A;)&2%;W8D50$]K]XQ_]1(P$*H]9X/4"[U(07!'X
MO<!_KR#H!8&>F<Z*GH<-EGBUX.R(>!NMLK4/>C*U6MDGM%WW)\G56Z)T<G6?
M9:RA4J M_HEW%=P@U<,;R-%G@G>D(I* N$&8YNBK+(&/N]''#4A,*O$)_8*>
MGS;HXX=/Z ,B%'TK62.41BQLJ2#;H>RL!WKH@+PK0#[ZPJ@L!?J5YI"?ZVUE
M;G#HG1P^>+,)OV!^BWSW!GF.YQEXUN^7NP;Y9EZ^@>R:_,R-/ZR7K_/Y5_+U
MRR3TBNBEPI5 ?]_OA.3J#/TS,T0P#!'H(8(K0SQ"T="\'04!55EI!J@ ,*YE
MERG2F=I/S,O*2UPO4//\,IXC4U@2..D0=@8:#J#A+.AIIV:,*O=-]R')F)!&
MU"Y7.&)P(]^+XPM40UB<IFEH1HT&U.A=J(1*X""D"3":C.R'<>A?\$VCPM0?
M3?@97CS@Q;-XW='&IV_!H=MD>H_AGKQZ/?<F^'B"Y;FAZ[@7](8P+X[\Q(R?
M#/C)6[-[!GYCHNX^8DP[?<-,,J&,TM"/+Y=B&A:'H9\$9C/I8":=-?-,<<VX
M)/\I?,HH-Y]&$W8ZX0G2Q'&<"^QT<AB#-!J'G6&[SNM-XLR";SG+ '*!"LYJ
M=0ZKT]W.BADCYBO",6RGB9-U'S:VXH;7G8SN1'=^/W4+@-^F-\*[4ZK4 #\-
M4\7:!-X>W>TU\+VND032&[Z[!(?>H0Z[U]7'1?^#>[?NJJG7-%UQIZZX/:$"
M55"HE,YMK.:==_52UY#LH"N('9.J'M&/I:HQ@;<!ZGW!F#PUV@&&JG7U/U!+
M P04    " !&@J14X*_982 #  #R$0  #0   'AL+W-T>6QE<RYX;6S=6%%K
MVS 0_BM&':.#4<=QZ\9K'-@"A<$V"NW#WHH2RXE ECQ9Z9+^^NDLQW%27>GZ
ML&532"W=I_ONT^E<B8QKLQ'L=LF8"=:ED'5&EL94'\*PGB]92>LS53%ID4+I
MDAH[U(NPKC2C>0U.I0B'@T$2EI1+,AG+57E=FCJ8JY4T&3GO3(%[?,XS$B7G
M)'!T4Y6SC-R?OOVQ4N;J3>">)^]/3@;W[ZX.[:<-\(Z$7M*+%Y">#7!>BV'4
MR3YU.]TR;3TQQTNO([2>,[2&(&RS-QD72NZ2&!-GL!%HR8('*C(RI8+/- >O
M@I9<;)QY"(:Y$DH'QNZ>#1F!I7YT<.1&L+$M3\FETDUL%\']G;73#X#M" 1R
M(3J!0^(,DW%%C6%:7MM!,[DQ/H&"MG^WJ:S"A::;:'A!=@[-PP:9*9TSW86)
MR-8T&0M6@!S-%TMX&E6% !JC2MO).5TH21L-6X^V8VGG3(A;J/KOQ1[WNNCM
MW0!V3G9=*ZCM.AHW /X^F^/NT[Z.-ZCX@S*?5G8YLAE#F;(;S0J^;L;KHA.
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( $:"I%3+>2)S(P8  ',U   /    >&PO=V]R:V)O;VLN>&ULQ9O?;]LV
M$(#_%<)/&[#,L7ZF15,@M9W50.)X49K7@9%HFZA$>B3EK/WK1TKQ>FJ2PUXN
M?K(ER]+GH\CO>*(_/&KS]4'KK^R?IE;V?+1U;O=^/+;E5C3<_JYW0OE/UMHT
MW/E-LQG;G1&\LELA7%./H]/3;-QPJ48?/QS.M3)CN*&=*)W4RN\,.^ZE>+0_
M/@^;;"^M?)"U=-_.1]W[6HQ8(Y5LY'=1G8].1\QN]>-G;>1WK1ROB]+HNCX?
M3?H/[H5QLGRVNPB0=_S!=GL<?[CE'N1\E)WZ$ZZEL:X[HCL_]XQ[X0_NMUJG
M+V7MA)EQ)_XPNMU)M0FG\;]B#'Y&%X?#:Q_$]^;_A%&OU[(4,UVVC5"NCZ,1
M=0!4=BMW=L04;\3Y:*KWPK 5WXCPH_Q5%E7_ YTG ^$R[Z7_P"RJCI&0YV99
MW%PM9A=W\QG[='%UL9S.6?%Y/K\K &"$ $9' V2_K#B C!'(^ TABSO_<CU?
M>L";2W:SFM\"R 2!3(X&.;VY7@'(%(%,CP8Y__/+ D!F"&1V1,B_(@"9(Y#Y
M\9K[HO@,(,\0R#-:R$^ME4I8"VC>(33O:&F*MFFX^<;TFA5RHZ3_&E>.792E
M;I63<,0^Q8;L4UK,6\%K-N\NS^X,5Y9W1H9!G*!*(7;*3-J=MK+;'V()>;FJ
M("8FE@FQ6:X$MV(0-,P@$V*%7&G?D#Y4I9![WEWZ!Q<FC0FQ-19J+ZP+!UDF
M56@_=E'MN2J%94XSB(EI8T+LC87/(]4F7'30HI@D)L26F(D'!UDP%TRH9:";
M1CZU8FC"J<^[?0HL5"F' <-<,"&6P?SOUL\9.KY;40E_/G]]MM2J]+1&0TQ,
M$A-B2\RY43YVEJU\)A\"JQ4KMMS +AMA?HB(_5"(33B"^7&XK+5MS:")(TP-
M$;$:BG:WJT4XR"MARNV67=;ZD2U4?S:(B<XYB-5PSXWL;CX_K @?/L?FOK^X
M85^),%U$Q+JXY-*P>UZW@EU[C_DV[CHWQ,.L$1%;8R:,UUB8@[-+J;PMI&_O
MA;+.=-^$F)@U(F)K/&5VOBOS;Z&]?PNYGFE%Q:Y\^\.$+\),$A&;!,U+!_.-
M")-,1"P9'#.&F)AF(F+-H.GI,)J89B)BS?3I*?OE+MR8]E=8Z,#D$A/+Y><\
M]45 3#$QL6+0A'70O#&FF)A8,2!A?3&$:#6+6"XA<WT1"E-*3*P4-#L<MBNF
ME)A8*:]FAWU (2:FE)A:*<]SQ!=;'/-)3.X3)%D<MCCFDYC8)Z\GBUU$(2;F
MDYC8)Z]DC(=6AS5JS"\)L5_0S''0Z EFF838,FCF.,3$+),06P9/R1*(B0DG
M(18.CIE"3/0!"K&"7BN\LI,NB828F((28@4AF#.QAV6*!%-00ET?0_-P.%U(
M, LEQ!;",0=="+-0<M19S: +819*WF96<\*Z-WY@+W7C4Z.9<%S6@]0CQ2R4
M4L]R#IA+;DQOHQ<9,06EQ KZCW$FC2C=09=JT\<68F(*2JD?L_P\83QAA3]M
MU?JW_CZ%F)B"TC=^_O)3VT-,3$$IL8+0: [RCA1]BD^L(!P3CNTIIJ"46$%X
MK6" B2DH)580K!6<,+CUK*=C"DJ)%81B#N]-3$$IL8*&F,\&>+C$!%-01CX1
M>G">[Q-77_V<0G6#Y=2(2KKN/H68F(4RZH?]/6:H= C33=96?!>6N!F],;R!
MF)B%,F(+/6$60DEMV!=E1>EGP!5;:A?FZ1 3LU#V%I6W$W:MC=OPC6!])>Z%
MS"/#))21/]WI*+N7:^Y:\U3M>.*$F)B$,NJU9-A#[V&;HXO)B"6$%S:AA#),
M0AFQA'!,. _*, EEU(L(7JV_=F,]Q,0DE!UK$4$_EL(EA)B$\K=?2A!&T:=R
M#5R.F6,2RH^YK&#0A7),0CEY-0[#A%THQR24DU?C,$Q82L@Q"^7$%D+J[J&K
M0TS,0CFQA5#,HH28F(5R8@NAF%.X^"I'%S436^C5IQC/DO<<LU!.78U#GV(,
M!B3,0CFQA7!,.""=818Z([80_K %1O,,L]!9_W^?[F#[\4,EUGY:52W]):S?
M7_*Z7!D67KHEAE&2AF6&Z[:NIW[?C;K2O#K\9^CP?Z>/_P)02P,$%     @
M1H*D5*N<,4MN @  VB\  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<\W:2VZC0!2%X:U8+""X;MT':<49]2335C: G/)#L8T%M#K9?5O.P#ZH!SV)
M."-4("Z_&'Q"P-.O<FC'?7<:=OOSL/@X'D[#JMJ-X_E'70_K73FVPT-W+J?+
MD4W7']OQLNRW];E=O[?;4LMRZ75_/Z-Z?KJ?N7C]/)?_F=AM-OMU^=FM?Q_+
M:?S'X/I/U[\/NU+&:O':]MLRKJKZXW#;/=3737JX3*X6+V^KJG]Y2U4]=Y!
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MWLUWZCV,GX<RW'J^UGC][Z1ZO)Q;;I>_+K]V3F["%>?ZOF)X_@M02P,$%
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M2P$"% ,4    " !&@J14!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $:"I%0_E8;][@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M $:"I%297)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ 1H*D5+#X?'5.!0  !!8  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M $:"I%2N@=CQ% @  +L>   8              " @9$-  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " !&@J14<,!61]P"   K"   &
M            @(';%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ 1H*D5$Q]PUE&!P  B!\  !@              ("![1@  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( $:"I%00<5%I[P,  ),,
M   8              " @6D@  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " !&@J14HX&JFM0'   H)P  &               @(&.)
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 1H*D5/"9F7%[
M @  8P4  !@              ("!F"P  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( $:"I%2#I7)N(PD  #,F   8              "
M@4DO  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !&@J14
M_%/L!RX%  !9"P  &               @(&B.   >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ 1H*D5&4D?$?'#   RR(  !D
M     ("!!CX  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $:"I%19-X_P=P4  (\,   9              "
M@0EN  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 1H*D
M5'R;Z[BP P  =PH  !D              ("!MW,  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " !&@J14R\FM*/$-  !T*0  &0
M        @(&>=P  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( $:"I%3[=L-S604  /P,   9              " @<:%  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ 1H*D5#)=L%@@!P  2Q(
M !D              ("!5HL  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " !&@J14>OD]=C &   I$0  &0              @(&MD@
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( $:"I%3O+JU,
M<0P  %(I   9              " @129  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ 1H*D5',ZO^[W!   U@L  !D
M ("!O*4  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !&
M@J14E@D(0#T-  #S,0  &0              @('JJ@  >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( $:"I%31)@<RHP0  +D*   9
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M970R."YX;6Q02P$"% ,4    " !&@J14KB'59.L%   /#P  &0
M    @(' TP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M $:"I%1-J;<[/@,  (<'   9              " @>+9  !X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ 1H*D5'JFN^X&!0  ^@X  !D
M             ("!5]T  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    " !&@J14=5.YE8H$  "_"0  &0              @(&4X@  >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( $:"I%2[M8ZZ/@,
M '8(   9              " @57G  !X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ 1H*D5.V: ;'$!0  -@\  !D              ("!
MRNH  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !&@J14
M:[E2-I<"  "5!0  &0              @('%\   >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( $:"I%1[3/!B&P0  %\*   9
M      " @9/S  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ 1H*D5%5%YCO2"   WQP  !D              ("!Y?<  'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " !&@J143'@')",%  "(#
M&0              @('N  $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( $:"I%1@Y1>^3P4  #H-   9              " @4@& 0!X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ 1H*D5/]K3@2#
M!   *@H  !D              ("!S@L! 'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    " !&@J14E<G-N(T#  ",!P  &0
M@(&($ $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( $:"
MI%3G \Q#V0,  (8)   9              " @4P4 0!X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ 1H*D5.%DP1(^ P  .@H  !D
M         ("!7!@! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
M    " !&@J14NWRNESH#  "6"@  &0              @('1&P$ >&PO=V]R
M:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( $:"I%11A;!IZ04  * B
M   9              " @4(? 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL
M4$L! A0#%     @ 1H*D5/?/\'4_ @  #04  !D              ("!8B4!
M 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " !&@J14_&$C
MBT\+  "V50  &0              @('8)P$ >&PO=V]R:W-H965T<R]S:&5E
M=#0W+GAM;%!+ 0(4 Q0    ( $:"I%0HF>1<A@4  "48   9
M  " @5XS 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
M1H*D5..C!%Q9!   O X  !D              ("!&SD! 'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    " !&@J14S_1VAY$"  "0!@  &0
M            @(&K/0$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( $:"I%3^]F?K-@(  .8$   9              " @7-  0!X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ 1H*D5&BMJD>M @
M8P<  !D              ("!X$(! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6Q02P$"% ,4    " !&@J14+D:'6#<#  !7"@  &0              @('$
M10$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( $:"I%2'
M$#^)40D  $ U   9              " @3)) 0!X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L! A0#%     @ 1H*D5*48%K1T!0  VR   !D
M     ("!NE(! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $:"I%29YKCJ[ (  &T*   9              "
M@3UJ 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ 1H*D
M5(>E,&[;!   P1,  !D              ("!8&T! 'AL+W=O<FMS:&5E=',O
M<VAE970V,2YX;6Q02P$"% ,4    " !&@J140F;?$,\"  "P"   &0
M        @(%R<@$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0
M   ( $:"I%0P_[;"_00  -\:   9              " @7AU 0!X;"]W;W)K
M<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ 1H*D5(![^%D#!   EPX
M !D              ("!K'H! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q0
M2P$"% ,4    " !&@J140)LC-?\'   ^-   &0              @('F?@$
M>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( $:"I%1WE-0M
M3P(  *4%   9              " @1R' 0!X;"]W;W)K<VAE971S+W-H965T
M-C8N>&UL4$L! A0#%     @ 1H*D5.E"?"19!0  _!8  !D
M ("!HHD! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " !&
M@J14R-^O*F("  !U!0  &0              @($RCP$ >&PO=V]R:W-H965T
M<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( $:"I%0*8&6-Q@(   8(   9
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M970W,RYX;6Q02P$"% ,4    " !&@J14"LGZ'Z0#   +#@  &0
M    @(&GM $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    (
M $:"I%0O;/-LF@0  !83   9              " @8*X 0!X;"]W;W)K<VAE
M971S+W-H965T-S4N>&UL4$L! A0#%     @ 1H*D5%$^:0U2 @  QP4  !D
M             ("!4[T! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"
M% ,4    " !&@J14?(9%TIX'   N)@  &0              @('<OP$ >&PO
M=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( $:"I%1K?W",\ ,
M !D0   9              " @;'' 0!X;"]W;W)K<VAE971S+W-H965T-S@N
M>&UL4$L! A0#%     @ 1H*D5-)_.-Q#!   >!$  !D              ("!
MV,L! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    " !&@J14
M'83M Y$"  #+!@  &0              @(%2T $ >&PO=V]R:W-H965T<R]S
M:&5E=#@P+GAM;%!+ 0(4 Q0    ( $:"I%0HEG[R:P,  ,$*   9
M      " @1K3 0!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%
M  @ 1H*D5."OV6$@ P  \A$   T              ( !O-8! 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " !&@J14EXJ[',     3 @  "P
M@ $'V@$ 7W)E;',O+G)E;'-02P$"% ,4    " !&@J14RWDB<R,&  !S-0
M#P              @ 'PV@$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M1H*D5*N<,4MN @  VB\  !H              ( !0.$! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 1H*D5$3DWU@> @  ERX  !,
M             ( !YN,! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %D
,60!F&   ->8!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>294</ContextCount>
  <ElementCount>417</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>126</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/Business</Role>
      <ShortName>Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107103 - Disclosure - Real Estate Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/RealEstateTransactions</Role>
      <ShortName>Real Estate Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Dispositions of Real Estate and Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Loans Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivable</Role>
      <ShortName>Loans Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures</Role>
      <ShortName>Investments in and Advances to Unconsolidated Joint Ventures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2129108 - Disclosure - Intangibles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/Intangibles</Role>
      <ShortName>Intangibles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2134109 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2141110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2143111 - Disclosure - Equity and Redeemable Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2147112 - Disclosure - Earnings Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EarningsPerCommonShare</Role>
      <ShortName>Earnings Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2151113 - Disclosure - Segment Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SegmentDisclosures</Role>
      <ShortName>Segment Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2154114 - Disclosure - Supplemental Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>Supplemental Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2159115 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2164116 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2167117 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2171118 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities</Role>
      <ShortName>Accounts Payable, Accrued Liabilities, and Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Dispositions of Real Estate and Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - Loans Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableTables</Role>
      <ShortName>Loans Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/LoansReceivable</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables</Role>
      <ShortName>Investments in and Advances to Unconsolidated Joint Ventures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2330306 - Disclosure - Intangibles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/IntangiblesTables</Role>
      <ShortName>Intangibles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/Intangibles</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2335307 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/Debt</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2344308 - Disclosure - Equity and Redeemable Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2348309 - Disclosure - Earnings Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EarningsPerCommonShareTables</Role>
      <ShortName>Earnings Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/EarningsPerCommonShare</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2352310 - Disclosure - Segment Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SegmentDisclosuresTables</Role>
      <ShortName>Segment Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/SegmentDisclosures</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2355311 - Disclosure - Supplemental Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformationTables</Role>
      <ShortName>Supplemental Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2360312 - Disclosure - Variable Interest Entities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntitiesTables</Role>
      <ShortName>Variable Interest Entities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/VariableInterestEntities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2365313 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/FairValueMeasurements</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2368314 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2372315 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables</Role>
      <ShortName>Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Government Grant Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Government Grant Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Real Estate Transactions - Real Estate Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails</Role>
      <ShortName>Real Estate Transactions - Real Estate Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Real Estate Transactions - Development Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/RealEstateTransactionsDevelopmentActivitiesDetails</Role>
      <ShortName>Real Estate Transactions - Development Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Assets and Liabilities for Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations - Assets and Liabilities for Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails</Role>
      <ShortName>Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Leases - Lease Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LeasesLeaseIncomeDetails</Role>
      <ShortName>Leases - Lease Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Leases - Direct Financing Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails</Role>
      <ShortName>Leases - Direct Financing Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Loans Receivable - Schedule of Loans Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails</Role>
      <ShortName>Loans Receivable - Schedule of Loans Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Loans Receivable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableNarrativeDetails</Role>
      <ShortName>Loans Receivable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails</Role>
      <ShortName>Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Loans Receivable - Schedule of Reserve for Loan Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails</Role>
      <ShortName>Loans Receivable - Schedule of Reserve for Loan Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails</Role>
      <ShortName>Investments in and Advances to Unconsolidated Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - Intangibles - Intangibles Lease Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails</Role>
      <ShortName>Intangibles - Intangibles Lease Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Intangibles - Intangibles Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails</Role>
      <ShortName>Intangibles - Intangibles Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Intangibles - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/IntangiblesNarrativeDetails</Role>
      <ShortName>Intangibles - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2436419 - Disclosure - Debt - Bank Line of Credit and Term Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails</Role>
      <ShortName>Debt - Bank Line of Credit and Term Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2437420 - Disclosure - Debt - Commercial Paper Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails</Role>
      <ShortName>Debt - Commercial Paper Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2438421 - Disclosure - Debt - Senior Unsecured Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails</Role>
      <ShortName>Debt - Senior Unsecured Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2439422 - Disclosure - Debt - Mortgage Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtMortgageDebtDetails</Role>
      <ShortName>Debt - Mortgage Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - Debt - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DebtDebtMaturitiesDetails</Role>
      <ShortName>Debt - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/CommitmentsandContingencies</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Equity and Redeemable Noncontrolling Interests - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Equity and Redeemable Noncontrolling Interests - AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails</Role>
      <ShortName>Equity and Redeemable Noncontrolling Interests - AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - Earnings Per Common Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails</Role>
      <ShortName>Earnings Per Common Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - Earnings Per Common Share - Computation of EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails</Role>
      <ShortName>Earnings Per Common Share - Computation of EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2453429 - Disclosure - Segment Disclosures - Summary Information for the Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails</Role>
      <ShortName>Segment Disclosures - Summary Information for the Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2456430 - Disclosure - Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails</Role>
      <ShortName>Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2457431 - Disclosure - Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails</Role>
      <ShortName>Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2458432 - Disclosure - Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2461433 - Disclosure - Variable Interest Entities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails</Role>
      <ShortName>Variable Interest Entities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2462434 - Disclosure - Variable Interest Entities - Schedule of Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities - Schedule of Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2463435 - Disclosure - Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails</Role>
      <ShortName>Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2466436 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2469437 - Disclosure - Derivative Financial Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Financial Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2470438 - Disclosure - Derivative Financial Instruments - Schedule of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails</Role>
      <ShortName>Derivative Financial Instruments - Schedule of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="peak-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2473439 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails</Role>
      <ShortName>Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="peak-20220331.htm">peak-20220331.htm</File>
    <File>ex10103312022.htm</File>
    <File>ex31103312022.htm</File>
    <File>ex31203312022.htm</File>
    <File>ex32103312022.htm</File>
    <File>ex32203312022.htm</File>
    <File>peak-20220331.xsd</File>
    <File>peak-20220331_cal.xml</File>
    <File>peak-20220331_def.xml</File>
    <File>peak-20220331_lab.xml</File>
    <File>peak-20220331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1112">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>100
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "peak-20220331.htm": {
   "axisCustom": 2,
   "axisStandard": 37,
   "contextCount": 294,
   "dts": {
    "calculationLink": {
     "local": [
      "peak-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "peak-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "peak-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "peak-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "peak-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "peak-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 701,
   "entityCount": 1,
   "hidden": {
    "http://www.healthpeak.com/20220331": 2,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 7
   },
   "keyCustom": 118,
   "keyStandard": 299,
   "memberCustom": 64,
   "memberStandard": 53,
   "nsprefix": "peak",
   "nsuri": "http://www.healthpeak.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.healthpeak.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealEstateDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107103 - Disclosure - Real Estate Transactions",
     "role": "http://www.healthpeak.com/role/RealEstateTransactions",
     "shortName": "Real Estate Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealEstateDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Dispositions of Real Estate and Discontinued Operations",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations",
     "shortName": "Dispositions of Real Estate and Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Leases",
     "role": "http://www.healthpeak.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Loans Receivable",
     "role": "http://www.healthpeak.com/role/LoansReceivable",
     "shortName": "Loans Receivable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures",
     "role": "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures",
     "shortName": "Investments in and Advances to Unconsolidated Joint Ventures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129108 - Disclosure - Intangibles",
     "role": "http://www.healthpeak.com/role/Intangibles",
     "shortName": "Intangibles",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:IntangibleAssetsAndLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134109 - Disclosure - Debt",
     "role": "http://www.healthpeak.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.healthpeak.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143111 - Disclosure - Equity and Redeemable Noncontrolling Interests",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests",
     "shortName": "Equity and Redeemable Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentBuildingAndBuildingImprovements",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147112 - Disclosure - Earnings Per Common Share",
     "role": "http://www.healthpeak.com/role/EarningsPerCommonShare",
     "shortName": "Earnings Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151113 - Disclosure - Segment Disclosures",
     "role": "http://www.healthpeak.com/role/SegmentDisclosures",
     "shortName": "Segment Disclosures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2154114 - Disclosure - Supplemental Cash Flow Information",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformation",
     "shortName": "Supplemental Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:VariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159115 - Disclosure - Variable Interest Entities",
     "role": "http://www.healthpeak.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:VariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164116 - Disclosure - Fair Value Measurements",
     "role": "http://www.healthpeak.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2167117 - Disclosure - Derivative Financial Instruments",
     "role": "http://www.healthpeak.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2171118 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities",
     "role": "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities",
     "shortName": "Accounts Payable, Accrued Liabilities, and Other Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Dispositions of Real Estate and Discontinued Operations (Tables)",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables",
     "shortName": "Dispositions of Real Estate and Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Leases (Tables)",
     "role": "http://www.healthpeak.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - Loans Receivable (Tables)",
     "role": "http://www.healthpeak.com/role/LoansReceivableTables",
     "shortName": "Loans Receivable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Tables)",
     "role": "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables",
     "shortName": "Investments in and Advances to Unconsolidated Joint Ventures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330306 - Disclosure - Intangibles (Tables)",
     "role": "http://www.healthpeak.com/role/IntangiblesTables",
     "shortName": "Intangibles (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335307 - Disclosure - Debt (Tables)",
     "role": "http://www.healthpeak.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344308 - Disclosure - Equity and Redeemable Noncontrolling Interests (Tables)",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables",
     "shortName": "Equity and Redeemable Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348309 - Disclosure - Earnings Per Common Share (Tables)",
     "role": "http://www.healthpeak.com/role/EarningsPerCommonShareTables",
     "shortName": "Earnings Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352310 - Disclosure - Segment Disclosures (Tables)",
     "role": "http://www.healthpeak.com/role/SegmentDisclosuresTables",
     "shortName": "Segment Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2355311 - Disclosure - Supplemental Cash Flow Information (Tables)",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformationTables",
     "shortName": "Supplemental Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2360312 - Disclosure - Variable Interest Entities (Tables)",
     "role": "http://www.healthpeak.com/role/VariableInterestEntitiesTables",
     "shortName": "Variable Interest Entities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365313 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.healthpeak.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2368314 - Disclosure - Derivative Financial Instruments (Tables)",
     "role": "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2372315 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)",
     "role": "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables",
     "shortName": "Accounts Payable, Accrued Liabilities, and Other Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ib5e2b4520099480cbcf7ae7a10b2633a_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i65f4e28b0f2b4c9ca073348ac7c5830f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:GovernmentGrantIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Government Grant Income (Details)",
     "role": "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails",
     "shortName": "Summary of Significant Accounting Policies - Government Grant Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "peak:ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i65f4e28b0f2b4c9ca073348ac7c5830f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:GovernmentGrantIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "id9cece3770b941ee9ae47c83081b1562_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Real Estate Transactions - Real Estate Investments (Details)",
     "role": "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails",
     "shortName": "Real Estate Transactions - Real Estate Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "id9cece3770b941ee9ae47c83081b1562_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Real Estate Transactions - Development Activities (Details)",
     "role": "http://www.healthpeak.com/role/RealEstateTransactionsDevelopmentActivitiesDetails",
     "shortName": "Real Estate Transactions - Development Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "peak:CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnSalesOfInvestmentRealEstate",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Narrative (Details)",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
     "shortName": "Dispositions of Real Estate and Discontinued Operations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfRealEstate",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Assets and Liabilities for Discontinued Operations (Details)",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
     "shortName": "Dispositions of Real Estate and Discontinued Operations - Assets and Liabilities for Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "peak:DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "id50f8338c88249ecb8e1064283870f4f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRentalIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)",
     "role": "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails",
     "shortName": "Dispositions of Real Estate and Discontinued Operations - Schedule of Results of Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "id50f8338c88249ecb8e1064283870f4f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRentalIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Leases - Lease Income (Details)",
     "role": "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails",
     "shortName": "Leases - Lease Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DirectFinancingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfLeaseReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.healthpeak.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfLeaseReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectFinancingLeaseLeaseReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Leases - Direct Financing Leases (Details)",
     "role": "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails",
     "shortName": "Leases - Direct Financing Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectFinancingLeaseLeaseReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Loans Receivable - Schedule of Loans Receivable (Details)",
     "role": "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
     "shortName": "Loans Receivable - Schedule of Loans Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInFinancingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Loans Receivable - Narrative (Details)",
     "role": "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
     "shortName": "Loans Receivable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfFinanceReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic484d7102e0c4eef9210903e4b7f1b12_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)",
     "role": "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails",
     "shortName": "Loans Receivable - Schedule of Loans Receivable by Origination Year (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic484d7102e0c4eef9210903e4b7f1b12_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i52f832c5fe6045a8ad198b8d80128bd8_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Loans Receivable - Schedule of Reserve for Loan Losses (Details)",
     "role": "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails",
     "shortName": "Loans Receivable - Schedule of Reserve for Loan Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForLoanLossesExpensed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i52f832c5fe6045a8ad198b8d80128bd8_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Investments in and Advances to Unconsolidated Joint Ventures (Details)",
     "role": "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
     "shortName": "Investments in and Advances to Unconsolidated Joint Ventures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i2cfa7cca0e764481b533b63888796ec6_I20210331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - Intangibles - Intangibles Lease Assets (Details)",
     "role": "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails",
     "shortName": "Intangibles - Intangibles Lease Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:FiniteLivedIntangibleLiabilitiesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Intangibles - Intangibles Lease Liabilities (Details)",
     "role": "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails",
     "shortName": "Intangibles - Intangibles Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:FiniteLivedIntangibleLiabilitiesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i40a69eb101874a248f36e295dd95e2e3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i40a69eb101874a248f36e295dd95e2e3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Intangibles - Narrative (Details)",
     "role": "http://www.healthpeak.com/role/IntangiblesNarrativeDetails",
     "shortName": "Intangibles - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i6d31c765768641ccbf1ed5bdad055655_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436419 - Disclosure - Debt - Bank Line of Credit and Term Loans (Details)",
     "role": "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
     "shortName": "Debt - Bank Line of Credit and Term Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "iaa4506fa371a4f6b80d98b0ab321c80e_I20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "peak:DebtInstrumentCovenantDebtToAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437420 - Disclosure - Debt - Commercial Paper Program (Details)",
     "role": "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails",
     "shortName": "Debt - Commercial Paper Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438421 - Disclosure - Debt - Senior Unsecured Notes (Details)",
     "role": "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
     "shortName": "Debt - Senior Unsecured Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i1fd3f6bb6764474bab938ffb38345c92_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "peak:NumberOfBondOfferings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "bond",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439422 - Disclosure - Debt - Mortgage Debt (Details)",
     "role": "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
     "shortName": "Debt - Mortgage Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "iea6c0660aff54ba4b24294d1a82e7306_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "peak:DebtInstrumentCollateralHealthcareFacilitiesNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - Debt - Debt Maturities (Details)",
     "role": "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
     "shortName": "Debt - Debt Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "if6dac57d2d904eef8d5d5c6d6d560074_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic49d297efbc04b4899a13cad1f112a0b_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "peak:ContributionOfPropertyNumberOfProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Equity and Redeemable Noncontrolling Interests - Additional Information (Details)",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails",
     "shortName": "Equity and Redeemable Noncontrolling Interests - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareCashPaid",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Equity and Redeemable Noncontrolling Interests - AOCI (Details)",
     "role": "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails",
     "shortName": "Equity and Redeemable Noncontrolling Interests - AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Earnings Per Common Share - Narrative (Details)",
     "role": "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails",
     "shortName": "Earnings Per Common Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Earnings Per Common Share - Computation of EPS (Details)",
     "role": "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails",
     "shortName": "Earnings Per Common Share - Computation of EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453429 - Disclosure - Segment Disclosures - Summary Information for the Reportable Segments (Details)",
     "role": "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
     "shortName": "Segment Disclosures - Summary Information for the Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "peak:NumberofFacilitiesOwnedbyUnconsolidatedJointVenture",
      "reportCount": 1,
      "unique": true,
      "unitRef": "property",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456430 - Disclosure - Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails",
     "shortName": "Supplemental Cash Flow Information - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457431 - Disclosure - Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails",
     "shortName": "Supplemental Cash Flow Information - Summary of Cash Flow Information Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "id763cea71736445ca443b2ecd9a206b2_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458432 - Disclosure - Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Supplemental Cash Flow Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i9033e3f616764988932a09935d4445c5_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i52f832c5fe6045a8ad198b8d80128bd8_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "peak:ExchangeAccommodationTitleholderRealEstateCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461433 - Disclosure - Variable Interest Entities - Narrative (Details)",
     "role": "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
     "shortName": "Variable Interest Entities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "peak:ExchangeAccommodationTitleholderRealEstateCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i6e285ee41e894f3fb7a5abcc3f145a7e_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462434 - Disclosure - Variable Interest Entities - Schedule of Variable Interest Entities (Details)",
     "role": "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails",
     "shortName": "Variable Interest Entities - Schedule of Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i6e285ee41e894f3fb7a5abcc3f145a7e_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentBuildingAndBuildingImprovements",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463435 - Disclosure - Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)",
     "role": "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
     "shortName": "Variable Interest Entities - Consolidated Assets and Liabilities of VIEs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "peak:ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i6ba23ecabb554063a415b6201e35ad07_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentBuildingAndBuildingImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466436 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.healthpeak.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i647df0ef5da942b7835d88ac03d98c68_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LoansReceivableFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i33e11899bd7a43448fda5d94b27afd54_I20210430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "reportCount": 1,
      "unitRef": "derivativeheld",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469437 - Disclosure - Derivative Financial Instruments - Narrative (Details)",
     "role": "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
     "shortName": "Derivative Financial Instruments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i16a351f1ed484654b7fe74cc73addf0a_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i33e11899bd7a43448fda5d94b27afd54_I20210430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "reportCount": 1,
      "unitRef": "derivativeheld",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470438 - Disclosure - Derivative Financial Instruments - Schedule of Derivative Instruments (Details)",
     "role": "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails",
     "shortName": "Derivative Financial Instruments - Schedule of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b09eddbc9044df3944a2a85e555a381_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:RefundableEntranceFeesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473439 - Disclosure - Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)",
     "role": "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails",
     "shortName": "Accounts Payable, Accrued Liabilities, and Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "i8b4c4223887d4f649dd6bf793e09faaf_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "peak:RefundableEntranceFeesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Business",
     "role": "http://www.healthpeak.com/role/Business",
     "shortName": "Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "peak-20220331.htm",
      "contextRef": "ic201f4358f5a46b597eabc53b8f06427_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 126,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.healthpeak.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "peak_A2019TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Term Loan [Member]",
        "label": "2019 Term Loan [Member]",
        "terseLabel": "2019 Term Loan"
       }
      }
     },
     "localname": "A2019TermLoanMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_A2020ATMProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 ATM Program [Member]",
        "label": "2020 ATM Program [Member]",
        "terseLabel": "2020 ATM Program"
       }
      }
     },
     "localname": "A2020ATMProgramMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_A2020ATMProgramSettledMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 ATM Program, Settled",
        "label": "2020 ATM Program, Settled [Member]",
        "terseLabel": "2020 ATM Program, Settled"
       }
      }
     },
     "localname": "A2020ATMProgramSettledMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ATMDirectIssuancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM Direct Issuances [Member]",
        "label": "ATM Direct Issuances [Member]",
        "terseLabel": "ATM Direct Issuances"
       }
      }
     },
     "localname": "ATMDirectIssuancesMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ATMEquityOfferingProgramAggregateAmountRemaining": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM Equity Offering Program Aggregate Amount Remaining",
        "label": "ATM Equity Offering Program Aggregate Amount Remaining",
        "terseLabel": "ATM aggregate amount remaining"
       }
      }
     },
     "localname": "ATMEquityOfferingProgramAggregateAmountRemaining",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life",
        "label": "Acquired Finite-Lived Intangible Liabilities, Weighted Average Useful Life",
        "terseLabel": "Weighted average remaining amortization period in years",
        "verboseLabel": "Weighted average remaining amortization period, liabilities"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails",
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_AdjustedNetOperatingIncomeFromContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.",
        "label": "Adjusted Net Operating Income from Continuing Operations",
        "totalLabel": "Adjusted NOI"
       }
      }
     },
     "localname": "AdjustedNetOperatingIncomeFromContinuingOperations",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AdjustmentsOfPermanentEquityToTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments Of Permanent Equity To Temporary Equity",
        "label": "Adjustments Of Permanent Equity To Temporary Equity",
        "negatedTerseLabel": "Adjustments to redemption value of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "AdjustmentsOfPermanentEquityToTemporaryEquity",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AmortizationOfNonrefundableEntranceFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Nonrefundable Entrance Fee",
        "label": "Amortization Of Nonrefundable Entrance Fee",
        "terseLabel": "Amortization of nonrefundable entrance fee"
       }
      }
     },
     "localname": "AmortizationOfNonrefundableEntranceFee",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net",
        "label": "Amortization Of Nonrefundable Entrance Fees And Above/Below Market Lease Intangibles Net",
        "terseLabel": "Amortization of nonrefundable entrance fees and above/below market lease intangibles"
       }
      }
     },
     "localname": "AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AssetsHeldForSaleAndDiscontinuedOperationsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets Held For Sale And Discontinued Operations Net",
        "label": "Assets Held For Sale And Discontinued Operations Net",
        "totalLabel": "Assets held for sale and discontinued operations, net"
       }
      }
     },
     "localname": "AssetsHeldForSaleAndDiscontinuedOperationsNet",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_AtTheMarketProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The-Market Program [Member]",
        "label": "At-The-Market Program [Member]",
        "terseLabel": "At-The-Market Program"
       }
      }
     },
     "localname": "AtTheMarketProgramMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_AtmEquityOfferingProgramAggregateAmountAuthorized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum aggregate gross sales price of stock authorized to be sold through an at-the-market continuous equity offering program.",
        "label": "ATM Equity Offering Program Aggregate Amount Authorized",
        "terseLabel": "ATM aggregate amount authorized"
       }
      }
     },
     "localname": "AtmEquityOfferingProgramAggregateAmountAuthorized",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_BrookdaleMTCAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brookdale MTCA [Member]",
        "label": "Brookdale MTCA [Member]",
        "terseLabel": "Brookedale MTCA"
       }
      }
     },
     "localname": "BrookdaleMTCAMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_BrookdaleTripleNetPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brookdale Triple Net Portfolio",
        "label": "Brookdale Triple Net Portfolio [Member]",
        "terseLabel": "Brookdale Triple Net Portfolio"
       }
      }
     },
     "localname": "BrookdaleTripleNetPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CCRCSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CCRC Segment [Member]",
        "label": "CCRC Segment [Member]",
        "terseLabel": "CCRC"
       }
      }
     },
     "localname": "CCRCSegmentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CCRVJVInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the unconsolidated joint venture formed by the Company and Brookdale, under a RIDEA structure, to own and operate CCRC campuses.",
        "label": "CCRV JV Investment [Member]",
        "terseLabel": "CCRC JV"
       }
      }
     },
     "localname": "CCRVJVInvestmentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CapitalExpenditureFundingAmountCommitted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditure Funding, Amount Committed",
        "label": "Capital Expenditure Funding, Amount Committed",
        "terseLabel": "Capital expenditure funding, amount committed"
       }
      }
     },
     "localname": "CapitalExpenditureFundingAmountCommitted",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CapitalExpenditureFundingAmountFunded": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditure Funding, Amount Funded",
        "label": "Capital Expenditure Funding, Amount Funded",
        "terseLabel": "Capital expenditure funding, amount funded"
       }
      }
     },
     "localname": "CapitalExpenditureFundingAmountFunded",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CapitalExpenditureFundingCostOfCapitalPercentCommitted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditure Funding, Cost of Capital, Percent Committed",
        "label": "Capital Expenditure Funding, Cost of Capital, Percent Committed",
        "terseLabel": "Capital expenditure funding, cost of capital, percent committed"
       }
      }
     },
     "localname": "CapitalExpenditureFundingCostOfCapitalPercentCommitted",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents, Including Discontinued Operations, Total",
        "label": "Cash and Cash Equivalents, Including Discontinued Operations, Total",
        "totalLabel": "Cash and cash equivalents, total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations",
        "label": "Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations [Roll Forward]",
        "terseLabel": "Cash, Cash Equivalents, and Restricted Cash, Including Discontinued Operations [Roll Forward]"
       }
      }
     },
     "localname": "CashCashEquivalentsAndRestrictedCashIncludingDiscontinuedOperationsRollForward",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "peak_CommercialPaperProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper Program [Member]",
        "label": "Commercial Paper Program [Member]",
        "terseLabel": "Commercial Paper Program"
       }
      }
     },
     "localname": "CommercialPaperProgramMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments, Development and Redevelopment Projects and Tenant Improvements",
        "label": "Commitments, Development and Redevelopment Projects and Tenant Improvements",
        "terseLabel": "Development commitments"
       }
      }
     },
     "localname": "CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsDevelopmentActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments, Development and Redevelopment Projects, Increase (Decrease)",
        "label": "Commitments, Development and Redevelopment Projects and Tenant Improvements, Amount Increase (Decrease)",
        "negatedLabel": "Development and redevelopment projects, amount decrease"
       }
      }
     },
     "localname": "CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsDevelopmentActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_ContributionOfPropertyNumberOfProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contribution Of Property, Number Of Properties",
        "label": "Contribution Of Property, Number Of Properties",
        "terseLabel": "Number of properties may be contributed in the agreement"
       }
      }
     },
     "localname": "ContributionOfPropertyNumberOfProperties",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_DebtInstrumentCollateralHealthcareFacilitiesCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of healthcare facilities which are secured by mortgage debt.",
        "label": "Debt Instrument, Collateral Healthcare Facilities, Carrying Value",
        "terseLabel": "Debt instrument, collateral, healthcare facilities carrying value"
       }
      }
     },
     "localname": "DebtInstrumentCollateralHealthcareFacilitiesCarryingValue",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DebtInstrumentCollateralHealthcareFacilitiesNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of healthcare facilities which are secured by mortgage debt.",
        "label": "Debt Instrument, Collateral Healthcare Facilities, Number",
        "terseLabel": "Number of healthcare facilities used to secure debt (in facilities)"
       }
      }
     },
     "localname": "DebtInstrumentCollateralHealthcareFacilitiesNumber",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_DebtInstrumentCovenantDebtToAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The limit of the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Debt to Assets",
        "terseLabel": "Debt instrument, covenant debt to assets (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtToAssets",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_DebtInstrumentCovenantFixedChargeRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The required minimum Fixed Charge Coverage ratio contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Fixed Charge Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant minimum fixed charge coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantFixedChargeRatioMinimum",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "peak_DebtInstrumentCovenantNetWorth": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The required Minimum Consolidated Tangible Net Worth contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Net Worth",
        "terseLabel": "Debt instrument, covenant net worth"
       }
      }
     },
     "localname": "DebtInstrumentCovenantNetWorth",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DebtInstrumentCovenantSecuredDebtToAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The limit of the ratio of Secured Debt to Consolidated Total Asset Value contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Secured Debt to Assets",
        "terseLabel": "Debt instrument, covenant secured debt to assets (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantSecuredDebtToAssets",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The limit of the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value contained in the debt covenants.",
        "label": "Debt Instrument, Covenant Unsecured Debt to Unencumbered Assets",
        "terseLabel": "Debt instrument, covenant unsecured debt to unencumbered assets (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantUnsecuredDebtToUnencumberedAssets",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics",
        "label": "Debt Instrument, Interest Rate, Reduction Available For Sustainability Metrics",
        "terseLabel": "Debt Instrument, interest rate, reduction available for sustainability metrics"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateReductionAvailableForSustainabilityMetrics",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "peak_DebtInstrumentMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Borrowing Capacity",
        "label": "Debt Instrument, Maximum Borrowing Capacity",
        "terseLabel": "Maximum outstanding amount capacity"
       }
      }
     },
     "localname": "DebtInstrumentMaximumBorrowingCapacity",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DebtInstrumentNumberofExtensions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number of Extensions",
        "label": "Debt Instrument, Number of Extensions",
        "terseLabel": "Number of extensions"
       }
      }
     },
     "localname": "DebtInstrumentNumberofExtensions",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_DebtInstrumentPeriodOfExtension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the length of the debt instrument extension period.",
        "label": "Debt Instrument, Period of Extension",
        "terseLabel": "Length of debt instrument extension period (in months)"
       }
      }
     },
     "localname": "DebtInstrumentPeriodOfExtension",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_DebtInstrumentRedemptionPeriodThereafterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the period after the last period separately disclosed of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument Redemption Period Thereafter [Member]",
        "terseLabel": "Interest Rate Thereafter"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThereafterMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DebtInstrumentRedemptionRemainderOfFiscalYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption, Remainder of Fiscal Year",
        "label": "Debt Instrument, Redemption, Remainder of Fiscal Year [Member]",
        "terseLabel": "Interest Rate 2022"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionRemainderOfFiscalYearMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DebtInstrumentWeightedAverageMaturity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents weighted average maturity of debt.",
        "label": "Debt Instrument, Weighted Average Maturity",
        "terseLabel": "Weighted-average maturity (in years)"
       }
      }
     },
     "localname": "DebtInstrumentWeightedAverageMaturity",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_DefinitiveAgreementFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definitive Agreement Four",
        "label": "Definitive Agreement Four [Member]",
        "terseLabel": "Definitive Agreement Four"
       }
      }
     },
     "localname": "DefinitiveAgreementFourMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DefinitiveAgreementsAxisAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definitive Agreements Axis",
        "label": "Definitive Agreements Axis [Axis]",
        "terseLabel": "Definitive Agreements Axis [Axis]"
       }
      }
     },
     "localname": "DefinitiveAgreementsAxisAxis",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "peak_DefinitiveAgreementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definitive Agreements",
        "label": "Definitive Agreements [Domain]",
        "terseLabel": "Definitive Agreements [Domain]"
       }
      }
     },
     "localname": "DefinitiveAgreementsDomain",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DerivativeNotionalAmountTerminated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount, Terminated",
        "label": "Derivative, Notional Amount, Terminated",
        "terseLabel": "Derivative amount terminated"
       }
      }
     },
     "localname": "DerivativeNotionalAmountTerminated",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DiscoveryNaplesJVAndDiscoverySarasotaJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discovery Naples JV and Discovery Sarasota JV",
        "label": "Discovery Naples JV and Discovery Sarasota JV [Member]",
        "terseLabel": "Discovery Naples JV and Discovery Sarasota JV"
       }
      }
     },
     "localname": "DiscoveryNaplesJVAndDiscoverySarasotaJVMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DiscoveryNaplesJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discovery Naples JV [Member]",
        "label": "Discovery Naples JV [Member]",
        "terseLabel": "Discovery Naples JV"
       }
      }
     },
     "localname": "DiscoveryNaplesJVMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DiscoverySHOPPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discovery SHOP Portfolio",
        "label": "Discovery SHOP Portfolio [Member]",
        "terseLabel": "Discovery SHOP Portfolio"
       }
      }
     },
     "localname": "DiscoverySHOPPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DiscoverySarasotaJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discovery Sarasota JV [Member]",
        "label": "Discovery Sarasota JV [Member]",
        "terseLabel": "Discovery Sarasota JV"
       }
      }
     },
     "localname": "DiscoverySarasotaJVMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Accounts Receivable Net",
        "label": "Disposal Group Including Discontinued Operation Accounts Receivable Net",
        "terseLabel": "Accounts receivable, net of allowance of $4,146 and $4,138"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsReceivableNet",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Allowance For Doubtful Accounts Receivable",
        "label": "Disposal Group, Including Discontinued Operation, Allowance For Doubtful Accounts Receivable",
        "terseLabel": "Allowance for doubtful accounts receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Nonoperating Income Expense",
        "label": "Disposal Group Including Discontinued Operation Nonoperating Income Expense",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Operating Lease Liability",
        "label": "Disposal Group Including Discontinued Operation Operating Lease Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiability",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset",
        "label": "Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset",
        "terseLabel": "Right-of-use asset, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Income (Expense), Net",
        "label": "Disposal Group, Including Discontinued Operation, Other Income (Expense), Net",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Resident Fees And Services",
        "label": "Disposal Group Including Discontinued Operation Resident Fees And Services",
        "terseLabel": "Resident fees and services"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationResidentFeesAndServices",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents",
        "label": "Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Total Costs And Expenses",
        "label": "Disposal Group Including Discontinued Operation Total Costs And Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation Transaction Costs",
        "label": "Disposal Group Including Discontinued Operation Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransactionCosts",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "label": "Disposal Group Including Discontinued Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "terseLabel": "Equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "label": "Disposal Group, Including Discontinued Operations, Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DispositionOfPropertiesSoldNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of properties sold during the period, not categorized as discontinued operations.",
        "label": "Disposition of Properties Sold Number",
        "terseLabel": "Number of properties disposed"
       }
      }
     },
     "localname": "DispositionOfPropertiesSoldNumber",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from unconsolidated joint ventures in which the entity does not have sufficient US GAAP earnings (accumulated or in the current period) to distribute funds to partners, thereby constituting a return of investment.",
        "label": "Distributions in Excess of Earnings from Unconsolidated Joint Ventures",
        "terseLabel": "Distributions in excess of earnings from unconsolidated joint ventures"
       }
      }
     },
     "localname": "DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_DownREITMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to the conversion of DownREIT units that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Down R E I T [Member]",
        "terseLabel": "Down REIT"
       }
      }
     },
     "localname": "DownREITMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_DownreitPartnershipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a joint venture, DownREIT Partnerships.",
        "label": "Downreit Partnerships [Member]",
        "terseLabel": "DownREIT Partnerships"
       }
      }
     },
     "localname": "DownreitPartnershipsMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_EquityIncomeLossFromUnconsolidatedJointVenturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Income (Loss) From Unconsolidated Joint Ventures",
        "label": "Equity Income (Loss) From Unconsolidated Joint Ventures [Member]",
        "terseLabel": "Government grant income recorded in equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "EquityIncomeLossFromUnconsolidatedJointVenturesMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ExchangeAccommodationTitleholderRealEstateCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange Accommodation Titleholder, Real Estate, Carrying Value",
        "label": "Exchange Accommodation Titleholder, Real Estate, Carrying Value",
        "terseLabel": "Exchange accommodation titleholder, real estate, carrying value"
       }
      }
     },
     "localname": "ExchangeAccommodationTitleholderRealEstateCarryingValue",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Allowance For Credit Loss, Unfunded Loan Commitments",
        "label": "Financing Receivable, Allowance For Credit Loss, Unfunded Loan Commitments",
        "terseLabel": "Credit loss reserve on unfunded loan commitments"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossUnfundedLoanCommitments",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FinancingReceivableHeldForSaleNumberOfContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Held For Sale, Number Of Contracts",
        "label": "Financing Receivable, Held For Sale, Number Of Contracts",
        "terseLabel": "Number of loans held for sale"
       }
      }
     },
     "localname": "FinancingReceivableHeldForSaleNumberOfContracts",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_FinancingReceivableNumberOfContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Number of Contracts",
        "label": "Financing Receivable, Number of Contracts",
        "terseLabel": "Number of loans receivable"
       }
      }
     },
     "localname": "FinancingReceivableNumberOfContracts",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_FinancingReceivableNumberOfContractsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Number of Contracts Sold",
        "label": "Financing Receivable, Number of Contracts Sold",
        "terseLabel": "Number of loans sold"
       }
      }
     },
     "localname": "FinancingReceivableNumberOfContractsSold",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_FinancingReceivableRemainingCommitments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Remaining Commitments",
        "label": "Financing Receivable, Remaining Commitments",
        "terseLabel": "Remaining loans receivable commitments"
       }
      }
     },
     "localname": "FinancingReceivableRemainingCommitments",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FiniteLivedIntangibleLiabilitiesAccumulatedAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "peak_FiniteLivedIntangibleLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Liabilities Accumulated Amortization",
        "negatedLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleLiabilitiesAccumulatedAmortization",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FiniteLivedIntangibleLiabilitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "peak_FiniteLivedIntangibleLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of liabilities, excluding financial liabilities, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Liabilities, Gross",
        "terseLabel": "Gross intangible lease liabilities"
       }
      }
     },
     "localname": "FiniteLivedIntangibleLiabilitiesGross",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_FiniteLivedIntangibleLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate sum of the gross carrying value of major finite-lived intangible liabilities class, less accumulated accretion and any impairment charges.",
        "label": "Finite Lived Intangible Liabilities, Net",
        "totalLabel": "Intangible liabilities, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleLiabilitiesNet",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Contract Indexed to Issuer's Equity, Remainder Outstanding, Shares",
        "label": "Forward Contract Indexed to Issuer's Equity, Remainder Outstanding, Shares",
        "terseLabel": "Remainder outstanding (in shares)"
       }
      }
     },
     "localname": "ForwardContractIndexedtoIssuersEquityRemainderOutstandingShares",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "peak_GainLossFromChangeOfControl": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) From Change Of Control",
        "label": "Gain (Loss) From Change Of Control",
        "negatedTerseLabel": "Loss (gain) upon change of control, net"
       }
      }
     },
     "localname": "GainLossFromChangeOfControl",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_GainLossOnSaleOfRealEstateUnderDirectFinancingLease": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease",
        "label": "Gain (Loss) On Sale Of Real Estate Under Direct Financing Lease",
        "negatedTerseLabel": "Loss (gain) on sale of real estate under direct financing leases"
       }
      }
     },
     "localname": "GainLossOnSaleOfRealEstateUnderDirectFinancingLease",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_GovernmentAssistanceAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance",
        "label": "Government Assistance [Axis]",
        "terseLabel": "Government Assistance [Axis]"
       }
      }
     },
     "localname": "GovernmentAssistanceAxis",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "peak_GovernmentAssistanceCARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance, CARES Act",
        "label": "Government Assistance, CARES Act [Member]",
        "terseLabel": "Government Assistance, CARES Act"
       }
      }
     },
     "localname": "GovernmentAssistanceCARESActMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_GovernmentAssistanceDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance",
        "label": "Government Assistance [Domain]",
        "terseLabel": "Government Assistance [Domain]"
       }
      }
     },
     "localname": "GovernmentAssistanceDomain",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_GovernmentGrantIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Income",
        "label": "Government Grant Income",
        "terseLabel": "Government grant income received"
       }
      }
     },
     "localname": "GovernmentGrantIncome",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_GovernmentGrantIncomeFromCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 9.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Income From CARES Act",
        "label": "Government Grant Income From CARES Act",
        "terseLabel": "Government grant income"
       }
      }
     },
     "localname": "GovernmentGrantIncomeFromCARESAct",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_GovernmentGrantIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Income, Policy [Policy Text Block]",
        "label": "Government Grant Income, Policy [Policy Text Block]",
        "terseLabel": "Government Grant Income"
       }
      }
     },
     "localname": "GovernmentGrantIncomePolicyPolicyTextBlock",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_HCPVenturesIIILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to HCP Ventures III, LLC, an unconsolidated joint venture of the entity.",
        "label": "H C P Ventures III, LLC [Member]",
        "terseLabel": "HCP Ventures III, LLC"
       }
      }
     },
     "localname": "HCPVenturesIIILLCMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_HCPVenturesIVLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to HCP Ventures IV, LLC, an unconsolidated joint venture of the entity.",
        "label": "H C P Ventures IV, LLC [Member]",
        "terseLabel": "HCP Ventures IV, LLC"
       }
      }
     },
     "localname": "HCPVenturesIVLLCMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_HRATripleNetPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HRA Triple Net Portfolio",
        "label": "HRA Triple Net Portfolio [Member]",
        "terseLabel": "HRA Triple Net Portfolio"
       }
      }
     },
     "localname": "HRATripleNetPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ImpairmentsAndAllowanceForCreditLossReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairments And Allowance For Credit Loss Reserves",
        "label": "Impairments And Allowance For Credit Loss Reserves",
        "negatedLabel": "Impairments and loan loss reserves"
       }
      }
     },
     "localname": "ImpairmentsAndAllowanceForCreditLossReserves",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairments And Allowance For Credit Loss Reserves (Recoveries), Net",
        "label": "Impairments And Allowance For Credit Loss Reserves (Recoveries), Net",
        "terseLabel": "Impairments and loan loss reserves (recoveries), net"
       }
      }
     },
     "localname": "ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_IncomeLossFromDiscontinuedOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Loss From Discontinued Operations",
        "label": "Income Loss From Discontinued Operations [Member]",
        "terseLabel": "Government grant income recorded in income (loss) from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Loss From Equity Method Investments, Including Discontinued Operations",
        "label": "Income Loss From Equity Method Investments, Including Discontinued Operations",
        "negatedLabel": "Equity loss (income) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Common Shares Attributable to Dilutive Effect of Equity Awards",
        "label": "Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards",
        "terseLabel": "Outstanding equity awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "peak_IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements, Settled",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements, Settled",
        "terseLabel": "Forward sales agreements that have been settled (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardAgreementsSettled",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "peak_IntangibleAssetsAndLiabilitiesDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This block of text may be used to disclose all or part of the information related to intangible assets and liabilities.",
        "label": "Intangible Assets and Liabilities Disclosure [Text Block]",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "IntangibleAssetsAndLiabilitiesDisclosureTextBlock",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/Intangibles"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_IntangibleLiabilitiesAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Liabilities Acquired",
        "label": "Intangible Liabilities Acquired",
        "terseLabel": "Intangible liabilities acquired"
       }
      }
     },
     "localname": "IntangibleLiabilitiesAcquired",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_IntangiblesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangibles [Abstract]",
        "label": "Intangibles [Abstract]",
        "terseLabel": "Intangibles [Abstract]"
       }
      }
     },
     "localname": "IntangiblesAbstract",
     "nsuri": "http://www.healthpeak.com/20220331",
     "xbrltype": "stringItemType"
    },
    "peak_InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations",
        "label": "Interest Income, Excluded From Adjusted Government Grant Income From Continuing Operations",
        "terseLabel": "Less: Government grant income"
       }
      }
     },
     "localname": "InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 8.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations",
        "label": "Interest Income, Excluded From Adjusted Net Operating Income From Continuing Operations",
        "negatedLabel": "Less: Interest income"
       }
      }
     },
     "localname": "InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LessorAssetUnderOperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor Asset Under Operating Lease",
        "label": "Lessor Asset Under Operating Lease [Member]",
        "terseLabel": "Lessor Asset Under Operating Lease"
       }
      }
     },
     "localname": "LessorAssetUnderOperatingLeaseMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities Related to Assets Held For Sale And Discontinued Operations Net",
        "label": "Liabilities Related to Assets Held For Sale And Discontinued Operations Net",
        "totalLabel": "Liabilities related to assets held for sale and discontinued operations, net"
       }
      }
     },
     "localname": "LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LifeScienceJVsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to HCP Life Science, an unconsolidated joint venture of the entity.",
        "label": "Life Science JVs [Member]",
        "terseLabel": "Life Science JV"
       }
      }
     },
     "localname": "LifeScienceJVsMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LifeScienceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Properties that are part of continuing operations, and which are classified as life science.",
        "label": "Life Science [Member]",
        "terseLabel": "Life Science",
        "verboseLabel": "Life Science"
       }
      }
     },
     "localname": "LifeScienceMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LineOfCreditAndTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The combination of the entity's revolving line of credit facility and term loan.",
        "label": "Line Of Credit And Term Loan [Member]",
        "terseLabel": "Line of Credit and Term Loan"
       }
      }
     },
     "localname": "LineOfCreditAndTermLoanMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the maximum additional borrowing capacity available under the credit facility, subject to customary conditions.",
        "label": "Line of Credit, Facility Additional Available Borrowing Capacity Maximum",
        "terseLabel": "Line of credit facility additional aggregate amount, maximum"
       }
      }
     },
     "localname": "LineOfCreditFacilityAdditionalAvailableBorrowingCapacityMaximum",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_LoansReceivableInterestIncomeAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Receivable, Interest Income, Amortization Period",
        "label": "Loans Receivable, Interest Income, Amortization Period",
        "terseLabel": "Interest income, amortization period (in years)"
       }
      }
     },
     "localname": "LoansReceivableInterestIncomeAmortizationPeriod",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_LoansReceivableMarketRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Receivable, Market Rate",
        "label": "Loans Receivable, Market Rate",
        "terseLabel": "Loans receivable, market rate"
       }
      }
     },
     "localname": "LoansReceivableMarketRate",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_LoansReceivableStatedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Receivable, Stated Interest Rate",
        "label": "Loans Receivable, Stated Interest Rate",
        "terseLabel": "Loans receivable, stated interest rate"
       }
      }
     },
     "localname": "LoansReceivableStatedInterestRate",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "peak_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, After Year Four",
        "label": "Long-Term Debt, Maturity, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_MedicalOfficeHospitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Office, Hospital",
        "label": "Medical Office, Hospital [Member]",
        "terseLabel": "Medical Office, Hospital"
       }
      }
     },
     "localname": "MedicalOfficeHospitalMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MedicalOfficeJVsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Office JVs [Member]",
        "label": "Medical Office JVs [Member]",
        "terseLabel": "Medical Office JVs"
       }
      }
     },
     "localname": "MedicalOfficeJVsMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MedicalOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Properties that are part of continuing operations, and which are classified as medical office.",
        "label": "Medical Office [Member]",
        "terseLabel": "Medical Office Buildings",
        "verboseLabel": "Medical Office"
       }
      }
     },
     "localname": "MedicalOfficeMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MezzanineAndOtherLoansReceivableSecuredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents other secured loans receivable not otherwise specified in the taxonomy.",
        "label": "Mezzanine And Other Loans Receivable Secured [Member]",
        "terseLabel": "Mezzanine and other"
       }
      }
     },
     "localname": "MezzanineAndOtherLoansReceivableSecuredMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MezzanineAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mezzanine And Other [Member]",
        "label": "Mezzanine And Other [Member]",
        "terseLabel": "Mezzanine and other"
       }
      }
     },
     "localname": "MezzanineAndOtherMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MezzanineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mezzanine [Member]",
        "label": "Mezzanine [Member]",
        "terseLabel": "Secured Loans"
       }
      }
     },
     "localname": "MezzanineMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_MorganStanleyRealEstateInvestmentJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Morgan Stanley Real Estate Investment JV [Member]",
        "label": "Morgan Stanley Real Estate Investment JV [Member]",
        "terseLabel": "MSREI JV"
       }
      }
     },
     "localname": "MorganStanleyRealEstateInvestmentJVMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_NeedhamLandParcelJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Needham Land Parcel JV",
        "label": "Needham Land Parcel JV [Member]",
        "terseLabel": "Needham Land Parcel JV"
       }
      }
     },
     "localname": "NeedhamLandParcelJVMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income Loss Continuing Operations Available To Common Stockholders Basic",
        "label": "Net Income Loss Continuing Operations Available To Common Stockholders Basic",
        "totalLabel": "Income (loss) from continuing operations applicable to common shares"
       }
      }
     },
     "localname": "NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NetIncomeLossJointVenturePartnersAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss) Joint Venture Partners, Attributable To Parent",
        "label": "Net Income (Loss) Joint Venture Partners, Attributable To Parent",
        "terseLabel": "Less: Healthpeak\u2019s share of unconsolidated joint venture NOI"
       }
      }
     },
     "localname": "NetIncomeLossJointVenturePartnersAttributableToParent",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NetRealEstateAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Real Estate Assets",
        "label": "Net Real Estate Assets",
        "terseLabel": "Net real estate assets"
       }
      }
     },
     "localname": "NetRealEstateAssets",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 7.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees.",
        "label": "Non Cash Adjustments To Net Operating Income From Continuing Operations",
        "terseLabel": "Adjustments to NOI"
       }
      }
     },
     "localname": "NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash or Part Noncash, Discontinued Operations, Secured Debt Assumed by Buyer",
        "label": "Noncash or Part Noncash, Discontinued Operations, Secured Debt Assumed by Buyer",
        "terseLabel": "Carrying value of mortgages assumed by buyer in real estate dispositions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashDiscontinuedOperationsSecuredDebtAssumedByBuyer",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NoncashOrPartNoncashInterestIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash or Part Noncash, Interest Income",
        "label": "Noncash or Part Noncash, Interest Income",
        "terseLabel": "Non-cash interest income"
       }
      }
     },
     "localname": "NoncashOrPartNoncashInterestIncome",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NoncontrollingInterestsShareInDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests' Share In Discontinued Operations",
        "label": "Noncontrolling Interests' Share In Discontinued Operations",
        "terseLabel": "Noncontrolling interests' share in discontinued operations"
       }
      }
     },
     "localname": "NoncontrollingInterestsShareInDiscontinuedOperations",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_NumberOfAssetsClassifiedAsDiscontinuedOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Assets Classified as Discontinued Operations",
        "label": "Number of Assets Classified as Discontinued Operations",
        "terseLabel": "Number of assets classified as discontinued operations"
       }
      }
     },
     "localname": "NumberOfAssetsClassifiedAsDiscontinuedOperations",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfBondOfferings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Bond Offerings",
        "label": "Number Of Bond Offerings",
        "terseLabel": "Number of bond offerings"
       }
      }
     },
     "localname": "NumberOfBondOfferings",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfInterestRateDerivativesTerminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Interest Rate Derivatives Terminated",
        "label": "Number of Interest Rate Derivatives Terminated",
        "terseLabel": "Number of interest rate derivatives terminated"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesTerminated",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfPreferredEquityMethodInvestmentsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Preferred Equity Method Investments Sold",
        "label": "Number of Preferred Equity Method Investments Sold",
        "terseLabel": "Number of preferred equity method investments sold"
       }
      }
     },
     "localname": "NumberOfPreferredEquityMethodInvestmentsSold",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfPropertiesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Properties Acquired",
        "label": "Number Of Properties Acquired",
        "terseLabel": "Number of properties acquired"
       }
      }
     },
     "localname": "NumberOfPropertiesAcquired",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfPropertiesSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Properties Sold",
        "label": "Number Of Properties Sold",
        "terseLabel": "Number of properties sold"
       }
      }
     },
     "localname": "NumberOfPropertiesSold",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfPropertiesToBeSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Properties To Be Sold",
        "label": "Number Of Properties To Be Sold",
        "terseLabel": "Number of assets to be sold"
       }
      }
     },
     "localname": "NumberOfPropertiesToBeSold",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfRedeemableNoncontrollingInterestRedemptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Redeemable Noncontrolling Interest Redemptions",
        "label": "Number Of Redeemable Noncontrolling Interest Redemptions",
        "terseLabel": "Number of redeemable noncontrolling interest redemptions"
       }
      }
     },
     "localname": "NumberOfRedeemableNoncontrollingInterestRedemptions",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Redeemable Noncontrolling Interests, Redeemable Over Time",
        "label": "Number Of Redeemable Noncontrolling Interests, Redeemable Over Time",
        "terseLabel": "Number of interests redeemable over time"
       }
      }
     },
     "localname": "NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfUnconsolidatedJointVenture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of unconsolidated joint ventures between entity and an institutional capital partner.",
        "label": "Number of Unconsolidated Joint Venture",
        "terseLabel": "Number of unconsolidated joint ventures (in joint ventures)"
       }
      }
     },
     "localname": "NumberOfUnconsolidatedJointVenture",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberOfVieBorrowersWithMarketableDebtSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of VIE borrowers in which the entity has invested in marketable debt securities.",
        "label": "Number Of VIE Borrowers With Marketable Debt Securities",
        "terseLabel": "Number of VIE borrowers with marketable debt securities (in joint ventures)"
       }
      }
     },
     "localname": "NumberOfVieBorrowersWithMarketableDebtSecurities",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_NumberofFacilitiesOwnedbyUnconsolidatedJointVenture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Facilities Owned by Unconsolidated Joint Venture",
        "label": "Number of Facilities Owned by Unconsolidated Joint Venture",
        "terseLabel": "Number of facilities owned by unconsolidated joint venture"
       }
      }
     },
     "localname": "NumberofFacilitiesOwnedbyUnconsolidatedJointVenture",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_OakmontSHOPPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oakmont SHOP Portfolio",
        "label": "Oakmont SHOP Portfolio [Member]",
        "terseLabel": "Oakmont SHOP Portfolio"
       }
      }
     },
     "localname": "OakmontSHOPPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 6.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest",
        "label": "Operating Expenses From Joint Venture, Attributable To Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests\u2019 share of consolidated joint venture operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_OperatingExpensesFromJointVentureAttributableToParentNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 5.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses From Joint Venture, Attributable To Parent Net",
        "label": "Operating Expenses From Joint Venture, Attributable To Parent Net",
        "negatedTerseLabel": "Healthpeak\u2019s share of unconsolidated joint venture operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesFromJointVentureAttributableToParentNet",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_OptionIndexedToIssuersEquityTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option Indexed To Issuers Equity, Term",
        "label": "Option Indexed To Issuers Equity, Term",
        "terseLabel": "Option indexed to issuers equity, term (in years)"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTerm",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "peak_OtherDispositionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Dispositions",
        "label": "Other Dispositions [Member]",
        "terseLabel": "Other Dispositions"
       }
      }
     },
     "localname": "OtherDispositionsMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_OtherNonReportingSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to other non-reporting segment",
        "label": "Other Non-Reporting Segment [Member]",
        "netLabel": "Other Non-reportable",
        "terseLabel": "Other Non-Reporting Segment"
       }
      }
     },
     "localname": "OtherNonReportingSegmentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ParticipatingDevelopmentLoansAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Participating Development Loans And Other [Member]",
        "label": "Participating Development Loans And Other [Member]",
        "terseLabel": "Mezzanine and Other"
       }
      }
     },
     "localname": "ParticipatingDevelopmentLoansAndOtherMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities Distributed And Undistributed Earnings Loss Basic and Diluted",
        "negatedLabel": "Participating securities\u2019 share in earnings",
        "negatedTerseLabel": "Less: Participating securities' share in continuing operations"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_PaymentsToAcquireLoansReceivableAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Loans Receivable and Other",
        "label": "Payments to Acquire Loans Receivable and Other",
        "negatedLabel": "Investments in loans receivable and other"
       }
      }
     },
     "localname": "PaymentsToAcquireLoansReceivableAndOther",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_PlannedMOBDemolitionTenantRelocationAndOtherCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Planned MOB Demolition, Tenant Relocation And Other Costs",
        "label": "Planned MOB Demolition, Tenant Relocation And Other Costs [Member]",
        "terseLabel": "Planned MOB Demolition, Tenant Relocation and Other Costs"
       }
      }
     },
     "localname": "PlannedMOBDemolitionTenantRelocationAndOtherCostsMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ProceedsFromCollectionOfNonrefundableEntranceFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Collection Of Nonrefundable Entrance Fees",
        "label": "Proceeds From Collection Of Nonrefundable Entrance Fees",
        "terseLabel": "Proceeds from collection of nonrefundable entrance fees"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNonrefundableEntranceFees",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Sale of Financing Receivable, after Allowance for Credit Loss and Preferred Equity Method Investment",
        "label": "Proceeds from Sale of Financing Receivable, after Allowance for Credit Loss and Preferred Equity Method Investment",
        "terseLabel": "Proceeds from sale of loans and preferred equity method investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfFinancingReceivableAfterAllowanceForCreditLossAndPreferredEquityMethodInvestment",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_PropertiesHeldForSaleNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of properties held for sale at the reporting date.",
        "label": "Properties Held for Sale, Number",
        "terseLabel": "Number of properties classified as held for sale"
       }
      }
     },
     "localname": "PropertiesHeldForSaleNumber",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_PropertiesWithDirectFinancingLeasesNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of properties with direct financing leases at the balance sheet date.",
        "label": "Properties with Direct Financing Leases, Number",
        "terseLabel": "Properties subject to direct financing leases"
       }
      }
     },
     "localname": "PropertiesWithDirectFinancingLeasesNumber",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 3.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest",
        "label": "Real Estate Revenues From Joint Venture, Attributable To Noncontrolling Interest",
        "negatedTerseLabel": "Noncontrolling interests\u2019 share of consolidated joint venture total revenues"
       }
      }
     },
     "localname": "RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RealEstateRevenuesFromJointVentureAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Revenues From Joint Venture, Attributable To Parent",
        "label": "Real Estate Revenues From Joint Venture, Attributable To Parent",
        "terseLabel": "Healthpeak\u2019s share of unconsolidated joint venture total revenues"
       }
      }
     },
     "localname": "RealEstateRevenuesFromJointVentureAttributableToParent",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RealEstateRevenuesFromJointVentureGovernmentGrantIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 10.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Estate Revenues From Joint Venture Government Grant Income",
        "label": "Real Estate Revenues From Joint Venture Government Grant Income",
        "terseLabel": "Healthpeak\u2019s share of unconsolidated joint venture government grant income"
       }
      }
     },
     "localname": "RealEstateRevenuesFromJointVentureGovernmentGrantIncome",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the addback of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees from segment portfolio income to consolidated net income.",
        "label": "Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments",
        "terseLabel": "Plus: Adjustments to NOI"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RefundableEntranceFeesCurrentAndNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refundable Entrance Fees, Current and Noncurrent",
        "label": "Refundable Entrance Fees, Current and Noncurrent",
        "terseLabel": "Refundable entrance fees"
       }
      }
     },
     "localname": "RefundableEntranceFeesCurrentAndNoncurrent",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total",
        "label": "Restricted Cash and Cash Equivalents, Including Discontinued Operations, Total",
        "totalLabel": "Restricted cash, total"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_RestrictedStockVested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of stock issued upon which restrictions have lapsed.",
        "label": "Restricted Stock, Vested",
        "terseLabel": "Vesting of restricted stock units and conversion of non-managing member units into common stock"
       }
      }
     },
     "localname": "RestrictedStockVested",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_SHOPJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SHOP JV [Member]",
        "label": "SHOP JV [Member]",
        "verboseLabel": "SWF SH JV"
       }
      }
     },
     "localname": "SHOPJVMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SLCSHOPPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SLC SHOP Portfolio",
        "label": "SLC SHOP Portfolio [Member]",
        "terseLabel": "SLC SHOP Portfolio"
       }
      }
     },
     "localname": "SLCSHOPPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite Lived Intangible Liabilities by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Intangible Lease Liabilities"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleLiabilitiesByMajorClassTableTextBlock",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Government Grant Receivables, CARES Act",
        "label": "Schedule of Government Grant Receivables, CARES Act [Table Text Block]",
        "terseLabel": "Schedule of Government Grant Receivables, CARES Act"
       }
      }
     },
     "localname": "ScheduleOfGovernmentGrantReceivablesCARESActTableTextBlock",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of the net amount due as of the balance sheet date consisting of: (a) minimum lease payments due on direct financing and sales-type leases, (b) unguaranteed residual value, and (c) any unamortized initial direct costs on direct financing leases; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments.",
        "label": "Schedule of Net Investment in Direct Financing and Sales Type Leases [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Investment in DFLs"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentInDirectFinancingAndSalesTypeLeasesTableTextBlock",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the VIE's total assest and liabilities included in the consolidated balance sheet.",
        "label": "Schedule Of Variable Interest Entities Included In The Balance Sheet [Table Text Block]",
        "terseLabel": "Consolidated Assets and Liabilities of Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesIncludedInTheBalanceSheetTableTextBlock",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_SecuredMortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Mortgage Loans [Member]",
        "label": "Secured Mortgage Loans [Member]",
        "terseLabel": "Secured mortgage loans"
       }
      }
     },
     "localname": "SecuredMortgageLoansMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SellerFinancingProvidedOnDispositionofRealEstateAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Seller Financing Provided On Disposition of Real Estate Asset",
        "label": "Seller Financing Provided On Disposition of Real Estate Asset",
        "terseLabel": "Seller financing provided on disposition of real estate asset"
       }
      }
     },
     "localname": "SellerFinancingProvidedOnDispositionofRealEstateAsset",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_SeniorHousingOperatingPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent senior housing operating portfolio.",
        "label": "Senior Housing Operating Portfolio [Member]",
        "terseLabel": "SHOP"
       }
      }
     },
     "localname": "SeniorHousingOperatingPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SeniorHousingTripleNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to the Senior Housing Triple Net [Member].",
        "label": "Senior Housing Triple Net [Member]",
        "terseLabel": "Senior Housing Triple Net"
       }
      }
     },
     "localname": "SeniorHousingTripleNetMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SeniorNotesDue2023And2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Due 2023 and 2024",
        "label": "Senior Notes Due 2023 and 2024 [Member]",
        "terseLabel": "Senior Notes Due 2023 and 2024"
       }
      }
     },
     "localname": "SeniorNotesDue2023And2024Member",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SeniorNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Due 2025",
        "label": "Senior Notes Due 2025 [Member]",
        "terseLabel": "Senior Notes Due 2025"
       }
      }
     },
     "localname": "SeniorNotesDue2025Member",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SonataSHOPPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sonata SHOP Portfolio",
        "label": "Sonata SHOP Portfolio [Member]",
        "terseLabel": "Sonata SHOP Portfolio"
       }
      }
     },
     "localname": "SonataSHOPPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SuburbanPropertiesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Suburban Properties, LLC, an unconsolidated joint venture of the entity.",
        "label": "Suburban Properties L L C [Member]",
        "terseLabel": "Suburban Properties, LLC"
       }
      }
     },
     "localname": "SuburbanPropertiesLLCMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_SunriseSeniorHousingPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sunrise Senior Housing Portfolio",
        "label": "Sunrise Senior Housing Portfolio [Member]",
        "terseLabel": "Sunrise Senior Housing Portfolio"
       }
      }
     },
     "localname": "SunriseSeniorHousingPortfolioMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity",
        "label": "Temporary Equity, Adjustments Of Permanent Equity To Temporary Equity",
        "terseLabel": "Adjustments to redemption value of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest",
        "label": "Temporary Equity, Noncontrolling Interest, Contributions From Noncontrolling Interest",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary Equity, Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unamortized Nonrefundable Entrance Fee, Current and Noncurrent",
        "label": "Unamortized Nonrefundable Entrance Fee, Current and Noncurrent",
        "terseLabel": "Unamortized nonrefundable entrance fee"
       }
      }
     },
     "localname": "UnamortizedNonrefundableEntranceFeeCurrentAndNoncurrent",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "peak_UnsecuredNote1350PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Note 1.350 Percent",
        "label": "Unsecured Note 1.350 Percent [Member]",
        "terseLabel": "Unsecured Note 1.35 Percent"
       }
      }
     },
     "localname": "UnsecuredNote1350PercentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_UnsecuredNote213PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Note 2.13 Percent",
        "label": "Unsecured Note 2.13 Percent [Member]",
        "terseLabel": "Unsecured Note 2.13 Percent"
       }
      }
     },
     "localname": "UnsecuredNote213PercentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_UnsecuredNote3400PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Note 3.400 Percent",
        "label": "Unsecured Note 3.400 Percent [Member]",
        "terseLabel": "Unsecured Note 3.400 Percent"
       }
      }
     },
     "localname": "UnsecuredNote3400PercentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_UnsecuredNote3880PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Note 3.880 Percent",
        "label": "Unsecured Note 3.880 Percent [Member]",
        "terseLabel": "Unsecured Note 3.880 Percent"
       }
      }
     },
     "localname": "UnsecuredNote3880PercentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_UnsecuredNote4.250PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Note 4.250 Percent [Member]",
        "label": "Unsecured Note 4.250 Percent [Member]",
        "terseLabel": "Unsecured Note 4.250 Percent"
       }
      }
     },
     "localname": "UnsecuredNote4.250PercentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_UnsecuredNote4000PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Note 4.000 Percent",
        "label": "Unsecured Note 4.000 Percent [Member]",
        "terseLabel": "Unsecured Note 4.000 Percent"
       }
      }
     },
     "localname": "UnsecuredNote4000PercentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_UnsecuredNote4200PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured Note 4.200 Percent",
        "label": "Unsecured Note 4.200 Percent [Member]",
        "terseLabel": "Unsecured Note 4.200 Percent"
       }
      }
     },
     "localname": "UnsecuredNote4200PercentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_VariableInterestEntitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities [Abstract]",
        "label": "Variable Interest Entities [Abstract]",
        "terseLabel": "Variable Interest Entities [Abstract]"
       }
      }
     },
     "localname": "VariableInterestEntitiesAbstract",
     "nsuri": "http://www.healthpeak.com/20220331",
     "xbrltype": "stringItemType"
    },
    "peak_VariableInterestEntitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for variable interest entities, including description of the terms of arrangements and categorized by: (1) VIEs consolidated because the entity is the primary beneficiary, (2) VIEs not consolidated because the entity is not the primary beneficiary, and (3) VIEs or potential VIEs that are not consolidated because necessary information is not available.",
        "label": "Variable Interest Entities [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntitiesTextBlock",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "peak_VariableInterestEntityControllingOwnershipInterestThroughPartnership": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of controlling ownership interest entities, in which the company holds the interest and is the managing member of the partnership.",
        "label": "Variable Interest Entity Controlling Ownership Interest Through Partnership",
        "terseLabel": "Number of controlling ownership interest entities as a managing member"
       }
      }
     },
     "localname": "VariableInterestEntityControllingOwnershipInterestThroughPartnership",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "peak_VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a debt investment with a party that has been identified as a Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary.",
        "label": "Variable Interest Entity Not Primary Beneficiary Debt Investment [Member]",
        "terseLabel": "CMBS and LLC investment"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryDebtInvestmentMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to investments in an unconsolidated joint venture, which is a Variable Interest Entity (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary.",
        "label": "Variable Interest Entity Not Primary Beneficiary Investment In Joint Venture [Member]",
        "terseLabel": "Needham Land Parcel JV"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryInvestmentInJointVentureMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_VenturesVLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to HCP Ventures V.",
        "label": "Ventures V, LLC [Member]",
        "terseLabel": "Ventures V"
       }
      }
     },
     "localname": "VenturesVLLCMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_WatchListFinancingReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a financing receivable that is being monitored closely in order to spot irregularities.",
        "label": "Watch List Financing Receivable [Member]",
        "verboseLabel": "Watch list loans"
       }
      }
     },
     "localname": "WatchListFinancingReceivableMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "peak_WorkoutFinancingReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workout Financing Receivable [Member]",
        "label": "Workout Financing Receivable [Member]",
        "verboseLabel": "Workout loans"
       }
      }
     },
     "localname": "WorkoutFinancingReceivableMember",
     "nsuri": "http://www.healthpeak.com/20220331",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r154",
      "r327",
      "r332",
      "r340",
      "r460",
      "r461",
      "r466",
      "r467",
      "r565",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r154",
      "r327",
      "r332",
      "r340",
      "r460",
      "r461",
      "r466",
      "r467",
      "r565",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r154",
      "r208",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r228",
      "r232",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r337",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r154",
      "r208",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r228",
      "r232",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r337",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r73",
      "r75",
      "r152",
      "r153",
      "r346",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r345",
      "r390",
      "r429",
      "r431",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r581",
      "r646",
      "r648",
      "r694",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r345",
      "r390",
      "r429",
      "r431",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r581",
      "r646",
      "r648",
      "r694",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r345",
      "r390",
      "r419",
      "r429",
      "r431",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r581",
      "r646",
      "r648",
      "r694",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r345",
      "r390",
      "r419",
      "r429",
      "r431",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r581",
      "r646",
      "r648",
      "r694",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r74",
      "r75",
      "r152",
      "r153",
      "r346",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r3",
      "r156",
      "r157",
      "r158",
      "r160",
      "r161",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r194",
      "r266",
      "r267",
      "r441",
      "r448",
      "r508",
      "r512",
      "r513",
      "r514",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r3",
      "r156",
      "r157",
      "r158",
      "r160",
      "r161",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r194",
      "r266",
      "r267",
      "r441",
      "r448",
      "r508",
      "r512",
      "r513",
      "r514",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r170",
      "r171",
      "r173",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Error Correction, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Error Correction, Adjustment"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r169",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r169",
      "r175",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r236",
      "r237",
      "r416",
      "r418",
      "r647",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r236",
      "r237",
      "r416",
      "r418",
      "r647",
      "r677",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r169",
      "r175",
      "r311",
      "r430",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "CALIFORNIA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COLORADO",
        "terseLabel": "COLORADO"
       }
      }
     },
     "localname": "CO",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_FL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FLORIDA",
        "terseLabel": "FLORIDA"
       }
      }
     },
     "localname": "FL",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_KS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KANSAS",
        "terseLabel": "KANSAS"
       }
      }
     },
     "localname": "KS",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_LA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LOUISIANA",
        "terseLabel": "LOUISIANA"
       }
      }
     },
     "localname": "LA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "terseLabel": "MASSACHUSETTS"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NJ": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW JERSEY",
        "terseLabel": "NEW JERSEY"
       }
      }
     },
     "localname": "NJ",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TENNESSEE",
        "terseLabel": "TENNESSEE"
       }
      }
     },
     "localname": "TN",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "TEXAS"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WASHINGTON",
        "terseLabel": "WASHINGTON"
       }
      }
     },
     "localname": "WA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Loans Receivable:",
        "verboseLabel": "Loans receivable"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r596",
      "r630"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities",
        "negatedLabel": "Accounts payable, accrued liabilities, and other liabilities",
        "terseLabel": "Accounts payable, accrued liabilities, and other liabilities",
        "totalLabel": "Accounts payable, accrued liabilities, and other liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails",
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable, Accrued Liabilities, and Other Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r48",
      "r616",
      "r678"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Accounts receivable, net",
        "verboseLabel": "Accounts receivable, net of allowance of $2,068 and $1,870"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDistributionsInExcessOfNetIncome": {
     "auth_ref": [
      "r661"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount as of the balance sheet date by which cumulative distributions to shareholders (or partners) exceed retained earnings (or accumulated earnings).",
        "label": "Accumulated Distributions in Excess of Net Income",
        "negatedLabel": "Cumulative dividends in excess of earnings"
       }
      }
     },
     "localname": "AccumulatedDistributionsInExcessOfNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDistributionsInExcessOfNetIncomeMember": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative distributions to shareholders (or partners) in excess of retained earnings (or accumulated earnings).",
        "label": "Accumulated Distributions in Excess of Net Income [Member]",
        "terseLabel": "Cumulative Dividends In\u00a0Excess Of\u00a0Earnings"
       }
      }
     },
     "localname": "AccumulatedDistributionsInExcessOfNetIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r77",
      "r81",
      "r427"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Supplemental Executive Retirement Plan minimum liability"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r79",
      "r80",
      "r81",
      "r622",
      "r656",
      "r660"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "totalLabel": "Total accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r78",
      "r81",
      "r89",
      "r90",
      "r91",
      "r156",
      "r157",
      "r158",
      "r465",
      "r651",
      "r652",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average remaining amortization period in years"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails",
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r49",
      "r441",
      "r568"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r438",
      "r439",
      "r440",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r432",
      "r433",
      "r442",
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Amortization of stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "auth_ref": [
      "r242",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Financing Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r245",
      "r268",
      "r270",
      "r272"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r136",
      "r365",
      "r374",
      "r375",
      "r546"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Shares of anti-dilutive securities excluded from earnings per share calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails",
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfLand": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land held.",
        "label": "Area of Land",
        "terseLabel": "Area of land (in acres)"
       }
      }
     },
     "localname": "AreaOfLand",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r136",
      "r294"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "verboseLabel": "Impairments and loan loss reserves (recoveries), net"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r150",
      "r216",
      "r223",
      "r230",
      "r259",
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r460",
      "r466",
      "r524",
      "r566",
      "r568",
      "r590",
      "r618"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup": {
     "auth_ref": [
      "r292"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "peak_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets held-for-sale that are not part of a disposal group.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group",
        "terseLabel": "Assets held for sale, net"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroup",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r5",
      "r6",
      "r28",
      "r30",
      "r34",
      "r299"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "peak_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Assets held for sale and discontinued operations, net",
        "totalLabel": "Total assets of discontinued operations, net"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r453"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "negatedLabel": "Transaction costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r37",
      "r54",
      "r138"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "peak_CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r132",
      "r138",
      "r143"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Continuing operations"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r132",
      "r138",
      "r143"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash, total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r132",
      "r533"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashIncludingDiscontinuedOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Including Discontinued Operations [Abstract]",
        "terseLabel": "Discontinued operations"
       }
      }
     },
     "localname": "CashIncludingDiscontinuedOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r147",
      "r150",
      "r179",
      "r183",
      "r185",
      "r188",
      "r190",
      "r199",
      "r200",
      "r201",
      "r259",
      "r327",
      "r332",
      "r333",
      "r334",
      "r340",
      "r341",
      "r388",
      "r389",
      "r393",
      "r397",
      "r524",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r65",
      "r310",
      "r598",
      "r625"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r318",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Dividends paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared (in dollars per share)",
        "verboseLabel": "Common dividends, per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTSParenthetical",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r156",
      "r157",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r47",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r47",
      "r568"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $1.00 par value: 750,000,000 shares authorized; 539,523,537 and 539,096,879 shares issued and outstanding"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r85",
      "r87",
      "r88",
      "r102",
      "r608",
      "r638"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income (loss) attributable to Healthpeak Properties, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r85",
      "r87",
      "r101",
      "r458",
      "r459",
      "r478",
      "r607",
      "r637"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Total comprehensive (income) loss attributable to noncontrolling interests'"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r85",
      "r87",
      "r100",
      "r457",
      "r478",
      "r606",
      "r636"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r140",
      "r141",
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for construction in progress expenditures that have occurred.",
        "label": "Construction in Progress Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued construction costs"
       }
      }
     },
     "localname": "ConstructionInProgressExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r597",
      "r629"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables.",
        "label": "Construction Payable",
        "terseLabel": "Accrued construction costs"
       }
      }
     },
     "localname": "ConstructionPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r413",
      "r414",
      "r417"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r232",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate Non-segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r110",
      "r582"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Operating"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r146",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r359",
      "r366",
      "r367",
      "r369",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r149",
      "r154",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r372",
      "r373",
      "r374",
      "r375",
      "r548",
      "r591",
      "r592",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "verboseLabel": "Debt instrument, basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r44",
      "r370",
      "r592",
      "r615"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "totalLabel": "Total debt before discount, net",
        "verboseLabel": "Principal balance on debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r342",
      "r372",
      "r373",
      "r545",
      "r548",
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Amount",
        "verboseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r62",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Coupon Rate",
        "verboseLabel": "Interest Rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r63",
      "r149",
      "r154",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r372",
      "r373",
      "r374",
      "r375",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt instrument, periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "terseLabel": "Interest Rate 2026"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Interest Rate 2023"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Interest Rate 2025"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Interest Rate 2024"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r63",
      "r149",
      "r154",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r349",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r368",
      "r372",
      "r373",
      "r374",
      "r375",
      "r405",
      "r408",
      "r409",
      "r410",
      "r544",
      "r545",
      "r548",
      "r549",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term (in months)"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r355",
      "r544",
      "r545",
      "r546",
      "r547",
      "r549"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "(Discounts), premium and debt costs, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted-average interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r136",
      "r296"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "negatedLabel": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization of real estate, in-place lease, and other intangibles",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r481",
      "r482",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r71",
      "r72",
      "r75",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate cap assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Strike Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Increase in the fair value of the interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r75",
      "r488",
      "r490",
      "r493",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r503",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r486",
      "r488",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r480",
      "r483",
      "r484",
      "r486",
      "r487",
      "r492",
      "r493",
      "r497",
      "r498",
      "r499",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopmentInProcess": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current amount of expenditures for a real estate project that has not yet been completed.",
        "label": "Development in Process",
        "terseLabel": "Development costs and construction in progress",
        "verboseLabel": "Development costs and construction in progress"
       }
      }
     },
     "localname": "DevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectFinancingLeaseDeferredSellingProfit": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred selling profit from direct financing lease.",
        "label": "Direct Financing Lease, Deferred Selling Profit",
        "negatedLabel": "Less deferred selling profits"
       }
      }
     },
     "localname": "DirectFinancingLeaseDeferredSellingProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectFinancingLeaseInterestIncome": {
     "auth_ref": [
      "r197",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income from net investment in direct financing lease.",
        "label": "Direct Financing Lease, Interest Income",
        "terseLabel": "Interest income from direct financing leases"
       }
      }
     },
     "localname": "DirectFinancingLeaseInterestIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r197",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of lease income from direct financing lease.",
        "label": "Direct Financing Lease, Lease Income [Table Text Block]",
        "terseLabel": "Schedule of Company's Lease Income"
       }
      }
     },
     "localname": "DirectFinancingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DirectFinancingLeaseLeaseReceivable": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term, guaranteed by lessee or other third party unrelated to lessor, from direct financing lease.",
        "label": "Direct Financing Lease, Lease Receivable",
        "terseLabel": "Present value of minimum lease payments receivable"
       }
      }
     },
     "localname": "DirectFinancingLeaseLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectFinancingLeaseNetInvestmentInLease": {
     "auth_ref": [
      "r247",
      "r268",
      "r274",
      "r562"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of net investment in direct financing lease.",
        "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss",
        "totalLabel": "Net investment in direct financing leases"
       }
      }
     },
     "localname": "DirectFinancingLeaseNetInvestmentInLease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectFinancingLeaseRevenue": {
     "auth_ref": [
      "r197",
      "r557"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct financing lease revenue.",
        "label": "Direct Financing Lease, Revenue",
        "terseLabel": "Income from direct financing leases"
       }
      }
     },
     "localname": "DirectFinancingLeaseRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value expected to be derived from underlying asset, following end of lease term, not guaranteed by lessee or other third party unrelated to lessor.",
        "label": "Direct Financing Lease, Unguaranteed Residual Asset",
        "terseLabel": "Present value of estimated residual value"
       }
      }
     },
     "localname": "DirectFinancingLeaseUnguaranteedResidualAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesDirectFinancingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r12",
      "r14",
      "r18"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "totalLabel": "Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": {
     "auth_ref": [
      "r12",
      "r14",
      "r18",
      "r31"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax",
        "totalLabel": "Income (loss) from discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r18",
      "r26",
      "r31",
      "r444",
      "r449",
      "r451"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "negatedTerseLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "auth_ref": [
      "r8",
      "r11",
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r20",
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember": {
     "auth_ref": [
      "r293",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is disposed of by means of abandonment. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment [Member]",
        "terseLabel": "Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r5",
      "r6",
      "r28",
      "r299"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued liabilities, and other liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r5",
      "r6",
      "r28",
      "r299"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue": {
     "auth_ref": [
      "r5",
      "r6",
      "r28",
      "r299"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "auth_ref": [
      "r27",
      "r34"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)",
        "terseLabel": "Gain (loss) on sales of real estate, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": {
     "auth_ref": [
      "r16",
      "r17",
      "r27",
      "r35"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "peak_DisposalGroupIncludingDiscontinuedOperationTotalCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "terseLabel": "Operating"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r5",
      "r6",
      "r28",
      "r299"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRentalIncome": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rental income attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Rental Income",
        "terseLabel": "Rental and related revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRentalIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r27",
      "r34"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r36",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Dispositions of Real Estate and Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r411",
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedLabel": "Common dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Basic earnings (loss) per common share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r103",
      "r165",
      "r166",
      "r168",
      "r169",
      "r170",
      "r176",
      "r179",
      "r188",
      "r189",
      "r190",
      "r194",
      "r195",
      "r513",
      "r514",
      "r609",
      "r639"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Net income (loss) applicable to common shares (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic earnings (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Denominator"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r103",
      "r165",
      "r166",
      "r168",
      "r169",
      "r170",
      "r179",
      "r188",
      "r189",
      "r190",
      "r194",
      "r195",
      "r513",
      "r514",
      "r609",
      "r639"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Net income (loss) applicable to common shares (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings (loss) per common share:",
        "verboseLabel": "Diluted earnings (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r89",
      "r90",
      "r91",
      "r156",
      "r157",
      "r158",
      "r161",
      "r171",
      "r174",
      "r198",
      "r265",
      "r404",
      "r411",
      "r438",
      "r439",
      "r440",
      "r447",
      "r448",
      "r512",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r540",
      "r651",
      "r652",
      "r653",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r96",
      "r131",
      "r136",
      "r631"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Distributions of earnings from unconsolidated joint ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r34",
      "r150",
      "r259",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r34",
      "r150",
      "r259",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Investment ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r55",
      "r217",
      "r256"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investments in and Advances to Unconsolidated Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVentures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r357",
      "r372",
      "r373",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair\u00a0Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Summary of financial instruments"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r516",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r516",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Summary of Carry Amounts and Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r357",
      "r372",
      "r373",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r517",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r357",
      "r372",
      "r373",
      "r516",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r357",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r357",
      "r420",
      "r421",
      "r426",
      "r428",
      "r517",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r357",
      "r372",
      "r373",
      "r420",
      "r421",
      "r426",
      "r428",
      "r517",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r357",
      "r372",
      "r373",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentPerformanceStatusAxis": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of performance or non-performance status of financial instruments.",
        "label": "Financial Instrument Performance Status [Axis]",
        "terseLabel": "Financial Instrument Performance Status [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentPerformanceStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentPerformanceStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of performance or non-performance status of financial instruments, including but not limited to, financing receivables, loans, debt, and investments.",
        "label": "Financial Instrument Performance Status [Domain]",
        "terseLabel": "Financial Instrument Performance Status [Domain]"
       }
      }
     },
     "localname": "FinancialInstrumentPerformanceStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentsOwnedAtFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Owned, at Fair Value [Abstract]",
        "terseLabel": "Financial Instruments, Owned, at Fair Value [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsOwnedAtFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest",
        "negatedLabel": "Reserve for loan losses",
        "periodEndLabel": "Reserve for loan losses, end of period",
        "periodStartLabel": "Reserve for loan losses, beginning of period",
        "terseLabel": "Reserves for loans receivable"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Financing Receivable, Allowance for Credit Loss [Line Items]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Line Items]"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock": {
     "auth_ref": [
      "r243",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.",
        "label": "Financing Receivable Credit Quality Indicators [Table Text Block]",
        "terseLabel": "Schedule of Financing Receivable Credit Quality Indicators and by Year of Origination"
       }
      }
     },
     "localname": "FinancingReceivableCreditQualityIndicatorsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, after allowance for credit loss, of financing receivable.",
        "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss",
        "terseLabel": "Loans receivable, net of reserves of $1,944 and $1,813",
        "totalLabel": "Loans receivable, net",
        "verboseLabel": "Financing receivable, after allowance for credit loss"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "auth_ref": [
      "r268",
      "r276",
      "r277"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, before allowance for credit loss, of financing receivable.",
        "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss",
        "totalLabel": "Total",
        "verboseLabel": "Financing receivable, gross"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r276",
      "r279",
      "r282"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest of financing receivable originated more than five years prior to current fiscal year.",
        "label": "Financing Receivable, Excluding Accrued Interest, Originated, More than Five Years before Current Fiscal Year",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r276",
      "r279",
      "r282"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest of financing receivable originated four years prior to current fiscal year.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Five, Originated, Four Years before Current Fiscal Year",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r276",
      "r279",
      "r282"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest of financing receivable originated three years prior to current fiscal year.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Four, Originated, Three Years before Current Fiscal Year",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear": {
     "auth_ref": [
      "r276",
      "r279",
      "r282"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest of financing receivable originated in current fiscal year.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year One, Originated, Current Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r276",
      "r279",
      "r282"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest of financing receivable originated two years prior to current fiscal year.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Three, Originated, Two Years before Current Fiscal Year",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear": {
     "auth_ref": [
      "r276",
      "r279",
      "r282"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest of financing receivable originated in fiscal year prior to current fiscal year.",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Two, Originated, Fiscal Year before Current Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": {
     "auth_ref": [
      "r244",
      "r246",
      "r247",
      "r274",
      "r275",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Axis]",
        "terseLabel": "Class of Financing Receivable [Axis]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": {
     "auth_ref": [
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Domain]",
        "terseLabel": "Class of Financing Receivable [Domain]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancingReceivableSignificantSales": {
     "auth_ref": [
      "r241",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease from sale and reclassification to held-for-sale of financing receivable.",
        "label": "Financing Receivable, Sale",
        "negatedTerseLabel": "Expected loan losses related to loans sold and repaid"
       }
      }
     },
     "localname": "FinancingReceivableSignificantSales",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount": {
     "auth_ref": [
      "r245",
      "r250",
      "r251"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized loan commitment, origination, and other fees (costs) and purchase premium (discount) on financing receivable. Excludes financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, Unamortized Loan Fee (Cost) and Purchase Premium (Discount)",
        "terseLabel": "Unamortized discounts, fees, and costs"
       }
      }
     },
     "localname": "FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r291",
      "r587"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross intangible lease assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r291",
      "r583"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesIntangiblesLeaseAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForwardContractIndexedToIssuersEquityForwardRate": {
     "auth_ref": [
      "r379",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share price of the Company's stock at which the contract holder of the freestanding contract has the right to purchase or sell the Company's stock at a future date.",
        "label": "Forward Contract Indexed to Issuer's Equity, Forward Rate Per Share",
        "terseLabel": "Forward equity sales agreement, initial net price (in usd per share)"
       }
      }
     },
     "localname": "ForwardContractIndexedToIssuersEquityForwardRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares as a settlement alternative for each freestanding forward contract.",
        "label": "Forward Contract Indexed to Equity, Settlement, Number of Shares",
        "terseLabel": "Share settlement (in shares)"
       }
      }
     },
     "localname": "ForwardContractIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ForwardContractIndexedToIssuersEquityShares": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.",
        "label": "Forward Contract Indexed to Issuer's Equity, Shares",
        "terseLabel": "Maximum shares issuable under forward equity sales agreement (in shares)"
       }
      }
     },
     "localname": "ForwardContractIndexedToIssuersEquityShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "negatedLabel": "Loss (gain) on sales of real estate, net"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfNotesReceivable": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale of financing receivable.",
        "label": "Gain (Loss) on Sale of Financing Receivable",
        "terseLabel": "Gain on sale of direct financing lease",
        "verboseLabel": "Gain (loss) on sale of financing receivable"
       }
      }
     },
     "localname": "GainLossOnSaleOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r136",
      "r376",
      "r377"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss (gain) on debt extinguishments",
        "negatedTerseLabel": "Loss on extinguishment of debt",
        "terseLabel": "Gain (loss) on debt extinguishments",
        "verboseLabel": "Gain (loss) on debt extinguishments"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": {
     "auth_ref": [
      "r104",
      "r105",
      "r136",
      "r602",
      "r640",
      "r642",
      "r643",
      "r644"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.",
        "label": "Gains (Losses) on Sales of Investment Real Estate",
        "terseLabel": "Gain (loss) on sales of real estate, net"
       }
      }
     },
     "localname": "GainsLossesOnSalesOfInvestmentRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedLabel": "General and administrative",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r486",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "auth_ref": [
      "r254",
      "r255",
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Fair Value",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfRealEstate": {
     "auth_ref": [
      "r136",
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value.",
        "label": "Impairment of Real Estate",
        "terseLabel": "Impairment of real estate"
       }
      }
     },
     "localname": "ImpairmentOfRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r108",
      "r137",
      "r165",
      "r166",
      "r168",
      "r169",
      "r186",
      "r190",
      "r456"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "peak_NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to Healthpeak Properties, Inc."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": {
     "auth_ref": [
      "r454",
      "r457"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Noncontrolling interests' share in continuing operations",
        "negatedTerseLabel": "Noncontrolling interests\u2019 share in continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r216",
      "r222",
      "r226",
      "r229",
      "r232"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r150",
      "r160",
      "r216",
      "r222",
      "r226",
      "r229",
      "r232",
      "r259",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r457",
      "r514",
      "r524"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from continuing operations",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r93",
      "r103",
      "r160",
      "r165",
      "r166",
      "r168",
      "r169",
      "r179",
      "r188",
      "r189",
      "r514",
      "r599",
      "r603",
      "r609",
      "r632"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r93",
      "r103",
      "r160",
      "r165",
      "r166",
      "r168",
      "r169",
      "r179",
      "r188",
      "r189",
      "r190",
      "r514",
      "r609",
      "r632",
      "r635",
      "r639"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r15",
      "r18",
      "r31",
      "r34",
      "r452",
      "r633"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r15",
      "r18",
      "r26",
      "r31",
      "r454",
      "r457"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Noncontrolling interests\u2019 share in discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r97",
      "r103",
      "r183",
      "r188",
      "r189",
      "r609",
      "r633",
      "r635",
      "r639"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r183",
      "r188",
      "r189",
      "r479"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r96",
      "r136",
      "r213",
      "r256",
      "r601",
      "r631"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity income (loss) from unconsolidated joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r6",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r29",
      "r32",
      "r33",
      "r34",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsScheduleofResultsofDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r298",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r151",
      "r173",
      "r174",
      "r214",
      "r444",
      "r449",
      "r450",
      "r641"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "negatedTerseLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid (refunded)"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Increase (decrease) in accounts payable, accrued liabilities, and deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables, and operating assets classified as other.",
        "label": "Increase (Decrease) in Accounts Receivable and Other Operating Assets",
        "negatedLabel": "Decrease (increase) in accounts receivable and other assets, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFinanceReceivables": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in outstanding loans including accrued interest.",
        "label": "Increase (Decrease) in Finance Receivables",
        "negatedTerseLabel": "Decrease in financing receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements": {
     "auth_ref": [
      "r184",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shared included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity forward arrangements using the reverse treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements",
        "terseLabel": "Dilutive potential common shares - forward equity agreements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToEquityForwardAgreements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r190"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive potential common shares - equity awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndemnificationGuaranteeMember": {
     "auth_ref": [
      "r319",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.",
        "label": "Indemnification Agreement [Member]",
        "terseLabel": "Indemnification Agreement"
       }
      }
     },
     "localname": "IndemnificationGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuredEventGainLoss": {
     "auth_ref": [
      "r317"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess (deficiency) of insurance recovery over the loss incurred from an insured event.",
        "label": "Insured Event, Gain (Loss)",
        "negatedLabel": "Casualty-related loss (recoveries), net"
       }
      }
     },
     "localname": "InsuredEventGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r285",
      "r289"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest and Other Income [Abstract]",
        "terseLabel": "Interest and Other Income [Abstract]"
       }
      }
     },
     "localname": "InterestAndOtherIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r94",
      "r210",
      "r542",
      "r546",
      "r610"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOperating": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.",
        "label": "Interest Income, Operating",
        "terseLabel": "Interest income",
        "verboseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r129",
      "r133",
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid, net of capitalized interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r597",
      "r629"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all derivative assets not designated as hedging instruments.",
        "label": "Interest Rate Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest-rate Swap Contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentBuildingAndBuildingImprovements": {
     "auth_ref": [
      "r627"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.",
        "label": "Investment Building and Building Improvements",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "InvestmentBuildingAndBuildingImprovements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investment [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in and advances to unconsolidated joint ventures",
        "totalLabel": "Investments in and advances to unconsolidated joint ventures"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r38",
      "r56"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount lessor expects from underlying asset following end of direct financing lease term.",
        "label": "Lessor, Direct Financing Lease, Assumptions and Judgments, Value of Underlying Asset, Amount",
        "terseLabel": "Net investment in direct financing leases"
       }
      }
     },
     "localname": "LessorDirectFinancingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorDirectFinancingLeasesTextBlock": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's direct financing leases.",
        "label": "Lessor, Direct Financing Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorDirectFinancingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r61",
      "r150",
      "r224",
      "r259",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r461",
      "r466",
      "r467",
      "r524",
      "r566",
      "r567"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r53",
      "r150",
      "r259",
      "r524",
      "r568",
      "r594",
      "r624"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r5",
      "r6",
      "r28",
      "r30",
      "r34",
      "r299"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities related to assets held for sale and discontinued operations, net",
        "totalLabel": "Total liabilities of discontinued operations, net"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r44",
      "r592",
      "r615"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "netLabel": "Balance outstanding",
        "terseLabel": "Bank line of credit and commercial paper",
        "verboseLabel": "Bank line of credit and commercial paper"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Debt instrument, facility fee (as a percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Bank Line\u00a0of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Loans Receivable"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LoansReceivableFairValueDisclosure": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of loan receivable, including, but not limited to, mortgage loans held for investment, finance receivables held for investment, policy loans on insurance contracts.",
        "label": "Loans Receivable, Fair Value Disclosure",
        "terseLabel": "Loans receivable, net"
       }
      }
     },
     "localname": "LoansReceivableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r44",
      "r356",
      "r371",
      "r372",
      "r373",
      "r592",
      "r620"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r154",
      "r324",
      "r361"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r154",
      "r324",
      "r361"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r154",
      "r324",
      "r361"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r154",
      "r324",
      "r361"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r63",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails",
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MajorPropertyClassAxis": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of property owned but leased or available for lease to third parties, by major property class.",
        "label": "Major Property Class [Axis]",
        "terseLabel": "Major Property Class [Axis]"
       }
      }
     },
     "localname": "MajorPropertyClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MajorPropertyClassDomain": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major classes of assets leased or available for lease to third parties under operating lease agreements as of the balance sheet date.",
        "label": "Major Property Class [Domain]",
        "terseLabel": "Major Property Class [Domain]"
       }
      }
     },
     "localname": "MajorPropertyClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r70",
      "r150",
      "r259",
      "r327",
      "r332",
      "r333",
      "r334",
      "r340",
      "r341",
      "r524",
      "r593",
      "r623"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "totalLabel": "Total noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r411"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestInJointVentures": {
     "auth_ref": [
      "r455"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_MinorityInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of the equity interests owned by noncontrolling shareholders, partners, or other equity holders in joint ventures included in the entity's consolidated financial statements.",
        "label": "Noncontrolling Interest in Joint Ventures",
        "terseLabel": "Joint venture partners"
       }
      }
     },
     "localname": "MinorityInterestInJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestInPreferredUnitHolders": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_MinorityInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of the equity interests owned by noncontrolling preferred unit holders in an entity included in the reporting entity's consolidated financial statements.",
        "label": "Noncontrolling Interest in Preferred Unit Holders",
        "terseLabel": "Non-managing member unitholders"
       }
      }
     },
     "localname": "MinorityInterestInPreferredUnitHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due the Company for loans secured by the collateral of specified real estate property and which loan the borrower (debtor) is obligated to repay in accordance with a predetermined set of payments.",
        "label": "Mortgage Receivable [Member]",
        "verboseLabel": "Secured Mortgage Loans"
       }
      }
     },
     "localname": "MortgageReceivablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/Business"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "terseLabel": "Net cash provided by financing activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r132",
      "r134",
      "r137"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r34",
      "r83",
      "r86",
      "r91",
      "r98",
      "r137",
      "r150",
      "r160",
      "r165",
      "r166",
      "r168",
      "r169",
      "r173",
      "r174",
      "r186",
      "r216",
      "r222",
      "r226",
      "r229",
      "r232",
      "r259",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r514",
      "r524",
      "r604",
      "r634"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to Healthpeak Properties, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r165",
      "r166",
      "r168",
      "r169",
      "r176",
      "r177",
      "r187",
      "r190",
      "r216",
      "r222",
      "r226",
      "r229",
      "r232"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income (loss) applicable to common shares"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r383",
      "r463",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r168",
      "r175",
      "r194",
      "r252",
      "r253",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r326",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r445",
      "r446",
      "r447",
      "r448",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r564",
      "r584",
      "r585",
      "r586",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to nonredeemable noncontrolling shareholder, unit holder, partner, or other equity holder of a joint venture.",
        "label": "Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Nonredeemable",
        "negatedTerseLabel": "Plus: Noncontrolling interests\u2019 share of consolidated joint venture NOI"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r411",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Total Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r482",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of interest-rate contracts held"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfRealEstateProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of real estate properties owned as of the balance sheet date.",
        "label": "Number of Real Estate Properties",
        "terseLabel": "Property count"
       }
      }
     },
     "localname": "NumberOfRealEstateProperties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffMarketLeaseUnfavorable": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a liability associated with the acquisition of an off-market lease when the terms of the lease are unfavorable to the market terms for the lease at the date of acquisition.",
        "label": "Off-market Lease, Unfavorable",
        "terseLabel": "Intangible liabilities, net"
       }
      }
     },
     "localname": "OffMarketLeaseUnfavorable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 4.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTerseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r197",
      "r555",
      "r561"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Rental and related revenues"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": {
     "auth_ref": [
      "r197",
      "r559"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income, Lease Payments",
        "terseLabel": "Fixed income from operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r551"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use asset",
        "verboseLabel": "Right-of-use asset, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseVariableLeaseIncome": {
     "auth_ref": [
      "r197",
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from variable lease payments paid and payable to lessor, excluding amount included in measurement of lease receivable.",
        "label": "Operating Lease, Variable Lease Income",
        "terseLabel": "Variable income from operating leases"
       }
      }
     },
     "localname": "OperatingLeaseVariableLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessor's operating leases.",
        "label": "Lessor, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "OperatingLeasesOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "verboseLabel": "Operating Segment"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "Other Accounts Payable and Accrued Liabilities",
        "terseLabel": "Other accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r40",
      "r589",
      "r617"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 11.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r76",
      "r79"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Net unrealized gains (losses) on derivatives"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r79",
      "r82"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassification adjustment realized in net income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r84",
      "r87",
      "r89",
      "r90",
      "r92",
      "r99",
      "r404",
      "r534",
      "r539",
      "r540",
      "r605",
      "r635"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r77",
      "r79"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Change in Supplemental Executive Retirement Plan obligation and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r111",
      "r136",
      "r296"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization of real estate, in-place lease, and other intangibles"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Government grant income recorded in other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonrecurringExpense": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expense that is infrequent in occurrence or unusual in nature.",
        "label": "Other Nonrecurring Expense",
        "terseLabel": "Expense on other"
       }
      }
     },
     "localname": "OtherNonrecurringExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForLeasingCostsCommissionsAndTenantImprovements": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy; for costs that are essential to originating the lease and would not otherwise have been incurred without the lease agreement, including but not limited to, evaluating the lessee's credit condition, guarantees, and collateral and costs incurred in negotiating, processing, and executing the lease agreement; and for any commission(s) incurred.",
        "label": "Payments for Leasing Costs, Commissions, and Tenant Improvements",
        "negatedLabel": "Leasing costs, tenant improvements, and recurring capital expenditures",
        "terseLabel": "Leasing costs, tenant improvements, and recurring capital expenditures"
       }
      }
     },
     "localname": "PaymentsForLeasingCostsCommissionsAndTenantImprovements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "terseLabel": "Payments for repurchase of redeemable noncontrolling interest"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedLabel": "Payments for debt extinguishment and deferred financing costs"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "verboseLabel": "Payments to acquire equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireFinanceReceivables": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the purchase of amounts due from customers, clients, lessees, borrowers, or others under the terms of its agreements therewith.",
        "label": "Payments to Acquire Finance Receivables",
        "terseLabel": "Payments to acquire finance receivables"
       }
      }
     },
     "localname": "PaymentsToAcquireFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedLabel": "Contributions to unconsolidated joint ventures"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLand": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner.",
        "label": "Payments to Acquire Land",
        "terseLabel": "Payments to acquire land"
       }
      }
     },
     "localname": "PaymentsToAcquireLand",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherRealEstate": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of other real estate investments held by the entity for investment purposes not otherwise defined in the taxonomy.",
        "label": "Payments to Acquire Other Real Estate",
        "negatedLabel": "Acquisitions of real estate"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireRealEstate": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.",
        "label": "Payments to Acquire Real Estate",
        "terseLabel": "Payments to acquire real estate"
       }
      }
     },
     "localname": "PaymentsToAcquireRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopRealEstateAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.",
        "label": "Payments to Develop Real Estate Assets",
        "negatedLabel": "Development, redevelopment, and other major improvements of real estate",
        "terseLabel": "Development, redevelopment, and other major improvements of real estate"
       }
      }
     },
     "localname": "PaymentsToDevelopRealEstateAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Distributions to and purchase of noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformingFinancingReceivableMember": {
     "auth_ref": [
      "r243",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category status of financial instruments in which payments are received or paid on a timely basis in accordance with the terms of the contract. Financial instruments include, but are not limited to, financing receivables, loans, debt instruments, and investments.",
        "label": "Performing Financial Instruments [Member]",
        "terseLabel": "Performing loans"
       }
      }
     },
     "localname": "PerformingFinancingReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromCollectionOfFinanceReceivables": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the collection of receivables arising from the financing of goods and services.",
        "label": "Proceeds from Collection of Finance Receivables",
        "terseLabel": "Principal repayments received"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfLoansReceivable": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.",
        "label": "Proceeds from Collection of Loans Receivable",
        "terseLabel": "Proceeds from the collection of loans receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfLoansReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Issuance of common stock and exercise of options, net of offering costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r123",
      "r149"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under bank line of credit and commercial paper"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Contributions from and issuance of noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfFinanceReceivables": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale or collection of receivables arising from the financing of goods and services.",
        "label": "Proceeds from Sale and Collection of Finance Receivables",
        "verboseLabel": "Proceeds from sales/principal repayments on loans receivable and direct financing leases"
       }
      }
     },
     "localname": "ProceedsFromSaleAndCollectionOfFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfBuildings": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sale of buildings.",
        "label": "Proceeds from Sale of Buildings",
        "terseLabel": "Proceeds from sale of property",
        "verboseLabel": "Proceeds from sale of buildings"
       }
      }
     },
     "localname": "ProceedsFromSaleOfBuildings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfFinanceReceivables": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of receivables arising from the financing of goods and services.",
        "label": "Proceeds from Sale of Finance Receivables",
        "terseLabel": "Proceeds from sale of receivables"
       }
      }
     },
     "localname": "ProceedsFromSaleOfFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfLeaseReceivables": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of receivables arising from the lease of real estate, equipment or other fixed assets for a specified time in exchange for payment, usually in the form of rent; excludes proceeds from sales-type lease transactions, which are classified as operating activities.",
        "label": "Proceeds from Sale of Lease Receivables",
        "terseLabel": "Proceeds from sale of lease receivable"
       }
      }
     },
     "localname": "ProceedsFromSaleOfLeaseReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.",
        "label": "Proceeds from Sale of Real Estate Held-for-investment",
        "terseLabel": "Proceeds from sales of real estate, net"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r34",
      "r83",
      "r86",
      "r91",
      "r130",
      "r150",
      "r160",
      "r173",
      "r174",
      "r216",
      "r222",
      "r226",
      "r229",
      "r232",
      "r259",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r457",
      "r462",
      "r464",
      "r477",
      "r478",
      "r514",
      "r524",
      "r611"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForLoanLossesExpensed": {
     "auth_ref": [
      "r271",
      "r600"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable.",
        "label": "Financing Receivable, Credit Loss, Expense (Reversal)",
        "terseLabel": "Provision for expected loan losses"
       }
      }
     },
     "localname": "ProvisionForLoanLossesExpensed",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Abstract]",
        "terseLabel": "Real Estate [Abstract]"
       }
      }
     },
     "localname": "RealEstateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstateDisclosureTextBlock": {
     "auth_ref": [
      "r691",
      "r692",
      "r693",
      "r695",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures.",
        "label": "Real Estate Disclosure [Text Block]",
        "terseLabel": "Real Estate Transactions"
       }
      }
     },
     "localname": "RealEstateDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": {
     "auth_ref": [
      "r626"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes.",
        "label": "Real Estate Investment Property, Accumulated Depreciation",
        "negatedLabel": "Accumulated depreciation and amortization",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyNet": {
     "auth_ref": [
      "r627"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.",
        "label": "Real Estate Investment Property, Net",
        "totalLabel": "Net real estate"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateInvestmentPropertyNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate Investment Property, Net [Abstract]",
        "terseLabel": "Real estate:"
       }
      }
     },
     "localname": "RealEstateInvestmentPropertyNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "peak_LiabilitiesRelatedToAssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For banks, amount of all liabilities for which a financial institution is required to include in its calculation of net investment in real estate assets held for development or sale.",
        "label": "Real Estate Liabilities Associated with Assets Held for Development and Sale",
        "terseLabel": "Liabilities related to assets held for sale, net"
       }
      }
     },
     "localname": "RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Real Estate [Line Items]",
        "terseLabel": "Real Estate [Line Items]"
       }
      }
     },
     "localname": "RealEstateLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealEstateTable": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about real estate investment companies including, but not limited to, real estate investment trusts, real estate owned, retail land sales, and time share transactions.",
        "label": "Real Estate [Table]",
        "terseLabel": "Real Estate [Table]"
       }
      }
     },
     "localname": "RealEstateTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r381",
      "r382",
      "r384",
      "r385"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfBankDebt": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to settle a bank borrowing during the year.",
        "label": "Repayments of Bank Debt",
        "negatedLabel": "Repayments and repurchase of debt, excluding bank line of credit and commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfBankDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r126",
      "r149"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayments under bank line of credit and commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "terseLabel": "Repayment of 2019 term loan"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "terseLabel": "Repayments of secured debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r39",
      "r138",
      "r143",
      "r588",
      "r621"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r37",
      "r39",
      "r138",
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r207",
      "r208",
      "r221",
      "r227",
      "r228",
      "r235",
      "r236",
      "r239",
      "r415",
      "r416",
      "r582"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Resident fees and services"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r95",
      "r150",
      "r207",
      "r208",
      "r221",
      "r227",
      "r228",
      "r235",
      "r236",
      "r239",
      "r259",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r336",
      "r338",
      "r340",
      "r341",
      "r524",
      "r611"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "peak_AdjustedNetOperatingIncomeFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r553",
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "verboseLabel": "Increase in ROU asset in exchange for new lease liability related to operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivablebyOriginationYearDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Loans Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/AccountsPayableAccruedLiabilitiesandOtherLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r81",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r63",
      "r154",
      "r372",
      "r374",
      "r405",
      "r408",
      "r409",
      "r410",
      "r544",
      "r545",
      "r549",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Senior Notes Issuances"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r480",
      "r483",
      "r484",
      "r486",
      "r487",
      "r492",
      "r493",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r6",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r29",
      "r32",
      "r33",
      "r34",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Summary of Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EarningsPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r34",
      "r150",
      "r258",
      "r259",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": {
     "auth_ref": [
      "r273",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about allowance for credit loss on financing receivable.",
        "label": "Financing Receivable, Allowance for Credit Loss [Table]",
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Table]"
       }
      }
     },
     "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/LoansReceivableScheduleofLoansReceivableDetails",
      "http://www.healthpeak.com/role/LoansReceivableScheduleofReserveforLoanLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r286",
      "r290",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r286",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Lease Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/IntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Summary of Debt Maturities and Schedule Principal Repayments"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r216",
      "r219",
      "r225",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r216",
      "r219",
      "r225",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Financial Information of Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r67",
      "r147",
      "r199",
      "r200",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r397",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r460",
      "r461",
      "r466",
      "r467",
      "r468",
      "r470",
      "r472",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r468",
      "r470",
      "r472",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r44",
      "r592",
      "r620"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Mortgage debt",
        "verboseLabel": "Mortgage debt"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Mortgage Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentContinuingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity expected to operate in the foreseeable future.",
        "label": "Continuing Operations [Member]",
        "terseLabel": "Continuing Operations"
       }
      }
     },
     "localname": "SegmentContinuingOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "auth_ref": [
      "r7",
      "r9",
      "r10",
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations [Member]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "SegmentDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r204",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r239",
      "r305",
      "r306",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r216",
      "r220",
      "r226",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r238",
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Disclosures"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Disclosure"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]",
        "terseLabel": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Amortization of stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r41",
      "r568",
      "r591",
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtCommercialPaperProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r145",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r19",
      "r204",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r239",
      "r284",
      "r300",
      "r305",
      "r306",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CommitmentsandContingenciesDetails",
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsAssetsandLiabilitiesforDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/InvestmentsinandAdvancestoUnconsolidatedJointVenturesDetails",
      "http://www.healthpeak.com/role/LoansReceivableNarrativeDetails",
      "http://www.healthpeak.com/role/RealEstateTransactionsRealEstateInvestmentsDetails",
      "http://www.healthpeak.com/role/SegmentDisclosuresSummaryInformationfortheReportableSegmentsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r45",
      "r46",
      "r47",
      "r147",
      "r150",
      "r179",
      "r183",
      "r185",
      "r188",
      "r190",
      "r199",
      "r200",
      "r201",
      "r259",
      "r327",
      "r332",
      "r333",
      "r334",
      "r340",
      "r341",
      "r388",
      "r389",
      "r393",
      "r397",
      "r404",
      "r524",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r68",
      "r89",
      "r90",
      "r91",
      "r156",
      "r157",
      "r158",
      "r161",
      "r171",
      "r174",
      "r198",
      "r265",
      "r404",
      "r411",
      "r438",
      "r439",
      "r440",
      "r447",
      "r448",
      "r512",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r540",
      "r651",
      "r652",
      "r653",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "verboseLabel": "Quarterly Financial Data"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSummaryofCashFlowInformationDiscontinuedOperationsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r198",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r46",
      "r47",
      "r404",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r46",
      "r47",
      "r404",
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r46",
      "r47",
      "r404",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r46",
      "r47",
      "r404",
      "r411"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockTransactionsParentheticalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Transactions, Parenthetical Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Parenthetical Disclosures"
       }
      }
     },
     "localname": "StockTransactionsParentheticalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r47",
      "r51",
      "r52",
      "r150",
      "r248",
      "r259",
      "r524",
      "r568"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r90",
      "r150",
      "r156",
      "r157",
      "r158",
      "r161",
      "r171",
      "r259",
      "r265",
      "r411",
      "r438",
      "r439",
      "r440",
      "r447",
      "r448",
      "r454",
      "r455",
      "r476",
      "r512",
      "r524",
      "r534",
      "r535",
      "r540",
      "r652",
      "r653",
      "r722"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "negatedLabel": "Cumulative effect adjustment",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS",
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r148",
      "r389",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity and Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StraightLineRent": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between actual rental income due and rental income recognized on a straight-line basis.",
        "label": "Straight Line Rent",
        "negatedLabel": "Straight-line rents"
       }
      }
     },
     "localname": "StraightLineRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r541",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r541",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r541",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtMortgageDebtDetails",
      "http://www.healthpeak.com/role/DerivativeFinancialInstrumentsNarrativeDetails",
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails",
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/EquityandRedeemableNoncontrollingInterestsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SupplementalCashFlowInformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r66",
      "r150",
      "r259",
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYANDREDEEMABLENONCONTROLLINGINTERESTS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebt": {
     "auth_ref": [
      "r44",
      "r592",
      "r620"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Unsecured Debt",
        "terseLabel": "Senior unsecured notes"
       }
      }
     },
     "localname": "UnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.healthpeak.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Senior Unsecured Note"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtDebtMaturitiesDetails",
      "http://www.healthpeak.com/role/DebtSeniorUnsecuredNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DispositionsofRealEstateandDiscontinuedOperationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Unusual or Infrequent Item, or Both [Line Items]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Line Items]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemTable": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Table]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Table]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/SummaryofSignificantAccountingPoliciesGovernmentGrantIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r469",
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "verboseLabel": "Maximum Loss Exposure and Carrying Amount"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails",
      "http://www.healthpeak.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Unconsolidated Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "VIE ownership percentage"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r460",
      "r461",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Consolidated Lessees VIE"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/VariableInterestEntitiesConsolidatedAssetsandLiabilitiesofVIEsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/DebtBankLineofCreditandTermLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r178",
      "r190"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r176",
      "r190"
     ],
     "calculation": {
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.healthpeak.com/role/EarningsPerCommonShareComputationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.healthpeak.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1060-107759"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1063-107759"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2366-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL77927221-108306"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5066-111524"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=6378536&loc=d3e10092-111533"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10152-111534"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267963-210447"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919232-210447"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921833-210448"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123398962&loc=d3e400-110220"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123389529&loc=d3e10037-110241"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e13051-110250"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107425-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(14)(d))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.10)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123605564&loc=d3e23415-158514"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123605564&loc=d3e23439-158514"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123605587&loc=d3e23528-158515"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=d3e9120-115832"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123366838&loc=d3e3073-115593"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 5))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "970",
   "URI": "http://asc.fasb.org/topic&trid=2156125"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "972",
   "URI": "http://asc.fasb.org/topic&trid=2134617"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "974",
   "URI": "http://asc.fasb.org/topic&trid=2156429"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "976",
   "URI": "http://asc.fasb.org/topic&trid=2134846"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "978",
   "URI": "http://asc.fasb.org/topic&trid=2134977"
  },
  "r698": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r699": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r701": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r702": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r703": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r704": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r705": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r706": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r707": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r708": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r709": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r710": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1404"
  },
  "r711": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1404"
  },
  "r712": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)"
  },
  "r713": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(2)"
  },
  "r714": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)"
  },
  "r715": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(4)"
  },
  "r716": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405"
  },
  "r717": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>101
<FILENAME>0001628280-22-012290-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-012290-xbrl.zip
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M()-Y "<DGQ#I%0L>%5NZ?JYYOQ:<ZNJW#\$M<BLP>_NKX%= 2*!UIF W\-&
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M;RVI%92AD:KQN"6_VP;03&Z/Q,@8C8U2$710SR3ZD*6H1Z4S8+'KVY2R?.;
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M-BQO\M]U"8.F3*^VC5@ &?*RUB?-_JO,Y?6F+DK9B>F^0S/W3;W<MM9^H!P
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M. _L@!SW@W8BN!.F=RH>"BI:@>)QANCS%,/5J.?*.'3'75G%R@PZ&^VA/MD
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ME5[VSHAOP:>#=6<$NX,DG,-_)ODT>OW_4$L#!!0    ( $:"I%3T:1G/3 @
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MP<K%V3D#.K%:GS?A Z3!W#[<Y*$+G0_>PBT^_9U@=SOY]$]02P,$%     @
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MP$)_#NP0D5+QC3:Z/QA/AF^&_=/)<'0)HS=P-1Y>]H=7I^]@\''0?S\9_C[
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M2;UPE8]Z-A_U=;(]UNEY_>#IX< +GQS[1FI]"]G!AHU10)"WC7:CGE#@)(&
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MQR=[[/=(^JA-7PCWG6(@*8>MO*%;C?N[=,$68<'=%!Q#SE#JIZ<\U5!^\BM
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MW,V #%$QF[V/5O( (HM2ASX$91*#%)02*S+\,!F("S4C Q<.4\P,HR![R6+
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MPAL:-L'E_=@U3E(!LQ@TI3"8)\NRXPQR<%X3-73@)I")@^D>R,QPL>+"#;G
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M&VLO=O\HRSP:+[>W7FYLEYT3?FULMI]^5TWO<^'V-9]FL[V^\3_U2C/Y03/
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M(BB$)ZP$924H\Q(4(?Y64$J&P! /L3\JZZ#+)DT];/SR8C J%=U6"E,#A2D
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M-=X?'*?W\&G$PS<7CL:3TNN53S#-Q=E/WHS-C.78N >Z#3O3,&A(P=^T/[]
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M;>+J.KK/ *#6 E#$OQ[TA(U>US>VDCL>^6M]Y)1ECA%"E9*>1<&T]\)&J6E
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MJZ+-D&JG^5V4NF>EVN$"!G8*^.<,_BFAPHGR"?_ #$4Y$QR!#<J \S2X*)%
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M91U4;L60_YT0PT/JORUGG&LI(U6.(!P9Y2IRPX3E6@9C':=61208D7]O5#D
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MAW&><R3^S,]\1@<E[/[8CN;-R< 76567K-J9$6KWFM@HB81D5"59Q5T$&X4
MXS5R1.?R>"B?5&ES59>J6E"+::E!/#</<P%Q_2">LHV\4RY$)< K[X%AY$#C
MD.&,C$Z<'#A.NS@3;55;D^MB_2QK@'TC' T3+JMZ;Y4]9 YSHX'3ZA<EW/YH
MR8>7IF&M[]<N34(AT]I.Q^VMS6BW:T@45'+@7!-@(03003,@PAH>B,;8)FK
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M;Q"@DM %K#Q&4:<%P6T^_J_E0V(]Q9/87.S7)F(+]AN._:F,/*NLH,:#=TX
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M"+8J;$^X (-# (69IOF\NI2^5F?@HK0C*L16B.U1)'0AMEJ(;2HGW@1A(I5
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M_KU 5Y:!+0.[6%<^@Y2O#]4/P;=,NBGS.9S9RJW!\7@T-OWJ,4JV5\GV6I#
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MT6")<<Q3X[ *U;D7]NS.O13^>!*E5OBCR?PQI?@BI83;1!UI<B'M(SXQB?3
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MTB,9I%LQA!GH.TA_QQX\"?Q<TX6C[AQ_*-4^J^,'?K''.P\A$L89\CQ7]^G
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M1&-^?/AQU>8HTY#63&W*2FG(H_7QUJ65S7+<*M!T"VA:,M=8&X5I% )Y@@-
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M*N)8!VO[V#JYL!T+GQ;#^_Y^['6[L5?QMU7@V(02#J$BM8HD%(L2#N88LL8
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M>B+$>489TA8##C -.,"P0!I3EU@R)$15<*#@P+WA0#EZ?@08F#UZ%D0YS$Q
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MU=$+8!; +(!9BJX_*<2<$U<AA$PTH,131#QXB[3T%$5%L:=!!I_/4Y=2=+T
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M">+U\GJB%1PH.%".U%<""&:.U#F3R3C-D+,:%()(#3+4,J0B5HZ28+@L0%"
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MX#*;7VH3E83&A$@@@"XL1&2,H0 V/N HO0B!K+UF@JU3>><JJ;<0OH_9'*6
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MA56D#I0'S30+'O;;),*<=;34T5CB[K\ES3=[%O0R S(D!P@JQ"WVR.&@$6P
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M '$M!]%+(@*V8M%K)4&FU3@(Y!C#FRS# NAS/('=1[.K(E+-'=>824&C@WT
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MC*U9;= J #Q'(W(Q-U7F-B!-)$-6*\\M]U&SD),>^+I1L^5??BF5[I\#<S^
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M<S4%Q9UUANF4'--@)GDSSD(D%PIS%G9:$7::/=#ESL N&:2\P8@3(9 ./"!
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M32Z:)JR.QRFMY,\G?C^MY*_?XHLD015F@B1-;0I<8@UD9251QNO@(BA,-SA
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MR&OI<_TX,+ P##%'@XQ""OA'=H(:MAK<^VR<H(WD6/7X:(,.EBY=)MV@)OK
MI:+(<0GP@%F.+#$.T +H!JFC >V06_91O$IE(PV++[^V5"3'")@ FBK..=->
M!.:!(+!EC"?;@(,58-_I]L<JY8;5'!F7.VY&EN=08(X<I9XYKFRBNJDM;<#!
M"XR0-N!@Z=)E$AQPJ[P5Q"!/' %PD(,+07DP/1CWDDCOHLJ^@U6#!Z^CJE0V
MJ1\O,4KZKC=L1ODM1:3-&AWMJ)->2N18R,WX,$8N8(*8!QL7?B\3]2N6;]YP
M]TL*DDYS=X-:[L7BT\6E1FAB"$-8>(RX5@F90#$*A#NB$QRJE&N;9)TQO*[)
MO9VF*\SD37GI"PJ5-H)CR8)C*E(JC.*2>H5(XH -A)-(6Y^0CEHI+$,$R;&V
M*<52(J4K+#9>%XO/=(;*F&M*G<&12RZQ<MH'0(0,>X8C$Z9QACX]_TY'2H4A
M@D=#D"A3NKF1".A4([#DE-2@ZZ-1V1G*[NVK:,I%&LFQ2I'2!APL7;A,^D*E
M9TG% '  4X-X4@YIP 4H:,=5(,$D(M8V*>?K@KYDH^)U\?AL=."PBS980Z+G
MSBC-7&!.T]R90ADR)^;1H(-'9>"I4*F(1&4;#:5$<AM>&I%E#%@Y.$:5%S82
MGM$!:8I)&\GQHD*E#3I8NG"91 ="&ZR3QLA0D>,*+,\"D1@%J8,%.]))S  =
MK%,JUAF3JR%A7DM%Z?XQZ%6;0+LVJ2 K'#$]C?;++.%VOI6/K@F-+E.&S9AC
M&HEDA,F0"^(3XM(Q9#A+R#/%D]98*>U>0X'9JV?C>X9&&S9^3#:>"G]&:J0R
M02 3%" 1BP5RU M$&,NIO=K(^"K*P)LZT=4+?MY%-#2FRKWDPU24TRHE([<*
M*2P$@E-D2"L)0H(D10-V(I1ND'6ZG#CG"DN(U\7-,SV95H'A2J(!HO!<4V]C
M2(0D[(CW/&':>#*?GH.GXYP$U+L6C*! LK.!$8UT3GA*P+Y*<"&QC]F3>?_.
M54W11R,Y'B#.N2@.:%3][03%I%<R1)%4< 01(3GBT;G*I+=$L^!D]-KFA AY
M;W]DH^57A%=G-[_5."4?H]:.<8(!P(O$HQ0>@SU/C&^T_ HP[U2\4C(;F?0,
MJ0A_< !D2),4D=&>!TP]I]&L;8H-<^]X9:/E&\GQ /'*QMI_ BDR-3R<<\9H
M],AC'A%WBB.K#$9>&BR]QXH$-C+W5PL(O((BSMF;^]A)%Z[7#[&/!KW3-_FL
MBEZG'5JC=W_1$FY9-9[CN.A7V^^?PYYMG<!F#YI QQ)$V]Z,":%8T,@U,4@1
MJP ?$0?XB"04<%0\6L5M;N"]W%+.A5GE&65KOF+V7U(1Z.+LW\";>\F Z5I/
M[7,?"HRP2@EQ+CQR+CCDHHK),2L<H<NO]7QV4N")"D%?KV195I5H(UD>2;),
MA4F3D\HX')'#6@.ZD!098B)*4MLH66+"^;5-OJZ6TSCW^4N6I[U'(XT>H2RM
MD4:/)(UF59]1RB0GB"6>BU=R<B;!'D7IG!6!^FC(VB;C>MWH956W-L*H$4:K
MYU5NA-%C"Z-IGS(F D=ED14 BSA3!EF/.2)2>Z8YTV!4KVW*=?A@76/Z7,31
M*ZB$^6&[7?C,(<6/ZZW3?CQI#T]:MAN T]P 7KH8%.NM;APT<;5GYW7^"S[L
MP79\CV%TR']4![P;&R?T4F3AC*%KA#LA-%?(1I% % :'C,J1>JZ#HE)A%LEK
MR+9_]3S](*[DAJ<?@:>GG,H.[&6BG$0R:HRXR)T^@J/(!683(]2;W.GCY?-T
M4T&S**IZ<L_P+01%8PW=2UI,.8HYD2SDO#S,G$)<&X%TM!P)9;6/AC.NY-HF
M%^N&3Z?C__BRY,33WN-%RI9'<?,6\);P4R-C5D/&3+M_O12)P>DBIU,>Q& \
MLIX")/%).L.)D]+D.+=:E9*?E142C:!9 HAY&!]N(V >3<!,N72#LE(2;)'%
M3")NHD$VD@3R)CJ3-);!@X#A?!V.=350S W>VN69+,V5S96/<V5#TLV5+^S*
M^Q9Q/$2<?L% 8Z5NWC#03Z$W=)UX$6R\7_!^U6*"_^>.@=AE[,]*(^(G'A;6
M^/>7 '9W]M\/IJQIAU/ N;^=8LDC+J) CB>.  1SRF,*.MH'JAQ9 M,\<;95
M(ST;Z;FBP=/YTK/Q%]Q/A$XU)R"*JN2U14HEB[A-&EGKX0_#/4[<Y)GR#U9X
M\_R%Z$,@\D8P-X)Y1<N8&L'\4()Y;U(P8\>\)2")&14$<3@DI%WP"&MLK+)6
M!\-RW9(4?!V+936B?\F"N?%1/+W,:H3YZE2!-<+\P1P5^?]_E@+];/<[K.7H
MT$5FO#($40E"G">+D>,\(0<6DC2&I>#IVB83>%TU*+L1YHTP?R7"_"%F237"
M?+G"_&!2F#/-G!%:(XT=1IP*@;2E@-(E%D%9%IRU9=T<$^M"+[EN[@G%>1D$
M_&E@X:'P=VA_W?PW_#%:^(GM'[6[H_5)X)3Z-WE!<ER4?1X6@W8Z7S9[Z@GV
M5)/L23-['B[VGXOSF7S1>BM1EL=OB)[Y9M6OVMT0NX,W*%_TT.\Z)8K*=_V!
M7"3U//K3?Q[;*+TARUWXM7=R$ON^;3NM/^QI[+?^Z/>.^O:D!>3;[YW!]47+
M]F,K\T$!I',:0\N=MP;'L?4Q?NUUOL(5K7?6MSOMP?E&:ZMH%4-_O%Y> />&
MESQO 0'[8<<.X$7RKZLUPGTLD+<]BJU^/+'M;K[1 &1FJY=:[4'16F1EPZ+\
M%MSTI&Z"V0KPG'R+>2M\&71$5XV.WJ8409Q^C:UVW;^XU2]/'!1N/HHB=MN]
M/NC>(OIA'PZ_V\N?]FT7""#U>R>MVS5?#D2(Q+P,1#/N03GK%)F,W&DLA&"V
M:;X\K:P[\3\?SS_]$T[!1I6[GW>^??KLSP_HA_.#SW#?[;_.=W][>[[W#RCK
M_9VS[/;:V__8WMD_3OGGW:/#J'V '6=(@!H%]9H(,BP;44H[*:R-.*2U3;(A
MIK.E_]4:]&YYPDP&ZJV4TCC!/:/6PO^"Y,$9XQB>$[YJ3OBN)_P=H!3P4=!"
M!!2MD& 71XX,U0)Q9J-V5G#-!$"I6<VQ_]4Z:P^.6W9:O,?9HB$+Z=M1Q-W\
MYGP6/?Q3+W*K6N-5HGC51,"!S17142EJD9<V(8YSTK(7%"GG?,24X63*B<YL
MNB/.O\JN!S-HX$(]7Q[Z+K!CO^TGO&EP=TL(MYIC3EPTA$5I,9;>!2<5/MPN
MCYA@D#H79WVE+_8XKT^<\JA1]IA%!CK0OPG#_GFT_5=WWO#9UF'"*9ED@-]#
M+LSU#.PG1ATBW! +8EU)"6)=C0Z[/K?-5MZQXJ4 *O;< %6NZ3C*K%7V&+DS
MCA*<$VEH $[#W).DM9))$BJ=8Q[ 5:-EE\MP6<!2'P,/22&K#3"<$A%99Q42
MD4=0:4JZ1-8VZ8::]E7< 4<%D]ME**\851P[9Q@A0FOC@B1:.-Z<\')/6 ".
MTL(**B-!23,#*C0(Y+S(P\MCT#IQICF?,V3D$7#4W4)6#8Y:G A@7=E< L3$
M H'SSR,A*9A+E@=0LS* &:4<"=25.&HZ7>#>. K#,0+7\P2$R(E@CG'+A&.4
M<*QI$@V.6NYY<\!1*D8.V%BA@#W@YJ03TC@$A '#<D^MB5BO;?(Y.&H<1DU<
M4_X['W"[.[0EA91 J]SE9%E(B4MMB>!&!*><4![L\6!QB(H?2KXVWS]<NJ?I
M\F$7P0LY?W?W]M^V"-ZH?/"U)_X:NO9 LR ^A0;"YM()HZ(%R<J<3EARJJZA
MZY'8RG[%]B"3=;'5#;^6FWH4N[X=BUP?V^D5PW[<AR?^TNGY+T],RKN_UJ1\
M\I8??/YTLK-_Q'>VOU!XWO>#[T=BY^3O#I ?V?OG_;>]?P[HP3^[QY.D?+!_
MW-X].?BVMWUTMK?_Z61W>_?SWO87^#R':OX20/[BT^=/QP?T7=K9]VSGPR$G
MH*8<IL@[QT%T*9Q[OR?DB:>&*AHMLY52 8($N9!% )CB*6*E98B:4VQ<E-0P
M0):$>X"]8:T502&<PDF 5(F5Y[D^AU+:C9W$- /,,3*ND+&8%]0H0R07 9TJ
M+ ,$WK&G17PS^N'G4?YGNUN2:?FEG\>C*/D)$R&9\H'5QS^?M</@. <=-W 5
M>*PKM.HGUQ]OE!]-A)FJSXS>,'C^QWB#_&LL^#/HCRZHF4J4C#PGOCX6L*)S
M0U)C8?89,:8)253QQXV'OWALBCRD,"KO^*8]@,/S"YB%_XU'.?S0[_D8\^84
MB]#AXP37I@3L[#=XETW" =PQ&P[Y[_'03!MXKW5J^X HX/-.^;JGEZ^[WNK8
MLV+8KEFT!U_MMWS'MD]R*,<.6K;?+C(>+6\*!-;NVOXY4-^P7UQ$8>IGE84_
MZN>BY7+4)A;%1FM_?"7='MSP+$>;X)OY=U/K@4>,/;X]:+G8:<>OL&$G]KQU
M##AI'98#!],.0]OIG.=O#.R7""OL'<6\_G5X8P ML)UP;QN GXL1MA[9UI,K
M3O!:W3(2!90?VIGLUUN <X<=V!A8:^\4<%'^+6Q87J$MCENITSL;?\6+VYT"
MW_GRC6'/X[?3V(455.]:]@IMV3)0=EX&WMI=/^SW8]BXB?3F1GI7@9LP UK<
M[IUU/[Y]OU\1TUY)3'\ [77A"([;IS<R5_V&&:ZL#H.][V:BZ,;*\"IMMTQ"
M%3+.OP+Z\* S+#!)IPT:#]!\IVU=&8Z$KV;2 (77^B&3!\4_7VQ2^6_R\X_K
MK9.8C;B*PK/H[;?=$.P^>WK:!^LLF]Y C$ \8'AE>Q"(RK9&M\F\&;_YX\H_
M!,1Y\4&V$2L"!>J[N&TFXI+N0!$#46<.&MAO*,04,Q6N@]*H6"^_)#P?7?UF
MZRB_93]VRC5E@5->E-EC<,'A<+O+#ZM7VVC]IW<&3 R\V0;.O_*28>SK^;[]
MK+8N8M"CMZFDVO"RU<F<M95+C]_:)9=5+S$*&!=@K.:'%*>PJ2FK>'AW^*/G
MR[?))#NV],N;=X]&1[31 G(XR:*KEGT7ISDN=H^!PV-I*X=LS/>RR(HGW?*Q
MY6+M43_&"AO5)-4KX@4AG!WWQO;H*B5<[E>W7NAH#1NMO^ I_?R[4F;/>V)U
M")?O,(_.KJZ@/H[1 O,VSCBE3(PV[V()R 9]8#M[R3?EA_7NYP!QZ;K(BR@-
MI/$-/&MW.K"8]HDK-4VYS%*$PQ='B\C47K)B#)F2RQ.L5@XRM9<U(AQG%K9%
MKWZ["^Z]AGA&%#)!'O5>3RP"*++>\5;I&NG",CX"H0-HAE<)\8+K3T!%(3A6
MV)93>UX>PXC_1RPZXY+\(ITAW*;<U-91OU<4:'B::>!KNX!UC[Y[#7EEE9F5
M4+O68&4.1JU>*Z_RX+C?&QX=M\":,EE#PL-Z(/*O]3N-J'"R))&;0$T>(N4Q
M=UP;8PGS-I!$"+78W>B++)T3OUXYF;WT1_VHW9)>+OX-,O7" X5?GQ5'=HX.
MDX2=I%PC00Q%7&FPXBB5",QG2D2B)$6]MDFGPW@C(0)[>$U\9U4A[U:H(%KF
MT'&I 6(HX]W;>4N3#-8+%6@PF,>8=!!!>!ED$!)C-<=_3B?=#F__%V#T^0Y
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MQ'A+J"-:ZEH%<*K1Z(<;\I)R(+'7+?7"Q3F.'KY=O\?JN (>62V S?;]D"5
M'E08,/\915PKAYP)$E$)'*VPUTSIM4V\P::;$+=RY4V1M[**9?ARLX&F8;<G
M"*+TR;ELP8 L@FMV[#G07T6#V<(HKFCN3#W]C)M"#G:,3)).KXH:C2)$H[N8
MZB:+AD!*1EE5]MP>]D<U2P/ B#F1LSLXSN[@ .RV8_O^N,)1C-1;E_4L_$#&
M^?B20^'C<LOG'TUQ5V9ED1$L9+*8*,XC0%9OL<&,\H2!HES)K&2$U\@"280-
MLUZ'X;9WQ"%6AFF?%)!?'I%=]@ SGJ-(G8]2>YP(N;ZH><YAW@E\-X=YK\.T
M.MH4@D5228#C',[1\4A0"(392!5+)MSI,!^7,W\%:?('R)C7?9@N<I645$@R
MRO*T:((T=PXQY8!AB0/8?+?#?%S.; XS'Z9G20L3-6*$6C"4X42U,Q@QXT60
M6AF9?7$S,=&=?C&WN"2"&*#\ 1%'ZT$J6Q9\^"5\O)MI]82YJ5L#!(@7 23[
M$@>MVNFQEU(L 5Q=C?X"#,;WW=:[Z/K#G+D%X@6/X\P<['>==G%<0LV6'2#X
M%)U4FQ*K3>F--N6T+M'_ 4 ]R*,2TJ;9&6AUX'MK?V>TE9<)+V?';7_<.H.;
MG/1RE4/,GOT<;J]OV1X9%Y14X13?C[9. \AO/C(H1LLIEW M_IT0R,9+3;T%
MXT@2SA2U6298$YW@CG"N:NW*&4:C'\8:PJBQ>/76X*2BGA'QU"^\=734CSDH
M5(U7WQH.CGO]G+RR6,L8\\K$]MZV_W88J,=6B(1HS!UR!5'(X BR.X6HE,')
MX;(&G8HY?5X<6*EUR.LV%.&D"XX3YW._ 1+!AN;>&"L8459QQ6N*$".\)29:
M!.F&(AZ$(M@A"49RHA.27'+$3:)(&X^!(C0A-@H2-"F[$DS[-FI:6&^=#OO%
MT'8'F2HJX5/JK-)N'C.KCVW93B0+PM%156DW9?I8 1*G[4OQ,SQM*.PE4-C^
M@5@"A96IFRY6V0,_M'\<)<:-E.PHQ:I,?2QR"N.P[(/C;/<+:%)?YAC:$9'9
MHS)SJ]=OA=)AVSD?!? GKP=R[/KV*1!(OOJ'=O7DFYX"A'"6/<)%['1*7UT7
MUGYL.VF4ESVZ -C&'X/BA6NN<I"]O$/.J;Q(-FO]$&WN#03<<T7[CZXM@T>P
MB+&\M]:P\@C.NK HT^_.BO&=[+5R\*]*T2B9>,23=1\:6T5::_Z^FAB1?YCU
MG)S(<5%[N=YRPT&K3(<M<4G[Z\B;5Z>I%S7@F7X6L%N[ ZNJLEASVNF-F'CE
ML.+L<[A,<RFS"6UK;&VY,A"UOZ'C=@ [],VKD1VPGN^['PYMP)P+&Q'UPB,>
MJ$(N40JP)9AH*0X8F[7-7C?6Q'"EPGMF#)TP%FP06448CKDTW(AD2!0@G(33
M]*;2SKW3+)K> Y#^%L-^[WU1#"]"Z;EGX<RJSK->/Q2Q^\JD_^[G]W3GPR%)
MB6B//6)6!<2CP\AZRY"1PDIO51(),.?@K%=F*D_5=^:$VHW6UJ 4G:6D"5=B
M /#AN,&55441!X,L.<<%J<M>_PX(H7Z9FWUZ?%[D^/4\K%+KA'%I#GI@?23U
M)NM28B?6:6P@/<L  BB-+IAYU0,J@3RVHDJTCIF+WTYC%@GP\$H\@@@_S4LJ
MWZC4 KE@9C@ L[*;H]1S1/LHF)3OW0;0E(MO+M1.^=2KAFGYB'SI98U\EJ_K
MK6+H/N?"GJR50A:=5=(SW.E-J8>M]_UAE81?9BNL5TKRZKY=*KEZH^KMO6A#
M5Q7MK)>!&/@V?'U4[U%.EZJ7VX]AZ*L,ZXGC'UFKLS;B&6J(P:P@UOJMH+ &
MX$LPV-^1><Z<T-QH,+$=#BI)0_T-_M!)\WM_9Q$H_''4A;!!PC.UV>>WW_:V
M#BVH,NTB@%_O 0LK)Y#E6"+J%*5!<=!.+F-AHN>"X5?K"YU3#SDFM*M>F&7'
M!]ONE.E..1.XE+:7Q217O&:+)>@_K!OUEE6U>?7O:D'WZTCB/SM!=R60G]5^
M'<#?!J575O[4D@_^G$5R<V<X/];JK^KL(=@E9<W<F-H;U1 5L^FN5*G9_KJH
MLQJ9.V/.D>N*A"I8,9D?A*WS\%_)D^,XYA(AYQ3Q+LC(I& 3@4U")V2_F R%
MU90V(K39P/?/>BF+2'[YZB0__/OLT,M$!4T:D4!%#IA)9'-)$28&>^.9C\RN
M;9J-Z99&%10XJ5TAEV@UYYZ-";^G%,ZYF+U[ 36G&N]D&'SAW+M3WMO]Z'JJ
MGF@ALJXO&FO']-JBO3N?/^#=LT/ML)!&$L1$KA\26B(3L4/!2A$%H ["61[Y
M,2MR<)D$!R@_5V"49-LN2O&XT;IU2M>*ZH3;"6I%O8LLN1!,X()BQV(DWFA-
MX6\5YG01FY&KL)B OK ?MSIE(6TV\HI*;&\-WMEV_V_;&<8;I_N^/N']U[>=
M#X>&*NO F$*)1@G4KS"RU 1$=(Q6,Q!&TJ]M=GO3I%^+ZS,PCVLC/M2 8*;A
M7CH)^A%^'TL_PU.*]-F<]PA$?@E"2@-T-H$/Q@F\,C]A7_<N?2,-*KF6L#D0
MM@A P-P'9+UG>3!?1%;+W+M8>ZU-PLRJ6Z"2"_/KJH?J.G)_SF;+0LIJ,NVX
M7;;N']D,MS(9GJFI6E5%M#*WVJZ/S]I2O47*^4Q2N)WT#,X%QAF7C#@N$C"F
M#-@[:SW-#5+3[9-4RXS&4FZ&ZJT ;;=[H1*4L%WE1\6-*.#58>#O'\CNUB&.
MC/%(!(JY)) K@Y$3@2*A!?5:!H$S"KC=&7OEG,0".VT\)QY;DX0$> V@6FO
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MWM ;2G\GQU^.!EU> JEQ'#6"41\OI&HQW=,)+).+GDZO-6%^_P#6\Y[N?O]
M=K:WSG+RO#-:JJ11X+GWOB,TAT,"T@J(QRIJ#:%UKZ[)9/D:.2VB&4_B8#2"
MKYI46<&#"2Q7W:WR?5^!,[DK;OP6^[Z=86"8(%SXH5M1[S6PX,26(V-+*%2/
MDKW )U.J^*9R]^72.I*3]O<?]:S;=[W^QSCJQ70S\3=%DPN0_/G.UB%5W$9J
M(E(J@4GM#$56AXA EVB&2:)$@]Z0TUW0Q^LG+Q!J1;#7&PQ39'N=O"V9P7I
MHOT8%N2Q&6,QV^7$;4"S51NS_JC;TT(<>VRKJL=SX-P%N+>LF9E55Y?GK\]\
MR8U;*Y7ES0RXE5(I+B_8^QK[67LWRF56X<F^Y[MGAU0RZRTAB%!N$?=*(&.B
M0#HF[P1/-#F2RSC F)NK4B[)L&Z*5\8\KY#ME0J0ZTWED<65ZC[LMZ6Y0*FD
MU."@B.<Z*&.4(T1@Z2(A@<8)FEL6D&EH;E'I?C$_&8-T)SMGAXYKI05E2&DK
M$!>.(>>EAW_"GU@(YS6;#VCJ/OR9ZGK>#_O9%Y+E>]U*X1*EC&3I;0F*4>NP
MEM0ES( Y@HG,:QZUY=0DD' E0;$10?&&H)Z4H'(O5$T(,T(3Y!(!@LHU==9@
MC SW)G'K@-ALV0MUFJ" >/)ICN:9\5$_T6$?%/2%YIXCXT8>(0M&;^5-FO(#
M7LJ]:LYU]FJ4_LCOE2U8B],KGKL0O\9.[[0$P",OWFCZ1,8+92_3:F3W!?WG
M5QA!B'&H7#EUK_@5 :IVC^*XP[;R^8[ZH%YXNVH7U\4-Z^[04TZM*<?X8F.E
M%5Z[T9O^I".$Z6..$'YK^UE:70Q$6I'B6+;S:\W>GSW?V3XZW_OG+_%I^_@8
MGB=VO^]P^/L;L.OYP6=8U?>/G1QQFV3OW>]'9WO;[\6G_<Z7O=_>G>QN?X%K
MC^'OMWCW^^_MW<_^^^YO?\-:?DD[GX^^[7TXI%AQ WH=:6 [P"C<Y<[&.;RF
MF,&"F4BGIKX:B<$4CBQ$#BJ&.8<#H]A8$[V@G)FID<'UEK?^J"JI<S5YN??-
M=.!G-1WXYG,?IY/<J-Q'D$TV)$Z(,R3HB+63F#MMXNPRZ[G3@5?'T?B++4 P
MC==*G]9]X4;=A%H_U%,.WO[QYVBH058K.85QF-7*F&*8[CA8@IFKW1?J=@R7
MG8DV6MOM3GFK&U:RU*>V3CO#*@S4/CG-\Q'@XE$+H#I@-)I3,8I1M?) U[H#
M30ZU#?OG=3,)L*:/>]40T_$'Y@83E74S&J< JA.$1-E\"19;U"I]NW?6_?CV
M_7Z)-8OU^K:5LPS^>1%=B_T2X'7+5MS% &1-?NWJZOJK>1%#N'<Q* -WLR[:
M:.UU\[B-XSRIMMV%2X;5"XX&P[1"/I$R-[7>G.[,B*J;0T#5>95GUO6=83WM
M*LP]YNKZ*_Z4*CI6C.)U<3)0]@RBZ1\GM[ZDCH4/LMR]/.&D#7*P!(99DK=/
M;1D]!&@/FS5H1SAPT'<V#QBY&&%<>T.K6V2'#SPJQ?:@CDJWVE,0TI9D'WJQ
M**__6O:0S^OMQ])C-1I@4I+^60^5P?P1U9]E;VW%F/E>%4WD+X_..X[4YN)C
M]%;P-/.L%(##NSFZ34B5[0"O6/AA45P!YE/C4K*GL S5C\T.N#J 8$S&7,L$
M)6(?.<"O$$=Y=2^'PG+;UXIY>SD+H!AVRD.Y$#^CYUYY8NWT!)3@<X98_2XS
M#BU/?P#>C:?5>(52FEU9>*^DG6IV2K>>83 2'!5Y7-R\HA'0*-G+V.U=S+')
M0J":#5%VY<F39BZW;:/UG]X9$'!_/ XP+.H>(;-E<K9@ZC>KDCM&N[.>^0!N
ML'[=-MU\/!>6VBG\JZ20JRO>+_=HU$9Z?$\FA>F(74;:#(VTV;A*J6,<E8UQ
MR^';.>[R:AO7WZXCV/)'$[_/"3I5W7D]V+;N^PK2WPU+U+K?&^MXO'5!=ZO>
M)^SQK;[]@]PX4SJ2<.(4>:XB@G.R"$SJ@$QP"J>4%!C5M^X%M_0YQLW)+__D
M#8^4VL20%SX@#L89,DPH9!FQ*C O0NX0EW=J@1YQ4R*W?7EB%W)W4C?,L1(V
M)EKE/&HWM4FG4&GA;75#;6&M4A>U)W$4[9X=<LFD"U:C('3(<Q 3<M)H)'"
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M$9QBH#Y1*\N^LHI-%Y;>NJ_L"C7:;IA^B9"L8?J59OHIW&5=U-H$BJ3##O'
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M;%$5$XKW:(^.<:Y"%X@N$.OVC>XK$-TKNH<V#+PBY[4@Q3D#QN* KZZ&%+
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M0N0 ' 8<^)(,\ 7FN% Y*-C<,X']%X"1>[-U 9BH  R'SD1I,_\#)5$%5)3
M4\P@@B7K8E8&QVO?U@5@NEN!$0R:OA78.3T8^#I>DM9"<D)@FAZ($"'P+@!R
MKH9\X-!@PZ2V H=5.W+MZ/P7Q=/+YXVOI3"[+Q:SQ?-X0:TGW!7S<[8X/STI
M;:C3[)?SD[/+V6],UQ5__\G31[W$9%_=^.V6F"S5_@G=Z'<K;_WOMO3^]WKE
M?1<O+L_H8O'P\O+B)%U=QG1*/Y[S5_G;7;;O)-O_7&'GR%QXUXZ0M"9 J2U$
M83/((,G[$")%%NV OA^)VTN:1[!Q.LW;HGG@SI1H4DD>P:"3K4V^!,];<,[#
M8F;9MORY.3I&K3O->TGSFDR93O,F:%[AKCB)21 I2%E80)\)?,X1C,TQ5!E$
M\NGH6'>>]Y3G\6M-[L-SOW\R)NP#0R7Y@B1JA5RH':U(&1):9I]*UDGY;&/A
MX#W7PG3<=P;WK3DI(T#>_9)[\#WP2X*/!4608#4*0,-O;:# R;G-0F9=1#6E
MC[O94<PGX)?TJ#X!Z@>N2$[)";0!9)*.H[IV$%$7,+H:Y3%9$5QS182<2&^7
MPZIS^>[T:O%@]N2\61^7%^>G_(AGLY,;YW%QXY&\L4C68)#TNI@=D/=)M.!Z
M=Y6^L<<_*/S\@Q=4B%XTY>^B?B=1_Y^A9U)Y+^:+%F!J]8")")(R$HQT&6U4
MY(0_.M9#RZ2?>=D7R,>W3<:&O*=UXRG P&<ABL'8DMJ\4M[*Y1H@YB0A*AN*
M,8+S^MJ2.B6[".RO"(S>X&L=[/=[.)^,_0I#)EKKB]<92I86D-,Z"$EDP$I:
M!R1?B^YG7O<?_=%G\G3T)X;^P)[A_5L61D=(S8%%%3($,@6J)>]BE4J97N]R
M .B/WD6LHS\Q](?S?!PZ'QV"\%("RC:)3V)LE6^ZADJY^%[I<@#HCV_<]%W_
ME(5@8.;($'(AR4'?)T[_LPZ0 CD(H:C4[@E0R<M]_RZ-_=FS.I='-]-13IF8
MO\T2,1+T:F3*9?R=_TX\*S/ZOZN3RS]>CU*Y?G"].'_QEU4PBUX"\W$&?CJ_
M*'0!E^<O'[25LWP[9^W2[W> &*TGVJNX\$;\WU?6^/?E K]^W(]M>3\^.3N_
MX+7]*H@\/"OO_I:OETO_,5T^/R]OAL?U^L@1@\=/0],H!2&5B1ZRM:WU=,DM
M="0HQAJGJW.I-4YR<J[\\#3OIQW^^3@(=^A8T(&JRNC38;JJ[*BJ#(RHJBDG
M\A6L;3O3Z@F"UQ%"BI*DH(RMH;WQ<R7'&C73567"JK+=8J&N+SNN+RL<K^)=
MR#H&\.@]H!4&DA.<QBC).V&.1D;6-NG6"+S_^<6N+1/6EFW:8UU1=E91!D9:
MM5X9EPBLCQ70.P_!)-WV1*5*%55QQ#G+7&O14Y;]EY6[I"PC>&\]9=DW@1G8
M=4D897Q%*$NG'HN%&$A"M)SC5HDA2\T"X^96##=%/6?9)W'9YIBA+BD[*RD#
MXR\(AU$10O3\ 05Z2-Y)L %CDK84&?#HV.FY6U'&-<6DY;"JO!Z]MO]FB<ZH
MGES./J/K<5\#O>]%6P=XLF--QAV+^LU4N;]?+[M^2FL4C<Y#?RUZZSE,9RA*
M\:XR:0&!1(%$7@E'*I-V_8S6_I.\)K.LD[PND@>>ELF^5A4J1(W+RHH(P5K^
MS-KH,7)>KE0G>?])'KV\JI.\7I)7N$?!Q8S!1Y :6P.[$,%+I4&Z6LDY5#'T
MJ'P +*_)$.HLKX_E@6\C%(FJ4P(LDEH!5( @G(!DO%*X["W;1__M*LL;=F$^
M$N8.[1VA'98N9:]K30YD5(6AE6U<KT103CE9*D=ADD?'SMW'".FL3I?5-;D:
MG=7[LSHP&8R4U>M<H%T<9K7F-DM3@*]H8B7>"=LT(58/JZSHZUXPU&?F3,M=
M^* IW"7Y#I+\;.@IR)IS%E6"S-H :M;B5(H#)8-T+A>OG#DZ#O;>Q9Z]6^]D
MV5US\4UG=QQV!RZ"RK[DV/HS^HS\(7E@O:U0M3<5DY$)\>A8B;'.F'9VI\?N
MFAR$SNZX[*[P#5!7WIQ67JTR\E;(B0(^>@V4A0XI.^D;O4:/==BJTSL]>M=<
M1-+I'8O>@5-@*F4OHH1<L0):YGAY(R-X'6I&\M:'HV/M.KW[2^^:3((['83N
M_M\]J!Y8"4);,D4FR%II0%XA$*1R4$E)%25G5VVX9)]?L^]DK[E0HI<X; 3O
M@?M Z) H%Z"0'6"J%D)(&G0VQ;D<M4#/&^:Y\,-"[^W!_0$38MKWQ?LC^R.'
MCSS(TIRW#;7\NE1N=OZZ5JZ7Z7S<<88#K=[<0N<]?L3I57M'OSN_:%]X=[S>
MZHZN/8L9+8OY\^&*R4S>IEPT0@T^ !IE(1+O6((JDNDPBI([.G9JKO#>]Q[N
MQ-L.G8<Z4 '90I.]+B#;%I"!:VBMB:K$ %%* ^@H0$"4O!W*:$6RY-MH-^/G
M>/]^>EU IB\@N])/KTO)MJ5D5>L\$7WF!0!1I0J<B;;V$5Z#L,Z34D%D+.V.
M2K#F_B<ZNXQ,6$:FXWIV\9BF> R[Y 4G16NY645U@$I'\*KP?QJMM;4EQ%Q:
MESPG^D[F !1D5[KD=2W9OI8,G-O@2G&D/?#V!7E7HR0D;P)(1;R[2=F9+):[
M&KW"V^F9R#[IR'1\WJX>TU2/@3&LDDF5%P-X9]MQ:F\A61N!M[BA&"]+$:P>
MSLR%&FOJU<1ZW^UTX=H*@ZV<+&X\-BKWM=AZK=I^J?Z:C;2OWEIZ;W3_"5T^
MK3_&W_OQO5%D_.NA,X:F1(RJ@K&U'<G5#D*VG <&_J)QA3BD]\-[^X_WFFVN
MCO=&\![X5L&2,"DJ4%'%=N(^0)"D(2%%*U106HS79ZOC/5F\UUSQUO'>"-XK
MO"1A/:5:^;*5Q( ;D<&G8""HQ%<X&Y)6=\#W'_ UVT,=\ T!/O![B!RSZQEK
MY3P@"07!)0.Q).E(HRY"=L#W'_ UU\U]"/ .\AU!'DX?BM4I%07$T$!VR8'7
M)8&I0F,A)_DB'AWKT>:Q=HBG!_&:K9,.\<@0#SP/'5QU.1L052%@M)XAYN"<
MDZTY.%-$=%.#>,RZ(1FF;6KP6G^W%=\AEP=]I)MV?;T>:+[$Y?PJG=*UHW8/
M=WMJJ^+__42?\7[OS+X$K=&=G^\NSNO)90M:W:,?+UX]&IH[HD1?O&SW?(L%
MQ%"!MPL5K*B^9 I6)K6>LJ=[D;/E(T!=-KML3M%1Z[*Y'MD<F&;)&5%:7ZI(
MOC69<P92+@9J12*O@C9V3<5>73:[;.ZC;$ZC7*X+Z'H$=(4M:4P-TJ5VK"A1
MFXNL(5HGP2>A/ 55B?+8)6Y=/+MX[J-X;M,%[I*Y+LD<&KW&4%5!@$5?>;-.
M!GC/D" 9$;.,198JUE+8UW6SZ^8^ZN8T2B.[@JY+00<.>[2I*(T1LFO3*%U"
M\"WSQ$PF*I2HI%[NVX4=85165\^NGGNLGML\U= U<UV:.3C0$)S"JDF#=\@;
M=>VPM;B28)T+ 5V-%.RRB%.CWH.T<WD6XC^6=</\[W+RV_%_\H=73_E%O'AV
M<O;JF5GFY.8K[=G8=R7LEZO%Y4G]8VPX_2TXW6TX58/S7Q_WO]=7YO8+O7DK
MH>GP ^E7OK+K+YV<%3J[? #M0>M^K0,A6K[6S^3KT+SQO_[%.V^4_]PNWX7O
MZ>4%+5KS\=FS<UYN9ZT1^>S913Q[??CD@C*=_$:%99-7\^SR.<V^?/C]US_,
M'N;+^>S?ST_R\]G)HCVL+??"/S8[YP==O#Z\0M=35/\VGYTMC[1<_XJWYTG^
M<,G_6K9 GYW7V9OC7K//%D2S)^>7-%-_^WP_EH":\!)87%[$]FAH/\E7E+\V
MGWWUCV]GK)20XX(O]$U'@ODLOFC]"_Y<7JAVU5A>?N7+>TIQ0>UA\>S9"4O3
M8GG5^>'Y\BI>G,336?MC%[_Q2^)PR ]<7/%BRS3+I_'DQ>):AB^?Q\O9\_@;
MS1+165M(5Q<7O$[2U24_E4O^%2_YCU.9<^BM=''!OY6? :^V%RVT_S&KU/YN
M/"LS?K8O3LZNGV3[ZN>SZ_X+_.>O5^$+O@A_+(^<NR_X#7@>+ZC]KG=GH#ZC
ML[8DVS/XXZ]GH2[_*/U^\R?.WNGF\/K-6]S\O8_Z<W_QQSZ?O8O$34Q[<O6"
M%T>^_N^;0Y3+=^ =:-ZK_\?_F2[^X_B]L'WJS]VL0U37W01>GB].VG-Z<$&G
M_.1^HR_^?5(NG[_*V-[ZP9L0)M[\2$S\CEQ=OO]'WA_J,K5K,#;Z4GP4^PIO
M7:^W/CZ_>*-FSPC2!<5?(59^L@_BZ;_C'XNC_WCW)?+KN_66?N#=N'D?I?J8
M7.!=N<3/S5_I9:UK>].NGT=IL66YA!\L@U![%#^=.)GG,GM^T;8/_\])C;K4
MBM9':3"8DEPR+EL32Q2%'/[+'1W_V%*V1GUK#],T]C__(QZO6AFW\+W>&+AB
MHG-*DI4.0\(8DU7&9)+5^9SET7M^+HA<:W FM#+X*-%'D9-/U1"_(A+Y:/;Z
MO/7#R^69CY3)2"^U*TA!!!U4-3H29<D;(?'!-;;^!/,CL?O'^776<LD7B68O
M^/'/%S,Z:[G*XWB1GU_''"WG,][2R0?O5;"_3*G-^U[Q,D%_HV7+'0&_\M/X
M<D$/7GWRQ:MCKR=GR^>__*$OWOV#[2_<VA L_^#UM]_0_[FX5H";8](W?_GF
MVY\OOW5K>W/]/6T^=ZC>^VWQN?S__OJ>S90/#J]\#;>^9_3[WYR_^LF_>E,Y
MR0KFDWYK?Z[]N?;G^M?/U0G]4;_U V4CM^[&3/GN[NK;5+LBQG_QWG]$8<I?
M7*;KM'XS%^J#M[66%^K;DTJS'_()\=[V(R[7OKX-CZFT9S)[6NO)0;\17W[Y
M_9<'_/*?+N\(/CD_@^M[-RV_/>"WX\OSBY=M%TG+MV1!S]K-SP-^/WX\OXRG
M[[S^PYH0MWS]LPOZC7C__3%-*G<EO*_+QQ]Z:@=EUG_$R]\71]['BL6)$!-*
MK.1C%,ZJC*ZZ$)2Y/@<J7SGR\L.._/<WE!V"'\_/[<>??_GYE_SO)]_\4SW^
MZI]_/%%/GC_YY5?SD_H:GWSUR/ST)W]//3*W_?B?7_!K><'___.A^/FKG_AW
M/]+\,^KICZ>__/3C,_'XE]-?^'OZIU].Z^,?A%I6'?T@?G_\56Z_]U_!BUI=
M(BB.)""U$3$E2;!4!$9+:%OAD;1A'O2]A^W>%8[=.*O4->Y0-(YD*T.GZHUT
MZ%SQ24G,P2CEHRLI=HV;@L;A;8TKUI;D7 6E4 "*$MHAS0JYE&Q=E1RDJ&F<
MF"LAN\9UC3MDC;/5>8J)A2XC6LWO3+9"!S*ED@O*=HV;@L;]_OAV!;FG((Q.
M#J+F] VSI':^,@%6J\BYD*-1+'+2SJ7R7>2ZR!VRR-6@BI=D8F%&O'!)"1VM
MYATK4E2N)W(3$;G;W86T=U(6$2$D_H R1? V%ZA)&T)C/5_4H^,P%W+DD^-=
MXB:%>I>X#TI<2$'6H$LP%K'XDGRH*NJ:I+8B>3^2Q.U=Y^W-J=N3VRF<,3&5
M6DR;\^X "V]6DZP1M'8AV)2LJG6TOMM=W[J^[;*^:=)2&%NCD Z12A0YBB"T
MPBJ"4:FG<-,0N=LIG \I!O0.C"TL<L9H3N&" BMS,40F9.F/COGK<^76/L-Q
M+)$;:8SC1TO2^XJJ[-)!WPZ[WZRN2UM+%97YW)N/>%(KJE?:&@#]N5QQ2CO%
M!5U7++Q5_W=SSG^JOOU]'/[>07_#SO9+BK\^>(/)-XV2ZV[ZRR'$K5CS8;[L
M^?48H>=D:'6W+@ H58'@:VFMB1T$11IRRDY*X7QPL8^UV7^>1W-Q.\^;Y'E@
MZPKGDK?.@FO-)-"*"K'$ -$JC,&X6$7I/.\_SZ,YEI_"<]\?W@OJH8])%HM*
MKL5FY"CM.5XG@0GX8E9CL\N\7HZ.Y9QW_YWIO65Z-(.NQ^C-XGS[=D_)I?(&
MJC*_6 %+4I"B1' UF1C)2(E]6.P! #V:'=6!WBC0 Y-*A,R+57% EAC;I J"
ME$,"GTE2D29(W\>['P#0H_DO/>O> M6WP[0TJ"A+ 2Z0!=2V0F*L@3-N"KR7
M*@G3]++NPRH^_)86BP>S1S?-R6[9*Y/U'=98@_A16KSBDN^=%H_K4+Q:8=<B
M_/5UD[S2Q/AA:?V2J+3QOM?-'\^>O275UWVI^&MO.D/V/&P,Q?YC1=U>M<'S
M!08O5+VVT:,+'J+4.F45"]D\]EFA"1T'ZNBOQ<SHZ$\/_8'O$7TM+F8'JE;>
M@>EV@D9;"[9U":R.Z3>VH[__Z(_K>W3TIX?^T!VQINIJC *!U'KG9X(H*DM!
MX)V:C;40C>=Y=O8WR_Y=I@>-:Y"L#_Y^I^:>"G#[3HWS4DL?,M34[M3D4"%2
M2*"<<J8(M$'X]Y5 W7G@4$=_>F%_7">EA_T)0C\P76Q11:10P&F+@+SG@U@%
MXQ\-"L[[<JD][.\J^W<)^^.Z+CWL3U8!;H=]3*'R]?:MATT%3$E"3,FV+  #
MXQU4T),*^R.5Q.R(-_-?%$\OGS>HAC-J_FH0S>SR<#I*=F=]&V[.][PROUZT
MP5VO"AR;@O]W6X3_>[T&'UY>7IRDJV6OWQ_/OXMMGE17\['4G'.Y@7G#0FXI
MZ\AOJ&LGUZV%Y/A#T%5Z9[) Y9=NNQX.C>TG:/:%\W&MFT_EO*-\%Y0'9DS0
MSII&<9">40XN@:]D01>9DA86;6G#3*7I(.\MR.,:,3U@;YWRH>_BD'=8T5=0
MW@7 6"6D6!PD?H=Y?9,(OG4MF*._=V^]#OID01_7=.F@3P#TP4'8S-=5HP0?
M+(/NLP5?O(5L7.)-6%*FN-8K>.[,O5O,==(G2_JX)LL8I'<[Y9,A']@IE3@S
MBSI!445R-$=.WY6NH'4*2CICI Z]AF7_*1_73>GQ? *HWX[G9)S(SGF@:EM/
M12/ .QLA.)\\MG:+&(^.E9ZK,*5X?EB5+9_LGCS[ZYYCDS5'>E',_MDH*TL8
M>PXWAK"OF%OE57*E"@5:M4[@&",DH0I@"I2D4@ZC["=B]I_R39LHG?(U4CYP
M5ZP34<HJH>C0;KM:"<'P1DUE+8J4I+-,G?+]IWS3#LM[*.\TWX7FH8NB#)9,
MT7&H3H*#=K(0E-"@HRI64T@AY:-C&4)'>6]1WK2'TE$>!>5!&_<<C>64"W(R
M&E#7 E'["B6)8H/34BB.S)R'=Y3W%N5-FR0]]UXGX@.71&F?1!:MSCQ;X-6B
MP,>,X'/PR1JK9#$]^=Y_S#?MDO2(/0K.@TZ<(?E2<@6;I 0LSG#$Q@ Y%R<3
M*><5'AVC&FOH2B\BN2N33\Z;UW%Y<7[*WWLV.[FISEK<F")O/)%>3W+P+O==
MB@:W6U#R[JI^57+8]?PN>KYBFHF1TLJH+)#@% U9Q($OLX<D!$HGI,Q5'1W;
MX;GSCZ\&["=7ILOT=HM'WL=T/\HR&O##<2>*+V10#H@X:T.G%:0B,J=SR465
M!"GD_,W/PXH,KC,_5>8G;(+<'?E^]^53:1]Z)4E6%TVV8 )E0*42),>X%_[/
M()-U9<1.7YWZR5*_W9J33OUZJ;]]DT91310YM&>.YJT/>^OHZRHX6W1.1MIE
MFX]._;Y3O]WZDT[]6JD?SE3!4*31!K+$!&B2!6]B.]98'&=W6MK4ZU%VE?KM
MM??JN_H)LC]H["62R[Y4\ D=Y_DA0?1:0W FU^PP&^.7V_H@I[&M/ZS2E-?=
M[V;T^TLZ6^RYIW+0GOA6/)6K!3R+\>6#UPOMZYMUUG5W--U=,3_%^VJKE1%,
MCIIE-P6(QA#(;#'%HE'E>G2LPQSM?72W'VN9+L*C62@=X4T@/#!$BO:"4V,+
M)2D/2,9!LLJ!P6!8@J5(1A\=&SF7JB.\GPB/9HETA#>!\-#E\,4449T&S4(,
M6&( S]<-?)6YW0'S(8>CX\ ,NV%12&=XJ@QOP]_X2(3[?<M/IW=0!%*#)I<T
MD,H&,-76_#))P"I#ZZ4C28TW"[HS/%F&1W,K.L/K9G@X6@130-L:V(K*Y(92
M@;] H*O51CG'6Z+:&=Y1AK?B/?1<>C,DWX[&MA;3\FF(SKLV)"@PT\5 BLI*
MFT6(7AP=2R_G;BKWM ZKON.3VUR='Y8)T>WBK11V#/3Z8]H7/J%>RG$7Y7ZZ
M8AQ(%=E'%1,(RLV+,)R"Z>JA:%^S4L@75;;*O%[+L9\8CUO+T3'>#,8#/X+(
MH0TF@<)68)NJ@FA3!6VB\C5FO9P1H )VC/<2XW'K,SX=X[[)&HWQH6'!&^0L
M>9,,HL@(&*6 4&P%6TP.UGGM2;5!( Y[M-Y/S,<MR.B83P+SP93U2AE)(%0R
M',M],. I$0=TGT6JZ(SC;:U4<Q,ZY[O#^=8J,,;!O/L>GTSXBAD@2NJJ"D?N
MRION[#P$(2N@C3GE6(50L==<["CGVZNYZ/%\$K0/XKGQ)MD8(&3>H"-&#;'$
M"M$HSZKNHR%LWLA<F/N<,^IE%EML?75@+LE!&]N[8I+TYE?WU_,5TS^"<S8I
MG4"EZ@'5LC6IS1!)&PHZ>NOET;$2_;S*WF*]5=.D5\JNG?F!O6)L-AI%@%)K
MFP6"%OB2"T@496)9%](V>V5NQ-!@Z=CO"_9;-5EZ7XQU$C\T6VQRFHI+P&+/
MNS9?,OC@+)@H2'M-L8S8%Z-#/UGHMVJY=.C7"_WM6S4A1!&TT.!:,2<6&R!)
M_LP63]*)(OD2=^CW'_JM&C =^K5"/W!CG''28\V E 5_D)S<1X% Y)*4ME+5
MU*'??^BW:L;T7?T&R+\=[FNNPCA,(-!)0%<+I,J7UVB=,0J3G'/+;;V:TK;^
M ^[,KK@*_9']D2/78GVTRUA.?GOUNV]^!;3'/[!+LW([D>IA^>5J<=E&3RUF
ME^>S)T\?O1*749^,^=R;CW@^7[P\7YPTH7MP0:<<QWZC+R[/7SX _;EL/W[[
MC8T+:K_AZ/@S]<:QYG=Y$JNK5XGM<I78@E\O?_9.<L79TI=Q\?PM9#B#HLO7
M.=?UW+:6<7W)S^;D[(J_=O/-\[->"SQ:5O68LZE!5N6U1@SD 74QT'J,@N>5
M \FBHF)$\%X?'4LYYZ].X[Q+QWYZ564=^VEC_W10G1))E5PR:&LC8$T*0FEM
M/;+..IELBVH#UN=!Z4[]SE"_-7OTOJQWG.^$,V.\//' 2/_[R9_\_6?_"K%(
MM!(AZ=97*Q.!MSY"DE$;914ZM&,<=.I(3Q;I<<W/CO2&D7YT&^E$EO\7!<B0
M J#)&3PGZZ"U\:6*C*;(EIJKSO3>,CVNMSEF2MY-S7NP_L_;K,=@G9:Z594%
M ;SU5N"#]!!J0,P^E91S+S+;4=XW7&36-^-3Q_^GV_@;3(2"*HC"B3OG\<OL
M78,T,20A$DEJVW$]MV(/A_O(,.V:LVMJJ+QM\TS6_YA(I5@ZORAT <V&:I=Y
M68HW>W6E=D_"MU9&]FKM=;'>AE@_&AHFV>MJB[60J567H':05+) "@U+=FX'
MU-JN+,R-'JNL[*-AVJ'3:8<K$.,6I'6!V*Y #*P54<D:907G<LFT8ZH5(M8*
M9$6VSJ*3)K! "#F7QG:!Z *Q9F^F"\1V!6*%65.J9!U("5 Z!YBDAA"$YY0B
M<!@(EJ-!.\IJYVK%0+*N$%TAQK5ZND)L6R$&W@]Z)8@20K&I=0_E#\FC@J $
M7W#-66,2K7LH!M<%H@O$FGVC^PI$]XKNH0U#K\B054(4$*1;]B X>R"=6KL+
M47/,4NOQO**N#GNH#N,6S_7T8=L2,?"3T 5A716@DD'>99"'E),!8:L4+F<1
MV]$19>0<1VN"LW:)Z'5'1\??G5XM'LQZ]=%4']E//DS#-ON>^)?GD].39<!Y
M6E\'IN\NSNO)Y;?GBV6)]P_T[.8PQ)=OM0L='I;H 6N\@/5XZ*E%;V60T8&2
M3@,Z=!!]*1"$D\XKHM*&>[^G"*D??MH7"1C7&.L2,&$)&!8D9>U#=!643QZP
M! DQD -'-@E#B-*5]Q4D=068M )L>#36JN./HVM!Q_U.N*_PP'S*5B9,K;U^
M!%21@#,_ Y54J$5:;6)86;#4RP_W ?01'*P.^A1!'UA9V:04@W)07:R M48(
MUCK(!36BTR(OIXVO*&/JI$^5]*TY46M-ZKM-=0_N!S95(NV-E953>"D I4[@
MM2'P.2=1,&#UKI<T[;\ C&LV]5W]I%5@X$3ETM*ZF$&8(@&U1P@)$5PTBF-!
MS,:D]U8V;4\$#FNHUJL.IK.3I6W;:YQZ@]WQ_)BK!3R+\>6#5XOL^FC :]WN
M*=@HXOO/H:N"@DJI&@$Q6,!2+7CC^7*Y[*OU-<01!Y?V5MF3)7DT6Z63O!F2
M!^:(KLX6XPH(89GD6C)$*150X=Q:HQ/4)EIUDO>=Y-$*@SK)FR%YA>\A3*XZ
M$@$)IP #9?#>:?Y/W@_'& ..V.FELSQ9ED<KX;D3R_T.QWV!'O@;(5M*L1J0
M4DM @P("H>?UY52NM:32)M*$N9#W/KG0<9XLSJ/9'#TT;XKD@6.1G;&A% +C
M+>^:E360E.5EG+*J')B-;,.B>VC>=Y9'<RQZ:-XHT /SH8C@<Y&M.0]CC.0)
M@BR,MI:EH*]%V3R]T#Q2G<NN>0]T/7IMK\V'@_:,-SR*9K4$WPSXZ^IZ)W7]
MGQ7N@I.\6S4""*,&S$J"3Z[PY:B4O?269&QMCOJQKOTD=&VN0B?TTP@=N 9.
M:Y-("+#>!=[.5 ?M3!8$WMB(:FW6JG+V8SJ@>PGHVLR"UX#VW<MX]*X:Z5*U
M]5X*T*[-9V-1;5/9) BKJ\C9J2QI61(E?4=X9Q">@D6PDN!^+_$>\ Y< 5ET
M-LJYUG+#MJD."!Y% 1-(:KZ&.HGQ+/O.\'3#\-J,@1Z&UT+RP!4(FEP2UH!I
MO;XQR@#M[!S4-B11.)\3X=$QXMRI'H?WD^&U&0*=X;4P/# "!!F!(0<0(NC6
M<-="",F#D>BTLJFD$IEA._<XD7FGAU6 \!6]O.#5OJSIF<6S,HLOSOG)_;G\
MPEX[ @?MR6[5$7A[S3T\*P_?6G%=C\?3XY]6M'NJ,L92,T0G*Z W#A+:"LKH
MK%P*-09S=&S]'/6P.>''JW$_83%=FD=W#SK-&Z)Y8#/P&QE0>@6A,L.8 H%/
M,H-SWFD72L0V[\2X>3"=YOVD>72KH=.\(9I7#B=!BLZ8UC8X B^.9CMH =JD
M*KR0VK2]DF[CB^[3G*GS?#B^PT?CW#V(>Y \\""*BIFO'8)T-@$68<''$$#[
M[!OCR5+HYYGWG^?1+8C.\R9X'C@1,F/P& 4XJ35@*S**(B20T>00M,6*J?.\
MHSQOU8_H^?;&J!YX$QJ]X:BLH1C5BONC@RB# BU*2'R1T5/K?,P;:*/O8S#V
M"H5/)/,;.J.+>'KM2Y07)V<GB\N+Y9R+O78F#MH=WJ8Q<;/>F@Z_L]KZJ:TQ
MM3BO&.U>8](I1M!1>D"1;.M59UN3ADHY2D6(_<S6_A,]NCG1B=X,T0-O(AM-
M45H'*<<"B,J 3[R!TJJBTV2*+?T4Y@$0/;I!T8G>#-&K_ EE<HY1@C2J16F#
M$*0U4%#S9MC:J*AVIO>?Z=%=BL[TII@>.!766%(Y)1#D.=]V7D+,Q8(IR7N-
M5?@T7E.TSO1T[VR.;E7<">I^=_.^9 \\B]9QV&K>4V<1:NO_GL!;JR%DF74,
MV@?ICHX5SD/O%+"G3(_N5G2F-\KTL)JB\$6TEB]74A$P. =>B\H?9#8%,0=/
MTV+ZL*HI?KS@G[WA,I\O+A=[[5-TUWA;1L7?KQ;\A!:++\]?I).S:_,X_]_5
MR?4T^._;,'@J7[8%V%7W3JK[;.A-.*D3YE2AQ&7;:%/ ER) >^7194U)I:-C
M?1^][2<^ILONZ)9$9W=M[ Y<"%M#1E4B)"$#H$4-O@H/AO/BF)77*C1V=3].
MO9_PCNX^='C7!N\*PT'Z6G12'IQR!"AB@E1RX-V/4 4+?R'HHV/LL7=/\1W=
M:.CXKA'?@;<@I/*E6@0OA&IG !($$PI'7S2Q>J6*:_U;.KP[ ^\V_82[L-O]
MPI&8'K@**"2AC!E:^@28JH3D5095<PR1G-6V]$J('<5[J]Y"C\UKY'C@)&!.
M7K;!T!1EJV@JEE/KUJ=8&*\-AVU,G%J[T.L>MC&9X<7+>'*Q').^K'TX/>>G
M<'J^6,PNB'_C;[3?OL)!^[O;L!5>4OSUP5N+KOF[IZ?G_XYGF?YQ?O'E!963
MRV]Y_7U_L_QZAC6*,O\Z=!NT)$$Q(& 4G%^A\^!9JJ$5H$:OJ2;1SV,= -NC
MV0Z=[6VQ/7 CR+-::Z6@RIQX[U0$)!4=Y!H\:[8P*8\W%KZS/5FV1W,E.MO;
M8GN%64%&24NI@*L8 :L,O)F*!DA7J4,*0N7Q>D1TNJ=[9V0TU^*>>/?SE_=E
M?-C7":/1F463*DK ["($*AHB92>3#UZ0.#K6<X43.7[9X9ZHJ]%#]_:P'I@:
M+1_G5<N[[-H&R?N:(>6&-5((GGQ6VO30O:-T;\74Z*%[RXP/# ^3HK(Y1E!^
MR;BJ$"K'[RHHH$*+M14O3RAT?\#RV)7;^_V1_9&'60ST33PYFWW6;+N_S3CL
M%$IMU/HEOY"KD\7S95C8:QOOH(]2;+6-&2^\14LN:/'T[.MW5MS3^A4OP[Z7
M&"//^.7KH7U7E!4E8H:B/0*6UO8(O0"O5"A"V>CJ>&V/^O&HR3(]?B.SSO2&
MF![:=J5:D4* $EO1M9<*DC0$)@:KE=261&_^? !,C]_*K#.](:97V'4VD,12
MF&I57*LMTG ]>R55LD:XE*E3?0!4C]_,K%.],:J'P]]Y,R6K56 4:D"9,J0D
M%%!!(VK0GK_;J=Y1JC?<SFS!KY<_NR??_5;^?2$?V'5.>"4D.G"Y5?4C(03K
M% CA3<24HI3AZ%A:G*O02X/WD^\1G+K.]S3X'M8F1>0KFP)3[9EO%26GYOQ9
MK'QE8PX2@YL8WX=5G_3T\CE=S$[.\OD+FGU&U\W__C:?G='E7CL:!WV.8IN.
MQG+!/3D_.W])K>'DV;-'R[7WNNUDU]P[:.ZCH6W!NR'C39"P'%J)PG%&):R'
M2B2H&JPYZE6=&OK1ITDCN^$^9^])J#X$;\^FQB-[8%Z@#D69FB$D_L"J3)!,
MCE <)\E"AVBD/SI6<^7"-(X]=; G[EITG#>'\PK? CF=\K$@V!P-8#864O(9
MA-'2&^)_M&U 2V=[N-Y;JD=W+7J&/3*X VLBN%!RQ0#>)P=HLX=0+0&J*D2E
M[*WC2(Q^>$>C8[LOV([>%*T'XTTR/70B*E_** BLB^UH4# 0<RW@#%E-6E<5
MFA,Q]])UJO>6ZM%;H76J-TGUP'\H)%3RCN.S<0+0<)".U-J86B**7GCRN-PS
MBV'?\.U1?5C%%=_28O%@]LTY/Z6S9LW-GEU$_GCM2>RU"7'0%O'VNJ/Q;[Z@
MQ>4K)<ZG5X7*/R[.7SPLOUPM+JF\68O?M*5X_<#V@"_Y69V<7?$;_?1:S\_/
M>C7W./+]>&AE8!88=#9@T;06#9H@<!X&47)@=C)[Y7J#V@/ ?^0&:AW_2>(_
M\#NJ1)M,0J!"CG=DN4"0F<!7FWQ12J?:\=]5_#<\^N66G[E^(>A[N?NIP:H1
M,L(ZX4T 78T'S@018K$*E.9M'1;O59N8*>>\@Y_&2;(N!!-U2GH>,&GRAY/M
M<T85JX8@BFVE(!Z""Q942MX[XZS.LF<"^R\ ([=LZP(P40$8F#,AD784")R2
M+ !\22$)7Z!]C7,"G1WU6K!=%8#MUHKTK<#T]6!85H*&8X D*(I5%FTL$+30
M8"C54$MN2>*DM@*'551R[>C\%\73R^>-KZ4PNR\6L\7S>$&S\\J(,]:+\].3
MTD9!S7XY/SF[G/W&=%WQ]Y\\?;37ML]!F_%W4?L1?)]5:O^$;O2[E0;^=UMZ
M_WN]\KZ+%Y=G=+%X>'EY<9*N+F,ZI1_/^:O\[2[;=Y+M?P[M',E[=9=*!56E
MX%V<<Q#;[5TI7)1\B9V1C%*0$VG:V6F>?%E*IWEC- _<F<![+N%4;*UV,B!?
MQ38CHP+Y+$.[.R=*/CI&)3O-.T/SU@;?=(8WP?"JUEG>HLDZ U5; 47RX-$&
MT$+ZG/E#$/[HV Q'A_8CKY,F><-#;D:,R_W.R9C #ZP4E1.IUO(2BPB UFA(
MJ!4$'X6V*6%1A</V7'O3 _?.X+XU#V4$R+M3<@^^!TY)B4D:7QWHX%L'S&3!
M1VV8;T[*G,HNR_$.377,IQO5U^24]*@^ >H'?DCV&:4K?"FCC("!+,1L6Z],
MG7FG5CT'>T[CY];>QP_I%2Z?R.UWIU>+![,GY\WTN+PX/^5'/)N=W'B.BQMW
MY(TY<L#6R$$;X5MU1EX5++Z[2M\8XQ\4?O[!"RI$+YKR=U&_DZC_S] M8?T6
MEF2"8$,!=*%MU#)G<XFWY1:-D]CZ> UW:?VTR[Y OKX^7F-!WM.Z\11@Z+!P
MZAZ"MZ!,RJP Y"&2"2 )J\S55C+VZ-C.4=V[ST@7@<F*P.A-O];!?K^'\\G8
MKS!EB'PAWKR#JTD >AT@I5(@6M[+F^IL]OVX^P&@/WIGL([^Q- ?V#-(J&*H
MNG4ALH!&1XC%!<A4I>9%H#CO[^CO/_JC=Q?KZ$\,_8%SHXC3_.0)O,< F$J
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MZJXX B]6:I:/7UN>22ZF>(T4_A9"LWZ-0AYAH_%1&=C'V&['WAC-'IX5"34
MGCQ!P^/%F:(#56O7@)L#\2J9V@O;B7P,IG46[==7Y2*]':W1W\,EVNOL7"]0
M-WV Y7E3K$X!W6O?A/(I(/'>QTGBM;>S?4B99<0Q@XB%'UQQAARE"5E8;LDQ
M5X'QI76@K'8HUU?)ET:^EJ7D%>>ZEZ9?3FNZ\XH)0CT"-PM^2 -*[JA%,CCA
M\AZ"U>!B"6'JBB^K:F6UAWEWG=WVOG<>0U'59M [+Q77YQA\%0MZL%C0Z[')
MW^T ?!WU8K__)I<:"ZVBLM#NL.+2G^>#9G=P$(N,SPK!5A(D&FZ-)$.93"0
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M=N0U7QZ_SO.93_+ \_D,IJP2P4H$*Q%\QB+X@";:/#?A?%V>H2JJ%5P=HEI
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MYW*1?4'K8*W6J Y.I<SK15@J97X$99[9=<.4^T!90B[Y?%J?*62\#D@;H1U
M-;>Y'ZS4=5C(2IF?K3(O)6!2%:9>.WV?V:G"T0OEM4$ T^"(>*V1(]8@AR4Q
M4B<= ZD*4S]_A5]*N*$J3+V>6C^SR1-E$EP;B;!FN5(M=4@'39!@CH-&*VN5
M!LI>U^3>J365SJ^MSB_%R%>%:M=,V6?W1R)UP@&&(T\D03R%B #9#0K6NA",
M5HK[RD%_]NJ^%!-?J?O:J?OTWH*0@5-)$C)2!,2E,\B*XD"J\B1Y&:++>PNL
MK@5>(W6OZE*O75WJ<H+FG:&K*ATL:WZ>BW59YLFPJK+6HUL6L":#&<N"E6:*
M)H4"-CB7<@7+DA-MK"):1. 6PN<6\)S4B5Q68O/R5&W-\W0JS*TP]Q%/NU68
MNQ:8VYQVWA4#B-56(NJ,1IPQBQQ+#'E/"<>&I& X8"ZF=<SO3><KS*TPM\+<
MM=H9K4K-KA$X3Q-B3[1C2BJ$%6:(1T:0B09^6!&ILIBG9)=[SJ^"Y@J:*VA>
MCSWL"IK7!YKWIGES\K#B-"BD7#X4%'SNGL "*DMU6N:H#QM;7-2-6G(9VPJ;
M*VRNL'D=P\-5I=S'C";G_W\L4/I[\_((-XX.I4A1>"Z1$U8 ?58&&18<PIY)
MJ1-7@84<3S9U(BJ0KD"Z NGU)M 52#]]D-Z=!FF&G3!.,Q1L-(ASDQM"8(R"
MMP#27CAJ4P9I7<?D^8!TD8WRKX&%F\*_H?5M:_1HS?-3T$-?_CT4R$(4M_X7
M/E:*6;(LI,2EMD1P(X)33B@OA0T6AZCXH3(;H\OF+PWGX]3VCEJ=XJED@?5+
MA0N";RN$3C->-/?VW]2(V"Q7;KA^$X\^"1J>8I(X$SH)RR7(BHK6><&<3EAR
MJ@YW"F9',$'7%&_,X?[']EIYFG?AFCGUY0W,Z* 5^_MPAS_;7?_UD55W[^-(
M=3^)YN5?K8/]@Q\'^_[['J@0_"[V=N#US[ODR\Y?H$I_M1N7?QZ#&K;COS]<
M?/D<SASE\LO^5]8X_>NX>?+VN'FY#2K_#_S^E3?WOY*#DW^^-DZ;)Z#:EXUW
M;T$-&Q>-_8/#B%5RCDED-+>($R>0X=X@&5AR6$1"'2GQNT#$[8R 4A#+;,0T
M>,H3L<XEIWC"@L.T&R<W:A$ \0RF?M [CQM;H[FOC2:_-IK]66D?:O -,CM4
M51#;/\:DF!527&C1E<Z7F@O2W+9G_?AJ],L? >"^;2]>M3J%3!9?^F/RZCFG
M:TIK"ZTNW_[C>RL,CK/5V\2EY1MFDPWO/'Q[LWAK"HG*]XS>-/CFM_$F^9\)
M?!CT1A\8:I HGW<^P9O -'HC:LV6)9^$H2G4*97C]H6?%)3DN)4J*D>=XRX$
M';DD,6$=@TR89G1:=(W)*I&JN.*KU@ 6V_^<ZQ38]:D#CUE,J\WI<S\3[U\1
M9SE)@4_.^X-6NE@Y3L]_UNU!K6%[_KA$:$;JM0RO10;A3O3QU,7>Q%OP<W <
M:Z^[IS#8B]JQ#;56YQM,RFF1>=CJO*K]UOJ]=B-=/.FV.H/#;_#A\UZ<(HXA
M:D>-<BD:8(K "1(/G!CJL+;1!SO?N]]MOIVP!( U,.B]-+F*?^7[_C.Z[1C9
M@XGSF?!]!\7JQ\X5U\,OSF#LBD/+@Y$*)^2,H,#2G$26,8RX]DGX!$1>JY_X
M C]=W$"UQQ:3B!V/1&KE"4F*Y#_ X*OY3>*JQ5W>X@;"A;#&((:#1]R0W$+=
M"B22M5Z):'RNR3?XWIVAWS,OP))/0N3NFUJQ^+7AXI<YR+^U  H ^;[&TGB'
MZ,!>17_>*^ S=\I9 Z#XIQ7_[/9ZW>^QU__<&APWK@:\ ^/]>#7<2K+F2=;)
M-C[TU@;CDD2.,P5@H1.03&91P*#.7,KH<%P+V*B6^KY+':CCBIN -,PVXE81
MI&T^\ZF,-MQH:HC8V.IVX@(@ JBQ6=L?8Q,A L$Z!8X"I&)0:_5KG>Z@H!MG
M/5C8WD7-Q4Y,+=_*OP-X9(R!MWL15@O0I1O+;XQ!4WZ['_.=^O!E;\_AC];@
M^J/']EOQF9IUK79K<%$;= OYZW7;Y<LPU&\E6 V.[:!VV@7ZUP?:UH)AV,Z@
M?5%KP=A],<Q6KQ;AR]U3<&[/8J\0H8Z/F[4W/WP$I@XOC).GXCB\^J-?'-V
M6[=&]++5*3XVA;%3^/I;_LA__O-ZC'X5\]&,,1S;T]I_\A]_ [6+[=I?_]3
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MD=,A(8FC-9AAJO,>KBZ8R=IK<!7DVMC*/9I^B6LLZC$^::!:%M?(LUP!T[*
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M\B_\CL6$:O<NBA_@KXV?H^@;_KLP"U:*5VW  $LFC)*3_V0LAJ,QF,$226)
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MB)L$^]0 _4FA)#S%#0#J"G;Y#.LSWH-=C?Z;==-4Y\074"?&.\%YZK3 [E-
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MUW(/J42H*#_$\2'9&.I/B5BJX(>1Z?R(?@J:8BP/8S_!T#A] _L#LR8?6F(
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M8;Y>@8R<AKB1S*/ 10^.E>4-A7<J/5'0_>K,7UH63&=W_G-Y2E F07'>BG.
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M+K7%NN;Y=>NV.FVS?6),_QP]UM>[P9KISYKIK_IM$XS.E[7C]U/PLS<TMQ:
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M$J,@W4'W\.\.3^C@\H(HBA,B8%V919KRPOT@:[YDW \/8MQ;K8U8I3AM*H8
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M_J%DIE;Q$S8"%R]+5_]DM20[L%P>'XF?.O9<ADCI3YR][_[CA>^QMNMYG=Z
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MHGD71:>96=I9D5GZ9$>U;H;YUD5[)U27=_I]SS2[G1"[G5$&Y/G'7+2 7IZ
M'B<@J]GM0MEM6T>[?NQV0>?!Q;18K/IPZ/* "Q>FY^6^=;=UWS:-%IVN_ERV
MPEH+J;TMIDK]8F":W4Z(W8Y3AJ%#KL>\[M$">D("JL\#S6Z:W?1YL-)]^R%E
MHX KFQ_^4/.:L/C.#PF?H%M=&T+'^=[LN=<QF%M'?WX=-J[CM\?_5W5CEB^I
M!R^3Y&N@@GAE#98N4GSDARZX>Z\:^-"^E[U /EN@Z[_<BU.YR=NK&S5H]F@7
MOM)-YN<H3KTH\"/##YT@<^&5,4^R($VP3!G!<ACZHHGAQ='$</T$O%/PE:<"
M1\>'Q],QB-;=&/[+Y??DO1HN2WG36$G+DR*>73?B?>%3(!-L2V(P@H*<T-_3
MB  A_=!@CA/%+@L=;CSXZ=B(LMAPN>>'@CA VS*$9-/XPCT>X^__YR\#VVY=
M?XS"QD\W-Y^-=WX(H_C *A\X2S)X*SUA71ML%-UCN*0\,'$-3H&%;O4-Y\$(
M[;HQPCL42R2NY\=):F (*P5"VBW;,B2+,$7Q6S;AC=LTBKEI/'!@')>[KXPK
M_Z5AM6 I;.0',!D7>.>/S!=2G)CP/3S0+G\?<Y??\R":"J:;!LR!3X'I8%GW
MO@.C(_7A=SBR\>'3/T$WL-1X8*A;)L TKM F8QZXQ#\)"[CA!"Q)? ^.6WRQ
M&..!JU^(>79QM$0.QV..X+&NG.+"=VI 7%%2?5EYA@N_R]<#TE!9ZIGP<*=N
M/+P^Q<:-X(\P2M4!1:W3'):,U2,5#7CE-WG3%,92DL8,7]W :5# %]B93>#$
M\__,A0)LBF\\-0*.06&@.0OO?#"HX,DW[WXNW@7? &\DJ> <%[5E3*(@9OGR
M3'BC6S?>^&<>JU_@@Y3#R93"EPXHB-A'DN$(2%CB'V0'4$K\N\,3.I>\((KB
MA AX8CPD#5_A?Y Y/V<*[]^ZMUH;<5!QQE2.?R1:C-N#IJ,/DX<WHU9FTMK$
M740#$DS1('I GVRWO>C.NP7MY;NS?X';<+_(F.I=[T7J-IK"G!?5:79Q+Y"C
M84,;%<X&[N</+$BN-6V.21MY3))2Y(G# N&A7:-6T90Y)F7&\#T8WU,0&O@.
M=5XTX:3LP5EVT!2_XXT1:4$Z2794^(<)YVQ(BODPPBY:GX%=SO'L!3XFRUO\
MBOS9TH&"&UDY) ST4DL/^),I<])$GQU'E8*"Z,@"GG)0R25%$L)?[(J/J<^3
MFM K1Y%!NQED<@+*K.(!2\.U^'<E#@@.])C=<V/$>;@8%;A&O9CZ+  =$'E>
M F;%:*8I?TS*NWP#22W%=-<<6/)=';O9)^HLY# ]^&XZEG<9Y1]*"K>*G[!1
M$@59NOHGJWT?/&-Y?"0B=]IS^5>E/W'VOON/%[['VJ[G=7H#9G4[PZX[ZH^Z
M?:?792YKN;S?^<VR.R_4K\9Q$41 RP&(]:W!/%CB*Q8\L%GRXH?JQL"NS!'B
MD3V4NV_9F[B457&2/+1JJSUO?\Q,\P#FC<3EQ*L,IA2+++B_L]K,Q1C'W/O'
MB[\\3O,^F%%XBX?VT&MX(=J&?_^!_;B,GU;*P=ZY?OE]'L[7#S.TQEYC^N07
MGOK"F(.E3"99Z*>;:OG>@I:'-='U9J$L"',=UA:P:<)?J;]<HY(*V.R5'](,
MZ4?7BV?(W'TNT4Y\70A*LR6$1>;%RC?+KYOTU=RUN/AN.&@.6ZN_;C6M_#N9
M=SNG.^5ZEU]ABX7+I=@KVZ8MXM\]=C^\?.^M6KD8%9M?,D0V07_BS])])1/F
M"<;XT4M(0?RX,8'1QXG!02I=XP.+G;&(Z[4M4QJBXIRSC"L7F2FFF&$ZCC*8
ML9N8%#Z<BDQAY&6\UF0O'_4P3I!_[6ZSU1MNQ+_;#&NUFMUA=Z=AUW_7;6\F
M;'JR>K)G/ME>J[?-N;/JD*D%M-*C5T6;9,=:W14GYZ,-1Q>]B>,L>\'8HF7?
MWFZ0$/QH9MRY[@Z%(@5GY/'(;>J=SIG_-^JV6W/RDD'W01AT;PN#S@!;;C]B
M<4F;=C&RL>!4G0&5T9-YK@5ODE!]3AMGZ8W;8>->;]IQ_")W1\NCEL>CR^,%
MM+_XPA,?;R,04E<D]LG+QF1; (J-.>',2M2V7GZMBZ0LVS*[O1TQJ;91!G7&
MP]&L?!:L;/5,RQYH5M:L?.JLW#4[N\)2:D;6C%R?=6OS0K/RN;"R-B\T*Y\'
M*]?9O+@4A,6?L 0SI*R_NQBK,D7MRTGB*%HK<!1S^IUE!XZ>V>T>IYWU7M!_
MSI)&EMFV=!>M>M.H:]H=+4?UII'6=?6GD=9U]:?1D77=!5QP_HNS(!U/.?N&
M)816_SHQDC&6V42>D8&)'9++PK#>^O?(![O['DSP#+ZO@NCLU&WT9-L0TU;9
MU^?3B4!325-)4TE325/II*G4,3N#'2/NFD8'HM$5$>GE,>ASZ%CQ*9FS=^OC
MRY?A;NVFY;53K*FDJ:2I=(I4:F_=OE)3Z,!AVN%04ZC>%&IW:ANB5; G8438
M36N(JI\\S2<U USXDQ=P2?-)=,D)[PS^?<K#Y-+N6ZZ&?;,]/$[01 >U-B)0
MR^RT6YI M250SQSVM #5ESZ@X09'"@MK FU$(,NT^D--H-H2J&?V6\>AC[Y7
M67VO$CV/Z7JRP1$=!M94TE325-)4TE2J$Y6N.F:_T]W<7-+T.70J%Y!'7ZOH
M)^L95:_?A/63IWVM<JS"\IN%[O8G65-N/Z6F_&2#/CHM75-)4TE325-)4ZE.
M5+)WA'#3!#I4^,,^3K+"!5P5E?MS;QNZN%2\M*V77VOA:K?,OK5C3G!MD/\>
MB3YJ3KX$3K;[9JNU;46MYF3-R;7CY+;9;_7.FY&WN1!Z&E/7C[HML]OM:_*>
M*7GMGFG;EB;OF9*W8[;;==7-%U!=\S-/DE=&&(6-VUMCG?>ZS?I+A&G#UKM1
MAEW:-^C\53ONW+S;Y<XA)KV?>C_KO)]G&0*UMC88=9#ZL!3J#S2%ZDVAJ]Z1
MBAXOX![A.8RQQU==.Y9ZPG&VJ8>E=TSOV)YV3 >3+R*8K"_X-">?!2?K"S[-
MR>?!R76^X+N ('+953'^9CAC%MZM1@]^VMIKQWOU"&GJ'3O_@(O5;AXG)G8T
M'OG;L<5*WQ3H_=3[>:3]O)3VOI]C! I*9[#(+$Q/L@*S?9%=?:TC@A1H((D+
M(] &8YSU:: 9_L(8_CP)M&.B<AT)=/X7@Y<0NX.YL#MN1(Z3P=N=V66AJP]:
MS6U;K)QL3&6_T92S9(_^X')";D</MAUDC+-D4ZW%-'MH+59C+78IH<R*->ES
MU\A"/TU.,J39N<B09M<<MG7/P;K3:- ]8M=!'4;0H4NM>2Z21CUL W0^-#I_
MS7-! 4P6AAD+C)B'J3'E<=4$?8K?<V:9O\M66&NV'O1,>[#MO5;]BD$URYT0
MR[5,>^L.%/5CN6?2^+4CS_YR[[20GI"0]LSNUE4?]1-2S7*GPW+]H=GJ'N>F
M19\+NSM /Z1L%' 5R(4_U+PF++[S0TJ8Z]$./>ND!W.3[L]/VL9)_[;9_ZK!
MZ-(:)($:J 9>68,JB; NR_=FXB,_=,$Y>M7 A_:]U@4"T5JOK)=[N0O8Y.W7
ME8T:-'NT"U_X-.8)-<"YBX"50VR&8]S%#/[T0R>:</ H'>[?DR/I@E^9CKGQ
M^N;+VUOCQDE-XV'L.V/#3_ Q3+]TX6=&! _%ZO=7LOGK2],(.8XJABBWC;U-
MX3^B#4_D&9]$VUAXH'D>5+=K3'6VT ()*<0<)"8+'6X\^.G8B++8<+GGAW25
MA$0JUSPVC2_<0]:(#&Q18;>N/T9AXZ>;F\_&.S^$47P6&!\X2S)X*SUA71ML
M!/QF>%%Y8"(_3H&%;O4-Y\$([;HQPKLXFA!Q/3].4N./C,4I$-)NV98A680I
MBM^R"6_<IE',0>HY, X*N]6&YZA\PX>)IF.6XN_N_2A+@AFU?8Y]#FSD DEE
M/VB@> KZ1=Q*-HWSH&RG;I0MB_C22VF#H<Z>1C&*V&A&2ED1*"&YQ$_2<<QY
M8P)3&&-4T8_<U:(HK0EA :%!<5VU+Y;0[[FI9;4V(E?!RA4M0VKG:Y2"MOH,
M^^+!^115'X C+08]!O^:QCZL#J:&^\A@)Y,L2%%,<-?@ET'T@&;C[IM5H6I[
M^?;MG_TWW%!2ZKWKO<C 1E.H;I?5:79Q+PIR 5MSP=5 *1_WR_ X3ZXU?>I!
MGUV,SVN45TW 8Q(0M!Q0Y75T[X.(87X14$J:^\FU,05K DP_T)&1YR5@^X]F
MFES')-<8O@=Z!6![QX83)>D:#TL.UK&;?4P46TPC>_#=="PC#^4?2A*VBI^P
M$;AZ6;KZ)ZOM! <HR>,C4;'3F4N!*_V)L_?=?[SP/=9V/:_3&S"KVQEVW5%_
MU.T[O2YS6<OE_<YOEMU_H7XUC@OK]HXW1J#]OC68!TM\Q8('-DM>_%#=&-B5
M.4(\LH=R]RU[$_.K*B^2259MM>?MCUMI'BY&$,C=>$7:7B0B_IW59BX&&,/>
M/U[\Y7&: \6_8LP-#<+7\$*TP__^ _MQ&3\MEP,DX-[9?GE$[A-%;]Z+ QA-
MXK="HQOO4SY)'M/@./GN*F.? I&%HJ!R75A6P*8)?Z7^<JU:4OLA38Y^=%WE
M[R6YJ_1"\74A),V6$!29 R+?++]NTE=S 6SQW7#0'+96?]UJ6OEW,L=D3F\*
M45H1;!8+ETNQ5\)N+:90/Q;)77Y\6JO(<0RE^K7L'QF2(;().E-_4@B!2V>*
M@D$8FZA$$Y$?I85A^,B/55?5(%<U,7B(T8D/+';&(BK>MDP,:]@T ,4WKB@2
M&66P&#=Y^6IU(&+MWM:$U8?#YJ#;WH73>ZUFMSW<B-.W&=:RFM9PL-.PZ[_K
MMNV+GZS=VGA"2]2/XKDPHO/U3)]\)/6O%AE^CX;W-DGWL+J;+$H8TL=9UH*9
MT1(' >KK#T)?ORWTM0&J>H/<%LT=VR8#;8'T66_.P7/\N1:\26[ .6V<I3=N
MAXU[O2FD:_W.P2-HSW-(JW^/+,@3%8C>-MOI4G&UMUY^K1.JNF9GN&VEX;8[
M4//T2\W(Y\#(0[-EM34C:T8^=4:^:IM=:[AUV[4C,7']++=:6(-/!/<XIC4H
M0\\[@<2=;-ESNV]V!SOV%ZECW?-9$JG3,P>=;<]X3:0#'U]#T^[V-S^^]DZ?
M^ITFM3BA3B]>\0;S?1U?9&OC'2>;1#"Y/^F#R\(TM?I]L]_>T=VID4=SYE3J
M@E71WK;]GJ;28:EDMTQK6#LD@/J=,+4XM4[/K_J)ASQF@3BPW(D?^DD:4WKI
M97E8=ML<M"UMO->;2!USV+(UD6I-I"O+;/4M[6'5_:PZ/0_K*Q:M,H<<+*J=
MN"RORAZ>/M;,>5.H/]3>5+TI=-5MV5O?7>FC2;M1CUU/3:;,CP6(![I20013
M"*($*_QAQ'MXT17BL]PC&D,B@%@NR\&RVMIPKS>%VJ;=T32J-XVNVJ9EM;1S
M5?<3[/2<JY^8'QI7>&2]-,"_2EC J?XOYBPP>(+X8+N?6B=K+[;-05=[7?6F
M$4(]6/:UIE*MJ51+2:K?25.+T^OT_*^YT\OE(\P43&'VF9^,)P+]X9+<K=V4
MHC;G#WU7TNN8]G"+D)2FT('#%H) =9.C^ATRM3BX3L_M^K0:J/FR/"UK8+:M
MVAF(VHBO7D&:=JNE:51K&ED]TZJ?(-7O<*G%@75ZGI9$I4O9=V/$0^[Y:7%L
M79:+==7OUZF01!ON5>H,-&UJ2YM^;XL*8NU,:6=J,[YZ^T?FI[/<FQ+A0 \[
M;&3P4:G=S>^1'Z;&/0]3;(AR68Z6;;8&.T*J:!O^4#:\V;9U^5R]:=3O;5LN
MHITL[61MY6253S#8"3C"4C_,X/R*\@9ME^5RM:U^W2+QVK2O6A?]EMEJ;9L&
MKZET8 ?,[@W-WE!7:=7^[#H])^QCA+Y6&D=!@/T%? G<1&TGK?ZUD8Q9S+'%
MI3S.\*$GGF<G:T->M<U^>XMT7FWC'YP^[59/TZ>V].G8G1I1IW[G32W.L-/S
MOS8^P[17IG,-3X1*5VV[3I<NFCK5R(8]K)O\U._DV=MIMG-7M^=FEJ*%&XWX
MRD^!7LYZ_K'7=4MX?$&UZ4LWMP3#Y:HW\78-YM;T?.7<[MN=/:[!6//RO6_@
MRH[H\$7H^%,68+]Y-A-EZA*E,B_TPY+U1+9[ILYY8-Y0FS[9K\_>O>]\_:1D
M'D7Z%,5$-6'<54Z,E?R2\-"'H3(8W<EB^'488?-V8)X,1H%7"9 #^(9/IF3P
M&M3*D1N>'\/,B*\X&,:N\4?&8I@O<1ARTQDPT5J@UU/FK(T69A0MX[=C-_&O
M53SWRKCR7\)G"4<$#>>/S$>^<[,8_:^*&J*_7/GPM,OO>1!-J6>]XL?BDVD<
M_<X=& V.? ?& @Y%) [?X4N'/0/&7(WEN"E7KFY4?226?'Q)R1[T7Q ]\!C_
MG<:9DPIF$3H-S&@6.M@@-Z!$(M"&\1U?T\3]9)CG20@V\ZNN#?_LLJK=&6J.
MC5@^$BJ?):_.L+$YO0".V1B5%C*U0XP%RLQ/Z7EX<!*Y/&@:7ZDULYL)"+SE
M8VXY93\IB8&;P>\BF+<0@ 6+<,0"Y/[5W"[WOF,W^]@T>1HE/G5P)W$!H2W:
M@@-MRC^4\M$J?L)&211DZ>J?K%99HGOAD3BNTUW68E[\.<Y[E$_9'6^,@#>^
M-9@'DWW%@@<V2U[\4%TBK&]N2Q_9#;F/V+O^^E&=+C[R@3?"]%6CT^RN4T>>
MM[=-$_, 68E$^/05R04^!=-AM9F+ 1+E_>/%7WR/M5W/Z_0&S.IVAEUWU!]U
M^TZORUS6<GF_\UO_Q8]?26! ";R&%XKR<_;C,LXXQ;-B:ZR8DS$W-EQ8R0B6
MMN1SF!TX!KX2_[XLCK R!GBH[8E";@2^![-T?(YFD,<</\"4:SQUCAGZ^*LE
M4YIA[*#4;Z-6V_<(KQQS_S8,HQU_"X6TB$LYL%5 8QEW*+126E>)SL'XL,J&
M34/4=Z=C1G>%RKI)<@<"S*THBU7$91QE":YM"GZW%\$(&%AQ@LP5_NN2PH85
M%Y"H6O"K+$$=-0*G^,%$OHNY\8!_A%%9ITE%5TN*N\<DYY:Z_1RB6]L@Z9Q0
M;.MG=))6K.?9'#Z0JJ6ATTKD-(HK@=/2F2""IS)B*@.F] Z0^BF+A;9(Q^7A
MYN*P^".'QREIQ"P%X0[Q<E#-2H1Q*Z':ZMN>P, ')?66/+T)R,8)\?*:Y>P<
MG5UIE<K [,(IR^"P2J9( CS=4N,!^31@2>)[/KR"!GGS[N<B6LO"?'+(@G<8
M<PDI4GL7LS"_]1/A!ABA"(Z\OOGR]M:X<5)Y)66;!HA#ZK, 9AMY7@+K'LV*
M@"",A.$4N04\Q-'AO(V<(K(=T192$P$,.D<8]88?//CI&.8]#5@8XCY]^B?H
MA@D<Q"D=YC5EEJTOP3:HX*^U^&^ZO*=>6:QWU? -/BAF1P3[GL[>CS/8">C:
MI];@GB[C55?^^))W9\LY9B0'@C(2T0;A:64*..S/Z+/?2I_]W_^[7'U61BDL
MHF7CW?[ZSKC]%XQTGN;"#M5WM5[^)HM=ZTP^^PV;,"J*8<O&Q7S K6 [-(,#
MKNS<BCNMI&"5&VVJ&V/UQH^?WL-B O"+E?6]Y7C2KB';"(;%C=W9K%&[NNIU
MRPX&W_W'B\<CT5:[]6+KM#9[G^ZH9,;^<B_-!QWJHA;%[7W-A'WYA2= #.<L
M#HE?T65+?<S&2KFPG)'1'):,#0^X47![(7O :/?,#^@V@1Z2=W"2 \7OZ"<P
MRCW(&O .N'9@\SIT:^VD_CWP-"S@P0\",/@,YG)P^E"N)->%L#>&92MIQF'5
M5_!?GG!.;_<R/+7H*_ ^051(4H4D>YGP,V-T>N-211?\39GEUT($)YS3Q^2(
MJX2,F%/"!WGCUR712F"(Q)OA\^H50O+3V!]E0E15!.W_M_>EW6ECV:)_1:LZ
M=9?=3R:(F:0[:Q$GJ7+?2NQKNVZ]?E]Z"7$PZ@B)UF"'^O5O#T<3" QX0(+3
M'ZH=-)VS]SY['D+/^C[QG!$F&^$;7,\]*TKBAQ5,AW!33?N4>P]*OBD 1^/#
M9R*[&0(@$[LZ1E&PC"-<7)#!%!]R7-;0=+]KQ!SP%1S4/4'08M)\H_[^6MQ[
MSCU^\(OTI=,%X_TIX]>;3H4/UHD#,AL^B%DMP%>F.OYA"3$*4O886V9P98;9
MOC&-L*TCCU"RDW2Q , HS6 H.!3C\0L?BH7,Y^J>[@NP+D<CDB$(UIAF$3N9
MDV@.04CH1!YI9J:3L#Z7T;KB=/J(L'>[PTKFBY]AR<V[YB:!8:/W"O)@%6'
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M8+GLG<BRNS%5UK3;!T^2.MBM"R\G=.:BC7CKFUXW57^2,Y66Q  3>M.JQ[<
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MXV# (:BD>?Q0SW^-(AFP]W"2A4T&+B>DG'D1?'@4G+[;T2G07@4'N8I8V/G
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MY5=V/,//<K$XPHIR_2EAT[(BH!YK#I""_28MLX>1[8RX&A6!BS"F1'MXS)%
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M;, Q%OX]GFT/T_: H&3N'C*$.Q<H@_"1S?G#ER1WIB]8<@EOA:C5AW.ER/I
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MI5-_D6@6R>%XE26CG9R":@CT+0VMC"-COQ864^L?TG&</>YH/M JB2W0B0G
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M;CG2/M)MCW#,YV*.C>=CCHHWOAYO)/"^,H,T&EB44:\9?UT3 #'&K7YWE%_
M.:Q\Z-NK/FQL]&&:^-YZ7T!@BD<?-X\6/XRZ46\V#>H[1MR5>!4P4&!,+>U*
M^-02#7G?11+KPI8"VK?/EUKS[)_8R#)SUQFW0;].PU@W%''"M@;:(!XNJIV8
M(V^&5_&[BOT=O&IH9#B?8CR*\?R$3LT%QG..\!_C9!:,+X/:=3N!=03:5QS*
MYO_IW>E%RM::L0HZ-FT,(I.MZTP/V=S@&FQUSYWN6R>F8D5'P(H:BA4I5I1G
M18U'6-&5P"D6@YIV8P$N'F%$!2-I%"-2C&BY]MOXJ^)$BA/E.%&C?$K14([_
MZ6F_UVYJYS5\B%9C--MUQ:8.GTTU%)M2;&J!395-85),ZIB9E%$W:A??;LK,
MIN+<Z%=I:+LAV/[OQ^O?M LW",F_^\FS(G3.<OG/&8]JCR^.Y$7X [[O>B%.
M8D7?KQS22P,431XT^<D,33C3<#B'PC*C0-"\5OI8:-X%-($)1QZ-1ODQP!>4
M:\LWQM^KY5"J#NP!'=B;\U_5@=WAP-Z:/SS7F\Y!&(;"I5&[-]9$3,WD!*M#
M<["'YGSPFSHTSW-HSDW'BG@VN/:;[7['&CIUA [_"'WZ_$4=H><Y0I]P8K2M
M3M"1G:#?!A_5"7J>$_2;.11.H$[/$9V>J^O/ZO0\S^FYXN8-2H<[KC/44L=G
M*XC1V$;MRKQ;Y:<[X;FWF)!I!CD_'#K5+?B ";_0Z/,X_1TXV6G! 7NL_<[K
MM19XG?8[K]]&J+C3R%_9:[O)?[]0#0)6-Z#O=77_EM)LK6!OFMQ*Y+MV,*G4
M=F0R?L&>Y*:TKZ8+1Y6\[=C0 X\K3I4^]Z8SD'MFZ/ES3L&&'P>^C_&PO+C;
M=>LO48 @]UQ,BDLKYF5]H#%UVV_GR)][S89+Z]K'E*X+4VLA]KMC%Z;^3Q]>
MO@O3X3=<VOM:7KRWTM[/0;&N<W/QR[?![>_7GV\>ZY^T<N4Y2NLT7Z$AU#J!
MLL,VBD[,'O=QE4ESX59[_XELG\1Y$+?[6Y7^ I>-?K.ETTW7XLX.L#]?J$U
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MT6*7\5J@QCYYN&J),ACWGJ2U(EFQO3I9\>W0&\WA_R;AU/GP_P%02P,$%
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M6(6]L[._]0_=LPIB(0M,A;GMNAZR70OB:<I@4&'&][ E#&2/%PO+P%^(N[%
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M>R4-E1A,43]9WUN7R9KH^]Z*4.LOP5FV B95A=#NW8AVI1L5:2@5F#L0(VR
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MT0\BI* ^?*D:NV_5M:JJ*O9J)0SNTCE4&3#OK:!2=O1^9D%X-T#.&!<C44$
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M5RJQD&4\^*)^=M?KC\#0YL(]K-E2@J =TCE(M9"^\JI R.2O<L5-EDI:DL-
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MB<ZK8_/ST9ASY]F9DA&R)M((:;,O-C*PL59)%Z1M/.,% K)2S1+$U.=B\XZ
MA[#5'(B1>RS8G45\<$/O+2YJ#>'E51'U=SB_'*=:$Z)H;35GQ)R\JI2>P8EL
M0?,<E,TFY8<5S?:W;9[ ,H0MX\"4.X846VX4CVQA=^KX70_L]/$8[H]89K61
M[U5EXI&.0F>D]<-#G47%%+A ?EHP@9FDI-6BS[7ZQ@,Y6+#@41\WBA(26;/
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M$:%DN2IC8R&RZ"'&R)7V*'WJ=?2Y&<+]-_LOGW.=[/\.5[1?GPB.<I*N9)2
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MU*\T@#BI%L1E:Y/F@EH;'Q%W;H1X]Y0ZFZBD'66.<!L<CLX0X#G2;C1Y,_,
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M4?,M*/O7]?::N5U4;0>Q-EC)*U*_SL&IK&0N12VRL@GC3XP$G>8</1QK40C
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M$:4,Y1QZA?X;$[<*_*<X876<L']^-&A@TFL2JZ=P;COZ3*)IQ%%E&H>)2@Y
MHVV(W(0#A[+:=T[&0(P0C25!@282+"<V.4^X""'ZF(+*;3HHWF,BWQ$G/18>
M;Z+ZV@?);^#?__:CX>BB@IBDB*54$!,VE/)#D1'TTA)1'$+PV4#?F^:%#]Z_
M_WD W725!-L@1GK=C3Y-87Q:^K%<OD-#!S<#Y90XY0QBHH)8FC,1PG!E&3?:
MMZFMNPS-D^.WVO';67L5^X6MPG2^8/J@:NJ8+<=U&$]K=[W=080=A-[ $UJ!
MSFM)/=I*XDJRKA0,31_N%6A()>ZOP4G;J-C]/JEPAZ^R+R9L(NLFI[>77;\N
M<JHU%YKQ4L"02R*3Y\0K ,*D=\P(!4JWZ4MY"\K^79 :.KIU'+N+@!LX%A_.
MP@3^=88[Y\NOU]^X0Y 6E )TJRW"$NCY>*_0WXE!&>NE"MRVT?MR0$_NQ1I2
M5=#A;6IMW5!R#:R+%(\>P-K6[5\%[4 U_&LH\&Y2["#]%GO-2H!<0](6=],$
MX$N*#B..A4 $!G& JP)-8YNSE#W3XJX*_WMEQ29";\^&BV0MYJFEVA'F;.G9
MDQCQ7&'XSHW)X"7:Q3:7>$OA'*"^<1UUK2?!%K)NX(C\.CJ;G/F3X_&K41[/
MT96^3?,S/FHTSY (XS3CYNC+YJ@$"=1)QT%3)]H8A#6@GAR2U0Y)+5TNL3.M
M>'9Q)]$#75//9"V\PW@GU;39CR4[:*+!OK0>9,*@+1L?B&$EE2LQ31PX0S@+
MWEB:O&Z4K7L FMSAK1R&)9LHH/;=RSNTO"-(;XZ?OX#3[F0FXH\P\J/I>YC]
MTR+R49HELQQUD^E%NE5D$*C%$)]J84K]64.L1I'X)$$% /S&PGG:JN[/VP'8
MOQM348?=GA6PTM/YKY\6Q/<:OYS]8/;](I[WD'\H?_[Z_M6E*/_XXX^_? 9_
M,OU<IO 7W,M_FDGR>CF#[EJ_7C]**[*?)A.83O#'KX<^#,OD89*[\?)??@%3
M/SR9W)S49'CZY>3.ZM+[ ?;3E>1N2O0<W0TZWB,9PI]3&"5(/_XP3'_[<9BD
M9THSH(P;"9([QZ3PS"H538S1#_8#\;XWT7U]V90U6\DR8^CY:AIQ[4=%@N<)
MU[X67,K,1:,-=(^3W-4%F5/@69A,QSY.!XYJZW+I"J: $[18@G@A+0E"4QJ\
M"VC&FHCL)H['W1U[$UXN>BP[Z*MV0<\;LU\_^6<Q=F>CZ>0JA>(M3 >*!1,#
MDR39TE*)^=*B#+=J!*YH28 (J5_UQUV1[)]NNZBQ.Y0.6K__68__R$\^XU(L
M?[S\UQG.X*04A1AD$ZD&B0Z6S:&(+A(OI28R,IYT3AH6JY:U2,7?!OJ#9-UA
M%%>[6ND&Z"_?^KX&/X'WPT^?I\?YUPG,9#EPAM*<LB'!E6K=AI5NJ"&2Y$)I
MLBBR"OU*%M="]"!)=3B=5*R1NL7*F 6/<_D-(!AN-6/$YU+6QK!2?\8K8B%S
MHY/V/K=YM[8=W@?)LSVJJ&(YMYL".,X;H!]D-*YH2BTQ#A>$3 G70LEBYHX#
M"*T"7VQI7=6?WPCL@Z94:^54K!)T$_(O<))^[L;GC^'>^?%T81*#4F_:12V)
M+3759$28SEM!P*O,=%)"YS:9P#T!/@+>U%5"[<*RMS ^6W6@5"** $)($0/)
M-B5$"F@@9> D&8'0I5:IYRN!C89]D"1H+-T&#_2N'11N9.LNQ11ME*P$F!QT
M*@7L#7&0,0CPGIJLG>6BT;."'9$_'4FMS#;>)R>JU];<-NJXF/6W\C <8UD.
M)*N(IMF[1%S&=1FE0;$:R4+/AO:[8SE &O->E5\E7MQ.<X<]_+HXO'OGO\T>
M)\[Z78[Q-Z[)?R"9TL&B%+GDE,A2IL +&T@,$(2POER+'SJ$[#.1[X3%]X$&
M%0_6MIC."Q31> SI/7P%_,' 4Q%3HH&(*#21 B()@2IB=$Q&R22];?,N8'O,
M3UQMH=P&QW+;BFV0C7:2TDQ 68S2I=6(.Y:GODED9RR-T.9@;EO$WQDE]Z+8
M!L=Y5_D9UV: P6!7.E=#^N=P^OE&:/@"U]%)]Z6$ FCW2Z X,#D&%9(F=%;H
M'DJ3*"XBL1ZLY@D7VF+[O$K4W!W[=T;2/2N[=L>H:Z#?PZS'^L=NLW,+X8,5
M45*"RZHT1F*9H+M=[OVH*OER2BO:*TC:&<IWPKP#Z*WVN>,FHCHYZ?XHQR-E
M[71G89K/3FXG/ R<X#$B:'2(O463+SVQ#' '8!:_(3@8JZMGG/2"]G2\M'-^
M2WT*U$X[>#?N$&U9C=</_,]F><-:.)92>7@'09>GVKEDL",N;T,,"-G[?FV\
MU@SR1++EJ=Z5U%(Q:IGA0OM[Y3><WT%+M+F<:K3'Z*N6'K^BW @EP@1H'C*U
MMN=AXY(/?Z+'4GKLJH8&L</Z!!BJ@'D.@J!=LZ7T@R=>*T.B-DZ;+!1-H4E8
M<,\RD^X[N^IKLT&6P!'.NCBA)40Y.IM,4:+CJQ/T$+4W$8EO<_!$,EY*Y:&U
M9-Q%)X((3O@F5%L+ZXEJJZA63YL->DGLZ_6Q=]10:0*Q$#"2T<F2P#&Z8LI!
MXKBX!&U#VCU-L"+]_<G)PR?]?>35LNO$'XH:TO2O!02DO_TX'9_!U3=Q5/AS
M^O)D-H>__3B9U]YOW3+(4*>I#10GD3'^+\W*K?6*&)]*9529;-!-ULH=P!Y[
MA82-N+1ARZ!-='J0GB]] #ZU#-I1L1LW?]E&*P>AC\XVR90T\3Z4EB.SB@"<
MXX;AC ##)6]44_) M-FQ95!;UFRBC#9L66)CRSE/[L8(_+($LW'!@XY$I5EW
M#UV<8*[0OTC*H'^1M>[5:7<;SO0!>!][M&RDVMO$J:Z7%A4L+S?ZTO@1)I/S
MED?S1N,8?0=1WA<IGQ61Y830>X,J3B8RF07/H5$%L76PGERCU:Y1/7TVR)RZ
M:*=UOMWV -.VCN5U. >J75E/72M:EVTOZX;][<Y+UT#6'.-:-*H4S2L#9+S+
MFB3.@V;4^1S;=K([8'7*/>E]$Q'7[ZZ12F/BXXR[ZL5NEW5T$9@C:M;U+):Z
M05X 06M'@TN4<[90BW!EAXU;'WZ  I/;R[JK**C:=2]>#S-\B$,87:*Q+D0;
MLB'12MR1F .","C.U'A#*16F9]&M6Q_]8)6VFY!6KK5#%\;Z$#]#.CN!\LL3
MW SP7RW_Q7T6Q=H8U&$*8NTFNX5B6)E"B$Q9KW.2R@GGM<1X@Z>8G6 *-B^&
MM3&\^W[9<75X[J+3N(@YT:D\&DS)D^",) P," 8Y.-'&DWA A; VR#1ZCU/Q
M)_.Y#13U.M)H"96Z- ;C:"$YFDD(D)W,RCEQ\$<WUP$_[KO139B^P]N&K1EP
MP!I<:-6&"7'_## I.<4P_HK^U&20.-4F2=S3K3*X+PM6*KX[8JR '+,'2?LE
MGNV.Y8F;NR9!UE#R85\Z7CP7HLHS4#X2DZ@D4E-37K$A8@> [KX3U#<[D-T0
MZQ-MJYC4S?5^V->+KT930,%.7_[Y!483&-@LLN?)$69YJ3ME& F T2EC5%!#
MO=*V32.![3$_,;<"<W?AP8'KCUTD'EY 3R%$#0X!4\6)Y+$\+V*92,H-@,Y2
MQH,;W4703QRNP.&=F% QP7E3?^?CV(\F/I:_SHJP#W@V691F=SXR2B0*C 0F
M Q$^>1NU9=[YVM[L(H@G1N[JQNZDUMJ/'S?!W6%8.$.,8C]?2I.!\ +=;R\(
MHQ)=&J<S3L,%PH+#=05:<2ZK<W(9DB=B[DS,G17<(&]Z _SX*Y/)NW&7A]/7
M^+<!E1CYY<A)IA@22N]*U3+(A&97.G9I2-"F/N3VF)](7&&_WX4'%<O*;5S(
MJ51CG:OC?/&5-\J0K#>9&9*E+0EL9?DEC!N-YCYX69)"JMO7I4B>J+FK?=U=
MP16[V6\*_FTWZB[\Z!MS&"CGJ//"$A6,1Q]:J?D$A.?&4$C29U:;H2O1/+%T
M5Y;6472#KLC+;3VJJ!CYGU$O%Y,\7GZW^1QR-X;YE#[Z/P=6,^444P0=;$&D
MX@D=&P.$!Y=UD,(DN<>LV.TG\D3YC?)P]\28%ATXEWOM_L^7.4.<KIC$((32
M%*X\KRTON66,FH0H%4E1*)-!T<#WR/.[X#ZQ>2,V5]7^$L[NK0#M9&&QP>3E
MG].Q1QS#D1]_FXD/MZ;R#U&Y)[/-:7XT/? J\JA]Z:["<9Y)&N)*UQ\62KT3
MP6+F_8IR[P7N$\%W]5#V1)4EJZ'&#=SJ'>EX=,=^A.'"<2X;D?&AM+(71,B,
M$:U%3\PQW(V2LXH)GZ(V;1YYU\'_M 2V\EC:\&,)S7>^IMO7:YD@(G-1.61J
MQ,T-M",V:$HXPZA:>&#&M>GH^%3LX"#+XS[RZJ$4.U#!*^6X*X6)H61)X9Q
M2>(A<0XNY+3H)3T5.]@[ES8L=K")3@_R6KT/P*=B!SLJ=N-GZ]MHY2#TL3*
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MNW'$^5*:#!FO9+^Z3/?@Y/>PZMY)M UVE*N97[:##\ER!C&0P)PNA0_1NLG
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MD[=!L9A=9M*C2DD*#+&;O__H8TZ=!72H*G:5)O23XS&;O=2:*CHGQW#Q >C
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MM_#EK^(<_W-%*_SU>SWS-G$JYZQ6.A=:9$UWX)Y,D\"!R6*E<0A&^S;](78
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MH;,T%968"4(Q+;@CU-JS)+S2D!%D;E5B> C><[9,!M;6@&7]&]1;8&UN^SH
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M9PBU,G 3Y \A::<B,R@MTX8V3R^2H&U4A)RX,SJ97K;S]N>>$3M:2WUG->;
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M6ADP,,DUBP4OZRGU;CJIES+TZXOET+)5#\?YJYR7SZM=Y<MT=KD:E'9XKLA
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MNAMM ?&2B7-4!6QA3O_Y!==IITMIO/ZQE,TJYTRHX$Q1ED7+"9M.M<N%"$R
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M%QB#M_YK/H+]L3Y_!ZI@QPSV0^0W<(>^VW!TUM[6B?+!K'*3#(LF1\:U0U&
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MC _%V 2A":-^IG/K^)H:?#C1=%)G7*^<R^4E#\'L[F&J$G))A-HLVU6!]2R
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M.[%^3U2^[YW6(IC,0&<R.*O8P&!-)O0!?#)9EC;=/%],^7X?3@VM@::Y=:L
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MQ[@GNEM]6[+W;#AN5. I<5PB-21+W3V?_@ @60^IB@6P0*KVQL9ZU!))9/Y
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MC>1_-N--6_R'U[$)49UXP=H!5(D,E,Q@2VCP>R_V_W<ZMXT$:F,CUU)'C9+
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MV L8#Z+$Z@S;*<*<FV&VD1 H$4>98R=-CAE!S@7YY*Z_%=K61.@")J>4>))
MLY*C"^B>TJ239]H'N#_+5XY_X/>$5PM5A2G(4@ICSGR(_ C#- P#&. P$SY*
M,8E\TYCVUG//C<:4-9[734[Q$FPE#%DFUCT%[WCT>B0D$]/,:#2L@M9[=#\Y
M3KW]S-E"TWL4V8Y&[_OSB-#&%?[COBR:ZU^N/GV2=I$HEWG9?Z04I8AC ;TT
MIBKC3$@#)8J@G_"8)Y3C,#0*BQX9Y]P^VDY2H$0%:UDM]K<'(#6()+@!:NI
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M-*+^SW;N[ZMRN>2ZE>&5^%@6\O58%4PM06_4(4\)XUNNFJF1.$TSSF$2J9)
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M1C$+Y;@^#8QR\9U*=6Y4J\6#I8 J.4IEP#46#I3;^3(@YY>8A8G)O%<):)W
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M\2 *(<<BA"CT/"@)*(,)Y7Y(490%F"X>>45*4SXZ01J;#VU;IDD-M;;L8UZ
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M9O/'#_%N_.\"['WU7%G\QU$:WG4Y?/N,NRU'==C=93E^^;C X(>\*%4\I3^
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M])[Y+)H#TN[8,8>N<18[^\0K'225XE[+>5_U*96$)1$G:0P#@1.("*:0H"R
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MI3!+XP1&-$A%G&11F%++;>G1PIP;5^J]L?R1@X>R4<TD]=';38/D&D @6AT
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M*P%*I85*!ECMZ '^KA0!CZTF-DO^B(DRL9NFA7]JBVJ-_$9^<-4COZL"T#J
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M<!XK2V[XM%FKB]MI^+1(N.7=(]:"5Z\^O[KFM_>;0W<BB+GTH"F,*5&'\(,
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MB@C$5&*1$X84L[IA;-'7I<W/1EI#E0G7\JX*.SKX%R?P)2G&:5*DIB)A9.@
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M9"Q$1*S-L[\<EV:V5YJ8N,76;&F4 5O:^%GR,\;+PL*/,PH#6WZ/ 0"_-=H
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MA[J=G0B.Y<"&HY$7M *#5F+0BGP%&J'-C;<_V@<"!G6<8 I;<=.JYW'K;[J
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MKR"7ME1LZ0$J.6UFTF9]>)!3 =2\ EJY-M_U2-$3#V?4>RAY0J(TX0(F>5)
MQ&,&F2HXE 1+F9CD$9FX[ 9&&<K1-@M;">#&BE[ >-GM+<88A:$]A$YJT(C=
MQ)I;P<&VY)O@Z=4P6>/G(AF8Q-Q3F)&ISL^#[#4A^IGM>6R+=,M55^*N"\PT
ML<+MD/S]_$,Y73;E.I62?'&GVO/KZS]H)>I)G@I,\RR#,L[-KDEDD"B40)HC
M)0K&2"RMJ-7#B'-I*^7=)M *9",GH(V@[HR&@<;+8H<UZB@,?R15K4N==J'>
M-AR^<^QT/P<KA4"K$;A378(.:)4:=90<=G"CCM9(&SS+45N\'K6Y[:BY;=>"
M@=R[FSN_E_$V>\$0V=D+AFO58S%\7\WGOPN]:5DS7GR=5PLUGY;SCH&E4$4A
M8R%A(6D.4205I$+[+U'"!$8824D2Z\7N9'>7MIBM!=[F7%G+[& ?3P-ML4H%
MA6_@5:@?.1^BH-,0.BPA0:$<:8GP_!C=S+XU,+UF_70KXYEM:XUVS++]6WX1
MNO>T+O6F9Z_2RTO[YZ;2(,EQ1!11D"1Y"I&IS4(0SF"2)$4:(YDCSEWB<7;=
M7IP9-E*WQ48;SJQFHKF%92SQM@O"A$=Q:&N\ G C\E5;Z^D%_-;]=Y#:CVY(
M!0VI6'8]:@#%#8[]<(GCV_Z9:67#.&2X@]O4MQ]R9HI03:@2!2\(@0A'"41I
MED&&J$8^%XK&$J<I<V(HZ^GKTDS0EJA-@)]O"PO>?9DO)(@CQU(-?5C;6:)
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M3;M/E+>0*\K+:5/!46-O",/!5.L9BBG<"L;>4&%_"^,% :TTV0GOV;TQ>%K
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M7Z)MEDAC%X?&781+<W6,^$!-YW]T)<TV1HJN9?\O-U/E,2YVMFM8M$<XM&[
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MK]ZG:ZEDJX\+O4YE>]96YXUZ_WTE%Z7)"$IP&&*%8D@"H4W#5!#(:!#IGZC
M@1142F[?;[2;V-1T[2>YN%\]F*,L3*)ZON$<R)9E4'?/ #_E"_"X7*P>2LO>
M5%;@=^M4WY .?9<T&&Y9O6HODQK>#;L>L7-IA>D/PY$2V+Z:S,VRSHY^D&"^
M^:*:?YW[LOI*/K.$K;N9Y)DU1FP#:2?-?@-'RV?ZV=5-\\?%_2=3/UG]IQF(
M97YLDZYG&*5I$)CZ1I5(D^G,($L2 546)UDJ2<KBV,5NMB,[-5W](?^NC;"F
MJ7-5T+QLY=#'0S/N. +0$GP[J]<_I /KZ@W#H.+PJOZ?I@=N^Z^6;W^VJQM.
M7FU32]*CVIYN<!S:EHY/]]11IM+#A"H+^6"4WG-+8UF6;VGY\&&^_/-7*>[E
M+S1?F%_J&]"<EN4FV>5::>UP1[_/,DH9%PCIO:$)1%QED$F&8!C+ &6IB#'J
M,^36&X-6IW/\SBV'[.ZTZZJ*S?)_56H1+.1JO^6]HSKTML^6&G/4;1M)J5;%
M:WM"M5W%ZWFI5\"(!HQLH!+N"ACQ-G\]E/$*4".E2=[SJ(-](^]737OC;EQ-
M[AO4%\K>.X&>P2;^(,6Z<CC+>Z.$]$W%5$N8]AYJ63Q6M-[\:/YXIZ\F;S1.
M_YCA*$,9#BD,35\ 1(2 E,8"!E2$:4CCB! K-\.%?$S-JKU=/SZ:7C[Z9O=A
M4W:T(X'Y0RU9U?^O$<?1U.V[9Y;!K.%W8N@(5R-!Y=.MV00;(79WXPJP'YM/
M_'%7;8D1"%02^8R)78:IWT!93U[&C9Y=!MB+D-J%RUVL6TTP[\V/MT:#5U^S
MF<R"-(I)"M.,<H@R)K7^Q!0J1+(P3'FDE%.*7@>MR>G(W>-9!:'U*:S8;<Z@
M:QB_ V9GE7<)>&.J-3?<+E%8IQ 92BF]H/=:BN>4X!W*Y>0C/0(]'Q^?:%Y4
MYL'U0ES/M4%HBI,_+(NWA13YJC8*2UD\2V,<FKF=N2P_R]6,)0&)21#!(,$(
MHDBFD&(EH50)SDB2$:UXK$- O=F8FMK9$:3JG3!?T@4P-VM0-.R#GXJ- /KV
MIF_@#N&-_MME$30:91,&5E^[^&LAP$8*H,4 M1S " *^;O;CZ^Y^?!YI/QP"
M4:/LRT@AJD'WQRU0=3&LG2&L_JN/%]RZ&(&]L-?EJ_4T@$\;VU_ELURLY28;
MB2O!)0\SF$6D&LT10T(1AU&8B8!D*0Z(U3O+G?34WE-G;JP-]T#_ZH@GP29#
MZ=*MLK2I!]F H4WLH;%W-\2=8?1KE]N3']=,=X;EA=7NOD(_)5@WDOA=KAZ6
M8EL@5+=2WLPNKO\@99-V+@+*<)9*&,E$091E(:14)3#@61*CD =9;%7A<P$/
M4U.+3;.46@:P%:+ME[X= ]W*T;,JH,]^V:G$@7=A8-TXQ 8XJ\,+(/2J%_OP
M,:J"O "H0TUYR5(7S%#4FEE_=1]H*<6[=6$&X%3I6M_H?"UG/%.QE&D*E90"
M:HU(((DC!D7,N*F%E&D6]9@/UD6S1S[!X*D$+;?&)<B7CX_+!2B-'#T&?W7"
M;6GR>8%PQ'%=8(=94'/;)+E>@8IASU.X;+#Q/V"KD^KXL[-L0#@Z%LOJP4LC
M-=]HD1NCOAUN4;7\T9?A.IS . _3( V@OI)&$!'*(>-!#)% *I%I'(?4R2ZS
MI#LU6VPW$M$ROITWT[)^:32G>RM<(SO> !XQRG,!MA=$?*R0&BCZTTW[E2)!
M5H"<C@K9/>[S<FF\?+\M\\7JF_['6M/<UFQ*CC#-8BAI:L;3"U)/+F:*I;%,
M39\P=OG%\B3]J2FR4W>:.D)4B0!:&7J[UESWZ)++I!?D7^DBV1=T3Y?(L]"-
M<($\S<,$+H]G ;*[.)Y?YL+6S#=JDWKW95F/\MB<+11E+$DIABQ06O]%C$',
MH@0BI?\2,ZPOD4FO#LT=1*>F]#8\[V<IMFSW#R'8;(#M3=(OK(-?)B]&M']K
M9PN(ANGPW$7X=1H]6T!QLM^SS;,]LGAN?[WY\MNW=JQ:B@.<) 2J)*':^@HP
M) PSF 8R#D3&.4%L]BP+MK1*S=E=V^4T[%(8\%#\[0.X_17\]LTA:6,/K6Y5
M<1$"0^L#S986_/RDM#,(.&2B]$5BI.02:T3<$D6.2=V9^['WP'CI',?XW,O0
M./J!?G;0!YH7E4_LS8\W=&[R/&X?I%S]4BS73_GBOO:>"'W=8T:_(Q3J_V1I
M K&B^EJ(5,0I49'*G 8\VA"=FAUD>*[=O%4=0,,WJ!@'+>?]G%A6>V!G"OE&
M=F#5YP=49VO(!26OUI 5X5&M(1<H#JTAIV?[J:=W>?FT+.F\6O/CHAG29!KE
M+!>K?+&6HJF#7B[T1\KR2[%4=8;:+$$HDI0KF*5,093&*628"A@3%I @(Q'.
MG"YO_5F9FBJKJTZK,F%@8H!T+@^G5SKD,WO8*CO=-LX&#*SQ6B%J[78%-G*
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M&98L"%*$8!BE%"+!$"0T2Z%B*)4"A9A);C^@ZB2=J=GT-:?&B*1E*5>E?M,
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M2D"4\52?O%C;%UDLJ%(XB%(K1^DY0E,[CMO:]Z=M53*?T[+,52X%H"5XT#(
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M'8A#?=='(:.04/W51HSB,-&@!X2YE;)X^2:/4\72@; Q!@O3(EM6S9*O0+Z
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M!']J1D'+Z178\.K3TV$!B6=?1Q?%D;T=%L*_]'?8/.1U /BFXF!GU+12A/&
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MR_73>^2<V8#B.;&L<\B1L\=LU#].$;.ZJQ^??*Q*6:QT_MDL152*D'% HD@
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M(V+;=-K55[T'GZV3NB\HXWBG[?#HX9$^I?:5KNB]1X[L@SZESK'S^>15UQ>
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MTJ@]CJ4W0;S-$??RK8+LKV6Q6/VNQM ]UE>KJJ#KE9;YH?R@4-;EI,OYW%C
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M@*;GOK^#D8S%L!/J^=M%/@YW]O!1OZK*\A^<S,5O#W>W;4L_$D-"<PX0IQF
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MV?3J_,[F[)(*BAAC%9'@/0H O>:$C"NC7-9Q__.O^T_MIOZ&CT'W$N/ $/@
M\6*.\&4\?!PO)S#RH$.T@1)%;3G$%XEXZQP!CRY1S!(TYWM#X/Y3NT&@X?//
MO<0X, 0^SGW)<_KP[2S,)B/+$S=2(,VQ>+],XZ[EI2),2<E .QISWEO_=Q[9
M3?D-'VCN+L!&%O_)U_C93S_!ZM0^*)XEMYI 20:160MB:8B$*N 6T*,Q;G\
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MC@_-Y6I-E %-T0"AIE2J94Y]ZI98O1\=PQ9G'0B5A]97"_;TWF:!*^UX-IE
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M]A;^O"6N^6R*W\9U@+UY-8%B3 <NB0DJE,ZKL43;@8 &--;(KY1U)GEM2^G
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M?50HX2E:).^<(,)1RZ0*CH6GSG$[+>Q7;SKIV;2OYUVD-K22__/#B*MHHX!
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M6Y-!EUD%NNQ>,N-JT9(1+YE@.6B54IT$GL<H&O9*?E]-/PF<'<7> 'P^0+S
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MM;3(AL =W'N%^W8,RE@O5>!UADP_0E GY+A_YFVO#TVV"<C+=<HU)&W1H"<
M7^Y &7$L!"+01P44$ZZP.O'FHR0-W$^T#X4_#Z(=I-\>C*ZNT9FGEFI'F+.,
MR) P=.8*PQIN3 8O<875.<+>2$YS\-E%U4\#: >Y-P">WZ<7BPL_.9V_GN;Y
MFILRM'=]YD*-YAD289QF--&^F&@E2*!..@Z:.E''"CU!5#<@T7_FW;$OE;:+
MSLO%F]#OS,8'8LH<29F8)@XP%.(L>&-I\KI2:LV39 UKZGI3?C=0[:")H<]&
MW^&2G4+Z[?3%2SB;358+=CVI]#VL_K1H:II65X?'L\7RZF(\,@C48GA#M3"E
ME9@A5J,(?9*@ @"^<.] XI$SU!T):!)7N^A_=F!E-&#'ZF\;;\93* I9C-")
M22GBAL&<+PX(JL%ZW$DHU4%8X\#F.N'L 9GLMA;^J>>KM JYH<W_VXMB0*[[
M"(YA\6$V22,D,5A(GC#KT8*!C!A)2D%,-! ]M\E:W\FZ;_[\H;M&-8J%6;^*
M:<#2(_41("U>H1)*TM%I?G&!ND'!+48L*XY;DR.92O2_:&EJ7GH1*$M5 A-L
M]+2*97Z"J*$;4[4-S+ZUNC- O\ \S'J"Z"_HL2W>S!8+6)RN$N,6I_GFOORF
M$^LH<V^]I$"B41J]NE"Z$%).@I)>VZQ25G4\B:X4#MTMZ_L ;Q5]M[>-?YR]
M@-6.82P8*B$2:3@N2 >X(+G0)&<EC)0\>]8M4'O\&3]ZYX,JV_E."FIA2_??
M5M7='V='\>\7XSFL<XG@)I-H,<I,A<BB(PX]<V3).Q)<T"2JK+3UUL9*1Z4=
MB/O1BYU[VN)[UO+0!O+8KT;?G'P]ARG*&.7ZZF):A'AT-KN8+H]G9V?CY1+2
M2(40#8NEVR(M$QB9(Q:4)"%:%4-,@<=NL\BZ/O%'KSSLP7A645[CB"P_($<Y
M,>ZB"81KRW&-<4Z\B8Q8&[+7W&?1,56UT^-^]*J!^EC<06U# _'*-3E"EWBY
MN"I)@G2TV"S$D:+.X2)+A(52#J2=)<';1+1S.B8CN=;;'0YU??*/G@';HY]9
M19D->)_OX?S2,SG-MU+P1BDS;KD*Y4C,E-;:D7BPA@2A@@U*%!>[BL?Y"$$_
M>M9:/UYF']H<VGS>ZIMX_[1VO1A'SM-D&*=$&%Q=4BM*7)*E)H*)$#*+-.9.
M]O+91_WPZ2 ]6,A^]34T^M[.IM$O/I_.W_GY\O*'S:*[M;YP<[@X@_3BVXN+
M;Z6\-X$R&ODU.2LB/2XTYT(@-I;"7@J)A6XA3P_$_/!7F7WL\0?6^> 8OSX[
MNWSXR=\OQLMOO\'R\^Q6:=OZ@DR!H\PD1H"K1&2TDE@F//&)9>.M\+1C"\YM
MGMH-M?^T]T9UM3@T/!_>AFVJVLWXM*/)9/9G4<VKV?P8J1PORST$JN@9F6 X
MJ5TJ3>A"RF6..T5_2.;2V5GP[ -CJ>-U?'U:NRV%?]I;J!81TT!8]_KLW(_G
MA?+3?.L*3HDD6?"9X#\9S0!#"R"4(XIFGG663*LZ58^;Z>F&[7_:BZX>E=D
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M3K07><:_5_Y[=O;E3MK]$^_9T\6WEBJQ?VI)^(FO.=E4'(@LJ+6*LZUQ=H:
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MML'8&@Q1!5&C1!$<%1JFG=SN-'?: .'ON@$.C(DCLNOK1I$7ZKO<Z.V9&Y6
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MN1CVF36. &_]:GO1O^C'1M"O].]_XWPVOS[[O^1!<7[)A%I(*?A6V%H JRE
MR2<D0=7D;H_+'UE@W*.?D;'3A]"GZ7,?BVK>7'=*DUH[FX($\NTB6Y4$ :.
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MZW"0 9-S(*HDWHB*#*9NH='SBTT)*_LK=S&@I,=&SKH!QG=:_OCXCW?O']P
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MPJ7$,JN<%WI44%(VQ?D:''4[M7MD@2/"T"Y:??)L9@<13P8F#\Z2./QP+M8
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M@<Y%!"F%,-BM(J33<A,+YK?1W9WSA/YE._;9U7,</18G.HS%!U^A4+M5U"X
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M"A:2BIH-HG:HC C)':;KPS1[A6REXBZ]0K:1]P0Q<]76H#(3LFI0V;7!+H8
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M@2DLK[VB:&PL)2O0LM8D^I@A!N< DT'4GD46.\7%=D+*?1J&[([3BV"W0.4
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M3_!*:= Q$'A$49*U*0O?D^"1AG5WP=-#17@,T8W@VK_=XT:WD_J?71(S/_[
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M$V Z@;%/Z?7X9GJT6-S=F^ALN<1U;^+W]*O3\_7/Y^7/=V];Q.-V6[AQ3.X
M+APE+N>S9Y%Q ]K[.M&M1 A).,"0;;1T%I3M6&(ZDK@<H]N#%2,A:5[+MF@O
MSAL.B0GFI$-.IL?_'Y<[' S[QN5VD<\(XRKKV($IVEBZ+^B*R&1)TW[ (XN
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M'+[!!9VIU?3G56NF2>8H;.TR%T11U?RUX*RA+\*J$,@T8:E5(^W[E(SE[AT
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M,#(R+FAT;5!+ 0(4 Q0    ( $:"I%2=62&MAP4  '@9   1
M  "  1(\  !E>#,R,C S,S$R,#(R+FAT;5!+ 0(4 Q0    ( $:"I%2AU?WF
M$Q,# .8N*  1              "  <A!  !P96%K+3(P,C(P,S,Q+FAT;5!+
M 0(4 Q0    ( $:"I%3&^'@_:AT  #9; 0 1              "  0I5 P!P
M96%K+3(P,C(P,S,Q+GAS9%!+ 0(4 Q0    ( $:"I%2=*+0/9CD  -94 @ 5
M              "  :-R P!P96%K+3(P,C(P,S,Q7V-A;"YX;6Q02P$"% ,4
M    " !&@J14EK0WHNN7  #^E@8 %0              @ $\K , <&5A:RTR
M,#(R,#,S,5]D968N>&UL4$L! A0#%     @ 1H*D5(9+$T;)80$ D"8. !4
M             ( !6D0$ '!E86LM,C R,C S,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( $:"I%079LP!3]\  ,L%"@ 5              "  5:F!0!P96%K+3(P
D,C(P,S,Q7W!R92YX;6Q02P4&      L "P#% @  V(4&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
